PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Holker, F; Beare, D; Dorner, H; di Natale, A; Ratz, HJ; Temming, A; Casey, J				Hoelker, Franz; Beare, Doug; Doerner, Hendrik; di Natale, Antonio; Raetz, Hans-Joachim; Temming, Axel; Casey, John			Comment on "Impacts of biodiversity loss on ocean ecosystem services"	SCIENCE			English	Editorial Material									European Commiss, Directorate Gen Joint Res Ctr, Inst Protect & Secur Citizen, Age & Fisheries Unit, I-21020 Ispra, Italy; Aquastudio Res Inst, I-98121 Messina, Italy; Fed Res Ctr Fisheries, Inst Sea Fisheries, D-22767 Hamburg, Germany; Univ Hamburg, Inst Hydrobiol & Fishery Sci, D-22767 Hamburg, Germany; Ctr Environm Fisheries & Aquaculture Sci, Lowestoft Lab, Lowestoft NR33 0HT, Suffolk, England	European Commission Joint Research Centre; EC JRC ISPRA Site; University of Hamburg; Centre for Environment Fisheries & Aquaculture Science	Holker, F (corresponding author), European Commiss, Directorate Gen Joint Res Ctr, Inst Protect & Secur Citizen, Age & Fisheries Unit, TP 051, I-21020 Ispra, Italy.	franz.hoelker@jrc.it	Hölker, Franz/A-5683-2009; Beare, Doug/F-8299-2010	Hölker, Franz/0000-0001-5932-266X; Beare, Doug/0000-0003-0609-3845				*FAO FISH AQ DEP, 2007, STAT WORLD FISH AQ 2; *FED MIN LAB SOC A, 2006, STAT TASCH 2006 ARB; Laurel BJ, 2006, CAN J FISH AQUAT SCI, V63, P2603, DOI 10.1139/F06-151; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294	4	29	29	2	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 1	2007	316	5829					1285	1285		10.1126/science.1139114	http://dx.doi.org/10.1126/science.1139114			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	173PS	17540885				2022-12-28	WOS:000246885600028
J	Holm, S; Ashcroft, R				Holm, Soren; Ashcroft, Richard			Should genetic information be disclosed to insurers?	BRITISH MEDICAL JOURNAL			English	Article									Cardiff Law Sch, Ctr Eth Law & Soc, Cardiff CF10 3AX, Wales; Univ Oslo, Sect Med Eth, Oslo, Norway	Cardiff University; University of Oslo	Holm, S (corresponding author), Cardiff Law Sch, Ctr Eth Law & Soc, Cardiff CF10 3AX, Wales.	holms@cardiff.ac.uk; r.ashcroft@qmul.ac.uk		Holm, Soren/0000-0002-7200-5607					0	17	17	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUN 9	2007	334	7605					1196	1197		10.1136/bmj.39216.468495.AD	http://dx.doi.org/10.1136/bmj.39216.468495.AD			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	179GF	17556474	Green Published			2022-12-28	WOS:000247277000032
J	Marks, CO; Muller-Landau, HC				Marks, Christian O.; Muller-Landau, Helene C.			Comment on "From plant traits to plant communities: A statistical mechanistic approach to biodiversity"	SCIENCE			English	Editorial Material								Shipley et al. ( Reports, 3 November 2006, p. 812) predicted plant community composition and relative abundances with a high level of accuracy by maximizing Shannon's index of information entropy ( species diversity), subject to constraints on plant trait averages. We show that the entropy maximization assumption is relatively unimportant and that the high accuracy is due largely to a statistical effect.	Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities	Marks, CO (corresponding author), Univ Minnesota, Dept Ecol Evolut & Behav, 1987 Upper Buford Circle, St Paul, MN 55108 USA.	marks071@umn.edu	Mokany, Karel/C-1464-2009; Marks, Christian O./F-7403-2012	Marks, Christian O./0000-0002-8936-4753; Muller-Landau, Helene C./0000-0002-3526-9021				JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; Naeem S, 1997, NATURE, V390, P507, DOI 10.1038/37348; Shipley B, 2006, SCIENCE, V314, P812, DOI 10.1126/science.1131344; TILMAN D, 1994, NATURE, V367, P363, DOI 10.1038/367363a0	4	25	26	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 8	2007	316	5830								10.1126/science.1140190	http://dx.doi.org/10.1126/science.1140190			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176EE	17556570				2022-12-28	WOS:000247066400022
J	Wicks, E				Wicks, Emma			A patient's journey - Cystic fibrosis	BRITISH MEDICAL JOURNAL			English	Editorial Material									Cyst Fibrosis Trust, Bromley BR1 1B, Kent, England		Wicks, E (corresponding author), Cyst Fibrosis Trust, Bromley BR1 1B, Kent, England.	ewicks@cftrust.org.uk							0	3	3	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 16	2007	334	7606					1270	1271		10.1136/bmj.39188.741944.47	http://dx.doi.org/10.1136/bmj.39188.741944.47			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	183AM	17569935	Bronze, Green Published			2022-12-28	WOS:000247545100040
J	Boehm, JS; Zhao, JJ; Yao, J; Kim, SY; Firestein, R; Dunn, IF; Sjostrom, SK; Garraway, LA; Weremowicz, S; Richardson, AL; Greulich, H; Stewart, CJ; Mulvey, LA; Shen, RR; Ambrogio, L; Hirozane-Kishikawa, T; Hill, DE; Vidal, M; Meyerson, M; Grenier, JK; Hinkle, G; Root, DE; Roberts, TM; Lander, ES; Polyak, K; Hahn, WC				Boehm, Jesse S.; Zhao, Jean J.; Yao, Jun; Kim, So Young; Firestein, Ron; Dunn, Ian F.; Sjostrom, Sarah K.; Garraway, Levi A.; Weremowicz, Stanislawa; Richardson, Andrea L.; Greulich, Heidi; Stewart, Carly J.; Mulvey, Laura A.; Shen, Rhine R.; Ambrogio, Lauren; Hirozane-Kishikawa, Tomoko; Hill, David E.; Vidal, Marc; Meyerson, Matthew; Grenier, Jennifer K.; Hinkle, Greg; Root, David E.; Roberts, Thomas M.; Lander, Eric S.; Polyak, Kornelia; Hahn, William C.			Integrative genomic approaches identify IKBKE as a breast cancer oncogene	CELL			English	Article							NF-KAPPA-B; IKK-EPSILON; INDUCED SENESCENCE; GENETIC SCREEN; LUNG-CANCER; RNAI SCREEN; KINASE; MUTATIONS; CELLS; PHOSPHORYLATION	The karyotypic chaos exhibited by human epithelial cancers complicates efforts to identify mutations critical for malignant transformation. Here we integrate complementary genomic approaches to identify human oncogenes. We show that activation of the ERK and phosphatidylinositol 3-kinase (PI3K) signaling pathways cooperate to transform human cells. Using a library of activated kinases, we identify several kinases that replace PI3K signaling and render cells tumorigenic. Whole genome structural analyses reveal that one of these kinases, IKBKE (IKK epsilon), is amplified and overexpressed in breast cancer cell lines and patient-derived tumors. Suppression of IKK epsilon expression in breast cancer cell lines that harbor IKBKE amplifications induces cell death. IKK epsilon activates the nuclear factor-kappaB (NF-kappa B) pathway in both cell lines and breast cancers. These observations suggest a mechanism for NF-kappa B activation in breast cancer, implicate the NF-kappa B pathway as a downstream mediator of PI3K, and provide a framework for integrated genomic approaches in oncogene discovery.	Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA; Dana Farber Canc Inst, Ctr Canc Syst Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Neurosurg, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Surg, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Broad Inst, Cambridge, MA 02142 USA; MIT, Broad Inst, Cambridge, MA 02142 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Hahn, WC (corresponding author), Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA.	jean_zhao@dfci.harvard.edu; william_hahn@dfci.harvard.edu	Hill, David E/B-6617-2011; Meyerson, Matthew L/E-7123-2012	Boehm, Jesse/0000-0002-6795-6336	NATIONAL CANCER INSTITUTE [R37CA030002, P01CA089021, P50CA089393, R01CA094074, R01CA030002, K01CA094223] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA094074, R01 CA094074-03, CA015607, R01 CA094074-05, P50 CA089393-060014, P50 CA089393-070014, CA89021, CA30002, K01 CA94223, R01 CA094074-02, R01 CA094074-01A1, P50 CA089393, R01 CA094074-04, P50 CA089393-080014, P50 CA112962] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adli M, 2006, J BIOL CHEM, V281, P26976, DOI 10.1074/jbc.M603133200; Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; BARTKOVA J, 1994, INT J CANCER, V57, P353, DOI 10.1002/ijc.2910570311; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Biswas DK, 2004, P NATL ACAD SCI USA, V101, P10137, DOI 10.1073/pnas.0403621101; Boehm JS, 2005, MOL CELL BIOL, V25, P6464, DOI 10.1128/MCB.25.15.6464-6474.2005; BROWN K, 1995, SCIENCE, V267, P1485, DOI 10.1126/science.7878466; BRUNET A, 1994, ONCOGENE, V9, P3379; Chien YC, 2006, CELL, V127, P157, DOI 10.1016/j.cell.2006.08.034; Courtois-Cox S, 2006, CANCER CELL, V10, P459, DOI 10.1016/j.ccr.2006.10.003; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Dupuy AJ, 2006, HUM MOL GENET, V15, pR75, DOI 10.1093/hmg/ddl061; Eddy SF, 2005, CANCER RES, V65, P11375, DOI 10.1158/0008-5472.CAN-05-1602; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hamad NM, 2002, GENE DEV, V16, P2045, DOI 10.1101/gad.993902; Harris J, 2006, J IMMUNOL, V177, P2527, DOI 10.4049/jimmunol.177.4.2527; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Kim M, 2006, CELL, V125, P1269, DOI 10.1016/j.cell.2006.06.008; Klippel A, 1996, MOL CELL BIOL, V16, P4117; Kohn AD, 1996, J BIOL CHEM, V271, P21920, DOI 10.1074/jbc.271.36.21920; Kolfschoten IGM, 2005, CELL, V121, P849, DOI 10.1016/j.cell.2005.04.017; Kuranaga E, 2006, CELL, V126, P583, DOI 10.1016/j.cell.2006.05.048; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; MacKeigan JP, 2005, NAT CELL BIOL, V7, P591, DOI 10.1038/ncb1258; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Morrison C, 2005, J CLIN ONCOL, V23, P9369, DOI 10.1200/JCO.2005.03.7127; Ngo VN, 2006, NATURE, V441, P106, DOI 10.1038/nature04687; Oshima K, 2006, CURR BIOL, V16, P1531, DOI 10.1016/j.cub.2006.06.032; Ozes ON, 1999, NATURE, V401, P82; Paddison PJ, 2004, NATURE, V428, P427, DOI 10.1038/nature02370; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Peeper DS, 2002, NAT CELL BIOL, V4, P148, DOI 10.1038/ncb742; Peters RT, 2000, MOL CELL, V5, P513, DOI 10.1016/S1097-2765(00)80445-1; Rangarajan A, 2004, CANCER CELL, V6, P171, DOI 10.1016/j.ccr.2004.07.009; Rennstam K, 2003, CANCER RES, V63, P8861; Romashkova JA, 1999, NATURE, V401, P86, DOI 10.1038/43474; Rowland BD, 2005, NAT CELL BIOL, V7, P1074, DOI 10.1038/ncb1314; Rual JF, 2004, GENOME RES, V14, P2128, DOI 10.1101/gr.2973604; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Shapiro RS, 2006, DEVELOPMENT, V133, P1467, DOI 10.1242/dev.02318; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Sovak MA, 1997, J CLIN INVEST, V100, P2952, DOI 10.1172/JCI119848; STANTON VP, 1989, MOL CELL BIOL, V9, P639, DOI 10.1128/MCB.9.2.639; Tenoever BR, 2007, SCIENCE, V315, P1274, DOI 10.1126/science.1136567; Weinstein IB, 2006, NAT CLIN PRACT ONCOL, V3, P448, DOI 10.1038/ncponc0558; Westbrook TF, 2005, CELL, V121, P837, DOI 10.1016/j.cell.2005.03.033; Yao J, 2006, CANCER RES, V66, P4065, DOI 10.1158/0008-5472.CAN-05-4083; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhao JJ, 2004, TRENDS MOL MED, V10, P344, DOI 10.1016/j.molmed.2004.05.005; Zhao XJ, 2005, CANCER RES, V65, P5561, DOI 10.1158/0008-5472.CAN-04-4603	55	472	508	2	14	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 15	2007	129	6					1065	1079		10.1016/j.cell.2007.03.052	http://dx.doi.org/10.1016/j.cell.2007.03.052			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	180UA	17574021	Bronze			2022-12-28	WOS:000247390400012
J	Fitzgerald, KA; Golenbock, DT				Fitzgerald, Katherine A.; Golenbock, Douglas T.			Immunology - The shape of things to come	SCIENCE			English	Editorial Material							MD-2; BINDING		Univ Massachusetts, Sch Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Fitzgerald, KA (corresponding author), Univ Massachusetts, Sch Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA.	kate.fitzgerald@umassmed.edu; douglas.golenbock@umassmed.edu	Fitzgerald, Katherine/ABE-6317-2020	Fitzgerald, Kate/0000-0003-3175-609X				Georgel P, 2007, VIROLOGY, V362, P304, DOI 10.1016/j.virol.2006.12.032; Jiang ZF, 2005, NAT IMMUNOL, V6, P565, DOI 10.1038/ni1207; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Mata-Haro V, 2007, SCIENCE, V316, P1628, DOI 10.1126/science.1138963; Nishitani C, 2006, J BIOL CHEM, V281, P38322, DOI 10.1074/jbc.M606904200; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Ohto U, 2007, SCIENCE, V316, P1632, DOI 10.1126/science.1139111; Visintin A, 2005, J IMMUNOL, V175, P6465, DOI 10.4049/jimmunol.175.10.6465; Visintin A, 2003, J BIOL CHEM, V278, P48313, DOI 10.1074/jbc.M306802200	9	16	17	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 15	2007	316	5831					1574	1576		10.1126/science.1144483	http://dx.doi.org/10.1126/science.1144483			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178SH	17569850				2022-12-28	WOS:000247239900026
J	Harbaugh, WT; Mayr, U; Burghart, DR				Harbaugh, William T.; Mayr, Ulrich; Burghart, Daniel R.			Neural responses to taxation and voluntary giving reveal motives for charitable donations	SCIENCE			English	Article							PUBLIC-GOODS; WARM-GLOW; REWARD; ALTRUISM; PREFERENCES; PUNISHMENT; STRIATUM; BRAIN	Civil societies function because people pay taxes and make charitable contributions to provide public goods. One possible motive for charitable contributions, called "pure altruism," is satisfied by increases in the public good no matter the source or intent. Another possible motive, " warm glow," is only fulfilled by an individual's own voluntary donations. Consistent with pure altruism, we find that even mandatory, tax-like transfers to a charity elicit neural activity in areas linked to reward processing. Moreover, neural responses to the charity's financial gains predict voluntary giving. However, consistent with warm glow, neural activity further increases when people make transfers voluntarily. Both pure altruism and warm-glow motives appear to determine the hedonic consequences of financial transfers to the public good.	Univ Oregon, Dept Econ, Eugene, OR 97403 USA; Natl Bur Econ Res, Cambridge, MA 02138 USA; Univ Oregon, Dept Psychol, Eugene, OR 97403 USA	University of Oregon; National Bureau of Economic Research; University of Oregon	Harbaugh, WT (corresponding author), Univ Oregon, Dept Econ, Eugene, OR 97403 USA.	harbaugh@uoregon.edu; mayr@uoregon.edu	Harbaugh, William/A-8743-2008	Harbaugh, William/0000-0002-4127-3983	NATIONAL INSTITUTE ON AGING [R01AG019296] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG1929601A1] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Andreoni J, 2002, ECONOMETRICA, V70, P737, DOI 10.1111/1468-0262.00302; ANDREONI J, 1990, ECON J, V100, P464, DOI 10.2307/2234133; BERGSTROM T, 1986, J PUBLIC ECON, V29, P25, DOI 10.1016/0047-2727(86)90024-1; de Quervain DJF, 2004, SCIENCE, V305, P1254, DOI 10.1126/science.1100735; Delgado MR, 2000, J NEUROPHYSIOL, V84, P3072, DOI 10.1152/jn.2000.84.6.3072; Diamond P, 2006, J PUBLIC ECON, V90, P897, DOI 10.1016/j.jpubeco.2005.06.001; Eckel CC, 2003, J PUBLIC ECON, V87, P681, DOI 10.1016/S0047-2727(01)00094-9; Elliott R, 2004, NEUROIMAGE, V21, P984, DOI 10.1016/j.neuroimage.2003.10.010; FORSYTHE R, 1994, GAME ECON BEHAV, V6, P347, DOI 10.1006/game.1994.1021; Glimcher PW, 2004, SCIENCE, V306, P447, DOI 10.1126/science.1102566; Harbaugh WT, 1998, J PUBLIC ECON, V67, P269, DOI 10.1016/S0047-2727(97)00062-5; King-Casas B, 2005, SCIENCE, V308, P78, DOI 10.1126/science.1108062; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Knutson B, 2001, NEUROREPORT, V12, P3683, DOI 10.1097/00001756-200112040-00016; Knutson B, 2007, NEURON, V53, P147, DOI 10.1016/j.neuron.2006.11.010; Kolm S. -C., 1969, PUBLIC EC, P145, DOI DOI 10.1007/978-1-349-15294-0_7; Kuhnen CM, 2005, NEURON, V47, P763, DOI 10.1016/j.neuron.2005.08.008; Moll J, 2006, P NATL ACAD SCI USA, V103, P15623, DOI 10.1073/pnas.0604475103; Montague PR, 2002, NEURON, V36, P265, DOI 10.1016/S0896-6273(02)00974-1; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; Palfrey TR, 1997, AM ECON REV, V87, P829; Rilling JK, 2002, NEURON, V35, P395, DOI 10.1016/S0896-6273(02)00755-9; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Singer T, 2004, NEURON, V41, P653, DOI 10.1016/S0896-6273(04)00014-5; Tankersley D, 2007, NAT NEUROSCI, V10, P150, DOI 10.1038/nn1833; Tricomi EM, 2004, NEURON, V41, P281, DOI 10.1016/S0896-6273(03)00848-1; Zink CF, 2004, NEURON, V42, P509, DOI 10.1016/S0896-6273(04)00183-7	27	571	586	18	182	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 15	2007	316	5831					1622	1625		10.1126/science.1140738	http://dx.doi.org/10.1126/science.1140738			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	178SH	17569866				2022-12-28	WOS:000247239900043
J	Kiriakidou, M; Tan, GS; Lamprinaki, S; De Planell-Saguer, M; Nelson, PT; Mourelatos, Z				Kiriakidou, Marianthi; Tan, Grace S.; Lamprinaki, Styliani; De Planell-Saguer, Mariangels; Nelson, Peter T.; Mourelatos, Zissimos			An mRNA m(7)G cap binding-like motif within human Ago2 represses translation	CELL			English	Article							HUMAN-CELLS; CRYSTAL-STRUCTURE; PROTEIN-SYNTHESIS; ANIMAL MICRORNAS; ARGONAUTE FAMILY; SLICER ACTIVITY; IN-VIVO; RECOGNITION; INITIATION; COMPLEX	microRNAs (miRNAs) bind to Argonaute (Ago) proteins and inhibit translation or promote degradation of mRNA targets. Human let-7 miRNA inhibits translation initiation of mRNA targets in an m(7)G cap-dependent manner and also appears to block protein production, but the molecular mechanism(s) involved is unknown and the role of Ago proteins in translational regulation remains elusive. Here we identify a motif (MC) within the Mid domain of Ago proteins, which bears significant similarity to the m(7)G cap-binding domain of elF4E, an essential translation initiation factor. We identify conserved aromatic residues within the MC motif of human Ago2 that are required for binding to the m(7)G cap and for translational repression but do not affect the assembly of Ago2 with miRNA or its catalytic activity. We propose that Ago2 represses the initiation of mRNA translation by binding to the m(7)G cap of mRNA targets, thus likely precluding the recruitment of elF4E.	Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Pathol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Kiriakidou, M (corresponding author), Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA.	kiriakim@uphs.upenn.edu; mourelaz@uphs.upenn.edu		Mourelatos, Zissimos/0000-0002-9852-1845	NIAID NIH HHS [K08-AI63030] Funding Source: Medline; NICHD NIH HHS [PA30-HD026979] Funding Source: Medline; NIGMS NIH HHS [GM0720777] Funding Source: Medline; NINDS NIH HHS [NS053839, K08-NS050110] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD026979] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI063030] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS050110] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALTMANN M, 1988, J BIOL CHEM, V263, P17229; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Bonnet E, 2006, NEW PHYTOL, V171, P451, DOI 10.1111/j.1469-8137.2006.01806.x; Calero G, 2002, NAT STRUCT BIOL, V9, P912, DOI 10.1038/nsb874; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Chu CY, 2006, PLOS BIOL, V4, P1122, DOI 10.1371/journal.pbio.0040210; De Gregorio E, 1999, EMBO J, V18, P4865, DOI 10.1093/emboj/18.17.4865; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Gandikota M, 2007, PLANT J, V49, P683, DOI 10.1111/j.1365-313X.2006.02983.x; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Grivna ST, 2006, P NATL ACAD SCI USA, V103, P13415, DOI 10.1073/pnas.0605506103; Grivna ST, 2006, GENE DEV, V20, P1709, DOI 10.1101/gad.1434406; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Hodel AE, 1997, NAT STRUCT BIOL, V4, P350, DOI 10.1038/nsb0597-350; Hu GH, 1999, P NATL ACAD SCI USA, V96, P7149, DOI 10.1073/pnas.96.13.7149; Humphreys DT, 2005, P NATL ACAD SCI USA, V102, P16961, DOI 10.1073/pnas.0506482102; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Kataoka Y, 2001, GENES CELLS, V6, P313, DOI 10.1046/j.1365-2443.2001.00427.x; Kim J, 2004, P NATL ACAD SCI USA, V101, P360, DOI 10.1073/pnas.2333854100; Kim VN, 2006, GENE DEV, V20, P1993, DOI 10.1101/gad.1456106; Kiriakidou M, 2004, GENE DEV, V18, P1165, DOI 10.1101/gad.1184704; Kiriakidou M, 2005, METH MOL B, V309, P295; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lau NC, 2006, SCIENCE, V313, P363, DOI 10.1126/science.1130164; Legault P, 1998, CELL, V93, P289, DOI 10.1016/S0092-8674(00)81579-2; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Liu JD, 2005, NAT CELL BIOL, V7, P1261, DOI 10.1038/ncb1333; Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274; Marcotrigiano J, 1997, CELL, V89, P951, DOI 10.1016/S0092-8674(00)80280-9; Maroney PA, 2006, NAT STRUCT MOL BIOL, V13, P1102, DOI 10.1038/nsmb1174; Martinez J, 2002, CELL, V110, P563, DOI 10.1016/S0092-8674(02)00908-X; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Mello CC, 2004, NATURE, V431, P338, DOI 10.1038/nature02872; Merrick WC, 2004, GENE, V332, P1, DOI 10.1016/j.gene.2004.02.051; Meyer WJ, 2006, PLOS GENET, V2, P1224, DOI 10.1371/journal.pgen.0020134; Mourelatos Z, 2002, GENE DEV, V16, P720, DOI 10.1101/gad.974702; Mourelatos Z, 2001, EMBO J, V20, P5443, DOI 10.1093/emboj/20.19.5443; Murchison EP, 2004, CURR OPIN CELL BIOL, V16, P223, DOI 10.1016/j.ceb.2004.04.003; Nelson PT, 2004, RNA, V10, P387, DOI 10.1261/rna.5181104; Nottrott S, 2006, NAT STRUCT MOL BIOL, V13, P1108, DOI 10.1038/nsmb1173; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Parker JS, 2004, EMBO J, V23, P4727, DOI 10.1038/sj.emboj.7600488; Petersen CP, 2006, MOL CELL, V21, P533, DOI 10.1016/j.molcel.2006.01.031; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Pillai RS, 2004, RNA, V10, P1518, DOI 10.1261/rna.7131604; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Rehwinkel J, 2005, RNA, V11, P1640, DOI 10.1261/rna.2191905; Richter JD, 2005, NATURE, V433, P477, DOI 10.1038/nature03205; Rom E, 1998, J BIOL CHEM, V273, P13104, DOI 10.1074/jbc.273.21.13104; Saito K, 2006, GENE DEV, V20, P2214, DOI 10.1101/gad.1454806; Schmitter D, 2006, NUCLEIC ACIDS RES, V34, P4801, DOI 10.1093/nar/gkl646; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Sen GL, 2005, NAT CELL BIOL, V7, P633, DOI 10.1038/ncb1265; Sheth U, 2003, SCIENCE, V300, P805, DOI 10.1126/science.1082320; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Watanabe T, 2006, GENE DEV, V20, P1732, DOI 10.1101/gad.1425706; Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103; Yigit E, 2006, CELL, V127, P747, DOI 10.1016/j.cell.2006.09.033; Yuan YR, 2005, MOL CELL, V19, P405, DOI 10.1016/j.molcel.2005.07.011	74	306	339	0	25	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 15	2007	129	6					1141	1151		10.1016/j.cell.2007.05.016	http://dx.doi.org/10.1016/j.cell.2007.05.016			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	180UA	17524464	Bronze			2022-12-28	WOS:000247390400017
J	Zhang, WG; Mellone, BG; Karpen, GH				Zhang, Weiguo; Mellone, Barbara G.; Karpen, Gary H.			A specialized nucleosome has a "point" to make	CELL			English	Editorial Material							CENTROMERIC CHROMATIN	Three recent papers, including Mizuguchi et al. (2007) in this issue, show that the nonhistone protein Scm3 is required for the recruitment of the histone H3 variant Cse4 to centromeres in budding yeast. Scm3 forms a chromatin component with Cse4:histone H4 tetramers that appear to lack H2A/H2B histones. These studies provide key insights into the pathway that recruits Cse4 to centromeres and have important implications for other functions of chromatin.	Lawrence Berkeley Lab, Dept Genome & Computat Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Karpen, GH (corresponding author), Lawrence Berkeley Lab, Dept Genome & Computat Biol, MS 84-171,1 Cyclotron Rd, Berkeley, CA 94720 USA.	karpen@fruitfly.org		Mellone, Barbara/0000-0002-2785-5119; Zhang, Weiguo/0000-0002-3045-0569	NIGMS NIH HHS [R01 GM066272-06, R01 GM066272] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066272] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Black BE, 2004, NATURE, V430, P578, DOI 10.1038/nature02766; Blower MD, 2002, DEV CELL, V2, P319, DOI 10.1016/S1534-5807(02)00135-1; CAMAHORT R, 2007, MOL CELL; Chen YH, 2000, MOL CELL BIOL, V20, P7037, DOI 10.1128/MCB.20.18.7037-7048.2000; Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397; Jansen LET, 2007, J CELL BIOL, V176, P795, DOI 10.1083/jcb.200701066; Karpen GH, 1997, TRENDS GENET, V13, P489, DOI 10.1016/S0168-9525(97)01298-5; McAinsh AD, 2003, ANNU REV CELL DEV BI, V19, P519, DOI 10.1146/annurev.cellbio.19.111301.155607; Mellone BG, 2003, CURR OPIN GENET DEV, V13, P191, DOI 10.1016/S0959-437X(03)00019-4; STOLER S, 2007, P NATL ACAD SCI US	10	13	13	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 15	2007	129	6					1047	1049		10.1016/j.cell.2007.05.054	http://dx.doi.org/10.1016/j.cell.2007.05.054			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	180UA	17574019	Green Accepted, Bronze			2022-12-28	WOS:000247390400010
J	Sales, B; McKenzie, N				Sales, Becky; McKenzie, Nigel			Time to act on behalf of mentally disordered offenders	BRITISH MEDICAL JOURNAL			English	Editorial Material									HM Prison Pentonville, London, England		Sales, B (corresponding author), HM Prison Pentonville, London, England.	becky.sales@hmps.gsi.gov.uk							0	6	6	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUN 9	2007	334	7605					1222	1222		10.1136/bmj.39237.692975.94	http://dx.doi.org/10.1136/bmj.39237.692975.94			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	179GF	17556481	Green Published			2022-12-28	WOS:000247277000041
J	Murray, F				Murray, Fiona			The stem-cell market - Patents and the pursuit of scientific progress	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									MIT, Alfred P Sloan Sch Management, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Murray, F (corresponding author), MIT, Alfred P Sloan Sch Management, Cambridge, MA 02139 USA.							DASGUPTA P, 1994, RES POLICY, V23, P487; Thomson JA, 1998, SCIENCE, V282, P1827; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145	3	19	20	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 7	2007	356	23					2341	2343		10.1056/NEJMp068256	http://dx.doi.org/10.1056/NEJMp068256			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	175QY	17554114				2022-12-28	WOS:000247029300001
J	Wormser, GP				Wormser, Gary P.			Focus on research: Discovery of new infectious diseases - Bartonella species	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									New York Med Coll, Div Infect Dis, Valhalla, NY 10595 USA	New York Medical College	Wormser, GP (corresponding author), New York Med Coll, Div Infect Dis, Valhalla, NY 10595 USA.								0	8	9	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 7	2007	356	23					2346	2347		10.1056/NEJMp078069	http://dx.doi.org/10.1056/NEJMp078069			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	175QY	17554115				2022-12-28	WOS:000247029300003
J	Glickman, SW; Ou, FS; DeLong, ER; Roe, MT; Lytle, BL; Mulgund, J; Rumsfeld, JS; Gibler, WB; Ohman, EM; Schulman, KA; Peterson, ED				Glickman, Seth W.; Ou, Fang-Shu; DeLong, Elizabeth R.; Roe, Matthew T.; Lytle, Barbara L.; Mulgund, Jyotsna; Rumsfeld, John S.; Gibler, W. Brian; Ohman, E. Magnus; Schulman, Kevin A.; Peterson, Eric D.			Pay for performance, quality of care, and outcomes in acute myocardial infarction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE CORONARY SYNDROMES; HEALTH-CARE; FINANCIAL INCENTIVES; IMPORTANT DIFFERENCE; FOR-PERFORMANCE; UNSTABLE ANGINA; IMPROVEMENT; MANAGEMENT; ASSOCIATION; STRATEGIES	of Context Pay for performance has been promoted as a tool for improving quality of care. In 2003, the Centers for Medicare & Medicaid Services ( CMS) launched the largest pay-for-performance pilot project to date in the United States, including indicators for acute myocardial infarction. Objective To determine if pay for performance was associated with either improved processes of care and outcomes or unintended consequences for acute myocardial infarction at hospitals participating in the CMS pilot project. Design, Setting, and Participants An observational, patient-level analysis of 105 383 patients with acute non-ST-segment elevation myocardial infarction enrolled in the Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the American College of Cardiology/American Heart Association ( ACC/AHA) Guidelines ( CRUSADE) national quality-improvement initiative. Patients were treated between July 1, 2003, and June 30, 2006, at 54 hospitals in the CMS program and 446 control hospitals. Main Outcome Measures The differences in the use of ACC/AHA class I guideline recommended therapies and in-hospital mortality between pay for performance and control hospitals. Results Among treatments subject to financial incentives, there was a slightly higher rate of improvement for 2 of 6 targeted therapies at pay-for-performance vs control hospitals ( odds ratio [ OR] comparing adherence scores from 2003 through 2006 at half-year intervals for aspirin at discharge, 1.31; 95% confidence interval [ CI], 1.181.46 vs OR, 1.17; 95% CI, 1.12-1.21; P=. 04) and for smoking cessation counseling ( OR, 1.50; 95% CI, 1.29-1.73 vs OR, 1.28; 95% CI, 1.22-1.35; P=. 05). There was no significant difference in a composite measure of the 6 CMS rewarded therapies between the 2 hospital groups ( change in odds per half-year period of receiving CMS therapies: OR, 1.23; 95% CI, 1.15-1.30 vs OR, 1.17; 95% CI, 1.14-1.20; P=. 16). For composite measures of acute myocardial infarction treatments not subject to incentives, rates of improvement were not significantly different ( OR, 1.09; 95% CI, 1.051.14 vs OR, 1.08; 95% CI, 1.06- 1.09; P=. 49). Overall, there was no evidence that improvements in in-hospital mortality were incrementally greater at pay-for-performance sites ( change in odds of in-hospital death per half-year period, 0.91; 95% CI, 0.84-0.99 vs 0.97; 95% CI, 0.94-0.99; P=. 21). Conclusions Among hospitals participating in a voluntary quality-improvement initiative, the pay-for-performance program was not associated with a significant incremental improvement in quality of care or outcomes for acute myocardial infarction. Conversely, we did not find evidence that pay for performance had an adverse association with improvement in processes of care that were not subject to financial incentives. Additional studies of pay for performance are needed to determine its optimal role in quality-improvement initiatives.	Duke Clin Res Inst, Outcomes Res & Assessment Grp, Durham, NC 27715 USA; Duke Clin Res Inst, Ctr Clin & Genet Econ, Durham, NC 27715 USA; Duke Univ, Med Ctr, Dept Surg, Div Emergency Med, Durham, NC USA; Duke Univ, Med Ctr, Hlth Sector Management Program, Fuqua Sch Business, Durham, NC USA; Denver VA Med Ctr, Cardiol Sect, Denver, CO USA; Univ Cincinnati, Coll Med, Dept Emergency Med, Cincinnati, OH USA	Duke University; Duke University; Duke University; Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Denver; University System of Ohio; University of Cincinnati	Peterson, ED (corresponding author), Duke Clin Res Inst, Outcomes Res & Assessment Grp, POB 17969, Durham, NC 27715 USA.	peter016@mc.duke.edu	Peterson, Eric David/ABF-5033-2021; Greiver, Michelle/N-8764-2015	Greiver, Michelle/0000-0001-8957-0285	NATIONAL INSTITUTE ON AGING [R01AG025312] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG025312 01A1] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Barrett B, 2005, MED DECIS MAKING, V25, P250, DOI 10.1177/0272989X05276863; Berwick DM, 2003, HEALTH AFFAIR, V22, P8, DOI 10.1377/hlthaff.22.6.8; Bhatt DL, 2004, JAMA-J AM MED ASSOC, V292, P2096, DOI 10.1001/jama.292.17.2096; Birkmeyer NJO, 2006, NEW ENGL J MED, V354, P864, DOI 10.1056/NEJMsb053364; Boersma E, 2000, CIRCULATION, V101, P2557, DOI 10.1161/01.CIR.101.22.2557; Braunwald E, 2002, J AM COLL CARDIOL, V40, P1366, DOI 10.1016/S0735-1097(02)02336-7; Braunwald E, 2000, J AM COLL CARDIOL, V36, P970, DOI 10.1016/S0735-1097(00)00889-5; Chassin MR, 1998, JAMA-J AM MED ASSOC, V280, P1000, DOI 10.1001/jama.280.11.1000; *CMS QHID, IMPR CONT YEAR 2; Coeytaux RR, 2006, J CLIN EPIDEMIOL, V59, P374, DOI 10.1016/j.jclinepi.2005.05.010; Conrad DA, 2004, MED CARE RES REV, V61, p37S, DOI 10.1177/1077558704266770; *CTR MED MED SERV, HOSP QUAL IN WEB PAG; Darr Kurt, 2003, Hosp Top, V81, P30; Doran T, 2006, NEW ENGL J MED, V355, P375, DOI 10.1056/NEJMsa055505; Grumbach K, 1998, NEW ENGL J MED, V339, P1516, DOI 10.1056/NEJM199811193392106; Hoekstra JW, 2002, ACAD EMERG MED, V9, P1146, DOI 10.1111/j.1553-2712.2002.tb01569.x; JAESCHKE R, 1989, CONTROL CLIN TRIALS, V10, P407, DOI 10.1016/0197-2456(89)90005-6; KOHN A, 1993, HARVARD BUS REV, V71, P54; Lindenauer PK, 2007, NEW ENGL J MED, V356, P486, DOI 10.1056/NEJMsa064964; Marshall M, 2003, QUAL SAF HEALTH CARE, V12, P397, DOI 10.1136/qhc.12.6.397; Petersen LA, 2006, ANN INTERN MED, V145, P265, DOI 10.7326/0003-4819-145-4-200608150-00006; Peterson ED, 2006, JAMA-J AM MED ASSOC, V295, P1912, DOI 10.1001/jama.295.16.1912; Porter M.E., 2006, REDEFINING HLTH CARE; *PREM INC CMS, PREM HOSP QUAL INC D; Robinson JC, 2001, MILBANK Q, V79, P149, DOI 10.1111/1468-0009.00202; Roe MT, 2003, AM HEART J, V146, P605, DOI 10.1016/S0002-8703(03)00388-0; Rosenthal MB, 2006, MED CARE RES REV, V63, P135, DOI 10.1177/1077558705285291; Rosenthal MB, 2004, HEALTH AFFAIR, V23, P127, DOI 10.1377/hlthaff.23.2.127; Rowe JW, 2006, ANN INTERN MED, V145, P695, DOI 10.7326/0003-4819-145-9-200611070-00013; Staman Karen L, 2003, Crit Pathw Cardiol, V2, P34, DOI 10.1097/01.HPC.0000053684.59325.88	30	223	224	0	26	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 6	2007	297	21					2373	2380		10.1001/jama.297.21.2373	http://dx.doi.org/10.1001/jama.297.21.2373			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	175IL	17551130	Bronze			2022-12-28	WOS:000247007200019
J	Dubowitz, H; Bennett, S				Dubowitz, Howard; Bennett, Susan			Physical abuse and neglect of children	LANCET			English	Review							SHAKEN-BABY-SYNDROME; TRAUMATIC BRAIN-INJURY; INFLICTED HEAD-INJURY; UP SKELETAL SURVEYS; RIB FRACTURES; YOUNG-CHILDREN; CARDIOPULMONARY-RESUSCITATION; FOLLOW-UP; CLINICAL CHARACTERISTICS; OSTEOGENESIS IMPERFECTA	Child maltreatment includes physical abuse and neglect, and happens in all countries and cultures. Child maltreatment usually results from interactions between several risk factors (such as parental depression, stress, and social isolation). Physicians can incorporate methods to screen for risk factors into their usual appointments with the family. Detection of physical abuse is dependent on the doctor's ability to recognise suspicious injuries, such as bruising, bite marks, bums, bone fractures, or trauma to the head or abdomen. Neglect is the most common form of Child maltreatment in the USA. It can be caused by insufficient parental knowledge; intentional negligence is rare. Suspected cases of child abuse should be well documented and reported to the appropriate public agency which should assess the situation and help to protect the child.	Univ Maryland, Sch Med, Dept Pediat, Baltimore, MD 21201 USA; Univ Ottawa, Dept Pediat & Psychiat, Ottawa, ON, Canada	University System of Maryland; University of Maryland Baltimore; University of Ottawa	Dubowitz, H (corresponding author), Univ Maryland, Sch Med, Dept Pediat, Baltimore, MD 21201 USA.	hdubowitz@peds.umaryland.edu	Dubowitz, Howard/AAE-1782-2022					Ablin DS, 1998, CAN ASSOC RADIOL J, V49, P110; Andronicus M, 1998, BURNS, V24, P552, DOI 10.1016/S0305-4179(98)00062-X; Angel C, 2002, J PEDIATR SURG, V37, P99, DOI 10.1053/jpsu.2002.29437; ASNES RS, 1984, PEDIATRICS, V74, P321; Banaszkiewicz PA, 2002, J PEDIATR ORTHOPED, V22, P740, DOI 10.1097/00004694-200211000-00009; Barlow KM, 2005, PEDIATRICS, V116, pE174, DOI 10.1542/peds.2004-2739; Barnes PM, 2005, LANCET, V366, P234, DOI 10.1016/S0140-6736(05)66913-9; Baron JH, 2005, MT SINAI J MED, V72, P45; Barr RG, 2006, CHILD ABUSE NEGLECT, V30, P7, DOI 10.1016/j.chiabu.2005.06.009; Barsness KA, 2003, J TRAUMA, V54, P1107, DOI 10.1097/01.TA.0000068992.01030.A8; BETZ P, 1994, INT J LEGAL MED, V106, P215, DOI 10.1007/BF01371340; Bifulco A, 2005, BRIT J CLIN PSYCHOL, V44, P563, DOI 10.1348/014466505X35344; Blakemore LC, 1996, J PEDIATR ORTHOPED, V16, P585, DOI 10.1097/01241398-199609000-00007; BRAHAMS D, 1987, LANCET, V2, P51; BROOKE OG, 1985, ARCH DIS CHILD, V60, P682, DOI 10.1136/adc.60.7.682; Brown D, 2004, AM J PUBLIC HEALTH, V94, P558, DOI 10.2105/AJPH.94.4.558; Bulloch B, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.4.e48; Bullock K, 2000, AM FAM PHYSICIAN, V61, P2977; Bush CM, 1996, ANN EMERG MED, V28, P40, DOI 10.1016/S0196-0644(96)70137-3; Carpenter RF, 1999, ARCH DIS CHILD, V80, P363, DOI 10.1136/adc.80.4.363; Carrigan TD, 2000, J ACCID EMERG MED, V17, P138; CARTY HML, 1993, J BONE JOINT SURG BR, V75, P849, DOI 10.1302/0301-620X.75B6.8245070; Chalumeau M, 2002, PEDIATR RADIOL, V32, P644, DOI 10.1007/s00247-002-0755-y; Chapman S, 1997, PEDIATR RADIOL, V27, P106, DOI 10.1007/s002470050078; Chester DL, 2006, BURNS, V32, P222, DOI 10.1016/j.burns.2005.08.018; Chuang SS, 2003, BURNS, V29, P589, DOI 10.1016/S0305-4179(03)00151-7; COANT PN, 1992, PEDIATRICS, V89, P274; Coffey C, 2005, J PEDIATR SURG, V40, P120, DOI 10.1016/j.jpedsurg.2004.09.003; CUMMING WA, 1979, J CAN ASSOC RADIOL, V30, P30; DAHLENBURG SL, 1989, ARCH DIS CHILD, V64, P1384, DOI 10.1136/adc.64.10_Spec_No.1384; Davis R E, 2000, J Am Acad Nurse Pract, V12, P89, DOI 10.1111/j.1745-7599.2000.tb00173.x; Del Ciampo LA, 2001, ANN TROP PAEDIATR, V21, P239, DOI 10.1080/02724930120077826; Dias MS, 2005, PEDIATRICS, V115, DOI 10.1542/peds.2004-1896; Drago DA, 2005, PEDIATRICS, V115, P10, DOI 10.1542/peds.2004-0249; Dube SR, 2003, PREV MED, V37, P268, DOI 10.1016/S0091-7435(03)00123-3; DUBOWITZ H, 1993, CRIM JUSTICE BEHAV, V20, P8, DOI 10.1177/0093854893020001003; DUBOWITZ H, 1992, AM J DIS CHILD, V146, P596, DOI 10.1001/archpedi.1992.02160170076019; Dubowitz H, 2000, Pediatr Rev, V21, P111, DOI 10.1542/pir.21-4-111; DUBOWITZ H, 2005, CHILD MALTREATMENT C; DUBOWITZ H, 2001, CHILD ABUSE MED DIAG, P339; DUBOWITZ H, 2000, CHILD NEGLECT LONG T; Dubowitz H., 2000, HDB CHILD PROTECTION; Dubowitz H., 1999, NEGLECTED CHILDREN R; Dubowitz Howard, 2002, Pediatr Rev, V23, P191, DOI 10.1542/pir.23-6-191; Duhaime AC, 1998, NEW ENGL J MED, V338, P1822, DOI 10.1056/NEJM199806183382507; Durrant J., 2004, JOINT STATEMENT PHYS; Edwards VJ, 2003, AM J PSYCHIAT, V160, P1453, DOI 10.1176/appi.ajp.160.8.1453; ERDMANN TC, 1991, PEDIATRICS, V88, P572; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; FELDMAN KW, 1978, PEDIATRICS, V62, P1; FELDMAN KW, 1984, AM J DIS CHILD, V138, P768, DOI 10.1001/archpedi.1984.02140460058019; FELDMAN KW, 1984, PEDIATRICS, V73, P339; Flaherty EG, 2005, PEDIATR ANN, V34, P349, DOI 10.3928/0090-4481-20050501-08; FORJUOH SN, 1995, CHILD ABUSE NEGLECT, V19, P837, DOI 10.1016/0145-2134(95)00041-6; FRECHETTE A, 1992, PEDIATRICS, V89, P898; Freitag R, 1998, PEDIATR CLIN N AM, V45, P391, DOI 10.1016/S0031-3955(05)70014-6; GARCIA VF, 1990, J TRAUMA, V30, P695, DOI 10.1097/00005373-199006000-00007; Geddes JF, 2003, NEUROPATH APPL NEURO, V29, P14, DOI 10.1046/j.1365-2990.2003.00434.x; Geddes JF, 2001, BRAIN, V124, P1299, DOI 10.1093/brain/124.7.1299; Geddes JF, 2001, BRAIN, V124, P1290, DOI 10.1093/brain/124.7.1290; Glaser D, 2000, J CHILD PSYCHOL PSYC, V41, P97, DOI 10.1111/1469-7610.00551; Gnanaraj L, 2007, EYE, V21, P5, DOI 10.1038/sj.eye.6702174; Grant P, 2001, PEDIATRICS, V108, P1009, DOI 10.1542/peds.108.4.1009; Grayev AM, 2001, PEDIATR RADIOL, V31, P559, DOI 10.1007/s002470100497; Gunn VL, 2005, AMBUL PEDIATR, V5, P96, DOI 10.1367/A04-094R.1; Gushurst CA, 2003, PEDIATR CLIN N AM, V50, P919, DOI 10.1016/S0031-3955(03)00073-7; Hartmann RW, 1997, ARCH PEDIAT ADOL MED, V151, P947, DOI 10.1001/archpedi.1997.02170460085015; Hazen AL, 2006, PEDIATRICS, V117, P99, DOI 10.1542/peds.2004-2542; HENNES HM, 1990, PEDIATRICS, V86, P87; Hildyard KL, 2002, CHILD ABUSE NEGLECT, V26, P679, DOI 10.1016/S0145-2134(02)00341-1; HOBBS CJ, 1984, ARCH DIS CHILD, V59, P246, DOI 10.1136/adc.59.3.246; HOBBS CJ, 1989, BRIT MED J, V298, P1015, DOI 10.1136/bmj.298.6679.1015; HOBBS CJ, 1996, CURR PAEDIAT, V6, P183; HOLTER JC, 1969, AM J DIS CHILD, V118, P680, DOI 10.1001/archpedi.1969.02100040682002; Huntimer CM, 2000, PEDIATRICS, V106, P301, DOI 10.1542/peds.106.2.301; Hymel KP., 1998, CHILD MALTREAT, V3, P116, DOI [10.1177/1077559598003002006, DOI 10.1177/1077559598003002006]; Irazuzta JE, 1997, CHILD ABUSE NEGLECT, V21, P751, DOI 10.1016/S0145-2134(97)00036-7; JELLINEK MS, 1990, NEW ENGL J MED, V323, P1628, DOI 10.1056/NEJM199012063232311; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; Jenny C., 2003, INFLICTED CHILDHOOD, P49; Jenny C., 2001, CHILD ABUSE MED DIAG, P23; JOSEPH PR, 1990, AM J DIS CHILD, V144, P165, DOI 10.1001/archpedi.1990.02150260043024; Kairys SW, 2001, PEDIATRICS, V108, P206; KAUFMAN J, 1987, AM J ORTHOPSYCHIAT, V57, P186, DOI 10.1111/j.1939-0025.1987.tb03528.x; Keenan HT, 2004, PEDIATRICS, V114, P633, DOI 10.1542/peds.2003-1020-L; Kendall-Tackett K, 2005, CHILD ABUSE NEGLECT, V29, P147, DOI 10.1016/j.chiabu.2004.09.002; KING J, 1988, J PEDIATR ORTHOPED, V8, P585; King WJ, 2003, CAN MED ASSOC J, V168, P155; Kleinman PK, 1996, RADIOLOGY, V200, P807, DOI 10.1148/radiology.200.3.8756936; Kleinman PK, 1996, AM J ROENTGENOL, V167, P893, DOI 10.2214/ajr.167.4.8819377; KLEINMAN PK, 1998, DIAGNOSTIC IMAGING C; KOLKO DJ, 1992, J INTERPERS VIOLENCE, V7, P244, DOI 10.1177/088626092007002009; Korbin JE, 2003, CHILD ABUSE NEGLECT, V27, P137, DOI 10.1016/S0145-2134(02)00537-9; Labbe J, 2001, PEDIATRICS, V108, P271, DOI 10.1542/peds.108.2.271; Lane WG, 2002, JAMA-J AM MED ASSOC, V288, P1603, DOI 10.1001/jama.288.13.1603; Lantz PE, 2004, BRIT MED J, V328, P754, DOI 10.1136/bmj.328.7442.754; LEVENTHAL JM, 1993, AM J DIS CHILD, V147, P87, DOI 10.1001/archpedi.1993.02160250089028; Levin AV, 2000, RECENT ADV PAEDIAT, V18, P151; Loder R T, 1991, J Orthop Trauma, V5, P428, DOI 10.1097/00005131-199112000-00007; LYNCH A, 1975, J SCHOOL HEALTH, V45, P141, DOI 10.1111/j.1746-1561.1975.tb04481.x; LYSACK JT, 2003, PEDIATR RADIOL, V33; MacMillan HL, 2005, LANCET, V365, P1786, DOI 10.1016/S0140-6736(05)66388-X; Maguire S, 2005, ARCH DIS CHILD, V90, P182, DOI 10.1136/adc.2003.044065; Maguire S, 2005, ARCH DIS CHILD, V90, P187, DOI 10.1136/adc.2003.044073; Maguire S, 2006, CHILD ABUSE NEGLECT, V30, P739, DOI 10.1016/j.chiabu.2005.12.007; Mandelstam SA, 2003, ARCH DIS CHILD, V88, P387, DOI 10.1136/adc.88.5.387; MCMAHON P, 1995, J BONE JOINT SURG AM, V77A, P1179, DOI 10.2106/00004623-199508000-00006; Mellick LB, 1999, PEDIATR EMERG CARE, V15, P307, DOI 10.1097/00006565-199910000-00001; Mendelson KL, 2005, PEDIATR RADIOL, V35, P1036, DOI 10.1007/s00247-005-1573-9; MERTEN DF, 1983, RADIOLOGY, V146, P377, DOI 10.1148/radiology.146.2.6849085; MERTEN DF, 1990, PEDIATR CLIN N AM, V37, P815; Minns RA, 2005, J ROY COLL PHYS EDIN, V35, P5; MOLINA JA, 1983, INT J PSYCHIAT MED, V13, P29, DOI 10.2190/0UHQ-BXNE-6GGY-N1TF; Morris AAM, 1999, ARCH DIS CHILD, V80, P404, DOI 10.1136/adc.80.5.404; Morris S, 2002, J PEDIATR ORTHOPED, V22, P27, DOI 10.1097/00004694-200201000-00007; Naidoo S, 2000, CHILD ABUSE NEGLECT, V24, P521, DOI 10.1016/S0145-2134(00)00114-9; Olds DL, 1997, JAMA-J AM MED ASSOC, V278, P637, DOI 10.1001/jama.278.8.637; *PAN RES CHILD AB, 1993, COMM BEH SOC SCH ED; Partan G, 2003, EUR J RADIOL, V48, P103, DOI 10.1016/S0720-048X(03)00199-2; Paulson JA, 2001, PEDIATR CLIN N AM, V48, P1307, DOI 10.1016/S0031-3955(05)70376-X; PEREZ CM, 1994, CHILD ABUSE NEGLECT, V18, P617, DOI 10.1016/0145-2134(94)90012-4; Pierce MC, 2005, PEDIATRICS, V115, P1712, DOI 10.1542/peds.2004-0614; Pounder DJ, 1997, AM J FOREN MED PATH, V18, P321, DOI 10.1097/00000433-199712000-00001; PRANGE MT, 2003, PATHOBIOLOGY BIOMECH, P237; Prosser I, 2005, AM J ROENTGENOL, V184, P1282, DOI 10.2214/ajr.184.4.01841282; Reece RM, 2000, ARCH PEDIAT ADOL MED, V154, P11; REECE RM, 2003, INFLICTED CHILDHOOD; Reece RM, 2001, CHILD ABUSE MED DIAG; Renz B M, 1992, J Med Assoc Ga, V81, P574; RENZ BM, 1993, AM SURGEON, V59, P329; RIZZOLO PJ, 1989, J FAM PRACTICE, V29, P561; Roche KJ, 1995, PEDIATR RADIOL, V25, pS247; RORKE LB, 2003, INFLICTED CHILDHOOD; Rutter M, 2004, DEV PSYCHOL, V40, P81, DOI 10.1037/0012-1649.40.1.81; Salehi-Had H, 2006, PEDIATRICS, V117, pE1039, DOI 10.1542/peds.2005-0811; Sane SM, 2000, PEDIATRICS, V105, P1345; Satcher D, 2005, PEDIATRICS, V115, P1124, DOI 10.1542/peds.2004-2825C; Schuck AM, 2005, AM J COMMUN PSYCHOL, V36, P207, DOI 10.1007/s10464-005-8615-1; Schwend RM, 2000, J PEDIATR ORTHOPED, V20, P475, DOI 10.1097/00004694-200007000-00010; SEDLACK AJ, 1996, 3 NATL INCIDENCE STU; Sewell RD, 2000, PEDIATRICS, V106, part. no., DOI 10.1542/peds.106.5.e71; Sirotnak AP, 2004, PEDIATR REV, V25, P264, DOI 10.1542/pir.25-8-264; Skellern C, 2000, J PAEDIATR CHILD H, V36, P590, DOI 10.1046/j.1440-1754.2000.00592.x; SMITH SM, 1974, BMJ-BRIT MED J, V3, P666, DOI 10.1136/bmj.3.5932.666; Socolar RRS, 1998, PEDIATRICS, V101, P817, DOI 10.1542/peds.101.5.817; SPEVAK MR, 1994, JAMA-J AM MED ASSOC, V272, P617, DOI 10.1001/jama.272.8.617; SPIVACK BS, 2003, INFLICTED CHILDHOOD, P221; SPONSELLER P, 2000, CURR OPIN ORTHOP, V11, P461; Sugar NF, 1999, ARCH PEDIAT ADOL MED, V153, P399, DOI 10.1001/archpedi.153.4.399; SURRELL JA, 1987, J TRAUMA, V27, P935, DOI 10.1097/00005373-198708000-00014; Svedin CG, 2005, EUR CHILD ADOLES PSY, V14, P386, DOI 10.1007/s00787-005-0487-2; TENENBEIN M, 1990, AM J EMERG MED, V8, P208, DOI 10.1016/0735-6757(90)90324-S; THOMAS PS, 1977, ANN RADIOL, V20, P115; THOMAS SA, 1991, PEDIATRICS, V88, P471; U.S. Department of Health and Human Services, 2006, CHILD MALTR 2004; van der Kolk BA, 2003, CHILD ADOL PSYCH CL, V12, P293, DOI 10.1016/S1056-4993(03)00003-8; WARDINSKY TD, 1995, J FAM PRACTICE, V41, P377; Waterston T, 2000, ARCH DIS CHILD, V82, P429; Waterston T, 2005, ARCH DIS CHILD, V90, P178, DOI 10.1136/adc.2004.064014; WHEELER DM, 1988, BRIT MED J, V296, P1233, DOI 10.1136/bmj.296.6631.1233; Whitby EH, 2004, LANCET, V363, P846, DOI 10.1016/S0140-6736(04)15730-9; WHITTAKER DK, 1997, AMBULAT CHILD HLTH, V3, P225; Wilson SL, 2005, CHILD ABUSE NEGLECT, V29, P985, DOI 10.1016/j.chiabu.2005.03.007; WORLOCK P, 1986, BRIT MED J, V293, P100, DOI 10.1136/bmj.293.6539.100; Wu SS, 2004, CHILD ABUSE NEGLECT, V28, P1253, DOI 10.1016/j.chiabu.2004.07.005; Zimmerman S, 2005, CHILD ABUSE NEGLECT, V29, P1075, DOI 10.1016/j.chiabu.2004.08.012; [No title captured]; [No title captured]	168	156	160	2	37	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 2	2007	369	9576					1891	1899		10.1016/S0140-6736(07)60856-3	http://dx.doi.org/10.1016/S0140-6736(07)60856-3			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	173ZS	17544770				2022-12-28	WOS:000246911600034
J	Gornall, J				Gornall, Jonathan			Standing up for justice	BRITISH MEDICAL JOURNAL			English	Article												Jgornall@mac.com							0	1	1	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUN 2	2007	334	7604					1139	1141		10.1136/bmj.39219.530463.AD	http://dx.doi.org/10.1136/bmj.39219.530463.AD			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	177ES	17540941	Green Published			2022-12-28	WOS:000247137000026
J	Barker, PA				Barker, Philip A.			Atmospheric science - The monsoon's past	SCIENCE			English	Editorial Material							LAST DEGLACIATION; TERMINATION		Univ Lancaster, Lancaster Environm Ctr, Dept Geog, Lancaster LA1 4YQ, England	Lancaster University	Barker, PA (corresponding author), Univ Lancaster, Lancaster Environm Ctr, Dept Geog, Lancaster LA1 4YQ, England.	p.barker@lancaster.ac.uk	Barker, Philip/J-5938-2012	Barker, Philip/0000-0002-5334-9201				Alley RB, 1997, GEOLOGY, V25, P483, DOI 10.1130/0091-7613(1997)025<0483:HCIAPW>2.3.CO;2; Conley DJ, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2002GB001894; Dai A, 2002, J HYDROMETEOROL, V3, P660, DOI 10.1175/1525-7541(2002)003<0660:EOFDFC>2.0.CO;2; deMenocal P, 2000, QUATERNARY SCI REV, V19, P347, DOI 10.1016/S0277-3791(99)00081-5; Hughen KA, 1996, NATURE, V380, P51, DOI 10.1038/380051a0; Lea DW, 2003, SCIENCE, V301, P1361, DOI 10.1126/science.1088470; Marret F, 2001, J QUATERNARY SCI, V16, P761, DOI 10.1002/jqs.646; Schefuss E, 2005, NATURE, V437, P1003, DOI 10.1038/nature03945; Shanahan TM, 2006, PALAEOGEOGR PALAEOCL, V242, P287, DOI 10.1016/j.palaeo.2006.06.007; Trauth MH, 2003, EARTH PLANET SC LETT, V206, P297, DOI 10.1016/S0012-821X(02)01105-6; Weldeab S, 2007, SCIENCE, V316, P1303, DOI 10.1126/science.1140461	11	2	2	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 1	2007	316	5829					1295	1296		10.1126/science.1143451	http://dx.doi.org/10.1126/science.1143451			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	173PS	17540892				2022-12-28	WOS:000246885600037
J	Reeves, MB; Davies, AA; McSharry, BP; Wilkinson, GW; Sinclair, JH				Reeves, Matthew B.; Davies, Andrew A.; McSharry, Brian P.; Wilkinson, Gavin W.; Sinclair, John H.			Complex I binding by a virally encoded RNA regulates mitochondria-induced cell death	SCIENCE			English	Article							HUMAN CYTOMEGALOVIRUS; LOCALIZED INHIBITOR; GENE-EXPRESSION; APOPTOSIS; GRIM-19; PROTEIN; ACTIVATION; INFECTION; REVEALS; PRODUCT	Human cytomegalovirus infection perturbs multiple cellular processes that could promote the release of proapoptotic stimuli. Consequently, it encodes mechanisms to prevent cell death during infection. Using rotenone, a potent inhibitor of the mitochondrial enzyme complex I (reduced nicotinamide adenine dinucleotide-ubiquinone oxido-reductase), we found that human cytomegalovirus infection protected cells from rotenone-induced apoptosis, a protection mediated by a 2.7-kilobase virally encoded RNA (beta 2.7). During infection, beta 2.7 RNA interacted with complex I and prevented the relocalization of the essential subunit genes associated with retinoid/interferon-induced mortality-19, in response to apoptotic stimuli. This interaction, which is important for stabilizing the mitochondrial membrane potential, resulted in continued adenosine triphosphate production, which is critical for the successful completion of the virus' life cycle. Complex I targeting by a viral RNA represents a refined strategy to modulate the metabolic viability of the infected host cell.	Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 2QQ, England; Univ Wales Coll Cardiff, Coll Med, Sect Infect & Immun, Cardiff CF14 4XX, S Glam, Wales	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cardiff University	Sinclair, JH (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Med, Hills Rd, Cambridge CB2 2QQ, England.	js@mole.bio.cam.ac.uk	McSharry, Brian/AAE-3351-2019; Wilkinson, Gavin WG/J-6388-2015	McSharry, Brian/0000-0003-0473-2789; Wilkinson, Gavin WG/0000-0002-5623-0126; Reeves, Matthew/0000-0002-4909-1076	Medical Research Council [G9202171, G0700142] Funding Source: Medline; Wellcome Trust Funding Source: Medline; MRC [G9202171, G0700142] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Angell JE, 2000, J BIOL CHEM, V275, P33416, DOI 10.1074/jbc.M003929200; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Chernyak BV, 2005, BIOCHEMISTRY-MOSCOW+, V70, P240, DOI 10.1007/s10541-005-0106-3; Crowe WE, 2004, AM J PHYSIOL-CELL PH, V287, pC1023, DOI 10.1152/ajpcell.00511.2003; Eckert A, 2003, BIOCHEM PHARMACOL, V66, P1627, DOI 10.1016/S0006-2952(03)00534-3; Fish KN, 1998, J VIROL, V72, P5661, DOI 10.1128/JVI.72.7.5661-5668.1998; Gawn JM, 2002, J VIROL, V76, P4441, DOI 10.1128/JVI.76.9.4441-4455.2002; Goldmacher VS, 1999, P NATL ACAD SCI USA, V96, P12536, DOI 10.1073/pnas.96.22.12536; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; GREENAWAY PJ, 1987, VIRUS RES, V7, P17, DOI 10.1016/0168-1702(87)90055-4; Hertel L, 2004, J VIROL, V78, P11988, DOI 10.1128/JVI.78.21.11988-12011.2004; Huang GC, 2004, MOL CELL BIOL, V24, P8447, DOI 10.1128/MCB.24.19.8447-8456.2004; Ladha JS, 2005, CELL DEATH DIFFER, V12, P1417, DOI 10.1038/sj.cdd.4401668; Li J, 2005, J NEUROCHEM, V92, P462, DOI 10.1111/j.1471-4159.2004.02872.x; Li NY, 2003, J BIOL CHEM, V278, P8516, DOI 10.1074/jbc.M210432200; Lufei CC, 2003, EMBO J, V22, P1325, DOI 10.1093/emboj/cdg135; McCormick AL, 2003, J VIROL, V77, P631, DOI 10.1128/JVI.77.1.631-641.2003; McSharry BP, 2003, J GEN VIROL, V84, P2511, DOI 10.1099/vir.0.19298-0; Murata T, 2000, J GEN VIROL, V81, P401, DOI 10.1099/0022-1317-81-2-401; Newmeyer DD, 2003, CELL, V112, P481, DOI 10.1016/S0092-8674(03)00116-8; Reboredo M, 2004, J GEN VIROL, V85, P3555, DOI 10.1099/vir.0.80379-0; Simon DK, 1999, ANNU REV MED, V50, P111; Singer T P, 1979, Methods Enzymol, V55, P454; Sissons JGP, 2002, J INFECTION, V44, P73, DOI 10.1053/jinf.2001.0948; Skaletskaya A, 2001, P NATL ACAD SCI USA, V98, P7829, DOI 10.1073/pnas.141108798; Spector DH, 1996, INTERVIROLOGY, V39, P361, DOI 10.1159/000150507; Terhune S, 2007, J VIROL, V81, P3109, DOI 10.1128/JVI.02124-06	27	196	212	1	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 1	2007	316	5829					1345	1348		10.1126/science.1142984	http://dx.doi.org/10.1126/science.1142984			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173PS	17540903				2022-12-28	WOS:000246885600052
J	Riley, S				Riley, Steven			Large-scale spatial-transmission models of infectious disease	SCIENCE			English	Review							MOUTH EPIDEMIC; VACCINATION STRATEGIES; INTERNATIONAL SPREAD; PANDEMIC INFLUENZA; GLOBAL SPREAD; FOOT; IMPACT; PERSISTENCE; HIERARCHIES; DYNAMICS	During transmission of seasonal endemic diseases such as measles and influenza, spatial waves of infection have been observed between large distant populations. Also, during the initial stages of an outbreak of a new or reemerging pathogen, disease incidence tends to occur in spatial clusters, which makes containment possible if you can predict the subsequent spread of disease. Spatial models are being used with increasing frequency to help characterize these large-scale patterns and to evaluate the impact of interventions. Here, I review several recent studies on four diseases that show the benefits of different methodologies: measles ( patch models), foot-and-mouth disease (distance-transmission models), pandemic influenza (multigroup models), and smallpox ( network models). This review highlights the importance of the household in spatial studies of human diseases, such as smallpox and influenza. It also demonstrates the need to develop a simple model of household demographics, so that these large-scale models can be extended to the investigation of long-time scale human pathogens, such as tuberculosis and HIV.	Univ Hong Kong, Dept Community Med, Hong Kong, Hong Kong, Peoples R China; Univ Hong Kong, Fac Med, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Riley, S (corresponding author), Univ Hong Kong, Dept Community Med, Hong Kong, Hong Kong, Peoples R China.	steven.riley@hku.hk	Riley, Steven/C-4384-2009	Riley, Steven/0000-0001-7904-4804				ANDERSON RM, 1991, NATURE, V352, P581, DOI 10.1038/352581a0; Bolker BM, 1996, P NATL ACAD SCI USA, V93, P12648, DOI 10.1073/pnas.93.22.12648; Cooper BS, 2006, PLOS MED, V3, P845, DOI 10.1371/journal.pmed.0030212; Dobson JE, 2000, PHOTOGRAMM ENG REM S, V66, P849; Eubank S, 2004, NATURE, V429, P180, DOI 10.1038/nature02541; Fenner E., 1988, SMALLPOX ITS ERADICA; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Ferguson NM, 2001, NATURE, V413, P542, DOI 10.1038/35097116; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Ferguson NM, 2001, SCIENCE, V292, P1155, DOI 10.1126/science.1061020; Ferguson NM, 2003, NATURE, V425, P681, DOI 10.1038/nature02007; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Grenfell BT, 2001, NATURE, V414, P716, DOI 10.1038/414716a; Heesterbeek JAP, 2002, ACTA BIOTHEOR, V50, P189, DOI 10.1023/A:1016599411804; Hethcote HW, 1997, MATH BIOSCI, V145, P89, DOI 10.1016/S0025-5564(97)00014-X; Hollingsworth TD, 2006, NAT MED, V12, P497, DOI 10.1038/nm0506-497; Hufnagel L, 2004, P NATL ACAD SCI USA, V101, P15124, DOI 10.1073/pnas.0308344101; Keeling MJ, 2001, SCIENCE, V294, P813, DOI 10.1126/science.1065973; Keeling MJ, 1997, SCIENCE, V275, P65, DOI 10.1126/science.275.5296.65; Keeling MJ, 2003, NATURE, V421, P136, DOI 10.1038/nature01343; Levin SA, 1996, PHILOS T R SOC B, V351, P1615, DOI 10.1098/rstb.1996.0145; Levin SA, 1997, SCIENCE, V275, P334, DOI 10.1126/science.275.5298.334; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; LONGINI IM, 1986, AM J EPIDEMIOL, V123, P383, DOI 10.1093/oxfordjournals.aje.a114253; Mills CE, 2004, NATURE, V432, P904, DOI 10.1038/nature03063; Olson DR, 2005, P NATL ACAD SCI USA, V102, P11059, DOI 10.1073/pnas.0408290102; Quinn TC, 1996, LANCET, V348, P99, DOI 10.1016/S0140-6736(96)01029-X; Riley S, 2006, P NATL ACAD SCI USA, V103, P12637, DOI 10.1073/pnas.0510873103; RVACHEV LA, 1985, MATH BIOSCI, V75, P3, DOI 10.1016/0025-5564(85)90064-1; Tildesley MJ, 2006, NATURE, V440, P83, DOI 10.1038/nature04324; Viboud C, 2006, SCIENCE, V312, P447, DOI 10.1126/science.1125237; Williams BG, 2005, P NATL ACAD SCI USA, V102, P9619, DOI 10.1073/pnas.0501615102; Woolhouse M, 2001, NATURE, V411, P258, DOI 10.1038/35077149; Wu JT, 2006, PLOS MED, V3, P1532, DOI 10.1371/journal.pmed.0030361	35	389	407	2	154	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 1	2007	316	5829					1298	1301		10.1126/science.1134695	http://dx.doi.org/10.1126/science.1134695			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173PS	17540894				2022-12-28	WOS:000246885600039
J	Keefer, DK; Larsen, MC				Keefer, David K.; Larsen, Matthew C.			Assessing landslide hazards	SCIENCE			English	Editorial Material							FLUIDIZED GRANULAR MASSES; RAINFALL INTENSITY; DEBRIS FLOWS; TERRAIN		US Geol Survey, Menlo Pk, CA 94025 USA; US Geol Survey, Reston, VA USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey	Keefer, DK (corresponding author), US Geol Survey, 345 Middlefield Rd, Menlo Pk, CA 94025 USA.	dkeefer@usgs.gov; mclarsen@usgs.gov						CAINE N, 1980, GEOGR ANN A, V62, P23, DOI 10.2307/520449; Casadel M, 2003, EARTH SURF PROC LAND, V28, P925, DOI 10.1002/esp.470; Colesanti C, 2006, ENG GEOL, V88, P173, DOI 10.1016/j.enggeo.2006.09.013; Davies TR, 2006, Q J ENG GEOL HYDROGE, V39, P115, DOI 10.1144/1470-9236/05-041; Denlinger RP, 2001, J GEOPHYS RES-SOL EA, V106, P553, DOI 10.1029/2000JB900330; Ellen SD, 1988, 1434 US GEOL SURV; Evans SG, 2007, NAT HAZARD EARTH SYS, V7, P89, DOI 10.5194/nhess-7-89-2007; Fiorillo F, 2004, ENG GEOL, V75, P263, DOI 10.1016/j.enggeo.2004.06.014; Iverson RM, 2005, J GEOPHYS RES-EARTH, V110, DOI 10.1029/2004JF000268; Iverson RM, 2001, J GEOPHYS RES-SOL EA, V106, P537, DOI 10.1029/2000JB900329; Jibson R. W, 2005, 20051067 US GEOL SUR; Jibson R.W., 2003, 03005 US GEOL SURV; Jibson RW, 2000, ENG GEOL, V58, P271, DOI 10.1016/S0013-7952(00)00039-9; KEEFER DK, 1987, SCIENCE, V238, P921, DOI 10.1126/science.238.4829.921; Kieffer DS, 2006, EARTHQ SPECTRA, V22, pS47, DOI 10.1193/1.2173021; LARSEN MC, 1993, GEOGR ANN A, V75, P13, DOI 10.2307/521049; MILES SB, 2007, 20071072 US GEOL SUR; Petley DN, 2005, GEOLOGY, V33, P201, DOI 10.1130/G21147.1; Plafker G., 1978, ROCKSLIDES AVALANCHE, V1, P277, DOI DOI 10.1016/B978-0-444-41507-3.50016-7; Reid ME, 2004, GEOLOGY, V32, P373, DOI 10.1130/G20300.1; Schuster RL, 1996, LANDSLIDES INVESTIGA, P12; Schuster RL, 2007, B ENG GEOL ENVIRON, V66, P1, DOI 10.1007/s10064-006-0080-z; WANG WN, 2002, J JPN LANDSLIDE SOC, V38, P18	23	132	146	6	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 25	2007	316	5828					1136	1138		10.1126/science.1143308	http://dx.doi.org/10.1126/science.1143308			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	171GQ	17525325				2022-12-28	WOS:000246724300027
J	Shepard, JAO; Wright, CD; Hasserjian, RP; Fidias, P; Choi, NCH				Shepard, Jo-Anne O.; Wright, Cameron D.; Hasserjian, Robert P.; Fidias, Panos; Choi, Noah C. H.			Case 16-2007: A 61-year-old man with a mediastinal mass - Thymoma, WHO type B1, with individual changes after preoperative chemoradiation.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							STAGE-III THYMOMA; THYMIC EPITHELIAL TUMORS; RADIATION-THERAPY; MALIGNANT THYMOMA; SURGICAL RESECTION; INVASIVE THYMOMA; MULTIDISCIPLINARY APPROACH; ADJUVANT RADIATION; INTERGROUP TRIAL; LUNG-CANCER		Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Hematol & Oncol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Surg, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Med, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Radiat Oncol, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Radiol, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Pathol, Cambridge, MA 02138 USA; Massachusetts Gen Hosp, Dept Radiat Oncol, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard University; Harvard University; Harvard University; Harvard University; Massachusetts General Hospital	Shepard, JAO (corresponding author), Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA.							BERNATZ PE, 1961, J THORAC CARDIOV SUR, V42, P424; Bretti S, 2004, LUNG CANCER, V44, P69, DOI 10.1016/j.lungcan.2003.09.022; CIERNIK IF, 1994, J CLIN ONCOL, V12, P1484, DOI 10.1200/JCO.1994.12.7.1484; COWEN D, 1995, RADIOTHER ONCOL, V34, P9, DOI 10.1016/0167-8140(94)01493-M; CURRAN WJ, 1988, J CLIN ONCOL, V6, P1722, DOI 10.1200/JCO.1988.6.11.1722; Detterbeck FC, 2004, ANN THORAC SURG, V77, P1860, DOI 10.1016/j.athoracsur.2003.10.001; Engels EA, 2003, INT J CANCER, V105, P546, DOI 10.1002/ijc.11099; FORNASIERO A, 1991, CANCER, V68, P30, DOI 10.1002/1097-0142(19910701)68:1<30::AID-CNCR2820680106>3.0.CO;2-4; Giaccone G, 1996, J CLIN ONCOL, V14, P814, DOI 10.1200/JCO.1996.14.3.814; HANIUDA M, 1992, ANN THORAC SURG, V54, P311, DOI 10.1016/0003-4975(92)91391-L; HU E, 1986, CANCER, V57, P1101, DOI 10.1002/1097-0142(19860315)57:6<1101::AID-CNCR2820570606>3.0.CO;2-A; Jeong YJ, 2004, AM J ROENTGENOL, V183, P283, DOI 10.2214/ajr.183.2.1830283; Kim ES, 2004, LUNG CANCER, V44, P369, DOI 10.1016/j.lungcan.2003.12.010; Kondo K, 2003, ANN THORAC SURG, V76, P878, DOI 10.1016/S0003-4975(03)00555-1; KRUEGER JB, 1988, RADIOLOGY, V168, P855, DOI 10.1148/radiology.168.3.3136511; Kuo T, 2000, HISTOPATHOLOGY, V36, P403; Loehrer PJ, 2004, J CLIN ONCOL, V22, p629S; Loehrer PJ, 1997, J CLIN ONCOL, V15, P3093, DOI 10.1200/JCO.1997.15.9.3093; Loehrer PJ, 2001, CANCER-AM CANCER SOC, V91, P2010, DOI 10.1002/1097-0142(20010601)91:11<2010::AID-CNCR1226>3.0.CO;2-2; Mangi AA, 2005, ANN THORAC SURG, V79, P1834, DOI 10.1016/j.athoracsur.2004.12.051; Mangi AA, 2002, ANN THORAC SURG, V74, P1033, DOI 10.1016/S0003-4975(02)03828-6; MARINO M, 1985, VIRCHOWS ARCH A, V407, P119, DOI 10.1007/BF00737071; MARX A, 2004, TUMORS LUNG PLEURA T, P145; MASAOKA A, 1981, CANCER, V48, P2485, DOI 10.1002/1097-0142(19811201)48:11<2485::AID-CNCR2820481123>3.0.CO;2-R; MORNEX F, 1995, INT J RADIAT ONCOL, V32, P651, DOI 10.1016/0360-3016(95)00079-E; Myojin M, 2000, INT J RADIAT ONCOL, V46, P927, DOI 10.1016/S0360-3016(99)00514-3; Okumura M, 2002, CANCER-AM CANCER SOC, V94, P624, DOI 10.1002/cncr.10226; Palmieri G, 2002, CANCER-AM CANCER SOC, V94, P1414, DOI 10.1002/cncr.10374; Pottgen C, 2006, CLIN CANCER RES, V12, P97, DOI 10.1158/1078-0432.CCR-05-0510; QUINTANILLAMARTINEZ L, 1993, HUM PATHOL, V24, P958, DOI 10.1016/0046-8177(93)90109-T; QUINTANILLAMARTINEZ L, 1994, CANCER-AM CANCER SOC, V74, P606, DOI 10.1002/1097-0142(19940715)74:2<606::AID-CNCR2820740212>3.0.CO;2-T; Rosai J, 1976, ATLAS TUMOR PATHOLOG, P34; Rusch VW, 2001, J THORAC CARDIOV SUR, V121, P472, DOI 10.1067/mtc.2001.112465; Shimosato Y, 1997, ATLAS TUMOR PATHOL, P93; Shin DM, 1998, ANN INTERN MED, V129, P100, DOI 10.7326/0003-4819-129-2-199807150-00006; Tiseo M, 2005, J CLIN ONCOL, V23, P1578, DOI 10.1200/JCO.2005.03.115; URGESI A, 1990, RADIOTHER ONCOL, V19, P273, DOI 10.1016/0167-8140(90)90154-O; Venuta F, 2003, ANN THORAC SURG, V76, P1866, DOI 10.1016/S0003-4975(03)01020-8; Welsh JS, 2000, JAMA-J AM MED ASSOC, V283, P1142, DOI 10.1001/jama.283.9.1142; Wright CD, 2005, J THORAC CARDIOV SUR, V130, P1413, DOI 10.1016/j.jtcvs.2005.07.026	40	2	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 24	2007	356	21					2185	2193		10.1056/NEJMcpc079010	http://dx.doi.org/10.1056/NEJMcpc079010			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	170ON	17522403				2022-12-28	WOS:000246673100011
J	Dorsey, G; Staedke, S; Clark, TD; Njama-Meya, D; Nzarubara, B; Maiteki-Sebuguzi, C; Dokomajilar, C; Kamya, MR; Rosenthal, PJ				Dorsey, Grant; Staedke, Sarah; Clark, Tamara D.; Njama-Meya, Denise; Nzarubara, Bridget; Maiteki-Sebuguzi, Catherine; Dokomajilar, Christian; Kamya, Moses R.; Rosenthal, Philip J.			Combination therapy for uncomplicated falciparum malaria in Ugandan children - A randomized trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PLUS SULFADOXINE-PYRIMETHAMINE; ARTEMETHER-LUMEFANTRINE; AMODIAQUINE; ARTESUNATE; EFFICACY; ARTEMISININ	Context Combination therapy is now widely advocated as first-line treatment for uncomplicated malaria in Africa. However, it is not clear which treatment regimens are optimal or how to best assess comparative efficacies in highly endemic areas. Objective To compare the efficacy and safety of 3 leading combination therapies for the treatment of uncomplicated malaria. Design, Setting, and Participants Single-blind randomized clinical trial, conducted between November 2004 and June 2006, of treatment for all episodes of uncomplicated malaria in children in an urban community in Kampala, Uganda. A total of 601 healthy children (aged 1-10 years) were randomly selected and were followed up for 13 to 19 months, receiving all medical care at the study clinic. Interventions Study participants were randomized to receive 1 of 3 combination therapies (amodiaquine plus sulfadoxine-pyrimethamine, amodiaquine plus artesunate, or artemether-lumefantrine) when diagnosed with their first episode of uncomplicated malaria. The same assigned treatment was given for all subsequent episodes. Main Outcome Measure 28-Day risk of parasitological failure (unadjusted and adjusted by genotyping to distinguish recrudescence from new infection) for each episode of uncomplicated malaria treated with study drugs. Results Of enrolled children, 329 of 601 were diagnosed with at least 1 episode of uncomplicated malaria, and 687 episodes of Plasmodium falciparum malaria were treated with study drugs. The 28-day risk of treatment failure (unadjusted by genotyping) for individual episodes of malaria were 26.1% (95% CI, 21.1%-32.1%) for amodiaquine plus sulfadoxine-pyrimethamine, 17.4% (95% CI, 13.1%-23.1%) for amodiaquine plus artesunate, and 6.7% (95% CI, 3.9%-11.2%) for artemether-lumefantrine (P < .05 for all pairwise comparisons). When only recrudescent treatment failures were considered, the risks of failure were 14.1% (95% CI, 10.3%-19.2%), 4.6% (95% CI, 2.5%-8.3%), and 1.0% (95% CI, 0.3%-4.0%) for the same order of study drugs, respectively (P <= .008 for all pairwise comparisons, except amodiaquine plus artesunate vs artemether-lumefantrine, P = .05). There were no deaths or cases of severe malaria. Significant reductions in anemia (9.3% [ 95% CI, 7.0%-12.0%] at enrollment vs 0.6% [ 95% CI, 0.1%-2.2%] during the last 2 months of follow-up; P < .001) and asymptomatic parasitemia (18.6% [ 95% CI, 15.5%-22.1%] at enrollment vs 2.3% [ 95% CI, 1.5%-3.5%] during the last 2 months of follow-up; P < .001) were observed according to routine testing. Conclusions Artemether-lumefantrine was the most efficacious treatment for uncomplicated malaria in the study population. With all study regimens, the provision of prompt and reasonably effective facility-based treatment was associated with good outcomes in long-term health measures.	Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, San Francisco, CA 94143 USA; London Sch Hyg & Trop Med, London WC1, England; Makerere Univ, Sch Med, Kampala, Uganda	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University of London; London School of Hygiene & Tropical Medicine; Makerere University	Dorsey, G (corresponding author), Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, Box 0811, San Francisco, CA 94143 USA.	gdorsey@medsfgh.ucsf.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI052142] Funding Source: NIH RePORTER; NIAID NIH HHS [U01 AI052142] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adjuik M, 2004, LANCET, V363, P9, DOI 10.1016/S0140-6736(03)15162-8; [Anonymous], WHORBMHTM200350; Attaran A, 2004, LANCET, V363, P237, DOI 10.1016/S0140-6736(03)15330-5; Breman JG, 2004, AM J TROP MED HYG, V71, P1; Davis JC, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-18; Dorsey G, 2002, LANCET, V360, P2031, DOI 10.1016/S0140-6736(02)12021-6; Fanello CI, 2006, TROP MED INT HEALTH, V11, P589, DOI 10.1111/j.1365-3156.2006.01610.x; Giao PT, 2001, AM J TROP MED HYG, V65, P690, DOI 10.4269/ajtmh.2001.65.690; Greenhouse B, 2006, AM J TROP MED HYG, V75, P836, DOI 10.4269/ajtmh.2006.75.836; Karema C, 2006, T ROY SOC TROP MED H, V100, P1105, DOI 10.1016/j.trstmh.2006.01.001; Kremsner PG, 2004, LANCET, V364, P285, DOI 10.1016/S0140-6736(04)16680-4; Montori VM, 2005, JAMA-J AM MED ASSOC, V294, P2203, DOI 10.1001/jama.294.17.2203; Mutabingwa TK, 2005, LANCET, V365, P1474, DOI 10.1016/S0140-6736(05)66417-3; Rwagacondo CE, 2003, AM J TROP MED HYG, V68, P743, DOI 10.4269/ajtmh.2003.68.743; Staedke SG, 2004, LANCET, V364, P1950, DOI 10.1016/S0140-6736(04)17478-3; Stepniewska K, 2004, ANTIMICROB AGENTS CH, V48, P4271, DOI 10.1128/AAC.48.11.4271-4280.2004; White NJ, 2002, TRENDS PARASITOL, V18, P458, DOI 10.1016/S1471-4922(02)02373-5; *WHO, 2006, WHOHTMMAL20061108; *WHO, 2005, WHOHTMMAL20051103; Yeka A, 2005, PLOS MED, V2, P654, DOI 10.1371/journal.pmed.0020190; Zongo I, 2007, LANCET, V369, P491, DOI 10.1016/S0140-6736(07)60236-0	21	143	144	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 23	2007	297	20					2210	2219		10.1001/jama.297.20.2210	http://dx.doi.org/10.1001/jama.297.20.2210			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	170JM	17519410	Bronze			2022-12-28	WOS:000246659700020
J	Feachem, RGA; Sabot, OJ				Feachem, Richard G. A.; Sabot, Oliver J.			Global malaria control in the 21st century - A historic but fleeting opportunity	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Clinton Fdn, HIV AIDS Initiat, New York, NY 10024 USA; Univ Calif San Francisco, Global Fund Fight AIDS TB & Malaria, San Francisco, CA 94143 USA; Univ Calif San Francisco, Inst Global Hlth, San Francisco, CA 94143 USA; Univ Calif Berkeley, Berkeley, CA 94720 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Berkeley	Sabot, OJ (corresponding author), Clinton Fdn, HIV AIDS Initiat, 65 W 86th St, New York, NY 10024 USA.	osabot@clintonfoundation.org						Alilio MS, 2004, AM J TROP MED HYG, V71, P205, DOI 10.4269/ajtmh.2004.71.205; Alilio MS, 2004, AM J TROP MED HYG, V71, P268, DOI 10.4269/ajtmh.2004.71.268; [Anonymous], 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000363.PUB2; [Anonymous], 2005, GLOB STRAT PLAN ROLL; Ashley EA, 2005, CURR OPIN INFECT DIS, V18, P531, DOI 10.1097/01.qco.0000186848.46417.6c; BATE R, 2006, STILL TAXED DEATH AN; Booman Marlize, 2003, Malar J, V2, P13, DOI 10.1186/1475-2875-2-13; *CDCP, 2005, MMWR-MORBID MORTAL W, V55, P913; *CDCP, 2005, MMWR-MORBID MORTAL W, V54, P994; CHIKANDI S, 2005, 4 YEARS ABUJA MORE A; *GLOB FUND FIGHT A, 2006, FUND GLOB FIGHT HIV; Levine Ruth, 2004, MILLIONS SAVED PROVE; Lomborg B., 2004, GLOBAL CRISES GLOBAL; Low-Beer D., 2007, PARTNERS IMPACT RESU; Marsh VM, 2004, TROP MED INT HEALTH, V9, P451, DOI 10.1111/j.1365-3156.2004.01223.x; Nyarango PM, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-33; Trape JF, 2001, AM J TROP MED HYG, V64, P12, DOI 10.4269/ajtmh.2001.64.12; WHO UNICEF, 2005, WORLD MALARIA REPORT; Zambia Ministry of Health, 2006, ZAMB NAT MAL IND SUR; 2003, LANCET INFECT DIS, V3, P317; [No title captured]	21	17	17	0	11	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 23	2007	297	20					2281	2284		10.1001/jama.297.20.2281	http://dx.doi.org/10.1001/jama.297.20.2281			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	170JM	17519417				2022-12-28	WOS:000246659700028
J	Goodyer, I; Dubicka, B; Wilkinson, P; Kelvin, R; Roberts, C; Byford, S; Breen, S; Ford, C; Barrett, B; Leech, A; Rothwell, J; White, L; Harrington, R				Goodyer, Ian; Dubicka, Bernadka; Wilkinson, Paul; Kelvin, Raphael; Roberts, Chris; Byford, Sarah; Breen, Siobhan; Ford, Claire; Barrett, Barbara; Leech, Alison; Rothwell, Justine; White, Lydia; Harrington, Richard			Selective serotonin reuptake inhibitors (SSRIs) and routine specialist care with and without cognitive behaviour therapy in adolescents with major depression: randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							NATION OUTCOME SCALES; CHILDREN; RELIABILITY; CHILDHOOD; HEALTH; COMBINATION; DISORDERS; VALIDITY; HONOSCA; DESIGN	Objective To determine whether a combination of a selective serotonin reuptake inhibitor (SSRI) and cognitive behaviour therapy (CBT) together with clinical care is more effective in the short term than an SSRI and clinical care alone in adolescents with moderate to severe major depression. Design Pragmatic randomised controlled superiority trial. Setting 6 outpatient clinics in Manchester and Cambridge. Participants 208 adolescents, aged 11-17, with moderate to severe major or probable major depression who had not responded to a brief initial intervention. Adolescents with suicidality, depressive psychosis, or conduct disorder were included. Interventions 103 adolescents received an SSRI and routine care; 105 received an SSRI, routine care, and CBT. The trial tasted 12 weeks, followed by a 16 week maintenance phase. Main outcome measures Change in score on the Health of the Nation outcome scales for children and adolescents (primary outcome) from baseline with 12 weeks as the primary and 28 weeks as the follow-up end point. Secondary measures were change in scores on the mood and feelings questionnaire, the revised children's depression rating scale, the children's global assessment scale, and the clinical global impression improvement scale. Results At 12 weeks the treatment effect for the primary outcome was -0.64 (95% confidence interval -2.54 to 1.26, P=0.50). In a longitudinal analysis, there was no difference in effectiveness of treatment for the primary (average treatment effect 0.001, -1.52 to 1.52, P=0.99) or secondary outcome measures. On average there was a decrease in suicidal thoughts and self harm. There was no evidence of a protective effect of cognitive behaviour therapy on suicidal thinking or action. By 28 weeks, 57% were much or very much improved with 20% remaining unimproved. Conclusions For adolescents with moderate to severe major depression there is no evidence that the combination of CBT plus an SSRI in the presence of routine clinical care contributes to an improved outcome by 28 weeks compared with the provision of routine clinical care plus an SSRI alone.	Univ Cambridge, Dept Psychiat, Dev Psychiat Sect, Cambridge CB2 2AH, England; Univ Manchester, Dept Psychiat, Manchester M13 9PL, Lancs, England; Junct Adolescent Unit, Lancaster, England; Brookside Family Consultat Ctr, Cambridge, England; Univ Manchester, Div Epidemiol & Hlth Sci, Biostat Grp, Manchester M13 9PL, Lancs, England; Inst Psychiat, Ctr Econ Mental Hlth, London, England; Univ Sheffield, Dept Psychol, Clin Psychol Unit, Sheffield, S Yorkshire, England; Cambridgeshire Primary Care Trust, Cambridge, England; Thorn Rd Clin, Halton, Cheshire, England; Univ Manchester, Div Psychiat, Manchester M13 9PL, Lancs, England; Univ Manchester, Booth Hall Childrens Hosp, Acad Dept Child & Adolescent Psychiat, Manchester M13 9PL, Lancs, England; Univ Manchester, Royal Manchester Childrens Hosp, Dept Child & Adolescent Psychiat, Manchester M13 9PL, Lancs, England	University of Cambridge; University of Manchester; University of Manchester; University of London; King's College London; University of Sheffield; University of Manchester; Royal Manchester Children's Hospital; University of Manchester; Royal Manchester Children's Hospital; University of Manchester	Goodyer, I (corresponding author), Univ Cambridge, Dept Psychiat, Dev Psychiat Sect, Cambridge CB2 2AH, England.	ig104@cam.ac.uk	Byford, Sarah/D-1699-2010; Barrett, Barbara M/F-7606-2010	Byford, Sarah/0000-0001-7084-1495; Barrett, Barbara M/0000-0002-0270-6256; Dubicka, Bernadka/0000-0002-8907-8589				American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; Bilenberg N, 2003, EUR CHILD ADOLES PSY, V12, P298, DOI 10.1007/s00787-003-0343-1; Birmaher B, 2000, ARCH GEN PSYCHIAT, V57, P29, DOI 10.1001/archpsyc.57.1.29; Byford S, 1999, BRIT J PSYCHIAT, V174, P56, DOI 10.1192/bjp.174.1.56; Clarke G, 2005, J AM ACAD CHILD PSY, V44, P888, DOI 10.1016/S0890-8567(09)62194-8; CRITSCHRISTOPH P, 1991, J CONSULT CLIN PSYCH, V59, P20, DOI 10.1037/0022-006X.59.1.20; Curry J, 2006, J AM ACAD CHILD PSY, V45, P1427, DOI 10.1097/01.chi.0000240838.78984.e2; Diggle PJ, 1994, ANAL LONGITUDINAL DA; Dubicka B, 2006, BRIT J PSYCHIAT, V189, P393, DOI 10.1192/bjp.bp.105.011833; Dunn V, 2006, BRIT J PSYCHIAT, V188, P216, DOI 10.1192/bjp.188.3.216; Dyrborg J, 2000, EUR CHILD ADOLES PSY, V9, P195, DOI 10.1007/s007870070043; Fombonne E, 2001, BRIT J PSYCHIAT, V179, P210, DOI 10.1192/bjp.179.3.210; Gowers SG, 1999, BRIT J PSYCHIAT, V174, P413, DOI 10.1192/bjp.174.5.413; Guy W., 1976, ECDEU ASS MAN PSYCH; Guy W, 1976, ECDEU ASSESSMENT MAN, DOI DOI 10.1037/E591322011-001; Harrington R, 1998, BRIT MED J, V316, P1559, DOI 10.1136/bmj.316.7144.1559; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; March J, 2004, JAMA-J AM MED ASSOC, V292, P807; Melvin GA, 2006, J AM ACAD CHILD PSY, V45, P1151, DOI 10.1097/01.chi.0000233157.21925.71; *NAT COLL CTR MENT, 2004, 23 NAT COLL CTR MENT; National Collaborating Centre for Mental Health, 2004, DEPR MAN DEPR PRIM S; POZNANSKI EO, 1984, J AM ACAD CHILD PSY, V23, P191, DOI 10.1097/00004583-198403000-00011; Roberts C, 1999, STAT MED, V18, P2605, DOI 10.1002/(SICI)1097-0258(19991015)18:19<2605::AID-SIM237>3.0.CO;2-N; VALLIS TM, 1986, J CONSULT CLIN PSYCH, V54, P381, DOI 10.1037/0022-006X.54.3.381; Whittington CJ, 2004, LANCET, V363, P1341, DOI 10.1016/S0140-6736(04)16043-1; Wood A, 1995, J CHILD ADOL PSYCHOP, V36, P298	26	232	234	2	72	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 21	2007	335	7611					142	146A		10.1136/bmj.39224.494340.55	http://dx.doi.org/10.1136/bmj.39224.494340.55			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	195RA	17556431	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000248428100035
J	Shetty, KD; Bhattacharya, J				Shetty, Kanaka D.; Bhattacharya, Jayanta			Changes in hospital mortality associated with residency work-hour regulations	ANNALS OF INTERNAL MEDICINE			English	Article							GRADUATE MEDICAL-EDUCATION; REDUCED DUTY HOURS; PATIENT SAFETY; ERRORS; CARE; LIMITS; TESTS	Background: In 2002, the Accreditation Council on Graduate Medical Education enacted regulations, effective 1 July 2003, that limited work hours for all residency programs in the United States. Objective: To determine whether work-hour regulations were associated with changes in mortality in hospitalized patients. Design: Comparison of mortality rates in high-risk teaching service patients hospitalized before and after July 2003, with nonteaching service patients used as a control group. Setting: 551 U.S. community hospitals included in the Healthcare Cost and Utilization Project's Nationwide Inpatient Survey between January 2001 and December 2004. Patients: 1 511 945 adult patients admitted for 20 medical and 15 surgical diagnoses. Measurement: Inpatient mortality. Results: In 1 268738 medical patients examined, the regulations were associated with a 0.25% reduction in the absolute mortality rate (P = 0.043) and a 3.75% reduction in the relative risk for death. In subgroup analyses, particularly large improvements in mortality were observed among patients admitted for infectious diseases (change, -0.66%; P = 0.007) and in medical patients older than 80 years of age (change, -0.71 %; P = 0.005). By contrast, in 243 207 surgical patients, regulations were not associated with statistically significant changes (change, 0.13%; P 0.54). Limitations: Teaching status was assigned according to hospital characteristics because direct information on each patient's provider was not available. Results reflect changes associated with the sum of regulations, not specifically with caps on work hours. Conclusions: The work-hour regulations were associated with decreased short-term mortality among high-risk medical patients in teaching hospitals but were not associated with statistically significant changes among surgical patients in teaching hospitals.	Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA; Stanford Univ, Stanford, CA 94305 USA; Natl Bur Econ Res, Cambridge, MA 02138 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; National Bureau of Economic Research	Shetty, KD (corresponding author), Vet Affairs Palo Alto Hlth Care Syst, 3801 Miranda Ave, Palo Alto, CA 94304 USA.							Accreditation Council for Graduate Medical Education, ACGMES APPR LIM RES; Ai CR, 2003, ECON LETT, V80, P123, DOI 10.1016/S0165-1765(03)00032-6; Arora V, 2006, ANN INTERN MED, V144, P792, DOI 10.7326/0003-4819-144-11-200606060-00005; Bailit JL, 2004, OBSTET GYNECOL, V103, P613, DOI 10.1097/01.AOG.0000119225.57285.c1; Bertrand M, 2004, Q J ECON, V119, P249, DOI 10.1162/003355304772839588; Brotherton SE, 2004, JAMA-J AM MED ASSOC, V292, P1032, DOI 10.1001/jama.292.9.1032; Brotherton SE, 2005, JAMA-J AM MED ASSOC, V294, P1075, DOI 10.1001/jama.294.9.1075; Brotherton SE, 2000, JAMA-J AM MED ASSOC, V284, P1121, DOI 10.1001/jama.284.9.1121; Brotherton SE, 2003, JAMA-J AM MED ASSOC, V290, P1197, DOI 10.1001/jama.290.9.1197; Brotherton SE, 2001, JAMA-J AM MED ASSOC, V286, P1056, DOI 10.1001/jama.286.9.1056; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Davies HTO, 1998, BRIT MED J, V316, P989, DOI 10.1136/bmj.316.7136.989; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Ellman PI, 2004, ANN THORAC SURG, V78, P906, DOI 10.1016/j.athoracsur.2004.04.006; Fletcher KE, 2004, ANN INTERN MED, V141, P851, DOI 10.7326/0003-4819-141-11-200412070-00009; Goldman HH, 2006, NEW ENGL J MED, V354, P1378, DOI 10.1056/NEJMsa053737; HAUSMAN JA, 1978, ECONOMETRICA, V46, P1251, DOI 10.2307/1913827; Heckman J.J., 1981, STRUCTURAL ANAL DISC; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Howard DL, 2004, J GEN INTERN MED, V19, P1, DOI 10.1111/j.1525-1497.2004.30336.x; Irani JL, 2005, SURGERY, V138, P246, DOI 10.1016/j.surg.2005.06.010; Landrigan CP, 2006, JAMA-J AM MED ASSOC, V296, P1063, DOI 10.1001/jama.296.9.1063; Landrigan CP, 2004, NEW ENGL J MED, V351, P1838, DOI 10.1056/NEJMoa041406; Lieberman Jayme D, 2005, Curr Surg, V62, P231, DOI 10.1016/j.cursur.2004.06.015; Philibert I, 2002, JAMA-J AM MED ASSOC, V288, P1112, DOI 10.1001/jama.288.9.1112; PHILIBERT I, SELECTED ARTICLES RE; Poulose BK, 2005, ANN SURG, V241, P847, DOI 10.1097/01.sla.0000164075.18748.38; Vidyarthi A, 2005, J GEN INTERN MED, V20, P969, DOI 10.1111/j.1525-1497.2005.051477.x; Vidyarthi AR, 2006, ACAD MED, V81, P76, DOI 10.1097/00001888-200601000-00019; Volpp KGM, 2003, NEW ENGL J MED, V348, P851, DOI 10.1056/NEJMsb021667; Whang EE, 2003, ANN SURG, V237, P449, DOI 10.1097/00000658-200304000-00001; Winslow Emily R, 2004, Curr Surg, V61, P602, DOI 10.1016/j.cursur.2004.06.013; Wooldridge J., 2002, ECONOMETRIC ANAL CRO	33	130	130	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 17	2007	147	2					73	80		10.7326/0003-4819-147-2-200707170-00161	http://dx.doi.org/10.7326/0003-4819-147-2-200707170-00161			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	192CV	17548403				2022-12-28	WOS:000248179300001
J	Batt, CA				Batt, Carl A.			Materials science - Food pathogen detection	SCIENCE			English	Editorial Material							ESCHERICHIA-COLI O157-H7		Cornell Univ, Dept Food Sci, Ithaca, NY 14853 USA	Cornell University	Batt, CA (corresponding author), Cornell Univ, Dept Food Sci, Ithaca, NY 14853 USA.	cab10@cornell.edu						Cady NC, 2005, SENSOR ACTUAT B-CHEM, V107, P332, DOI 10.1016/j.snb.2004.10.022; Dierksen KP, 2004, J APPL TOXICOL, V24, P363, DOI 10.1002/jat.1030; FSIS-USDA, 1995, FED REGISTER, V60, P49553; Ilic B, 2001, J VAC SCI TECHNOL B, V19, P2825, DOI 10.1116/1.1421572; Ochoa ML, 2005, ANAL CHEM, V77, P5258, DOI 10.1021/ac0502596; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Ramos D, 2006, J APPL PHYS, V100, DOI 10.1063/1.2370507; Yu CX, 2006, ANAL CHEM, V78, P2500, DOI 10.1021/ac051828c	8	97	99	2	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 15	2007	316	5831					1579	1580		10.1126/science.1140729	http://dx.doi.org/10.1126/science.1140729			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178SH	17569853				2022-12-28	WOS:000247239900029
J	Kawaguchi, S; Ng, DTW				Kawaguchi, Shinichi; Ng, Davis T. W.			SnapShot: ER-associated protein degradation pathways	CELL			English	Editorial Material							ENDOPLASMIC-RETICULUM; QUALITY-CONTROL; UBIQUITIN LIGASE		Natl Univ Singapore, Temasek Life Sci Lab, Singapore 117604, Singapore; Natl Univ Singapore, Dept Biol Sci, Singapore 117604, Singapore	National University of Singapore; National University of Singapore	Kawaguchi, S (corresponding author), Natl Univ Singapore, Temasek Life Sci Lab, Singapore 117604, Singapore.							Hassink G, 2005, BIOCHEM J, V388, P647, DOI 10.1042/BJ20041241; Ismail N, 2006, CELL, V126, P237, DOI 10.1016/j.cell.2006.07.001; Kim I, 2006, J CELL BIOL, V172, P211, DOI 10.1083/jcb.200507149; McClellan AJ, 2005, NAT CELL BIOL, V7, P736, DOI 10.1038/ncb0805-736; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Moremen KW, 2006, CURR OPIN STRUC BIOL, V16, P592, DOI 10.1016/j.sbi.2006.08.005; Oda Y, 2006, J CELL BIOL, V172, P383, DOI 10.1083/jcb.200507057; Oyadomari S, 2006, CELL, V126, P727, DOI 10.1016/j.cell.2006.06.051; Romisch K, 2005, ANNU REV CELL DEV BI, V21, P435, DOI 10.1146/annurev.cellbio.21.012704.133250; Song BL, 2005, MOL CELL, V19, P829, DOI 10.1016/j.molcel.2005.08.009; Wang QY, 2006, J CELL BIOL, V174, P963, DOI 10.1083/jcb.200605100; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041	13	13	13	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 15	2007	129	6					1230	+						2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	180UA	17574032	Bronze			2022-12-28	WOS:000247390400026
J	Lietha, D; Cai, XM; Ceccarelli, DFJ; Li, YQ; Schaller, MD; Eck, MJ				Lietha, Daniel; Cai, Xinming; Ceccarelli, Derek F. J.; Li, Yiqun; Schaller, Michael D.; Eck, Michael J.			Structural basis for the autoinhibition of focal adhesion kinase	CELL			English	Article							PROTEIN-TYROSINE KINASE; FERM DOMAIN; CRYSTAL-STRUCTURE; GROWTH-FACTOR; PHOSPHORYLATION; FAK; BINDING; ACTIVATION; MECHANISMS; COMPLEX	Appropriate tyrosine kinase signaling depends on coordinated sequential coupling of protein-protein interactions with catalytic activation. Focal adhesion kinase (FAK) integrates signals from integrin and growth factor receptors to regulate cellular responses including cell adhesion, migration, and survival. Here, we describe crystal structures representing both autoinhibited and active states of FAK The inactive structure reveals a mechanism of inhibition in which the N-terminal FERM domain directly binds the kinase domain, blocking access to the catalytic cleft and protecting the FAK activation loop from Src phosphorylation. Additionally, the FERM domain sequesters the Tyr397 autophosphorylation and Src recruitment site, which lies in the linker connecting the FERM and kinase domains. The active phosphorylated FAK kinase adopts a conformation that is immune to FERM inhibition. Our biochemical and structural analysis shows how the architecture of autoinhibited FAK orchestrates an activation sequence of FERM domain displacement, linker autophosphorylation, Src recruitment, and full catalytic activation.	Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada	Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; University of North Carolina; University of North Carolina Chapel Hill; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Eck, MJ (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	eck@red.dfci.harvard.edu	Lietha, Daniel/L-8041-2014; Lietha, Daniel/AAD-1952-2022	Lietha, Daniel/0000-0002-6133-6486; Lietha, Daniel/0000-0002-6133-6486; Ceccarelli, Derek/0000-0002-2674-9234	NATIONAL CANCER INSTITUTE [T32CA009361, R01CA080942] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001646] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL048675, P01HL045100] Funding Source: NIH RePORTER; NCI NIH HHS [T32 CA009361, 5T32CA09361, R01 CA080942, R01 CA080942-07, CA080942] Funding Source: Medline; NCRR NIH HHS [P41 RR001646-220082, P41 RR001646-230082, P41 RR001646] Funding Source: Medline; NHLBI NIH HHS [P01 HL048675, HL048675, HL45100, P01 HL048675-135389, P01 HL045100] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Arold ST, 2002, STRUCTURE, V10, P319, DOI 10.1016/S0969-2126(02)00717-7; Bershadsky AD, 2003, ANNU REV CELL DEV BI, V19, P677, DOI 10.1146/annurev.cellbio.19.111301.153011; Boggon TJ, 2005, BLOOD, V106, P996, DOI 10.1182/blood-2005-02-0707; Boggon TJ, 2004, ONCOGENE, V23, P7918, DOI 10.1038/sj.onc.1208081; CALALB MB, 1995, MOL CELL BIOL, V15, P954; Carter N, 2002, NAT CELL BIOL, V4, P565, DOI 10.1038/ncb823; Ceccarelli DFJ, 2006, J BIOL CHEM, V281, P252, DOI 10.1074/jbc.M509188200; Chen SY, 2006, MOL CELL BIOL, V26, P5155, DOI 10.1128/MCB.02186-05; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Chishti AH, 1998, TRENDS BIOCHEM SCI, V23, P281, DOI 10.1016/S0968-0004(98)01237-7; Cohen LA, 2005, CURR CANCER DRUG TAR, V5, P629, DOI 10.2174/156800905774932798; Cohen LA, 2005, J BIOL CHEM, V280, P8197, DOI 10.1074/jbc.M412021200; Cooper LA, 2003, MOL CELL BIOL, V23, P8030, DOI 10.1128/MCB.23.22.8030-8041.2003; Deindl S, 2007, CELL, V129, P735, DOI 10.1016/j.cell.2007.03.039; DeLano W.L, PYMOL MOL GRAPHICS S; Dunty JM, 2004, MOL CELL BIOL, V24, P5353, DOI 10.1128/MCB.24.12.5353-5368.2004; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; GUAN JL, 1992, NATURE, V358, P690, DOI 10.1038/358690a0; Harrison SC, 2003, CELL, V112, P737, DOI 10.1016/S0092-8674(03)00196-X; Hayashi I, 2002, NAT STRUCT BIOL, V9, P101, DOI 10.1038/nsb755; Hubbard SR, 1997, EMBO J, V16, P5572, DOI 10.1093/emboj/16.18.5572; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Ilic D, 2003, CIRC RES, V92, P300, DOI 10.1161/01.RES.0000055016.36679.23; ILLC D, 1995, NATURE, V377, P539; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; LaFevre-Bernt M, 1998, J BIOL CHEM, V273, P32129, DOI 10.1074/jbc.273.48.32129; Leu TH, 2002, ONCOGENE, V21, P6992, DOI 10.1038/sj.onc.1205904; Lyons PD, 2001, J BIOL CHEM, V276, P24422, DOI 10.1074/jbc.M011080200; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; McLean GW, 2005, NAT REV CANCER, V5, P505, DOI 10.1038/nrc1647; Miao H, 2000, NAT CELL BIOL, V2, P62, DOI 10.1038/35000008; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Moarefi I, 1997, NATURE, V385, P650, DOI 10.1038/385650a0; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagar B, 2003, CELL, V112, P859, DOI 10.1016/S0092-8674(03)00194-6; Nikolopoulos SN, 2005, CELL CYCLE, V4, P429, DOI 10.4161/cc.4.3.1547; Nowakowski J, 2002, STRUCTURE, V10, P1659, DOI 10.1016/S0969-2126(02)00907-3; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Pearson MA, 2000, CELL, V101, P259, DOI 10.1016/S0092-8674(00)80836-3; REYNOLDS AB, 1989, MOL CELL BIOL, V9, P629, DOI 10.1128/MCB.9.2.629; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; SCHALLER MD, 1995, MOL CELL BIOL, V15, P2635; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; SCHALLER MD, 1992, P NATL ACAD SCI USA, V89, P5192, DOI 10.1073/pnas.89.11.5192; Schock F, 2002, ANNU REV CELL DEV BI, V18, P463, DOI 10.1146/annurev.cellbio.18.022602.131838; Sicheri F, 1997, CURR OPIN STRUC BIOL, V7, P777, DOI 10.1016/S0959-440X(97)80146-7; Sieg DJ, 2000, NAT CELL BIOL, V2, P249, DOI 10.1038/35010517; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Tachibana K, 1997, J BIOL CHEM, V272, P29083, DOI 10.1074/jbc.272.46.29083; Thomas JW, 1999, J BIOL CHEM, V274, P36684, DOI 10.1074/jbc.274.51.36684; Toutant M, 2002, MOL CELL BIOL, V22, P7731, DOI 10.1128/MCB.22.22.7731-7743.2002; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Yamaguchi H, 1996, NATURE, V384, P484, DOI 10.1038/384484a0; Zhu XT, 1999, STRUCTURE, V7, P651, DOI 10.1016/S0969-2126(99)80086-0	57	316	328	1	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 15	2007	129	6					1177	1187		10.1016/j.cell.2007.05.041	http://dx.doi.org/10.1016/j.cell.2007.05.041			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	180UA	17574028	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000247390400020
J	Nachury, MV; Loktev, AV; Zhang, Q; Westlake, CJ; Peranen, J; Merdes, A; Slusarski, DC; Scheller, RH; Bazan, JF; Sheffield, VC; Jackson, PK				Nachury, Maxence V.; Loktev, Alexander V.; Zhang, Qihong; Westlake, Christopher J.; Peranen, Johan; Merdes, Andreas; Slusarski, Diane C.; Scheller, Richard H.; Bazan, J. Fernando; Sheffield, Val C.; Jackson, Peter K.			A core complex of BBS proteins cooperates with the GTPase Rab8 to promote ciliary membrane biogenesis	CELL			English	Article							BARDET-BIEDL-SYNDROME; DIGENIC RETINITIS-PIGMENTOSA; INTRAFLAGELLAR TRANSPORT; MOLECULAR CHARACTERIZATION; PLASMA-MEMBRANE; IFT PARTICLES; CELLS ANTENNA; FLAGELLAR; CILIUM; GENES	Primary cilium dysfunction underlies the pathogenesis of Bardet-Biedl syndrome (BBS), a genetic disorder whose symptoms include obesity, retinal degeneration, and nephropathy. However, despite the identification of 12 BBS genes, the molecular basis of BBS remains elusive. Here we identify a complex composed of seven highly conserved BBS proteins. This complex, the BBSome, localizes to nonmembranous centriolar satellites in the cytoplasm but also to the membrane of the cilium. Interestingly, the BBSome is required for ciliogenesis but is dispensable for centriolar satellite function. This ciliogenic function is mediated in part by the Rab8 GDP/GTP exchange factor, which localizes to the basal body and contacts the BBSome. Strikingly, Rab8(GTP) enters the primary cilium and promotes extension of the ciliary membrane. Conversely, preventing Rab8 GTP production blocks ciliation in cells and yields characteristic BBS phenotypes in zebrafish. Our data reveal that BBS may be caused by defects in vesicular transport to the cilium.	Genentech Inc, San Francisco, CA 94080 USA; Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; Univ Iowa, Howard Hughes Med Inst, Iowa City, IA 52242 USA; Univ Helsinki, Inst Biotechnol, FIN-00014 Helsinki, Finland; CNRS, Ctr Rech Pierre Fabre, Inst Sci & Technol Medicament Toulouse, F-31400 Toulouse, France; Univ Iowa, Dept Biol Sci, Iowa City, IA 52242 USA	Roche Holding; Genentech; University of Iowa; Howard Hughes Medical Institute; University of Iowa; University of Helsinki; Centre National de la Recherche Scientifique (CNRS); University of Iowa	Nachury, MV (corresponding author), Genentech Inc, San Francisco, CA 94080 USA.	nachury@gene.com	Nachury, Maxence/H-3695-2019; Westlake, Christopher/AAG-1150-2019; Nachury, Maxence/A-8759-2008; Bazan, J. Fernando/B-4562-2010	Nachury, Maxence/0000-0003-4918-1562; Westlake, Christopher/0000-0001-7476-2014; Nachury, Maxence/0000-0003-4918-1562; Slusarski, Diane/0000-0003-3793-8636; Jackson, Peter/0000-0002-1742-2539; Sheffield, Val/0000-0002-6282-0835	NATIONAL EYE INSTITUTE [R01EY011298] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054811] Funding Source: NIH RePORTER; NEI NIH HHS [R01-EY-11298] Funding Source: Medline; NIGMS NIH HHS [R01-GM-54811] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ang AL, 2003, J CELL BIOL, V163, P339, DOI 10.1083/jcb.200307046; Ansley SJ, 2003, NATURE, V425, P628, DOI 10.1038/nature02030; Avidor-Reiss T, 2004, CELL, V117, P527, DOI 10.1016/S0092-8674(04)00412-X; Begley MJ, 2003, MOL CELL, V12, P1391, DOI 10.1016/S1097-2765(03)00486-6; Blacque OE, 2006, CELL MOL LIFE SCI, V63, P2145, DOI 10.1007/s00018-006-6180-x; Blacque OE, 2004, GENE DEV, V18, P1630, DOI 10.1101/gad.1194004; CHEESEMAN IM, 2005, SCI STKE, pPI1, DOI DOI 10.1126/STKE.2662005PI1; Chiang AP, 2004, AM J HUM GENET, V75, P475, DOI 10.1086/423903; Cole DG, 1998, J CELL BIOL, V141, P993, DOI 10.1083/jcb.141.4.993; Dammermann A, 2002, J CELL BIOL, V159, P255, DOI 10.1083/jcb.200204023; Deane JA, 2001, CURR BIOL, V11, P1586, DOI 10.1016/S0960-9822(01)00484-5; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; DOWLER S, 2002, SCI STKE, pPL6, DOI DOI 10.1126/STKE.2002.129.PL6; Essner JJ, 2002, NATURE, V418, P37, DOI 10.1038/418037a; Fan YL, 2004, NAT GENET, V36, P989, DOI 10.1038/ng1414; Follit JA, 2006, MOL BIOL CELL, V17, P3781, DOI 10.1091/mbc.E06-02-0133; Hames RS, 2005, MOL BIOL CELL, V16, P1711, DOI 10.1091/mbc.E04-08-0688; Hattula K, 2002, MOL BIOL CELL, V13, P3268, DOI 10.1091/mbc.E02-03-0143; Haycraft CJ, 2005, PLOS GENET, V1, P480, DOI 10.1371/journal.pgen.0010053; HUBER LA, 1993, J CELL BIOL, V123, P35, DOI 10.1083/jcb.123.1.35; Inglis PN, 2006, TRENDS GENET, V22, P491, DOI 10.1016/j.tig.2006.07.006; Jekely G, 2006, BIOESSAYS, V28, P191, DOI 10.1002/bies.20369; KAJIWARA K, 1994, SCIENCE, V264, P1604, DOI 10.1126/science.8202715; Katsanis N, 2004, HUM MOL GENET, V13, pR65, DOI 10.1093/hmg/ddh092; Kim JC, 2005, J CELL SCI, V118, P1007, DOI 10.1242/jcs.01676; Kim JC, 2004, NAT GENET, V36, P462, DOI 10.1038/ng1352; KOZMINSKI KG, 1993, P NATL ACAD SCI USA, V90, P5519, DOI 10.1073/pnas.90.12.5519; Kubo A, 1999, J CELL BIOL, V147, P969, DOI 10.1083/jcb.147.5.969; Laurier V, 2006, EUR J HUM GENET, V14, P1195, DOI 10.1038/sj.ejhg.5201688; Li JB, 2004, CELL, V117, P541, DOI 10.1016/S0092-8674(04)00450-7; Loewen CJR, 2001, J BIOL CHEM, V276, P22388, DOI 10.1074/jbc.M011710200; Mak HY, 2006, NAT GENET, V38, P363, DOI 10.1038/ng1739; Marshall WF, 2006, CURR BIOL, V16, pR604, DOI 10.1016/j.cub.2006.07.012; May SR, 2005, DEV BIOL, V287, P378, DOI 10.1016/j.ydbio.2005.08.050; Mikule K, 2007, NAT CELL BIOL, V9, P160, DOI 10.1038/ncb1529; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P1068, DOI 10.1093/nar/18.4.1068; Moritz OL, 2001, MOL BIOL CELL, V12, P2341, DOI 10.1091/mbc.12.8.2341; Nishimura DY, 2004, P NATL ACAD SCI USA, V101, P16588, DOI 10.1073/pnas.0405496101; OHLEMILLER KK, 1995, NEUROREPORT, V6, P845, DOI 10.1097/00001756-199504190-00005; Ou GS, 2005, NATURE, V436, P583, DOI 10.1038/nature03818; Pazour GJ, 1999, J CELL BIOL, V144, P473, DOI 10.1083/jcb.144.3.473; Peranen J, 1996, J CELL BIOL, V135, P153, DOI 10.1083/jcb.135.1.153; Santagata S, 2001, SCIENCE, V292, P2041, DOI 10.1126/science.1061233; Scholey JM, 2006, CELL, V125, P439, DOI 10.1016/j.cell.2006.04.013; Singla V, 2006, SCIENCE, V313, P629, DOI 10.1126/science.1124534; Teo HL, 2006, CELL, V125, P99, DOI 10.1016/j.cell.2006.01.047; WalchSolimena C, 1997, J CELL BIOL, V137, P1495, DOI 10.1083/jcb.137.7.1495; Wang CW, 2006, J CELL BIOL, V174, P973, DOI 10.1083/jcb.200605106; Yen HJ, 2006, HUM MOL GENET, V15, P667, DOI 10.1093/hmg/ddi468; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	50	964	993	2	66	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 15	2007	129	6					1201	1213		10.1016/j.cell.2007.03.053	http://dx.doi.org/10.1016/j.cell.2007.03.053			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	180UA	17574030	Bronze			2022-12-28	WOS:000247390400022
J	Coombes, R				Coombes, Rebecca			Cold turkey	BRITISH MEDICAL JOURNAL			English	Article												rcoombes@bmjgroup.com						Advisory Council on the Misuse of Drugs, 2005, METH REV; Fulde GWO, 2007, MED J AUSTRALIA, V186, P334, DOI 10.5694/j.1326-5377.2007.tb00931.x; GLOSSOP M, 2006, BRIT MED J, V333, P272; Gray SD, 2007, MED J AUSTRALIA, V186, P336, DOI 10.5694/j.1326-5377.2007.tb00932.x; *HAMPSH CONST, 2007, NAT PROBL PROF METH; *PROPR ASS GREAT B, 2007, INF US COUNT PSEUD L	6	2	2	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUN 9	2007	334	7605					1190	1192		10.1136/bmj.39223.422824.AD	http://dx.doi.org/10.1136/bmj.39223.422824.AD			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	179GF	17556470	Green Published			2022-12-28	WOS:000247277000028
J	Rocha, V; Gluckman, E				Rocha, Vanderson; Gluckman, Eliane			Outcomes of transplantation in children with acute leukaemia	LANCET			English	Editorial Material							UMBILICAL-CORD BLOOD; BONE-MARROW-TRANSPLANTATION; UNRELATED DONORS; HEMATOLOGIC MALIGNANCY; CELL TRANSPLANTATION; ADULTS; RECONSTITUTION		Hop St Louis, Bone Marrow Transplant Unit, F-75010 Paris, France; Hop St Louis, Clin Res Lab Cell Therapy, F-75010 Paris, France; Hop St Louis, Dept Haematol, F-75010 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite	Rocha, V (corresponding author), Hop St Louis, Bone Marrow Transplant Unit, F-75010 Paris, France.	vanderson.rocha@sls.ap-hop-paris.fr	eliane, Gluckman/AAA-5024-2021; Rocha, Vanderson/AAO-1691-2020					Barker JN, 2005, BLOOD, V105, P1343, DOI 10.1182/blood-2004-07-2717; Eapen M, 2007, LANCET, V369, P1947, DOI 10.1016/S0140-6736(07)60915-5; Flomenberg N, 2004, BLOOD, V104, P1923, DOI 10.1182/blood-2004-03-0803; Gluckman E, 2004, EXP HEMATOL, V32, P397, DOI 10.1016/j.exphem.2004.01.002; GLUCKMAN E, 1989, NEW ENGL J MED, V321, P1174, DOI 10.1056/NEJM198910263211707; Grewal SS, 2003, BLOOD, V101, P4233, DOI 10.1182/blood-2002-08-2510; Laughlin MJ, 2004, NEW ENGL J MED, V351, P2265, DOI 10.1056/NEJMoa041276; Rocha V, 2001, BLOOD, V97, P2962, DOI 10.1182/blood.V97.10.2962; Rocha V, 2004, NEW ENGL J MED, V351, P2276, DOI 10.1056/NEJMoa041469; RUBINSTEIN P, 1995, P NATL ACAD SCI USA, V92, P10119, DOI 10.1073/pnas.92.22.10119; Takahashi S, 2004, BLOOD, V104, P3813, DOI 10.1182/blood-2004-03-1001; Yakoub-Agha I, 2006, J CLIN ONCOL, V24, P5695, DOI 10.1200/JCO.2006.08.0952	12	6	12	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 9	2007	369	9577					1906	1908		10.1016/S0140-6736(07)60892-7	http://dx.doi.org/10.1016/S0140-6736(07)60892-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	177IQ	17560429				2022-12-28	WOS:000247147200006
J	Marvier, M; McCreedy, C; Regetz, J; Kareiva, P				Marvier, Michelle; McCreedy, Chanel; Regetz, James; Kareiva, Peter			A meta-analysis of effects of Bt cotton and maize on nontarget invertebrates	SCIENCE			English	Article							TRANSGENIC CROPS; RISK-ASSESSMENT; BIOTECHNOLOGY; ENVIRONMENT	Although scores of experiments have examined the ecological consequences of transgenic Bacillus thuringiensis ( Bt) crops, debates continue regarding the nontarget impacts of this technology. Quantitative reviews of existing studies are crucial for better gauging risks and improving future risk assessments. To encourage evidence-based risk analyses, we constructed a searchable database for nontarget effects of Bt crops. A meta-analysis of 42 field experiments indicates that nontarget invertebrates are generally more abundant in Bt cotton and Bt maize fields than in nontransgenic fields managed with insecticides. However, in comparison with insecticide-free control fields, certain nontarget taxa are less abundant in Bt fields.	Santa Clara Univ, Inst Environm Studies, Santa Clara, CA 95053 USA; Univ Calif Santa Barbara, NCEAS, Santa Barbara, CA 93101 USA; Nature Conservancy, Seattle, WA 98105 USA	Santa Clara University; National Center for Ecological Analysis & Synthesis; University of California System; University of California Santa Barbara; Nature Conservancy	Marvier, M (corresponding author), Santa Clara Univ, Inst Environm Studies, Santa Clara, CA 95053 USA.	mmarvier@scu.edu		Marvier, Michelle/0000-0001-8360-9265				Andow DA, 2006, ECOL LETT, V9, P196, DOI 10.1111/j.1461-0248.2005.00846.x; BRECKLING B, 2004, RISK HAZARD DAMAGE S, V1, P256; Clark BW, 2005, J AGR FOOD CHEM, V53, P4643, DOI 10.1021/jf040442k; Lovei GL, 2005, ENTOMOL EXP APPL, V114, P1, DOI 10.1111/j.0013-8703.2005.00235.x; Marvier M, 2002, ECOL APPL, V12, P1119, DOI 10.1890/1051-0761(2002)012[1119:IRAFNS]2.0.CO;2; Romeis J, 2006, NAT BIOTECHNOL, V24, P63, DOI 10.1038/nbt1180; Snow AA, 2005, ECOL APPL, V15, P377, DOI 10.1890/04-0539; Sturgis P, 2005, NEW GENET SOC, V24, P31, DOI 10.1080/14636770500037693; Torgersen H, 2004, EMBO REP, V5, pS17, DOI 10.1038/sj.embor.7400231; USDA, 2006, AGR CHEM US 2005 FIE; Wolfenbarger LL, 2000, SCIENCE, V290, P2088, DOI 10.1126/science.290.5499.2088	12	288	329	5	151	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 8	2007	316	5830					1475	1477		10.1126/science.1139208	http://dx.doi.org/10.1126/science.1139208			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176EE	17556584				2022-12-28	WOS:000247066400042
J	Ward, L; Franks, P				Ward, Lisa; Franks, Peter			Changes in health care expenditure associated with gaining or losing health insurance	ANNALS OF INTERNAL MEDICINE			English	Article							UNINSURED ADULTS; MEDICAL-CARE; COVERAGE; ACCESS; SERVICES; MATTER; MODEL; COST	Background: Cross-sectional data suggest that changes in health insurance status are associated with expenditures. No national longitudinal analysis has examined this relationship. Objective: To evaluate the association between changes in health insurance status and expenditures. Design: Cohort analyses using the 2000 to 2003 Medical Expenditure Panel Surveys. Setting: U.S. civilian noninstitutionalized population. Participants: Three 2-year cohorts that included 20 848 adults age 21 to 64 years who were stratified by insurance type (private, public, military, or none): 17 130 participants were insured in both years, 342 participants were insured in year 1 and were uninsured in year 2, 385 participants were uninsured in year 1 and were insured in year 2, and 2991 participants were uninsured in both years. Persons who were insured for longer than 2 months but less than 10 months or who switched insurance type were excluded (n = 4039). Measurements: Annual health care expenditures (any or none; amount, contingent on any expenditure; and the difference between year 1 and year 2). Results: Adjusted expenditure probabilities were similar among all participant groups while insured and were higher than those for all participant groups while uninsured: 92.1% (95% CI, 91.4% to 92.7%) in year 1 and 91.8% (CI, 90.9% to 92.5%) in year 2 for persons insured in both years, 74.2% (CI, 71.7% to 76.5%) in year 1 and 74.8% (CI, 72.1% to 77.4%) in year 2 for persons uninsured in both years, and 90.7% (CI, 87.1 % to 93.4%) for persons insured in year 1 and 74.6% (CI, 69.4% to 79.2%) for persons uninsured in year 2. The pattern was also consistent for the group that was uninsured in year 1 but insured in year 2. Adjusted annual expenditures among all participant groups with insurance were similar; expenditures among participant groups without insurance were similar but were lower than those among participants with insurance. Consistent differences in expenditures between year 1 and year 2 were observed for all groups. Limitation: Few participants changed insurance status. Conclusion: Changing insurance status is associated with changes in expenditures to levels that are similar to those for persons who are continuously insured or uninsured.	Univ Calif San Francisco, Dept Family & Community Med, San Francisco, CA 94110 USA	University of California System; University of California San Francisco	Ward, L (corresponding author), Univ Calif San Francisco, Dept Family & Community Med, 1001 Potrero Ave,Ward 83, San Francisco, CA 94110 USA.	lward@fcm.ucsf.edu						*AG HEALTHC RES QU, 2003, MED EXP PAN SURV HC; *AG HEALTHC RES QU, 2004, MED EXP PAN SURV HC; ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; Ayanian JZ, 2000, JAMA-J AM MED ASSOC, V284, P2061, DOI 10.1001/jama.284.16.2061; Bednarek HL, 2003, J HEALTH CARE POOR U, V14, P403, DOI 10.1177/1049208903255800; Broyles RW, 2002, J HEALTH CARE POOR U, V13, P95, DOI 10.1177/10492080222148647; Buchmueller TC, 2005, MED CARE RES REV, V62, P3, DOI 10.1177/1077558704271718; Burstin HR, 1998, INQUIRY-J HEALTH CAR, V35, P389; COHEN J, 1997, AG HEALTHC RES QUAL; DeNavas-Walt Carmen. Income poverty and health insurance coverage in the United States, 2005, CURRENT POPULATION R, V2006, P60; DOTY MM, 2004, ISSUE BRIEF COMMONW, V729, P1; DUAN NH, 1987, J ECONOMETRICS, V35, P25, DOI 10.1016/0304-4076(87)90079-0; Franks Peter, 2003, Ann Fam Med, V1, P156, DOI 10.1370/afm.24; Graubard BI, 1999, BIOMETRICS, V55, P652, DOI 10.1111/j.0006-341X.1999.00652.x; Gross CP, 2006, JAMA-J AM MED ASSOC, V296, P2815, DOI 10.1001/jama.296.23.2815; HADLEY J, 2003, HLTH AFF MILLWOOD S; HAFNEREATON C, 1993, JAMA-J AM MED ASSOC, V269, P787, DOI 10.1001/jama.269.6.787; *I MED BOARD HLTH, 2002, CAR COV TOO LITTL TO; LOHR KN, 1986, MED CARE, V24, pUS1; LONG SH, 1994, HEALTH AFFAIR, V13, P211, DOI 10.1377/hlthaff.13.2.211; LURIE N, 1984, NEW ENGL J MED, V311, P480, DOI 10.1056/NEJM198408163110735; MACHLIN MS, 2000, AHRQ PUBLICATION; MACHLIN MS, 2004, OVERVIEW METHODOLOGY; McWilliams JM, 2003, JAMA-J AM MED ASSOC, V290, P757, DOI 10.1001/jama.290.6.757; Muennig P, 2005, AM J PREV MED, V28, P59, DOI 10.1016/j.amepre.2004.09.005; PAULY MV, 1968, AM ECON REV, V58, P531; Short PF, 2003, HEALTH AFFAIR, V22, P244, DOI 10.1377/hlthaff.22.6.244; SHORT PF, 2003, ISSUE BRIEF COMMONW, V688, P1; Sudano JJ, 2003, AM J PUBLIC HEALTH, V93, P130, DOI 10.2105/AJPH.93.1.130; Van Buuren S, 1999, STAT MED, V18, P681, DOI 10.1002/(SICI)1097-0258(19990330)18:6<681::AID-SIM71>3.0.CO;2-R	30	24	24	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 5	2007	146	11					768	774		10.7326/0003-4819-146-11-200706050-00005	http://dx.doi.org/10.7326/0003-4819-146-11-200706050-00005			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	175HR	17548408				2022-12-28	WOS:000247005200002
J	Ormiston, J; Webster, M				Ormiston, John; Webster, Mark			Absorbable coronary stents	LANCET			English	Editorial Material							ELUTING STENT; ANGIOPLASTY; IMPLANTATION		Mercy Angiog, Auckland, New Zealand; Auckland City Hosp, Auckland, New Zealand	Auckland City Hospital	Ormiston, J (corresponding author), Mercy Angiog, Auckland, New Zealand.	johno@mercyangiography.co.nz						DUDEK D, 2007, ABSORB TRIAL 9 MONTH; Erbel R, 2007, LANCET, V369, P1869, DOI 10.1016/S0140-6736(07)60853-8; Finn AV, 2007, CIRCULATION, V115, P2435, DOI 10.1161/CIRCULATIONAHA.107.693739; Kotani J, 2006, J AM COLL CARDIOL, V47, P2108, DOI 10.1016/j.jacc.2005.11.092; Mintz GS, 1996, CIRCULATION, V94, P35, DOI 10.1161/01.CIR.94.1.35; Ormiston JA, 1997, CIRCULATION, V96, P468; Ormiston JA, 2007, CATHETER CARDIO INTE, V69, P128, DOI 10.1002/ccd.20895; SERRUYS PW, 1994, NEW ENGL J MED, V331, P489, DOI 10.1056/NEJM199408253310801; Virmani R, 2004, CIRCULATION, V109, P701, DOI 10.1161/01.CIR.0000116202.41966.D4	9	11	12	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 2	2007	369	9576					1839	1840		10.1016/S0140-6736(07)60829-0	http://dx.doi.org/10.1016/S0140-6736(07)60829-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	173ZS	17544749				2022-12-28	WOS:000246911600006
J	Doiron-Leyraud, N; Proust, C; LeBoeuf, D; Levallois, J; Bonnemaison, JB; Liang, RX; Bonn, DA; Hardy, WN; Taillefer, L				Doiron-Leyraud, Nicolas; Proust, Cyril; LeBoeuf, David; Levallois, Julien; Bonnemaison, Jean-Baptiste; Liang, Ruixing; Bonn, D. A.; Hardy, W. N.; Taillefer, Louis			Quantum oscillations and the Fermi surface in an underdoped high-T-c superconductor	NATURE			English	Article							STATE	Despite twenty years of research, the phase diagram of high-transition-temperature superconductors remains enigmatic(1,2). A central issue is the origin of the differences in the physical properties of these copper oxides doped to opposite sides of the superconducting region. In the overdoped regime, the material behaves as a reasonably conventional metal, with a large Fermi surface(3,4). The underdoped regime, however, is highly anomalous and appears to have no coherent Fermi surface, but only disconnected 'Fermi arcs'(5,6). The fundamental question, then, is whether underdoped copper oxides have a Fermi surface, and if so, whether it is topologically different from that seen in the overdoped regime. Here we report the observation of quantum oscillations in the electrical resistance of the oxygen-ordered copper oxide YBa2Cu3O6.5, establishing the existence of a well-defined Fermi surface in the ground state of underdoped copper oxides, once superconductivity is suppressed by a magnetic field. The low oscillation frequency reveals a Fermi surface made of small pockets, in contrast to the large cylinder characteristic of the overdoped regime. Two possible interpretations are discussed: either a small pocket is part of the band structure specific to YBa2Cu3O6.5 or small pockets arise from a topological change at a critical point in the phase diagram. Our understanding of high-transition-temperature (high-T-c) superconductors will depend critically on which of these two interpretations proves to be correct.	UPS, INSA 5147, UMR CNRS, Lab Natl Champs Magnet, F-31400 Toulouse, France; Univ Sherbrooke, Dept Phys, Sherbrooke, PQ J1K 2R1, Canada; Univ Sherbrooke, RQMP, Sherbrooke, PQ J1K 2R1, Canada; Univ British Columbia, Dept Phys & Astron, Vancouver, BC V6T 1Z4, Canada; Canadian Inst Adv Res, Toronto, ON M5G 1Z8, Canada	Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; University of Sherbrooke; University of Sherbrooke; University of British Columbia; Canadian Institute for Advanced Research (CIFAR)	Proust, C (corresponding author), UPS, INSA 5147, UMR CNRS, Lab Natl Champs Magnet, F-31400 Toulouse, France.	proust@lncmp.org; louis.taillefer@physique.usherbrooke.ca	Hardy, Walter Newbold/AAN-7827-2020					Andersen OK, 1995, J PHYS CHEM SOLIDS, V56, P1573, DOI 10.1016/0022-3697(95)00269-3; Basciano Heather, 2005, Nutr Metab (Lond), V2, P5, DOI 10.1186/1743-7075-2-5; Bascones E, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.012505; CAMPUZANO JC, 1990, PHYS REV LETT, V64, P2308, DOI 10.1103/PhysRevLett.64.2308; Chakravarty S, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.094503; FOWLER CM, 1992, PHYS REV LETT, V68, P534, DOI 10.1103/PhysRevLett.68.534; HAANAPPEL EG, 1993, J PHYS CHEM SOLIDS, V54, P1261, DOI 10.1016/0022-3697(93)90178-T; Hussey NE, 2003, NATURE, V425, P814, DOI 10.1038/nature01981; KIDO G, 1991, J PHYS CHEM SOLIDS, V52, P1465, DOI 10.1016/0022-3697(91)90126-K; Kyung B, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.165114; Lee PA, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.224517; Liang RX, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.180505; Liang RX, 2000, PHYSICA C, V336, P57, DOI 10.1016/S0921-4534(00)00091-5; Lin J, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.214506; Loram JW, 1998, J PHYS CHEM SOLIDS, V59, P2091, DOI 10.1016/S0022-3697(98)00180-2; Mackenzie AP, 1996, PHYS REV B, V53, P5848, DOI 10.1103/PhysRevB.53.5848; Nakayama K, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.014513; Norman MR, 2005, ADV PHYS, V54, P715, DOI [10.1080/00018730500459906, 10.1080/00018730500489906]; Norman MR, 1998, NATURE, V392, P157, DOI 10.1038/32366; Oganesyan V, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.195109; Orenstein J, 2000, SCIENCE, V288, P468, DOI 10.1126/science.288.5465.468; Pereg-Barnea T, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.184513; PICKETT WE, 1990, PHYS REV B, V42, P8764, DOI 10.1103/PhysRevB.42.8764; Plate M, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.077001; Portugall O, 2004, PHYSICA B, V346, P668, DOI 10.1016/j.physb.2004.01.080; Shen KM, 2005, SCIENCE, V307, P901, DOI 10.1126/science.1103627; SPRINGFORD M, 1992, PHYS REV LETT, V69, P2453, DOI 10.1103/PhysRevLett.69.2453; Stanescu TD, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.125110; Wosnitza J, 2000, PHYS REV B, V62, P11973, DOI 10.1103/PhysRevB.62.R11973; Yang KY, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.174501	30	764	773	4	191	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 31	2007	447	7144					565	568		10.1038/nature05872	http://dx.doi.org/10.1038/nature05872			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172YZ	17538614	Green Submitted			2022-12-28	WOS:000246842000042
J	Pitkin, J				Pitkin, Joan			Dysfunctional uterine bleeding	BRITISH MEDICAL JOURNAL			English	Editorial Material									Northwick Pk Hosp & Clin Res Ctr, NW London Hosp NHS Trust, Harrow HA1 3UJ, Middx, England	Imperial College London	Pitkin, J (corresponding author), Northwick Pk Hosp & Clin Res Ctr, NW London Hosp NHS Trust, Harrow HA1 3UJ, Middx, England.	Joan.Pitkin@nwlh.nhs.uk						*NAT I HLTH CLIN E, DIAGN MAN HEAV MENST; *ROYAL COLL OBST G, 1998, NAT EV CLIN GUID IN	2	13	14	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 26	2007	334	7603					1110	1111		10.1136/bmj.39203.399502.BE	http://dx.doi.org/10.1136/bmj.39203.399502.BE			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	174XB	17525454	Green Published			2022-12-28	WOS:000246975000036
J	Edgren, G; Hjalgrim, H; Reilly, M; Tran, TN; Rostgaard, K; Shanwell, A; Titlestad, K; Adami, J; Wikman, A; Jersild, C; Gridley, G; Wideroff, L; Nyren, O; Melbye, M				Edgren, Gustaf; Hjalgrim, Henrik; Reilly, Marie; Tran, Trung Nam; Rostgaard, Klaus; Shanwell, Agneta; Titlestad, Kjell; Adami, Johanna; Wikman, Agneta; Jersild, Casper; Gridley, Gloria; Wideroff, Louise; Nyren, Olof; Melbye, Mads			Risk of cancer after blood transfusion from donors with subclinical cancer: a retrospective cohort study	LANCET			English	Article							NON-HODGKINS-LYMPHOMA; TRAUMA PATIENTS; OLDER WOMEN; RECIPIENTS; TRANSMISSION; MICROCHIMERISM; LEUKEMIA; HISTORY; MORBIDITY; REGISTRY	Background Although mechanisms for detection of short-term complications after blood transfusions are well developed, complications with delayed onset, notably transmission of chronic diseases such as cancer, have been difficult to assess. Our aim was to investigate the possible risk of cancer transmission from blood donors to recipients through blood transfusion. Methods We did a register-based retrospective cohort study of cancer incidence among patients who received blood from donors deemed to have a subclinical cancer at the time of donation. These precancerous donors were diagnosed with a cancer within 5 years of the donation. Data from all computerised blood bank registers in Sweden and Denmark gathered between 1968 and 2002 were merged into a common database. Demographic and medical data, including mortality and cancer incidence, were ascertained through linkages with nationwide, and essentially complete, population and health-care registers. The risk of cancer in exposed recipients relative to that in recipients who received blood from non-cancerous donors was estimated with multivariate Poisson regression, adjusting for potential confounding factors. Findings Of the 354094 transfusion recipients eligible for this analysis, 12012 (3%) were exposed to blood products from precancerous donors. There was no excess risk of cancer overall (adjusted relative risk 1.00, 95% CI 0.94-1.07) or in crude anatomical subsites among recipients of blood from precancerous donors compared with recipients of blood from non-cancerous donors. Interpretation Our data provide no evidence that blood transfusions from precancerous blood donors are associated with increased risk of cancer among recipients compared with transfusions from non-cancerous donors.	Karolinska Inst, Dept Med Epidemiol & Biostat, SE-17177 Stockholm, Sweden; Karolinska Inst, Dept Clin Immunol & Transfus Med, SE-17177 Stockholm, Sweden; Karolinska Inst, Dept Med, Clin Epidemiol Unit, SE-17177 Stockholm, Sweden; Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark; Odense Univ Hosp, Dept Clin Immunol, DK-5000 Odense, Denmark; Aarhus Univ Hosp, Dept Clin Immunol, DK-8000 Aarhus, Denmark; NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; NCI, Div Canc Control & Populat Sci, NIH, Bethesda, MD 20892 USA	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Statens Serum Institut; University of Southern Denmark; Odense University Hospital; Aarhus University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Nyren, O (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, Box 281, SE-17177 Stockholm, Sweden.	olof.nyren@ki.se	Hjalgrim, Henrik/AAG-4973-2021; Adami, Johanna/AAA-3312-2021; Hernandez, Jessica/G-6527-2011; Edgren, Gustaf/F-4013-2014	Edgren, Gustaf/0000-0002-2198-4745; melbye, mads/0000-0001-8264-6785; Rostgaard, Klaus/0000-0001-6220-9414; Wikman, Agneta/0000-0002-8810-7974	NCI NIH HHS [N01-CP-21175] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adami J, 1997, ANN INTERN MED, V127, P365, DOI 10.7326/0003-4819-127-5-199709010-00004; Barozzi P, 2003, NAT MED, V9, P554, DOI 10.1038/nm862; Berg KD, 2001, NEW ENGL J MED, V345, P1458, DOI 10.1056/NEJMoa010041; BLOMBERG J, 1993, EUR J CANCER, V29A, P2101, DOI 10.1016/0959-8049(93)90042-E; Bodo I, 1999, NEW ENGL J MED, V341, P807, DOI 10.1056/NEJM199909093411105; Brandt L, 1996, BRIT J CANCER, V73, P1148, DOI 10.1038/bjc.1996.220; Buell Joseph F, 2004, Ann Transplant, V9, P53; Cerhan JR, 1997, J NATL CANCER I, V89, P314, DOI 10.1093/jnci/89.4.314; Cerhan JR, 2001, CANCER EPIDEM BIOMAR, V10, P361; CERHAN JR, 1993, ANN INTERN MED, V119, P8, DOI 10.7326/0003-4819-119-1-199307010-00002; Chow EJ, 2002, EPIDEMIOL REV, V24, P269, DOI 10.1093/epirev/mxf005; Chow EJ, 2002, AM J EPIDEMIOL, V155, P725, DOI 10.1093/aje/155.8.725; COMAN DR, 1951, CANCER RES, V11, P648; Edgren G, 2006, VOX SANG, V91, P316, DOI 10.1111/j.1423-0410.2006.00817.x; Ekstrom AM, 1999, JNCI-J NATL CANCER I, V91, P786, DOI 10.1093/jnci/91.9.786; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Gartner HV, 1996, NEW ENGL J MED, V335, P1494, DOI 10.1056/NEJM199611143352004; GRAMEN K, 1928, ACTA CHIR SCAND, V64, P369; GREENWALD P, 1976, CANCER, V38, P324, DOI 10.1002/1097-0142(197607)38:1<324::AID-CNCR2820380147>3.0.CO;2-Q; GUGEL EA, 1986, NEW ENGL J MED, V315, P1487; Haque T, 1996, J GEN VIROL, V77, P1169, DOI 10.1099/0022-1317-77-6-1169; Hladik W, 2006, NEW ENGL J MED, V355, P1331, DOI 10.1056/NEJMoa055009; Kauffman HM, 2002, TRANSPLANTATION, V74, P358, DOI 10.1097/00007890-200208150-00011; Kleinman SH, 2000, BEST PRACT RES CL HA, V13, P631, DOI 10.1053/beha.2000.0104; LANMAN JT, 1950, BLOOD, V5, P1099, DOI 10.1182/blood.V5.12.1099.1099; Lee TH, 2005, TRANSFUSION, V45, P1280, DOI 10.1111/j.1537-2995.2005.00201.x; Lee TH, 1999, BLOOD, V93, P3127; Maguire-Boston EK, 1999, AM J EPIDEMIOL, V149, P1113; MEMON A, 1994, INT J CANCER, V58, P366, DOI 10.1002/ijc.2910580310; Racila E, 1998, P NATL ACAD SCI USA, V95, P4589, DOI 10.1073/pnas.95.8.4589; SCHIFFER CA, 1983, AM J HEMATOL, V15, P65, DOI 10.1002/ajh.2830150108; SOUTHAM C M, 1958, Bull N Y Acad Med, V34, P416; Storm HH, 1997, DAN MED BULL, V44, P535; THIERSCH JB, 1946, CANCER RES, V6, P695; THIERSCH JB, 1945, J LAB CLIN MED, V30, P866; Utter GH, 2004, J TRAUMA, V57, P702, DOI 10.1097/01.TA.0000140666.15972.37; Vamvakas EC, 2001, BLOOD, V97, P1180, DOI 10.1182/blood.V97.5.1180; WEISS L, 1992, CLIN EXP METASTAS, V10, P191, DOI 10.1007/BF00132751; Zhang YW, 2004, AM J EPIDEMIOL, V160, P325, DOI 10.1093/aje/kwh233	40	55	55	0	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 20	2007	369	9574					1724	1730		10.1016/S0140-6736(07)60779-X	http://dx.doi.org/10.1016/S0140-6736(07)60779-X			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	169ZT	17512857				2022-12-28	WOS:000246631300028
J							US Preventive Services Task Force	Screening for chlamydial infection: US preventive services task force recommendation statement	ANNALS OF INTERNAL MEDICINE			English	Article							TRACHOMATIS; UPDATE	Description: Update of 2001 U.S. Preventive Services Task Force (USPSTF) recommendations about screening sexually active adolescents and adults for chlamydial infection. Methods: The USPSTF weighed the benefits (improved fertility, pregnancy outcomes, and infection transmission) and harms (anxiety, relationship problems, and unnecessary treatment of false-positive results) of chlamydial screening identified in their 2001 recommendations and the accompanying systematic review of English-language articles published between July 2000 and July 2005. Recommendations: Screen for chlamydial infection in all sexually active nonpregnant young women age 24 years or younger and for older nonpregnant women who are at increased risk. (A recommendation) Screen for chlamyclial infection in all pregnant women age 24 years or younger and in older pregnant women who are at increased risk. (B recommendation) Do not routinely screen for chlamyclial infection in women age 25 years or older, regardless of whether they are pregnant, if they are not at increased risk. (C recommendation) Current evidence is insufficient to assess the balance of benefits and harms of screening for chlamyclial infection for men.	Agcy Healthcare Res & Qual, US Prevent Serv Task Force, Rockville, MD USA	Agency for Healthcare Research & Quality	Agcy Healthcare Res & Qual, US Prevent Serv Task Force, Rockville, MD USA.							Smith Nicole M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Barton MB, 2007, ANN INTERN MED, V147, P123, DOI 10.7326/0003-4819-147-2-200707170-00171; Cook RL, 2005, ANN INTERN MED, V142, P914, DOI 10.7326/0003-4819-142-11-200506070-00010; Guirguis-Blake J, 2007, ANN INTERN MED, V147, P117, DOI 10.7326/0003-4819-147-2-200707170-00170; Johnson Robert E, 2002, MMWR Recomm Rep, V51, P1; Meyers DS, 2007, ANN INTERN MED, V147, P135, DOI 10.7326/0003-4819-147-2-200707170-00173; Nelson HD, 2001, AM J PREV MED, V20, P95, DOI 10.1016/S0749-3797(01)00253-7; Ostergaard L, 2000, CLIN INFECT DIS, V31, P951, DOI 10.1086/318139; Scholes D, 1996, NEW ENGL J MED, V334, P1362, DOI 10.1056/NEJM199605233342103	9	174	180	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 17	2007	147	2					128	134		10.7326/0003-4819-147-2-200707170-00172	http://dx.doi.org/10.7326/0003-4819-147-2-200707170-00172			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	192CV	17576996				2022-12-28	WOS:000248179300008
J	Maser, RS; Choudhury, B; Campbell, PJ; Feng, B; Wong, KK; Protopopov, A; O'Neil, J; Gutierrez, A; Ivanova, E; Perna, I; Lin, E; Mani, V; Jiang, S; McNamara, K; Zaghlul, S; Edkins, S; Stevens, C; Brennan, C; Martin, ES; Wiedemeyer, R; Kabbarah, O; Nogueira, C; Histen, G; Aster, J; Mansour, M; Duke, V; Foroni, L; Fielding, AK; Goldstone, AH; Rowe, JM; Wang, YQA; Look, AT; Stratton, MR; Chin, L; Futreal, PA; DePinho, RA				Maser, Richard S.; Choudhury, Bhudipa; Campbell, Peter J.; Feng, Bin; Wong, Kwok-Kin; Protopopov, Alexei; O'Neil, Jennifer; Gutierrez, Alejandro; Ivanova, Elena; Perna, Ilana; Lin, Eric; Mani, Vidya; Jiang, Shan; McNamara, Kate; Zaghlul, Sara; Edkins, Sarah; Stevens, Claire; Brennan, Cameron; Martin, Eric S.; Wiedemeyer, Ruprecht; Kabbarah, Omar; Nogueira, Cristina; Histen, Gavin; Aster, Jon; Mansour, Marc; Duke, Veronique; Foroni, Letizia; Fielding, Adele K.; Goldstone, Anthony H.; Rowe, Jacob M.; Wang, Yaoqi A.; Look, A. Thomas; Stratton, Michael R.; Chin, Lynda; Futreal, P. Andrew; DePinho, Ronald A.			Chromosomally unstable mouse tumours have genomic alterations similar to diverse human cancers	NATURE			English	Article							DNA COPY NUMBER; TELOMERE DYSFUNCTION; PANCREATIC ADENOCARCINOMA; GENE AMPLIFICATION; MUTATIONS; P53; TRANSLOCATIONS; CELLS; ATM; IDENTIFICATION	Highly rearranged and mutated cancer genomes present major challenges in the identification of pathogenetic events driving the neoplastic transformation process. Here we engineered lymphoma-prone mice with chromosomal instability to assess the usefulness of mouse models in cancer gene discovery and the extent of cross-species overlap in cancer-associated copy number aberrations. Along with targeted re-sequencing, our comparative oncogenomic studies identified FBXW7 and PTEN to be commonly deleted both in murine lymphomas and in human T-cell acute lymphoblastic leukaemia/lymphoma (T-ALL). The murine cancers acquire widespread recurrent amplifications and deletions targeting loci syntenic to those not only in human T-ALL but also in diverse human haematopoietic, mesenchymal and epithelial tumours. These results indicate that murine and human tumours experience common biological processes driven by orthologous genetic events in their malignant evolution. The highly concordant nature of genomic events encourages the use of genomically unstable murine cancer models in the discovery of biological driver events in the human oncogenome.	Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; Dana Farber Canc Inst, Belfer Inst Innovat Canc Sci, Ctr Appl Canc Sci, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; Wellcome Trust Sanger Inst, Canc Genome Project, Cambridge CB10 1SA, England; Childrens Hosp, Div Hematol, Boston, MA 02115 USA; Mem Sloan Kettering Canc Ctr, Dept Neurosurg, New York, NY 10021 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet & Med, Boston, MA 02115 USA; Royal Free & Univ Coll Med Sch, London NW3 2PF, England; UCL Hosp, London NW1 2BU, England; Technion Israel Inst Technol, IL-31096 Haifa, Israel; Rambam Med Ctr, IL-31096 Haifa, Israel	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; University of Cambridge; Wellcome Trust Sanger Institute; Harvard University; Boston Children's Hospital; Memorial Sloan Kettering Cancer Center; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; Technion Israel Institute of Technology; Rambam Health Care Campus; Technion Israel Institute of Technology	DePinho, RA (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.	ron_depinho@dfci.harvard.edu	Brennan, Cameron/R-7082-2019; Nogueira, Cristina/N-4574-2015; Fielding, adele/B-2848-2009; Choudhury, Bhudipa/D-3863-2011; Maser, Richard/B-2970-2012	Brennan, Cameron/0000-0003-4064-8891; Nogueira, Cristina/0000-0002-0853-5304; Choudhury, Bhudipa/0000-0002-1392-6414; wong, kwok kin/0000-0001-6323-235X; Mansour, Marc/0000-0001-6835-3791; Ivanova, Elena/0000-0002-5069-4974; DePinho, Ronald/0000-0002-5625-577X; Gutierrez, Alejandro/0000-0002-0249-9007	MRC [G0500389] Funding Source: UKRI; Medical Research Council [G0500389] Funding Source: Medline; Wellcome Trust [088340, 077012] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Aguirre AJ, 2004, P NATL ACAD SCI USA, V101, P9067, DOI 10.1073/pnas.0402932101; Artandi SE, 2000, NATURE, V406, P641, DOI 10.1038/35020592; Bardeesy N, 2006, P NATL ACAD SCI USA, V103, P5947, DOI 10.1073/pnas.0601273103; Carrasco DR, 2006, CANCER CELL, V9, P313, DOI 10.1016/j.ccr.2006.03.019; Casanovas O, 2005, ONCOGENE, V24, P6597, DOI 10.1038/sj.onc.1208823; Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X; Davies H, 2005, CANCER RES, V65, P7591, DOI 10.1158/0008-5472.CAN-05-1855; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Graux C, 2004, NAT GENET, V36, P1084, DOI 10.1038/ng1425; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Hodgson G, 2001, NAT GENET, V29, P459, DOI 10.1038/ng771; Kemp Z, 2005, CANCER RES, V65, P11361, DOI 10.1158/0008-5472.CAN-05-2565; Kim M, 2006, CELL, V125, P1269, DOI 10.1016/j.cell.2006.06.008; Kwak EL, 2005, GYNECOL ONCOL, V98, P124, DOI 10.1016/j.ygyno.2005.04.007; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; Liyanage M, 2000, BLOOD, V96, P1940, DOI 10.1182/blood.V96.5.1940.h8001940_1940_1946; Mansour MR, 2006, LEUKEMIA, V20, P537, DOI 10.1038/sj.leu.2404101; Mao JH, 2004, NATURE, V432, P775, DOI 10.1038/nature03155; Minella AC, 2005, CELL CYCLE, V4, P1356, DOI 10.4161/cc.4.10.2058; O'Hagan RC, 2003, CANCER RES, V63, P5352; O'Hagan RC, 2002, CANCER CELL, V2, P149, DOI 10.1016/S1535-6108(02)00094-6; O'Neil J, 2006, BLOOD, V107, P781, DOI 10.1182/blood-2005-06-2553; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Orlicky S, 2003, CELL, V112, P243, DOI 10.1016/S0092-8674(03)00034-5; Pelham RJ, 2006, P NATL ACAD SCI USA, V103, P19848, DOI 10.1073/pnas.0609635104; Pinkel D, 2005, NAT GENET, V37, pS11, DOI 10.1038/ng1569; Qi L, 2005, NAT CELL BIOL, V7, P706, DOI 10.1038/ncb1276; Qi L, 2003, CANCER RES, V63, P8188; Radtke F, 2004, NAT IMMUNOL, V5, P247, DOI 10.1038/ni1045; Rajagopalan H, 2004, NATURE, V428, P77, DOI 10.1038/nature02313; Rudolph KL, 2001, NAT GENET, V28, P155, DOI 10.1038/88871; Sansal I, 2004, J CLIN ONCOL, V22, P2954, DOI 10.1200/jco.2004.02.141; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Sharma VM, 2007, CELL CYCLE, V6, P927, DOI 10.4161/cc.6.8.4134; Shigeno K, 2004, CANCER LETT, V213, P11, DOI 10.1016/S0304-3835(03)00442-7; Shiloh Y, 2001, ADV CANCER RES, V83, P209, DOI 10.1016/S0065-230X(01)83007-4; Suzuki A, 1998, CURR BIOL, V8, P1169, DOI 10.1016/S0960-9822(07)00488-5; Sweet-Cordero A, 2005, NAT GENET, V37, P48, DOI 10.1038/ng1490; Sweet-Cordero A, 2006, GENE CHROMOSOME CANC, V45, P338, DOI 10.1002/gcc.20296; Tonon G, 2005, P NATL ACAD SCI USA, V102, P9625, DOI 10.1073/pnas.0504126102; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; WINANDY S, 1995, CELL, V83, P289, DOI 10.1016/0092-8674(95)90170-1; WINDLE B, 1991, GENE DEV, V5, P160, DOI 10.1101/gad.5.2.160; Wong KK, 2003, NATURE, V421, P643, DOI 10.1038/nature01385; Yang L, 2004, CANCER RES, V64, P4394, DOI 10.1158/0008-5472.CAN-04-0343; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhu CM, 2002, CELL, V109, P811, DOI 10.1016/S0092-8674(02)00770-5	50	293	308	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 21	2007	447	7147					966	U3		10.1038/nature05886	http://dx.doi.org/10.1038/nature05886			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	180NU	17515920	Green Accepted			2022-12-28	WOS:000247373100039
J	Getahun, H; Harrington, M; O'Brien, R; Nunn, P				Getahun, Haileyesus; Harrington, Mark; O'Brien, Rick; Nunn, Paul			Diagnosis of smear-negative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: informing urgent policy changes	LANCET			English	Article							BLOOD-STREAM INFECTIONS; GROWTH INDICATOR TUBE; MYCOBACTERIUM-TUBERCULOSIS; CLINICAL-DIAGNOSIS; AFRICAN CHILDREN; RURAL DISTRICT; SPUTUM SMEARS; PREVALENCE; MICROSCOPY; NAIROBI	The HIV epidemic has led to large increases in the frequency of smear-negative pulmonary tuberculosis, which has poor treatment outcomes and excessive early mortality compared with smear-positive disease. We used a combination of systematic review, document analysis, and global expert opinion to review the extent of this problem. We also looked at policies of national tuberculosis control programmes for the diagnosis of smear-negative pulmonary tuberculosis to assess their coverage, identify the diagnostic difficulties, and find ways to improve the diagnosis of this type of tuberculosis, with a focus on resource-constrained settings with high HIV infection rates. We propose that the internationally recommended algorithm for the diagnosis of smear-negative pulmonary tuberculosis should be revised to include HIV status, severity of AIDS and tuberculosis, and early use of chest radiography in the decision tree. Increased use of promising methods of diagnosis such as sputum liquefaction and concentration and increased availability of fluorescence microscopy should be explored and encouraged. Culturing of sputum in resource-constrained settings with high HIV infection rates should also be encouraged, existing facilities should be made full use of and upgraded, and effective quality-assurance systems should be used. Innovative ways to address human resources issues involved in addressing the diagnostic difficulties are also needed. The development of rapid, simple, and accurate tuberculosis diagnostic tools with applicability at point of care and remote location is essential. To achieve these goals, greater political commitment, scientific interest, and investment are needed.	WHO, Stop TB Dept, CH-1211 Geneva 27, Switzerland; Treatment Act Grp, New York, NY USA; Fdn Innovat New Diagnost, Geneva, Switzerland	World Health Organization; Foundation For Innovative New Diagnostics	Getahun, H (corresponding author), WHO, Stop TB Dept, 20 Ave Appia, CH-1211 Geneva 27, Switzerland.	getahunh@who.int	Getahun, Haileyesus/ABC-5181-2020					Aderaye G, 2004, INFECTION, V32, P333, DOI 10.1007/s15010-004-3089-x; Aerts D, 2004, INT J TUBERC LUNG D, V8, P785; Albert H, 2002, INT J TUBERC LUNG D, V6, P529; Angeby KAK, 2004, INT J TUBERC LUNG D, V8, P806; Ansari NA, 2002, INT J TUBERC LUNG D, V6, P55; Arthur G, 2001, CLIN INFECT DIS, V33, P248, DOI 10.1086/321820; BAVA Amadeo Javier, 2002, Rev. Inst. Med. trop. S. Paulo, V44, P279, DOI 10.1590/S0036-46652002000500009; Behr MA, 1999, LANCET, V353, P444, DOI 10.1016/S0140-6736(98)03406-0; BOUZA E, 1993, ARCH INTERN MED, V153, P496, DOI 10.1001/archinte.153.4.496; BRINDLE RJ, 1993, AM REV RESPIR DIS, V147, P958, DOI 10.1164/ajrccm/147.4.958; Bruchfeld J, 2002, SCAND J INFECT DIS, V34, P331, DOI 10.1080/00365540110080025; Bruchfeld J, 2000, T ROY SOC TROP MED H, V94, P677, DOI 10.1016/S0035-9203(00)90230-X; Burgess AL, 2001, AIDS, V15, P1875, DOI 10.1097/00002030-200109280-00018; Chapman ALN, 2002, AIDS, V16, P2285, DOI 10.1097/00002030-200211220-00008; Chintu C, 2005, INT J TUBERC LUNG D, V9, P477; Chintu C, 2002, LANCET, V360, P985, DOI 10.1016/S0140-6736(02)11082-8; Coetzee D, 2004, TROP MED INT HEALTH, V9, pA11, DOI 10.1111/j.1365-3156.2004.01259.x; Colebunders R, 2000, INT J TUBERC LUNG D, V4, P97; COLEBUNDERS RL, 1989, AM REV RESPIR DIS, V139, P1082, DOI 10.1164/ajrccm/139.5.1082; Crump JA, 2003, J CLIN MICROBIOL, V41, P1987, DOI 10.1128/JCM.41.5.1987-1990.2003; David ST, 2004, INDIAN J MED RES, V119, P259; David T, 2000, LANCET, V355, P143, DOI 10.1016/S0140-6736(05)72054-7; Dheda K, 2005, CURR OPIN PULM MED, V11, P195, DOI 10.1097/01.mcp.0000158726.13159.5e; Diraa O, 2003, INT J TUBERC LUNG D, V7, P1010; ELLIOTT AM, 1993, TUBERCLE LUNG DIS, V74, P191, DOI 10.1016/0962-8479(93)90010-U; Foulds J, 1998, INT J TUBERC LUNG D, V2, P778; Frieden TR, 2003, LANCET, V362, P887, DOI 10.1016/S0140-6736(03)14333-4; GILKS CF, 1990, AIDS, V4, P981, DOI 10.1097/00002030-199010000-00006; GILKS CF, 1995, J ACQ IMMUN DEF SYND, V8, P195; GREENBERG SD, 1994, RADIOLOGY, V193, P115, DOI 10.1148/radiology.193.1.7916467; HANNA BA, 1995, J CLIN MICROBIOL, V33, P3315, DOI 10.1128/JCM.33.12.3315-3316.1995; Hargreaves NJ, 2001, INT J TUBERC LUNG D, V5, P847; Harries AD, 1998, B WORLD HEALTH ORGAN, V76, P651; Harries AD, 1998, INT J TUBERC LUNG D, V2, P999; Harries AD, 2003, INT J TUBERC LUNG D, V7, P953; Harries AD, 1997, ANN TROP MED PARASIT, V91, P771, DOI 10.1080/00034989760527; Huang TS, 2004, J ANTIMICROB CHEMOTH, V53, P600, DOI 10.1093/jac/dkh120; Hudson CP, 2000, INT J TUBERC LUNG D, V4, P240; Johnson JL, 1998, INT J TUBERC LUNG D, V2, P397; Kang'ombe CT, 2004, INT J TUBERC LUNG D, V8, P829; Katoch VM, 2004, INDIAN J MED RES, V119, pXI; Kivihya-Ndugga LEA, 2003, INT J TUBERC LUNG D, V7, P1163; Lambert ML, 2003, INT J TUBERC LUNG D, V7, P485; Lewis DK, 2002, INT J TUBERC LUNG D, V6, P1067; Liebeschuetz S, 2004, LANCET, V364, P2196, DOI 10.1016/S0140-6736(04)17592-2; LONG R, 1991, AM J PUBLIC HEALTH, V81, P1326, DOI 10.2105/AJPH.81.10.1326; Mbulo GMK, 2004, INT J TUBERC LUNG D, V8, P1342; McDonald LC, 1999, LANCET, V354, P1159, DOI 10.1016/S0140-6736(98)12325-5; Monforte AD, 1996, EUR J CLIN MICROBIOL, V15, P453, DOI 10.1007/BF01691311; Mukadi YD, 2001, AIDS, V15, P143, DOI 10.1097/00002030-200101260-00002; Mundy CJF, 2002, INT J TUBERC LUNG D, V6, P47; NUNN P, 1992, TUBERCLE LUNG DIS, V73, P45, DOI 10.1016/0962-8479(92)90079-Y; Pai M, 2004, LANCET INFECT DIS, V4, P761, DOI 10.1016/S1473-3099(04)01206-X; Palmieri F, 2002, INFECTION, V30, P68, DOI 10.1007/s15010-002-2062-9; Peters RPH, 2004, TROP MED INT HEALTH, V9, P928, DOI 10.1111/j.1365-3156.2004.01288.x; Steingart K, 2006, LANCET INFECT DIS, V6, P570, DOI 10.1016/S1473-3099(06)70578-3; Ramachandran R, 2003, INDIAN J MED RES, V118, P147; Rana FS, 2000, J ACQ IMMUN DEF SYND, V24, P23; Range N, 2001, INT J TUBERC LUNG D, V5, P405; Siddiqi K, 2003, LANCET INFECT DIS, V3, P288, DOI 10.1016/S1473-3099(03)00609-1; Steingart KR, 2006, LANCET INFECT DIS, V6, P664, DOI 10.1016/S1473-3099(06)70602-8; *TBCTA, 2006, INT STAND TUB CAR; Toman K., 2004, TOMANS TUBERCULOSIS, V2; Tortoli E, 1999, J CLIN MICROBIOL, V37, P3578, DOI 10.1128/JCM.37.11.3578-3582.1999; Venkataraman P, 1998, INDIAN J MED RES, V108, P120; *WHO, 1998, WHOTUBERCULOSIS98258; *WHO, 2007, WHOHTMTB2007379; *WHO, 2004, WHOHTMHIV20041; *WHO, 2002, TBHIVWHOCDSTB2002296; Wilkinson D, 2000, INT J TUBERC LUNG D, V4, P513; World Health Organization, 2003, TREATM TUB GUID NAT, DOI DOI 10.1016/S0035-9203(99)90185-2; World Health Organization, 2006, WHOHTMTB2006362; World Health Organization, 2005, WHOHTMTB2005355, P355; Worodria W, 2003, INT J TUBERC LUNG D, V7, P117; Yassin MA, 2004, SCAND J INFECT DIS, V36, P670, DOI 10.1080/00365540410020848; Zachariah R, 2003, INT J TUBERC LUNG D, V7, P65	76	396	409	0	22	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 16	2007	369	9578					2042	2049		10.1016/S0140-6736(07)60284-0	http://dx.doi.org/10.1016/S0140-6736(07)60284-0			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	180HT	17574096				2022-12-28	WOS:000247354400029
J	Lundqvist, T; Fisher, SL; Kern, G; Folmer, RHA; Xue, YF; Newton, DT; Keating, TA; Alm, RA; de Jonge, BLM				Lundqvist, Tomas; Fisher, Stewart L.; Kern, Gunther; Folmer, Rutger H. A.; Xue, Yafeng; Newton, D. Trevor; Keating, Thomas A.; Alm, Richard A.; de Jonge, Boudewijn L. M.			Exploitation of structural and regulatory diversity in glutamate racemases	NATURE			English	Article							AMINO-ACID TRANSAMINASE; ESCHERICHIA-COLI; ALLOSTERIC SITE; L-ALANINE; INHIBITION; MECHANISM; IDENTIFICATION; PHOSPHATASE; MUTAGENESIS; DISCOVERY	Glutamate racemase is an enzyme essential to the bacterial cell wall biosynthesis pathway, and has therefore been considered as a target for antibacterial drug discovery. We characterized the glutamate racemases of several pathogenic bacteria using structural and biochemical approaches. Here we describe three distinct mechanisms of regulation for the family of glutamate racemases: allosteric activation by metabolic precursors, kinetic regulation through substrate inhibition, and D-glutamate recycling using a D-amino acid transaminase. In a search for selective inhibitors, we identified a series of uncompetitive inhibitors specifically targeting Helicobacter pylori glutamate racemase that bind to a cryptic allosteric site, and used these inhibitors to probe the mechanistic and dynamic features of the enzyme. These structural, kinetic and mutational studies provide insight into the physiological regulation of these essential enzymes and provide a basis for designing narrow-spectrum antimicrobial agents.	AstraZeneca R&D Boston, Infect Discovery, Waltham, MA 02451 USA; AstraZeneca R&D, AstraZeneca Global Struct Chem, SE-43188 Molndal, Sweden	AstraZeneca; AstraZeneca	Fisher, SL (corresponding author), AstraZeneca R&D Boston, Infect Discovery, Waltham, MA 02451 USA.	stewart.fisher@astrazeneca.com	DeJonge, Boudewijn/AAR-6717-2020	Xue, Yafeng/0000-0002-7526-8672				ANDERSON M, 2005, Patent No. 20050037478; ASHIUCHI M, 1993, BIOSCI BIOTECH BIOCH, V57, P1978, DOI 10.1271/bbb.57.1978; de Dios A, 2002, J MED CHEM, V45, P4559, DOI 10.1021/jm020901d; DOUBLET P, 1994, BIOCHEMISTRY-US, V33, P5285, DOI 10.1021/bi00183a035; Doublet P, 1996, MICROB DRUG RESIST, V2, P43, DOI 10.1089/mdr.1996.2.43; FISHER LM, 1986, BIOCHEMISTRY-US, V25, P2529, DOI 10.1021/bi00357a037; Fotheringham IG, 1998, J BACTERIOL, V180, P4319, DOI 10.1128/JB.180.16.4319-4323.1998; GHOSH NK, 1966, J BIOL CHEM, V241, P2516; Glavas S, 1997, BIOORG MED CHEM LETT, V7, P2265, DOI 10.1016/S0960-894X(97)00413-7; Glavas S, 2001, BIOCHEMISTRY-US, V40, P6199, DOI 10.1021/bi002703z; Hardy JA, 2004, CURR OPIN STRUC BIOL, V14, P706, DOI 10.1016/j.sbi.2004.10.009; Hardy JA, 2004, P NATL ACAD SCI USA, V101, P12461, DOI 10.1073/pnas.0404781101; HO HT, 1995, BIOCHEMISTRY-US, V34, P2464, DOI 10.1021/bi00008a009; Hwang KY, 1999, NAT STRUCT BIOL, V6, P422; McGovern SL, 2003, J MED CHEM, V46, P4265, DOI 10.1021/jm030266r; MENGINLECREULX D, 1982, J BACTERIOL, V151, P1109, DOI 10.1128/JB.151.3.1109-1117.1982; Newsholme P, 2003, CELL BIOCHEM FUNCT, V21, P1, DOI 10.1002/cbf.1003; Oikonomakos NG, 2000, STRUCTURE, V8, P575, DOI 10.1016/S0969-2126(00)00144-1; Pargellis C, 2002, NAT STRUCT BIOL, V9, P268, DOI 10.1038/nsb770; PUCCI MJ, 1995, J BACTERIOL, V177, P336, DOI 10.1128/jb.177.2.336-342.1995; Ruzheinikov SN, 2005, STRUCTURE, V13, P1707, DOI 10.1016/j.str.2005.07.024; Seidler J, 2003, J MED CHEM, V46, P4477, DOI 10.1021/jm030191r; Song JH, 2005, MOL CELLS, V19, P365; TANNER ME, 1994, TETRAHEDRON LETT, V35, P4073, DOI 10.1016/S0040-4039(00)73115-7; van Heijenoort J, 2001, NAT PROD REP, V18, P503, DOI 10.1039/a804532a; WANG L, 2005, Patent No. 20050026189A1; Wiesmann C, 2004, NAT STRUCT MOL BIOL, V11, P730, DOI 10.1038/nsmb803	27	108	136	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 14	2007	447	7146					817	822		10.1038/nature05689	http://dx.doi.org/10.1038/nature05689			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178FV	17568739				2022-12-28	WOS:000247207500035
J	Eapen, M; Rubinstein, P; Zhang, MJ; Stevens, C; Kurtzberg, J; Scaradavou, A; Loberiza, FR; Champlin, RE; Klein, JP; Horowitz, MM; Wagner, JE				Eapen, Mary; Rubinstein, Pablo; Zhang, Mei-Jie; Stevens, Cladd; Kurtzberg, Joanne; Scaradavou, Andromachi; Loberiza, Fausto R.; Champlin, Richard E.; Klein, John P.; Horowitz, Mary M.; Wagner, John E.			Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study	LANCET			English	Article							HEMATOPOIETIC STEM-CELLS; VERSUS-HOST-DISEASE; PLACENTAL-BLOOD; ADULTS; ENGRAFTMENT; RECIPIENTS; RECOVERY; SURVIVAL	Background Although umbilical cord blood is an accepted alternative to bone marrow for transplantation, allele-matched bone marrow is generally regarded as the preferred graft source. Our aim was to assess leukaemia-free survival after transplantations of these alternatives compared with present HLA-matching practices, and to assess the relative effect of cell dose and HLA match, and their potential interaction on leukaemia-free survival after cord-blood transplantation. Methods Outcomes of 503 children (<16 years) with acute leukaemia and transplanted with umbilical cord blood were compared with outcomes of 282 bone-marrow recipients. All transplantation took place in the USA. Recipients of umbilical cord blood were transplanted with grafts that were HLA-matched (n=35) or HLA-mismatched for one (n=201) or two antigens (n=267) (typing at antigen level for HLA-A and HLA-B, and allele level for HLA-DRB1). Bone-marrow recipients were transplanted with grafts that were matched at the allele level for HLA-A, HLA-B, HLA-C, and HLA-DRB (n=116), or mismatched (n=166). The primary endpoint was 5-year leukaemia-free survival. Findings In comparison with allele-matched bone-marrow transplants, 5-year leukaemia-free survival was similar to that after transplants of umbilical cord blood mismatched for either one or two antigens and possibly higher after transplants of HLA-matched umbilical cord blood. Transplant-related mortality rates were higher after transplants of two-antigen HLA-mismatched umbilical cord blood (relative risk 2.31, p=0.0003) and possibly after one-antigen HLA-mismatched low-cell-dose umbilical-cord-blood transplants (1.88, p=0.0455). Relapse rates were lower after two-antigen HLA-mismatched umbilical-cord-blood transplants (0.54, p=0.0045). Interpretation These data support the use of HLA-matched and one- or two-antigen HLA-mismatched umbilical cord blood in children with acute leukaemia who need transplantation. Because better HLA matching and higher cell doses significantly decrease the risk of transplant-related mortality after umbilical-cord-blood transplantation, greater investment in large-scale banking is needed to increase HLA diversity.	Univ Minnesota, Div Pediat Hematol Oncol, Minneapolis, MN 55455 USA; Univ Minnesota, Blood & Marrow Transplant Program, Minneapolis, MN 55455 USA; Med Coll Wisconsin, Ctr Stat, Ctr Int Blood & Marrow Transplant Res, Milwaukee, WI 53226 USA; New York Blood Ctr, Natl Cord Blood Program, New York, NY 10021 USA; Duke Univ, Med Ctr, Pediat Blood & Marrow Transplant Program, Durham, NC USA; Univ Nebraska, Med Ctr, Omaha, NE USA; Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Center for International Blood & Marrow Transplant Research; Medical College of Wisconsin; New York Blood Center; Duke University; University of Nebraska System; University of Nebraska Medical Center; University of Texas System; UTMD Anderson Cancer Center	Wagner, JE (corresponding author), Univ Minnesota, Div Pediat Hematol Oncol, Minneapolis, MN 55455 USA.	wagne002@umn.edu	horowitz, Mary/ABH-2173-2021	Eapen, Mary/0000-0001-6193-4243	NCI NIH HHS [U24 CA076518, U24-CA76518-08] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U24CA076518] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Andersen PK, 1999, STAT MED, V18, P1489, DOI 10.1002/(SICI)1097-0258(19990630)18:12<1489::AID-SIM140>3.0.CO;2-#; Barker JN, 2005, BLOOD, V105, P1343, DOI 10.1182/blood-2004-07-2717; Copelan EA, 2006, NEW ENGL J MED, V354, P1813, DOI 10.1056/NEJMra052638; COX DR, 1972, J R STAT SOC B, V34, P187; Fernandez MN, 2003, EXP HEMATOL, V31, P535, DOI 10.1016/S0301-472X(03)00067-5; Flomenberg N, 2004, BLOOD, V104, P1923, DOI 10.1182/blood-2004-03-0803; Flowers MED, 1999, HEMATOL ONCOL CLIN N, V13, P1091, DOI 10.1016/S0889-8588(05)70111-8; Gluckman E, 1997, NEW ENGL J MED, V337, P373, DOI 10.1056/NEJM199708073370602; Gluckman E, 2001, NEW ENGL J MED, V344, P1860, DOI 10.1056/NEJM200106143442410; Jaroscak J, 2003, BLOOD, V101, P5061, DOI 10.1182/blood-2001-12-0290; Klein J. P., 2003, SURVIVAL ANAL TECHNI; Klein JP, 2004, HDB STAT ADV SURVIVA; Kurtzberg J, 1996, NEW ENGL J MED, V335, P157, DOI 10.1056/NEJM199607183350303; Laughlin MJ, 2004, NEW ENGL J MED, V351, P2265, DOI 10.1056/NEJMoa041276; Locatelli F, 1999, BLOOD, V93, P3662; Margo E, 2006, HEMATOLOGICA, V91, P640; Michel G, 2003, BLOOD, V102, P4290, DOI 10.1182/blood-2003-04-1288; PRZEPIORKA D, 1995, BONE MARROW TRANSPL, V15, P825; Robinson SN, 2006, BONE MARROW TRANSPL, V37, P359, DOI 10.1038/sj.bmt.1705258; Rocha V, 2006, BIOL BLOOD MARROW TR, V12, P34, DOI 10.1016/j.bbmt.2005.09.006; Rocha V, 2004, NEW ENGL J MED, V351, P2276, DOI 10.1056/NEJMoa041469; Rubinstein P, 1998, NEW ENGL J MED, V339, P1565, DOI 10.1056/NEJM199811263392201; Rubinstein P, 2001, NEW ENGL J MED, V345, P1842, DOI 10.1056/NEJM200112203452511; Shpall EJ, 2002, BIOL BLOOD MARROW TR, V8, P368, DOI 10.1053/bbmt.2002.v8.pm12171483; Takahashi S, 2004, BLOOD, V104, P3813, DOI 10.1182/blood-2004-03-1001; Wadhwa PD, 2003, LEUKEMIA RES, V27, P215, DOI 10.1016/S0145-2126(02)00090-5; Wagner JE, 2002, BLOOD, V100, P1611, DOI 10.1182/blood-2002-01-0294; Wagner JE, 1996, BLOOD, V88, P795	28	595	631	0	96	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 9	2007	369	9577					1947	1954		10.1016/S0140-6736(07)60915-5	http://dx.doi.org/10.1016/S0140-6736(07)60915-5			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	177IQ	17560447				2022-12-28	WOS:000247147200028
J	Winikoff, B; Davis, AR				Winikoff, Beverly; Davis, Anne Rachel			Abortion is for women	LANCET			English	Editorial Material							EARLY-PREGNANCY TERMINATION; UNITED-STATES; MIFEPRISTONE-MISOPROSTOL; ACCEPTABILITY; TRIAL; MORTALITY; RISK		Gynuity Hlth Projects, New York, NY 10010 USA; Columbia Univ, Sch Publ Hlth, New York, NY USA; Columbia Presbyterian Med Ctr, Dept Obstet & Gynecol, New York, NY 10032 USA	Columbia University; Columbia University; NewYork-Presbyterian Hospital	Winikoff, B (corresponding author), Gynuity Hlth Projects, New York, NY 10010 USA.	bwinikoff@gynuity.org						Bartlett LA, 2004, OBSTET GYNECOL, V103, P729, DOI 10.1097/01.AOG.0000116260.81570.60; Goldberg AB, 2001, NEW ENGL J MED, V344, P38, DOI 10.1056/NEJM200101043440107; Grimes DA, 2006, AM J OBSTET GYNECOL, V194, P92, DOI 10.1016/j.ajog.2005.06.070; Jain JK, 2002, HUM REPROD, V17, P1477, DOI 10.1093/humrep/17.6.1477; Jain JK, 1999, CONTRACEPTION, V60, P353, DOI 10.1016/S0010-7824(99)00105-5; *POLL REP COM, 2007, AB BIRTH CONTR; Spitz IM, 1998, NEW ENGL J MED, V338, P1241, DOI 10.1056/NEJM199804303381801; Teal SB, 2007, CONTRACEPTION, V75, P224, DOI 10.1016/j.contraception.2006.10.008; von Hertzen H, 2007, LANCET, V369, P1938, DOI 10.1016/S0140-6736(07)60914-3; Winikoff B, 1998, ARCH FAM MED, V7, P360, DOI 10.1001/archfami.7.4.360; Winikoff B, 1997, AM J OBSTET GYNECOL, V176, P431, DOI 10.1016/S0002-9378(97)70511-8	11	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 9	2007	369	9577					1904	1906		10.1016/S0140-6736(07)60891-5	http://dx.doi.org/10.1016/S0140-6736(07)60891-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	177IQ	17560428				2022-12-28	WOS:000247147200005
J	Kawakatsu, H; Watada, S				Kawakatsu, Hitoshi; Watada, Shingo			Seismic evidence for deep-water transportation in the mantle	SCIENCE			English	Article							BENEATH NORTHEASTERN JAPAN; DEHYDRATION REACTIONS; SUBDUCTION ZONES; ARC MAGMATISM; KM DEPTH; P-WAVE; WEDGE; MIGRATION; GENESIS; PHASES	We report seismic evidence for the transportation of water into the deep mantle in the subduction zone beneath northeastern Japan. Our data indicate that water is released from the hydrated oceanic crust at shallow depths (less than or similar to 100 kilometers) and then forms a channel of hydrated mantle material on top of the subducting plate that is the pathway for water into the deep mantle. Our result provides direct evidence that shows how water is transported from the ocean to the deep mantle in a cold subduction zone environment.	Univ Tokyo, Earthquake Res Inst, Bunkyo Ku, Tokyo 1130032, Japan	University of Tokyo	Kawakatsu, H (corresponding author), Univ Tokyo, Earthquake Res Inst, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan.	hitosi@eri.u-tokyo.ac.jp	watada, shingo/M-7237-2015	watada, shingo/0000-0001-9924-968X				Abers GA, 2000, EARTH PLANET SC LETT, V176, P323, DOI 10.1016/S0012-821X(00)00007-8; AMMON CJ, 1991, B SEISMOL SOC AM, V81, P2504; Ferris A, 2003, EARTH PLANET SC LETT, V214, P575, DOI 10.1016/S0012-821X(03)00403-5; Furumura T, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2004JB003486; Hacker BR, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2001JB001129; Hacker BR, 2004, GEOCHEM GEOPHY GEOSY, V5, DOI 10.1029/2003GC000614; Hasegawa A, 2004, GEOPHYS MONOGR SER, V150, P81, DOI 10.1029/150GM08; HASEGAWA A, 1978, TECTONOPHYSICS, V47, P43, DOI 10.1016/0040-1951(78)90150-6; HELFFRICH G, 1996, GEOPHYS MONOGR SER, V96, P215; Honda S, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2004GC000785; Iwamori H, 2000, GEOPHYS RES LETT, V27, P425, DOI 10.1029/1999GL010917; Iwamori H, 2007, CHEM GEOL, V239, P182, DOI 10.1016/j.chemgeo.2006.08.011; Karato S.-i, 2003, GEOPHYS MONOGR AM GE, V138, P135; KAWAKATSU H, 2005, EOS T AGU S, V86; Kita S, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL028239; LANGSTON CA, 1979, J GEOPHYS RES, V84, P4749, DOI 10.1029/JB084iB09p04749; MAGEE ME, 1993, GEOLOGY, V21, P809, DOI 10.1130/0091-7613(1993)021<0809:EFAWIT>2.3.CO;2; MATSUZAWA T, 1986, GEOPHYS J INT, V86, P767, DOI 10.1111/j.1365-246X.1986.tb00659.x; Nakajima J, 2005, EARTH PLANET SC LETT, V234, P59, DOI 10.1016/j.epsl.2005.02.033; Nakajima J, 2004, EARTH PLANET SC LETT, V225, P365, DOI 10.1016/j.epsl.2004.06.011; Nakajima J, 2001, J GEOPHYS RES-SOL EA, V106, P21843, DOI 10.1029/2000JB000008; Obara K, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.1854197; OKADA H, 1979, J PHYS EARTH S, V27, pS53; PEACOCK SM, 1993, GEOL SOC AM BULL, V105, P684, DOI 10.1130/0016-7606(1993)105<0684:TIOBED>2.3.CO;2; Tamura Y, 2002, EARTH PLANET SC LETT, V197, P105, DOI 10.1016/S0012-821X(02)00465-X; TATSUMI Y, 1989, J GEOPHYS RES-SOLID, V94, P4697, DOI 10.1029/JB094iB04p04697; VINNIK LP, 1977, PHYS EARTH PLANET IN, V15, P39, DOI 10.1016/0031-9201(77)90008-5; Yuan X, 2000, NATURE, V408, P958, DOI 10.1038/35050073; ZHAO DP, 1992, J GEOPHYS RES-SOL EA, V97, P19909, DOI 10.1029/92JB00603	29	231	239	3	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 8	2007	316	5830					1468	1471		10.1126/science.1140855	http://dx.doi.org/10.1126/science.1140855			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176EE	17556582				2022-12-28	WOS:000247066400040
J	Menand, B; Yi, KK; Jouannic, S; Hoffmann, L; Ryan, E; Linstead, P; Schaefer, DG; Dolan, L				Menand, Benoit; Yi, Keke; Jouannic, Stefan; Hoffmann, Laurent; Ryan, Eoin; Linstead, Paul; Schaefer, Didier G.; Dolan, Liam			An ancient mechanism controls the development of cells with a rooting function in land plants	SCIENCE			English	Article							MOSS PHYSCOMITRELLA-PATENS; ARABIDOPSIS-THALIANA; ORIGIN; GROWTH; FAMILY; AUXIN; HAIRS; GENE	Root hairs and rhizoids are cells with rooting functions in land plants. We describe two basic helix-loop-helix transcription factors that control root hair development in the sporophyte ( 2n) of the angiosperm Arabidopsis thaliana and rhizoid development in the gametophytes ( n) of the bryophyte Physcomitrella patens. The phylogeny of land plants supports the hypothesis that early land plants were bryophyte-like and possessed a dominant gametophyte and later the sporophyte rose to dominance. If this hypothesis is correct, our data suggest that the increase in morphological complexity of the sporophyte body in the Paleozoic resulted at least in part from the recruitment of regulatory genes from gametophyte to sporophyte.	John Innes Ctr, Dept Cell & Dev Biol, Norwich NR4 7UH, Norfolk, England; Zhejiang Univ, Coll Life Sci, State Key Lab Plant Physiol & Biochem, Hangzhou 310058, Peoples R China; Univ Lausanne, Dept Biol Mol Vegetale, CH-1015 Lausanne, Switzerland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Zhejiang University; University of Lausanne	Dolan, L (corresponding author), John Innes Ctr, Dept Cell & Dev Biol, Norwich NR4 7UH, Norfolk, England.	liam.dolan@bbsrc.ac.uk	Yi, Keke/N-8482-2019; Yi, Keke/P-3964-2017	Yi, Keke/0000-0002-3916-477X; Yi, Keke/0000-0002-3916-477X; Dolan, Liam/0000-0003-1206-7096; Menand, Benoit/0000-0001-9713-5275	Biotechnology and Biological Sciences Research Council [BBS/E/J/0000A218] Funding Source: Medline; Natural Environment Research Council [NE/C510732/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Bailey PC, 2003, PLANT CELL, V15, P2497, DOI 10.1105/tpc.151140; Berner R. A., 2001, PLANTS INVADE LAND E, P173; Blackwell WH, 2003, BOT REV, V69, P125, DOI 10.1663/0006-8101(2003)069[0125:TTOOOT]2.0.CO;2; Carol RJ, 2002, PHILOS T ROY SOC B, V357, P815, DOI 10.1098/rstb.2002.1092; DUCKETT JG, 1998, BRYOLOGY 21 CENTURY, P223; EDWARDS D, 1995, NATURE, V374, P635, DOI 10.1038/374635a0; Gahoonia TS, 1997, PLANT SOIL, V191, P181, DOI 10.1023/A:1004270201418; Graham LE, 2000, P NATL ACAD SCI USA, V97, P4535, DOI 10.1073/pnas.97.9.4535; Heim MA, 2003, MOL BIOL EVOL, V20, P735, DOI 10.1093/molbev/msg088; Kenrick P, 1997, NATURE, V389, P33, DOI 10.1038/37918; Kenrick P., 2004, FOSSIL PLANTS; Kerp H, 2004, T ROY SOC EDIN-EARTH, V94, P411, DOI 10.1017/S026359330000078X; Kerp H., 2001, PLANTS INVADE LAND E, P52, DOI 10.7312/gens11160-005; Liljegren SJ, 2004, CELL, V116, P843, DOI 10.1016/S0092-8674(04)00217-X; MASUCCI JD, 1994, PLANT PHYSIOL, V106, P1335, DOI 10.1104/pp.106.4.1335; Menand B, 2007, J EXP BOT, V58, P1843, DOI 10.1093/jxb/erm047; Sakakibara K, 2003, DEVELOPMENT, V130, P4835, DOI 10.1242/dev.00644; Schiefelbein J, 2003, CURR OPIN PLANT BIOL, V6, P74, DOI 10.1016/S136952660200002X; Tanahashi T, 2005, DEVELOPMENT, V132, P1727, DOI 10.1242/dev.01709; Thelander M, 2005, J EXP BOT, V56, P653, DOI 10.1093/jxb/eri040; Wellman CH, 2003, NATURE, V425, P282, DOI 10.1038/nature01884	21	284	297	11	123	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 8	2007	316	5830					1477	1480		10.1126/science.1142618	http://dx.doi.org/10.1126/science.1142618			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176EE	17556585	Green Submitted			2022-12-28	WOS:000247066400043
J	Ellman, JA				Ellman, Jonathan A.			The direct approach	SCIENCE			English	Editorial Material							ARYL BOND FORMATION; ARYLATION		Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Ellman, JA (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	jellman@berkeley.edu	Ellman, Jonathan A/C-7732-2013		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069559] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM69559] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alberico D, 2007, CHEM REV, V107, P174, DOI 10.1021/cr0509760; de Meijere A., 2004, METAL CATALYZED CROS, V2nd, DOI 10.1002/9783527619535; Dyker G, 2005, HANDBOOK OF C-H TRANSFORMATIONS: APPLICATIONS IN ORGANIC SYNTHESIS, VOL 1, pV; Gauthier DR, 2005, J ORG CHEM, V70, P5938, DOI 10.1021/jo0507035; Godula K, 2006, SCIENCE, V312, P67, DOI 10.1126/science.1114731; Hassan J, 2002, CHEM REV, V102, P1359, DOI 10.1021/cr000664r; Hull KL, 2006, J AM CHEM SOC, V128, P14047, DOI 10.1021/ja065718e; Kakiuchi F, 2004, TOP ORGANOMETAL CHEM, V11, P45; Miura M, 2005, TOP ORGANOMETAL CHEM, V14, P55; Stuart DR, 2007, SCIENCE, V316, P1172, DOI 10.1126/science.1141956	10	20	20	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2007	316	5828					1131	1132		10.1126/science.1143373	http://dx.doi.org/10.1126/science.1143373			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	171GQ	17525322				2022-12-28	WOS:000246724300023
J	Brown, M; Boon, N; Brooks, N; Camm, J; Corris, P; Caulfield, M; Chilvers, E; Ewan, P; Gibson, J; Griffin, G; Grossman, A; Hall, A; Hart, G; Heagerty, T; Hodgson, H; Home, P; Hughes, R; Khaw, KT; Lazarus, J; Leaper, D; Monson, J; O'Rahilly, S; Rowlands, B; Scolding, N; Sutton, R; Taylor, R; Watkins, H; Wright, N				Brown, Morris; Boon, Nick; Brooks, Nick; Camm, John; Corris, Paul; Caulfield, Mark; Chilvers, Edwin; Ewan, Pamela; Gibson, John; Griffin, George; Grossman, Ashley; Hall, Alistair; Hart, George; Heagerty, Tony; Hodgson, Humphrey; Home, Philip; Hughes, Richard; Khaw, Kay-Tee; Lazarus, John; Leaper, David; Monson, John; O'Rahilly, Stephen; Rowlands, Brian; Scolding, Neil; Sutton, Robert; Taylor, Roy; Watkins, Hugh; Wright, Nick			Medical training in the UK: sleepwalking to disaster	LANCET			English	Editorial Material							EDUCATION; BOARD		Univ Cambridge, Cambridge CB2 2QQ, England; Addenbrookes Hosp, Cambridge, England; British Cardiovasc Soc, London, England; Gen Hosp St Georg, Sch Med, London, England; Univ Newcastle, Newcastle Upon Tyne, Tyne & Wear, England; Univ Liverpool, Liverpool L69 3BX, Merseyside, England; Univ Leeds, Leeds, W Yorkshire, England; UCL Royal Free & Univ Coll Med Sch, London, England; Univ Manchester, Manchester, Lancs, England; Kings Coll London, London WC2R 2LS, England; Cardiff Univ, Cardiff, Wales; Univ Hull, Kingston Upon Hull HU6 7RX, N Humberside, England; Univ Nottingham, Nottingham NG7 2RD, England; Univ Bristol, Bristol, Avon, England; Univ Oxford, Oxford, England	University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; St Georges University London; Newcastle University - UK; University of Liverpool; University of Leeds; University of London; University College London; UCL Medical School; University of Manchester; University of London; King's College London; Cardiff University; University of Hull; University of Nottingham; University of Bristol; University of Oxford	Brown, M (corresponding author), Univ Cambridge, Cambridge CB2 2QQ, England.	mjb14@medschl.cam.ac.uk	Sutton, Robert/I-3587-2016; Khaw, Kay-Tee/AAZ-3209-2021; Hall, Alistair/K-1953-2019; O'Rahilly, Stephen/ABF-6509-2020	Sutton, Robert/0000-0001-6600-562X; O'Rahilly, Stephen/0000-0003-2199-4449; Chilvers, Edwin/0000-0002-4230-9677; Hall, Alistair/0000-0003-0306-7887; Caulfield, Mark/0000-0001-9295-3594				BROWN M, 2007, TIME JUNK APPOINTMEN; Brown M, 2007, LANCET, V369, P967, DOI 10.1016/S0140-6736(07)60459-0; CROCKARD A, 2007, COMMUNICATION   0331; *DEP HLTH, CHIEF MED OFF; *GOV NEWS NETW, 2007, TERMS REF MOD MED CA; *ROYAL COLL PHYS, 2007, MTAS REAL PROGR ACH; Rubin P, 2007, LANCET, V369, P1341, DOI 10.1016/S0140-6736(07)60620-5; 2007, DAILY HANSARD   0424	8	2	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 20	2007	369	9574					1673	1675		10.1016/S0140-6736(07)60754-5	http://dx.doi.org/10.1016/S0140-6736(07)60754-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	169ZT	17512840				2022-12-28	WOS:000246631300008
J	Baldwin, MP; Dameris, M; Shepherd, TG				Baldwin, Mark P.; Dameris, Martin; Shepherd, Theodore G.			Atmosphere - How will the stratosphere affect climate change?	SCIENCE			English	Editorial Material							TROPOSPHERE; WEATHER		NW Res Associates Inc, Bellevue, WA 98009 USA; Inst Phys Atmosphare, D-82234 Wessling, Germany; Univ Toronto, Dept Phys, Toronto, ON M5S 1A7, Canada	NorthWest Research Associates; University of Toronto	Baldwin, MP (corresponding author), NW Res Associates Inc, POB 3027, Bellevue, WA 98009 USA.	mark@nwra.com; martin.dameris@dlr.de; tgs@atmosp.physics.utoronto.ca	Baldwin, Mark/J-6720-2012	Dameris, Martin/0000-0001-6700-0628				[Anonymous], 2005, IPCC SPECIAL REPORT; [Anonymous], 2007, CONTRIBUTION WORKING; Baldwin MP, 2001, SCIENCE, V294, P581, DOI 10.1126/science.1063315; Butchart N, 2006, CLIM DYNAM, V27, P727, DOI 10.1007/s00382-006-0162-4; Forster PMD, 2005, CLIMATIC CHANGE, V71, P249, DOI 10.1007/s10584-005-5955-7; Gillett NP, 2003, SCIENCE, V302, P273, DOI 10.1126/science.1087440; HOLTON JR, 1995, REV GEOPHYS, V33, P403, DOI 10.1029/95RG02097; Shine KP, 2003, Q J ROY METEOR SOC, V129, P1565, DOI 10.1256/QJ.02.186; Thompson DWJ, 2006, J ATMOS SCI, V63, P2616, DOI 10.1175/JAS3771.1; Thompson DWJ, 2001, SCIENCE, V293, P85, DOI 10.1126/science.1058958; Thompson DWJ, 2002, J CLIMATE, V15, P1421, DOI 10.1175/1520-0442(2002)015<1421:SCTNHW>2.0.CO;2; 2007, WMO UNEP SCI ASSESSM	12	61	72	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 15	2007	316	5831					1576	1577		10.1126/science.1144303	http://dx.doi.org/10.1126/science.1144303			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178SH	17569851				2022-12-28	WOS:000247239900027
J	Wu, RC; Feng, Q; Lonard, DM; O'Malley, BW				Wu, Ray-Chang; Feng, Qin; Lonard, David M.; O'Malley, Bert W.			SRC-3 coactivator functional lifetime is regulated by a phospho-dependent ubiquitin time clock	CELL			English	Article							ESTROGEN-RECEPTOR; PROTEIN-DEGRADATION; STEROID-RECEPTOR; CYCLIN-E; KINASE; AIB1; PHOSPHORYLATION; LIGASE; CANCER; ACTIVATION	SRC-3/AlB1 is an important growth coactivator whose activity should be tightly regulated since excess activation results in oncogenesis. Herein, we provide evidence that coordinated phosphorylation-dependent ubiquitination regulates SRC-3 coactivator activation and transcriptional specificity. We discovered a critical "actron/degron" element in SRC-3 that is required for this phosphorylation-dependent ubiquitination event and identified GSK3 and SCIFFbw7 alpha as the respective responsible kinase and E3 ubiquitin ligase. Interestingly, despite that SCFFbw7 alpha enhances ubiquitination and promotes eventual transcription-coupled degradation of SRC-3 in a phosphorylation- and Fbw7 alpha dosage-dependent manner, our results also uncovered a nonproteolytic "activation" code for SRC-3 ubiquitination induced by Fbw7a. We propose that ubiquitination of SRC-3 is a phospho-mediated biphasic event and that a transition from multi-(mono)ubiquitination (SRC-3 activation) to long-chain polyubiquitination (SIRC-3 degradation) is processive during the transcriptional coactivation of select transcription factors and can serve as a "transcriptional time clock" to control both the activation and the functional lifetime of coactivators.	Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Baylor College of Medicine	O'Malley, BW (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, 1 Baylor Plaza, Houston, TX 77030 USA.	berto@bcm.tmc.edu	高, 雨莉/HGU-8187-2022; Wu, Ray-chang/X-2018-2019					Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; Bornstein G, 2003, J BIOL CHEM, V278, P25752, DOI 10.1074/jbc.M301774200; Brazil DP, 2004, TRENDS BIOCHEM SCI, V29, P233, DOI 10.1016/j.tibs.2004.03.006; Cohen P, 1999, PHILOS T R SOC B, V354, P485, DOI 10.1098/rstb.1999.0399; de Mora JF, 2000, MOL CELL BIOL, V20, P5041, DOI 10.1128/MCB.20.14.5041-5047.2000; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; ELLEDGE SJ, 1998, BIOCHIM BIOPHYS ACTA, V1377, P61; Feng Q, 2006, MOL CELL BIOL, V26, P7846, DOI 10.1128/MCB.00568-06; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Kamura T, 2003, P NATL ACAD SCI USA, V100, P10231, DOI 10.1073/pnas.1831009100; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; Kuang SQ, 2004, CANCER RES, V64, P1875, DOI 10.1158/0008-5472.CAN-03-3745; Li XT, 2006, CELL, V124, P381, DOI 10.1016/j.cell.2005.11.037; Lonard DM, 2000, MOL CELL, V5, P939, DOI 10.1016/S1097-2765(00)80259-2; Lonard DM, 2004, MOL CELL BIOL, V24, P14, DOI 10.1128/MCB.24.1.14-24.2004; Moberg KH, 2001, NATURE, V413, P311, DOI 10.1038/35095068; Oberg C, 2001, J BIOL CHEM, V276, P35847, DOI 10.1074/jbc.M103992200; Schmitt-Ulms G, 2001, J MOL BIOL, V314, P1209, DOI 10.1006/jmbi.2000.5183; Shao WL, 2004, P NATL ACAD SCI USA, V101, P11599, DOI 10.1073/pnas.0402997101; Torres-Arzayus MI, 2004, CANCER CELL, V6, P263, DOI 10.1016/j.ccr.2004.06.027; Varshavsky A, 2005, TRENDS BIOCHEM SCI, V30, P283, DOI 10.1016/j.tibs.2005.04.005; Varshavsky A, 1997, TRENDS BIOCHEM SCI, V22, P383, DOI 10.1016/S0968-0004(97)01122-5; Wei WY, 2005, CANCER CELL, V8, P25, DOI 10.1016/j.ccr.2005.06.005; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Wu RC, 2002, MOL CELL BIOL, V22, P3549, DOI 10.1128/MCB.22.10.3549-3561.2002; Wu RC, 2004, MOL CELL, V15, P937, DOI 10.1016/j.molcel.2004.08.019; Yi P, 2005, MOL CELL BIOL, V25, P9687, DOI 10.1128/MCB.25.21.9687-9699.2005; Zheng FHF, 2005, MOL CELL BIOL, V25, P8273, DOI 10.1128/MCB.25.18.8273-8284.2005	31	183	188	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 15	2007	129	6					1125	1140		10.1016/j.cell.2007.04.039	http://dx.doi.org/10.1016/j.cell.2007.04.039			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	180UA	17574025	Bronze			2022-12-28	WOS:000247390400016
J	Grant, PM				Grant, Paul M.			Chauncey Starr (1912-2007) - Physicist, engineer and leader in the development of nuclear power - Obituary	NATURE			English	Biographical-Item									W2AGZ Technol, San Jose, CA 95120 USA		Grant, PM (corresponding author), W2AGZ Technol, 1147 Mockingbird Hill Lane, San Jose, CA 95120 USA.	w2agz@pacbell.net							0	1	1	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 14	2007	447	7146					789	789		10.1038/447789a	http://dx.doi.org/10.1038/447789a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178FV	17568737	Bronze			2022-12-28	WOS:000247207500032
J	Pastorello, A; Smartt, SJ; Mattila, S; Eldridge, JJ; Young, D; Itagaki, K; Yamaoka, H; Navasardyan, H; Valenti, S; Patat, F; Agnoletto, I; Augusteijn, T; Benetti, S; Cappellaro, E; Boles, T; Bonnet-Bidaud, JM; Botticella, MT; Bufano, F; Cao, C; Deng, J; Dennefeld, M; Elias-Rosa, N; Harutyunyan, A; Keenan, FP; Iijima, T; Lorenzi, V; Mazzali, PA; Meng, X; Nakano, S; Nielsen, TB; Smoker, JV; Stanishev, V; Turatto, M; Xu, D; Zampieri, L				Pastorello, A.; Smartt, S. J.; Mattila, S.; Eldridge, J. J.; Young, D.; Itagaki, K.; Yamaoka, H.; Navasardyan, H.; Valenti, S.; Patat, F.; Agnoletto, I.; Augusteijn, T.; Benetti, S.; Cappellaro, E.; Boles, T.; Bonnet-Bidaud, J.-M.; Botticella, M. T.; Bufano, F.; Cao, C.; Deng, J.; Dennefeld, M.; Elias-Rosa, N.; Harutyunyan, A.; Keenan, F. P.; Iijima, T.; Lorenzi, V.; Mazzali, P. A.; Meng, X.; Nakano, S.; Nielsen, T. B.; Smoker, J. V.; Stanishev, V.; Turatto, M.; Xu, D.; Zampieri, L.			A giant outburst two years before the core-collapse of a massive star	NATURE			English	Article							SUPERNOVAE; PROGENITORS; EVOLUTION; LINES	The death of massive stars produces a variety of supernovae, which are linked to the structure of the exploding stars(1,2). The detection of several precursor stars of type II supernovae has been reported ( see, for example, ref. 3), but we do not yet have direct information on the progenitors of the hydrogen-deficient type Ib and Ic supernovae. Here we report that the peculiar type Ib supernova SN 2006jc is spatially coincident with a bright optical transient(4) that occurred in 2004. Spectroscopic and photometric monitoring of the supernova leads us to suggest that the progenitor was a carbon-oxygen Wolf - Rayet star embedded within a helium-rich circumstellar medium. There are different possible explanations for this pre-explosion transient. It appears similar to the giant outbursts of luminous blue variable stars (LBVs) of 60 - 100 solar masses(5), but the progenitor of SN 2006jc was helium- and hydrogen-deficient ( unlike LBVs). An LBV-like outburst of a Wolf - Rayet star could be invoked, but this would be the first observational evidence of such a phenomenon. Alternatively, a massive binary system composed of an LBV that erupted in 2004, and a Wolf - Rayet star exploding as SN 2006jc, could explain the observations.	Queens Univ Belfast, Sch Math & Phys, Astrophys Res Ctr, Belfast BT7 1NN, Antrim, North Ireland; Itagaki Astron Observ, Teppo, Yamagata 9902492, Japan; Kyushu Univ, Dept Phys, Fukuoka 8108560, Japan; Osserv Astron Padova, INAF, I-35122 Padua, Italy; European So Observ, D-85748 Garching, Germany; Univ Ferrara, Dipartmento Fis, I-44100 Ferrara, Italy; Univ Padua, Dipartimento Astron, I-35122 Padua, Italy; Nord Opt Telescope, E-38700 Tenerife, Spain; Coddenham Astron Observ, Coddenham IP6 9QY, Suffolk, England; Ctr Etud Saclay, Serv Astrophys, DSM, DAPNIA,SAp, F-91191 Gif Sur Yvette, France; Univ Teramo, Dipartimento Sci Comunicaz, I-64100 Teramo, Italy; Chinese Acad Sci, Natl Astron Observ, Beijing 100012, Peoples R China; CNRS, IN2P3, Ctr Phys Particules Marseille, F-13288 Marseille 9, France; Univ Aix Marseille 2, F-13288 Marseille 9, France; CNRS, Inst Astrophys, F-75014 Paris, France; Univ Paris 06, F-75014 Paris, France; Univ La Laguna, E-38206 Tenerife, Spain; Osserv Astron Padova, INAF, I-36012 Vicenza, Italy; Telescopio Nazl Galileo, Fdn Galileo Galilei, INAF, E-38700 Tenerife, Spain; Max Planck Inst Astrophys, D-85741 Garching, Germany; Osserv Astron Trieste, INAF, I-34131 Trieste, Italy; Oriental Astron Assoc, CtrAstrodynam, Comp & Minor Planet Sect, Sumoto, Hyogo 6560011, Japan; Stockholm Univ, AlbaNova Univ Ctr, Dept Phys, SE-10691 Stockholm, Sweden	Queens University Belfast; Kyushu University; Istituto Nazionale Astrofisica (INAF); University of Padua; European Southern Observatory; University of Ferrara; University of Padua; CEA; UDICE-French Research Universities; Universite Paris Saclay; University of Teramo; Chinese Academy of Sciences; National Astronomical Observatory, CAS; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Universidad de la Laguna; Istituto Nazionale Astrofisica (INAF); University of Padua; Istituto Nazionale Astrofisica (INAF); Max Planck Society; Istituto Nazionale Astrofisica (INAF); Stockholm University	Pastorello, A (corresponding author), Queens Univ Belfast, Sch Math & Phys, Astrophys Res Ctr, Belfast BT7 1NN, Antrim, North Ireland.	a.pastorello@qub.ac.uk	Valenti, Stefano/M-5924-2017; Stanishev, Vallery/M-8930-2013; Botticella, Maria Teresa/AAJ-9694-2020; Elias-Rosa, Nancy/D-3759-2014	Valenti, Stefano/0000-0001-8818-0795; Stanishev, Vallery/0000-0002-7626-1181; Botticella, Maria Teresa/0000-0002-3938-692X; Elias-Rosa, Nancy/0000-0002-1381-9125; Young, David/0000-0002-1229-2499; Turatto, Massimo/0000-0002-9719-3157; Zampieri, Luca/0000-0002-6516-1329; BUFANO, Filomena/0000-0002-3429-2481; Mazzali, Paolo/0000-0001-6876-8284; Benetti, Stefano/0000-0002-3256-0016; Cappellaro, Enrico/0000-0001-5008-8619; Patat, Ferdinando/0000-0002-0537-3573; Eldridge, Jan/0000-0002-1722-6343; Mattila, Seppo/0000-0001-7497-2994; Lorenzi, Vania/0000-0002-1958-9930	Science and Technology Facilities Council [PP/E003303/1] Funding Source: researchfish; STFC [PP/E003303/1] Funding Source: UKRI	Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))		BENETTI S, 2006, CENT BUR ELECT TEL, V674, P2; Crotts A., 2006, CBET, V672, P1; Davidson K, 1997, ANNU REV ASTRON ASTR, V35, P1, DOI 10.1146/annurev.astro.35.1.1; Eldridge JJ, 2004, MON NOT R ASTRON SOC, V353, P87, DOI 10.1111/j.1365-2966.2004.08041.x; FESEN R, 2006, CENT BUR ELECT TEL, V672, P2; FILIPPENKO AV, 2002, 7825 IAU; Foley RJ, 2007, ASTROPHYS J, V657, pL105, DOI 10.1086/513145; Heger A, 2003, ASTROPHYS J, V591, P288, DOI 10.1086/375341; Hillier DJ, 2001, ASTROPHYS J, V553, P837, DOI 10.1086/320948; IMMLER S, 2006, ASTRON TEL, P934; Iping RC, 2005, ASTROPHYS J, V633, pL37, DOI 10.1086/498268; Koenigsberger G, 2002, ASTROPHYS J, V581, P598, DOI 10.1086/344215; Kotak R, 2006, ASTRON ASTROPHYS, V460, pL5, DOI 10.1051/0004-6361:20065800; MacFadyen AI, 2001, ASTROPHYS J, V550, P410, DOI 10.1086/319698; Matheson T, 2000, ASTRON J, V119, P2303, DOI 10.1086/301352; Maund JR, 2006, MON NOT R ASTRON SOC, V369, P390, DOI 10.1111/j.1365-2966.2006.10308.x; Mazzali P. A., 2002, APJ, V572, P61; Mazzali PA, 2005, SCIENCE, V308, P1284, DOI 10.1126/science.1111384; Mazzali PA, 2006, NATURE, V442, P1018, DOI 10.1038/nature05081; MODJAZ M, 2006, CBET, V677, P1; Nakano S., 2006, CENTRAL BUREAU ELECT, P666; Nomoto K, 2003, P IAU S, V212, P395; Patat F, 2001, ASTROPHYS J, V555, P900, DOI 10.1086/321526; Pian E, 2006, NATURE, V442, P1011, DOI 10.1038/nature05082; PODSIADLOWSKI P, 1992, ASTROPHYS J, V391, P246, DOI 10.1086/171341; Richmond MW, 1996, ASTRON J, V111, P327, DOI 10.1086/117785; Smartt SJ, 2004, SCIENCE, V303, P499, DOI 10.1126/science.1092967; Smith N, 2006, ASTROPHYS J, V645, pL45, DOI 10.1086/506523; VANDYK SV, 2006, UNPUB PUBL ASTRON SO	29	275	276	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 14	2007	447	7146					829	832		10.1038/nature05825	http://dx.doi.org/10.1038/nature05825			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178FV	17568740	Green Submitted			2022-12-28	WOS:000247207500037
J	Egli, D; Rosains, J; Birkhoff, G; Eggan, K				Egli, Dieter; Rosains, Jacqueline; Birkhoff, Garrett; Eggan, Kevin			Developmental reprogramming after chromosome transfer into mitotic mouse zygotes	NATURE			English	Article							EMBRYONIC STEM-CELLS; ADULT SOMATIC-CELLS; NUCLEAR TRANSFER; ENUCLEATED ZYGOTES; HUMAN OOCYTES; MICE; TRANSPLANTATION; CLONING; FETAL; DIFFERENTIATION	Until now, animal cloning and the production of embryonic stem cell lines by somatic cell nuclear transfer have relied on introducing nuclei into meiotic oocytes. In contrast, attempts at somatic cell nuclear transfer into fertilized interphase zygotes have failed. As a result, it has generally been assumed that unfertilized human oocytes will be required for the generation of tailored human embryonic stem cell lines from patients by somatic cell nuclear transfer. Here we report, however, that, unlike interphase zygotes, mouse zygotes temporarily arrested in mitosis can support somatic cell reprogramming, the production of embryonic stem cell lines and the full-term development of cloned animals. Thus, human zygotes and perhaps human embryonic blastomeres may be useful supplements to human oocytes for the creation of patient-derived human embryonic stem cells.	Harvard Univ, Stowers Med Inst, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; Harvard Univ, Stowers Med Inst, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University; Stowers Institute for Medical Research; Harvard University; Stowers Institute for Medical Research	Eggan, K (corresponding author), Harvard Univ, Stowers Med Inst, Harvard Stem Cell Inst, Cambridge, MA 02138 USA.	eggan@mcb.harvard.edu	Eggan, Kevin/P-7119-2018					Beard C, 2006, GENESIS, V44, P23, DOI 10.1002/gene.20180; BECK F, 1995, DEV DYNAM, V204, P219, DOI 10.1002/aja.1002040302; Boiani M, 2002, GENE DEV, V16, P1209, DOI 10.1101/gad.966002; Campbell KHS, 1996, NATURE, V380, P64, DOI 10.1038/380064a0; CHEONG HT, 1992, JPN J VET RES, V40, P149; CHEONG HT, 1993, THERIOGENOLOGY, V39, P451, DOI 10.1016/0093-691X(93)90388-L; Chesne P, 2002, NAT BIOTECHNOL, V20, P366, DOI 10.1038/nbt0402-366; Cowan CA, 2005, SCIENCE, V309, P1369, DOI 10.1126/science.1116447; Damario MA, 1999, FERTIL STERIL, V72, P1049, DOI 10.1016/S0015-0282(99)00444-6; Do JT, 2004, STEM CELLS, V22, P941, DOI 10.1634/stemcells.22-6-941; Eggan K, 2001, P NATL ACAD SCI USA, V98, P6209, DOI 10.1073/pnas.101118898; Ehrhardt AG, 2005, J CELL PHYSIOL, V204, P808, DOI 10.1002/jcp.20335; Gao SR, 2002, BIOL REPROD, V67, P928, DOI 10.1095/biolreprod.102.004606; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Greda P, 2006, REPRODUCTION, V132, P741, DOI 10.1530/rep.1.01204; Hall VJ, 2007, HUM REPROD, V22, P52, DOI 10.1093/humrep/del345; HAMILTON BT, 1982, EUR J CELL BIOL, V28, P190; Kato Y, 1998, SCIENCE, V282, P2095, DOI 10.1126/science.282.5396.2095; KOLA I, 1987, BIOL REPROD, V37, P395, DOI 10.1095/biolreprod37.2.395; MCGRATH J, 1983, SCIENCE, V220, P1300, DOI 10.1126/science.6857250; MCGRATH J, 1984, SCIENCE, V226, P1317, DOI 10.1126/science.6542249; Munne S, 1998, HUM REPROD UPDATE, V4, P842, DOI 10.1093/humupd/4.6.842; Nagy A., 2003, MANIPULATING MOUSE E; Nikolettos N, 2000, MOL CELL ENDOCRINOL, V169, P55, DOI 10.1016/S0303-7207(00)00352-X; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; NORSIGIAN J, 2005, BOSTON GLOBE    0225, pA13; Ono Y, 2001, BIOL REPROD, V64, P44, DOI 10.1095/biolreprod64.1.44; Polejaeva IA, 2000, NATURE, V407, P86, DOI 10.1038/35024082; PRATHER RS, 1989, BIOL REPROD, V41, P414, DOI 10.1095/biolreprod41.3.414; ROBL JM, 1987, J ANIM SCI, V64, P642, DOI 10.2527/jas1987.642642x; Rudner AD, 1996, CURR OPIN CELL BIOL, V8, P773, DOI 10.1016/S0955-0674(96)80077-9; SATHANANTHAN AH, 1991, P NATL ACAD SCI USA, V88, P4806, DOI 10.1073/pnas.88.11.4806; SCHOLER HR, 1990, EMBO J, V9, P2185, DOI 10.1002/j.1460-2075.1990.tb07388.x; Schurmann A, 2006, REPRODUCTION, V132, P839, DOI 10.1530/REP-06-0054; Steinbrook R, 2006, NEW ENGL J MED, V354, P324, DOI 10.1056/NEJMp058313; STICE SL, 1988, BIOL REPROD, V39, P657, DOI 10.1095/biolreprod39.3.657; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; Tada M, 1997, EMBO J, V16, P6510, DOI 10.1093/emboj/16.21.6510; Tada M, 2001, CURR BIOL, V11, P1553, DOI 10.1016/S0960-9822(01)00459-6; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; VANDERVEN HH, 1985, ANN NY ACAD SCI, V442, P88; Wakayama S, 2004, J REPROD DEVELOP, V50, P627, DOI 10.1262/jrd.50.627; Wakayama S, 2007, CURR BIOL, V17, pR120, DOI 10.1016/j.cub.2006.12.020; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Wakayama T, 1999, P NATL ACAD SCI USA, V96, P14984, DOI 10.1073/pnas.96.26.14984; Wakayama T, 2000, NAT GENET, V24, P108, DOI 10.1038/72749; Wakayama T, 1999, NAT GENET, V22, P127, DOI 10.1038/9632; WILLADSEN SM, 1986, NATURE, V320, P63, DOI 10.1038/320063a0; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Wolf JP, 1997, FERTIL STERIL, V67, P1095, DOI 10.1016/S0015-0282(97)81445-8; Yoshimizu T, 1999, DEV GROWTH DIFFER, V41, P675; Zhou Q, 2003, SCIENCE, V302, P1179, DOI 10.1126/science.1088313; 2004, FERTIL STERIL, V81, P1207	53	213	235	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 7	2007	447	7145					679	U8		10.1038/nature05879	http://dx.doi.org/10.1038/nature05879			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175RI	17554301				2022-12-28	WOS:000247030700036
J	Kaurah, P; MacMillan, A; Boyd, N; Senz, J; De Luca, A; Chun, N; Suriano, G; Zaor, S; Van Manen, L; Gilpin, C; Nikkel, S; Connolly-Wilson, M; Weissman, S; Rubinstein, WS; Sebold, C; Greenstein, R; Stroop, J; Yim, D; Panzini, B; McKinnon, W; Greenblatt, M; Wirtzfeld, D; Fontaine, D; Coit, D; Yoon, S; Chung, D; Lauwers, G; Pizzuti, A; Vaccaro, C; Redal, MA; Oliveira, C; Tischkowitz, M; Olschwang, S; Gallinger, S; Lynch, H; Green, J; Ford, J; Pharoah, P; Fernandez, B; Huntsman, D				Kaurah, Pardeep; MacMillan, Andree; Boyd, Niki; Senz, Janine; De Luca, Alessandro; Chun, Nicki; Suriano, Gianpaolo; Zaor, Sonya; Van Manen, Lori; Gilpin, Cathy; Nikkel, Sarah; Connolly-Wilson, Mary; Weissman, Scott; Rubinstein, Wendy S.; Sebold, Courtney; Greenstein, Robert; Stroop, Jennifer; Yim, Dwight; Panzini, Benoit; McKinnon, Wendy; Greenblatt, Marc; Wirtzfeld, Debrah; Fontaine, Daniel; Coit, Daniel; Yoon, Sam; Chung, Daniel; Lauwers, Gregory; Pizzuti, Antonio; Vaccaro, Carlos; Redal, Maria Ana; Oliveira, Carla; Tischkowitz, Marc; Olschwang, Sylviane; Gallinger, Steven; Lynch, Henry; Green, Jane; Ford, James; Pharoah, Paul; Fernandez, Bridget; Huntsman, David			Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							E-CADHERIN GENE; PROPHYLACTIC TOTAL GASTRECTOMY; GERMLINE MISSENSE MUTATIONS; BREAST-CANCER; COLORECTAL-CANCER; MESSENGER-RNA; CARCINOMA; PREDISPOSITION; NEWFOUNDLAND; MANAGEMENT	Context Hereditary diffuse gastric cancer is caused by germline mutations in the epithelial cadherin ( CDH1) gene and is characterized by an increased risk for diffuse gastric cancer and lobular breast cancer. Objective To determine whether recurring germline CDH1 mutations occurred due to independent mutational events or common ancestry. Design, Setting, and Patients Thirty-eight families diagnosed clinically with hereditary diffuse gastric cancer were accrued between November 2004 and January 2006 and were analyzed for CDH1 mutations as part of an ongoing study at the British Columbia Cancer Agency. Twenty-six families had at least 2 gastric cancer cases with 1 case of diffuse gastric cancer in a person younger than 50 years; 12 families had either a single case of diffuse gastric cancer diagnosed in a person younger than 35 years or multiple cases of diffuse gastric cancer diagnosed in persons older than 50 years. Main Outcome Measures Classification of family members as carriers or noncarriers of CDH1 mutations. Haplotype analysis to assess recurring mutations for common ancestry was performed on 7 families from this study and 7 previously reported families with the same mutations. Results Thirteen mutations ( 6 novel) were identified in 15 of the 38 families ( 40% detection rate). The 1137G > A splicing mutation and the 1901C > T ( A634V) missense/splicing mutation occurred on common haplotypes in 2 families but on different haplotypes in a third family. The 2195G > A ( R732Q) missense/splicing mutation occurred in 2 families on different haplotypes. The 2064-2065delTG mutation occurred on a common haplotype in 2 families. Two families from this study plus 2 additional families carrying the novel 2398delC mutation shared a common haplotype, suggesting a founder effect. All 4 families originate from the southeast coast of Newfoundland. Due to concentrations of lobular breast cancer cases, 2 branches of this family had been diagnosed as having hereditary breast cancer and were tested for BRCA mutations. Within these 4 families, the cumulative risk by age 75 years in mutation carriers for clinically detected gastric cancer was 40% ( 95% confidence interval [ CI], 12%91%) for males and 63% ( 95% CI, 19%-99%) for females and the risk for breast cancer in female mutation carriers was 52% ( 95% CI, 29%-94%). Conclusions Recurrent CDH1 mutations in families with hereditary diffuse gastric cancer are due to both independent mutational events and common ancestry. The presence of a founder mutation from Newfoundland is strongly supported.	British Columbia Canc Agcy, Hereditary Canc Program, Ctr Translat & Appl Genom, Vancouver, BC V5Z 4E6, Canada; Hlth Sci Ctr, Prov Med Genet Program, St John, NF, Canada; Stanford Univ, Sch Med, Canc Genet Program, Div Oncol, Stanford, CA 94305 USA; Univ Porto, Inst Mol Pathol & Immunol, Fac Med, P-4100 Oporto, Portugal; Sir Mortimer B Davis Jewish Hosp, Canc Prevent Ctr, Montreal, PQ H3T 1E2, Canada; Kingston Gen Hosp, Familial Oncol Program, Canc Ctr SE Ontario, Kingston, ON K7L 2V7, Canada; Childrens Hosp Eastern Ontario, Dept Genet, Ottawa, ON K1H 8L1, Canada; Evanston NW Healthcare, Ctr Med Genet, Evanston, IL USA; Wilford Hall USAF Med Ctr, Pediat Subspecialty Clin, San Antonio, TX 78236 USA; Univ Connecticut, Ctr Hlth, Hereditary Canc Program, Div Med Genet, Farmington, CT USA; Kaiser Permanente, Dept Pediat, Honolulu, HI USA; CHUM Hotel Dieu, Clin Canc Hereditaires, Montreal, PQ, Canada; CHUM Hop Notre Dame, Serv Gastroenterol, Montreal, PQ, Canada; Univ Vermont, Coll Med, Familial Canc Program, Burlington, VT USA; Mem Univ Newfoundland, Div Surg, St John, NF, Canada; Mem Univ Newfoundland, Div Clin Genet, St John, NF, Canada; Mem Univ Newfoundland, Dept Anat Pathol, St John, NF, Canada; Mem Univ Newfoundland, Discipline Genet, Fac Med, St John, NF, Canada; Mem Sloan Kettering Canc Ctr, Gastric & Mixed Tumor Serv, Dept Surg, New York, NY 10021 USA; Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA; Massachusetts Gen Hosp, Gastroenterol Unit, Boston, MA 02114 USA; Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; Massachusetts Gen Hosp, Gastrointestinal Pathol Serv, Dept Pathol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA; IRCCS, CCS Hosp, San Giovanni Rotondo, Italy; CSS Mendel Inst, Rome, Italy; Hosp Italiano Buenos Aires, Serv Gen Surg, Buenos Aires, DF, Argentina; Hosp Italiano Buenos Aires, Inst Ciencias Basicas & Med Expt, Buenos Aires, DF, Argentina; McGill Univ, Program Canc Genet, Montreal, PQ, Canada; McGill Univ, Dept Oncol, Montreal, PQ, Canada; McGill Univ, Dept Human Genet, Montreal, PQ, Canada; Inst J Paoli I Calmettes, INSERM, U599, F-13009 Marseille, France; Univ Toronto, Hepatobiliary & Pancreat Surg Grp, Div Gen Surg, Univ Hlth Network, Toronto, ON, Canada; Univ Toronto, Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada; Creighton Univ, Dept Prevent Med & Publ Hlth, Omaha, NE 68178 USA; Univ Cambridge, Dept Oncol, Cambridge, England	British Columbia Cancer Agency; Memorial University Newfoundland; University of Manitoba; Children's Hospital Research Institute of Manitoba; Stanford University; Universidade do Porto; McGill University; Cancer Care Ontario; Queens University - Canada; University of Ottawa; Children's Hospital of Eastern Ontario; NorthShore University Health System; United States Department of Defense; United States Air Force; University of Connecticut; Kaiser Permanente; Universite de Montreal; Universite de Montreal; University of Vermont; Memorial University Newfoundland; Memorial University Newfoundland; Memorial University Newfoundland; Memorial University Newfoundland; Memorial Sloan Kettering Cancer Center; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; IRCCS Casa Sollievo Della Sofferenza; IRCCS Casa Sollievo Della Sofferenza; Istituto CSS Mendel; Hospital Italiano de Buenos Aires; University of Buenos Aires; Hospital Italiano de Buenos Aires; University of Buenos Aires; McGill University; McGill University; McGill University; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Institut Paoli-Calmette (IPC); University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Creighton University; University of Cambridge	Huntsman, D (corresponding author), British Columbia Canc Agcy, Hereditary Canc Program, Ctr Translat & Appl Genom, 600 W 10th Ave, Vancouver, BC V5Z 4E6, Canada.	dhuntsma@bccancer.bc.ca	Oliveira, Carla/F-8188-2011; Huntsman, David/ABE-6082-2020; Pharoah, Paul/V-6658-2019; Gallinger, Steven/E-4575-2013; Tischkowitz, Marc/O-4452-2018; Olschwang, Sylviane/G-2716-2013; De Luca, Alessandro/B-2179-2017	Oliveira, Carla/0000-0001-8340-2264; Pharoah, Paul/0000-0001-8494-732X; Tischkowitz, Marc/0000-0002-7880-0628; Olschwang, Sylviane/0000-0001-7078-3029; De Luca, Alessandro/0000-0002-4408-8062; Vaccaro, Carlos/0000-0002-1299-5864; Ford, James/0000-0002-2513-7025; PIZZUTI, Antonio/0000-0003-3245-1925	NATIONAL CANCER INSTITUTE [U01CA086389] Funding Source: NIH RePORTER; NCI NIH HHS [5UO1 CA86389] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alberts SR, 2003, ANN ONCOL, V14, P31, DOI 10.1093/annonc/mdg726; Bacani JT, 2006, J MED GENET, V43, P867, DOI 10.1136/jmg.2006.043133; BEAR JC, 1988, AM J MED GENET, V29, P649, DOI 10.1002/ajmg.1320290324; BECKER KF, 1994, CANCER RES, V54, P3845; Berx G, 1996, ONCOGENE, V13, P1919; Blair V, 2006, CLIN GASTROENTEROL H, V4, P262, DOI 10.1016/j.cgh.2005.12.003; Brooks-Wilson AR, 2004, J MED GENET, V41, P508, DOI 10.1136/jmg.2004.018275; BRUNAK S, 1991, J MOL BIOL, V220, P49, DOI 10.1016/0022-2836(91)90380-O; Caldas C, 1999, J MED GENET, V36, P873; *CAN CANC SOC, 2006, CAN CANC STAT; Carneiro F, 2004, J PATHOL, V203, P681, DOI 10.1002/path.1564; Chun YS, 2001, CANCER, V92, P181, DOI 10.1002/1097-0142(20010701)92:1<181::AID-CNCR1307>3.0.CO;2-J; Crew KD, 2006, WORLD J GASTROENTERO, V12, P354, DOI 10.3748/wjg.v12.i3.354; Dussaulx-Garin L, 2001, EUR J GASTROEN HEPAT, V13, P711, DOI 10.1097/00042737-200106000-00016; FISHER B, 1989, NEW ENGL J MED, V320, P479, DOI 10.1056/NEJM198902233200802; Frebourg T, 2006, J MED GENET, V43, P138, DOI 10.1136/jmg.2005.031385; Gayther SA, 1998, CANCER RES, V58, P4086; GIARDIELLO FM, 1987, NEW ENGL J MED, V316, P1511, DOI 10.1056/NEJM198706113162404; Guilford P, 1998, NATURE, V392, P402, DOI 10.1038/32918; Hebsgaard SM, 1996, NUCLEIC ACIDS RES, V24, P3439, DOI 10.1093/nar/24.17.3439; Henson DE, 2004, ARCH PATHOL LAB MED, V128, P765; Humar B, 2002, HUM MUTAT, V19, P518, DOI 10.1002/humu.10067; Huntsman DG, 2001, NEW ENGL J MED, V344, P1904, DOI 10.1056/NEJM200106213442504; Jonsson BA, 2002, INT J CANCER, V98, P838, DOI 10.1002/ijc.10258; Keller G, 1999, AM J PATHOL, V155, P337, DOI 10.1016/S0002-9440(10)65129-2; Keller G, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.015594; Kim HC, 2000, GUT, V47, P262, DOI 10.1136/gut.47.2.262; Kriege M, 2004, NEW ENGL J MED, V351, P427, DOI 10.1056/NEJMoa031759; LARUE L, 1994, P NATL ACAD SCI USA, V91, P8263, DOI 10.1073/pnas.91.17.8263; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Lewis FR, 2001, SURGERY, V130, P612, DOI 10.1067/msy.2001.117099; Lynch HT, 2005, J SURG ONCOL, V90, P114, DOI 10.1002/jso.20214; LYNCH HT, 1993, GASTROENTEROLOGY, V104, P1535, DOI 10.1016/0016-5085(93)90368-M; More H, 2007, HUM MUTAT, V28, DOI 10.1002/humu.9473; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Ng PC, 2002, GENOME RES, V12, P436, DOI 10.1101/gr.212802; Norton JA, 2007, ANN SURG, V245, P873, DOI 10.1097/01.sla.0000254370.29893.e4; Oliveira C, 2006, INT J SURG PATHOL, V14, P21, DOI 10.1177/106689690601400105; Oliveira C, 2004, EUR J CANCER, V40, P1897, DOI 10.1016/j.ejca.2004.04.027; Oliveira C, 2003, EXPERT REV MOL DIAGN, V3, P201; Oliveira C, 2002, HUM MUTAT, V19, P510, DOI 10.1002/humu.10068; Oliveira Carla, 2004, Hered Cancer Clin Pract, V2, P51, DOI 10.1186/1897-4287-2-2-51; PFEIFFER CJ, 1977, DIGESTION, V16, P1, DOI 10.1159/000198048; PFEIFFER CJ, 1973, CAN MED ASSOC J, V108, P1374; Pharoah PDP, 2001, GASTROENTEROLOGY, V121, P1348, DOI 10.1053/gast.2001.29611; Richards FM, 1999, HUM MOL GENET, V8, P607, DOI 10.1093/hmg/8.4.607; Sarrio D, 2003, INT J CANCER, V106, P208, DOI 10.1002/ijc.11197; Shinmura K, 1999, CARCINOGENESIS, V20, P1127, DOI 10.1093/carcin/20.6.1127; Suriano G, 2003, HUM MOL GENET, V12, P3007, DOI 10.1093/hmg/ddg316; Suriano G, 2005, CLIN CANCER RES, V11, P5401, DOI 10.1158/1078-0432.CCR-05-0247; Suriano G, 2003, HUM MOL GENET, V12, P575, DOI 10.1093/hmg/ddg048; Suriano G, 2006, J MOL MED-JMM, V84, P1023, DOI 10.1007/s00109-006-0091-z; van Kouwen MCA, 2004, CLIN CANCER RES, V10, P6456, DOI 10.1158/1078-0432.CCR-04-0599; VARLEY JM, 1995, J MED GENET, V32, P942, DOI 10.1136/jmg.32.12.942; Vecsey-Semjen B, 2002, ONCOGENE, V21, P4646, DOI 10.1038/sj.onc.1205577; Wolmark N, 2001, ANN NY ACAD SCI, V949, P99	56	301	308	1	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 6	2007	297	21					2360	2372		10.1001/jama.297.21.2360	http://dx.doi.org/10.1001/jama.297.21.2360			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	175IL	17545690	Bronze			2022-12-28	WOS:000247007200018
J	Shorvon, S				Shorvon, Simon			The prosecution of research - experience from Singapore	LANCET			English	Editorial Material									UCL, Inst Neurol, London WC1N 3BG, England	University of London; University College London	Shorvon, S (corresponding author), UCL, Inst Neurol, London WC1N 3BG, England.	s.shorvon@ion.ucl.ac.uk	Shorvon, Simon D/A-2019-2009	Shorvon, Simon/0000-0003-0313-2001				Barr Michael D., 2000, LK YEW BELIEFS MAN; BURTON J, 2004, FINANCIAL TIMES 0708; DOLL R, 2004, EXPERT REPORT; Gibson W, 1993, WIRED MAGAZINE, P1; *INT PRESS I, 2005, SING 2005 WORLD PRES; Lingle C., 1996, SINGAPORES AUTHORITA; Lydgate Chris, 2003, LEES LAW SINGAPORE C; *NAT NEUR I, 2003, REP INQ PAN NAT NEUR; SEOW F, 1998, MEDIA ENTHRALLED; SEOW F, 2006, MONOGRAPH YALE U, V55; SINGAPORE GC, 2000, AIR CONDITIONED NATI; 2003, TODAY           0118, P1; 2006, 3 ANN WORLDWIDE PRES	13	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 2	2007	369	9576					1835	1837		10.1016/S0140-6736(07)60827-7	http://dx.doi.org/10.1016/S0140-6736(07)60827-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	173ZS	17544747				2022-12-28	WOS:000246911600004
J	Rathmell, JC; Kornbluth, S				Rathmell, Jeffrey C.; Kornbluth, Sally			Filling a GAP(DH) in caspase-independent cell death	CELL			English	Editorial Material							GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; APOPTOSIS		Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; Duke Univ, Dept Immunol, Durham, NC 27710 USA; Duke Univ, Sarah W Stedman Nutr & Metab Ctr, Durham, NC 27710 USA	Duke University; Duke University; Duke University	Kornbluth, S (corresponding author), Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA.	kornb001@mc.duke.edu			NCI NIH HHS [R01 CA123350-01A1, R01 CA123350] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA123350] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		COLELL A, 2007, CELL; Gottlob K, 2001, GENE DEV, V15, P1406, DOI 10.1101/gad.889901; Hao ZY, 2005, CELL, V121, P579, DOI 10.1016/j.cell.2005.03.016; SABATH DE, 1990, GENE, V91, P185, DOI 10.1016/0378-1119(90)90087-8; Semenza G L, 2001, Novartis Found Symp, V240, P251; Sirover MA, 2005, J CELL BIOCHEM, V95, P45, DOI 10.1002/jcb.20399; Tanida I, 2004, INT J BIOCHEM CELL B, V36, P2503, DOI 10.1016/j.biocel.2004.05.009; Wright KM, 2006, CELL CYCLE, V5, P1616, DOI 10.4161/cc.5.15.3129; ZHAO Y, 2007, IN PRESS MOL CELL BI	9	8	8	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 1	2007	129	5					861	863		10.1016/j.cell.2007.05.030	http://dx.doi.org/10.1016/j.cell.2007.05.030			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	176KT	17540167	Green Accepted, Bronze			2022-12-28	WOS:000247084600007
J	Thorpe, SKS; Holder, RL; Crompton, RH				Thorpe, S. K. S.; Holder, R. L.; Crompton, R. H.			Origin of human bipedalism as an adaptation for locomotion on flexible branches	SCIENCE			English	Article							CHIMPANZEES; EVOLUTION; ECOLOGY; WALKING	Human bipedalism is commonly thought to have evolved from a quadrupedal terrestrial precursor, yet some recent paleontological evidence suggests that adaptations for bipedalism arose in an arboreal context. However, the adaptive benefit of arboreal bipedalism has been unknown. Here we show that it allows the most arboreal great ape, the orangutan, to access supports too flexible to be negotiated otherwise. Orangutans react to branch flexibility like humans running on springy tracks, by increasing knee and hip extension, whereas all other primates do the reverse. Human bipedalism is thus less an innovation than an exploitation of a locomotor behavior retained from the common great ape ancestor.	Univ Liverpool, Sch Biomed Sci, Liverpool L69 3GE, Merseyside, England; Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England; Univ Birmingham, Dept Primary Care & Gen Practice, Birmingham B15 2TT, W Midlands, England	University of Liverpool; University of Birmingham; University of Birmingham	Crompton, RH (corresponding author), Univ Liverpool, Sch Biomed Sci, Sherrington Bldg,Ashton St, Liverpool L69 3GE, Merseyside, England.	rhcromp@liv.ac.uk						Alexander RM., 2003, PRINCIPLES ANIMAL LO; CARTMILL M, 1977, AM J PHYS ANTHROPOL, V47, P249, DOI 10.1002/ajpa.1330470206; Crompton RH, 2003, COUR FOR SEKENBG, V243, P135; FLEAGLE JG, 1981, S ZOOLOGICAL SOC LON, V48, P359; Gommery Dominique, 2002, Annales de Paleontologie, V88, P167, DOI 10.1016/S0753-3969(02)01044-3; Haile-Selassie Y, 2001, NATURE, V412, P178, DOI 10.1038/35084063; Hunt KD, 1996, PRIMATES, V37, P363, DOI 10.1007/BF02381373; HUNT KD, 1994, J HUM EVOL, V26, P183, DOI 10.1006/jhev.1994.1011; KINGDON J, 2003, LOWLY ORIGINS; KOVAROVIC K, IN PRESS J HUM EVOL, DOI DOI 10.1016/J.JHEVOI.2007.01.001; Larney E, 2004, AM J PHYS ANTHROPOL, V125, P42, DOI 10.1002/ajpa.10366; Patterson N, 2006, NATURE, V441, P1103, DOI 10.1038/nature04789; Payne RC, 2006, J ANAT, V208, P709, DOI 10.1111/j.1469-7580.2006.00563.x; PICKFORD M, 2005, ANTHROPOLOGIE, V69, P191; Pickford Martin, 1999, P27; Pontzer H, 2004, J HUM EVOL, V46, P317, DOI 10.1016/j.jhevol.2003.12.006; Richmond BG, 2000, NATURE, V404, P382, DOI 10.1038/35006045; Senut B, 2006, DEV PRIMATOL-PROG PR, P199, DOI 10.1007/0-387-29798-7_15; Stern J., 1975, YEARB PHYS ANTHROPOL, V19, P59; Thorpe SKS, 2005, AM J PHYS ANTHROPOL, V127, P58, DOI 10.1002/ajpa.20151; Thorpe SKS, 1999, AM J PHYS ANTHROPOL, V110, P179, DOI 10.1002/(SICI)1096-8644(199910)110:2<179::AID-AJPA5>3.0.CO;2-Z; Thorpe SKS, 2006, AM J PHYS ANTHROPOL, V131, P384, DOI 10.1002/ajpa.20422; Ward C, 1999, EVOL ANTHROPOL, V7, P197, DOI 10.1002/(SICI)1520-6505(1999)7:6<197::AID-EVAN4>3.0.CO;2-T; Ward CV, 2002, YEARB PHYS ANTHROPOL, V45, P185, DOI 10.1002/ajpa.10185; Ward CV, 2007, HDB PALEOANTHROPOLOG, V2, P1011; White TD, 2006, NATURE, V440, P883, DOI 10.1038/nature04629; Wrangham RW, 1998, INT J PRIMATOL, V19, P949, DOI 10.1023/A:1020318102257; Young NM, 2004, J HUM EVOL, V46, P163, DOI 10.1016/j.jhevol.2003.11.002; Zollikofer CPE, 2005, NATURE, V434, P755, DOI 10.1038/nature03397	29	185	192	2	265	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 1	2007	316	5829					1328	1331		10.1126/science.1140799	http://dx.doi.org/10.1126/science.1140799			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	173PS	17540902				2022-12-28	WOS:000246885600048
J	Stowell, CP; Gelfand, JA; Shepard, JO; Kratz, A; Nundy, S				Stowell, Christopher P.; Gelfand, Jeffrey A.; Shepard, Jo-Anne O.; Kratz, Alexander; Nundy, Surajit			A woman with relapsing fevers and recent onset of dyspnea - Recurrent, fulminant babesiosis in an asplenic patient	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BOVIS-INFECTED ERYTHROCYTES; EXCHANGE-TRANSFUSION; BLOOD-DONORS; MALARIA; CLINDAMYCIN; PARASITEMIA; MICROTI; QUININE		Massachusetts Gen Hosp, Blood Transfus Serv, Boston, MA 02114 USA; Massachusetts Gen Hosp, Infect Dis Unit, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Pathol, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Med, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Radiol, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard University	Stowell, CP (corresponding author), Massachusetts Gen Hosp, Blood Transfus Serv, Boston, MA 02114 USA.		Gelfand, Jeffrey A/G-1885-2018	Gelfand, Jeffrey A/0000-0002-4118-5676				BOUSTANI MR, 1994, AM J RESP CRIT CARE, V149, P1689, DOI 10.1164/ajrccm.149.6.8004331; Chen QJ, 2000, CLIN MICROBIOL REV, V13, P439, DOI 10.1128/CMR.13.3.439-450.2000; Corpelet C, 2005, EUR J CLIN MICROBIOL, V24, P74, DOI 10.1007/s10096-004-1270-x; Dorman SE, 2000, TRANSFUSION, V40, P375, DOI 10.1046/j.1537-2995.2000.40030375.x; Dzikowski R, 2006, MOL MICROBIOL, V59, P364, DOI 10.1111/j.1365-2958.2005.05007.x; Falagas ME, 1996, CLIN INFECT DIS, V22, P809, DOI 10.1093/clinids/22.5.809; Fraser IP, 2006, NEW ENGL J MED, V355, P1715, DOI 10.1056/NEJMcpc069022; Gelfand JA, 1998, CURR CLIN TOPICS INF, V18, P201; Hatcher JC, 2001, CLIN INFECT DIS, V32, P1117, DOI 10.1086/319742; Hemmer RM, 2000, PARASITOL RES, V86, P121, DOI 10.1007/s004360050021; HUGHES WT, 1995, J INFECT DIS, V172, P1042, DOI 10.1093/infdis/172.4.1042; JACOBY GA, 1980, NEW ENGL J MED, V303, P1098, DOI 10.1056/NEJM198011063031906; Krause PJ, 1998, NEW ENGL J MED, V339, P160, DOI 10.1056/NEJM199807163390304; Kutter Dolphe, 2002, Clin Lab, V48, P163; Leiby DA, 2005, TRANSFUSION, V45, P1804, DOI 10.1111/j.1537-2995.2005.00609.x; Leiby DA, 2002, TRANSFUSION, V42, P1585, DOI 10.1046/j.1537-2995.2002.00251.x; O'Connor RM, 2000, J IMMUNOL, V164, P2037, DOI 10.4049/jimmunol.164.4.2037; O'Connor RM, 1999, INFECT IMMUN, V67, P3921; Pantanowitz L, 2002, TRANSFUS MED REV, V16, P131, DOI 10.1053/tmrv.2002.31462; Powell VI, 2002, TRANSFUS MED REV, V16, P239, DOI 10.1053/tmrv.2002.33437; RAOULT D, 1987, ANN INTERN MED, V107, P943, DOI 10.7326/0003-4819-107-6-944_2; ROSNER F, 1984, AM J MED, V76, P696, DOI 10.1016/0002-9343(84)90298-5; Setty S, 2003, AM J CLIN PATHOL, V120, P554, DOI 10.1309/N3DP9MFPNUJD4XJY; Shaio MF, 1998, AM J TROP MED HYG, V58, P335, DOI 10.4269/ajtmh.1998.58.335; Weiss LM, 2001, NEW ENGL J MED, V344, P773; White DJ, 1998, ARCH INTERN MED, V158, P2149, DOI 10.1001/archinte.158.19.2149	26	29	29	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 31	2007	356	22					2313	2319		10.1056/NEJMcpc079011	http://dx.doi.org/10.1056/NEJMcpc079011			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	172PO	17538091				2022-12-28	WOS:000246816500012
J	Sobhian, B; Shao, GZ; Lilli, DR; Culhane, AC; Moreau, LA; Xia, B; Livingston, DM; Greenberg, RA				Sobhian, Bijan; Shao, Genze; Lilli, Dana R.; Culhane, Aedin C.; Moreau, Lisa A.; Xia, Bing; Livingston, David M.; Greenberg, Roger A.			RAP80 targets BRCA1 to specific ubiquitin structures at DNA damage sites	SCIENCE			English	Article							HISTONE H2AX; GENOMIC INSTABILITY; PHOSPHORYLATION; PROTEIN; REPAIR; MDC1; K6	Mutations affecting the BRCT domains of the breast cancer-associated tumor suppressor BRCA1 disrupt the recruitment of this protein to DNA double-strand breaks (DSBs). The molecular structures at DSBs recognized by BRCA1 are presently unknown. We report the interaction of the BRCA1 BRCT domain with RAP80, a ubiquitin-binding protein. RAP80 targets a complex containing the BRCA1-BARD1 (BRCA1-associated ring domain protein 1) E3 ligase and the deubiquitinating enzyme (DUB) BRCC36 to MDC1-gamma H2AX- dependent lysine(6)- and lysine(63)-linked ubiquitin polymers at DSBs. These events are required for cell cycle checkpoint and repair responses to ionizing radiation, implicating ubiquitin chain recognition and turnover in the BRCA1-mediated repair of DSBs.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Univ Penn, Sch Med, Dept Canc Biol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Pathol, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute	Livingston, DM (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, 44 Binney St, Boston, MA 02115 USA.	david_livingston@dfci.harvard.edu; rogergr@mail.med.upenn.edu	Culhane, Aedin/AAG-8490-2019	Culhane, Aedin/0000-0002-1395-9734; Sobhian, Bijan/0000-0001-7255-6006	NCI NIH HHS [K08 CA106597, K08 CA106597-01A2] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K08CA106597] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ambroggio XI, 2004, PLOS BIOL, V2, P113, DOI 10.1371/journal.pbio.0020002; Bassing CH, 2003, CELL, V114, P359, DOI 10.1016/S0092-8674(03)00566-X; Bassing CH, 2002, P NATL ACAD SCI USA, V99, P8173, DOI 10.1073/pnas.122228699; Bekker-Jensen S, 2006, J CELL BIOL, V173, P195, DOI 10.1083/jcb.200510130; Cantor SB, 2001, CELL, V105, P149, DOI 10.1016/S0092-8674(01)00304-X; Celeste A, 2003, NAT CELL BIOL, V5, P675, DOI 10.1038/ncb1004; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Celeste A, 2003, CELL, V114, P371, DOI 10.1016/S0092-8674(03)00567-1; Chen XW, 2006, CANCER RES, V66, P5039, DOI 10.1158/0008-5472.CAN-05-4194; Dong YS, 2003, MOL CELL, V12, P1087, DOI 10.1016/S1097-2765(03)00424-6; Greenberg RA, 2006, GENE DEV, V20, P34, DOI 10.1101/gad.1381306; Morris JR, 2004, HUM MOL GENET, V13, P807, DOI 10.1093/hmg/ddh095; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Polanowska J, 2006, EMBO J, V25, P2178, DOI 10.1038/sj.emboj.7601102; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Wang YX, 2005, NAT GENET, V37, P750, DOI 10.1038/ng1587; Wu-Baer F, 2003, J BIOL CHEM, V278, P34743, DOI 10.1074/jbc.C300249200; Yu X, 1998, J BIOL CHEM, V273, P25388, DOI 10.1074/jbc.273.39.25388; Yu XC, 2006, GENE DEV, V20, P1721, DOI 10.1101/gad.1431006	22	537	551	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2007	316	5828					1198	1202		10.1126/science.1139516	http://dx.doi.org/10.1126/science.1139516			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171GQ	17525341	Green Accepted, Green Submitted			2022-12-28	WOS:000246724300045
J	Donnelly, JP; Woodruff, JD				Donnelly, Jeffrey P.; Woodruff, Jonathan D.			Intense hurricane activity over the past 5,000 years controlled by El Nino and the West African monsoon	NATURE			English	Article							RADIOCARBON AGE CALIBRATION; EASTERN EQUATORIAL ATLANTIC; CAL KYR BP; TROPICAL CYCLONES; LATE HOLOCENE; RECORD; VARIABILITY	The processes that control the formation, intensity and track of hurricanes are poorly understood(1). It has been proposed that an increase in sea surface temperatures caused by anthropogenic climate change has led to an increase in the frequency of intense tropical cyclones(2,3), but this proposal has been challenged on the basis that the instrumental record is too short and unreliable to reveal trends in intense tropical cyclone activity(4). Storm-induced deposits preserved in the sediments of coastal lagoons offer the opportunity to study the links between climatic conditions and hurricane activity on longer timescales, because they provide centennial- to millennial-scale records of past hurricane landfalls(5-8). Here we present a record of intense hurricane activity in the western North Atlantic Ocean over the past 5,000 years based on sediment cores from a Caribbean lagoon that contain coarse-grained deposits associated with intense hurricane landfalls. The record indicates that the frequency of intense hurricane landfalls has varied on centennial to millennial scales over this interval. Comparison of the sediment record with palaeo-climate records indicates that this variability was probably modulated by atmospheric dynamics associated with variations in the El Nino/ Southern Oscillation and the strength of the West African monsoon, and suggests that sea surface temperatures as high as at present are not necessary to support intervals of frequent intense hurricanes. To accurately predict changes in intense hurricane activity, it is therefore important to understand how the El Nino/ Southern Oscillation and the West African monsoon will respond to future climate change.	Woods Hole Oceanog Inst, Coastal Syst Grp, Woods Hole, MA 02543 USA	Woods Hole Oceanographic Institution	Donnelly, JP (corresponding author), Woods Hole Oceanog Inst, Coastal Syst Grp, 360 Woods Hole Rd, Woods Hole, MA 02543 USA.	jdonnelly@whoi.edu						BELL GD, 2006, J CLIMATOL, V19, P950; Boose ER, 2004, ECOL MONOGR, V74, P335, DOI 10.1890/02-4057; Bove MC, 1998, B AM METEOROL SOC, V79, P2477, DOI 10.1175/1520-0477(1998)079<2477:EOENOO>2.0.CO;2; Cook KH, 1999, J CLIMATE, V12, P1165, DOI 10.1175/1520-0442(1999)012<1165:GOTAEJ>2.0.CO;2; COOPER JAG, 1991, MAR GEOL, V98, P145, DOI 10.1016/0025-3227(91)90042-3; Croudace IW, 2006, GEOL SOC SPEC PUBL, V267, P51, DOI 10.1144/GSL.SP.2006.267.01.04; Donnelly JP, 2004, MAR GEOL, V210, P107, DOI 10.1016/j.margeo.2004.05.005; Donnelly JP, 2001, GEOL SOC AM BULL, V113, P714, DOI 10.1130/0016-7606(2001)113<0714:YSROIH>2.0.CO;2; DONNELLY JP, 2005, J COAST RES S, V142, P201; Elsner JB, 2000, J CLIMATE, V13, P2293, DOI 10.1175/1520-0442(2000)013<2293:SVIMUS>2.0.CO;2; Emanuel K, 2005, NATURE, V436, P686, DOI 10.1038/nature03906; EMANUEL KA, 1987, NATURE, V326, P483, DOI 10.1038/326483a0; Garcia-Herrera R, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005272; Goldenberg SB, 2001, SCIENCE, V293, P474, DOI 10.1126/science.1060040; GRAY ST, 2004, GEOPHYS RES LETT, V31, P1; GRAY WM, 1984, MON WEATHER REV, V112, P1649, DOI 10.1175/1520-0493(1984)112<1649:ASHFPI>2.0.CO;2; Hughen KA, 2004, RADIOCARBON, V46, P1059, DOI 10.1017/S0033822200033002; Janicot S, 1998, J CLIMATE, V11, P1874, DOI 10.1175/1520-0442-11.8.1874; Landsea CW, 2006, SCIENCE, V313, P452, DOI 10.1126/science.1128448; Lighty R.G., 1982, Coral Reefs, V1, P125, DOI 10.1007/BF00301694; Liu KB, 2000, QUATERNARY RES, V54, P238, DOI 10.1006/qres.2000.2166; Moy CM, 2002, NATURE, V420, P162, DOI 10.1038/nature01194; Nguetsop VF, 2004, QUATERNARY SCI REV, V23, P591, DOI 10.1016/j.quascirev.2003.10.007; Nyberg J, 2002, PALAEOGEOGR PALAEOCL, V183, P25, DOI 10.1016/S0031-0182(01)00446-1; Reimer PJ, 2004, RADIOCARBON, V46, P1029, DOI 10.1017/S0033822200032999; Roy P.S., 1994, COASTAL EVOLUTION LA, P121, DOI DOI 10.1017/CBO9780511564420; SCILEPPI E, IN PRESS GEOCHEM GEO; Weldeab S, 2005, GEOLOGY, V33, P981, DOI 10.1130/G21874.1; Winter A, 2000, GEOPHYS RES LETT, V27, P3365, DOI 10.1029/2000GL011426	30	309	323	0	125	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 24	2007	447	7143					465	468		10.1038/nature05834	http://dx.doi.org/10.1038/nature05834			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170VA	17522681				2022-12-28	WOS:000246693100045
J	Griffith, KS; Lewis, LS; Mali, S; Parise, ME				Griffith, Kevin S.; Lewis, Linda S.; Mali, Sonja; Parise, Monica E.			Treatment of malaria in the United States - A systematic review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							PLASMODIUM-FALCIPARUM MALARIA; QUININE-CLINDAMYCIN TREATMENT; IN-VIVO RESISTANCE; ATOVAQUONE-PROGUANIL; DOUBLE-BLIND; EXCHANGE-TRANSFUSION; CEREBRAL MALARIA; PYRIMETHAMINE-SULFADOXINE; ANTIMALARIAL-DRUGS; IMPORTED MALARIA	Context Many US clinicians and laboratory personnel are unfamiliar with the diagnosis and treatment of malaria. Objectives To examine the evidence base for management of uncomplicated and severe malaria and to provide clinicians with practical recommendations for the diagnosis and treatment of malaria in the United States. Evidence Acquisition Systematic MEDLINE search from 1966 to 2006 using the search term malaria ( with the subheadings congenital, diagnosis, drug therapy, epidemiology, and therapy). Additional references were obtained from searching the bibliographies of pertinent articles and by reviewing articles suggested by experts in the treatment of malaria in North America. Evidence Synthesis Important measures to reduce morbidity and mortality from malaria in the United States include the following: obtaining a travel history, considering malaria in the differential diagnosis of fever based on the travel history, and prompt and accurate diagnosis and treatment. Chloroquine remains the treatment of choice for Plasmodium falciparum acquired in areas without chloroquine-resistant strains. In areas with chloroquine resistance, a combination of atovaquone and proguanil or quinine plus tetracycline or doxycycline or clindamycin are the best treatment options. Chloroquine remains the treatment of choice for all other malaria species, with the exception of P vivax acquired in Indonesia or Papua New Guinea, in which case atovaquone-proguanil is best, with mefloquine or quinine plus tetracycline or doxycycline as alternatives. Quinidine is currently the recommended treatment for severe malaria in the United States because the artemisinins are not yet available. Severe malaria occurs when a patient with asexual malaria parasitemia, and no other confirmed cause of symptoms, has 1 or more designated clinical or laboratory findings. The only adjunctive measure recommended in severe malaria is exchange transfusion. Conclusions Malaria remains a diagnostic and treatment challenge for US clinicians as increasing numbers of persons travel to and emigrate from malarious areas. A strong evidence base exists to help clinicians rapidly initiate appropriate therapy and minimize the major mortality and morbidity burdens caused by this disease.	Ctr Dis Control & Prevent, Malaria Branch, Div Parasit Dis,Coordinating Ctr Infect Dis, Natl Ctr Zoonot Vector Borne & Enter Dis, Atlanta, GA USA; Butte Cty Dept Publ Hlth, Oroville, CA USA	Centers for Disease Control & Prevention - USA	Parise, ME (corresponding author), Ctr Dis Control & Prevent, Parasit Dis Branch, Div Parasit Dis, Natl Ctr Zoonot Vector Borne & Enter Dis, 4770 Buford Hwy NE MS F22, Atlanta, GA 30341 USA.	MParise@cdc.gov	schultz-lewis, linda/GQY-8336-2022					Adehossi E, 2003, ANTIMICROB AGENTS CH, V47, P1173, DOI 10.1128/AAC.47.3.1173.2003; Agbenyega T, 2003, J CLIN PHARMACOL, V43, P386, DOI 10.1177/0091270003251392; ALCANTARA A K, 1985, Southeast Asian Journal of Tropical Medicine and Public Health, V16, P534; ALVING A S, 1960, Bull World Health Organ, V22, P621; Anabwani G, 1999, PEDIATR INFECT DIS J, V18, P456, DOI 10.1097/00006454-199905000-00011; Andersen SL, 1998, CLIN INFECT DIS, V26, P146, DOI 10.1086/516281; Baird JK, 2004, CLIN INFECT DIS, V39, P1336, DOI 10.1086/424663; BAIRD JK, 1995, J INFECT DIS, V171, P1678, DOI 10.1093/infdis/171.6.1678; Baird JK, 1997, AM J TROP MED HYG, V56, P627, DOI 10.4269/ajtmh.1997.56.627; Baird JK, 1996, T ROY SOC TROP MED H, V90, P409, DOI 10.1016/S0035-9203(96)90526-X; Barata L C, 1986, Rev Soc Bras Med Trop, V19, P135; Baudon D, 1999, T ROY SOC TROP MED H, V93, P302, DOI 10.1016/S0035-9203(99)90030-5; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Beg MA, 2002, AM J TROP MED HYG, V67, P230, DOI 10.4269/ajtmh.2002.67.230; BLANCHARD TJ, 1994, T ROY SOC TROP MED H, V88, P693, DOI 10.1016/0035-9203(94)90233-X; Boggild AK, 2007, AM J TROP MED HYG, V76, P208, DOI 10.4269/ajtmh.2007.76.208; BOROCHOV.D, 1970, BRIT MED J, V2, P710, DOI 10.1136/bmj.2.5711.710; Bouchaud O, 2000, AM J TROP MED HYG, V63, P274; Bunnag Danai, 1996, Southeast Asian Journal of Tropical Medicine and Public Health, V27, P15; Burchard GD, 1997, TROP MED INT HEALTH, V2, P733, DOI 10.1046/j.1365-3156.1997.d01-375.x; Bustos DG, 1999, J INFECT DIS, V179, P1587, DOI 10.1086/314770; BUTLER T, 1973, AM J MED SCI, V265, P63, DOI 10.1097/00000441-197301000-00006; CAILLON E, 1992, AM J PSYCHIAT, V149, P712; *CATMAT LAB DIS CO, 2000, CAN COMMUN DIS RE S2, V26, P1; CLYDE DF, 1975, AM J TROP MED HYG, V24, P369, DOI 10.4269/ajtmh.1975.24.369; COLLIGNON P, 1991, J INFECT DIS, V164, P222, DOI 10.1093/infdis/164.1.222; COLWELL EJ, 1973, ANN TROP MED PARASIT, V67, P125, DOI 10.1080/00034983.1973.11686870; COLWELL EJ, 1972, J AMER MED ASSOC, V220, P684, DOI 10.1001/jama.220.5.684; CONCHIE JM, 1970, CAN MED ASSOC J, V103, P351; Crawley J, 2000, LANCET, V355, P701, DOI 10.1016/S0140-6736(99)07148-2; Curlin ME, 1999, CLIN INFECT DIS, V28, P1166, DOI 10.1086/517767; D'Acremont V, 2002, AM J TROP MED HYG, V66, P481, DOI 10.4269/ajtmh.2002.66.481; David KP, 2003, SCAND J INFECT DIS, V35, P897, DOI 10.1080/00365540310016862; DAVIS TME, 1991, CLIN SCI, V81, P297, DOI 10.1042/cs0810297; deAlencar FEC, 1997, J INFECT DIS, V175, P1544, DOI 10.1086/516497; Di Perri G, 2002, ANN INTERN MED, V136, P339, DOI 10.7326/0003-4819-136-4-200202190-00016; DIXON KE, 1985, AM J TROP MED HYG, V34, P435, DOI 10.4269/ajtmh.1985.34.435; Dorsey G, 2000, ARCH INTERN MED, V160, P2505, DOI 10.1001/archinte.160.16.2505; Duarte EC, 1996, AM J TROP MED HYG, V54, P197, DOI 10.4269/ajtmh.1996.54.197; Dubos F, 2004, PEDIATR INFECT DIS J, V23, P679, DOI 10.1097/01.inf.0000130957.91308.fa; EKUE JMK, 1985, B WORLD HEALTH ORGAN, V63, P339; Faiz MA, 2005, LANCET, V366, P717; Farnert A, 2003, BMJ-BRIT MED J, V326, P628, DOI 10.1136/bmj.326.7390.628; Fivelman Quinton L, 2002, Malar J, V1, P1; Fryauff DJ, 1998, AM J TROP MED HYG, V59, P513, DOI 10.4269/ajtmh.1998.59.513; GARNHAM P, 1988, MALARIA PRINCIPLES P, V1, P69; Giao PT, 2003, ANN TROP MED PARASIT, V97, P575, DOI 10.1179/000349803225001427; GREENWOOD BM, 1987, T ROY SOC TROP MED H, V81, P478, DOI 10.1016/0035-9203(87)90170-2; HALL AP, 1977, BRIT MED J, V1, P1626, DOI 10.1136/bmj.1.6077.1626; HALL AP, 1975, BRIT MED J, V2, P12, DOI 10.1136/bmj.2.5961.12; HANNA J, 1993, MED J AUSTRALIA, V158, P502, DOI 10.5694/j.1326-5377.1993.tb137591.x; HARINASUTA T, 1985, LANCET, V1, P885; HEMMER CJ, 1991, AM J TROP MED HYG, V45, P608, DOI 10.4269/ajtmh.1991.45.608; HENNEQUIN C, 1994, ARCH INTERN MED, V154, P2360, DOI 10.1001/archinte.154.20.2360; Hill DR, 2006, AM J TROP MED HYG, V75, P402, DOI 10.4269/ajtmh.2006.75.402; HOFFMAN SL, 1988, J INFECT DIS, V158, P325, DOI 10.1093/infdis/158.2.325; Hoontrakoon S, 1998, TROP MED INT HEALTH, V3, P156, DOI 10.1111/j.1365-3156.1998.00198.x; Humar A, 1997, CAN MED ASSOC J, V156, P1165; ISLAM N, 1995, TROP GEOGR MED, V47, P141; Jamaiah I, 1998, Med J Malaysia, V53, P6; Jimenez BC, 2006, J TRAVEL MED, V13, P373, DOI 10.1111/j.1708-8305.2006.00073.x; Kain KC, 1996, LANCET, V348, P621, DOI 10.1016/S0140-6736(05)64843-X; KARBWANG J, 1991, Southeast Asian Journal of Tropical Medicine and Public Health, V22, P72; KARBWANG J, 1994, B WORLD HEALTH ORGAN, V72, P233; KARWACKI J J, 1989, Southeast Asian Journal of Tropical Medicine and Public Health, V20, P555; Kochar D, 1997, J ASSOC PHYSICIAN I, V45, P123; Kochar DK, 2005, EMERG INFECT DIS, V11, P132, DOI 10.3201/eid1101.040519; KREMSNER PG, 1988, J INFECT DIS, V158, P1368, DOI 10.1093/infdis/158.6.1368; KREMSNER PG, 1994, J INFECT DIS, V169, P467, DOI 10.1093/infdis/169.2.467; Kuhn S, 2005, AM J TROP MED HYG, V72, P407, DOI 10.4269/ajtmh.2005.72.407; Kurcer MA, 2006, ANN TROP MED PARASIT, V100, P109, DOI 10.1179/136485906X86284; Kurcer MA, 2004, ANN TROP MED PARASIT, V98, P447, DOI 10.1179/000349804225021343; LACKRITZ EM, 1991, JAMA-J AM MED ASSOC, V265, P383, DOI 10.1001/jama.265.3.383; Lacy MD, 2002, CLIN INFECT DIS, V35, pE92, DOI 10.1086/343750; Llanos-Cuentas A, 2001, Braz J Infect Dis, V5, P67; LOBEL HO, 1985, J INFECT DIS, V152, P613, DOI 10.1093/infdis/152.3.613; Looareesuwan S, 1999, T ROY SOC TROP MED H, V93, P637, DOI 10.1016/S0035-9203(99)90079-2; Looareesuwan S, 1996, AM J TROP MED HYG, V54, P62, DOI 10.4269/ajtmh.1996.54.62; LOOAREESUWAN S, 1990, Q J MED, V75, P471; LOOAREESUWAN S, 1994, ACTA TROP, V57, P47, DOI 10.1016/0001-706X(94)90092-2; Looareesuwan S, 1998, AM J TROP MED HYG, V58, P348, DOI 10.4269/ajtmh.1998.58.348; Looareesuwan S, 1999, AM J TROP MED HYG, V60, P526, DOI 10.4269/ajtmh.1999.60.526; LOOAREESUWAN S, 1985, LANCET, V2, P4, DOI 10.1016/S0140-6736(85)90056-X; LOOAREESUWAN S, 1992, LANCET, V339, P369, DOI 10.1016/0140-6736(92)91690-A; Luxemburger C, 1996, ANN TROP PAEDIATR, V16, P281, DOI 10.1080/02724936.1996.11747839; LUXEMBURGER C, 1991, LANCET, V338, P1268, DOI 10.1016/0140-6736(91)92131-K; LYNK A, 1989, PEDIATR INFECT DIS J, V8, P745, DOI 10.1097/00006454-198911000-00003; Maguire JD, 2006, CLIN INFECT DIS, V42, P1067, DOI 10.1086/501357; Malvy D, 2002, Med Trop (Mars), V62, P229; MARINO PL, 1998, ICU BOOK; MARLARTHAN, 1995, T ROY SOC TROP MED H, V89, P307, DOI 10.1016/0035-9203(95)90556-1; MARSEPOIL T, 1993, REV MED INTERNE, V14, P788, DOI 10.1016/S0248-8663(05)81426-2; MCCASLIN RI, 1994, PEDIATR INFECT DIS J, V13, P709, DOI 10.1097/00006454-199408000-00006; McGready R, 2003, T ROY SOC TROP MED H, V97, P592, DOI 10.1016/S0035-9203(03)80040-8; McGready R, 2003, EUR J CLIN PHARMACOL, V59, P545, DOI 10.1007/s00228-003-0652-9; McGready R, 2001, T ROY SOC TROP MED H, V95, P651, DOI 10.1016/S0035-9203(01)90106-3; Mendis K, 2001, AM J TROP MED HYG, V64, P97, DOI 10.4269/ajtmh.2001.64.97; METZGER W, 1995, ANTIMICROB AGENTS CH, V39, P245, DOI 10.1128/AAC.39.1.245; MILLER KD, 1989, NEW ENGL J MED, V321, P65, DOI 10.1056/NEJM198907133210201; MILLER L H, 1974, American Journal of Tropical Medicine and Hygiene, V23, P565; Molineaux L., 1988, MALARIA PRINCIPLES P, V2, P927; MOLYNEUX ME, 1991, LANCET, V337, P1379, DOI 10.1016/0140-6736(91)93063-F; Moody A, 2002, CLIN MICROBIOL REV, V15, P66, DOI 10.1128/CMR.15.1.66-78.2002; Moore T A, 1994, Arch Fam Med, V3, P130, DOI 10.1001/archfami.3.2.130; Muhlberger N, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-5; Mulenga M, 1999, CLIN THER, V21, P841, DOI 10.1016/S0149-2918(99)80006-X; MUNIR M, 1980, Paediatrica Indonesiana, V20, P47; MURPHY GS, 1993, LANCET, V341, P96, DOI 10.1016/0140-6736(93)92568-E; Murphy S, 1996, T ROY SOC TROP MED H, V90, P298, DOI 10.1016/S0035-9203(96)90260-6; MYATPHONEKYAW, 1993, T ROY SOC TROP MED H, V87, P687, DOI 10.1016/0035-9203(93)90294-Z; NAHLEN BL, 1991, TRANSFUSION, V31, P798, DOI 10.1046/j.1537-2995.1991.31992094665.x; Newman RD, 2004, ANN INTERN MED, V141, P547, DOI 10.7326/0003-4819-141-7-200410050-00012; Newton CRJC, 2000, J NEUROL NEUROSUR PS, V69, P433, DOI 10.1136/jnnp.69.4.433; Newton PN, 2003, CLIN INFECT DIS, V37, P7, DOI 10.1086/375059; NOSTEN F, 1990, BRIT J CLIN PHARMACO, V30, P79, DOI 10.1111/j.1365-2125.1990.tb03746.x; NOSTEN F, 1994, J INFECT DIS, V169, P595, DOI 10.1093/infdis/169.3.595; Nosten F, 1999, CLIN INFECT DIS, V28, P808, DOI 10.1086/515183; Ohrt C, 1997, ANN INTERN MED, V126, P963, DOI 10.7326/0003-4819-126-12-199706150-00006; PANG L, 1988, J INFECT DIS, V158, P1124, DOI 10.1093/infdis/158.5.1124; PANG LW, 1987, LANCET, V1, P1161; Parise ME, 2005, P C C I D, V9, P17; Parola P, 2001, ANTIMICROB AGENTS CH, V45, P932, DOI 10.1128/AAC.45.3.932-935.2001; Pasvol G, 1999, J INFECTION, V39, P183, DOI 10.1016/S0163-4453(99)90045-2; PATCHEN LC, 1989, NEW ENGL J MED, V321, P1415; Phan GT, 2002, TROP MED INT HEALTH, V7, P858, DOI 10.1046/j.1365-3156.2002.00948.x; PHILLIPS RE, 1986, Q J MED, V58, P305; PHILLIPS RE, 1985, NEW ENGL J MED, V312, P1273, DOI 10.1056/NEJM198505163122001; PHILLIPS RE, 1986, BRIT MED J, V292, P1319, DOI 10.1136/bmj.292.6531.1319; Phillips-Howard PA, 1998, J TRAVEL MED, V5, P121, DOI 10.1111/j.1708-8305.1998.tb00484.x; PHILLIPSHOWARD PA, 1995, DRUG SAFETY, V12, P370, DOI 10.2165/00002018-199512060-00003; Povinelli L, 2003, J TRAVEL MED, V10, P353, DOI 10.2310/7060.2003.9318; Powell VI, 2002, TRANSFUS MED REV, V16, P239, DOI 10.1053/tmrv.2002.33437; Prasad K, 2000, COCHRANE DB SYST REV; Price R, 1999, AM J TROP MED HYG, V60, P547, DOI 10.4269/ajtmh.1999.60.547; Pukrittayakamee S, 2000, ANTIMICROB AGENTS CH, V44, P1680, DOI 10.1128/AAC.44.6.1680-1685.2000; Pukrittayakamee S, 2000, ANTIMICROB AGENTS CH, V44, P2395, DOI 10.1128/AAC.44.9.2395-2398.2000; Pukrittayakamee S, 2004, ANTIMICROB AGENTS CH, V48, P1329, DOI 10.1128/AAC.48.4.1329-1334.2004; PUNYAGUPTA S, 1974, American Journal of Tropical Medicine and Hygiene, V23, P551; PUNYAGUPTA S, 1972, Journal of the Medical Association of Thailand, V55, P121; Radloff PD, 1996, LANCET, V347, P1511, DOI 10.1016/S0140-6736(96)90671-6; Ramharter M, 2005, CLIN INFECT DIS, V40, P1777, DOI 10.1086/430309; Rampengan T H, 1991, Paediatr Indones, V31, P59; REACHER M, 1981, LANCET, V2, P1066, DOI 10.1016/S0140-6736(81)91274-5; REID HA, 1975, LANCET, V1, P167; Rendi-Wagner P, 2002, ACTA TROP, V81, P167, DOI 10.1016/S0001-706X(01)00210-8; Riddle MS, 2002, CLIN INFECT DIS, V34, P1192, DOI 10.1086/339810; RIECKMANN KH, 1989, LANCET, V2, P1183, DOI 10.1016/S0140-6736(89)91792-3; RIECKMANN KH, 1993, MED J AUSTRALIA, V158, P446, DOI 10.5694/j.1326-5377.1993.tb137571.x; Rosenthal PJ, 1996, NEW ENGL J MED, V335, P138, DOI 10.1056/NEJM199607113350218; ROUVEIX B, 1989, ANN INTERN MED, V110, P577, DOI 10.7326/0003-4819-110-7-577; Sabchareon A, 1998, T ROY SOC TROP MED H, V92, P201, DOI 10.1016/S0035-9203(98)90749-0; SACHDEV HS, 1985, J TROP PEDIATRICS, V31, P213, DOI 10.1093/tropej/31.4.213; SANCHEZ JL, 1993, LANCET, V341, P1021, DOI 10.1016/0140-6736(93)91107-W; SCHUURKAMP GJ, 1992, T ROY SOC TROP MED H, V86, P121, DOI 10.1016/0035-9203(92)90531-G; Schwartz E, 2003, CLIN INFECT DIS, V37, P450, DOI 10.1086/375599; SCHWARTZ IK, 1991, NEW ENGL J MED, V324, P927; Schwobel B, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-5; Shamiss A, 1996, AVIAT SPACE ENVIR MD, V67, P872; SHANKS D, 1995, MIL MED, V160, P443, DOI 10.1093/milmed/160.9.443; SHANKS GD, 1995, MED J AUSTRALIA, V162, P306, DOI 10.5694/j.1326-5377.1995.tb139906.x; SILAMUT K, 1991, BRIT J CLIN PHARMACO, V32, P311, DOI 10.1111/j.1365-2125.1991.tb03904.x; SINDEN REG, 2002, ESSENTIAL MALARIOLOG, P26; Singh K, 2003, ARCH INTERN MED, V163, P2027, DOI 10.1001/archinte.163.17.2027; Singh RK, 2000, T ROY SOC TROP MED H, V94, P327, DOI 10.1016/S0035-9203(00)90305-5; Skarbinski Jacek, 2006, Morbidity and Mortality Weekly Report, V55, P23; SOWUNMI A, 1994, E AFR MED J, V71, P818; SOWUNMI A, 1995, T ROY SOC TROP MED H, V89, P303, DOI 10.1016/0035-9203(95)90554-5; SOWUNMI A, 1995, TROP GEOGR MED, V47, P179; SOWUNMI A, 1993, T ROY SOC TROP MED H, V87, P462, DOI 10.1016/0035-9203(93)90037-Q; SPEICH R, 1994, NEW ENGL J MED, V331, P57, DOI 10.1056/NEJM199407073310120; Steketee RW, 1996, AM J TROP MED HYG, V55, P50, DOI 10.4269/ajtmh.1996.55.50; STUIVER PC, 1989, LANCET, V2, P282; Sumawinata IW, 2003, AM J TROP MED HYG, V68, P416, DOI 10.4269/ajtmh.2003.68.416; SVENSON JE, 1995, ARCH INTERN MED, V155, P861, DOI 10.1001/archinte.155.8.861; Tanios MA, 2001, CRIT CARE MED, V29, P665, DOI 10.1097/00003246-200103000-00037; Taylor WRJ, 1999, CLIN INFECT DIS, V28, P74, DOI 10.1086/515071; TERKUILE FO, 1992, J INFECT DIS, V166, P1393, DOI 10.1093/infdis/166.6.1393; terKuile FO, 1995, B WORLD HEALTH ORGAN, V73, P631; Thuma PE, 1998, T ROY SOC TROP MED H, V92, P214, DOI 10.1016/S0035-9203(98)90753-2; Thuma PE, 1998, AM J TROP MED HYG, V58, P358, DOI 10.4269/ajtmh.1998.58.358; Thybo SR, 2004, J TRAVEL MED, V11, P220, DOI 10.2310/7060.2004.19005; Uchiyama H, 2004, INTERNAL MED, V43, P624, DOI 10.2169/internalmedicine.43.624; *UDE GROUP, 2003, USP DI DRUG INF HEAL; Vaillant M, 1997, TROP MED INT HEALTH, V2, P917, DOI 10.1046/j.1365-3156.1997.d01-411.x; van Vugt M, 2002, CLIN INFECT DIS, V35, P1498, DOI 10.1086/344901; Vanhauwere B, 1998, AM J TROP MED HYG, V58, P17, DOI 10.4269/ajtmh.1998.58.17; vanHensbroek MB, 1996, NEW ENGL J MED, V335, P69, DOI 10.1056/NEJM199607113350201; Vanijanonta S, 1996, ANN TROP MED PARASIT, V90, P269, DOI 10.1080/00034983.1996.11813052; WARRELL DA, 1982, NEW ENGL J MED, V306, P313, DOI 10.1056/NEJM198202113060601; WEINKE T, 1991, AM J TROP MED HYG, V45, P86, DOI 10.4269/ajtmh.1991.45.86; WHITBY M, 1989, LANCET, V2, P1395, DOI 10.1016/S0140-6736(89)92002-3; WHITE NJ, 1988, LANCET, V2, P64; White NJ, 1996, NEW ENGL J MED, V335, P800, DOI 10.1056/NEJM199609123351107; WHITE NJ, 1983, NEW ENGL J MED, V309, P61, DOI 10.1056/NEJM198307143090201; WHITE NJ, 1981, LANCET, V2, P1069, DOI 10.1016/S0140-6736(81)91275-7; WHITE NJ, 1982, BRIT MED J, V285, P439, DOI 10.1136/bmj.285.6339.439; WHITE NJ, 1995, BAILLIERE CLIN INF D, V2, P309; *WHO, 2000, WHO GUID TREATM MAL; Wichmann O, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-14; WINSTANLEY P, 1993, T ROY SOC TROP MED H, V87, P201, DOI 10.1016/0035-9203(93)90494-B; ZINGMAN BS, 1993, CLIN INFECT DIS, V16, P223, DOI 10.1093/clind/16.2.223; ZUCKER JR, 1993, INFECT DIS CLIN N AM, V7, P547; 1989, B SHO, V67, P601; 2007, HLTH INFORM INT TRAV; 2000, MMWR MORB MORTAL WKL, V49, P1138; 2005, HLTH INF INT TRAV 20	206	142	152	1	23	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 23	2007	297	20					2264	2277		10.1001/jama.297.20.2264	http://dx.doi.org/10.1001/jama.297.20.2264			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	170JM	17519416	Bronze			2022-12-28	WOS:000246659700026
J	Schein, LB				Schein, L. B.			Applied physics - Recent progress and continuing puzzles in electrostatics	SCIENCE			English	Editorial Material							BASE CHARGING MODEL; TONER ADHESION; EXPERIMENTAL-VERIFICATION; CONTACT ELECTRIFICATION; PROXIMITY THEORY; TRIBOELECTRIFICATION					schein@prodigy.net						Castle GSP, 1995, J ELECTROSTAT, V36, P165, DOI 10.1016/0304-3886(95)00043-7; Czarnecki WS, 2004, J ELECTROSTAT, V61, P107, DOI 10.1016/j.elstat.2004.01.022; Duke CB, 2002, SURF SCI, V500, P1005, DOI 10.1016/S0039-6028(01)01527-8; Gady B, 1999, J IMAGING SCI TECHN, V43, P288; Hays DA, 1995, J ADHESION, V51, P41, DOI 10.1080/00218469508009988; KONDO A, 1980, P TECHN ASS PULP PAP, P153; KONDO A, 1979, DENSHI SYASIN GAKKAI, V43, P26; LEE LH, 1978, PHOTOGR SCI ENG, V22, P228; LOWELL J, 1980, ADV PHYS, V29, P947, DOI 10.1080/00018738000101466; Schein LB, 2004, J IMAGING SCI TECHN, V48, P412; Schein LB, 2004, J IMAGING SCI TECHN, V48, P417; SCHEIN LB, 1992, PHYS LETT A, V167, P79, DOI 10.1016/0375-9601(92)90630-5; SCHEIN LB, 1996, ELECTROPHOTOGRAPHY D; Veregin RPN, 2006, J IMAGING SCI TECHN, V50, P282, DOI 10.2352/J.ImagingSci.Technol.(2006)50:3(282); VereginA RPN, 2006, J IMAGING SCI TECHN, V50, P288, DOI 10.2352/J.ImagingSci.Technol.(2006)50:3(288); Wang BB, 2006, J IMAGING SCI TECHN, V50, P368, DOI 10.2352/J.ImagingSci.Technol.(2006)50:4(368)	16	98	99	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 15	2007	316	5831					1572	1573		10.1126/science.1142325	http://dx.doi.org/10.1126/science.1142325			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178SH	17569848				2022-12-28	WOS:000247239900024
J	Whittall, JB; Hodges, SA				Whittall, Justen B.; Hodges, Scott A.			Pollinator shifts drive increasingly long nectar spurs in columbine flowers	NATURE			English	Article							ANCESTRAL CHARACTER STATES; EVOLUTION; RATES	Directional evolutionary trends have long garnered interest because they suggest that evolution can be predictable. However, the identification of the trends themselves and the underlying processes that may produce them have often been controversial(1). In 1862, in explaining the exceptionally long nectar spur of Angraecum sesquipedale, Darwin proposed that a coevolutionary 'race' had driven the directional increase in length of a plant's spur and its pollinator's tongue(2). Thus he predicted the existence of an exceptionally long-tongued moth. Though the discovery of Xanthopan morgani ssp. praedicta in 1903 with a tongue length of 22 cm validated Darwin's prediction(3), his 'race' model for the evolution of long-spurred flowers remains contentious(4). Spurs may also evolve to exceptional lengths by way of pollinator shifts as plants adapt to a series of unrelated pollinators, each with a greater tongue length(5). Here, using a species-level phylogeny of the columbine genus, Aquilegia, we show a significant evolutionary trend for increasing spur length during directional shifts to pollinators with longer tongues. In addition, we find evidence for 'punctuated' change in spur length during speciation events(6), suggesting that Aquilegia nectar spurs rapidly evolve to fit adaptive peaks predefined by pollinator morphology. These findings show that evolution may proceed in predictable pathways without reversals and that change may be concentrated during speciation.	Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	Whittall, JB (corresponding author), Univ Calif Davis, Sect Evolut & Ecol, 1 Shields Ave, Davis, CA 95616 USA.	jbwhittall@ucdavis.edu; hodges@lifesci.ucsb.edu		Hodges, Scott/0000-0002-0401-6072				[Anonymous], 1862, VARIOUS CONTRIVANCES; Butler MA, 2004, AM NAT, V164, P683, DOI 10.1086/426002; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Fulton M, 1999, P ROY SOC B-BIOL SCI, V266, P2247, DOI 10.1098/rspb.1999.0915; GARLAND T, 1992, SYST BIOL, V41, P18, DOI 10.2307/2992503; Gould SJ, 1997, NATURE, V385, P199, DOI 10.1038/385199a0; GRANT V, 1992, P NATL ACAD SCI USA, V89, P9400, DOI 10.1073/pnas.89.20.9400; GRANT V, 1949, EVOLUTION, V3, P82, DOI 10.2307/2405454; GRANT VERNE, 1952, ALISO, V2, P341; HODGES SA, 1994, P NATL ACAD SCI USA, V91, P5129, DOI 10.1073/pnas.91.11.5129; HODGES SA, 1995, AM J BOT, V82, P197, DOI 10.2307/2445527; Hodges SA, 1995, P ROY SOC B-BIOL SCI, V262, P343, DOI 10.1098/rspb.1995.0215; Hodges SA, 2004, NEW PHYTOL, V161, P113, DOI 10.1046/j.1469-8137.2003.00950.x; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hundsdoerfer AK, 2005, MOL PHYLOGENET EVOL, V35, P442, DOI 10.1016/j.ympev.2005.02.004; Johnson SD, 1997, EVOLUTION, V51, P45, DOI 10.1111/j.1558-5646.1997.tb02387.x; Kay KM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-36; Lee Chunghau, 2006, Evolutionary Bioinformatics Online, V2, P193; MADDISON WP, 2004, MESQUITE MODULAR SYS; Midford P. E., 2005, PDAP PACKAGE MESQUIT; Millard E., 1997, GENDER EDUC, V9, P31, DOI DOI 10.1080/09540259721439; Nilsson LA, 1998, TRENDS ECOL EVOL, V13, P259, DOI 10.1016/S0169-5347(98)01359-7; Pagel M, 1999, SYST BIOL, V48, P612, DOI 10.1080/106351599260184; Pagel M, 2004, SYST BIOL, V53, P673, DOI 10.1080/10635150490522232; ROTHENBORG HW, 1972, CRYOBIOLOGY, V9, P1, DOI 10.1016/0011-2240(72)90002-8; Sanderson MJ, 2003, BIOINFORMATICS, V19, P301, DOI 10.1093/bioinformatics/19.2.301; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; WALLACE AR, 1867, Q J SCI S, V140, P471; Wasserthal LT, 1997, BOT ACTA, V110, P343, DOI 10.1111/j.1438-8677.1997.tb00650.x	29	465	485	25	596	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 7	2007	447	7145					706	U12		10.1038/nature05857	http://dx.doi.org/10.1038/nature05857			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175RI	17554306				2022-12-28	WOS:000247030700042
J	Kawai, T; Akira, S				Kawai, Taro; Akira, Shizuo			SnapShot: Pattern-recognition receptors	CELL			English	Editorial Material									Osaka Univ, Res Inst Microbial Dis, Suita, Osaka 565, Japan	Osaka University	Kawai, T (corresponding author), Osaka Univ, Res Inst Microbial Dis, Suita, Osaka 565, Japan.			Kawai, Taro/0000-0001-7510-4662					0	25	28	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 1	2007	129	5					1024	U20	1024.e1	10.1016/j.cell.2007.05.017	http://dx.doi.org/10.1016/j.cell.2007.05.017			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	176KT	17540179	Bronze			2022-12-28	WOS:000247084600020
J	Tanatar, MA; Paglione, J; Petrovic, C; Taillefer, L				Tanatar, Makariy A.; Paglione, Johnpierre; Petrovic, Cedomir; Taillefer, Louis			Anisotropic violation of the Wiedemann-Franz law at a quantum critical point	SCIENCE			English	Article							FERMI-LIQUID BEHAVIOR; HEAVY; SUPERCONDUCTIVITY; TEMPERATURE; ALLOY	A quantum critical point transforms the behavior of electrons so strongly that new phases of matter can emerge. The interactions at play are known to fall outside the scope of the standard model of metals, but a fundamental question remains: Is the basic concept of a quasiparticle - a fermion with renormalized mass - still valid in such systems? The Wiedemann-Franz law, which states that the ratio of heat and charge conductivities in a metal is a universal constant in the limit of zero temperature, is a robust consequence of Fermi-Dirac statistics. We report a violation of this law in the heavy-fermion metal CeColn(5) when tuned to its quantum critical point, depending on the direction of electron motion relative to the crystal lattice, which points to an anisotropic destruction of the Fermi surface.	Univ Sherbrooke, Dept Phys, Sherbrooke, PQ, Canada; Univ Sherbrooke, RQMP, Sherbrooke, PQ, Canada; Univ Toronto, Dept Phys, Toronto, ON, Canada; Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA; Brookhaven Natl Lab, Condensed Matter Phys & Mat Sci Dept, Upton, NY 11973 USA; Canadian Inst Adv Res, Toronto, ON, Canada	University of Sherbrooke; University of Sherbrooke; University of Toronto; University of California System; University of California San Diego; United States Department of Energy (DOE); Brookhaven National Laboratory; Canadian Institute for Advanced Research (CIFAR)	Taillefer, L (corresponding author), Univ Sherbrooke, Dept Phys, Sherbrooke, PQ, Canada.	louis.taillefer@physique.usherbrooke.ca	Paglione, Johnpierre/B-4433-2018; Petrovic, Cedomir/A-8789-2009	Paglione, Johnpierre/0000-0001-7257-014X; Petrovic, Cedomir/0000-0001-6063-1881				Abdel-Jawad M, 2006, NAT PHYS, V2, P821, DOI 10.1038/nphys449; Bianchi A, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.257001; Borzi RA, 2007, SCIENCE, V315, P214, DOI 10.1126/science.1134796; Coleman P, 2005, NATURE, V433, P226, DOI 10.1038/nature03279; Coleman P, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.245111; Coleman P, 2001, J PHYS-CONDENS MAT, V13, pR723, DOI 10.1088/0953-8984/13/35/202; Custers J, 2003, NATURE, V424, P524, DOI 10.1038/nature01774; Dell'Anna L, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.136402; Franz R., 1853, ANN PHYS-NEW YORK, V165, P497, DOI 10.1002/andp.18531650802; Gegenwart P, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.056402; Kanigel A, 2006, NAT PHYS, V2, P447, DOI 10.1038/nphys334; Kawasaki Y, 2003, J PHYS SOC JPN, V72, P2308, DOI [10.1143/JPSJ.72.2308, 10.1143/JPSJ.72.72.2308]; Knebel G, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.020501; LANDAU LD, 1957, SOV PHYS JETP-USSR, V3, P920; Levy F, 2005, SCIENCE, V309, P1343, DOI 10.1126/science.1115498; Mathur ND, 1998, NATURE, V394, P39, DOI 10.1038/27838; McCollam A, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.186401; MILLIS AJ, 1993, PHYS REV B, V48, P7183, DOI 10.1103/PhysRevB.48.7183; MORIYA T, 1995, J PHYS SOC JPN, V64, P960, DOI 10.1143/JPSJ.64.960; Neubert A, 1997, PHYSICA B, V230, P587, DOI 10.1016/S0921-4526(96)00754-5; Norman MR, 1998, NATURE, V392, P157, DOI 10.1038/32366; Paglione J, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.246405; Paglione J, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.216602; Paglione J, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.106606; Park T, 2006, NATURE, V440, P65, DOI 10.1038/nature04571; Paul I, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.026402; Pham LD, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.056404; Rego LGC, 1999, PHYS REV B, V59, P13080, DOI 10.1103/PhysRevB.59.13080; Rosch A, 1997, PHYS REV LETT, V79, P159, DOI 10.1103/PhysRevLett.79.159; Saxena SS, 2000, NATURE, V406, P587, DOI 10.1038/35020500; Senthil T, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.035111; Si QM, 2001, NATURE, V413, P804, DOI 10.1038/35101507; Sommerfeld A, 1927, NATURWISSENSCHAFTEN, V15, P825, DOI 10.1007/BF01505083; VONLOHNEYSEN H, 1994, PHYS REV LETT, V72, P3262, DOI 10.1103/PhysRevLett.72.3262	34	100	103	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 1	2007	316	5829					1320	1322		10.1126/science.1140762	http://dx.doi.org/10.1126/science.1140762			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173PS	17540899				2022-12-28	WOS:000246885600045
J	Von Hippel, D; Hayes, P				Von Hippel, David; Hayes, Peter			International security - Energy security for North Korea	SCIENCE			English	Editorial Material									Nautilus Inst, Eugene, OR 97401 USA; Nautilus Inst, Melbourne, Vic, Australia		Von Hippel, D (corresponding author), Nautilus Inst, Eugene, OR 97401 USA.	dvonhip@igc.org; peter.hayes@rmit.edu.au						ADEN N, 2006, DPRK EN EXP STUD GRO; CHUNG WJ, 2006, DPRK EN EXP STUD GRO; Hayes Peter, 2007, BEIJING DEAL IS NOT; Lee SH, 2006, DPRK EN EXP STUD GRO; *STANF U, 2006, DPRK EN EXP STUD GRO; VONHIPPEL D, 2002, DPRK ENERGY SECTOR E; VONHIPPEL D, 2003, EN PATHS AN METH TRA; Williams J, 1999, B ATOM SCI, V55, P40; YOON JY, ANAL PRESENT STATUS; 2007, 3 SESS 5 ROUND 6 PAR	10	3	3	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 1	2007	316	5829					1288	1289		10.1126/science.1142090	http://dx.doi.org/10.1126/science.1142090			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	173PS	17540887				2022-12-28	WOS:000246885600032
J	Di Rosa, I; Simoncelli, F; Fagotti, A; Pascolini, R				Di Rosa, Ines; Simoncelli, Francesca; Fagotti, Anna; Pascolini, Rita			Ecology - The proximate cause of frog declines?	NATURE			English	Letter							AMPHIBIAN POPULATION DECLINES; EMERGING INFECTIOUS-DISEASE; RANA-ESCULENTA COMPLEX		Univ Perugia, Dipartimento Biol Cellulare & Ambientale, I-06123 Perugia, Italy	University of Perugia	Di Rosa, I (corresponding author), Univ Perugia, Dipartimento Biol Cellulare & Ambientale, Via Pascoli 1, I-06123 Perugia, Italy.	inesdir@unipg.it	Di Rosa, Ines/M-5612-2014; Fagotti, Anna/M-5651-2014					Berger L, 2005, DIS AQUAT ORGAN, V68, P51, DOI 10.3354/dao068051; Bosch J, 2007, P ROY SOC B-BIOL SCI, V274, P253, DOI 10.1098/rspb.2006.3713; Daszak P, 2005, ECOLOGY, V86, P3232, DOI 10.1890/05-0598; Fagotti A, 2005, AMPHIBIA-REPTILIA, V26, P93, DOI 10.1163/1568538053693297; Garner TWJ, 2005, EMERG INFECT DIS, V11, P1639; Kiesecker JM, 2001, NATURE, V410, P681, DOI 10.1038/35070552; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; Mendelson JR, 2004, REV BIOL TROP, V52, P991; Pascolini R, 2003, DIS AQUAT ORGAN, V56, P65, DOI 10.3354/dao056065; Pereira CN, 2005, J CLIN MICROBIOL, V43, P192, DOI 10.1128/JCM.43.1.192-198.2005; Pounds JA, 2006, NATURE, V439, P161, DOI 10.1038/nature04246; Rachowicz LJ, 2006, ECOLOGY, V87, P1671, DOI 10.1890/0012-9658(2006)87[1671:EIDAAP]2.0.CO;2; Reading CJ, 2007, OECOLOGIA, V151, P125, DOI 10.1007/s00442-006-0558-1; Simoncelli Francesca, 2005, EcoHealth, V2, P307, DOI 10.1007/s10393-005-8337-8; Stott PA, 2004, NATURE, V432, P610, DOI 10.1038/nature03089	15	68	79	2	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 31	2007	447	7144					E4	E5		10.1038/nature05941	http://dx.doi.org/10.1038/nature05941			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172YZ	17538572				2022-12-28	WOS:000246842000036
J	Weinstein, JN; Lurie, JD; Tosteson, TD; Hanscom, B; Tosteson, ANA; Blood, EA; Birkmeyer, NJO; Hilibrand, AS; Herkowitz, H; Cammisa, FP; Albert, TJ; Emery, SE; Lenke, LG; Abdu, WA; Longley, M; Errico, TJ; Hu, SS				Weinstein, James N.; Lurie, Jon D.; Tosteson, Tor D.; Hanscom, Brett; Tosteson, Anna N. A.; Blood, Emily A.; Birkmeyer, Nancy J. O.; Hilibrand, Alan S.; Herkowitz, Harry; Cammisa, Frank P.; Albert, Todd J.; Emery, Sanford E.; Lenke, Lawrence G.; Abdu, William A.; Longley, Michael; Errico, Thomas J.; Hu, Serena S.			Surgical versus nonsurgical treatment for lumbar degenerative spondylolisthesis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RESEARCH TRIAL SPORT; HEALTH SURVEY SF-36; SPINAL STENOSIS; NONOPERATIVE TREATMENT; DISK HERNIATION; OUTCOMES; PATIENT; RELIABILITY; MANAGEMENT; QUALITY	BACKGROUND: Management of degenerative spondylolisthesis with spinal stenosis is controversial. Surgery is widely used, but its effectiveness in comparison with that of nonsurgical treatment has not been demonstrated in controlled trials. METHODS: Surgical candidates from 13 centers in 11 U.S. states who had at least 12 weeks of symptoms and image-confirmed degenerative spondylolisthesis were offered enrollment in a randomized cohort or an observational cohort. Treatment was standard decompressive laminectomy (with or without fusion) or usual nonsurgical care. The primary outcome measures were the Medical Outcomes Study 36-Item Short-Form General Health Survey (SF-36) bodily pain and physical function scores (100-point scales, with higher scores indicating less severe symptoms) and the modified Oswestry Disability Index (100-point scale, with lower scores indicating less severe symptoms) at 6 weeks, 3 months, 6 months, 1 year, and 2 years. RESULTS: We enrolled 304 patients in the randomized cohort and 303 in the observational cohort. The baseline characteristics of the two cohorts were similar. The one-year crossover rates were high in the randomized cohort (approximately 40% in each direction) but moderate in the observational cohort (17% crossover to surgery and 3% crossover to nonsurgical care). The intention-to-treat analysis for the randomized cohort showed no statistically significant effects for the primary outcomes. The as-treated analysis for both cohorts combined showed a significant advantage for surgery at 3 months that increased at 1 year and diminished only slightly at 2 years. The treatment effects at 2 years were 18.1 for bodily pain (95% confidence interval [CI], 14.5 to 21.7), 18.3 for physical function (95% CI, 14.6 to 21.9), and -16.7 for the Oswestry Disability Index (95% CI, -19.5 to -13.9). There was little evidence of harm from either treatment. CONCLUSIONS: In nonrandomized as-treated comparisons with careful control for potentially confounding baseline factors, patients with degenerative spondylolisthesis and spinal stenosis treated surgically showed substantially greater improvement in pain and function during a period of 2 years than patients treated nonsurgically.	Dartmouth Med Sch, Dept Orthopaed, Lebanon, NH 03756 USA; Dartmouth Med Sch, Dept Med, Lebanon, NH USA; Dartmouth Med Sch, Dept Community & Family Med, Lebanon, NH USA; Univ Michigan, Ann Arbor, MI 48109 USA; Thomas Jefferson Univ, Rothman Inst, Philadelphia, PA 19107 USA; William H Beaumont Hosp, Royal Oak, MI USA; Hosp Special Surg, New York, NY 10021 USA; Univ Hosp Cleveland, Cleveland, OH 44106 USA; Case Western Reserve Univ, Cleveland, OH 44106 USA; Washington Univ, St Louis, MO 63130 USA; Nebraska Fdn Hosp Spinal Res, Omaha, NE USA; Hosp Joint Dis & Med Ctr, New York, NY USA; Univ Calif San Francisco, San Francisco, CA 94143 USA	Dartmouth College; Dartmouth College; Dartmouth College; University of Michigan System; University of Michigan; Jefferson University; Rothman Institute; Beaumont Health; University Hospitals of Cleveland; Case Western Reserve University; Washington University (WUSTL); NYU Langone Medical Center; Hospital for Joint Disease NYULMC; University of California System; University of California San Francisco	Weinstein, JN (corresponding author), Dartmouth Med Sch, Dept Orthopaed, Lebanon, NH 03756 USA.	SPORT@dartmouth.edu	Hilibrand, Alan/AAL-5114-2020	Errico, Thomas/0000-0002-5375-328X	NCI NIH HHS [P30 CA023108] Funding Source: Medline; NIAMS NIH HHS [U01-AR45444-01A1, K23 AR048138, U01 AR045444, K23 AR 048138-01, P60 AR048094, U01 AR045444-09, P60-AR048094-01A1] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA023108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [U01AR045444, K23AR048138, P60AR048094] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Atlas SJ, 1996, SPINE, V21, P1787, DOI 10.1097/00007632-199608010-00012; Atlas SJ, 2000, SPINE, V25, P556, DOI 10.1097/00007632-200003010-00005; Atlas SJ, 1996, SPINE, V21, P2885, DOI 10.1097/00007632-199612150-00020; Balding DJ, 2004, APPL LONGITUDINAL AN; Birkmeyer NJO, 2002, SPINE, V27, P1361, DOI 10.1097/00007632-200206150-00020; BODEN SD, 1990, J BONE JOINT SURG AM, V72A, P403, DOI 10.2106/00004623-199072030-00013; BRIDWELL KH, 1993, J SPINAL DISORD, V6, P461, DOI 10.1097/00002517-199306060-00001; Cummins J, 2006, SPINE, V31, P806, DOI 10.1097/01.brs.0000207473.09030.0d; Daltroy LH, 1996, SPINE, V21, P741, DOI 10.1097/00007632-199603150-00017; DEYO RA, 1993, SPINE, V18, P1463; DEYO RA, 1986, SPINE, V11, P28, DOI 10.1097/00007632-198601000-00008; *DHHS, 1994, AHCPR PUBL; Fischgrund JS, 1997, SPINE, V22, P2807, DOI 10.1097/00007632-199712150-00003; HERKOWITZ HN, 1991, J BONE JOINT SURG AM, V73A, P802, DOI 10.2106/00004623-199173060-00002; Jacobsen S, 2007, SPINE, V32, P120, DOI 10.1097/01.brs.0000250979.12398.96; Malmivaara A, 2007, SPINE, V32, P1, DOI 10.1097/01.brs.0000251014.81875.6d; MCHORNEY CA, 1994, MED CARE, V32, P40, DOI 10.1097/00005650-199401000-00004; MORGAN FP, 1957, J BONE JOINT SURG BR, V39, P6, DOI 10.1302/0301-620X.39B1.6; *N AM SPIN SOC, 2000, N AM SPIN SOC PHAS I; PATRICK DL, 1995, SPINE, V20, P1899, DOI 10.1097/00007632-199509000-00011; Phelan EA, 2001, SPINE, V26, P206, DOI 10.1097/00007632-200101150-00016; STEWART AL, 1989, JAMA-J AM MED ASSOC, V262, P907, DOI 10.1001/jama.262.7.907; Tunis SR, 2003, JAMA-J AM MED ASSOC, V290, P1624, DOI 10.1001/jama.290.12.1624; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Ware JE, 1993, SF36 HLTH SURVEY MAN; Weinstein JN, 2006, JAMA-J AM MED ASSOC, V296, P2451, DOI 10.1001/jama.296.20.2451; Weinstein JN, 2006, JAMA-J AM MED ASSOC, V296, P2441, DOI 10.1001/jama.296.20.2441; Weinstein JN, 2005, SPINE, V30, P269, DOI 10.1097/01.brs.0000155479.88200.32; Yukawa Y, 2002, J BONE JOINT SURG AM, V84A, P1954, DOI 10.2106/00004623-200211000-00008; [No title captured]	30	557	582	1	43	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 31	2007	356	22					2257	2270		10.1056/NEJMoa070302	http://dx.doi.org/10.1056/NEJMoa070302			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	172PO	17538085	Green Accepted, Green Published			2022-12-28	WOS:000246816500005
J	Daher, CM				Daher, Carolyn M.			Don't sleep with your chickens	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												carolyndaher@gmail.com							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 23	2007	297	20					2174	2176		10.1001/jama.297.20.2174	http://dx.doi.org/10.1001/jama.297.20.2174			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	170JM	17519402				2022-12-28	WOS:000246659700001
J	Wong, MC; Chung, JWY; Wong, TKS				Wong, Man-chun; Chung, Joanne W. Y.; Wong, Thomas K. S.			Effects of treatments for symptoms of painful diabetic neuropathy: systematic review	BMJ-BRITISH MEDICAL JOURNAL			English	Review							PERIPHERAL NEUROPATHY; DOUBLE-BLIND; MICROVASCULAR COMPLICATIONS; CLINICAL-TRIALS; POLYNEUROPATHY; MULTICENTER; PREVALENCE; QUALITY; EFFICACY; TRAMADOL	Objective To evaluate the effects of treatments for the symptoms of painful diabetic neuropathy. Design Systematic review. Data sources Articles (English and full text) on double blind randomised trials found by searching with the key words anticonvulsant, antidepressant, non-steroidal antiinflammatory drugs, tramadol, opioid, ion channel blocker, diabetic neuropathy, diabetic peripheral neuropathy, peripheral neuropathy, and neuropathy. The search included Medline, Embase, EMB reviews-AP Journal club, and the Cochrane central register of controlled trials. Study selection Randomised controlled trials comparing topically applied and orally administered drugs with a placebo in adults with painful diabetic neuropathy. Data extraction Data were extracted to examine quality of methods, characteristics of studies and patients, efficacy, and side effects. The primary outcome was dichotomous information for 50% or moderate reduction of pain. Secondary outcomes were 30% reduction of pain and withdrawals related to adverse events. Results Odds ratios were calculated for achievement of 30%, 50%, or moderate pain relief and for withdrawals related to adverse effects. Twenty five reports were included and seven were excluded. The 25 included reports compared anticonvulsants (n=1270), antidepressants (94), opioids (329), ion channel blockers (173), N-methyl-D-aspartate antagonist (14), duloxetine (805), capsaicin (277), and isosorbide dinitrate spray (22) with placebo. The odds ratios in terms of 50% pain relief were 5.33 (95% confidence interval 1.77 to 16.02) for traditional anticonvulsants, 3.25 (2.27 to 4.66) for newer generation anticonvulsants, and 22.24 (5.83 to 84.75) for tricylic antidepressants. The odds ratios in terms of withdrawals related to adverse events were 1.51 (0.33 to 6.96) for traditional anticonvulsants, 2.98 (1.75 to 5.07) for newer generation anticonvulsants, and 2.32 (0.59 to 9.69) for tricylic antidepressants. Insufficient dichotomous data were available to calculate the odds ratios for ion channel blockers. Conclusion Anticonvulsants and antidepressants are still the most commonly used options to manage diabetic neuropathy. Oral tricyclic antidepressants and traditional anticonvulsants are better for short term pain relief than newer generation anticonvulsants. Evidence of the long term effects of Oral antidepressants and anticonvulsants is still tacking. Further studies are needed on opioids, N-methyl-D-aspartate antagonists, and ion channel blockers.	United Christian Hosp, Nursing Serv Div, Hong Kong, Hong Kong, Peoples R China; Hong Kong Polytech Univ, Sch Nursing, Hong Kong, Hong Kong, Peoples R China	United Christian Hospital; Hong Kong Polytechnic University	Wong, MC (corresponding author), United Christian Hosp, Nursing Serv Div, 130 Hip Wo St, Hong Kong, Hong Kong, Peoples R China.	wongmc0829@yahoo.com.hk		Chung, Joanne/0000-0001-9884-9800				[Anonymous], 1995, ANN INTERN MED, V122, P561, DOI 10.7326/0003-4819-122-8-199504150-00001; BOULTON AJM, 1985, DIABETES CARE, V8, P125, DOI 10.2337/diacare.8.2.125; Curtin F, 2002, STAT MED, V21, P2161, DOI 10.1002/sim.1207; Daousi C, 2004, DIABETIC MED, V21, P976, DOI 10.1111/j.1464-5491.2004.01271.x; Erdemoglu AK, 2006, NEUROL INDIA, V54, P173; Ertas M, 1998, PAIN, V75, P257, DOI 10.1016/S0304-3959(98)00003-7; Fedele D, 1997, DIABETES CARE, V20, P836, DOI 10.2337/diacare.20.5.836; Freynhagen R, 2005, PAIN, V115, P254, DOI 10.1016/j.pain.2005.02.032; Galer BS, 2000, DIABETES RES CLIN PR, V47, P123, DOI 10.1016/S0168-8227(99)00112-6; Gorson KC, 1999, J NEUROL NEUROSUR PS, V66, P251, DOI 10.1136/jnnp.66.2.251; Greene Douglas A., 1999, American Journal of Medicine, V107, p2S; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; KLEIN C, 2001, BLUE BOOK PRACT NEUR, V25, P261; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; OHKUBO Y, 1995, DIABETES RES CLIN PR, V28, P103, DOI 10.1016/0168-8227(95)01064-K; Otto M, 2003, PAIN, V101, P187, DOI 10.1016/S0304-3959(02)00313-5; PARTANEN J, 1995, NEW ENGL J MED, V333, P89, DOI 10.1056/NEJM199507133330203; REICHARD P, 1993, NEW ENGL J MED, V329, P304, DOI 10.1056/NEJM199307293290502; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Sindrup SH, 1999, PAIN, V83, P389, DOI 10.1016/S0304-3959(99)00154-2; Sindrup SH, 1999, PAIN, V83, P85, DOI 10.1016/S0304-3959(99)00079-2; Sindrup SH, 1999, CLIN PHARMACOL THER, V66, P636, DOI 10.1016/S0009-9236(99)90074-7; Sorensen L, 2002, DIABETES RES CLIN PR, V57, P45, DOI 10.1016/S0168-8227(02)00010-4; STRACKE H, 1992, DIABETES CARE, V15, P1550, DOI 10.2337/diacare.15.11.1550; Tapp RJ, 2003, DIABETIC MED, V20, P105, DOI 10.1046/j.1464-5491.2003.00881.x; YOUNG MJ, 1993, DIABETOLOGIA, V36, P150, DOI 10.1007/BF00400697	26	109	120	1	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 14	2007	335	7610					87	90A		10.1136/bmj.39213.565972.AE	http://dx.doi.org/10.1136/bmj.39213.565972.AE			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	192JM	17562735	Green Submitted, Bronze, Green Published			2022-12-28	WOS:000248197500035
J	Bhargava, P; Longhi, LP				Bhargava, Parul; Longhi, Lorinda P.			Peripheral smear with Malassezia furfur	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center	Bhargava, P (corresponding author), Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA.	pbhargav@bidmc.harvard.edu							0	9	9	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 14	2007	356	24					E25	E25		10.1056/NEJMicm063672	http://dx.doi.org/10.1056/NEJMicm063672			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	178DR	17568022				2022-12-28	WOS:000247201900012
J	Blow, N				Blow, Nathan			Antibodies: The generation game	NATURE			English	Editorial Material																			0	32	36	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 7	2007	447	7145					741	+		10.1038/447741a	http://dx.doi.org/10.1038/447741a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175RI	17554312	Bronze			2022-12-28	WOS:000247030700049
J	Wasserstein, AG				Wasserstein, Alan G.			Lessons in medical humanism: The case of Montaigne	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Penn, Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania	Wasserstein, AG (corresponding author), Univ Penn, Sch Med, Hosp Univ Penn, 3400 Spruce St, Philadelphia, PA 19104 USA.	alan.wasserstein@uphs.upenn.edu						Bernard Claude, 1957, INTRO EXPT MED; COE FL, 1988, NEPHROLITHIASIS PATH, P22; Frame Donald M., 1955, MONTAIGNES DISCOVERY; Frankl VE, 1963, MANS SEARCH MEANING; Healy M, 2005, LIT MED, V24, P231, DOI 10.1353/lm.2006.0006; MONTAIGNE M, 2003, COMPLETE WORKS, P1276; MONTAIGNE M, 2003, COMPLETE WORKS, P696; MONTAIGNE M, 2003, COMPLETE WORKS, P1047; MONTAIGNE M, 2003, COMPLETE WORKS, P992; Saunders Jason Lewis, 1955, PHILOS RENAISSANCE S	10	6	8	1	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 5	2007	146	11					809	813		10.7326/0003-4819-146-11-200706050-00009	http://dx.doi.org/10.7326/0003-4819-146-11-200706050-00009			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	175HR	17548412				2022-12-28	WOS:000247005200006
J	Chadha, NK; Chadha, R				Chadha, Neil K.; Chadha, Rashmi			10-minute consultation - Sinusitis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Torbay Hosp, ENT Dept, Torquay TQ2 7AA, England; Ivybridge Hlth Ctr, Ivybridge PL21 0AJ, Devon, England		Chadha, NK (corresponding author), Torbay Hosp, ENT Dept, Torquay TQ2 7AA, England.	neil_chadha@hotmail.com	Chadha, Neil K/H-6606-2019	Chadha, Neil K/0000-0002-1417-2175				*ENT UK, INF PAT SIN INF SIN; Fokkens W, 2005, RHINOLOGY, P1; Lindbaek M, 2002, BRIT J GEN PRACT, V52, P491; Williams Jr JW, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000243	4	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 2	2007	334	7604					1165	1165		10.1136/bmj.39161.557211.47	http://dx.doi.org/10.1136/bmj.39161.557211.47			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	177ES	17540947	Green Published			2022-12-28	WOS:000247137000037
J	Richardson, M; Lakhanpaul, M				Richardson, Martin; Lakhanpaul, Monica		Guideline Dev Grp; Technical Team	NICE guidelines - Assessment and initial management of feverish illness in children younger than 5 years: summary of NICE guidance	BRITISH MEDICAL JOURNAL			English	Article									Peterborough & Stamford Hosp NHS Fdn Trust, Peterborough PE3 6DA, England; Royal Coll Obstetricians & Gynaecologists, Natl Collaborating Ctr Women & Childrens Hlth, London, England; Univ Leicester, Leicester LE1 7RH, Leics, England	University of Leicester	Richardson, M (corresponding author), Peterborough & Stamford Hosp NHS Fdn Trust, Peterborough PE3 6DA, England.	martin.richardson@pbh-tr.nhs.uk	Richardson, Martin/H-2272-2018	Richardson, Martin/0000-0002-1280-3834; Lakhanpaul, Monica/0000-0002-9855-2043				Armon K, 2004, ARCH DIS CHILD, V89, P159, DOI 10.1136/adc.2002.024406; Baraff LJ, 2000, ANN EMERG MED, V36, P602, DOI 10.1067/mem.2000.110820; *NAT I HLTH CLIN E, 2007, FEV ILLN ASS IN MAN; Ninis N, 2005, BRIT MED J, V330, P1475, DOI 10.1136/bmj.330.7506.1475	4	50	54	1	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUN 2	2007	334	7604					1163	1164		10.1136/bmj.39218.495255.AE	http://dx.doi.org/10.1136/bmj.39218.495255.AE			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	177ES	17540946	Green Published			2022-12-28	WOS:000247137000036
J	Colell, A; Ricci, JE; Tait, S; Milasta, S; Maurer, U; Bouchier-Hayes, L; Fitzgerald, P; Guio-Carrion, A; Waterhouse, NJ; Li, CW; Mari, B; Barbry, P; Newmeyer, DD; Beere, HM; Green, DR				Colell, Anna; Ricci, Jean-Ehrland; Tait, Stephen; Milasta, Sandra; Maurer, Ulrich; Bouchier-Hayes, Lisa; Fitzgerald, Patrick; Guio-Carrion, Ana; Waterhouse, Nigel J.; Li, Cindy Wei; Mari, Bernard; Barbry, Pascal; Newmeyer, Donald D.; Beere, Helen M.; Green, Douglas R.			GAPDH and autophagy preserve survival after apoptotic cytochrome c release in the absence of caspase activation	CELL			English	Article							GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE GENE; CELL-DEATH; MITOCHONDRIAL-FUNCTION; NUCLEAR TRANSLOCATION; SIGNALING PATHWAY; PROSTATE-CANCER; MEMBRANE-FUSION; OVARIAN-CANCER; BREAST-CANCER; ACTINOMYCIN-D	In cells undergoing apoptosis, mitochondrial outer-membrane permeabilization (MOMP) is followed by paspase activation promoted by released cytochrome c. Although caspases mediate the apoptotic phenotype, caspase inhibition is generally not sufficient for survival following MOMP; instead cells undergo a "caspase-independent cell death" (CICD). Thus, MOMP may represent a point of commitment to cell death. Here, we identify glyceraidehyde-3-phosphate dehydrogenase (GAPDH) as a critical regulator of CICD. GAPDH-expressing cells preserved their clonogenic potential following MOMP, provided that caspase activation was blocked. GAPDHmediated protection of cells from CICD involved an elevation in glycolysis and a nuclear function that correlated with and was replaced by an increase in Atg12 expression. Consistent with this, protection from CICD reflected an increase in and a dependence upon autophagy, associated with a transient decrease in mitochondrial mass. Therefore, GAPDH mediates an elevation in glycolysis and enhanced autophagy that cooperate to protect cells from CICD.	St Jude Childrens Hosp, Dept Immunol, Memphis, TN 38105 USA; CSIC, IDIBAPS, Dept Cell Death & Proliferat, IIBB, Barcelona 08036, Spain; Univ Nice Sophia Antipolis, Inserm U526, Equipe Avenir, IFR 50,Fac Med, F-06107 Nice, France; Univ Freiburg, Inst Mol Med & Cell Res, Freiburg, Germany; La Jolla Inst Allergy & Immunol, Div Cellular Immunol, San Diego, CA 92121 USA; Univ Melbourne, Peter MacCallum Canc Ctr, Melbourne, Vic 8006, Australia; Univ Melbourne, Dept Pathol, Melbourne, Vic 8006, Australia; Univ Nice Sophia Antipolis, CNRS, Inst Pharmacol Mol & Cellulaire, UMR6097, F-06560 Valbonne, France	St Jude Children's Research Hospital; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas de Barcelona (IIBB); University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; University of Freiburg; La Jolla Institute for Immunology; Peter Maccallum Cancer Center; University of Melbourne; University of Melbourne; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur	Green, DR (corresponding author), St Jude Childrens Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	douglas.green@stjude.org	Ricci, Jean Ehrland/I-7117-2016; Green, Douglas R/N-8083-2018; Barbry, Pascal/O-5021-2016; Mari, Bernard P/GVS-3100-2022; Colell, Anna/N-8710-2014; Bouchier-Hayes, Lisa/T-9491-2019; Mari, Bernard/Q-5832-2019; Mari, Bernard P/D-7445-2015; RICCI, Jean Ehrland/AAS-4379-2020; Mari, Bernard P/F-8960-2013; Waterhouse, Nigel/I-9813-2016	Ricci, Jean Ehrland/0000-0003-1585-8117; Green, Douglas R/0000-0002-7332-1417; Barbry, Pascal/0000-0001-9632-6483; Mari, Bernard P/0000-0002-0422-9182; Colell, Anna/0000-0001-5236-1834; Bouchier-Hayes, Lisa/0000-0003-3886-5977; Mari, Bernard/0000-0002-0422-9182; Mari, Bernard P/0000-0002-0422-9182; RICCI, Jean Ehrland/0000-0003-1585-8117; Mari, Bernard P/0000-0002-0422-9182; Guio-Carrion, Ana/0000-0002-8963-4389; Tait, Stephen/0000-0001-7697-132X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040646] Funding Source: NIH RePORTER; NIAID NIH HHS [AI40646] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Amarante-Mendes GP, 1998, CELL DEATH DIFFER, V5, P298, DOI 10.1038/sj.cdd.4400354; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Brown VM, 2004, J BIOL CHEM, V279, P5984, DOI 10.1074/jbc.M307071200; Carujo S, 2006, ONCOGENE, V25, P4033, DOI 10.1038/sj.onc.1209433; Chesney J, 1999, P NATL ACAD SCI USA, V96, P3047, DOI 10.1073/pnas.96.6.3047; Chipuk JE, 2005, NAT REV MOL CELL BIO, V6, P268, DOI [10.1038/nrm1573, 10.1038/nrm2239]; Dastoor Z, 2001, J CELL SCI, V114, P1643; Deshmukh M, 2000, J CELL BIOL, V150, P131, DOI 10.1083/jcb.150.1.131; Devarajan E, 2002, ONCOGENE, V21, P8843, DOI 10.1038/sj.onc.1206044; Deveraux QL, 1998, EMBO J, V17, P2215, DOI 10.1093/emboj/17.8.2215; Elmore SP, 2001, FASEB J, V15, P2286, DOI 10.1096/fj.01-0206fje; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; Ferraro E, 2003, J CELL MOL MED, V7, P21, DOI 10.1111/j.1582-4934.2003.tb00199.x; Ferreira CG, 2001, CLIN CANCER RES, V7, P2468; Fischer U, 2003, CELL DEATH DIFFER, V10, P76, DOI 10.1038/sj.cdd.4401160; Glaser PE, 2002, P NATL ACAD SCI USA, V99, P14104, DOI 10.1073/pnas.222542999; Goldstein JC, 2000, NAT CELL BIOL, V2, P156, DOI 10.1038/35004029; Green DR, 2002, CANCER CELL, V1, P19, DOI 10.1016/S1535-6108(02)00024-7; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Hao ZY, 2005, CELL, V121, P579, DOI 10.1016/j.cell.2005.03.016; Haraguchi M, 2000, J EXP MED, V191, P1709, DOI 10.1084/jem.191.10.1709; Hietanen S, 2000, P NATL ACAD SCI USA, V97, P8501, DOI 10.1073/pnas.97.15.8501; HUE L, 1987, BIOCHEM J, V245, P313, DOI 10.1042/bj2450313; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kaneda M, 1997, J BIOCHEM-TOKYO, V122, P1233; Kennedy SG, 1997, GENE DEV, V11, P701, DOI 10.1101/gad.11.6.701; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Krajewska M, 2003, CLIN CANCER RES, V9, P4914; Kundu M, 2005, CELL DEATH DIFFER, V12, P1484, DOI 10.1038/sj.cdd.4401780; Kuwana T, 2003, CURR OPIN CELL BIOL, V15, P691, DOI 10.1016/j.ceb.2003.10.004; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Liu JR, 2002, CANCER RES, V62, P924; Majeski AE, 2004, INT J BIOCHEM CELL B, V36, P2435, DOI 10.1016/j.biocel.2004.02.013; Martinou I, 1999, J CELL BIOL, V144, P883, DOI 10.1083/jcb.144.5.883; Mazzola JL, 2003, BBA-GEN SUBJECTS, V1622, P50, DOI 10.1016/S0304-4165(03)00117-X; McCarthy NJ, 1997, J CELL BIOL, V136, P215, DOI 10.1083/jcb.136.1.215; MEYERSIEGLER K, 1991, P NATL ACAD SCI USA, V88, P8460, DOI 10.1073/pnas.88.19.8460; Mischo HE, 2005, J BIOL CHEM, V280, P9586, DOI 10.1074/jbc.M411444200; Nakagawa T, 2003, J BIOL CHEM, V278, P20395, DOI 10.1074/jbc.M210824200; Onishi M, 1996, EXP HEMATOL, V24, P324; Revillion F, 2000, EUR J CANCER, V36, P1038, DOI 10.1016/S0959-8049(00)00051-4; Ricci JE, 2004, CELL, V117, P773, DOI 10.1016/j.cell.2004.05.008; Ricci JE, 2003, J CELL BIOL, V160, P65, DOI 10.1083/jcb.200208089; Rondinelli RH, 1997, PROSTATE CANCER P D, V1, P66, DOI 10.1038/sj.pcan.4500208; Saunders PA, 1999, J NEUROCHEM, V72, P925, DOI 10.1046/j.1471-4159.1999.0720925.x; SAWICKI SG, 1972, J CELL BIOL, V55, P299, DOI 10.1083/jcb.55.2.299; SCHEK N, 1988, CANCER RES, V48, P6354; Schmitt CA, 2002, CANCER CELL, V1, P289, DOI 10.1016/S1535-6108(02)00047-8; Scott CL, 2004, J CELL BIOL, V164, P89, DOI 10.1083/jcb.200310041; Sirover MA, 1999, BBA-PROTEIN STRUCT M, V1432, P159, DOI 10.1016/S0167-4838(99)00119-3; Soengas MS, 2001, NATURE, V409, P207, DOI 10.1038/35051606; Sundararaj KP, 2004, J BIOL CHEM, V279, P6152, DOI 10.1074/jbc.M310549200; Tamm I, 2000, CLIN CANCER RES, V6, P1796; Teague TK, 1999, P NATL ACAD SCI USA, V96, P12691, DOI 10.1073/pnas.96.22.12691; TOKUNAGA K, 1987, CANCER RES, V47, P5616; Waterhouse NJ, 2001, J CELL BIOL, V153, P319, DOI 10.1083/jcb.153.2.319; Wolf BB, 2001, J BIOL CHEM, V276, P34244, DOI 10.1074/jbc.M011778200; Xiang JL, 1996, P NATL ACAD SCI USA, V93, P14559, DOI 10.1073/pnas.93.25.14559; Xue L, 2001, CURR BIOL, V11, P361, DOI 10.1016/S0960-9822(01)00100-2; Yang W, 2003, BRIT J PHARMACOL, V140, P402, DOI 10.1038/sj.bjp.0705450; Zheng L, 2003, CELL, V114, P255, DOI 10.1016/S0092-8674(03)00552-X	61	401	421	2	45	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 1	2007	129	5					983	997		10.1016/j.cell.2007.03.045	http://dx.doi.org/10.1016/j.cell.2007.03.045			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	176KT	17540177	Bronze			2022-12-28	WOS:000247084600017
J	Stewart, AJ; Schmidt, MW; van Westrenen, W; Liebske, C				Stewart, Andrew J.; Schmidt, Max W.; van Westrenen, Wim; Liebske, Christian			Mars: A new core-crystallization regime	SCIENCE			English	Article							THERMAL EVOLUTION; HIGH-PRESSURE; INNER-CORE; DYNAMO; INTERIOR; EQUATION; SULFUR; POINT; STATE; MODEL	The evolution of the martian core is widely assumed to mirror the characteristics observed for Earth's core. Data from experiments performed on iron-sulfur and iron-nickel-sulfur systems at pressures corresponding to the center of Mars indicate that its core is presently completely liquid and that it will not form an outwardly crystallizing iron-rich inner core, as does Earth. Instead, planetary cooling will lead to core crystallization following either a "snowing-core" model, whereby iron-rich solids nucleate in the outer portions of the core and sink toward the center, or a "sulfide inner-core" model, where an iron-sulfide phase crystallizes to form a solid inner core.	ETH, Inst Mineral & Petrol, CH-8092 Zurich, Switzerland; Vrije Univ Amsterdam, Fac Earth & Life Sci, NL-1081 HV Amsterdam, Netherlands	Swiss Federal Institutes of Technology Domain; ETH Zurich; Vrije Universiteit Amsterdam	Schmidt, MW (corresponding author), ETH, Inst Mineral & Petrol, CH-8092 Zurich, Switzerland.	max.schmidt@erdw.ethz.ch	Schmidt, Max/A-1676-2008; van Westrenen, Wim/D-6495-2012	van Westrenen, Wim/0000-0001-5828-8885; Schmidt, Max W./0000-0002-3870-5781				Acuna MH, 1999, SCIENCE, V284, P790, DOI 10.1126/science.284.5415.790; Balog PS, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2001JB001646; Bertka CM, 1997, J GEOPHYS RES-SOL EA, V102, P5251, DOI 10.1029/96JB03270; BESSON JM, 1990, J GEOPHYS RES-SOLID, V95, P21717, DOI 10.1029/JB095iB13p21717; BOEHLER R, 1993, NATURE, V363, P534, DOI 10.1038/363534a0; Connerney JEP, 1999, SCIENCE, V284, P794, DOI 10.1126/science.284.5415.794; Fei YW, 2005, SCIENCE, V308, P1120, DOI 10.1126/science.1110531; Fei YW, 2000, AM MINERAL, V85, P1830; Hauck SA, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2001JE001801; Hauck SA, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002557; Heimpel MH, 2005, EARTH PLANET SC LETT, V236, P542, DOI 10.1016/j.epsl.2005.04.032; Ito E, 1998, GEOPHYS RES LETT, V25, P821, DOI 10.1029/98GL00519; KAWAI N, 1970, REV SCI INSTRUM, V41, P1178, DOI 10.1063/1.1684753; Li J, 2001, EARTH PLANET SC LETT, V193, P509, DOI 10.1016/S0012-821X(01)00521-0; Lodders K, 1997, ICARUS, V126, P373, DOI 10.1006/icar.1996.5653; Nimmo F, 2000, J GEOPHYS RES-PLANET, V105, P11969, DOI 10.1029/1999JE001216; Sakuraba A, 1999, PHYS EARTH PLANET IN, V111, P105, DOI 10.1016/S0031-9201(98)00150-2; Sanloup C, 1999, PHYS EARTH PLANET IN, V112, P43, DOI 10.1016/S0031-9201(98)00175-7; Sanloup C, 2000, GEOPHYS RES LETT, V27, P811, DOI 10.1029/1999GL008431; Seagle CT, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB004091; Sohl F, 2005, J GEOPHYS RES-PLANET, V110, DOI 10.1029/2005JE002520; Solomon SC, 2005, SCIENCE, V307, P1214, DOI 10.1126/science.1101812; Stevenson DJ, 2001, NATURE, V412, P214, DOI 10.1038/35084155; Von Platen B., 1962, MODERN VERY HIGH PRE, P118; WALKER D, 1991, AM MINERAL, V76, P1092; WANKE H, 1988, PHILOS T R SOC A, V325, P545, DOI 10.1098/rsta.1988.0067; Williams JP, 2004, GEOLOGY, V32, P97, DOI 10.1130/G19975.1; Yoder CF, 2003, SCIENCE, V300, P299, DOI 10.1126/science.1079645	28	161	164	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 1	2007	316	5829					1323	1325		10.1126/science.1140549	http://dx.doi.org/10.1126/science.1140549			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173PS	17540900				2022-12-28	WOS:000246885600046
J	English, V; Wright, L				English, Veronica; Wright, Linda			Is presumed consent the answer to organ shortages?	BRITISH MEDICAL JOURNAL			English	Editorial Material									British Med Assoc, Med Eth, London WC1H 9JP, England; Univ Toronto, Toronto Gen Hosp, Joint Ctr Bioeth, Toronto, ON M5G 2N2, Canada; Univ Toronto, Toronto Gen Hosp, Univ Hlth Network, Toronto, ON M5G 2N2, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	English, V (corresponding author), British Med Assoc, Med Eth, London WC1H 9JP, England.	venglish@bma.org.uk; Linda.wright@uhn.on.ca							0	42	41	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAY 26	2007	334	7603					1088	1089		10.1136/bmj.39199.475301.AD	http://dx.doi.org/10.1136/bmj.39199.475301.AD			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	174XB	17525449	Green Published			2022-12-28	WOS:000246975000029
J	Kilickap, S; Yalcin, B				Kilickap, Saadettin; Yalcin, Basak			The sign of Leser-Trelat	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Hacettepe Univ, Inst Oncol, TR-06100 Ankara, Turkey	Hacettepe University	Kilickap, S (corresponding author), Hacettepe Univ, Inst Oncol, TR-06100 Ankara, Turkey.	skilickap@yahoo.com	Kilickap, Saadettin/AAP-3732-2021	Kilickap, Saadettin/0000-0003-1637-7390					0	5	6	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 24	2007	356	21					2184	2184		10.1056/NEJMicm062851	http://dx.doi.org/10.1056/NEJMicm062851			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	170ON	17522402				2022-12-28	WOS:000246673100009
J	Okita, K; Ichisaka, T; Yamanaka, S				Okita, Keisuke; Ichisaka, Tomoko; Yamanaka, Shinya			Generation of germline-competent induced pluripotent stem cells	NATURE			English	Article							SELF-RENEWAL; MOUSE DEVELOPMENT; ES CELLS; EXPRESSION; NANOG; METHYLATION; GENE; DIFFERENTIATION; IGF2R; LINES	We have previously shown that pluripotent stem cells can be induced from mouse fibroblasts by retroviral introduction of Oct3/4 (also called Pou5f1), Sox2, c-Myc and Klf4, and subsequent selection for Fbx15 (also called Fbxo15) expression. These induced pluripotent stem (iPS) cells (hereafter called Fbx15 iPS cells) are similar to embryonic stem (ES) cells in morphology, proliferation and teratoma formation; however, they are different with regards to gene expression and DNA methylation patterns, and fail to produce adult chimaeras. Here we show that selection for Nanog expression results in germline-competent iPS cells with increased ES-cell-like gene expression and DNA methylation patterns compared with Fbx15 iPS cells. The four transgenes (Oct3/4, Sox2, c-myc and Klf4) were strongly silenced in Nanog iPS cells. We obtained adult chimaeras from seven Nanog iPS cell clones, with one clone being transmitted through the germ line to the next generation. Approximately 20% of the offspring developed tumours attributable to reactivation of the c-myc transgene. Thus, iPS cells competent for germline chimaeras can be obtained from fibroblasts, but retroviral introduction of c-Myc should be avoided for clinical application.	Kyoto Univ, Inst Frontier Med Sci, Dept Stem Cell Biol, Kyoto 6068507, Japan; Japan Sci & Technol Agcy, CREST, Kawaguchi 3320012, Japan	Kyoto University; Japan Science & Technology Agency (JST)	Yamanaka, S (corresponding author), Kyoto Univ, Inst Frontier Med Sci, Dept Stem Cell Biol, Kyoto 6068507, Japan.	yamanaka@frontier.kyoto-u.ac.jp	Wilson, Matthew H/K-3193-2013	Okita, Keisuke/0000-0001-5806-1090				Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; BRANDEIS M, 1993, EMBO J, V12, P3669, DOI 10.1002/j.1460-2075.1993.tb06041.x; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chen TP, 2002, J BIOL CHEM, V277, P38746, DOI 10.1074/jbc.M205312200; Cherry SR, 2000, MOL CELL BIOL, V20, P7419, DOI 10.1128/MCB.20.20.7419-7426.2000; Copeland NG, 2001, NAT REV GENET, V2, P769, DOI 10.1038/35093556; DAVID B V, 1985, Pesticides (Bombay), V19, P9; Geijsen N, 2004, NATURE, V427, P148, DOI 10.1038/nature02247; Hochedlinger K, 2006, NATURE, V441, P1061, DOI 10.1038/nature04955; Kato Y, 1999, DEVELOPMENT, V126, P1823; Kuroda T, 2005, MOL CELL BIOL, V25, P2475, DOI 10.1128/MCB.25.6.2475-2485.2005; LABOSKY PA, 1994, DEVELOPMENT, V120, P3197; Lee J, 2002, DEVELOPMENT, V129, P1807; Li Y, 2005, BLOOD, V105, P635, DOI 10.1182/blood-2004-07-2681; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; Meiner VL, 1996, P NATL ACAD SCI USA, V93, P14041, DOI 10.1073/pnas.93.24.14041; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; Sato S, 2003, MOL REPROD DEV, V65, P41, DOI 10.1002/mrd.10264; Silva J, 2006, NATURE, V441, P997, DOI 10.1038/nature04914; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Testa G, 2003, NAT BIOTECHNOL, V21, P443, DOI 10.1038/nbt804; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tokuzawa Y, 2003, MOL CELL BIOL, V23, P2699, DOI 10.1128/MCB.23.8.2699-2708.2003	28	3191	3661	58	1570	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 19	2007	448	7151					313	U1		10.1038/nature05934	http://dx.doi.org/10.1038/nature05934			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191GC	17554338				2022-12-28	WOS:000248118300049
J	Lashof, AO; Lesterhuis, WJ; Wanten, G; Beckers, P; Keuter, M				Lashof, Astrid Oude; Lesterhuis, W. Joost; Wanten, Geert; Beckers, Pieter; Keuter, Monique			Colitis in an alcohol-dependent woman	LANCET			English	Editorial Material							STRONGYLOIDES-STERCORALIS; INFECTION		Radboud Univ Nijmegen Med Ctr, Nijmegen Univ Ctr Infect Dis, Nijmegen, Netherlands; Radboud Univ Nijmegen Med Ctr, Dept Gen Internal Med, Nijmegen, Netherlands; Radboud Univ Nijmegen Med Ctr, Dept Gastroenterol & Hepatol, Nijmegen, Netherlands; Radboud Univ Nijmegen Med Ctr, Dept Med Microbiol, Nijmegen, Netherlands; Radboud Univ Nijmegen Med Ctr, NUCI Int Hlth, Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Lashof, AO (corresponding author), Radboud Univ Nijmegen Med Ctr, Nijmegen Univ Ctr Infect Dis 463, POB 9101, NL-6500 HB Nijmegen, Netherlands.	a.oudelashof@aig.umcn.nl	Keuter, M./L-4430-2015; Wanten, G.J.A./L-4742-2015	Lesterhuis, Willem Joost/0000-0002-2718-276X				Gill GV, 2004, QJM-INT J MED, V97, P789, DOI 10.1093/qjmed/hch133; Gutierrez Y, 1996, AM J SURG PATHOL, V20, P603, DOI 10.1097/00000478-199605000-00007; Keiser PB, 2004, CLIN MICROBIOL REV, V17, P208, DOI 10.1128/CMR.17.1.208-217.2004; ROBINSON RD, 1994, J INFECT DIS, V169, P692, DOI 10.1093/infdis/169.3.692; Roman-Sanchez P, 2003, AM J TROP MED HYG, V69, P336, DOI 10.4269/ajtmh.2003.69.336	5	5	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 16	2007	369	9578					2050	2050		10.1016/S0140-6736(07)60945-3	http://dx.doi.org/10.1016/S0140-6736(07)60945-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	180HT	17574097				2022-12-28	WOS:000247354400030
J	Peters, RJG; Mehta, S; Yusuf, S				Peters, Ron J. G.; Mehta, Shamir; Yusuf, Salim			Acute coronary syndromes without ST segment elevation	BMJ-BRITISH MEDICAL JOURNAL			English	Review							MYOCARDIAL-INFARCTION; UNSTABLE ANGINA; VASCULAR-DISEASE; RISK SCORE; GUIDELINES; MANAGEMENT; METAANALYSIS; CLOPIDOGREL; INHIBITORS; DIAGNOSIS		Acad Med Ctr, Dept Cardiol, NL-1100 AC Amsterdam, Netherlands; McMaster Univ, Dept Med, Hamilton, ON L8L 2X2, Canada; Populat Hlth Res Inst, Hamilton, ON L8L 2X2, Canada	University of Amsterdam; Academic Medical Center Amsterdam; McMaster University; Population Health Research Institute	Peters, RJG (corresponding author), Acad Med Ctr, Dept Cardiol, POB 22660, NL-1100 AC Amsterdam, Netherlands.	r.j.peters@amc.uva.nl		Yusuf, Salim/0000-0003-4776-5601				Antman EM, 2000, JAMA-J AM MED ASSOC, V284, P835, DOI 10.1001/jama.284.7.835; APERT JS, 2000, J AM COLL CARDIOL, V36, P959; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Bertrand ME, 2002, EUR HEART J, V23, P1809, DOI 10.1053/euhj.2002.3385; Boersma E, 2000, CIRCULATION, V101, P2557, DOI 10.1161/01.CIR.101.22.2557; Boersma E, 2002, LANCET, V359, P189, DOI 10.1016/S0140-6736(02)07442-1; Braunwald E, 2002, J AM COLL CARDIOL, V40, P1366, DOI 10.1016/S0735-1097(02)02336-7; Collinson J, 2000, EUR HEART J, V21, P1450, DOI 10.1053/euhj.1999.1995; Dagenais GR, 2006, LANCET, V368, P581, DOI 10.1016/S0140-6736(06)69201-5; De Backer G, 2003, EUR J CARDIOV PREV R, V10, pS1, DOI 10.1097/01.hjr.0000087913.96265.e2; de Winter RJ, 2005, NEW ENGL J MED, V353, P1095, DOI 10.1056/NEJMoa044259; DIAMOND GA, 1979, NEW ENGL J MED, V300, P1350, DOI 10.1056/NEJM197906143002402; Eagle KA, 2004, JAMA-J AM MED ASSOC, V291, P2727, DOI 10.1001/jama.291.22.2727; Eikelboom JW, 2000, LANCET, V355, P1936, DOI 10.1016/S0140-6736(00)02324-2; Gibler WB, 2005, CIRCULATION, V111, P2699, DOI 10.1161/01.CIR.0000165556.44271.BE; Goodacre S, 2002, ACAD EMERG MED, V9, P203; Hoenig MR, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004815.pub2; Jacobs DR, 1999, CIRCULATION, V100, P599, DOI 10.1161/01.CIR.100.6.599; Kastrati A, 2006, JAMA-J AM MED ASSOC, V295, P1531, DOI 10.1001/jama.295.13.joc60034; MCCAIG LF, 2004, ADV DATA VITAL HLTH; MCCARTHY BD, 1990, J GEN INTERN MED, V5, P365, DOI 10.1007/BF02600409; Mehta SR, 2005, JAMA-J AM MED ASSOC, V293, P2908, DOI 10.1001/jama.293.23.2908; Smith SC, 2006, CIRCULATION, V113, P2363, DOI 10.1161/CIRCULATIONAHA.106.174516; Yusuf S, 2006, NEW ENGL J MED, V354, P1464; Yusuf S, 2001, NEW ENGL J MED, V345, P494	25	6	6	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 16	2007	334	7606					1265	1269		10.1136/bmj.39220.618646.AE	http://dx.doi.org/10.1136/bmj.39220.618646.AE			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	183AM	17569934	Green Published			2022-12-28	WOS:000247545100035
J	Li, W; Baker, NE				Li, Wei; Baker, Nicholas E.			Engulfment is required for cell competition	CELL			English	Article							ALDRICH-SYNDROME PROTEIN; PHOSPHATIDYLSERINE RECEPTOR; APOPTOTIC CELLS; CORPSE ENGULFMENT; WING DISK; DROSOPHILA; DEATH; PHAGOCYTOSIS; CLEARANCE; GENES	Genetic mosaics that place cells in competition within tissues may model features of tissue repair and tumor development and may reveal mechanisms of growth regulation. In one example, normal cells eliminate "Minute" cells that have reduced ribosomal protein gene dose and grow at their expense, replacing the Minute cells within developing compartments. We describe genes that are required by wild-type cells to kill Minute neighbors in Drosophila. The engulfment genes draper, wasp, the phosphatidylserine receptor, mbc/dock180, and rac1 are needed in wild-type cells for the death of Minute neighbors, whose corpses are engulfed by wild-type cells. Wild-type cells can themselves be killed by cells with elevated engulfing activity. Thus engulfment genes act downstream of growth differences between cells to eliminate cells with reduced ribosomal gene dose.	Albert Einstein Coll Med, Dept Mol Genet, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Baker, NE (corresponding author), Albert Einstein Coll Med, Dept Mol Genet, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	nbaker@aecom.yu.edu		Li, Wei/0000-0001-5696-4309	NIGMS NIH HHS [R01 GM061230, GM61230] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061230] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABRAMS JM, 1993, DEVELOPMENT, V117, P29; Awasaki T, 2006, NEURON, V50, P855, DOI 10.1016/j.neuron.2006.04.027; BAKER BS, 1983, ANNU REV GENET, V17, P345, DOI 10.1146/annurev.ge.17.120183.002021; Bogdan S, 2003, DEVELOPMENT, V130, P4427, DOI 10.1242/dev.00663; BORING LF, 1989, DEV BIOL, V132, P343, DOI 10.1016/0012-1606(89)90231-5; Cikala M, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-26; Cohen Stephen M., 1993, P747; Cui P, 2004, EXP CELL RES, V293, P154, DOI 10.1016/j.yexcr.2003.09.023; de la Cova C, 2004, CELL, V117, P107, DOI 10.1016/S0092-8674(04)00214-4; deCelis JF, 1996, NATURE, V381, P421, DOI 10.1038/381421a0; Edgar BA, 2006, CELL, V124, P267, DOI 10.1016/j.cell.2006.01.005; Fadok VA, 2000, NATURE, V405, P85, DOI 10.1038/35011084; FADOK VA, 1992, J IMMUNOL, V148, P2207; Firth LC, 2006, METHOD ENZYMOL, V407, P711, DOI 10.1016/S0076-6879(05)07056-4; Franc NC, 1999, CURR OPIN IMMUNOL, V11, P47, DOI 10.1016/S0952-7915(99)80009-0; Franc NC, 1999, SCIENCE, V284, P1991, DOI 10.1126/science.284.5422.1991; Freeman MR, 2003, NEURON, V38, P567, DOI 10.1016/S0896-6273(03)00289-7; FRISTROM D, 1969, MOL GEN GENET, V103, P363, DOI 10.1007/BF00383486; GARCIABELLIDO A, 1973, NATURE-NEW BIOL, V245, P251, DOI 10.1038/newbio245251a0; Gibson MC, 2005, SCIENCE, V307, P1785, DOI 10.1126/science.1104751; HAY BA, 1994, DEVELOPMENT, V120, P2121; Hoeppner DJ, 2001, NATURE, V412, P202, DOI 10.1038/35084103; Hong JR, 2004, DEVELOPMENT, V131, P5417, DOI 10.1242/dev.01409; Huh JR, 2004, CURR BIOL, V14, P1262, DOI 10.1016/j.cub.2004.06.015; Kinchen JM, 2005, NATURE, V434, P93, DOI 10.1038/nature03263; Lambertsson A, 1998, ADV GENET, V38, P69, DOI 10.1016/S0065-2660(08)60142-X; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Li MO, 2003, SCIENCE, V302, P1560, DOI 10.1126/science.1087621; Lorenzi R, 2000, BLOOD, V95, P2943, DOI 10.1182/blood.V95.9.2943.009k17_2943_2946; MacDonald JM, 2006, NEURON, V50, P869, DOI 10.1016/j.neuron.2006.04.028; Manaka J, 2004, J BIOL CHEM, V279, P48466, DOI 10.1074/jbc.M408597200; MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545; Mitchell JE, 2006, J BIOL CHEM, V281, P5718, DOI 10.1074/jbc.M509775200; MORATA G, 1975, DEV BIOL, V42, P211, DOI 10.1016/0012-1606(75)90330-9; Moreno E, 2004, CELL, V117, P117, DOI 10.1016/S0092-8674(04)00262-4; Moreno E, 2002, NATURE, V416, P755, DOI 10.1038/416755a; Nesbit CE, 1999, ONCOGENE, V18, P3004, DOI 10.1038/sj.onc.1202746; Neufeld TP, 1998, CELL, V93, P1183, DOI 10.1016/S0092-8674(00)81462-2; Newsome TP, 2000, DEVELOPMENT, V127, P851; Nolan KM, 1998, GENE DEV, V12, P3337, DOI 10.1101/gad.12.21.3337; Oertel M, 2006, GASTROENTEROLOGY, V130, P507, DOI 10.1053/j.gastro.2005.10.049; Oliver ER, 2004, DEVELOPMENT, V131, P3907, DOI 10.1242/dev.01268; Pearson AM, 2003, MICROBES INFECT, V5, P815, DOI 10.1016/S1286-4579(03)00157-6; Perez-Garijo A, 2004, DEVELOPMENT, V131, P5591, DOI 10.1242/dev.01432; Reddien PW, 2004, ANNU REV CELL DEV BI, V20, P193, DOI 10.1146/annurev.cellbio.20.022003.114619; Reddien PW, 2001, NATURE, V412, P198, DOI 10.1038/35084096; Reddien PW, 2000, NAT CELL BIOL, V2, P131, DOI 10.1038/35004000; Rosenblatt J, 2001, CURR BIOL, V11, P1847, DOI 10.1016/S0960-9822(01)00587-5; Ryoo HD, 2004, DEV CELL, V7, P491, DOI 10.1016/j.devcel.2004.08.019; Shen J, 2005, SCIENCE, V307, P1789, DOI 10.1126/science.1104784; SIMPSON P, 1979, DEV BIOL, V69, P182, DOI 10.1016/0012-1606(79)90284-7; SIMPSON P, 1981, DEV BIOL, V85, P299, DOI 10.1016/0012-1606(81)90261-X; Tanimoto H, 2000, MOL CELL, V5, P59, DOI 10.1016/S1097-2765(00)80403-7; TEPASS U, 1994, DEVELOPMENT, V120, P1829; Tyler DM, 2007, GENETICS, V175, P643, DOI 10.1534/genetics.106.061929; van den Eijnde SM, 1998, APOPTOSIS, V3, P9, DOI 10.1023/A:1009650917818; VERHOVEN B, 1995, J EXP MED, V182, P1597, DOI 10.1084/jem.182.5.1597; Vidal M, 2006, DEV CELL, V10, P33, DOI 10.1016/j.devcel.2005.11.007; Wang XC, 2003, SCIENCE, V302, P1563, DOI 10.1126/science.1087641; Wu YC, 1998, NATURE, V392, P501, DOI 10.1038/33163; XU T, 1993, DEVELOPMENT, V117, P1223; Zhang J, 1999, J EXP MED, V190, P1329, DOI 10.1084/jem.190.9.1329; Zhou Z, 2001, CELL, V104, P43, DOI 10.1016/S0092-8674(01)00190-8	63	173	176	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 15	2007	129	6					1215	1225		10.1016/j.cell.2007.03.054	http://dx.doi.org/10.1016/j.cell.2007.03.054			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	180UA	17574031	Bronze			2022-12-28	WOS:000247390400023
J	Moreau, JW; Weber, PK; Martin, MC; Gilbert, B; Hutcheon, ID; Banfield, JF				Moreau, John W.; Weber, Peter K.; Martin, Michael C.; Gilbert, Benjamin; Hutcheon, Ian D.; Banfield, Jillian F.			Extracellular proteins limit the dispersal of biogenic nanoparticles	SCIENCE			English	Article							SULFATE-REDUCING BACTERIA; METAL; RESISTANCE; ZINC; ION; CONTAMINATION; GEOCHEMISTRY; AGGREGATION; SPHALERITE; PRODUCTS	High-spatial-resolution secondary ion microprobe spectrometry, synchrotron radiation-based Fourier-transform infrared spectroscopy, and polyacrylamide gel analysis demonstrated the intimate association of proteins with spheroidal aggregates of biogenic zinc sulfide nanocrystals, an example of extracellular biomineralization. Experiments involving synthetic zinc sulfide nanoparticles and representative amino acids indicated a driving role for cysteine in rapid nanoparticle aggregation. These findings suggest that microbially derived extracellular proteins can limit the dispersal of nanoparticulate metal-bearing phases, such as the mineral products of bioremediation, that may otherwise be transported away from their source by subsurface fluid flow.	Lawrence Livermore Natl Lab, Glenn T Seaborg Inst, Livermore, CA 94551 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Div Earth Sci, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Moreau, JW (corresponding author), US Geol Survey, Div Water Resources, Middleton, WI 53562 USA.	jwmoreau@usgs.gov	Martin, Michael C./ABH-9841-2020; Gilbert, Benjamin/E-3182-2010; Moreau, John/A-8061-2013; Weber, Peter Kilian/AAP-9517-2020; 1.4, ALS Beamline/I-1886-2014	Martin, Michael C./0000-0002-6611-070X; Weber, Peter Kilian/0000-0001-6022-6050; Banfield, Jill/0000-0001-8203-8771; Moreau, John W/0000-0002-5997-522X; Gilbert, Benjamin/0000-0003-0853-0826				Ahn JS, 2005, ENVIRON GEOCHEM HLTH, V27, P147, DOI 10.1007/s10653-005-0121-8; Allain C, 1996, J COLLOID INTERF SCI, V178, P411, DOI 10.1006/jcis.1996.0135; Barkay T, 2001, CURR OPIN MICROBIOL, V4, P318, DOI 10.1016/S1369-5274(00)00210-1; Bebie J., 2000, GEOCHEM T, V1, P47, DOI DOI 10.1186/1467-4866-1-47; Blindauer CA, 2001, P NATL ACAD SCI USA, V98, P9593, DOI 10.1073/pnas.171120098; Bradford SA, 2002, WATER RESOUR RES, V38, DOI 10.1029/2002WR001340; Bridge TAM, 1999, MICROBIOL-SGM, V145, P2987, DOI 10.1099/00221287-145-10-2987; Diallo MS, 2005, J NANOPART RES, V7, P325, DOI 10.1007/s11051-005-8543-x; Hauri EH, 2002, CHEM GEOL, V185, P149, DOI 10.1016/S0009-2541(01)00400-4; HERING JG, 1990, REV MINERAL, V23, P427; Hochella MF, 2002, GEOCHIM COSMOCHIM AC, V66, P735, DOI 10.1016/S0016-7037(01)00868-7; Hockin SL, 2003, APPL ENVIRON MICROB, V69, P7063, DOI 10.1128/AEM.69.12.7063-7072.2003; Honeyman BD, 1999, NATURE, V397, P23, DOI 10.1038/16150; KHAZAELI MB, 1981, APPL ENVIRON MICROB, V41, P46, DOI 10.1128/AEM.41.1.46-50.1981; Kloepfer JA, 2005, APPL ENVIRON MICROB, V71, P2548, DOI 10.1128/AEM.71.5.2548-2557.2005; KUREK E, 1991, ARCH ENVIRON CON TOX, V21, P106, DOI 10.1007/BF01055564; Labrenz M, 2000, SCIENCE, V290, P1744, DOI 10.1126/science.290.5497.1744; Lloyd JR, 2001, HYDROMETALLURGY, V59, P327, DOI 10.1016/S0304-386X(00)00175-4; Lu QY, 2002, NANOTECHNOLOGY, V13, P741, DOI 10.1088/0957-4484/13/6/309; Luther GW, 1999, GEOCHIM COSMOCHIM AC, V63, P3159, DOI 10.1016/S0016-7037(99)00243-4; Mantsch H. H., 1996, INFRARED SPECTROSCOP; Moreau JW, 2004, AM MINERAL, V89, P950; Naz N, 2005, APPL ENVIRON MICROB, V71, P4610, DOI 10.1128/AEM.71.8.4610-4618.2005; NIES DH, 1992, J BACTERIOL, V174, P8102, DOI 10.1128/JB.174.24.8102-8110.1992; RONNGREN L, 1991, J COLLOID INTERF SCI, V145, P396, DOI 10.1016/0021-9797(91)90370-N; Rosen BP, 1996, J BIOL INORG CHEM, V1, P273, DOI 10.1007/s007750050053; STUMM W, 1996, AQUATIC CHEM CHEM EQ, P400; Suzuki Y, 2002, NATURE, V419, P134, DOI 10.1038/419134a; Torres-Martinez CL, 1999, NANOTECHNOLOGY, V10, P340, DOI 10.1088/0957-4484/10/3/319; Vogel W, 2000, LANGMUIR, V16, P2032, DOI 10.1021/la9910071; WAYCHUNAS GA, 1990, REV MINERAL GEOCHEM, V44, P105; ZHANG JW, 1990, REV MINERAL, V23, P365	32	214	222	2	178	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 15	2007	316	5831					1600	1603		10.1126/science.1141064	http://dx.doi.org/10.1126/science.1141064			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178SH	17569859	Green Submitted			2022-12-28	WOS:000247239900036
J	Panne, D; Maniatis, T; Harrison, SC				Panne, Daniel; Maniatis, Tom; Harrison, Stephen C.			An atomic model of the interferon-beta enhanceosome	CELL			English	Article							PROTEIN HMG I(Y); KAPPA-B SITE; CRYSTAL-STRUCTURE; TRANSCRIPTION FACTORS; DNA-BINDING; VIRUS INDUCTION; P50/P65 HETERODIMER; COOPERATIVE BINDING; REGULATORY FACTORS; POSITIVE FEEDBACK	Transcriptional activation of the interferon-beta (IFN-beta) gene requires assembly of an enhanceo-some containing ATF-2/c-Jun, IRF-3/IRF-7, and NF kappa B. These factors bind cooperatively to the IFN-beta enhancer and recruit coactivators and chromatin-remodeling proteins to the IFN-beta promoter. We describe here a crystal structure of the DNA-binding domains of IRF-3, IRF-7, and NF kappa B, bound to one half of the enhancer, and use a previously described structure of the remaining half to assemble a complete picture of enhanceosome architecture in the vicinity of the DNA. Association of eight proteins with the enhancer creates a continuous surface for recognizing a composite DNA-binding element. Paucity of local protein-protein contacts suggests that cooperative occupancy of the enhancer comes from both binding-induced changes in DNA conformation and interactions with additional components such as CBP. Contacts with virtually every nucleotide pair account for the evolutionary invariance of the enhancer sequence.	Harvard Univ, Sch Med, Jack & Eileen Connors Struct Biol Lab, Dept Biol Chem & Mol Pharmacol,Howard Hughes Med, Boston, MA 02115 USA; Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University	Harrison, SC (corresponding author), Harvard Univ, Sch Med, Jack & Eileen Connors Struct Biol Lab, Dept Biol Chem & Mol Pharmacol,Howard Hughes Med, 250 Longwood Ave, Boston, MA 02115 USA.	harrison@crystal.harvard.edu	Panne, Daniel/I-8368-2017	Panne, Daniel/0000-0001-9158-5507	NIAID NIH HHS [R01 AI020642, R01 AI020642-23, R01AI020642] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020642] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; Arnosti DN, 2005, J CELL BIOCHEM, V94, P890, DOI 10.1002/jcb.20352; Bannister AJ, 1995, ONCOGENE, V11, P2509; Berkowitz B, 2002, J BIOL CHEM, V277, P24694, DOI 10.1074/jbc.M200006200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carey M, 2000, TRANSCRIPTIONAL REGU; Chen FE, 1998, NATURE, V391, P410, DOI 10.1038/34956; Chen FE, 1999, ONCOGENE, V18, P6845, DOI 10.1038/sj.onc.1203224; Chen L, 1998, NATURE, V392, P42, DOI 10.1038/32100; Chen-Park FE, 2002, J BIOL CHEM, V277, P24701, DOI 10.1074/jbc.M200007200; DU W, 1992, P NATL ACAD SCI USA, V89, P2150, DOI 10.1073/pnas.89.6.2150; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Escalante CR, 2007, MOL CELL, V26, P703, DOI 10.1016/j.molcel.2007.04.022; Escalante CR, 2002, MOL CELL, V10, P1097, DOI 10.1016/S1097-2765(02)00703-7; Escalante CR, 2002, STRUCTURE, V10, P383, DOI 10.1016/S0969-2126(02)00723-2; Escalante CR, 1998, NATURE, V391, P103, DOI 10.1038/34224; Falvo JV, 1995, CELL, V83, P1101, DOI 10.1016/0092-8674(95)90137-X; Falvo JV, 2000, MOL CELL BIOL, V20, P4814, DOI 10.1128/MCB.20.13.4814-4825.2000; Fujii Y, 1999, EMBO J, V18, P5028, DOI 10.1093/emboj/18.18.5028; FUJITA T, 1988, EMBO J, V7, P3397, DOI 10.1002/j.1460-2075.1988.tb03213.x; GHOSH G, 1995, NATURE, V373, P303, DOI 10.1038/373303a0; GOODBOURN S, 1988, P NATL ACAD SCI USA, V85, P1447, DOI 10.1073/pnas.85.5.1447; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Huth JR, 1997, NAT STRUCT BIOL, V4, P657, DOI 10.1038/nsb0897-657; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kawasaki H, 1998, GENE DEV, V12, P233, DOI 10.1101/gad.12.2.233; Klemm JD, 1996, GENE DEV, V10, P27, DOI 10.1101/gad.10.1.27; LAVERY R, 1988, J BIOMOL STRUCT DYN, V6, P63, DOI 10.1080/07391102.1988.10506483; Lin CH, 2001, MOL CELL, V8, P581, DOI 10.1016/S1097-2765(01)00333-1; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; Lin RT, 2000, MOL CELL BIOL, V20, P6342, DOI 10.1128/MCB.20.17.6342-6353.2000; Lomvardas S, 2001, CELL, V106, P685, DOI 10.1016/S0092-8674(01)00490-1; Lu XJ, 2003, NUCLEIC ACIDS RES, V31, P5108, DOI 10.1093/nar/gkg680; Ludwig MZ, 2005, PLOS BIOL, V3, P588, DOI 10.1371/journal.pbio.0030093; Ludwig MZ, 2000, NATURE, V403, P564, DOI 10.1038/35000615; Luscombe NM, 1997, NUCLEIC ACIDS RES, V25, P4940, DOI 10.1093/nar/25.24.4940; Mamane Y, 1999, GENE, V237, P1, DOI 10.1016/S0378-1119(99)00262-0; Maniatis T, 1998, COLD SPRING HARB SYM, V63, P609, DOI 10.1101/sqb.1998.63.609; Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660; Merika M, 1998, MOL CELL, V1, P277, DOI 10.1016/S1097-2765(00)80028-3; Merika M, 2001, CURR OPIN GENET DEV, V11, P205, DOI 10.1016/S0959-437X(00)00180-5; Morin P, 2002, J MOL BIOL, V316, P1009, DOI 10.1006/jmbi.2001.5401; MULLER CW, 1995, NATURE, V373, P311, DOI 10.1038/373311a0; Munshi N, 1999, COLD SPRING HARB SYM, V64, P149, DOI 10.1101/sqb.1999.64.149; Munshi N, 2001, SCIENCE, V293, P1133, DOI 10.1126/science.293.5532.1133; Panne D, 2004, EMBO J, V23, P4384, DOI 10.1038/sj.emboj.7600453; PTASHNE M, 2002, GENES SIGNALS; Qin BY, 2005, STRUCTURE, V13, P1269, DOI 10.1016/j.str.2005.06.011; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Sato M, 1998, FEBS LETT, V441, P106, DOI 10.1016/S0014-5793(98)01514-2; SMALL S, 1991, GENE DEV, V5, P827, DOI 10.1101/gad.5.5.827; Struhl K, 2001, SCIENCE, V293, P1054, DOI 10.1126/science.1064050; THANOS D, 1993, COLD SPRING HARB SYM, V58, P73, DOI 10.1101/SQB.1993.058.01.011; Thanos D, 1995, CELL, V83, P1091, DOI 10.1016/0092-8674(95)90136-1; THANOS D, 1992, CELL, V71, P777, DOI 10.1016/0092-8674(92)90554-P; Thomas JO, 2001, BIOCHEM SOC T, V29, P395, DOI 10.1042/BST0290395; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Wathelet MG, 1998, MOL CELL, V1, P507, DOI 10.1016/S1097-2765(00)80051-9; Yie JM, 1999, P NATL ACAD SCI USA, V96, P13108, DOI 10.1073/pnas.96.23.13108	59	422	433	1	31	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 15	2007	129	6					1111	1123		10.1016/j.cell.2007.05.019	http://dx.doi.org/10.1016/j.cell.2007.05.019			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	180UA	17574024	Green Accepted, Bronze			2022-12-28	WOS:000247390400015
J	Parson, WW				Parson, William W.			Long live electronic coherence!	SCIENCE			English	Editorial Material							PHOTOSYNTHETIC REACTION CENTERS; BACTERIAL REACTION CENTERS; ENERGY-TRANSFER PATHWAYS; PROTEIN; DYNAMICS		Univ Washington, Dept Biochem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Parson, WW (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.	parsonb@u.washington.edu						Engel GS, 2007, NATURE, V446, P782, DOI 10.1038/nature05678; ERMLER U, 1994, STRUCTURE, V2, P925, DOI 10.1016/S0969-2126(94)00094-8; King BA, 2000, J PHYS CHEM B, V104, P8895, DOI 10.1021/jp001745u; Lee H, 2007, SCIENCE, V316, P1462, DOI 10.1126/science.1142188; Mukamel S., 1995, PRINCIPLES NONLINEAR, V1st; Parson W. W., 2006, MODERN OPTICAL SPECT; Stanley RJ, 1996, J PHYS CHEM-US, V100, P12052, DOI 10.1021/jp9614916; Vos MH, 1997, J PHYS CHEM B, V101, P9820, DOI 10.1021/jp971486h; VOS MH, 1993, NATURE, V363, P320, DOI 10.1038/363320a0; VOS MH, 1994, P NATL ACAD SCI USA, V91, P12701, DOI 10.1073/pnas.91.26.12701; Wang HY, 2007, SCIENCE, V316, P747, DOI 10.1126/science.1140030	11	15	15	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 8	2007	316	5830					1438	1439		10.1126/science.1143907	http://dx.doi.org/10.1126/science.1143907			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176EE	17556574				2022-12-28	WOS:000247066400029
J	Prusinkiewicz, P; Erasmus, Y; Lane, B; Harder, LD; Coen, E				Prusinkiewicz, Przemyslaw; Erasmus, Yvette; Lane, Brendan; Harder, Lawrence D.; Coen, Enrico			Evolution and development of inflorescence architectures	SCIENCE			English	Article							REPRODUCTIVE GROWTH; ANNUAL PLANTS; ARABIDOPSIS; ENVIRONMENTS; INITIATION; IDENTITY	To understand the constraints on biological diversity, we analyzed how selection and development interact to control the evolution of inflorescences, the branching structures that bear flowers. We show that a single developmental model accounts for the restricted range of inflorescence types observed in nature and that this model is supported by molecular genetic studies. The model predicts associations between inflorescence architecture, climate, and life history, which we validated empirically. Paths, or evolutionary wormholes, link different architectures in a multidimensional fitness space, but the rate of evolution along these paths is constrained by genetic and environmental factors, which explains why some evolutionary transitions are rare between closely related plant taxa.	John Innes Ctr, Dept Cell & Dev Biol, Norwich NR4 7UH, Norfolk, England; Univ Calgary, Dept Comp Sci, Calgary, AB T2N 1N4, Canada; Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of Calgary; University of Calgary	Coen, E (corresponding author), John Innes Ctr, Dept Cell & Dev Biol, Colney Lane, Norwich NR4 7UH, Norfolk, England.	enrico.coen@bbsrc.ac.uk	Harder, Lawrence/H-9715-2012; Wilson, Yvette/C-2115-2011	Harder, Lawrence/0000-0002-2303-5076; 				BARTHELEMY D, 1991, ACTA BIOTHEOR, V39, P309, DOI 10.1007/BF00114184; BIAZQUEZ MA, 1997, DEVELOPMENT, V124, P3835; Bradley D, 1997, SCIENCE, V275, P80, DOI 10.1126/science.275.5296.80; COHEN D, 1966, J THEOR BIOL, V12, P119, DOI 10.1016/0022-5193(66)90188-3; ERICKSON RO, 1957, AM J BOT, V44, P297, DOI 10.2307/2438380; Etherington I.M.H., 1939, P R SOC EDINBURGH, V59, P153; GATSUK LE, 1980, J ECOL, V68, P675, DOI 10.2307/2259429; Gavrilets S., 2004, MONOGRAPHS POPULATIO; HACCOU P, 1995, THEOR POPUL BIOL, V47, P212, DOI 10.1006/tpbi.1995.1009; Hopper KR, 2003, OIKOS, V101, P219, DOI 10.1034/j.1600-0706.2003.12051.x; Keller T, 2006, PLANT CELL, V18, P598, DOI 10.1105/tpc.105.038588; Kellogg EA., 2000, MONOCOTS SYSTEMATICS, P84, DOI DOI 10.1016/J.YMPEV.2012.02.005; KING D, 1982, THEOR POPUL BIOL, V21, P194, DOI 10.1016/0040-5809(82)90013-2; KING D, 1982, THEOR POPUL BIOL, V22, P1, DOI 10.1016/0040-5809(82)90032-6; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; Long J, 2000, DEV BIOL, V218, P341, DOI 10.1006/dbio.1999.9572; NIKIAS KJ, 1997, EVOLUTIONARY BIOL PL; PARRY F, 2002, DEVELOPMENT, V129, P2519; PRUSINKIEWICZ P, 1990, ALGORITHMIC BEAUTY P; RAFF RA, 1966, SHAPE LIFE; Ratcliffe OJ, 1998, DEVELOPMENT, V125, P1609; Ratcliffe OJ, 1999, DEVELOPMENT, V126, P1109; Raup D. M., 1967, Journal of Paleontology, V41, P43; RAUP DM, 1965, SCIENCE, V147, P1294, DOI 10.1126/science.147.3663.1294; Sachs T, 1999, PLANT CELL ENVIRON, V22, P757, DOI 10.1046/j.1365-3040.1999.00220.x; SCHULTZ EA, 1993, DEVELOPMENT, V119, P745; SHANNON S, 1991, PLANT CELL, V3, P877, DOI 10.1105/tpc.3.9.877; Simpson GG, 2002, SCIENCE, V296, P285, DOI 10.1126/science.296.5566.285; SMITH JM, 1985, Q REV BIOL, V60, P265, DOI 10.1086/414425; Troll W., 1969, INFLORESZENZEN, VII-1; Troll W., 1964, INFLORESZENZEN, VI; Watson L., 2006, FAMILIES FLOWERING P; Weberling F., 1992, MORPHOLOGY FLOWERS I; WEIGEL D, 1992, CELL, V69, P843, DOI 10.1016/0092-8674(92)90295-N; Whibley AC, 2006, SCIENCE, V313, P963, DOI 10.1126/science.1129161; [No title captured]	36	266	274	1	86	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 8	2007	316	5830					1452	1456		10.1126/science.1140429	http://dx.doi.org/10.1126/science.1140429			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176EE	17525303				2022-12-28	WOS:000247066400035
J	Babu, V				Babu, Varsha			Images in clinical medicine: Chronic calcific pancreatitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Govt Primary Hlth Care, Thiruvaniyoor, Kerala, India		Babu, V (corresponding author), Govt Primary Hlth Care, Thiruvaniyoor, Kerala, India.	varshababu@gmail.com							0	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 7	2007	356	23					E24	E24		10.1056/NEJMicm062300	http://dx.doi.org/10.1056/NEJMicm062300			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	175QY	17554113				2022-12-28	WOS:000247029300011
J	Sridhar, VV; Kapoor, A; Zhang, KL; Zhu, JJ; Zhou, T; Hasegawa, PM; Bressan, RA; Zhu, JK				Sridhar, Vaniyambadi V.; Kapoor, Avnish; Zhang, Kangling; Zhu, Jianjun; Zhou, Tao; Hasegawa, Paul M.; Bressan, Ray A.; Zhu, Jian-Kang			Control of DNA methylation and heterochromatic silencing by histone H2B deubiquitination	NATURE			English	Article							ARABIDOPSIS-THALIANA; GLYCOSYLASE/LYASE ROS1; H3 METHYLTRANSFERASE; UBIQUITINATION; PLANTS; CHROMATIN; PATHWAYS; PATTERNS; CLONING	Epigenetic regulation involves reversible changes in DNA-methylation and/or histone modification patterns(1-7). Short interfering RNAs ( siRNAs) can direct DNA methylation and heterochromatic histone modifications, causing sequence-specific transcriptional gene silencing(1,4,8,9). In animals and yeast, histone H2B is known to be monoubiquitinated, and this regulates the methylation of histone H3 ( refs 10, 11). However, the relationship between histone ubiquitination and DNA methylation has not been investigated. Here we show that mutations in an Arabidopsis deubiquitination enzyme, SUP32/UBP26, decrease the dimethylation on lysine 9 of H3, suppress siRNA-directed methylation of DNA and release heterochromatic silencing of transgenes as well as transposons. We found that Arabidopsis histone H2B is monoubiquitinated at lysine 143 and that the levels of ubiquitinated H2B and trimethyl H3 at lysine 4 increase in sup32 mutant plants. SUP32/UBP26 can deubiquitinate H2B, and chromatin immunoprecipitation assays suggest an association between H2B ubiquitination and release of silencing. These data suggest that H2B deubiquitination by SUP32/UBP26 is required for heterochromatic histone H3 methylation and DNA methylation.	Univ Calif Riverside, Ctr Plant Cell Biol, Riverside, CA 92521 USA; Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA; Univ Calif Riverside, Mass Spectrometry Facil, Dept Chem, Riverside, CA 92521 USA; Purdue Univ, Dept Hort & Landscape Architecture, W Lafayette, IN 47907 USA	University of California System; University of California Riverside; University of California System; University of California Riverside; University of California System; University of California Riverside; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Zhu, JK (corresponding author), Univ Calif Riverside, Ctr Plant Cell Biol, Riverside, CA 92521 USA.	jian-kang.zhu@ucr.edu	Zhu, Jian-Kang/F-7658-2011; Hu, Ruogu/B-2203-2008; Grieshaber-Bouyer, Ricardo/R-7512-2016	Zhu, Jian-Kang/0000-0001-5134-731X; Grieshaber-Bouyer, Ricardo/0000-0002-2873-5135				Agius F, 2006, P NATL ACAD SCI USA, V103, P11796, DOI 10.1073/pnas.0603563103; Bastow R, 2004, NATURE, V427, P164, DOI 10.1038/nature02269; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Chan SWL, 2005, NAT REV GENET, V6, P351, DOI 10.1038/nrg1601; Chinnusamy V., 2002, SCI STKE, V140, pPL10; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Gardner RG, 2005, MOL CELL BIOL, V25, P6123, DOI 10.1128/MCB.25.14.6123-6139.2005; Gendrel AV, 2002, SCIENCE, V297, P1871, DOI 10.1126/science.1074950; Gong ZH, 2002, CELL, V111, P803, DOI 10.1016/S0092-8674(02)01133-9; Grewal SIS, 2003, SCIENCE, V301, P798, DOI 10.1126/science.1086887; He YH, 2005, TRENDS PLANT SCI, V10, P30, DOI 10.1016/j.tplants.2004.11.003; Henry KW, 2003, GENE DEV, V17, P2648, DOI 10.1101/gad.1144003; Ishitani M, 1997, PLANT CELL, V9, P1935, DOI 10.1105/tpc.9.11.1935; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Kapoor A, 2005, CURR BIOL, V15, P1912, DOI 10.1016/j.cub.2005.09.013; LIU YG, 1995, PLANT J, V8, P457, DOI 10.1046/j.1365-313X.1995.08030457.x; Martienssen RA, 2001, SCIENCE, V293, P1070, DOI 10.1126/science.293.5532.1070; Matzke MA, 2005, NAT REV GENET, V6, P24, DOI 10.1038/nrg1500; Ng HH, 2002, J BIOL CHEM, V277, P34655, DOI 10.1074/jbc.C200433200; Rao-Naik C, 2000, ARCH BIOCHEM BIOPHYS, V379, P198, DOI 10.1006/abbi.2000.1874; Richards EJ, 2002, CELL, V108, P489, DOI 10.1016/S0092-8674(02)00644-X; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Tamaru H, 2001, NATURE, V414, P277, DOI 10.1038/35104508; Tariq M, 2004, TRENDS GENET, V20, P244, DOI 10.1016/j.tig.2004.04.005; WATERBORG JH, 1987, ARCH BIOCHEM BIOPHYS, V256, P167, DOI 10.1016/0003-9861(87)90435-8; Yan N, 2000, PLANT PHYSIOL, V124, P1828, DOI 10.1104/pp.124.4.1828; Zhang Y, 2003, GENE DEV, V17, P2733, DOI 10.1101/gad.1156403; Zhu JH, 2007, CURR BIOL, V17, P54, DOI 10.1016/j.cub.2006.10.059	28	184	219	2	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 7	2007	447	7145					735	U18		10.1038/nature05864	http://dx.doi.org/10.1038/nature05864			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175RI	17554311				2022-12-28	WOS:000247030700048
J	Giraud, E; Moulin, L; Vallenet, D; Barbe, V; Cytryn, E; Avarre, JC; Jaubert, M; Simon, D; Cartieaux, F; Prin, Y; Bena, G; Hannibal, L; Fardoux, J; Kojadinovic, M; Vuillet, L; Lajus, A; Cruveiller, S; Rouy, Z; Mangenot, S; Segurens, B; Dossat, C; Franck, WL; Chang, WS; Saunders, E; Bruce, D; Richardson, P; Normand, P; Dreyfus, B; Pignol, D; Stacey, G; Emerich, D; Vermeglio, A; Medigue, C; Sadowsky, M				Giraud, Eric; Moulin, Lionel; Vallenet, David; Barbe, Valerie; Cytryn, Eddie; Avarre, Jean-Christophe; Jaubert, Marianne; Simon, Damien; Cartieaux, Fabienne; Prin, Yves; Bena, Gilles; Hannibal, Laure; Fardoux, Joel; Kojadinovic, Mila; Vuillet, Laurie; Lajus, Aurelie; Cruveiller, Stephane; Rouy, Zoe; Mangenot, Sophie; Segurens, Beatrice; Dossat, Carole; Franck, William L.; Chang, Woo-Suk; Saunders, Elizabeth; Bruce, David; Richardson, Paul; Normand, Philippe; Dreyfus, Bernard; Pignol, David; Stacey, Gary; Emerich, David; Vermeglio, Andre; Medigue, Claudine; Sadowsky, Michael			Legumes symbioses: Absence of Nod genes in photosynthetic bradyrhizobia	SCIENCE			English	Article							RHIZOBIUM-LEGUMINOSARUM; SINORHIZOBIUM-MELILOTI; ROOT-NODULE; MOLECULAR-BASIS; NODULATION; JAPONICUM; GENOME; BACTERIA; AUXOTROPHS; SEQUENCE	Leguminous plants ( such as peas and soybeans) and rhizobial soil bacteria are symbiotic partners that communicate through molecular signaling pathways, resulting in the formation of nodules on legume roots and occasionally stems that house nitrogen-fixing bacteria. Nodule formation has been assumed to be exclusively initiated by the binding of bacterial, host-specific lipochito-oligosaccharidic Nod factors, encoded by the nodABC genes, to kinase-like receptors of the plant. Here we show by complete genome sequencing of two symbiotic, photosynthetic, Bradyrhizobium strains, BTAi1 and ORS278, that canonical nodABC genes and typical lipochito-oligosaccharidic Nod factors are not required for symbiosis in some legumes. Mutational analyses indicated that these unique rhizobia use an alternative pathway to initiate symbioses, where a purine derivative may play a key role in triggering nodule formation.	Univ Montpellier 2, INRA,AGRO Montpellier, Inst Rech Dev,Ctr Cooperat Int Rech Agron Dev, Lab Symbioses Trop & Mediterraneennes,UMR 113, F-34398 Montpellier 5, France; Genoscope, CNRS, UMR 8030, F-91057 Evry, France; Genoscope, Ctr Natl Sequencage, F-91057 Evry, France; Univ Minnesota, Dept Soil Water & Climate, St Paul, MN 55108 USA; Univ Minnesota, Inst Biotechnol, St Paul, MN 55108 USA; Univ Minnesota, Microbial & Plant Genom Inst, St Paul, MN 55108 USA; Univ Aix Marseille, CNRS,UMR 6191,CEA Cadarache,Direct Sci Vivant, Inst Biol Environm & Biotechnol,Serv Biol Vegetal, Lab Bioenerget Cellulaire DSV IBEB SBVME LBC, F-13108 St Paul Les Durance, France; Univ Missouri, Natl Ctr Soybean Biotechnol, Div Plant Sci, Dept Mol Microbiol & Immunol, Columbia, MO 65211 USA; Univ Missouri, Natl Ctr Soybean Biotechnol, Div Biochem, Dept Mol Microbiol & Immunol, Columbia, MO 65211 USA; Los Alamos Natl Lab, US DOE, Joint Genome Inst, Los Alamos, NM 87545 USA; DOE Joint Genome Inst, Walnut Creek, CA 94598 USA; Univ Lyon 1, CNRS, UMR 5557, F-69365 Lyon, France	CIRAD; INRAE; Institut Agro; Montpellier SupAgro; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA; CEA; UDICE-French Research Universities; Universite Paris Saclay; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); VetAgro Sup	Giraud, E (corresponding author), Univ Montpellier 2, INRA,AGRO Montpellier, Inst Rech Dev,Ctr Cooperat Int Rech Agron Dev, Lab Symbioses Trop & Mediterraneennes,UMR 113, TA A-82-J,Campus Baillarguet, F-34398 Montpellier 5, France.	giraud@mpl.ird.fr; sadowsky@umn.edu	Giraud, Eric/GLS-1036-2022; Moulin, Lionel/C-2921-2008; Normand, Philippe/ABD-2235-2020; Bena, Gilles/GOG-7902-2022; Normand, Philippe/A-1142-2012; Cartieaux, Fabienne/GNH-3617-2022; Sadowsky, Michael/J-2507-2016; Avarre, Jean-Christophe/E-4170-2019	Moulin, Lionel/0000-0001-9068-6912; Normand, Philippe/0000-0002-2139-2141; Bena, Gilles/0000-0003-3080-8441; Vallenet, David/0000-0001-6648-0332; Cartieaux, Fabienne/0000-0002-8992-0131; Sadowsky, Michael/0000-0001-8779-2781; Avarre, Jean-Christophe/0000-0001-6899-7052; PIGNOL, David/0000-0002-8070-0319				Barnett MJ, 2001, P NATL ACAD SCI USA, V98, P9883, DOI 10.1073/pnas.161294798; Boiero L, 2007, APPL MICROBIOL BIOT, V74, P874, DOI 10.1007/s00253-006-0731-9; Broughton WJ, 2000, J BACTERIOL, V182, P5641, DOI 10.1128/JB.182.20.5641-5652.2000; Chaintreuil C, 2001, FEMS MICROBIOL LETT, V194, P83, DOI 10.1111/j.1574-6968.2001.tb09450.x; Collavino M, 2005, MOL PLANT MICROBE IN, V18, P742, DOI 10.1094/MPMI-18-0742; COOPER JB, 1994, PLANT CELL, V6, P215, DOI 10.1105/tpc.6.2.215; COSTACURTA A, 1995, CRIT REV MICROBIOL, V21, P1, DOI 10.3109/10408419509113531; D'Haeze W, 2004, TRENDS MICROBIOL, V12, P555, DOI 10.1016/j.tim.2004.10.009; DENARIE J, COMMUNICATION; DENARIE J, 1975, SYMBIOTIC NITROGEN F, P47; Freiberg C, 1997, NATURE, V387, P394, DOI 10.1038/387394a0; Galibert F, 2001, SCIENCE, V293, P668, DOI 10.1126/science.1060966; Geurts R, 2005, CURR OPIN PLANT BIOL, V8, P346, DOI 10.1016/j.pbi.2005.05.013; Giraud E, 2004, PHOTOSYNTH RES, V82, P115, DOI 10.1007/s11120-004-1768-1; Giraud E, 2000, P NATL ACAD SCI USA, V97, P14795, DOI 10.1073/pnas.250484097; Gonzalez V, 2006, P NATL ACAD SCI USA, V103, P3834, DOI 10.1073/pnas.0508502103; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; Kaneko T, 2000, DNA RES, V7, P331, DOI 10.1093/dnares/7.6.331; Kaneko T, 2002, DNA RES, V9, P189, DOI 10.1093/dnares/9.6.189; LEIGH JA, 1992, ANNU REV MICROBIOL, V46, P307, DOI 10.1146/annurev.mi.46.100192.001515; Lerouge I, 2002, FEMS MICROBIOL REV, V26, P17, DOI 10.1111/j.1574-6976.2002.tb00597.x; MEADE HM, 1982, J BACTERIOL, V149, P114, DOI 10.1128/JB.149.1.114-122.1982; Moulin L, 2001, NATURE, V411, P948, DOI 10.1038/35082070; Murray JD, 2007, SCIENCE, V315, P101, DOI 10.1126/science.1132514; NEWMAN JD, 1994, J BACTERIOL, V176, P3286, DOI 10.1128/jb.176.11.3286-3294.1994; NOEL KD, 1988, ARCH MICROBIOL, V149, P499, DOI 10.1007/BF00446751; PANKHURST CE, 1974, ARCH MICROBIOL, V100, P219, DOI 10.1007/BF00446319; Parniske M, 2003, NATURE, V425, P569, DOI 10.1038/425569a; Patriarca EJ, 2002, MICROBIOL MOL BIOL R, V66, P203, DOI 10.1128/MMBR.66.2.203-222.2002; Perret X, 2000, MICROBIOL MOL BIOL R, V64, P180, DOI 10.1128/MMBR.64.1.180-201.2000; Reeve WG, 1999, MICROBIOL-SGM, V145, P1307, DOI 10.1099/13500872-145-6-1307; ROCHE P, 1991, J BIOL CHEM, V266, P10933; SADOWSKY MJ, 1986, ARCH MICROBIOL, V144, P334, DOI 10.1007/BF00409881; Schluter A, 2000, MICROBIOL-SGM, V146, P2987, DOI 10.1099/00221287-146-11-2987; SO JS, 1987, MOL GEN GENET, V207, P15, DOI 10.1007/BF00331485; Stacey G, 2006, CURR OPIN PLANT BIOL, V9, P110, DOI 10.1016/j.pbi.2006.01.005; STURTEVANT DB, 1989, PLANT PHYSIOL, V89, P1247, DOI 10.1104/pp.89.4.1247; Tirichine L, 2007, SCIENCE, V315, P104, DOI 10.1126/science.1132397; Vallenet D, 2006, NUCLEIC ACIDS RES, V34, P53, DOI 10.1093/nar/gkj406; Young JPW, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r34; YOUNG JPW, 1991, J BACTERIOL, V173, P2271	41	430	1116	5	199	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 1	2007	316	5829					1307	1312		10.1126/science.1139548	http://dx.doi.org/10.1126/science.1139548			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173PS	17540897				2022-12-28	WOS:000246885600042
J	Kuang, SH; Kuroda, K; Le Grand, F; Rudnicki, MA				Kuang, Shihuan; Kuroda, Kazuki; Le Grand, Fabien; Rudnicki, Michael A.			Asymmetric self-renewal and commitment of satellite stem cells in muscle	CELL			English	Article							SKELETAL-MUSCLE; MYOGENIC SPECIFICATION; PROGENITOR CELLS; SOMITIC ORIGIN; M-CADHERIN; EXPRESSION; MYOBLASTS; POPULATION; NUMB; DIFFERENTIATION	Satellite cells play a central role in mediating the growth and regeneration of skeletal muscle. However, whether satellite cells are stem cells, committed progenitors, or dedifferentiated myoblasts has remained unclear. Using Myf5Cre and ROSA26-YFP Cre-reporter alleles, we observed that in vivo 10% of sublaminar Pax7-expressing satellite cells have never expressed Myf5. Moreover, we found that Pax7(+)/ Myf5(-) satellite cells gave rise to Pax7(+)/Myf5(+) satellite cells through apical-basal oriented divisions that asymmetrically generated a basal Pax7(+)/Myf5(-) and an apical Pax7(+)/Myf5(+) cells. Prospective isolation and transplantation into muscle revealed that whereas Pax7(+)/Myf5(+) cells exhibited precocious differentiation, Pax7(+)/ Myf5(-) cells extensively contributed to the satellite cell reservoir throughout the injected muscle. Therefore, we conclude that satellite cells are a heterogeneous population composed of stem cells and committed progenitors. These results provide critical insights into satellite cell biology and open new avenues for therapeutic treatment of neuromuscular diseases.	Sprott Ctr Stem Cell Res, Ottawa Hlth Res Inst, Program Mol Med, Ottawa, ON K1H 8L6, Canada; Univ Ottawa, Dept Med, Ottawa, ON K1H 8L6, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa	Rudnicki, MA (corresponding author), Sprott Ctr Stem Cell Res, Ottawa Hlth Res Inst, Program Mol Med, 501 Smyth Rd, Ottawa, ON K1H 8L6, Canada.	mrudnicki@ohri.ca	Le Grand, Fabien/D-8803-2019	Le Grand, Fabien/0000-0002-7843-3899; Kuang, Shihuan/0000-0001-9180-3180; Rudnicki, Michael/0000-0002-3866-5249	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044031] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR044031-11, R01 AR044031] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ARMAND O, 1983, ARCH ANAT MICROSC MO, V72, P163; Asakura A, 2002, J CELL BIOL, V159, P123, DOI 10.1083/jcb.200202092; Beauchamp JR, 2000, J CELL BIOL, V151, P1221, DOI 10.1083/jcb.151.6.1221; Beauchamp JR, 1999, J CELL BIOL, V144, P1113, DOI 10.1083/jcb.144.6.1113; Ben-Yair R, 2005, DEVELOPMENT, V132, P689, DOI 10.1242/dev.01617; Betschinger J, 2003, NATURE, V422, P326, DOI 10.1038/nature01486; Betschinger J, 2004, CURR BIOL, V14, pR674, DOI 10.1016/j.cub.2004.08.017; Bischoff R., 1994, MYOLOGY, VVolume 1, P97; Blanco-Bose WE, 2001, EXP CELL RES, V265, P212, DOI 10.1006/excr.2001.5191; BORNEMANN A, 1994, ANAT REC, V239, P119, DOI 10.1002/ar.1092390202; Burkin DJ, 1999, CELL TISSUE RES, V296, P183, DOI 10.1007/s004410051279; Carmena A, 1998, GENE DEV, V12, P304, DOI 10.1101/gad.12.3.304; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; COLLO G, 1993, J BIOL CHEM, V268, P19019; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Cousins JC, 2004, J CELL SCI, V117, P3259, DOI 10.1242/jcs.01161; De Angelis L, 1999, J CELL BIOL, V147, P869, DOI 10.1083/jcb.147.4.869; Delfini MC, 2000, DEVELOPMENT, V127, P5213; El Fahime E, 2003, BIOCHEM CELL BIOL, V81, P81, DOI 10.1139/O03-054; Fan Y, 1996, MUSCLE NERVE, V19, P853, DOI 10.1002/(SICI)1097-4598(199607)19:7<853::AID-MUS7>3.0.CO;2-8; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Gros J, 2005, NATURE, V435, P954, DOI 10.1038/nature03572; Heslop L, 2001, GENE THER, V8, P778, DOI 10.1038/sj.gt.3301463; Heslop L, 2000, J CELL SCI, V113, P2299; Hodgetts SI, 2000, CELL TRANSPLANT, V9, P489, DOI 10.1177/096368970000900406; Holowacz T, 2006, DEV DYNAM, V235, P633, DOI 10.1002/dvdy.20672; IRINTCHEV A, 1994, DEV DYNAM, V199, P326, DOI 10.1002/aja.1001990407; Kassar-Duchossoy L, 2005, GENE DEV, V19, P1426, DOI 10.1101/gad.345505; KNOBLICH JA, 1995, NATURE, V377, P624, DOI 10.1038/377624a0; KNOBLICH JA, 2001, S SOC EXP BIOL, V53, P75; Kuang S, 2006, J CELL BIOL, V172, P103, DOI 10.1083/jcb.200508001; Kuroda K, 1999, J BIOL CHEM, V274, P7238, DOI 10.1074/jbc.274.11.7238; LaBarge MA, 2002, CELL, V111, P589, DOI 10.1016/S0092-8674(02)01078-4; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; McKinnell IW, 2005, CURR TOP DEV BIOL, V71, P113, DOI 10.1016/S0070-2153(05)71004-8; Megeney LA, 1996, GENE DEV, V10, P1173, DOI 10.1101/gad.10.10.1173; Minoguchi S, 1997, MOL CELL BIOL, V17, P2679, DOI 10.1128/MCB.17.5.2679; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Polesskaya A, 2003, CELL, V113, P841, DOI 10.1016/S0092-8674(03)00437-9; Qu ZQ, 1998, J CELL BIOL, V142, P1257, DOI 10.1083/jcb.142.5.1257; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; Relaix F, 2005, NATURE, V435, P948, DOI 10.1038/nature03594; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; ROSENBLATT JD, 1995, IN VITRO CELL DEV-AN, V31, P773; Schienda J, 2006, P NATL ACAD SCI USA, V103, P945, DOI 10.1073/pnas.0510164103; Schultz E, 1996, DEV BIOL, V175, P84, DOI 10.1006/dbio.1996.0097; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Shinin V, 2006, NAT CELL BIOL, V8, P677, DOI 10.1038/ncb1425; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Tajbakhsh S, 1996, NATURE, V384, P266, DOI 10.1038/384266a0; Tallquist MD, 2000, DEVELOPMENT, V127, P5059; Venters S, 2005, ANAT EMBRYOL, V209, P449, DOI 10.1007/s00429-005-0461-2; Yablonka-Reuveni Z, 2006, DEV DYNAM, V235, P203, DOI 10.1002/dvdy.20602	54	901	934	5	101	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 1	2007	129	5					999	1010		10.1016/j.cell.2007.03.044	http://dx.doi.org/10.1016/j.cell.2007.03.044			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	176KT	17540178	Bronze, Green Accepted			2022-12-28	WOS:000247084600018
J	Trojer, P; Li, G; Sims, RJ; Vaquero, A; Kalakonda, N; Boccuni, P; Lee, D; Erdjument-Bromage, H; Tempst, P; Nimer, SD; Wang, YH; Reinberg, D				Trojer, Patrick; Li, Guohong; Sims, Robert J., III; Vaquero, Alejandro; Kalakonda, Nagesh; Boccuni, Piernicola; Lee, Donghoon; Erdjument-Bromage, Hediye; Tempst, Paul; Nimer, Stephen D.; Wang, Yuh-Hwa; Reinberg, Danny			L3MBTL1, a histone-methylation-dependent chromatin lock	CELL			English	Article							POLYCOMB GROUP PROTEIN; RNA POLYMERASE-II; LYSINE METHYLATION; TRANSCRIPTIONAL REPRESSOR; MAMMALIAN NUCLEI; MOLECULAR-BASIS; HP1 BINDING; PHD FINGER; IN-VITRO; H3 TAIL	Distinct histone lysine methylation marks are involved in transcriptional repression linked to the formation and maintenance of facultative heterochromatin, although the underlying mechanisms remain unclear. We demonstrate that the malignant-brain-tumor (MBT) protein L3MBTL1 is in a complex with core histones, histone H1b, HP1 gamma, and Rb. The MBT domain is structurally related to protein domains that directly bind methylated histone residues. Consistent with this, we found that the L3MBTL1 MBT domains compact nucleosomal arrays dependent on mono- and dimethylation of histone H4 lysine 20 and of histone H1b lysine 26. The MBT domains bind at least two nuclecisomes simultaneously, linking repression of transcription to recognition of different histone marks by L3MBTL1. Consistently, L3MBTL1 was found to negatively regulate the expression of a subset of genes regulated by E2F, a factor that interacts with Rb.	CSIC IRB, IBMB, Barcelona 08028, Spain; Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Div Nucl Acids Enzymol, Howard Hughes Med Inst, Piscataway, NJ 08854 USA; Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Div Nucl Acids Enzymol, Dept Biochem, Piscataway, NJ 08854 USA; NYU, Sch Med, Dept Biochem, New York, NY 10016 USA; Sloan Kettering Inst Canc Res, Lab Mol Aspects Hemaopoiesis, New York, NY 10021 USA; Sloan Kettering Inst Canc Res, Prot Ctr, New York, NY 10021 USA; Sloan Kettering Inst Canc Res, Mol Biol Program, New York, NY 10021 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); Howard Hughes Medical Institute; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; New York University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Reinberg, D (corresponding author), ICREA, Parc Cientific Barcelona,Josep Samitier 1-5, Barcelona 08028, Spain.	reinbd01@med.nyu.edu	Vaquero, Alejandro/I-9845-2014; Vaquero, Alejandro/ABG-8634-2020	Vaquero, Alejandro/0000-0002-8735-4156; Tempst, Paul/0000-0002-6680-3987; Erdjument-Bromage, Hediye/0000-0003-0224-3594; Reinberg, Danny/0000-0003-4288-2016	NATIONAL CANCER INSTITUTE [R01CA102202, R01CA113863, R01CA085826] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM071166, R01GM064844] Funding Source: NIH RePORTER; NCI NIH HHS [CA085826, CA 102202, CA113863] Funding Source: Medline; NIGMS NIH HHS [GM-64844, GM-71166] Funding Source: Medline; ICREA Funding Source: Custom	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); ICREA(ICREA)		[Anonymous], 2003, EAU UPDATE; Bednar J, 1998, P NATL ACAD SCI USA, V95, P14173, DOI 10.1073/pnas.95.24.14173; BEDNAR J, 1995, J CELL BIOL, V131, P1365, DOI 10.1083/jcb.131.6.1365; Boccuni P, 2003, J BIOL CHEM, V278, P15412, DOI 10.1074/jbc.M300592200; Cheung E, 2002, MOL CELL BIOL, V22, P2463, DOI 10.1128/MCB.22.8.2463-2471.2002; CROSTON GE, 1991, SCIENCE, V251, P643, DOI 10.1126/science.1899487; Daujat S, 2005, J BIOL CHEM, V280, P38090, DOI 10.1074/jbc.C500229200; Devroe E, 2004, J BIOL CHEM, V279, P24444, DOI 10.1074/jbc.M401999200; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dou YL, 1999, MOL CELL, V4, P641, DOI 10.1016/S1097-2765(00)80215-4; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Flanagan JF, 2005, NATURE, V438, P1181, DOI 10.1038/nature04290; Francis NJ, 2004, SCIENCE, V306, P1574, DOI 10.1126/science.1100576; GRIFFITH JD, 1978, ANNU REV BIOPHYS BIO, V7, P19, DOI 10.1146/annurev.bb.07.060178.000315; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Huang Y, 2006, SCIENCE, V312, P748, DOI 10.1126/science.1125162; Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473; Jacobs SA, 2001, EMBO J, V20, P5232, DOI 10.1093/emboj/20.18.5232; Kim J, 2006, EMBO REP, V7, P397, DOI 10.1038/sj.embor.7400625; Kim MY, 2004, CELL, V119, P803, DOI 10.1016/j.cell.2004.11.002; Klymenko T, 2006, GENE DEV, V20, P1110, DOI 10.1101/gad.377406; Kuzmichev A, 2005, P NATL ACAD SCI USA, V102, P1859, DOI 10.1073/pnas.0409875102; Kuzmichev A, 2004, MOL CELL, V14, P183, DOI 10.1016/S1097-2765(04)00185-6; LAYBOURN PJ, 1991, SCIENCE, V254, P238, DOI 10.1126/science.1718039; Lever MA, 2000, NATURE, V408, P873, DOI 10.1038/35048603; Lewis BA, 2005, MOL CELL, V18, P471, DOI 10.1016/j.molcel.2005.04.005; Lewis PW, 2004, GENE DEV, V18, P2929, DOI 10.1101/gad.1255204; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Loyola A, 2001, GENE DEV, V15, P2837; MacGrogan D, 2001, ONCOGENE, V20, P4150, DOI 10.1038/sj.onc.1204540; Maison C, 2002, NAT GENET, V30, P329, DOI 10.1038/ng843; Meehan RR, 2003, EMBO J, V22, P3164, DOI 10.1093/emboj/cdg306; Minc E, 2000, CYTOGENET CELL GENET, V90, P279, DOI 10.1159/000056789; Misteli T, 2000, NATURE, V408, P877, DOI 10.1038/35048610; Nielsen PR, 2002, NATURE, V416, P103, DOI 10.1038/nature722; Nielsen SJ, 2001, NATURE, V412, P561, DOI 10.1038/35087620; Nilsson JA, 2003, ONCOGENE, V22, P9007, DOI 10.1038/sj.onc.1207261; Nishioka K, 2002, MOL CELL, V9, P1201, DOI 10.1016/S1097-2765(02)00548-8; Nishioka K, 2003, METHODS, V31, P49, DOI 10.1016/S1046-2023(03)00087-2; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; Parseghian MH, 2001, BIOCHEM CELL BIOL, V79, P289; Patnaik D, 2004, J BIOL CHEM, V279, P53248, DOI 10.1074/jbc.M409604200; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; Sato MH, 1999, FEBS LETT, V452, P267, DOI 10.1016/S0014-5793(99)00644-4; Schotta G, 2002, EMBO J, V21, P1121, DOI 10.1093/emboj/21.5.1121; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Sims RJ, 2005, J BIOL CHEM, V280, P41789, DOI 10.1074/jbc.C500395200; Sims RJ, 2003, TRENDS GENET, V19, P629, DOI 10.1016/j.tig.2003.09.007; Sims RJ, 2006, METHODS, V40, P331, DOI 10.1016/j.ymeth.2006.07.031; Springhetti EM, 2003, J BIOL CHEM, V278, P43384, DOI 10.1074/jbc.M307635200; Tachibana M, 2001, J BIOL CHEM, V276, P25309, DOI 10.1074/jbc.M101914200; van Holde K, 2006, J BIOL CHEM, V281, P12197, DOI 10.1074/jbc.R500025200; VANHOLDE KE, 1989, CHROMATIN, V1; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; Wang WK, 2003, STRUCTURE, V11, P775, DOI 10.1016/S0969-2126(03)00127-8; WISMAR J, 1995, MECH DEVELOP, V53, P141, DOI 10.1016/0925-4773(95)00431-9; Wolffe AP, 1997, INT J BIOCHEM CELL B, V29, P1463, DOI 10.1016/S1357-2725(97)00026-5; WOLLFE A, 1998, CHROMATIN STRUCTURE; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Yohn CB, 2003, GENETICS, V165, P1889; Zhao T, 2000, J BIOL CHEM, V275, P28332; Zufferey R, 1998, J VIROL, V72, P9873, DOI 10.1128/JVI.72.12.9873-9880.1998	62	266	272	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 1	2007	129	5					915	928		10.1016/j.cell.2007.03.048	http://dx.doi.org/10.1016/j.cell.2007.03.048			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	176KT	17540172	Bronze			2022-12-28	WOS:000247084600012
J	Alford, RA; Bradfield, KS; Richards, SJ				Alford, Ross A.; Bradfield, Kay S.; Richards, Stephen J.			Ecology - Global warming and amphibian losses	NATURE			English	Letter							EPIDEMIC DISEASE; CATASTROPHIC DECLINE; POPULATION; STRESS		James Cook Univ N Queensland, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia	James Cook University	Alford, RA (corresponding author), James Cook Univ N Queensland, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia.	ross.alford@jcu.edu.au	Alford, Ross A/H-1577-2011	Alford, Ross A/0000-0002-3010-6768; Bradfield, Kay/0000-0002-2447-3596				Alford R. A., 1999, DECLINES DISAPPEARAN, P34; Alford RA, 1997, CONSERV BIOL, V11, P1026, DOI 10.1046/j.1523-1739.1997.96403.x; Bosch J, 2007, P ROY SOC B-BIOL SCI, V274, P253, DOI 10.1098/rspb.2006.3713; Burgin Shelley, 2005, Acta Zoologica Sinica, V51, P344; Dongen SV, 2006, J EVOLUTION BIOL, V19, P1727, DOI 10.1111/j.1420-9101.2006.01175.x; Kiesecker JM, 2001, NATURE, V410, P681, DOI 10.1038/35070552; Laurance WF, 1996, BIOL CONSERV, V77, P203, DOI 10.1016/0006-3207(95)00142-5; Laurance WF, 1996, CONSERV BIOL, V10, P406, DOI 10.1046/j.1523-1739.1996.10020406.x; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; Parris MJ, 2004, ECOLOGY, V85, P3385, DOI 10.1890/04-0383; Pounds JA, 2006, SCIENCE, V314, P1541, DOI 10.1126/science.314.5805.1541; Pounds JA, 2006, NATURE, V439, P161, DOI 10.1038/nature04246; Reading CJ, 2007, OECOLOGIA, V151, P125, DOI 10.1007/s00442-006-0558-1; Richards SJ, 2005, AUST J ZOOL, V53, P229, DOI 10.1071/ZO03036; Soderman F, 2007, OECOLOGIA, V151, P593, DOI 10.1007/s00442-006-0611-0	15	84	92	4	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 31	2007	447	7144					E3	E4		10.1038/nature05940	http://dx.doi.org/10.1038/nature05940			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172YZ	17538571	Green Accepted			2022-12-28	WOS:000246842000035
J	Hell, SW				Hell, Stefan W.			Far-field optical nanoscopy	SCIENCE			English	Review							FLUORESCENCE MICROSCOPY; STIMULATED-EMISSION; LATERAL RESOLUTION; LIGHT-MICROSCOPY; AXIAL RESOLUTION; IMPROVEMENT; EXCITATION; BREAKING; LIMIT; LOCALIZATION	In 1873, Ernst Abbe discovered what was to become a well-known paradigm: the inability of a lens-based optical microscope to discern details that are closer together than half of the wavelength of light. However, for its most popular imaging mode, fluorescence microscopy, the diffraction barrier is crumbling. Here, I discuss the physical concepts that have pushed fluorescence microscopy to the nanoscale, once the prerogative of electron and scanning probe microscopes. Initial applications indicate that emergent far-field optical nanoscopy will have a strong impact in the life sciences and in other areas benefiting from nanoscale visualization.	Max Planck Inst Biophys Chem, Dept Nanobiophoton, D-37070 Gottingen, Germany; Deutsch Krebsforschungszentrum, German Canc Res Ctr, High Resolut Opt Microscopy Div, D-69120 Heidelberg, Germany	Max Planck Society; Helmholtz Association; German Cancer Research Center (DKFZ)	Hell, SW (corresponding author), Max Planck Inst Biophys Chem, Dept Nanobiophoton, D-37070 Gottingen, Germany.	shell@gwdg.de						Ando R, 2004, SCIENCE, V306, P1370, DOI 10.1126/science.1102506; BAILEY B, 1993, NATURE, V366, P44, DOI 10.1038/366044a0; BETZIG E, 1995, OPT LETT, V20, P237, DOI 10.1364/OL.20.000237; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Bewersdorf J, 2006, P NATL ACAD SCI USA, V103, P18137, DOI 10.1073/pnas.0608709103; Born M., 2002, PRINCIPLES OPTICS; Bossi M, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/11/275; Boyer D, 2002, SCIENCE, V297, P1160, DOI 10.1126/science.1073765; BRETSCHNEIDER S, COMMUNICATION; CREMER C, 1978, MICROSC ACTA, V81, P31; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; DIFRANCIA GT, 1952, NUOVO CIMENTO SUPPL, V9, P426; Donnert G, 2007, BIOPHYS J, V92, pL67, DOI 10.1529/biophysj.107.104497; Donnert G, 2006, P NATL ACAD SCI USA, V103, P11440, DOI 10.1073/pnas.0604965103; Dyba M, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.163901; Egner A, 2005, TRENDS CELL BIOL, V15, P207, DOI 10.1016/j.tcb.2005.02.003; Enderlein J, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2034116; Gugel H, 2004, BIOPHYS J, V87, P4146, DOI 10.1529/biophysj.104.045815; Gustafsson MGL, 1999, J MICROSC-OXFORD, V195, P10, DOI 10.1046/j.1365-2818.1999.00576.x; GUSTAFSSON MGL, 1995, P SOC PHOTO-OPT INS, V2412, P147, DOI 10.1117/12.205334; Gustafsson MGL, 2000, J MICROSC-OXFORD, V198, P82, DOI 10.1046/j.1365-2818.2000.00710.x; Gustafsson MGL, 2005, P NATL ACAD SCI USA, V102, P13081, DOI 10.1073/pnas.0406877102; Heintzmann R, 2002, J OPT SOC AM A, V19, P1599, DOI 10.1364/JOSAA.19.001599; HELL S, 1992, OPT COMMUN, V93, P277, DOI 10.1016/0030-4018(92)90185-T; Hell S. W., 1995, Bioimaging, V3, P64, DOI 10.1002/1361-6374(199506)3:2<64::AID-BIO2>3.3.CO;2-F; Hell SW, 2004, PHYS LETT A, V326, P140, DOI 10.1016/j.physleta.2004.03.082; Hell SW, 2003, NAT BIOTECHNOL, V21, P1347, DOI 10.1038/nbt895; Hell SW, 2003, APPL PHYS A-MATER, V77, P859, DOI 10.1007/s00339-003-2292-4; HELL SW, 1995, APPL PHYS B-LASERS O, V60, P495, DOI 10.1007/BF01081333; HELL SW, 1994, OPT LETT, V19, P780, DOI 10.1364/OL.19.000780; HELL SW, 1994, OPT COMMUN, V106, P19, DOI 10.1016/0030-4018(94)90050-7; HELL SW, 2006, SCI MICROSCOPY, P790; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Hofmann M, 2005, P NATL ACAD SCI USA, V102, P17565, DOI 10.1073/pnas.0506010102; Kastrup L, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.178104; Kellner RR, 2007, NEUROSCIENCE, V144, P135, DOI 10.1016/j.neuroscience.2006.08.071; Kittel RJ, 2006, SCIENCE, V312, P1051, DOI 10.1126/science.1126308; Klar TA, 2000, P NATL ACAD SCI USA, V97, P8206, DOI 10.1073/pnas.97.15.8206; Kural C, 2005, SCIENCE, V308, P1469, DOI 10.1126/science.1108408; LANG M, COMMUNICATION; Lang MC, 2007, OPT LETT, V32, P259, DOI 10.1364/OL.32.000259; LARIG M, 2007, OPT EXPRESS, V15, P2459; LETOKHOV VS, 1995, ULTRASFAST PROCESSES, P195; Lidke KA, 2005, OPT EXPRESS, V13, P7052, DOI 10.1364/OPEX.13.007052; Liu ZW, 2007, SCIENCE, V315, P1686, DOI 10.1126/science.1137368; Lukyanov KA, 2000, J BIOL CHEM, V275, P25879, DOI 10.1074/jbc.C000338200; Moerner WE, 2006, NAT METHODS, V3, P781, DOI 10.1038/nmeth1006-781; Novotny I., 2006, PRINCIPLES NANOOPTIC; Pawley J.B., 2006, HDB BIOL CONFOCAL MI, DOI [10.1007/978-0-387-45524-2_23, 10.1007/978-0-387-45524-2, DOI 10.1007/978-0-387-45524-2]; Pendry JB, 2000, PHYS REV LETT, V85, P3966, DOI 10.1103/PhysRevLett.85.3966; Podolskiy VA, 2005, OPT LETT, V30, P75, DOI 10.1364/OL.30.000075; Qu XH, 2004, P NATL ACAD SCI USA, V101, P11298, DOI 10.1073/pnas.0402155101; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Sharonov A, 2006, P NATL ACAD SCI USA, V103, P18911, DOI 10.1073/pnas.0609643104; Sieber JJ, 2006, BIOPHYS J, V90, P2843, DOI 10.1529/biophysj.105.079574; Smolyaninov II, 2007, SCIENCE, V315, P1699, DOI 10.1126/science.1138746; van Oijen AM, 1999, J OPT SOC AM A, V16, P909, DOI 10.1364/JOSAA.16.000909; Westphal V, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.143903; Willig KI, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/6/106; Willig KI, 2006, NATURE, V440, P935, DOI 10.1038/nature04592; Wilson T., 1984, THEORY PRACTICE SCAN	61	2137	2229	11	825	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2007	316	5828					1153	1158		10.1126/science.1137395	http://dx.doi.org/10.1126/science.1137395			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171GQ	17525330	Green Published			2022-12-28	WOS:000246724300032
J	Klimov, VI; Ivanov, SA; Nanda, J; Achermann, M; Bezel, I; McGuire, JA; Piryatinski, A				Klimov, Victor I.; Ivanov, Sergei A.; Nanda, Jagjit; Achermann, Marc; Bezel, Ilya; McGuire, John A.; Piryatinski, Andrei			Single-exciton optical gain in semiconductor nanocrystals	NATURE			English	Article							AMPLIFIED SPONTANEOUS EMISSION; QUANTUM DOTS; STIMULATED-EMISSION; CONFINEMENT; ENERGY	Nanocrystal quantum dots have favourable light-emitting properties. They show photoluminescence with high quantum yields, and their emission colours depend on the nanocrystal size - owing to the quantum-confinement effect - and are therefore tunable. However, nanocrystals are difficult to use in optical amplification and lasing. Because of an almost exact balance between absorption and stimulated emission in nanoparticles excited with single electron - hole pairs (excitons), optical gain can only occur in nanocrystals that contain at least two excitons. A complication associated with this multiexcitonic nature of light amplification is fast optical-gain decay induced by non-radiative Auger recombination, a process in which one exciton recombines by transferring its energy to another. Here we demonstrate a practical approach for obtaining optical gain in the single-exciton regime that eliminates the problem of Auger decay. Specifically, we develop core/ shell hetero-nanocrystals engineered in such a way as to spatially separate electrons and holes between the core and the shell (type-II heterostructures). The resulting imbalance between negative and positive charges produces a strong local electric field, which induces a giant (similar to 100 meV or greater) transient Stark shift of the absorption spectrum with respect to the luminescence line of singly excited nanocrystals. This effect breaks the exact balance between absorption and stimulated emission, and allows us to demonstrate optical amplification due to single excitons.	Los Alamos Natl Lab, Los Alamos, NM 87545 USA	United States Department of Energy (DOE); Los Alamos National Laboratory	Klimov, VI (corresponding author), Los Alamos Natl Lab, POB 1663, Los Alamos, NM 87545 USA.	klimov@lanl.gov	Ivanov, Sergei A/B-5505-2011; McGuire, John A/C-3380-2015; Klimov, Victor/Y-2823-2019; Piryatinski, Andrei/B-5543-2009; Achermann, Marc/A-1849-2011	Ivanov, Sergei A/0000-0001-6790-5187; McGuire, John A/0000-0002-0682-0953; Klimov, Victor/0000-0003-1158-3179; Piryatinski, Andrei/0000-0001-9218-1678; Achermann, Marc/0000-0002-3939-9309				Achermann M, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.245302; Alivisatos AP, 1996, SCIENCE, V271, P933, DOI 10.1126/science.271.5251.933; Cao YC, 2004, J AM CHEM SOC, V126, P14336, DOI 10.1021/ja0459678; EFROS AL, 1989, SOLID STATE COMMUN, V72, P645, DOI 10.1016/0038-1098(89)90665-0; Eisler HJ, 2002, APPL PHYS LETT, V80, P4614, DOI 10.1063/1.1485125; Htoon H, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.227401; Ivanov SA, 2004, J PHYS CHEM B, V108, P10625, DOI 10.1021/jp0483371; KANG KI, 1993, PHYS REV B, V48, P15449, DOI 10.1103/PhysRevB.48.15449; Kazes M, 2002, ADV MATER, V14, P317, DOI 10.1002/1521-4095(20020219)14:4<317::AID-ADMA317>3.0.CO;2-U; Klimov V. I., 2004, SEMICONDUCTOR METAL; Klimov VI, 2000, SCIENCE, V290, P314, DOI 10.1126/science.290.5490.314; Klimov VI, 1998, OPT LETT, V23, P277, DOI 10.1364/OL.23.000277; Klimov VI, 2000, SCIENCE, V287, P1011, DOI 10.1126/science.287.5455.1011; Klimov VI, 2000, J PHYS CHEM B, V104, P6112, DOI 10.1021/jp9944132; Malko AV, 2002, APPL PHYS LETT, V81, P1303, DOI 10.1063/1.1497708; Mikhailovsky AA, 2002, APPL PHYS LETT, V80, P2380, DOI 10.1063/1.1463704; MURRAY CB, 1993, J AM CHEM SOC, V115, P8706, DOI 10.1021/ja00072a025; Nanda J, 2006, J APPL PHYS, V99, DOI 10.1063/1.2168032; NORRIS DJ, 1994, PHYS REV LETT, V72, P2612, DOI 10.1103/PhysRevLett.72.2612; Piryatinski A, 2007, NANO LETT, V7, P108, DOI 10.1021/nl0622404; Schaller RD, 2003, J PHYS CHEM B, V107, P13765, DOI 10.1021/jp0311660; Shaklee K. L., 1973, Journal of Luminescence, V7, P284, DOI 10.1016/0022-2313(73)90072-0	22	810	825	9	486	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 24	2007	447	7143					441	446		10.1038/nature05839	http://dx.doi.org/10.1038/nature05839			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170VA	17522678				2022-12-28	WOS:000246693100040
J	Kulkarni, SR; Ofek, EO; Rau, A; Cenko, SB; Soderberg, AM; Fox, DB; Gal-Yam, A; Capak, PL; Moon, DS; Li, W; Filippenko, AV; Egami, E; Kartaltepe, J; Sanders, DB				Kulkarni, S. R.; Ofek, E. O.; Rau, A.; Cenko, S. B.; Soderberg, A. M.; Fox, D. B.; Gal-Yam, A.; Capak, P. L.; Moon, D. S.; Li, W.; Filippenko, A. V.; Egami, E.; Kartaltepe, J.; Sanders, D. B.			An unusually brilliant transient in the galaxy M85	NATURE			English	Article							V838 MONOCEROTIS; ERUPTION; M31; PROJECT; NOVAE	Historically, variable and transient sources have both surprised astronomers and provided new views of the heavens. Here we report the discovery of an optical transient in the outskirts of the lenticular galaxy Messier 85 in the Virgo cluster. With a peak absolute R magnitude of - 12, this event is distinctly brighter than novae, but fainter than type Ia supernovae ( which are expected in a population of old stars in lenticular galaxies). Archival images of the field do not show a luminous star at that position with an upper limit in the g filter of about - 4.1 mag, so it is unlikely to be a giant eruption from a luminous blue variable star. Over a two-month period, the transient source emitted radiation energy of almost 10 47 erg and subsequently faded in the optical sky. It is similar to, but six times more luminous at peak than, an enigmatic transient in the galaxy M31 (ref. 1). A possible origin of M85 OT2006-1 is a stellar merger. If so, searches for similar events in nearby galaxies will not only allow study of the physics of hyper-Eddington sources, but also probe an important phase in the evolution of stellar binary systems.	CALTECH, Caltech Opt Observ 105 24, Pasadena, CA 91125 USA; CALTECH, Space Radiat Lab 220 47, Pasadena, CA 91125 USA; Penn State Univ, Dept Astron, University Pk, PA 16802 USA; Univ Calif Berkeley, Dept Astron, Berkeley, CA 94720 USA; Univ Arizona, Steward Observ, Tucson, AZ 85721 USA; Univ Hawaii, Astron Inst, Honolulu, HI 96822 USA	California Institute of Technology; California Institute of Technology; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of California System; University of California Berkeley; University of Arizona; University of Hawaii System	Kulkarni, SR (corresponding author), CALTECH, Caltech Opt Observ 105 24, Pasadena, CA 91125 USA.	srk@astro.caltech.edu	Capak, Peter/AAK-4282-2020; Kartaltepe, Jeyhan/ABI-1561-2020	Capak, Peter/0000-0003-3578-6843; Kartaltepe, Jeyhan/0000-0001-9187-3605; Sanders, David/0000-0002-1233-9998; Fox, Derek/0000-0002-3714-672X				BROWN NJ, 2002, 7785 IAU; CAPACCIOLI M, 1989, ASTRON J, V97, P1622, DOI 10.1086/115104; Darnley MJ, 2004, MON NOT R ASTRON SOC, V353, P571, DOI 10.1111/j.1365-2966.2004.08087.x; Emsellem E, 2004, MON NOT R ASTRON SOC, V352, P721, DOI 10.1111/j.1365-2966.2004.07948.x; Freedman WL, 2001, ASTROPHYS J, V553, P47, DOI 10.1086/320638; Humphreys RM, 2006, ASTRON J, V131, P2105, DOI 10.1086/500811; HUMPHREYS RM, 1994, PUBL ASTRON SOC PAC, V106, P1025, DOI 10.1086/133478; OKE JB, 1995, PUBL ASTRON SOC PAC, V107, P375, DOI 10.1086/133562; OKE JB, 1981, B AAS, V13, P509; OSTERBROCK DE, 1989, ASTROPHYSICS GASEOUS, pCH4; Retter A, 2003, MON NOT R ASTRON SOC, V345, pL25, DOI 10.1046/j.1365-8711.2003.07190.x; RICH RM, 1989, ASTROPHYS J, V341, pL51, DOI 10.1086/185455; Schlegel DJ, 1998, ASTROPHYS J, V500, P525, DOI 10.1086/305772; Sivakoff GR, 2003, ASTROPHYS J, V599, P218, DOI 10.1086/379115; Smith RJ, 2000, MON NOT R ASTRON SOC, V313, P469, DOI 10.1046/j.1365-8711.2000.03251.x; Tylenda R, 2005, ASTRON ASTROPHYS, V436, P1009, DOI 10.1051/0004-6361:20052800	17	126	129	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 24	2007	447	7143					458	460		10.1038/nature05822	http://dx.doi.org/10.1038/nature05822			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170VA	17522679	Green Submitted, Green Accepted			2022-12-28	WOS:000246693100043
J	Meyers, DS; Halvorson, H; Luckhaupt, S				Meyers, David S.; Halvorson, Heather; Luckhaupt, Sara			Screening for chlamydial infection: An evidence update for the US preventive services task force	ANNALS OF INTERNAL MEDICINE			English	Article							SEXUALLY-TRANSMITTED-DISEASES; TRACHOMATIS; PREVALENCE; HEALTH; WOMEN	Background: Chlamydial infection is the most common sexually transmitted bacterial infection in the United States, with an estimated 3 million new cases annually. In 2001, the U.S. Preventive Services Task Force (USPSTF) recommended that clinicians screen all sexually active women at increased risk for infection for Chlamydia trachomatis. Purpose: To summarize a systematic evidence review commissioned by the USPSTF in preparation for an update of its 2001 recommendation. Data Sources: English-language articles identified in PubMed between July 2000 and July 2005. Additional articles were identified by bibliographic reviews and discussions with experts. A total of 452 articles were identified. Study Selection: Explicit inclusion and exclusion criteria were used for each of 3 key questions. For studies of screening in nonpregnant women at increased risk, review was limited to randomized, controlled trials. For other groups, both randomized, controlled studies and nonrandomized, prospective, controlled studies were included. Data Abstraction: Using standardized forms, staff of the Agency for Healthcare Research and Quaity abstracted data on study design, setting, sample, randomization, blinding, results, and harms. Data Synthesis: Only 1 new study met inclusion criteria. This poor-quality study of the effectiveness of screening for chlamydial infection among nonpregnant women at increased risk found that screening was associated with a lower prevalence of chlamydial infection and fewer reported cases of pelvic inflammatory disease at 1-year follow-up. Limitations: No new evidence was found on screening in pregnant women, nonpregnant women not at increased risk, or men. Conclusions: A systematic review found a small amount of new evidence to inform the USPSTF as it updates its recommendations regarding screening for chlamydial infection. There are large gaps in the evidence about screening men to improve health outcomes in women.	Agcy Healthcare Res & Qual, Rockville, MD USA	Agency for Healthcare Research & Quality	Meyers, DS (corresponding author), Agcy Healthcare Res & Qual, Rockville, MD USA.							Baeten JM, 2003, CURR HIV RES, V1, P69, DOI 10.2174/1570162033352110; *CDCP, 2005, SEX TRANSM DIS SURV; Clark KL, 2002, SEX TRANSM DIS, V29, P1, DOI 10.1097/00007435-200201000-00001; Cook RL, 2005, ANN INTERN MED, V142, P914, DOI 10.7326/0003-4819-142-11-200506070-00010; Darroch J, 2003, SEX TRANSM INFECT, V79, P372, DOI 10.1136/sti.79.5.372; Duncan B, 2001, BRIT MED J, V322, P195, DOI 10.1136/bmj.322.7280.195; Guirguis-Blake J, 2007, ANN INTERN MED, V147, P117, DOI 10.7326/0003-4819-147-2-200707170-00170; Hu D, 2004, ANN INTERN MED, V141, P501, DOI 10.7326/0003-4819-141-7-200410050-00006; Hwang Loris, 2004, Adv Pediatr, V51, P379; Johnson Robert E, 2002, MMWR Recomm Rep, V51, P1; Mardh PA, 2002, BEST PRACT RES CL OB, V16, P847, DOI 10.1053/beog.2002.0329; Meyers DS, 2007, AHRQ PUBLICATION; Miller WC, 2004, JAMA-J AM MED ASSOC, V291, P2229, DOI 10.1001/jama.291.18.2229; *NAT COMM QUAL ASS, 2005, STAT HLTH CAR QUAL 2; Nelson HD, 2001, AM J PREV MED, V20, P95, DOI 10.1016/S0749-3797(01)00253-7; Ostergaard L, 2000, CLIN INFECT DIS, V31, P951, DOI 10.1086/318139; Pimenta JM, 2003, SEX TRANSM INFECT, V79, P22, DOI 10.1136/sti.79.1.22; Risser William L, 2005, Semin Pediatr Infect Dis, V16, P160, DOI 10.1053/j.spid.2005.04.004; Rottingen JA, 2001, SEX TRANSM DIS, V28, P579; Scholes D, 1996, NEW ENGL J MED, V334, P1362, DOI 10.1056/NEJM199605233342103; Silins I, 2005, INT J CANCER, V116, P110, DOI 10.1002/ijc.20970; Stamm WE, 2004, ANN INTERN MED, V141, P570, DOI 10.7326/0003-4819-141-7-200410050-00016; Steen R, 2000, SEX TRANSM DIS, V27, P1, DOI 10.1097/00007435-200001000-00001; STEINER K, 2003, 15 BIENN C INT SOC S; Weinstock H, 2004, PERSPECT SEX REPRO H, V36, P6, DOI 10.1111/j.1931-2393.2004.tb00002.x	25	67	69	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 17	2007	147	2					135	142		10.7326/0003-4819-147-2-200707170-00173	http://dx.doi.org/10.7326/0003-4819-147-2-200707170-00173			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	192CV	17576995				2022-12-28	WOS:000248179300009
J	Carlton, JG; Martin-Serrano, J				Carlton, Jez G.; Martin-Serrano, Juan			Parallels between cytokinesis and retroviral budding: A role for the ESCRT machinery	SCIENCE			English	Article							PROTEIN; TSG101; MIDBODY; REVEALS; NETWORK; MECHANISMS; ABSCISSION; COMPLEXES; DOMAINS; CEP55	During cytokinesis, as dividing animal cells pull apart into two daughter cells, the final stage, termed abscission, requires breakage of the midbody, a thin membranous stalk connecting the daughter cells. This membrane fission event topologically resembles the budding of viruses, such as HIV-1, from infected cells. We found that two proteins involved in HIV-1 budding-tumor susceptibility gene 101 (Tsg101), a subunit of the endosomal sorting complex required for transport I (ESCRT-I), and Alix, an ESCRT-associated protein-were recruited to the midbody during cytokinesis by interaction with centrosome protein 55 (Cep55), a centrosome and midbody protein essential for abscission. Tsg101, Alix, and possibly other components of ESCRT-I were required for the completion of cytokinesis. Thus, HIV-1 budding and cytokinesis use a similar subset of cellular components to carry out topologically similar membrane fission events.	Kings Coll London, Sch Med, Dept Infect Dis, London, England	University of London; King's College London	Martin-Serrano, J (corresponding author), Kings Coll London, Sch Med, Dept Infect Dis, London, England.	juan.martin_serrano@kcl.ac.uk	Carlton, Jeremy/X-2918-2019; Carlton, Jeremy/C-7702-2014	Carlton, Jeremy/0000-0002-7255-1894; Martin-Serrano, Juan/0000-0002-8183-3914	Medical Research Council [G0400207] Funding Source: Medline; MRC [G0400207] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Albertson R, 2005, TRENDS CELL BIOL, V15, P92, DOI 10.1016/j.tcb.2004.12.008; Bieniasz PD, 2006, VIROLOGY, V344, P55, DOI 10.1016/j.virol.2005.09.044; Eggert US, 2006, ANNU REV BIOCHEM, V75, P543, DOI 10.1146/annurev.biochem.74.082803.133425; Fabbro M, 2005, DEV CELL, V9, P477, DOI 10.1016/j.devcel.2005.09.003; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; Glotzer M, 2001, ANNU REV CELL DEV BI, V17, P351, DOI 10.1146/annurev.cellbio.17.1.351; Gromley A, 2005, CELL, V123, P75, DOI 10.1016/j.cell.2005.07.027; Hurley JH, 2006, ANNU REV BIOPH BIOM, V35, P277, DOI 10.1146/annurev.biophys.35.040405.102126; Jantsch-Plunger V, 1999, CURR BIOL, V9, P738, DOI 10.1016/S0960-9822(99)80333-9; Krempler A, 2002, J BIOL CHEM, V277, P43216, DOI 10.1074/jbc.M207662200; Low SH, 2003, DEV CELL, V4, P753, DOI 10.1016/S1534-5807(03)00122-9; Martin-Serrano J, 2003, P NATL ACAD SCI USA, V100, P12414, DOI 10.1073/pnas.2133846100; Martin-Serrano J, 2003, J VIROL, V77, P4794, DOI 10.1128/JVI.77.8.4794-4804.2003; Martin-Serrano J, 2001, NAT MED, V7, P1313, DOI 10.1038/nm1201-1313; Pornillos O, 2002, EMBO J, V21, P2397, DOI 10.1093/emboj/21.10.2397; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Ruland J, 2001, P NATL ACAD SCI USA, V98, P1859, DOI 10.1073/pnas.98.4.1859; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Skop AR, 2004, SCIENCE, V305, P61, DOI 10.1126/science.1097931; Spitzer C, 2006, DEVELOPMENT, V133, P4679, DOI 10.1242/dev.02654; Strack B, 2003, CELL, V114, P689, DOI 10.1016/S0092-8674(03)00653-6; VerPlank L, 2001, P NATL ACAD SCI USA, V98, P7724, DOI 10.1073/pnas.131059198; von Schwedler UK, 2003, CELL, V114, P701, DOI 10.1016/S0092-8674(03)00714-1; Welsch S, 2006, TRAFFIC, V7, P1551, DOI 10.1111/j.1600-0854.2006.00489.x; Xie WQ, 1998, P NATL ACAD SCI USA, V95, P1595, DOI 10.1073/pnas.95.4.1595; Zhao WM, 2006, MOL BIOL CELL, V17, P3881, DOI 10.1091/mbc.E06-01-0015	26	537	547	0	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 29	2007	316	5833					1908	1912		10.1126/science.1143422	http://dx.doi.org/10.1126/science.1143422			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	183WI	17556548	Green Submitted			2022-12-28	WOS:000247602700043
J	Linding, R; Jensen, LJ; Ostheimer, GJ; van Vugt, MATM; Jorgensen, C; Miron, IM; Diella, F; Colwill, K; Taylor, L; Elder, K; Metalnikov, P; Nguyen, V; Pasculescu, A; Jin, J; Park, JG; Samson, LD; Woodgett, JR; Russell, RB; Bork, P; Yaffe, MB; Pawson, T				Linding, Rune; Jensen, Lars Juhl; Ostheimer, Gerard J.; van Vugt, Marcel A. T. M.; Jorgensen, Claus; MIron, Ioana M.; Diella, Francesca; Colwill, Karen; Taylor, Lorne; Elder, Kelly; Metalnikov, Pavel; Nguyen, Vivian; Pasculescu, Adrian; Jin, Jing; Park, Jin Gyoon; Samson, Leona D.; Woodgett, James R.; Russell, Robert B.; Bork, Peer; Yaffe, Michael B.; Pawson, Tony			Systematic discovery of in vivo phosphorylation networks	CELL			English	Article							DNA-DAMAGE RESPONSE; SPECTROMETRY-BASED PROTEOMICS; MASS-SPECTROMETRY; PROTEIN-PHOSPHORYLATION; EUKARYOTIC PROTEINS; SIGNALING NETWORKS; KINASE; 53BP1; ATM; ACTIVATION	Protein kinases control cellular decision processes by phosphorylating specific substrates. Thousands of in vivo phosphorylation sites have been identified, mostly by proteome-wide mapping. However, systematically matching these sites to specific kinases is presently infeasible, due to limited specificity of consensus motifs, and the influence of contextual factors, such as protein scaffolds, localization, and expression, on cellular substrate specificity. We have developed an approach ( NetworKIN) that augments motif-based predictions with the network context of kinases and phosphoproteins. The latter provides 60%-80% of the computational capability to assign in vivo substrate specificity. NetworKIN pinpoints kinases responsible for specific phosphorylations and yields a 2.5-fold improvement in the accuracy with which phosphorylation networks can be constructed. Applying this approach to DNA damage signaling, we show that 53BP1 and Rad50 are phosphorylated by CDK1 and ATM, respectively. We describe a scalable strategy to evaluate predictions, which suggests that BCLAF1 is a GSK-3 substrate.	Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; MIT, Ctr Canc Res, Cambridge, MA 02139 USA; European Mol Biol Lab, Heidelberg, Germany; MIT, Ctr Environm Hlth Sci, Cambridge, MA 02139 USA; Erasmus Univ, Dept Cell Biol & Genet, NL-3000 DR Rotterdam, Netherlands; Max Delbruck Ctr Mol Med, Berlin, Germany	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Massachusetts Institute of Technology (MIT); European Molecular Biology Laboratory (EMBL); Massachusetts Institute of Technology (MIT); Erasmus University Rotterdam; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Linding, R (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	linding@mshri.on.ca; bork@embl.de; myaffe@mit.edu; pawson@mshri.on.ca	Jensen, Lars Juhl/C-6492-2008; Russell, Robert/GWU-6389-2022; Bork, Peer/F-1813-2013; Pawson, Tony J/E-4578-2013; Russell, Rob/AAH-9145-2019; Woodgett, Jim/F-1087-2010; Colwill, Karen/K-5101-2012	Jensen, Lars Juhl/0000-0001-7885-715X; Russell, Robert/0000-0002-7213-1398; Bork, Peer/0000-0002-2627-833X; Russell, Rob/0000-0002-1905-4717; Woodgett, Jim/0000-0003-3731-5797; Colwill, Karen/0000-0002-8979-1659; Metalnikov, Pavel/0000-0003-3261-4421; Jorgensen, Claus/0000-0002-7841-943X; Linding, Rune/0000-0003-0420-4839	Canadian Institutes of Health Research [12043] Funding Source: Medline; NCI NIH HHS [U54 CA112967-03, U54-CA112967-03, U54 CA112967] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U54CA112967] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Aloy P, 2002, TRENDS BIOCHEM SCI, V27, P633, DOI 10.1016/S0968-0004(02)02204-1; Anderson L, 2006, MOL CELL PROTEOMICS, V5, P573, DOI 10.1074/mcp.M500331-MCP200; Anderson L, 2001, MOL CELL BIOL, V21, P1719, DOI 10.1128/MCB.21.5.1719-1729.2001; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Beausoleil SA, 2004, P NATL ACAD SCI USA, V101, P12130, DOI 10.1073/pnas.0404720101; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Bhattacharyya RP, 2006, SCIENCE, V311, P822, DOI 10.1126/science.1120941; Bullock AN, 2005, J BIOL CHEM, V280, P41675, DOI 10.1074/jbc.M510711200; Chen PL, 2005, MOL CELL BIOL, V25, P3535, DOI 10.1128/MCB.25.9.3535-3542.2005; Dar AC, 2005, CELL, V122, P887, DOI 10.1016/j.cell.2005.06.044; Diella F, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-79; Foster LJ, 2006, CELL, V125, P187, DOI 10.1016/j.cell.2006.03.022; Hjerrild M, 2004, J PROTEOME RES, V3, P426, DOI 10.1021/pr0341033; HOUTHAEVE T, 1995, FEBS LETT, V376, P91, DOI 10.1016/0014-5793(95)01242-7; Hutti JE, 2004, NAT METHODS, V1, P27, DOI 10.1038/NMETH708; Ira G, 2004, NATURE, V431, P1011, DOI 10.1038/nature02964; Kamer I, 2005, CELL, V122, P593, DOI 10.1016/j.cell.2005.06.014; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Kasof GM, 1999, MOL CELL BIOL, V19, P4390; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Manke IA, 2005, MOL CELL, V17, P37, DOI 10.1016/j.molcel.2004.11.021; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Mizukami Y, 1997, J BIOL CHEM, V272, P16657, DOI 10.1074/jbc.272.26.16657; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Ong SE, 2005, NAT CHEM BIOL, V1, P252, DOI 10.1038/nchembio736; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; Puntervoll P, 2003, NUCLEIC ACIDS RES, V31, P3625, DOI 10.1093/nar/gkg545; Rappold I, 2001, J CELL BIOL, V153, P613, DOI 10.1083/jcb.153.3.613; Rashi-Elkeles S, 2006, ONCOGENE, V25, P1584, DOI 10.1038/sj.onc.1209189; Remenyi A, 2005, MOL CELL, V20, P951, DOI 10.1016/j.molcel.2005.10.030; Saric J, 2006, BIOINFORMATICS, V22, P645, DOI 10.1093/bioinformatics/bti597; Schmezle K, 2006, CURR OPIN BIOTECH, V17, P406, DOI 10.1016/j.copbio.2006.06.004; Schultz LB, 2000, J CELL BIOL, V151, P1381, DOI 10.1083/jcb.151.7.1381; Seet BT, 2006, NAT REV MOL CELL BIO, V7, P473, DOI 10.1038/nrm1960; Shiloh Y, 2006, TRENDS BIOCHEM SCI, V31, P402, DOI 10.1016/j.tibs.2006.05.004; Takemoto A, 2004, J BIOL CHEM, V279, P4551, DOI 10.1074/jbc.M310925200; von Mering C, 2005, NUCLEIC ACIDS RES, V33, pD433, DOI 10.1093/nar/gki005; Wang Y, 2000, GENE DEV, V14, P927; Ward IM, 2003, MOL CELL BIOL, V23, P2556, DOI 10.1128/MCB.23.7.2556-2563.2003; Whitmarsh AJ, 2001, GENE DEV, V15, P2421, DOI 10.1101/gad.922801; Wolf-Yadlin A, 2007, P NATL ACAD SCI USA, V104, P5860, DOI 10.1073/pnas.0608638104; Wu ZH, 2006, SCIENCE, V311, P1141, DOI 10.1126/science.1121513; Yu XC, 2006, GENE DEV, V20, P1721, DOI 10.1101/gad.1431006; Zinkel SS, 2005, CELL, V122, P579, DOI 10.1016/j.cell.2005.06.022	46	579	601	0	55	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 29	2007	129	7					1415	1426		10.1016/j.cell.2007.05.052	http://dx.doi.org/10.1016/j.cell.2007.05.052			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	188HQ	17570479	Green Accepted, Bronze			2022-12-28	WOS:000247911400025
J	Hart, RG; Pearce, LA; Aguilar, MI				Hart, Robert G.; Pearce, Lesly A.; Aguilar, Maria I.			Meta-analysis: Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation	ANNALS OF INTERNAL MEDICINE			English	Review							FIXED MINIDOSE WARFARIN; DOSE-ADJUSTED WARFARIN; SECONDARY PREVENTION; THROMBOEMBOLIC COMPLICATIONS; COMBINATION THERAPY; RANDOMIZED-TRIAL; ANTICOAGULATION; ASPIRIN; RISK; INTENSITY	Background: Atrial fibrillation is a strong independent risk factor for stroke. Purpose: To characterize the efficacy and safety of antithrombotic agents for stroke prevention in patients who have atrial fibrillation, adding 13 recent randomized trials to a previous meta-analysis. Data Sources: Randomized trials identified by using the Cochrane Stroke Group search strategy, 1966 to March 2007, unrestricted by language. Study Selection: All published randomized trials with a mean follow-up of 3 months or longer that tested antithrombotic agents in patients who have nonvalvular atrial fibrillation. Data Extraction: Two coauthors independently extracted information regarding interventions; participants; and occurrences of ischemic and hemorrhagic stroke, major extracranial bleeding, and death. Data Synthesis: Twenty-nine trials included 28 044 participants (mean age, 71 years; mean follow-up, 1.5 years). Compared with the control, adjusted-dose warfarin (6 trials, 2900 participants) and antiplatelet agents (8 trials, 4876 participants) reduced stroke by 64% (95% CI, 49% to 74%) and 22% (CI, 6% to 35%), respectively. Adjusted-dose warfarin was substantially more efficacious than antiplatelet therapy (relative risk reduction, 39% [CI, 22% to 52%1) (12 trials, 12 963 participants). Other randomized comparisons were inconclusive. Absolute increases in major extracranial hemorrhage were small (!s;0.3% per year) on the basis of metaanalysis. Limitation: Methodological features and quality varied substantially and often were incompletely reported. Conclusions: Adjusted-dose warfarin and antiplatelet agents reduce stroke by approximately 60% and by approximately 20%, respectively, in patients who have atrial fibrillation. Warfarin is substantially more efficacious (by approximately 40%) than antiplatelet therapy. Absolute increases in major extracranial hemorrhage associated with antithrombotic therapy in participants from the trials included in this meta-analysis were less than the absolute reductions in stroke. Judicious use of antithrombotic therapy importantly reduces stroke for most patients who have atrial fibrillation.	Univ Texas, Hlth Sci Ctr, Dept Med Urol, San Antonio, TX 78229 USA; Mayo Clin Scottsdale, Scottsdale, AZ USA	University of Texas System; University of Texas Health San Antonio; Mayo Clinic; Mayo Clinic Phoenix	Hart, RG (corresponding author), Univ Texas, Hlth Sci Ctr, Dept Med Urol, 7703 Floyd Curl Dr,MC 7883, San Antonio, TX 78229 USA.	hartr@uthscsa.edu		Pearce, Lesly/0000-0002-0838-1739				Albers GW, 2005, JAMA-J AM MED ASSOC, V293, P690; Albers GW, 2003, LANCET, V362, P1691; Anderson DR, 2005, CAN J CARDIOL, V21, P257; Benavente O, 1999, STROKE MODULE COCHRA; Connolly S, 2006, LANCET, V367, P1903, DOI 10.1016/s0140-6736(06)68845-4; Connolly S, 2006, AM HEART J, V151, P1187, DOI 10.1016/j.ahj.2005.06.026; CONNOLLY SJ, 1991, J AM COLL CARDIOL, V18, P349, DOI 10.1016/0735-1097(91)90585-W; Cooper NJ, 2006, ARCH INTERN MED, V166, P1269, DOI 10.1001/archinte.166.12.1269; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Diener HC, 1997, J NEUROL SCI, V153, P112; Edvardsson N, 2003, J INTERN MED, V254, P95, DOI 10.1046/j.1365-2796.2003.01159.x; EZEKOWITZ MD, 1992, NEW ENGL J MED, V327, P1406, DOI 10.1056/NEJM199211123272002; Fang MC, 2006, J AM GERIATR SOC, V54, P1231, DOI 10.1111/j.1532-5415.2006.00828.x; Fang MC, 2004, ANN INTERN MED, V141, P745, DOI 10.7326/0003-4819-141-10-200411160-00005; FORNARO G, 1993, CIRCULATION, V87, P162, DOI 10.1161/01.CIR.87.1.162; Gage BF, 2004, CIRCULATION, V110, P2287, DOI 10.1161/01.CIR.0000145172.55640.93; Go AS, 2005, PROG CARDIOVASC DIS, V48, P108, DOI 10.1016/j.pcad.2005.06.007; Go AS, 2003, JAMA-J AM MED ASSOC, V290, P2685, DOI 10.1001/jama.290.20.2685; Gullov AL, 1998, ARCH INTERN MED, V158, P1513, DOI 10.1001/archinte.158.14.1513; Hallas J, 2006, BMJ-BRIT MED J, V333, P726, DOI 10.1136/bmj.38947.697558.AE; HARENBERG J, 1993, SEMIN THROMB HEMOST, V19, P116; Hart RG, 2004, STROKE, V35, P948, DOI 10.1161/01.STR.0000120741.34866.1D; Hart RG, 1999, ANN INTERN MED, V131, P492, DOI 10.7326/0003-4819-131-7-199910050-00003; Hart RG, 2003, ANN INTERN MED, V138, P831, DOI 10.7326/0003-4819-138-10-200305200-00011; Hart RG, 2000, CEREBROVASC DIS, V10, P39, DOI 10.1159/000016023; Hart RG, 1998, ANN INTERN MED, V128, P408, DOI 10.7326/0003-4819-128-5-199803010-00012; Hellemons BSP, 1999, BMJ-BRIT MED J, V319, P958, DOI 10.1136/bmj.319.7215.958; Hu Da-yi, 2006, Zhonghua Xinxueguanbing Zazhi, V34, P295; Hylek EM, 2003, NEW ENGL J MED, V349, P1019, DOI 10.1056/NEJMoa022913; *JAP ATR FIBR STRO, 2006, JAPAN ATRIAL FIBRILL, V37, P447; Kamath S, 2002, J AM COLL CARDIOL, V40, P484, DOI 10.1016/S0735-1097(02)01984-8; KISTLER JP, 1990, NEW ENGL J MED, V323, P1505; Klein AL, 2006, EUR HEART J, V27, P2858, DOI 10.1093/eurheartj/ehl353; Lechat P, 2001, CEREBROVASC DIS, V12, P245, DOI 10.1159/000047711; Li-Saw-Hee FL, 2000, STROKE, V31, P828, DOI 10.1161/01.STR.31.4.828; Lorenzoni R, 2004, AM HEART J, V148, DOI 10.1016/j.jahj.2004.02.008; MCBRIDE R, 1991, CIRCULATION, V84, P527, DOI 10.1161/01.CIR.84.2.527; *MIDL RES CONS GEN, 2003, BMC CARDIOVASC DISOR, V3, P9; Morocutti C, 1997, STROKE, V28, P1015, DOI 10.1161/01.STR.28.5.1015; Oden A, 2006, THROMB RES, V117, P493, DOI 10.1016/j.thromres.2004.11.025; Pengo V, 2003, THROMB HAEMOSTASIS, V89, P760; Pengo V, 1998, AM J CARDIOL, V82, P433, DOI 10.1016/S0002-9149(98)00357-9; Perez-Gomez F, 2004, J AM COLL CARDIOL, V44, P1557, DOI 10.1016/j.jacc.2004.05.084; PETERSEN P, 1989, LANCET, V1, P175; PETERSEN P, 1990, NEW ENGL J MED, V323, P482; Petersen P, 2003, J AM COLL CARDIOL, V41, P1445, DOI 10.1016/S0735-1097(03)00255-9; Posada IS, 1999, AM HEART J, V138, P137, DOI 10.1016/S0002-8703(99)70259-0; Rash A, 2007, AGE AGEING, V36, P151, DOI 10.1093/ageing/afl129; Shireman TI, 2004, STROKE, V35, P2362, DOI 10.1161/01.STR.0000141933.75462.c2; Stellbrink C, 2004, CIRCULATION, V109, P997, DOI 10.1161/01.CIR.0000120509.64740.DC; van Walraven C, 2002, JAMA-J AM MED ASSOC, V288, P2441, DOI 10.1001/jama.288.19.2441; Venimos KN, 2006, EUR J INTERN MED, V17, P48, DOI 10.1016/j.ejim.2005.08.005; WALLENTIN L, 2005, EUR SOC CARD ANN M S; Yamaguchi T, 2000, STROKE, V31, P817, DOI 10.1161/01.STR.31.4.817; YIGIT Z, 2000, TURK KARDIYOLOJI DER, V28, P8; 1998, JAMA, V279, P1273; 1993, LANCET, V342, P1255; 1996, LANCET, V348, P633; 1994, LANCET, V343, P687; 1997, LANCET, V350, P389	60	3236	3444	7	170	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 19	2007	146	12					857	867		10.7326/0003-4819-146-12-200706190-00007	http://dx.doi.org/10.7326/0003-4819-146-12-200706190-00007			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	180FF	17577005				2022-12-28	WOS:000247347100004
J	Mitchell, JD; Borasio, GD				Mitchell, J. D.; Borasio, G. D.			Amyotrophic lateral sclerosis	LANCET			English	Review							QUALITY-OF-LIFE; STEM-CELL THERAPY; SELECTIVE MOTONEURON VULNERABILITY; RANDOMIZED CLINICAL-TRIAL; MOTOR-NEURON DISEASE; ALS PATIENTS; NATURAL-HISTORY; DOUBLE-BLIND; NONINVASIVE VENTILATION; PROLONGS SURVIVAL	Amyotrophic lateral sclerosis (known in the UK as motor neuron disease) is a devastating illness with uncertain pathogenesis. In this Seminar, we review its natural history, clinical features, diagnostic criteria, variant and mimic syndromes, genetic forms, and epidemiology. Several hypotheses about causes of the disorder are discussed, such as excitotoxicity and oxidant stress, and we review past and present putative disease-modifying treatments. Disease-management strategies, from telling the patient about their illness to end-of-life decisions and palliative care, are presented. We review options for control of the main symptoms of amyotrophic lateral sclerosis-including dysphagia, dysarthria, respiratory distress, pain, and psychological disorders-and care in the terminal phase. The need for good psychosocial and spiritual care of patients and families is emphasised. We conclude with an overview of some current major issues and future prospects, ranging from the search for disease markers to challenging developments such as stem-cell and gene therapy.	Royal Preston Hosp, Motor Neurone Dis Care & Res Ctr, Preston PR2 9HT, Lancs, England; Munich Univ Hosp, Dept Neurol, Interdisciplinary Ctr Palliat Med, D-81366 Munich, Germany; Munich Univ Hosp, Dept Neurol, Motor Neurone Dis Res Grp, D-81366 Munich, Germany	Royal Preston Hospital; University of Munich; University of Munich	Mitchell, JD (corresponding author), Royal Preston Hosp, Motor Neurone Dis Care & Res Ctr, Preston PR2 9HT, Lancs, England.	Douglas.Mitchell@lthtr.nhs.uk		Borasio, Gian Domenico/0000-0002-2737-3662				ALEXIANU ME, 1994, ANN NEUROL, V36, P846, DOI 10.1002/ana.410360608; Andersen PM, 2006, CURR NEUROL NEUROSCI, V6, P37, DOI 10.1007/s11910-996-0008-9; Andersen PM, 2005, EUR J NEUROL, V12, P921, DOI 10.1111/j.1468-1331.2005.01351.x; Aoki Shigeki, 2005, Radiat Med, V23, P195; APPEL SH, 2004, AMYOTROPH LATERAL S2, V5, P54; APPEL V, 1987, ANN NEUROL, V22, P328, DOI 10.1002/ana.410220308; Armon C, 2003, NEUROEPIDEMIOLOGY, V22, P217, DOI 10.1159/000070562; Armon C, 2001, NEUROEPIDEMIOLOGY, V20, P2, DOI 10.1159/000054751; Azzouz M, 2004, NATURE, V429, P413, DOI 10.1038/nature02544; Bacman SR, 2006, MOL NEUROBIOL, V33, P113, DOI 10.1385/MN:33:2:113; Beghi E, 2000, NEUROLOGY, V54, P469, DOI 10.1212/WNL.54.2.469; BENSIMON G, 1994, NEW ENGL J MED, V330, P585, DOI 10.1056/NEJM199403033300901; Bongioanni P, 2004, Cochrane Database Syst Rev, pCD004302, DOI 10.1002/14651858.CD004302.pub2; Borasio GD, 1998, J NEUROL, V245, P717, DOI 10.1007/s004150050273; Borasio GD, 2001, AMYOTROPH LATERAL SC, V2, P159, DOI 10.1080/146608201753275517; Borasio GD, 1998, J NEUROL SCI, V160, pS127, DOI 10.1016/S0022-510X(98)00211-1; Borasio GD, 2001, NEUROL CLIN, V19, P829, DOI 10.1016/S0733-8619(05)70049-9; BORASIO GD, 2006, PALLIATIVE CARE AMYO, P55; Bourke SC, 2006, LANCET NEUROL, V5, P140, DOI 10.1016/S1474-4422(05)70326-4; Bowser R, 2006, EXPERT REV MOL DIAGN, V6, P387, DOI 10.1586/14737159.6.3.387; Brooks BR, 2004, NEUROLOGY, V63, P1364; BROOKS BR, 1994, J NEUROL SCI, V124, P96, DOI 10.1016/0022-510X(94)90191-0; Brooks BR, 1996, ARCH NEUROL-CHICAGO, V53, P141; Ceroni M, 1999, NEUROLOGY, V53, P1064, DOI 10.1212/WNL.53.5.1064; Chevalier-Larsen E, 2006, BBA-MOL BASIS DIS, V1762, P1094, DOI 10.1016/j.bbadis.2006.04.002; Chio A, 2005, BRAIN, V128, P472, DOI 10.1093/brain/awh373; Chio A, 2004, J NEUROL NEUROSUR PS, V75, P645, DOI 10.1136/jnnp.2003.020347; Cudkowicz ME, 2003, NEUROLOGY, V61, P456, DOI 10.1212/WNL.61.4.456; de Carvalho M, 2005, AMYOTROPH LATERAL SC, V6, P17, DOI 10.1080/14660820410020600; de Paulis Tomas, 2003, Curr Opin Investig Drugs, V4, P863; Desnuelle C, 2001, AMYOTROPH LATERAL SC, V2, P9, DOI 10.1080/146608201300079364; Federici T, 2006, MUSCLE NERVE, V33, P302, DOI 10.1002/mus.20439; Figlewicz DA, 2003, AMYOTROPH LATERAL SC, V4, P225, DOI 10.1080/14660820310011287; GALLAGHER D, 2006, PALLIATIVE CARE AMYO, P143; Ganzini L, 1998, NEW ENGL J MED, V339, P967, DOI 10.1056/NEJM199810013391406; Giess R, 2000, J NEUROL NEUROSUR PS, V69, P121, DOI 10.1136/jnnp.69.1.121; Gordon PH, 2006, NEUROLOGY, V66, P1117, DOI 10.1212/01.wnl.0000204235.81272.e2; Gordon PH, 2006, NEUROLOGY, V66, P647, DOI 10.1212/01.wnl.0000200962.94777.71; Gordon PH, 2004, NEUROLOGY, V62, P1845, DOI 10.1212/01.WNL.0000125321.92112.7E; Gregory S, 2002, NEUROLOGY, V58, P485, DOI 10.1212/WNL.58.3.485; Groeneveld GJ, 2003, ANN NEUROL, V53, P437, DOI 10.1002/ana.10554; HAVERKAMP LJ, 1995, BRAIN, V118, P707, DOI 10.1093/brain/118.3.707; HILLEL AD, 1989, NEUROEPIDEMIOLOGY, V8, P142, DOI 10.1159/000110176; Ince PG, 2005, NEUROPATH APPL NEURO, V31, P345, DOI 10.1111/j.1365-2990.2005.00686.x; Jenkinson C, 2000, J NEUROL SCI, V180, P94, DOI 10.1016/S0022-510X(00)00420-2; JONES CT, 1995, J MED GENET, V32, P290, DOI 10.1136/jmg.32.4.290; Kasarskis EJ, 1999, J NEUROL SCI, V169, P118, DOI 10.1016/S0022-510X(99)00230-0; Kasarskis EJ, 1999, NEUROLOGY, V52, P1427; Kaspar BK, 2003, SCIENCE, V301, P839, DOI 10.1126/science.1086137; KENNEDY WR, 1968, NEUROLOGY, V18, P671, DOI 10.1212/WNL.18.7.671; Kleopa KA, 1999, J NEUROL SCI, V164, P82, DOI 10.1016/S0022-510X(99)00045-3; Kubler A, 2005, NEUROLOGY, V64, P1775, DOI 10.1212/01.WNL.0000158616.43002.6D; Lacomblez L, 1996, LANCET, V347, P1425, DOI 10.1016/S0140-6736(96)91680-3; LAMBERT R, 2006, PALLIATIVE CARE AMYO, P169; Lyall R, 2006, PALLIATIVE CARE AMYO, P63; Mazzini L, 2003, AMYOTROPH LATERAL SC, V4, P158, DOI 10.1080/14660820310014653; MCMURRAY A, 2006, PALLIATIVE CARE AMYO, P301; Meininger V, 2006, NEUROLOGY, V66, P88, DOI 10.1212/01.wnl.0000191326.40772.62; Meininger V, 2004, AMYOTROPH LATERAL SC, V5, P107, DOI 10.1080/14660820410019602; Miller RG, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001447.pub2; Miller RG, 2001, NEUROLOGY, V56, P843, DOI 10.1212/WNL.56.7.843; Miller RG, 1999, NEUROLOGY, V52, P1311, DOI 10.1212/WNL.52.7.1311; Mills KR, 2003, BRAIN, V126, P2558, DOI 10.1093/brain/awg260; Mitchell JD, 2006, AMYOTROPH LATERAL SC, V7, P67, DOI 10.1080/14660820500396984; Mitchell JD, 2000, AMYOTROPH LATERAL SC, V1, P235, DOI 10.1080/14660820050515061; MITCHELL JD, 1987, J NEUROL NEUROSUR PS, V50, P919, DOI 10.1136/jnnp.50.7.919; MITCHELL JD, 1987, NEUROL CLIN, V5, P43, DOI 10.1016/S0733-8619(18)30934-4; MITCHELL JD, 2002, COCHRANE DB SYST REV, V3; Mitsumoto H, 2005, AMYOTROPH LATERAL SC, V6, P145, DOI 10.1080/14660820510028647; Murphy PL, 2000, NEUROLOGY, V55, P1581, DOI 10.1212/WNL.55.10.1581; Mustfa N, 2006, NEUROLOGY, V66, P1211, DOI 10.1212/01.wnl.0000208957.88534.11; *NAT I CLIN EXC, 2001, GUID US RIL RIL TREA; Neary D, 2000, J NEUROL SCI, V180, P15, DOI 10.1016/S0022-510X(00)00425-1; Neudert C, 2001, J NEUROL SCI, V191, P103, DOI 10.1016/S0022-510X(01)00612-8; Neudert C, 2001, J NEUROL, V248, P612, DOI 10.1007/s004150170140; Neudert Christian, 2004, J Palliat Med, V7, P551, DOI 10.1089/1096621041838443; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; NEWRICK PG, 1985, J NEUROL NEUROSUR PS, V48, P838, DOI 10.1136/jnnp.48.8.838; OBRIEN T, 1992, BRIT MED J, V304, P471, DOI 10.1136/bmj.304.6825.471; Ochs G, 2000, AMYOTROPH LATERAL SC, V1, P201, DOI 10.1080/14660820050515197; Oliver D, 1996, J NEUROL SCI, V139, P134, DOI 10.1016/0022-510X(96)00087-1; Oliver D., 2006, PALLIATIVE CARE AMYO; Orrell RW, 2006, CURR OPIN INVEST DR, V7, P70; ORRELL RW, 2005, COCHRANE DB SYST REV, V1; Parkinson N, 2006, NEUROLOGY, V67, P1074, DOI 10.1212/01.wnl.0000231510.89311.8b; Pellegrino TR, 1998, NEUROLOGY, V50, P596; Pontieri FE, 2005, NEUROL SCI, V26, P285, DOI 10.1007/s10072-005-0474-x; Qureshi MM, 2006, AMYOTROPH LATERAL SC, V7, P173, DOI 10.1080/14660820600640596; Rabkin JG, 2005, NEUROLOGY, V65, P62, DOI 10.1212/01.wnl.0000167187.14501.0c; Rabkin JG, 2000, PSYCHOSOM MED, V62, P271, DOI 10.1097/00006842-200003000-00020; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Ryberg H, 2003, ACTA NEUROL SCAND, V108, P1, DOI 10.1034/j.1600-0404.2003.00111.x; Sancho J, 2004, CHEST, V125, P1400, DOI 10.1378/chest.125.4.1400; SCOTT A, 2006, PALLIATIVE CARE AMYO, P213; Silahtaroglu AN, 2002, BMC GENET, V3, DOI 10.1186/1471-2156-3-5; Silani V, 2004, CURR NEUROVASC RES, V1, P283, DOI 10.2174/1567202043362243; Silani V, 2004, LANCET, V364, P200, DOI 10.1016/S0140-6736(04)16634-8; Silani V, 2003, AMYOTROPH LATERAL SC, V4, P8, DOI 10.1080/14660820301177; SILVERSTEIN MD, 1991, MAYO CLIN PROC, V66, P906, DOI 10.1016/S0025-6196(12)61577-8; Simmons Z, 2005, NEUROLOGIST, V11, P257, DOI 10.1097/01.nrl.0000178758.30374.34; Simmons Z, 2000, NEUROLOGY, V55, P388, DOI 10.1212/WNL.55.3.388; Stalpers LJA, 2002, NEUROLOGY, V58, P1308, DOI 10.1212/WNL.58.8.1308; Storkebaum E, 2005, NAT NEUROSCI, V8, P85, DOI 10.1038/nn1360; Strong MJ, 2005, J NEUROPATH EXP NEUR, V64, P649, DOI 10.1097/01.jnen.0000173889.71434.ea; Sykes N, 2003, LANCET ONCOL, V4, P312, DOI 10.1016/S1470-2045(03)01079-9; UMAPATHI T, COCHRANE DATABASE SY, V3; Van den Berg JP, 2005, NEUROLOGY, V65, P1264, DOI 10.1212/01.wnl.0000180717.29273.12; VANSCHAIK IN, 2005, COCHRANE DATABASE SY, V2; Veldink JH, 2002, NEW ENGL J MED, V346, P1638, DOI 10.1056/NEJMsa012739; von Lewinski F, 2005, TRENDS NEUROSCI, V28, P494, DOI 10.1016/j.tins.2005.07.001; WAGNERSONNTAG E, 2006, PALLIATIVE CARE AMYO, P95; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wasner M, 2001, J NEUROL SCI, V191, P151, DOI 10.1016/S0022-510X(01)00615-3; Weisskopf MG, 2004, AM J EPIDEMIOL, V160, P26, DOI 10.1093/aje/kwh179; Weisskopf MG, 2005, NEUROLOGY, V64, P32, DOI 10.1212/01.WNL.0000148649.17706.D9; *WORLD FED NEUR RE, ESC REV REV CRIT DIA; 1999, THERAPEUTIC DRUGS, pR37	117	443	487	1	133	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 16	2007	369	9578					2031	2041		10.1016/S0140-6736(07)60944-1	http://dx.doi.org/10.1016/S0140-6736(07)60944-1			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	180HT	17574095				2022-12-28	WOS:000247354400028
J	Palmer, LJ				Palmer, Lyle J.			UK Biobank: bank on it	LANCET			English	Editorial Material							MENDELIAN RANDOMIZATION; EPIDEMIOLOGY; ENVIRONMENT		Univ Western Australia, Lab Genet Epidemiol, Western Australia Inst Med Res, Perth, WA 6008, Australia; Univ Western Australia, UWA Ctr Med Res, Perth, WA 6008, Australia	University of Western Australia; University of Western Australia	Palmer, LJ (corresponding author), Univ Western Australia, Lab Genet Epidemiol, Western Australia Inst Med Res, Perth, WA 6008, Australia.	lyle@cyllene.uwa.edu.au	Palmer, Lyle John/K-3196-2014; Palmer, Lyle John/N-1948-2019	Palmer, Lyle John/0000-0002-1628-3055; Palmer, Lyle John/0000-0002-1628-3055				BURTON PR, 2005, UK BIOBANK EXPECTED; Coghlan A, 2006, NEW SCI, V189, P8; Dwyer T, 2007, INT J OBESITY, V31, P797, DOI 10.1038/sj.ijo.0803472; Hunter DJ, 2005, NAT REV GENET, V6, P287, DOI 10.1038/nrg1578; Ioannidis JPA, 2006, NAT GENET, V38, P3, DOI 10.1038/ng0106-3; Manolio TA, 2006, NAT REV GENET, V7, P812, DOI 10.1038/nrg1919; *NAT OFF PUBL HLTH, CDC HUM GEN EP NETW; Ollier W, 2005, PHARMACOGENOMICS, V6, P639, DOI 10.2217/14622416.6.6.639; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Timpson NJ, 2005, LANCET, V366, P1954, DOI 10.1016/S0140-6736(05)67786-0; *UK BIOB, WELC UK BIOB	11	139	141	3	19	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 16	2007	369	9578					1980	1982		10.1016/S0140-6736(07)60924-6	http://dx.doi.org/10.1016/S0140-6736(07)60924-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	180HT	17574079				2022-12-28	WOS:000247354400007
J	Lee, A; Dennis, C; Campbell, P				Lee, Adrian; Dennis, Carina; Campbell, Philip			Nature's guide for mentors	NATURE			English	Article									Univ New S Wales, Kensington, NSW 2033, Australia	University of New South Wales Sydney	Lee, A (corresponding author), Univ New S Wales, Kensington, NSW 2033, Australia.								0	100	107	6	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 14	2007	447	7146					791	797		10.1038/447791a	http://dx.doi.org/10.1038/447791a			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178FV	17568738	Bronze			2022-12-28	WOS:000247207500033
J	Yang, WL; Fabbri, JD; Willey, TM; Lee, JRI; Dahl, JE; Carlson, RMK; Schreiner, PR; Fokin, AA; Tkachenko, BA; Fokina, NA; Meevasana, W; Mannella, N; Tanaka, K; Zhou, XJ; van Buuren, T; Kelly, MA; Hussain, Z; Melosh, NA; Shen, ZX				Yang, W. L.; Fabbri, J. D.; Willey, T. M.; Lee, J. R. I.; Dahl, J. E.; Carlson, R. M. K.; Schreiner, P. R.; Fokin, A. A.; Tkachenko, B. A.; Fokina, N. A.; Meevasana, W.; Mannella, N.; Tanaka, K.; Zhou, X. J.; van Buuren, T.; Kelly, M. A.; Hussain, Z.; Melosh, N. A.; Shen, Z.-X.			Monochromatic electron photoemission from diamondoid monolayers	SCIENCE			English	Article							SELF-ASSEMBLED MONOLAYERS; SURFACES; SPECTROSCOPY; THIOL; FILMS; GAAS; GOLD	We found monochromatic electron photoemission from large-area self-assembled monolayers of a functionalized diamondoid, [ 121]tetramantane-6-thiol. Photoelectron spectra of the diamondoid monolayers exhibited a peak at the low-kinetic energy threshold; up to 68% of all emitted electrons were emitted within this single energy peak. The intensity of the emission peak is indicative of diamondoids being negative electron affinity materials. With an energy distribution width of less than 0.5 electron volts, this source of monochromatic electrons may find application in technologies such as electron microscopy, electron beam lithography, and field-emission flat-panel displays.	Stanford Univ, Geballe Lab Adv Mat, Stanford, CA 94305 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Adv Light Source, Berkeley, CA 94720 USA; Lawrence Livermore Natl Lab, Livermore, CA 94550 USA; Chevron Technol Ventures, Mol Diamond Technol, Richmond, CA 94802 USA; Univ Giessen, Inst Organ Chem, D-35392 Giessen, Germany; Kiev Polytech Inst, UA-03056 Kiev, Ukraine	Stanford University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Chevron; Justus Liebig University Giessen; Ministry of Education & Science of Ukraine; Igor Sikorsky Kyiv Polytechnic Institute	Yang, WL (corresponding author), Stanford Univ, Geballe Lab Adv Mat, Stanford, CA 94305 USA.		Willey, Trevor/A-8778-2011; Fokin, Andrey/A-2869-2010; Lee, Jonathan/M-5442-2017; Mannella, Norman/Z-1949-2019; Willey, Trevor/AAJ-9285-2020; Schreiner, Peter Richard R/A-4084-2008; Yang, Wanli/D-7183-2011; Fokin, Andrey A/I-3146-2018	Willey, Trevor/0000-0002-9667-8830; Lee, Jonathan/0000-0001-7316-7643; Mannella, Norman/0000-0002-3490-6041; Willey, Trevor/0000-0002-9667-8830; Schreiner, Peter Richard R/0000-0002-3608-5515; Yang, Wanli/0000-0003-0666-8063; Fokin, Andrey A/0000-0002-6381-8948; TANAKA, Kiyohisa/0000-0003-2779-5870; Van Buuren, Anthony/0000-0002-4488-6742				BAIN CD, 1989, J AM CHEM SOC, V111, P321, DOI 10.1021/ja00183a049; BELI RL, 1973, NEGATIVE ELECT AFFIN; Castner DG, 1996, LANGMUIR, V12, P5083, DOI 10.1021/la960465w; Dahl JE, 2003, SCIENCE, V299, P96, DOI 10.1126/science.1078239; Drummond ND, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.096801; EDEN RC, 1967, PHYS REV LETT, V18, P597, DOI 10.1103/PhysRevLett.18.597; Fokin AA, 2006, J ORG CHEM, V71, P8532, DOI 10.1021/jo061561x; Hahner G, 2006, CHEM SOC REV, V35, P1244, DOI 10.1039/b509853j; HIMPSEL FJ, 1979, PHYS REV B, V20, P624, DOI 10.1103/PhysRevB.20.624; JAMES LW, 1969, PHYS REV, V183, P740, DOI 10.1103/PhysRev.183.740; LAIBINIS PE, 1991, J AM CHEM SOC, V113, P7152, DOI 10.1021/ja00019a011; Love JC, 2005, CHEM REV, V105, P1103, DOI 10.1021/cr0300789; PAOLETTI A, 1997, PHYS DIAMOND; PATE BB, 1986, SURF SCI, V165, P83, DOI 10.1016/0039-6028(86)90665-5; Shaporenko A, 2005, LANGMUIR, V21, P4370, DOI 10.1021/la040118j; Stohr J, 2013, SPRINGE SER SURF SCI; Tkachenko BA, 2006, ORG LETT, V8, P1767, DOI 10.1021/ol053136g; Ulman A, 1996, CHEM REV, V96, P1533, DOI 10.1021/cr9502357; VANDERWEIDE J, 1993, APPL PHYS LETT, V62, P1878, DOI 10.1063/1.109639; Willey TM, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.205432; Willey TM, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.113401; Yang WL, 2003, SCIENCE, V300, P303, DOI 10.1126/science.1082174; Zharnikov M, 2001, J PHYS-CONDENS MAT, V13, P11333, DOI 10.1088/0953-8984/13/49/314	23	218	222	5	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 8	2007	316	5830					1460	1462		10.1126/science.1141811	http://dx.doi.org/10.1126/science.1141811			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176EE	17556579	Green Submitted			2022-12-28	WOS:000247066400037
J	Eder, L; Bitterman, H				Eder, Lihi; Bitterman, Haim			Images in clinical medicine: Amyloid purpura	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Carmel Hosp, IL-34362 Haifa, Israel	Clalit Health Services; Carmel Medical Center	Eder, L (corresponding author), Carmel Hosp, IL-34362 Haifa, Israel.	ben@usha.org.il							0	20	21	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 7	2007	356	23					2406	2406		10.1056/NEJMicm061510	http://dx.doi.org/10.1056/NEJMicm061510			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	175QY	17554122				2022-12-28	WOS:000247029300010
J	Kruhlak, M; Crouch, EE; Orlov, M; Montano, C; Gorski, SA; Nussenzweig, A; Misteli, T; Phair, RD; Casellas, R				Kruhlak, Michael; Crouch, Elizabeth E.; Orlov, Marika; Montano, Carolina; Gorski, Stanislaw A.; Nussenzweig, Andre; Misteli, Tom; Phair, Robert D.; Casellas, Rafael			The ATM repair pathway inhibits RNA polymerase I transcription in response to chromosome breaks	NATURE			English	Article							DOUBLE-STRAND BREAKS; DNA-DAMAGE; CELLS; PHOSPHORYLATION; COMPONENTS; NUCLEOLUS; STRESS; GENOME; KINASE; VIVO	DNA lesions interfere with DNA and RNA polymerase activity. Cyclobutane pyrimidine dimers and photoproducts generated by ultraviolet irradiation cause stalling of RNA polymerase II, activation of transcription-coupled repair enzymes, and inhibition of RNA synthesis(1,2). During the S phase of the cell cycle, collision of replication forks with damaged DNA blocks ongoing DNA replication while also triggering a biochemical signal that suppresses the firing of distant origins of replication(3,4). Whether the transcription machinery is affected by the presence of DNA double-strand breaks remains a long-standing question. Here we monitor RNA polymerase I ( Pol I) activity in mouse cells exposed to genotoxic stress and show that induction of DNA breaks leads to a transient repression in Pol I transcription. Surprisingly, we find Pol I inhibition is not itself the direct result of DNA damage but is mediated by ATM kinase activity and the repair factor proteins NBS1 ( also known as NLRP2) and MDC1. Using live-cell imaging, laser micro-irradiation, and photobleaching technology we demonstrate that DNA lesions interfere with Pol I initiation complex assembly and lead to a premature displacement of elongating holoenzymes from ribosomal DNA. Our data reveal a novel ATM/NBS1/MDC1-dependent pathway that shuts down ribosomal gene transcription in response to chromosome breaks.	NIAMS, NIH, Bethesda, MD 20892 USA; NCI, NIH, Bethesda, MD 20892 USA; Integrat Bioinformat, Los Altos, CA 94024 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Casellas, R (corresponding author), NIAMS, NIH, Bethesda, MD 20892 USA.	casellar@mail.nih.gov		Montano, Carolina/0000-0002-2772-2025; Gorski, Stan/0000-0003-0539-3395; Crouch, Elizabeth/0000-0002-4110-9892; Orlov, Marika/0000-0003-1961-0813	NATIONAL CANCER INSTITUTE [ZIABC010283, Z01BC010283, ZIABC010309, Z01BC010309] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041149, Z01AR041149] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Bartek J, 2004, NAT REV MOL CELL BIO, V5, P792, DOI 10.1038/nrm1493; Chen DY, 2001, J CELL BIOL, V153, P169, DOI 10.1083/jcb.153.1.169; Difilippantonio S, 2005, NAT CELL BIOL, V7, P675, DOI 10.1038/ncb1270; Dundr M, 2002, SCIENCE, V298, P1623, DOI 10.1126/science.1076164; Hanawalt PC, 2002, ONCOGENE, V21, P8949, DOI 10.1038/sj.onc.1206096; Kastan MB, 2000, NAT REV MOL CELL BIO, V1, P179, DOI 10.1038/35043058; Kleiman FE, 2005, GENE DEV, V19, P1227, DOI 10.1101/gad.1309505; Kruhlak MJ, 2006, J CELL BIOL, V172, P823, DOI 10.1083/jcb.200510015; Mari PO, 2006, P NATL ACAD SCI USA, V103, P18597, DOI 10.1073/pnas.0609061103; Mayer C, 2005, CELL CYCLE, V4, P1036, DOI 10.4161/cc.4.8.1925; Mayer C, 2005, GENE DEV, V19, P933, DOI 10.1101/gad.333205; MAYNE LV, 1982, CANCER RES, V42, P1473; Michaelidis TM, 2002, BIOL CHEM, V383, P1683, DOI 10.1515/BC.2002.189; Mone MJ, 2001, EMBO REP, V2, P1013, DOI 10.1093/embo-reports/kve224; Nyberg KA, 2002, ANNU REV GENET, V36, P617, DOI 10.1146/annurev.genet.36.060402.113540; Olson Mark O J, 2004, Sci STKE, V2004, ppe10; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Seither P, 1997, MOL GEN GENET, V255, P180, DOI 10.1007/s004380050487; Shav-Tal Y, 2005, MOL BIOL CELL, V16, P2395, DOI 10.1091/mbc.E04-11-0992; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Stefanovsky V, 2006, MOL CELL, V21, P629, DOI 10.1016/j.molcel.2006.01.023	22	215	220	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 7	2007	447	7145					730	U16		10.1038/nature05842	http://dx.doi.org/10.1038/nature05842			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175RI	17554310				2022-12-28	WOS:000247030700047
J	Haag, AL				Haag, Amanda Leigh			Algae bloom again	NATURE			English	News Item																			0	73	86	3	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 31	2007	447	7144					520	521		10.1038/447520a	http://dx.doi.org/10.1038/447520a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172YZ	17538590				2022-12-28	WOS:000246842000013
J	Bizzarro, M; Ulfbeck, D; Trinquier, A; Thrane, K; Connelly, JN; Meyer, BS				Bizzarro, Martin; Ulfbeck, David; Trinquier, Anne; Thrane, Kristine; Connelly, James N.; Meyer, Bradley S.			Evidence for a late supernova injection of Fe-60 into the protoplanetary disk	SCIENCE			English	Article							NEARBY SUPERNOVA; SOLAR; NUCLEOSYNTHESIS; HETEROGENEITY; WINDS; AL-26	High-precision Fe-60-Ni-60 isotope data show that most meteorites originating from differentiated planetesimals that accreted within 1 million years of the solar system's formation have Ni-60/Ni-58 ratios that are similar to 25 parts per million lower than samples from Earth, Mars, and chondrite parent bodies. This difference indicates that the oldest solar system planetesimals formed in the absence of Fe-60. Evidence for live Fe-60 in younger objects suggests that Fe-60 was injected into the protoplanetary disk similar to 1 million years after solar system formation, when Al-26 was already homogeneously distributed. Decoupling the first appearance of Al-26 and Fe-60 constrains the environment where the Sun's formation could have taken place, indicating that it occurred in a dense stellar cluster in association with numerous massive stars.	Univ Copenhagen, Inst Geol, DK-1350 Copenhagen, Denmark; Univ Copenhagen, Geol Museum, DK-1350 Copenhagen, Denmark; Univ Texas, Jackson Sch Geosci, Austin, TX 78712 USA; Clemson Univ, Dept Phys & Astron, Clemson, SC 29634 USA	University of Copenhagen; University of Copenhagen; University of Texas System; University of Texas Austin; Clemson University	Bizzarro, M (corresponding author), Univ Copenhagen, Inst Geol, OSter Voldgade 10, DK-1350 Copenhagen, Denmark.	bizzarro@geol.ku.dk	Bizzarro, Martin/I-8701-2012; Bizzarro, Martin/M-7474-2019; Connelly, James/O-7996-2015; Trinquier, Anne/AAH-1911-2021; Thrane, Kristine/H-5644-2018	Bizzarro, Martin/0000-0001-9966-2124; Bizzarro, Martin/0000-0001-9966-2124; Thrane, Kristine/0000-0003-2113-6962; trinquier, anne/0000-0002-3959-0090				Amelin Y, 2002, SCIENCE, V297, P1678, DOI 10.1126/science.1073950; AMELIN Y, 2007, LUNAR PLANET SCI, V38, P1669; Arnould M, 2006, ASTRON ASTROPHYS, V453, P653, DOI 10.1051/0004-6361:20053966; Baker J, 2005, NATURE, V436, P1127, DOI 10.1038/nature03882; BAKER JA, 2005, PROT PLAN 5 M HILT W; Bizzarro M, 2005, ASTROPHYS J, V632, pL41, DOI 10.1086/497638; Boss AP, 2006, METEORIT PLANET SCI, V41, P1695, DOI 10.1111/j.1945-5100.2006.tb00445.x; Drake MJ, 2002, NATURE, V416, P39, DOI 10.1038/416039a; Glavin DP, 2004, METEORIT PLANET SCI, V39, P693, DOI 10.1111/j.1945-5100.2004.tb00112.x; HESTER JJ, 2005, CHONDRITES PROTOPLAN, P107; JACOBSEN SB, 2005, CHONDRITES PROTOPLAN, P548; JONES JH, 1983, GEOCHIM COSMOCHIM AC, V47, P1199, DOI [10.1016/0016-7037(83)90062-5, 10.1016/0016-7037(86)90405-9]; Limongi M, 2006, ASTROPHYS J, V647, P483, DOI 10.1086/505164; MARKOWSKI A, 2006, METEORIT PLANET SCI, V41, P5195; MEYER BS, 2005, CHONDRITES PROTOPLAN, P515; Meynet G, 2005, ASTRON ASTROPHYS, V429, P581, DOI 10.1051/0004-6361:20047106; Mostefaoui S, 2005, ASTROPHYS J, V625, P271, DOI 10.1086/429555; OUELLETTE N, 2005, CHONDRITES PROTOPLAN, P527; Palacios A, 2005, ASTRON ASTROPHYS, V429, P613, DOI 10.1051/0004-6361:20041757; Rathborne JM, 2002, MON NOT R ASTRON SOC, V331, P85, DOI 10.1046/j.1365-8711.2002.05149.x; Shu FH, 1997, SCIENCE, V277, P1475, DOI 10.1126/science.277.5331.1475; SHUKOLYUKOV A, 1993, EARTH PLANET SC LETT, V119, P159, DOI 10.1016/0012-821X(93)90013-Y; SHUKOLYUKOV A, 2006, LUNAR PLANET SCI, V38, P1478; Tachibana S, 2006, ASTROPHYS J, V639, pL87, DOI 10.1086/503201; Thrane K, 2006, ASTROPHYS J, V646, pL159, DOI 10.1086/506910; Trinquier A, 2007, ASTROPHYS J, V655, P1179, DOI 10.1086/510360; Wasserburg GJ, 2006, NUCL PHYS A, V777, P5, DOI 10.1016/j.nuclphysa.2005.07.015; Woosley SE, 1997, ASTROPHYS J, V476, P801, DOI 10.1086/303650	30	81	83	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2007	316	5828					1178	1181		10.1126/science.1141040	http://dx.doi.org/10.1126/science.1141040			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171GQ	17525336				2022-12-28	WOS:000246724300039
J	Landry, CR; Lemos, B; Rifkin, SA; Dickinson, WJ; Hartl, DL				Landry, Christian R.; Lemos, Bernardo; Rifkin, Scott A.; Dickinson, W. J.; Hartl, Daniel L.			Genetic properties influencing the evolvability of gene expression	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; EVOLUTION; GENOME; CANALIZATION; PROFILES; MUTATION; REVEALS; YEAST; NOISE; CONSEQUENCES	Identifying the properties of gene networks that influence their evolution is a fundamental research goal. However, modes of evolution cannot be inferred solely from the distribution of natural variation, because selection interacts with demography and mutation rates to shape polymorphism and divergence. We estimated the effects of naturally occurring mutations on gene expression while minimizing the effect of natural selection. We demonstrate that sensitivity of gene expression to mutations increases with both increasing trans-mutational target size and the presence of a TATA box. Genes with greater sensitivity to mutations are also more sensitive to systematic environmental perturbations and stochastic noise. These results provide a mechanistic basis for gene expression evolvability that can serve as a foundation for realistic models of regulatory evolution.	Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Harvard University; Utah System of Higher Education; University of Utah	Landry, CR (corresponding author), Univ Montreal, Dept Biochim, 2900 Blvd Edouard Montpetit, Montreal, PQ H3T 1J4, Canada.	clandry@post.harvard.edu; blemos@oeb.harvard.edu	Landry, Christian R/F-3890-2011; Lemos, Bernardo/AAL-2429-2020	Lemos, Bernardo/0000-0001-6996-9483; Landry, Christian/0000-0003-3028-6866; Rifkin, Scott/0000-0001-8476-3256				Basehoar AD, 2004, CELL, V116, P699, DOI 10.1016/S0092-8674(04)00205-3; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Denver DR, 2005, NAT GENET, V37, P544, DOI 10.1038/ng1554; Featherstone DE, 2002, BIOESSAYS, V24, P267, DOI 10.1002/bies.10054; Gibson G, 2000, BIOESSAYS, V22, P372, DOI 10.1002/(SICI)1521-1878(200004)22:4<372::AID-BIES7>3.0.CO;2-J; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Huisinga KL, 2004, MOL CELL, V13, P573, DOI 10.1016/S1097-2765(04)00087-5; Kim JW, 2004, MOL CELL BIOL, V24, P8104, DOI 10.1128/MCB.24.18.8104-8112.2004; Landry CR, 2006, GENE, V366, P343, DOI 10.1016/j.gene.2005.10.042; Lemos B, 2005, MOL BIOL EVOL, V22, P1345, DOI 10.1093/molbev/msi122; Lemos B, 2005, EVOLUTION, V59, P126; Lemos B, 2004, NAT GENET, V36, P1059, DOI 10.1038/ng1427; Lenski RE, 2006, PLOS BIOL, V4, P2190, DOI 10.1371/journal.pbio.0040428; LYNCH M, 1988, GENET RES, V51, P137, DOI 10.1017/S0016672300024150; Lynch M., 1998, GENETICS ANAL QUANTI; Meiklejohn CD, 2002, TRENDS ECOL EVOL, V17, P468, DOI 10.1016/S0169-5347(02)02596-X; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; OHTA T, 1973, NATURE, V246, P96, DOI 10.1038/246096a0; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Rifkin SA, 2005, NATURE, V438, P220, DOI 10.1038/nature04114; Tirosh I, 2006, NAT GENET, V38, P830, DOI 10.1038/ng1819; Townsend JP, 2003, MOL BIOL EVOL, V20, P955, DOI 10.1093/molbev/msg106; Wagner GP, 1997, EVOLUTION, V51, P329, DOI [10.2307/2411105, 10.1111/j.1558-5646.1997.tb02420.x]	24	234	236	0	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 6	2007	317	5834					118	121		10.1126/science.1140247	http://dx.doi.org/10.1126/science.1140247			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186KD	17525304				2022-12-28	WOS:000247776700065
J	Breidthardt, T; Namdar, M; Hess, B				Breidthardt, Tobias; Namdar, Mehdi; Hess, Bernhard			Limits of radiology	LANCET			English	Editorial Material									Univ Zurich Hosp, Ctr Cardiovasc, CH-8091 Zurich, Switzerland; Univ Basel Hosp, Dept Internal Med, CH-4031 Basel, Switzerland; Klin Pk, CH-8038 Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Basel	Namdar, M (corresponding author), Univ Zurich Hosp, Ctr Cardiovasc, Ramistr 100, CH-8091 Zurich, Switzerland.	mehdi.namdar@usz.ch	Hess, Bernhard/GNP-1214-2022	Breidthardt, Tobias/0000-0003-2671-6456; Namdar, Mehdi/0000-0002-5779-7431					0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 16	2007	369	9578					2030	2030		10.1016/S0140-6736(07)60943-X	http://dx.doi.org/10.1016/S0140-6736(07)60943-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	180HT	17574094	Bronze			2022-12-28	WOS:000247354400027
J	Wald, NJ; Oakley, GP				Wald, Nicholas J.; Oakley, Godfrey P.			Should folic acid fortification be mandatory?	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London, Queen Marys Sch Med & Dent, Wolfson Inst Prevent Med, London EC1M 6BQ, England; Emory Univ, Dept Epidemiol, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA	University of London; Queen Mary University London; Emory University; Rollins School Public Health	Wald, NJ (corresponding author), Univ London, Queen Marys Sch Med & Dent, Wolfson Inst Prevent Med, London EC1M 6BQ, England.	n.j.wald@qmul.ac.uk	Wald, Nicholas/AAY-8924-2021; Wald, Nicholas/AAY-2814-2021						0	22	23	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUN 16	2007	334	7606					1252	1252		10.1136/bmj.39232.493252.47	http://dx.doi.org/10.1136/bmj.39232.493252.47			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	183AM	17569931	Green Published			2022-12-28	WOS:000247545100030
J	Kleiner, K				Kleiner, Kurt			Shades of success	NATURE			English	News Item																			0	0	0	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 14	2007	447	7146					766	767		10.1038/447766a	http://dx.doi.org/10.1038/447766a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178FV	17568718				2022-12-28	WOS:000247207500014
J	Gilligan, D; Nicolson, M; Smith, I; Groen, H; Dalesio, O; Goldstraw, P; Hatton, M; Hopwood, P; Manegold, C; Schramel, F; Smit, H; van Meerbeeck, J; Nankivell, M; Parmar, M; Pugh, C; Stephens, R				Gilligan, David; Nicolson, Marianne; Smith, Ian; Groen, Harry; Dalesio, Otilia; Goldstraw, Peter; Hatton, Matthew; Hopwood, Penelope; Manegold, Christian; Schramel, Franz; Smit, Hans; van Meerbeeck, Jan; Nankivell, Matthew; Parmar, Mahesh; Pugh, Cheryl; Stephens, Richard			Preoperative chemotherapy in patients with resectable non-small cell lung cancer: results of the MRC LU22/NVALT 2/EORTC 08012 multicentre randomised trial and update of systematic review	LANCET			English	Article							COMPARING PERIOPERATIVE CHEMOTHERAPY; GROWTH-STIMULATING FACTOR; PRIMARY TUMOR REMOVAL; SURGERY; METAANALYSIS	Background Although surgery offers the best chance of cure for patients with non-small cell lung cancer (NSCLC), the overall 5-year survival rate is modest, and improvements are urgently needed. In the 1990s, much interest was generated from two small trials that reported striking results with neo-adjuvant chemotherapy, and therefore our intergroup randomised trial was designed to investigate whether, in patients with operable non-small cell lung cancer of any stage, outcomes could be improved by giving platinum-based chemotherapy before surgery. Methods Patients were randomised to receive either surgery alone (S), or three cycles of platinum-based chemotherapy followed by surgery (CT-S). Before randomisation, clinicians chose the chemotherapy that would be given from a list of six standard regimens. The primary outcome measure was overall survival, which was analysed on an intention-to-treat basis. This study is registered as an International Standard Randomised Controlled Trial, number ISRCTN25582437. Results 519 patients were randomised (S: 261, CT-S: 258) from 70 centres in the UK, Netherlands, Germany, and Belgium. Most (61%) were clinical stage I, with 31% stage II, and 7% stage III. Neo-adjuvant chemotherapy was feasible (75% of patients received all three cycles of chemotherapy), resulted in a good response rate (49% [95% CI 43%-55%]) and down-staging in 31% (25%-37%) of patients, and did not alter the type or completeness of the surgery (lobectomy: S: 56%, CT-S: 60%, complete resection: S: 80%, CT-S: 82%). Post-operative complications were not increased in the CT-S group, and no impairment of quality of life was observed. However, there was no evidence of a benefit in terms of overall survival (hazard ratio [HR] 1.02, 95% Cl 0.80-1.31, p=0.86). Updating the systematic review by addition of the present result suggests a 12% relative survival benefit with the addition of neoadjuvant chemotherapy (1507 patients, HR 0.88, 95% CI 0.76-1.01, p=0.07), equivalent to an absolute improvement in survival of 5% at 5 years Interpretation Although there was no evidence of a difference in overall survival with neo-adjuvant chemotherapy, the result is statistically consistent with previous trials, and therefore adds considerable weight to the current evidence.	Addenbrookes Hosp, Cambridge, England; Aberdeen Royal Hosp Trust, Aberdeen, Scotland; Royal Marsden Hosp, London SW3 6JJ, England; Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands; Netherlands Canc Inst, Amsterdam, Netherlands; Royal Brompton Hosp, London SW3 6LY, England; Weston Pk Hosp, Sheffield, S Yorkshire, England; Christie & Wythenshawe Hosp Natl Hlth Serv Trusts, Manchester, Lancs, England; Heidelberg Univ, Univ Med Ctr Mannheim, Heidelberg, Germany; St Antonius Hosp, Nieuwegein, Netherlands; Rijnstate Hosp Arnhem, Arnhem, Netherlands; Univ Hosp, Ghent, Belgium; MRC, Clin Trials Unit, London NW1 2DA, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Royal Marsden NHS Foundation Trust; University of Groningen; Netherlands Cancer Institute; Royal Brompton Hospital; Weston Park Hospital; Christie NHS Foundation Trust; Christie Hospital; Wythenshawe Hospital NHS Foundation Trust; Ruprecht Karls University Heidelberg; St. Antonius Hospital Utrecht; Rijnstate Hospital; Ghent University; Ghent University Hospital; Medical Research Council Clinical Trials Unit	Stephens, R (corresponding author), MRC, Clin Trials Unit, London NW1 2DA, England.	rs@ctu.mrc.ac.uk	van Meerbeeck, Jan/ABA-5109-2020; Groen, Harry/AAP-2242-2021	Groen, Harry J.M./0000-0002-2978-5265	Medical Research Council [MC_U122861375] Funding Source: Medline; MRC [MC_U122861375] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ALBERTI W, 1995, BRIT MED J, V311, P899; Balduyck B, 2007, LUNG CANCER, V56, P423, DOI 10.1016/j.lungcan.2007.01.013; Burdett S, 1998, LANCET, V352, P257; Burdett S, 2006, J THORAC ONCOL, V1, P611; DAUTZENBERG B, 1990, CANCER, V65, P2435, DOI 10.1002/1097-0142(19900601)65:11<2435::AID-CNCR2820651105>3.0.CO;2-2; Depierre A, 2002, J CLIN ONCOL, V20, P247, DOI 10.1200/JCO.20.1.247; FISHER B, 1989, CANCER RES, V49, P2002; FISHER B, 1989, CANCER RES, V49, P1996; Hotta K, 2004, J CLIN ONCOL, V22, P3860, DOI 10.1200/JCO.2004.01.153; Mountain CF, 1997, CHEST, V111, P1710, DOI 10.1378/chest.111.6.1710; MOUNTAIN CF, 1977, ANN THORAC SURG, V24, P365, DOI 10.1016/S0003-4975(10)63416-9; Nagai K, 2003, J THORAC CARDIOV SUR, V125, P254, DOI 10.1067/mtc.2003.15; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Pignon JP, 2006, J CLIN ONCOL, V24, p366S; PISTERS K, 2005, P ASCO, V24; Rosell R, 1999, LUNG CANCER, V26, P7, DOI 10.1016/S0169-5002(99)00045-8; ROSELL R, 1994, NEW ENGL J MED, V330, P153, DOI 10.1056/NEJM199401203300301; Roth JA, 1998, LUNG CANCER-J IASLC, V21, P1, DOI 10.1016/S0169-5002(98)00046-4; ROTH JA, 1994, J NATL CANCER I, V86, P673, DOI 10.1093/jnci/86.9.673; SORENSEN JB, 2005, P AN M AM SOC CLIN, V24, P7146; Wachowicz Malgorzata, 2003, Pneumonol Alergol Pol, V71, P121; Ware JE, SF 36 HLTH SURVEY MA; *WHO, WHO OFFS PUBL, V48; Ychou M, 2006, J CLIN ONCOL, V24, p185S	24	225	233	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 9	2007	369	9577					1929	1937		10.1016/S0140-6736(07)60714-4	http://dx.doi.org/10.1016/S0140-6736(07)60714-4			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	177IQ	17544497				2022-12-28	WOS:000247147200026
J	Sakellariou, D; Le Goff, G; Jacquinot, JF				Sakellariou, D.; Le Goff, G.; Jacquinot, J.-F.			High-resolution, high-sensitivity NMR of nanolitre anisotropic samples by coil spinning	NATURE			English	Article							NUCLEAR-MAGNETIC-RESONANCE; LIQUID-STATE NMR; TO-NOISE RATIO; H-1-NMR SPECTROSCOPY; SINGLE NEURONS; MICROCOILS; DESIGN; SPECTRA; PROBE	Nuclear magnetic resonance ( NMR) can probe the local structure and dynamic properties of liquids and solids, making it one of the most powerful and versatile analytical methods available today. However, its intrinsically low sensitivity precludes NMR analysis of very small samples - as frequently used when studying isotopically labelled biological molecules or advanced materials, or as preferred when conducting high-throughput screening of biological samples or 'lab-on-a-chip' studies. The sensitivity of NMR has been improved by using static micro-coils(1), alternative detection schemes(2,3) and pre-polarization approaches(4). But these strategies cannot be easily used in NMR experiments involving the fast sample spinning essential for obtaining well-resolved spectra(5,6) from non-liquid samples. Here we demonstrate that inductive coupling allows wireless transmission of radio-frequency pulses and the reception of NMR signals under fast spinning of both detector coil and sample. This enables NMR measurements characterized by an optimal filling factor, very high radio-frequency field amplitudes and enhanced sensitivity that increases with decreasing sample volume. Signals obtained for nanolitre-sized samples of organic powders and biological tissue increase by almost one order of magnitude ( or, equivalently, are acquired two orders of magnitude faster), compared to standard NMR measurements. Our approach also offers optimal sensitivity when studying samples that need to be confined inside multiple safety barriers, such as radioactive materials. In principle, the co-rotation of a micrometre-sized detector coil with the sample and the use of inductive coupling ( techniques that are at the heart of our method) should enable highly sensitive NMR measurements on any mass-limited sample that requires fast mechanical rotation to obtain well-resolved spectra. The method is easy to implement on a commercial NMR set-up and exhibits improved performance with miniaturization, and we accordingly expect that it will facilitate the development of novel solid-state NMR methodologies and find wide use in high-throughput chemical and biomedical analysis.	CEA Saclay, Lab Struct & Dynam Resonance Magnet, Serv Chim Mol, CNRS,DSM DRECAM SCM,URA 331, F-91191 Gif Sur Yvette, France; CEA Saclay, Serv Phys Etat Condense, DSM DRECAM SPEC, CNRS,URA 2464, F-91191 Gif Sur Yvette, France	CEA; Centre National de la Recherche Scientifique (CNRS); CEA; Centre National de la Recherche Scientifique (CNRS)	Sakellariou, D (corresponding author), CEA Saclay, Lab Struct & Dynam Resonance Magnet, Serv Chim Mol, CNRS,DSM DRECAM SCM,URA 331, F-91191 Gif Sur Yvette, France.	dimitrios.sakellariou@cea.fr	Sakellariou, Dimitrios/O-7949-2019; Sakellariou, Dimitrios/F-2846-2010	Sakellariou, Dimitrios/0000-0001-7424-5543; Sakellariou, Dimitrios/0000-0001-7424-5543				ANDREW ER, 1958, NATURE, V182, P1659, DOI 10.1038/1821659a0; Ardenkjaer-Larsen JH, 2003, P NATL ACAD SCI USA, V100, P10158, DOI 10.1073/pnas.1733835100; BARBARA TM, 1994, J MAGN RESON SER A, V109, P265, DOI 10.1006/jmra.1994.1168; Brey WW, 2006, J MAGN RESON, V179, P290, DOI 10.1016/j.jmr.2005.12.008; Chen JH, 2003, MAGNET RESON MED, V50, P515, DOI 10.1002/mrm.10569; Cheng LL, 1997, P NATL ACAD SCI USA, V94, P6408, DOI 10.1073/pnas.94.12.6408; Farnan I, 2004, REV SCI INSTRUM, V75, P5232, DOI 10.1063/1.1818512; Ginefri JC, 2001, MAGNET RESON MED, V45, P376, DOI 10.1002/1522-2594(200103)45:3<376::AID-MRM1049>3.0.CO;2-R; Govindaraju V, 2000, NMR BIOMED, V13, P129, DOI 10.1002/1099-1492(200005)13:3<129::AID-NBM619>3.0.CO;2-V; Grant SC, 2000, MAGNET RESON MED, V44, P19, DOI 10.1002/1522-2594(200007)44:1<19::AID-MRM4>3.0.CO;2-F; Grant SC, 2001, MAGN RESON MED, V46, P1107, DOI 10.1002/mrm.1306; Hoult DI, 2002, CONCEPT MAGNETIC RES, V15, P262, DOI 10.1002/cmr.10047; HOULT DI, 1976, J MAGN RESON, V24, P71, DOI 10.1016/0022-2364(76)90233-X; Hu JZ, 2002, MAGNET RESON MED, V47, P829, DOI 10.1002/mrm.10139; Janssen H, 2006, J AM CHEM SOC, V128, P8722, DOI 10.1021/ja061350+; LOWE IJ, 1959, PHYS REV LETT, V2, P285, DOI 10.1103/PhysRevLett.2.285; Malba V, 2003, BIOMED MICRODEVICES, V5, P21, DOI 10.1023/A:1024407231584; Minard KR, 2002, J MAGN RESON, V154, P336, DOI 10.1006/jmre.2001.2494; OLSON DL, 1995, SCIENCE, V270, P1967, DOI 10.1126/science.270.5244.1967; RAAD A, 1992, MAGN RESON IMAGING, V10, P55, DOI 10.1016/0730-725X(92)90373-8; Rogers JA, 1997, APPL PHYS LETT, V70, P2464, DOI 10.1063/1.118857; RUGAR D, 1994, SCIENCE, V264, P1560, DOI 10.1126/science.264.5165.1560; Savukov IM, 2006, NATURE, V442, P1021, DOI 10.1038/nature05088; SCHNALL MD, 1986, J MAGN RESON, V68, P161, DOI 10.1016/0022-2364(86)90326-4; Terman F. E., 1955, ELECT RADIO ENG; TURNER JD, 1989, J PHYS E SCI INSTRUM, V22, P82, DOI 10.1088/0022-3735/22/2/003; van Bentum PJM, 2004, ANALYST, V129, P793, DOI 10.1039/b404497p; Webb AG, 1997, PROG NUCL MAG RES SP, V31, P1, DOI 10.1016/S0079-6565(97)00004-6; Wu J, 2004, J MICROMECH MICROENG, V14, P576, DOI 10.1088/0960-1317/14/4/019; Yamauchi K, 2004, J MAGN RESON, V167, P87, DOI 10.1016/j.jmr.2003.12.003	30	132	137	3	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 7	2007	447	7145					694	+		10.1038/nature05897	http://dx.doi.org/10.1038/nature05897			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175RI	17554303				2022-12-28	WOS:000247030700039
J	Wadman, M				Wadman, Meredith			Meeting in the middle	NATURE			English	News Item																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 7	2007	447	7145					629	629		10.1038/447629a	http://dx.doi.org/10.1038/447629a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175RI	17554281	Bronze			2022-12-28	WOS:000247030700014
J	Bevan, MJ				Bevan, Michael J.			Immunology - The cutting edge of T cell selection	SCIENCE			English	Editorial Material							RECEPTOR		Univ Washington, Howard Hughes Med Inst, Dept Immunol, Seattle, WA 98195 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Bevan, MJ (corresponding author), Univ Washington, Howard Hughes Med Inst, Dept Immunol, Box 357370, Seattle, WA 98195 USA.	mbevan@u.washington.edu						Daniels MA, 2006, NATURE, V444, P724, DOI 10.1038/nature05269; Goldrath AW, 1999, NATURE, V402, P255, DOI 10.1038/35005508; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; MARRACK P, 1987, SCIENCE, V238, P1073, DOI 10.1126/science.3317824; Murata S, 2007, SCIENCE, V316, P1349, DOI 10.1126/science.1141915; Nakagawa T, 1998, SCIENCE, V280, P450, DOI 10.1126/science.280.5362.450; Nil A, 2004, EUR J IMMUNOL, V34, P2681, DOI 10.1002/eji.200425032; RAMMENSEE HG, 1993, ANNU REV IMMUNOL, V11, P213, DOI 10.1146/annurev.iy.11.040193.001241	8	4	4	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 1	2007	316	5829					1291	1292		10.1126/science.1143806	http://dx.doi.org/10.1126/science.1143806			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	173PS	17540889				2022-12-28	WOS:000246885600034
J	Behrens, MR; Mutlu, N; Chakraborty, S; Dumitru, R; Jiang, WZ; LaVallee, BJ; Herman, PL; Clemente, TE; Weeks, DP				Behrens, Mark R.; Mutlu, Nedim; Chakraborty, Sarbani; Dumitru, Razvan; Jiang, Wen Zhi; LaVallee, Bradley J.; Herman, Patricia L.; Clemente, Thomas E.; Weeks, Donald P.			Dicamba resistance: Enlarging and preserving biotechnology-based weed management strategies	SCIENCE			English	Article							PSEUDOMONAS-MALTOPHILIA; O-DEMETHYLASE; STRAIN DI-6; HEALTH	The advent of biotechnology-derived, herbicide-resistant crops has revolutionized farming practices in many countries. Facile, highly effective, environmentally sound, and profitable weed control methods have been rapidly adopted by crop producers who value the benefits associated with biotechnology-derived weed management traits. But a rapid rise in the populations of several troublesome weeds that are tolerant or resistant to herbicides currently used in conjunction with herbicide-resistant crops may signify that the useful lifetime of these economically important weed management traits will be cut short. We describe the development of soybean and other broadleaf plant species resistant to dicamba, a widely used, inexpensive, and environmentally safe herbicide. The dicamba resistance technology will augment current herbicide resistance technologies and extend their effective lifetime. Attributes of both nuclear- and chloroplast-encoded dicamba resistance genes that affect the potency and expected durability of the herbicide resistance trait are examined.	Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA; Univ Nebraska, Ctr Biotechnol, Lincoln, NE 68588 USA; Univ Nebraska, Dept Agron & Hort, Lincoln, NE 68588 USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Weeks, DP (corresponding author), Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA.	dweeks1@unl.edu	Mutlu, Nedim/B-9280-2016; MUTLU, Nedim/AAB-9844-2020	MUTLU, Nedim/0000-0001-7252-5883; Behrens, Mark/0000-0001-8230-120X				[Anonymous], [No title captured]; Cerdeira AL, 2006, J ENVIRON QUAL, V35, P1633, DOI 10.2134/jeq2005.0378; Chakraborty S, 2005, ARCH BIOCHEM BIOPHYS, V437, P20, DOI 10.1016/j.abb.2005.02.024; CORK DJ, 1991, ADV APPL MICROBIOL, V36, P1; Dufourmantel N, 2004, PLANT MOL BIOL, V55, P479, DOI 10.1007/s11103-004-0192-4; Herman PL, 2005, J BIOL CHEM, V280, P24759, DOI 10.1074/jbc.M500597200; Hossain F, 2004, INT J OCCUP ENV HEAL, V10, P296, DOI 10.1179/oeh.2004.10.3.296; Huang JK, 2005, SCIENCE, V308, P688, DOI 10.1126/science.1108972; *INT SERV ACQ AGR, 2006, GLOB STAT COMM BIOT; Maiti IB, 1998, BIOCHEM BIOPH RES CO, V244, P440, DOI 10.1006/bbrc.1998.8287; Maliga P, 2005, PHOTOCH PHOTOBIO SCI, V4, P971, DOI 10.1039/b514699m; Steven JT, 1991, HDB PESTICIDE TOXICO, P1317; *US EPA OFF DRINK, 1988, HLTH ADV SUMM DIC; Wang XZ, 1997, APPL ENVIRON MICROB, V63, P1623, DOI 10.1128/AEM.63.4.1623-1626.1997; *WEED SCI SOC AM, 1994, HERB HDB; YANG J, 1994, ANAL BIOCHEM, V219, P37, DOI 10.1006/abio.1994.1228; EXTOXNET PESTICDE IN	17	197	241	6	99	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2007	316	5828					1185	1188		10.1126/science.1141596	http://dx.doi.org/10.1126/science.1141596			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171GQ	17525337	Green Published			2022-12-28	WOS:000246724300041
J	Barsh, G; Attardi, LD				Barsh, Gregory; Attardi, Laura D.			Clinical implications of basic research: A healthy tan?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PIGMENTATION; RECEPTOR		Stanford Univ, Sch Med, Stanford, CA 94305 USA	Stanford University	Barsh, G (corresponding author), Stanford Univ, Sch Med, Stanford, CA 94305 USA.							Cui RT, 2007, CELL, V128, P853, DOI 10.1016/j.cell.2006.12.045; Rees JL, 2004, AM J HUM GENET, V75, P739, DOI 10.1086/425285; Slominski A, 2005, ENDOCRINOLOGY, V146, P1245, DOI 10.1210/en.2004-0733; Suzuki I, 1999, J INVEST DERM SYMP P, V4, P29, DOI 10.1038/sj.jidsp.5640177; Tsatmali M, 2000, PIGM CELL RES, V13, P125, DOI 10.1034/j.1600-0749.13.s8.22.x	5	17	17	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 24	2007	356	21					2208	2210		10.1056/NEJMcibr071775	http://dx.doi.org/10.1056/NEJMcibr071775			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	170ON	17522405				2022-12-28	WOS:000246673100016
J	Mullan, F; Frehywot, S				Mullan, Fitzhugh; Frehywot, Seble			Non-physician clinicians in 47 sub-Saharan African countries	LANCET			English	Article							PRIMARY-CARE	Many countries have health-care providers who are not trained as physicians but who take on many of the diagnostic and clinical functions of medical doctors. We identified non-physician clinicians (NPCs) in 25 of 47 countries in sub-Saharan Africa, although their roles varied widely between countries. In nine countries, numbers of NPCs equalled or exceeded numbers of physicians. In general NPCs were trained with less cost than were physicians, and for only 3-4 years after secondary school. All NPCs did basic diagnosis and medical treatment, but some were trained in specialty activities such as Caesarean section, ophthalmology, and anaesthesia. Many NPCs were recruited from rural and poor areas, and worked in these same regions. Low training costs, reduced training duration, and success in rural placements suggest that NPCs could have substantial roles in the scale-up of health workforces in sub-Saharan African countries, including for the planned expansion of HIV/AIDS prevention and treatment programmes.	[Mullan, Fitzhugh; Frehywot, Seble] George Washington Univ, Sch Publ Hlth & Hlth Serv, Dept Hlth Policy, Washington, DC 20006 USA	George Washington University	Mullan, F (corresponding author), George Washington Univ, Sch Publ Hlth & Hlth Serv, Dept Hlth Policy, 2021 K St NW, Washington, DC 20006 USA.	fmullan@gwu.edu						ADAIR M, 2006, 16 INT AIDS C TOR CA; *AMREF, 2006, STOP AFR BRAIN DRAIN; [Anonymous], 2004, HUM RES HLTH OV CRIS; Beck A., 1970, HIST BRIT MED ADM E, P71; Bryan L, 2006, INVESTING TANZANIAN; Buchan J. M. D., 2003, GLOBAL WORKFORCE STR, V21, P275; *CART CTR, 1997, CART CTR ETH PUBL HL; Cheung Y B, 1995, Community Dev J, V30, P317; Cooper RA, 1998, JAMA-J AM MED ASSOC, V280, P788, DOI 10.1001/jama.280.9.788; Dovlo Delanyo, 2004, Hum Resour Health, V2, P7, DOI 10.1186/1478-4491-2-7; Druss BG, 2003, NEW ENGL J MED, V348, P130, DOI 10.1056/NEJMsa020993; DUGGER C, 2004, NY TIMES        1123; Fenton PM, 2003, BRIT MED J, V327, P587, DOI 10.1136/bmj.327.7415.587; FULOP T, 1987, 83 WHO; GHEBREYESUS TA, 2006, P 2006 CLINT GLOB IN; Grumbach K, 1998, JAMA-J AM MED ASSOC, V280, P825, DOI 10.1001/jama.280.9.825; HELLER R, 1978, MED HIST, V22, P25, DOI 10.1017/S0025727300031732; Hongoro C, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1309; JANSSENS PG, 1997, HLTH CENTRAL AFRIC, P113; KNOTT P, 2000, HOSP PHYS, V36, P67; Lesotho Ministry of Health and Social Welfare, 2004, HUM RES DEV STRAT PL; MARYINEZ L, 2004, CRISIS HUMAN RESOURC; *MIN HLTH ETH, 2005, GUID IMPL ANT VIR TH; *MIN HLTH POP, 2003, CLIN OFF MAL ANN REP; *MIN HLTH SAN, 2006, HUM RES HLTH; MWAGIRU D, MARIDI HLTH TRAIN I; NGOMA E, 2005, ED HLTH MIN GIV 60 D; *NIG MED ASS, 2005, COMM ISS END M NAT E; Nkumbe H, 2005, REPORT HUMAN RESOURC; NWADIBIA AG, 2001, AM J HLTH PROMOTION, V3; *OFF AC REG KIU, 2002, COURS GUID; OLOO A, 2003, E AFRICAN       1109; Ramer S, 1976, Bull Hist Med, V50, P213; Resnick Andrew S, 2006, Curr Surg, V63, P155, DOI 10.1016/j.cursur.2005.12.009; ROEMER MI, 1977, INT J HEALTH SERV, V7, P545, DOI 10.2190/PWAR-VJ44-AQ79-CKGC; *S AFR MIN HLTH, 2005, STRAT FRAM HUM RES H; SHIBESSHI W, 2004, P PROCOR GLOB C CARD; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; *TROP HLTH ED TRUS, GHAN COUNTR REP; TSHABALAMSIMANG M, 2004, LAUNCH MED ASS PROGR; Vaz F, 1999, B WORLD HEALTH ORGAN, V77, P688; VERGARA A, 2005, 2 ANN FIELD M SUPP N; *WHO, 2006, GLOB ATL HLTH WORK F; WILSON B, 2005, DEV COUNTRIES SEE HL; World Health Organization (WHO), 2006, WORLD HLTH REP 2006; PHYS HUMAN RIGHTS G8	46	293	294	0	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC-JAN	2007	370	9605					2158	2163		10.1016/S0140-6736(07)60785-5	http://dx.doi.org/10.1016/S0140-6736(07)60785-5			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	247DY	17574662				2022-12-28	WOS:000252058600037
J	Martrat, B; Grimalt, JO; Shackleton, NJ; de Abreu, L; Hutterli, MA; Stocker, TF				Martrat, Belen; Grimalt, Joan O.; Shackleton, Nicholas J.; de Abreu, Lucia; Hutterli, Manuel A.; Stocker, Thomas F.			Four climate cycles of recurring deep and surface water destabilizations on the Iberian margin	SCIENCE			English	Article							NORTH-ATLANTIC; THERMOHALINE CIRCULATION; PLANKTONIC-FORAMINIFERA; SOUTHERN EUROPE; SCALE; VARIABILITY; INSTABILITY; GREENLAND; RECORDS; OCEAN	Centennial climate variability over the last ice age exhibits clear bipolar behavior. High-resolution analyses of marine sediment cores from the Iberian margin trace a number of associated changes simultaneously. Proxies of sea surface temperature and water mass distribution, as well as relative biomarker content, demonstrate that this typical north-south coupling was pervasive for the cold phases of climate during the past 420,000 years. Cold episodes after relatively warm and largely ice-free periods occurred when the predominance of deep water formation changed from northern to southern sources. These results reinforce the connection between rapid climate changes at Mediterranean latitudes and century-to-millennial variability in northern and southern polar regions.	IIQAB CSIC, Dept Environm Chem, Chem & Environm Res Inst Barcelona, Spanish Natl Res Council, Barcelona 08034, Spain; Univ Cambridge, Dept Earth Sci, Godwin Lab Palaeoclimate Res, Cambridge CB2 3EQ, England; British Antarctic Survey, Cambridge CB3 0ET, England; Univ Bern, Inst Phys, CH-3012 Bern, Switzerland	Consejo Superior de Investigaciones Cientificas (CSIC); University of Cambridge; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; University of Bern	Grimalt, JO (corresponding author), IIQAB CSIC, Dept Environm Chem, Chem & Environm Res Inst Barcelona, Spanish Natl Res Council, Barcelona 08034, Spain.	jgoqam@cid.csic.es	Grimalt, Joan O/E-2073-2011; Stocker, Thomas/B-1273-2013; Martrat, Belen/I-5952-2015	Grimalt, Joan O/0000-0002-7391-5768; Martrat, Belen/0000-0001-9904-9178	NERC [bas010016] Funding Source: UKRI; Natural Environment Research Council [bas010016] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Adkins JF, 2005, QUATERNARY SCI REV, V24, P581, DOI 10.1016/j.quascirev.2004.11.005; Allen JRM, 1999, NATURE, V400, P740, DOI 10.1038/23432; Alley RB, 2003, SCIENCE, V299, P2005, DOI 10.1126/science.1081056; Andersen KK, 2004, NATURE, V431, P147, DOI 10.1038/nature02805; Augustin L, 2004, NATURE, V429, P623, DOI 10.1038/nature02599; Bar-Matthews M, 2003, GEOCHIM COSMOCHIM AC, V67, P3181, DOI 10.1016/S0016-7037(02)01031-1; Barbante C, 2006, NATURE, V444, P195, DOI 10.1038/nature05301; Bard E, 2004, QUATERNARY RES, V61, P204, DOI 10.1016/j.yqres.2003.11.006; BERGER AL, 1978, J ATMOS SCI, V35, P2362, DOI 10.1016/0033-5894(78)90064-9; Blunier T, 2001, SCIENCE, V291, P109, DOI 10.1126/science.291.5501.109; Bond G, 1997, SCIENCE, V278, P1257, DOI 10.1126/science.278.5341.1257; BOND G, 1993, NATURE, V365, P143, DOI 10.1038/365143a0; Cacho I, 1999, PALEOCEANOGRAPHY, V14, P698, DOI 10.1029/1999PA900044; Cacho I, 2000, EARTH PLANET SC LETT, V183, P417, DOI 10.1016/S0012-821X(00)00296-X; Cheddadi R, 2005, P NATL ACAD SCI USA, V102, P13939, DOI 10.1073/pnas.0501752102; de Abreu C, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2004PA001091; Delmotte M, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD004417; Duplessy JC, 1988, PALEOCEANOGRAPHY, V3, P343, DOI 10.1029/PA003i003p00343; Fluckiger J, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2005PA001204; Huybers P, 2006, NATURE, V441, P329, DOI 10.1038/nature04745; Kanfoush SL, 2000, SCIENCE, V288, P1815, DOI 10.1126/science.288.5472.1815; Knorr G, 2003, NATURE, V424, P532, DOI 10.1038/nature01855; Knutti R, 2004, NATURE, V430, P851, DOI 10.1038/nature02786; Mangerud J, 2004, QUATERNARY SCI REV, V23, P1313, DOI 10.1016/j.quascirev.2003.12.009; Martrat B, 2004, SCIENCE, V306, P1762, DOI 10.1126/science.1101706; McManus JF, 1999, SCIENCE, V283, P971, DOI 10.1126/science.283.5404.971; McManus JF, 2004, NATURE, V428, P834, DOI 10.1038/nature02494; Mollenhauer G, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2004PA001103; Pahnke K, 2005, SCIENCE, V307, P1741, DOI 10.1126/science.1102163; Pailler D, 2002, PALAEOGEOGR PALAEOCL, V181, P431, DOI 10.1016/S0031-0182(01)00444-8; Parrenin F, 2003, EARTH PLANET SC LETT, V214, P243, DOI 10.1016/S0012-821X(03)00363-7; Shackleton NJ, 2004, QUATERNARY SCI REV, V23, P1513, DOI 10.1016/j.quascirev.2004.03.006; Shackleton NJ, 2000, PALEOCEANOGRAPHY, V15, P565, DOI 10.1029/2000PA000513; SHACKLETON NJ, 2005, GEOPH RES ABSTR, V7; Siddall M, 2006, QUATERNARY SCI REV, V25, P3185, DOI 10.1016/j.quascirev.2005.12.014; Siegenthaler U, 2005, SCIENCE, V310, P1313, DOI 10.1126/science.1120130; Skinner LC, 2007, PALEOCEANOGRAPHY, V22, DOI 10.1029/2006PA001338; Skinner LC, 2005, QUATERNARY SCI REV, V24, P571, DOI 10.1016/j.quascirev.2004.11.008; Stocker TF, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2004PA001108; Stocker TF, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2003PA000920; Stocker TF, 2000, P NATL ACAD SCI USA, V97, P1362, DOI 10.1073/pnas.97.4.1362; STOCKER TF, 1991, NATURE, V351, P729, DOI 10.1038/351729a0; Stocker TF, 1992, PALEOCEANOGRAPHY, V7, P529, DOI 10.1029/92PA01695; TOGGWEILER JR, 1995, DEEP-SEA RES PT I, V42, P477, DOI 10.1016/0967-0637(95)00012-U; Tzedakis PC, 2004, SCIENCE, V306, P2231, DOI 10.1126/science.1102398; Tzedakis PC, 2003, EARTH PLANET SC LETT, V212, P197, DOI 10.1016/S0012-821X(03)00233-4; Wang YJ, 2001, SCIENCE, V294, P2345, DOI 10.1126/science.1064618; Yuan DX, 2004, SCIENCE, V304, P575, DOI 10.1126/science.1091220; Zahn R, 1997, PALEOCEANOGRAPHY, V12, P696, DOI 10.1029/97PA00581	49	453	460	3	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 27	2007	317	5837					502	507		10.1126/science.1139994	http://dx.doi.org/10.1126/science.1139994			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194JD	17569824				2022-12-28	WOS:000248339800042
J	Barton, MB; Miller, T; Wolff, T; Petitti, D; LeFevre, M; Sawaya, G; Yawn, B; Guirguis-Blake, J; Calonge, N; Harris, R				Barton, Mary B.; Miller, Therese; Wolff, Tracy; Petitti, Diana; LeFevre, Michael; Sawaya, George; Yawn, Barbara; Guirguis-Blake, Janelle; Calonge, Ned; Harris, Russell		U S Preventive Services Task Force	How to read the new recommendation statement: methods update from the US preventive services task force	ANNALS OF INTERNAL MEDICINE			English	Article								Since 2001, the U.S. Preventive Services Task Force (USPSTF) has worked to refine its methods of evidence review and assessment and to create more usable documents in response to clinicians' needs. These changes have resulted in a revised grading system, as well as a new format and new language for the recommendation statement. This paper focuses on the changes to and the new look of the USPSTF recommendation statement. The new recommendation statement comprises 9 sections. Important changes include standardization of the format of the summary statement to specify what service is being recommended in what population; standardization of the headings in the rationale section; a change in the wording of the grade C recommendation and the I statement; and a new section, called "Other Considerations," in which salient issues related to cost-effectiveness, mandates, and other implementation issues are described.	Agcy Healthcare Res & Qual, US Prevent Serv Task Force, Rockville, MD USA	Agency for Healthcare Research & Quality	Barton, MB (corresponding author), Agcy Healthcare Res & Qual, US Prevent Serv Task Force, Rockville, MD USA.							Atkins D, 2004, BMC HEALTH SERV RES, V4, DOI 10.1186/1472-6963-4-38; Atkins D, 2004, BMJ-BRIT MED J, V328, P1490; Atkins D, 2005, BMC HEALTH SERV RES, V5, DOI 10.1186/1472-6963-5-25; *COCHR COLL, 2007, COCHR MAN, P2; Guirguis-Blake J, 2007, ANN INTERN MED, V147, P117, DOI 10.7326/0003-4819-147-2-200707170-00170; Haynes RB, 2002, BMJ-BRIT MED J, V324, P1350, DOI 10.1136/bmj.324.7350.1350; *METH WORK GROUP, 2001, AM J PREV MED, V20, P31; US Preventive Services Task Force, 2007, ANN INTERN MED, V147, P128, DOI 10.7326/0003-4819-147-2-200707170-00172	8	51	51	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 17	2007	147	2					123	127		10.7326/0003-4819-147-2-200707170-00171	http://dx.doi.org/10.7326/0003-4819-147-2-200707170-00171			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	192CV	17576997				2022-12-28	WOS:000248179300007
J	Bautista, DM; Siemens, J; Glazer, JM; Tsuruda, PR; Basbaum, AI; Stucky, CL; Jordt, SE; Julius, D				Bautista, Diana M.; Siemens, Jan; Glazer, Joshua M.; Tsuruda, Pamela R.; Basbaum, Allan I.; Stucky, Cheryl L.; Jordt, Sven-Eric; Julius, David			The menthol receptor TRPM8 is the principal detector of environmental cold	NATURE			English	Article							PRIMARY SENSORY NEURONS; ION-CHANNEL TRPA1; MOLECULAR LOGIC; TRANSDUCTION; SKIN; THERMOSENSATION; TEMPERATURE; SENSATION; STIMULI; ANKTM1	Sensory nerve fibres can detect changes in temperature over a remarkably wide range, a process that has been proposed to involve direct activation of thermosensitive excitatory transient receptor potential (TRP) ion channels(1-4). One such channel TRP melastatin 8 (TRPM8) or cold and menthol receptor 1 (CMR1)-is activated by chemical cooling agents (such as menthol) or when ambient temperatures drop below similar to 26 degrees C, suggesting that it mediates the detection of cold thermal stimuli by primary afferent sensory neurons(5,6). However, some studies have questioned the contribution of TRPM8 to cold detection or proposed that other excitatory or inhibitory channels are more critical to this sensory modality in vivo(7-10). Here we show that cultured sensory neurons and intact sensory nerve fibres from TRPM8-deficient mice exhibit profoundly diminished responses to cold. These animals also show clear behavioural deficits in their ability to discriminate between cold and warm surfaces, or to respond to evaporative cooling. At the same time, TRPM8 mutant mice are not completely insensitive to cold as they avoid contact with surfaces below 10 degrees C, albeit with reduced efficiency. Thus, our findings demonstrate an essential and predominant role for TRPM8 in thermosensation over a wide range of cold temperatures, validating the hypothesis(2) that TRP channels are the principal sensors of thermal stimuli in the peripheral nervous system.	Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Anat & Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, WM Keck Ctr Integrat Neurosci, San Francisco, CA 94143 USA; Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA; Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Medical College of Wisconsin; Yale University	Julius, D (corresponding author), Univ Calif San Francisco, Dept Physiol, Box 0444, San Francisco, CA 94143 USA.	cstucky@mcw.edu; sven.jordt@yale.edu; julius@cmp.ucsf.edu	Jordt, Sven-Eric/ABE-6517-2020	Jordt, Sven-Eric/0000-0001-6171-5622; Siemens, Jan/0000-0001-9051-9217	NIEHS NIH HHS [R01 ES015056] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015056] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Askwith CC, 2001, P NATL ACAD SCI USA, V98, P6459, DOI 10.1073/pnas.111155398; Babes A, 2006, EUR J NEUROSCI, V24, P691, DOI 10.1111/j.1460-9568.2006.04941.x; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Bunting M, 1999, GENE DEV, V13, P1524, DOI 10.1101/gad.13.12.1524; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; Dhaka A, 2006, ANNU REV NEUROSCI, V29, P135, DOI 10.1146/annurev.neuro.29.051605.112958; DOERNER JF, 2007, J BIOL CHEM; FRUHSTORFER H, 1983, PAIN, V17, P235, DOI 10.1016/0304-3959(83)90096-9; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; HENSEL H, 1951, ACTA PHYSIOL SCAND, V24, P27, DOI 10.1111/j.1748-1716.1951.tb00824.x; IGGO A, 1969, J PHYSIOL-LONDON, V200, P403, DOI 10.1113/jphysiol.1969.sp008701; Jordt SE, 2003, CURR OPIN NEUROBIOL, V13, P487, DOI 10.1016/S0959-4388(03)00101-6; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Koltzenburg M, 1997, J NEUROPHYSIOL, V78, P1841, DOI 10.1152/jn.1997.78.4.1841; KREH A, 1984, EXP NEUROL, V85, P533, DOI 10.1016/0014-4886(84)90029-3; Lumpkin EA, 2007, NATURE, V445, P858, DOI 10.1038/nature05662; Madrid R, 2006, J NEUROSCI, V26, P12512, DOI 10.1523/JNEUROSCI.3752-06.2006; Maingret F, 2000, EMBO J, V19, P2483, DOI 10.1093/emboj/19.11.2483; McKemy DD, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-16; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; PIERAU FK, 1974, BRAIN RES, V73, P156, DOI 10.1016/0006-8993(74)91015-4; Rainville P, 1999, EXP BRAIN RES, V125, P28, DOI 10.1007/s002210050654; Reid G, 2005, PFLUG ARCH EUR J PHY, V451, P250, DOI 10.1007/s00424-005-1437-z; Reid G, 2001, NATURE, V413, P480, DOI 10.1038/35097164; Reid G, 2001, NEUROSCI LETT, V297, P171, DOI 10.1016/S0304-3940(00)01694-3; SCHAFER K, 1988, PFLUG ARCH EUR J PHY, V412, P188, DOI 10.1007/BF00583749; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Stucky CL, 1999, J NEUROSCI, V19, P8509; Viana F, 2002, NAT NEUROSCI, V5, P254, DOI 10.1038/nn809; Zurborg S, 2007, NAT NEUROSCI, V10, P277, DOI 10.1038/nn1843	32	849	878	3	134	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 12	2007	448	7150					204	208		10.1038/nature05910	http://dx.doi.org/10.1038/nature05910			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188QN	17538622				2022-12-28	WOS:000247934500045
J	Ronco, G; Cuzick, J; Pierotti, P; Cariaggi, MP; Dalla Palma, P; Naldoni, C; Ghiringhello, B; Giorgi-Rossi, P; Minucci, D; Parisio, F; Pojer, A; Schiboni, ML; Sintoni, C; Zorzi, M; Segnan, N; Confortini, M				Ronco, Guglielmo; Cuzick, Jack; Pierotti, Paola; Cariaggi, Maria Paola; Dalla Palma, Paolo; Naldoni, Carlo; Ghiringhello, Bruno; Giorgi-Rossi, Paolo; Minucci, Daria; Parisio, Franca; Pojer, Ada; Schiboni, Maria Luisa; Sintoni, Catia; Zorzi, Manuel; Segnan, Nereo; Confortini, Massimo		NTCC Working Grp	Accuracy of liquid based versus conventional cytology: overall results of new technologies for cervical cancer screening: randomised controlled trial	BRITISH MEDICAL JOURNAL			English	Article							PAPANICOLAOU SMEARS; FOLLOW-UP; RECRUITMENT; PERFORMANCE; SAMPLE	Objective To compare the accuracy of conventional cytology with liquid based cytology for primary screening of cervical cancer. Design Randomised controlled trial. Setting Nine screening programmes in Italy. Participants Women aged 25-60 attending for a new screening round: 22 466 were assigned to the conventional arm and 22 708 were assigned to the experimental arm. Interventions Conventional cytology compared with liquid based cytology and testing for human papillomavirus. Main outcome measure Relative sensitivity for cervical intraepithelial neoplasia of grade 2 or more at blindly reviewed histology, with atypical cells of undetermined significance or more severe cytology considered a positive result. Results In an intention to screen analysis liquid based cytology showed no significant increase in sensitivity for cervical intraepithelial neoplasia of grade 2 or more (relative sensitivity 1.17, 95% confidence interval 0.87 to 1.56) whereas the positive predictive value was reduced (relative positive predictive value v conventional cytology 0.58, 0.44 to 0.77). Liquid based cytology detected more lesions of grade I or more (relative sensitivity 1.68, 1.40 to 2.02), with a larger increase among women aged 25-34 (P for heterogeneity 0.0006), but-did not detect more lesions of grade 3 or more (relative sensitivity 0.84, 0.56 to 1.25). Results were similar when only tow grade intraepithelial lesions or more severe cytology were considered a positive result. No evidence was found of heterogeneity between centres or of improvement with increasing time from start of the study. The relative frequency of women with at least one unsatisfactory result was tower with liquid based cytology (0.62, 0.56 to 0.69). Conclusion Liquid based cytology showed no statistically significant difference in sensitivity to conventional cytology for detection of cervical intraepithelial neoplasia of grade 2 or more. More positive results were found, however, leading to a lower positive predictive value. A large reduction in unsatisfactory smears was evident.	Ctr Canc Prevent, Canc Epidemiol Unit, I-10123 Turin, Italy; St Anna Hosp, Turin, Italy; Sci Inst Canc Prevent Tuscany Reg, Florence, Italy; Santa Chiara Hosp, Trento, Italy; Ist Oncol Veneto, Venetian Tumour Registry, Padua, Italy; Univ Hosp, Unit Obstet & Gynaecol, Padua, Italy; Emilia Romagna Reg, Bologna, Italy; Maggiore Hosp, AU SL Bologna, Italy; S Maria Croci Hosp, Ravenna, Italy; Agcy Publ Hlth Lazio, Hlth Technol Unit, Rome, Italy; S Giovanni Hosp, Rome, Italy; Queen Marys Sch Med & Dent, Canc Res UK Clin Ctr, London, England	A.O.U. Citta della Salute e della Scienza di Torino; University of Ferrara; Arcispedale Sant'Anna; Santa Chiara Hospital; IRCCS Istituto Oncologico Veneto (IOV); University of Padua; Azienda Ospedaliera - Universita di Padova; Cancer Research UK; University of London; Queen Mary University London	Ronco, G (corresponding author), Ctr Canc Prevent, Canc Epidemiol Unit, Via S Francesco da Paola, I-10123 Turin, Italy.	guglielmo.ronco@cpo.it	Zorzi, Manuel/J-7029-2016; Rossi, Paolo Giorgi/K-6367-2016	Zorzi, Manuel/0000-0001-6025-5214; Rossi, Paolo Giorgi/0000-0001-9703-2460; Confortini, Massimo/0000-0002-9978-8592; Segnan, Nereo/0000-0002-4730-5384				Abulafia O, 2003, GYNECOL ONCOL, V90, P137, DOI 10.1016/S0090-8258(03)00176-8; Bergeron C, 2001, ACTA CYTOL, V45, P519, DOI 10.1159/000327858; Bernstein SJ, 2001, AM J OBSTET GYNECOL, V185, P308, DOI 10.1067/mob.2001.116736; Coste J, 2003, BMJ-BRIT MED J, V326, P733, DOI 10.1136/bmj.326.7392.733; Davey E, 2006, LANCET, V367, P122, DOI 10.1016/S0140-6736(06)67961-0; Ferenczy A, 1996, ACTA CYTOL, V40, P1136; Hessling JJ, 2001, J REPROD MED, V46, P880; Klinkhamer PJJM, 2003, CANCER CYTOPATHOL, V99, P263, DOI 10.1002/cncr.11673; Laverty CR, 1997, ANAL QUANT CYTOL, V19, P239; Moseley RP, 2002, CYTOPATHOLOGY, V13, P71, DOI 10.1046/j.1365-2303.2002.00394.x; Nanda K, 2000, ANN INTERN MED, V132, P810, DOI 10.7326/0003-4819-132-10-200005160-00009; Obwegeser JH, 2001, ACTA CYTOL, V45, P709, DOI 10.1159/000328292; Ronco G, 2006, JNCI-J NATL CANCER I, V98, P765, DOI 10.1093/jnci/djj209; Ronco G, 2006, LANCET ONCOL, V7, P547, DOI 10.1016/S1470-2045(06)70731-8; Sherman ME, 1998, MODERN PATHOL, V11, P837; Sulik SM, 2001, J FAM PRACTICE, V50, P1040	16	166	180	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUL 7	2007	335	7609					28	31		10.1136/bmj.39196.740995.BE	http://dx.doi.org/10.1136/bmj.39196.740995.BE			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	191LY	17517761	Bronze, Green Published			2022-12-28	WOS:000248133900031
J	Bilic, J; Huang, YL; Davidson, G; Zimmermann, T; Cruciat, CM; Bienz, M; Niehrs, C				Bilic, Josipa; Huang, Ya-Lin; Davidson, Gary; Zimmermann, Timo; Cruciat, Cristina-Maria; Bienz, Mariann; Niehrs, Christof			Wnt induces LRP6 signalosomes and promotes dishevelled-dependent LRP6 phosphorylation	SCIENCE			English	Article							RECEPTOR-RELATED PROTEIN-5; SIGNALING PATHWAY; PLASMA-MEMBRANE; DIX DOMAIN; AXIN; POLARITY; ENCODES	Multiple signaling pathways, including Wnt signaling, participate in animal development, stem cell biology, and human cancer. Although many components of the Wnt pathway have been identified, unresolved questions remain as to the mechanism by which Wnt binding to its receptors Frizzled and Low-density lipoprotein receptor-related protein 6 (LRP6) triggers downstream signaling events. With live imaging of vertebrate cells, we show that Wnt treatment quickly induces plasma membrane-associated LRP6 aggregates. LRP6 aggregates are phosphorylated and can be detergent-solubilized as ribosome-sized multiprotein complexes. Phospho-LRP6 aggregates contain Wnt-pathway components but no common vesicular traffic markers except caveolin. The scaffold protein Dishevelled (Dvl) is required for LRP6 phosphorylation and aggregation. We propose that Wnts induce coclustering of receptors and Dvl in LRP6-signalosomes, which in turn triggers LRP6 phosphorylation to promote Axin recruitment and beta-catenin stabilization.	Deutsch Krebsforschungszentrum, Div Mol Embryol, D-69120 Heidelberg, Germany; European Mol Biol Lab, Adv Light Microscopy Facil, D-69117 Heidelberg, Germany; MRC, Mol Biol Lab, Cambridge C82 2QH, England	Helmholtz Association; German Cancer Research Center (DKFZ); European Molecular Biology Laboratory (EMBL); MRC Laboratory Molecular Biology	Niehrs, C (corresponding author), Deutsch Krebsforschungszentrum, Div Mol Embryol, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	Niehrs@DKFZ-Heidelberg.DE	Zimmermann, Timo/G-1681-2015; Davidson, Gary/J-6059-2013; Davidson, Gary/AAA-7321-2021	Zimmermann, Timo/0000-0001-7098-0700; Davidson, Gary/0000-0002-2264-5518; Huang, Ya-Lin/0000-0002-4965-7543; Bilic Zimmermann, Josipa/0000-0001-9642-6265	Medical Research Council [MC_U105184273, MC_U105192713] Funding Source: Medline; MRC [MC_U105184273] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Axelrod JD, 1998, GENE DEV, V12, P2610, DOI 10.1101/gad.12.16.2610; Blitzer JT, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-28; Capelluto DGS, 2002, NATURE, V419, P726, DOI 10.1038/nature01056; Cliffe A, 2003, CURR BIOL, V13, P960, DOI 10.1016/S0960-9822(03)00370-1; Cong F, 2004, DEVELOPMENT, V131, P5103, DOI 10.1242/dev.01318; Davidson G, 2005, NATURE, V438, P867, DOI 10.1038/nature04170; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; Itoh Keiji, 2005, J Biol, V4, P3, DOI 10.1186/jbiol20; Kishida S, 1999, MOL CELL BIOL, V19, P4414; KLINGENSMITH J, 1994, GENE DEV, V8, P118, DOI 10.1101/gad.8.1.118; Li L, 2002, J BIOL CHEM, V277, P5977, DOI 10.1074/jbc.M111131200; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Malbon CC, 2006, CURR TOP DEV BIOL, V72, P153, DOI 10.1016/S0070-2153(05)72002-0; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Polakis P, 2000, GENE DEV, V14, P1837; Rothbacher U, 2000, EMBO J, V19, P1010, DOI 10.1093/emboj/19.5.1010; Schwarz-Romond T, 2005, J CELL SCI, V118, P5269, DOI 10.1242/jcs.02646; Schwarz-Romond T, 2007, NAT STRUCT MOL BIOL, V14, P484, DOI 10.1038/nsmb1247; Smalley MJ, 2005, J CELL SCI, V118, P5279, DOI 10.1242/jcs.02647; Tolwinski NS, 2004, TRENDS GENET, V20, P177, DOI 10.1016/j.tig.2004.02.003; Tolwinski NS, 2003, DEV CELL, V4, P407, DOI 10.1016/S1534-5807(03)00063-7; Weaver C, 2004, DEVELOPMENT, V131, P3491, DOI 10.1242/dev.01284; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; Yamamoto H, 2006, DEV CELL, V11, P213, DOI 10.1016/j.devcel.2006.07.003; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185	27	653	676	2	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 15	2007	316	5831					1619	1622		10.1126/science.1137065	http://dx.doi.org/10.1126/science.1137065			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178SH	17569865				2022-12-28	WOS:000247239900042
J	Hao, X				Hao, Xin			Monkey research in China: Developing a natural resource	CELL			English	Editorial Material								China's contribution to primate research is no longer limited to supplying monkeys to scientists abroad. With an abundance of wild rhesus macaques, low labor costs, and a nonhostile environment for animal research, scientists are finding that China is the place to be for research using macaques as models of human disease.											0	14	15	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 15	2007	129	6					1033	1036		10.1016/j.cell.2007.05.051	http://dx.doi.org/10.1016/j.cell.2007.05.051			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	180UA	17574013	Bronze			2022-12-28	WOS:000247390400004
J	Imura, A; Tsuji, Y; Murata, M; Maeda, R; Kubota, K; Iwano, A; Obuse, C; Togashi, K; Tominaga, M; Kita, N; Tomiyama, K; Iijima, J; Nabeshima, Y; Fujioka, M; Asato, R; Tanaka, S; Kojima, K; Ito, J; Nozaki, K; Hashimoto, N; Ito, T; Nishio, T; Uchiyama, T; Fujimori, T; Nabeshima, YI				Imura, Akihiro; Tsuji, Yoshihito; Murata, Miyahiko; Maeda, Ryota; Kubota, Koji; Iwano, Akiko; Obuse, Chikashi; Togashi, Kazuya; Tominaga, Makoto; Kita, Naoko; Tomiyama, Ken-ichi; Iijima, Junko; Nabeshima, Yoko; Fujioka, Makio; Asato, Ryo; Tanaka, Shinzo; Kojima, Ken; Ito, Juichi; Nozaki, Kazuhiko; Hashimoto, Nobuo; Ito, Tetsufumi; Nishio, Takeshi; Uchiyama, Takashi; Fujimori, Toshihiko; Nabeshima, Yo-ichi			alpha-klotho as a regulator of calcium homeostasis	SCIENCE			English	Article							MICE; NA,K-ATPASE; GENE; EXPRESSION; CELLS; SUPPRESSION; ACTIVATION; NA,K-PUMP; RECEPTOR; PROTEIN	alpha-klotho was identified as a gene associated with premature aging-like phenotypes characterized by short lifespan. In mice, we found the molecular association of alpha-Klotho (alpha-Kl) and Na+, K+-adenosine triphosphatase (Na+, K+-ATPase) and provide evidence for an increase of abundance of Na+, K+-ATPase at the plasma membrane. Low concentrations of extracellular free calcium ([Ca2+](e)) rapidly induce regulated parathyroid hormone (PTH) secretion in an alpha-Kl- and Na+, K+-ATPase-dependent manner. The increased Na+ gradient created by Na+, K+-ATPase activity might drive the transepithelial transport of Ca2+ in cooperation with ion channels and transporters in the choroid plexus and the kidney. Our findings reveal fundamental roles of alpha-Kl in the regulation of calcium metabolism.	Kyoto Univ, Grad Sch Med, Dept Pathol & Tumor Biol, Kyoto 6068501, Japan; Kyoto Univ, Grad Sch Med, Horizontal Med Res Org, Kyoto 6068501, Japan; Kyoto Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Kyoto 6068501, Japan; Kyoto Univ, Grad Sch Med, Dept Neurosurg, Kyoto 6068501, Japan; Kyoto Univ, Grad Sch Med, Dept Hematol & Oncol, Kyoto 6068501, Japan; Kyoto Univ, Grad Sch Med, Ctr Electron Microscopy, Kyoto 6068501, Japan; Japan Sci & Technol Corp, Core Res Evolut Sci & Technol, Saitama 3320012, Japan; Hokkaido Univ, Grad Sch Life Sci, Lab Funct Networks Chromosome Inheritance, Sapporo, Hokkaido 0010021, Japan; Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Sect Cell Signaling, Aichi 4448787, Japan; Univ Fukui, Fac Med Sci, Dept Anat, Fukui 9101193, Japan	Kyoto University; Kyoto University; Kyoto University; Kyoto University; Kyoto University; Kyoto University; Japan Science & Technology Agency (JST); Hokkaido University; National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB); University of Fukui	Nabeshima, YI (corresponding author), Kyoto Univ, Grad Sch Med, Dept Pathol & Tumor Biol, Kyoto 6068501, Japan.	nabemr@lmls.med.kyoto-u.ac.jp	Ito, Tetsufumi/M-2668-2019; 伊藤, 哲史/D-4275-2016; Obuse, Chikashi/F-5273-2011; Fujimori, Toshihiko/L-7711-2016	Ito, Tetsufumi/0000-0003-4516-9283; 伊藤, 哲史/0000-0003-4516-9283; Fujimori, Toshihiko/0000-0001-5200-4634; Maeda, Ryota/0000-0002-1514-1071				BILEZIKIAN JP, 2005, PARATHYROIDS BASIC C; BRINGHURST FR, 2003, WILLIAMS TXB ENDOCRI; BROWN EM, 1987, METABOLISM, V36, P36, DOI 10.1016/0026-0495(87)90060-6; CAPLAN MJ, 1990, J BIOL CHEM, V265, P3528; GEERING K, 1991, FEBS LETT, V285, P189, DOI 10.1016/0014-5793(91)80801-9; GORVEL JP, 1991, CELL, V64, P915, DOI 10.1016/0092-8674(91)90316-Q; HOOTMAN SR, 1988, METHOD ENZYMOL, V156, P213; Imura A, 2004, FEBS LETT, V565, P143, DOI 10.1016/j.febslet.2004.03.090; Ito S, 2000, MECH DEVELOP, V98, P115, DOI 10.1016/S0925-4773(00)00439-1; Ito S, 2005, J CLIN INVEST, V115, P2202, DOI 10.1172/JCI23076; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; MURPHY VA, 1989, BRAIN RES, V484, P65, DOI 10.1016/0006-8993(89)90348-X; NABESHIMA Y, 2006, SCI AGING KNOWLEDGE, DOI DOI 10.1126/SAGEKE.2006.8.PE11; Razzaque MS, 2006, FASEB J, V20, P720, DOI 10.1096/fj.05-5432fje; Shimada T, 2004, J CLIN INVEST, V113, P561, DOI 10.1172/JCI200419081; SKOU JC, 1992, J BIOENERG BIOMEMBR, V24, P249; SKOU JC, 1988, METHOD ENZYMOL, V156, P1; Somjen GG, 2002, NEUROSCIENTIST, V8, P254, DOI 10.1177/1073858402008003011; Takeshita K, 2004, CIRCULATION, V109, P1776, DOI 10.1161/01.CIR.0000124224.48962.32; Tominaga M, 2004, J NEUROBIOL, V61, P3, DOI 10.1002/neu.20079; Tsujikawa H, 2003, MOL ENDOCRINOL, V17, P2393, DOI 10.1210/me.2003-0048; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; Watanabe H, 2002, J BIOL CHEM, V277, P13569, DOI 10.1074/jbc.M200062200; Yoshida T, 2002, ENDOCRINOLOGY, V143, P683, DOI 10.1210/en.143.2.683	27	318	338	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 15	2007	316	5831					1615	1618		10.1126/science.1135901	http://dx.doi.org/10.1126/science.1135901			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178SH	17569864				2022-12-28	WOS:000247239900041
J	Mizuguchi, G; Xiao, H; Wisniewski, J; Smith, MM; Wu, C				Mizuguchi, Gaku; Xiao, Hua; Wisniewski, Jan; Smith, M. Mitchell; Wu, Carl			Nonhistone Scm3 and histones CenH3-H4 assemble the core of centromere-specific nucleosomes	CELL			English	Article							A CENP-A; BUDDING YEAST; KINETOCHORE COMPLEX; CHROMATIN; PROTEIN; DNA; CSE4P; H3; EPIGENETICS; COMPONENT	The budding yeast histone H3 variant, Cse4, replaces conventional histone H3 in centromeric chromatin and, together with centromere-specific DNA-binding factors, directs assembly of the kinetochore, a multiprotein complex mediating chromosome segregation. We have identified Scm3, a nonhistone protein that colocalizes with Cse4 and is required for its centromeric association. Bacterially expressed Scm3 binds directly to and reconstitutes a stoichiometric complex with Cse4 and histone H4 but not with conventional histone H3 and H4. A conserved acidic domain of Scm3 is responsible for directing the Cse4-specific interaction. Strikingly, binding of Scm3 can replace histones H2A-H2B from preassembled Cse4-containing histone octamers. This incompatibility between Scm3 and histones H2A-H2B is correlated with diminished in vivo occupancy of histone H2B, H2A, and H2AZ at centromeres. Our findings indicate that nonhistone Scm3 serves to assemble and maintain Cse4-H4 at centromeres and may replace histone H2A-H2B dimers in a centromere-specific nucleosome core.	NCI, Lab Biochem & Mol Biol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; Univ Virginia, Hlth Syst, Dept Microbiol, Charlottesville, VA 22908 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Virginia	Wu, C (corresponding author), NCI, Lab Biochem & Mol Biol, Ctr Canc Res, NIH, Bldg 37,Room 6068, Bethesda, MD 20892 USA.	carlwu@helix.nih.gov			NATIONAL CANCER INSTITUTE [Z01BC005263] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NIGMS NIH HHS [GM28930] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amor DJ, 2004, TRENDS CELL BIOL, V14, P359, DOI 10.1016/j.tcb.2004.05.009; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Belli G, 1998, NUCLEIC ACIDS RES, V26, P942, DOI 10.1093/nar/26.4.942; Black BE, 2004, NATURE, V430, P578, DOI 10.1038/nature02766; Blat Y, 1999, CELL, V98, P249, DOI 10.1016/S0092-8674(00)81019-3; Bloom K, 2006, CURR BIOL, V16, pR276, DOI 10.1016/j.cub.2006.03.054; Blower MD, 2002, DEV CELL, V2, P319, DOI 10.1016/S1534-5807(02)00135-1; Carroll CW, 2006, TRENDS CELL BIOL, V16, P70, DOI 10.1016/j.tcb.2005.12.008; Chen YH, 2000, MOL CELL BIOL, V20, P7037, DOI 10.1128/MCB.20.18.7037-7048.2000; Choo KHA., 1997, CENTROMERE; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; Collins KA, 2005, MOL BIOL CELL, V16, P5649, DOI 10.1091/mbc.E05-08-0771; Collins KA, 2004, CURR BIOL, V14, P1968, DOI 10.1016/j.cub.2004.10.024; Connelly C, 1996, CELL, V86, P275, DOI 10.1016/S0092-8674(00)80099-9; Crotti LB, 2004, EMBO J, V23, P1804, DOI 10.1038/sj.emboj.7600161; Dawe RK, 2006, TRENDS BIOCHEM SCI, V31, P662, DOI 10.1016/j.tibs.2006.10.004; DOHMEN RJ, 1994, SCIENCE, V263, P1273, DOI 10.1126/science.8122109; EICKBUSH TH, 1978, BIOCHEMISTRY-US, V17, P4955, DOI 10.1021/bi00616a016; Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397; Furuyama T, 2006, P NATL ACAD SCI USA, V103, P6172, DOI 10.1073/pnas.0601686103; Gardner RD, 2001, GENETICS, V157, P1493; Glowczewski L, 2000, MOL CELL BIOL, V20, P5700, DOI 10.1128/MCB.20.15.5700-5711.2000; GODFREY JE, 1980, BIOCHEMISTRY-US, V19, P1339, DOI 10.1021/bi00548a012; Hecht A, 1999, METHOD ENZYMOL, V304, P399; Henikoff S, 2005, CURR OPIN GENET DEV, V15, P177, DOI 10.1016/j.gde.2005.01.004; Heun P, 2006, DEV CELL, V10, P303, DOI 10.1016/j.devcel.2006.01.014; Izuta H, 2006, GENES CELLS, V11, P673, DOI 10.1111/j.1365-2443.2006.00969.x; Karpen GH, 1997, TRENDS GENET, V13, P489, DOI 10.1016/S0168-9525(97)01298-5; Keith KC, 2000, GENETICS, V156, P973; Kitagawa K, 2001, NAT REV MOL CELL BIO, V2, P678, DOI 10.1038/35089568; KORNBERG RD, 1974, SCIENCE, V184, P865, DOI 10.1126/science.184.4139.865; Krogan NJ, 2004, P NATL ACAD SCI USA, V101, P13513, DOI 10.1073/pnas.0405753101; Lew DJ, 2003, ANNU REV GENET, V37, P251, DOI 10.1146/annurev.genet.37.042203.120656; Luger K, 1999, METHOD ENZYMOL, V304, P3; Luk E, 2007, MOL CELL, V25, P357, DOI 10.1016/j.molcel.2006.12.015; Malik HS, 2002, CURR OPIN GENET DEV, V12, P711, DOI 10.1016/S0959-437X(02)00351-9; McAinsh AD, 2003, ANNU REV CELL DEV BI, V19, P519, DOI 10.1146/annurev.cellbio.19.111301.155607; Megee PC, 1999, MOL CELL, V4, P445, DOI 10.1016/S1097-2765(00)80347-0; Meluh PB, 1997, GENE DEV, V11, P3401, DOI 10.1101/gad.11.24.3401; Meluh PB, 1998, CELL, V94, P607, DOI 10.1016/S0092-8674(00)81602-5; Meraldi P, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-r23; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; Nakayama J, 2000, CELL, V101, P307, DOI 10.1016/S0092-8674(00)80840-5; NIEDENTHAL RK, 1993, NUCLEIC ACIDS RES, V21, P4726, DOI 10.1093/nar/21.20.4726; Obuse C, 2004, GENES CELLS, V9, P105, DOI 10.1111/j.1365-2443.2004.00705.x; Okada M, 2006, NAT CELL BIOL, V8, P446, DOI 10.1038/ncb1396; Ortiz J, 1999, GENE DEV, V13, P1140, DOI 10.1101/gad.13.9.1140; Pietrasanta LI, 1999, P NATL ACAD SCI USA, V96, P3757, DOI 10.1073/pnas.96.7.3757; Schueler MG, 2006, ANNU REV GENOM HUM G, V7, P301, DOI 10.1146/annurev.genom.7.080505.115613; Seol JH, 2001, NAT CELL BIOL, V3, P384, DOI 10.1038/35070067; Sharp JA, 2003, GENE DEV, V17, P2356, DOI 10.1101/gad.1131103; Sharp JA, 2002, GENE DEV, V16, P85, DOI 10.1101/gad.925302; Shelby RD, 1997, J CELL BIOL, V136, P501, DOI 10.1083/jcb.136.3.501; Smith MM, 1996, MOL CELL BIOL, V16, P1017; Smith MM, 2002, CURR OPIN CELL BIOL, V14, P279, DOI 10.1016/S0955-0674(02)00331-9; STOLER S, 1995, GENE DEV, V9, P573, DOI 10.1101/gad.9.5.573; Tanaka TU, 1999, CELL, V98, P847, DOI 10.1016/S0092-8674(00)81518-4; Van Hooser AA, 2001, J CELL SCI, V114, P3529; Vos LJ, 2006, BIOCHEM CELL BIOL, V84, P619, DOI 10.1139/O06-078; Weber SA, 2004, PLOS BIOL, V2, P1340, DOI 10.1371/journal.pbio.0020260; Westermann S, 2003, J CELL BIOL, V163, P215, DOI 10.1083/jcb.200305100; Wieland G, 2004, MOL CELL BIOL, V24, P6620, DOI 10.1128/mcb.24.15.6620-6630.2004; Wu WH, 2005, NAT STRUCT MOL BIOL, V12, P1064, DOI 10.1038/nsmb1023; Yoda K, 2000, P NATL ACAD SCI USA, V97, P7266, DOI 10.1073/pnas.130189697; ZINKOWSKI RP, 1991, J CELL BIOL, V113, P1091, DOI 10.1083/jcb.113.5.1091	65	233	244	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 15	2007	129	6					1153	1164		10.1016/j.cell.2007.04.026	http://dx.doi.org/10.1016/j.cell.2007.04.026			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	180UA	17574026	Bronze			2022-12-28	WOS:000247390400018
J	Saschenbrecker, S; Bracher, A; Rao, KV; Rao, BV; Hartl, FU; Hayer-Hartl, M				Saschenbrecker, Sandra; Bracher, Andreas; Rao, Karnam Vasudeva; Rao, Bharathi Vasudeva; Hartl, F. Ulrich; Hayer-Hartl, Manajit			Structure and function of RbcX, an assembly chaperone for hexadecameric rubisco	CELL			English	Article							RIBULOSE-BISPHOSPHATE CARBOXYLASE; MOLECULAR CHAPERONES; ESCHERICHIA-COLI; LARGE SUBUNITS; RIBULOSE-1,5-BISPHOSPHATE CARBOXYLASE/OXYGENASE; 1,5-BISPHOSPHATE CARBOXYLASE/OXYGENASE; NASCENT CHAIN; OXYGENASE; PROTEINS; CATALYSIS	After folding, many proteins must assemble into oligomeric complexes to become biologically active. Here we describe the role of RbcX as an assembly chaperone of ribulose-bisphosphate carboxylase/oxygenase (Rubisco), the enzyme responsible for the fixation of atmospheric carbon dioxide. In cyanobacteria and plants, Rubisco is an similar to 520 kDa complex composed of eight large subunits (RbcL) and eight small subunits (RbcS). We found that cyanobacterial RbcX functions downstream of chaperonin-mediated RbcL folding in promoting the formation of RbcL(8) core complexes. Structural analysis revealed that the 15 kDa RbcX forms a homodimer with two cooperating RbcL-binding regions. A central cleft specifically binds the exposed C-terminal peptide of RbcL subunits, enabling a peripheral surface of RbcX to mediate RbcL8 assembly. Due to the dynamic nature of these interactions, RbcX is readily displaced from RbcL8 complexes by RbcS, producing the active enzyme. The strategies employed by RbcX in achieving substrate specificity and efficient product release may be generally relevant in assisted assembly reactions.	Max Planck Inst Biochem, Dept Cellular Biochem, D-82152 Martinsried, Germany	Max Planck Society	Bracher, A (corresponding author), Max Planck Inst Biochem, Dept Cellular Biochem, Klopferspitz 18, D-82152 Martinsried, Germany.	bracher@biochem.mpg.de; uhartl@biochem.mpg.de; mhartl@biochem.mpg.de	Hartl, F. Ulrich/Y-8206-2019; Hayer-Hartl, Manajit/V-8078-2017	Hayer-Hartl, Manajit/0000-0001-8213-6742; Saschenbrecker, Sandra/0000-0002-4769-915X				Agashe VR, 2004, CELL, V117, P199, DOI 10.1016/S0092-8674(04)00299-5; Andersson I, 2003, ARCH BIOCHEM BIOPHYS, V414, P130, DOI 10.1016/S0003-9861(03)00164-4; Andrews T.J., 1987, BIOCH PLANTS, P131, DOI 10.1016/B978-0-12-675410-0.50009-9; Andrews TJ, 2003, ARCH BIOCHEM BIOPHYS, V414, P159, DOI 10.1016/S0003-9861(03)00100-0; ANDREWS TJ, 1985, J BIOL CHEM, V260, P4632; ANDREWS TJ, 1988, J BIOL CHEM, V263, P12213; BARRACLOUGH R, 1980, BIOCHIM BIOPHYS ACTA, V608, P18; Brinker A, 2001, CELL, V107, P223, DOI 10.1016/S0092-8674(01)00517-7; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; CURMI PMG, 1992, J BIOL CHEM, V267, P16980; Duff AP, 2000, J MOL BIOL, V298, P903, DOI 10.1006/jmbi.2000.3724; Ellis RJ, 2006, TRENDS BIOCHEM SCI, V31, P395, DOI 10.1016/j.tibs.2006.05.001; Emlyn-Jones D, 2006, PLANT CELL PHYSIOL, V47, P1630, DOI 10.1093/pcp/pcl028; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; GOLOUBINOFF P, 1989, NATURE, V342, P884, DOI 10.1038/342884a0; GOLOUBINOFF P, 1989, NATURE, V337, P44, DOI 10.1038/337044a0; GUTTERIDGE S, 1995, PLANT CELL, V7, P809, DOI 10.1105/tpc.7.7.809; Hansen WJ, 1999, J CELL BIOL, V145, P265, DOI 10.1083/jcb.145.2.265; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hill JE, 2001, CELL STRESS CHAPERON, V6, P190, DOI 10.1379/1466-1268(2001)006<0190:ATTIAI>2.0.CO;2; HUBBS AE, 1993, J BIOL CHEM, V268, P13519; LARIMER FW, 1993, GENE, V126, P85, DOI 10.1016/0378-1119(93)90593-R; Li LA, 1997, J BACTERIOL, V179, P3793, DOI 10.1128/jb.179.11.3793-3796.1997; Onizuka T, 2004, PLANT CELL PHYSIOL, V45, P1390, DOI 10.1093/pcp/pch160; ROY H, 1989, PLANT CELL, V1, P1035, DOI 10.1105/tpc.1.11.1035; Rudiger S, 1997, EMBO J, V16, P1501, DOI 10.1093/emboj/16.7.1501; Tabita FR, 1999, PHOTOSYNTH RES, V60, P1, DOI 10.1023/A:1006211417981; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Zhu GH, 1998, PHOTOSYNTH RES, V57, P71, DOI 10.1023/A:1006020424581; Zhu XT, 1996, SCIENCE, V272, P1606, DOI 10.1126/science.272.5268.1606	30	103	106	2	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 15	2007	129	6					1189	1200		10.1016/j.cell.2007.04.025	http://dx.doi.org/10.1016/j.cell.2007.04.025			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	180UA	17574029	hybrid, Green Accepted			2022-12-28	WOS:000247390400021
J	Zimmermann, K; Leffler, A; Babes, A; Cendan, CM; Carr, RW; Kobayashi, J; Nau, C; Wood, JN; Reeh, PW				Zimmermann, Katharina; Leffler, Andreas; Babes, Alexandru; Cendan, Cruz Miguel; Carr, Richard W.; Kobayashi, Jin-ichi; Nau, Carla; Wood, John N.; Reeh, Peter W.			Sensory neuron sodium channel Na(v)1.8 is essential for pain at low temperatures	NATURE			English	Article							MEMBRANE-PROPERTIES; NA+ CHANNELS; COLD; TRANSDUCTION; NERVE; POTENTIALS; DEPENDENCE; PATHWAYS; INVITRO; CELLS	Sensory acuity and motor dexterity deteriorate when human limbs cool down, but pain perception persists and cold-induced pain can become excruciating(1). Evolutionary pressure to enforce protective behaviour requires that damage-sensing neurons (nociceptors) continue to function at low temperatures. Here we show that this goal is achieved by endowing superficial endings of slowly conducting nociceptive fibres with the tetrodotoxin-resistant voltage-gated sodium channel (VGSC) Na(v)1.8 ( ref. 2). This channel is essential for sustained excitability of nociceptors when the skin is cooled. We show that cooling excitable membranes progressively enhances the voltage-dependent slow inactivation of tetrodotoxin-sensitive VGSCs. In contrast, the inactivation properties of Na(v)1.8 are entirely cold-resistant. Moreover, low temperatures decrease the activation threshold of the sodium currents and increase the membrane resistance, augmenting the voltage change caused by any membrane current. Thus, in the cold, Na(v)1.8 remains available as the sole electrical impulse generator in nociceptors that transmits nociceptive information to the central nervous system. Consistent with this concept is the observation that Na(v)1.8-null mutant mice(3) show negligible responses to noxious cold and mechanical stimulation at low temperatures. Our data present strong evidence for a specialized role of Na(v)1.8 in nociceptors as the critical molecule for the perception of cold pain and pain in the cold.	Univ Erlangen Nurnberg, Fac Med, Dept Physiol & Pathophysiol, D-91054 Erlangen, Germany; Univ Erlangen Nurnberg, Fac Med, Dept Anesthesiol, D-91054 Erlangen, Germany; Univ Bucharest, Fac Biol, Dept Anim Physiol & Biophys, Bucharest 050095, Romania; UCL, Dept Biol, London WC1E 6BT, England; Kyushu Univ, Fac Dent Sci, Dept Fixed Prosthodont, Higashi Ku, Fukuoka 8128582, Japan	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Bucharest; University of London; University College London; Kyushu University	Zimmermann, K (corresponding author), Univ Erlangen Nurnberg, Fac Med, Dept Physiol & Pathophysiol, D-91054 Erlangen, Germany.	zimmermann@physiologie1.uni-erlangen.de	Carr, Richard/AAE-9188-2020; Leffler, Andreas/K-1191-2012; Carr, Richard/GSD-4859-2022; Babes, Alexandru/ABB-9128-2021; Martínez, Cruz Miguel Cendán/ABH-1404-2020; Reeh, Peter W./J-8981-2012; Babes, Alexandru/A-6212-2010; Leffler, Andreas/C-6552-2009	Carr, Richard/0000-0001-8617-9133; Leffler, Andreas/0000-0003-1121-6387; Babes, Alexandru/0000-0002-7110-6908; Martínez, Cruz Miguel Cendán/0000-0001-5431-4513; Reeh, Peter W./0000-0002-4367-094X; Zimmermann, Katharina/0000-0003-2529-0692	Medical Research Council [G9717869] Funding Source: Medline; Wellcome Trust Funding Source: Medline; MRC [G9717869] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Akopian AN, 1999, NAT NEUROSCI, V2, P541, DOI 10.1038/9195; Akopian AN, 1996, NATURE, V379, P257, DOI 10.1038/379257a0; Babes A, 2004, EUR J NEUROSCI, V20, P2276, DOI 10.1111/j.1460-9568.2004.03695.x; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Blair NT, 2002, J NEUROSCI, V22, P10277; BOSTOCK H, 1983, J PHYSIOL-LONDON, V341, P59, DOI 10.1113/jphysiol.1983.sp014792; Brock JA, 1998, J PHYSIOL-LONDON, V512, P211, DOI 10.1111/j.1469-7793.1998.211bf.x; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; Dib-Hajj S, 2002, TRENDS NEUROSCI, V25, P253, DOI 10.1016/S0166-2236(02)02150-1; Dittert I, 2006, J NEUROSCI METH, V151, P178, DOI 10.1016/j.jneumeth.2005.07.005; Goldin AL, 2002, J EXP BIOL, V205, P575; HODKIN AL, 1949, J PHYSIOL-LONDON, V109, P240; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Leffler A, 2007, J PHARMACOL EXP THER, V320, P354, DOI 10.1124/jpet.106.109025; Matthews EA, 2006, MOL PAIN, V2, DOI 10.1186/1744-8069-2-5; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; PIERAU FK, 1974, BRAIN RES, V73, P156, DOI 10.1016/0006-8993(74)91015-4; REEH PW, 1986, NEUROSCI LETT, V66, P141, DOI 10.1016/0304-3940(86)90180-1; Reid G, 2001, NEUROSCI LETT, V297, P171, DOI 10.1016/S0304-3940(00)01694-3; Renganathan M, 2001, J NEUROPHYSIOL, V86, P629, DOI 10.1152/jn.2001.86.2.629; Rush AM, 2006, P NATL ACAD SCI USA, V103, P8245, DOI 10.1073/pnas.0602813103; Solomon S, 1999, P NATL ACAD SCI USA, V96, P13012, DOI 10.1073/pnas.96.23.13012; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Strassman AM, 1999, J NEUROPHYSIOL, V81, P413, DOI 10.1152/jn.1999.81.2.413; THOMPSON SM, 1985, J NEUROSCI, V5, P817; Viana F, 2002, NAT NEUROSCI, V5, P254, DOI 10.1038/nn809; Volgushev M, 2000, J PHYSIOL-LONDON, V522, P59, DOI 10.1111/j.1469-7793.2000.0059m.x; Wood JN, 2004, J NEUROBIOL, V61, P55, DOI 10.1002/neu.20094; [No title captured]	30	300	309	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 14	2007	447	7146					855	858		10.1038/nature05880	http://dx.doi.org/10.1038/nature05880			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178FV	17568746				2022-12-28	WOS:000247207500044
J	Flexman, AM; Del Vicario, G; Schwarz, SKW				Flexman, Alana M.; Del Vicario, Giuseppe; Schwarz, Stephan K. W.			Dark green blood in the operating theatre	LANCET			English	Editorial Material							SULFHEMOGLOBINEMIA		Univ British Columbia, St Pauls Hosp, Dept Anesthesia, Vancouver, BC V5Z 1M9, Canada	St. Paul's Hospital; University of British Columbia; University of Saskatchewan	Schwarz, SKW (corresponding author), Univ British Columbia, St Pauls Hosp, Dept Anesthesia, Vancouver, BC V5Z 1M9, Canada.	stephan.schwarz@ubc.ca		Schwarz, Stephan/0000-0002-3584-1032				Aravindhan N, 2000, ANESTHESIOLOGY, V93, P883, DOI 10.1097/00000542-200009000-00040; BRANDENBURG RO, 1951, AM HEART J, V42, P582, DOI 10.1016/0002-8703(51)90153-6; FINCH CA, 1948, NEW ENGL J MED, V239, P470, DOI 10.1056/NEJM194809232391305; Lu HC, 1998, ARCH PEDIAT ADOL MED, V152, P803; Tfelt-Hansen P, 2000, DRUGS, V60, P1259, DOI 10.2165/00003495-200060060-00003	5	20	20	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 9	2007	369	9577					1972	1972		10.1016/S0140-6736(07)60918-0	http://dx.doi.org/10.1016/S0140-6736(07)60918-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	177IQ	17560450				2022-12-28	WOS:000247147200031
J	Johnson, DS; Mortazavi, A; Myers, RM; Wold, B				Johnson, David S.; Mortazavi, Ali; Myers, Richard M.; Wold, Barbara			Genome-wide mapping of in vivo protein-DNA interactions	SCIENCE			English	Article							NEURON-RESTRICTIVE SILENCER; TRANSCRIPTION-FACTOR	In vivo protein-DNA interactions connect each transcription factor with its direct targets to form a gene network scaffold. To map these protein-DNA interactions comprehensively across entire mammalian genomes, we developed a large-scale chromatin immunoprecipitation assay ( ChIPSeq) based on direct ultrahigh-throughput DNA sequencing. This sequence census method was then used to map in vivo binding of the neuron-restrictive silencer factor ( NRSF; also known as REST, for repressor element-1 silencing transcription factor) to 1946 locations in the human genome. The data display sharp resolution of binding position [ +/- 50 base pairs ( bp)], which facilitated our finding motifs and allowed us to identify noncanonical NRSF-binding motifs. These ChIPSeq data also have high sensitivity and specificity [ ROC ( receiver operator characteristic) area >= 0.96] and statistical confidence ( P < 10(-4)), properties that were important for inferring new candidate interactions. These include key transcription factors in the gene network that regulates pancreatic islet cell development.	Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA; CALTECH, Beckman Inst, Pasadena, CA 91125 USA	Stanford University; California Institute of Technology; California Institute of Technology	Wold, B (corresponding author), Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA.	myers@shgc.stanford.edu; woldb@its.caltech.edu			NHGRI NIH HHS [U01 HG003162] Funding Source: Medline; NIGMS NIH HHS [5T32GM07616] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG003162] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007616] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Atouf F, 1997, J BIOL CHEM, V272, P1929, DOI 10.1074/jbc.272.3.1929; Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Impey S, 2004, CELL, V119, P1041, DOI 10.1016/j.cell.2004.10.032; Kim TH, 2006, ANNU REV GENOM HUM G, V7, P81, DOI 10.1146/annurev.genom.7.080505.115634; Schoenherr CJ, 1996, P NATL ACAD SCI USA, V93, P9881, DOI 10.1073/pnas.93.18.9881; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043	7	1843	1950	6	227	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 8	2007	316	5830					1497	1502		10.1126/science.1141319	http://dx.doi.org/10.1126/science.1141319			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176EE	17540862				2022-12-28	WOS:000247066400049
J	Rajkumar, SV; Gertz, MA				Rajkumar, S. Vincent; Gertz, Morie A.			Advances in the treatment of amyloidosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							LIVER-TRANSPLANTATION; SERUM; AL; POLYNEUROPATHY; DISEASE		Mayo Clin, Coll Med, Div Hematol, Rochester, MN 55905 USA	Mayo Clinic	Rajkumar, SV (corresponding author), Mayo Clin, Coll Med, Div Hematol, Rochester, MN 55905 USA.		Gertz, Morie/K-2873-2019; Rajkumar, S. Vincent/AAV-1834-2021	Rajkumar, S. Vincent/0000-0002-5862-1833				Dember LM, 2007, NEW ENGL J MED, V356, P2349, DOI 10.1056/NEJMoa065644; Fernandez-Nebro A, 2006, AM J MED, V119, P191, DOI 10.1016/j.amjmed.2005.12.008; Fernandez-Nebro A, 2005, AM J MED, V118, P552, DOI 10.1016/j.amjmed.2005.01.028; Gertz MA, 2005, BEST PRACT RES CL HA, V18, P709, DOI 10.1016/j.beha.2005.01.030; Gertz MA, 2005, AM J HEMATOL, V79, P319, DOI 10.1002/ajh.20381; Gertz MA, 2007, CURR OPIN ONCOL, V19, P136, DOI 10.1097/CCO.0b013e32801494c6; Gillmore JD, 2001, LANCET, V358, P24, DOI 10.1016/S0140-6736(00)05252-1; Olofsson BO, 2002, TRANSPLANTATION, V73, P745, DOI 10.1097/00007890-200203150-00015; Palladini G, 2004, BLOOD, V103, P2936, DOI 10.1182/blood-2003-08-2788; Pepys MB, 2002, NATURE, V417, P254, DOI 10.1038/417254a; Rajkumar, 2006, MAYO CLIN PROC, V81, P1509; Rajkumar SV, 2006, MAYO CLIN PROC, V81, P693, DOI 10.4065/81.5.693; Sharma P, 2003, LIVER TRANSPLANT, V9, P1273, DOI 10.1016/j.lts.2003.09.016; Sipe JD, 2000, J STRUCT BIOL, V130, P88, DOI 10.1006/jsbi.2000.4221; Tojo K, 2006, NEUROSCI RES, V56, P441, DOI 10.1016/j.neures.2006.08.014	15	39	49	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 7	2007	356	23					2413	2415		10.1056/NEJMe078027	http://dx.doi.org/10.1056/NEJMe078027			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	175QY	17554124				2022-12-28	WOS:000247029300013
J	Quarrie, KL; Gianotti, SM; Hopkins, WG; Hume, PA				Quarrie, Kenneth L.; Gianotti, Simon M.; Hopkins, Will G.; Hume, Patria A.			Effect of nationwide injury prevention programme on serious spinal injuries in New Zealand rugby union: ecological study	BRITISH MEDICAL JOURNAL			English	Article							CORD; LESSONS	Objective To investigate the effect of RugbySmart, a nationwide educational injury prevention programme, on the frequency of spinal cord injuries. Design Ecological study. Setting New Zealand rugby union. Participants Population at risk of injury comprised all New Zealand rugby union players. Intervention From 2001, all New Zealand rugby coaches and referees have been required to complete RugbySmart, which focuses on educating rugby participants about physical conditioning, injury management, and safe techniques in the contact phases of rugby. Main outcome measures Numbers of all spinal injuries due to participation in rugby union resulting in permanent disablement in 1976-2005, grouped into five year periods; observed compared with predicted number of spinal injuries in 2001-5. Results Eight spinal injuries occurred in 2001-5, whereas the predicted number was 18.9 (relative rate=0.46, 95% confidence interval 0.19 to 1.14). Only one spinal injury resulted from scrums over the period; the predicted number was 9.0 (relative rate=0.11, 0.02 to 0.74). Corresponding observed and predicted rates for spinal injuries resulting from other phases of play (tackle, ruck, and maul) were 7 and 9.0 (relative rate=0.83, 0.29 to 2.36). Conclusions The introduction of the RugbySmart programme coincided with a reduction in the rate of disabling spinal injuries arising from scrums in rugby union. This study exemplifies the benefit of educational initiatives in injury prevention and the need for comprehensive injury surveillance systems for evaluating injury prevention initiatives in sport.	New Zealand Rugby Unit, Wellington, New Zealand; Accid Compensat Corp, Sport & Rd, Wellington, New Zealand; AUT Unit, Fac Hlth & Environm Sci, Inst Sport & Recreat Res New Zealand, Auckland, New Zealand	Auckland University of Technology	Quarrie, KL (corresponding author), New Zealand Rugby Unit, POB 2172, Wellington, New Zealand.	ken.quarrie@nzrugby.co.nz	Hume, Patria/AAN-5514-2021; Hume, Patria Anne/P-1084-2017	Hume, Patria/0000-0003-1847-8128; Hume, Patria Anne/0000-0003-1847-8128; Quarrie, Ken/0000-0003-1703-8489				Berry JG, 2006, AUST NZ J PUBL HEAL, V30, P268, DOI 10.1111/j.1467-842X.2006.tb00869.x; Bourke JB, 2006, BRIT MED J, V332, P1281, DOI 10.1136/bmj.332.7552.1281; Carmody DJ, 2005, MED J AUSTRALIA, V182, P561, DOI 10.5694/j.1326-5377.2005.tb06814.x; Chalmers DJ, 2004, J SCI MED SPORT, V7, P74, DOI 10.1016/S1440-2440(04)80046-X; GARRAWAY WM, 1991, BRIT MED J, V303, P1082, DOI 10.1136/bmj.303.6810.1082; Haylen PT, 2004, MED J AUSTRALIA, V181, P48, DOI 10.5694/j.1326-5377.2004.tb06161.x; *INT RUGB BOARD, 2004, RUGB WORLD CUP 2003; Merton RK, 1936, AM SOCIOL REV, V1, P894, DOI 10.2307/2084615; Quarrie KL, 2007, J SPORT SCI, V25, P895, DOI 10.1080/02640410600944659; Quarrie KL, 2002, SPORTS MED, V32, P633, DOI 10.2165/00007256-200232100-00003; VANMECHELEN W, 1992, SPORTS MED, V14, P82, DOI 10.2165/00007256-199214020-00002	11	93	94	0	19	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 2	2007	334	7604					1150	1153		10.1136/bmj.39185.605914.AE	http://dx.doi.org/10.1136/bmj.39185.605914.AE			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	177ES	17513314	Green Published, Bronze			2022-12-28	WOS:000247137000030
J	Sablina, AA; Chen, W; Arroyo, JD; Corral, L; Hector, M; Bulmer, SE; DeCaprio, JA; Hahn, WC				Sablina, Anna A.; Chen, Wen; Arroyo, Jason D.; Corral, Laura; Hector, Melissa; Bulmer, Sara E.; DeCaprio, James A.; Hahn, William C.			The tumor suppressor PP2A A beta regulates the RaIA GTPase	CELL			English	Article							PROTEIN PHOSPHATASE 2A; HUMAN CELL-TRANSFORMATION; SMALL-T-ANTIGEN; RAL-GTPASES; SUBUNIT INTERACTION; SIGNALING PATHWAY; PPP2R1B GENE; CANCER-CELLS; ACTIVATION; ALPHA	The serine-threonine protein phosphatase 2A (PP2A) is a heterotrimeric enzyme family that regulates numerous signaling pathways. Biallelic mutations of the structural PP2A A beta subunit occur in several types of human tumors; however, the functional consequences of these cancer-associated PP2A A beta mutations in cell transformation remain undefined. Here we show that suppression of PP2A A beta expression permits immortalized human cells to achieve a tumorigenic state. Cancer-associated A beta mutants fail to reverse tumorigenic phenotype induced by PP2A A beta suppression, indicating that these mutants function as null alleles. Wild-type PP2A A beta but not cancer-derived A beta mutants form a complex with the small GTPase RalA. PP2A A beta-containing complexes dephosphorylate RalA at Ser183 and Ser194, inactivating RalA and abolishing its transforming function. These observations identify PP2A A beta as a tumor suppressor gene that transforms immortalized human cells by regulating the function of RalA.	Brigham & Womens Hosp, Dept Med Oncol, Dana Farber Canc Inst, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Broad Inst, Cambridge, MA 02142 USA; MIT, Cambridge, MA 02142 USA; Sun Yat Sen Univ, Sch Publ Hlth, Dept Toxicol, Guangzhou 510080, Peoples R China; Dana Farber Canc Inst, DF HCC Monoclonal Antibody Core, Boston, MA 02215 USA	Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Sun Yat Sen University; Harvard University; Dana-Farber Cancer Institute	Hahn, WC (corresponding author), Brigham & Womens Hosp, Dept Med Oncol, Dana Farber Canc Inst, Dept Med, 75 Francis St, Boston, MA 02115 USA.	william_hahn@dfci.harvard.edu	Sablina, Anna/B-2217-2017; Sablina, Anna/P-2818-2019	Sablina, Anna/0000-0001-9526-4014; Sablina, Anna/0000-0001-9526-4014; Hector-Greene, Melissa/0000-0001-7263-1440; Arroyo, Jason/0000-0002-5674-6739	NATIONAL CANCER INSTITUTE [P01CA050661] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA050661-190009, P01 CA50661, P01 CA050661] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ali SH, 2001, SEMIN CANCER BIOL, V11, P15, DOI 10.1006/scbi.2000.0342; ALTSCHULER D, 1993, J BIOL CHEM, V268, P7527; Baysal BE, 2001, EUR J HUM GENET, V9, P121, DOI 10.1038/sj.ejhg.5200585; Boehm JS, 2005, MOL CELL BIOL, V25, P6464, DOI 10.1128/MCB.25.15.6464-6474.2005; Broach JR, 1997, CURR OPIN GENET DEV, V7, P1, DOI 10.1016/S0959-437X(97)80102-5; Calin GA, 2000, ONCOGENE, V19, P1191, DOI 10.1038/sj.onc.1203389; Camonis JH, 2005, TRENDS CELL BIOL, V15, P327, DOI 10.1016/j.tcb.2005.04.002; Chen W, 2004, CANCER CELL, V5, P127, DOI 10.1016/S1535-6108(04)00026-1; Chen W, 2005, CANCER RES, V65, P8183, DOI 10.1158/0008-5472.CAN-05-1103; Chien YC, 2003, EMBO REP, V4, P800, DOI 10.1038/sj.embor.embor899; Cho US, 2007, NATURE, V445, P53, DOI 10.1038/nature05351; Drayton S, 2003, CANCER CELL, V4, P301, DOI 10.1016/S1535-6108(03)00242-3; EMKEY R, 1991, J BIOL CHEM, V266, P9703; Feig LA, 2003, TRENDS CELL BIOL, V13, P419, DOI 10.1016/S0962-8924(03)00152-1; Feinstein E, 2005, ONCOGENE, V24, P326, DOI 10.1038/sj.onc.1208252; Gildea JJ, 2002, CANCER RES, V62, P982; Goi T, 2000, EMBO J, V19, P623, DOI 10.1093/emboj/19.4.623; Gotz J, 2000, MECH DEVELOP, V93, P83, DOI 10.1016/S0925-4773(00)00267-7; Hahn WC, 2002, MOL CELL BIOL, V22, P2111, DOI 10.1128/MCB.22.7.2111-2123.2002; Hahn WC, 1999, NAT MED, V5, P1164, DOI 10.1038/13495; Hahn WC, 2002, NEW ENGL J MED, V347, P1593, DOI 10.1056/NEJMra021902; Hamad NM, 2002, GENE DEV, V16, P2045, DOI 10.1101/gad.993902; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HEMMINGS BA, 1990, BIOCHEMISTRY-US, V29, P3166, DOI 10.1021/bi00465a002; HENDRIX P, 1993, J BIOL CHEM, V268, P15267; Hu CD, 1999, J BIOL CHEM, V274, P48, DOI 10.1074/jbc.274.1.48; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; JIANG H, 1995, NATURE, V378, P409, DOI 10.1038/378409a0; Lim KH, 2005, CANCER CELL, V7, P533, DOI 10.1016/j.ccr.2005.04.030; Lim KH, 2006, CURR BIOL, V16, P2385, DOI 10.1016/j.cub.2006.10.023; Lundberg AS, 2002, ONCOGENE, V21, P4577, DOI 10.1038/sj.onc.1205550; Moskalenko S, 2002, NAT CELL BIOL, V4, P66, DOI 10.1038/ncb728; Ohta Y, 1999, P NATL ACAD SCI USA, V96, P2122, DOI 10.1073/pnas.96.5.2122; PALLAS DC, 1990, CELL, V60, P167, DOI 10.1016/0092-8674(90)90726-U; Panner A, 2006, MOL CELL BIOL, V26, P7345, DOI 10.1128/MCB.00126-06; Quilliam LA, 2002, PROG NUCLEIC ACID RE, V71, P391, DOI 10.1016/S0079-6603(02)71047-7; QUILLIAM LA, 1991, J IMMUNOL, V147, P1628; Rangarajan A, 2004, CANCER CELL, V6, P171, DOI 10.1016/j.ccr.2004.07.009; Ruediger R, 2001, ONCOGENE, V20, P1892, DOI 10.1038/sj.onc.1204279; Ruediger R, 2001, ONCOGENE, V20, P10, DOI 10.1038/sj.onc.1204059; Schonthal AH, 2001, CANCER LETT, V170, P1, DOI 10.1016/S0304-3835(01)00561-4; Seger YR, 2002, CANCER CELL, V2, P401, DOI 10.1016/S1535-6108(02)00183-6; Silverstein AM, 2002, P NATL ACAD SCI USA, V99, P4221, DOI 10.1073/pnas.072071699; SUGANO S, 1982, J VIROL, V41, P1073, DOI 10.1128/JVI.41.3.1073-1075.1982; SUGANUMA M, 1988, P NATL ACAD SCI USA, V85, P1768, DOI 10.1073/pnas.85.6.1768; TAKATA K, 2000, BREED RES, V2, P11; Tamaki M, 2004, ONCOL REP, V11, P655; Urano T, 1996, EMBO J, V15, P810, DOI 10.1002/j.1460-2075.1996.tb00416.x; van Dam EM, 2006, INT J BIOCHEM CELL B, V38, P1841, DOI 10.1016/j.biocel.2006.04.006; Voorhoeve PM, 2003, CANCER CELL, V4, P311, DOI 10.1016/S1535-6108(03)00223-X; Wang SS, 1998, SCIENCE, V282, P284, DOI 10.1126/science.282.5387.284; Wu JC, 2005, J BIOL CHEM, V280, P9013, DOI 10.1074/jbc.M411068200; Xu YH, 2006, CELL, V127, P1239, DOI 10.1016/j.cell.2006.11.033; Yeh E, 2004, NAT CELL BIOL, V6, P308, DOI 10.1038/ncb1110; Yu J, 2001, VIROLOGY, V290, P192, DOI 10.1006/viro.2001.1204; Zhao JJ, 2003, CANCER CELL, V3, P483, DOI 10.1016/S1535-6108(03)00088-6; Zhao JJ, 2004, TRENDS MOL MED, V10, P344, DOI 10.1016/j.molmed.2004.05.005; Zhou J, 2003, BIOCHEM J, V369, P387, DOI 10.1042/BJ20021244	58	160	169	1	14	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 1	2007	129	5					969	982		10.1016/j.cell.2007.03.047	http://dx.doi.org/10.1016/j.cell.2007.03.047			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	176KT	17540176	Bronze, Green Accepted			2022-12-28	WOS:000247084600016
J	Skinner, JS; Cooper, A; Feder, GS				Skinner, J. S.; Cooper, A.; Feder, G. S.		Guideline Dev Grp	Secondary prevention for patients after a myocardial infarction: summary of NICE guidance	BRITISH MEDICAL JOURNAL			English	Article									Royal Victoria Infirm, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; Royal Coll Gen Practitioners, Natl Collaborating Ctr Primary Care, London, England; Barts & London Queen Marys Sch Med & Dent, London, England	Newcastle University - UK; University of London; Queen Mary University London	Skinner, JS (corresponding author), Royal Victoria Infirm, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.	Jane.Skinner@nuth.nhs.uk		Feder, Gene/0000-0002-7890-3926				Bethell H J, 2001, J Cardiopulm Rehabil, V21, P111, DOI 10.1097/00008483-200103000-00008; *NAT I CLIN EXC, 2006, 43 NICE; *NAT I CLIN EXC, 2002, TA039 NICE; *NAT I CLIN EXC, 2006, PHI001 NICE; *NAT I CLIN EXC, 2004, TA080 NICE; *NAT I HLTH CLIN E, 2006, TA095 NICE; *NAT I HLTH CLIN E, 2007, 48 NICE; *ROYAL COLL PHYS, MYOC INF NAT AUD PRO; *U YORK, CARD REH	9	19	19	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAY 26	2007	334	7603					1112	1113		10.1136/bmj.39204.531586.AD	http://dx.doi.org/10.1136/bmj.39204.531586.AD			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	174XB	17525455	Green Published			2022-12-28	WOS:000246975000037
J	Wang, B; Matsuoka, S; Ballif, BA; Zhang, D; Smogorzewska, A; Gygi, SP; Elledge, SJ				Wang, Bin; Matsuoka, Shuhei; Ballif, Bryan A.; Zhang, Dong; Smogorzewska, Agata; Gygi, Steven P.; Elledge, Stephen J.			Abraxas and RAP80 form a BRCA1 protein complex required for the DNA damage response	SCIENCE			English	Article							LIGASE ACTIVITY; F-BOX; PHOSPHORYLATION; REPAIR; HETERODIMER; PROTEOMICS; INTERACTS; DOMAINS; BREAKS; CTIP	The BRCT repeats of the breast and ovarian cancer predisposition protein BRCA1 are essential for tumor suppression. Phosphopeptide affinity proteomic analysis identified a protein, Abraxas, that directly binds the BRCA1 BRCT repeats through a phospho- Ser-X-X-Phe motif. Abraxas binds BRCA1 to the mutual exclusion of BACH1 (BRCA1-associated C-terminal helicase) and CtIP (CtBP-interacting protein), forming a third type of BRCA1 complex. Abraxas recruits the ubiquitin-interacting motif (UIM)-containing protein RAP80 to BRCA1. Both Abraxas and RAP80 were required for DNA damage resistance, G(2)- M checkpoint control, and DNA repair. RAP80 was required for optimal accumulation of BRCA1 on damaged DNA ( foci) in response to ionizing radiation, and the UIM domains alone were capable of foci formation. The RAP80-Abraxas complex may help recruit BRCA1 to DNA damage sites in part through recognition of ubiquitinated proteins.	Harvard Univ, Brigham & Womens Hosp, Sch Med,Howard Hughes Med Inst, Dept Genet, Boston, MA 02115 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med,Howard Hughes Med Inst, Ctr Genet & Genom, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02214 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Elledge, SJ (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med,Howard Hughes Med Inst, Dept Genet, Boston, MA 02115 USA.	selledge@genetics.med.harvard.edu	Smogorzewska, Agata/B-8891-2011	Zhang, Dong/0000-0002-4515-2070; Smogorzewska, Agata/0000-0001-6285-1562	NATIONAL CANCER INSTITUTE [K01CA116275, T32CA009216] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [K01 CA116275, 1KO1, CA116275-01, T32CA09216, T32 CA009216] Funding Source: Medline; PHS HHS [1U19A1067751] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		AMANCHY R, 2005, SCI STKE, pPL2, DOI DOI 10.1126/STKE.2672005PL2; Baer R, 2002, CURR OPIN GENET DEV, V12, P86, DOI 10.1016/S0959-437X(01)00269-6; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Cantor SB, 2001, CELL, V105, P149, DOI 10.1016/S0092-8674(01)00304-X; Cortez D, 1999, SCIENCE, V286, P1162, DOI 10.1126/science.286.5442.1162; Everley PA, 2004, MOL CELL PROTEOMICS, V3, P729, DOI 10.1074/mcp.M400021-MCP200; Greenberg RA, 2006, GENE DEV, V20, P34, DOI 10.1101/gad.1381306; Hashizume R, 2001, J BIOL CHEM, V276, P14537, DOI 10.1074/jbc.C000881200; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Manke IA, 2003, SCIENCE, V302, P636, DOI 10.1126/science.1088877; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Moynahan ME, 2001, MOL CELL, V7, P263, DOI 10.1016/S1097-2765(01)00174-5; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; Nakanishi K, 2005, P NATL ACAD SCI USA, V102, P1110, DOI 10.1073/pnas.0407796102; Narod SA, 2004, NAT REV CANCER, V4, P665, DOI 10.1038/nrc1431; Ong SE, 2003, METHODS, V29, P124, DOI 10.1016/S1046-2023(02)00303-1; Rodriguez M, 2003, J BIOL CHEM, V278, P52914, DOI 10.1074/jbc.C300407200; Ruffner H, 2001, P NATL ACAD SCI USA, V98, P5134, DOI 10.1073/pnas.081068398; Scully R, 1997, CELL, V90, P425, DOI 10.1016/S0092-8674(00)80503-6; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Wu LJC, 1996, NAT GENET, V14, P430, DOI 10.1038/ng1296-430; Xu B, 2002, MOL CELL BIOL, V22, P1049, DOI 10.1128/MCB.22.4.1049-1059.2002; Yan J, 2007, NUCLEIC ACIDS RES, V35, P1673, DOI 10.1093/nar/gkl1112; Yan ZJ, 2002, J BIOL CHEM, V277, P32379, DOI 10.1074/jbc.M203475200; Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753; Yu XC, 2004, MOL CELL BIOL, V24, P9478, DOI 10.1128/MCB.24.21.9478-9486.2004; Yu XC, 2006, GENE DEV, V20, P1721, DOI 10.1101/gad.1431006; Zhang D, 2006, CELL, V126, P529, DOI 10.1016/j.cell.2006.06.039	29	550	580	2	99	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 25	2007	316	5828					1194	1198		10.1126/science.1139476	http://dx.doi.org/10.1126/science.1139476			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171GQ	17525340	Green Accepted			2022-12-28	WOS:000246724300044
J	DeMaria, EJ				DeMaria, Eric J.			Bariatric surgery for morbid obesity	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GASTRIC BYPASS; UNITED-STATES; RISK-FACTORS; FOLLOW-UP; SURGICAL-TREATMENT; HOSPITAL VOLUME; MANAGEMENT; MORTALITY; QUALITY; ASSOCIATION		Duke Univ, Med Ctr, Duke Endosurg Ctr, Durham, NC 27710 USA; Duke Univ, Med Ctr, Duke Weight Loss Surg Ctr, Durham, NC USA	Duke University; Duke University	DeMaria, EJ (corresponding author), Duke Univ, Med Ctr, Duke Endosurg Ctr, DUMC-3288, Durham, NC 27710 USA.	demaria@duke.edu						Ali MR, 2006, J AM COLL SURGEONS, V202, P70, DOI 10.1016/j.jamcollsurg.2005.09.014; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Blanck H. M., 2006, Morbidity and Mortality Weekly Report, V55, P985; BROLIN RE, 1992, ANN SURG, V215, P387, DOI 10.1097/00000658-199204000-00014; Brownson RC, 2005, ANNU REV PUBL HEALTH, V26, P421, DOI 10.1146/annurev.publhealth.26.021304.144437; Buchwald H, 2005, JAMA-J AM MED ASSOC, V293, P1728; Buchwald H, 2004, JAMA-J AM MED ASSOC, V292, P1724, DOI 10.1001/jama.292.14.1724; Buchwald H, 2004, OBES SURG, V14, P1157, DOI 10.1381/0960892042387057; Buchwald H, 2005, J AM COLL SURGEONS, V200, P593, DOI 10.1016/j.jamcollsurg.2004.10.039; Christou NV, 2004, ANN SURG, V240, P416, DOI 10.1097/01.sla.0000137343.63376.19; Collazo-Clavell ML, 2006, MAYO CLIN PROC, V81, pS11; Colquitt J, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003641.pub2; *COMM MA B LEHM CT, 2004, EX REP; Cope MB, 2006, OBESITY, V14, p156S, DOI 10.1038/oby.2006.297; Courcoulas A, 2003, SURGERY, V134, P613, DOI 10.1016/S0039-6060(03)00306-4; Craig BM, 2002, AM J MED, V113, P491, DOI 10.1016/S0002-9343(02)01266-4; Crookes PE, 2006, ANNU REV MED, V57, P243, DOI 10.1146/annurev.med.56.062904.144928; *CTR MED MED SERV, 2007, MED PHYS FEE SCHED; DeMaria EJ, 2005, SURG CLIN N AM, V85, P773, DOI 10.1016/j.suc.2005.04.008; Department of Health and Human Services. National Heart Lung and Blood Institute, 1998, CLIN GUID ID EV TREA; Dimick JB, 2004, JAMA-J AM MED ASSOC, V292, P847, DOI 10.1001/jama.292.7.847; Dixon John, 2006, Surg Obes Relat Dis, V2, P585; Fernandez AZ, 2004, ANN SURG, V239, P698, DOI 10.1097/01.sla.0000124295.41578.ab; Flum DR, 2005, JAMA-J AM MED ASSOC, V294, P1903, DOI 10.1001/jama.294.15.1903; Flum DR, 2004, J AM COLL SURGEONS, V199, P543, DOI 10.1016/j.jamcollsurg.2004.06.014; Harper J, 2007, AM SURGEON, V73, P181; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Hutter MM, 2006, ANN SURG, V243, P657, DOI 10.1097/01.sla.0000216784.05951.0b; *I CLIN SYST IMPR, 2006, PREV MAN OB MAT AD A; Inge TH, 2004, PEDIATRICS, V114, P217, DOI 10.1542/peds.114.1.217; Jamal Mohammad Khalid, 2005, Surg Obes Relat Dis, V1, P511, DOI 10.1016/j.soard.2005.08.010; Kalarchian MA, 2007, AM J PSYCHIAT, V164, P328, DOI 10.1176/appi.ajp.164.2.328; Kaplan LM, 2005, GASTROENTEROL CLIN N, V34, P105, DOI 10.1016/j.gtc.2004.12.004; Ledikwe JH, 2006, AM J CLIN NUTR, V83, P1362, DOI 10.1093/ajcn/83.6.1362; Li ZP, 2005, SURG CLIN N AM, V85, P681, DOI 10.1016/j.suc.2005.04.006; Livingston EH, 2005, AM J SURG, V190, P816, DOI 10.1016/j.amjsurg.2005.07.026; Livingston EH, 2002, ANN SURG, V236, P576, DOI 10.1097/00000658-200211000-00007; MacDonald K G Jr, 1997, J Gastrointest Surg, V1, P213, DOI 10.1016/S1091-255X(97)80112-6; Madan AK, 2003, SURG ENDOSC, V17, P685, DOI 10.1007/s00464-002-8610-7; Maes HHM, 1997, BEHAV GENET, V27, P325, DOI 10.1023/A:1025635913927; Maggard MA, 2005, ANN INTERN MED, V142, P547, DOI 10.7326/0003-4819-142-7-200504050-00013; McMahon MM, 2006, MAYO CLIN PROC, V81, pS34; Mokdad AH, 2005, JAMA-J AM MED ASSOC, V293, P293, DOI 10.1001/jama.293.3.293; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; Naslund E, 2005, SURG CLIN N AM, V85, P725, DOI 10.1016/j.suc.2005.03.006; Nathan DM, 2006, DIABETOLOGIA, V49, P2816, DOI 10.1007/s00125-006-0415-0; Nathan DM, 2006, DIABETES CARE, V29, P1963, DOI 10.2337/dc06-9912; National Institutes of Health (USA), 1992, American Journal of Clinical Nutrition, V55, p615S; Nguyen NT, 2004, ANN SURG, V240, P586, DOI 10.1097/01.sla.0000140752.74893.24; Nguyen NT, 2006, ARCH SURG-CHICAGO, V141, P445, DOI 10.1001/archsurg.141.5.445; *NY HLTH PLAN ASS, SURG MAN OB CONS GUI; O'Brien PE, 2006, ANN INTERN MED, V144, P625, DOI 10.7326/0003-4819-144-9-200605020-00005; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Olshansky SJ, 2005, NEW ENGL J MED, V352, P1138, DOI 10.1056/NEJMsr043743; Poulose BK, 2005, J SURG RES, V127, P1, DOI 10.1016/j.jss.2004.12.017; Pratt Gary M, 2006, Surg Obes Relat Dis, V2, P497, DOI 10.1016/j.soard.2006.07.004; Puzziferri N, 2006, ANN SURG, V243, P181, DOI 10.1097/01.sla.0000197381.01214.76; Raftopoulos I, 2005, J GASTROINTEST SURG, V9, P44, DOI 10.1016/j.gassur.2004.10.004; Raftopoulos Yannis, 2005, JSLS, V9, P272; RENQUIST K, 1992, OBES SURG, V2, P361, DOI 10.1381/096089292765559963; Salant T, 2006, SOC SCI MED, V62, P2445, DOI 10.1016/j.socscimed.2005.10.021; Sauerland S, 2005, SURG ENDOSC, V19, P200, DOI 10.1007/s00464-004-9194-1; Sjostrom L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622; Snow V, 2005, ANN INTERN MED, V142, P525, DOI 10.7326/0003-4819-142-7-200504050-00011; Stocker DJ, 2003, ENDOCRIN METAB CLIN, V32, P437, DOI 10.1016/S0889-8529(03)00002-1; Sugerman HJ, 2004, ANN SURG, V240, P243, DOI 10.1097/01.sla.0000133361.68436.da; SUGERMAN HJ, 1987, ANN SURG, V205, P613, DOI 10.1097/00000658-198706000-00002; Sugerman HJ, 2001, ANN SURG, V234, P41, DOI 10.1097/00000658-200107000-00007; van Hout GCM, 2005, OBES SURG, V15, P552, DOI 10.1381/0960892053723484; Weller WE, 2006, J AM COLL SURGEONS, V202, P753, DOI 10.1016/j.jamcollsurg.2006.02.002; Wolf AM, 1998, OBES RES, V6, P97, DOI 10.1002/j.1550-8528.1998.tb00322.x; Zingmond DS, 2005, JAMA-J AM MED ASSOC, V294, P1918, DOI 10.1001/jama.294.15.1918	72	283	296	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 24	2007	356	21					2176	2183		10.1056/NEJMct067019	http://dx.doi.org/10.1056/NEJMct067019			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	170ON	17522401				2022-12-28	WOS:000246673100007
J	Chretien, JP; Fukuda, M; Noedl, H				Chretien, Jean-Paul; Fukuda, Mark; Noedl, Harald			Improving surveillance for antimalarial drug resistance	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MALARIA; ARTEMISININ; MUTATIONS; EFFICACY		US Dept Def, Global Emerging Infect Surveillance & Response Sy, Silver Spring, MD 20910 USA; Armed Forces Res Inst Med Sci, Dept Immunol & Med, Bangkok 10400, Thailand; Med Univ Vienna, Dept Specif Prophylaxis & Trop Med, Vienna, Austria	United States Department of Defense; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); Medical University of Vienna	Chretien, JP (corresponding author), US Dept Def, Global Emerging Infect Surveillance & Response Sy, 2900 Linden Lane, Silver Spring, MD 20910 USA.	jean-paul.chretien@na.amedd.army.mil		Chretien, Jean-Paul/0000-0001-8143-6823				Adjuik M, 2004, LANCET, V363, P9, DOI 10.1016/S0140-6736(03)15162-8; Afonso A, 2006, ANTIMICROB AGENTS CH, V50, P480, DOI 10.1128/AAC.50.2.480-489.2006; Attaran A, 2004, LANCET, V363, P237, DOI 10.1016/S0140-6736(03)15330-5; Francis D, 2006, J INFECT DIS, V193, P978, DOI 10.1086/500951; *GLOB FUND FIGHT A, 2004, TUB MAL REV ANT TREA; Global Fund to Fight AIDS Tuberculosis and Malaria, 2006, MON EV TOOLK HIV AID; Institute of Medicine (US) Committee on the Economics of Antimalarial Drugs, 2004, SAVING LIVES BUYING, P1125; Jambou R, 2005, LANCET, V366, P1960, DOI 10.1016/S0140-6736(05)67787-2; Kachur SP, 2006, LANCET, V368, P10, DOI 10.1016/S0140-6736(06)68945-9; Kerr C, 2006, LANCET INFECT DIS, V6, P397, DOI 10.1016/S1473-3099(06)70508-4; Krishna S, 2006, TRENDS MOL MED, V12, P200, DOI 10.1016/j.molmed.2006.03.005; Magill A, 2005, NEW ENGL J MED, V353, P335, DOI 10.1056/NEJMp058167; Newton PN, 2006, PLOS MED, V3, P752, DOI 10.1371/journal.pmed.0030197; Noedl H, 2005, TRENDS PARASITOL, V21, P404, DOI 10.1016/j.pt.2005.06.012; Plowe CV, 1997, J INFECT DIS, V176, P1590, DOI 10.1086/514159; Price RN, 1996, LANCET, V347, P1654, DOI 10.1016/S0140-6736(96)91488-9; Sibley CH, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-48; Uhlemann AC, 2005, NAT STRUCT MOL BIOL, V12, P628, DOI 10.1038/nsmb947; WHO, 2005, SUSC PLASM FALC ANT; WHO, 2006, GUID TREATM MAL; *WHO, 2006, FACTS ACTS; Wongsrichanalai C, 2002, LANCET INFECT DIS, V2, P209, DOI 10.1016/S1473-3099(02)00239-6; World Health Organization, 1993, GLOB STRAT MAL CONTR	23	7	7	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 23	2007	297	20					2278	2281		10.1001/jama.297.20.2278	http://dx.doi.org/10.1001/jama.297.20.2278			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	170JM	17522014				2022-12-28	WOS:000246659700027
J	Leslie, T; Mayan, MI; Hasan, MA; Safi, MH; Klinkenberg, E; Whitty, CJM; Rowland, M				Leslie, Toby; Mayan, M. Ismail; Hasan, M. Anwar; Safi, M. Hanif; Klinkenberg, Eveline; Whitty, Christopher J. M.; Rowland, Mark			Sulfadoxine-pyrimethamine, chlorproguanil-dapsone, or chloroquine for the treatment of Plasmodium vivax malaria in Afghanistan and Pakistan - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							UNCOMPLICATED FALCIPARUM-MALARIA; PRIMAQUINE THERAPY; DRUG-RESISTANCE; MUTATIONS; DHFR; INFECTIONS; DEFICIENCY; CHALLENGES; TANZANIA/; THAILAND	Context In areas where Plasmodium falciparum and Plasmodium vivax coexist and treatments for the 2 species differ, misdiagnosis can lead to poor outcomes in either disease. A unified therapy effective against both species would reduce reliance on species-specific diagnosis, which in many areas is difficult to maintain. The antifolates are an important and affordable antimalarial class to which it is often assumed P vivax malaria is intrinsically resistant. Objective To test the relative efficacy and safety of 2 antifolate drugs against P vivax malaria and compare each with chloroquine. Design, Setting, and Patients An open-label randomized controlled trial comparing chloroquine, sulfadoxine-pyrimethamine, and chlorproguanil-dapsone for the treatment of P vivax malaria was conducted in eastern Afghanistan and northwestern Pakistan, areas in which P vivax malaria predominates. A total of 20 410 patients older than 3 years were screened; 767 patients (315 in Pakistan and 452 in Afghanistan) with confirmed P vivax malaria were enrolled and followed up daily for 4 days, then weekly for 28 days, between March 2004 and June 2006. Main Outcome Measures Complete clearance of parasites with no recrudescence by day 14. Secondary outcomes included being parasite-free by day 28, clinical failure, and anemia. Results By day 14, only 1 patient in the sulfadoxine-pyrimethamine group had parasites. By day 28, failure rates were found in 2 of 153 patients (1.3%) in the chloroquine group, 5 of 290 patients (1.7%) in the sulfadoxine-pyrimethamine group, and 27 of 272 patients (9.9%) in the chlorproguanil-dapsone group. Chlorproguanil-dapsone was less effective than sulfadoxine-pyrimethamine (adjusted odds ratio [ OR], 6.4; 95% confidence interval [CI], 2.4-17.0; P < .001) and chloroquine (adjusted OR, 8.4; 95% CI, 2.0-36.5; P = .004). Chloroquine and sulfadoxine-pyrimethamine were equivalent in efficacy at day 28 (adjusted OR, 1.3; 95% CI, 0.3-7.0; P = .73). Chloroquine cleared gametocytes and asexual parasites more rapidly than sulfadoxine-pyrimethamine or chlorproguanil-dapsone did. All drugs were well tolerated. Conclusions Although chloroquine remains the drug of choice, antifolates are effective against P vivax malaria in South Asia. These drugs may be appropriate for unified treatment where species-specific diagnosis is unavailable, most likely in combination with other drugs.	Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1E 7HT, England; TPO Malaria & Leishmaniasis Control Programme, Peshawar, Pakistan	University of London; London School of Hygiene & Tropical Medicine	Leslie, T (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, Keppel St, London WC1E 7HT, England.	toby.leslie@lshtm.ac.uk	Whitty, Christopher/C-7740-2012	Whitty, Christopher/0000-0002-6076-5027				Ali Nadir, 2005, J Coll Physicians Surg Pak, V15, P137; Alloueche A, 2004, LANCET, V363, P1843, DOI 10.1016/S0140-6736(04)16350-2; Amukoye E, 1997, ANTIMICROB AGENTS CH, V41, P2261, DOI 10.1128/AAC.41.10.2261; Baird JK, 2004, ANTIMICROB AGENTS CH, V48, P4075, DOI 10.1128/AAC.48.11.4075-4083.2004; Baird JK, 2003, TRENDS PARASITOL, V19, P115, DOI 10.1016/S1471-4922(03)00005-9; Bell D, 2006, NAT REV MICROBIOL, pS7, DOI [10.1038/nrmico1525, 10.1038/nrmicro1525]; BOUMA MJ, 1995, T ROY SOC TROP MED H, V89, P62, DOI 10.1016/0035-9203(95)90661-4; Brooker S, 2006, EMERG INFECT DIS, V12, P1600, DOI 10.3201/eid1210.060051; Connolly MA, 2004, LANCET, V364, P1974, DOI 10.1016/S0140-6736(04)17481-3; Curtis J, 2002, J INFECT DIS, V186, P1861, DOI 10.1086/345765; Durrani N, 2005, TROP MED INT HEALTH, V10, P521, DOI 10.1111/j.1365-3156.2005.01429.x; FIGUEIREDO MS, 1989, ACTA HAEMATOL-BASEL, V82, P144; Guerra CA, 2006, ADV PARASIT, V62, P157, DOI 10.1016/S0065-308X(05)62005-2; Guerra CA, 2006, TRENDS PARASITOL, V22, P353, DOI 10.1016/j.pt.2006.06.006; Imwong M, 2005, ANTIMICROB AGENTS CH, V49, P4393, DOI 10.1128/AAC.49.10.4393-4395.2005; Imwong M, 2001, ANTIMICROB AGENTS CH, V45, P3122, DOI 10.1128/AAC.45.11.3122-3127.2001; Kolaczinski J, 2005, LANCET, V365, P1506, DOI 10.1016/S0140-6736(05)66423-9; KOLACZINSKI K, IN PRESS T R SOC TRO; Lang T, 2003, LANCET INFECT DIS, V3, P162, DOI 10.1016/S1473-3099(03)00547-4; Leslie T, 2004, T ROY SOC TROP MED H, V98, P168, DOI 10.1016/S0035-9203(03)00041-5; Mendis K, 2001, AM J TROP MED HYG, V64, P97, DOI 10.4269/ajtmh.2001.64.97; Mutabingwa T, 2001, LANCET, V358, P1218, DOI 10.1016/S0140-6736(01)06344-9; Mutabingwa TK, 2001, T ROY SOC TROP MED H, V95, P433, DOI 10.1016/S0035-9203(01)90207-X; Nzila AM, 2000, J INFECT DIS, V181, P2023, DOI 10.1086/315520; Pukrittayakamee S, 2000, ANTIMICROB AGENTS CH, V44, P1680, DOI 10.1128/AAC.44.6.1680-1685.2000; Rowland M, 2002, SOC SCI MED, V55, P2061, DOI 10.1016/S0277-9536(01)00341-0; Rowland M, 1999, T ROY SOC TROP MED H, V93, P641, DOI 10.1016/S0035-9203(99)90081-0; RUWENDE C, 1995, NATURE, V376, P246, DOI 10.1038/376246a0; Sulo J, 2002, LANCET, V360, P1136, DOI 10.1016/S0140-6736(02)11198-6; Tjitra E, 2002, ANTIMICROB AGENTS CH, V46, P3947, DOI 10.1128/AAC.46.12.3947-3953.2002; *UN HIGH COMM REF, TOP 5 REF HOST COUNT; White NJ, 2004, J CLIN INVEST, V113, P1084, DOI [10.1172/JCI21682, 10.1172/JCI200421682]; *WHO, US RAP MAL DIAGN TES; *WHO, WHOHTMMAL20061108; Wilairatana P, 1999, AM J TROP MED HYG, V61, P973, DOI 10.4269/ajtmh.1999.61.973; Young M. D., 1959, Bulletin of the World Health Organization, V20, P27	36	47	50	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 23	2007	297	20					2201	2209		10.1001/jama.297.20.2201	http://dx.doi.org/10.1001/jama.297.20.2201			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	170JM	17519409	Bronze			2022-12-28	WOS:000246659700019
J	May, J; Evans, JA; Timmann, C; Ehmen, C; Busch, W; Thye, T; Agbenyega, T; Horstmann, RD				May, Juergen; Evans, Jennifer A.; Timmann, Christian; Ehmen, Christa; Busch, Wibke; Thye, Thorsten; Agbenyega, Tsiri; Horstmann, Rolf D.			Hemoglobin variants and disease manifestations in severe falciparum malaria	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SICKLE-CELL TRAIT; AFRICAN CHILDREN; ALPHA(+)-THALASSEMIA PROTECTS; ALPHA-THALASSEMIA; GHANAIAN CHILDREN; POLYMORPHISM; CHLOROQUINE; POPULATION; RESISTANCE; PARASITES	Context The geographical distributions of hemoglobin S (HbS), hemoglobin C (HbC), and alpha(+)-thalassemia (-alpha) strongly suggest balancing selection with malaria. However, whereas several studies indicate that the HbS carrier state protects against all major forms of clinical malaria, malaria protection on clinical grounds has been more difficult to confirm for HbC and -alpha, and questions remain as to whether it applies to all forms of the disease. Objective To assess the association between major clinical forms of severe falciparum malaria and HbS, HbC, and -alpha. Design, Setting, and Participants Case-control study of 2591 children with severe falciparum malaria enrolled at a tertiary referral center in Ghana, West Africa, and 2048 age-, sex-, and ethnicity-matched control participants recruited by community surveys. Main Outcome Measures Frequencies of HbS, HbC, and -alpha in patients and controls, including stratifications of patients for signs of disease. Results Patients presented with partly overlapping signs of disease, including severe anemia (64%), cerebral malaria (22%), respiratory distress (30%), hyperparasitemia (32%), prostration (52%), acidosis (59%), and hyperlactatemia (56%). Carrier states of HbS, HbC, and -alpha were found in 1.4%, 9.4%, and 25.2% of the patients, respectively, and 14.8%, 8.7%, and 27.3% of controls. The HbS carrier state was negatively associated with all forms of the disease studied (overall odds ratio [OR], 0.08; 95% confidence interval [CI], 0.06-0.12). The HbC carrier state showed a negative association selectively with cerebral malaria (OR, 0.64; 95% CI, 0.45-0.91), and the -alpha carrier state showed a negative association selectively with severe anemia (OR, 0.82; 95% CI, 0.69-0.96). Conclusion Whereas the HbS carrier state was found to be negatively associated with all major forms of severe falciparum malaria, the negative associations of the carrier states of HbC and -alpha appeared to be limited to cerebral malaria and severe anemia, respectively.	Bernhard Nocht Inst Trop Med, D-20359 Hamburg, Germany; Kwame Nkrumah Univ Sci & Technol, Kumasi Ctr Collaborat Res Trop Med, Kumasi, Ghana; Univ Schleswig Holstein, Inst Med Biometry & Stat, Kiel, Germany; Kwame Nkrumah Univ Sci & Technol, Sch Med Sci, Kumasi, Ghana; Komfo Anokye Teaching Hosp, Dept Child Hlth, Kumasi, Ghana	Bernhard Nocht Institut fur Tropenmedizin; Kumasi Center for Collaborative Research; Kwame Nkrumah University Science & Technology; University of Kiel; Schleswig Holstein University Hospital; Kwame Nkrumah University Science & Technology; Kwame Nkrumah University Science & Technology	Horstmann, RD (corresponding author), Bernhard Nocht Inst Trop Med, Bernhard Nocht Str 74, D-20359 Hamburg, Germany.	horstmann@bni-hamburg.de	May, Jürgen/E-7857-2011	May, Jurgen/0000-0001-7831-8420				Agarwal A, 2000, BLOOD, V96, P2358, DOI 10.1182/blood.V96.7.2358.h8002358_2358_2363; Allen S, 1996, LANCET, V348, P1168, DOI 10.1016/S0140-6736(05)65301-9; Allen SJ, 1997, P NATL ACAD SCI USA, V94, P14736, DOI 10.1073/pnas.94.26.14736; ALLISON AC, 1964, COLD SPRING HARB SYM, V29, P137, DOI 10.1101/SQB.1964.029.01.018; Altman DG, 2003, BMJ-BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; BEUTLER E, 2001, WILLIAMS HEMATOLOGY, P581; CARSON JL, 1988, LANCET, V1, P727; Chong SS, 2000, BLOOD, V95, P360; Cockburn IA, 2004, P NATL ACAD SCI USA, V101, P272, DOI 10.1073/pnas.0305306101; Evans JA, 2005, QJM-INT J MED, V98, P789, DOI 10.1093/qjmed/hci121; Evans JA, 2004, QJM-INT J MED, V97, P591, DOI 10.1093/qjmed/hch093; Fairhurst RM, 2005, NATURE, V435, P1117, DOI 10.1038/nature03631; Flint J, 1998, BAILLIERE CLIN HAEM, V11, P1, DOI 10.1016/S0950-3536(98)80069-3; GILLES HM, 1967, LANCET, V1, P138; Herrmann MG, 2000, CLIN CHEM, V46, P425; HILL AVS, 1991, NATURE, V352, P595, DOI 10.1038/352595a0; Kyes S, 2001, ANNU REV MICROBIOL, V55, P673, DOI 10.1146/annurev.micro.55.1.673; Maitland K, 2004, ACTA TROP, V90, P131, DOI 10.1016/j.actatropica.2003.11.010; MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102; Meerman L, 2005, J INFECT DIS, V192, P1651, DOI 10.1086/496887; Mockenhaupt FP, 2004, BLOOD, V104, P2003, DOI 10.1182/blood-2003-11-4090; Mockenhaupt FP, 2004, J INFECT DIS, V190, P1006, DOI 10.1086/422847; Modiano D, 2001, NATURE, V414, P305, DOI 10.1038/35104556; Newton CRJC, 2000, J NEUROL NEUROSUR PS, V69, P433, DOI 10.1136/jnnp.69.4.433; Pasvol G, 2006, PLOS MED, V3, P591, DOI 10.1371/journal.pmed.0030235; Rees DC, 1998, BRIT J HAEMATOL, V103, P365; Roberts DJ, 2005, CURR TOP MICROBIOL, V295, P137; Shute G. T., 1988, Malaria: principles and practice of malariology. Volume 1., P781; Silamut K, 1999, AM J PATHOL, V155, P395, DOI 10.1016/S0002-9440(10)65136-X; SNOW R, 2003, 11 NIH FOG INT CTR, P1; Taylor T, 2006, T ROY SOC TROP MED H, V100, P615, DOI 10.1016/j.trstmh.2005.09.021; Wambua S, 2006, PLOS MED, V3, P643, DOI 10.1371/journal.pmed.0030158; Williams TN, 2006, CURR OPIN MICROBIOL, V9, P388, DOI 10.1016/j.mib.2006.06.009; Williams TN, 2005, BLOOD, V106, P368, DOI 10.1182/blood-2005-01-0313; Williams TN, 2005, NAT GENET, V37, P1253, DOI 10.1038/ng1660; Williams TN, 2005, J INFECT DIS, V192, P178, DOI 10.1086/430744	37	122	123	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 23	2007	297	20					2220	2226		10.1001/jama.297.20.2220	http://dx.doi.org/10.1001/jama.297.20.2220			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	170JM	17519411				2022-12-28	WOS:000246659700021
J	Michel, FM; Ehm, L; Antao, SM; Lee, PL; Chupas, PJ; Liu, G; Strongin, DR; Schoonen, MAA; Phillips, BL; Parise, JB				Michel, F. Marc; Ehm, Lars; Antao, Sytle M.; Lee, Peter L.; Chupas, Peter J.; Liu, Gang; Strongin, Daniel R.; Schoonen, Martin A. A.; Phillips, Brian L.; Parise, John B.			The structure of ferrihydrite, a nanocrystalline material	SCIENCE			English	Article							SYNTHETIC 6-LINE FERRIHYDRITE; MAGNETIC-PROPERTIES; IRON; NANOPARTICLES; MODEL	Despite the ubiquity of ferrihydrite in natural sediments and its importance as an industrial sorbent, the nanocrystallinity of this iron oxyhydroxide has hampered accurate structure determination by traditional methods that rely on long-range order. We uncovered the atomic arrangement by real-space modeling of the pair distribution function (PDF) derived from direct Fourier transformation of the total x-ray scattering. The PDF for ferrihydrite synthesized with the use of different routes is consistent with a single phase (hexagonal space group P6(3)mc; a = similar to 5.95 angstroms, c = similar to 9.06 angstroms). In its ideal form, this structure contains 20% tetrahedrally and 80% octahedrally coordinated iron and has a basic structural motif closely related to the Baker-Figgis delta-Keggin cluster. Real-space fitting indicates structural relaxation with decreasing particle size and also suggests that second-order effects such as internal strain, stacking faults, and particle shape contribute to the PDFs.	SUNY Stony Brook, CEMS, Stony Brook, NY 11794 USA; SUNY Stony Brook, Dept Geosci, Stony Brook, NY 11794 USA; Argonne Natl Lab, Adv Photon Source, Argonne, IL 60439 USA; Temple Univ, Dept Chem, Philadelphia, PA 19122 USA; SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; United States Department of Energy (DOE); Argonne National Laboratory; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Michel, FM (corresponding author), SUNY Stony Brook, CEMS, Stony Brook, NY 11794 USA.	fmichel@ic.sunysb.edu	Schoonen, martin A/E-7703-2011; Ehm, Lars/AAX-1317-2020; Michel, F. Marc/E-1813-2018	Ehm, Lars/0000-0001-5485-0316; Michel, F. Marc/0000-0003-2817-980X				Billinge SJL, 2004, CHEM COMMUN, P749, DOI 10.1039/b309577k; BRADY GW, 1968, BIOCHEMISTRY-US, V7, P2185, DOI 10.1021/bi00846a022; Casey WH, 2006, CHEM REV, V106, P1, DOI 10.1021/cr040095d; Cornell R.M., 1996, CORROS SCI, DOI [DOI 10.1016/S0010-938X(99)00005-0, DOI 10.1016/S0010-938X(97)00096-6]; DRITS VA, 1993, CLAY MINER, V28, P185, DOI 10.1180/claymin.1993.028.2.02; Egami T, 2003, PERGAMON MATER SER, V7, pVII; EGGLETON RA, 1988, CLAY CLAY MINER, V36, P111, DOI 10.1346/CCMN.1988.0360203; Gilbert B, 2004, SCIENCE, V305, P651, DOI 10.1126/science.1098454; Guyodo Y, 2006, PHYS EARTH PLANET IN, V154, P222, DOI 10.1016/j.pepi.2005.05.009; HUFFMAN GP, 1993, ENERG FUEL, V7, P285, DOI 10.1021/ef00038a020; Hwang SL, 2006, INT GEOL REV, V48, P754, DOI 10.2747/0020-6814.48.8.754; Jambor JL, 1998, CHEM REV, V98, P2549, DOI 10.1021/cr970105t; Janney DE, 2000, AM MINERAL, V85, P1180, DOI 10.2138/am-2000-8-910; Janney DE, 2001, AM MINERAL, V86, P327; Jansen E, 2002, APPL PHYS A-MATER, V74, pS1004, DOI 10.1007/s003390101175; Joumard I, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.205411; Juhas P, 2006, NATURE, V440, P655, DOI 10.1038/nature04556; Kodama K, 2006, ACTA CRYSTALLOGR A, V62, P444, DOI 10.1107/S0108767306034635; Lewin A, 2005, DALTON T, P3597, DOI 10.1039/b506071k; Michel FM, 2007, CHEM MATER, V19, P1489, DOI 10.1021/cm062585n; MURAD E, 1980, AM MINERAL, V65, P1044; Paglia G, 2006, CHEM MATER, V18, P3242, DOI 10.1021/cm060277j; Pan Y, 2006, MICRON, V37, P403, DOI 10.1016/j.micron.2005.12.009; PAN Y, 2007, THESIS U LEEDS LEEDS; PANKHURST QA, 1992, CLAY CLAY MINER, V40, P268, DOI 10.1346/CCMN.1992.0400303; Petkov V, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.092105; Rancourt DG, 2001, AM MINERAL, V86, P834; Riveros PA, 2001, CAN METALL QUART, V40, P395; SCHWERTMANN U, 1987, CLAY CLAY MINER, V35, P297, DOI 10.1346/CCMN.1987.0350407; van Slageren J, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.014422	30	642	653	12	521	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 22	2007	316	5832					1726	1729		10.1126/science.1142525	http://dx.doi.org/10.1126/science.1142525			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	180XE	17525301				2022-12-28	WOS:000247400500041
J	Jacob, M; Chappell, D; Rehm, M				Jacob, Matthias; Chappell, Daniel; Rehm, Markus			Clinical update: perioperative fluid management	LANCET			English	Article							RADICAL HYSTERECTOMY; INDUCED HYPOTENSION; SURGERY; TRIAL; RESTRICTION; VOLUME; RESPONSIVENESS; RESECTION; RECOVERY; THERAPY		Univ Munich, Clin Anaesthesiol, D-80336 Munich, Germany	University of Munich	Jacob, M (corresponding author), Univ Munich, Clin Anaesthesiol, D-80336 Munich, Germany.	matthias.jacob@med.uni-muenchen.de						Bendjelid K, 2003, INTENS CARE MED, V29, P352, DOI 10.1007/s00134-002-1615-9; Brandstrup B, 2003, ANN SURG, V238, P641, DOI 10.1097/01.sla.0000094387.50865.23; Desborough JP, 2000, BRIT J ANAESTH, V85, P109, DOI 10.1093/bja/85.1.109; Holte K, 2006, J AM COLL SURGEONS, V202, P971, DOI 10.1016/j.jamcollsurg.2006.01.003; JACKSON R, 1995, BRIT J ANAESTH, V75, P262, DOI 10.1093/bja/75.3.262; LAMKE LO, 1977, ACTA CHIR SCAND, V143, P279; Lobo DN, 2002, LANCET, V359, P1812, DOI 10.1016/S0140-6736(02)08711-1; MacKay G, 2006, BRIT J SURG, V93, P1469, DOI 10.1002/bjs.5593; Moller AM, 2002, EUR J ANAESTH, V19, P57, DOI 10.1017/S0265021502000091; Nisanevich V, 2005, ANESTHESIOLOGY, V103, P25, DOI 10.1097/00000542-200507000-00008; Noblett SE, 2006, BRIT J SURG, V93, P1069, DOI 10.1002/bjs.5454; Rehm M, 2001, ANESTHESIOLOGY, V95, P849, DOI 10.1097/00000542-200110000-00011; Rehm M, 2000, ANESTHESIOLOGY, V92, P657, DOI 10.1097/00000542-200003000-00008; Sear JW, 2005, BRIT J ANAESTH, V95, P20, DOI 10.1093/bja/aei018; SHIRES T, 1961, ANN SURG, V154, P803, DOI 10.1097/00000658-196111000-00005; SHOEMAKER WC, 1973, ARCH SURG-CHICAGO, V106, P630; Solus-Biguenet H, 2006, BRIT J ANAESTH, V97, P808, DOI 10.1093/bja/ael250; Spahn DR, 2006, ANESTH ANALG, V102, P344, DOI 10.1213/01.ane.0000196511.48033.0b; Tavernier B, 1998, ANESTHESIOLOGY, V89, P1313, DOI 10.1097/00000542-199812000-00007; Wiedemann HP, 2006, NEW ENGL J MED, V354, P2564	20	90	95	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 16	2007	369	9578					1984	1986		10.1016/S0140-6736(07)60926-X	http://dx.doi.org/10.1016/S0140-6736(07)60926-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	180HT	17574081				2022-12-28	WOS:000247354400009
J	Kerr, JT; Kharouba, HM; Currie, DJ				Kerr, Jeremy T.; Kharouba, Heather M.; Currie, David J.			The macroecological contribution to global change solutions	SCIENCE			English	Review							AVIAN SPECIES RICHNESS; CLIMATE-CHANGE; METABOLIC THEORY; LAND-USE; BIODIVERSITY; DISTRIBUTIONS; PATTERNS; RANGE; MODEL; ECOLOGY	Anthropogenic global changes threaten species and the ecosystem services upon which society depends. Effective solutions to this multifaceted crisis need scientific responses spanning disciplines and spatial scales. Macroecology develops broad-scale predictions of species' distributions and abundances, complementing the frequently local focus of global change biology. Macroecological discoveries rely particularly on correlative methods but have still proven effective in predicting global change impacts on species. However, global changes create pseudo-experimental opportunities to build stronger, mechanistic theories in macroecology that successfully predict multiple phenomena across spatial scales. Such macroecological perspectives will help address the biotic consequences of global change.	Univ Ottawa, Dept Biol, Canadian Facil Ecoinformat Res, Ottawa, ON K1N 6N5, Canada	University of Ottawa	Kerr, JT (corresponding author), Univ Ottawa, Dept Biol, Canadian Facil Ecoinformat Res, Ottawa, ON K1N 6N5, Canada.	jkerr@uottawa.ca		Currie, David J./0000-0002-4906-2363				Algar AC, 2007, GLOBAL ECOL BIOGEOGR, V16, P170, DOI 10.1111/j.1466-8238.2006.00275.x; Allen AP, 2006, P NATL ACAD SCI USA, V103, P9130, DOI 10.1073/pnas.0603587103; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Blackburn TM, 2006, GLOBAL ECOL BIOGEOGR, V15, P537, DOI 10.1111/j.1466-8238.2006.00276.x; Blackburn TM, 2005, SCIENCE, V307, P1412, DOI 10.1126/science.1107480; Blackburn TM, 2004, SCIENCE, V305, P1955, DOI 10.1126/science.1101617; Botkin DB, 2007, BIOSCIENCE, V57, P227, DOI 10.1641/B570306; Brown J.H., 1995, MACROECOLOGY; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Burgess ND, 2007, BIOL CONSERV, V134, P164, DOI 10.1016/j.biocon.2006.08.024; Currie DJ, 2004, ECOL LETT, V7, P1121, DOI 10.1111/j.1461-0248.2004.00671.x; Davis AJ, 1998, NATURE, V391, P783, DOI 10.1038/35842; Didham RK, 2005, SCIENCE, V307, P1412, DOI 10.1126/science.1107333; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Evans KL, 2005, GLOBAL ECOL BIOGEOGR, V14, P187, DOI 10.1111/j.1466-822X.2004.00139.x; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Francis AP, 2003, AM NAT, V161, P523, DOI 10.1086/368223; Graham CH, 2004, TRENDS ECOL EVOL, V19, P497, DOI 10.1016/j.tree.2004.07.006; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; H-Acevedo D, 2003, GLOBAL ECOL BIOGEOGR, V12, P461, DOI 10.1046/j.1466-822X.2003.00058.x; Harte J, 2006, ENVIRON RES LETT, V1, DOI 10.1088/1748-9326/1/1/014001; Hawkins BA, 2004, ECOGRAPHY, V27, P268, DOI 10.1111/j.0906-7590.2004.03883.x; Hubbell Stephen P., 2001, V32, pi; Jackson ST, 2004, ANNU REV EARTH PL SC, V32, P495, DOI 10.1146/annurev.earth.32.101802.120435; Jetz W, 2002, SCIENCE, V297, P1548, DOI 10.1126/science.1072779; Kalmar A, 2007, ECOLOGY, V88, P1309, DOI 10.1890/06-1368; Kerr JT, 2003, TRENDS ECOL EVOL, V18, P299, DOI 10.1016/S0169-5347(03)00071-5; Kerr JT, 2003, GLOBAL ECOL BIOGEOGR, V12, P161, DOI 10.1046/j.1466-822X.2003.00017.x; LAYBERRY R., 1998, BUTTERFLIES CANADA; Lemoine N, 2007, GLOBAL ECOL BIOGEOGR, V16, P55, DOI 10.1111/j.1466-8238.2006.00252.x; LEVINS R, 1966, AM SCI, V54, P421; MAC ARTHUR ROBERT H., 1967; May Robert M., 1995, P1; McGill B, 2003, OIKOS, V102, P679, DOI 10.1034/j.1600-0706.2003.12617.x; McGill BJ, 2006, ECOLOGY, V87, P1411, DOI 10.1890/0012-9658(2006)87[1411:EEONT]2.0.CO;2; Parmesan C, 2005, OIKOS, V108, P58, DOI 10.1111/j.0030-1299.2005.13150.x; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pearson RG, 2006, J BIOGEOGR, V33, P1704, DOI 10.1111/j.1365-2699.2006.01460.x; Pereira HM, 2006, ECOLOGY, V87, P1877, DOI 10.1890/0012-9658(2006)87[1877:MBDICL]2.0.CO;2; Pereira HM, 2006, TRENDS ECOL EVOL, V21, P123, DOI 10.1016/j.tree.2005.10.015; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Rahbek C, 2007, P ROY SOC B-BIOL SCI, V274, P165, DOI 10.1098/rspb.2006.3700; Rangel TFLVB, 2005, ECOGRAPHY, V28, P253, DOI 10.1111/j.0906-7590.2005.04038.x; Raxworthy CJ, 2003, NATURE, V426, P837, DOI 10.1038/nature02205; ROOT RL, 2005, PRESENT FUTURE PHENO, P61; ROOT T, 1988, ECOLOGY, V69, P330, DOI 10.2307/1940431; Sanderson EW, 2002, BIOSCIENCE, V52, P891, DOI 10.1641/0006-3568(2002)052[0891:THFATL]2.0.CO;2; Sax DF, 2002, AM NAT, V160, P766, DOI 10.1086/343877; Scholes RJ, 2005, NATURE, V434, P45, DOI 10.1038/nature03289; Schroter D, 2005, SCIENCE, V310, P1333, DOI 10.1126/science.1115233; Storch D, 2006, ECOL LETT, V9, P1308, DOI 10.1111/j.1461-0248.2006.00984.x; Thuiller W, 2006, ECOGRAPHY, V29, P733, DOI 10.1111/j.0906-7590.2006.04674.x; Tilman D, 2004, P NATL ACAD SCI USA, V101, P10854, DOI 10.1073/pnas.0403458101; Turner W, 2003, TRENDS ECOL EVOL, V18, P306, DOI 10.1016/S0169-5347(03)00070-3; White P, 2006, ECOGRAPHY, V29, P908, DOI 10.1111/j.2006.0906-7590.04685.x; Whittaker R. J., 2007, ISLAND BIOGEOGRAPHY; Willis KJ, 2006, SCIENCE, V314, P1261, DOI 10.1126/science.1122667; Willis KJ, 2002, SCIENCE, V295, P1245, DOI 10.1126/science.1067335; Wilson RJ, 2005, ECOL LETT, V8, P1138, DOI 10.1111/j.1461-0248.2005.00824.x; *WORLD RES I, 2005, MILL EC ASS	61	172	176	4	102	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 15	2007	316	5831					1581	1584		10.1126/science.1133267	http://dx.doi.org/10.1126/science.1133267			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178SH	17569854				2022-12-28	WOS:000247239900030
J	Walkley, CR; Olsen, GH; Dworkin, S; Fabb, SA; Swann, J; McArthur, GA; Westmoreland, SV; Chambon, P; Scadden, DT; Purton, LE				Walkley, Carl R.; Olsen, Gemma Haines; Dworkin, Sebastian; Fabb, Stewart A.; Swann, Jeremy; McArthur, Grant A.; Westmoreland, Susan V.; Chambon, Pierre; Scadden, David T.; Purton, Louise E.			A microenvironment-induced myeloproliferative syndrome caused by retinoic acid receptor gamma deficiency	CELL			English	Article							TUMOR-NECROSIS-FACTOR; HEMATOPOIETIC STEM-CELLS; BONE-MARROW; SELF-RENEWAL; DIFFERENTIATION; MICE; INFLAMMATION; PROGENITORS; EXPRESSION; DISEASE	Myeloproliferative syndromes (IMPS) are a heterogeneous subclass of nonlymphoid hematopoietic neoplasms which are considered to be intrinsic to hematopoietic cells. The causes of MPS are largely unknown. Here, we demonstrate that mice deficient for retinoic acid receptor gamma (RAR gamma), develop MPS induced solely by the RAR gamma-deficient microenvironment. RAR gamma(-/-) mice had significantly increased granulocyte/macrophage progenitors and granulocytes in bone marrow (BM), peripheral blood, and spleen. The MPS phenotype continued for the lifespan of the mice and was more pronounced in older mice. Unexpectedly, transplant studies revealed this disease was not intrinsic to the hematopoietic cells. BM from wild-type mice transplanted into mice with an RAR gamma(-/-) microenvironment rapidly developed the MPS, which was partially caused by significantly elevated TNF alpha in RAR gamma(-/-) mice. These data show that loss of RAR gamma results in a nonhematopoietic cell-intrinsic MPS, revealing the capability of the microenvironment to be the sole cause of hematopoietic disorders.	Peter MacCallum Canc Ctr, Trescowthick Res Labs, Melbourne, Vic 3002, Australia; Univ Melbourne, Dept Med, Fitzroy, Vic 3065, Australia; Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Div Hematol Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Childrens Hosp, Boston, MA 02115 USA; Peter MacCallum Canc Ctr, Dept Haematol & Oncol, Melbourne, Vic 3002, Australia; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; ULP, INSERM, CNRS, Coll France,Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, CU Strasbourg, France; Harvard Univ, Stem Cell Inst, Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA	Peter Maccallum Cancer Center; University of Melbourne; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Peter Maccallum Cancer Center; Harvard University; Massachusetts General Hospital; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Harvard University; Massachusetts General Hospital	Purton, LE (corresponding author), Peter MacCallum Canc Ctr, Trescowthick Res Labs, Melbourne, Vic 3002, Australia.	lpurton@partners.org	Walkley, Carl/AAO-6021-2020; Purton, Louise/AAI-8956-2021	Walkley, Carl/0000-0002-4784-9031; Purton, Louise/0000-0001-6593-3168; Dworkin, Sebastian/0000-0001-5828-9992; Fabb, Stewart/0000-0002-8887-7661	NHLBI NIH HHS [R01 HL044851, R01 HL044851-14] Funding Source: Medline; NIDDK NIH HHS [DK84551, R21 DK071773-02, R21 DK071773, R21 DK071773-01A1, DK71773] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL044851] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK071773] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Altucci L, 2001, NAT REV CANCER, V1, P181, DOI 10.1038/35106036; Araki T, 2004, NAT MED, V10, P849, DOI 10.1038/nm1084; Avecilla ST, 2004, NAT MED, V10, P64, DOI 10.1038/nm973; Balmer JE, 2005, J STEROID BIOCHEM, V96, P347, DOI 10.1016/j.jsbmb.2005.05.005; Balmer JE, 2002, J LIPID RES, V43, P1773, DOI 10.1194/jlr.R100015-JLR200; Bennett BD, 1996, CURR BIOL, V6, P1170, DOI 10.1016/S0960-9822(02)70684-2; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Corre J, 2004, BRIT J HAEMATOL, V127, P344, DOI 10.1111/j.1365-2141.2004.05198.x; Cousin B, 2003, BIOCHEM BIOPH RES CO, V301, P1016, DOI 10.1016/S0006-291X(03)00061-5; Flores-Figueroa E, 2002, LEUKEMIA RES, V26, P677, DOI 10.1016/S0145-2126(01)00193-X; Gainsford T, 1996, P NATL ACAD SCI USA, V93, P14564, DOI 10.1073/pnas.93.25.14564; GIROIR BP, 1992, P NATL ACAD SCI USA, V89, P4864, DOI 10.1073/pnas.89.11.4864; HANGOC G, 1993, EXP HEMATOL, V21, P502; Jones DH, 2006, NATURE, V440, P692, DOI 10.1038/nature04524; Kastner P, 2001, BLOOD, V97, P1314, DOI 10.1182/blood.V97.5.1314; Kogan SC, 2002, BLOOD, V100, P238, DOI 10.1182/blood.V100.1.238; Korner H, 1997, EUR J IMMUNOL, V27, P2600, DOI 10.1002/eji.1830271020; Kuwata T, 2000, BLOOD, V95, P3349, DOI 10.1182/blood.V95.11.3349; Lapidot T, 2005, BLOOD, V106, P1901, DOI 10.1182/blood-2005-04-1417; Le DT, 2004, BLOOD, V103, P4243, DOI 10.1182/blood-2003-08-2650; LOHNES D, 1993, CELL, V73, P643, DOI 10.1016/0092-8674(93)90246-M; Minucci S, 1999, SEMIN CELL DEV BIOL, V10, P215, DOI 10.1006/scdb.1999.0303; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Passegue E, 2004, CELL, V119, P431, DOI 10.1016/j.cell.2004.10.010; Purton LE, 2000, BLOOD, V95, P470, DOI 10.1182/blood.V95.2.470; Purton LE, 1999, BLOOD, V94, P483, DOI 10.1182/blood.V94.2.483.414k12_483_495; Purton LE, 2006, J EXP MED, V203, P1283, DOI 10.1084/jem.20052105; Rupec RA, 2005, IMMUNITY, V22, P479, DOI 10.1016/j.immuni.2005.02.009; SZILVASSY SJ, 1990, P NATL ACAD SCI USA, V87, P8736, DOI 10.1073/pnas.87.22.8736; Szlosarek P, 2006, EUR J CANCER, V42, P745, DOI 10.1016/j.ejca.2006.01.012; Tokoyoda K, 2004, IMMUNITY, V20, P707, DOI 10.1016/j.immuni.2004.05.001; TRENTIN JJ, 1971, AM J PATHOL, V65, P621; Ueda Y, 2005, J EXP MED, V201, P1771, DOI 10.1084/jem.20041419; Ueda Y, 2004, J EXP MED, V199, P47, DOI 10.1084/jem.20031104; Van Etten RA, 2004, CANCER CELL, V6, P547, DOI 10.1016/j.ccr.2004.12.004; Vettor R, 2005, ALIMENT PHARM THER, V22, P3, DOI 10.1111/j.1365-2036.2005.02587.x; Walkley CR, 2007, CELL, V129, P1081, DOI 10.1016/j.cell.2007.03.055; Walkley CR, 2005, NAT CELL BIOL, V7, P172, DOI 10.1038/ncb1214; Walkley CR, 2002, LEUKEMIA, V16, P1763, DOI 10.1038/sj.leu.2402625; Wernig G, 2006, BLOOD, V107, P4274, DOI 10.1182/blood-2005-12-4824; YAN XQ, 1994, ONCOGENE, V9, P163; Yokota T, 2000, BLOOD, V96, P1723, DOI 10.1182/blood.V96.5.1723; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	44	396	410	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 15	2007	129	6					1097	1110		10.1016/j.cell.2007.05.014	http://dx.doi.org/10.1016/j.cell.2007.05.014			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	180UA	17574023	Bronze, Green Accepted			2022-12-28	WOS:000247390400014
J	Higashi, T; Wenger, NS; Adams, JL; Fung, C; Roland, M; McGlynn, EA; Reeves, D; Asch, SM; Kerr, EA; Shekelle, PG				Higashi, Takahiro; Wenger, Neil S.; Adams, John L.; Fung, Constance; Roland, Martin; McGlynn, Elizabeth A.; Reeves, David; Asch, Steven M.; Kerr, Eve A.; Shekelle, Paul G.			Relationship between number of medical conditions and quality of care	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VULNERABLE OLDER-PEOPLE; UNITED-STATES; HEALTH-CARE; PRACTICE GUIDELINES; PERFORMANCE DATA; DIABETES CARE; DISEASES; ELDERS; PAY; GENERALIST	BACKGROUND: There is emerging concern that the methods used to measure the quality of care unfairly penalize providers caring for patients with multiple chronic conditions. We therefore sought to study the relationship between the quality of care and the number of medical conditions a patient has. METHODS: We assessed measurements of the quality of medical care received in three cohorts of community-dwelling adult patients in the Community Quality Index study, the Assessing Care of Vulnerable Elders study, and the Veterans Health Administration project (7680 patients in total). We analyzed the relationship between the quality of care that patients received, defined as the percentage of quality indicators satisfied among those for which patients were eligible, and the number of chronic medical conditions each patient had. We further explored the roles of characteristics of patients, use of health care (number of office visits and hospitalizations), and care provided by specialists as explanations for the observed relationship. RESULTS: The quality of care increased as the number of medical conditions increased. Each additional condition was associated with an increase in the quality score of 2.2% (95% confidence interval [CI], 1.7 to 2.7) in the Community Quality Index cohort, of 1.7% (95% CI, 1.1 to 2.4) in the Assessing Care of Vulnerable Elders cohort, and of 1.7% (95% CI, 0.7 to 2.8) in the Veterans Health Administration cohort. The relationship between the quality of care and the number of conditions was little affected by adjustment for the difficulty of delivering the care recommended in a quality indicator and for the fact that, because of multiple conditions requiring the same care, a patient could be eligible to receive the same care process more than once. Adjustment for characteristics of patients, use of health care, and care provided by specialists diminished the relationship, but it remained positive. CONCLUSIONS: The quality of care, measured according to whether patients were offered recommended services, increases as a patient's number of chronic conditions increases.	RAND Corp, Santa Monica, CA 90407 USA; Univ Calif Los Angeles, Los Angeles, CA USA; Vet Affairs Greater Los Angeles Healthcare Syst, Los Angeles, CA USA; Kyoto Univ, Kyoto, Japan; Univ Manchester, Natl Primary Care Res & Dev Ctr, Manchester, Lancs, England; Vet Affairs Ann Arbor Hlth Care Syst, Ann Arbor, MI USA; Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA	RAND Corporation; University of California System; University of California Los Angeles; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; Kyoto University; University of Manchester; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Michigan System; University of Michigan	Shekelle, PG (corresponding author), RAND Corp, 1776 Main St,POB 2138, Santa Monica, CA 90407 USA.	shekelle@rand.org	Reeves, David/H-6203-2014; Adams, John/ABE-6170-2021; Kerr, Eve/I-3330-2013	Reeves, David/0000-0001-6377-6859; Roland, Martin/0000-0002-8533-3060				Asch SM, 2004, ANN INTERN MED, V141, P938, DOI 10.7326/0003-4819-141-12-200412210-00010; BERENSON RA, 2003, HLTH AFF MILLWOOD S; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Christianson JB, 2006, J GEN INTERN MED, V21, pS9, DOI 10.1111/j.1525-1497.2006.00356.x; Ciechanowski PS, 2000, ARCH INTERN MED, V160, P3278, DOI 10.1001/archinte.160.21.3278; Davies HTO, 1999, LANCET, V353, P1639, DOI 10.1016/S0140-6736(99)90047-8; Davies HTO, 2002, J HEALTH POLIT POLIC, V27, P379, DOI 10.1215/03616878-27-3-379; Desai MM, 2002, AM J PSYCHIAT, V159, P1584, DOI 10.1176/appi.ajp.159.9.1584; Diette GB, 2001, PEDIATRICS, V108, P432, DOI 10.1542/peds.108.2.432; Donohoe MT, 1998, ARCH INTERN MED, V158, P1596, DOI 10.1001/archinte.158.15.1596; Epstein AM, 2006, NEW ENGL J MED, V355, P406, DOI 10.1056/NEJMe068131; Forrest CB, 2006, AM J MANAG CARE, V12, P83; Harrold LR, 1999, J GEN INTERN MED, V14, P499, DOI 10.1046/j.1525-1497.1999.08168.x; Heflin MT, 2002, J AM GERIATR SOC, V50, P1651, DOI 10.1046/j.1532-5415.2002.50456.x; Jencks SF, 2000, JAMA-J AM MED ASSOC, V284, P1670, DOI 10.1001/jama.284.13.1670; Kizer KW, 2000, MED CARE, V38, pS7; Mannion Russell, 2005, J Health Serv Res Policy, V10, P18; Marshall MN, 2000, JAMA-J AM MED ASSOC, V283, P1866, DOI 10.1001/jama.283.14.1866; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; Min LC, 2005, J AM GERIATR SOC, V53, P1705, DOI 10.1111/j.1532-5415.2005.53520.x; Ostbye T, 2005, ANN FAM MED, V3, P209, DOI 10.1370/afm.310; Piette JD, 2006, DIABETES CARE, V29, P725, DOI 10.2337/diacare.29.03.06.dc05-2078; *RAND, 2006, QUAL HLTH CAR DEL AD; Redelmeier DA, 1998, NEW ENGL J MED, V338, P1516, DOI 10.1056/NEJM199805213382106; Saliba D, 2001, J AM GERIATR SOC, V49, P1691, DOI 10.1046/j.1532-5415.2001.49281.x; Schuster MA, 1998, MILBANK Q, V76, P517, DOI 10.1111/1468-0009.00105; Shekelle PG, 2001, ANN INTERN MED, V135, P647, DOI 10.7326/0003-4819-135-8_Part_2-200110161-00003; Shen YJ, 2003, HEALTH SERV RES, V38, P535, DOI 10.1111/1475-6773.00132; Walter LC, 2004, JAMA-J AM MED ASSOC, V291, P2466, DOI 10.1001/jama.291.20.2466; Wenger NS, 2003, ANN INTERN MED, V139, P740, DOI 10.7326/0003-4819-139-9-200311040-00008; Wenger NS, 2001, ANN INTERN MED, V135, P642, DOI 10.7326/0003-4819-135-8_Part_2-200110161-00002; Werner RM, 2005, JAMA-J AM MED ASSOC, V293, P1239, DOI 10.1001/jama.293.10.1239; Wolff JL, 2002, ARCH INTERN MED, V162, P2269, DOI 10.1001/archinte.162.20.2269; Yarnall KSH, 2003, AM J PUBLIC HEALTH, V93, P635, DOI 10.2105/AJPH.93.4.635	34	209	210	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 14	2007	356	24					2496	2504		10.1056/NEJMsa066253	http://dx.doi.org/10.1056/NEJMsa066253			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	178DR	17568030				2022-12-28	WOS:000247201900009
J	Kaufman, DS; Young, RH; McDougal, WS; Zietman, AL; Tabatabaei, S; Harris, NL				Kaufman, Donald S.; Young, Robert H.; McDougal, W. Scott; Zietman, Anthony L.; Tabatabaei, Shahin; Harris, Nancy Lee			A 54-year-old man with early-stage prostate cancer - Adenocarcinoma of the prostate, Gleason score 7 of 10 (predominantly grade 3), organ confined.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PERMANENT SEED IMPLANTATION; RADIATION; RADIOTHERAPY; SURVIVAL; THERAPY; TRIAL		Massachusetts Gen Hosp, Dept Hematol Oncol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Urol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Radiat Oncol, Boston, MA 02114 USA; Harvard Med Sch, Dept Med, Boston, MA USA; Harvard Med Sch, Dept Urol, Boston, MA USA; Harvard Med Sch, Dept Radiat Oncol, Boston, MA USA; Harvard Med Sch, Dept Pathol, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Kaufman, DS (corresponding author), Massachusetts Gen Hosp, Dept Hematol Oncol, Boston, MA 02114 USA.							Albertsen PC, 2005, JAMA-J AM MED ASSOC, V293, P2095, DOI 10.1001/jama.293.17.2095; AMIN MB, 2004, GLEASON GRADING PROS; Aus G, 2007, EUR UROL, V51, P659, DOI 10.1016/j.eururo.2006.07.012; Chun FKH, 2006, WORLD J UROL, V24, P273, DOI 10.1007/s00345-006-0058-2; Concato J, 2006, ARCH INTERN MED, V166, P38, DOI 10.1001/archinte.166.1.38; Epstein JI, 2005, AM J SURG PATHOL, V29, P1228, DOI 10.1097/01.pas.0000173646.99337.b1; Fowler FJ, 2000, JAMA-J AM MED ASSOC, V283, P3217, DOI 10.1001/jama.283.24.3217; Jemal A, 2005, CANCER EPIDEM BIOMAR, V14, P590, DOI 10.1158/1055-9965.EPI-04-0522; Klotz L, 2005, J CLIN ONCOL, V23, P8165, DOI 10.1200/JCO.2005.03.3134; Kuban D, 2005, INT J RADIAT ONCOL, V61, P409, DOI 10.1016/j.ijrobp.2004.05.021; Parker C, 2006, BRIT J CANCER, V94, P1361, DOI 10.1038/sj.bjc.6603105; Peeters STH, 2006, J CLIN ONCOL, V24, P1990, DOI 10.1200/JCO.2005.05.2530; Potters L, 2004, RADIOTHER ONCOL, V71, P29, DOI 10.1016/j.radonc.2003.12.011; Takahashi S, 2006, PROSTATE, V66, P211, DOI 10.1002/pros.20336; Talcott JA, 2003, J CLIN ONCOL, V21, P3979, DOI 10.1200/JCO.2003.01.199; Zelefsky MJ, 2007, INT J RADIAT ONCOL, V67, P327, DOI 10.1016/j.ijrobp.2006.08.056; Zietman AL, 2004, J UROLOGY, V171, P210, DOI 10.1097/01.ju.0000100980.13364.a6	17	2	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 14	2007	356	24					2515	2520		10.1056/NEJMcpc079012	http://dx.doi.org/10.1056/NEJMcpc079012			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	178DR	17568033				2022-12-28	WOS:000247201900013
J	Schwab, JM; Chiang, N; Arita, M; Serhan, CN				Schwab, Jan M.; Chiang, Nan; Arita, Makoto; Serhan, Charles N.			Resolvin E1 and protectin D1 activate inflammation-resolution programmes	NATURE			English	Article							ANTIINFLAMMATORY PROPERTIES; DOCOSAHEXAENOIC ACID; APOPTOTIC LEUKOCYTES; PHAGOCYTOSIS; MACROPHAGES; CELLS; CYCLOOXYGENASE; DOCOSATRIENES	Resolution of acute inflammation is an active process essential for appropriate host responses, tissue protection and the return to homeostasis(1-3). During resolution, specific omega-3 polyunsaturated fatty-acid-derived mediators are generated within resolving exudates, including resolvin E1 (RvE1)(4) and protectin D1 (PD1)(5). It is thus important to pinpoint specific actions of RvE1 and PD1 in regulating tissue resolution. Here we report that RvE1 and PD1 in nanogram quantities promote phagocyte removal during acute inflammation by regulating leukocyte infiltration, increasing macrophage ingestion of apoptotic polymorphonuclear neutrophils in vivo and in vitro, and enhancing the appearance of phagocytes carrying engulfed zymosan in lymph nodes and spleen. In this tissue terrain, inhibition of either cyclooxygenase or lipoxygenases - pivotal enzymes in the temporal generation of both pro-inflammatory and pro-resolving mediators - caused a 'resolution deficit' that was rescued by RvE1, PD1 or aspirin-triggered lipoxin A(4) analogue. Also, new resolution routes were identified that involve phagocytes traversing perinodal adipose tissues and non-apoptotic polymorphonuclear neutrophils carrying engulfed zymosan to lymph nodes. Together, these results identify new active components for postexudate resolution traffic, and demonstrate that RvE1 and PD1 are potent agonists for resolution of inflamed tissues.	Brigham & Womens Hosp, Ctr Expt Therapeut & Reperfus Injury, Dept Anesthesiol Perioperat & Pain Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Serhan, CN (corresponding author), Brigham & Womens Hosp, Ctr Expt Therapeut & Reperfus Injury, Dept Anesthesiol Perioperat & Pain Med, 75 Francis St, Boston, MA 02115 USA.	cnserhan@zeus.bwh.harvard.edu	Chiang, Nan/ABA-4924-2021	Chiang, Nan/0000-0003-1963-1585; Arita, Makoto/0000-0001-9902-0463; Schwab, Jan/0000-0001-6784-4919	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P50DE016191] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM038765, R01GM038765] Funding Source: NIH RePORTER; NIDCR NIH HHS [P50 DE016191, P50 DE016191-03] Funding Source: Medline; NIDDK NIH HHS [R01 DK074448-02, R01 DK074448] Funding Source: Medline; NIGMS NIH HHS [R01 GM038765, R37 GM038765, R37 GM038765-20] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arita M, 2005, J EXP MED, V201, P713, DOI 10.1084/jem.20042031; Bannenberg GL, 2005, J IMMUNOL, V174, P4345, DOI 10.4049/jimmunol.174.7.4345; Bazan NG, 2006, TRENDS NEUROSCI, V29, P263, DOI 10.1016/j.tins.2006.03.005; Bellingan GJ, 2002, J EXP MED, V196, P1515, DOI 10.1084/jem.20011794; Cao CZ, 2005, BLOOD, V106, P3234, DOI 10.1182/blood-2005-03-1288; Cotran R. S., 1999, ROBBINS PATHOLOGIC B, V6th; Freire-de-Lima CG, 2006, J BIOL CHEM, V281, P38376, DOI 10.1074/jbc.M605146200; Gilroy DW, 2004, NAT REV DRUG DISCOV, V3, P401, DOI 10.1038/nrd1383; Gilroy DW, 1999, NAT MED, V5, P698, DOI 10.1038/9550; Gronert K, 2005, J BIOL CHEM, V280, P15267, DOI 10.1074/jbc.M410638200; Hong S, 2003, J BIOL CHEM, V278, P14677, DOI 10.1074/jbc.M300218200; Levy BD, 2001, NAT IMMUNOL, V2, P612, DOI 10.1038/89759; Liu YQ, 1999, J IMMUNOL, V162, P3639; Maddox JE, 1996, J EXP MED, V183, P137, DOI 10.1084/jem.183.1.137; Maderna P, 2005, J IMMUNOL, V174, P3727, DOI 10.4049/jimmunol.174.6.3727; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; Pond CM, 2005, PROSTAG LEUKOTR ESS, V73, P17, DOI 10.1016/j.plefa.2005.04.005; Reville K, 2006, J IMMUNOL, V176, P1878, DOI 10.4049/jimmunol.176.3.1878; Rossi AG, 2006, NAT MED, V12, P1056, DOI 10.1038/nm1468; Sadik CD, 2003, BIOCHEM PHARMACOL, V65, P773, DOI 10.1016/S0006-2952(02)01621-0; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Sawatzky DA, 2006, AM J PATHOL, V168, P33, DOI 10.2353/ajpath.2006.050058; Serhan CN, 2006, J IMMUNOL, V176, P1848, DOI 10.4049/jimmunol.176.3.1848; Serhan CN, 2005, PROSTAG LEUKOTR ESS, V73, P139, DOI 10.1016/j.plefa.2005.07.001; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Serhan CN, 2000, J EXP MED, V192, P1197, DOI 10.1084/jem.192.8.1197; Underhill DM, 2003, J ENDOTOXIN RES, V9, P176, DOI 10.1179/096805103125001586; Vandivier RW, 2006, CHEST, V129, P1673, DOI 10.1378/chest.129.6.1673; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102	29	887	932	2	123	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 14	2007	447	7146					869	874		10.1038/nature05877	http://dx.doi.org/10.1038/nature05877			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178FV	17568749	Green Accepted			2022-12-28	WOS:000247207500047
J	Ogilvie, D; Foster, CE; Rothnie, H; Cavill, N; Hamilton, V; Fitzsimons, CF; Mutrie, N				Ogilvie, David; Foster, Charles E.; Rothnie, Helen; Cavill, Nick; Hamilton, Val; Fitzsimons, Claire F.; Mutrie, Nanette			Interventions to promote walking: systematic review	BMJ-BRITISH MEDICAL JOURNAL			English	Review							PHYSICAL-ACTIVITY; PUBLIC-HEALTH	Objective To assess the effects of interventions to promote walking in individuals and populations. Design Systematic review. Data sources Published and unpublished reports in any language identified by searching 25 electronic databases, by searching websites, reference lists, and existing systematic reviews, and by contacting experts. Review methods Systematic search for and appraisal of controlled before and after studies of the effects of any type of intervention on how much people walk, the distribution of effects on walking between social groups, and any associated effects on overall physical activity, fitness, risk factors for disease, health, and wellbeing. Results We included 19 randomised controlled trials and 29 non-randomised controlled studies. Interventions tailored to people's needs, targeted at the most sedentary or at those most motivated to change, and delivered either at the level of the individual (brief advice, supported use of pedometers, telecommunications) or household (individualised marketing) or through groups, can encourage people to walk more, although the sustainability, generalisabitity, and clinical benefits of many of these approaches are uncertain. Evidence for the effectiveness of interventions applied to workplaces, schools, communities, or areas typically depends on isolated studies or subgroup analysis. Conclusions The most successful interventions could increase walking among targeted participants by up to 30-60 minutes a week on average, at least in the short term. From a perspective of improving population health, much of the research currently provides evidence of efficacy rather than effectiveness. Nevertheless, interventions to promote walking could contribute substantially towards increasing the activity levels of the most sedentary.	MRC, Social & Publ Hlth Sci Unit, Glasgow G12 8RZ, Lanark, Scotland; Univ Oxford, Promot Res Grp, British Heart Fdn Hlth, Oxford, England; Univ Strathclyde, Dept Sport Culture & Arts, Glasgow, Lanark, Scotland; Univ Glasgow, Dev & Alumni Off, Glasgow, Lanark, Scotland	MRC/CSO SOCIAL AND PUBLIC HEALTH SCIENCES UNIT; University of Oxford; University of Strathclyde; University of Glasgow	Ogilvie, D (corresponding author), MRC, Social & Publ Hlth Sci Unit, Glasgow G12 8RZ, Lanark, Scotland.	d.ogilvie@msoc.mrc.gla.ac.uk	Ogilvie, David/B-2444-2012	Ogilvie, David/0000-0002-0270-4672	Medical Research Council [G106/1203] Funding Source: researchfish; MRC [MC_U130059812, MC_U106179474, G106/1203] Funding Source: UKRI; Medical Research Council [MC_U106179474, MC_U130059812] Funding Source: Medline; Chief Scientist Office [SPHSU1] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Chief Scientist Office		Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Alfonzo MA, 2005, ENVIRON BEHAV, V37, P808, DOI 10.1177/0013916504274016; Bromley C, 2005, SCOTTISH HLTH SURVEY; Chief Medical Officer, 2004, LEAST 5 WEEK EV IMP; Coote A, 2006, BRIT MED J, V332, P1343, DOI 10.1136/bmj.332.7554.1343; Deeks J J, 2003, Health Technol Assess, V7, piii; Department for Transport (DfT), 2004, WALK CYCL ACT PLAN; Department of Health, 2004, CHOOS HLTH MAK HLTH; Foster C, 2004, J SPORT SCI, V22, P755, DOI 10.1080/02640410410001712458; Hillsdon M., 2005, EFFECTIVENESS PUBLIC; HILLSDON M, 2007, COCHRANE DB SYST REV; Kahn EB, 2002, AM J PREV MED, V22, P73, DOI 10.1016/S0749-3797(02)00434-8; Morris JN, 1997, SPORTS MED, V23, P306, DOI 10.2165/00007256-199723050-00004; Mutrie N., 2004, International Journal of Health Promotion and Education, V42, P109; NICE, 2006, 4 COMM US METH INCR; Nutbeam D, 2003, HLTH PROMOT J AUST, V14, P154, DOI DOI 10.1071/HE03154; Ogilvie D, 2004, BMJ-BRIT MED J, V329, P763, DOI 10.1136/bmj.38216.714560.55; Ogilvie D, 2006, AM J PREV MED, V31, P118, DOI 10.1016/j.amepre.2006.03.030; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; Petticrew M, 2005, PUBLIC HEALTH, V119, P751, DOI 10.1016/j.puhe.2004.11.008; Physical Activity Task Force, 2003, LETS MAK SCOTL MOR A; Scottish Executive, 2003, WALK STRAT SCOTL CON; Sproston K., 2006, HLTH SURVEY ENGLAND; Whitehead M, 2004, J EPIDEMIOL COMMUN H, V58, P817, DOI 10.1136/jech.2003.015297	24	456	460	6	95	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 9	2007	334	7605					1204	1207		10.1136/bmj.39198.722720.BE	http://dx.doi.org/10.1136/bmj.39198.722720.BE			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	179GF	17540909	Green Published, Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000247277000035
J	Phillips, P; Balatsky, AV				Phillips, Philip; Balatsky, Alexander V.			Cracking the supersolid	SCIENCE			English	Editorial Material									Univ Illinois, Loomis Lab Phys, Urbana, IL 61801 USA; Los Alamos Natl Lab, Div Theoret, Los Alamos, NM 87545 USA; Los Alamos Natl Lab, Ctr Integrated Nanotechnol, Los Alamos, NM 87545 USA	University of Illinois System; University of Illinois Urbana-Champaign; United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory	Phillips, P (corresponding author), Univ Illinois, Loomis Lab Phys, 1110 W Green St, Urbana, IL 61801 USA.	dimer@uiuc.edu; avb@lanl.gov						Anderson PW, 2005, SCIENCE, V310, P1164, DOI 10.1126/science.1118625; ANDREEV AF, 1969, SOV PHYS JETP-USSR, V29, P1107; Balatsky AV, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.094201; Boninsegni M, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.080401; Boninsegni M, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.105301; Clark AC, 2005, J LOW TEMP PHYS, V138, P853, DOI 10.1007/s10909-005-2314-z; Day J, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.105304; HEALD SM, 1984, PHYS REV B, V30, P2531, DOI 10.1103/PhysRevB.30.2531; Kim E, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.115302; Kim E, 2004, SCIENCE, V305, P1941, DOI 10.1126/science.1101501; Kim E, 2004, NATURE, V427, P225, DOI 10.1038/nature02220; LEGGETT AJ, 1970, PHYS REV LETT, V25, P1543, DOI 10.1103/PhysRevLett.25.1543; REATTO L, 1967, PHYS REV, V155, P88, DOI 10.1103/PhysRev.155.88; Rittner ASC, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.175302; Sasaki S, 2006, SCIENCE, V313, P1098, DOI 10.1126/science.1130879; SHIRAHAMA K, 2006, B AM PHYS SOC, V51, P450	16	12	12	1	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 8	2007	316	5830					1435	1436		10.1126/science.1143866	http://dx.doi.org/10.1126/science.1143866			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176EE	17556572				2022-12-28	WOS:000247066400027
J	Burton, PR; Clayton, DG; Cardon, LR; Craddock, N; Deloukas, P; Duncanson, A; Kwiatkowski, DP; McCarthy, MI; Ouwehand, WH; Samani, NJ; Todd, JA; Donnelly, P; Barrett, JC; Davison, D; Easton, D; Evans, D; Leung, HT; Marchini, JL; Morris, AP; Spencer, CCA; Tobin, MD; Attwood, AP; Boorman, JP; Cant, B; Everson, U; Hussey, JM; Jolley, JD; Knight, AS; Koch, K; Meech, E; Nutland, S; Prowse, CV; Stevens, HE; Taylor, NC; Walters, GR; Walker, NM; Watkins, NA; Winzer, T; Jones, RW; McArdle, WL; Ring, SM; Strachan, DP; Pembrey, M; Breen, G; St Clair, D; Caesar, S; Gordon-Smith, K; Jones, L; Fraser, C; Green, EK; Grozeva, D; Hamshere, ML; Holmans, PA; Jones, IR; Kirov, G; Moskvina, V; Nikolov, I; O'Donovan, MC; Owen, MJ; Collier, DA; Elkin, A; Farmer, A; Williamson, R; McGuffin, P; Young, AH; Ferrier, IN; Ball, SG; Balmforth, AJ; Barrett, JH; Bishop, DT; Iles, MM; Maqbool, A; Yuldasheva, N; Hall, AS; Braund, PS; Dixon, RJ; Mangino, M; Stevens, S; Thompson, JR; Bredin, F; Tremelling, M; Parkes, M; Drummond, H; Lees, CW; Nimmo, ER; Satsangi, J; Fisher, SA; Forbes, A; Lewis, CM; Onnie, CM; Prescott, NJ; Sanderson, J; Mathew, CG; Barbour, J; Mohiuddin, MK; Todhunter, CE; Mansfield, JC; Ahmad, T; Cummings, FR; Jewell, DP; Webster, J; Brown, MJ; Lathrop, GM; Connell, J; Dominiczak, A; Marcano, CAB; Burke, B; Dobson, R; Gungadoo, J; Lee, KL; Munroe, PB; Newhouse, SJ; Onipinla, A; Wallace, C; Xue, MZ; Caulfield, M; Farrall, M; Barton, A; Bruce, IN; Donovan, H; Eyre, S; Gilbert, PD; Hider, SL; Hinks, AM; John, SL; Potter, C; Silman, AJ; Symmons, DPM; Thomson, W; Worthington, J; Dunger, DB; Widmer, B; Frayling, TM; Freathy, RM; Lango, H; Perry, JRB; Shields, BM; Weedon, MN; Hattersley, AT; Hitman, GA; Walker, M; Elliott, KS; Groves, CJ; Lindgren, CM; Rayner, NW; Timpson, NJ; Zeggini, E; Newport, M; Sirugo, G; Lyons, E; Vannberg, F; Brown, MA; Franklyn, JA; Heward, JM; Simmonds, MJ; Hill, AVS; Bradbury, LA; Farrar, C; Pointon, JJ; Wordsmith, P; Gough, SCL; Seal, S; Stratton, MR; Rahman, N; Ban, M; Goris, A; Sawcer, SJ; Compston, A; Conway, D; Jallow, M; Bumpstead, SJ; Chaney, A; Downes, K; Ghori, MJR; Gwilliam, R; Inouye, M; Keniry, A; King, E; McGinnis, R; Potter, S; Ravindrarajah, R; Whittaker, P; Withers, D; Easton, D; Pereira-Gale, J; Hallgrimsdottir, IB; Howie, BN; Su, Z; Teo, YY; Vukcevic, D; Bentley, D; Caulfield, M; Mathew, CG; Worthington, J				Burton, Paul R.; Clayton, David G.; Cardon, Lon R.; Craddock, Nick; Deloukas, Panos; Duncanson, Audrey; Kwiatkowski, Dominic P.; McCarthy, Mark I.; Ouwehand, Willem H.; Samani, Nilesh J.; Todd, John A.; Donnelly, Peter; Barrett, Jeffrey C.; Davison, Dan; Easton, Doug; Evans, David; Leung, Hin-Tak; Marchini, Jonathan L.; Morris, Andrew P.; Spencer, Chris C. A.; Tobin, Martin D.; Attwood, Antony P.; Boorman, James P.; Cant, Barbara; Everson, Ursula; Hussey, Judith M.; Jolley, Jennifer D.; Knight, Alexandra S.; Koch, Kerstin; Meech, Elizabeth; Nutland, Sarah; Prowse, Christopher V.; Stevens, Helen E.; Taylor, Niall C.; Walters, Graham R.; Walker, Neil M.; Watkins, Nicholas A.; Winzer, Thilo; Jones, Richard W.; McArdle, Wendy L.; Ring, Susan M.; Strachan, David P.; Pembrey, Marcus; Breen, Gerome; St Clair, David; Caesar, Sian; Gordon-Smith, Katherine; Jones, Lisa; Fraser, Christine; Green, Elain K.; Grozeva, Detelina; Hamshere, Marian L.; Holmans, Peter A.; Jones, Ian R.; Kirov, George; Moskvina, Valentina; Nikolov, Ivan; O'Donovan, Michael C.; Owen, Michael J.; Collier, David A.; Elkin, Amanda; Farmer, Anne; Williamson, Richard; McGuffin, Peter; Young, Allan H.; Ferrier, I. Nicol; Ball, Stephen G.; Balmforth, Anthony J.; Barrett, Jennifer H.; Bishop, D. Timothy; Iles, Mark M.; Maqbool, Azhar; Yudasheve, Nadira; Hall, Alistair S.; Braund, Peter S.; Dixon, Richard J.; Mangino, Massimo; Stevens, Suzanne; Thompson, John R.; Bredin, Francesca; Tremelling, Mark; Parkes, Miles; Drummond, Hazel; Lees, Charles W.; Nimmo, Elaine R.; Satsangi, Jack; Fisher, Sheila A.; Forbes, Alistair; Lewis, Cathryn M.; Onnie, Clive M.; Prescott, Natalie J.; Sanderson, Jeremy; Mathew, Christopher G.; Barbour, Jamie; Mohiuddin, M. Khalid; Todhunter, Catherine E.; Mansfield, John C.; Ahmad, Tariq; Cummings, Fraser R.; Jewell, Derek P.; Webster, John; Brown, Morris J.; Lathrop, G. Mark; Connell, John; Dominiczak, Anna; Marcano, Carolina A. Braga; Burke, Beverley; Dobson, Richard; Gungadoo, Johannie; Lee, Kate L.; Munroe, Patricia B.; Newhouse, Stephen J.; Onipinla, Abiodun; Wallace, Chris; Xue, Mingzhan; Caulfield, Mark; Farrall, Martin; Barton, Anne; Bruce, Ian N.; Donovan, Hannah; Eyre, Steve; Gilbert, Paul D.; Hider, Samantha L.; Hinks, Anne M.; John, Sally L.; Potter, Catherine; Silman, Alan J.; Symmons, Deborah P. M.; Thomson, Wendy; Worthington, Jane; Dunger, David B.; Widmer, Barry; Frayling, Timothy M.; Freathy, Rachel M.; Lango, Hana; Perry, John R. B.; Shields, Beverley M.; Weedon, Michael N.; Hattersley, Andrew T.; Hitman, Graham A.; Walker, Mark; Elliott, Kate S.; Groves, Christopher J.; Lindgren, Cecilia M.; Rayner, Nigel W.; Timpson, Nicholas J.; Zeggini, Eleftheria; Newport, Melanie; Sirugo, Giorgio; Lynons, Emily; Vannberg, Fredrik; Brown, Matthew A.; Franklyn, Jayne A.; Heward, Joanne M.; Simmonds, Matthew J.; Hill, Adrian V. S.; Bradbury, Linda A.; Farrar, Claire; Pointon, Jennifer J.; Wordsmith, Paul; Gough, Stephen C. L.; Seal, Sheila; Stratton, Michael R.; Rahman, Nazneen; Ban, Maria; Goris, An; Sawcer, Stephen J.; Compston, Alistair; Conway, David; Jallow, Muminatou; Bumpstead, Suzannah J.; Chaney, Amy; Downes, Kate; Ghori, Mohammed J. R.; Gwilliam, Rhian; Inouye, Michael; Keniry, Andrew; King, Emma; McGinnis, Ralph; Potter, Simon; Ravindrarajah, Rathi; Whittaker, Pamela; Withers, David; Easton, Doug; Pereira-Gale, Joanne; Hallgrimsdottir, Ingilef B.; Howie, Bryan N.; Su, Zhan; Teo, Yik Ying; Vukcevic, Damjan; Bentley, David; Caulfield, Mark; Mathew, Christopher G.; Worthington, Jane		Wellcome Trust Case Control Cons; Biol RA Genet & Genom Study; Breast Canc Susceptib Collaborat	Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls	NATURE			English	Review							SINGLE-NUCLEOTIDE POLYMORPHISMS; CORONARY-ARTERY-DISEASE; MITOCHONDRIAL C-1-TETRAHYDROFOLATE SYNTHASE; LYMPHOID TYROSINE PHOSPHATASE; RHEUMATOID-ARTHRITIS FAMILIES; INFLAMMATORY-BOWEL-DISEASE; MULTILOCUS GENOTYPE DATA; AFFECTED SIBLING PAIRS; TYPE-1 DIABETES LOCUS; BIPOLAR DISORDER	There is increasing evidence that genome-wide association ( GWA) studies represent a powerful approach to the identification of genes involved in common human diseases. We describe a joint GWA study ( using the Affymetrix GeneChip 500K Mapping Array Set) undertaken in the British population, which has examined similar to 2,000 individuals for each of 7 major diseases and a shared set of similar to 3,000 controls. Case-control comparisons identified 24 independent association signals at P < 5 X 10(-7): 1 in bipolar disorder, 1 in coronary artery disease, 9 in Crohn's disease, 3 in rheumatoid arthritis, 7 in type 1 diabetes and 3 in type 2 diabetes. On the basis of prior findings and replication studies thus-far completed, almost all of these signals reflect genuine susceptibility effects. We observed association at many previously identified loci, and found compelling evidence that some loci confer risk for more than one of the diseases studied. Across all diseases, we identified a large number of further signals ( including 58 loci with single-point P values between 10(-5) and 5 X 10(-7)) likely to yield additional susceptibility loci. The importance of appropriately large samples was confirmed by the modest effect sizes observed at most loci identified. This study thus represents a thorough validation of the GWA approach. It has also demonstrated that careful use of a shared control group represents a safe and effective approach to GWA analyses of multiple disease phenotypes; has generated a genome-wide genotype database for future studies of common diseases in the British population; and shown that, provided individuals with non-European ancestry are excluded, the extent of population stratification in the British population is generally modest. Our findings offer new avenues for exploring the pathophysiology of these important disorders. We anticipate that our data, results and software, which will be widely available to other investigators, will provide a powerful resource for human genetics research.	Univ Leicester, Dept Hlth Sci, Genet Epidemiol Grp, Adrian Bldg, Leicester LE1 7RH, Leics, England; Univ Oxford, Dept Stat, Oxford OX1 3TG, England; Univ Cambridge, Dept Med Genet,Cambridge Inst Med Res, Wellcome Trust Diabet & Inflammat Lab, Juvenile Diabet Res Fdn, Cambridge CB2 0XY, England; Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Cardiff Univ, Sch Med, Dept Psychol Med, Cardiff CF14 4XN, Wales; Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; Wellcome Trust Res Labs, London NW1 2BE, England; Univ Oxford, Oxford Ctr Diabet Endocrinol & Med, Churchill Hosp, Oxford OX3 7LJ, England; Univ Cambridge, Dept Haematol, Cambridge CB2 2PT, England; Cambridge Ctr, Natl Hlth Serv Blood & Transplant, Cambridge CB2 2PT, England; Univ Leicester, Dept Cardiovasc Sci, Glenfield Gen Hosp, Leicester LE3 9QP, Leics, England; Strangeways Res Lab, Canc Res UK Genet Epidemiol Unit, Cambridge CB1 8RN, England; Natl Hlth Serv Blood & Transplant, Sheffield S5 7JN, S Yorkshire, England; Welsh Blood Serv, Pontyclun CF72 9WB, Wales; Scottish Natl Blood Transfus Serv, Edinburgh EH17 7QT, Midlothian, Scotland; Southampton Ctr, Natl Hlth Serv Blood & Transplant, Southampton SO16 5AF, Hants, England; Univ Bristol, Avon Longitudinal Study Parents & Children, Bristol BS8 1TQ, Avon, England; St Georges Univ London, Div Community Hlth Serv, London SW17 0RE, England; UCL, Inst Child Hlth, London WC1N 1EH, England; Univ Aberdeen, Inst Med Sci, Aberdeen AB25 2ZD, Scotland; Univ Birmingham, Div Neurosci, Dept Psychiat, Birmingham B15 2QZ, W Midlands, England; Cardiff Univ, Sch Med, Dept Psychol Med, Cardiff CF14 4XN, Wales; Kings Coll London, Inst Psychiat, London SE5 8AF, England; Royal Victoria Infirm, Sch Neurol Neurobiol & Psychiat, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; Univ Leeds, Fac Med & Hlth, LIGHT Res Inst, Leeds LS1 3EX, W Yorkshire, England; Univ Leeds, Fac Med & Hlth, LIMM Res Inst, Leeds LS1 3EX, W Yorkshire, England; Univ Cambridge, IBD Res Grp, Addenbrookes Hosp, Cambridge CB2 2QQ, England; Univ Edinburgh, Sch Mol & Clin Med, Gastrointestinal Unit, Western Gen Hosp, Edinburgh EH4 2XU, Midlothian, Scotland; Kings Coll London, Dept Med & Mol Genet, Guys Hosp, Sch Med, London SE1 9RT, England; UCL Hosp Trust, Inst Digest Dis, London NW1 2BU, England; Guys & St Thomas NHS Fdn Trust, Dept Gastroenterol, London SE1 7EH, England; Newcastle Univ, Dept Gastroenterol & Hepatol, Royal Victoria Infirm, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; Univ Oxford, Gastroenterol Unit, Radcliffe Infirm, Oxford OX2 6HE, England; Aberdeen Royal Infirm, Aberdeen AB9 2ZB, Scotland; Univ Cambridge, Clin Pharmacol Unit, Addenbrookes Hosp, Cambridge CB2 2QQ, England; Univ Cambridge, Diabet & Inflammat Lab, Addenbrookes Hosp, Cambridge CB2 2QQ, England; Ctr Natl Genotypage, F-91057 Paris, France; Univ Glasgow, BHF Glasgow Cardiovasc Res Ctr, Glasgow G12 8TA, Lanark, Scotland; Queen Marys Sch Med, William Harvey Res Inst, Clin Pharmacol Ctr, London EC1M 6BQ, England; Queen Marys Sch Med, William Harvey Res Inst, Barts & London Genome Ctr, London EC1M 6BQ, England; Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Univ Manchester, ARC Epidemiol Res Unit, Manchester M13 9PT, Lancs, England; Univ Cambridge, Dept Paediat, Addenbrookes Hosp, Cambridge CB2 2QQ, England; Peninsula Med Sch, Inst Biomed & Clin Sci, Exeter EX1 2LU, Devon, England; Peninsula Med Sch, Inst Biomed & Clin Sci, Exeter EX2 5DU, Devon, England; Royal London Hosp, Ctr Diabet & Metab Med, London E1 1BB, England; Univ Newcastle, Sch Clin Med Sci, Diabet Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Univ Bristol, MRC Ctr Causal Anal Translat Epidemiol, Bristol BS2 8PR, Avon, England; MRC Labs, Fajara, Gambia; Univ Queensland, Princess Alexandra Hosp, Diamantina Inst Canc Immunol & Metab Med, Brisbane, Qld 4102, Australia; Univ Oxford, Botnar Res Ctr, Oxford OX3 7BN, England; Univ Birmingham, Inst Biomed Res, Div Med Sci, Dept Med, Birmingham B15 2TT, W Midlands, England; Inst Canc Res, Sect Canc Genet, Sutton SM2 5NG, Surrey, England; Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; Univ Cambridge, Dept Clin Neurosci, Addenbrookes Hosp, Cambridge CB2 2QQ, England	University of Leicester; University of Oxford; University of Cambridge; University of Oxford; Wellcome Centre for Human Genetics; Cardiff University; Wellcome Trust Sanger Institute; University of Oxford; University of Cambridge; NHS Blood & Transplant (NHSBT); University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; Cancer Research UK; University of Cambridge; NHS Blood & Transplant (NHSBT); NHS Blood & Transplant (NHSBT); University of Southampton; University of Bristol; St Georges University London; University of London; University College London; University of Aberdeen; University of Birmingham; Cardiff University; University of London; King's College London; Newcastle University - UK; University of Leeds; University of Leeds; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Edinburgh; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; Guy's & St Thomas' NHS Foundation Trust; Newcastle University - UK; Radcliffe Infirmary; University of Oxford; University of Aberdeen; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; CEA; University of Glasgow; University of London; Queen Mary University London; University of London; Queen Mary University London; University of Oxford; Wellcome Centre for Human Genetics; University of Manchester; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Exeter; University of Exeter; Barts Health NHS Trust; Royal London Hospital; Newcastle University - UK; University of Bristol; MRC Laboratory Molecular Biology; University of Queensland; University of Oxford; University of Birmingham; University of London; Institute of Cancer Research - UK; Wellcome Trust Sanger Institute; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Burton, PR (corresponding author), Univ Leicester, Dept Hlth Sci, Genet Epidemiol Grp, Adrian Bldg, Leicester LE1 7RH, Leics, England.		Lewis, Cathryn M/A-5225-2010; Goris, An/L-5852-2019; Breen, Gerome D/A-5540-2010; Attrill, Lauren/V-1688-2018; Mangino, Massimo/F-5134-2011; Deloukas, Panos/B-2922-2013; Rahman, Nazneen/B-8890-2012; Sirugo, Giorgio/N-9056-2019; HILL, Adrian V>S>/C-1306-2008; Peng, Bo/A-6920-2009; Barton, Anne/N-2053-2014; Marchini, Jonathan/ABE-9024-2020; Dobson, Richard j/C-9269-2011; Breen, Gerome/Y-2706-2019; St Clair, David/AAN-2412-2021; Jones, Ian R/B-4925-2009; Lewis, Cathryn/M-8766-2019; Newhouse, Stephen J/C-9330-2011; Timpson, Nicholas John/O-7548-2015; Todd, John A/A-3542-2010; Allen, Hana Lango/G-9026-2012; Yuldasheva, Dr. Nadira Yusupovna/GXM-9013-2022; O'Donovan, Michael C/P-7005-2018; McGuffin, Peter/A-1565-2012; Prescott, Natalie J/F-6490-2011; Hall, Alistair/K-1953-2019; Evans, David M/H-6325-2013; Sirugo, Giorgio/L-1628-2016; Holmans, Peter/F-4518-2015; Brown, Matthew A/E-5749-2010; Burton, Paul R/H-7527-2016; Fox, Laura J/C-6249-2016; Dominiczak, Anna F/D-2262-2009; eyre, stephen/K-3776-2017; Goris, An/F-2943-2010; Worthington, Jane/M-9770-2014; Mathew, Christopher George/G-3434-2015; McCarthy, Mark/M-3763-2015; Rahman, Nazneen/D-2802-2013	Lewis, Cathryn M/0000-0002-8249-8476; Goris, An/0000-0002-1276-6682; Breen, Gerome D/0000-0003-2053-1792; Mangino, Massimo/0000-0002-2167-7470; Deloukas, Panos/0000-0001-9251-070X; Peng, Bo/0000-0001-8225-2284; Barton, Anne/0000-0003-3316-2527; Marchini, Jonathan/0000-0003-0610-8322; Dobson, Richard j/0000-0003-4224-9245; Breen, Gerome/0000-0003-2053-1792; Jones, Ian R/0000-0001-5821-5889; Lewis, Cathryn/0000-0002-8249-8476; Newhouse, Stephen J/0000-0002-1843-9842; Timpson, Nicholas John/0000-0002-7141-9189; Todd, John A/0000-0003-2740-8148; Allen, Hana Lango/0000-0002-7803-8688; Yuldasheva, Dr. Nadira Yusupovna/0000-0001-6213-6358; O'Donovan, Michael C/0000-0001-7073-2379; McGuffin, Peter/0000-0002-9888-2907; Prescott, Natalie J/0000-0002-5901-7371; Evans, David M/0000-0003-0663-4621; Holmans, Peter/0000-0003-0870-9412; Brown, Matthew A/0000-0003-0538-8211; eyre, stephen/0000-0002-1251-6974; Goris, An/0000-0002-1276-6682; Worthington, Jane/0000-0003-0544-042X; Walker, Neil/0000-0001-9796-7688; Caulfield, Mark/0000-0001-9295-3594; Cummings, Fraser/0000-0002-9659-3247; Escott-Price, Valentina/0000-0003-1784-5483; Munroe, Patricia/0000-0002-4176-2947; Hattersley, Andrew/0000-0001-5620-473X; Dunger, Professor David/0000-0002-2566-9304; Grozeva, Detelina/0000-0003-3239-8415; Hunt, Sarah/0000-0002-8350-1235; Thomson, Wendy/0000-0002-9022-5179; Bruce, Ian/0000-0003-3047-500X; Vukcevic, Damjan/0000-0001-7780-9586; Hallgrimsdottir, Ingileif/0000-0002-4710-0047; Forbes, Alastair/0000-0001-7416-9843; Weedon, Michael/0000-0002-6174-6135; Jones, Lisa/0000-0002-5122-8334; Mathew, Christopher George/0000-0003-4178-1838; Kirov, George/0000-0002-3427-3950; Kwiatkowski, Dominic/0000-0002-5023-0176; McCarthy, Mark/0000-0002-4393-0510; Gordon-Smith, Katherine/0000-0003-4083-1143; Inouye, Michael/0000-0001-9413-6520; Bishop, Tim/0000-0002-8752-8785; Donnelly, Peter/0000-0001-9495-3408; Barrett, Jenny/0000-0002-1720-7724; Zeggini, Eleftheria/0000-0003-4238-659X; Morgan, Ann/0000-0003-1109-624X; Potter, Simon/0000-0003-4208-4102; s, hema/0000-0002-3440-9475; Lees, Charlie/0000-0002-0732-8215; Parkes, Miles/0000-0002-6467-0631; Lee, Kathryn/0000-0001-6848-4767; Newport, Melanie/0000-0002-8946-7525; Iles, Mark/0000-0002-2603-6509; Hall, Alistair/0000-0003-0306-7887; Wallace, Chris/0000-0001-9755-1703; Rahman, Nazneen/0000-0003-4376-0440; Lindgren, Cecilia/0000-0002-4903-9374; Freathy, Rachel/0000-0003-4152-2238; Tobin, Martin/0000-0002-3596-7874	Medical Research Council [G0600705, G9806740, G0600329, G0800759, G0901461, G0501942, G0100594, G9810900, G90/106, G19/9, G0000934] Funding Source: Medline; Wellcome Trust [076113, 077011, 090532] Funding Source: Medline; Chief Scientist Office [CZB/4/540] Funding Source: Medline; Medical Research Council [G9817803B] Funding Source: researchfish; MRC [G9810900, G0501942, G0000934, G0600705, G19/9, G0600329, G90/106, G9806740, G0100594] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Chief Scientist Office; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Barrett JC, 2006, NAT GENET, V38, P659, DOI 10.1038/ng1801; Battegay E. J., 2005, HYPERTENSION PRINCIP; Begovich AB, 2004, AM J HUM GENET, V75, P330, DOI 10.1086/422827; Benkusky NA, 2004, BIOCHEM BIOPH RES CO, V322, P1280, DOI 10.1016/j.bbrc.2004.08.033; Bersaglieri T, 2004, AM J HUM GENET, V74, P1111, DOI 10.1086/421051; Blackwood DHR, 2001, AM J HUM GENET, V69, P428, DOI 10.1086/321969; Bottini N, 2004, NAT GENET, V36, P337, DOI 10.1038/ng1323; Brand OJ, 2007, CLIN ENDOCRINOL, V66, P508, DOI 10.1111/j.1365-2265.2007.02762.x; Caulfield M, 2003, LANCET, V361, P2118, DOI 10.1016/S0140-6736(03)13722-1; CLAYTON D, 2003, HDB STAT GENETICS, P939; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Coelho M, 2005, HUM GENET, V117, P329, DOI 10.1007/s00439-005-1322-z; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Colhoun HM, 2003, LANCET, V361, P865, DOI 10.1016/S0140-6736(03)12715-8; Craddock N, 2005, BRIT J PSYCHIAT, V186, P364, DOI 10.1192/bjp.186.5.364; Craddock N, 1996, BRIT J PSYCHIAT, V169, P58, DOI 10.1192/bjp.169.1.58; Craddock N, 2005, J MED GENET, V42, P193, DOI 10.1136/jmg.2005.030718; Devendra D, 2004, BMJ-BRIT MED J, V328, P750, DOI 10.1136/bmj.328.7442.750; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Di XJ, 2005, BIOINFORMATICS, V21, P1958, DOI 10.1093/bioinformatics/bti275; Dominiczak AF, 2004, CLIN EXP HYPERTENS, V26, P611, DOI 10.1081/CEH-200031939; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Falush D, 2003, GENETICS, V164, P1567; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Frayling TM, 1999, DIABETES, V48, P2475, DOI 10.2337/diabetes.48.12.2475; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; Gaya DR, 2006, LANCET, V367, P1271, DOI 10.1016/S0140-6736(06)68345-1; Gloyn AL, 2003, DIABETES, V52, P568, DOI 10.2337/diabetes.52.2.568; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Graves TD, 2005, POSTGRAD MED J, V81, P20, DOI 10.1136/pgmj.2004.022012; Green EK, 2006, BRIT J PSYCHIAT, V188, P21, DOI 10.1192/bjp.bp.105.009969; Green EK, 2005, ARCH GEN PSYCHIAT, V62, P642, DOI 10.1001/archpsyc.62.6.642; GREGERSEN PK, 1987, ARTHRITIS RHEUM, V30, P1205, DOI 10.1002/art.1780301102; Gregory JF, 2000, AM J CLIN NUTR, V72, P1535; Groves CJ, 2006, DIABETES, V55, P2640, DOI 10.2337/db06-0355; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; HANNON GJ, 1994, NATURE, V371, P257, DOI 10.1038/371257a0; Hayes B, 2001, GENET SEL EVOL, V33, P209, DOI 10.1051/gse:2001117; Helgadottir A, 2006, NAT GENET, V38, P68, DOI 10.1038/ng1692; Helgadottir A, 2004, NAT GENET, V36, P233, DOI 10.1038/ng1311; Helgason A, 2007, NAT GENET, V39, P218, DOI 10.1038/ng1960; Hinks A, 2007, ANN RHEUM DIS, V66, P683, DOI 10.1136/ard.2006.060459; HIRSCHHORN JN, 2005, NATURE REV GENETICS, V6, P108; Hubner N, 2005, NAT GENET, V37, P243, DOI 10.1038/ng1522; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Hutchison KE, 2004, PSYCHOL BULL, V130, P66, DOI 10.1037/0033-2909.130.1.66; Hyttinen V, 2003, DIABETES, V52, P1052, DOI 10.2337/diabetes.52.4.1052; Janssens ACJW, 2006, GENET MED, V8, P395, DOI 10.1097/01.gim.0000229689.18263.f4; Jawaheer D, 2001, AM J HUM GENET, V68, P927, DOI 10.1086/319518; John S, 2004, AM J HUM GENET, V75, P54, DOI 10.1086/422195; JONSSONRYLANDER A, 2004, ARTER THROMB VAS BIO, V25, P180; Kalinina N, 2004, ARTERIOSCL THROM VAS, V24, P1391, DOI 10.1161/01.ATV.0000133605.89421.79; Klerk M, 2002, JAMA-J AM MED ASSOC, V288, P2023, DOI 10.1001/jama.288.16.2023; Kobberling J, 1982, GENETICS DIABETES ME; Krystal JH, 2002, MOL PSYCHIATR, V7, pS71, DOI 10.1038/sj.mp.4001021; Lennard-Jones JE, 1989, SCAND J GASTROENTE S, V170, P6; LENNARDJONES JE, 1989, SCAND J GASTROENTERO, V24, P2, DOI 10.3109/00365528909091339; Leonard EJ, 1997, CIBA F SYMP, V212, P183; LEONARD EJ, 1997, CIBA F SYMP, V212, P192; Li N, 2003, GENETICS, V165, P2213; Libby P, 2005, CIRCULATION, V111, P3481, DOI 10.1161/CIRCULATIONAHA.105.537878; Libioulle C, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030058; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Lowe SW, 2003, CURR OPIN GENET DEV, V13, P77, DOI 10.1016/S0959-437X(02)00013-8; Lusis MJ, 2004, ANNU REV GENOM HUM G, V5, P189, DOI [10.1146/annurev.genom.5.061903.175930, 10.1016/j.tig.2012.03.001]; MACGREGOR AJ, 1994, J RHEUMATOL, V21, P1420; MacKay K, 2002, ARTHRITIS RHEUM, V46, P632, DOI 10.1002/art.10147; Mackay TEC, 2006, ANNU REV GENOM HUM G, V7, P339, DOI 10.1146/annurev.genom.7.080505.115758; MANTEL N, 1963, J AM STAT ASSOC, V58, P690; Marchini J, 2005, NAT GENET, V37, P413, DOI 10.1038/ng1537; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Matsuzaki H, 2004, NAT METHODS, V1, P109, DOI 10.1038/nmeth718; MCGUFFIN P, 1991, ARCH GEN PSYCHIAT, V48, P764; McGuffin P, 2003, ARCH GEN PSYCHIAT, V60, P497, DOI 10.1001/archpsyc.60.5.497; McQueen MB, 2005, AM J HUM GENET, V77, P582, DOI 10.1086/491603; Mein CA, 2004, HUM MOL GENET, V13, pR169, DOI 10.1093/hmg/ddh078; MENOZZI P, 1978, SCIENCE, V201, P786, DOI 10.1126/science.356262; Muller-Oerlinghausen B, 2002, LANCET, V359, P241, DOI 10.1016/S0140-6736(02)07450-0; Murray CJL, 1996, SCIENCE, V274, P740, DOI 10.1126/science.274.5288.740; Mustelin T, 2005, NAT REV IMMUNOL, V5, P43, DOI 10.1038/nri1530; Newhouse SJ, 2005, HUM MOL GENET, V14, P1805, DOI 10.1093/hmg/ddi187; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; OTSU K, 1990, J BIOL CHEM, V265, P13472; Ozeki Y, 2003, P NATL ACAD SCI USA, V100, P289, DOI 10.1073/pnas.0136913100; Pabst O, 2000, EMBO J, V19, P2015, DOI 10.1093/emboj/19.9.2015; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Pietravalle F, 1996, J BIOL CHEM, V271, P5965, DOI 10.1074/jbc.271.11.5965; Power C, 2006, INT J EPIDEMIOL, V35, P34, DOI 10.1093/ije/dyi183; Prasannan P, 2003, J BIOL CHEM, V278, P43178, DOI 10.1074/jbc.M304319200; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; Rabbee N, 2006, BIOINFORMATICS, V22, P7, DOI 10.1093/bioinformatics/bti741; Randak C, 2000, J INHERIT METAB DIS, V23, P520, DOI 10.1023/A:1005667707355; RICE J, 1987, ARCH GEN PSYCHIAT, V44, P441; Rioux JD, 2001, NAT GENET, V29, P223, DOI 10.1038/ng1001-223; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Samani NJ, 2005, AM J HUM GENET, V77, P1011; Sartor RB, 2006, NAT CLIN PRACT GASTR, V3, P390, DOI 10.1038/ncpgasthep0528; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Saxena R, 2006, DIABETES, V55, P2890, DOI 10.2337/db06-0381; Schmid M, 2000, ONCOGENE, V19, P5747, DOI 10.1038/sj.onc.1203942; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Sharfe N, 1997, P NATL ACAD SCI USA, V94, P3168, DOI 10.1073/pnas.94.7.3168; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Smyth D, 2004, DIABETES, V53, P3020, DOI 10.2337/diabetes.53.11.3020; Smyth DJ, 2006, NAT GENET, V38, P617, DOI 10.1038/ng1800; SPITZER RL, 1978, ARCH GEN PSYCHIAT, V35, P773, DOI 10.1001/archpsyc.1978.01770300115013; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; STIRLING WD, 1982, STATISTICIAN, V31, P211; STRACHAN DP, 2007, INT J EPIDEMIOL, DOI DOI 10.1093/IJE/DY1309; Stumvoll M, 2005, LANCET, V365, P1333, DOI 10.1016/S0140-6736(05)61032-X; SYMMONS DPM, 1994, BRIT J RHEUMATOL, V33, P735; Tobin MD, 2005, CIRCULATION, V112, P3423, DOI 10.1161/CIRCULATIONAHA.105.555474; Todd JA, 2006, NAT GENET, V38, P731, DOI 10.1038/ng0706-731; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Topol EJ, 2006, HUM MOL GENET, V15, pR117, DOI 10.1093/hmg/ddl183; Travis SPL, 2006, GUT, V55, DOI 10.1136/gut.2005.081950b; TYSK C, 1988, GUT, V29, P990, DOI 10.1136/gut.29.7.990; Ubeda M, 2006, J BIOL CHEM, V281, P28858, DOI 10.1074/jbc.M604690200; Valdar W, 2006, NAT GENET, V38, P879, DOI 10.1038/ng1840; Vawter MP, 2002, MOL PSYCHIATR, V7, P571, DOI 10.1038/sj.mp.4001158; Vella A, 2005, AM J HUM GENET, V76, P773, DOI 10.1086/429843; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Walkup AS, 2005, ARCH BIOCHEM BIOPHYS, V442, P196, DOI 10.1016/j.abb.2005.08.007; Watkins H, 2006, NAT REV GENET, V7, P163, DOI 10.1038/nrg1805; Wight TN, 2005, ARTERIOSCL THROM VAS, V25, P12, DOI 10.1161/01.ATV.0000150043.43083.aa; Wiltshire S, 2001, AM J HUM GENET, V69, P553, DOI 10.1086/323249; WING JK, 1990, ARCH GEN PSYCHIAT, V47, P589; WORDSWORTH P, 1991, ANN RHEUM DIS, V50, P343, DOI 10.1136/ard.50.6.343; WORTHINGTON J, 1994, BRIT J RHEUMATOL, V33, P970; Worthington J, 2005, EPIDEMIOLOGY RHEUMAT; Yamanouchi J, 2007, NAT GENET, V39, P329, DOI 10.1038/ng1958; Yamazaki K, 2005, HUM MOL GENET, V14, P3499, DOI 10.1093/hmg/ddi379; Yang QH, 2005, INT J EPIDEMIOL, V34, P1129, DOI 10.1093/ije/dyi130; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Zeggini E, 2007, DIABETOLOGIA, V50, P1, DOI 10.1007/s00125-006-0507-x; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a; Zondervan KT, 2004, NAT REV GENET, V5, P89, DOI 10.1038/nrg1270	144	7124	7344	22	1007	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 7	2007	447	7145					661	678		10.1038/nature05911	http://dx.doi.org/10.1038/nature05911			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175RI	17554300	Bronze, Green Accepted			2022-12-28	WOS:000247030700035
J	Chanock, SJ; Manolio, T; Boehnke, M; Boerwinkle, E; Hunter, DJ; Thomas, G; Hirschhorn, JN; Abecasis, G; Altshuler, D; Bailey-Wilson, JE; Brooks, LD; Cardon, LR; Daly, M; Donnelly, P; Fraumeni, JF; Freimer, NB; Gerhard, DS; Gunter, C; Guttmacher, AE; Guyer, MS; Harris, EL; Hoh, J; Hoover, R; Kong, CA; Merikangas, KR; Morton, CC; Palmer, LJ; Phimister, EG; Rice, JP; Roberts, J; Rotimi, C; Tucker, MA; Vogan, KJ; Wacholder, S; Wijsman, EM; Winn, DM; Collins, FS				Chanock, Stephen J.; Manolio, Teri; Boehnke, Michael; Boerwinkle, Eric; Hunter, David J.; Thomas, Gilles; Hirschhorn, Joel N.; Abecasis, Goncalo; Altshuler, David; Bailey-Wilson, Joan E.; Brooks, Lisa D.; Cardon, Lon R.; Daly, Mark; Donnelly, Peter; Fraumeni, Joseph F., Jr.; Freimer, Nelson B.; Gerhard, Daniela S.; Gunter, Chris; Guttmacher, Alan E.; Guyer, Mark S.; Harris, Emily L.; Hoh, Josephine; Hoover, Robert; Kong, C. Augustine; Merikangas, Kathleen R.; Morton, Cynthia C.; Palmer, Lyle J.; Phimister, Elizabeth G.; Rice, John P.; Roberts, Jerry; Rotimi, Charles; Tucker, Margaret A.; Vogan, Kyle J.; Wacholder, Sholom; Wijsman, Ellen M.; Winn, Deborah M.; Collins, Francis S.		NCI-NHGRI Working Grp Rep	Replicating genotype-phenotype associations	NATURE			English	Article							GENOME-WIDE ASSOCIATION; SINGLE-NUCLEOTIDE POLYMORPHISMS; COMMON GENETIC-VARIANTS; FACTOR-H POLYMORPHISM; PARKINSON-DISEASE; PROSTATE-CANCER; DYSBINDIN GENE; RISK LOCUS; DTNBP1; SUSCEPTIBILITY		NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; NCI, Canc Res Ctr, Bethesda, MD 20892 USA; NHGRI, NIH, Bethesda, MD 20892 USA; Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; Univ Texas, Hlth Sci Ctr, Ctr Human Genet, Houston, TX 77030 USA; Harvard Univ, Sch Med, Childrens Hosp, Broad Inst MIT & Harvard,Cambridge Ctr 7, Boston, MA 02114 USA; Massachusetts Gen Hosp, Broad Inst MIT & Harvard, Boston, MA 02114 USA; Fred Hutchinson Canc Res Ctr, Human Biol Div, Seattle, WA 98109 USA; Univ Oxford, Oxford OX1 3TG, England; Univ Calif Los Angeles, Ctr Neurobehav Genet, Los Angeles, CA 90095 USA; NCI, Off Canc Genom, NIH, Bethesda, MD 20892 USA; Nature, New York, NY 10013 USA; Yale Univ, Sch Med, New Haven, CT 06510 USA; DeCode Genet, IS-101 Reykjavik, Iceland; NIMH, NIH, Bethesda, MD 20892 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Boston, MA 02115 USA; Western Australian Inst Med Res, Nedlands, WA 6009, Australia; Univ Western Australia, Queen Elizabeth II Med Ctr, Nedlands, WA 6009, Australia; New England Journal Med, Boston, MA 02115 USA; Washington Univ, Sch Med, St Louis, MO 63110 USA; Howard Univ, Genet Epidemiol Unit, Natl Human Genome Ctr, Washington, DC 20060 USA; Nature Genet, Cambridge, MA 02141 USA; Univ Washington, Div Med Genet, Seattle, WA 98195 USA; Univ Washington, Dept Biostat, Seattle, WA 98195 USA; NCI, Epidemiol & Genet Res Program, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Michigan System; University of Michigan; University of Texas System; University of Texas Health Science Center Houston; Harvard University; Boston Children's Hospital; Harvard Medical School; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Broad Institute; Fred Hutchinson Cancer Center; University of Oxford; University of California System; University of California Los Angeles; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Center for Cancer Genomics (CCG); Yale University; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Western Australia; University of Western Australia; Washington University (WUSTL); Howard University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Chanock, SJ (corresponding author), NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA.	chanocks@mail.nih.gov; manoliot@nhgri.nih.gov	Palmer, Lyle John/N-1948-2019; Tucker, Margaret A/B-4297-2015; Altshuler, David M/A-4476-2009; Daly, Mark J/B-2453-2017; Abecasis, Goncalo R/B-7840-2010; Palmer, Lyle John/K-3196-2014; Gunter, Chris/AHA-7271-2022	Palmer, Lyle John/0000-0002-1628-3055; Altshuler, David M/0000-0002-7250-4107; Daly, Mark J/0000-0002-0949-8752; Palmer, Lyle John/0000-0002-1628-3055; Merikangas, Kathkeen/0000-0002-4667-2414; Wijsman, Ellen/0000-0002-2725-6669; Vogan, Kyle/0000-0001-9565-9665; Kong, Augustine/0000-0001-8193-5438; Bailey-Wilson, Joan/0000-0002-9153-2920; Gunter, Chris/0000-0001-9369-7537; Abecasis, Goncalo/0000-0003-1509-1825; Donnelly, Peter/0000-0001-9495-3408	NATIONAL CANCER INSTITUTE [Z01SC010083] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG000153, Z01HG200331] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [Z01MH002804] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; ANGELL M, 1990, NEW ENGL J MED, V323, P823, DOI 10.1056/NEJM199009203231209; [Anonymous], 1999, NAT GENET, V22, P1; Bray NJ, 2005, HUM MOL GENET, V14, P1947, DOI 10.1093/hmg/ddi199; Chandak GR, 2007, DIABETOLOGIA, V50, P63, DOI 10.1007/s00125-006-0502-2; Clarimon J, 2006, AM J HUM GENET, V78, P1082, DOI 10.1086/504727; Clark AG, 2005, GENOME RES, V15, P1463, DOI 10.1101/gr.4244005; Clarke R, 2006, PLOS GENET, V2, P990, DOI 10.1371/journal.pgen.0020107; Colhoun HM, 2003, LANCET, V361, P865, DOI 10.1016/S0140-6736(03)12715-8; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Dina C, 2007, SCIENCE, V315, DOI [10.1126/science.1129402, 10.1126/science.1130571, 10.1126/science.1130012]; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; EASTON DF, 2007, NATURE          0527, DOI DOI 10.1038/NATURE05887; Economou M, 2004, AM J GASTROENTEROL, V99, P2393, DOI 10.1111/j.1572-0241.2004.40304.x; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Farrer MJ, 2006, AM J HUM GENET, V78, P1084, DOI 10.1086/504728; Field SF, 2007, DIABETOLOGIA, V50, P212, DOI 10.1007/s00125-006-0506-y; Flint J, 2007, PSYCHOL MED, V37, P163, DOI 10.1017/S0033291706008750; Freedman ML, 2006, P NATL ACAD SCI USA, V103, P14068, DOI 10.1073/pnas.0605832103; Freimer N, 2003, NAT GENET, V34, P15, DOI 10.1038/ng0503-15; Freimer NB, 2007, NATURE, V445, P828, DOI 10.1038/nature05568; Funke B, 2004, AM J HUM GENET, V75, P891, DOI 10.1086/425279; Gavin JR, 1997, DIABETES CARE, V20, P1183; Goris A, 2006, AM J HUM GENET, V78, P1088, DOI 10.1086/504726; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Gretarsdottir S, 2005, STROKE, V36, P1824, DOI 10.1161/01.STR.0000176497.94458.27; Groves CJ, 2006, DIABETES, V55, P2640, DOI 10.2337/db06-0355; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Hall DH, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-83; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Helgason A, 2007, NAT GENET, V39, P218, DOI 10.1038/ng1960; Herbert A, 2006, SCIENCE, V312, P279, DOI 10.1126/science.1124779; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002; Horikoshi M, 2007, DIABETOLOGIA, V50, P747, DOI 10.1007/s00125-006-0588-6; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Ioannidis JPA, 2006, JNCI-J NATL CANCER I, V98, P1350, DOI 10.1093/jnci/djj392; Ioannidis JPA, 2006, AM J EPIDEMIOL, V164, P609, DOI 10.1093/aje/kwj259; Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1439, DOI 10.1001/archopht.119.10.1439; Kirov G, 2004, BIOL PSYCHIAT, V55, P971, DOI 10.1016/j.biopsych.2004.01.025; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Li YH, 2006, AM J HUM GENET, V78, P1090, DOI 10.1086/504725; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Manolio TA, 2006, NAT REV GENET, V7, P812, DOI 10.1038/nrg1919; Maraganore DM, 2005, AM J HUM GENET, V77, P685, DOI 10.1086/496902; MCPHERSON R, 2007, SCIENCE         0503, DOI DOI 10.1126/SCIENCE.11142447; Mutsuddi M, 2006, AM J HUM GENET, V79, P903, DOI 10.1086/508942; Myers RH, 2006, AM J HUM GENET, V78, P1081; Neale BM, 2004, AM J HUM GENET, V75, P353, DOI 10.1086/423901; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Patterson M, 2005, PLOS BIOL, V3, P1511, DOI 10.1371/journal.pbio.0030327; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Roeder K, 2006, AM J HUM GENET, V78, P243, DOI 10.1086/500026; Rosand J, 2006, NAT GENET, V38, P1091, DOI 10.1038/ng1006-1091; Rothman N, 2006, LANCET ONCOL, V7, P27, DOI 10.1016/S1470-2045(05)70434-4; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Saxena R, 2006, DIABETES, V55, P2890, DOI 10.2337/db06-0381; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Spielman RS, 1996, AM J HUM GENET, V59, P983; Stacey SN, 2007, NAT GENET, V39, P865, DOI 10.1038/ng2064; Straub RE, 2002, AM J HUM GENET, V71, P337, DOI 10.1086/341750; Todd JA, 2006, NAT GENET, V38, P731, DOI 10.1038/ng0706-731; Van Den Bogaert A, 2003, AM J HUM GENET, V73, P1438, DOI 10.1086/379928; Wacholder S, 2000, J NATL CANCER I, V92, P1151, DOI 10.1093/jnci/92.14.1151; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; Zollner S, 2007, AM J HUM GENET, V80, P605, DOI 10.1086/512821	79	1091	1116	0	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 7	2007	447	7145					655	660		10.1038/447655a	http://dx.doi.org/10.1038/447655a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175RI	17554299	Bronze, Green Submitted			2022-12-28	WOS:000247030700034
J	Cole, BF; Baron, JA; Sandler, RS; Haile, RW; Ahnen, DJ; Bresalier, RS; McKeown-Eyssen, G; Summers, RW; Rothstein, RI; Burke, CA; Snover, DC; Church, TR; Allen, JI; Robertson, DJ; Beck, GJ; Bond, JH; Byers, T; Mandel, JS; Mott, LA; Pearson, LH; Barry, EL; Rees, JR; Marcon, N; Saibil, F; Ueland, PM; Greenberg, ER				Cole, Bernard F.; Baron, John A.; Sandler, Robert S.; Haile, Robert W.; Ahnen, Dennis J.; Bresalier, Robert S.; McKeown-Eyssen, Gail; Summers, Robert W.; Rothstein, Richard I.; Burke, Carol A.; Snover, Dale C.; Church, Timothy R.; Allen, John I.; Robertson, Douglas J.; Beck, Gerald J.; Bond, John H.; Byers, Tim; Mandel, Jack S.; Mott, Leila A.; Pearson, Loretta H.; Barry, Elizabeth L.; Rees, Judy R.; Marcon, Norman; Saibil, Fred; Ueland, Per Magne; Greenberg, E. Robert		Polyp Prevention Study Grp	Folic acid for the prevention of colorectal adenomas - A randomized clinical trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DIETARY-FOLATE; PROSTATE-CANCER; DNA METHYLATION; PLASMA FOLATE; COLON-CANCER; 5-METHYLCYTOSINE CONTENT; MICROBIOLOGICAL ASSAY; METHYLMALONIC ACID; SERRATED POLYPS; SERUM FOLATE	Context Laboratory and epidemiological data suggest that folic acid may have an antineoplastic effect in the large intestine. Objective To assess the safety and efficacy of folic acid supplementation for preventing colorectal adenomas. Design, Setting, and Participants A double-blind, placebo-controlled, 2-factor, phase 3, randomized clinical trial conducted at 9 clinical centers between July 6, 1994, and October 1, 2004. Participants included 1021 men and women with a recent history of colorectal adenomas and no previous invasive large intestine carcinoma. Intervention Participants were randomly assigned in a 1: 1 ratio to receive 1 mg/d of folic acid ( n= 516) or placebo ( n= 505), and were separately randomized to receive aspirin ( 81 or 325 mg/d) or placebo. Follow-up consisted of 2 colonoscopic surveillance cycles ( the first interval was at 3 years and the second at 3 or 5 years later). Main Outcome Measures The primary outcome measure was occurrence of at least 1 colorectal adenoma. Secondary outcomes were the occurrence of advanced lesions (similar to 25% villous features, high-grade dysplasia, size similar to 1 cm, or invasive cancer) and adenoma multiplicity ( 0, 1-2, or similar to 3 adenomas). Results During the first 3 years, 987 participants ( 96.7%) underwent colonoscopic follow-up, and the incidence of at least 1 colorectal adenoma was 44.1% for folic acid ( n= 221) and 42.4% for placebo ( n= 206) ( unadjusted risk ratio [ RR], 1.04; 95% confidence interval [ CI], 0.90-1.20; P=. 58). Incidence of at least 1 advanced lesion was 11.4% for folic acid ( n= 57) and 8.6% for placebo ( n= 42) ( unadjusted RR, 1.32; 95% CI, 0.90-1.92; P=. 15). A total of 607 participants ( 59.5%) underwent a second follow-up, and the incidence of at least 1 colorectal adenoma was 41.9% for folic acid ( n= 127) and 37.2% for placebo ( n= 113) ( unadjusted RR, 1.13; 95% CI, 0.93-1.37; P=. 23); and incidence of at least 1 advanced lesion was 11.6% for folic acid ( n= 35) and 6.9% for placebo ( n= 21) ( unadjusted RR, 1.67; 95% CI, 1.00-2.80; P=. 05). Folic acid was associated with higher risks of having 3 or more adenomas and of noncolorectal cancers. There was no significant effect modification by sex, age, smoking, alcohol use, body mass index, baseline plasma folate, or aspirin allocation. Conclusions Folic acid at 1 mg/d does not reduce colorectal adenoma risk. Further research is needed to investigate the possibility that folic acid supplementation might increase the risk of colorectal neoplasia.	Dartmouth Med Sch, Dept Community & Family Med, Hanover, NH USA; Dartmouth Med Sch, Dept Med, Hanover, NH USA; Univ N Carolina, Dept Med, Chapel Hill, NC USA; Univ So Calif, Dept Prevent Med, Keck Sch Med, Los Angeles, CA 90089 USA; Univ Colorado, Dept Med, Denver, CO 80202 USA; Univ Colorado, Dept Prevent Med & Biometr, Denver, CO 80202 USA; Univ Texas, MD Anderson Canc Ctr, Dept Gastrointestinal Med & Nutr, Houston, TX 77030 USA; Univ Toronto, Dept Publ Hlth Sci & Nutr Sci, Toronto, ON, Canada; Univ Toronto, Dept Med, Toronto, ON, Canada; Univ Iowa, Carver Coll Med, Div Gastroenterol Hepatol, Iowa City, IA USA; Cleveland Clin Fdn, Dept Gastroenterol, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Dept Quantitat Hlth Sci, Cleveland, OH 44195 USA; Fairview Southdale Hosp, Dept Pathol, Edina, MN USA; Univ Minnesota, Sch Publ Hlth, Div Environm Hlth Sci, Minneapolis, MN USA; Minneapolis Vet Affairs Med Ctr, Dept Med, Minneapolis, MN USA; Dept Vet Affairs Med Ctr, Gastroenterol Sect, White River Jct, VT USA; Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA; Univ Bergen, Pharmacol Sect, Inst Med, Bergen, Norway; Haukeland Hosp, N-5021 Bergen, Norway	Dartmouth College; Dartmouth College; University of North Carolina; University of North Carolina Chapel Hill; University of Southern California; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Denver; University of Texas System; UTMD Anderson Cancer Center; University of Toronto; University of Toronto; University of Iowa; Cleveland Clinic Foundation; Cleveland Clinic Foundation; University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; Emory University; Rollins School Public Health; University of Bergen	Cole, BF (corresponding author), Dartmouth Hitchcock Med Ctr, Dept Community & Family Med, 7927 Rubin Bldg, Lebanon, NH 03756 USA.	bernard.cole@dartmouth.edu	Ueland, Per M/C-7340-2013; Church, Timothy/AAH-7017-2020; Barry, Elizabeth/AAB-7916-2019	Church, Timothy/0000-0003-3292-5035; Bresalier, Robert/0000-0002-9740-281X; Ueland, Per Magne/0000-0002-1903-0571	NCI NIH HHS [U54 CA100971, R01 CA059005] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U54CA100971, R01CA059005] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BAGGOTT JE, 1992, JNCI-J NATL CANCER I, V84, P1740, DOI 10.1093/jnci/84.22.1740; Baron JA, 1998, J NATL CANCER I, V90, P57, DOI 10.1093/jnci/90.1.57; Baron JA, 2003, NEW ENGL J MED, V348, P891, DOI 10.1056/NEJMoa021735; BEDFORD MT, 1987, CANCER RES, V47, P5274; BENITO E, 1993, INT J CANCER, V55, P213, DOI 10.1002/ijc.2910550208; BILLS ND, 1992, JNCI-J NATL CANCER I, V84, P332, DOI 10.1093/jnci/84.5.332; BIRD CL, 1995, CANCER EPIDEM BIOMAR, V4, P709; BLOUNT BC, 1995, BAILLIERE CLIN HAEM, V8, P461, DOI 10.1016/S0950-3536(05)80216-1; Breuer-Katschinski B, 2001, DIGEST DIS SCI, V46, P86, DOI 10.1023/A:1005519920643; Charles D, 2004, BMJ-BRIT MED J, V329, P1375, DOI 10.1136/bmj.329.7479.1375; CRAVO ML, 1992, CANCER RES, V52, P5002; FEINBERG AP, 1988, CANCER RES, V48, P1159; GAMASOSA MA, 1983, NUCLEIC ACIDS RES, V11, P6883, DOI 10.1093/nar/11.19.6883; GIOVANNUCCI E, 1995, JNCI-J NATL CANCER I, V87, P265, DOI 10.1093/jnci/87.4.265; GIOVANNUCCI E, 1993, J NATL CANCER I, V85, P875, DOI 10.1093/jnci/85.11.875; Giovannucci E, 1998, ANN INTERN MED, V129, P517, DOI 10.7326/0003-4819-129-7-199810010-00002; Giovannucci E, 2002, J NUTR, V132, p2350S, DOI 10.1093/jn/132.8.2350S; Glynn SA, 1996, CANCER EPIDEM BIOMAR, V5, P487; GOELZ SE, 1985, SCIENCE, V228, P187, DOI 10.1126/science.2579435; Harnack L, 2002, NUTR CANCER, V43, P152, DOI 10.1207/S15327914NC432_5; HERBERT V, 1999, NUTR HLTH DIS; Hultdin J, 2005, INT J CANCER, V113, P819, DOI 10.1002/ijc.20646; Kambara T, 2004, GUT, V53, P1137, DOI 10.1136/gut.2003.037671; Kato I, 1999, BRIT J CANCER, V79, P1917, DOI 10.1038/sj.bjc.6690305; KELLEHER BP, 1991, J CLIN PATHOL, V44, P592, DOI 10.1136/jcp.44.7.592; Kim YI, 2004, ENVIRON MOL MUTAGEN, V44, P10, DOI 10.1002/em.20025; Kim YI, 1996, GUT, V39, P732, DOI 10.1136/gut.39.5.732; Kotsopoulos J, 2005, CARCINOGENESIS, V26, P1603, DOI 10.1093/carcin/bgi117; Le Leu RK, 2000, CARCINOGENESIS, V21, P2261, DOI 10.1093/carcin/21.12.2261; Little R. J. A., 1987, STAT ANAL MISSING DA; Lonn E, 2006, NEW ENGL J MED, V354, P1567, DOI 10.1056/NEJMoa060900; Martinez ME, 2006, INT J CANCER, V119, P1440, DOI 10.1002/ijc.21978; Martinez ME, 2004, AM J CLIN NUTR, V79, P691; Mills JL, 2000, NEW ENGL J MED, V342, P1442, DOI 10.1056/NEJM200005113421911; Molloy AM, 1997, METHOD ENZYMOL, V281, P43; NEUGUT AI, 1993, CANCER EPIDEM BIOMAR, V2, P159; PASPATIS GA, 1995, DIS COLON RECTUM, V38, P64, DOI 10.1007/BF02053860; PEIPINS LA, 1994, EPIDEMIOL REV, V16, P273, DOI 10.1093/oxfordjournals.epirev.a036154; Pelucchi C, 2005, CANCER EPIDEM BIOMAR, V14, P944, DOI 10.1158/1055-9965.EPI-04-0787; POGRIBNY IP, 1995, CANCER RES, V55, P1894; RASMUSSEN K, 1989, CLIN CHEM, V35, P260; RAZIN A, 1991, MICROBIOL REV, V55, P451, DOI 10.1128/MMBR.55.3.451-458.1991; SHAW GM, 1995, EPIDEMIOLOGY, V6, P219, DOI 10.1097/00001648-199505000-00005; Snover DC, 2005, SEMIN DIAGN PATHOL, V22, P301, DOI 10.1053/j.semdp.2006.04.003; Song J, 2000, CANCER RES, V60, P5434; Stevens VL, 2006, AM J EPIDEMIOL, V163, P989, DOI 10.1093/aje/kwj126; Stolzenberg-Solomon RZ, 2006, AM J CLIN NUTR, V83, P895, DOI 10.1093/ajcn/83.4.895; Tseng M, 1996, AM J EPIDEMIOL, V144, P1005, DOI 10.1093/oxfordjournals.aje.a008871; U. S. Food and Drug Administration, 1993, FED REGISTER, V58, P53305; Van Guelpen B, 2006, GUT, V55, DOI 10.1136/gut.2005.085480; Wargovich MJ, 1996, CANCER EPIDEM BIOMAR, V5, P355; Weinstein SJ, 2003, CANCER EPIDEM BIOMAR, V12, P1271; Whelan RL, 1999, DIS COLON RECTUM, V42, P212, DOI 10.1007/BF02237131; Windelberg A, 2005, CLIN CHEM, V51, P2103, DOI 10.1373/clinchem.2005.053835; 1993, FED REG, V58, P2606	55	677	709	1	41	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 6	2007	297	21					2351	2359		10.1001/jama.297.21.2351	http://dx.doi.org/10.1001/jama.297.21.2351			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	175IL	17551129	Bronze			2022-12-28	WOS:000247007200017
J	Carlsson, CM				Carlsson, Cynthia M.			Lowering homocysteine for stroke prevention	LANCET			English	Editorial Material							FOLIC-ACID SUPPLEMENTATION; CARDIOVASCULAR EVENTS; MYOCARDIAL-INFARCTION; TRIAL; DISEASE; INTERVENTION; HYPERTENSION; MORTALITY; RISK		Univ Wisconsin, Sch Med & Publ Hlth, Dept Med, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison	Carlsson, CM (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Med, Madison, WI 53705 USA.	cmc@medicine.wisc.edu						ALBERT CM, 2007, CLIN CARDIOL, V30, P50; Bazzano LA, 2006, JAMA-J AM MED ASSOC, V296, P2720, DOI 10.1001/jama.296.22.2720; Bonaa KH, 2006, NEW ENGL J MED, V354, P1578, DOI 10.1056/NEJMoa055227; Liem A, 2003, J AM COLL CARDIOL, V41, P2105, DOI 10.1016/S0735-1097(03)00485-6; Lonn E, 2006, NEW ENGL J MED, V354, P1567, DOI 10.1056/NEJMoa060900; Mark SD, 1996, AM J EPIDEMIOL, V143, P658, DOI 10.1093/oxfordjournals.aje.a008798; Mark SD, 1998, EPIDEMIOLOGY, V9, P9, DOI 10.1097/00001648-199801000-00005; Righetti M, 2006, BLOOD PURIFICAT, V24, P379, DOI 10.1159/000093680; Toole JF, 2004, JAMA-J AM MED ASSOC, V291, P565, DOI 10.1001/jama.291.5.565; Wang XB, 2007, LANCET, V369, P1876, DOI 10.1016/S0140-6736(07)60854-X; Wrone EM, 2004, J AM SOC NEPHROL, V15, P420, DOI 10.1097/01.ASN.0000110181.64655.6C; Yang QH, 2006, CIRCULATION, V113, P1335, DOI 10.1161/CIRCULATIONAHA.105.570846; Zoungas S, 2006, J AM COLL CARDIOL, V47, P1108, DOI 10.1016/j.jacc.2005.10.064	13	13	14	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 2	2007	369	9576					1841	1842		10.1016/S0140-6736(07)60830-7	http://dx.doi.org/10.1016/S0140-6736(07)60830-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	173ZS	17544750				2022-12-28	WOS:000246911600007
J	Welch, J; Mason, F				Welch, Jan; Mason, Fiona			Rape and sexual assault	BMJ-BRITISH MEDICAL JOURNAL			English	Review							PROPHYLAXIS; VICTIMS		Kings Coll Hosp London, Haven Camberwell, London SE5 9RS, England; St Andrews Healthcare, Northampton, England	King's College Hospital NHS Foundation Trust; King's College Hospital	Welch, J (corresponding author), Kings Coll Hosp London, Haven Camberwell, Denmark Hill, London SE5 9RS, England.	jan.welch@kingsch.nhs.uk						Campbell R, 1998, AM J COMMUN PSYCHOL, V26, P537, DOI 10.1023/A:1022140921921; Centers for Disease Control and Prevention, 2006, MMWR Recomm Rep, V55, P1; Dalton M, 2004, FORENSIC GYNAECOLOGY; Fisher M, 2006, INT J STD AIDS, V17, P81, DOI 10.1258/095646206775455829; Gibb AM, 2003, INT J STD AIDS, V14, P99, DOI 10.1258/095646203321156854; *GLOB COAL WOM AID, 2004, WHO INF B SER, V2; Holmes MM, 1996, AM J OBSTET GYNECOL, V175, P320, DOI 10.1016/S0002-9378(96)70141-2; Horvath MAH, 2006, MED SCI LAW, V46, P219, DOI 10.1258/rsmmsl.46.3.219; HURLEY M, 2006, J CLIN FORENSIC MED, V13, P107; Jewkes R., 2002, WORLD REPORT VIOLENC, P149; Kelly L., 2002, RES REV REPORTING IN; Kelly L., 2003, GOOD PRACTICE MED RE; KILPATRICK DG, 1989, BEHAV THER, V20, P199, DOI 10.1016/S0005-7894(89)80069-3; KILPATRICK DG, 1985, J CONSULT CLIN PSYCH, V53, P866, DOI 10.1037/0022-006X.53.6.866; Lovett J, 2004, HOME OFFICE RES STUD, V285; National Institute for Health and Clinical Excellence, 2005, MAN PTSD AD CHILDR P; NUTTALL M, 1998, IT COULD HAVE BEEN Y; RESICK PA, 1981, J CONSULT CLIN PSYCH, V49, P705, DOI 10.1037/0022-006X.49.5.705; Rogers Deborah J, 2002, J Fam Plann Reprod Health Care, V28, P127, DOI 10.1783/147118902101196513; ROTHBAUM BO, 1992, J TRAUMA STRESS, V5, P455, DOI 10.1007/BF00977239; Sijbrandij M, 2006, BRIT J PSYCHIAT, V189, P150, DOI 10.1192/bjp.bp.105.021121; Sugar NF, 2004, AM J OBSTET GYNECOL, V190, P71, DOI 10.1016/S0002-9378(03)00912-8; von Hertzen H, 2002, LANCET, V360, P1803, DOI 10.1016/S0140-6736(02)11767-3; Walby S., 2004, HOME OFFICE RES STUD; WESSELY S, 2001, COCHRANE DB SYST REV; White Catherine, 2006, J Clin Forensic Med, V13, P172, DOI 10.1016/j.jcfm.2006.02.006; World Health Organization, 2003, GUID MED CAR VICT SE	27	55	55	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 2	2007	334	7604					1154	1158		10.1136/bmj.39211.403970.BE	http://dx.doi.org/10.1136/bmj.39211.403970.BE			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	177ES	17540944	Green Published			2022-12-28	WOS:000247137000031
J	Bos, JL; Rehmann, H; Wittinghofer, A				Bos, Johannes L.; Rehmann, Holger; Wittinghofer, Alfred			GEFs and GAPs: Critical elements in the control of small G proteins	CELL			English	Review							GUANINE-NUCLEOTIDE-EXCHANGE; GTPASE-ACTIVATING-PROTEIN; STRUCTURAL BASIS; SIGNALING PATHWAY; RHO-GTPASES; CYCLIC-AMP; TUBEROUS SCLEROSIS; CRYSTAL-STRUCTURE; PLASMA-MEMBRANE; FAMILY PROTEINS		UMC Utrecht, Dept Physiol Chem, Utrecht, Netherlands; UMC Utrecht, Ctr Biomed Genet, Utrecht, Netherlands; Abt Strukturelle Biol Max Planck Inst Mol Physiol, D-44227 Dortmund, Germany	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Max Planck Society	Bos, JL (corresponding author), UMC Utrecht, Dept Physiol Chem, Universiteitsweg 100, Utrecht, Netherlands.	j.l.bos@umcutrecht.nl						Aghazadeh B, 2000, CELL, V102, P625, DOI 10.1016/S0092-8674(00)00085-4; Aicher LD, 2001, J BIOL CHEM, V276, P21017, DOI 10.1074/jbc.C100136200; ARONHEIM A, 1994, CELL, V78, P949, DOI 10.1016/0092-8674(94)90271-2; Arthur WT, 2004, J CELL BIOL, V167, P111, DOI 10.1083/jcb.200404068; Avruch J, 2006, ONCOGENE, V25, P6361, DOI 10.1038/sj.onc.1209882; Bai YF, 2004, CANCER RES, V64, P8808, DOI 10.1158/0008-5472.CAN-04-3143; Bernards A, 2004, TRENDS CELL BIOL, V14, P377, DOI 10.1016/j.tcb.2004.05.003; Bi XP, 2002, NATURE, V419, P271, DOI 10.1038/nature01040; Bivona TG, 2003, NATURE, V424, P694, DOI 10.1038/nature01806; Blangy A, 2006, BIOL CELL, V98, P511, DOI 10.1042/BC20060023; Boriack-Sjodin PA, 1998, NATURE, V394, P337, DOI 10.1038/28548; Bos JL, 2006, TRENDS BIOCHEM SCI, V31, P680, DOI 10.1016/j.tibs.2006.10.002; Boykevisch S, 2006, CURR BIOL, V16, P2173, DOI 10.1016/j.cub.2006.09.033; Caloca MJ, 2004, J BIOL CHEM, V279, P20435, DOI 10.1074/jbc.M313013200; Caloca MJ, 2003, BIOCHEM J, V375, P313, DOI 10.1042/BJ20030727; Canagarajah B, 2004, CELL, V119, P407, DOI 10.1016/j.cell.2004.10.012; Clyde-Smith J, 2000, J BIOL CHEM, V275, P32260, DOI 10.1074/jbc.M006087200; Coleman ML, 2004, NAT REV MOL CELL BIO, V5, P355, DOI 10.1038/nrm1365; Crittenden JR, 2004, NAT MED, V10, P982, DOI 10.1038/nm1098; Cullen PJ, 2002, NAT REV MOL CELL BIO, V3, P339, DOI 10.1038/nrm808; D'Angelo I, 2006, EMBO REP, V7, P174, DOI 10.1038/sj.embor.7400602; Daumke O, 2004, NATURE, V429, P197, DOI 10.1038/nature02505; Ebinu JO, 1998, SCIENCE, V280, P1082, DOI 10.1126/science.280.5366.1082; ECCLESTON JF, 1993, J BIOL CHEM, V268, P27012; Engers R, 2000, INT J CANCER, V88, P369, DOI 10.1002/1097-0215(20001101)88:3<369::AID-IJC8>3.0.CO;2-K; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; Fernandez-Zapico ME, 2005, CANCER CELL, V7, P39, DOI 10.1016/j.ccr.2004.11.024; Fujikawa K, 2003, J EXP MED, V198, P1595, DOI 10.1084/jem.20030874; Fukuhara S, 2005, MOL CELL BIOL, V25, P136, DOI 10.1128/MCB.25.1.136-146.2005; Fukuhara S, 2001, ONCOGENE, V20, P1661, DOI 10.1038/sj.onc.1204182; Gan BY, 2006, J BIOL CHEM, V281, P37321, DOI 10.1074/jbc.M605241200; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Goldberg J, 1998, CELL, V95, P237, DOI 10.1016/S0092-8674(00)81754-7; Gonzalez-Garcia A, 2005, CANCER CELL, V7, P219, DOI 10.1016/j.ccr.2005.01.029; Hafner M, 2006, NATURE, V444, P941, DOI 10.1038/nature05415; Han JW, 1998, SCIENCE, V279, P558, DOI 10.1126/science.279.5350.558; Innocenti M, 2003, J CELL BIOL, V160, P17, DOI 10.1083/jcb.200206079; Innocenti M, 2002, J CELL BIOL, V156, P125, DOI 10.1083/jcb.200108035; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Itzen A, 2006, EMBO J, V25, P1445, DOI 10.1038/sj.emboj.7601044; Jordan JD, 1999, J BIOL CHEM, V274, P21507, DOI 10.1074/jbc.274.31.21507; Khanday FA, 2006, J CELL BIOL, V172, P817, DOI 10.1083/jcb.200506001; Kozminski KG, 2003, MOL BIOL CELL, V14, P4958, DOI 10.1091/mbc.E03-06-0426; Krugmann S, 2004, CURR BIOL, V14, P1380, DOI 10.1016/j.cub.2004.07.058; Kupzig S, 2006, J BIOL CHEM, V281, P9891, DOI 10.1074/jbc.M512802200; Lambert JM, 2002, NAT CELL BIOL, V4, P621, DOI 10.1038/ncb833; Li Y, 2006, J BIOL CHEM, V281, P2506, DOI 10.1074/jbc.M508165200; Liu Q, 2005, J CELL BIOL, V170, P183, DOI 10.1083/jcb.200504167; Llorca O, 2005, EMBO J, V24, P1330, DOI 10.1038/sj.emboj.7600617; Malliri A, 2002, NATURE, V417, P867, DOI 10.1038/nature00848; Margarit SM, 2003, CELL, V112, P685, DOI 10.1016/S0092-8674(03)00149-1; Mayer G, 2001, P NATL ACAD SCI USA, V98, P4961, DOI 10.1073/pnas.091100698; Miura K, 2002, MOL CELL, V9, P109, DOI 10.1016/S1097-2765(02)00428-8; Mochizuki N, 1999, NATURE, V400, P891, DOI 10.1038/23738; Movilla N, 1999, MOL CELL BIOL, V19, P7870; Ozaki N, 2000, NAT CELL BIOL, V2, P805, DOI 10.1038/35041046; Pan XJ, 2006, NATURE, V442, P303, DOI 10.1038/nature04847; Rehmann H, 2006, NATURE, V439, P625, DOI 10.1038/nature04468; Renault L, 2003, NATURE, V426, P525, DOI 10.1038/nature02197; Renault L, 2001, CELL, V105, P245, DOI 10.1016/S0092-8674(01)00315-4; Rittinger K, 1997, NATURE, V389, P758, DOI 10.1038/39651; Roberts AE, 2007, NAT GENET, V39, P70, DOI 10.1038/ng1926; Rossman KL, 2002, EMBO J, V21, P1315, DOI 10.1093/emboj/21.6.1315; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Seewald MJ, 2002, NATURE, V415, P662, DOI 10.1038/415662a; Snyder JT, 2001, J BIOL CHEM, V276, P45868, DOI 10.1074/jbc.M106731200; Soisson SM, 1998, CELL, V95, P259, DOI 10.1016/S0092-8674(00)81756-0; Sondermann H, 2004, CELL, V119, P393, DOI 10.1016/j.cell.2004.10.005; Tall GG, 2001, DEV CELL, V1, P73, DOI 10.1016/S1534-5807(01)00008-9; TANAKA S, 1994, P NATL ACAD SCI USA, V91, P3443, DOI 10.1073/pnas.91.8.3443; Tartaglia M, 2007, NAT GENET, V39, P75, DOI 10.1038/ng1939; Thomas C, 2007, MOL CELL, V25, P141, DOI 10.1016/j.molcel.2006.11.023; Turner M, 2002, NAT REV IMMUNOL, V2, P476, DOI 10.1038/nri840; Urano T, 1996, EMBO J, V15, P810, DOI 10.1002/j.1460-2075.1996.tb00416.x; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; WATERS SB, 1995, MOL CELL BIOL, V15, P2791; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660; Worthylake DK, 2000, NATURE, V408, P682, DOI 10.1038/35047014; Yamada T, 2005, J BIOL CHEM, V280, P33026, DOI 10.1074/jbc.M504587200; Yohe ME, 2007, J BIOL CHEM, V282, P13813, DOI 10.1074/jbc.M700185200	82	1187	1223	6	139	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 1	2007	129	5					865	877		10.1016/j.cell.2007.05.018	http://dx.doi.org/10.1016/j.cell.2007.05.018			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	176KT	17540168	Bronze			2022-12-28	WOS:000247084600008
J	Rothman, DH; Forney, DC				Rothman, Daniel H.; Forney, David C.			Physical model for the decay and preservation of marine organic carbon	SCIENCE			English	Article							MATTER DECOMPOSITION; SEDIMENTS; FLUXES; SOILS	Degradation of marine organic carbon provides a major source of atmospheric carbon dioxide, whereas preservation in sediments results in accumulation of oxygen. These processes involve the slow decay of chemically recalcitrant compounds and physical protection. To assess the importance of physical protection, we constructed a reaction-diffusion model in which organic matter differs only in its accessibility to microbial degradation but not its intrinsic reactivity. The model predicts that organic matter decays logarithmically with time t and that decay rates decrease approximately as 0.2 x t(-1) until burial. Analyses of sediment-core data are consistent with these predictions.	MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; MIT, Dept Mech Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Rothman, DH (corresponding author), MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA.	dhr@mit.edu						ABELSON PH, 1978, ANNU REV EARTH PL SC, V6, P325, DOI 10.1146/annurev.ea.06.050178.001545; Armstrong RA, 2001, DEEP-SEA RES PT II, V49, P219, DOI 10.1016/S0967-0645(01)00101-1; Bender C.M., 1978, ADV MATH METHODS SCI; Berner R.A., 1980, EARLY DIAGENESIS THE; Berner R.A., 2004, PHANEROZOIC CARBON C; BETTS JN, 1991, GLOBAL PLANET CHANGE, V97, P5, DOI 10.1016/0031-0182(91)90178-T; BOUDREAU BP, 1991, AM J SCI, V291, P507, DOI 10.2475/ajs.291.5.507; Burdige DJ, 1999, GEOCHIM COSMOCHIM AC, V63, P1507, DOI 10.1016/S0016-7037(99)00066-6; De Leeuw J.W., 1993, ORG GEOCHEM, V11, P23, DOI [10.1007/978-1-4615-2890-6_2, DOI 10.1007/978-1-4615-2890-6]; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; HEDGES JI, 1995, MAR CHEM, V49, P81, DOI 10.1016/0304-4203(95)00008-F; Hedges JI, 1997, ORG GEOCHEM, V27, P319, DOI 10.1016/S0146-6380(97)00056-9; Hedges JI, 2001, NATURE, V409, P801, DOI 10.1038/35057247; Holland H. D., 1978, CHEM ATMOSPHERE OCEA; JORGENSEN BB, 1978, GEOMICROBIOL J, V1, P29; KEIL RG, 1994, GEOCHIM COSMOCHIM AC, V58, P879, DOI 10.1016/0016-7037(94)90512-6; KEIL RG, 1994, NATURE, V370, P549, DOI 10.1038/370549a0; KIRKPATRICK S, 1973, REV MOD PHYS, V45, P574, DOI 10.1103/RevModPhys.45.574; Knoll AH., 2003, LIFE YOUNG PLANET; MAYER LM, 1994, GEOCHIM COSMOCHIM AC, V58, P1271, DOI 10.1016/0016-7037(94)90381-6; MAYER LM, 1994, CHEM GEOL, V114, P347, DOI 10.1016/0009-2541(94)90063-9; MIDDELBURG JJ, 1993, GLOBAL PLANET CHANGE, V8, P47, DOI 10.1016/0921-8181(93)90062-S; MIDDELBURG JJ, 1989, GEOCHIM COSMOCHIM AC, V53, P1577, DOI 10.1016/0016-7037(89)90239-1; Premuzic E.T., 1982, ORG GEOCHEM, V4, P63, DOI [10.1016/0146-6380(82)90009-2., DOI 10.1016/0146-6380(82)90009-2]; Ransom B, 1997, MAR GEOL, V138, P1, DOI 10.1016/S0025-3227(97)00012-1; REIMERS CE, 1983, MAR CHEM, V13, P141, DOI 10.1016/0304-4203(83)90022-1; Schmidt JL, 1998, LIMNOL OCEANOGR, V43, P976, DOI 10.4319/lo.1998.43.5.0976; Schrag DP, 2007, SCIENCE, V315, P812, DOI 10.1126/science.1137632; SMITH DC, 1992, NATURE, V359, P139, DOI 10.1038/359139a0; Steen AD, 2006, MAR CHEM, V101, P266, DOI 10.1016/j.marchem.2006.04.001; TEGELAAR EW, 1989, GEOCHIM COSMOCHIM AC, V53, P3103, DOI 10.1016/0016-7037(89)90191-9; Vetter YA, 1998, MICROBIAL ECOL, V36, P75, DOI 10.1007/s002489900095	32	91	93	3	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 1	2007	316	5829					1325	1328		10.1126/science.1138211	http://dx.doi.org/10.1126/science.1138211			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173PS	17540901				2022-12-28	WOS:000246885600047
J	Enns, GM; Berry, SA; Berry, GT; Rhead, WJ; Brusilow, SW; Hamosh, A				Enns, Gregory M.; Berry, Susan A.; Berry, Gerard T.; Rhead, William J.; Brusilow, Saul W.; Hamosh, Ada			Survival after treatment with phenylacetate and benzoate for urea-cycle disorders	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INBORN-ERRORS; LIVER-TRANSPLANTATION; NITROGEN-EXCRETION; THERAPY; HEMODIALYSIS; DEFICIENCY; HYPERAMMONEMIA; ENCEPHALOPATHY; ENZYMOPATHIES; PATHWAYS	BACKGROUND: The combination of intravenous sodium phenylacetate and sodium benzoate has been shown to lower plasma ammonium levels and improve survival in small cohorts of patients with historically lethal urea-cycle enzyme defects. METHODS: We report the results of a 25-year, open-label, uncontrolled study of sodium phenylacetate and sodium benzoate therapy (Ammonul, Ucyclyd Pharma) in 299 patients with urea-cycle disorders in whom there were 1181 episodes of acute hyperammonemia. RESULTS: Overall survival was 84% (250 of 299 patients). Ninety-six percent of the patients survived episodes of hyperammonemia (1132 of 1181 episodes). Patients over 30 days of age were more likely than neonates to survive an episode (98% vs. 73%, P < 0.001). Patients 12 or more years of age (93 patients), who had 437 episodes, were more likely than all younger patients to survive (99%, P < 0.001). Eighty-one percent of patients who were comatose at admission survived. Patients less than 30 days of age with a peak ammonium level above 1000 micromol per liter (1804 microg per deciliter) were least likely to survive a hyperammonemic episode (38%, P < 0.001). Dialysis was also used in 56 neonates during 60% of episodes and in 80 patients 30 days of age or older during 7% of episodes. CONCLUSIONS: Prompt recognition of a urea-cycle disorder and treatment with both sodium phenylacetate and sodium benzoate, in conjunction with other therapies, such as intravenous arginine hydrochloride and the provision of adequate calories to prevent catabolism, effectively lower plasma ammonium levels and result in survival in the majority of patients. Hemodialysis may also be needed to control hyperammonemia, especially in neonates and older patients who do not have a response to intravenous sodium phenylacetate and sodium benzoate.	Stanford Univ, Dept Pediat, Stanford, CA 94305 USA; Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA; Thomas Jefferson Univ, Dept Pediat, Philadelphia, PA 19107 USA; Med Coll Wisconsin, Dept Pediat, Milwaukee, WI USA; Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Inst Med Genet, Baltimore, MD USA	Stanford University; University of Minnesota System; University of Minnesota Twin Cities; Jefferson University; Medical College of Wisconsin; Johns Hopkins University; Johns Hopkins University	Enns, GM (corresponding author), Stanford Univ, Lucile Packard Childrens Hosp,Sch Med, Dept Pediat, Div Med Genet, 300 Pasteur Dr,H-315, Stanford, CA 94305 USA.	greg.enns@stanford.edu		Berry, Susan/0000-0001-7970-688X; Berry, Gerard/0000-0001-5299-3313	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000052, M01RR000240, M01RR020359] Funding Source: NIH RePORTER; NCRR NIH HHS [M01-RR-020359, M01-RR-00052, M01-RR-000240] Funding Source: Medline; PHS HHS [11134, 26358] Funding Source: Medline; FDA HHS [FD-R000198] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); FDA HHS		Bachmann C, 2005, ACTA GASTRO-ENT BELG, V68, P466; BATSHAW M, 1975, NEW ENGL J MED, V292, P1085, DOI 10.1056/NEJM197505222922101; BATSHAW ML, 1982, NEW ENGL J MED, V306, P1387, DOI 10.1056/NEJM198206103062303; Batshaw ML, 2001, J PEDIATR-US, V138, pS46, DOI 10.1067/mpd.2001.111836; Batshaw ML, 2002, J PEDIAT, V140, P490; BATSHAW ML, 1998, J INHERIT METAB D S1, V21, P151; BRUSILOW S, 1980, SCIENCE, V207, P659, DOI 10.1126/science.6243418; Brusilow S W, 1996, Adv Pediatr, V43, P127; BRUSILOW SW, 1984, NEW ENGL J MED, V310, P1630, DOI 10.1056/NEJM198406213102503; BRUSILOW SW, 1979, LANCET, V2, P452, DOI 10.1016/S0140-6736(79)91503-4; BRUSILOW SW, 1979, LANCET, V1, P124; Dhawan A, 2006, J INHERIT METAB DIS, V29, P431, DOI 10.1007/s10545-006-0245-8; DONN SM, 1979, J PEDIATR-US, V95, P67, DOI 10.1016/S0022-3476(79)80085-2; Francois B, 1976, Arch Dis Child, V51, P228; KILEY JE, 1958, NEW ENGL J MED, V259, P1156, DOI 10.1056/NEJM195812112592403; MAESTRI NE, 1991, J PEDIATR-US, V119, P923, DOI 10.1016/S0022-3476(05)83044-6; McBride KL, 2004, PEDIATRICS, V114, pE523, DOI 10.1542/peds.2004-0198; Morioka D, 2005, LIVER TRANSPLANT, V11, P1332, DOI 10.1002/lt.20587; MSALL M, 1984, NEW ENGL J MED, V310, P1500, DOI 10.1056/NEJM198406073102304; Msall M, 1988, Acta Paediatr Jpn, V30, P435; NAGATA N, 1991, AM J MED GENET, V40, P477, DOI 10.1002/ajmg.1320400421; Nassogne M, 2005, J INHERIT METAB DIS, V28, P407, DOI 10.1007/s10545-005-0303-7; Praphanproj V, 2000, J INHERIT METAB DIS, V23, P129, DOI 10.1023/A:1005661631281; RUTLEDGE SL, 1990, J PEDIATR-US, V116, P125, DOI 10.1016/S0022-3476(05)81661-0; SHIH VE, 1976, UREA CYCLE, P367; SIMMONS F, 1970, GASTROENTEROLOGY, V59, P827; THIBAULT A, 1994, CANCER RES, V54, P1690; WEBSTER LT, 1976, J BIOL CHEM, V251, P3352; Whitington PF, 1998, J INHERIT METAB DIS, V21, P112, DOI 10.1023/A:1005317909946	29	247	272	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 31	2007	356	22					2282	2292		10.1056/NEJMoa066596	http://dx.doi.org/10.1056/NEJMoa066596			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	172PO	17538087				2022-12-28	WOS:000246816500007
J	Hudes, G; Carducci, M; Tomczak, P; Dutcher, J; Figlin, R; Kapoor, A; Staroslawska, E; Sosman, J; McDermott, D; Bodrogi, I; Kovacevic, Z; Lesovoy, V; Schmidt-Wolf, IGH; Barbarash, O; Gokmen, E; O'Toole, T; Lustgarten, S; Moore, L; Motzer, RJ				Hudes, Gary; Carducci, Michael; Tomczak, Piotr; Dutcher, Janice; Figlin, Robert; Kapoor, Anil; Staroslawska, Elzbieta; Sosman, Jeffrey; McDermott, David; Bodrogi, Istvan; Kovacevic, Zoran; Lesovoy, Vladimir; Schmidt-Wolf, Ingo G. H.; Barbarash, Olga; Gokmen, Erhan; O'Toole, Timothy; Lustgarten, Stephanie; Moore, Laurence; Motzer, Robert J.		Global ARCC Trial	Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HIGH-DOSE INTERLEUKIN-2; RANDOMIZED PHASE-II; PROGNOSTIC-FACTORS; MAMMALIAN TARGET; 13-CIS-RETINOIC ACID; MTOR INHIBITOR; CANCER; CCI-779; TRIAL; RAPAMYCIN	BACKGROUND: Interferon alfa is widely used for metastatic renal-cell carcinoma but has limited efficacy and tolerability. Temsirolimus, a specific inhibitor of the mammalian target of rapamycin kinase, may benefit patients with this disease. METHODS: In this multicenter, phase 3 trial, we randomly assigned 626 patients with previously untreated, poor-prognosis metastatic renal-cell carcinoma to receive 25 mg of intravenous temsirolimus weekly, 3 million U of interferon alfa (with an increase to 18 million U) subcutaneously three times weekly, or combination therapy with 15 mg of temsirolimus weekly plus 6 million U of interferon alfa three times weekly. The primary end point was overall survival in comparisons of the temsirolimus group and the combination-therapy group with the interferon group. RESULTS: Patients who received temsirolimus alone had longer overall survival (hazard ratio for death, 0.73; 95% confidence interval [CI], 0.58 to 0.92; P=0.008) and progression-free survival (P < 0.001) than did patients who received interferon alone. Overall survival in the combination-therapy group did not differ significantly from that in the interferon group (hazard ratio, 0.96; 95% CI, 0.76 to 1.20; P=0.70). Median overall survival times in the interferon group, the temsirolimus group, and the combination-therapy group were 7.3, 10.9, and 8.4 months, respectively. Rash, peripheral edema, hyperglycemia, and hyperlipidemia were more common in the temsirolimus group, whereas asthenia was more common in the interferon group. There were fewer patients with serious adverse events in the temsirolimus group than in the interferon group (P=0.02). CONCLUSIONS: As compared with interferon alfa, temsirolimus improved overall survival among patients with metastatic renal-cell carcinoma and a poor prognosis. The addition of temsirolimus to interferon did not improve survival.	Fox Chase Canc Ctr, Dept Med Oncol, Philadelphia, PA 19111 USA; Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA; Oddzial Chemioterapii, Klin Onkol, Poznan, Poland; Our Lady Mercy Med Ctr, Bronx, NY USA; Univ Calif Los Angeles, Los Angeles, CA USA; McMaster Univ, Hamilton, ON, Canada; Lublin Oncol Ctr, Lublin, Poland; Vanderbilt Univ, Med Ctr, Nashville, TN USA; Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; Natl Inst Oncol, Budapest, Hungary; Mil Med Acad, Belgrade, Serbia; Reg Clin Ctr Urol & Nephrol, Kharkov, Ukraine; Univ Bonn, D-5300 Bonn, Germany; Kemerovo State Med Acad, Reg Clin Hosp, Kemerovo, Russia; Ege Univ, Fac Med, Izmir, Turkey; Wyeth Res, Cambridge, MA USA; Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA	Fox Chase Cancer Center; Johns Hopkins University; Johns Hopkins Medicine; University of California System; University of California Los Angeles; McMaster University; Vanderbilt University; Harvard University; Beth Israel Deaconess Medical Center; National Institute of Oncology Hungary; University of Bonn; Kemerovo State Medical Academy; Ege University; Pfizer; Memorial Sloan Kettering Cancer Center	Hudes, G (corresponding author), Fox Chase Canc Ctr, Dept Med Oncol, Rm 307,333 Cottman Ave, Philadelphia, PA 19111 USA.	gary.hudes@fccc.edu	Carducci, Michael/R-8164-2019; Toon, Christopher W/G-3610-2012; Kapoor, Anil/AAQ-7184-2021; Barbarash, Olga/A-4834-2017	Kapoor, Anil/0000-0001-9180-8029; Motzer, Robert/0000-0001-6925-2327; Laber, Damian/0000-0003-1041-4429; Barbarash, Olga/0000-0002-4642-3610				Aass N, 2005, J CLIN ONCOL, V23, P4172, DOI 10.1200/JCO.2005.07.114; ATKINS MB, 1993, J CLIN ONCOL, V11, P661, DOI 10.1200/JCO.1993.11.4.661; Atkins MB, 2004, J CLIN ONCOL, V22, P909, DOI 10.1200/JCO.2004.08.185; Bukowski RM, 2004, CLIN CANCER RES, V10, p6310S, DOI 10.1158/1078-0432.CCR-050000; Del Bufalo D, 2006, CANCER RES, V66, P5549, DOI 10.1158/0008-5472.CAN-05-2825; Escudier B, 2007, NEW ENGL J MED, V356, P125, DOI 10.1056/NEJMoa060655; Fingar DC, 2004, MOL CELL BIOL, V24, P200, DOI 10.1128/MCB.24.1.200-216.2004; FYFE G, 1995, J CLIN ONCOL, V13, P688, DOI 10.1200/JCO.1995.13.3.688; Harding MW, 2003, CLIN CANCER RES, V9, P2882; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hidalgo M, 2006, CLIN CANCER RES, V12, P5755, DOI 10.1158/1078-0432.CCR-06-0118; Hudson CC, 2002, MOL CELL BIOL, V22, P7004, DOI 10.1128/MCB.22.20.7004-7014.2002; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Ko Y., 2004, P AN M AM SOC CLIN, V22, p14S; McDermott DF, 2005, J CLIN ONCOL, V23, P133, DOI 10.1200/JCO.2005.03.206; McDermott DF, 2005, J CLIN ONCOL, V23, P2877; Mekhail TM, 2005, J CLIN ONCOL, V23, P832, DOI 10.1200/JCO.2005.05.179; Motzer RJ, 2002, J CLIN ONCOL, V20, P289, DOI 10.1200/JCO.20.1.289; Motzer RJ, 2000, J CLIN ONCOL, V18, P2972, DOI 10.1200/JCO.2000.18.16.2972; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; Negrier S, 1998, NEW ENGL J MED, V338, P1272, DOI 10.1056/NEJM199804303381805; Negrier S, 2002, ANN ONCOL, V13, P1460, DOI 10.1093/annonc/mdf257; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Pantuck AJ, 2003, CLIN CANCER RES, V9, P4641; Raymond E, 2004, J CLIN ONCOL, V22, P2336, DOI 10.1200/JCO.2004.08.116; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Skotnicki JS, 2001, CLIN CANCER RES, V7, p3749S; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Thomas GV, 2006, NAT MED, V12, P122, DOI 10.1038/nm1337; Yu K, 2001, ENDOCR-RELAT CANCER, V8, P249, DOI 10.1677/erc.0.0080249	30	3027	3135	1	125	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 31	2007	356	22					2271	2281		10.1056/NEJMoa066838	http://dx.doi.org/10.1056/NEJMoa066838			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	172PO	17538086				2022-12-28	WOS:000246816500006
J	Samet, JM; Geyh, AS; Utell, MJ				Samet, Jonathan M.; Geyh, Alison S.; Utell, Mark J.			The legacy of World Trade Center dust	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CENTER DISASTER; EXPOSURE; COLLAPSE; FIRE		Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21218 USA; Univ Rochester, Sch Med & Dent, Rochester, NY USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Rochester	Samet, JM (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21218 USA.							Banauch GI, 2006, AM J RESP CRIT CARE, V174, P312, DOI 10.1164/rccm.200511-1736OC; Edelman P, 2003, ENVIRON HEALTH PERSP, V111, P1906, DOI 10.1289/ehp.6315; Fireman EM, 2004, ENVIRON HEALTH PERSP, V112, P1564, DOI 10.1289/ehp.7233; Geyh AS, 2005, J OCCUP ENVIRON HYG, V2, P179, DOI 10.1080/15459620590923154; Landrigan PJ, 2004, ENVIRON HEALTH PERSP, V112, P731, DOI 10.1289/ehp.6702	5	16	16	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 31	2007	356	22					2233	2236		10.1056/NEJMp068287	http://dx.doi.org/10.1056/NEJMp068287			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	172PO	17538082				2022-12-28	WOS:000246816500001
J	Greiner, T				Greiner, Ted			Fortification of processed cereals should be mandatory	LANCET			English	Editorial Material							CONTROLLED-TRIAL; DOUBLE-BLIND; DEFICIENCY; IRON		PATH, Washington, DC 20006 USA		Greiner, T (corresponding author), PATH, Washington, DC 20006 USA.	tgreiner@path.org	Greiner, Ted/O-4301-2015	Greiner, Ted/0000-0001-8711-768X				Allen L, 2006, GUIDELINES FOOD FORT; Andang'o PEA, 2007, LANCET, V369, P1799, DOI 10.1016/S0140-6736(07)60817-4; Butterworth RF, 2001, AM J CLIN NUTR, V74, P712; DARY O, 2002, NUTR REV, V60, P50; Juliano BO., 1993, FOOD NUTR SERIES; *MAR SECR AGR CATT, 2007, I JOIN FIGHT BER MAR; Moretti D, 2006, AM J CLIN NUTR, V84, P822, DOI 10.1093/ajcn/84.4.822; *PATH, PATHS ULTR RIC PROJ; Seal AJ, 2007, AM J CLIN NUTR, V85, P218, DOI 10.1093/ajcn/85.1.218; Zimmermann MB, 2005, AM J CLIN NUTR, V82, P1276, DOI 10.1093/ajcn/82.6.1276	10	6	6	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 26	2007	369	9575					1766	1768		10.1016/S0140-6736(07)60791-0	http://dx.doi.org/10.1016/S0140-6736(07)60791-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	172QP	17531867	Green Submitted			2022-12-28	WOS:000246819300005
J	Feve, G; Mahe, A; Berroir, JM; Kontos, T; Placais, B; Glattli, DC; Cavanna, A; Etienne, B; Jin, Y				Feve, G.; Mahe, A.; Berroir, J. M.; Kontos, T.; Placais, B.; Glattli, D. C.; Cavanna, A.; Etienne, B.; Jin, Y.			An on-demand coherent single-electron source	SCIENCE			English	Article							TURNSTILE DEVICE; QUANTUM; QUANTIZATION; CONDUCTANCE; TRANSPORT	We report on the electron analog of the single-photon gun. On-demand single-electron injection in a quantum conductor was obtained using a quantum dot connected to the conductor via a tunnel barrier. Electron emission was triggered by the application of a potential step that compensated for the dot-charging energy. Depending on the barrier transparency, the quantum emission time ranged from 0.1 to 10 nanoseconds. The single-electron source should prove useful for the use of quantum bits in ballistic conductors. Additionally, periodic sequences of single-electron emission and absorption generate a quantized alternating current.	Ecole Normale Super, Dept Phys, Lab Pierre Aigrain, F-75231 Paris 05, France; CEA Saclay, Serv Phys Etat Condense, F-91191 Gif Sur Yvette, France; CNRS, UPR 20, Lab Photon & Nanostruct, F-91460 Marcoussis, France	UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Universite Paris Cite; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS)	Glattli, DC (corresponding author), Ecole Normale Super, Dept Phys, Lab Pierre Aigrain, 24 Rue Lhomond, F-75231 Paris 05, France.	glattli@lpa.ens.fr	GLATTLI, D. Christian/A-3748-2019; Placais, Bernard/E-3014-2016; Feve, Gwendal/E-2796-2016; Placais, Bernard/U-7000-2018; Berroir, Jean-Marc/F-8090-2016	GLATTLI, D. Christian/0000-0002-1457-0915; Placais, Bernard/0000-0003-2408-7393; Feve, Gwendal/0000-0001-5587-7537; Placais, Bernard/0000-0003-2408-7393; Berroir, Jean-Marc/0000-0001-7344-0929				Beenakker C. W. J., 2005, QUANTUM COMPUTERS AL, P307; BEENAKKER CWJ, 1991, SOLID STATE PHYS, V44, P1; Beenakker CWJ, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.147901; Bertoni A, 2000, PHYS REV LETT, V84, P5912, DOI 10.1103/PhysRevLett.84.5912; Blanter YM, 2000, PHYS REP, V336, P1, DOI 10.1016/S0370-1573(99)00123-4; BUTTIKER M, 1993, PHYS LETT A, V180, P364, DOI 10.1016/0375-9601(93)91193-9; BUTTIKER M, 1993, PHYS REV LETT, V70, P4114, DOI 10.1103/PhysRevLett.70.4114; BUTTIKER M, 1992, PHYS REV B, V46, P12485, DOI 10.1103/PhysRevB.46.12485; FEVE G, 2006, THESIS U P M CURIE P; Fujiwara A, 2004, APPL PHYS LETT, V84, P1323, DOI 10.1063/1.1650036; Gabelli J, 2006, SCIENCE, V313, P499, DOI 10.1126/science.1126940; GEERLIGS LJ, 1990, PHYS REV LETT, V64, P2691, DOI 10.1103/PhysRevLett.64.2691; Gisin N, 2002, REV MOD PHYS, V74, P145, DOI 10.1103/RevModPhys.74.145; IMAMOGLU A, 1994, PHYS REV LETT, V72, P210, DOI 10.1103/PhysRevLett.72.210; Ionicioiu R, 2001, INT J MOD PHYS B, V15, P125, DOI 10.1142/S0217979201003521; Ji Y, 2003, NATURE, V422, P415, DOI 10.1038/nature01503; Jonckheere T, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.205321; Keeling J, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.116403; Kok P, 2007, REV MOD PHYS, V79, P135, DOI 10.1103/RevModPhys.79.135; KOUWENHOVEN LP, 1991, PHYS REV LETT, V67, P1626, DOI 10.1103/PhysRevLett.67.1626; Levitov LS, 1996, J MATH PHYS, V37, P4845, DOI 10.1063/1.531672; POTHIER H, 1992, EUROPHYS LETT, V17, P249, DOI 10.1209/0295-5075/17/3/011; Pretre A, 1996, PHYS REV B, V54, P8130, DOI 10.1103/PhysRevB.54.8130; Samuelsson P, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.026805; Stace TM, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.126804; van Haeringen W., 1990, ANALOGIES OPTICS MIC; VANWEES BJ, 1988, PHYS REV LETT, V60, P848, DOI 10.1103/PhysRevLett.60.848; WHARAM DA, 1988, J PHYS C SOLID STATE, V21, pL209, DOI 10.1088/0022-3719/21/8/002	28	431	433	0	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2007	316	5828					1169	1172		10.1126/science.1141243	http://dx.doi.org/10.1126/science.1141243			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171GQ	17525333	Green Submitted			2022-12-28	WOS:000246724300036
J	Hamer, DH; Ndhlovu, M; Zurovac, D; Fox, M; Yeboah-Antwi, K; Chanda, P; Sipilinyambe, N; Simon, JL; Snow, RW				Hamer, Davidson H.; Ndhlovu, Micky; Zurovac, Dejan; Fox, Matthew; Yeboah-Antwi, Kojo; Chanda, Pascalina; Sipilinyambe, Naawa; Simon, Jonathon L.; Snow, Robert W.			Improved diagnostic testing and malaria treatment practices in Zambia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FEBRILE ILLNESS; CASE-MANAGEMENT; MICROSCOPY; TANZANIA	Context Improving the accuracy of malaria diagnosis with rapid antigen-detection diagnostic tests (RDTs) has been proposed as an approach for reducing overtreatment of malaria in the current era of widespread implementation of artemisinin-based combination therapy in sub-Saharan Africa. Objective To assess the association between use of microscopy and RDT and the prescription of antimalarials. Design, Setting, and Participants Cross-sectional, cluster sample survey, carried out between March and May 2006, of all outpatients treated during 1 working day at government and mission health facilities in 4 sentinel districts in Zambia. Main Outcome Measure Proportions of patients undergoing malaria diagnostic procedures and receiving antimalarial treatment. Results Seventeen percent of the 104 health facilities surveyed had functional microscopy, 63% had RDTs available, and 73% had 1 or more diagnostics available. Of patients with fever (suspected malaria), 27.8% (95% confidence interval [CI], 13.1%-42.5%) treated in health facilities with malaria diagnostics were tested and 44.6% had positive test results. Of patients with negative blood smear results, 58.4% (95% CI, 36.7%-80.2%) were prescribed an antimalaria drug, as were 35.5% (95% CI, 16.0%-55.0%) of those with a negative RDT result. Of patients with fever who did not have diagnostic tests done, 65.9% were also prescribed antimalarials. In facilities with artemether-lumefantrine in stock, this antimalarial was prescribed to a large proportion of febrile patients with a positive diagnostic test result (blood smear, 75.0% [95% CI, 51.7%-98.3%]; RDT, 70.4% [95% CI, 39.3%-100.0%]), but also to some of those with a negative diagnostic test result (blood smear, 30.4% [95% CI, 8.0%-52.9%]; RDT, 26.7% [95% CI, 5.7%-47.7%]). Conclusions Despite efforts to expand the provision of malaria diagnostics in Zambia, they continue to be underused and patients with negative test results frequently receive antimalarials. Provision of new tools to reduce inappropriate use of new expensive antimalarial treatments must be accompanied by a major change in clinical treatment of patients presenting with fever but lacking evidence of malaria infection.	Boston Univ, Sch Publ Hlth, Ctr Int Hlth & Dev, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Med, Infect Dis Sect, Boston, MA 02118 USA; Chainama Hills Coll Hosp Hlth Sci, Lusaka, Zambia; KEMRI Wellcome Trust Collaborat Programme, Ctr Geog Med, Malaria Publ Hlth & Epidemiol Grp, Nairobi, Kenya; Univ Oxford, John Radcliffe Hosp, Ctr Trop Med, Oxford OX3 9DU, England; Minist Hlth, Natl Malaria Control Ctr, Lusaka, Zambia	Boston University; Boston University; University of Oxford	Hamer, DH (corresponding author), Boston Univ, Sch Publ Hlth, Ctr Int Hlth & Dev, 85 Concord St,5th Floor, Boston, MA 02118 USA.	dhamer@bu.edu	Hamer, Davidson Howes/J-2020-2019; Yeboah-Antwi, Kojo/AAI-8519-2020; Snow, Robert William/AFR-1436-2022	Hamer, Davidson Howes/0000-0002-4700-1495; Snow, Robert William/0000-0003-3725-6088; Simon, Jonathon/0000-0001-6740-549X; Chanda-Kapata, Pascalina/0000-0003-3271-5265; Yeboah-Antwi, Kojo/0000-0002-3516-9266; Fox, Matthew/0000-0001-9887-0634	Wellcome Trust [058992, 079080] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Amexo M, 2004, LANCET, V364, P1896, DOI 10.1016/S0140-6736(04)17446-1; Barat L, 1999, AM J TROP MED HYG, V60, P1024, DOI 10.4269/ajtmh.1999.60.1024; Barnish G, 2004, BRIT MED J, V328, P1151; Bell D, 2006, NAT REV MICROBIOL, pS7, DOI [10.1038/nrmico1525, 10.1038/nrmicro1525]; Central Board of Health (Zambia), 2003, GUID DIAGN TREATM MA; *MIN HLTH, 2006, ROAD MAP IMP MAL ZAM; *MIN HLTH CENTR ST, 2006, ZAMB NAT MAL IND SUR; Moody A, 2002, CLIN MICROBIOL REV, V15, P66, DOI 10.1128/CMR.15.1.66-78.2002; MUDONDO C, 2005, ARTEMISININ BASED CO; Murray CK, 2003, TROP MED INT HEALTH, V8, P876, DOI 10.1046/j.1365-3156.2003.01115.x; *NAT MAL CONTR CTR, 2004, TRAIN DIAGN MAN MAL; *NAT MAL CONTR CTR, 2005, 2004 FOLL UP ROLL BA; Proux S, 2001, TROP MED INT HEALTH, V6, P99, DOI 10.1046/j.1365-3156.2001.00694.x; Reyburn H, 2004, BMJ-BRIT MED J, V329, P1212, DOI 10.1136/bmj.38251.658229.55; Reyburn H, 2007, BRIT MED J, V334, P403, DOI 10.1136/bmj.39073.496829.AE; *WHO, 2006, WHOHTMMAL20061108; Zurovac D, 2006, TROP MED INT HEALTH, V11, P1185, DOI 10.1111/j.1365-3156.2006.01674.x; Zurovac D, 2006, TROP MED INT HEALTH, V11, P432, DOI 10.1111/j.1365-3156.2006.01587.x; Zurovac D, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-31	19	193	193	1	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 23	2007	297	20					2227	2231		10.1001/jama.297.20.2227	http://dx.doi.org/10.1001/jama.297.20.2227			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	170JM	17519412	Green Accepted			2022-12-28	WOS:000246659700022
J	Mayer, L; Kazantzidis, S; Madau, P; Colpi, M; Quinn, T; Wadsley, J				Mayer, L.; Kazantzidis, S.; Madau, P.; Colpi, M.; Quinn, T.; Wadsley, J.			Rapid formation of supermassive black hole binaries in galaxy mergers with gas	SCIENCE			English	Article							GALACTIC NUCLEI; STAR-FORMATION; MASS; GASDYNAMICS; EVOLUTION; DYNAMICS	Supermassive black holes (SMBHs) are a ubiquitous component of the nuclei of galaxies. It is normally assumed that after the merger of two massive galaxies, a SMBH binary will form, shrink because of stellar or gas dynamical processes, and ultimately coalesce by emitting a burst of gravitational waves. However, so far it has not been possible to show how two SMBHs bind during a galaxy merger with gas because of the difficulty of modeling a wide range of spatial scales. Here we report hydrodynamical simulations that track the formation of a SMBH binary down to scales of a few light years after the collision between two spiral galaxies. A massive, turbulent, nuclear gaseous disk arises as a result of the galaxy merger. The black holes form an eccentric binary in the disk in less than 1 million years as a result of the gravitational drag from the gas rather than from the stars.	Univ Zurich, Inst Theoret Phys, CH-8057 Zurich, Switzerland; ETH, Inst Astron, CH-8093 Zurich, Switzerland; Stanford Univ, Dept Phys, Kavli Inst Particle Astrophys & Cosmol, Stanford, CA 94309 USA; Univ Calif Santa Cruz, Dept Astron, Santa Cruz, CA 95064 USA; Max Planck Inst Astrophys, D-85740 Garching, Germany; Univ Milano Bicocca, Dipartimento Fis, I-20126 Milan, Italy; Univ Washington, Dept Astron, Seattle, WA 98195 USA; McMaster Univ, Dept Phys & Astron, Hamilton, ON L8S 4M1, Canada	University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Stanford University; University of California System; University of California Santa Cruz; Max Planck Society; University of Milano-Bicocca; University of Washington; University of Washington Seattle; McMaster University	Mayer, L (corresponding author), Univ Zurich, Inst Theoret Phys, Winterthurestr 190, CH-8057 Zurich, Switzerland.	lucio@phys.ethz.ch; stelios@slac.stanford.edu	Bullock, James/K-1928-2015	Bullock, James/0000-0003-4298-5082; Madau, Piero/0000-0002-6336-3293; Quinn, Thomas/0000-0001-5510-2803				Armitage PJ, 2002, ASTROPHYS J, V567, pL9, DOI 10.1086/339770; Barnes JE, 1996, ASTROPHYS J, V471, P115, DOI 10.1086/177957; BEGELMAN MC, 1980, NATURE, V287, P307, DOI 10.1038/287307a0; Berczik P, 2005, ASTROPHYS J, V633, P680, DOI 10.1086/491598; CUTLER C, 2002, P 16 C GEN REL GRAV; Davies RI, 2004, ASTROPHYS J, V613, P781, DOI 10.1086/423315; Davies RI, 2004, ASTROPHYS J, V602, P148, DOI 10.1086/380995; Dotti M, 2006, MON NOT R ASTRON SOC, V367, P103, DOI 10.1111/j.1365-2966.2005.09956.x; Downes D, 1998, ASTROPHYS J, V507, P615, DOI 10.1086/306339; Escala A, 2005, ASTROPHYS J, V630, P152, DOI 10.1086/431747; Escala A, 2004, ASTROPHYS J, V607, P765, DOI 10.1086/386278; Genzel R, 2006, NATURE, V442, P786, DOI 10.1038/nature05052; Graham AW, 2004, ASTROPHYS J, V613, pL33, DOI 10.1086/424928; GREVE TR, ASTROPH0610378; Kazantzidis S, 2005, ASTROPHYS J, V623, pL67, DOI 10.1086/430139; Khochfar S, 2006, ASTRON ASTROPHYS, V445, P403, DOI 10.1051/0004-6361:20053241; Klessen RS, 2007, MON NOT R ASTRON SOC, V374, pL29, DOI 10.1111/j.1745-3933.2006.00258.x; KORMENDY J, 1995, ANNU REV ASTRON ASTR, V33, P581, DOI 10.1146/annurev.aa.33.090195.003053; Lauer TR, 1995, ASTRON J, V110, P2622, DOI 10.1086/117719; Merritt D, 2006, ASTROPHYS J, V648, P976, DOI 10.1086/506139; Milosavljevic M, 2001, ASTROPHYS J, V563, P34, DOI 10.1086/323830; Ostriker EC, 1999, ASTROPHYS J, V513, P252, DOI 10.1086/306858; Richstone D, 1998, NATURE, V395, pA14; Sesana A, 2005, ASTROPHYS J, V623, P23, DOI 10.1086/428492; Spaans M, 2000, ASTROPHYS J, V538, P115, DOI 10.1086/309118; Springel V, 2005, NATURE, V435, P629, DOI 10.1038/nature03597; Springel V, 2005, MON NOT R ASTRON SOC, V361, P776, DOI 10.1111/j.1365-2966.2005.09238.x; Tremaine S, 2002, ASTROPHYS J, V574, P740, DOI 10.1086/341002; Volonteri M, 2003, ASTROPHYS J, V582, P559, DOI 10.1086/344675	29	221	221	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 29	2007	316	5833					1874	1877		10.1126/science.1141858	http://dx.doi.org/10.1126/science.1141858			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	183WI	17556550	Green Submitted			2022-12-28	WOS:000247602700032
J	Hubner, R; Houlston, RD; Muir, KR				Hubner, Richard; Houlston, Richard D.; Muir, Kenneth R.			Should folic acid fortification be mandatory? No	BRITISH MEDICAL JOURNAL			English	Editorial Material									Inst Canc Res, Sect Canc Genet, Sutton SM2 5NG, Surrey, England; Univ Nottingham, Div Epidemiol & Publ Hlth, Queens Med Ctr, Nottingham NG7 2UH, England	University of London; Institute of Cancer Research - UK; University of Nottingham	Hubner, R (corresponding author), Inst Canc Res, Sect Canc Genet, Sutton SM2 5NG, Surrey, England.	richard.hubner@icr.ac.uk	Hubner, Richard/N-8051-2015	Hubner, Richard/0000-0002-7081-8823					0	22	22	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUN 16	2007	334	7606					1253	1253		10.1136/bmj.39232.496227.47	http://dx.doi.org/10.1136/bmj.39232.496227.47			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	183AM	17569932	Green Published			2022-12-28	WOS:000247545100031
J	Ohto, U; Fukase, K; Miyake, K; Satow, Y				Ohto, Umeharu; Fukase, Koichi; Miyake, Kensuke; Satow, Yoshinori			Crystal structures of human MD-2 and its complex with antiendotoxic lipid IVa	SCIENCE			English	Article							LIPOPOLYSACCHARIDE; TLR4; RECOGNITION; IMMUNITY; BINDING	Endotoxic lipopolysaccharide (LPS) with potent immunostimulatory activity is recognized by the receptor complex of MD-2 and Toll-like receptor 4. Crystal structures of human MD-2 and its complex with the antiendotoxic tetra-acylated lipid A core of LPS have been determined at 2.0 and 2.2 angstrom resolutions, respectively. MD-2 shows a deep hydrophobic cavity sandwiched by two beta sheets, in which four acyl chains of the ligand are fully confined. The phosphorylated glucosamine moieties are located at the entrance to the cavity. These structures suggest that MD-2 plays a principal role in endotoxin recognition and provide a basis for antiseptic drug development.	Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; Osaka Univ, Grad Sch Sci, Dept Chem, Osaka 5600043, Japan; Univ Tokyo, Inst Med Sci, Div Infect Genet, Minato Ku, Tokyo 1088639, Japan; Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan	University of Tokyo; Osaka University; University of Tokyo; Japan Science & Technology Agency (JST)	Satow, Y (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	satowy@mol.f.u-tokyo.ac.jp						Akashi S, 2003, J EXP MED, V198, P1035, DOI 10.1084/jem.20031076; Alexander C, 2002, TRENDS GLYCOSCI GLYC, V14, P69, DOI 10.4052/tigg.14.69; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Ferguson AD, 1998, SCIENCE, V282, P2215, DOI 10.1126/science.282.5397.2215; Fritz JH, 2006, NAT IMMUNOL, V7, P1250, DOI 10.1038/ni1412; Gangloff M, 2004, TRENDS BIOCHEM SCI, V29, P294, DOI 10.1016/j.tibs.2004.04.008; Gruber A, 2004, J BIOL CHEM, V279, P28475, DOI 10.1074/jbc.M400993200; Inohara N, 2002, TRENDS BIOCHEM SCI, V27, P219, DOI 10.1016/S0968-0004(02)02084-4; Kim JI, 2005, J BIOL CHEM, V280, P11347, DOI 10.1074/jbc.M414607200; Kobayashi M, 2006, J IMMUNOL, V176, P6211, DOI 10.4049/jimmunol.176.10.6211; Kusumoto S, 2003, J ENDOTOXIN RES, V9, P361, DOI 10.1179/096805103225002737; Lien E, 2000, J CLIN INVEST, V105, P497, DOI 10.1172/JCI8541; Mancek M, 2002, BIOCHEM BIOPH RES CO, V292, P880, DOI 10.1006/bbrc.2002.6748; Means TK, 2000, CYTOKINE GROWTH F R, V11, P219, DOI 10.1016/S1359-6101(00)00006-X; Miyake K, 2004, SEMIN IMMUNOL, V16, P11, DOI 10.1016/j.smim.2003.10.007; Montminy SW, 2006, NAT IMMUNOL, V7, P1066, DOI 10.1038/ni1386; Mullen GED, 2003, P NATL ACAD SCI USA, V100, P3919, DOI 10.1073/pnas.0630495100; Muroi M, 2006, J BIOL CHEM, V281, P5484, DOI 10.1074/jbc.M509193200; Muroi M, 2002, INFECT IMMUN, V70, P3546, DOI 10.1128/IAI.70.7.3546-3550.2002; Nagai Y, 2002, NAT IMMUNOL, V3, P667, DOI 10.1038/ni809; Poltorak A, 2000, P NATL ACAD SCI USA, V97, P2163, DOI 10.1073/pnas.040565397; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Re F, 2003, J IMMUNOL, V171, P5272, DOI 10.4049/jimmunol.171.10.5272; Viriyakosol S, 2001, J BIOL CHEM, V276, P38044; Visintin A, 2003, J BIOL CHEM, V278, P48313, DOI 10.1074/jbc.M306802200; Visintin A, 2006, IMMUNOBIOLOGY, V211, P437, DOI 10.1016/j.imbio.2006.05.010; WILSON IA, 1994, CURR OPIN STRUC BIOL, V4, P857, DOI 10.1016/0959-440X(94)90267-4; Wright CS, 2004, J MOL BIOL, V342, P585, DOI 10.1016/j.jmb.2004.07.063	29	372	381	1	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 15	2007	316	5831					1632	1634		10.1126/science.1139111	http://dx.doi.org/10.1126/science.1139111			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178SH	17569869				2022-12-28	WOS:000247239900046
J	Tang, X; Orlicky, S; Lin, Z; Willems, A; Neculai, D; Ceccarelli, D; Mercurio, F; Shilton, BH; Sicheri, F; Tyers, M				Tang, Xiaojing; Orlicky, Stephen; Lin, Zhenyuan; Willems, Andrew; Neculai, Dante; Ceccarelli, Derek; Mercurio, Frank; Shilton, Brian H.; Sicheri, Frank; Tyers, Mike			Suprafacial orientation of the SCFCdc4 dimer accommodates multiple geometries for substrate ubiquitination	CELL			English	Article							F-BOX PROTEINS; ANGLE SCATTERING DATA; CYCLIN-E; LIGASE COMPLEX; MULTISITE PHOSPHORYLATION; DEPENDENT UBIQUITINATION; STRUCTURAL-ANALYSIS; SCF; DEGRADATION; PROTEOLYSIS	SCF ubiquitin ligases recruit substrates for degradation via F box protein adaptor subunits. WD40 repeat F box proteins, such as Cdc4 and beta-TrCP, contain a conserved dimerization motif called the D domain. Here, we report that the D domain protomers of yeast Cdc4 and human beta-TrCP form a superhelical homotypic dimer. Disruption of the D domain compromises the activity of yeast SCFCdc4 toward the CDK inhibitor Sicl and other substrates. SCFCdc4 dimerization has little effect on the affinity for Sicl but markedly stimulates ubiquitin conjugation. A model of the dimeric holo-SCFCdc4 complex based on small-angle X-ray scatter measurements reveals a suprafacial configuration, in which substrate-binding sites and E2 catalytic sites lie in the same plane with a separation of 64 angstrom within and 102 angstrom between each SCIF monomer. This spatial variability may accommodate diverse acceptor lysine geometries in both substrates and the elongating ubiquitin chain and thereby increase catalytic efficiency.	Samuel Lunenfeld Res Inst, Ctr Syst Biol, Toronto, ON M5G 1X5, Canada; Cellgene Corp, Summit, NJ 07901 USA; Univ Western Ontario, Dept Biochem, London, ON N6A 5C1, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Western University (University of Western Ontario); University of Toronto	Tyers, M (corresponding author), Samuel Lunenfeld Res Inst, Ctr Syst Biol, Toronto, ON M5G 1X5, Canada.	sicheri@mshri.on.ca; tyers@mshri.on.ca	Shilton, Brian H/A-6667-2011; Sicheri, Frank/F-8856-2013; Tyers, Michael/ABE-3194-2021; Neculai, Dante/A-9923-2011; Neculai, Dante/M-2884-2013	Neculai, Dante/0000-0001-8887-9168; Orlicky, Stephen/0000-0002-8172-2042; Ceccarelli, Derek/0000-0002-2674-9234	NCRR NIH HHS [RR-08630] Funding Source: Medline	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Ang XLL, 2005, ONCOGENE, V24, P2860, DOI 10.1038/sj.onc.1208614; Aviv T, 2003, NAT STRUCT BIOL, V10, P614, DOI 10.1038/nsb956; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Chi Y, 2001, GENE DEV, V15, P1078, DOI 10.1101/gad.867501; Chung J, 2006, ONCOGENE, V25, P3079, DOI 10.1038/sj.onc.1209328; Dixon C, 2003, EUKARYOT CELL, V2, P123, DOI 10.1128/EC.2.1.123-133.2003; Eletr ZM, 2005, NAT STRUCT MOL BIOL, V12, P933, DOI 10.1038/nsmb984; Feldman RMR, 1997, CELL, V91, P221, DOI 10.1016/S0092-8674(00)80404-3; Flick K, 2004, NAT CELL BIOL, V6, P634, DOI 10.1038/ncb1143; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Jia JH, 2005, DEV CELL, V9, P819, DOI 10.1016/j.devcel.2005.10.006; Klein P, 2003, CURR BIOL, V13, P1669, DOI 10.1016/j.cub.2003.09.027; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; Kominami K, 1998, GENES CELLS, V3, P721, DOI 10.1046/j.1365-2443.1998.00225.x; Kostic M, 2006, J MOL BIOL, V363, P433, DOI 10.1016/j.jmb.2006.08.027; MCTIGUE MA, 1995, J MOL BIOL, V246, P21, DOI 10.1006/jmbi.1994.0061; Moberg KH, 2004, CURR BIOL, V14, P965, DOI 10.1016/j.cub.2004.04.040; Moberg KH, 2001, NATURE, V413, P311, DOI 10.1038/35095068; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; Orlicky S, 2003, CELL, V112, P243, DOI 10.1016/S0092-8674(03)00034-5; Passmore LA, 2005, MOL CELL, V20, P855, DOI 10.1016/j.molcel.2005.11.003; Patton EE, 1998, GENE DEV, V12, P692, DOI 10.1101/gad.12.5.692; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Petroski MD, 2006, MOL CELL, V24, P523, DOI 10.1016/j.molcel.2006.10.010; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Petroski MD, 2005, CELL, V123, P1107, DOI 10.1016/j.cell.2005.09.033; Petroski MD, 2003, MOL CELL, V11, P1435, DOI 10.1016/S1097-2765(03)00221-1; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Pintard L, 2004, EMBO J, V23, P1681, DOI 10.1038/sj.emboj.7600186; Rajagopalan H, 2004, NATURE, V428, P77, DOI 10.1038/nature02313; SCHWOB E, 1994, CELL, V79, P233, DOI 10.1016/0092-8674(94)90193-7; SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Spruck CH, 2002, CANCER RES, V62, P4535; Stogios PJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r82; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; Suzuki H, 2000, J BIOL CHEM, V275, P2877, DOI 10.1074/jbc.275.4.2877; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Tang XJ, 2005, METHOD ENZYMOL, V399, P433, DOI 10.1016/S0076-6879(05)99030-7; Vander Kooi CW, 2006, BIOCHEMISTRY-US, V45, P121, DOI 10.1021/bi051787e; Varelas X, 2003, MOL CELL BIOL, V23, P5388, DOI 10.1128/MCB.23.15.5388-5400.2003; Verma R, 1997, SCIENCE, V278, P455, DOI 10.1126/science.278.5337.455; Welcker M, 2003, MOL CELL, V12, P381, DOI 10.1016/S1097-2765(03)00287-9; Welcker M, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-7; Willems AR, 2004, BBA-MOL CELL RES, V1695, P133, DOI 10.1016/j.bbamcr.2004.09.027; Wolf DA, 1999, CURR BIOL, V9, P373, DOI 10.1016/S0960-9822(99)80165-1; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Ye X, 2004, J BIOL CHEM, V279, P50110, DOI 10.1074/jbc.M409226200; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	50	160	166	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 15	2007	129	6					1165	1176		10.1016/j.cell.2007.04.042	http://dx.doi.org/10.1016/j.cell.2007.04.042			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	180UA	17574027	Bronze			2022-12-28	WOS:000247390400019
J	Eremeeva, ME; Gerns, HL; Lydy, SL; Goo, JS; Ryan, ET; Mathew, SS; Ferraro, MJ; Holden, JM; Nicholson, WL; Dasch, GA; Koehler, JE				Eremeeva, Marina E.; Gerns, Helen L.; Lydy, Shari L.; Goo, Jeanna S.; Ryan, Edward T.; Mathew, Smitha S.; Ferraro, Mary Jane; Holden, Judith M.; Nicholson, William L.; Dasch, Gregory A.; Koehler, Jane E.			Bacteremia, fever, and splenomegaly caused by a newly recognized bartonella species	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CAT-SCRATCH DISEASE; BACILLARY ANGIOMATOSIS; 2-DIMENSIONAL ELECTROPHORESIS; IDENTIFICATION; HENSELAE; GENE; EPIDEMIOLOGY; PROTEINS; INFECTIONS; PATHOGEN	Bartonella species cause serious human infections globally, including bacillary angiomatosis, Oroya fever, trench fever, and endocarditis. We describe a patient who had fever and splenomegaly after traveling to Peru and also had bacteremia from an organism that resembled Bartonella bacilliformis, the causative agent of Oroya fever, which is endemic to Peru. However, genetic analyses revealed that this fastidious bacterium represented a previously uncultured and unnamed bartonella species, closely related to B. clarridgeiae and more distantly related to B. bacilliformis. We characterized this isolate, including its ability to cause fever and sustained bacteremia in a rhesus macaque. The route of infection and burden of human disease associated with this newly described pathogen are currently unknown.	Univ Calif San Francisco, Div Infect Dis, San Francisco, CA 94143 USA; Ctr Dis Control & Prevent, Atlanta, GA USA; Massachusetts Gen Hosp, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA	University of California System; University of California San Francisco; Centers for Disease Control & Prevention - USA; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Koehler, JE (corresponding author), Univ Calif San Francisco, Div Infect Dis, Box 0654, San Francisco, CA 94143 USA.			Dasch, Gregory/0000-0001-6090-1810	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043703, R01AI052813] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI52813, R01 AI43703, R01 AI052813, R01 AI043703] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Anderson B, 1994, J Fla Med Assoc, V81, P835; Bergmans AMC, 1996, J CLIN MICROBIOL, V34, P254, DOI 10.1128/JCM.34.2.254-260.1996; Boulouis HJ, 2005, VET RES, V36, P383, DOI 10.1051/vetres:2005009; DALTON MJ, 1995, ARCH INTERN MED, V155, P1670, DOI 10.1001/archinte.155.15.1670; DOLAN MJ, 1993, ANN INTERN MED, V118, P331, DOI 10.7326/0003-4819-118-5-199303010-00002; Fournier PE, 2001, MEDICINE, V80, P245, DOI 10.1097/00005792-200107000-00003; Gaynor EC, 2001, MOL MICROBIOL, V39, P1546, DOI 10.1046/j.1365-2958.2001.02341.x; Gurfield AN, 2001, VET MICROBIOL, V80, P185, DOI 10.1016/S0378-1135(01)00304-2; Houpikian P, 2001, J CLIN MICROBIOL, V39, P2768, DOI 10.1128/JCM.39.8.2768-2778.2001; Koehler JE, 1997, NEW ENGL J MED, V337, P1876, DOI 10.1056/NEJM199712253372603; KOEHLER JE, 1992, NEW ENGL J MED, V327, P1625, DOI 10.1056/NEJM199212033272303; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; La Scola B, 2003, TRENDS MICROBIOL, V11, P318, DOI 10.1016/S0966-842X(03)00143-4; Maguina C, 2001, CLIN INFECT DIS, V33, P772, DOI 10.1086/322614; MURPHY TF, 1983, J INFECT DIS, V147, P838, DOI 10.1093/infdis/147.5.838; NORMAN AF, 1995, J CLIN MICROBIOL, V33, P1797, DOI 10.1128/JCM.33.7.1797-1803.1995; OConnell KL, 1997, ELECTROPHORESIS, V18, P349, DOI 10.1002/elps.1150180309; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; Park SY, 2001, J BACTERIOL, V183, P5751, DOI 10.1128/JB.183.19.5751-5755.2001; Parola P, 2002, AM J TROP MED HYG, V67, P135, DOI 10.4269/ajtmh.2002.67.135; Reeves WK, 2005, ENTOMOL NEWS, V116, P263; REGNERY RL, 1992, LANCET, V339, P1443, DOI 10.1016/0140-6736(92)92032-B; RELMAN DA, 1990, NEW ENGL J MED, V323, P1573, DOI 10.1056/NEJM199012063232301; Renesto P, 2001, J CLIN MICROBIOL, V39, P430, DOI 10.1128/JCM.39.2.430-437.2001; Rhomberg TA, 2004, PROTEOMICS, V4, P3021, DOI 10.1002/pmic.200400933; SLATER LN, 1990, NEW ENGL J MED, V323, P1587, DOI 10.1056/NEJM199012063232303; ZANGWILL KM, 1993, NEW ENGL J MED, V329, P8, DOI 10.1056/NEJM199307013290102	27	143	152	1	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 7	2007	356	23					2381	2387		10.1056/NEJMoa065987	http://dx.doi.org/10.1056/NEJMoa065987			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	175QY	17554119				2022-12-28	WOS:000247029300007
J	Rossi, DJ; Bryder, D; Seita, J; Nussenzweig, A; Hoeijmakers, J; Weissman, IL				Rossi, Derrick J.; Bryder, David; Seita, Jun; Nussenzweig, Andre; Hoeijmakers, Jan; Weissman, Irving L.			Deficiencies in DNA damage repair limit the function of haematopoietic stem cells with age	NATURE			English	Article							LIFE-SPAN; SERIAL TRANSPLANTATION; SELF-RENEWAL; MOUSE MODEL; MICE; TELOMERASE; CANCER; TRANSCRIPTION; DEFECTS; STRESS	A diminished capacity to maintain tissue homeostasis is a central physiological characteristic of ageing. As stem cells regulate tissue homeostasis, depletion of stem cell reserves and/or diminished stem cell function have been postulated to contribute to ageing(1). It has further been suggested that accumulated DNA damage could be a principal mechanism underlying age-dependent stem cell decline(2). We have tested these hypotheses by examining haematopoietic stem cell reserves and function with age in mice deficient in several genomic maintenance pathways including nucleotide excision repair(3,4), telomere maintenance(5,6) and non-homologous end-joining(7,8). Here we show that although deficiencies in these pathways did not deplete stem cell reserves with age, stem cell functional capacity was severely affected under conditions of stress, leading to loss of reconstitution and proliferative potential, diminished self-renewal, increased apoptosis and, ultimately, functional exhaustion. Moreover, we provide evidence that endogenous DNA damage accumulates with age in wild-type stem cells. These data are consistent with DNA damage accrual being a physiological mechanism of stem cell ageing that may contribute to the diminished capacity of aged tissues to return to homeostasis after exposure to acute stress or injury.	Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; NCI, Lab Receptor Biol, NIH, Bethesda, MD 20892 USA; Erasmus MC, MGC CBG Dept Cell Biol & Genet, NL-3000 DR Rotterdam, Netherlands	Stanford University; Stanford University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Erasmus University Rotterdam; Erasmus MC	Rossi, DJ (corresponding author), Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA.	drossi@stanford.edu	Seita, Jun/AAM-1478-2020; Hoeijmakers, Jan/AAX-6972-2021; Bryder, David/Q-6292-2019	Seita, Jun/0000-0002-3008-3615; Bryder, David/0000-0002-8761-4237	NATIONAL CANCER INSTITUTE [ZIABC010283, Z01BC010283] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Allsopp RC, 2003, BLOOD, V102, P517, DOI 10.1182/blood-2002-07-2334; Allsopp RC, 2001, J EXP MED, V193, P917, DOI 10.1084/jem.193.8.917; Bender CF, 2002, GENE DEV, V16, P2237, DOI 10.1101/gad.1007902; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Bryder D, 2006, AM J PATHOL, V169, P338, DOI 10.2353/ajpath.2006.060312; Choudhury AR, 2007, NAT GENET, V39, P99, DOI 10.1038/ng1937; de Boer J, 1998, MOL CELL, V1, P981, DOI 10.1016/S1097-2765(00)80098-2; de Boer J, 2002, SCIENCE, V296, P1276, DOI 10.1126/science.1070174; Difilippantonio MJ, 2000, NATURE, V404, P510, DOI 10.1038/35006670; Domen J, 2000, J EXP MED, V191, P253, DOI 10.1084/jem.191.2.253; Hathcock KS, 2002, P NATL ACAD SCI USA, V99, P3591, DOI 10.1073/pnas.012549799; Herrera E, 1999, EMBO J, V18, P2950, DOI 10.1093/emboj/18.11.2950; Ishikawa K, 2006, DNA CELL BIOL, V25, P406, DOI 10.1089/dna.2006.25.406; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989; Kim M, 2003, ANN NY ACAD SCI, V996, P195, DOI 10.1111/j.1749-6632.2003.tb03247.x; Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Morales M, 2005, GENE DEV, V19, P3043, DOI 10.1101/gad.1373705; Morrison SJ, 1996, NAT MED, V2, P1011, DOI 10.1038/nm0996-1011; Navarro S, 2006, MOL THER, V14, P525, DOI 10.1016/j.ymthe.2006.05.018; Nussenzweig A, 1996, NATURE, V382, P551, DOI 10.1038/382551a0; Nussenzweig A, 1997, P NATL ACAD SCI USA, V94, P13588, DOI 10.1073/pnas.94.25.13588; Park Y, 2005, ANNU REV MED, V56, P495, DOI 10.1146/annurev.med.56.082103.104546; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; Prasher JM, 2005, EMBO J, V24, P861, DOI 10.1038/sj.emboj.7600542; Reese JS, 2003, BLOOD, V102, P1626, DOI 10.1182/blood-2002-10-3035; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Samper E, 2002, BLOOD, V99, P2767, DOI 10.1182/blood.V99.8.2767; Schlessinger D, 2001, MECH AGEING DEV, V122, P1537, DOI 10.1016/S0047-6374(01)00299-8; Seita J, 2007, P NATL ACAD SCI USA, V104, P2349, DOI 10.1073/pnas.0606238104; Sudo K, 2000, J EXP MED, V192, P1273, DOI 10.1084/jem.192.9.1273; Yamazaki S, 2006, EMBO J, V25, P3515, DOI 10.1038/sj.emboj.7601236	35	816	847	2	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 7	2007	447	7145					725	U15		10.1038/nature05862	http://dx.doi.org/10.1038/nature05862			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175RI	17554309				2022-12-28	WOS:000247030700046
J	Karunajeewa, HA; Manning, L; Mueller, I; Ilett, KF; Davis, TME				Karunajeewa, Harin A.; Manning, Laurens; Mueller, Ivo; Ilett, Kenneth F.; Davis, Timothy M. E.			Rectal administration of artemisinin derivatives for the treatment of malaria	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							ACUTE FALCIPARUM-MALARIA; RANDOMIZED CLINICAL-TRIAL; PAPUA-NEW-GUINEA; MODERATELY SEVERE MALARIA; ARTESUNATE SUPPOSITORIES; UNCOMPLICATED MALARIA; INTRAVENOUS QUININE; INTRAMUSCULAR ARTEMETHER; SEQUENTIAL TREATMENTS; VIETNAMESE PATIENTS	Context Rectal administration of artemisinin derivatives is a potentially lifesaving emergency treatment of severe malaria. Many different preparations are marketed in tropical countries, but their pharmacokinetic disposition and clinical efficacy may vary. Objective To review the pharmacokinetics, efficacy, and safety of rectally administered artesunate, artemisinin, dihydroartemisinin, and artemether. Data Sources We searched the MEDLINE, EMBASE, Cochrane Database of Clinical Reviews, Global Health, Web of Science, and CINAHL computerized databases up to December 2006, along with reviewing unpublished data from conference proceedings, pharmaceutical companies, and regulatory applications. Studies in languages other than English were translated. Study Selection Studies were included involving rectal administration of an artemisinin derivative to healthy volunteers or patients with measurement of plasma drug concentrations or rates of initial parasite clearance. Both single-arm and comparative trials were included. Data Extraction Forty-five studies were identified, of which 39 eligible studies were included in the review. Primary efficacy outcome measures included parasite density as a percentage of baseline at 12 and 24 hours following the first dose. Pharmacokinetic variables included maximum plasma concentration ( C-max), time to C-max ( T-max), and area under the plasma concentration-time curve. Weighted means were calculated from available data. Data Synthesis Thirty-two studies provided valid clinical efficacy data: 19 of artesunate, 10 of artemisinin, 2 of dihydroartemisinin, and 1 of artemether. All demonstrated prompt parasite clearance, with evidence of a dose-dependent effect for artesunate. Mortality rates in severe malaria ( weighted means, 0%-13%) were consistent with those expected. Eight studies compared rectal artemisinin with conventional parenteral treatment ( quinine, artemether, or artesunate) for severe malaria. Despite similar clinical outcomes, rectal artemisinin derivatives initiated parasite clearance more rapidly than parenteral treatment ( percentage of baseline at 12 hours, <= 27% vs >= 56%, respectively). Eighteen pharmacokinetic studies were identified, including 13 of artesunate. There was marked interindividual variability in most pharmacokinetic variables, but artesunate achieved an earlier T-max and higher C-max and area under the plasma concentration - time curve than other artemisinin derivatives. Conclusions Available rectal preparations of artemisinin derivatives differ in their pharmacokinetic disposition. Most available evidence pertains to artesunate and artemisinin. Despite marked interindividual variability in bioavailability, rectal preparations appear to have acceptable therapeutic efficacy, including in severe illness.	Fremantle Hosp, Sch Med & Pharmacol, Med Unit, Fremantle, WA 6959, Australia; Univ Western Australia, Pharmacol Unit, Sch Med & Pharmacol, Nedlands, WA 6009, Australia; Papua New Guinea Inst Med Res, Goroka, Papua N Guinea	University of Western Australia; University of Western Australia; PNG Institute Of Medical Research	Davis, TME (corresponding author), Fremantle Hosp, Sch Med & Pharmacol, Med Unit, POB 480, Fremantle, WA 6959, Australia.	tdavis@cyllene.uwa.edu.au	Davis, Timothy ME/M-5144-2014; Manning, Laurens A/H-5360-2014; Torero, Rebeca/C-1703-2012; Mueller, Ivo/C-7251-2013	Manning, Laurens A/0000-0003-4334-5351; Mueller, Ivo/0000-0001-6554-6889; Davis, Timothy/0000-0003-0749-7411				Aceng JR, 2005, BMJ-BRIT MED J, V330, P334, DOI 10.1136/bmj.330.7487.334; Anstey NM, 2006, MED J AUSTRALIA, V184, P3, DOI 10.5694/j.1326-5377.2006.tb00084.x; ARNOLD K, 1990, T ROY SOC TROP MED H, V84, P499, DOI 10.1016/0035-9203(90)90012-4; Ashton M, 1998, CLIN PHARMACOL THER, V63, P482, DOI 10.1016/S0009-9236(98)90044-3; Awad MI, 2004, TROP DOCT, V34, P132, DOI 10.1177/004947550403400302; Awad MI, 2003, AM J TROP MED HYG, V68, P153, DOI 10.4269/ajtmh.2003.68.153; Barennes H, 2006, BMJ-BRIT MED J, V332, P1055, DOI 10.1136/bmj.332.7549.1055; Barnes KI, 2004, LANCET, V363, P1598, DOI 10.1016/S0140-6736(04)16203-X; Benakis A, 2006, EUR J DRUG METAB PH, V31, P41, DOI 10.1007/BF03190641; BENAKIS A, 1996, JAP J TROP MED HY S1, V24, P39; Bhatt K M, 1996, JPN J TROP MED HY S1, V24, P59; Birku Y, 1999, E AFR MED J, V76, P154; Breman JG, 2001, AM J TROP MED HYG, V64, P1; BREWER TG, 1994, AM J TROP MED HYG, V51, P251, DOI 10.4269/ajtmh.1994.51.251; Davis TME, 2001, ANTIMICROB AGENTS CH, V45, P181, DOI 10.1128/AAC.45.1.181-186.2001; Esamai F, 2000, E AFR MED J, V77, P273; Faiz MA, 2005, LANCET, V366, P717; Gomez EA, 2003, ACTA TROP, V89, P47, DOI 10.1016/j.actatropica.2003.09.003; Guo X B, 1989, Zhong Xi Yi Jie He Za Zhi, V9, P475; GUO XB, 1989, ZHONG XI YI JIE HE Z, V9, P453; Halpaap B, 1998, AM J TROP MED HYG, V58, P365, DOI 10.4269/ajtmh.1998.58.365; Hien T T, 1994, Trans R Soc Trop Med Hyg, V88 Suppl 1, pS7; HIEN TT, 1994, T ROY SOC TROP MED H, V88, P688, DOI 10.1016/0035-9203(94)90231-3; HIEN TT, 1992, T ROY SOC TROP MED H, V86, P582, DOI 10.1016/0035-9203(92)90137-2; HIEN TT, 1991, T ROY SOC TROP MED H, V85, P210, DOI 10.1016/0035-9203(91)90024-S; HIEN TT, 1993, LANCET, V341, P603; Ilett KF, 2002, BRIT J CLIN PHARMACO, V53, P23, DOI 10.1046/j.0306-5251.2001.01519.x; ILETT KF, 2005, ANTIMICROBIAL THERAP, V2, P981; Kaona FAD, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-28; Karunajeewa HA, 2003, PEDIATR INFECT DIS J, V22, P251, DOI 10.1097/00006454-200303000-00010; Karunajeewa HA, 2006, ANTIMICROB AGENTS CH, V50, P968, DOI 10.1128/AAC.50.3.968-974.2006; Karunajeewa HA, 2004, ANTIMICROB AGENTS CH, V48, P2966, DOI 10.1128/AAC.48.8.2966-2972.2004; Koopmans R, 1999, AM J TROP MED HYG, V60, P244, DOI 10.4269/ajtmh.1999.60.244; Koopmans R, 1998, T ROY SOC TROP MED H, V92, P434, DOI 10.1016/S0035-9203(98)91082-3; Krishna S, 2001, ANTIMICROB AGENTS CH, V45, P509, DOI 10.1128/AAC.45.2.509-516.2001; LANDIRES EAG, 1996, JAPANESE J TROPIC S1, V24, P17; LI G, 1985, Journal of Traditional Chinese Medicine, V5, P159; LI GQ, 1989, 4 WORLD C CLIN PHARM; Li Y Q, 1984, Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V2, P279; LOOAREESUWAN S, 1995, ANN TROP MED PARASIT, V89, P469, DOI 10.1080/00034983.1995.11812979; Looareesuwan S, 1997, AM J TROP MED HYG, V57, P348, DOI 10.4269/ajtmh.1997.57.348; Looareesuwan S, 1996, JPN J TROP MED HYG, V24, P13; Makundi EA, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-58; McIntosh H M, 2000, Cochrane Database Syst Rev, pCD000527, DOI 10.1002/14651858.CD000527; McIntosh HM, 2000, COCHRANE DB SYST REV, V2; Navaratnam V, 1998, EUR J CLIN PHARMACOL, V54, P411, DOI 10.1007/s002280050484; Pengsaa Krisana, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P597; Phuong CXT, 1997, T ROY SOC TROP MED H, V91, P335, DOI 10.1016/S0035-9203(97)90099-7; Price R, 1999, AM J TROP MED HYG, V60, P547, DOI 10.4269/ajtmh.1999.60.547; Sabchareon A, 1998, AM J TROP MED HYG, V58, P11, DOI 10.4269/ajtmh.1998.58.11; Simpson JA, 2006, PLOS MED, V3, P2113, DOI 10.1371/journal.pmed.0030444; TejaIsavadharm P, 1996, BRIT J CLIN PHARMACO, V42, P599, DOI 10.1111/j.1365-2125.1996.tb00115.x; Thwe Y, 1996, JPN J TROP MED HYG, V24, P25; van Tulder M, 2003, SPINE, V28, P1290, DOI 10.1097/01.BRS.0000065484.95996.AF; Vinh H, 1997, T ROY SOC TROP MED H, V91, P465, DOI 10.1016/S0035-9203(97)90287-X; White NJ, 1997, ANTIMICROB AGENTS CH, V41, P1413, DOI 10.1128/AAC.41.7.1413; *WHO, 2002, FDA BRIEF DOC ANT DR; Wilairatna P, 2000, AM J TROP MED HYG, V63, P290, DOI 10.4269/ajtmh.2000.63.290; Zhao K C, 1993, Yao Xue Xue Bao, V28, P342; 1999, 15 PROGR REP UNDP WO	60	29	30	3	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 6	2007	297	21					2381	2390		10.1001/jama.297.21.2381	http://dx.doi.org/10.1001/jama.297.21.2381			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	175IL	17551131				2022-12-28	WOS:000247007200020
J	Gill, SS; Bronskill, SE; Normand, SLT; Anderson, GM; Sykora, K; Lam, K; Bell, CM; Lee, PE; Fischer, HD; Herrmann, N; Gurwitz, JH; Rochon, PA				Gill, Sudeep S.; Bronskill, Susan E.; Normand, Sharon-Lise T.; Anderson, Geoffrey M.; Sykora, Kathy; Lam, Kelvin; Bell, Chaim M.; Lee, Philip E.; Fischer, Hadas D.; Herrmann, Nathan; Gurwitz, Jerry H.; Rochon, Paula A.			Antipsychotic drug use and mortality in older adults with dementia	ANNALS OF INTERNAL MEDICINE			English	Article							SUDDEN CARDIAC DEATH; RANDOMIZED CONTROLLED-TRIAL; PROPENSITY SCORE MODELS; QUALITY-OF-LIFE; NURSING-HOMES; ATYPICAL ANTIPSYCHOTICS; PSYCHOLOGICAL SYMPTOMS; ELDERLY-PATIENTS; NEUROPSYCHIATRIC SYMPTOMS; VENOUS THROMBOEMBOLISM	Background: Antipsychotic drugs are widely used to manage behavioral and psychological symptoms in dementia despite concerns about their safety. Objective: To examine the association between treatment with antipsychotics (both conventional and atypical) and all-cause mortality. Design: Population -based, retrospective cohort study. Setting: Ontario, Canada. Patients: Older adults with dementia who were followed between 1 April 1997 and 31 March 2003. Measurements: The risk for death was determined at 30, 60, 120, and 180 days after the initial dispensing of antipsychotic medication. Two pairwise comparisons were made: atypical versus no antipsychotic use and conventional versus atypical antipsychotic use. Groups were stratified by place of residence (community or long-term care). Propensity score matching was used to adjust for differences in baseline health status. Results: A total of 27 259 matched pairs were identified. New use of atypical antipsychotics was associated with a statistically significant increase in the risk for death at 30 days compared with nonuse in both the community-dwelling cohort (adjusted hazard ratio, 1.31 [95% CI, 1.02 to 1.70]; absolute risk difference, 0.2 percentage point) and the long-term care cohort (adjusted hazard ratio, 1.55 [CI, 1.15 to 2.07]; absolute risk difference, 1.2 percentage points). Excess risk seemed to persist to 180 days, but unequal rates of censoring over time may have affected these results. Relative to atypical antipsychotic use, conventional antipsychotic use was associated with a higher risk for death at all time points. Sensitivity analysis revealed that unmeasured confounders that in- crease the risk for death could diminish or eliminate the observed associations. Limitations: Information on causes of death was not available. Many patents did not continue their initial treatments after 1 month of therapy. Unmeasured confounders could affect associations. Conclusions: Atypical antipsychotic use is associated with an increased risk for death compared with nonuse among older adults with dementia. The risk for death may be greater with conventional antipsychotics than with atypical antipsychotics.	Queens Univ, Kingston, ON K7L 2V7, Canada; Univ Toronto, Toronto, ON M4X 1K9, Canada; Inst Clin Evaluat Sci, Toronto, ON M4X 1K9, Canada; Harvard Univ, Sch Med, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; Univ Massachusetts, Sch Med, Meyers Primary Care Inst, Fallon Clin Fdn, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Meyers Primary Care Inst, Fallon Community Hlth Plan, Worcester, MA 01605 USA	Queens University - Canada; University of Toronto; University of Toronto; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; University of British Columbia; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Gill, SS (corresponding author), St Marys Lake Hosp, 340 Union St, Kingston, ON K7L 5A2, Canada.		Bell, Chaim/C-4611-2015; Rochon, Paula A/J-2918-2016	Bell, Chaim/0000-0002-3778-9469; Rochon, Paula A/0000-0002-5973-4151; Normand, Sharon-Lise/0000-0001-7027-4769				Austin PC, 2007, STAT MED, V26, P734, DOI 10.1002/sim.2580; Ballard C, 2005, INT PSYCHOGERIATR, V17, P4, DOI 10.1017/S1041610205221026; Ballard CG, 2004, J CLIN PSYCHIAT, V65, P23; Barnett MJ, 2006, J CLIN PSYCHOPHARM, V26, P182, DOI 10.1097/01.jcp.0000203598.43314.34; Belle SH, 2006, ANN INTERN MED, V145, P727, DOI 10.7326/0003-4819-145-10-200611210-00005; Berzlanovich AM, 1999, AM J MED, V107, P351, DOI 10.1016/S0002-9343(99)00242-9; Bronskill SE, 2004, J AM GERIATR SOC, V52, P749, DOI 10.1111/j.1532-5415.2004.52212.x; Brookhart MA, 2006, AM J EPIDEMIOL, V163, P1149, DOI 10.1093/aje/kwj149; Callahan CM, 2006, JAMA-J AM MED ASSOC, V295, P2148, DOI 10.1001/jama.295.18.2148; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Covinsky KE, 2006, ANN INTERN MED, V145, P780, DOI 10.7326/0003-4819-145-10-200611210-00011; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; DAGOSTINO RB, 2004, TUTORIALS BIOSTSATIS, V1; Fahey T, 2003, BRIT MED J, V326, P580, DOI 10.1136/bmj.326.7389.580; Fossey J, 2006, BMJ-BRIT MED J, V332, P756, DOI 10.1136/bmj.38782.575868.7C; Gill SS, 2005, BMJ-BRIT MED J, V330, P445, DOI 10.1136/bmj.38330.470486.8F; Gill SS, 2006, JAMA-J AM MED ASSOC, V295, P495, DOI 10.1001/jama.295.5.495-b; Gurwitz JH, 2005, AM J MED, V118, P251, DOI 10.1016/j.amjmed.2004.09.018; Hennessy S, 2004, BRIT J CLIN PHARMACO, V58, P81, DOI 10.1111/j.1365-2125.2004.02098.x; Hennessy S, 2002, BRIT MED J, V325, P1070, DOI 10.1136/bmj.325.7372.1070; *HLTH CAN, 2005, 200563 HLTH CAN; Joukamaa M, 2006, BRIT J PSYCHIAT, V188, P122, DOI 10.1192/bjp.188.2.122; Keene J, 2001, INT J GERIATR PSYCH, V16, P969, DOI 10.1002/gps.474; Kern LM, 2005, ANN INTERN MED, V142, P173, DOI 10.7326/0003-4819-142-3-200502010-00007; Kryzhanovskaya LA, 2006, J CLIN PSYCHIAT, V67, P933, DOI 10.4088/JCP.v67n0610; Lanctot KL, 1998, J CLIN PSYCHIAT, V59, P550, DOI 10.4088/JCP.v59n1010; Lee PE, 2004, BMJ-BRIT MED J, V329, P75, DOI 10.1136/bmj.38125.465579.55; Levy Adrian R, 2003, Can J Clin Pharmacol, V10, P67; Liperoti R, 2003, J CLIN PSYCHIAT, V64, P1106, DOI 10.4088/JCP.v64n0918; Liperoti R, 2005, J CLIN PSYCHIAT, V66, P1090, DOI 10.4088/JCP.v66n0901; Liperoti R, 2005, ARCH INTERN MED, V165, P2677, DOI 10.1001/archinte.165.22.2677; Liperoti R, 2005, ARCH INTERN MED, V165, P696, DOI 10.1001/archinte.165.6.696; Livingston G, 2007, J NEUROL NEUROSUR PS, V78, P25, DOI 10.1136/jnnp.2006.094342; Livingston G, 2005, AM J PSYCHIAT, V162, P1996, DOI 10.1176/appi.ajp.162.11.1996; McKeith I, 2005, LANCET NEUROL, V4, P735, DOI 10.1016/S1474-4422(05)70219-2; Meador KG, 1997, J AM GERIATR SOC, V45, P207, DOI 10.1111/j.1532-5415.1997.tb04509.x; Nasrallah HA, 2004, AM J GERIAT PSYCHIAT, V12, P437, DOI 10.1176/appi.ajgp.12.4.437; Normand SLT, 2005, BMJ-BRIT MED J, V330, P1021, DOI 10.1136/bmj.330.7498.1021; Rabins PV, 2005, JAMA-J AM MED ASSOC, V294, P1963, DOI 10.1001/jama.294.15.1963; Rapoport M, 2005, INT J GERIATR PSYCH, V20, P749, DOI 10.1002/gps.1358; RAY WA, 1993, ARCH INTERN MED, V153, P713, DOI 10.1001/archinte.153.6.713; Ray WA, 2005, NEW ENGL J MED, V353, P2319, DOI 10.1056/NEJMp058267; Ray WA, 2003, AM J EPIDEMIOL, V158, P915, DOI 10.1093/aje/kwg231; Ray WA, 2002, BRIT J PSYCHIAT, V180, P483, DOI 10.1192/bjp.180.6.483; Ray WA, 2001, ARCH GEN PSYCHIAT, V58, P1161, DOI 10.1001/archpsyc.58.12.1161; ROSENBAUM PR, 1985, AM STAT, V39, P33, DOI 10.2307/2683903; Ruschena D, 2003, BRIT J PSYCHIAT, V183, P446, DOI 10.1192/bjp.183.5.446; Scarmeas N, 2005, ARCH NEUROL-CHICAGO, V62, P1601, DOI 10.1001/archneur.62.10.1601; Schneeweiss S, 2006, PHARMACOEPIDEM DR S, V15, P291, DOI 10.1002/pds.1200; Schneider LS, 2006, NEW ENGL J MED, V355, P1525, DOI 10.1056/NEJMoa061240; SCHNEIDER LS, 1990, J AM GERIATR SOC, V38, P553, DOI 10.1111/j.1532-5415.1990.tb02407.x; Schneider LS, 2005, JAMA-J AM MED ASSOC, V294, P1934, DOI 10.1001/jama.294.15.1934; Shah A, 2005, INT PSYCHOGERIATR, V17, P12, DOI 10.1017/S1041610205231022; Sink KM, 2005, JAMA-J AM MED ASSOC, V293, P596, DOI 10.1001/jama.293.5.596; Straus SMJM, 2004, ARCH INTERN MED, V164, P1293, DOI 10.1001/archinte.164.12.1293; Straus SMJM, 2005, EUR HEART J, V26, P2007, DOI 10.1093/eurheartj/ehi312; Suh GH, 2005, INT PSYCHOGERIATR, V17, P429, DOI 10.1017/S1041610205002243; THAPA PB, 1994, J AM GERIATR SOC, V42, P280, DOI 10.1111/j.1532-5415.1994.tb01752.x; Tiihonen J, 2006, BRIT MED J, V333, P224, DOI 10.1136/bmj.38881.382755.2F; TRIFIRO G, 2006, PHARMACOEPIDEMIOL DR; Tschanz JT, 2004, NEUROLOGY, V62, P1156, DOI 10.1212/01.WNL.0000118210.12660.C2; *US FDA, T0513 US FDA; van Reekum R, 2002, INT PSYCHOGERIATR, V14, P197, DOI 10.1017/S1041610202008396; Vickrey BG, 2006, ANN INTERN MED, V145, P713, DOI 10.7326/0003-4819-145-10-200611210-00004; Wang PS, 2005, NEW ENGL J MED, V353, P2335, DOI 10.1056/NEJMoa052827; Warner J, 2004, LANCET, V363, P674, DOI 10.1016/S0140-6736(04)15664-X; Zornberg GL, 2000, LANCET, V356, P1219, DOI 10.1016/S0140-6736(00)02784-7	67	410	417	0	52	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 5	2007	146	11					775	786		10.7326/0003-4819-146-11-200706050-00006	http://dx.doi.org/10.7326/0003-4819-146-11-200706050-00006			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	175HR	17548409	Green Published			2022-12-28	WOS:000247005200003
J	Erbel, R; Di Mario, C; Bartunek, J; Bonnier, J; de Bruyne, B; Eberli, FR; Erne, P; Haude, M; Heublein, B; Horrigan, M; Ilsley, C; Bose, D; Koolen, J; Luscher, TF; Weissman, N; Waksman, R				Erbel, Raimund; Di Mario, Carlo; Bartunek, Jozef; Bonnier, Johann; de Bruyne, Bernard; Eberli, Franz R.; Erne, Paul; Haude, Michael; Heublein, Bernd; Horrigan, Mark; Ilsley, Charles; Boese, Dirk; Koolen, Jacques; Luescher, Thomas F.; Weissman, Neil; Waksman, Ron		PROGRESS-AMS Investigators	Temporary scaffolding of coronary arteries with bioabsorbable magnesium stents: a prospective, non-randomised multicentre trial	LANCET			English	Article							SIROLIMUS-ELUTING STENTS; BALLOON ANGIOPLASTY; INTRAVASCULAR ULTRASOUND; EUROPEAN-SOCIETY; METAL STENTS; TASK-FORCE; RESTENOSIS; IMPLANTATION; INTERVENTIONS; CARDIOLOGY	Background Coronary stents improve immediate and late results of balloon angioplasty by tacking up dissections and preventing wall recoil. These goals are achieved within weeks after angioplasty, but with current technology stents permanently remain in the artery, with many limitations including the need for long-term antiplatelet treatment to avoid thrombosis. We report a prospective multicentre clinical trial of coronary implantations of absorbable magnesium stents. Methods We enrolled 63 patients (44 men; mean age 61.3 [SD 9.5 years]) in eight centres with single de novo lesions in a native coronary artery in a multicentre, non-randomised prospective study. Follow-up included coronary angiography and intravascular ultrasound at 4 months and clinical assessment at 6 months and 12 months. The primary endpoint was cardiac death, non-fatal myocardial infarction, or clinically driven target lesion revascularisation at 4 months Findings 71 stents, 10-15 mm in length and 3.0-3.5 mm in diameter, were successfully implanted after pre-dilatation in 63 patients. Diameter stenosis was reduced from 61.5 (SD 13.1%) to 12.6 (5.6%) with an acute gain of 1.41 mm (0.46 mm) and in-stent late loss of 1.08 mm (0.49 mm). The ischaemia-driven target lesion revascularisation rate was 23.8% after 4 months, and the overall target lesion revascularisation rate was 45% after 1 year. No myocardial infarction, subacute or late thrombosis, or death occurred. Angiography at 4 months showed an increased diameter stenosis of 48.4 (17. 0%). After serial intravascular ultrasound examinations, only small remnants of the original struts were visible, well embedded into the intima. Neointimal growth and negative remodelling were the main operating mechanisms of restenosis. Interpretation This study shows that biodegradable magnesium stents can achieve an immediate angiographic result similar to the result of other metal stents and can be safely degraded after 4 months. Modifications of stent characteristics with prolonged degradation and drug elution are currently in development.	Univ Duisburg Essen, W German Heart Ctr, Dept Cardiol, D-45122 Essen, Germany; Royal Brompton Hosp, London SW3 6LY, England; Harefield Hosp, London, England; Univ London Imperial Coll Sci Technol & Med, London, England; Catharina Hosp, Dept Cardiol, Eindhoven, Netherlands; Onze Lieve Vrouw Hosp, Ctr Cardiovasc, Aalst, Belgium; Univ Zurich Hosp, Dept Cardiol, CH-8091 Zurich, Switzerland; Kantonal Hosp, Dept Cardiol, Luzern, Switzerland; Hannover Med Sch, Leibniz Lab Biotechnol & Artificial Organs, D-3000 Hannover, Germany; Austin & Repatriat Med Ctr, Dept Cardiol, Melbourne, Vic, Australia; Washington Hosp Ctr, Washington, DC 20010 USA	University of Duisburg Essen; Royal Brompton Hospital; Royal Brompton & Harefield NHS Foundation Trust; Harefield Hospital; Imperial College London; Catharina Hospital; Cardiovascular Center Aalst; University of Zurich; University Zurich Hospital; Lucerne Cantonal Hospital; Hannover Medical School; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; MedStar Washington Hospital Center	Erbel, R (corresponding author), Univ Duisburg Essen, W German Heart Ctr, Dept Cardiol, Hufelandstr 55, D-45122 Essen, Germany.	erbel@uk-essen.de	Di Mario, Carlo/K-5185-2018	Di Mario, Carlo/0000-0002-4461-2055				Cheneau E, 2005, AM J CARDIOL, V95, P1240, DOI 10.1016/j.amjcard.2005.01.056; Colombo A, 1996, J AM COLL CARDIOL, V28, P830, DOI 10.1016/S0735-1097(96)00266-5; Di Mario Carlo, 2004, J Interv Cardiol, V17, P391, DOI 10.1111/j.1540-8183.2004.04081.x; Eggebrecht H, 2005, CIRCULATION, V112, pE303, DOI 10.1161/CIRCULATIONAHA.104.521641; Erbel R, 1998, NEW ENGL J MED, V339, P1672, DOI 10.1056/NEJM199812033392304; Fajadet J, 2005, CIRCULATION, V111, P1040, DOI 10.1161/01.CIR.0000156334.24955.B2; Gershlick A, 2004, CIRCULATION, V109, P487, DOI 10.1161/01.CIR.0000109694.58299.A0; Grube E, 2003, CIRCULATION, V107, P38, DOI 10.1161/01.CIR.0000047700.58683.A1; Haude M, 2000, Am Heart J, V140, pe26; Heublein B, 2003, HEART, V89, P651, DOI 10.1136/heart.89.6.651; Hofma SH, 2006, EUR HEART J, V27, P166, DOI 10.1093/eurheartj/ehi571; Joner M, 2006, J AM COLL CARDIOL, V48, P193, DOI 10.1016/j.jacc.2006.03.042; Lind A Y, 2005, Heart, V91, P1604, DOI 10.1136/hrt.2005.064113; Mauri L, 2005, CIRCULATION, V111, P3435, DOI 10.1161/CIRCULATIONAHA.104.513952; Mintz GS, 2001, J AM COLL CARDIOL, V37, P1478, DOI 10.1016/S0735-1097(01)01175-5; Morice M, 2002, NEW ENGL J MED, V346, P1773, DOI 10.1056/NEJMoa012843; MORICE MC, 1995, CATHETER CARDIO DIAG, V35, P1, DOI 10.1002/ccd.1810350102; Moses JW, 2003, NEW ENGL J MED, V349, P1315, DOI 10.1056/NEJMoa035071; Nebeker JR, 2006, J AM COLL CARDIOL, V47, P175, DOI 10.1016/j.jacc.2005.07.071; Nordmann AJ, 2006, EUR HEART J, V27, P2784, DOI 10.1093/eurheartj/ehl282; Peeters P, 2005, J ENDOVASC THER, V12, P1, DOI 10.1583/04-1349R.1; Savage MP, 2002, CLIN CARDIOL, V25, P213, DOI 10.1002/clc.4950250504; Savage MP, 1997, NEW ENGL J MED, V337, P740, DOI 10.1056/NEJM199709113371103; SCHATZ RA, 1991, CIRCULATION, V83, P148, DOI 10.1161/01.CIR.83.1.148; SERRUYS PW, 1994, NEW ENGL J MED, V331, P489, DOI 10.1056/NEJM199408253310801; SIGWART U, 1987, NEW ENGL J MED, V316, P701, DOI 10.1056/NEJM198703193161201; Silber S, 2005, EUR HEART J, V26, P804, DOI 10.1093/eurheartj/ehi138; Tamai H, 2000, CIRCULATION, V102, P399; TANIMOTO S, 2006, AM J C S1, V98, P306; Togni M, 2005, J AM COLL CARDIOL, V46, P231, DOI 10.1016/j.jacc.2005.01.062; Tung R, 2006, ANN INTERN MED, V144, P913, DOI 10.7326/0003-4819-144-12-200606200-00009; Waksman R, 2006, CATHETER CARDIO INTE, V68, P607, DOI 10.1002/ccd.20727	32	659	740	12	195	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 2	2007	369	9576					1869	1875		10.1016/S0140-6736(07)60853-8	http://dx.doi.org/10.1016/S0140-6736(07)60853-8			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	173ZS	17544767				2022-12-28	WOS:000246911600030
J	Lauria, G; Lombardi, R				Lauria, Giuseppe; Lombardi, Raffaella			Recent advances - Skin biopsy: a new tool for diagnosing peripheral neuropathy	BRITISH MEDICAL JOURNAL			English	Article							EPIDERMAL NERVE-FIBERS; PAINFUL NEUROPATHIES; AXONAL SWELLINGS; ROSS-SYNDROME; ERYTHROPOIETIN; DEGENERATION; DENERVATION; CAPSAICIN; DENSITY		Natl Neurol Inst Carlo Besta, Neuromuscular Dis Unit, I-20133 Milan, Italy	IRCCS Istituto Neurologico Besta	Lauria, G (corresponding author), Natl Neurol Inst Carlo Besta, Neuromuscular Dis Unit, I-20133 Milan, Italy.	glauria@istituto-besta.it	Lombardi, Raffaella/K-7951-2016; lauria, giuseppe/AAN-5371-2020; Lauria, Giuseppe/T-1378-2017	Lombardi, Raffaella/0000-0003-0080-6699; lauria, giuseppe/0000-0001-9773-020X; Lauria, Giuseppe/0000-0001-9773-020X				Beghi E, 1998, J CLIN EPIDEMIOL, V51, P697, DOI 10.1016/S0895-4356(98)00039-0; Bianchi R, 2006, CLIN CANCER RES, V12, P2607, DOI 10.1158/1078-0432.CCR-05-2177; Bianchi R, 2004, P NATL ACAD SCI USA, V101, P823, DOI 10.1073/pnas.0307823100; Hahn K, 2006, J PERIPHER NERV SYST, V11, P142, DOI 10.1111/j.1085-9489.2006.00079.x; Herrmann DN, 2004, MUSCLE NERVE, V29, P420, DOI 10.1002/mus.10567; Herrmann DN, 1999, NEUROLOGY, V53, P1634, DOI 10.1212/WNL.53.8.1634; Holland NR, 1998, ANN NEUROL, V44, P47, DOI 10.1002/ana.410440111; Lauria G, 2003, NEUROLOGY, V61, P631, DOI 10.1212/01.WNL.0000070781.92512.A4; LAURIA G, 2005, EUR J NEUROL, V12, P1; Lauria G, 2006, J PERIPHER NERV SYST, V11, P262, DOI 10.1111/j.1529-8027.2006.0097.x; Lee JE, 2005, ARCH NEUROL-CHICAGO, V62, P1570, DOI 10.1001/archneur.62.10.1570; Li J, 2005, BRAIN, V128, P1168, DOI 10.1093/brain/awh483; Perretti A, 2003, CLIN NEUROPHYSIOL, V114, P7, DOI 10.1016/S1388-2457(02)00323-1; Polydefkis M, 2004, BRAIN, V127, P1606, DOI 10.1093/brain/awh175; Sabet A, 2006, NEUROLOGY, V67, P1141, DOI 10.1212/01.wnl.0000238499.37764.b1; Sghirlanzoni A, 2005, LANCET NEUROL, V4, P349, DOI 10.1016/S1474-4422(05)70096-X; Shun CT, 2004, BRAIN, V127, P1593, DOI 10.1093/brain/awh180; Shy ME, 2003, NEUROLOGY, V60, P898, DOI 10.1212/01.WNL.0000058546.16985.11; Simone DA, 1998, J NEUROSCI, V18, P8947; Sommer C, 2002, ANN NEUROL, V52, P247, DOI 10.1002/ana.10256; Sumner CJ, 2003, NEUROLOGY, V60, P108, DOI 10.1212/WNL.60.1.108; Toth C, 2006, DIABETOLOGIA, V49, P1081, DOI 10.1007/s00125-006-0169-8	22	68	69	1	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUN 2	2007	334	7604					1159	1162		10.1136/bmj.39192.488125.BE	http://dx.doi.org/10.1136/bmj.39192.488125.BE			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	177ES	17540945	Green Published			2022-12-28	WOS:000247137000035
J	Bishop, NA; Guarente, L				Bishop, Nicholas A.; Guarente, Leonard			Two neurons mediate diet-restriction-induced longevity in C-elegans	NATURE			English	Article							LIFE-SPAN; CAENORHABDITIS-ELEGANS; CHEMOSENSORY NEURONS; CALORIC RESTRICTION; LARVAL DEVELOPMENT; OXIDATIVE STRESS; METABOLIC-RATE; GENETICS; INTERFERENCE; SPECIFY	Dietary restriction extends lifespan and retards age-related disease in many species and profoundly alters endocrine function in mammals. However, no causal role of any hormonal signal in diet-restricted longevity has been demonstrated. Here we show that increased longevity of diet-restricted Caenorhabditis elegans requires the transcription factor gene skn-1 acting in the ASIs, a pair of neurons in the head. Dietary restriction activates skn-1 in these two neurons, which signals peripheral tissues to increase metabolic activity. These findings demonstrate that increased lifespan in a diet-restricted metazoan depends on cell non-autonomous signalling from central neuronal cells to non-neuronal body tissues, and suggest that the ASI neurons mediate diet-restriction-induced longevity by an endocrine mechanism.	MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Guarente, L (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	leng@mit.edu						Alcedo J, 2004, NEURON, V41, P45, DOI 10.1016/S0896-6273(03)00816-X; An JH, 2003, GENE DEV, V17, P1882, DOI 10.1101/gad.1107803; Apfeld J, 1999, NATURE, V402, P804, DOI 10.1038/45544; AVERY L, 1989, NEURON, V3, P473, DOI 10.1016/0896-6273(89)90206-7; BARGMANN CI, 1991, NEURON, V7, P729, DOI 10.1016/0896-6273(91)90276-6; BARGMANN CI, 1991, SCIENCE, V251, P1243, DOI 10.1126/science.2006412; Bartke A, 2001, NATURE, V414, P412, DOI 10.1038/35106646; BOWERMAN B, 1992, CELL, V68, P1061, DOI 10.1016/0092-8674(92)90078-Q; Braeckman BP, 2002, AGING CELL, V1, P82, DOI 10.1046/j.1474-9728.2002.00021.x; BRENNER S, 1974, GENETICS, V77, P71; de Cabo R, 2003, EXP GERONTOL, V38, P631, DOI 10.1016/S0531-5565(03)00055-X; Dowell P, 2005, ANNU REV BIOCHEM, V74, P515, DOI 10.1146/annurev.biochem.73.011303.074027; Golden TR, 2002, AGING CELL, V1, P117, DOI 10.1046/j.1474-9728.2002.00015.x; Houthoofd K, 2003, EXP GERONTOL, V38, P947, DOI 10.1016/S0531-5565(03)00161-X; Houthoofd K, 2002, EXP GERONTOL, V37, P1359, DOI 10.1016/S0531-5565(02)00172-9; Houthoofd K, 2002, EXP GERONTOL, V37, P1371, DOI 10.1016/S0531-5565(02)00173-0; Jansen G, 1999, NAT GENET, V21, P414, DOI 10.1038/7753; Jin Y., 1999, C ELEGANS PRACTICAL, P69; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Kim K, 2005, DEV BIOL, V286, P136, DOI 10.1016/j.ydbio.2005.07.024; Koubova J, 2003, GENE DEV, V17, P313, DOI 10.1101/gad.1052903; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; Lawless J.F, 1982, STAT MODELS METHODS; Li C, 2005, PARASITOLOGY, V131, pS109, DOI 10.1017/S0031182005009376; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Mobbs CV, 2001, J GERONTOL A-BIOL, V56, P34, DOI 10.1093/gerona/56.suppl_1.34; Peckol EL, 1999, DEVELOPMENT, V126, P1891; Ren PF, 1996, SCIENCE, V274, P1389, DOI 10.1126/science.274.5291.1389; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Walker G, 2005, MECH AGEING DEV, V126, P929, DOI 10.1016/j.mad.2005.03.014; Wang D, 2005, NATURE, V436, P593, DOI 10.1038/nature04010; Wilson MA, 2006, AGING CELL, V5, P59, DOI 10.1111/j.1474-9726.2006.00192.x; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100	37	483	507	1	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 31	2007	447	7144					545	+		10.1038/nature05904	http://dx.doi.org/10.1038/nature05904			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172YZ	17538612				2022-12-28	WOS:000246842000038
J	Germanos, S; Gourgiotis, S; Kocher, HM				Germanos, Stylianos; Gourgiotis, Stavros; Kocher, Hemant M.			Clinical update: early surgery for acute cholecystitis	LANCET			English	Article							DELAYED LAPAROSCOPIC CHOLECYSTECTOMY; SURGICAL-MANAGEMENT; IMPACT		Leighton Hosp, Leighton, Cheshire, England; Royal London Hosp, Barts & London HPB Ctr, London E1 1BB, England	Barts Health NHS Trust; Royal London Hospital	Kocher, HM (corresponding author), Leighton Hosp, Leighton, Cheshire, England.	hemant.kocher@cancer.org.uk	Gourgiotis, Stavros/AAD-8696-2019	Gourgiotis, Stavros/0000-0002-7923-6395; Kocher, Hemant M/0000-0001-6771-1905; Germanos, Stylianos/0000-0002-1640-1226				Askew J, 2005, ANZ J SURG, V75, P1086, DOI 10.1111/j.1445-2197.2005.03617.x; BATES T, 1992, GUT, V33, P103, DOI 10.1136/gut.33.1.103; Bhattacharya Debashis, 2002, J Hepatobiliary Pancreat Surg, V9, P538, DOI 10.1007/s005340200070; Cameron IC, 2004, POSTGRAD MED J, V80, P292, DOI 10.1136/pgmj.2002.004085; Giger U, 2005, LANGENBECK ARCH SURG, V390, P373, DOI 10.1007/s00423-004-0509-4; Greenwald JA, 2000, ANN SURG, V231, P339, DOI 10.1097/00000658-200003000-00006; Gurusamy KS, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005440.pub2; *HESONLINE, PRIM DIAGN MAIN OP 4; Kolla SB, 2004, SURG ENDOSC, V18, P1323, DOI 10.1007/s00464-003-9230-6; Lai PBS, 1998, BRIT J SURG, V85, P764; Lo CM, 1998, ANN SURG, V227, P461, DOI 10.1097/00000658-199804000-00001; Papi C, 2004, AM J GASTROENTEROL, V99, P147, DOI 10.1046/j.1572-0241.2003.04002.x; Peng WK, 2005, BRIT J SURG, V92, P586, DOI 10.1002/bjs.4831; Schirmer Bruce D, 2005, J Long Term Eff Med Implants, V15, P329, DOI 10.1615/JLongTermEffMedImplants.v15.i3.90; Sekimoto M, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-40; Senapati PSP, 2003, ANN ROY COLL SURG, V85, P306, DOI 10.1308/003588403769162404; Somasekar K, 2002, POSTGRAD MED J, V78, P668, DOI 10.1136/pmj.78.925.668; Vecchio R, 1998, INT SURG, V83, P215; WILSON P, 1991, LANCET, V338, P795, DOI 10.1016/0140-6736(91)90674-E; Yamashita Y, 2006, J HEPATO-BILIARY-PAN, V13, P409, DOI 10.1007/s00534-005-1088-7	20	20	21	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 26	2007	369	9575					1774	1776		10.1016/S0140-6736(07)60796-X	http://dx.doi.org/10.1016/S0140-6736(07)60796-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	172QP	17531872				2022-12-28	WOS:000246819300010
J	Hayee, B; Forgacs, I				Hayee, Bu'Hussain; Forgacs, Ian			Psychological approach to managing irritable bowel syndrome	BMJ-BRITISH MEDICAL JOURNAL			English	Review							FUNCTIONAL GASTROINTESTINAL DISORDERS; COGNITIVE-BEHAVIOR THERAPY; METAANALYSIS; ANTIDEPRESSANTS; HYPNOTHERAPY; MEDICATIONS; DEPRESSION; MANAGEMENT		Kings Coll Hosp London, Dept Gastroenterol, London SE5 9RS, England	King's College Hospital NHS Foundation Trust; King's College Hospital	Forgacs, I (corresponding author), Kings Coll Hosp London, Dept Gastroenterol, Denmark Hill, London SE5 9RS, England.	ian.forgacs@kcl.ac.uk		Hayee, Bu'Hussain/0000-0003-1670-8815				BERGERON CM, 1985, AM J GASTROENTEROL, V80, P448; Creed F, 2006, GUT, V55, P1065, DOI 10.1136/gut.2005.086348; CREED F, 1994, BRIT MED J, V309, P1647, DOI 10.1136/bmj.309.6969.1647; DeRubeis RJ, 2005, ARCH GEN PSYCHIAT, V62, P409, DOI 10.1001/archpsyc.62.4.409; Furukawa TA, 2002, BMJ-BRIT MED J, V325, P991, DOI 10.1136/bmj.325.7371.991; Herschbach P, 1999, PSYCHOSOM MED, V61, P148, DOI 10.1097/00006842-199903000-00005; Heymann-Monnikes I, 2000, AM J GASTROENTEROL, V95, P981; Hutton J, 2005, EUR J GASTROEN HEPAT, V17, P11, DOI 10.1097/00042737-200501000-00003; Jackson JL, 2000, AM J MED, V108, P65, DOI 10.1016/S0002-9343(99)00299-5; JONES J, 2000, BRIT SOC GASTROENTER; Jones R, 2006, ALIMENT PHARM THER, V24, P879, DOI 10.1111/j.1365-2036.2006.03044.x; Kennedy T, 2005, BRIT MED J, V331, P435, DOI 10.1136/bmj.38545.505764.06; Lackner JA, 2004, J CONSULT CLIN PSYCH, V72, P1100, DOI 10.1037/0022-006X.72.6.1100; Lea R, 2004, Minerva Med, V95, P443; Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061; Olden KW, 2005, CNS SPECTRUMS, V10, P891, DOI 10.1017/S1092852900019866; Parry S, 2005, EUR J GASTROEN HEPAT, V17, P5, DOI 10.1097/00042737-200501000-00002; *ROYAL COL PSYCH, COGN BEH THER; RUMSEY N, 1991, CONFIDENT MANAGEMENT, P33; St John of God Health Care, 2019, OUR VIS; Tack J, 2006, GUT, V55, P1095, DOI 10.1136/gut.2005.077503; Talley NJ, 2006, GUT, V55, P1694, DOI 10.1136/gut.2006.108837; Toner BB, 2005, CNS SPECTRUMS, V10, P883, DOI 10.1017/S1092852900019854; Whorwell PJ, 2006, INT J CLIN EXP HYP, V54, P21, DOI 10.1080/00207140500323006; Whorwell PJ, 2005, ALIMENT PHARM THER, V22, P1061, DOI 10.1111/j.1365-2036.2005.02697.x; Wilhelmsen I, 2000, GUT, V47, P73; Wilson S, 2006, ALIMENT PHARM THER, V24, P769, DOI 10.1111/j.1365-2036.2006.03028.x	27	26	28	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 26	2007	334	7603					1105	1109		10.1136/bmj.39199.679236.AE	http://dx.doi.org/10.1136/bmj.39199.679236.AE			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	174XB	17525453	Green Published			2022-12-28	WOS:000246975000035
J	Lord, GM; Trembath, RC				Lord, Graham M.; Trembath, Richard C.			A strategy for translation	LANCET			English	Editorial Material							CLINICAL-RESEARCH; NIH ROADMAP; MEDICINE		Guys & St Thomas Hosp NHS Fdn Trust, NIHR Comprehens Biomed Res Ctr, London SE1 9RT, England; Kings Coll London, London SE1 9RT, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Lord, GM (corresponding author), Guys & St Thomas Hosp NHS Fdn Trust, NIHR Comprehens Biomed Res Ctr, London SE1 9RT, England.	graham.lord@kcl.ac.uk	Abraham, Sabu/E-1144-2019; Lord, Graham M/B-3797-2011	Abraham, Sabu/0000-0002-0916-5827; Lord, Graham/0000-0003-2069-4743; Trembath, Richard/0000-0003-0550-3400	MRC [G108/380] Funding Source: UKRI; Medical Research Council [G108/380] Funding Source: Medline; Medical Research Council [G0400503B] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Cooksey D., 2006, REV UK HLTH RES FUND; Crowley W, 2006, J CLIN INVEST, V116, P2058, DOI 10.1172/JCI29557; *DEP HLTH, 2006, NHS CONTR HLTH RES E; Kaiser J, 2006, SCIENCE, V314, P237; Littman BH, 2007, CLIN SCI, V112, P217, DOI 10.1042/CS20060108; *NAT I HLTH RES, BIOM RES CTR; Stewart PM, 2002, BRIT MED J, V324, P437, DOI 10.1136/bmj.324.7335.437; Suntharalingam G, 2006, NEW ENGL J MED, V355, P1018, DOI 10.1056/NEJMoa063842; *UK GOV, 2006, PM SEEKS PREM LEAG M; Zerhouni EA, 2005, JAMA-J AM MED ASSOC, V294, P1352, DOI 10.1001/jama.294.11.1352; Zerhouni EA, 2006, J INVEST MED, V54, P171, DOI 10.2310/6650.2006.X0016; 2006, LANCET, V368, P2105	12	6	6	1	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 26	2007	369	9575					1771	1773		10.1016/S0140-6736(07)60794-6	http://dx.doi.org/10.1016/S0140-6736(07)60794-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	172QP	17531870				2022-12-28	WOS:000246819300008
J	Elf, J; Li, GW; Xie, XS				Elf, Johan; Li, Gene-Wei; Xie, X. Sunney			Probing transcription factor dynamics at the single-molecule level in a living cell	SCIENCE			English	Article							COLI-LAC REPRESSOR; DIFFUSION-DRIVEN MECHANISMS; ESCHERICHIA-COLI; PROTEIN TRANSLOCATION; NUCLEIC-ACIDS; OPERATOR INTERACTION; GENE-EXPRESSION; DNA; BINDING; TIME	Transcription factors regulate gene expression through their binding to DNA. In a living Escherichia coli cell, we directly observed specific binding of a lac repressor, labeled with a fluorescent protein, to a chromosomal lac operator. Using single-molecule detection techniques, we measured the kinetics of binding and dissociation of the repressor in response to metabolic signals. Furthermore, we characterized the nonspecific binding to DNA, one-dimensional (1D) diffusion along DNA segments, and 3D translocation among segments through cytoplasm at the single-molecule level. In searching for the operator, a lac repressor spends similar to 90% of time nonspecifically bound to and diffusing along DNA with a residence time of < 5 milliseconds. The methods and findings can be generalized to other nucleic acid binding proteins.	Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA; Harvard Univ, Dept Phys, Cambridge, MA 02138 USA	Harvard University; Harvard University	Xie, XS (corresponding author), Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA.	xie@chemistry.harvard.edu	Li, Gene-Wei/E-7657-2010	Li, Gene-Wei/0000-0001-7036-8511; elf, johan/0000-0001-5522-1810	NIH HHS [DP1 OD000277, DP1 OD000277-02] Funding Source: Medline; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000277] Funding Source: NIH RePORTER	NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Bates D, 2005, CELL, V121, P899, DOI 10.1016/j.cell.2005.04.013; BERG OG, 1981, BIOCHEMISTRY-US, V20, P6929, DOI 10.1021/bi00527a028; BERG OG, 1976, BIOPHYS CHEM, V4, P367, DOI 10.1016/0301-4622(76)80017-8; Blainey PC, 2006, P NATL ACAD SCI USA, V103, P5752, DOI 10.1073/pnas.0509723103; DUNAWAY M, 1980, J BIOL CHEM, V255, P115; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; FIECK A, 1992, NUCLEIC ACIDS RES, V20, P1785, DOI 10.1093/nar/20.7.1785; GILBERT W, 1966, P NATL ACAD SCI USA, V56, P1891, DOI 10.1073/pnas.56.6.1891; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; Golding I, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.098102; JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7; KAOHUANG Y, 1977, P NATL ACAD SCI USA, V74, P4228, DOI 10.1073/pnas.74.10.4228; Kepes A, 1969, Prog Biophys Mol Biol, V19, P199, DOI 10.1016/0079-6107(69)90006-6; Le TT, 2005, P NATL ACAD SCI USA, V102, P9160, DOI 10.1073/pnas.0503311102; Lewis M, 2005, CR BIOL, V328, P521, DOI 10.1016/j.crvi.2005.04.004; Lewis M, 1996, SCIENCE, V271, P1247, DOI 10.1126/science.271.5253.1247; Mller-Hill B., 1996, LAC OPERON; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; OEHLER S, 1994, EMBO J, V13, P3348, DOI 10.1002/j.1460-2075.1994.tb06637.x; OEHLER S, 1990, EMBO J, V9, P973, DOI 10.1002/j.1460-2075.1990.tb08199.x; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; VONHIPPEL PH, 1989, J BIOL CHEM, V264, P675; WANG AC, 1977, NUCLEIC ACIDS RES, V4, P1579, DOI 10.1093/nar/4.5.1579; WINTER RB, 1981, BIOCHEMISTRY-US, V20, P6961, DOI 10.1021/bi00527a030; WINTER RB, 1981, BIOCHEMISTRY-US, V20, P6948, DOI 10.1021/bi00527a029; Yao J, 2006, NATURE, V442, P1050, DOI 10.1038/nature05025; Yu J, 2006, SCIENCE, V311, P1600, DOI 10.1126/science.1119623	29	779	792	2	184	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 25	2007	316	5828					1191	1194		10.1126/science.1141967	http://dx.doi.org/10.1126/science.1141967			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171GQ	17525339	Green Accepted			2022-12-28	WOS:000246724300043
J	Elmegreen, BG				Elmegreen, Bruce G.			Dark matter in galactic collisional debris	SCIENCE			English	Editorial Material							MILKY-WAY; GALAXY; MASS; DISK; GAS		IBM Corp, Div Res, Thomas J Watson Res Ctr, Yorktown Hts, NY 10598 USA	International Business Machines (IBM)	Elmegreen, BG (corresponding author), IBM Corp, Div Res, Thomas J Watson Res Ctr, Yorktown Hts, NY 10598 USA.	bge@us.ibm.com						Bienayme O, 1999, ASTRON ASTROPHYS, V341, P86; Bournaud F, 2007, SCIENCE, V316, P1166, DOI 10.1126/science.1142114; Creze M, 1998, ASTRON ASTROPHYS, V329, P920; ELMEGREEN BG, 1996, NEW EXTRAGALCTIC PER, P468; Hibbard JE, 2001, ASTRON J, V122, P2969, DOI 10.1086/324102; Higdon SJ, 2006, ASTROPHYS J, V640, P768, DOI 10.1086/500254; Kalberla PMW, 2003, ASTROPHYS J, V588, P805, DOI 10.1086/374330; KUIJKEN K, 1989, MON NOT R ASTRON SOC, V239, P651, DOI 10.1093/mnras/239.2.651; LEQUEUX J, 1993, ASTRON ASTROPHYS, V280, pL23; PFENNIGER D, 1994, ASTRON ASTROPHYS, V285, P79; Sodroski TJ, 1997, ASTROPHYS J, V480, P173, DOI 10.1086/303961; ZWICKY F, 1956, ERG EXAKT NATURWISS, V29, P344, DOI 10.1007/BFb0118841	13	7	7	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2007	316	5828					1132	1133		10.1126/science.1143506	http://dx.doi.org/10.1126/science.1143506			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	171GQ	17525323				2022-12-28	WOS:000246724300024
J	Mattaj, IW; Tocchini-Valentini, GP				Mattaj, Iain W.; Tocchini-Valentini, Glauco P.			Laying solid foundations for Europe	NATURE			English	Editorial Material									European Mol Biol Lab, D-69117 Heidelberg, Germany; CNR, CNR, I-00015 Monterotondo, Italy	European Molecular Biology Laboratory (EMBL); Consiglio Nazionale delle Ricerche (CNR)	Mattaj, IW (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.			Mattaj, Iain/0000-0002-5537-8284					0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 24	2007	447	7143					377	378		10.1038/447377a	http://dx.doi.org/10.1038/447377a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	170VA	17522655				2022-12-28	WOS:000246693100019
J	Gray, RH; Makumbi, F; Serwadda, D; Lutalo, T; Nalugoda, F; Opendi, P; Kigozi, G; Reynolds, SJ; Sewankambo, NK; Wawer, MJ				Gray, Ronald H.; Makumbi, Fredrick; Serwadda, David; Lutalo, Tom; Nalugoda, Fred; Opendi, Pius; Kigozi, Godfrey; Reynolds, Steven J.; Sewankambo, Nelson K.; Wawer, Maria J.			Limitations of rapid HIV-1 tests during screening for trials in Uganda: diagnostic test accuracy study	BRITISH MEDICAL JOURNAL			English	Article								Objective To evaluate the limitations of rapid tests for HIV-1. Design Diagnostic test accuracy study. Setting Rural Rakai, Uganda. Participants 1517 mates aged 15-49 screened for trials of circumcision for HIV prevention. Main outcome measures Sensitivity, specificity, negative predictive values, and positive predictive values of an algorithm using three rapid tests for HIV, compared with the results of enzyme immunoassay and western blotting as the optimal methods. Results Rapid test results were evaluated by enzyme immunoassay and western blotting. Sensitivity was 97.7%. Among 639 samples where the strength of positive bands was coded if the sample showed positivity for HIV, the algorithm had low specificity (94.1%) and a low positive predictive value (74.0%). Exclusion of 37 samples (5.8%) with a weak positive band improved the specificity (99.6%) and positive predictive value (97.7%.). Conclusion Weak positive bands on rapid tests for HIV should be confirmed by enzyme immunoassay and western blotting before disclosing the diagnosis. Programmes using rapid tests routinely should use standard serological assays for quality control.	Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA; Uganda Virus Res Inst, Rakai Hlth Sci Program, Entebbe, Uganda; Makerere Univ, Inst Publ Hlth, Kampala, Uganda; NIH, NIAID, Entebbe, Uganda; Makerere Univ, Sch Med, Kampala, Uganda	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Columbia University; Rakai Health Sciences Program; Uganda Virus Research Institute; Makerere University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Makerere University	Gray, RH (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA.	rgray@jhsph.edu		Sewankambo, Nelson/0000-0001-9362-053X; Reynolds, Steven/0000-0002-5403-2759	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000361, Z01AI001040] Funding Source: NIH RePORTER; FIC NIH HHS [2D43TW00001019-AITRP] Funding Source: Medline; NIAID NIH HHS [UO1 AI11171-01-02] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		De Cock KM, 2006, NEW ENGL J MED, V354, P440, DOI 10.1056/NEJMp058327; Downing RG, 1998, J ACQ IMMUN DEF SYND, V18, P384, DOI 10.1097/00042560-199808010-00011; Kassler WJ, 1998, INT J STD AIDS, V9, P134, DOI 10.1258/0956462981921882; McKenna SL, 1997, AIDS, V11, pS103; Wright AA, 2006, NEW ENGL J MED, V354, P437, DOI 10.1056/NEJMp058302	5	89	92	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUL 28	2007	335	7612					188	190		10.1136/bmj.39210.582801.BE	http://dx.doi.org/10.1136/bmj.39210.582801.BE			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	198YA	17545184	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000248662200029
J	Horwitz, LI; Kosiborod, M; Lin, ZQ; Krumholz, HM				Horwitz, Leora I.; Kosiborod, Mikhail; Lin, Zhenqiu; Krumholz, Harlan M.			Changes in outcomes for internal medicine inpatients after work-hour regulations	ANNALS OF INTERNAL MEDICINE			English	Article							COMMUNICATION FAILURES; PATIENT-CARE; RESIDENTS; QUALITY; STAFF; REDUCTION; EVENTS; IMPACT	Background: Limits on resident work hours are intended to reduce fatigue-related errors, but may raise risk by increasing transfers of responsibility for patients. Objective: To examine changes in outcomes for internal medicine patients after the implementation of work-hour regulations. Design: Retrospective cohort study. Setting: Urban, academic medical center. Patients: 14 260 consecutive patients discharged from the teaching (housestaff) service and 6664 consecutive patients discharged from the nonteaching (hospitalist) service between 1 July 2002 and 30 June 2004. Measurements: Outcomes included intensive care unit utilization, length of stay, discharge disposition, 30-day readmission rate to the study institution, pharmacist interventions to prevent error, drug-drug interactions and in-hospital death. Results: The teaching service had net improvements in 3 outcomes. Relative to changes experienced by the nonteaching service, the rate of intensive care unit utilization decreased by 2.1% (95% Cl, -3.3% to -0.7%; P = 0.002), the rate of discharge to home or rehabilitation facility versus elsewhere improved by 5.3% (Cl, 2.6% to 7.6%; P < 0.001), and pharmacist interventions to prevent error were reduced by 1.92 interventions per 100 patient-days (Cl, -2.74 to -1.03 interventions per 100 patient-days; P < 0.001). Teaching and nonteaching services had similar changes over time in length of stay, 30-day readmission rate, and adverse drug-drug interactions. In-hospital death was uncommon in both groups, and change over time was similar in the 2 groups. Limitations: The study was a retrospective, nonrandomized design that assessed a limited number of outcomes. Teaching and nonteaching cohorts may not have been affected similarly by secular trends in patient care. Conclusions: After the implementation of work-hour regulations, 3 of 7 outcomes improved for patients in the teaching service relative to those in the nonteaching service. The authors found no evidence of adverse unintended consequences after the institution of work-hour regulations.	Yale Univ, Sch Med, Sect Gen Internal Med, New Haven, CT 06520 USA; Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA; Univ Missouri, Kansas City, MO 64110 USA; Mid Amer Heart Inst, Kansas City, MO USA	Yale University; Yale University; University of Missouri System; University of Missouri Kansas City; Saint Luke's Mid America Heart Institute	Horwitz, LI (corresponding author), Yale Univ, Sch Med, Sect Gen Internal Med, IE-61 SHM,333 Cedar St,POB 208088, New Haven, CT 06520 USA.	leora.horwitz@yale.edu	Horwitz, Leora/ABD-1292-2020; , Harlan/AAI-2875-2020; Horwitz, Leora/A-6959-2009; Kosiborod, Mikhail/HDO-1541-2022	Horwitz, Leora/0000-0003-1800-6040; Kosiborod, Mikhail/0000-0002-3750-9789				*ACCR COUNC GRAD M, 2002, STAT JUST IMP FIN AP; *ACCR COUNC GRAD M, 2004, COMM PROGR REQ VF; Ai CR, 2003, ECON LETT, V80, P123, DOI 10.1016/S0165-1765(03)00032-6; Arora V, 2005, QUAL SAF HEALTH CARE, V14, P401, DOI 10.1136/qshc.2005.015107; Bailit JL, 2004, OBSTET GYNECOL, V103, P613, DOI 10.1097/01.AOG.0000119225.57285.c1; Bollschweiler E, 2001, LANGENBECK ARCH SURG, V386, P104, DOI 10.1007/s004230000188; Britt LD, 2005, ANN SURG, V241, P856; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chassin MR, 2002, ANN INTERN MED, V136, P826, DOI 10.7326/0003-4819-136-11-200206040-00012; *CTR SAF EM CAR, 2003, ACAD EMERG MED, V10, P364; DAIGLER GE, 1990, AM J DIS CHILD, V144, P799, DOI 10.1001/archpedi.1990.02150310067030; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Efron B., 1994, MONOGRAPHS STAT APPL; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Fletcher KE, 2005, JAMA-J AM MED ASSOC, V294, P1088, DOI 10.1001/jama.294.9.1088; Fletcher KE, 2004, ANN INTERN MED, V141, P851, DOI 10.7326/0003-4819-141-11-200412070-00009; Gandhi TK, 2005, ANN INTERN MED, V142, P352, DOI 10.7326/0003-4819-142-5-200503010-00010; GARNICK DW, 1995, HEALTH SERV RES, V29, P679; Harrell F.E., 2015, REGRESSION MODELING, DOI [10.1007/978-3-319-19425-7, DOI 10.1007/978-3-319-19425-7, 10.1007/978-1-4757-3462-1]; *HCUP CCS, 2007, HEALTHC COST UT PROJ; Horwitz LI, 2006, ARCH INTERN MED, V166, P1173, DOI 10.1001/archinte.166.11.1173; Howard DL, 2004, J GEN INTERN MED, V19, P1, DOI 10.1111/j.1525-1497.2004.30336.x; Iezzoni LI, 1997, ANN INTERN MED, V127, P666, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00048; Kaafarani HMA, 2005, J SURG RES, V126, P167, DOI 10.1016/j.jss.2004.12.024; LAINE C, 1993, JAMA-J AM MED ASSOC, V269, P374, DOI 10.1001/jama.269.3.374; Landrigan CP, 2004, NEW ENGL J MED, V351, P1838, DOI 10.1056/NEJMoa041406; LOFGREN RP, 1990, J GEN INTERN MED, V5, P501, DOI 10.1007/BF02600880; Mann F A, 1993, Invest Radiol, V28, P92, DOI 10.1097/00004424-199301000-00032; Mycyk MB, 2005, AM J HEALTH-SYST PH, V62, P1592, DOI 10.2146/ajhp040527; Nuckols TK, 2005, J GEN INTERN MED, V20, P873, DOI 10.1111/j.1525-1497.2005.0133.x; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; PETERSEN LA, 1994, ANN INTERN MED, V121, P866, DOI 10.7326/0003-4819-121-11-199412010-00008; Poulose BK, 2005, ANN SURG, V241, P847, DOI 10.1097/01.sla.0000164075.18748.38; Schenarts P, 2005, AM J SURG, V190, P147, DOI 10.1016/j.amjsurg.2005.03.026; Sutcliffe KM, 2004, ACAD MED, V79, P186, DOI 10.1097/00001888-200402000-00019; VIDYARTHI AR, 2006, AHRQ WEBM M	36	77	77	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 17	2007	147	2					97	103		10.7326/0003-4819-147-2-200707170-00163	http://dx.doi.org/10.7326/0003-4819-147-2-200707170-00163			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	192CV	17548401				2022-12-28	WOS:000248179300004
J	Easton, DF; Pooley, KA; Dunning, AM; Pharoah, PDP; Thompson, D; Ballinger, DG; Struewing, JP; Morrison, J; Field, H; Luben, R; Wareham, N; Ahmed, S; Healey, CS; Bowman, R; Meyer, KB; Haiman, CA; Kolonel, LK; Henderson, BE; Le Marchand, L; Brennan, P; Sangrajrang, S; Gaborieau, V; Odefrey, F; Shen, CY; Wu, PE; Wang, HC; Eccles, D; Evans, DG; Peto, J; Fletcher, O; Johnson, N; Seal, S; Stratton, MR; Rahman, N; Chenevix-Trench, G; Bojesen, SE; Nordestgaard, BG; Axelsson, CK; Garcia-Closas, M; Brinton, L; Chanock, S; Lissowska, J; Peplonska, B; Nevanlinna, H; Fagerholm, R; Eerola, H; Kang, D; Yoo, KY; Noh, DY; Ahn, SH; Hunter, DJ; Hankinson, SE; Cox, DG; Hall, P; Wedren, S; Liu, JJ; Low, YL; Bogdanova, N; Schurmann, P; Dork, T; Tollenaar, RAEM; Jacobi, CE; Devilee, P; Klijn, JGM; Sigurdson, AJ; Doody, MM; Alexander, BH; Zhang, JH; Cox, A; Brock, IW; MacPherson, G; Reed, MWR; Couch, FJ; Goode, EL; Olson, JE; Meijers-Heijboer, H; van den Ouweland, A; Uitterlinden, A; Rivadeneira, F; Milne, RL; Ribas, G; Gonzalez-Neira, A; Benitez, J; Hopper, JL; McCredie, M; Southey, M; Giles, GG; Schroen, C; Justenhoven, C; Brauch, H; Hamann, U; Ko, YD; Spurdle, AB; Beesley, J; Chen, XQ; Mannermaa, A; Kosma, VM; Kataja, V; Hartikainen, J; Day, NE; Cox, DR; Ponder, BAJ				Easton, Douglas F.; Pooley, Karen A.; Dunning, Alison M.; Pharoah, Paul D. P.; Thompson, Deborah; Ballinger, Dennis G.; Struewing, Jeffery P.; Morrison, Jonathan; Field, Helen; Luben, Robert; Wareham, Nicholas; Ahmed, Shahana; Healey, Catherine S.; Bowman, Richard; Meyer, Kerstin B.; Haiman, Christopher A.; Kolonel, Laurence K.; Henderson, Brian E.; Le Marchand, Loic; Brennan, Paul; Sangrajrang, Suleeporn; Gaborieau, Valerie; Odefrey, Fabrice; Shen, Chen-Yang; Wu, Pei-Ei; Wang, Hui-Chun; Eccles, Diana; Evans, D. Gareth; Peto, Julian; Fletcher, Olivia; Johnson, Nichola; Seal, Sheila; Stratton, Michael R.; Rahman, Nazneen; Chenevix-Trench, Georgia; Bojesen, Stig E.; Nordestgaard, Borge G.; Axelsson, Christen K.; Garcia-Closas, Montserrat; Brinton, Louise; Chanock, Stephen; Lissowska, Jolanta; Peplonska, Beata; Nevanlinna, Heli; Fagerholm, Rainer; Eerola, Hannaleena; Kang, Daehee; Yoo, Keun-Young; Noh, Dong-Young; Ahn, Sei-Hyun; Hunter, David J.; Hankinson, Susan E.; Cox, David G.; Hall, Per; Wedren, Sara; Liu, Jianjun; Low, Yen-Ling; Bogdanova, Natalia; Schuermann, Peter; Doerk, Thilo; Tollenaar, Rob A. E. M.; Jacobi, Catharina E.; Devilee, Peter; Klijn, Jan G. M.; Sigurdson, Alice J.; Doody, Michele M.; Alexander, Bruce H.; Zhang, Jinghui; Cox, Angela; Brock, Ian W.; MacPherson, Gordon; Reed, Malcolm W. R.; Couch, Fergus J.; Goode, Ellen L.; Olson, Janet E.; Meijers-Heijboer, Hanne; van den Ouweland, Ans; Uitterlinden, Andre; Rivadeneira, Fernando; Milne, Roger L.; Ribas, Gloria; Gonzalez-Neira, Anna; Benitez, Javier; Hopper, John L.; McCredie, Margaret; Southey, Melissa; Giles, Graham G.; Schroen, Chris; Justenhoven, Christina; Brauch, Hiltrud; Hamann, Ute; Ko, Yon-Dschun; Spurdle, Amanda B.; Beesley, Jonathan; Chen, Xiaoqing; Mannermaa, Arto; Kosma, Veli-Matti; Kataja, Vesa; Hartikainen, Jaana; Day, Nicholas E.; Cox, David R.; Ponder, Bruce A. J.		SEARCH Collaborators; kConFab; AOCS Management Grp	Genome-wide association study identifies novel breast cancer susceptibility loci	NATURE			English	Article							GROWTH-FACTOR RECEPTOR-2; OVARIAN-CANCER; BRCA2 MUTATIONS; PROSTATE-CANCER; GENE; DISEASE; CHEK2-ASTERISK-1100DELC; POPULATIONS; PATTERNS; DATABASE	Breast cancer exhibits familial aggregation, consistent with variation in genetic susceptibility to the disease. Known susceptibility genes account for less than 25% of the familial risk of breast cancer, and the residual genetic variance is likely to be due to variants conferring more moderate risks. To identify further susceptibility alleles, we conducted a two-stage genome-wide association study in 4,398 breast cancer cases and 4,316 controls, followed by a third stage in which 30 single nucleotide polymorphisms (SNPs) were tested for confirmation in 21,860 cases and 22,578 controls from 22 studies. We used 227,876 SNPs that were estimated to correlate with 77% of known common SNPs in Europeans at r(2) > 0.5. SNPs in five novel independent loci exhibited strong and consistent evidence of association with breast cancer (P < 10(-7)). Four of these contain plausible causative genes (FGFR2, TNRC9, MAP3K1 and LSP1). At the second stage, 1,792 SNPs were significant at the P < 0.05 level compared with an estimated 1,343 that would be expected by chance, indicating that many additional common susceptibility alleles may be identifiable by this approach.	Univ Cambridge, Dept Publ Hlth & Primary Care, CR UK Genet Epidemiol Unit, Cambridge CB1 8RN, England; Univ Cambridge, Dept Oncol, Cambridge CB1 8RN, England; Canc Council Victoria, Canc Epidemiol Ctr, Carlton, Vic 3053, Australia; Univ Otago, Dept Prevent & Social Med, Dunedin 9001, New Zealand; Univ Melbourne, Ctr Mol Environm Genet & Analyt Epidemiol, Carlton, Vic 3053, Australia; Spanish Natl Canc Ctr CNIO, E-28029 Madrid, Spain; Erasmus Univ, Dept Clin Genet, NL-3015 GE Rotterdam, Netherlands; Mayo Clin, Coll Med, Rochester, MN 55905 USA; Univ Sheffield, Sch Med, Acad Unit Surg Oncol, Sheffield S10 2RX, S Yorkshire, England; Univ Sheffield, Sch Med, Inst Canc Studies, Sheffield S10 2RX, S Yorkshire, England; Univ Minnesota, Minneapolis, MN 55455 USA; NCI, Radiat Epidemiol Branch, Div Canc Epidemiol & Genet, NIH,DHHS, Bethesda, MD 20892 USA; Dr Daniel Den Hoed Canc Ctr, Erasmus MC, Dept Med Oncol, Family Canc Clin, NL-3075 EA Rotterdam, Netherlands; Leiden Univ, Med Ctr, Dept Human Genet, NL-2333 ZA Leiden, Netherlands; Leiden Univ, Med Ctr, Dept Pathol, NL-2333 ZA Leiden, Netherlands; Leiden Univ, Med Ctr, Dept Med Decis Making, NL-2333 ZA Leiden, Netherlands; Leiden Univ, Med Ctr, Dept Surg, NL-2333 ZA Leiden, Netherlands; Hannover Med Sch, Dept Obstet & Gynecol, D-30625 Hannover, Germany; Hannover Med Sch, Dept Radiat Oncol, D-30625 Hannover, Germany; Genome Inst Singapore, Singapore 138672, Singapore; Karolinska Inst, Dept Med Epidemiol & Biostat, SE-17177 Stockholm, Sweden; Harvard Univ, Sch Med, Boston, MA 02115 USA; Brigham & Womens Hosp, Channing Lab, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Program Mol & Genet Epidemiol, Boston, MA 02115 USA; Univ Ulsan, Coll Med, Ulsan 680749, South Korea; Natl Canc Ctr, Goyang 411769, South Korea; Seoul Natl Univ, Coll Med, Seoul 151742, South Korea; Univ Helsinki, Cent Hosp, Dept Oncol, Helsinki 00029, Finland; Univ Helsinki, Cent Hosp, Dept Obstet & Gynecol, Helsinki 00029, Finland; Nofer Inst Occupat Med, PL-90950 Lodz, Poland; M Sklodowska Curie Inst Oncol, PL-02781 Warsaw, Poland; Ctr Canc, PL-02781 Warsaw, Poland; NCI, Ctr Adv Technol, Gaithersburg, MD 20877 USA; NCI, Div Canc Epidemiol & Genet, Rockville, MD 20852 USA; Univ Copenhagen, Herlev Univ Hosp, Dept Clin Biochem, DK-2730 Herlev, Denmark; Univ Copenhagen, Bispebjerg Univ Hosp, Dept Breast Surg, DK-2730 Herlev, Denmark; Queensland Inst Med Res, Brisbane, Qld 4006, Australia; Wellcome Trust Sanger Inst, Canc Genome Project, Cambridge CB10 1SA, England; Inst Canc Res, Sect Canc Genet, Sutton SM2 5NG, Surrey, England; Breakthrought Breast Canc Res Ctr, London SW3 6JB, England; Inst Canc Res, Sutton SM2 5NG, Surrey, England; Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; St Marys Hosp, Reg Genet Serv, Manchester M13 0JH, Lancs, England; Princess Anne Hosp, Wessex Clin Genet Serv, Southampton SO16 5YA, Hants, England; Acad Sinica, Inst Biomed Sci, Taipei 11529, Taiwan; NCI, Bangkok 10400, Thailand; Int Agcy Res Canc, F-69008 Lyon, France; Univ Hawaii, Canc Res Ctr Hawaii, Program Epidemiol, Honolulu, HI 96813 USA; Univ Calif Los Angeles, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; MRC, Dunn Clin Nutr Ctr, Cambridge CB2 0XY, England; Univ Cambridge, Dept Publ Hlth & Primary Care, EPIC, Cambridge CB1 8RN, England; NCI, Lab Populat Genet, Bethesda, MD 20892 USA; Perlegen Sci Inc, Mountain View, CA 94043 USA; Univ Melbourne, Dept Pathol, Genet Epidemiol Lab, Parkville, Vic 3052, Australia; Vaasa Cent Hosp, Dept Oncol, Vaasa 65130, Finland; Kuopio Univ Hosp, Dept Oncol, FIN-70211 Kuopio, Finland; Kuopio Univ Hosp, Dept Pathol, FIN-70211 Kuopio, Finland; Univ Kuopio, Inst Clin Med Pathol & Forens Med, FIN-70210 Kuopio, Finland; Peter MacCallum Canc Ctr, Melbourne, Vic 3002, Australia; Evangel Kliniken Bonn GGmbh, Johanniter Krankenhaus, D-53113 Bonn, Germany; Deutsch Krebsforschungszentrum, D-69120 Heidelberg, Germany; Univ Tubingen, D-72074 Tubingen, Germany; Dr Margarete Fischer Bosch Inst Clin Pharmacol, D-70376 Stuttgart, Germany	University of Cambridge; University of Cambridge; Cancer Council Victoria; University of Otago; University of Melbourne; Centro Nacional de Investigaciones Oncologicas (CNIO); Erasmus University Rotterdam; Mayo Clinic; University of Sheffield; University of Sheffield; University of Minnesota System; University of Minnesota Twin Cities; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Hannover Medical School; Hannover Medical School; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Karolinska Institutet; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; University of Ulsan; National Cancer Center - Korea (NCC); Seoul National University (SNU); University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; Nofer Institute of Occupational Medicine; Maria Sklodowska-Curie National Research Institute of Oncology; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Bispebjerg Hospital; QIMR Berghofer Medical Research Institute; University of Cambridge; Wellcome Trust Sanger Institute; University of London; Institute of Cancer Research - UK; University of London; Institute of Cancer Research - UK; University of London; Institute of Cancer Research - UK; University of London; London School of Hygiene & Tropical Medicine; University of Manchester; Academia Sinica - Taiwan; World Health Organization; International Agency for Research on Cancer (IARC); Cancer Research Center of Hawaii; University of Hawaii System; University of California System; University of California Los Angeles; University of Cambridge; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Melbourne; Vaasa Central Hospital; Kuopio University Hospital; Kuopio University Hospital; University of Eastern Finland; Peter Maccallum Cancer Center; Helmholtz Association; German Cancer Research Center (DKFZ); Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Easton, DF (corresponding author), Univ Cambridge, Dept Publ Hlth & Primary Care, CR UK Genet Epidemiol Unit, Cambridge CB1 8RN, England.	d.easton@srl.cam.ac.uk	Brinton, Louise A/G-7486-2015; Osborne, Richard H/A-9447-2010; Wang, Hui-Chun/C-5680-2009; Cox, David/ABA-7454-2020; DeFazio, Anna/O-2385-2019; Devilee, Peter/GXV-8005-2022; Chenevix-Trench, Georgia/AAV-2014-2020; Pharoah, Paul/V-6658-2019; Zhang, Jing/GWZ-7332-2022; Cox, David G/A-2023-2009; Reed, Malcolm Walter/AAG-9219-2020; DEVILEE, PETER/ABR-2140-2022; Garcia-Closas, Montserrat/F-3871-2015; Luben, Robert N/H-5519-2015; Lissowska, Jolanta/AAH-3252-2020; Bogdanova, Natalia V./Y-2205-2019; Spurdle, Amanda B/A-4978-2011; Ward, Robyn L/I-2313-2013; Ribas-Despuig, Gloria/M-6190-2017; Rahman, Nazneen/B-8890-2012; Struewing, Jeffery P/I-7502-2013; Hartikainen, Jaana M/E-6256-2015; Yoo, Keun-Young/J-5548-2012; Eccles, Diana/K-6327-2019; Gonzalez-Neira, Anna/C-5791-2015; Nordestgaard, Borge Gronne/ABF-1310-2020; Taylor, Donna B/I-5714-2015; Peplonska, Beata/F-6004-2010; Peplonska, Beata/AAO-1265-2020; Amor, David J/A-6478-2018; Rivadeneira, Fernando/O-5385-2015; Evans, D Gareth/AAB-4308-2022; xin, xp/C-7350-2009; Bowtell, David/H-1007-2016; Brennan, Meagan E/P-8274-2019; Dörk, Thilo/J-8620-2012; Noh, Dong-Young/G-5531-2011; Kang, Dae Hee/E-8631-2012; Liu, Jianjun/AAK-4989-2020; Garcia-Closas, Montserrat/AAZ-6930-2021; Zhang, Jing/HII-4294-2022; Shen, CY/F-6271-2010; Rahman, Nazneen/D-2802-2013; Saunders, Christobel/H-5779-2014; Ribas, Gloria/K-3379-2013; Mann, Graham/G-4758-2014; Marsh, Deborah/I-1491-2014; Webb, Penelope/D-5736-2013; Jenkins, Mark/P-7803-2015; Scott, Rodney/B-2827-2013	Brinton, Louise A/0000-0003-3853-8562; Osborne, Richard H/0000-0002-9081-2699; DeFazio, Anna/0000-0003-0057-4744; Chenevix-Trench, Georgia/0000-0002-1878-2587; Pharoah, Paul/0000-0001-8494-732X; Cox, David G/0000-0002-2152-9259; Reed, Malcolm Walter/0000-0001-7442-2132; Garcia-Closas, Montserrat/0000-0003-1033-2650; Luben, Robert N/0000-0002-5088-6343; Lissowska, Jolanta/0000-0003-2695-5799; Spurdle, Amanda B/0000-0003-1337-7897; Ward, Robyn L/0000-0002-6877-8906; Struewing, Jeffery P/0000-0002-4848-3334; Hartikainen, Jaana M/0000-0001-8267-1905; Eccles, Diana/0000-0002-9935-3169; Gonzalez-Neira, Anna/0000-0002-5421-2020; Taylor, Donna B/0000-0002-1481-1141; Peplonska, Beata/0000-0003-3915-2872; Amor, David J/0000-0001-7191-8511; Rivadeneira, Fernando/0000-0001-9435-9441; Evans, D Gareth/0000-0002-8482-5784; Bowtell, David/0000-0001-9089-7525; Brennan, Meagan E/0000-0002-3281-7643; Dörk, Thilo/0000-0002-9458-0282; Liu, Jianjun/0000-0002-3255-3019; Garcia-Closas, Montserrat/0000-0003-1033-2650; Rahman, Nazneen/0000-0003-4376-0440; Clarke, Christine/0000-0001-7568-111X; Thorne, Heather/0000-0003-3610-2511; Brauch, Hiltrud/0000-0001-7531-2736; Southey, Melissa/0000-0002-6313-9005; Robinson, Bridget/0000-0001-9483-9146; Gaff, Clara/0000-0003-0160-4159; Winship, Ingrid/0000-0001-8535-6003; Kang, Daehee/0000-0003-4031-5878; Kataja, Vesa/0000-0003-4846-4843; Bowcock, Anne/0000-0001-8691-9090; Cox, Angela/0000-0002-5138-1099; Bennett, Ian/0000-0002-3634-9680; Saunders, Christobel/0000-0003-2281-9829; Richards, Robert Ian/0000-0002-5978-6453; Edsall, Lee Elizabeth/0000-0002-0326-2829; Fletcher, Olivia/0000-0001-9387-7116; Ribas, Gloria/0000-0001-6883-4130; Mann, Graham/0000-0003-1301-405X; Bowman, Richard/0000-0002-6348-2241; Marsh, Deborah/0000-0001-5899-4931; Brown, Melissa/0000-0002-2830-9259; Giles, Graham/0000-0003-4946-9099; Kefford, Richard/0000-0001-9251-9229; Nevanlinna, Heli/0000-0002-0916-2976; Lindeman, Geoffrey/0000-0001-9386-2416; Webb, Penelope/0000-0003-0733-5930; Shelling, Andrew/0000-0002-5300-1934; Beesley, Jonathan/0000-0003-1942-325X; Dunning, Alison Margaret/0000-0001-6651-7166; Wang, Hui-Chun/0000-0003-1414-1595; Jenkins, Mark/0000-0002-8964-6160; Callen, David/0000-0002-6189-9991; Scott, Rodney/0000-0001-7724-3404; Phillips, Kelly-Anne/0000-0002-0475-1771; Cox, David/0000-0003-2047-4687	Cancer Research UK [A3353] Funding Source: Medline; Breast Cancer Now [BREAST CANCER NOW RESEARCH CENTRE, 2004NOV49] Funding Source: Medline; NATIONAL CANCER INSTITUTE [Z01SC010083] Funding Source: NIH RePORTER	Cancer Research UK(Cancer Research UK); Breast Cancer Now; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ADNANE J, 1991, ONCOGENE, V6, P659; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Antoniou AC, 2004, BRIT J CANCER, V91, P1580, DOI 10.1038/sj.bjc.6602175; Antoniou AC, 2003, GENET EPIDEMIOL, V25, P190, DOI 10.1002/gepi.10261; Beral V, 2001, LANCET, V358, P1389, DOI 10.1016/S0140-6736(01)06524-2; Cox A, 2007, NAT GENET, V39, P688, DOI 10.1038/ng0507-688b; Cox A, 2007, NAT GENET, V39, P352, DOI 10.1038/ng1981; Day N, 1999, BRIT J CANCER, V80, P95; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Easton D, 2004, AM J HUM GENET, V74, P1175, DOI 10.1086/421251; EASTON DF, 1999, BREAST CANCER RES, V1, P1; Erkko H, 2007, NATURE, V446, P316, DOI 10.1038/nature05609; Ferretti V, 2007, NUCLEIC ACIDS RES, V35, pD122, DOI 10.1093/nar/gkl879; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Hubbard T, 2002, NUCLEIC ACIDS RES, V30, P38, DOI 10.1093/nar/30.1.38; Jang JH, 2001, CANCER RES, V61, P3541; Kruglyak L, 2001, NAT GENET, V27, P234, DOI 10.1038/85776; Lesueur F, 2005, HUM MOL GENET, V14, P2349, DOI 10.1093/hmg/ddi237; Meijers-Heijboer H, 2002, NAT GENET, V31, P55, DOI 10.1038/ng879; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Moffa AB, 2004, MOL CANCER RES, V2, P643; Pharoah P, 2006, JNCI-J NATL CANCER I, V98, P1382, DOI 10.1093/jnci/djj374; Pharoah PDP, 2002, NAT GENET, V31, P33, DOI 10.1038/ng853; Rahman N, 2007, NAT GENET, V39, P165, DOI 10.1038/ng1959; Renwick A, 2006, NAT GENET, V38, P873, DOI 10.1038/ng1837; Satagopan JM, 2002, BIOMETRICS, V58, P163, DOI 10.1111/j.0006-341X.2002.00163.x; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Seal S, 2006, NAT GENET, V38, P1239, DOI 10.1038/ng1902; Smith P, 2006, GENE CHROMOSOME CANC, V45, P646, DOI 10.1002/gcc.20330; Thomas DC, 2005, AM J HUM GENET, V77, P337, DOI 10.1086/432962; Thompson D, 2005, JNCI-J NATL CANCER I, V97, P813, DOI 10.1093/jnci/dji141; Tyrer J, 2006, GENET EPIDEMIOL, V30, P636, DOI 10.1002/gepi.20175; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022	40	1768	1840	2	231	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 28	2007	447	7148					1087	U7		10.1038/nature05887	http://dx.doi.org/10.1038/nature05887			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	183HT	17529967	Green Accepted, Green Published			2022-12-28	WOS:000247564600032
J	Pandey, UB; Nie, ZP; Batlevi, Y; McCray, BA; Ritson, GP; Nedelsky, NB; Schwartz, SL; DiProspero, NA; Knight, MA; Schuldiner, O; Padmanabhan, R; Hild, M; Berry, DL; Garza, D; Hubbert, CC; Yao, TP; Baehrecke, EH; Taylor, JP				Pandey, Udai Bhan; Nie, Zhiping; Batlevi, Yakup; McCray, Brett A.; Ritson, Gillian P.; Nedelsky, Natalia B.; Schwartz, Stephanie L.; DiProspero, Nicholas A.; Knight, Melanie A.; Schuldiner, Oren; Padmanabhan, Ranjani; Hild, Marc; Berry, Deborah L.; Garza, Dan; Hubbert, Charlotte C.; Yao, Tso-Pang; Baehrecke, Eric H.; Taylor, J. Paul			HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS	NATURE			English	Article							UBIQUITIN-PROTEASOME SYSTEM; ANDROGEN RECEPTOR; PROTEIN; DISEASE; DEGRADATION; DROSOPHILA; ACETYLATION; INCLUSIONS; TOXICITY; PATHWAYS	A prominent feature of late-onset neurodegenerative diseases is accumulation of misfolded protein in vulnerable neurons(1). When levels of misfolded protein overwhelm degradative pathways, the result is cellular toxicity and neurodegeneration(2). Cellular mechanisms for degrading misfolded protein include the ubiquitin-proteasome system ( UPS), the main non-lysosomal degradative pathway for ubiquitinated proteins, and autophagy, a lysosome-mediated degradative pathway(3). The UPS and autophagy have long been viewed as complementary degradation systems with no point of intersection(4,5). This view has been challenged by two observations suggesting an apparent interaction: impairment of the UPS induces autophagy in vitro, and conditional knockout of autophagy in the mouse brain leads to neurodegeneration with ubiquitin-positive pathology(6-9). It is not known whether autophagy is strictly a parallel degradation system, or whether it is a compensatory degradation system when the UPS is impaired; furthermore, if there is a compensatory interaction between these systems, the molecular link is not known. Here we show that autophagy acts as a compensatory degradation system when the UPS is impaired in Drosophila melanogaster, and that histone deacetylase 6 (HDAC6), a microtubule-associated deacetylase that interacts with polyubiquitinated proteins(10), is an essential mechanistic link in this compensatory interaction. We found that compensatory autophagy was induced in response to mutations affecting the proteasome and in response to UPS impairment in a fly model of the neurodegenerative disease spinobulbar muscular atrophy. Autophagy compensated for impaired UPS function in an HDAC6-dependent manner. Furthermore, expression of HDAC6 was sufficient to rescue degeneration associated with UPS dysfunction in vivo in an autophagy-dependent manner. This study suggests that impairment of autophagy ( for example, associated with ageing or genetic variation) might predispose to neurodegeneration. Morover, these findings suggest that it may be possible to intervene in neurodegeneration by augmenting HDAC6 to enhance autophagy.	Univ Penn, Sch Med, Dept Neurol, Philadelphia, PA 19104 USA; Univ Maryland, Inst Biotechnol, Ctr Biosyst Res, College Pk, MD 20742 USA; NINDS, Neurogenet Branch, NIH, Bethesda, MD 20817 USA; Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Novartis Inst Biomed Res, Cambridge, MA 02139 USA; Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA	University of Pennsylvania; University System of Maryland; University of Maryland Baltimore; University of Maryland College Park; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Stanford University; Novartis; Duke University	Taylor, JP (corresponding author), Univ Penn, Sch Med, Dept Neurol, Philadelphia, PA 19104 USA.	jpt@mail.med.upenn.edu	Schuldiner, Oren/K-1353-2012; Taylor, J. Paul/N-2482-2018	Schuldiner, Oren/0000-0002-7350-9380; Taylor, J. Paul/0000-0002-5794-0349	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS003038, R01NS054022] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS054022, R01 NS054022-02] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chan HYE, 2002, HUM MOL GENET, V11, P2895, DOI 10.1093/hmg/11.23.2895; CIECHANOVER A, 1984, CELL, V37, P57, DOI 10.1016/0092-8674(84)90300-3; Ciechanover A, 2003, NEURON, V40, P427, DOI 10.1016/S0896-6273(03)00606-8; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Harris Thurl E, 2003, Sci STKE, V2003, pre15; Iwata A, 2005, J BIOL CHEM, V280, P40282, DOI 10.1074/jbc.M508786200; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kovacs JJ, 2005, MOL CELL, V18, P601, DOI 10.1016/j.molcel.2005.04.021; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; Li M, 1998, ANN NEUROL, V44, P249, DOI 10.1002/ana.410440216; McGuire S. E., 2004, SCI STKE, V2004, pp16, DOI DOI 10.1125/STKE.2202004P16; Neefjes J, 2004, NAT REV DRUG DISCOV, V3, P58, DOI 10.1038/nrd1282; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Rideout HJ, 2004, INT J BIOCHEM CELL B, V36, P2551, DOI 10.1016/j.biocel.2004.05.008; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Smyth KA, 1999, GENETICS, V151, P211; Takeyama K, 2002, NEURON, V35, P855, DOI 10.1016/S0896-6273(02)00875-9; Taylor JP, 2002, SCIENCE, V296, P1991, DOI 10.1126/science.1067122; Taylor JP, 2003, HUM MOL GENET, V12, P749, DOI 10.1093/hmg/ddg074; Taylor JP, 2003, GENE DEV, V17, P1463, DOI 10.1101/gad.1087503; Trojanowski JQ, 2000, ANN NY ACAD SCI, V924, P62	25	948	983	0	101	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 14	2007	447	7146					859	863		10.1038/nature05853	http://dx.doi.org/10.1038/nature05853			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178FV	17568747				2022-12-28	WOS:000247207500045
J	Xu, X; Tan, QW; Wang, JM; Zhao, XJ; Tan, L				Xu, Xing; Tan, Qingwei; Wang, Jianmin; Zhao, Xijin; Tan, Lin			Agigantic bird-like dinosaur from the Late Cretaceous of China	NATURE			English	Article							THEROPODA; EVOLUTION; HISTORY	An evolutionary trend of decreasing size is present along the line to birds in coelurosaurian theropod evolution(1,2), but size increases are seen in many coelurosaurian subgroups, in which large forms are less bird-like(2,3). Here we report on a new non-avian dinosaur, Gigantoraptor erlianensis, gen. et sp. nov., from the Late Cretaceous Iren Dabasu Formation of Nei Mongol, China. Although it has a body mass of about 1,400 kg, a phylogenetic analysis positions this new taxon within the Oviraptorosauria, a group of small, feathered theropods rarely exceeding 40 kg in body mass(2,4-7). A histological analysis suggests that Gigantoraptor gained this size by a growth rate considerably faster than large North American tyrannosaurs such as Albertosaurus and Gorgosaurus(8). Gigantoraptor possesses several salient features previously unknown in any other dinosaur and its hind limb bone scaling and proportions are significantly different from those of other coelurosaurs(9,10), thus increasing the morphological diversity among dinosaurs. Most significantly, the gigantic Gigantoraptor shows many birdlike features absent in its smaller oviraptorosaurian relatives, unlike the evolutionary trend seen in many other coelurosaurian subgroups(2,3).	Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Beijing 100044, Peoples R China; Long Hao Inst Geol & Paleontol, Hohhot 010010, Nei Mongol, Peoples R China; Dept Land Resources, Hohhot 010010, Nei Mongol, Peoples R China	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS	Xu, X (corresponding author), Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Beijing 100044, Peoples R China.	xu.xing@ivpp.ac.cn	wang, jian/GVS-0711-2022					BARSBOLD R, 1976, DOKL AKAD NAUK SSSR+, V226, P685; Chiappe Luis M., 1996, Muenchner Geowissenschaftliche Abhandlungen Reihe A Geologie und Palaeontologie, V30, P203; Chinsamy-Turan A., 2005, MICROSTRUCTURE DINOS; Chrtstiansen P, 1999, J VERTEBR PALEONTOL, V19, P666, DOI 10.1080/02724634.1999.10011180; Clark JM, 2002, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2002)364<0001:CAOCOT>2.0.CO;2; Currie Philip J., 2000, Gaia (Lisboa), V15, P271; CURRIE PJ, 1993, CAN J EARTH SCI, V30, P2255, DOI 10.1139/e93-196; CURRIE PJ, 1993, CRETACEOUS RES, V14, P127, DOI 10.1006/cres.1993.1011; Erickson GM, 2004, NATURE, V430, P772, DOI 10.1038/nature02699; GATESY SM, 1991, J MORPHOL, V209, P83, DOI 10.1002/jmor.1052090107; Gaudin Timothy J., 2006, P1; HOLTZ TR, 1994, J VERTEBR PALEONTOL, V14, P480, DOI 10.1080/02724634.1995.10011574; Horner JR, 2004, P ROY SOC B-BIOL SCI, V271, P1875, DOI 10.1098/rspb.2004.2829; Hwang SH, 2002, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2002)381<0001:NSOMZT>2.0.CO;2; Ji Q, 1998, NATURE, V393, P753, DOI 10.1038/31635; Makovicky PJ, 2004, DINOSAURIA, 2ND EDITION, P184; Makovicky Peter J., 1998, American Museum Novitates, V3240, P1; Maryanska T, 2002, ACTA PALAEONTOL POL, V47, P97; Norell MA, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P49; Osmolska H, 2004, DINOSAURIA, 2ND EDITION, P165; Sander PM, 2004, ORG DIVERS EVOL, V4, P165, DOI 10.1016/j.ode.2003.12.002; Senter Phil, 2004, Bulletin of Gunma Museum of Natural History, V8, P1; Sereno PC, 1999, SCIENCE, V284, P2137, DOI 10.1126/science.284.5423.2137; Spinage C.A., 1994, ELEPHANTS; Sues HD, 1997, J VERTEBR PALEONTOL, V17, P698, DOI 10.1080/02724634.1997.10011018; UPCHURCH P, 1995, PHILOS T R SOC B, V349, P365, DOI 10.1098/rstb.1995.0125; Xing X, 2006, GEOL J, V41, P419, DOI 10.1002/gj.1044; Xu X, 2004, NATURE, V431, P838, DOI 10.1038/nature02898; Xu X, 2004, NATURE, V431, P680, DOI 10.1038/nature02855; Zanno LE, 2005, J VERTEBR PALEONTOL, V25, P897, DOI 10.1671/0272-4634(2005)025[0897:ANOTMF]2.0.CO;2	30	89	102	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 14	2007	447	7146					844	847		10.1038/nature05849	http://dx.doi.org/10.1038/nature05849			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178FV	17565365				2022-12-28	WOS:000247207500041
J	Giles, PD; Fitzmaurice, DA				Giles, Paul D.; Fitzmaurice, David A.			Formula estimation of glomerular filtration rate: have we gone wrong?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SERUM CREATININE; CHRONIC KIDNEY; RENAL-FUNCTION; DISEASE; HEALTH		Manor Hosp, Dept Biochem, Walsall WS2 9PS, W Midlands, England; Univ Birmingham, Dept Primary Care & Gen Practice, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Giles, PD (corresponding author), Manor Hosp, Dept Biochem, Walsall WS2 9PS, W Midlands, England.	paul.giles@walsallhospitals.nhs.uk						[Anonymous], CRIT APPR VIAB EFF A; Diskin CJ, 2007, ANN CLIN BIOCHEM, V44, P16, DOI 10.1258/000456307779595940; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; El Nahas AM, 2005, LANCET, V365, P331, DOI 10.1016/S0140-6736(05)17789-7; LEVEY AS, 2000, J AM SOC NEPHROL, V11, P828; Mahajan S, 2005, NEPHRON CLIN PRACT, V101, P128, DOI 10.1159/000086683; Myers GL, 2006, CLIN CHEM, V52, P5, DOI 10.1373/clinchem.2005.0525144; *NAT LIB HLTH, NAT SCREEN COMM POL; *NAT SERV FRAM REN, 2005, PART 2 CHRON KIDN DI; Poggio ED, 2005, J AM SOC NEPHROL, V16, P459, DOI 10.1681/ASN.2004060447; Preiss DJ, 2007, ANN CLIN BIOCHEM, V44, P35, DOI 10.1258/000456307779595995; *REN ASS, 2006, CHRON KIDN DIS AD UK; Rule AD, 2004, ANN INTERN MED, V141, P929, DOI 10.7326/0003-4819-141-12-200412210-00009; SHEMESH O, 1985, KIDNEY INT, V28, P830, DOI 10.1038/ki.1985.205; Traynor J, 2006, BMJ-BRIT MED J, V333, P733, DOI 10.1136/bmj.38975.390370.7C; Verhave JC, 2005, AM J KIDNEY DIS, V46, P233, DOI 10.1053/j.ajkd.2005.05.011	16	37	37	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 9	2007	334	7605					1198	1200		10.1136/bmj.39226.400694.80	http://dx.doi.org/10.1136/bmj.39226.400694.80			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	179GF	17556476	Green Published			2022-12-28	WOS:000247277000033
J	Iheanacho, I				Iheanacho, Ike			All together now	BRITISH MEDICAL JOURNAL			English	Editorial Material												iiheanacho@bmjgroup.com							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUN 9	2007	334	7605					1224	1224		10.1136/bmj.39234.611505.59	http://dx.doi.org/10.1136/bmj.39234.611505.59			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	179GF	17556482	Green Published			2022-12-28	WOS:000247277000043
J	Nyberg, J; Malmgren, BA; Winter, A; Jury, MR; Kilbourne, KH; Quinn, TM				Nyberg, Johan; Malmgren, Bjorn A.; Winter, Amos; Jury, Mark R.; Kilbourne, K. Halimeda; Quinn, Terrence M.			Low Atlantic hurricane activity in the 1970s and 1980s compared to the past 270 years	NATURE			English	Article							TROPICAL ATLANTIC; MAUNDER MINIMUM; CORAL SKELETONS; INTENSITY; FREQUENCY; SEA; LUMINESCENCE; VARIABILITY; CENTURIES; RAINFALL	Hurricane activity in the North Atlantic Ocean has increased significantly since 1995 ( refs 1,2). This trend has been attributed to both anthropogenically induced climate change(3) and natural variability(1), but the primary cause remains uncertain. Changes in the frequency and intensity of hurricanes in the past can provide insights into the factors that influence hurricane activity, but reliable observations of hurricane activity in the North Atlantic only cover the past few decades(2). Here we construct a record of the frequency of major Atlantic hurricanes over the past 270 years using proxy records of vertical wind shear and sea surface temperature ( the main controls on the formation of major hurricanes kin this region(1,3-5)) from corals and a marine sediment core. The record indicates that the average frequency of major hurricanes decreased gradually from the 1760s until the early 1990s, reaching anomalously low values during the 1970s and 1980s. Furthermore, the phase of enhanced hurricane activity since 1995 is not unusual compared to other periods of high hurricane activity in the record and thus appears to represent a recovery to normal hurricane activity, rather than a direct response to increasing sea surface temperature. Comparison of the record with a reconstruction of vertical wind shear indicates that variability in this parameter primarily controlled the frequency of major hurricanes in the Atlantic over the past 270 years, suggesting that changes in the magnitude of vertical wind shear will have a significant influence on future hurricane activity.	Geol Survey Sweden, SE-75128 Uppsala, Sweden; Univ Gothenburg, Dept Earth Sci, SE-40530 Gothenburg, Sweden; Univ Puerto Rico, Dept Phys, Mayaguez, PR 00681 USA; Univ S Florida, Coll Marine Sci, St Petersburg, FL 33707 USA; NOAA, Earth Syst Res Lab, Phys Sci Div R PSD1, Boulder, CO 80305 USA; Univ Texas, Dept Geol Sci, Jackson Sch Geosci, Austin, TX 78712 USA; Univ Texas, Inst Geophys, Austin, TX 78758 USA	University of Gothenburg; University of Puerto Rico; University of Puerto Rico Mayaguez; State University System of Florida; University of South Florida; National Oceanic Atmospheric Admin (NOAA) - USA; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Nyberg, J (corresponding author), Geol Survey Sweden, Box 670, SE-75128 Uppsala, Sweden.	johan.nyberg@sgu.se	Kilbourne, Kelly H/D-6560-2012; Kilbourne, Hali/AAD-6043-2022; Quinn, Terrence/A-5755-2008; Malmgren, Bjorn A/A-6283-2009	Kilbourne, Kelly H/0000-0001-7864-8438; Kilbourne, Hali/0000-0001-7864-8438; 				Aiyyer AR, 2006, J CLIMATE, V19, P2969, DOI 10.1175/JCLI3685.1; Avila LA, 2000, MON WEATHER REV, V128, P3695, DOI 10.1175/1520-0493(2000)128<3695:ATSOAY>2.0.CO;2; Barnes DJ, 2003, J EXP MAR BIOL ECOL, V295, P91, DOI 10.1016/S0022-0981(03)00274-0; Black DE, 1999, SCIENCE, V286, P1709, DOI 10.1126/science.286.5445.1709; Curry JA, 2006, B AM METEOROL SOC, V87, P1025, DOI 10.1175/BAMS-87-8-1025; DEMARIA M, 1993, J ATMOS SCI, V50, P1133, DOI 10.1175/1520-0469(1993)050<1133:ULEAMF>2.0.CO;2; Dong BW, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025766; Elsner JB, 2006, J CLIMATE, V19, P2935, DOI 10.1175/JCLI3729.1; Elsner JB, 1999, J CLIMATE, V12, P427, DOI 10.1175/1520-0442(1999)012<0427:FINAHF>2.0.CO;2; Elsner JB, 2000, GEOPHYS RES LETT, V27, P1743, DOI 10.1029/2000GL011453; Emanuel K, 2005, NATURE, V436, P686, DOI 10.1038/nature03906; Enfield DB, 2001, GEOPHYS RES LETT, V28, P2077, DOI 10.1029/2000GL012745; Goldenberg SB, 1996, J CLIMATE, V9, P1169, DOI 10.1175/1520-0442(1996)009<1169:PMFTAO>2.0.CO;2; Goldenberg SB, 2001, SCIENCE, V293, P474, DOI 10.1126/science.1060040; Gray ST, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019932; Held IM, 2006, J CLIMATE, V19, P5686, DOI 10.1175/JCLI3990.1; Hendy EJ, 2003, HOLOCENE, V13, P187, DOI 10.1191/0959683603hl606rp; JARVINEN BR, 1984, NOAA TECH MEMO NWS N, V22, P1; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Knaff JA, 1997, J CLIMATE, V10, P789, DOI 10.1175/1520-0442(1997)010<0789:IOSSLP>2.0.CO;2; Landsea CW, 2004, HURRICANES AND TYPHOONS: PAST, PRESENT, AND FUTURE, P177; Landsea CW, 1996, GEOPHYS RES LETT, V23, P1697, DOI 10.1029/96GL01029; Lean J, 2000, GEOPHYS RES LETT, V27, P2425, DOI 10.1029/2000GL000043; Mann M.E., 2006, EOS, V87, P233, DOI 10.1029/2006EO240001; Mann ME, 1998, NATURE, V392, P779, DOI 10.1038/33859; NEUMANN CJ, 1999, TROPICAL CYCLONES N, P11; Nyberg J, 2002, PHILOS T ROY SOC A, V360, P749, DOI 10.1098/rsta.2001.0963; Shapiro LJ, 1998, J CLIMATE, V11, P578, DOI 10.1175/1520-0442(1998)011<0578:ASSTAT>2.0.CO;2; Shindell DT, 2001, SCIENCE, V294, P2149, DOI 10.1126/science.1064363; Smith TM, 2004, J CLIMATE, V17, P2466, DOI 10.1175/1520-0442(2004)017<2466:IEROS>2.0.CO;2; Vitart F, 2001, J CLIMATE, V14, P533, DOI 10.1175/1520-0442(2001)014<0533:SOATSF>2.0.CO;2; Watanabe T, 2002, CORAL REEFS, V21, P169, DOI 10.1007/s00338-002-0218-9; WOODRUFF SD, 1987, B AM METEOROL SOC, V68, P1239, DOI 10.1175/1520-0477(1987)068<1239:ACOADS>2.0.CO;2	33	106	109	0	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 7	2007	447	7145					698	U11		10.1038/nature05895	http://dx.doi.org/10.1038/nature05895			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175RI	17554304				2022-12-28	WOS:000247030700040
J	Gerlt, JA				Gerlt, John A.			Frank H. Westheimer (1912-2007) - Pioneering chemist at the interface with biology - Obituary	NATURE			English	Biographical-Item									Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; Univ Illinois, Dept Chem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Gerlt, JA (corresponding author), Univ Illinois, Dept Biochem, 600 S Mathews Ave, Urbana, IL 61801 USA.	j-gerlt@uiuc.edu							0	2	2	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 31	2007	447	7144					543	543		10.1038/447543a	http://dx.doi.org/10.1038/447543a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172YZ	17538611	Bronze			2022-12-28	WOS:000246842000034
J	Yeh, BJ; Rutigliano, RJ; Deb, A; Bar-Sagi, D; Lim, WA				Yeh, Brian J.; Rutigliano, Robert J.; Deb, Anrica; Bar-Sagi, Dafna; Lim, Wendell A.			Rewiring cellular morphology pathways with synthetic guanine nucleotide exchange factors	NATURE			English	Article							RHO GTPASES; PROTEIN-KINASE; N-WASP; DOMAINS; ACTIVATION; MECHANISMS; CIRCUITS; SIGNALS; COMPLEX; CASCADE	Eukaryotic cells mobilize the actin cytoskeleton to generate a remarkable diversity of morphological behaviours, including motility, phagocytosis and cytokinesis. Much of this diversity is mediated by guanine nucleotide exchange factors ( GEFs) that activate Rho family GTPases - the master regulators of the actin cytoskeleton(1-3). There are over 80 Rho GEFs in the human genome ( compared to only 22 genes for the Rho GTPases themselves), and the evolution of new and diverse GEFs is thought to provide a mechanism for linking the core cytoskeletal machinery to a wide range of new control inputs. Here we test this hypothesis and ask if we can systematically reprogramme cellular morphology by engineering synthetic GEF proteins. We focused on Dbl family Rho GEFs, which have a highly modular structure common to many signalling proteins(4,5): they contain a catalytic Dbl homology (DH) domain linked to diverse regulatory domains, many of which autoinhibit GEF activity(2,3). Here we show that by recombining catalytic GEF domains with new regulatory modules, we can generate synthetic GEFs that are activated by non-native inputs. We have used these synthetic GEFs to reprogramme cellular behaviour in diverse ways. The GEFs can be used to link specific cytoskeletal responses to normally unrelated upstream signalling pathways. In addition, multiple synthetic GEFs can be linked as components in series to form an artificial cascade with improved signal processing behaviour. These results show the high degree of evolutionary plasticity of this important family of modular signalling proteins, and indicate that it may be possible to use synthetic biology approaches to manipulate the complex spatio-temporal control of cell morphology.	Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA USA; Univ Calif San Francisco, Cell Propuls Lab, UCSF UCB NIH Nanomed Dev Ctr, San Francisco, CA USA; Univ Calif San Francisco, Chem & Chem Biol Grad Program, San Francisco, CA USA; SUNY Stony Brook, Sch Med, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA; NYU, Sch Med, Dept Biochem, New York, NY 10016 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; New York University	Bar-Sagi, D (corresponding author), Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA USA.	dafna.bar-sagi@med.nyu.edu; lim@cmp.ucsf.edu		Bar-Sagi, Dafna/0000-0003-2597-8948				Bhattacharyya RP, 2006, ANNU REV BIOCHEM, V75, P655, DOI 10.1146/annurev.biochem.75.103004.142710; Colicelli John, 2004, Sci STKE, V2004, pRE13, DOI 10.1126/stke.2502004re13; Debant A, 1996, P NATL ACAD SCI USA, V93, P5466, DOI 10.1073/pnas.93.11.5466; Dueber JE, 2003, SCIENCE, V301, P1904, DOI 10.1126/science.1085945; DUEBER JE, 2007, IN PRESS NATURE BIOT; Ferrell JE, 1996, TRENDS BIOCHEM SCI, V21, P460, DOI 10.1016/S0968-0004(96)20026-X; Hoffman GR, 2002, FEBS LETT, V513, P85, DOI 10.1016/S0014-5793(01)03310-5; Hooshangi S, 2005, P NATL ACAD SCI USA, V102, P3581, DOI 10.1073/pnas.0408507102; Howard PL, 2003, P NATL ACAD SCI USA, V100, P11267, DOI 10.1073/pnas.1934711100; Inoue T, 2005, NAT METHODS, V2, P415, DOI 10.1038/NMETH763; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kim AS, 2000, NATURE, V404, P151, DOI 10.1038/35004513; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Miki H, 1998, NATURE, V391, P93, DOI 10.1038/34208; Nimnual AS, 1998, SCIENCE, V279, P560, DOI 10.1126/science.279.5350.560; Park SH, 2003, SCIENCE, V299, P1061, DOI 10.1126/science.1076979; Patel JC, 2005, CURR OPIN MICROBIOL, V8, P10, DOI 10.1016/j.mib.2004.09.001; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Prehoda KE, 2000, SCIENCE, V290, P801, DOI 10.1126/science.290.5492.801; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; SEAMON KB, 1981, J CYCLIC NUCL PROT, V7, P201; Snyder JT, 2002, NAT STRUCT BIOL, V9, P468, DOI 10.1038/nsb796; Sprinzak D, 2005, NATURE, V438, P443, DOI 10.1038/nature04335; Voigt CA, 2006, CURR OPIN BIOTECH, V17, P548, DOI 10.1016/j.copbio.2006.09.001; WALSH DA, 1994, FASEB J, V8, P1227, DOI 10.1096/fasebj.8.15.8001734; Wiedemann U, 2004, J MOL BIOL, V343, P703, DOI 10.1016/j.jmb.2004.08.064; Yamauchi J, 2005, P NATL ACAD SCI USA, V102, P14889, DOI 10.1073/pnas.0507125102; Zamanian JL, 2003, MOL BIOL CELL, V14, P1624, DOI 10.1091/mbc.E02-08-0494; ZHOU SY, 1994, CURR BIOL, V4, P973, DOI 10.1016/S0960-9822(00)00221-9	30	98	102	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 31	2007	447	7144					596	600		10.1038/nature05851	http://dx.doi.org/10.1038/nature05851			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172YZ	17515921				2022-12-28	WOS:000246842000050
J	Sullivan, F; Butler, C; Cupples, M; Kinmonth, AL				Sullivan, Frank; Butler, Chris; Cupples, Margaret; Kinmonth, Ann-Louise			Primary care research networks in the United Kingdom	BRITISH MEDICAL JOURNAL			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL		Univ Dundee, Tayside Ctr Gen Practice, Dundee DD2 4BF, Scotland; Cardiff Univ, Sch Med, Dept Primary Care & Publ Hlth, Cardiff CF14 4XN, S Glam, Wales; Queens Univ Belfast, Dept Gen Practice, Belfast BT9 9HR, Antrim, North Ireland; Univ Cambridge Forvie Site, Dept Publ Hlth & Primary Care, Cambridge CB2 2SR, England	University of Dundee; Cardiff University; Queens University Belfast; University of Cambridge	Sullivan, F (corresponding author), Univ Dundee, Tayside Ctr Gen Practice, Dundee DD2 4BF, Scotland.	f.m.sullivan@dundee.ac.uk	Sullivan, Frank m/A-7767-2009; Sullivan, Frank/L-8286-2019; Butler, Christopher C/B-5048-2009	Sullivan, Frank/0000-0002-6623-4964; Butler, Christopher/0000-0002-0102-3453; Cupples, Margaret/0000-0002-4248-9700				Black DA, 2007, BMJ-BRIT MED J, V334, P3, DOI 10.1136/bmj.39027.550324.47; Cooksey D., 2006, REV UK HLTH RES FUND; *DEP HLTH, 2006, IMPL PLAN 5 1A COMPR; Department of Health, 2006, BEST RES BEST HLTH N; HANCOCK B, 2006, PRIMARY HLTH CARE RE, V7, P10, DOI DOI 10.1191/1463423606PC2760A; HOWIE JGR, 1986, BRIT MED J, V292, P1567, DOI 10.1136/bmj.292.6535.1567; Leggett P, 2004, FAM PRACT, V21, P54, DOI 10.1093/fampra/cmh112; Murchie P, 2003, BRIT MED J, V326, P84, DOI 10.1136/bmj.326.7380.84; *RES DEV OFF HPSS, 2005, R D TOD; Russell I, 2003, BMC HEALTH SERV RES, V3; Scottish Executive, 2003, RES STRAT HLTH HEALT; Stange KC, 2001, FAM MED, V33, P286; Starfield B, 2005, MILBANK Q, V83, P457, DOI 10.1111/j.1468-0009.2005.00409.x; Thomas P, 2006, ANN FAM MED, V4, P235, DOI 10.1370/afm.521	14	30	30	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAY 26	2007	334	7603					1093	1094		10.1136/bmj.39190.648785.80	http://dx.doi.org/10.1136/bmj.39190.648785.80			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	174XB	17525452	Green Published			2022-12-28	WOS:000246975000031
J	Richland, LE; Zur, O; Holyoak, KJ				Richland, Lindsey E.; Zur, Osnat; Holyoak, Keith J.			Cognitive supports for analogies in the mathematics classroom	SCIENCE			English	Editorial Material							PHYSICS		Univ Calif Irvine, Dept Educ, Irvine, CA 92697 USA; Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA	University of California System; University of California Irvine; University of California System; University of California Los Angeles	Richland, LE (corresponding author), Univ Calif Irvine, Dept Educ, Irvine, CA 92697 USA.	l.e.richland@uci.edu		Holyoak, Keith/0000-0001-8010-6267; Richland, Lindsey/0000-0003-1514-6013				ALIBALI MW, 2007, VIDEO RES LEARNING S; Bransford J. D, 1999, PEOPLE LEARN BRAIN M; Carey S., 1985, CONCEPTUAL CHANGE CH; CHI MTH, 1981, COGNITIVE SCI, V5, P121, DOI 10.1207/s15516709cog0502_2; CLEMENT J, 1993, J RES SCI TEACH, V30, P1241, DOI 10.1002/tea.3660301007; English L., 1995, MATH ED MODELS PROCE; Findell, 2001, ADDING IT UP HELPING; Gattis M, 2004, COGNITIVE SCI, V28, P589, DOI 10.1016/j.cogsci.2004.02.001; Gelman R, 2000, J APPL DEV PSYCHOL, V21, P27, DOI 10.1016/S0193-3973(99)00048-9; Gentner D, 2003, J EDUC PSYCHOL, V95, P393, DOI 10.1037/0022-0663.95.2.393; GENTNER D, 1983, COGNITIVE SCI, V7, P155, DOI 10.1016/S0364-0213(83)80009-3; GICK ML, 1983, COGNITIVE PSYCHOL, V15, P1, DOI 10.1016/0010-0285(83)90002-6; Glynn S. M., 1995, LEARNING SCI SCH RES, P247; Goldin-Meadow S, 2003, HEARING GESTURE OUR; GONZALES P, 2000, 2001028 NCES US DEP; Goswami U., 1992, ANALOGICAL REASONING; Hiebert J., 2003, 2003013 NCES US DEP; Hummel JE, 2003, PSYCHOL REV, V110, P220, DOI 10.1037/0033-295X.110.2.220; INAGAKI K, 1987, CHILD DEV, V58, P1013; Kosslyn S.M., 2006, GRAPH DESIGN EYE MIN, DOI [10.1093/acprof:oso/9780195311846.001.0001, DOI 10.1093/ACPROF:OSO/9780195311846.001.0001]; Linn MC, 2006, SCIENCE, V313, P1049, DOI 10.1126/science.1131408; Martin M. O., 2004, TIMSS 2003 TECHNICAL; Novick L. R., 2005, CAMBRIDGE HDB THINKI, P321; Richland LE, 2004, COGNITION INSTRUCT, V22, P37, DOI 10.1207/s1532690Xci2201_2; Richland LE, 2006, J EXP CHILD PSYCHOL, V94, P249, DOI 10.1016/j.jecp.2006.02.002; SILVER EA, 2000, RESULTS 7 MATH ASSES; Stigler JW, 2000, EDUC PSYCHOL, V35, P87, DOI 10.1207/S15326985EP3502_3; ULAM SM, 1990, ANALOGIES ANALOGIES, P513; ZOOK KB, 1994, J EDUC PSYCHOL, V86, P589, DOI 10.1037/0022-0663.86.4.589	29	167	170	1	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 25	2007	316	5828					1128	1129		10.1126/science.1142103	http://dx.doi.org/10.1126/science.1142103			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	171GQ	17525320				2022-12-28	WOS:000246724300021
J	Shiroguchi, K; Kinosita, K				Shiroguchi, Katsuyuki; Kinosita, Kazuhiko, Jr.			Myosin V walks by lever action and Brownian motion	SCIENCE			English	Article							HAND-OVER-HAND; UNCONVENTIONAL MYOSIN; PROCESSIVE MYOSIN; MECHANISM; MOTOR; KINESIN; STEPS; FILAMENTS; DYNAMICS; HEAD	Myosin V is a molecular motor that moves cargo along actin filaments. Its two heads, each attached to a long and relatively stiff neck, move alternately forward in a "hand-over-hand" fashion. To observe under a microscope how the necks move, we attached a micrometer-sized rod to one of the necks. The leading neck swings unidirectionally forward, whereas the trailing neck, once lifted, undergoes extensive Brownian rotation in all directions before landing on a site ahead of the leading head. The neck-neck joint is essentially free, and the neck motion supports a mechanism where the active swing of the leading neck biases the random motion of the lifted head to let it eventually land on a forward site.	Waseda Univ, Fac Sci & Engn, Dept Phys, Shinjuku Ku, Tokyo 1698555, Japan	Waseda University	Kinosita, K (corresponding author), Waseda Univ, Fac Sci & Engn, Dept Phys, Shinjuku Ku, Okubo 3-4-1, Tokyo 1698555, Japan.	kazuhiko@waseda.jp						Ali MY, 2004, BIOPHYS J, V86, P3804, DOI 10.1529/biophysj.103.037416; Ali MY, 2002, NAT STRUCT BIOL, V9, P464, DOI 10.1038/nsb803; CHENEY RE, 1993, CELL, V75, P13, DOI 10.1016/0092-8674(93)90675-G; Coureux PD, 2004, EMBO J, V23, P4527, DOI 10.1038/sj.emboj.7600458; Crevel IMTC, 2004, EMBO J, V23, P23, DOI 10.1038/sj.emboj.7600042; De La Cruz EM, 1999, P NATL ACAD SCI USA, V96, P13726, DOI 10.1073/pnas.96.24.13726; Dunn AR, 2007, NAT STRUCT MOL BIOL, V14, P246, DOI 10.1038/nsmb1206; ESPREAFICO EM, 1992, J CELL BIOL, V119, P1541, DOI 10.1083/jcb.119.6.1541; Forkey JN, 2003, NATURE, V422, P399, DOI 10.1038/nature01529; HUXLEY HE, 1969, SCIENCE, V164, P1356, DOI 10.1126/science.164.3886.1356; KINOSITA K, 1984, BIOCHEMISTRY-US, V23, P5963, DOI 10.1021/bi00320a012; Kinosita K, 2005, ADV EXP MED BIOL, V565, P205; Kinosita K, 2007, ADV EXP MED BIOL, V592, P369; Mallik R, 2004, NATURE, V427, P649, DOI 10.1038/nature02293; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; Moore JR, 2001, J CELL BIOL, V155, P625, DOI 10.1083/jcb.200103128; Nishikawa S, 2002, BIOCHEM BIOPH RES CO, V290, P311, DOI 10.1006/bbrc.2001.6142; Okada T, 2007, BIOCHEM BIOPH RES CO, V354, P379, DOI 10.1016/j.bbrc.2006.12.200; Reck-Peterson SL, 2006, CELL, V126, P335, DOI 10.1016/j.cell.2006.05.046; Rock RS, 2001, P NATL ACAD SCI USA, V98, P13655, DOI 10.1073/pnas.191512398; Sellers JR, 2006, CURR OPIN CELL BIOL, V18, P68, DOI 10.1016/j.ceb.2005.12.014; SVOBODA K, 1993, NATURE, V365, P721, DOI 10.1038/365721a0; Toba S, 2006, P NATL ACAD SCI USA, V103, P5741, DOI 10.1073/pnas.0508511103; Toprak E, 2006, P NATL ACAD SCI USA, V103, P6495, DOI 10.1073/pnas.0507134103; Vale RD, 2003, J CELL BIOL, V163, P445, DOI 10.1083/jcb.200308093; Veigel C, 2002, NAT CELL BIOL, V4, P59, DOI 10.1038/ncb732; Walker ML, 2000, NATURE, V405, P804, DOI 10.1038/35015592; Yasuda R, 2001, NATURE, V410, P898, DOI 10.1038/35073513; Yildiz A, 2004, SCIENCE, V303, P676, DOI 10.1126/science.1093753; Yildiz A, 2004, J BIOL CHEM, V279, P37223, DOI 10.1074/jbc.C400252200; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398	31	99	103	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2007	316	5828					1208	1212		10.1126/science.1140468	http://dx.doi.org/10.1126/science.1140468			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171GQ	17525343				2022-12-28	WOS:000246724300048
J	Berger, SL				Berger, Shelley L.			The complex language of chromatin regulation during transcription	NATURE			English	Review							RNA-POLYMERASE-II; HISTONE H3; DNA METHYLATION; LYSINE-4 METHYLATION; GENE-EXPRESSION; CODING REGIONS; TRIMETHYLATION; ELONGATION; DOMAIN; DEMETHYLATION	An important development in understanding the influence of chromatin on gene regulation has been the finding that DNA methylation and histone post-translational modifications lead to the recruitment of protein complexes that regulate transcription. Early interpretations of this phenomenon involved gene regulation reflecting predictive activating or repressing types of modification. However, further exploration reveals that transcription occurs against a backdrop of mixtures of complex modifications, which probably have several roles. Although such modifications were initially thought to be a simple code, a more likely model is of a sophisticated, nuanced chromatin 'language' in which different combinations of basic building blocks yield dynamic functional outcomes.	Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA	The Wistar Institute	Berger, SL (corresponding author), Wistar Inst Anat & Biol, 3601 Spruce St,Room 201, Philadelphia, PA 19104 USA.	berger@wistar.org	Hu, Ruogu/B-2203-2008	Berger, Shelley/0000-0001-5398-4400				Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Belotserkovskaya R, 2003, SCIENCE, V301, P1090, DOI 10.1126/science.1085703; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Boeger H, 2003, MOL CELL, V11, P1587, DOI 10.1016/S1097-2765(03)00231-4; Brinkman AB, 2006, EMBO REP, V7, P628, DOI 10.1038/sj.embor.7400686; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Christensen J, 2007, CELL, V128, P1063, DOI 10.1016/j.cell.2007.02.003; Cloos PAC, 2006, NATURE, V442, P307, DOI 10.1038/nature04837; Couture JF, 2006, NAT STRUCT MOL BIOL, V13, P698, DOI 10.1038/nsmb1116; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; Govind CK, 2007, MOL CELL, V25, P31, DOI 10.1016/j.molcel.2006.11.020; Henikoff S, 2005, ANNU REV CELL DEV BI, V21, P133, DOI 10.1146/annurev.cellbio.21.012704.133518; Henry KW, 2003, GENE DEV, V17, P2648, DOI 10.1101/gad.1144003; Howe L, 2001, GENE DEV, V15, P3144, DOI 10.1101/gad.931401; Huang Y, 2006, SCIENCE, V312, P748, DOI 10.1126/science.1125162; Iwase S, 2007, CELL, V128, P1077, DOI 10.1016/j.cell.2007.02.017; Joshi AA, 2005, MOL CELL, V20, P971, DOI 10.1016/j.molcel.2005.11.021; Kaplan CD, 2003, SCIENCE, V301, P1096, DOI 10.1126/science.1087374; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Kouzarides T, 2006, EPIGENETICS, P191; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lee MG, 2005, NATURE, V437, P432, DOI 10.1038/nature04021; Lee MG, 2007, CELL, V128, P877, DOI 10.1016/j.cell.2007.02.004; Lieb JD, 2005, CELL, V123, P1187, DOI 10.1016/j.cell.2005.12.010; Martin DGE, 2006, MOL CELL BIOL, V26, P7871, DOI 10.1128/MCB.00573-06; Morillon A, 2005, MOL CELL, V18, P723, DOI 10.1016/j.molcel.2005.05.009; Nelson CJ, 2006, CELL, V126, P905, DOI 10.1016/j.cell.2006.07.026; Pavri R, 2006, CELL, V125, P703, DOI 10.1016/j.cell.2006.04.029; Pray-Grant MG, 2005, NATURE, V433, P434, DOI 10.1038/nature03242; Reinke H, 2003, MOL CELL, V11, P1599, DOI 10.1016/S1097-2765(03)00186-2; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Sims RJ, 2006, GENE DEV, V20, P2779, DOI 10.1101/gad.1468206; Steward MM, 2006, NAT STRUCT MOL BIOL, V13, P852, DOI 10.1038/nsmb1131; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Vakoc CR, 2005, MOL CELL, V19, P381, DOI 10.1016/j.molcel.2005.06.011; Wang A, 2002, SCIENCE, V298, P1412, DOI 10.1126/science.1077790; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Wood A, 2007, MOL CELL BIOL, V27, P709, DOI 10.1128/MCB.01627-06; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Xiao TJ, 2007, MOL CELL BIOL, V27, P721, DOI 10.1128/MCB.01628-06; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zilberman D, 2007, NAT GENET, V39, P61, DOI 10.1038/ng1929	50	2023	2123	10	316	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 24	2007	447	7143					407	412		10.1038/nature05915	http://dx.doi.org/10.1038/nature05915			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170VA	17522673				2022-12-28	WOS:000246693100035
J	Reynwar, BJ; Illya, G; Harmandaris, VA; Muller, MM; Kremer, K; Deserno, M				Reynwar, Benedict J.; Illya, Gregoria; Harmandaris, Vagelis A.; Mueller, Martin M.; Kremer, Kurt; Deserno, Markus			Aggregation and vesiculation of membrane proteins by curvature-mediated interactions	NATURE			English	Article							ENDOPLASMIC-RETICULUM; DYNAMICS; BAR; ATTRACTION; INCLUSIONS; GEOMETRY; BILAYERS; SURFACE; COATS	Membrane remodelling(1-5) plays an important role in cellular tasks such as endocytosis, vesiculation and protein sorting, and in the biogenesis of organelles such as the endoplasmic reticulum or the Golgi apparatus. It is well established that the remodelling process is aided by specialized proteins that can sense(4) as well as create(6) membrane curvature, and trigger tubulation(7-9) when added to synthetic liposomes. Because the energy needed for such large-scale changes in membrane geometry significantly exceeds the binding energy between individual proteins and between protein and membrane, cooperative action is essential. It has recently been suggested(10,11) that curvature-mediated attractive interactions could aid cooperation and complement the effects of specific binding events on membrane remodelling. But it is difficult to experimentally isolate curvature-mediated interactions from direct attractions between proteins. Moreover, approximate theories predict repulsion between isotropically curving proteins(12-15). Here we use coarse-grained membrane simulations to show that curvature-inducing model proteins adsorbed on lipid bilayer membranes can experience attractive interactions that arise purely as a result of membrane curvature. We find that once a minimal local bending is realized, the effect robustly drives protein cluster formation and subsequent transformation into vesicles with radii that correlate with the local curvature imprint. Owing to its universal nature, curvature-mediated attraction can operate even between proteins lacking any specific interactions, such as newly synthesized and still immature membrane proteins in the endoplasmic reticulum.	Max Planck Inst Polymer Res, D-55128 Mainz, Germany	Max Planck Society	Deserno, M (corresponding author), Max Planck Inst Polymer Res, Ackermannweg 10, D-55128 Mainz, Germany.	kremer@mpip-mainz.mpg.de; deserno@mpip-mainz.mpg.de	Müller, Martin Michael/B-3677-2009; Kremer, Kurt/G-5652-2011; Harmandaris, Vagelis/B-2958-2009; Deserno, Markus/P-1699-2014	Müller, Martin Michael/0000-0002-6062-8073; Kremer, Kurt/0000-0003-1842-9369; Harmandaris, Vagelis/0000-0002-9613-7639; Deserno, Markus/0000-0001-5692-1595				Antonny B, 2006, CURR OPIN CELL BIOL, V18, P386, DOI 10.1016/j.ceb.2006.06.003; Bannykh SI, 1997, J CELL BIOL, V138, P1, DOI 10.1083/jcb.138.1.1; Bartolo D, 2003, EUR PHYS J E, V11, P141, DOI 10.1140/epje/i2002-10154-5; Blood PD, 2006, P NATL ACAD SCI USA, V103, P15068, DOI 10.1073/pnas.0603917103; Brannigan G, 2006, EUR BIOPHYS J BIOPHY, V35, P104, DOI 10.1007/s00249-005-0013-y; Chou T, 2001, BIOPHYS J, V80, P1075, DOI 10.1016/S0006-3495(01)76086-9; Cooke IR, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.011506; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Fournier JB, 2003, CR BIOL, V326, P467, DOI 10.1016/S1631-0691(03)00096-9; Gottwein E, 2003, J VIROL, V77, P9474, DOI 10.1128/JVI.77.17.9474-9485.2003; Goulding D, 1999, EUROPHYS LETT, V46, P407, DOI 10.1209/epl/i1999-00276-4; GOULIAN M, 1993, EUROPHYS LETT, V22, P145, DOI 10.1209/0295-5075/22/2/012; Harmandaris VA, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2372761; HELFRICH W, 1973, Z NATURFORSCH C, VC 28, P693, DOI 10.1515/znc-1973-11-1209; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Kim KS, 1998, BIOPHYS J, V75, P2274, DOI 10.1016/S0006-3495(98)77672-6; Koltover I, 1999, PHYS REV LETT, V82, P1991, DOI 10.1103/PhysRevLett.82.1991; Lippincott-Schwartz J, 2000, ANNU REV CELL DEV BI, V16, P557, DOI 10.1146/annurev.cellbio.16.1.557; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Muller M, 2006, PHYS REP, V434, P113, DOI 10.1016/j.physrep.2006.08.003; Muller MM, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.061407; Muller MM, 2005, EUROPHYS LETT, V69, P482, DOI 10.1209/epl/i2004-10368-1; Takei K, 1999, NAT CELL BIOL, V1, P33, DOI 10.1038/9004; Venturoli M, 2006, PHYS REP, V437, P1, DOI 10.1016/j.physrep.2006.07.006; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; Weikl TR, 1998, PHYS REV E, V57, P6988, DOI 10.1103/PhysRevE.57.6988; Zimmerberg J, 2006, NAT REV MOL CELL BIO, V7, P9, DOI 10.1038/nrm1784; Zimmerberg J, 2004, CURR BIOL, V14, pR250, DOI 10.1016/j.cub.2004.02.060	29	583	589	2	231	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 24	2007	447	7143					461	464		10.1038/nature05840	http://dx.doi.org/10.1038/nature05840			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170VA	17522680				2022-12-28	WOS:000246693100044
J	Miller, JM; Korenromp, EL; Nahlen, BL; Steketee, RW				Miller, John M.; Korenromp, Eline L.; Nahlen, Bernard L.; Steketee, Richard W.			Estimating the number of insecticide-treated nets required by African households to reach continent-wide malaria coverage targets	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							KASSENA-NANKANA DISTRICT; PERMETHRIN-IMPREGNATED BEDNETS; BED-NETS; CHILD-MORTALITY; WESTERN KENYA; MOSQUITO-NETS; MORBIDITY; IMPACT; TRANSMISSION; PREGNANCY	Context African countries are scaling up malaria interventions, especially insecticide-treated nets (ITNs), for which ambitious coverage targets have been set. Objective To estimate how many ITNs are available in African households that are at risk of malaria and how many ITNs are needed to reach targets for use by children younger than 5 years and pregnant women. Data Sources Primary sources of data were the Multiple Indicator Cluster Surveys II, the Demographic and Health Surveys, or other nationally representative or large-scale household surveys that measured household possession and use of nets or ITNs among children younger than 5 years. Data Extraction Data from 42 household surveys between 1999 and 2006 on net and ITN coverage (either household possession or use) and average numbers of nets and ITNs per household were compared with populations and households at risk. Data are included for 43 sub-Saharan African countries. Data Synthesis For the median survey year 2003, the population-weighted mean proportion of households possessing at least 1 ITN was 6.7% (range among countries, 0.1%-71.0%) and was 23.8% (range, 5.0%-91.2%) for any type of net. Based on an average of 0.13 ITNs per household, we estimated that 53.6 million nets, of which 16.7 million were ITNs, were available in households at risk of malaria. Between 130 million and 264 million ITNs are required in 2007 to reach the 80% coverage target for about 133 million children younger than 5 years and pregnant women living in 123 million households in risk areas; the exact number depends on usage patterns (best estimate, assuming 55% of owned ITNs are used by the target groups, 192 million ITNs). Conclusion To achieve the targeted ITN usage rates, numbers of ITNs available to African households must be dramatically increased.	Natl Malaria Control Ctr, PATH MACEPA, Lusaka, Zambia; Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA 70118 USA; Global Fund Fight AIDS TB & Malaria, Geneva, Switzerland; Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; PATH MACEPA, Ferney Voltaire, France	Tulane University; Erasmus University Rotterdam; Erasmus MC	Miller, JM (corresponding author), Natl Malaria Control Ctr, PATH MACEPA, PostNet POB 370,P Bag E10, Lusaka, Zambia.	jmiller@path.org	Nahlen, Bernard/AAH-2051-2021; Miller, John J/GZG-5663-2022					*AM RED CROSS, MEASL IN; Binka FN, 1996, TROP MED INT HEALTH, V1, P147; Binka FN, 1997, HEALTH POLICY, V41, P229, DOI 10.1016/S0168-8510(97)00035-3; BRADLEY AK, 1986, LANCET, V2, P204; Browne ENL, 2001, TROP MED INT HEALTH, V6, P667, DOI 10.1046/j.1365-3156.2001.00759.x; *CDCP, 2005, MMWR-MORBID MORTAL W, V54, P994; Craig MH, 1999, PARASITOL TODAY, V15, P105, DOI 10.1016/S0169-4758(99)01396-4; Curtis C, 2003, LANCET INFECT DIS, V3, P304, DOI 10.1016/S1473-3099(03)00612-1; DAlessandro U, 1996, T ROY SOC TROP MED H, V90, P487, DOI 10.1016/S0035-9203(96)90289-8; Deichmann U, 1996, AFRICAN POPULATION D; GEBREMESKEL TKJ, 2004, BED NET OWNERSHIP US; Gonzalez JO, 2002, T ROY SOC TROP MED H, V96, P370, DOI 10.1016/S0035-9203(02)90363-9; Johnson K, 2005, J EVAL CLIN PRACT, V11, P257, DOI 10.1111/j.1365-2753.2005.00532.x; Korenromp EL, 2003, TROP MED INT HEALTH, V8, P693, DOI 10.1046/j.1365-3156.2003.01084.x; Lengeler C, 2004, COCHRANE DATABASE SY; Lindblade KA, 2005, TROP MED INT HEALTH, V10, P1141, DOI 10.1111/j.1365-3156.2005.01501.x; Mabaso MLH, 2004, TROP MED INT HEALTH, V9, P846, DOI 10.1111/j.1365-3156.2004.01263.x; *MARA ARMA, MOD MAPS MAL TRANSM; Ministry of Health [Zambia], 2006, ZAMB NAT MAL IND SUR; Monasch R, 2004, AM J TROP MED HYG, V71, P232, DOI 10.4269/ajtmh.2004.71.232; Nevill CG, 1996, TROP MED INT HEALTH, V1, P139; *PATH, OV PATH MACEPA ACT; Phillips-Howard PA, 2003, AM J TROP MED HYG, V68, P23, DOI 10.4269/ajtmh.2003.68.23; *PMI, OV PMI ACT; *PROGR NAT LUTT PA, 2005, COMM BAS CROSS SECT; *ROLL BACK MAL PAR, 2005, ROLL BACK MAL GLOB S; Schellenberg JRMA, 1999, T ROY SOC TROP MED H, V93, P225, DOI 10.1016/S0035-9203(99)90001-9; Shirayama Y, 2007, PUBLIC HEALTH, V121, P122, DOI 10.1016/j.puhe.2006.06.016; Snow RW, 1999, B WORLD HEALTH ORGAN, V77, P624; ter Kuile FO, 2003, AM J TROP MED HYG, V68, P50, DOI 10.4269/ajtmh.2003.68.50; The Global Fund to fight AIDS Tuberculosis and Malaria, 2006, GLOBAL FUND FIGHT AI; *UG MIN HLTH, 2006, UG HIV AIDS SER SURV; UN, 2006, MILL DEV GOALS REP 2; *UN CHILDR FUND, CHILD MON SIT CHILDR; *UN POP DIV, 2005, WORLD POP PROSP 2002; United Nations Children's Fund, 2006, STAT WORLDS CHILDR 2; VanBortel W, 1996, TROP MED INT HEALTH, V1, P824; WEBSTER JLI, 2006, PROTECTING AL PREGNA; *WHO, 2006, PERM LONG LAST INC F; *WHO, 2005, NAT MAL PREV SURV JA; *WHO, 2007, TECHN CONS SPEC QUAL; *WHO ROLL BACK MAL, 2003, WHOCDSRBM200017; *WHO UN CHILDR FUN, 2003, WHOCDSMAL20031093; WHO UNICEF, 2005, WORLD MALARIA REPORT; *WHOPES\, 2007, 10 WHOPES WORK GROUP; World Bank, BOOST PROGR MAL CONT; Yates A, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-52	47	36	38	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 23	2007	297	20					2241	2250		10.1001/jama.297.20.2241	http://dx.doi.org/10.1001/jama.297.20.2241			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	170JM	17519414				2022-12-28	WOS:000246659700024
J	Armitage, J				Armitage, Jane			The safety of statins in clinical practice	LANCET			English	Review							HMG-COA REDUCTASE; RENAL-TRANSPLANT RECIPIENTS; PLACEBO-CONTROLLED TRIAL; CORONARY-HEART-DISEASE; HIGH-DOSE ATORVASTATIN; FAMILIAL HYPERCHOLESTEROLEMIA; CHOLESTEROL REDUCTION; CARDIAC OUTCOMES; MYOCARDIAL-INFARCTION; DEPRESSIVE SYMPTOMS	Statins are effective cholesterol-lowering drugs that reduce the risk of cardiovascular disease events (heart attacks, strokes, and the need for arterial revascularisation). Adverse effects from some statins on muscle, such as myopathy and rhabdomyolysis, are rare at standard doses, and on the liver, in increasing levels of transaminases, are unusual. Myopathy-muscle pain or weakness with blood creatine kinase levels more than ten times the upper limit of the normal range-typically occurs in fewer than one in 10000 patients on standard statin doses. However, this risk varies between statins, and increases with use of higher doses and interacting drugs. Rhabdomyolysis is a rarer and more severe form of myopathy, with myoglobin release into the circulation and risk of renal failure. Stopping statin use reverses these side-effects, usually leading to a full recovery. Asymptornatic increases in concentrations of liver transaminases are recorded with all statins, but are not clearly associated with an increased risk of liver disease. For most people, statins are safe and well-tolerated, and their widespread use has the potential to have a major effect on the global burden of cardiovascular disease.	Univ Oxford, Clin Trial Serv Unit, Oxford OX3 7LF, England; Univ Oxford, Epidemiol Studies Unit, Oxford OX3 7LF, England	University of Oxford; University of Oxford	Armitage, J (corresponding author), Univ Oxford, Clin Trial Serv Unit, Richard Doll Bldg,Old Rd Campus, Oxford OX3 7LF, England.	jane.armitage@ctsu.ox.ac.uk						Alsheikh-Ali AA, 2005, CIRCULATION, V111, P3051, DOI 10.1161/CIRCULATIONAHA.105.555482; Amarenco P, 2006, NEW ENGL J MED, V355, P549; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; ARAD Y, 1992, METABOLISM, V41, P487, DOI 10.1016/0026-0495(92)90206-P; Ashton Emma, 2003, Heart Fail Monit, V3, P82; Baigent C, 2004, CURR OPIN NEPHROL HY, V13, P601, DOI 10.1097/00041552-200411000-00004; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Ballantyne CM, 2003, AM HEART J, V146, P862, DOI 10.1016/S0002-8703(03)00440-X; Bays H, 2002, EXPERT OPIN INV DRUG, V11, P1587, DOI 10.1517/13543784.11.11.1587; Bellosta S, 2004, CIRCULATION, V109, P50, DOI 10.1161/01.CIR.0000131519.15067.1f; BLACK DM, 1990, JAMA-J AM MED ASSOC, V264, P1105, DOI 10.1001/jama.1990.03450090041020; BRADFORD RH, 1994, AM J CARDIOL, V74, P667, DOI 10.1016/0002-9149(94)90307-7; BRADFORD RH, 1991, AM J MED, V91, pS18, DOI 10.1016/0002-9343(91)90052-Y; Brewer HB, 2003, AM J CARDIOL, V92, p23K, DOI 10.1016/S0002-9149(03)00779-3; BROWN MS, 1980, J LIPID RES, V21, P505; BROWN SL, 1994, BRIT MED J, V308, P1328, DOI 10.1136/bmj.308.6940.1328; Bruckert E, 2005, CARDIOVASC DRUG THER, V19, P403, DOI 10.1007/s10557-005-5686-z; Cannon CP, 2006, J AM COLL CARDIOL, V48, P438, DOI 10.1016/j.jacc.2006.04.070; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Capuzzi DM, 1998, AM J CARDIOL, V82, p74U, DOI 10.1016/S0002-9149(98)00731-0; Chalasani N, 2004, GASTROENTEROLOGY, V126, P1287, DOI 10.1053/j.gastro.2004.02.015; CHEN ZM, 1991, BRIT MED J, V303, P276, DOI 10.1136/bmj.303.6797.276; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Colhoun HM, 2004, LANCET, V364, P685, DOI 10.1016/S0140-6736(04)16895-5; Collins R, 2004, LANCET, V363, P757; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Collins R, 2003, LANCET, V361, P2005; Davidson MH, 2006, AM J CARDIOL, V97, p32C, DOI 10.1016/j.amjcard.2005.12.008; de Jongh S, 2002, CIRCULATION, V106, P2231, DOI 10.1161/01.CIR.0000035247.42888.82; de Lemos JA, 2004, JAMA-J AM MED ASSOC, V292, P1307, DOI 10.1001/jama.292.11.1307; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; Edison RJ, 2004, NEW ENGL J MED, V350, P1579, DOI 10.1056/NEJM200404083501524; Fried LF, 2001, KIDNEY INT, V59, P260, DOI 10.1046/j.1523-1755.2001.00487.x; Furberg CD, 2001, CURR CONTR TRIALS C, V2, P205, DOI 10.1186/CVM-2-5-205; Gaist D, 2002, NEUROLOGY, V58, P1333, DOI 10.1212/WNL.58.9.1333; Gaist D, 2001, EUR J CLIN PHARMACOL, V56, P931, DOI 10.1007/s002280000248; GERSON RJ, 1990, EXP EYE RES, V50, P65, DOI 10.1016/0014-4835(90)90012-J; Gibb H, 2005, AM J MED GENET A, V135A, P230, DOI 10.1002/ajmg.a.30685; Gibson K, 2005, AM J CARDIOL, V96, P1278, DOI 10.1016/j.amjcard.2005.06.071; Grundy SM, 2005, CIRCULATION, V111, P3016, DOI 10.1161/CIRCULATIONAHA.105.557652; GRUNDY SM, 1988, NEW ENGL J MED, V319, P24; HARRIS ML, 1995, BRIT J OPHTHALMOL, V79, P996, DOI 10.1136/bjo.79.11.996; HARRISON RWS, 1994, BRIT J CLIN PHARMACO, V37, P231, DOI 10.1111/j.1365-2125.1994.tb04268.x; Heart Protection Study Collaborat, 2007, J AM COLL CARDIOL, V49, P311, DOI 10.1016/j.jacc.2006.08.052; Holdaas H, 2005, AM J TRANSPLANT, V5, P2929, DOI 10.1111/j.1600-6143.2005.01105.x; Holdaas H, 2003, LANCET, V361, P2024, DOI 10.1016/S0140-6736(03)13638-0; Horwich TB, 2002, J CARD FAIL, V8, P216, DOI 10.1054/jcaf.2002.126519a; Illingworth RD, 2001, CURR MED RES OPIN, V17, P43; JACOBS D, 1992, CIRCULATION, V86, P1046, DOI 10.1161/01.CIR.86.3.1046; Jacobson TA, 2006, AM J CARDIOL, V97, p44C, DOI 10.1016/j.amjcard.2005.12.009; Jick H, 2000, LANCET, V356, P1627, DOI 10.1016/S0140-6736(00)03155-X; KEECH A, 1994, EUR HEART J, V15, P255, DOI 10.1093/oxfordjournals.eurheartj.a060485; Keech AC, 1996, BRIT J CLIN PHARMACO, V42, P483, DOI 10.1111/j.1365-2125.1996.tb00012.x; Khush KK, 2007, CIRCULATION, V115, P576, DOI 10.1161/CIRCULATIONAHA.106.625574; Kinlay S, 2004, CIRCULATION, V110, P386, DOI 10.1161/01.CIR.0000136588.62638.5E; KRUM H, 2002, J AM COLL CARDIOL, V8, P216; Lane R, 2003, BMJ-BRIT MED J, V327, P115, DOI 10.1136/bmj.327.7407.115; Lankas GR, 2004, BIRTH DEFECTS RES B, V71, P111, DOI 10.1002/bdrb.20005; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; LATIES AM, 1991, AM J CARDIOL, V67, P447, DOI 10.1016/0002-9149(91)90002-3; Law M, 2006, AM J CARDIOL, V97, p52C, DOI 10.1016/j.amjcard.2005.12.010; Maddrey WC, 2005, J CLIN GASTROENTEROL, V39, pS83, DOI 10.1097/01.mcg.0000155548.91524.6e; McCrindle BW, 2003, J PEDIATR-US, V143, P74, DOI 10.1016/S0022-3476(03)00186-0; McKenney JM, 2006, AM J CARDIOL, V97, p89C, DOI 10.1016/j.amjcard.2006.02.030; Melli G, 2005, MEDICINE, V84, P377, DOI 10.1097/01.md.0000188565.48918.41; Mohler ER, 2003, CIRCULATION, V108, P1481, DOI 10.1161/01.CIR.0000090686.57897.F5; MORGAN RE, 1993, LANCET, V341, P75, DOI 10.1016/0140-6736(93)92556-9; Mukhtar RYA, 2005, INT J CLIN PRACT, V59, P239, DOI 10.1111/j.1742-1241.2005.00461.x; Muldoon MF, 2001, BRIT MED J, V322, P11, DOI 10.1136/bmj.322.7277.11; MULDOON MF, 1994, BRIT MED J, V308, P1104, DOI 10.1136/bmj.308.6936.1104a; Nathwani RA, 2005, HEPATOLOGY, V41, P380, DOI 10.1002/hep.20548; Navarro VJ, 2006, NEW ENGL J MED, V354, P731, DOI 10.1056/NEJMra052270; NEATON JD, 1992, ARCH INTERN MED, V152, P1490, DOI 10.1001/archinte.152.7.1490; Newman C, 2006, AM J CARDIOL, V97, P61, DOI 10.1016/j.amjcard.2005.07.108; Newman CB, 2003, AM J CARDIOL, V92, P670, DOI 10.1016/S0002-9149(03)00820-8; Park S, 2005, CLIN THER, V27, P1074, DOI 10.1016/j.clinthera.2005.07.007; Pasco JA, 2002, ARCH INTERN MED, V162, P537, DOI 10.1001/archinte.162.5.537; Pasternak RC, 2002, J AM COLL CARDIOL, V40, P567, DOI 10.1016/S0735-1097(02)02030-2; Pasternak RC, 2002, STROKE, V33, P2337, DOI 10.1161/01.str.0000034125.94759.41; Pedersen TR, 1996, DRUG SAFETY, V14, P11, DOI 10.2165/00002018-199614010-00003; Pedersen TR, 1996, ARCH INTERN MED, V156, P2085, DOI 10.1001/archinte.156.18.2085; PEDERSEN TR, 1994, LANCET, V344, P1383; Pedersen TR, 2005, JAMA-J AM MED ASSOC, V294, P2437, DOI 10.1001/jama.294.19.2437; PETO R, 1985, CIRCULATION, V72, P451; Pfeffer MA, 2002, CIRCULATION, V105, P2341, DOI 10.1161/01.CIR.0000017634.00171.24; Pollack PS, 2005, BIRTH DEFECTS RES A, V73, P888, DOI 10.1002/bdra.20181; Prueksaritanont T, 2002, J PHARMACOL EXP THER, V301, P1042, DOI 10.1124/jpet.301.3.1042; Raina A, 2006, AM HEART J, V152, P39, DOI 10.1016/j.ahj.2005.09.008; Rauchhaus M, 2003, J AM COLL CARDIOL, V42, P1933, DOI 10.1016/j.jacc.2003.07.016; Reid IR, 2001, LANCET, V357, P509, DOI 10.1016/S0140-6736(00)04042-3; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Sakaeda T, 2006, PHARM RES-DORDR, V23, P506, DOI 10.1007/s11095-005-9371-5; Sandhu S, 2006, J AM SOC NEPHROL, V17, P2006, DOI 10.1681/ASN.2006010012; Sankatsing RR, 2005, ARTERIOSCL THROM VAS, V25, P1979, DOI 10.1161/01.ATV.0000176191.64314.07; Schuster H, 2004, EXPERT OPIN PHARMACO, V5, P1187, DOI 10.1517/eoph.5.5.1187.31087; Serruys PWJC, 2002, JAMA-J AM MED ASSOC, V287, P3215, DOI 10.1001/jama.287.24.3215; Sever PS, 2003, LANCET, V361, P1149, DOI 10.1016/S0140-6736(03)12948-0; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X; Shitara Y, 2006, PHARMACOL THERAPEUT, V112, P71, DOI 10.1016/j.pharmthera.2006.03.003; Simes RJ, 2002, LANCET, V359, P1379; Stein EA, 1999, JAMA-J AM MED ASSOC, V281, P137, DOI 10.1001/jama.281.2.137; Strandberg TE, 2004, LANCET, V364, P771, DOI 10.1016/S0140-6736(04)16936-5; Thompson PD, 2003, JAMA-J AM MED ASSOC, V289, P1681, DOI 10.1001/jama.289.13.1681; TOBERT JA, 1988, AM J CARDIOL, V62, pJ28, DOI 10.1016/0002-9149(88)90004-5; Tobert JA, 2003, NAT REV DRUG DISCOV, V2, P517, DOI 10.1038/nrd1112; Tolman KG, 2002, AM J CARDIOL, V89, P1374, DOI 10.1016/S0002-9149(02)02355-X; Tolman KG, 2000, AM J CARDIOL, V85, p15E; Tonelli M, 2003, J AM SOC NEPHROL, V14, P1605, DOI 10.1097/01.ASN.0000068461.45784.2F; U.S. Food and Drug Administration, MED PROD SAF INF; U.S. Food and Drug Administration (FDA), FDA AL HEALTHC PROF; *US FDA, BAYC WITHD LETT; Vidt DG, 2004, CARDIOLOGY, V102, P52, DOI 10.1159/000077704; Wagstaff LR, 2003, PHARMACOTHERAPY, V23, P871, DOI 10.1592/phco.23.7.871.32720; Wanner C, 2005, NEW ENGL J MED, V353, P238, DOI 10.1056/NEJMoa043545; Wardle J, 1996, BRIT MED J, V313, P75, DOI 10.1136/bmj.313.7049.75; Wiviott SD, 2006, CIRCULATION, V113, P1406, DOI 10.1161/CIRCULATIONAHA.105.586347; Wood D, 2005, HEART, V91, P1, DOI 10.1136/hrt.2005.079988; [No title captured]	118	578	612	0	86	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 24	2007	370	9601					1781	1790		10.1016/S0140-6736(07)60716-8	http://dx.doi.org/10.1016/S0140-6736(07)60716-8			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	234DI	17559928				2022-12-28	WOS:000251140500023
J	McHugh, TJ; Jones, MW; Quinn, JJ; Balthasar, N; Coppari, R; Elmquist, JK; Lowell, BB; Fanselow, MS; Wilson, MA; Tonegawa, S				McHugh, Thomas J.; Jones, Matthew W.; Quinn, Jennifer J.; Balthasar, Nina; Coppari, Roberto; Elmquist, Joel K.; Lowell, Bradford B.; Fanselow, Michael S.; Wilson, Matthew A.; Tonegawa, Susumu			Dentate gyrus NMDA receptors mediate rapid pattern separation in the hippocampal network	SCIENCE			English	Article							SPATIAL EXPERIENCE; NEURONAL ENSEMBLES; EPISODIC MEMORY; KNOCKOUT MICE; PLACE CELLS; CA3; REPRESENTATION; RAT; SLEEP; PLASTICITY	Forming distinct representations of multiple contexts, places, and episodes is a crucial function of the hippocampus. The dentate gyrus subregion has been suggested to fulfill this role. We have tested this hypothesis by generating and analyzing a mouse strain that lacks the gene encoding the essential subunit of the N-methyl-D-aspartate (NMDA) receptor NR1, specifically in dentate gyrus granule cells. The mutant mice performed normally in contextual fear conditioning, but were impaired in the ability to distinguish two similar contexts. A significant reduction in the context-specific modulation of firing rate was observed in the CA3 pyramidal cells when the mutant mice were transferred from one context to another. These results provide evidence that NMDA receptors in the granule cells of the dentate gyrus play a crucial role in the process of pattern separation.	MIT, Picower Inst Learning & Memory, RIKEN MIT Neurosci Res Ctr, Dept Biol, Cambridge, MA 02139 USA; MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Endocrinol, Boston, MA 02215 USA	Massachusetts Institute of Technology (MIT); Northwell Health; RIKEN; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); University of California System; University of California Los Angeles; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Tonegawa, S (corresponding author), MIT, Picower Inst Learning & Memory, RIKEN MIT Neurosci Res Ctr, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	tonegawa@mit.edu	McHugh, Thomas/M-6159-2019; McHugh, Thomas J/A-6693-2010; Coppari, Roberto/B-4799-2014	McHugh, Thomas/0000-0002-1243-5189; McHugh, Thomas J/0000-0002-1243-5189; Jones, Matthew/0000-0001-5396-3108; COPPARI, Roberto/0000-0003-1288-6948	MRC [G0501146] Funding Source: UKRI; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH058880, R01MH062122] Funding Source: NIH RePORTER; Medical Research Council [G0501146] Funding Source: Medline; NIMH NIH HHS [MH62122, P50-MH58880] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Balthasar N, 2004, NEURON, V42, P983, DOI 10.1016/j.neuron.2004.06.004; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Cravens CJ, 2006, EUR J NEUROSCI, V24, P1771, DOI 10.1111/j.1460-9568.2006.05044.x; FANSELOW MS, 1981, LEARN MOTIV, V12, P398, DOI 10.1016/0023-9690(81)90002-3; Fyhn M, 2007, NATURE, V446, P190, DOI 10.1038/nature05601; Gilbert PE, 2006, BEHAV BRAIN RES, V169, P142, DOI 10.1016/j.bbr.2006.01.002; Gilbert PE, 2001, HIPPOCAMPUS, V11, P626, DOI 10.1002/hipo.1077; Hollup SA, 2001, EUR J NEUROSCI, V13, P1197, DOI 10.1046/j.0953-816x.2001.01487.x; Huerta PT, 2000, NEURON, V25, P473, DOI 10.1016/S0896-6273(00)80909-5; JARRARD LE, 1993, BEHAV NEURAL BIOL, V60, P9, DOI 10.1016/0163-1047(93)90664-4; Lee I, 2004, NATURE, V430, P456, DOI 10.1038/nature02739; Leutgeb JK, 2007, SCIENCE, V315, P961, DOI 10.1126/science.1135801; Leutgeb S, 2005, SCIENCE, V309, P619, DOI 10.1126/science.1114037; Leutgeb S, 2004, SCIENCE, V305, P1295, DOI 10.1126/science.1100265; Leutgeb S, 2006, HIPPOCAMPUS, V16, P765, DOI 10.1002/hipo.20201; Lever C, 2002, NATURE, V416, P90, DOI 10.1038/416090a; Louie K, 2001, NEURON, V29, P145, DOI 10.1016/S0896-6273(01)00186-6; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; McClelland JL, 1996, HIPPOCAMPUS, V6, P654; McHugh TJ, 1996, CELL, V87, P1339, DOI 10.1016/S0092-8674(00)81828-0; McNaughton BL, 1990, NEUROSCIENCE CONNECT, P1; Moita MAP, 2004, J NEUROSCI, V24, P7015, DOI 10.1523/JNEUROSCI.5492-03.2004; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; Nakazawa K, 2003, NEURON, V38, P305, DOI 10.1016/S0896-6273(03)00165-X; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OREILLY RC, 1994, HIPPOCAMPUS, V4, P661, DOI 10.1002/hipo.450040605; Rondi-Reig L, 2001, P NATL ACAD SCI USA, V98, P3543, DOI 10.1073/pnas.041620798; SCOVILLE W, 1957, J NEUROPSYCHIATRY CL, V12, P103; Shen JM, 1998, J SLEEP RES, V7, P6, DOI 10.1046/j.1365-2869.7.s1.2.x; Skaggs WE, 1996, SCIENCE, V271, P1870, DOI 10.1126/science.271.5257.1870; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Wills TJ, 2005, SCIENCE, V308, P873, DOI 10.1126/science.1108905; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520	35	662	677	1	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 6	2007	317	5834					94	99		10.1126/science.1140263	http://dx.doi.org/10.1126/science.1140263			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186KD	17556551				2022-12-28	WOS:000247776700057
J	Penn, RL				Penn, R. Lee			Resolving an elusive structure	SCIENCE			English	Editorial Material							FERRIHYDRITE; GROWTH		Univ Minnesota, Dept Chem, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Penn, RL (corresponding author), Univ Minnesota, Dept Chem, 207 Pleasant St SE, Minneapolis, MN 55455 USA.	penn@chem.umn.edu						Banfield JF, 2000, SCIENCE, V289, P751, DOI 10.1126/science.289.5480.751; Berquo TS, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2006JB004583; DRITS VA, 1993, CLAY MINER, V28, P185, DOI 10.1180/claymin.1993.028.2.02; Ford RG, 1997, ENVIRON SCI TECHNOL, V31, P2028, DOI 10.1021/es960824+; Fortin D, 2005, EARTH-SCI REV, V72, P1, DOI 10.1016/j.earscirev.2005.03.002; Jambor JL, 1998, CHEM REV, V98, P2549, DOI 10.1021/cr970105t; Michel FM, 2007, SCIENCE, V316, P1726, DOI 10.1126/science.1142525; Michel FM, 2005, CHEM MATER, V17, P6246, DOI 10.1021/cm050886b; Penn RL, 2006, J CRYST GROWTH, V293, P1, DOI 10.1016/j.jcrysgro.2006.05.005; Petkov V, 2002, J AM CHEM SOC, V124, P10157, DOI 10.1021/ja026143y; Petkov V, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.195402; Raven KP, 1998, ENVIRON SCI TECHNOL, V32, P344, DOI 10.1021/es970421p	12	14	14	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 22	2007	316	5832					1704	1705		10.1126/science.1144002	http://dx.doi.org/10.1126/science.1144002			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	180XE	17525300				2022-12-28	WOS:000247400500031
J	Sugase, K; Dyson, HJ; Wright, PE				Sugase, Kenji; Dyson, H. Jane; Wright, Peter E.			Mechanism of coupled folding and binding of an intrinsically disordered protein	NATURE			English	Article							TRANSCRIPTION FACTOR-BINDING; CHEMICAL-EXCHANGE; KIX DOMAIN; UNSTRUCTURED PROTEINS; MACROMOLECULAR INTERACTIONS; TRANSACTIVATION DOMAIN; NMR-SPECTROSCOPY; CREB; CBP; COACTIVATOR	Protein folding and binding are analogous processes, in which the protein 'searches' for favourable intramolecular or intermolecular interactions on a funnelled energy landscape(1,2). Many eukaryotic proteins are disordered under physiological conditions, and fold into ordered structures only on binding to their cellular targets(3-6). The mechanism by which folding is coupled to binding is poorly understood, but it has been hypothesized on theoretical grounds that the binding kinetics may be enhanced by a 'fly-casting' effect, where the disordered protein binds weakly and non-specifically to its target and folds as it approaches the cognate binding site(7). Here we show, using NMR titrations and N-15 relaxation dispersion, that the phosphorylated kinase inducible activation domain (pKID) of the transcription factor CREB forms an ensemble of transient encounter complexes on binding to the KIX domain of the CREB binding protein. The encounter complexes are stabilized primarily by non-specific hydrophobic contacts, and evolve by way of an intermediate to the fully bound state without dissociation from KIX. The carboxy-terminal helix of pKID is only partially folded in the intermediate, and becomes stabilized by intermolecular interactions formed in the final bound state. Future applications of our method will provide new understanding of the molecular mechanisms by which intrinsically disordered proteins perform their diverse biological functions.	Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; Suntory Inst Bioorgan Res, Shimamoto, Osaka 6188503, Japan	Scripps Research Institute; Scripps Research Institute; Suntory Holdings Ltd	Wright, PE (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	wright@scripps.edu	Dyson, Jane/D-4160-2011; Sugase, Kenji/AAF-4552-2021; Sugase, Kenji/S-3132-2016	Dyson, Jane/0000-0001-6855-3398; Sugase, Kenji/0000-0001-8623-7743; Sugase, Kenji/0000-0001-8623-7743; Wright, Peter/0000-0002-1368-0223				ALLERHAN.A, 1965, J CHEM PHYS, V42, P1587, DOI 10.1063/1.1696165; BERG OG, 1985, ANNU REV BIOPHYS BIO, V14, P131, DOI 10.1146/annurev.biophys.14.1.131; CARVER JP, 1972, J MAGN RESON, V6, P89, DOI 10.1016/0022-2364(72)90090-X; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; De Guzman RN, 2006, J MOL BIOL, V355, P1005, DOI 10.1016/j.jmb.2005.09.059; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0; Gabdoulline RR, 2002, CURR OPIN STRUC BIOL, V12, P204, DOI 10.1016/S0959-440X(02)00311-1; Goto NK, 2002, J BIOL CHEM, V277, P43168, DOI 10.1074/jbc.M207660200; Grey MJ, 2003, J AM CHEM SOC, V125, P14324, DOI 10.1021/ja0367389; Huth JR, 1997, PROTEIN SCI, V6, P2359; JOHNSON CS, 1973, J CHEM EDUC, V50, P477, DOI 10.1021/ed050p477; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; KWOK RPS, 1994, NATURE, V370, P223, DOI 10.1038/370223a0; Levy Y, 2005, J MOL BIOL, V346, P1121, DOI 10.1016/j.jmb.2004.12.021; Loria JP, 1999, J AM CHEM SOC, V121, P2331, DOI 10.1021/ja983961a; McElheny D, 2005, P NATL ACAD SCI USA, V102, P5032, DOI 10.1073/pnas.0500699102; Mulder FAA, 2001, NAT STRUCT BIOL, V8, P932, DOI 10.1038/nsb1101-932; Parker D, 1996, MOL CELL BIOL, V16, P694; Parker D, 1998, MOL CELL, V2, P353, DOI 10.1016/S1097-2765(00)80279-8; Radhakrishnan I, 1997, CELL, V91, P741, DOI 10.1016/S0092-8674(00)80463-8; Selzer T, 2001, PROTEINS, V45, P190, DOI 10.1002/prot.1139; Shaywitz AJ, 2000, MOL CELL BIOL, V20, P9409, DOI 10.1128/MCB.20.24.9409-9422.2000; Shih HM, 1996, P NATL ACAD SCI USA, V93, P13896, DOI 10.1073/pnas.93.24.13896; Shoemaker BA, 2000, P NATL ACAD SCI USA, V97, P8868, DOI 10.1073/pnas.160259697; SHOUP D, 1982, BIOPHYS J, V40, P33, DOI 10.1016/S0006-3495(82)84455-X; Tang C, 2006, NATURE, V444, P383, DOI 10.1038/nature05201; Tollinger M, 2001, J AM CHEM SOC, V123, P11341, DOI 10.1021/ja011300z; Tsai CJ, 1999, PROTEIN SCI, V8, P1181, DOI 10.1110/ps.8.6.1181; Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102; Volkov AN, 2006, P NATL ACAD SCI USA, V103, P18945, DOI 10.1073/pnas.0603551103; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Zor T, 2004, J MOL BIOL, V337, P521, DOI 10.1016/j.jmb.2004.01.038	33	806	822	5	217	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 21	2007	447	7147					1021	U11		10.1038/nature05858	http://dx.doi.org/10.1038/nature05858			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	180NU	17522630				2022-12-28	WOS:000247373100051
J	Rehm, J; Gmel, G				Rehm, Juergen; Gmel, Gerhard			Alcohol consumption and public health in Russia	LANCET			English	Editorial Material							MORTALITY; DRINKING; BURDEN		Ctr Addict & Mental Hlth, Toronto, ON M51 2S1, Canada; Tech Univ Dresden, D-8027 Dresden, Germany; Schweizerische Fachstelle Alkohol & Andere Drogen, Lausanne, Switzerland	University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; Technische Universitat Dresden	Rehm, J (corresponding author), Ctr Addict & Mental Hlth, Toronto, ON M51 2S1, Canada.	jtrehm@aol.com	Rem, Jürgen/H-1309-2011; Rehm, Jürgen/K-2147-2012	Rehm, Jürgen/0000-0001-5665-0385; Gmel, Gerhard/0000-0001-9403-9405				KIMBALL AW, 1992, AM J EPIDEMIOL, V135, P1279, DOI 10.1093/oxfordjournals.aje.a116234; KRUSE JA, 1992, INTENS CARE MED, V18, P391, DOI 10.1007/BF01694340; Laranjeira R, 1998, ADDICTION, V93, P1103, DOI 10.1080/09652149835279; Leon DA, 1997, LANCET, V350, P383, DOI 10.1016/S0140-6736(97)03360-6; Leon DA, 2007, LANCET, V369, P2001, DOI 10.1016/S0140-6736(07)60941-6; McKee M, 2005, ALCOHOL CLIN EXP RES, V29, P1884, DOI 10.1097/01.alc.0000183012.93303.90; POPOVA S, 2007, ALCOHOL, DOI DOI 10.1093/ALCALC/AGL124; Rehm J, 2003, ADDICTION, V98, P1209, DOI 10.1046/j.1360-0443.2003.00467.x; Rehm J, 2003, EUR ADDICT RES, V9, P157, DOI 10.1159/000072222; Savchuk SA, 2006, J ANAL CHEM+, V61, P1198, DOI 10.1134/S1061934806120136; Steinkamp Peter, 2006, Praxis (Bern 1994), V95, P1997; World Health Organization (WHO), 2013, WORLD HLTH REPORT 20	12	10	10	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 16	2007	369	9578					1975	1976		10.1016/S0140-6736(07)60922-2	http://dx.doi.org/10.1016/S0140-6736(07)60922-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	180HT	17574077				2022-12-28	WOS:000247354400004
J	Weatherhead, S; Robson, SC; Reynolds, NJ				Weatherhead, Sophie; Robson, Stephen C.; Reynolds, Nick J.			Pregnancy plus - Management of psoriasis in pregnancy	BRITISH MEDICAL JOURNAL			English	Article							LOW-DOSE METHOTREXATE; FUMARIC-ACID ESTERS; 1ST-TRIMESTER; HYDROXYUREA; WOMEN; 8-METHOXYPSORALEN; ANOMALIES; EXPOSURE; DISEASE; PUVA		Univ Newcastle Upon Tyne, Sch Med, Inst Cellular Med, Uterine Cell Signalling Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Newcastle University - UK	Reynolds, NJ (corresponding author), Univ Newcastle Upon Tyne, Sch Med, Inst Cellular Med, Uterine Cell Signalling Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	N.J.Reynolds@ncl.ac.uk	Weatherhead, Sophie/AAQ-3019-2021	Weatherhead, Sophie/0000-0002-8705-8867; Reynolds, Nick/0000-0002-6484-825X				Barker JNWN, 2001, CLIN EXP DERMATOL, V26, P321, DOI 10.1046/j.1365-2230.2001.00830.x; Baysal V, 2003, J Dermatolog Treat, V14, P22, DOI 10.1080/09546630305550; Boyd AS, 1996, INT J DERMATOL, V35, P169, DOI 10.1111/j.1365-4362.1996.tb01632.x; Buckley LM, 1997, ARTHRITIS RHEUM, V40, P971, DOI 10.1002/art.1780400527; Byrd DC, 1999, PHARMACOTHERAPY, V19, P1459, DOI 10.1592/phco.19.18.1459.30901; DUNNA SF, 1989, BRIT J DERMATOL, V120, P584, DOI 10.1111/j.1365-2133.1989.tb01338.x; ELLIS CN, 1991, NEW ENGL J MED, V324, P277, DOI 10.1056/NEJM199101313240501; Gelfand JM, 2005, ARCH DERMATOL, V141, P1537, DOI 10.1001/archderm.141.12.1537; Granzow JW, 2003, J CRANIOFAC SURG, V14, P747, DOI 10.1097/00001665-200309000-00027; Hoefnagel JJ, 2003, BRIT J DERMATOL, V149, P363, DOI 10.1046/j.1365-2133.2003.05433.x; Katz JA, 2004, AM J GASTROENTEROL, V99, P2385, DOI 10.1111/j.1572-0241.2004.30186.x; KOZLOWSKI RD, 1990, AM J MED, V88, P589, DOI 10.1016/0002-9343(90)90522-F; Lewden B, 2004, J RHEUMATOL, V31, P2360; Mrowietz U, 1999, BRIT J DERMATOL, V141, P424; Murase JE, 2005, ARCH DERMATOL, V141, P601, DOI 10.1001/archderm.141.5.601; Nguyen C, 2002, OBSTET GYNECOL, V99, P599, DOI 10.1016/S0029-7844(01)01607-6; Pata O, 2004, AM J PERINAT, V21, P135, DOI 10.1055/s-2004-823773; PATEL M, 1991, AM J OBSTET GYNECOL, V165, P565, DOI 10.1016/0002-9378(91)90285-Y; PHAM CT, 1993, J AM ACAD DERMATOL, V28, P460, DOI 10.1016/0190-9622(93)70068-5; ROSA FW, 1986, TERATOLOGY, V33, P355, DOI 10.1002/tera.1420330315; Saini R, 2003, DERMATOL SURG, V29, P735, DOI 10.1046/j.1524-4725.2003.29188.x; Saito S, 1999, CLIN EXP IMMUNOL, V117, P550; SARDAS S, 1994, MUTAT RES, V312, P79, DOI 10.1016/0165-1161(94)90012-4; Seeger JD, 2007, DERMATOLOGY, V214, P32, DOI 10.1159/000096910; Smith CH, 2006, BMJ-BRIT MED J, V333, P380, DOI 10.1136/bmj.333.7564.380; Stern RS, 2004, J INVEST DERM SYMP P, V9, P136, DOI 10.1046/j.1087-0024.2003.09102.x; Swanbeck G, 1997, BRIT J DERMATOL, V137, P939, DOI 10.1111/j.1365-2133.1997.tb01555.x; Tauscher AE, 2002, J CUTAN MED SURG, V6, P561, DOI 10.1007/s10227-001-0147-1	29	38	39	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUN 9	2007	334	7605					1218	1220B		10.1136/bmj.39202.518484.80	http://dx.doi.org/10.1136/bmj.39202.518484.80			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	179GF	17556479	Green Published			2022-12-28	WOS:000247277000039
J	Spangler, JG				Spangler, John G.			The sounds of silence	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												jspangle@wfubmc.edu							0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 6	2007	297	21					2329	2330		10.1001/jama.297.21.2329	http://dx.doi.org/10.1001/jama.297.21.2329			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	175IL	17551118				2022-12-28	WOS:000247007200001
J	Reithinger, R; Megazzini, K; Durako, SJ; Harris, DR; Vermund, SH				Reithinger, Richard; Megazzini, Karen; Durako, Stephen J.; Harris, D. Robert; Vermund, Sten H.			Monitoring and evaluation of programmes to prevent mother to child transmission of HIV in Africa	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							WIDE PROGRAM; NEVIRAPINE; LUSAKA		WESTAT Corp, Clin Trials Area, Rockville, MD 20850 USA; Vanderbilt Univ, Sch Med, Inst Global Hlth, Nashville, TN 37212 USA	Westat; Vanderbilt University	Reithinger, R (corresponding author), WESTAT Corp, Clin Trials Area, Rockville, MD 20850 USA.	rreithinger@yahoo.co.uk	Vermund, Sten/AAD-3592-2020	Vermund, Sten/0000-0001-7289-8698; Reithinger, Richard/0000-0001-5710-1556				Alioum A, 2003, AM J EPIDEMIOL, V158, P596, DOI 10.1093/aje/kwg188; Ayouba A, 2003, JAIDS-J ACQ IMM DEF, V34, P274, DOI 10.1097/00126334-200311010-00003; Bhadrakom C, 2000, AIDS, V14, P509, DOI 10.1097/00002030-200003310-00006; Chi BH, 2006, HIV CLIN TRIALS, V7, P263, DOI 10.1310/hct0705-263; Chopra M, 2005, ACTA PAEDIATR, V94, P357, DOI 10.1111/j.1651-2227.2005.tb03080.x; Coetzee D, 2005, B WORLD HEALTH ORGAN, V83, P489; Doherty Tanya M, 2005, Afr Health Sci, V5, P213; *GLOB HIV PREV WOR, NEW APPR HIV PREV; Manzi M, 2005, TROP MED INT HEALTH, V10, P1242, DOI 10.1111/j.1365-3156.2005.01526.x; Nduati R, 2000, JAMA-J AM MED ASSOC, V283, P1167, DOI 10.1001/jama.283.9.1167; Perez F, 2004, BRIT MED J, V329, P1147, DOI 10.1136/bmj.329.7475.1147; Perez-Then E, 2003, JAIDS-J ACQ IMM DEF, V34, P506, DOI 10.1097/00126334-200312150-00010; *SECR GEN UN, 2006, DECL COMM HIV AIDS 5; Sherman GG, 2004, SAMJ S AFR MED J, V94, P289; Siika AM, 2005, INT J MED INFORM, V74, P345, DOI 10.1016/j.ijmedinf.2005.03.002; Stringer EM, 2003, AIDS, V17, P1377, DOI 10.1097/00002030-200306130-00012; Stringer JSA, 2005, AIDS, V19, P1309, DOI 10.1097/01.aids.0000180102.88511.7d; Temmerman M, 2003, AIDS, V17, P1239, DOI 10.1097/00002030-200305230-00016; *UNAIDS, AIDS EP UPD DEC 2006; *UNICEF, 2003, EV UN SUPP PIL PROJ, P46; United States Department of State, 2006, PRES EM PLAN AIDS RE; *USAID, 2005, PRES EM PLAN AIDS RE; *USAID, 2003, EXP RESP GUID COR IN; van't Hoog AH, 2005, JAIDS-J ACQ IMM DEF, V40, P344, DOI 10.1097/01.qai.0000160712.86580.ff; Victora CG, 2000, LANCET, V355, P451, DOI 10.1016/S0140-6736(00)82011-5; WHO, 2006, ANT DRUGS TREAT PREG	26	27	27	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 2	2007	334	7604					1143	1146		10.1136/bmj.39211.527488.94	http://dx.doi.org/10.1136/bmj.39211.527488.94			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	177ES	17540943	Green Published			2022-12-28	WOS:000247137000028
J	Gao, HX; Zhou, ZH; Rawat, U; Huang, C; Bouakaz, L; Wang, CH; Cheng, ZH; Liu, YY; Zavialov, A; Gursky, R; Sanyal, S; Ehrenberg, M; Frank, J; Song, HW				Gao, Haixiao; Zhou, Zhihong; Rawat, Urmila; Huang, Chenhui; Bouakaz, Lamine; Wang, Chernhoe; Cheng, Zhihong; Liu, Yuying; Zavialov, Andrey; Gursky, Richard; Sanyal, Suparna; Ehrenberg, Mans; Frank, Joachim; Song, Haiwei			RF3 induces ribosomal conformational changes responsible for dissociation of class I release factors	CELL			English	Article							COLI 70S RIBOSOME; ELONGATION-FACTOR-G; FACTOR EF-TU; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; TRANSLATION TERMINATION; GTPASE ACTIVITY; TRANSFER-RNA; PROTEIN; VISUALIZATION	During translation termination, class II release factor RF3 binds to the ribosome to promote rapid dissociation of a class I release factor (RF) in a GTP-dependent manner. We present the crystal structure of E coli RF39GDP, which has a three-domain architecture strikingly similar to the structure of EF-Tu center dot GTP. Biochemical data on RF3 mutants show that a surface region involving domains II and III is important for distinct steps in the action cycle of RF3. Furthermore, we present a cryo-electron microscopy (cryo-EM) structure of the posttermination ribosome bound with RF3 in the GTP form. Our data show that RF3 center dot GTP binding induces large conformational changes in the ribosome, which break the interactions of the class I RF with both the decoding center and the GTPase-associated center of the ribosome, apparently leading to the release of the class I RF.	Hlth Res Inc, Howard Hughes Med Inst, Albany, NY 12201 USA; Watsworth Ctr, Albany, NY 12201 USA; Inst Mol & Cell Biol, Lab Macromol Struct, Singapore 138673, Singapore; Univ Michigan, Sch Med, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; Uppsala Univ, Dept Cell & Mol Biol, S-75124 Uppsala, Sweden; SUNY Albany, Dept Biomed Sci, Albany, NY 12201 USA; Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore	Health Research Inc; Howard Hughes Medical Institute; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Howard Hughes Medical Institute; University of Michigan System; University of Michigan; Uppsala University; State University of New York (SUNY) System; State University of New York (SUNY) Albany; National University of Singapore	Ehrenberg, M (corresponding author), Hlth Res Inc, Howard Hughes Med Inst, Empire State Plaza, Albany, NY 12201 USA.	ehrenberg@xray.bmc.uu.se; joachim@wadsworth.org; haiwei@imcb.a-star.edu.sg	song, haiwei/H-6082-2011; Cheng, Zhihong/F-8933-2011	Zavialov, Andrey/0000-0001-6420-0368	NIGMS NIH HHS [R01 GM 55440, R37 GM29169, GM70768] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM029169, R01GM055440] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agrawal RK, 1998, P NATL ACAD SCI USA, V95, P6134, DOI 10.1073/pnas.95.11.6134; Agrawal RK, 1999, NAT STRUCT BIOL, V6, P643, DOI 10.1038/10695; Agrawal RK, 2001, J MOL BIOL, V311, P777, DOI 10.1006/jmbi.2001.4907; Allen GS, 2005, CELL, V121, P703, DOI 10.1016/j.cell.2005.03.023; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bouakaz L, 2006, J BIOL CHEM, V281, P4548, DOI 10.1074/jbc.M510433200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHAPMAN MS, 1995, ACTA CRYSTALLOGR A, V51, P69, DOI 10.1107/S0108767394007130; CZWORKOWSKI J, 1994, EMBO J, V13, P3661, DOI 10.1002/j.1460-2075.1994.tb06675.x; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Freistroffer DV, 1997, EMBO J, V16, P4126, DOI 10.1093/emboj/16.13.4126; FROLOVA L, 1994, NATURE, V372, P701, DOI 10.1038/372701a0; Gabashvili IS, 2000, CELL, V100, P537, DOI 10.1016/S0092-8674(00)80690-X; Gao HX, 2003, CELL, V113, P789, DOI 10.1016/S0092-8674(03)00427-6; Graille M, 2005, MOL CELL, V20, P917, DOI 10.1016/j.molcel.2005.10.025; GRENTZMANN G, 1994, P NATL ACAD SCI USA, V91, P5848, DOI 10.1073/pnas.91.13.5848; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ito K, 2000, NATURE, V403, P680, DOI 10.1038/35001115; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kisselev L, 2003, EMBO J, V22, P175, DOI 10.1093/emboj/cdg017; Kisselev LL, 2000, TRENDS BIOCHEM SCI, V25, P561, DOI 10.1016/S0968-0004(00)01669-8; KJELDGAARD M, 1993, STRUCTURE, V1, P35, DOI 10.1016/0969-2126(93)90007-4; Klaholz BP, 2003, NATURE, V421, P90, DOI 10.1038/nature01225; Klaholz BP, 2004, NATURE, V427, P862, DOI 10.1038/nature02332; Kong CG, 2004, MOL CELL, V14, P233, DOI 10.1016/S1097-2765(04)00206-0; La Teana A, 2001, RNA, V7, P1173, DOI 10.1017/S1355838201010366; Laurberg M, 2000, J MOL BIOL, V303, P593, DOI 10.1006/jmbi.2000.4168; MIKUNI O, 1994, P NATL ACAD SCI USA, V91, P5798, DOI 10.1073/pnas.91.13.5798; MILLER R, 1994, J APPL CRYSTALLOGR, V27, P613, DOI 10.1107/S0021889894000191; Moorhouse E. R., 1992, Biocontrol Science and Technology, V2, P49, DOI 10.1080/09583159209355217; Mora L, 2003, MOL MICROBIOL, V50, P1467, DOI 10.1046/j.1365-2958.2003.03799.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakamura Y, 2003, TRENDS BIOCHEM SCI, V28, P99, DOI 10.1016/S0968-0004(03)00006-9; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Petry S, 2005, CELL, V123, P1255, DOI 10.1016/j.cell.2005.09.039; Rawat U, 2006, J MOL BIOL, V357, P1144, DOI 10.1016/j.jmb.2006.01.038; Rawat UBS, 2003, NATURE, V421, P87, DOI 10.1038/nature01224; REMMERS AE, 1994, J BIOL CHEM, V269, P13771; Schutze Norbert, 2005, Cell Commun Signal, V3, P5, DOI 10.1186/1478-811X-3-5; SCOLNICK E, 1968, P NATL ACAD SCI USA, V61, P768, DOI 10.1073/pnas.61.2.768; Shin DH, 2004, J MOL BIOL, V341, P227, DOI 10.1016/j.jmb.2004.05.055; Song HW, 1999, J MOL BIOL, V285, P1245, DOI 10.1006/jmbi.1998.2387; Spahn CMT, 2001, MOL CELL, V7, P1037, DOI 10.1016/S1097-2765(01)00238-6; STANSFIELD I, 1995, EMBO J, V14, P4365, DOI 10.1002/j.1460-2075.1995.tb00111.x; Stark H, 1997, NATURE, V389, P403, DOI 10.1038/38770; TRONRUD DE, 1987, ACTA CRYSTALLOGR A, V43, P489, DOI 10.1107/S0108767387099124; Valle M, 2003, CELL, V114, P123, DOI 10.1016/S0092-8674(03)00476-8; Valle M, 2002, EMBO J, V21, P3557, DOI 10.1093/emboj/cdf326; Vestergaard B, 2005, MOL CELL, V20, P929, DOI 10.1016/j.molcel.2005.11.022; Vestergaard B, 2001, MOL CELL, V8, P1375, DOI 10.1016/S1097-2765(01)00415-4; Zavialov AV, 2002, MOL CELL, V10, P789, DOI 10.1016/S1097-2765(02)00691-3; Zavialov AV, 2003, CELL, V114, P113, DOI 10.1016/S0092-8674(03)00478-1; Zavialov AV, 2001, CELL, V107, P115, DOI 10.1016/S0092-8674(01)00508-6; Zhang BL, 2005, BIOCHEMISTRY-US, V44, P2566, DOI 10.1021/bi048755w; ZHOURAVLEVA G, 1995, EMBO J, V14, P4065, DOI 10.1002/j.1460-2075.1995.tb00078.x	57	102	107	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 1	2007	129	5					929	941		10.1016/j.cell.2007.03.050	http://dx.doi.org/10.1016/j.cell.2007.03.050			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	176KT	17540173	Bronze			2022-12-28	WOS:000247084600013
J	Middelburg, JJ; Meysman, FJR				Middelburg, Jack J.; Meysman, Filip J. R.			Ocean science - Burial at sea	SCIENCE			English	Editorial Material							ORGANIC-MATTER; MARINE-SEDIMENTS		Netherlands Inst Ecol, Ctr Estuarine & Marine Ecol, NL-4401 NT Yerseke, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW)	Middelburg, JJ (corresponding author), Netherlands Inst Ecol, Ctr Estuarine & Marine Ecol, NL-4401 NT Yerseke, Netherlands.	j.middelburg@nioo.knaw.nl; f.meysman@nioo.knaw.nl	Middelburg, Jack/B-4951-2011; Meysman, Filip JR/C-9585-2009	Middelburg, Jack/0000-0003-3601-9072; Meysman, Filip JR/0000-0001-5334-7655				Biddle JF, 2006, P NATL ACAD SCI USA, V103, P3846, DOI 10.1073/pnas.0600035103; BOUDREAU BP, 1991, AM J SCI, V291, P507, DOI 10.2475/ajs.291.5.507; Burdige DJ, 2007, CHEM REV, V107, P467, DOI 10.1021/cr050347q; Mayer LM, 2004, MAR CHEM, V92, P135, DOI 10.1016/j.marchem.2004.06.022; MIDDELBURG JJ, 1989, GEOCHIM COSMOCHIM AC, V53, P1577, DOI 10.1016/0016-7037(89)90239-1; Rothman DH, 2007, SCIENCE, V316, P1325, DOI 10.1126/science.1138211; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578	7	54	55	2	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 1	2007	316	5829					1294	1295		10.1126/science.1144001	http://dx.doi.org/10.1126/science.1144001			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	173PS	17540891				2022-12-28	WOS:000246885600036
J	Mannucci, PM; Levi, M				Mannucci, Pier Mannuccio; Levi, Marcel			Drug therapy: Prevention and treatment of major blood loss	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							RECOMBINANT-FACTOR-VIIA; CORONARY-ARTERY-BYPASS; LOW-DOSE APROTININ; RANDOMIZED CONTROLLED-TRIALS; EPSILON-AMINOCAPROIC ACID; COULD CLINICAL EQUIPOISE; ACTIVATED FACTOR-VII; DOUBLE-BLIND; TRANEXAMIC ACID; CARDIAC-SURGERY		Univ Milan, Angelo Bianchi Bonomi Hemophilia & Thrombosis Ctr, I-20122 Milan, Italy; Univ Milan, Dept Med & Med Specialties, I-20122 Milan, Italy; Maggiore Hosp, Ist Ric & Cura Carattere Sci, Milan, Italy; Mangiagalli & Regina Elena Fdn, Milan, Italy; Univ Amsterdam, Acad Med Ctr, Dept Med & Vasc Med, NL-1105 AZ Amsterdam, Netherlands	University of Milan; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Amsterdam; Academic Medical Center Amsterdam	Mannucci, PM (corresponding author), Via Pace 9, I-20122 Milan, Italy.	pmmannucci@libero.it	Levi, Marcel/AAZ-8559-2020					Acosta JA, 1998, J AM COLL SURGEONS, V186, P528, DOI 10.1016/S1072-7515(98)00082-9; Alanay A, 1999, SPINE, V24, P877, DOI 10.1097/00007632-199905010-00008; Alderman EL, 1998, J THORAC CARDIOV SUR, V116, P716, DOI 10.1016/S0022-5223(98)00431-0; ALVAREZ JM, 1995, J CARDIOTHOR VASC AN, V9, P29, DOI 10.1016/S1053-0770(05)80052-7; ALVING BM, 1995, TRANSFUSION, V35, P783, DOI 10.1046/j.1537-2995.1995.35996029166.x; [Anonymous], 1989, LANCET, V1, P938; ANSELL J, 1992, J THORAC CARDIOV SUR, V104, P117; Baele P L, 1992, Acta Anaesthesiol Belg, V43, P103; BAILEY CR, 1994, BRIT J SURG, V81, P969, DOI 10.1002/bjs.1800810713; Blajchman MA, 2006, NEW ENGL J MED, V355, P1303, DOI 10.1056/NEJMp068178; Boffard KD, 2005, J TRAUMA, V59, P8, DOI 10.1097/01.TA.0000171453.37949.B7; BOND L, 1988, NEW ENGL J MED, V318, P121; Bosch J, 2004, GASTROENTEROLOGY, V127, P1123, DOI 10.1053/j.gastro.2004.07.015; Butenas S, 2002, BLOOD, V99, P923, DOI 10.1182/blood.V99.3.923; BYRNES JJ, 1988, AM J HEMATOL, V28, P63, DOI 10.1002/ajh.2830280115; Carrera A, 1994, Rev Esp Anestesiol Reanim, V41, P13; CASAS JI, 1995, J THORAC CARDIOV SUR, V110, P1107, DOI 10.1016/S0022-5223(05)80180-1; CATTANEO M, 1995, THROMB HAEMOSTASIS, V74, P1064; Chalmers I, 2005, CLIN TRIALS, V2, P229; Cheng DC, 2005, ANESTHESIOLOGY, V102, P188, DOI 10.1097/00000542-200501000-00028; CORBEAU JJ, 1995, ANN FR ANESTH, V14, P154, DOI 10.1016/S0750-7658(95)70013-2; COSGROVE DM, 1992, ANN THORAC SURG, V54, P1031, DOI 10.1016/0003-4975(92)90066-D; Dacey LJ, 1998, ARCH SURG-CHICAGO, V133, P442, DOI 10.1001/archsurg.133.4.442; DAmbra MN, 1996, J THORAC CARDIOV SUR, V112, P1081, DOI 10.1016/S0022-5223(96)70110-1; DEFRANCHIS R, 1993, HEPATOLOGY, V18, P1102; DIPROSE P, 2003, BRIT J ANAESTH, V95, P596; *FDA, MEDWATCH 2006 SAF SU; FEINDT PR, 1995, ANN THORAC SURG, V60, P1076, DOI 10.1016/0003-4975(95)00525-P; Fergusson D, 2005, CLIN TRIALS, V2, P218, DOI 10.1191/1740774505cn085oa; Ferraris VA, 2006, NEW ENGL J MED, V354, P1953; Ferreira-Gonzalez IJ, 2006, EUR HEART J, V27, P2473, DOI 10.1093/eurheartj/ehl256; FREMES SE, 1994, ANN THORAC SURG, V58, P1580, DOI 10.1016/0003-4975(94)91636-5; Friederich PW, 2003, LANCET, V361, P201, DOI 10.1016/S0140-6736(03)12268-4; Friederich PW, 2003, LANCET, V361, P1138; Ghosh S, 2007, J THROMB HAEMOST, V5, P336, DOI 10.1111/j.1538-7836.2007.02308.x; GUAY J, 1992, ANESTH ANALG, V75, P405; HACKMANN T, 1989, NEW ENGL J MED, V321, P1437, DOI 10.1056/NEJM198911233212104; Hall TS, 2002, CARDIOVASC SURG, V10, P146, DOI 10.1016/S0967-2109(01)00129-6; HARDY JF, 1993, CAN J ANAESTH, V40, P625, DOI 10.1007/BF03009699; Hendriks HGD, 2001, TRANSPLANTATION, V71, P402, DOI 10.1097/00007890-200102150-00011; HENRY DA, 2004, COCHRANE DATABASE SY, V1; Henry DA, 2001, COCHRANE DB SYST REV, V1; Hiatt WR, 2006, NEW ENGL J MED, V355, P2171, DOI 10.1056/NEJMp068252; HORROW JC, 1995, ANESTHESIOLOGY, V82, P383, DOI 10.1097/00000542-199502000-00009; HORROW JC, 1991, CIRCULATION, V84, P2063, DOI 10.1161/01.CIR.84.5.2063; *INT STAND RAND CO, ISRCTN15166455; Isetta C., 1993, European Heart Journal, V14, P424; KALANGOS A, 1994, EUR J CARDIO-THORAC, V8, P651, DOI 10.1016/S1010-7940(05)80140-X; Karkouti K, 2006, J THROMB HAEMOST, V4, P1879, DOI 10.1111/j.1538-7836.2006.02106.x; Karkouti K, 2006, TRANSFUSION, V46, P327, DOI 10.1111/j.1537-2995.2006.00724.x; Karkouti K, 2005, TRANSFUSION, V45, P26, DOI 10.1111/j.1537-2995.2005.04216.x; KARSKI JM, 1995, J THORAC CARDIOV SUR, V110, P835, DOI 10.1016/S0022-5223(95)70118-4; Katsaros D, 1996, ANN THORAC SURG, V61, P1131, DOI 10.1016/0003-4975(96)00022-7; Kenet G, 1999, LANCET, V354, P1879, DOI 10.1016/S0140-6736(99)05155-7; KOBRINSKY NL, 1984, LANCET, V1, P1145; KOBRINSKY NL, 1987, ANN INTERN MED, V107, P446, DOI 10.7326/0003-4819-107-4-446; Landymore RW, 1997, EUR J CARDIO-THORAC, V11, P798; Laupacis A, 1997, ANESTH ANALG, V85, P1258, DOI 10.1097/00000539-199712000-00014; LEMMER JH, 1994, J THORAC CARDIOV SUR, V107, P543, DOI 10.1016/S0022-5223(94)70101-6; Lemmer JH, 1996, ANN THORAC SURG, V62, P1659, DOI 10.1016/S0003-4975(96)00451-1; Levi M, 2005, CRIT CARE MED, V33, P883, DOI 10.1097/01.CCM.0000159087.85970.38; Levi M, 1999, LANCET, V354, P1940, DOI 10.1016/S0140-6736(99)01264-7; Levy JH, 2006, J THROMB HAEMOST, V4, P1875, DOI 10.1111/j.1538-7836.2006.02107.x; Levy JH, 2006, TRANSFUSION, V46, P919, DOI 10.1111/j.1537-2995.2006.00824.x; LEVY JH, 1995, CIRCULATION, V92, P2236, DOI 10.1161/01.CIR.92.8.2236; Lisman T, 2002, BLOOD, V99, P175, DOI 10.1182/blood.V99.1.175; Lodge JPA, 2005, LIVER TRANSPLANT, V11, P973, DOI 10.1002/lt.20470; Lodge JPA, 2005, ANESTHESIOLOGY, V102, P269, DOI 10.1097/00000542-200502000-00006; Mangano DT, 2006, NEW ENGL J MED, V354, P353, DOI 10.1056/NEJMoa051379; Mannucci PM, 2007, PLATELETS, 2ND EDITION, P1237, DOI 10.1016/B978-012369367-9/50829-6; Mannucci PM, 1998, NEW ENGL J MED, V339, P245, DOI 10.1056/NEJM199807233390407; MANNUCCI PM, 1977, LANCET, V1, P869; MANNUCCI PM, 1975, BRIT J HAEMATOL, V30, P81, DOI 10.1111/j.1365-2141.1975.tb00521.x; MANNUCCI PM, 1983, NEW ENGL J MED, V308, P8, DOI 10.1056/NEJM198301063080102; MANNUCCI PM, 1994, THROMB HAEMOSTASIS, V71, P154; Mayer SA, 2005, NEW ENGL J MED, V352, P777, DOI 10.1056/NEJMoa042991; MCLEOD BC, 1990, LANCET, V336, P1137, DOI 10.1016/0140-6736(90)92623-P; Menichetti A, 1996, J CARDIOVASC SURG, V37, P401; MOIA M, 1987, LANCET, V2, P1227; Munoz JJ, 1999, CIRCULATION, V99, P81, DOI 10.1161/01.CIR.99.1.81; O'Connell KA, 2006, JAMA-J AM MED ASSOC, V295, P293, DOI 10.1001/jama.295.3.293; OBRIEN JR, 1989, LANCET, V1, P664, DOI 10.1016/S0140-6736(89)92161-2; PUGH SC, 1995, J CARDIOTHOR VASC AN, V9, P240, DOI 10.1016/S1053-0770(05)80314-3; Ray MJ, 1997, ANN THORAC SURG, V63, P57; Roberts, 2005, BLOOD, V105, P2257; Roberts HR, 2004, BLOOD, V104, P3858, DOI 10.1182/blood-2004-06-2223; ROCHA E, 1988, CIRCULATION, V77, P1319, DOI 10.1161/01.CIR.77.6.1319; ROYSTON D, 1987, LANCET, V2, P1289; RUGGERI ZM, 1982, BLOOD, V59, P1272; SAKARIASSEN KS, 1984, BLOOD, V64, P229; SALZMAN EW, 1986, NEW ENGL J MED, V314, P1402, DOI 10.1056/NEJM198605293142202; Sedrakyan A, 2004, J THORAC CARDIOV SUR, V128, P442, DOI 10.1016/j.jtcvs.2004.03.041; Shao YF, 2006, AM J SURG, V191, P245, DOI 10.1016/j.amjsurg.2005.10.019; Silverman T, 2005, TRANSFUSION, V45, p14S, DOI 10.1111/j.0041-1132.2005.00157.x; SPEEKENBRINK RGH, 1995, ANN THORAC SURG, V59, P438, DOI 10.1016/0003-4975(94)00865-5; Speekenbrink RGH, 1996, J THORAC CARDIOV SUR, V112, P523, DOI 10.1016/S0022-5223(96)70281-7; TENCATE H, 1993, J CLIN INVEST, V92, P1207, DOI 10.1172/JCI116691; Theroux MC, 1997, ANESTHESIOLOGY, V87, P260, DOI 10.1097/00000542-199708000-00012; Tranholm M, 2003, BLOOD, V102, P3615, DOI 10.1182/blood-2003-05-1369; UNSWORTHWHITE MJ, 1995, ANN THORAC SURG, V59, P664; VanderSalm TJ, 1996, J THORAC CARDIOV SUR, V112, P1098, DOI 10.1016/S0022-5223(96)70112-5; Weiskopf RB, 2006, J THROMB HAEMOST, V4, P2074, DOI 10.1111/j.1538-7836.2006.02145.x; Wong AYC, 2003, CAN J ANAESTH, V50, P14, DOI 10.1007/BF03020180	103	311	335	2	24	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 31	2007	356	22					2301	2311		10.1056/NEJMra067742	http://dx.doi.org/10.1056/NEJMra067742			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	172PO	17538089				2022-12-28	WOS:000246816500009
J	Chipman, A				Chipman, Andrea			London calling	NATURE			English	News Item																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 24	2007	447	7143					367	367		10.1038/447367a	http://dx.doi.org/10.1038/447367a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170VA	17522648				2022-12-28	WOS:000246693100012
J	Home, PD; Pocock, SJ; Beck-Nielsen, H; Gomis, R; Hanefeld, M; Jones, NP; Komajda, M; McMurray, JJV				Home, Philip D.; Pocock, Stuart J.; Beck-Nielsen, Henning; Gomis, Ramon; Hanefeld, Markolf; Jones, Nigel P.; Komajda, Michel; McMurray, John J. V.		RECORD Study Grp	Rosiglitazone evaluated for cardiovascular outcomes - An interim analysis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MORTALITY; PREVENTION; EVENTS; PEOPLE; RECORD; RISK	BACKGROUND: A recent meta-analysis raised concern regarding an increased risk of myocardial infarction and death from cardiovascular causes associated with rosiglitazone treatment of type 2 diabetes. METHODS: We conducted an unplanned interim analysis of a randomized, multicenter, open-label, noninferiority trial involving 4447 patients with type 2 diabetes who had inadequate glycemic control while receiving metformin or sulfonylurea, in which 2220 patients were assigned to receive add-on rosiglitazone (rosiglitazone group), and 2227 to receive a combination of metformin plus sulfonylurea (control group). The primary end point was hospitalization or death from cardiovascular causes. RESULTS: Because the mean follow-up was only 3.75 years, our interim analysis had limited statistical power to detect treatment differences. A total of 217 patients in the rosiglitazone group and 202 patients in the control group had the adjudicated primary end point (hazard ratio, 1.08; 95% confidence interval [CI], 0.89 to 1.31). After the inclusion of end points pending adjudication, the hazard ratio was 1.11 (95% CI, 0.93 to 1.32). There were no statistically significant differences between the rosiglitazone group and the control group regarding myocardial infarction and death from cardiovascular causes or any cause. There were more patients with heart failure in the rosiglitazone group than in the control group (hazard ratio, 2.15; 95% CI, 1.30 to 3.57). CONCLUSIONS: Our interim findings from this ongoing study were inconclusive regarding the effect of rosiglitazone on the overall risk of hospitalization or death from cardiovascular causes. There was no evidence of any increase in death from either cardiovascular causes or all causes. Rosiglitazone was associated with an increased risk of heart failure. The data were insufficient to determine whether the drug was associated with an increase in the risk of myocardial infarction.	Univ Newcastle, Newcastle Upon Tyne, Tyne & Wear, England; Newcastle Diabet Ctr, Newcastle Upon Tyne, Tyne & Wear, England; London Sch Hyg & Trop Med, Med Stat Unit, London WC1, England; Odense Univ Hosp, Dept Endocrinol & Metab, DK-5000 Odense, Denmark; Univ Barcelona, Hosp Clin, Barcelona, Spain; Zentrum Klin Studien Forschungsbereich Endokrinol, Dresden, Germany; GlaxoSmithKline, Harlow, Essex, England; Univ Paris 06, Paris, France; Hop La Pitie Salpetriere, Paris, France; Univ Glasgow, Western Infirm, Dept Cardiol, Glasgow G11 6NT, Lanark, Scotland	Newcastle University - UK; Newcastle University - UK; University of London; London School of Hygiene & Tropical Medicine; University of Southern Denmark; Odense University Hospital; University of Barcelona; Hospital Clinic de Barcelona; Technische Universitat Dresden; GlaxoSmithKline; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Glasgow	Home, PD (corresponding author), Med Sch Newcastle Upon Tyne, SCMS Diabet, Framingham Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	philip.home@newcastle.ac.uk	mcmurray, John/B-2467-2013	mcmurray, John/0000-0002-6317-3975				Colhoun HM, 2004, LANCET, V364, P685, DOI 10.1016/S0140-6736(04)16895-5; Collins R, 2003, LANCET, V361, P2005; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; GARCIA MJ, 1974, DIABETES, V23, P105, DOI 10.2337/diab.23.2.105; Home PD, 2007, DIABETIC MED, V24, P626, DOI 10.1111/j.1464-5491.2007.02160.x; Home PD, 2005, DIABETOLOGIA, V48, P1726, DOI 10.1007/s00125-005-1869-1; IDF Clinical Guidelines Task Force, 2005, GLOB GUID TYP 2 DIAB; Kahn SE, 2007, NEW ENGL J MED, V356, P1387; Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224; Keech A, 2006, LANCET, V367, P1142, DOI 10.1016/S0140-6736(06)68501-2; Keech A, 2005, LANCET, V366, P1849, DOI 10.1016/S0140-6736(05)67667-2; Keech A, 2006, LANCET, V368, P1415, DOI 10.1016/S0140-6736(06)69594-9; KRALL RL, IN PRESS LANCET; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; PANZRAM G, 1987, DIABETOLOGIA, V30, P123, DOI 10.1007/BF00274216; PANZRAM G, 1987, DIABETOLOGIA, V30, P364; Psaty BM, 2007, NEW ENGL J MED, V356, P2522, DOI 10.1056/NEJMe078099; STAMLER J, 1993, DIABETES CARE, V16, P434, DOI 10.2337/diacare.16.2.434; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Wittes J, 2001, CURR CONTR TRIALS C, V2, P59, DOI 10.1186/CVM-2-1-059; World Health Organization, 1999, WHONCDNCS992	22	580	603	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 5	2007	357	1					28	38		10.1056/NEJMoa073394	http://dx.doi.org/10.1056/NEJMoa073394			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	185OR	17551159	Green Accepted			2022-12-28	WOS:000247720800006
J	Leonard, TA; Hurley, JH				Leonard, Thomas A.; Hurley, James H.			Two kinase family dramas	CELL			English	Editorial Material							TYROSINE KINASE; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; AUTOINHIBITION; RECEPTOR; SRC	In this issue, Lietha and colleagues (2007) report the structure of focal adhesion kinase (FAK) and reveal how FAK maintains an autoinhibited state. Together with the structure of another tyrosine kinase, ZAP-70 (Deindl et al., 2007), this work highlights the diversity of mechanisms that nature has evolved within the kinase superfamily to regulate their activity through autoinhibition.	NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Hurley, JH (corresponding author), NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA.	hurley@helix.nih.gov	Leonard, Thomas/A-5143-2013	Leonard, Thomas/0000-0001-6853-666X	Intramural NIH HHS [Z01 DK036118-14] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK036118, Z01DK036127] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Deindl S, 2007, CELL, V129, P735, DOI 10.1016/j.cell.2007.03.039; Goldberg J, 1996, CELL, V84, P875, DOI 10.1016/S0092-8674(00)81066-1; HATADA MH, 1995, NATURE, V377, P32, DOI 10.1038/377032a0; Kim C, 2005, SCIENCE, V307, P690, DOI 10.1126/science.1104607; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Nagar B, 2006, MOL CELL, V21, P787, DOI 10.1016/j.molcel.2006.01.035; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; Wybenga-Groot LE, 2001, CELL, V106, P745, DOI 10.1016/S0092-8674(01)00496-2; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0	9	4	4	3	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 15	2007	129	6					1037	1038		10.1016/j.cell.2007.06.001	http://dx.doi.org/10.1016/j.cell.2007.06.001			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	180UA	17574014	Green Accepted, Bronze			2022-12-28	WOS:000247390400005
J	Blumenthal, D; Glaser, JP				Blumenthal, David; Glaser, John P.			Information technology comes to medicine	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ELECTRONIC HEALTH RECORDS; ORDER ENTRY SYSTEMS; INCREASED MORTALITY; CARE; IMPLEMENTATION		Massachusetts Gen Hosp, Boston, MA 02114 USA; Partners Hlth Care Syst, Boston, MA USA	Harvard University; Massachusetts General Hospital; Partners Healthcare System	Blumenthal, D (corresponding author), Massachusetts Gen Hosp, Boston, MA 02114 USA.		Tao, Youyou/D-2367-2014					*AM HLTH INF MAN A, 2006, STAT LEV HLTH INF EX; Bartschat Wanda, 2006, J AHIMA, V77, p64A; BLUMENTHAL D, 2006, HLTH INFORMATION TEC; Bodenheimer T, 2003, JAMA-J AM MED ASSOC, V290, P259, DOI 10.1001/jama.290.2.259; Burt C.W., 2005, ELECT MED RECORD USE; Chaudhry B, 2006, ANN INTERN MED, V144, P742, DOI 10.7326/0003-4819-144-10-200605160-00125; Del Beccaro MA, 2006, PEDIATRICS, V118, P290, DOI 10.1542/peds.2006-0367; Earnest MA, 2004, J AM MED INFORM ASSN, V11, P410, DOI 10.1197/jamia.M1479; GERBER T, 2006, STATES GETTING CONNE; Han, 2006, PEDIATRICS, V117, P594, DOI 10.1542/peds.2005-2970; Han YY, 2005, PEDIATRICS, V116, P1506, DOI 10.1542/peds.2005-1287; Hillestad R, 2005, HEALTH AFFAIR, V24, P1103, DOI 10.1377/hlthaff.24.5.1103; Institute of Medicine, 2003, KEY CAP EL HLTH REC; Jha AK, 2006, HEALTH AFFAIR, V25, pW496, DOI 10.1377/hlthaff.25.w496; Kaushal R, 2006, J AM MED INFORM ASSN, V13, P261, DOI 10.1197/jamia.M1984; Koppel R, 2005, JAMA-J AM MED ASSOC, V293, P1197, DOI 10.1001/jama.293.10.1197; LANDA SN, 2006, AMNEWS, V49; Lohr Steven, 2006, NY TIMES        0820; MANOS D, 2006, HEALTHCARE IT N 1214; Markle Foundation, 2003, CONN HLTH PERS HLTH; Middleton B, 2005, J AM MED INFORM ASSN, V12, P13, DOI 10.1197/jamia.M1669; Miller R, 2003, ELECT MED RECORDS LE; Miller RH, 2005, HEALTH AFFAIR, V24, P1127, DOI 10.1377/hlthaff.24.5.1127; Naik G., 2006, WALL STREET JOURNAL, pA1; *NAT ALL HLTH INF, SEN EX GUID NEW STAR; Poon EG, 2004, HEALTH AFFAIR, V23, P184, DOI 10.1377/hlthaff.23.4.184; REIDER J, 2003, CEDARS SINAI MED CTR; Schoen C, 2006, HEALTH AFFAIR, V25, pW555, DOI 10.1377/hlthaff.25.w555; STROBBE M, 2006, GEORGIA INSURERS UNV; SUTHERLAND J, 2005, REGIONAL HLTH INFORM; Waegemann C Peter, 2005, Health Manag Technol, V26, P18; WAEGEMANN CP, 2005, HLTH MANAG TECHNOL, V26, P18; Wang SJ, 2003, AM J MED, V114, P397, DOI 10.1016/S0002-9343(03)00057-3	33	223	226	2	28	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 14	2007	356	24					2527	2534		10.1056/NEJMhpr066212	http://dx.doi.org/10.1056/NEJMhpr066212			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	178DR	17568035				2022-12-28	WOS:000247201900016
J	Nissen, SE; Wolski, K				Nissen, Steven E.; Wolski, Kathy			Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TYPE-2 DIABETES-MELLITUS; RANDOMIZED CONTROLLED-TRIAL; IMPROVES GLYCEMIC CONTROL; COMBINATION THERAPY; METFORMIN; SULFONYLUREA; EVENTS; PIOGLITAZONE; MONOTHERAPY; GLYBURIDE	BACKGROUND: Rosiglitazone is widely used to treat patients with type 2 diabetes mellitus, but its effect on cardiovascular morbidity and mortality has not been determined. METHODS: We conducted searches of the published literature, the Web site of the Food and Drug Administration, and a clinical-trials registry maintained by the drug manufacturer (GlaxoSmithKline). Criteria for inclusion in our meta-analysis included a study duration of more than 24 weeks, the use of a randomized control group not receiving rosiglitazone, and the availability of outcome data for myocardial infarction and death from cardiovascular causes. Of 116 potentially relevant studies, 42 trials met the inclusion criteria. We tabulated all occurrences of myocardial infarction and death from cardiovascular causes. RESULTS: Data were combined by means of a fixed-effects model. In the 42 trials, the mean age of the subjects was approximately 56 years, and the mean baseline glycated hemoglobin level was approximately 8.2%. In the rosiglitazone group, as compared with the control group, the odds ratio for myocardial infarction was 1.43 (95% confidence interval [CI], 1.03 to 1.98; P=0.03), and the odds ratio for death from cardiovascular causes was 1.64 (95% CI, 0.98 to 2.74; P=0.06). CONCLUSIONS: Rosiglitazone was associated with a significant increase in the risk of myocardial infarction and with an increase in the risk of death from cardiovascular causes that had borderline significance. Our study was limited by a lack of access to original source data, which would have enabled time-to-event analysis. Despite these limitations, patients and providers should consider the potential for serious adverse cardiovascular effects of treatment with rosiglitazone for type 2 diabetes.	Cleveland Clin Fdn, Dept Cardiovasc Med, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Nissen, SE (corresponding author), Cleveland Clin Fdn, Dept Cardiovasc Med, 9500 Euclid Ave, Cleveland, OH 44195 USA.	nissens@ccf.org						*AM DIAB ASS, COMPL DIAB US; Baksi A, 2004, ACTA DIABETOL, V41, P63, DOI 10.1007/s00592-004-0146-y; Barnett AH, 2003, DIABETIC MED, V20, P387, DOI 10.1046/j.1464-5491.2003.00925.x; Bradburn MJ, 2007, STAT MED, V26, P53, DOI 10.1002/sim.2528; Campbell IW, 2005, CURR MOL MED, V5, P349, DOI 10.2174/1566524053766068; Center for Drug Evaluation and Research, MED REV; *CTR DRUG EV RES, 21071 SMITHKL BEECH; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; El-Hage J., 2006, PEROXISOME PROLIFERA; Fonseca V, 2000, JAMA-J AM MED ASSOC, V284, P1384; Fonseca V, 2000, JAMA-J AM MED ASSOC, V283, P1695, DOI 10.1001/jama.283.13.1695; Gerstein HC, 2006, LANCET, V368, P1096, DOI 10.1016/S0140-6736(06)69420-8; *GLAXOSMITHKL, ROS STUD; Goldberg RB, 2005, DIABETES CARE, V28, P1547, DOI 10.2337/diacare.28.7.1547; Home PD, 2005, DIABETOLOGIA, V48, P1726, DOI 10.1007/s00125-005-1869-1; Jones TA, 2003, DIABETES OBES METAB, V5, P163, DOI 10.1046/j.1463-1326.2003.00258.x; Kahn SE, 2007, NEW ENGL J MED, V356, P1387; Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224; Kerenyi Z, 2004, DIABETES RES CLIN PR, V63, P213, DOI 10.1016/j.diabres.2003.09.009; Lebovitz HE, 2001, J CLIN ENDOCR METAB, V86, P1659; Lebovitz HE, 2001, J CLIN ENDOCR METAB, V86, P280, DOI 10.1210/jc.86.1.280; Lebovitz HE, 2002, J CLIN ENDOCR METAB, V2, piv; Lemay DG, 2006, J LIPID RES, V47, P1583, DOI 10.1194/jlr.M500504-JLR200; Lygate CA, 2003, CARDIOVASC RES, V58, P632, DOI 10.1016/S0008-6363(03)00289-X; Nesto RW, 2003, CIRCULATION, V108, P2941, DOI 10.1161/01.CIR.0000103683.99399.7E; Nissen SE, 2005, JAMA-J AM MED ASSOC, V294, P2581, DOI 10.1001/JAMA.294.20.JOC50147; Phillips LS, 2001, DIABETES CARE, V24, P973; Phillips LS, 2001, DIABETES CARE, V24, P308, DOI 10.2337/diacare.24.2.308; Raskin P, 2001, DIABETES CARE, V24, P1226, DOI 10.2337/diacare.24.7.1226; Riveline JP, 2003, DIABETES METAB, V29, P207, DOI 10.1016/S1262-3636(07)70030-7; SUTTON AJ, 2002, PHARMACOECONOMICS OU, V2, P367; Sutton MS, 2002, DIABETES CARE, V25, P2058, DOI 10.2337/diacare.25.11.2058; Sweeting M, 2006, STAT MED, V25, P2700, DOI 10.1002/sim.2536; Sweeting MJ, 2004, STAT MED, V23, P1351, DOI 10.1002/sim.1761; Vamecq J, 1999, LANCET, V354, P141, DOI 10.1016/S0140-6736(98)10364-1; Vongthavaravat V, 2002, CURR MED RES OPIN, V18, P456, DOI 10.1185/030079902125001236; Weissman P, 2005, CURR MED RES OPIN, V21, P2029, DOI 10.1185/030079905X74844; Wolffenbuttel BHR, 2000, DIABETIC MED, V17, P40, DOI 10.1046/j.1464-5491.2000.00224.x; Zhu X-X, 2003, Diabetes Technol Ther, V5, P33, DOI 10.1089/152091503763816445; 2007, AVANDIA ROSIGLITAZON; 2006, LANCET, V368, P1770	41	3463	3625	1	188	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 14	2007	356	24					2457	2471		10.1056/NEJMoa072761	http://dx.doi.org/10.1056/NEJMoa072761			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	178DR	17517853				2022-12-28	WOS:000247201900006
J	Laine, C; Horton, R; DeAngelis, CD; Drazen, JM; Frizelle, FA; Godlee, F; Haug, C; Hebert, PC; Kotzin, S; Marusic, A; Sahni, P; Schroeder, TV; Sox, HC; Van der Weyden, MB; Verheugt, FWA				Laine, Christine; Horton, Richard; DeAngelis, Catherine D.; Drazen, Jeffrey M.; Frizelle, Frank A.; Godlee, Fiona; Haug, Charlotte; Hebert, Paul C.; Kotzin, Sheldon; Marusic, Ana; Sahni, Peush; Schroeder, Torben V.; Sox, Harold C.; Van der Weyden, Martin B.; Verheugt, Freek W. A.			Clinical trial registration: looking back and moving ahead	LANCET			English	Editorial Material									Canadian Med Assoc, Ottawa, ON, Canada; Natl Lib Med, MEDLINE, Bethesda, MD 20894 USA	National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)				Schroeder, Torben/0000-0002-9827-9438; Sahni, Peush/0000-0002-6910-062X				*INT COMM MED J ED, IS THIS CLIN TRIAL F; *INT COMM MED J ED, 2007, CLIN TRIAL REG STAT; SIMES RJ, 1986, J CLIN ONCOL, V4, P1529, DOI 10.1200/JCO.1986.4.10.1529; *WHO, 2007, INT CLIN TRIALS REG; Zarin DA, 2005, NEW ENGL J MED, V353, P2779, DOI 10.1056/NEJMsa053234	5	51	55	0	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 9	2007	369	9577					1909	1911		10.1016/S0140-6736(07)60894-0	http://dx.doi.org/10.1016/S0140-6736(07)60894-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	177IQ	17560431	Green Submitted, Green Published			2022-12-28	WOS:000247147200008
J	Gaffney, KJ; Chapman, HN				Gaffney, K. J.; Chapman, H. N.			Imaging atomic structure and dynamics with ultrafast X-ray scattering	SCIENCE			English	Review							COHERENT PHONONS; DIFFRACTION; PULSES; GENERATION; BISMUTH	Measuring atomic-resolution images of materials with x-ray photons during chemical reactions or physical transformations resides at the technological forefront of x-ray science. New x-ray-based experimental capabilities have been closely linked with advances in x-ray sources, a trend that will continue with the impending arrival of x-ray-free electron lasers driven by electron accelerators. We discuss recent advances in ultrafast x-ray science and coherent imaging made possible by linear-accelerator-based light sources. These studies highlight the promise of ultrafast x-ray lasers, as well as the technical challenges and potential range of applications that will accompany these transformative x-ray light sources.	Stanford Univ, Stanford Linear Accelerator Ctr, PULSE Ctr, Stanford, CA 94305 USA; Lawrence Livermore Natl Lab, Livermore, CA 94550 USA	Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; United States Department of Energy (DOE); Lawrence Livermore National Laboratory	Gaffney, KJ (corresponding author), Stanford Univ, Stanford Linear Accelerator Ctr, PULSE Ctr, Stanford, CA 94305 USA.	kgaffney@slac.stanford.edu; henry.chapman@llnl.gov	FRS, Henry N Chapman/G-2153-2010; Gaffney, Kelly J/N-1597-2017; Gaffney, Kelly/AAG-7136-2020	FRS, Henry N Chapman/0000-0002-4655-1743; Gaffney, Kelly J/0000-0002-0525-6465; 				Adiga U, 2005, J STRUCT BIOL, V152, P211, DOI 10.1016/j.jsb.2005.09.007; Ayvazyan V, 2006, EUR PHYS J D, V37, P297, DOI 10.1140/epjd/e2005-00308-1; Cavalieri AL, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.114801; Cavalleri A, 2006, NATURE, V442, P664, DOI 10.1038/nature05041; Chapman HN, 2006, NAT PHYS, V2, P839, DOI 10.1038/nphys461; Chapman HN, 2006, J OPT SOC AM A, V23, P1179, DOI 10.1364/JOSAA.23.001179; CHENG TK, 1990, APPL PHYS LETT, V57, P1004, DOI 10.1063/1.104090; Dauter Z, 2006, ACTA CRYSTALLOGR D, V62, P1, DOI 10.1107/S0907444905034050; Fritz DM, 2007, SCIENCE, V315, P633, DOI 10.1126/science.1135009; Gaffney KJ, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.125701; Hau-Riege SP, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.051906; Hau-Riege SP, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.145502; Hillyard PB, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.125501; Huldt G, 2003, J STRUCT BIOL, V144, P219, DOI 10.1016/j.jsb.2003.09.025; HUNSCHE S, 1995, PHYS REV LETT, V75, P1815, DOI 10.1103/PhysRevLett.75.1815; Ihee H, 2005, SCIENCE, V309, P1223, DOI [10.1126/science.1114782, 10.1126/scheme.1114782]; Jurek Z, 2004, EUR PHYS J D, V29, P217, DOI 10.1140/epjd/e2004-00033-3; Lindenberg AM, 2005, SCIENCE, V308, P392, DOI 10.1126/science.1107996; Liu C, 2005, J APPL PHYS, V98, DOI 10.1063/1.2138378; Miao JW, 2004, ANNU REV BIOPH BIOM, V33, P157, DOI 10.1146/annurev.biophys.33.110502.140405; MURNANE MM, 1991, SCIENCE, V251, P531, DOI 10.1126/science.251.4993.531; Neutze R, 2000, NATURE, V406, P752, DOI 10.1038/35021099; Rousse A, 2001, NATURE, V410, P65, DOI 10.1038/35065045; SAYRE D, 1952, ACTA CRYSTALLOGR, V5, P843, DOI 10.1107/S0365110X52002276; Sayre D, 2002, STRUCT CHEM, V13, P81, DOI 10.1023/A:1013477415486; Schoenlein RW, 2000, SCIENCE, V287, P2237, DOI 10.1126/science.287.5461.2237; Schotte F, 2003, SCIENCE, V300, P1944, DOI 10.1126/science.1078797; SHANK CV, 1983, PHYS REV LETT, V50, P454, DOI 10.1103/PhysRevLett.50.454; Shapiro D, 2005, P NATL ACAD SCI USA, V102, P15343, DOI 10.1073/pnas.0503305102; Siwick BJ, 2003, SCIENCE, V302, P1382, DOI 10.1126/science.1090052; Sokolowski-Tinten K, 2003, NATURE, V422, P287, DOI 10.1038/nature01490; SOLEM JC, 1982, SCIENCE, V218, P229, DOI 10.1126/science.218.4569.229; Spielmann C, 1997, SCIENCE, V278, P661, DOI 10.1126/science.278.5338.661; STAMPFLI P, 1992, PHYS REV B, V46, P10686, DOI 10.1103/PhysRevB.46.10686; Stapelfeldt H, 2003, REV MOD PHYS, V75, P543, DOI 10.1103/RevModPhys.75.543; Stevens TE, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.144304; Tatchyn R, 1996, NUCL INSTRUM METH A, V375, P274, DOI 10.1016/0168-9002(96)00042-3; Williamson JC, 1997, NATURE, V386, P159, DOI 10.1038/386159a0	38	289	299	5	144	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 8	2007	316	5830					1444	1448		10.1126/science.1135923	http://dx.doi.org/10.1126/science.1135923			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176EE	17556577				2022-12-28	WOS:000247066400033
J	Goldston, D				Goldston, David			Over a pork barrel	NATURE			English	Editorial Material									Princeton Univ, Woodrow Wilson Sch Publ & Int Affairs, Princeton, NJ 08544 USA	Princeton University	Goldston, D (corresponding author), Princeton Univ, Woodrow Wilson Sch Publ & Int Affairs, Princeton, NJ 08544 USA.								0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 7	2007	447	7145					628	628		10.1038/447628a	http://dx.doi.org/10.1038/447628a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175RI	17554280	Bronze			2022-12-28	WOS:000247030700013
J	Greenstone, CL; Saint, S; Moseley, RH				Greenstone, Clinton L.; Saint, Sanjay; Moseley, Richard H.			A hand-carried diagnosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							SYPHILITIC HEPATITIS; TREPONEMA-PALLIDUM; PATIENT		Vet Adm Med Ctr, Ambulatory Care Div, Ann Arbor, MI 48105 USA; Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Michigan System; University of Michigan	Greenstone, CL (corresponding author), Vet Adm Med Ctr, Ambulatory Care Div, 11A,2215 Fuller Rd, Ann Arbor, MI 48105 USA.	clintong@umich.edu	Saint, Sanjay/AAF-5126-2019					[Anonymous], 2002, MMWR Recomm Rep, V51, P1; [Anonymous], TREAT GUIDEL MED LET; BLAIR EK, 1990, MAYO CLIN PROC, V65, P1365, DOI 10.1016/S0025-6196(12)62147-8; Collis TK, 2001, CLIN INFECT DIS, V32, P611, DOI 10.1086/318722; MAGNUSON HJ, 1956, MEDICINE, V35, P33, DOI 10.1097/00005792-195602000-00002; Mandache C, 2006, J INTERN MED, V259, P214, DOI 10.1111/j.1365-2796.2005.01596.x; Mullick CJ, 2004, CLIN INFECT DIS, V39, pE100, DOI 10.1086/425501; Norris SJ, 2001, J MOL MICROB BIOTECH, V3, P37; PEDERSEN OM, 1987, SCAND J GASTROENTERO, V22, P975, DOI 10.3109/00365528708991945; Sellati TJ, 1998, J IMMUNOL, V160, P5455; YOUNG MF, 1992, J CLIN GASTROENTEROL, V15, P174; Zellan Jonathan, 2004, Curr HIV/AIDS Rep, V1, P142, DOI 10.1007/s11904-004-0021-z; Zeltser R, 2004, CLIN DERMATOL, V22, P461, DOI 10.1016/j.clindermatol.2004.07.009; 2006, MMWR MORB MORTAL WKL, V55, P269	14	7	8	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 7	2007	356	23					2407	2411		10.1056/NEJMcps062271	http://dx.doi.org/10.1056/NEJMcps062271			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	175QY	17554123				2022-12-28	WOS:000247029300012
J	Liu, B; Yang, YH; Chernishof, V; Loo, RRO; Jang, H; Tahk, S; Yang, R; Mink, S; Shultz, D; Bellone, CJ; Loo, JA; Shuai, K				Liu, Bin; Yang, Yonghui; Chernishof, Vasili; Loo, Rachel R. Ogorzalek; Jang, Hyunduk; Tahk, Samuel; Yang, Randy; Mink, Sheldon; Shultz, David; Bellone, Clifford J.; Loo, Joseph A.; Shuai, Ke			Proinflammatory stimuli induce IKK alpha-mediated phosphorylation of PIAS1 to restrict inflammation and immunity	CELL			English	Article							NF-KAPPA-B; NEGATIVE REGULATION; GENE-ACTIVATION; KINASE-ALPHA; PROTEINS; TRANSCRIPTION; INHIBITION; CYTOKINE	How inflammatory stimuli signal to the nucleus to restrict inflammation is poorly understood. Protein inhibitor of activated STAT1 (PIAS1), a transcriptional regulator that possesses small ubiquitin-related modifier (SUMO) E3 ligase activity, inhibits immune responses by selectively blocking the binding of NF-kappa B and STAT1 to gene promoters. We report here that PIAS1 becomes rapidly phosphorylated on Ser90 residue in response to various inflammatory stimuli. Mutational studies indicate that Ser90 phosphorylation is required for PIAS1 to repress transcription. Upon TNF treatment, wild-type PIAS1, but not the Ser90A mutant, becomes rapidly associated with the promoters of NF-kappa B target genes. Furthermore, IKK alpha, but not IKK beta, interacts with PIAS1 in vivo and mediates PIAS1 Ser90 phosphorylation, a process that requires the SUMO ligase activity of PIAS1. Our results identify a signaling pathway in which proinflammatory stimuli activate the IKK alpha-mediated sumoylation-dependent phosphorylation of PIAS1 for the immediate repression of inflammatory gene activation.	Univ Calif Los Angeles, Dept Med, Div Hematol Oncol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Mol Biol Inst, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, UCLA, DOE Inst Genom & Proteom, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; Cleveland Clin Fdn, Lerner Res Inst, Dept Mol Genet, Cleveland, OH 44195 USA; St Louis Univ, Sch Med, Dept Mol Microbiol & Immunol, St Louis, MO 63104 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; United States Department of Energy (DOE); University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Cleveland Clinic Foundation; Saint Louis University	Shuai, K (corresponding author), Univ Calif Los Angeles, Dept Med, Div Hematol Oncol, Los Angeles, CA 90095 USA.	kshuai@mednet.ucla.edu		Shultz, David/0000-0001-8242-6555	NIAMS NIH HHS [K01 AR52717-01] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR052717] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Anest V, 2003, NATURE, V423, P659, DOI 10.1038/nature01648; Bottero V, 2006, CELL DEATH DIFFER, V13, P785, DOI 10.1038/sj.cdd.4401888; Chung CD, 1997, SCIENCE, V278, P1803, DOI 10.1126/science.278.5344.1803; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Godambe Sandip A., 1995, Am J Ther, V2, P677, DOI 10.1097/00045391-199509000-00017; Hoberg JE, 2004, MOL CELL, V16, P245, DOI 10.1016/j.molcel.2004.10.010; Johnson ES, 2001, CELL, V106, P735, DOI 10.1016/S0092-8674(01)00491-3; Kato T, 2003, MOL CELL, V12, P829, DOI 10.1016/S1097-2765(03)00358-7; Kotaja N, 2002, MOL CELL BIOL, V22, P5222, DOI 10.1128/MCB.22.14.5222-5234.2002; Lawrence T, 2005, NATURE, V434, P1138, DOI 10.1038/nature03491; Li NX, 1998, P NATL ACAD SCI USA, V95, P13012, DOI 10.1073/pnas.95.22.13012; Li QT, 2005, P NATL ACAD SCI USA, V102, P12425, DOI 10.1073/pnas.0505997102; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Liu B, 2004, NAT IMMUNOL, V5, P891, DOI 10.1038/ni1104; Liu B, 1998, P NATL ACAD SCI USA, V95, P10626, DOI 10.1073/pnas.95.18.10626; Liu B, 2005, MOL CELL BIOL, V25, P1113, DOI 10.1128/MCB.25.3.1113-1123.2005; Liu B, 2001, P NATL ACAD SCI USA, V98, P3203, DOI 10.1073/pnas.051489598; Naka T, 2005, ADV IMMUNOL, V87, P61, DOI 10.1016/S0065-2776(05)87003-8; Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988; Sharrocks AD, 2006, GENE DEV, V20, P754, DOI 10.1101/gad.1421006; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shuai K, 2005, NAT REV IMMUNOL, V5, P593, DOI 10.1038/nri1667; Shuai K, 2003, NAT REV IMMUNOL, V3, P900, DOI 10.1038/nri1226; Yamamoto Y, 2003, NATURE, V423, P655, DOI 10.1038/nature01576	26	124	130	1	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 1	2007	129	5					903	914		10.1016/j.cell.2007.03.056	http://dx.doi.org/10.1016/j.cell.2007.03.056			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	176KT	17540171	Bronze			2022-12-28	WOS:000247084600011
J	Raval, A; Tanner, SM; Byrd, JC; Angerman, EB; Perko, JD; Chen, SS; Hackanson, B; Grever, MR; Lucas, DM; MatkoviC, JJ; Lin, TS; Kipps, TJ; Murray, F; Weisenburger, D; Sanger, W; Lynch, J; Watson, P; Jansen, M; Yoshinaga, Y; Rosenquist, R; de Jong, PJ; Coggill, P; Beck, S; Lynch, H; de la Chapelle, A; Plass, C				Raval, Aparna; Tanner, Stephan M.; Byrd, John C.; Angerman, Elizabeth B.; Perko, James D.; Chen, Shih-Shih; Hackanson, Bjoern; Grever, Michael R.; Lucas, David M.; MatkoviC, Jennifer J.; Lin, Thomas S.; Kipps, Thomas J.; Murray, Fiona; Weisenburger, Dennis; Sanger, Warren; Lynch, Jane; Watson, Patrice; Jansen, Mary; Yoshinaga, Yuko; Rosenquist, Richard; de Jong, Pieter J.; Coggill, Penny; Beck, Stephan; Lynch, Henry; de la Chapelle, Albert; Plass, Christoph			Downregulation of death-associated protein kinase 1 (DAPK1) in chronic lymphocytic leukemia	CELL			English	Article							TUMOR-SUPPRESSOR GENES; P2X7 RECEPTOR GENE; DNA HYPERMETHYLATION; APOPTOTIC CHECKPOINT; CPG ISLAND; KINASE; CANCER; METHYLATION; TRANSCRIPTION; POLYMORPHISM	The heritability of B cell chronic lymphocytic leukemia (CLL) is relatively high; however, no predisposing mutation has been convincingly identified. We show that loss or reduced expression of death-associated protein kinase 1 (DAPK1) underlies cases of heritable predisposition to CLL and the majority of sporadic CLL. Epigenetic silencing of DAPK1 by promoter methylation occurs in almost all sporadic CLL cases. Furthermore, we defined a disease haplotype, which segregates with the CLL phenotype in a large family. DAM expression of the CLL allele is downregulated by 75% in germline cells due to increased HOXB7 binding. In the blood cells from affected family members, promoter methylation results in additional loss of DAM expression. Thus, reduced expression of DAM can result from germline predisposition, as well as epigenetic or somatic events causing or contributing to the CILL phenotype.	Ohio State Univ, Ctr Comprehens Canc, Human Canc Gent Program, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43214 USA; Ohio State Univ, Div Hematol & Oncol, Dept Internal Med, Columbus, OH 43214 USA; Childrens Hosp Oakland Res Inst, Oakland, CA 94609 USA; Creighton Univ, Dept Prevent Med & Publ Hlth, Omaha, NE 68178 USA; Wellcome Trust Sanger Inst, Cambridge, England; Univ Calif San Diego, Dept Internal Med, San Diego, CA 92093 USA; Uppsala Univ, Rudbeck Lab, Dept Genet & Pathol, SE-75185 Uppsala, Sweden; Univ Freiburg, Ctr Med, Dept Hematol Oncol, Freiburg, Germany	James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Creighton University; Wellcome Trust Sanger Institute; University of California System; University of California San Diego; Uppsala University; University of Freiburg	de la Chapelle, A (corresponding author), Ohio State Univ, Human Canc Genet Program, Tzagournis Med Res Facil 464A, 420 W 12th Ave, Columbus, OH 43210 USA.	albert.delachapelle@osumc.edu; christoph.plass@osumc.edu	Plass, Christoph/H-7192-2014; Lucas, David M/E-3555-2011	Rosenquist, Richard/0000-0002-0211-8788; Edsall, Lee Elizabeth/0000-0002-0326-2829	NATIONAL CANCER INSTITUTE [P30CA016058, P01CA081534, R21CA110496, T32CA106196, P01CA101956, U01CA086389, P20CA081534] Funding Source: NIH RePORTER; NCI NIH HHS [CA101956, P01 CA101956, U01 CA086389, CA81534, P30 CA16058, 5U01 CA86389, P01 CA081534, T32 CA106196, R21 CA110496, P30 CA016058, CA110496] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Wellcome Trust(Wellcome TrustEuropean Commission)		Amundadottir LT, 2004, PLOS MED, V1, P229, DOI 10.1371/journal.pmed.0010065; Bialik S, 2006, ANNU REV BIOCHEM, V75, P189, DOI 10.1146/annurev.biochem.75.103004.142615; Brenner C, 2005, EMBO J, V24, P336, DOI 10.1038/sj.emboj.7600509; Bullrich F, 2001, CANCER RES, V61, P6640; Calin GA, 2006, SEMIN ONCOL, V33, P167, DOI 10.1053/j.seminoncol.2006.01.010; Calin GA, 2005, NEW ENGL J MED, V352, P1667, DOI 10.1056/NEJMoa042280; Caporaso N, 2006, BLOOD, V108, P415, DOI 10.1182/blood-2006-05-019489; Chen CH, 2005, EMBO J, V24, P294, DOI 10.1038/sj.emboj.7600510; Cheson BD, 1996, BLOOD, V87, P4990, DOI 10.1182/blood.V87.12.4990.bloodjournal87124990; Chim CS, 2006, J HUM GENET, V51, P832, DOI 10.1007/s10038-006-0029-x; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Cohen O, 1997, EMBO J, V16, P998, DOI 10.1093/emboj/16.5.998; Cohen O, 1999, J CELL BIOL, V146, P141; Corcoran M, 2005, HAEMATOLOGICA, V90, P1078; Dao-Ung LP, 2004, BRIT J HAEMATOL, V125, P815, DOI 10.1111/j.1365-2141.2004.04976.x; DEISS LP, 1995, GENE DEV, V9, P15, DOI 10.1101/gad.9.1.15; Di Croce L, 2002, SCIENCE, V295, P1079, DOI 10.1126/science.1065173; Dohner H, 2000, NEW ENGL J MED, V343, P1910, DOI 10.1056/NEJM200012283432602; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Esteller M, 2002, ONCOGENE, V21, P5427, DOI 10.1038/sj.onc.1205600; Frissora F, 2003, EUR J IMMUNOL, V33, P907, DOI 10.1002/eji.200323657; GOLDGAR DE, 1994, J NATL CANCER I, V86, P1600, DOI 10.1093/jnci/86.21.1600; Goldin LR, 2004, BLOOD, V104, P1850, DOI 10.1182/blood-2004-01-0341; Goldin LR, 2003, BRIT J HAEMATOL, V121, P866, DOI 10.1046/j.1365-2141.2003.04372.x; Inbal B, 1997, NATURE, V390, P180, DOI 10.1038/36599; Jang CW, 2002, NAT CELL BIOL, V4, P51, DOI 10.1038/ncb731; Katzenellenbogen RA, 1999, BLOOD, V93, P4347, DOI 10.1182/blood.V93.12.4347.412k31_4347_4353; Leu YW, 2004, CANCER RES, V64, P8184, DOI 10.1158/0008-5472.CAN-04-2045; Liechti-Gallati S, 1999, EUR J HUM GENET, V7, P590, DOI 10.1038/sj.ejhg.5200338; LILL MC, 1995, BLOOD, V85, P692, DOI 10.1182/blood.V85.3.692.bloodjournal853692; Lynch HT, 2002, AM J MED GENET, V115, P113, DOI 10.1002/ajmg.10686; Martoriati A, 2005, ONCOGENE, V24, P1461, DOI 10.1038/sj.onc.1208256; Mertens D, 2002, BLOOD, V99, P4116, DOI 10.1182/blood.V99.11.4116; PAPADOPOULOS N, 1995, NAT GENET, V11, P99, DOI 10.1038/ng0995-99; Raval A, 2005, J CLIN ONCOL, V23, P3877, DOI 10.1200/JCO.2005.02.196; Raveh T, 2001, NAT CELL BIOL, V3, P1, DOI 10.1038/35050500; Risch N, 2001, CANCER EPIDEM BIOMAR, V10, P733; Rosenwald A, 2003, J EXP MED, V198, P851, DOI 10.1084/jem.20031074; Rudd MF, 2006, BLOOD, V108, P638, DOI 10.1182/blood-2005-12-5022; Rush LJ, 2004, CANCER RES, V64, P2424, DOI 10.1158/0008-5472.CAN-03-2870; Sellick GS, 2006, SEMIN ONCOL, V33, P195, DOI 10.1053/j.seminoncol.2006.01.013; Sellick GS, 2005, AM J HUM GENET, V77, P420, DOI 10.1086/444472; SHEN WF, 1989, ADV EXP MED BIOL, V271, P211; Stilgenbauer S, 2005, CURR TOP MICROBIOL, V294, P147, DOI 10.1007/3-540-29933-5_9; Stirzaker C, 2004, CANCER RES, V64, P3871, DOI 10.1158/0008-5472.CAN-03-3690; Thunberg U, 2002, LANCET, V360, P1935, DOI 10.1016/S0140-6736(02)11917-9; Wiley JS, 2002, LANCET, V359, P1114, DOI 10.1016/S0140-6736(02)08156-4; Wilson JD., HARRISONS PRINCIPLES, V1994, P472; Yu L, 2004, GENOMICS, V84, P647, DOI 10.1016/j.ygeno.2004.06.010; Yu L, 2005, NAT GENET, V37, P265, DOI 10.1038/ng1521; Yuille MR, 2000, BRIT J HAEMATOL, V109, P794, DOI 10.1046/j.1365-2141.2000.02111.x	52	284	303	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 1	2007	129	5					879	890		10.1016/j.cell.2007.03.043	http://dx.doi.org/10.1016/j.cell.2007.03.043			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	176KT	17540169	Green Published, Bronze			2022-12-28	WOS:000247084600009
J	Wahlman, J; DeMartino, GN; Skach, WR; Bulleid, NJ; Brodsky, JL; Johnson, AE				Wahlman, Judit; DeMartino, George N.; Skach, William R.; Bulleid, Neil J.; Brodsky, Jeffrey L.; Johnson, Arthur E.			Real-time fluorescence detection of ERAD substrate retrotranslocation in a mammalian in vitro system	CELL			English	Article							PROTEIN DISULFIDE-ISOMERASE; RETICULUM-ASSOCIATED DEGRADATION; MISFOLDED SECRETORY PROTEIN; ENDOPLASMIC-RETICULUM; QUALITY-CONTROL; MEMBRANE-PROTEIN; RETRO-TRANSLOCATION; MOLECULAR CHAPERONES; CHOLERA-TOXIN; PROTEASOME	Secretory proteins unable to assemble into their native states in the endoplasmic reticulum (ER) are transported back or "retrotranslocated" into the cytosol for ER-associated degradation (ERAD). To examine the roles of different components in ERAD, one fluorescencelabeled ERAD substrate was encapsulated with selected lumenal factors inside mammalian microsomes. After mixing microsomes with fluorescence-quenching agents and selected cytosolic proteins, the rate of substrate efflux was monitored continuously in real time by the decrease in fluorescence intensity as cytosolic quenchers contacted dye-labeled substrates. The retrotranslocation kinetics of nonglycosylated pro-alpha factor were not significantly altered by replacing all lumenal proteins with only protein disuifide isomerase or all cytosolic proteins with only PA700, the 19S regulatory particle of the 26S proteasome. Retrotranslocation was blocked by antibodies against a putative retrotranslocation channel protein, derlin-1, but not Sec61 alpha. In addition, pro-alpha factor photocrosslinked derlin-1, but not Sec61 alpha. Thus, derlin-1 appears to be involved in pro-alpha factor retrotranslocation.	Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA; Univ Texas, SW Med Ctr, Dept Physiol, Dallas, TX 75390 USA; Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; Texas A&M Univ Syst, Ctr Hlth Sci, Dept Mol & Cellular Med, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Oregon Health & Science University; University of Manchester; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Texas A&M University System; Texas A&M University College Station	Johnson, AE (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA.	ajohnson@medicine.tamhsc.edu	Johnson, Arthur E/G-3457-2012	Bulleid, Neil/0000-0002-9839-5279	Biotechnology and Biological Sciences Research Council [BB/D00764X/1] Funding Source: Medline; NIDDK NIH HHS [R01 DK046181, R56 DK046181, R01 DK051818, DK51818, DK46181] Funding Source: Medline; NIGMS NIH HHS [R01 GM026494, GM26494, GM75061, GM53457, R01 GM075061, R01 GM053457] Funding Source: Medline; Wellcome Trust [074081] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK046181, R01DK046181, R01DK051818] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075061, R01GM053457, R01GM026494] Funding Source: NIH RePORTER; BBSRC [BB/D00764X/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Alder NN, 2005, J CELL BIOL, V168, P389, DOI 10.1083/jcb.200409174; Bays NW, 2002, CURR BIOL, V12, pR366, DOI 10.1016/S0960-9822(02)00862-X; Brodsky JL, 1999, J BIOL CHEM, V274, P3453, DOI 10.1074/jbc.274.6.3453; BULLEID NJ, 1988, NATURE, V335, P649, DOI 10.1038/335649a0; CAI H, 1994, J BIOL CHEM, V269, P24550; CAPLAN S, 1991, J BACTERIOL, V173, P627, DOI 10.1128/jb.173.2.627-635.1991; Carlson EJ, 2006, EMBO J, V25, P4557, DOI 10.1038/sj.emboj.7601307; Chillaron J, 2000, MOL BIOL CELL, V11, P217, DOI 10.1091/mbc.11.1.217; CROWLEY KS, 1994, CELL, V78, P461, DOI 10.1016/0092-8674(94)90424-3; DEMARTINO GN, 1994, J BIOL CHEM, V269, P20878; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Fewell SW, 2001, J BIOL CHEM, V276, P910, DOI 10.1074/jbc.M008535200; Flanagan JJ, 2003, J BIOL CHEM, V278, P18628, DOI 10.1074/jbc.M300173200; Gaczynska Maria, 2005, V301, P3; Gillece P, 2000, P NATL ACAD SCI USA, V97, P4609, DOI 10.1073/pnas.090083497; Gillece P, 1999, J CELL BIOL, V147, P1443, DOI 10.1083/jcb.147.7.1443; Haigh NG, 2002, J CELL BIOL, V156, P261, DOI 10.1083/jcb.200110074; Hamman BD, 1998, CELL, V92, P747, DOI 10.1016/S0092-8674(00)81403-8; Hampton RY, 1996, MOL BIOL CELL, V7, P2029, DOI 10.1091/mbc.7.12.2029; Hebert DN, 2005, TRENDS CELL BIOL, V15, P364, DOI 10.1016/j.tcb.2005.05.007; Hiller MM, 1996, SCIENCE, V273, P1725, DOI 10.1126/science.273.5282.1725; JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4; Johnson AE, 2000, CELL, V102, P709, DOI 10.1016/S0092-8674(00)00059-3; Johnson AE, 2005, TRAFFIC, V6, P1078, DOI 10.1111/j.1600-0854.2005.00340.x; Johnson AE, 1999, ANNU REV CELL DEV BI, V15, P799, DOI 10.1146/annurev.cellbio.15.1.799; JOHNSON AE, 1982, J MOL BIOL, V156, P113, DOI 10.1016/0022-2836(82)90462-4; Kabani M, 2003, MOL BIOL CELL, V14, P3437, DOI 10.1091/mbc.E02-12-0847; Kalies KU, 2005, EMBO J, V24, P2284, DOI 10.1038/sj.emboj.7600731; Kostova Z, 2003, EMBO J, V22, P2309, DOI 10.1093/emboj/cdg227; Kothe M, 2005, J BIOL CHEM, V280, P28127, DOI 10.1074/jbc.M503138200; KRIEG UC, 1986, P NATL ACAD SCI USA, V83, P8604, DOI 10.1073/pnas.83.22.8604; Lee RJ, 2004, EMBO J, V23, P2206, DOI 10.1038/sj.emboj.7600232; Lilley BN, 2005, P NATL ACAD SCI USA, V102, P14296, DOI 10.1073/pnas.0505014102; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Lilley BN, 2006, J VIROL, V80, P8739, DOI 10.1128/JVI.00791-06; Liu CW, 2002, J BIOL CHEM, V277, P26815, DOI 10.1074/jbc.M201782200; Mayer TU, 1998, EMBO J, V17, P3251, DOI 10.1093/emboj/17.12.3251; McCormick PJ, 2003, MOL CELL, V12, P329, DOI 10.1016/S1097-2765(03)00304-6; McCracken AA, 1996, J CELL BIOL, V132, P291, DOI 10.1083/jcb.132.3.291; McCracken AA, 2003, BIOESSAYS, V25, P868, DOI 10.1002/bies.10320; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Ng WY, 2007, J CELL SCI, V120, P682, DOI 10.1242/jcs.03351; NICCHITTA CV, 1993, CELL, V73, P989, DOI 10.1016/0092-8674(93)90276-V; Nishikawa S, 2005, J BIOCHEM, V137, P551, DOI 10.1093/jb/mvi068; Oda Y, 2006, J CELL BIOL, V172, P383, DOI 10.1083/jcb.200507057; Pilon M, 1997, EMBO J, V16, P4540, DOI 10.1093/emboj/16.15.4540; Plemper RK, 1997, NATURE, V388, P891, DOI 10.1038/42276; PUIG A, 1994, J BIOL CHEM, V269, P7764; Romisch K, 2005, ANNU REV CELL DEV BI, V21, P435, DOI 10.1146/annurev.cellbio.21.012704.133250; Schekman R, 2004, NATURE, V429, P817, DOI 10.1038/429817a; Schmitz A, 2000, J CELL BIOL, V148, P1203, DOI 10.1083/jcb.148.6.1203; SOMMER T, 1993, NATURE, V365, P176, DOI 10.1038/365176a0; Strickland E, 2000, J BIOL CHEM, V275, P5565, DOI 10.1074/jbc.275.8.5565; SU K, 1993, J BIOL CHEM, V268, P14301; Trombetta ES, 2003, ANNU REV CELL DEV BI, V19, P649, DOI 10.1146/annurev.cellbio.19.110701.153949; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; Tsai B, 2001, CELL, V104, P937, DOI 10.1016/S0092-8674(01)00289-6; Walter J, 2001, EMBO J, V20, P3124, DOI 10.1093/emboj/20.12.3124; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0; Wilkinson B, 2004, BBA-PROTEINS PROTEOM, V1699, P35, DOI 10.1016/j.bbapap.2004.02.017; Wojcik C, 2006, MOL BIOL CELL, V17, P4606, DOI 10.1091/mbc.E06-05-0432; Woolhead CA, 2004, CELL, V116, P725, DOI 10.1016/S0092-8674(04)00169-2; YE J, 1991, J BIOL CHEM, V266, P23016; Ye YH, 2005, P NATL ACAD SCI USA, V102, P14132, DOI 10.1073/pnas.0505006102; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Zhou MY, 1999, MOL CELL, V4, P925, DOI 10.1016/S1097-2765(00)80222-1	67	106	107	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 1	2007	129	5					943	955		10.1016/j.cell.2007.03.046	http://dx.doi.org/10.1016/j.cell.2007.03.046			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	176KT	17540174	hybrid, Green Published			2022-12-28	WOS:000247084600014
J	Dettman, JR; Sirjusingh, C; Kohn, LM; Anderson, JB				Dettman, Jeremy R.; Sirjusingh, Caroline; Kohn, Linda M.; Anderson, James B.			Incipient speciation by divergent adaptation and antagonistic epistasis in yeast	NATURE			English	Article							ANTIFUNGAL DRUG-RESISTANCE; MISMATCH REPAIR SYSTEM; EXPERIMENTAL EVOLUTION; BUDDING YEAST; SACCHAROMYCES; HYBRID; BOTTLENECKS; MECHANISMS; DROSOPHILA; STERILITY	Establishing the conditions that promote the evolution of reproductive isolation and speciation has long been a goal in evolutionary biology(1-3). In ecological speciation, reproductive isolation between populations evolves as a by-product of divergent selection and the resulting environment-specific adaptations(4-6). The leading genetic model of reproductive isolation predicts that hybrid inferiority is caused by antagonistic epistasis between incompatible alleles at interacting loci(1,7). The fundamental link between divergent adaptation and reproductive isolation through genetic incompatibilities has been predicted(1,4,5), but has not been directly demonstrated experimentally. Here we empirically tested key predictions of speciation theory by evolving the initial stages of speciation in experimental populations of the yeast Saccharomyces cerevisiae. After replicate populations adapted to two divergent environments, we consistently observed the evolution of two forms of postzygotic isolation in hybrids: reduced rate of mitotic reproduction and reduced efficiency of meiotic reproduction. This divergent selection resulted in greater reproductive isolation than parallel selection, as predicted by the ecological speciation theory. Our experimental system allowed controlled comparison of the relative importance of ecological and genetic isolation, and we demonstrated that hybrid inferiority can be ecological and/or genetic in basis. Overall, our results show that adaptation to divergent environments promotes the evolution of reproductive isolation through antagonistic epistasis, providing evidence of a plausible common avenue to speciation and adaptive radiation in nature.	Univ Toronto, Dept Ecol & Evolutionary Biol, Mississauga, ON L5L 1C6, Canada	University of Toronto; University Toronto Mississauga	Dettman, JR (corresponding author), Univ Toronto, Dept Ecol & Evolutionary Biol, Mississauga, ON L5L 1C6, Canada.	jdettman@utm.utoronto.ca						Anderson JB, 2006, EUKARYOT CELL, V5, P1243, DOI 10.1128/EC.00048-06; Anderson JB, 2003, GENETICS, V163, P1287; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; Coyne J.A., 2004, SPECIATION; COYNE JA, 1992, NATURE, V355, P511, DOI 10.1038/355511a0; de Oliveira A. K., 1980, HEREDITY, V44, P123; Delneri D, 2003, NATURE, V422, P68, DOI 10.1038/nature01418; Demuth JP, 2005, AM NAT, V165, P524, DOI 10.1086/429276; Dobzhansky T., 1937; Fischer G, 2000, NATURE, V405, P451, DOI 10.1038/35013058; Funk DJ, 2006, P NATL ACAD SCI USA, V103, P3209, DOI 10.1073/pnas.0508653103; Greig D, 2003, J EVOLUTION BIOL, V16, P429, DOI 10.1046/j.1420-9101.2003.00546.x; Greig D, 2002, P ROY SOC B-BIOL SCI, V269, P1167, DOI 10.1098/rspb.2002.1989; Greig D, 2007, PLOS GENET, V3, P281, DOI 10.1371/journal.pgen.0030021; Hunter N, 1996, EMBO J, V15, P1726, DOI 10.1002/j.1460-2075.1996.tb00518.x; Kohn LM, 2005, ANNU REV PHYTOPATHOL, V43, P279, DOI 10.1146/annurev.phyto.43.040204.135958; Leu JY, 2006, CURR BIOL, V16, P280, DOI 10.1016/j.cub.2005.12.028; McKinnon JS, 2004, NATURE, V429, P294, DOI 10.1038/nature02556; Mooers AO, 1999, AM NAT, V153, P437, DOI 10.1086/303186; Muller HJ, 1942, BIOL S, V6, P71; Orr HA, 2001, EVOLUTION, V55, P1085; Presgraves DC, 2003, NATURE, V423, P715, DOI 10.1038/nature01679; RICE WR, 1993, EVOLUTION, V47, P1637, DOI [10.2307/2410209, 10.1111/j.1558-5646.1993.tb01257.x]; Rieseberg LH, 2001, TRENDS ECOL EVOL, V16, P351, DOI 10.1016/S0169-5347(01)02187-5; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; Rundle HD, 2005, PLOS BIOL, V3, P1988, DOI 10.1371/journal.pbio.0030368; Rundle HD, 2003, EVOLUTION, V57, P2557; Rundle HD, 2001, EVOLUTION, V55, P198; Schluter D, 2001, TRENDS ECOL EVOL, V16, P372, DOI 10.1016/S0169-5347(01)02198-X; Schluter D., 2000, ECOLOGY ADAPTIVE RAD	30	143	145	2	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 31	2007	447	7144					585	+		10.1038/nature05856	http://dx.doi.org/10.1038/nature05856			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172YZ	17538619				2022-12-28	WOS:000246842000047
J	Basavaraju, KP; Hunt, CR; Ahluwalia, NK				Basavaraju, Krishna P.; Hunt, C. Roger; Ahluwalia, Navneet K.			9 years of recurrent dysphagia	LANCET			English	Editorial Material									Stepping Hill Hosp, Dept Gastroenterol, Stockport SK2 7JE, Lancs, England; Stepping Hill Hosp, Dept Histopathol, Stockport SK2 7JE, Lancs, England		Basavaraju, KP (corresponding author), Stepping Hill Hosp, Dept Gastroenterol, Stockport SK2 7JE, Lancs, England.	kpbasavaraju@talk21.com							0	5	5	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 26	2007	369	9575					1814	1814		10.1016/S0140-6736(07)60819-8	http://dx.doi.org/10.1016/S0140-6736(07)60819-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	172QP	17531889				2022-12-28	WOS:000246819300032
J	Pinhas-Hamiel, O; Zeitler, P				Pinhas-Hamiel, Orit; Zeitler, Philip			Acute and chronic complications of type 2 diabetes mellitus in children and adolescents	LANCET			English	Review							PIMA-INDIANS; INITIAL PRESENTATION; BLOOD-PRESSURE; ONSET; YOUTH; NIDDM; KETOACIDOSIS; NEPHROPATHY; PREVALENCE; DISEASE	With the increase in prevalence of type 2 diabetes mellitus in adolescents, a rise in incidence of secondary comorbidifies - including hypertension, hyperlipidaemia, nephropathy, and retinopathy - is anticipated. Furthermore, findings of studies in young adults have suggested that the development and progression of clinical complications might be especially rapid when the onset of type 2 diabetes is early, raising the possibility of a serious public-health challenge in the next few decades. To date, reports of the epidemiology and natural history of secondary complications specifically in adolescents with type 2 diabetes have been scarce. Yet, we must begin to understand the extent of the coming challenge. To this end, we have reviewed reports on acute and long-term comorbidities associated with type 2 diabetes in young people and have looked at mounting evidence that this group could be at increased risk for development of early complications.	Chaim Sheba Med Ctr, IL-52621 Tel Hashomer, Ramat Gan, Israel; Univ Colorado, Dept Pediat, Div Endocrinol, Denver, CO 80202 USA	Chaim Sheba Medical Center; University of Colorado System; University of Colorado Denver	Pinhas-Hamiel, O (corresponding author), Chaim Sheba Med Ctr, IL-52621 Tel Hashomer, Ramat Gan, Israel.	orithami@sheba.health.gov.il	Pinhas-Hamiel, Orit/K-5198-2013	Zeitler, Philip/0000-0001-5756-7858				American Diabetes Association, 2001, Diabetes Care, V24, P1988; Angulo P, 1999, HEPATOLOGY, V30, P1356, DOI 10.1002/hep.510300604; Bhowmick Samar K, 2005, Endocr Pract, V11, P23; Carchman Rebecca M, 2005, Pediatr Crit Care Med, V6, P20, DOI 10.1097/01.PCC.0000149134.61673.77; Dabelea D, 2000, J Matern Fetal Med, V9, P83, DOI 10.1002/(SICI)1520-6661(200001/02)9:1<83::AID-MFM17>3.0.CO;2-O; Dean H, 2001, DIABETES, V50, pA378; Dean H, 1998, CLIN PEDIATR, V37, P89, DOI 10.1177/000992289803700205; DEAN H, 2002, DIABETES S2, V51, pOR99; Dunger DB, 2004, ARCH DIS CHILD, V89, P188, DOI 10.1136/adc.2003.044875; Ehtisham S, 2000, DIABETIC MED, V17, P867, DOI 10.1046/j.1464-5491.2000.00409.x; Eppens MC, 2006, DIABETES CARE, V29, P1300, DOI 10.2337/dc05-2470; Ettinger LM, 2005, J PEDIATR-US, V147, P67, DOI 10.1016/j.jpeds.2005.02.003; Fagot-Campagna A, 1998, DIABETES, V47, pA155; Fourtner SH, 2005, PEDIATR DIABETES, V6, P129, DOI 10.1111/j.1399-543X.2005.00113.x; Gahagan S, 2003, PEDIATRICS, V112, pE328, DOI 10.1542/peds.112.4.e328; GOLAND R, 2003, DIABETES S1, V52, pP1749; Gungor N, 2005, DIABETES CARE, V28, P1219, DOI 10.2337/diacare.28.5.1219; Hillier TA, 2003, DIABETES CARE, V26, P2999, DOI 10.2337/diacare.26.11.2999; Hollander AS, 2003, PEDIATRICS, V111, P1447, DOI 10.1542/peds.111.6.1447; Hotu S, 2004, J PAEDIATR CHILD H, V40, P201, DOI 10.1111/j.1440-1754.2004.00337.x; Katz LEL, 2005, PEDIATR DIABETES, V6, P84, DOI 10.1111/j.1399-543X.2005.00105.x; KAWAHARA R, 1994, DIABETES RES CLIN PR, V24, P181, DOI 10.1016/0168-8227(94)90114-7; Kershnar AK, 2006, J PEDIATR-US, V149, P314, DOI 10.1016/j.jpeds.2006.04.065; KORNER AM, 2002, 38 EASD ANN M BUD HU; Krakoff J, 2003, DIABETES CARE, V26, P76, DOI 10.2337/diacare.26.1.76; Macintosh MCM, 2006, BRIT MED J, V333, P177, DOI 10.1136/bmj.38856.692986.AE; McDonnell CM, 2005, PEDIATR DIABETES, V6, P90, DOI 10.1111/j.1399-543X.2005.00107.x; McGrath NM, 1999, DIABETES RES CLIN PR, V43, P205, DOI 10.1016/S0168-8227(99)00003-0; Morales AE, 2004, J PEDIATR-US, V144, P270, DOI 10.1016/j.jpeds.2003.10.061; Nadeau KJ, 2005, J PEDIATR GASTR NUTR, V41, P94, DOI 10.1097/01.MPG.0000164698.03164.E5; NELSON RG, 1988, DIABETES CARE, V11, P8, DOI 10.2337/diacare.11.1.8; Nelson RG, 1998, DIABETES, V47, P1489, DOI 10.2337/diabetes.47.9.1489; Newfield R, 2003, DIABETES, V52, pA404; NEWFIELD R, 2003, DIABETES S1, V52, pP1754; Okudaira M, 2000, J DIABETES COMPLICAT, V14, P281, DOI 10.1016/S1056-8727(00)00114-8; OMORI Y, 1994, DIABETES RES CLIN PR, V24, pS273, DOI 10.1016/0168-8227(94)90261-5; Palmert MR, 2002, J CLIN ENDOCR METAB, V87, P1017, DOI 10.1210/jc.87.3.1017; Pihoker Catherine, 2006, Curr Diab Rep, V6, P108, DOI 10.1007/s11892-006-0020-0; Pinhas-Hamiel O, 2005, J PEDIATR-US, V146, P693, DOI 10.1016/j.jpeds.2004.12.042; Pinhas-Hamiel O, 1999, NEW ENGL J MED, V340, P1418, DOI 10.1056/NEJM199905063401808; Pinhas-Hamiel O, 1999, ARCH PEDIAT ADOL MED, V153, P1063, DOI 10.1001/archpedi.153.10.1063; Pinhas-Hamiel Orit, 2005, Adv Pediatr, V52, P223, DOI 10.1016/j.yapd.2005.03.008; Pinhas-Hamiel O, 2006, CURR OPIN PEDIATR, V18, P206, DOI 10.1097/01.mop.0000193286.79399.43; Pinhas-Hamiel Orit, 2003, Pediatr Diabetes, V4, P24, DOI 10.1034/j.1399-5448.2003.00027.x; PinhasHamiel O, 1997, DIABETES CARE, V20, P484, DOI 10.2337/diacare.20.4.484; Rettig KR, 2000, CLIN PEDIATR, V39, P439, DOI 10.1177/000992280003900715; Roberts EA, 2005, FRONT BIOSCI-LANDMRK, V10, P2306, DOI 10.2741/1699; Scott Adrian, 2006, N Z Med J, V119, pU2015; Scott CR, 1997, PEDIATRICS, V100, P84, DOI 10.1542/peds.100.1.84; Sellers EAC, 2000, DIABETES CARE, V23, P1202, DOI 10.2337/diacare.23.8.1202; Sievers ML, 1999, DIABETES, V48, P896, DOI 10.2337/diabetes.48.4.896; Szabo RM, 2001, PEDIATR DERMATOL, V18, P316, DOI 10.1046/j.1525-1470.2001.01935.x; Upchurch SL, 2003, DIABETES CARE, V26, P2209, DOI 10.2337/diacare.26.7.2209; Varni JW, 2003, DIABETES CARE, V26, P631, DOI 10.2337/diacare.26.3.631; Wei JN, 2003, JAMA-J AM MED ASSOC, V290, P1345, DOI 10.1001/jama.290.10.1345; Yokoyama H, 1998, DIABETES CARE, V21, P1080, DOI 10.2337/diacare.21.7.1080; Yokoyama H, 1997, DIABETES CARE, V20, P844, DOI 10.2337/diacare.20.5.844; Yokoyama H, 2000, KIDNEY INT, V58, P302, DOI 10.1046/j.1523-1755.2000.00166.x; Yoo EG, 2004, J PEDIATR ENDOCR MET, V17, P1423; Yung G, 2003, DIABETES, V52, pA405; Zdravkovic V, 2004, DIABETIC MED, V21, P1144, DOI 10.1111/j.1464-5491.2004.01297.x	62	244	258	1	31	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 26	2007	369	9575					1823	1831		10.1016/S0140-6736(07)60821-6	http://dx.doi.org/10.1016/S0140-6736(07)60821-6			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	172QP	17531891				2022-12-28	WOS:000246819300034
J	Jiang, W; Yun, D; Saleh, L; Barr, EW; Xing, G; Hoffart, LM; Maslak, MA; Krebs, C; Bollinger, JM				Jiang, Wei; Yun, Danny; Saleh, Lana; Barr, Eric W.; Xing, Gang; Hoffart, Lee M.; Maslak, Monique-Anne; Krebs, Carsten; Bollinger, J. Martin, Jr.			A manganese(IV)/iron(III) cofactor in Chlamydia trachomatis ribonucleotide reductase	SCIENCE			English	Article							ESCHERICHIA-COLI; NITRIC-OXIDE; INACTIVATION; RADICALS; ENZYME; DIPHOSPHATES; CATALYSIS; MECHANISM; IRON; SITE	In a conventional class I ribonucleotide reductase (RNR), a diiron(II/II) cofactor in the R2 subunit reacts with oxygen to produce a diiron(III/IV) intermediate, which generates a stable tyrosyl radical (Y.). The Y. reversibly oxidizes a cysteine residue in the R1 subunit to a cysteinyl radical (C.), which abstracts the 3'-hydrogen of the substrate to initiate its reduction. The RNR from Chlamydia trachomatis lacks the Y., and it had been proposed that the diiron(III/IV) complex in R2 directly generates the C. in R1. By enzyme activity measurements and spectroscopic methods, we show that this RNR actually uses a previously unknown stable manganese(IV)/iron( III) cofactor for radical initiation.	Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; Penn State Univ, Dept Chem, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Krebs, C (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA.	ckrebs@psu.edu	Bollinger, Joseph/C-1425-2016; Krebs, Carsten/D-4773-2009	Krebs, Carsten/0000-0002-3302-7053	NIGMS NIH HHS [GM55365] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Behravan G, 1995, BBA-GENE STRUCT EXPR, V1264, P323, DOI 10.1016/0167-4781(95)00168-9; ELIASSON R, 1994, J BIOL CHEM, V269, P26116; Fontecave M, 1998, CELL MOL LIFE SCI, V54, P684, DOI 10.1007/s000180050195; Fontecave M, 2002, PROG NUCLEIC ACID RE, V72, P95, DOI 10.1016/S0079-6603(02)72068-0; Fritscher J, 2005, J AM CHEM SOC, V127, P7729, DOI 10.1021/ja043111x; Guittet O, 1999, CELL MOL LIFE SCI, V55, P1054, DOI 10.1007/s000180050356; HASSAN HM, 1994, FEMS MICROBIOL REV, V14, P315, DOI 10.1111/j.1574-6976.1994.tb00105.x; Hogbom M, 2004, SCIENCE, V305, P245, DOI 10.1126/science.1098419; Lawrence CC, 1998, CURR OPIN CHEM BIOL, V2, P650, DOI 10.1016/S1367-5931(98)80097-5; LEPOIVRE M, 1991, BIOCHEM BIOPH RES CO, V179, P442, DOI 10.1016/0006-291X(91)91390-X; Licht S, 1996, SCIENCE, V271, P477, DOI 10.1126/science.271.5248.477; Munck E., 2000, PHYS METHODS BIOINOR, P287; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; Roshick C, 2000, J BIOL CHEM, V275, P38111, DOI 10.1074/jbc.M006367200; SALOWE S, 1993, BIOCHEMISTRY-US, V32, P12749, DOI 10.1021/bi00210a026; Sinnecker S, 2005, J BIOL INORG CHEM, V10, P231, DOI 10.1007/s00775-005-0633-9; SJOBERG BM, 1983, J BIOL CHEM, V258, P8060; Stubbe J, 2003, CHEM REV, V103, P2167, DOI 10.1021/cr020421u; Stubbe J, 2000, CURR OPIN STRUC BIOL, V10, P731, DOI 10.1016/S0959-440X(00)00153-6; Stubbe J, 1998, CHEM REV, V98, P705, DOI 10.1021/cr9400875; Stubble J, 2003, CURR OPIN CHEM BIOL, V7, P183, DOI 10.1016/S1367-5931(03)00025-5; THELANDER L, 1976, J BIOL CHEM, V251, P1398; Voevodskaya N, 2006, P NATL ACAD SCI USA, V103, P9850, DOI 10.1073/pnas.0600603103; Voevodskaya N, 2005, BIOCHEM BIOPH RES CO, V330, P1213, DOI 10.1016/j.bbrc.2005.03.104; ZHENG M, 1994, INORG CHEM, V33, P382, DOI 10.1021/ic00080a030	25	154	156	0	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2007	316	5828					1188	1191		10.1126/science.1141179	http://dx.doi.org/10.1126/science.1141179			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171GQ	17525338				2022-12-28	WOS:000246724300042
J	Manheimer, E; Linde, K; Lao, LX; Bouter, LM; Berman, BM				Manheimer, Eric; Linde, Klaus; Lao, Lixing; Bouter, Lex M.; Berman, Brian M.			Meta-analysis: Acupuncture for osteoarthritis of the knee	ANNALS OF INTERNAL MEDICINE			English	Review							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; RANDOMIZED CONTROLLED-TRIAL; CONTROLLED CLINICAL-TRIALS; LOW-BACK-PAIN; HIP OSTEOARTHRITIS; ADJUNCTIVE THERAPY; SYSTEMATIC REVIEWS; PRAGMATIC TRIALS; HEALTH-CARE; PLACEBO	Background: Knee osteoarthritis is a major cause of pain and functional limitation. Purpose: To evaluate the effects of acupuncture for treating knee osteoarthritis. Data Sources: Cochrane Central Register of Controlled Trials MEDLINE, and EMBASE databases to January 2007. No language restrictions were applied. Study Selection: Randomized trials longer than 6 weeks in duration that compared needle acupuncture with a sham, usual care, or waiting list control group for patients with knee osteoarthritis. Data Extraction: Two authors independently agreed on eligibility, assessed methodological quality and acupuncture adequacy, and extracted outcome data on pain and function measures. Data Synthesis: Eleven trials met the selection criteria, and 9 reported sufficient data for pooling. Standardized mean differences were calculated by using differences in improvements from baseline between patients assigned to acupuncture and those assigned to control groups. Compared with patients in waiting list control groups, patients who received acupuncture reported clinically relevant short-term improvements in pain (standardized mean difference, -0.96 [95% CI, -1.21 to -0.701) and function (standardized mean difference, -0.93 [CI, -1.16 to -0.69]). Patients who received acupuncture also reported clinically relevant short- and long-term improvements in pain and function compared with patients in usual care control groups. Compared with a sham control, acupuncture provided clinically irrelevant short-term improvements in pain (standardized mean difference, -0.35 [CI, -0.55 to -0.15]) and function (standardized mean difference, -0.35 [CI, -0.56 to -0.141) and clinically irrelevant long-term improvements in pain (standardized mean difference, -0.13 [CI, -0.24 to -0.01]) and function (standardized mean difference, -0.14 [CI, -0.26 to -0.031). Limitation: Sham-controlled trials had heterogeneous results that were probably due to the variability of acupuncture and sham protocols, patient samples, and settings. Conclusions: Sham-controlled trials show clinically irrelevant shortterm benefits of acupuncture for treating knee osteoarthritis. Waiting list-controlled trials suggest clinically relevant benefits, some of which may be due to placebo or expectation effects.	Univ Maryland, Ctr Integrat Med, Sch Med, Baltimore, MD 21207 USA; Tech Univ Munich, D-8000 Munich, Germany; Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands	University System of Maryland; University of Maryland Baltimore; Technical University of Munich; Vrije Universiteit Amsterdam	Manheimer, E (corresponding author), Univ Maryland, Ctr Integrat Med, Sch Med, 2200 Kernan Dr,Kernan Hosp Mans, Baltimore, MD 21207 USA.		Lao, Lixing/I-7979-2013; Bouter, Lex/X-1003-2019	Bouter, Lex/0000-0002-2659-5482; Linde, Klaus/0000-0002-2902-970X; Lao, Lixing/0000-0003-0198-9714	NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [P01AT002605] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [R24AT001293] Funding Source: NIH RePORTER; NCCIH NIH HHS [R24 AT001293, P01 AT002605-01A1] Funding Source: Medline	NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCCIH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)		Angst F, 2002, J RHEUMATOL, V29, P131; Ausiello JC, 2002, J RHEUMATOL, V29, P999; Bellamy N, 2005, CLIN EXP RHEUMATOL, V23, pS148; BELLAMY N, 1988, J RHEUMATOL, V15, P1833; Berman BM, 1999, RHEUMATOLOGY, V38, P346, DOI 10.1093/rheumatology/38.4.346; Berman BM, 2004, ANN INTERN MED, V141, P901, DOI 10.7326/0003-4819-141-12-200412210-00006; Birch S, 2006, J ALTERN COMPLEM MED, V12, P303, DOI 10.1089/acm.2006.12.303; Birch S, 2004, J ALTERN COMPLEM MED, V10, P481, DOI 10.1089/1075553041323911; Birch S, 1998, JAPANESE ACUPUNCTURE; Bjordal JM, 2004, BMJ-BRIT MED J, V329, P1317, DOI 10.1136/bmj.38273.626655.63; Blower AL, 1997, ALIMENT PHARM THERAP, V11, P283, DOI 10.1046/j.1365-2036.1997.d01-604.x; Cherkin DC, 2003, ANN INTERN MED, V138, P898, DOI 10.7326/0003-4819-138-11-200306030-00011; Cherkin DC, 2005, ANN INTERN MED, V142, P872, DOI 10.7326/0003-4819-142-10-200505170-00019; CHRISTENSEN BV, 1992, ACTA ANAESTH SCAND, V36, P519, DOI 10.1111/j.1399-6576.1992.tb03511.x; Christensen R, 2007, ANN RHEUM DIS, V66, P433, DOI 10.1136/ard.2006.065904; *COCHR COLL NORD C, 2003, REV MAN REVMAN COMP; DEEKS JJ, 2003, STANDARD STAT ALGORI; DEEKS JJ, 2005, COCHRANE HDB SYSTEMA; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Ernst E, 1997, SCAND J RHEUMATOL, V26, P444, DOI 10.3109/03009749709065717; Ernst E, 2006, RHEUMATOLOGY, V45, P125, DOI 10.1093/rheumatology/kei256; Ezzo J, 2001, ARTHRITIS RHEUM, V44, P819, DOI 10.1002/1529-0131(200104)44:4<819::AID-ANR138>3.0.CO;2-P; Felson DT, 1998, ARTHRITIS RHEUM, V41, P1343, DOI 10.1002/1529-0131(199808)41:8<1343::AID-ART3>3.0.CO;2-9; Fransen M, 2003, COCHRANE DB SYST REV; Furlan AD, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001351.pub2; Glanville JM, 2006, J MED LIBR ASSOC, V94, P130; GREENLAND S, 1994, AM J EPIDEMIOL, V140, P290, DOI 10.1093/oxfordjournals.aje.a117248; Hernandez-Diaz S, 2000, ARCH INTERN MED, V160, P2093, DOI 10.1001/archinte.160.14.2093; Jordan KM, 2003, ANN RHEUM DIS, V62, P1145, DOI 10.1136/ard.2003.011742; Juni P, 2001, BMJ-BRIT MED J, V323, P42, DOI 10.1136/bmj.323.7303.42; Juni P, 1999, JAMA-J AM MED ASSOC, V282, P1054, DOI 10.1001/jama.282.11.1054; Kalauokalani D, 2001, SPINE, V26, P1418, DOI 10.1097/00007632-200107010-00005; Kwon YD, 2006, RHEUMATOLOGY, V45, P1331, DOI 10.1093/rheumatology/kel207; LEBARS D, 1979, PAIN, V6, P283, DOI 10.1016/0304-3959(79)90049-6; Lethbridge-Cejku M, 2004, VITAL HLTH STAT, V10, P1; Linde K, 2001, BMC Complement Altern Med, V1, P3; Linde Klaus, 2004, Z Arztl Fortbild Qualitatssich, V98, P467; MACDONALD AJR, 1983, ANN ROY COLL SURG, V65, P44; MacPherson H, 2001, BMJ-BRIT MED J, V323, P486, DOI 10.1136/bmj.323.7311.486; McGettigan P, 2006, JAMA-J AM MED ASSOC, V296, P1633, DOI 10.1001/jama.296.13.jrv60011; Melchart D, 2004, ARCH INTERN MED, V164, P104, DOI 10.1001/archinte.164.1.104; Moerman DE, 2002, ANN INTERN MED, V136, P471, DOI 10.7326/0003-4819-136-6-200203190-00011; Molsberger A, 1994, Schmerz, V8, P37, DOI 10.1007/BF02527508; Ng MML, 2003, J ALTERN COMPLEM MED, V9, P641, DOI 10.1089/107555303322524490; OLIVERIA SA, 1995, ARTHRITIS RHEUM, V38, P1134, DOI 10.1002/art.1780380817; Pariente J, 2005, NEUROIMAGE, V25, P1161, DOI 10.1016/j.neuroimage.2005.01.016; Paterson C, 2005, BMJ-BRIT MED J, V330, P1202, DOI 10.1136/bmj.330.7501.1202; Peat G, 2001, ANN RHEUM DIS, V60, P91, DOI 10.1136/ard.60.2.91; PETROU P, 1988, SCAND J ACUPUNCT, V3, P113; Roland M, 1998, BRIT MED J, V316, P285, DOI 10.1136/bmj.316.7127.285; Sangdee Chaichan, 2002, BMC Complement Altern Med, V2, P3, DOI 10.1186/1472-6882-2-3; Scharf HP, 2006, ANN INTERN MED, V145, P12, DOI 10.7326/0003-4819-145-1-200607040-00005; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Schulz KF, 2002, LANCET, V359, P696, DOI 10.1016/S0140-6736(02)07816-9; Streitberger K, 1998, LANCET, V352, P364, DOI 10.1016/S0140-6736(97)10471-8; Takeda W, 1994, Arthritis Care Res, V7, P118, DOI 10.1002/art.1790070304; Towheed TE, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004257.pub2; Tukmachi Emad, 2004, Acupunct Med, V22, P14; Ulett GA, 1998, BIOL PSYCHIAT, V44, P129, DOI 10.1016/S0006-3223(97)00394-6; van Tulder M, 2003, SPINE, V28, P1290, DOI 10.1097/01.BRS.0000065484.95996.AF; Vas J, 2004, BMJ-BRIT MED J, V329, P1216, DOI 10.1136/bmj.38238.601447.3A; Wegman A, 2004, J RHEUMATOL, V31, P344; White A, 2007, RHEUMATOLOGY, V46, P384, DOI 10.1093/rheumatology/kel413; White A, 2001, BRIT MED J, V323, P485, DOI 10.1136/bmj.323.7311.485; White P, 2004, ANN INTERN MED, V141, P911, DOI 10.7326/0003-4819-141-12-200412210-00007; Witt C, 2005, LANCET, V366, P136, DOI 10.1016/S0140-6736(05)66871-7; Witt CM, 2006, ARTHRITIS RHEUM-US, V54, P3485, DOI 10.1002/art.22154; World Health Organization, 1991, PROP STAND INT AC NO; Yurtkuran M, 1999, Am J Acupunct, V27, P133; 2001, MMWR MORB MORTAL WKL, V51, P948	70	158	166	1	30	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 19	2007	146	12					868	877		10.7326/0003-4819-146-12-200706190-00008	http://dx.doi.org/10.7326/0003-4819-146-12-200706190-00008			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	180FF	17577006	Green Published			2022-12-28	WOS:000247347100005
J	Marini, H; Minutoli, L; Polito, F; Bitto, A; Altavilla, D; Atteritano, M; Gaudio, A; Mazzaferro, S; Frisina, A; Frisina, N; Lubrano, C; Bonaiuto, M; D'Anna, R; Cannata, ML; Corrado, F; Adamo, EB; Wilson, S; Squadrito, F				Marini, Herbert; Minutoli, Letteria; Polito, Francesca; Bitto, Alessandra; Altavilla, Domenica; Atteritano, Marco; Gaudio, Agostino; Mazzaferro, Susanna; Frisina, Alessia; Frisina, Nicola; Lubrano, Carla; Bonaiuto, Michele; D'Anna, Rosario; Cannata, Maria Letizia; Corrado, Francesco; Adamo, Elena Bianca; Wilson, Steven; Squadrito, Francesco			Effects of the phytoestrogen genistein on bone metabolism in osteopenic postmenopausal women - A randomized trial	ANNALS OF INTERNAL MEDICINE			English	Article							HORMONE-REPLACEMENT THERAPY; SOY PHYTOESTROGENS; BREAST-CANCER; HOT FLASHES; ISOFLAVONES; DAIDZEIN; BETA; OSTEOPROTEGERIN; OSTEOPOROSIS; INHIBITION	Background: Observational studies and small trials of short duration suggest that the isoflavone phytoestrogen genistein reduces bone loss, but the evidence is not definitive. Objective: To assess the effects of genistein on bone metabolism in osteopenic postmenopausal women. Design: Randomized, double-blind, placebo-controlled trial. Setting: 3 university medical centers in Italy. Patients: 389 postmenopausal women with a bone mineral density (BMD) less than 0.795 g/cm(2) at the femoral neck and no significant comorbid conditions. Intervention: After a 4-week stabilization period during which participants received a low-soy, reduced-fat diet, participants were randomly assigned to receive placebo (n = 191) or 54 mg of genistein (n = 198) daily for 24 months. Both the genistein and placebo tablets contained calcium and vitamin D. Measurements: The primary outcome was BMD at the anteroposterior lumbar spine and femoral neck at 24 months. Secondary outcomes were serum levels of bone-specific alkaline phosphatase and insulin-like growth factor 1, urinary excretion of pyridinoline and deoxypyridinoline, and endometrial thickness. Data on adverse events were also collected. Results: At 24 months, BMD had increased in genistein recipients and decreased in placebo recipients at the anteroposterior lumbar spine (change, 0.049 g/cm(2) [95% CI, 0.035 to 0.059] vs. -0.053 g/cm(2) [CI, -0.058 to -0.035]; difference, 0.10 g/cm(2) [CI, 0.08 to 0.121; P < 0.001) and the femoral neck (change, 0.035 g/cm(2) [Cl, 0.025 to 0.0421 vs. -0.037 g/cm(2) [CI, -0.044 to -0.0271; difference, 0.062 g/cm(2) [CI, 0.049 to 0.073]; P < 0.001). Genistein statistically significantly decreased urinary excretion of pyridinoline and deoxypyriclinoline, increased levels of bone-specific alkaline phosphatase and insulin-like growth factor 1, and did not change endometrial thickness compared with placebo. More genistein recipients than placebo recipients experienced gastrointestinal side effects (19% vs. 8%; P = 0.002) and discontinued the study. Limitations: The study did not measure fractures and had limited power to evaluate adverse effects. Conclusion: Twenty-four months of treatment with genistein has positive effects on BMD in osteopenic postmenopausal women.	Univ Messina, Dept Expt & Clin Med & Pharmacol, Pharmacol Sect, Azienda Osped,Policlin G Martino, I-98125 Messina, Italy	AOU Policlinico Gaetano Martino; University of Messina	Squadrito, F (corresponding author), Univ Messina, Dept Expt & Clin Med & Pharmacol, Pharmacol Sect, Azienda Osped,Policlin G Martino, 5th Floor,Via C Valeria, I-98125 Messina, Italy.	Francesco.Squadrito@unime.it	lubrano, carla/F-4419-2011; Marini, Herbert Ryan/U-6004-2019; Atteritano, Marco/AAL-9565-2020; Gaudio, Agostino/AAL-4380-2020; Gaudio, Agostino/G-1265-2011; Gaudio, Agostino/AAK-3940-2020	Marini, Herbert Ryan/0000-0002-8254-177X; Gaudio, Agostino/0000-0002-9958-9606; Atteritano, Marco/0000-0001-9342-802X				Adlercreutz H, 1998, ANAL BIOCHEM, V265, P208, DOI 10.1006/abio.1998.2886; Adlercreutz H, 1997, ANN MED, V29, P95, DOI 10.3109/07853899709113696; Ahlborg HG, 2004, BJOG-INT J OBSTET GY, V111, P335, DOI 10.1111/j.1471-0528.2004.00068.x; AKIYAMA T, 1987, J BIOL CHEM, V262, P5592; Albright F, 1941, J AMER MED ASSOC, V116, P2465, DOI 10.1001/jama.1941.02820220007002; Altavilla Domenica, 2004, Current Medicinal Chemistry - Cardiovascular & Hematological Agents, V2, P179, DOI 10.2174/1568016043477297; Anderson JJB, 1998, P SOC EXP BIOL MED, V217, P345, DOI 10.3181/00379727-217-44243; Banks E, 2003, LANCET, V362, P419, DOI 10.1016/S0140-6736(03)14065-2; BASSON MD, 1994, J CELL PHYSIOL, V160, P491, DOI 10.1002/jcp.1041600312; Beral V, 1997, LANCET, V350, P1047, DOI 10.1016/S0140-6736(97)08233-0; Bingham SA, 1998, BRIT J NUTR, V79, P393, DOI 10.1079/BJN19980068; Castelo-Branco C, 1999, EUR J OBSTET GYN R B, V83, P207, DOI 10.1016/S0301-2115(98)00313-3; COWARD L, 1993, J AGR FOOD CHEM, V41, P1961, DOI 10.1021/jf00035a027; Crisafulli A, 2004, MENOPAUSE, V11, P400, DOI 10.1097/01.GME.0000109314.11228.E5; Crisafulli A, 2005, MENOPAUSE, V12, P186, DOI 10.1097/00042192-200512020-00013; Crisafulli A, 2004, J CLIN ENDOCR METAB, V89, P188, DOI 10.1210/jc.2003-030891; Fanti P, 1998, OSTEOPOROSIS INT, V8, P274, DOI 10.1007/s001980050065; Gao YH, 1999, BIOCHEM PHARMACOL, V58, P767, DOI 10.1016/S0006-2952(99)00162-8; Gao YH, 1999, MOL CELL BIOCHEM, V194, P93, DOI 10.1023/A:1006949912266; Harkness LS, 2004, J WOMENS HEALTH, V13, P1000, DOI 10.1089/jwh.2004.13.1000; Joo SS, 2004, ARCH PHARM RES, V27, P99, DOI 10.1007/BF02980054; Klotz DM, 2000, ENDOCRINOLOGY, V141, P3430, DOI 10.1210/en.141.9.3430; KOROMA BM, 1994, BIOCHEM PHARMACOL, V48, P809, DOI 10.1016/0006-2952(94)90060-4; Kuiper GGJM, 1998, ENDOCRINOLOGY, V139, P4252, DOI 10.1210/en.139.10.4252; Lydeking-Olsen E, 2004, EUR J NUTR, V43, P246, DOI 10.1007/s00394-004-0497-8; Messina M, 2004, CURR OPIN CLIN NUTR, V7, P649, DOI 10.1097/00075197-200411000-00010; Morabito N, 2002, J BONE MINER RES, V17, P1904, DOI 10.1359/jbmr.2002.17.10.1904; Nakajima Daito, 2001, Journal of Physiological Anthropology and Applied Human Science, V20, P285, DOI 10.2114/jpa.20.285; Okamoto F, 2001, JPN J PHYSIOL, V51, P501, DOI 10.2170/jjphysiol.51.501; Onoe Y, 1997, ENDOCRINOLOGY, V138, P4509, DOI 10.1210/en.138.10.4509; POUYSSEGUR J, 1992, ANNU REV PHYSIOL, V54, P195, DOI 10.1146/annurev.ph.54.030192.001211; Quella SK, 2000, J CLIN ONCOL, V18, P1068, DOI 10.1200/JCO.2000.18.5.1068; RECKER RR, 1993, J CLIN ENDOCR METAB, V76, P14, DOI 10.1210/jc.76.1.14; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Scharbo-Dehaan M, 1996, Nurse Pract, V21, P1; SCHOT LPC, 1990, J STEROID BIOCHEM, V37, P167, DOI 10.1016/0960-0760(90)90325-F; Seeman Ego, 2004, Curr Osteoporos Rep, V2, P90, DOI 10.1007/s11914-004-0016-0; Setchell KDR, 1998, AM J CLIN NUTR, V68, p1333S, DOI 10.1093/ajcn/68.6.1333S; Setchell KDR, 2003, AM J CLIN NUTR, V78, p593S, DOI 10.1093/ajcn/78.3.593S; Somekawa Y, 2001, OBSTET GYNECOL, V97, P109, DOI 10.1016/S0029-7844(00)01080-2; Van Patten CL, 2002, J CLIN ONCOL, V20, P1449, DOI 10.1200/JCO.20.6.1449; Viereck V, 2002, J CELL BIOCHEM, V84, P725, DOI 10.1002/jcb.10087; Williams JP, 1998, AM J CLIN NUTR, V68, p1369S, DOI 10.1093/ajcn/68.6.1369S; Yamaguchi M, 2000, MOL CELL BIOCHEM, V214, P97, DOI 10.1023/A:1007199120295; Yamaguchi M, 2000, J BONE MINER METAB, V18, P77, DOI 10.1007/s007740050015	45	215	225	0	14	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 19	2007	146	12					839	847		10.7326/0003-4819-146-12-200706190-00005	http://dx.doi.org/10.7326/0003-4819-146-12-200706190-00005			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	180FF	17577003				2022-12-28	WOS:000247347100002
J	Reynolds, T				Reynolds, Toby			The course left out in the cold	BRITISH MEDICAL JOURNAL			English	Article									Univ London St Georges Hosp, London SW17 0RE, England	St Georges University London	Reynolds, T (corresponding author), Univ London St Georges Hosp, London SW17 0RE, England.	Toby.reynolds@gmail.com						*EUR MIN ED, 2005, BOL DECL 19 JUN 1999; *LOND COMM, 2007, EUR HIGH ED AR RESP; World Federation of Medical Education, 2005, STAT BOL PROC MED ED	3	2	2	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUN 16	2007	334	7606					1246	1248		10.1136/bmj.39237.543889.AD	http://dx.doi.org/10.1136/bmj.39237.543889.AD			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	183AM	17569927	Green Published			2022-12-28	WOS:000247545100027
J	Sharp, D				Sharp, David			Synchrotrons as "super microscopes"	LANCET			English	Editorial Material							RADIATION-DAMAGE		Lancet, London NW1 7BY, England		Sharp, D (corresponding author), Lancet, London NW1 7BY, England.							*DIAM LIGHT SOURC, DIAM WELC 1 US; DURRANI M, 2007, DIAMOND LIGHT S 0206; Gupta S, 2007, J SYNCHROTRON RADIAT, V14, P233, DOI 10.1107/S0909049507013118; Jabbour E, 2007, SEMIN HEMATOL, V44, pS25, DOI 10.1053/seminhematol.2006.12.003; Massover WH, 2007, J SYNCHROTRON RADIAT, V14, P116, DOI 10.1107/S0909049506052307; Ravelli RBG, 2006, CURR OPIN STRUC BIOL, V16, P624, DOI 10.1016/j.sbi.2006.08.001; Smith CV, 2004, TUBERCULOSIS, V84, P45, DOI 10.1016/j.tube.2003.08.019; Sorensen TLM, 2006, TRENDS BIOTECHNOL, V24, P500, DOI 10.1016/j.tibtech.2006.09.006; 2000, PHYS WORLD MARCH	9	1	1	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 16	2007	369	9578					1982	1983		10.1016/S0140-6736(07)60925-8	http://dx.doi.org/10.1016/S0140-6736(07)60925-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	180HT	17574080				2022-12-28	WOS:000247354400008
J	Plantenberg, JH; de Groot, PC; Harmans, CJPM; Mooij, JE				Plantenberg, J. H.; de Groot, P. C.; Harmans, C. J. P. M.; Mooij, J. E.			Demonstration of controlled-NOT quantum gates on a pair of superconducting quantum bits	NATURE			English	Article							STATES; QUBITS	Quantum computation requires quantum logic gates that use the interaction within pairs of quantum bits (qubits) to perform conditional operations(1). Superconducting qubits may offer an attractive route towards scalable quantum computing. In previous experiments on coupled superconducting qubits, conditional gate behaviour(2) and entanglement(3) were demonstrated. Here we demonstrate selective execution of the complete set of four different controlled-NOT ( CNOT) quantum logic gates, by applying microwave pulses of appropriate frequency to a single pair of coupled flux qubits. All two-qubit computational basis states and their superpositions are used as input, while two independent single-shot SQUID detectors measure the output state, including qubit - qubit correlations. We determined the gate's truth table by directly measuring the state transfer amplitudes and by acquiring the relevant quantum phase shift using a Ramsey-like interference experiment. The four conditional gates result from the symmetry of the qubits in the pair: either qubit can assume the role of control or target, and the gate action can be conditioned on either the 0-state or the 1-state. These gates are now sufficiently characterized to be used in quantum algorithms, and together form an efficient set of versatile building blocks.	Delft Univ Technol, Kavli Inst Nanosci, NL-2600 GA Delft, Netherlands	Delft University of Technology	Plantenberg, JH (corresponding author), Delft Univ Technol, Kavli Inst Nanosci, POB 5046, NL-2600 GA Delft, Netherlands.	j.h.plantenberg@tudelft.nl; j.e.mooij@tudelft.nl	Mooij, Johan/B-1371-2012					Berkley AJ, 2003, SCIENCE, V300, P1548, DOI 10.1126/science.1084528; Chiorescu I, 2003, SCIENCE, V299, P1869, DOI 10.1126/science.1081045; Cory DG, 1998, PHYSICA D, V120, P82, DOI 10.1016/S0167-2789(98)00046-3; Grajcar M, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.047006; Hime T, 2006, SCIENCE, V314, P1427, DOI 10.1126/science.1134388; Lupascu A, 2007, NAT PHYS, V3, P119, DOI 10.1038/nphys509; Majer JB, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.090501; Majer JB, 2002, APPL PHYS LETT, V80, P3638, DOI 10.1063/1.1478150; McDermott R, 2005, SCIENCE, V307, P1299, DOI 10.1126/science.1107572; Mooij JE, 1999, SCIENCE, V285, P1036, DOI 10.1126/science.285.5430.1036; Nakamura Y, 1999, NATURE, V398, P786, DOI 10.1038/19718; Nielsen Michael A., 2002, QUANTUM COMPUTATION; Pashkin YA, 2003, NATURE, V421, P823, DOI 10.1038/nature01365; Steffen M, 2006, SCIENCE, V313, P1423, DOI 10.1126/science.1130886; TERHAAR ACJ, 2005, THESIS DELFT U TECHN; Vion D, 2002, SCIENCE, V296, P886, DOI 10.1126/science.1069372; Yamamoto T, 2003, NATURE, V425, P941, DOI 10.1038/nature02015	18	271	279	0	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 14	2007	447	7146					836	839		10.1038/nature05896	http://dx.doi.org/10.1038/nature05896			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178FV	17568742				2022-12-28	WOS:000247207500039
J	Khan, MS; Dar, O; Sismanidis, C; Shah, K; Godfrey-Faussett, P				Khan, Mishal Sameer; Dar, Osman; Sismanidis, Charalambos; Shah, Karam; Godfrey-Faussett, Peter			Improvement of tuberculosis case detection and reduction of discrepancies between men and women by simple sputum-submission instructions: a pragmatic randomised controlled trial	LANCET			English	Article							GENDER; SMEAR; TB; DIAGNOSIS	Background In several settings, women with suspected tuberculosis are less likely to test smear positive than are men. Submission of poor-quality sputum specimens by women might be one reason for the difference between the sexes. We did a pragmatic randomised controlled trial to assess the effect of sputum-submission instructions on female patients. Methods 1494 women and 1561 men with suspected tuberculosis attending the Federal Tuberculosis Centre in Rawalpindi, Pakistan, were randomly assigned between May and July, 2005 either to receive sputum-submission guidance before specimen submission or to submit specimens without specific guidance, according to prevailing practice. Of enrolled patients, 133 (4%) declined to participate. The primary outcome measure was the proportion of instructed and non-instructed women testing smear positive. Intention-to-treat analysis was undertaken on the basis of treatment allocation. This study is registered with the International Standard Randomised Controlled Trial number 34123170. Findings Instructed women were more likely to test smear positive than were controls (Risk ratio 1.63 [95% Cl 1.19-2.22]). Instructions were associated with a higher rate of smear-positive case detection (58 [8%] in controls vs 95 [13%] in the intervention group; p=0.002), a decrease in spot-saliva submission (p=0.003), and an increase in the number of women returning with an early-morning specimen (p=0.02). In men, instructions did not have a significant effect on the proportion testing smear positive or specimen quality. Interpretation In the Federal Tuberculosis Centre in Rawalpindi, lower smear positivity in women than in men was mainly a function of poor-quality specimen submission. Smear positivity in women was increased substantially by provision of brief instructions. Sputum-submission guidance might be a highly cost-effective intervention to improve smear-positive case detection and reduce the disparity between the sexes in tuberculosis control in low-income countries.	Univ London London Sch Hyg & Trop Med, Clin Res Unit, London WC1E 7HT, England; Addenbrookes Hosp, Cambridge, England; Natl TB Control Programme, Rawalpindi, Pakistan	University of London; London School of Hygiene & Tropical Medicine; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Khan, MS (corresponding author), Univ London London Sch Hyg & Trop Med, Clin Res Unit, Keppel St, London WC1E 7HT, England.	Mishalk@cantab.net			Medical Research Council [G0700837] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Alisjahbana B, 2005, INT J TUBERC LUNG D, V9, P814; Austin JF, 2004, INT J TUBERC LUNG D, V8, P435; BARTLETT RC, 1997, MED MICROBIOLOGY QUA; Begum V, 2001, INT J TUBERC LUNG D, V5, P604; Boeree MJ, 2000, INT J TUBERC LUNG D, V4, P882; Dye C, 2003, TUBERCULOSIS, V83, P35, DOI 10.1016/S1472-9792(02)00056-2; Fairall LR, 2005, BMJ-BRIT MED J, V331, P750, DOI 10.1136/bmj.331.7519.750; Godwin Marshall, 2003, BMC Med Res Methodol, V3, P28, DOI 10.1186/1471-2288-3-28; Hirooka Tetsuhisa, 2004, Kekkaku, V79, P33; Kernan WN, 1999, J CLIN EPIDEMIOL, V52, P19, DOI 10.1016/S0895-4356(98)00138-3; Khan M S, 2004, THESIS LONDON SCH HY; Kivihya-Ndugga LEA, 2005, INT J TUBERC LUNG D, V9, P294; Kumaresan J. A., 1996, TUBERCULOSIS GLOBAL; McCarter YS, 1996, AM J CLIN PATHOL, V105, P769; Thorson A, 2004, J CLIN EPIDEMIOL, V57, P398, DOI 10.1016/j.jclinepi.2002.11.001; Uplekar M, 2000, GENDER TUBERCULOSIS; Warren JR, 2000, AM J RESP CRIT CARE, V161, P1559, DOI 10.1164/ajrccm.161.5.9908063; *WHO, 2006, GLOB TUB CONTR SURV; *WHO, 2000, TUB SUST DEV STOP TB; *WHO, GUID STAND OP PROC M, pCH17	20	104	108	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 9	2007	369	9577					1955	1960		10.1016/S0140-6736(07)60916-7	http://dx.doi.org/10.1016/S0140-6736(07)60916-7			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	177IQ	17560448				2022-12-28	WOS:000247147200029
J	Sobel, JD				Sobel, Jack D.			Vulvovaginal candidosis	LANCET			English	Review							MANNOSE-BINDING LECTIN; VIRUS-INFECTED WOMEN; RISK-FACTORS; FLUCONAZOLE SUSCEPTIBILITY; YEAST COLONIZATION; MICROBIAL-FLORA; AMPHOTERICIN-B; NITRIC-OXIDE; ALBICANS; CANDIDIASIS	Despite therapeutic advances, vulvovaginal candidosis remains a common problem worldwide, affecting an strata of society Understanding of anti-candida host defence mechanisms in the vagina has developed slowly and, despite a growing list of recognised risk factors, a fundamental grasp of pathogenic mechanisms continues to elude us. The absence of rapid, simple, and inexpensive diagnostic tests continues to result in both overdiagnosis and underdiagnosis of vulvovaginal candidosis. I review the epidemiology and pathogenesis-of this infection, and also discuss management strategies.	Wayne State Univ, Sch Med, Dept Med, Detroit, MI 48201 USA	Wayne State University	Sobel, JD (corresponding author), Harper Univ Hosp, Div Infect Dis, 3990 John R, Detroit, MI 48201 USA.	jsobel@med.wayne.edu						AGNEW KJ, 1995, SEX TRANSM DIS, V22, P269, DOI 10.1097/00007435-199509000-00001; Al- Hedaithy Saleh S A, 2002, Med Sci Monit, V8, pCR498; Anderson MR, 2004, JAMA-J AM MED ASSOC, V291, P1368, DOI 10.1001/jama.291.11.1368; [Anonymous], 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000225; Aperis G, 2006, EXPERT OPIN INV DRUG, V15, P579, DOI 10.1517/13543784.15.6.579; ASHMAN RB, 1995, MICROBIOL REV, V59, P646, DOI 10.1128/MMBR.59.4.646-672.1995; AUGER P, 1980, OBSTET GYNECOL, V55, P397, DOI 10.1097/00006250-198003000-00029; Babula O, 2005, CLIN INFECT DIS, V40, P1258, DOI 10.1086/429246; BARBONE F, 1990, AM J OBSTET GYNECOL, V163, P510, DOI 10.1016/0002-9378(90)91186-G; Barousse MM, 2005, INFECT IMMUN, V73, P7765, DOI 10.1128/IAI.73.11.7765-7767.2005; Barousse MM, 2004, SEX TRANSM INFECT, V80, P48, DOI 10.1136/sti.2002.003855; Bauters TGM, 2002, AM J OBSTET GYNECOL, V187, P569, DOI 10.1067/mob.2002.125897; Beigi RH, 2004, OBSTET GYNECOL, V104, P926, DOI 10.1097/01.AOG.0000140687.51048.73; BERG AO, 1984, JAMA-J AM MED ASSOC, V251, P620, DOI 10.1001/jama.251.5.620; BERGMAN JJ, 1984, J FAM PRACTICE, V18, P549; BERTHOLF ME, 1983, J FAM PRACTICE, V16, P919; Bland PB, 1937, ARCH DERMATOL SYPH, V36, P760, DOI 10.1001/archderm.1937.01480040077006; Bluestein D, 1991, Fam Pract Res J, V11, P319; Bradshaw CS, 2005, OBSTET GYNECOL, V106, P105, DOI 10.1097/01.AOG.0000163247.78533.7b; Buscemi Luis, 2004, Revista Iberoamericana de Micologia, V21, P177; Calderon L, 2003, MED MYCOL, V41, P143, DOI 10.1080/mmy.41.2.143.147; CARPENTER CCJ, 1989, AM J MED, V86, P771, DOI 10.1016/0002-9343(89)90471-3; Carvalho LP, 2002, J ALLERGY CLIN IMMUN, V109, P102, DOI 10.1067/mai.2002.120555; Cassone A, 2005, CURR MOL MED, V5, P377, DOI 10.2174/1566524054022549; Cauwenbergh G., 1990, CURR PROB OBST GYN F, V8, P241; CENCI E, 1993, EUR J IMMUNOL, V23, P1034, DOI 10.1002/eji.1830230508; Chaim W, 1997, J INFECT DIS, V176, P828, DOI 10.1086/517314; Chong PP, 2003, J MED MICROBIOL, V52, P657, DOI 10.1099/jmm.0.04973-0; CHOW AW, 1986, AM J OBSTET GYNECOL, V154, P120, DOI 10.1016/0002-9378(86)90406-0; Corsello S, 2003, EUR J OBSTET GYN R B, V110, P66, DOI 10.1016/S0301-2115(03)00096-4; Cotch MF, 1998, AM J OBSTET GYNECOL, V178, P374, DOI 10.1016/S0002-9378(98)80028-8; DAVIDSON F, 1985, BRIT J OBSTET GYNAEC, V92, P1265, DOI 10.1111/j.1471-0528.1985.tb04873.x; DAVIDSON F, 1978, BRIT J VENER DIS, V54, P176; De Bernardis F, 2007, J INFECT DIS, V195, P149, DOI 10.1086/509891; Carvalho Ricardo José Victal de, 2003, Rev. Assoc. Med. Bras., V49, P434; de Leon EM, 2002, BMC INFECT DIS, V2, DOI 10.1186/1471-2334-2-1; DEBERNARDIS F, 1990, J INFECT DIS, V161, P1276, DOI 10.1093/infdis/161.6.1276; Dellenbach P, 2000, INT J GYNECOL OBSTET, V71, pS47, DOI 10.1016/S0020-7292(00)00348-9; Demirezen S., 2005, Central European Journal of Public Health, V13, P32; Dennerstein GJ, 2001, AUST NZ J OBSTET GYN, V41, P326, DOI 10.1111/j.1479-828X.2001.tb01238.x; DENNERSTEIN GJ, 1986, J REPROD MED, V31, P801; DIAMOND RD, 1978, J CLIN INVEST, V61, P349, DOI 10.1172/JCI108945; Donders GGG, 2002, AM J OBSTET GYNECOL, V187, P989, DOI 10.1067/mob.2002.126285; Duerr A, 2003, OBSTET GYNECOL, V101, P548, DOI 10.1016/S0029-7844(02)02729-1; Eckert LO, 1998, OBSTET GYNECOL, V92, P757, DOI 10.1016/S0029-7844(98)00264-6; Erdem H, 2003, AUST NZ J OBSTET GYN, V43, P312, DOI 10.1046/j.0004-8666.2003.00089.x; Ferris DG, 2002, OBSTET GYNECOL, V99, P419, DOI 10.1016/S0029-7844(01)01759-8; Fidel Paul L Jr, 2005, Curr Opin Infect Dis, V18, P107; Fidel PL, 2004, TRENDS MICROBIOL, V12, P220, DOI 10.1016/j.tim.2004.03.006; Fidel PL, 2004, INFECT IMMUN, V72, P2939, DOI 10.1128/IAI.72.5.2939-2946.2004; Fidel PL, 1999, CLIN MICROBIOL REV, V12, P80, DOI 10.1128/CMR.12.1.80; FLEURY F J, 1981, Clinical Obstetrics and Gynecology, V24, P407, DOI 10.1097/00003081-198106000-00008; FONG IW, 1992, GENITOURIN MED, V68, P174; FOXMAN B, 1990, AM J PUBLIC HEALTH, V80, P329, DOI 10.2105/AJPH.80.3.329; Foxman B, 1998, J WOMENS HEALTH, V7, P1167, DOI 10.1089/jwh.1998.7.1167; Foxman B, 2000, SEX TRANSM DIS, V27, P230, DOI 10.1097/00007435-200004000-00009; GARCIATAMAYO J, 1982, ACTA CYTOL, V26, P7; Geiger AM, 1996, EPIDEMIOLOGY, V7, P182, DOI 10.1097/00001648-199603000-00013; Glover Douglas D, 2003, Infect Dis Obstet Gynecol, V11, P157, DOI 10.1080/10647440300025514; GOLDACRE MJ, 1979, BMJ-BRIT MED J, V1, P1450, DOI 10.1136/bmj.1.6176.1450; Goswami R, 2000, J INFECTION, V41, P162, DOI 10.1053/jinf.2000.0723; Han YM, 1998, INFECT IMMUN, V66, P5771, DOI 10.1128/IAI.66.12.5771-5776.1998; HILTON E, 1992, ANN INTERN MED, V116, P353, DOI 10.7326/0003-4819-116-5-353; Holland J, 2003, SEX TRANSM INFECT, V79, P249, DOI 10.1136/sti.79.3.249; HURLEY R, 1979, POSTGRAD MED J, V55, P645, DOI 10.1136/pgmj.55.647.645; Ip WK, 2004, J INFECT DIS, V190, P632, DOI 10.1086/422397; KING RD, 1980, INFECT IMMUN, V27, P667, DOI 10.1128/IAI.27.2.667-674.1980; KLEIN RS, 1984, NEW ENGL J MED, V311, P354, DOI 10.1056/NEJM198408093110602; Landers DV, 2004, AM J OBSTET GYNECOL, V190, P1004, DOI 10.1016/j.ajog.2004.02.015; Leigh JE, 2001, J INFECT DIS, V183, P277, DOI 10.1086/317944; Lian C, 2004, MYCOSES, V47, P495, DOI 10.1111/j.1439-0507.2004.01049.x; Macura AB, 1998, ZBL BAKT-INT J MED M, V287, P501; Mathema B, 2001, CLIN INFECT DIS, V33, pE23, DOI 10.1086/322600; MCCORMACK WM, 1994, SEX TRANSM DIS, V21, P63, DOI 10.1097/00007435-199403000-00001; MERSONDAVIES LA, 1991, EUR J OBSTET GYN R B, V42, P49, DOI 10.1016/0028-2243(91)90159-I; MILES MR, 1977, JAMA-J AM MED ASSOC, V238, P1836; MOORS MA, 1992, J EXP MED, V175, P1643, DOI 10.1084/jem.175.6.1643; Moosa MYS, 2004, ANTIMICROB AGENTS CH, V48, P161, DOI 10.1128/AAC.48.1.161-167.2004; Mostad SB, 1997, LANCET, V350, P922, DOI 10.1016/S0140-6736(97)04240-2; Naglik JR, 2003, J INFECT DIS, V188, P469, DOI 10.1086/376536; Naidu AS, 2004, J REPROD MED, V49, P859; Neves NA, 2005, CLIN EXP IMMUNOL, V142, P167, DOI 10.1111/j.1365-2249.2005.02891.x; Nyirjesy Paul, 2005, Infect Dis Obstet Gynecol, V13, P37; Odds FC, 1988, CANDIDA CANDIDOSIS R, V2nd, P124; Okungbowa Francisca I., 2003, Revista Iberoamericana de Micologia, V20, P60; ORIEL JD, 1975, J CLIN PATHOL, V28, P403, DOI 10.1136/jcp.28.5.403; Pellis V, 2005, CLIN EXP IMMUNOL, V139, P120, DOI 10.1111/j.1365-2249.2005.02660.x; Petersen KA, 2006, J CLIN IMMUNOL, V26, P465, DOI 10.1007/s10875-006-9037-z; Phillips AJ, 2005, AM J OBSTET GYNECOL, V192, P2009, DOI 10.1016/j.ajog.2005.03.034; Pirotta MV, 2006, J CLIN MICROBIOL, V44, P3213, DOI 10.1128/JCM.00218-06; Pirotta MV, 2003, MED J AUSTRALIA, V179, P43, DOI 10.5694/j.1326-5377.2003.tb05418.x; POLONELLI L, 1994, J IMMUNOL, V152, P3175; POWELL BL, 1984, EXP MYCOL, V8, P304, DOI 10.1016/0147-5975(84)90054-9; Pultz NJ, 2005, ANTIMICROB AGENTS CH, V49, P438, DOI 10.1128/AAC.49.1.438-440.2005; Reed BD, 2003, J WOMENS HEALTH, V12, P979, DOI 10.1089/154099903322643901; REEF SE, 1995, CLIN INFECT DIS, V20, pS80, DOI 10.1093/clinids/20.Supplement_1.S80; RHOADS JL, 1987, JAMA-J AM MED ASSOC, V257, P3105, DOI 10.1001/jama.257.22.3105; Richter SS, 2005, J CLIN MICROBIOL, V43, P2155, DOI 10.1128/JCM.43.5.2155-2162.2005; RIGG D, 1990, AM J OBSTET GYNECOL, V162, P332, DOI 10.1016/0002-9378(90)90380-P; RITTER W, 1985, AM J OBSTET GYNECOL, V152, P945, DOI 10.1016/S0002-9378(85)80006-5; ROSEDALE N, 1979, ANN ALLERGY, V43, P250; SAVAGE DC, 1969, J BACTERIOL, V98, P1278, DOI 10.1128/JB.98.3.1278-1283.1969; SCHAAF VM, 1990, ARCH INTERN MED, V150, P1929, DOI 10.1001/archinte.150.9.1929; Schaller M, 2003, INFECT IMMUN, V71, P3227, DOI 10.1128/IAI.71.6.3227-3234.2003; SCHROPPEL K, 1994, J CLIN MICROBIOL, V32, P2646; Schuman P, 1997, ANN INTERN MED, V126, P689, DOI 10.7326/0003-4819-126-9-199705010-00003; Schuman P, 1998, CLIN INFECT DIS, V27, P1161, DOI 10.1086/514979; Seidman Larry S, 2005, Infect Dis Obstet Gynecol, V13, P197, DOI 10.1155/2005/453239; SHAH DT, 1995, GYNECOL OBSTET INVES, V39, P67, DOI 10.1159/000292381; Shann S, 2003, SEX TRANSM INFECT, V79, P265, DOI 10.1136/sti.79.3.265-a; Singh S, 2002, CLIN INFECT DIS, V35, P1066, DOI 10.1086/343826; SLUTSKY B, 1985, SCIENCE, V230, P666, DOI 10.1126/science.3901258; SOBEL JD, 1995, AM J OBSTET GYNECOL, V172, P1263, DOI 10.1016/0002-9378(95)91490-0; Sobel JD, 2004, NEW ENGL J MED, V351, P876, DOI 10.1056/NEJMoa033114; Sobel JD, 2003, AM J OBSTET GYNECOL, V189, P1297, DOI 10.1067/S0002-9378(03)00726-9; SOBEL JD, 1986, NEW ENGL J MED, V315, P1455, DOI 10.1056/NEJM198612043152305; Sobel JD, 2003, ANTIMICROB AGENTS CH, V47, P34, DOI 10.1128/AAC.47.1.34-38.2003; SOBEL JD, 1984, INFECT IMMUN, V44, P576, DOI 10.1128/IAI.44.3.576-580.1984; SOBEL JD, 1981, J INFECT DIS, V143, P76, DOI 10.1093/infdis/143.1.76; SOBEL JD, 1985, AM J OBSTET GYNECOL, V152, P924, DOI 10.1016/S0002-9378(85)80003-X; Sobel JD, 1996, CLIN INFECT DIS, V22, P726, DOI 10.1093/clinids/22.4.726; Sobel JD, 2001, J INFECT DIS, V183, P286, DOI 10.1086/317936; Sobel JD, 2001, AM J OBSTET GYNECOL, V185, P363, DOI 10.1067/mob.2001.115116; SOLL DR, 1988, AM J OBSTET GYNECOL, V158, P997, DOI 10.1016/0002-9378(88)90113-5; SOLL DR, 1989, J CLIN MICROBIOL, V27, P681, DOI 10.1128/JCM.27.4.681-690.1989; Spellberg BJ, 2006, J INFECT DIS, V194, P256, DOI 10.1086/504691; SPINILLO A, 1992, J REPROD MED, V37, P343; Spinillo A, 1999, AM J OBSTET GYNECOL, V180, P14, DOI 10.1016/S0002-9378(99)70141-9; Tarry W, 2005, J SURG RES, V129, P278, DOI 10.1016/j.jss.2005.05.019; Taylor BN, 2005, INFECT IMMUN, V73, P1828, DOI 10.1128/IAI.73.3.1828-1835.2005; THIN RN, 1977, BRIT MED J, V2, P93, DOI 10.1136/bmj.2.6079.93; TOOLEY PJH, 1985, PRACTITIONER, V229, P655; Trama Jason P, 2005, Infect Dis Obstet Gynecol, V13, P63, DOI 10.1080/10647440400025629; TRUMBORE DJ, 1986, OBSTET GYNECOL, V67, P810, DOI 10.1097/00006250-198606000-00012; Vazquez JA, 2001, CLIN INFECT DIS, V33, P1069, DOI 10.1086/322641; WALDMAN RH, 1972, CLIN EXP IMMUNOL, V10, P427; Walker PP, 2000, SEX TRANSM INFECT, V76, P437, DOI 10.1136/sti.76.6.437; Wang CC, 2001, J INFECT DIS, V183, P1017, DOI 10.1086/319287; Watson MC, 2002, BJOG-INT J OBSTET GY, V109, P85, DOI 10.1111/j.1471-0528.2002.01142.x; Wilton LV, 2003, DRUG SAFETY, V26, P589, DOI 10.2165/00002018-200326080-00005; WITKIN SS, 1989, J MED VET MYCOL, V27, P57; Wozniak KL, 2002, INFECT IMMUN, V70, P5790, DOI 10.1128/IAI.70.10.5790-5799.2002	142	789	863	9	82	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 9	2007	369	9577					1961	1971		10.1016/S0140-6736(07)60917-9	http://dx.doi.org/10.1016/S0140-6736(07)60917-9			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	177IQ	17560449				2022-12-28	WOS:000247147200030
J	Wareham, DW; Breuer, J				Wareham, David W.; Breuer, Judith			Herpes zoster	BMJ-BRITISH MEDICAL JOURNAL			English	Review							POSTHERPETIC NEURALGIA; DOUBLE-BLIND; IMMUNOCOMPETENT PATIENTS; ORAL ACYCLOVIR; PLACEBO; AMITRIPTYLINE; BRIVUDIN; PREVENT; PAIN; VACCINATION		Barts & London Queen Marys Sch Med & Dent, Inst Cellular & Mol Sci, Ctr Infect Dis, London E1 2AT, England; Barts & London NHS Trust, Div Infect, London E1 1BB, England	University of London; Queen Mary University London; Barts Health NHS Trust	Wareham, DW (corresponding author), Barts & London Queen Marys Sch Med & Dent, Inst Cellular & Mol Sci, Ctr Infect Dis, London E1 2AT, England.	d.w.wareham@qmul.ac.uk		Breuer, Judith/0000-0001-8246-0534; Wareham, David/0000-0003-4331-5224				Alper BS, 2000, J FAM PRACTICE, V49, P255; Berry JD, 2005, NEUROLOGY, V65, P444, DOI 10.1212/01.WNL.0000168259.94991.8a; Boureau F, 2003, PAIN, V104, P323, DOI 10.1016/S0304-3959(03)00020-4; Bowsher D, 1997, J PAIN SYMPTOM MANAG, V13, P327, DOI 10.1016/S0885-3924(97)00077-8; COBO LM, 1986, OPHTHALMOLOGY, V93, P763; DAVIES L, 1994, PHARMACOECONOMICS, V6, P142, DOI 10.2165/00019053-199406020-00006; de Jong MD, 2001, LANCET, V357, P2101, DOI 10.1016/S0140-6736(00)05199-0; DeBenedittis G, 1996, PAIN, V65, P45, DOI 10.1016/0304-3959(95)00155-7; Dubinsky RM, 2004, NEUROLOGY, V63, P959, DOI 10.1212/01.WNL.0000140708.62856.72; Dworkin RH, 2003, NEUROLOGY, V60, P1274, DOI 10.1212/01.WNL.0000055433.55136.55; Dworkin RH, 2007, CLIN INFECT DIS, V44, pS1, DOI 10.1086/510206; Edmunds WJ, 2001, VACCINE, V19, P3076, DOI 10.1016/S0264-410X(01)00044-5; Galer BS, 1999, PAIN, V80, P533, DOI 10.1016/S0304-3959(98)00244-9; HE L, 2006, COCHRANE DATABASE SY, V1; HOPESIMPSON RE, 1965, P ROY SOC MED, V58, P9, DOI 10.1177/003591576505800106; Jackson JL, 1997, ARCH INTERN MED, V157, P909, DOI 10.1001/archinte.157.8.909; JOHNSON R, 1995, J INFECTION, V30, P193; Jumaan AO, 2005, J INFECT DIS, V191, P2002, DOI 10.1086/430325; Jung BF, 2004, NEUROLOGY, V62, P1545, DOI 10.1212/01.WNL.0000123261.00004.29; KISHOREKUMAR R, 1990, CLIN PHARMACOL THER, V47, P305, DOI 10.1038/clpt.1990.33; MAHALINGAM R, 1990, NEW ENGL J MED, V323, P627, DOI 10.1056/NEJM199009063231002; MAX MB, 1988, NEUROLOGY, V38, P1427, DOI 10.1212/WNL.38.9.1427; Oxman MN, 2005, NEW ENGL J MED, V352, P2271, DOI 10.1056/NEJMoa051016; Pasqualucci A, 2000, ACTA ANAESTH SCAND, V44, P910, DOI 10.1034/j.1399-6576.2000.440803.x; Raja SN, 2002, NEUROLOGY, V59, P1015, DOI 10.1212/WNL.59.7.1015; Rice ASC, 2001, PAIN, V94, P215, DOI 10.1016/S0304-3959(01)00407-9; Rowbotham M, 1998, JAMA-J AM MED ASSOC, V280, P1837, DOI 10.1001/jama.280.21.1837; ROWBOTHAM MC, 1995, ANN NEUROL, V37, P246, DOI 10.1002/ana.410370216; SAARTO T, 2005, COCHRANE DATABASE SY, V3; Scott Fiona T., 2003, Journal of Medical Virology, V70, pS24, DOI 10.1002/jmv.10316; Scott FT, 2006, VACCINE, V24, P1308, DOI 10.1016/j.vaccine.2005.09.026; Shafran SD, 2004, J CLIN VIROL, V29, P248, DOI 10.1016/S1386-6532(03)00164-1; Shen Meng-Chuan, 2004, Journal of Microbiology Immunology and Infection, V37, P75; van Wijck AJM, 2006, LANCET, V367, P219, DOI 10.1016/S0140-6736(06)68032-X; Wassilew SW, 2005, J EUR ACAD DERMATOL, V19, P47, DOI 10.1111/j.1468-3083.2004.01119.x; Wassilew SW, 2003, ANTIVIR RES, V59, P49, DOI 10.1016/S0166-3542(03)00065-2; Wassilew SW, 2003, ANTIVIR RES, V59, P57, DOI 10.1016/S0166-3542(03)00064-0; WATSON CP, 1982, NEUROLOGY, V32, P671, DOI 10.1212/WNL.32.6.671; Watson CPN, 1998, NEUROLOGY, V51, P1166, DOI 10.1212/WNL.51.4.1166; WATSON CPN, 1993, CLIN THER, V15, P510; WATSON CPN, 1992, PAIN, V48, P29, DOI 10.1016/0304-3959(92)90128-X; Watson CPN, 1998, NEUROLOGY, V50, P1837; Whitley RJ, 1996, ANN INTERN MED, V125, P376, DOI 10.7326/0003-4819-125-5-199609010-00004; WHITLEY RJ, 2004, MANDELL DOUGLAS BENN	44	93	97	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 9	2007	334	7605					1211	1215C		10.1136/bmj.39206.571042.AE	http://dx.doi.org/10.1136/bmj.39206.571042.AE			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	179GF	17556477	Green Published			2022-12-28	WOS:000247277000037
J	Cognet, L; Tsyboulski, DA; Rocha, JDR; Doyle, CD; Tour, JM; Weisman, RB				Cognet, Laurent; Tsyboulski, Dmitri A.; Rocha, John-David R.; Doyle, Condell D.; Tour, James M.; Weisman, R. Bruce			Stepwise quenching of exciton fluorescence in carbon nanotubes by single-molecule reactions	SCIENCE			English	Article							FUNCTIONALIZATION	Single-molecule chemical reactions with individual single-walled carbon nanotubes were observed through near-infrared photoluminescence microscopy. The emission intensity within distinct submicrometer segments of single nanotubes changed in discrete steps after exposure to acid, base, or diazonium reactants. The steps were uncorrelated in space and time and reflected the quenching of mobile excitons at localized sites of reversible or irreversible chemical attack. Analysis of step amplitudes revealed an exciton diffusional range of about 90 nanometers, independent of nanotube structure. Each exciton visited about 10,000 atomic sites during its lifetime, providing highly efficient sensing of local chemical and physical perturbations.	Univ Bordeaux 1, Ctr Phys Mol Opt & Hertzienne, F-33405 Talence, France; CNRS, F-33405 Talence, France; Rice Univ, Dept Chem, Ctr Biol & Environm Nanotechnol, Houston, TX 77005 USA; Rice Univ, RE Smalley Inst Nanoscale Sci & Technol, Houston, TX 77005 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); Rice University; Rice University	Cognet, L (corresponding author), Univ Bordeaux 1, Ctr Phys Mol Opt & Hertzienne, F-33405 Talence, France.	lcognet@u-bordeaux1.fr; weisman@rice.edu	Rocha, John-David Ray/AAV-1170-2020; Cognet, Laurent/F-4163-2011; Cognet, Laurent/M-4505-2019	Rocha, John-David Ray/0000-0001-6394-4349; Cognet, Laurent/0000-0002-3573-5387; Tour, James/0000-0002-8479-9328; Weisman, R. Bruce/0000-0001-8546-9980				Bachilo SM, 2002, SCIENCE, V298, P2361, DOI 10.1126/science.1078727; Bahr JL, 2001, J AM CHEM SOC, V123, P6536, DOI 10.1021/ja010462s; Bonifazi D, 2006, NANO LETT, V6, P1408, DOI 10.1021/nl060394d; Chen J, 2005, SCIENCE, V310, P1171, DOI 10.1126/science.1119177; Cognet L., 2006, SCI STKE, V2006, ppe13, DOI DOI 10.1126/STKE.3272006PE13; Dickson RM, 1996, SCIENCE, V274, P966, DOI 10.1126/science.274.5289.966; Dresselhaus M. S., 2001, CARBON NANOTUBES SYN; Dukovic G, 2004, J AM CHEM SOC, V126, P15269, DOI 10.1021/ja046526r; Dyke CA, 2004, SYNLETT, P155, DOI 10.1055/s-2003-44983; Hagen A, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.197401; Hartschuh A, 2003, SCIENCE, V301, P1354, DOI 10.1126/science.1087118; Heller DA, 2004, J AM CHEM SOC, V126, P14567, DOI 10.1021/ja046450z; Htoon H, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.027401; Jones M, 2007, NANO LETT, V7, P300, DOI 10.1021/nl0622808; Korovyanko OJ, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.017403; Lefebvre J, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.075403; Ma YZ, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.157402; Moerner WE, 1999, SCIENCE, V283, P1670, DOI 10.1126/science.283.5408.1670; O'Connell MJ, 2002, SCIENCE, V297, P593, DOI 10.1126/science.1072631; Pedersen TG, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.073401; Perebeinos V, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.257402; Russo RM, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.041405; Spataru CD, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.247402; Spataru CD, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.077402; Strano MS, 2003, J PHYS CHEM B, V107, P6979, DOI 10.1021/jp027664a; Strano MS, 2003, SCIENCE, V301, P1519, DOI 10.1126/science.1087691; Tsyboulski DA, 2005, NANO LETT, V5, P975, DOI 10.1021/nl050366f; Usrey ML, 2005, J AM CHEM SOC, V127, P16129, DOI 10.1021/ja0537530; Wang F, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.241403	29	387	393	6	123	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 8	2007	316	5830					1465	1468		10.1126/science.1141316	http://dx.doi.org/10.1126/science.1141316			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176EE	17556581	Green Submitted			2022-12-28	WOS:000247066400039
J	Marcovitch, H; Jones, DPH				Marcovitch, Harvey; Jones, David P. H.			Protecting abused children	LANCET			English	Editorial Material									BMJ Journals, London WC1H 9JR, England; Pk Hosp Children, Oxford, England		Marcovitch, H (corresponding author), BMJ Journals, Tavistock House, London WC1H 9JR, England.	h.marcovitch@btinternet.com						*DEP HLTH HOM OFF, 2002, SAF CHILDR WHOM ILLN; Dubowitz H, 2007, LANCET, V369, P1891, DOI 10.1016/S0140-6736(07)60856-3; *FDN STUD INF DEAT, 1998, REP 5000 BAB US CONI; Harris D, 2007, ARCH DIS CHILD, V92, P71, DOI 10.1136/adc.2006.094730; HM Government, 2004, WORK SAF CHILDR; Hymel KP, 2006, PEDIATRICS, V118, P1296, DOI 10.1542/peds.2006-1780; Kmietowicz Z, 2004, BRIT MED J, V328, P601, DOI 10.1136/bmj.328.7440.601; *LAMING, 2003, VICTORIA CLIMBIE INQ; Manly JT, 2005, CHILD ABUSE NEGLECT, V29, P425, DOI 10.1016/j.chiabu.2005.04.001; *ROYAL COLL PAED C, 2006, INV NAT IMP COMPL MA; World Health Organization, 2002, WORLD REPORT VIOLENC	11	3	3	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 2	2007	369	9576					1844	1846		10.1016/S0140-6736(07)60831-9	http://dx.doi.org/10.1016/S0140-6736(07)60831-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	173ZS	17544751				2022-12-28	WOS:000246911600009
J	Weldeab, S; Lea, DW; Schneider, RR; Andersen, N				Weldeab, Syee; Lea, David W.; Schneider, Ralph R.; Andersen, Nils			155,000 years of West African monsoon and ocean thermal evolution	SCIENCE			English	Article							SEA-SURFACE TEMPERATURE; PAST 110,000 YEARS; PLANKTONIC-FORAMINIFERA; CLIMATE OSCILLATIONS; ISOTOPIC COMPOSITION; TROPICAL ATLANTIC; LATE PLEISTOCENE; SOUTH-ATLANTIC; ASIAN MONSOON; HOLOCENE	A detailed reconstruction of West African monsoon hydrology over the past 155,000 years suggests a close linkage to northern high-latitude climate oscillations. Ba/Ca ratio and oxygen isotope composition of planktonic foraminifera in a marine sediment core from the Gulf of Guinea, in the eastern equatorial Atlantic (EEA), reveal centennial-scale variations of riverine freshwater input that are synchronous with northern high-latitude stadials and interstadials of the penultimate interglacial and the last deglaciation. EEA Mg/Ca-based sea surface temperatures (SSTs) were decoupled from northern high-latitude millennial-scale fluctuation and primarily responded to changes in atmospheric greenhouse gases and low-latitude solar insolation. The onset of enhanced monsoon precipitation lags behind the changes in EEA SSTs by up to 7000 years during glacial-interglacial transitions. This study demonstrates that the stadial-interstadial and deglacial climate instability of the northern high latitudes exerts dominant control on the West African monsoon dynamics through an atmospheric linkage.	Univ Calif Santa Barbara, Dept Earth Sci, Santa Barbara, CA 93106 USA; Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA; Univ Kiel, Inst Geowissensch, D-24098 Kiel, Germany; Univ Kiel, Leibniz Lab Altersbestimmung & Isotopenforsch, D-24098 Kiel, Germany	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of Kiel; University of Kiel	Weldeab, S (corresponding author), Univ Kiel, IFM GEOMAR, Leibniz Inst Meereswissensch, D-24098 Kiel, Germany.	sweldeab@ifm-geomar.de		Schneider, Ralph/0000-0003-1453-9181; Weldeab, Syee/0000-0002-4829-5237				Adegbie AT, 2003, PALAEOGEOGR PALAEOCL, V197, P323, DOI 10.1016/S0031-0182(03)00474-7; Andersen KK, 2004, NATURE, V431, P147, DOI 10.1038/nature02805; Bemis BE, 1998, PALEOCEANOGRAPHY, V13, P150, DOI 10.1029/98PA00070; BERGER A, 1991, QUATERNARY SCI REV, V10, P297, DOI 10.1016/0277-3791(91)90033-Q; BIJMA J, 1990, J FORAMIN RES, V20, P95, DOI 10.2113/gsjfr.20.2.95; Brook EJ, 1996, SCIENCE, V273, P1087, DOI 10.1126/science.273.5278.1087; Burns SJ, 2003, SCIENCE, V301, P1365, DOI 10.1126/science.1086227; Camberlin P, 2001, INT J CLIMATOL, V21, P973, DOI 10.1002/joc.673; Coffey M, 1997, ESTUAR COAST SHELF S, V45, P113, DOI 10.1006/ecss.1996.0157; Dekens PS, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2001GC000200; deMenocal P, 2000, SCIENCE, V288, P2198, DOI 10.1126/science.288.5474.2198; EDMOND JM, 1978, NETH J SEA RES, V12, P324, DOI 10.1016/0077-7579(78)90034-0; Fleitmann D, 2003, SCIENCE, V300, P1737, DOI 10.1126/science.1083130; Ganopolski A, 1998, SCIENCE, V280, P1916, DOI 10.1126/science.280.5371.1916; Gasse F, 2000, QUATERNARY SCI REV, V19, P189, DOI 10.1016/S0277-3791(99)00061-X; Gu GJ, 2004, J CLIMATE, V17, P3364, DOI [10.1175/1520-0442(2004)017<3364:SEAVAW>2.0.CO;2, 10.1175/1520-0442(2004)017&lt;3364:SEAVAW&gt;2.0.CO;2]; HALL JM, 2004, PALEOCEANOGRAPHY, V19, pPA101; Haug GH, 2001, SCIENCE, V293, P1304, DOI 10.1126/science.1059725; Janowiak JE, 1999, J CLIMATE, V12, P3335, DOI 10.1175/1520-0442(1999)012<3335:COAGSR>2.0.CO;2; Kelly MJ, 2006, PALAEOGEOGR PALAEOCL, V236, P20, DOI 10.1016/j.palaeo.2005.11.042; Kutzbach JE, 1997, SCIENCE, V278, P440, DOI 10.1126/science.278.5337.440; Lea DW, 2003, SCIENCE, V301, P1361, DOI 10.1126/science.1088470; Lea DW, 2000, SCIENCE, V289, P1719, DOI 10.1126/science.289.5485.1719; Lea DW, 2004, J CLIMATE, V17, P2170, DOI 10.1175/1520-0442(2004)017<2170:TYCITS>2.0.CO;2; LEA DW, 1994, PALEOCEANOGRAPHY, V9, P445, DOI 10.1029/94PA00151; Levitus S., 1994, WORLD OCEAN ATLAS 19, V4; Lezine AM, 2005, PALAEOGEOGR PALAEOCL, V219, P225, DOI 10.1016/j.palaeo.2004.12.027; Lisiecki LE, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2005PA001164; Liu ZY, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL028062; Peterson LC, 2000, SCIENCE, V290, P1947, DOI 10.1126/science.290.5498.1947; PETERSON RG, 1991, PROG OCEANOGR, V26, P1, DOI 10.1016/0079-6611(91)90006-8; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Salzmann U, 2002, QUATERNARY RES, V58, P73, DOI 10.1006/qres.2002.2356; Saraswat R, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024093; Schmidt GA, 1999, PALEOCEANOGRAPHY, V14, P482, DOI 10.1029/1999PA900025; SCHNEIDER RR, 1995, PALEOCEANOGRAPHY, V10, P197, DOI 10.1029/94PA03308; Schulz H, 1998, NATURE, V393, P54, DOI 10.1038/31750; Severinghaus JP, 1998, NATURE, V391, P141, DOI 10.1038/34346; Shanahan TM, 2006, PALAEOGEOGR PALAEOCL, V242, P287, DOI 10.1016/j.palaeo.2006.06.007; Stott L, 2002, SCIENCE, V297, P222, DOI 10.1126/science.1071627; TALBOT MR, 1992, EARTH PLANET SC LETT, V110, P23, DOI 10.1016/0012-821X(92)90036-U; Waelbroeck C, 2002, QUATERNARY SCI REV, V21, P295, DOI 10.1016/S0277-3791(01)00101-9; Wang XF, 2004, NATURE, V432, P740, DOI 10.1038/nature03067; Wang YJ, 2001, SCIENCE, V294, P2345, DOI 10.1126/science.1064618; Weldeab S, 2006, EARTH PLANET SC LETT, V241, P699, DOI 10.1016/j.epsl.2005.11.012; Weldeab S, 2005, GEOLOGY, V33, P981, DOI 10.1130/G21874.1; Yuan DX, 2004, SCIENCE, V304, P575, DOI 10.1126/science.1091220	47	312	325	7	101	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 1	2007	316	5829					1303	1307		10.1126/science.1140461	http://dx.doi.org/10.1126/science.1140461			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173PS	17540896				2022-12-28	WOS:000246885600041
J	MacDonald, R				MacDonald, Rhona			The continuing battle over baby-milk formula	LANCET			English	Editorial Material									Lancet, London NW1 7BY, England		MacDonald, R (corresponding author), Lancet, London NW1 7BY, England.							Cawthorne P, 2007, LANCET, V369, P974, DOI 10.1016/S0140-6736(07)60473-5; Ferriman A, 1999, BRIT MED J, V318, P417, DOI 10.1136/bmj.318.7181.417a; Moorhead Joanna, 2007, GUARDIAN        0515; PARSONS H, 2007, GUARDIAN        0522, P35; *SAV CHILDR UK, 2007, GEN BAB MILK MARK ST	5	1	1	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 26	2007	369	9575					1773	1773		10.1016/S0140-6736(07)60795-8	http://dx.doi.org/10.1016/S0140-6736(07)60795-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	172QP	17531871				2022-12-28	WOS:000246819300009
J	Berghuis, P; Rajnicek, AM; Morozov, YM; Ross, RA; Mulder, J; Urban, GM; Monory, K; Marsicano, G; Matteoli, M; Canty, A; Irving, AJ; Katona, I; Yanagawa, Y; Rakic, P; Lutz, B; Mackie, K; Harkany, T				Berghuis, Paul; Rajnicek, Ann M.; Morozov, Yury M.; Ross, Ruth A.; Mulder, Jan; Urban, Gabriella M.; Monory, Krisztina; Marsicano, Giovanni; Matteoli, Michela; Canty, Alison; Irving, Andrew J.; Katona, Istvan; Yanagawa, Yuchio; Rakic, Pasko; Lutz, Beat; Mackie, Ken; Harkany, Tibor			Hardwiring the brain: Endocannabinoids shape neuronal connectivity	SCIENCE			English	Article							GROWTH CONE GUIDANCE; RHO GTPASES; CANNABINOIDS; INTERNEURONS; EXPRESSION; SYNAPSES; KINASE	The roles of endocannabinoid signaling during central nervous system development are unknown. We report that CB1 cannabinoid receptors (CB(1)Rs) are enriched in the axonal growth cones of gamma-aminobutyric acid-containing ( GABAergic) interneurons in the rodent cortex during late gestation. Endocannabinoids trigger CB1R internalization and elimination from filopodia and induce chemorepulsion and collapse of axonal growth cones of these GABAergic interneurons by activating RhoA. Similarly, endocannabinoids diminish the galvanotropism of Xenopus laevis spinal neurons. These findings, together with the impaired target selection of cortical GABAergic interneurons lacking CB(1)Rs, identify endocannabinoids as axon guidance cues and demonstrate that endocannabinoid signaling regulates synaptogenesis and target selection in vivo.	Karolinska Inst, Dept Med Biochem & Biophys, Div Mol Neurobiol, S-17177 Stockholm, Sweden; Univ Aberdeen, Inst Med Sci, Sch Med Sci, Aberdeen AB25 2ZD, Scotland; Yale Univ, Sch Med, Kavli Inst Neurosci, Dept Neurobiol, New Haven, CT 06510 USA; Karolinska Inst, Dept Neurosci, S-17177 Stockholm, Sweden; Hungarian Acad Sci, Inst Expt Med, Lab Cerebral Cortex Res, H-1083 Budapest, Hungary; Johannes Gutenberg Univ Mainz, Dept Physiol Chem, D-55099 Mainz, Germany; Univ Milan, Dept Med Pharmacol, I-20129 Milan, Italy; Univ Milan, CNR, Inst Neurosci, I-20129 Milan, Italy; Univ Dundee, Ninewells Hosp & Med Sch, Inst Neurosci, Div Pathol & Neurosci, Dundee DD1 9SY, Scotland; Gunma Univ, Grad Sch Med, Maebashi, Gunma 3718511, Japan; Japan Sci & Technol Corp, Solut Oriented Res Sci & Technol, Maebashi, Gunma 3718511, Japan; Univ Washington, Dept Anesthesiol Physiol, Seattle, WA 98195 USA; Univ Washington, Dept Biophys, Seattle, WA 98195 USA	Karolinska Institutet; University of Aberdeen; Yale University; Karolinska Institutet; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; Johannes Gutenberg University of Mainz; University of Milan; Consiglio Nazionale delle Ricerche (CNR); University of Milan; University of Dundee; Gunma University; Japan Science & Technology Agency (JST); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Harkany, T (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Div Mol Neurobiol, S-17177 Stockholm, Sweden.	Tibor.Harkany@ki.se	Lutz, Beat/AFK-6229-2022; Mulder, Jan/G-3909-2011; Rajnicek, Ann/K-7991-2014; Mulder, Jan/B-2972-2010; Canty, Alison/J-7649-2014; Mackie, Ken/E-3715-2013; Mulder, Jan/AAG-9761-2021; Katona, Istvan/D-9729-2011; Lutz, Beat/AAG-4538-2022; Matteoli, Michela/K-4526-2018; Mackie, Kenneth P/B-7358-2011; Marsicano, Giovanni/I-9603-2016	Mulder, Jan/0000-0003-3717-5018; Rajnicek, Ann/0000-0003-2706-0014; Canty, Alison/0000-0001-5165-2365; Mackie, Ken/0000-0001-8501-6199; Katona, Istvan/0000-0003-2808-3330; Matteoli, Michela/0000-0002-3569-7843; Morozov, Yury/0000-0002-3679-6819; Marsicano, Giovanni/0000-0003-3804-1951	NATIONAL INSTITUTE ON DRUG ABUSE [P01DA015916, K02DA000286, R01DA011322] Funding Source: NIH RePORTER; NIDA NIH HHS [DA00286, DA11322, DA015916] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Aguado T, 2005, FASEB J, V19, P1704, DOI 10.1096/fj.05-3995fje; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Berghuis P, 2005, P NATL ACAD SCI USA, V102, P19115, DOI 10.1073/pnas.0509494102; BICKNESE AR, 1994, J NEUROSCI, V14, P3500; Bisogno T, 2003, J CELL BIOL, V163, P463, DOI 10.1083/jcb.200305129; Derkinderen P, 2003, J NEUROSCI, V23, P2371; Domenici MR, 2006, J NEUROSCI, V26, P5794, DOI 10.1523/JNEUROSCI.0372-06.2006; Freund TF, 2003, PHYSIOL REV, V83, P1017, DOI 10.1152/physrev.00004.2003; Harkany T, 2004, J NEUROSCI, V24, P4978, DOI 10.1523/JNEUROSCI.4884-03.2004; Hioki H, 2004, CEREB CORTEX, V14, P1266, DOI 10.1093/cercor/bhh088; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kim D, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-10-j0004.2001; Kozma R, 1997, MOL CELL BIOL, V17, P1201, DOI 10.1128/MCB.17.3.1201; Mato S, 2003, EUR J NEUROSCI, V17, P1747, DOI 10.1046/j.1460-9568.2003.02599.x; Monory K, 2006, NEURON, V51, P455, DOI 10.1016/j.neuron.2006.07.006; Morii H, 2006, J NEUROBIOL, V66, P1101, DOI 10.1002/neu.20295; Morozov YM, 2003, EUR J NEUROSCI, V18, P1213, DOI 10.1046/j.1460-9568.2003.02852.x; Morozov YM, 2006, J NEUROSCI, V26, P5017, DOI 10.1523/JNEUROSCI.0272-06.2006; OCONNOR TP, 1990, J NEUROSCI, V10, P3935, DOI 10.1523/JNEUROSCI.10-12-03935.1990; Patapoutian A, 2001, CURR OPIN NEUROBIOL, V11, P272, DOI 10.1016/S0959-4388(00)00208-7; Rajnicek AM, 2006, J CELL SCI, V119, P1723, DOI 10.1242/jcs.02896; Rakic P, 2006, CEREB CORTEX, V16, pI3, DOI 10.1093/cercor/bhk036; Spano MS, 2007, BIOL PSYCHIAT, V61, P554, DOI 10.1016/j.biopsych.2006.03.073; Wang GX, 2005, NATURE, V434, P898, DOI 10.1038/nature03478; Wang X, 2003, NEUROSCIENCE, V118, P681, DOI 10.1016/S0306-4522(03)00020-4; Wonders CP, 2006, NAT REV NEUROSCI, V7, P687, DOI 10.1038/nrn1954; Xiang Y, 2002, NAT NEUROSCI, V5, P843, DOI 10.1038/nn899; Yuan XB, 2003, NAT CELL BIOL, V5, P38, DOI 10.1038/ncb895	28	366	378	3	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2007	316	5828					1212	1216		10.1126/science.1137406	http://dx.doi.org/10.1126/science.1137406			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171GQ	17525344				2022-12-28	WOS:000246724300049
J	Sotomayor, M; Schulten, K				Sotomayor, Marcos; Schulten, Klaus			Single-molecule experiments in vitro and in silico	SCIENCE			English	Review							ATOMIC-FORCE MICROSCOPY; TITIN IMMUNOGLOBULIN DOMAINS; DYNAMICS SIMULATIONS; SPECTRIN REPEATS; MECHANICAL STABILITY; ANKYRIN REPEATS; CELL-ADHESION; III MODULES; IG DOMAIN; PROTEINS	Single-molecule force experiments in vitro enable the characterization of the mechanical response of biological matter at the nanometer scale. However, they do not reveal the molecular mechanisms underlying mechanical function. These can only be readily studied through molecular dynamics simulations of atomic structural models: "in silico" ( by computer analysis) single-molecule experiments. Steered molecular dynamics simulations, in which external forces are used to explore the response and function of macromolecules, have become a powerful tool complementing and guiding in vitro single-molecule experiments. The insights provided by in silico experiments are illustrated here through a review of recent research in three areas of protein mechanics: elasticity of the muscle protein titin and the extracellular matrix protein fibronectin; linker-mediated elasticity of the cytoskeleton protein spectrin; and elasticity of ankyrin repeats, a protein module found ubiquitously in cells but with an as-yet unclear function.	Univ Illinois, Dept Phys, Urbana, IL 61801 USA; Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Schulten, K (corresponding author), Univ Illinois, Dept Phys, 405 N Mathews Ave, Urbana, IL 61801 USA.	kschulte@ks.uiuc.edu	Schulten, Klaus/D-5561-2009; Sotomayor, Marcos/T-2411-2019; Sotomayor, Marcos/J-4898-2012	Sotomayor, Marcos/0000-0002-3333-1805; Sotomayor, Marcos/0000-0002-3333-1805	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR005969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073655] Funding Source: NIH RePORTER; NCRR NIH HHS [P41 RR05969] Funding Source: Medline; NIGMS NIH HHS [1 R01 GM073655] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adcock SA, 2006, CHEM REV, V106, P1589, DOI 10.1021/cr040426m; Altmann SM, 2002, STRUCTURE, V10, P1085, DOI 10.1016/S0969-2126(02)00808-0; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; Best RB, 2003, J MOL BIOL, V330, P867, DOI 10.1016/S0022-2836(03)00618-1; Boggon TJ, 2002, SCIENCE, V296, P1308, DOI 10.1126/science.1071559; Cailliez F, 2005, BIOPHYS J, V89, P3895, DOI 10.1529/biophysj.105.067322; Carrion-Vazquez M, 2003, NAT STRUCT BIOL, V10, P738, DOI 10.1038/nsb965; Corey DP, 2004, NATURE, V428, P901, DOI 10.1038/428901a; Craig D, 2004, STRUCTURE, V12, P21, DOI 10.1016/j.str.2003.11.024; Craig D, 2001, P NATL ACAD SCI USA, V98, P5590, DOI 10.1073/pnas.101582198; Discher DE, 2001, CELL MOL BIOL LETT, V6, P593; Evans E, 1997, BIOPHYS J, V72, P1541, DOI 10.1016/S0006-3495(97)78802-7; FLORIN EL, 1994, SCIENCE, V264, P415, DOI 10.1126/science.8153628; Fowler SB, 2002, J MOL BIOL, V322, P841, DOI 10.1016/S0022-2836(02)00805-7; Gao M, 2003, P NATL ACAD SCI USA, V100, P14784, DOI 10.1073/pnas.2334390100; Gao M, 2002, J MUSCLE RES CELL M, V23, P513, DOI 10.1023/A:1023466608163; Gao M, 2002, J MOL BIOL, V323, P939, DOI 10.1016/S0022-2836(02)01001-X; Gao M, 2006, PHYS CHEM CHEM PHYS, V8, P3692, DOI 10.1039/b606019f; Grater F, 2005, BIOPHYS J, V88, P790, DOI 10.1529/biophysj.104.052423; Grubmueller Helmut, 2005, V305, P493; Grubmuller H, 1996, SCIENCE, V271, P997, DOI 10.1126/science.271.5251.997; Howard J, 2004, CURR BIOL, V14, pR224, DOI 10.1016/j.cub.2004.02.050; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Improta S, 1996, STRUCTURE, V4, P323, DOI 10.1016/S0969-2126(96)00036-6; Isralewitz B, 2001, CURR OPIN STRUC BIOL, V11, P224, DOI 10.1016/S0959-440X(00)00194-9; Johnson CP, 2007, BLOOD, V109, P3538, DOI 10.1182/blood-2006-07-038588; Kellermayer MSZ, 1997, SCIENCE, V276, P1112, DOI 10.1126/science.276.5315.1112; Kusunoki H, 2004, STRUCTURE, V12, P645, DOI 10.1016/j.str.2004.02.022; Law R, 2003, BIOPHYS J, V84, P533, DOI 10.1016/S0006-3495(03)74872-3; Leckband D, 2006, ANNU REV BIOMED ENG, V8, P259, DOI 10.1146/annurev.bioeng.8.061505.095753; Lee G, 2006, NATURE, V440, P246, DOI 10.1038/nature04437; Li LW, 2006, BIOPHYS J, V90, pL30, DOI 10.1529/biophysj.105.078436; Li LW, 2005, J MOL BIOL, V345, P817, DOI 10.1016/j.jmb.2004.11.021; Lu H, 1999, CHEM PHYS, V247, P141, DOI 10.1016/S0301-0104(99)00164-0; Lu H, 2000, BIOPHYS J, V79, P51, DOI 10.1016/S0006-3495(00)76273-4; Lu H, 1998, BIOPHYS J, V75, P662, DOI 10.1016/S0006-3495(98)77556-3; Lu H, 1999, PROTEINS, V35, P453, DOI 10.1002/(SICI)1097-0134(19990601)35:4<453::AID-PROT9>3.3.CO;2-D; Lu ZY, 2006, BIOPHYS J, V91, pL57, DOI 10.1529/biophysj.106.090324; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Marino M, 2006, STRUCTURE, V14, P1437, DOI 10.1016/j.str.2006.07.009; Marszalek PE, 1999, NATURE, V402, P100, DOI 10.1038/47083; Mehta AD, 1999, SCIENCE, V283, P1689, DOI 10.1126/science.283.5408.1689; Michaely P, 2002, EMBO J, V21, P6387, DOI 10.1093/emboj/cdf651; Mohler PJ, 2002, J CELL SCI, V115, P1565; Mosavi LK, 2004, PROTEIN SCI, V13, P1435, DOI 10.1110/ps.03554604; Mosavi LK, 2002, P NATL ACAD SCI USA, V99, P16029, DOI 10.1073/pnas.252537899; Oberhauser AF, 2002, J MOL BIOL, V319, P433, DOI 10.1016/S0022-2836(02)00306-6; Ortiz V, 2005, J MOL BIOL, V349, P638, DOI 10.1016/j.jmb.2005.03.086; Paci E, 1999, J MOL BIOL, V288, P441, DOI 10.1006/jmbi.1999.2670; Paramore S, 2006, BIOPHYS J, V91, P3436, DOI 10.1529/biophysj.106.091108; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Randles LG, 2007, BIOPHYS J, V92, P571, DOI 10.1529/biophysj.106.093690; Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109; Rief M, 2002, CHEMPHYSCHEM, V3, P255, DOI 10.1002/1439-7641(20020315)3:3<255::AID-CPHC255>3.0.CO;2-M; Rief M, 1999, J MOL BIOL, V286, P553, DOI 10.1006/jmbi.1998.2466; Rounsevell RWS, 2004, STRUCTURE, V12, P4, DOI 10.1016/j.str.2003.12.006; Siemens J, 2004, NATURE, V428, P950, DOI 10.1038/nature02483; Sollner C, 2004, NATURE, V428, P955, DOI 10.1038/nature02484; Sotomayor M, 2005, STRUCTURE, V13, P669, DOI 10.1016/j.str.2005.03.001; TAKEICHI M, 1990, ANNU REV BIOCHEM, V59, P237, DOI 10.1146/annurev.biochem.59.1.237; Tskhovrebova L, 2003, NAT REV MOL CELL BIO, V4, P679, DOI 10.1038/nrm1198; Tskhovrebova L, 1997, NATURE, V387, P308, DOI 10.1038/387308a0; Vogel V, 2006, ANNU REV BIOPH BIOM, V35, P459, DOI 10.1146/annurev.biophys.35.040405.102013; Williams PM, 2003, NATURE, V422, P446, DOI 10.1038/nature01517; Yi M, 2001, P NATL ACAD SCI USA, V98, P620, DOI 10.1073/pnas.98.2.620; Zlatanova J, 2006, MOL CELL, V24, P317, DOI 10.1016/j.molcel.2006.10.017	67	432	440	3	147	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2007	316	5828					1144	1148		10.1126/science.1137591	http://dx.doi.org/10.1126/science.1137591			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171GQ	17525328				2022-12-28	WOS:000246724300030
J	Rubin, BP; Heinrich, MC; Corless, CL				Rubin, Brian P.; Heinrich, Michael C.; Corless, Christopher L.			Gastrointestinal stromal tumour	LANCET			English	Review							RECEPTOR TYROSINE KINASE; AUTONOMIC NERVE TUMORS; OF-FUNCTION MUTATIONS; EORTC-SOFT-TISSUE; C-KIT; GERMLINE MUTATION; IMATINIB MESYLATE; INTERSTITIAL-CELLS; PROGNOSTIC-FACTORS; NEUROFIBROMATOSIS TYPE-1	Gastrointestinal stromal tumours are the most common mesenchymal neoplasm of the gastrointestinal tract and are highly resistant to conventional chemotherapy and radiotherapy. Such tumours usually have activating mutations in either KIT (75-80%) or PDGFRA (5-10%), two closely related receptor tyrosine kinases. These mutations lead to ligand-independent activation and signal transduction mediated by constitutively activated KIT or PDGFRA. Targeting these activated proteins with imatinib mesylate, a small-molecule kinase inhibitor, has proven useful in the treatment of recurrent or metastatic gastrointestinal stromal tumours and is now being tested as an adjuvant or neoadjuvant. However, resistance to imatinib is a growing problem and other targeted therapeutics such as sunitinib are available. The important interplay between the molecular genetics of gastrontestinal stromal turnout and responses to targeted therapeutics serves as a model for the study of targeted therapies in other solid tumours.	Cleveland Clin Fdn, Dept Anat Pathol, Taussig Canc Ctr, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Dept Mol Genet, Taussig Canc Ctr, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Lerner Res Inst, Cleveland, OH 44195 USA; Oregon Hlth & Sci Univ, Inst Canc, Dept Pathol, Portland, OR 97239 USA; Oregon Hlth & Sci Univ, Inst Canc, Dept Med, Portland, OR 97239 USA; Oregon Hlth & Sci Univ, Inst Canc, Dept Cell & Dev Biol, Portland, OR 97239 USA; Portland VA Med Ctr, Portland, OR 97239 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center	Rubin, BP (corresponding author), Cleveland Clin Fdn, Dept Anat Pathol, Taussig Canc Ctr, 9500 Euclid Ave, Cleveland, OH 44195 USA.	rubinb2@ccf.org	Heinrich, Michael/AAC-6745-2019; ravegnini, gloria/K-1330-2016; Chu, Kent/C-4251-2009	ravegnini, gloria/0000-0002-7774-402X; Heinrich, Michael/0000-0003-3790-0478				Abdulkader I, 2005, HISTOPATHOLOGY, V46, P470, DOI 10.1111/j.1365-2559.2005.02014.x; Agaimy A, 2005, Z GASTROENTEROL, V43, P1025, DOI 10.1055/s-2005-858378; Agaimy A, 2007, AM J SURG PATHOL, V31, P113, DOI 10.1097/01.pas.0000213307.05811.f0; Andersson J, 2005, AM J SURG PATHOL, V29, P1170, DOI 10.1097/01.pas.0000159775.77912.15; [Anonymous], 1893, CR SOC BIOL, V5, P217; Antonescu CR, 2005, CLIN CANCER RES, V11, P4182, DOI 10.1158/1078-0432.CCR-04-2245; Bauer S, 2006, CANCER RES, V66, P9153, DOI 10.1158/0008-5472.CAN-06-0165; Bedard ELR, 2006, SURG ENDOSC, V20, P500, DOI 10.1007/s00464-005-0287-2; Beghini A, 2001, CANCER, V92, P657, DOI 10.1002/1097-0142(20010801)92:3<657::AID-CNCR1367>3.0.CO;2-D; Benjamin RS, 2006, ONCOLOGIST, V11, P9, DOI 10.1634/theoncologist.11-1-9; BENJAMIN RS, 2003, P AN M AM SOC CLIN, V22, P814; Bergmann F, 1998, PROCEEDINGS OF THE GERMAN SOCIETY FOR PATHOLOGY 82ND MEETING - 1998, P275; Blackstein ME, 2006, CAN J GASTROENTEROL, V20, P157, DOI 10.1155/2006/434761; Blanke C, 2005, AM J GASTROENTEROL, V100, P2366, DOI 10.1111/j.1572-0241.2005.50650_6.x; Blay JY., 2004, P AM SOC CLIN ONCOL, V23, P815; BLUMEJENSEN P, 1991, EMBO J, V10, P4121, DOI 10.1002/j.1460-2075.1991.tb04989.x; Brainard JA, 1997, AM J SURG PATHOL, V21, P407, DOI 10.1097/00000478-199704000-00006; Buchdunger E, 2000, J PHARMACOL EXP THER, V295, P139; Carballo M, 2005, AM J MED GENET A, V132A, P361, DOI 10.1002/ajmg.a.30388; Carney JA, 1999, MAYO CLIN PROC, V74, P543, DOI 10.4065/74.6.543; Chang PM, 2003, MOL CELL BIOL, V23, P3067, DOI 10.1128/MCB.23.9.3067-3078.2003; Chen LL, 2004, CANCER RES, V64, P5913, DOI 10.1158/0008-5472.CAN-04-0085; Choi H, 2004, AM J ROENTGENOL, V183, P1619, DOI 10.2214/ajr.183.6.01831619; Chompret A, 2004, GASTROENTEROLOGY, V126, P318, DOI 10.1053/j.gastro.2003.10.079; Corless CL, 2002, AM J PATHOL, V160, P1567, DOI 10.1016/S0002-9440(10)61103-0; Corless CL, 2004, J CLIN ONCOL, V22, P3813, DOI 10.1200/JCO.2004.05.140; Debiec-Rychter M, 2005, GASTROENTEROLOGY, V128, P270, DOI 10.1053/j.gastro.2004.11.020; Debiec-Rychter M, 2001, CANCER GENET CYTOGEN, V128, P24, DOI 10.1016/S0165-4608(01)00395-8; Debiec-Rychter M, 2004, EUR J CANCER, V40, P689, DOI 10.1016/j.ejca.2003.11.025; Debiec-Rychter M, 2006, EUR J CANCER, V42, P1093, DOI 10.1016/j.ejca.2006.01.030; DeMatteo RP, 2000, ANN SURG, V231, P51, DOI 10.1097/00000658-200001000-00008; DeMatteo RP, 2002, HUM PATHOL, V33, P466, DOI 10.1053/hupa.2002.124122; DEMETRI G. D., 2004, J NATL COMPR CANC NE, V2, pS1; Demetri GD, 2002, NEW ENGL J MED, V347, P472, DOI 10.1056/NEJMoa020461; Demetri GD, 2006, LANCET, V368, P1329, DOI 10.1016/S0140-6736(06)69446-4; Desai J, 2004, J CLIN ONCOL, V22, p197S; Duensing A, 2004, ONCOGENE, V23, P3999, DOI 10.1038/sj.onc.1207525; El-Rifai W, 2000, CANCER RES, V60, P3899; El-Rifai W, 2000, GENE CHROMOSOME CANC, V27, P387, DOI 10.1002/(SICI)1098-2264(200004)27:4<387::AID-GCC8>3.0.CO;2-C; ElRifai W, 1996, CANCER RES, V56, P3230; Fletcher CDM, 2002, HUM PATHOL, V33, P459, DOI 10.1053/hupa.2002.123545; Fletcher J.A., 2003, P AM SOC CLIN ONCOL, V22, P815; Fukasawa T, 2000, JPN J CANCER RES, V91, P1241, DOI 10.1111/j.1349-7006.2000.tb00910.x; Gayed I, 2004, J NUCL MED, V45, P17; Granger SR, 2006, SURG ENDOSC, V20, P1299, DOI 10.1007/s00464-005-0328-x; Guerin E, 2006, ACTA CHIR BELG, V106, P605; Hartmann K, 2005, GASTROENTEROLOGY, V129, P1042, DOI 10.1053/j.gastro.2005.06.060; Heinrich MC, 2005, J CLIN ONCOL, V23, p3S; Heinrich MC, 2002, HUM PATHOL, V33, P484, DOI 10.1053/hupa.2002.124124; Heinrich MC, 2002, J CLIN ONCOL, V20, P1692, DOI 10.1200/JCO.2002.20.6.1692; Heinrich MC, 2003, SCIENCE, V299, P708, DOI 10.1126/science.1079666; Heinrich MC, 2003, J CLIN ONCOL, V21, P4342, DOI 10.1200/JCO.2003.04.190; Heinrich MC, 2006, J CLIN ONCOL, V24, P4764, DOI 10.1200/JCO.2006.06.2265; Hirota S, 1998, SCIENCE, V279, P577, DOI 10.1126/science.279.5350.577; Hirota S, 2000, AM J SURG PATHOL, V24, P326, DOI 10.1097/00000478-200002000-00045; Hirota S, 2003, GASTROENTEROLOGY, V125, P660, DOI 10.1016/S0016-5085(03)01046-1; Hirota S, 2002, GASTROENTEROLOGY, V122, P1493, DOI 10.1053/gast.2002.33024; Hutchins LF, 2005, J CLIN ONCOL, V23, P8313, DOI 10.1200/JCO.2005.08.071; Isozaki K, 2000, AM J PATHOL, V157, P1581, DOI 10.1016/S0002-9440(10)64795-5; Joensuu H, 2001, NEW ENGL J MED, V344, P1052, DOI 10.1056/NEJM200104053441404; Kim HJ, 2005, PATHOL INT, V55, P655, DOI 10.1111/j.1440-1827.2005.01885.x; Kim NG, 2000, INT J CANCER, V85, P633, DOI 10.1002/(SICI)1097-0215(20000301)85:5<633::AID-IJC6>3.3.CO;2-X; Kindblom LG, 1998, AM J PATHOL, V152, P1259; Kinoshita K, 2004, J PATHOL, V202, P80, DOI 10.1002/path.1487; KITAYAMA H, 1995, BLOOD, V85, P790, DOI 10.1182/blood.V85.3.790.bloodjournal853790; Kluppel M, 1998, DEV DYNAM, V211, P60; Kobayashi K, 2006, CANCER-AM CANCER SOC, V107, P2833, DOI 10.1002/cncr.22336; Lasota J, 1999, AM J PATHOL, V154, P53, DOI 10.1016/S0002-9440(10)65250-9; Lasota J, 2004, LAB INVEST, V84, P874, DOI 10.1038/labinvest.3700122; Lasota J, 2006, AM J SURG PATHOL, V30, P1342, DOI 10.1097/01.pas.0000213364.56498.3b; Li FP, 2005, J CLIN ONCOL, V23, P2735, DOI 10.1200/JCO.2005.06.009; Loughrey MB, 2006, HISTOPATHOLOGY, V49, P99, DOI 10.1111/j.1365-2559.2006.02336.x; Ma YS, 1999, J BIOL CHEM, V274, P13399, DOI 10.1074/jbc.274.19.13399; Maeyama H, 2001, GASTROENTEROLOGY, V120, P210; MAKI R, 2005, P AM SOC CLIN ONCOL, V24; Miettinen M, 2000, AM J SURG PATHOL, V24, P1339, DOI 10.1097/00000478-200010000-00003; Miettinen M, 2006, AM J SURG PATHOL, V30, P90, DOI 10.1097/01.pas.0000176433.81079.bd; Miettinen M, 2005, AM J SURG PATHOL, V29, P1373, DOI 10.1097/01.pas.0000172190.79552.8b; Miettinen M, 2003, AM J SURG PATHOL, V27, P625, DOI 10.1097/00000478-200305000-00006; Miettinen M, 2001, VIRCHOWS ARCH, V438, P1, DOI 10.1007/s004280000338; Miettinen M, 2006, AM J SURG PATHOL, V30, P477, DOI 10.1097/00000478-200604000-00008; Miettinen M, 2000, AM J SURG PATHOL, V24, P211, DOI 10.1097/00000478-200002000-00007; Miettinen M, 2001, AM J SURG PATHOL, V25, P1121, DOI 10.1097/00000478-200109000-00002; Miettinen M, 2005, AM J SURG PATHOL, V29, P52, DOI 10.1097/01.pas.0000146010.92933.de; Miettinen M, 1999, AM J SURG PATHOL, V23, P1109, DOI 10.1097/00000478-199909000-00015; Miettinen M, 2006, SEMIN DIAGN PATHOL, V23, P70, DOI 10.1053/j.semdp.2006.09.001; MIN KW, 1993, ULTRASTRUCT PATHOL, V17, P307, DOI 10.3109/01913129309027777; Mol CD, 2004, J BIOL CHEM, V279, P31655, DOI 10.1074/jbc.M403319200; Nakatani H, 2005, CANCER SCI, V96, P116, DOI 10.1111/j.1349-7006.2005.00018.x; NG EH, 1992, ANN SURG, V215, P68, DOI 10.1097/00000658-199201000-00010; NG EH, 1992, CANCER, V69, P1334, DOI 10.1002/1097-0142(19920315)69:6<1334::AID-CNCR2820690606>3.0.CO;2-S; Nguyen SQ, 2006, SURG ENDOSC, V20, P713, DOI 10.1007/s00464-005-0435-8; Nickl NJ, 2004, CURR OPIN GASTROEN, V20, P482, DOI 10.1097/00001574-200409000-00011; Nilsson B, 2005, CANCER-AM CANCER SOC, V103, P821, DOI 10.1002/cncr.20862; Nishida T, 1998, NAT GENET, V19, P323, DOI 10.1038/1209; Novitsky YW, 2006, ANN SURG, V243, P738, DOI 10.1097/01.sla.0000219739.11758.27; O'Brien P, 1999, AM J SURG PATHOL, V23, P198, DOI 10.1097/00000478-199902000-00009; O'Leary T, 1999, LAB INVEST, V79, P1461; O'Riain C, 2005, AM J SURG PATHOL, V29, P1680, DOI 10.1097/01.pas.0000173024.79852.08; Prakash S, 2005, J PEDIAT HEMATOL ONC, V27, P179, DOI 10.1097/01.mph.0000157790.81329.47; RANKIN C, 2004, P AN M AM SOC CLIN, V23, P815; Reith JD, 2000, MODERN PATHOL, V13, P577, DOI 10.1038/modpathol.3880099; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; Rosenbaum SJ, 2006, ABDOM IMAGING, V31, P25, DOI 10.1007/s00261-005-0031-3; Rubin BP, 2001, CANCER RES, V61, P8118; Rubin BP, 2005, CANCER RES, V65, P6631, DOI 10.1158/0008-5472.CAN-05-0891; Sakurai S, 2001, JPN J CANCER RES, V92, P494, DOI 10.1111/j.1349-7006.2001.tb01121.x; Sanders KM, 1996, GASTROENTEROLOGY, V111, P492, DOI 10.1053/gast.1996.v111.pm8690216; Sarlomo-Rikala M, 1998, MODERN PATHOL, V11, P728; Schneider-Stock R, 2003, J CLIN ONCOL, V21, P1688, DOI 10.1200/JCO.2003.08.101; Shankar S, 2005, RADIOLOGY, V235, P892, DOI 10.1148/radiol.2353040332; SHIU MH, 1982, CANCER, V49, P177, DOI 10.1002/1097-0142(19820101)49:1<177::AID-CNCR2820490136>3.0.CO;2-K; Sommer G, 2003, P NATL ACAD SCI USA, V100, P6706, DOI 10.1073/pnas.1037763100; Takazawa Y, 2005, AM J SURG PATHOL, V29, P755, DOI 10.1097/01.pas.0000163359.32734.f9; Tamborini E, 2004, GASTROENTEROLOGY, V127, P294, DOI 10.1053/j.gastro.2004.02.021; Tamborini E, 2006, ONCOGENE, V25, P6140, DOI 10.1038/sj.onc.1209639; Tarn C, 2006, CANCER RES, V66, P5477, DOI 10.1158/0008-5472.CAN-05-3906; THUNEBERG L, 1982, ADV ANAT EMBRYOL CEL, V71, P1; Trent JC, 2006, CURR OPIN ONCOL, V18, P386, DOI 10.1097/01.cco.0000228747.02660.e2; Tryggvason G, 2005, INT J CANCER, V117, P289, DOI 10.1002/ijc.21167; Tuveson DA, 2001, ONCOGENE, V20, P5054, DOI 10.1038/sj.onc.1204704; Tworek JA, 1999, AM J SURG PATHOL, V23, P937, DOI 10.1097/00000478-199908000-00012; Tworek JA, 1997, MODERN PATHOL, V10, P200; Tworek JA, 1999, AM J SURG PATHOL, V23, P946, DOI 10.1097/00000478-199908000-00013; Van den Abbeele AD, 2002, EUR J CANCER, V38, pS60, DOI 10.1016/S0959-8049(02)80604-9; Van Glabbeke M, 2006, EUR J CANCER, V42, P2277, DOI 10.1016/j.ejca.2006.03.029; van Oosterom AT, 2001, LANCET, V358, P1421, DOI 10.1016/S0140-6736(01)06535-7; Verweij J, 2003, EUR J CANCER, V39, P2006, DOI 10.1016/S0959-8049(02)00836-5; Verweij J, 2004, LANCET, V364, P1127, DOI 10.1016/S0140-6736(04)17098-0; von Mehren M, 2005, HEMATOL ONCOL CLIN N, V19, P547, DOI 10.1016/j.hoc.2005.03.010; VONMEHREN M, 2002, P AN M AM SOC CLIN, V21, pA403; Wardelmann E, 2003, INT J CANCER, V106, P887, DOI 10.1002/ijc.11323; Yantiss RK, 2005, MODERN PATHOL, V18, P475, DOI 10.1038/modpathol.3800334; Zalcberg JR, 2005, EUR J CANCER, V41, P1751, DOI 10.1016/j.ejca.2005.04.034; Zoller MET, 1997, CANCER-AM CANCER SOC, V79, P2125	135	433	491	5	32	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 20	2007	369	9574					1731	1741		10.1016/S0140-6736(07)60780-6	http://dx.doi.org/10.1016/S0140-6736(07)60780-6			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	169ZT	17512858				2022-12-28	WOS:000246631300029
J	Chow, CY; Zhang, YL; Dowling, JJ; Jin, N; Adamska, M; Shiga, K; Szigeti, K; Shy, ME; Li, J; Zhang, XB; Lupski, JR; Weisman, LS; Meisler, MH				Chow, Clement Y.; Zhang, Yanling; Dowling, James J.; Jin, Natsuko; Adamska, Maja; Shiga, Kensuke; Szigeti, Kinga; Shy, Michael E.; Li, Jun; Zhang, Xuebao; Lupski, James R.; Weisman, Lois S.; Meisler, Miriam H.			Mutation of FIG4 causes neurodegeneration in the pale tremor mouse and patients with CMT4J	NATURE			English	Article							CHARCOT-MARIE-TOOTH; PHOSPHATIDYLINOSITOL 3,5-BISPHOSPHATE; MYOTUBULARIN FAMILY; MEMBRANE DYNAMICS; SODIUM-CHANNEL; PHOSPHATASE; DISEASE; NEUROPATHY; PROTEIN; GENE	Membrane-bound phosphoinositides are signalling molecules that have a key role in vesicle trafficking in eukaryotic cells(1). Proteins that bind specific phosphoinositides mediate interactions between membrane-bounded compartments whose identity is partially encoded by cytoplasmic phospholipid tags. Little is known about the localization and regulation of mammalian phosphatidylinositol-3,5-bisphosphate ( PtdIns( 3,5)P-2), a phospholipid present in small quantities that regulates membrane trafficking in the endosome - lysosome axis in yeast(2). Here we describe a multi-organ disorder with neuronal degeneration in the central nervous system, peripheral neuronopathy and diluted pigmentation in the 'pale tremor' mouse. Positional cloning identified insertion of ETn2 beta ( early transposon 2 beta)(3) into intron 18 of Fig4 (A530089I17Rik), the homologue of a yeast SAC ( suppressor of actin) domain PtdIns(3,5) P-2 5-phosphatase located in the vacuolar membrane. The abnormal concentration of PtdIns( 3,5) P2 in cultured fibroblasts from pale tremor mice demonstrates the conserved biochemical function of mammalian Fig4. The cytoplasm of fibroblasts from pale tremor mice is filled with large vacuoles that are immunoreactive for LAMP-2 (lysosomal-associated membrane protein 2), consistent with dysfunction of the late endosome - lysosome axis. Neonatal neurodegeneration in sensory and autonomic ganglia is followed by loss of neurons from layers four and five of the cortex, deep cerebellar nuclei and other localized brain regions. The sciatic nerve exhibits reduced numbers of large-diameter myelinated axons, slowed nerve conduction velocity and reduced amplitude of compound muscle action potentials. We identified pathogenic mutations of human FIG4 (KIAA0274) on chromosome 6q21 in four unrelated patients with hereditary motor and sensory neuropathy. This novel form of autosomal recessive Charcot - Marie - Tooth disorder is designated CMT4J.	Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Cellular & Dev Biol, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; Texas Childrens Hosp, Houston, TX 77030 USA; Wayne State Univ, Sch Med, Dept Neurol, Detroit, MI 48201 USA; John D Dingle VA Med Ctr, Detroit, MI 48201 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Wayne State University	Meisler, MH (corresponding author), Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA.	meislerm@umich.edu	Zhang, Yanling/E-8932-2013; Adamska, Maja/M-4128-2014; Adamska, Maja/L-3306-2015	Zhang, Yanling/0000-0002-1483-9021; Shy, Michael/0000-0001-8460-6971; Adamska, Maja/0000-0002-4223-8450	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM024872, T32GM007544] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064015] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM024872-30, R01 GM024872, T32 GM007544] Funding Source: Medline; NINDS NIH HHS [R01 NS064015] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adamska M, 2005, DEV DYNAM, V233, P368, DOI 10.1002/dvdy.20437; Begley MJ, 2006, P NATL ACAD SCI USA, V103, P927, DOI 10.1073/pnas.0510006103; Bolino A, 2004, J CELL BIOL, V167, P711, DOI 10.1083/jcb.200407010; Bolino A, 2000, NAT GENET, V25, P17, DOI 10.1038/75542; Bonangelino CJ, 2002, J CELL BIOL, V156, P1015, DOI 10.1083/jcb.200201002; Bonneick S, 2005, HUM MOL GENET, V14, P3685, DOI 10.1093/hmg/ddi400; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Duex JE, 2006, EUKARYOT CELL, V5, P723, DOI 10.1128/EC.5.4.723-731.2006; Duex JE, 2006, J CELL BIOL, V172, P693, DOI 10.1083/jcb.200512105; Escayg A, 2000, NAT GENET, V24, P343, DOI 10.1038/74159; Gary JD, 2002, MOL BIOL CELL, V13, P1238, DOI 10.1091/mbc.01-10-0498; Hughes WE, 2000, BIOCHEM J, V350, P337, DOI 10.1042/0264-6021:3500337; Kohrman DC, 1996, J BIOL CHEM, V271, P17576, DOI 10.1074/jbc.271.29.17576; Li J, 2006, J COMP NEUROL, V498, P252, DOI 10.1002/cne.21051; Maksakova IA, 2006, PLOS GENET, V2, P1, DOI 10.1371/journal.pgen.0020002; Marks MS, 2001, NAT REV MOL CELL BIO, V2, P738, DOI 10.1038/35096009; Michell RH, 2006, TRENDS BIOCHEM SCI, V31, P52, DOI 10.1016/j.tibs.2005.11.013; Park M, 2006, NEURON, V52, P817, DOI 10.1016/j.neuron.2006.09.040; Rainier S, 2006, ARCH NEUROL-CHICAGO, V63, P445, DOI 10.1001/archneur.63.3.445; Rudge SA, 2004, MOL BIOL CELL, V15, P24, DOI 10.1091/mbc.E03-05-0297; Rutherford AC, 2006, J CELL SCI, V119, P3944, DOI 10.1242/jcs.03153; Schmitt-John T, 2005, NAT GENET, V37, P1213, DOI 10.1038/ng1661; Schroder JM, 2006, NEUROMOL MED, V8, P23, DOI 10.1385/NMM:8:1-2:23; Senderek J, 2003, HUM MOL GENET, V12, P349, DOI 10.1093/hmg/ddg030; STENDEL C, IN PRESS AM J HUM GE; Szigeti K, 2006, GENET MED, V8, P86, DOI 10.1097/01.gim.0000200160.29385.73; Verhoeven K, 2003, AM J HUM GENET, V72, P722, DOI 10.1086/367847; Zuchner S, 2005, NAT GENET, V37, P289, DOI 10.1038/ng1514	28	357	373	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 5	2007	448	7149					68	72		10.1038/nature05876	http://dx.doi.org/10.1038/nature05876			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185OS	17572665	Green Accepted, Green Published			2022-12-28	WOS:000247720900039
J	Molnar, A; Schwach, F; Studholme, DJ; Thuenemann, EC; Baulcombe, DC				Molnar, Attila; Schwach, Frank; Studholme, David J.; Thuenemann, Eva C.; Baulcombe, David C.			miRNAs control gene expression in the single-cell alga Chlamydomonas reinhardtii	NATURE			English	Article							TRANS-ACTING SIRNAS; SMALL RNAS; MICRORNAS; METHYLATION; SEQUENCES; CLONING	MicroRNAs (miRNAs) in eukaryotes guide post-transcriptional regulation by means of targeted RNA degradation and translational arrest(1). They are released by a Dicer nuclease as a 21-24-nucleotide RNA duplex from a precursor in which an imperfectly matched inverted repeat forms a partly double-stranded region. One of the two strands is then recruited by an Argonaute nuclease that is the effector protein of the silencing mechanism. Short interfering RNAs (siRNAs), which are similar to miRNAs, are also produced by Dicer but the precursors are perfectly double-stranded RNA. These siRNAs guide post-transcriptional regulation, as with miRNAs, and epigenetic genome modification. Diverse eukaryotes including fungi, plants, protozoans and metazoans produce siRNAs(2-5) but, until now, miRNAs have not been described in unicellular organisms and it has been suggested that they evolved together with multicellularity in separate plant and animal lineages(6). Here we show that the unicellular alga Chlamydomonas reinhardtii contains miRNAs, putative evolutionary precursors of miRNAs and species of siRNAs resembling those in higher plants. The common features of miRNAs and siRNAs in an alga and in higher plants indicate that complex RNA-silencing systems evolved before multicellularity and were a feature of primitive eukaryotic cells.	John Innes Ctr Plant Sci Res, Sainsbury Lab, Norwich NR4 7UH, Norfolk, England; Univ E Anglia, Sch Comp Sci, Norwich NR4 7TJ, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of East Anglia	Baulcombe, DC (corresponding author), John Innes Ctr Plant Sci Res, Sainsbury Lab, Norwich NR4 7UH, Norfolk, England.	david.baulcombe@tsl.ac.uk	Molnar, Attila/F-5833-2011; Studholme, David/H-6790-2019	Molnar, Attila/0000-0002-1044-6327; Studholme, David/0000-0002-3010-6637; Schwach, Frank/0000-0001-5495-7535; Baulcombe, David/0000-0003-0780-6878				Allen E, 2004, NAT GENET, V36, P1282, DOI 10.1038/ng1478; Ambros V, 2003, CURR BIOL, V13, P807, DOI 10.1016/S0960-9822(03)00287-2; Arazi T, 2005, PLANT J, V43, P837, DOI 10.1111/j.1365-313X.2005.02499.x; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Baumberger N, 2005, P NATL ACAD SCI USA, V102, P11928, DOI 10.1073/pnas.0505461102; Bonnet E, 2004, BIOINFORMATICS, V20, P2911, DOI 10.1093/bioinformatics/bth374; Borsani O, 2005, CELL, V123, P1279, DOI 10.1016/j.cell.2005.11.035; Cerutti H, 2006, CURR GENET, V50, P81, DOI 10.1007/s00294-006-0078-x; CHAPPELL L, 2005, CURRENT PROTOCOLS MI; Djikeng A, 2001, RNA, V7, P1522; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Floyd SK, 2004, NATURE, V428, P485, DOI 10.1038/428485a; Han J, 2001, DRUG DELIV, V8, P125; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Li JJ, 2005, CURR BIOL, V15, P1501, DOI 10.1016/j.cub.2005.07.029; Llave C, 2002, PLANT CELL, V14, P1605, DOI 10.1105/tpc.003210; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Lu C, 2006, GENOME RES, V16, P1276, DOI 10.1101/gr.5530106; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Pazour GJ, 2005, J CELL BIOL, V170, P103, DOI 10.1083/jcb.200504008; Peragine A, 2004, GENE DEV, V18, P2368, DOI 10.1101/gad.1231804; Reinhart BJ, 2002, SCIENCE, V297, P1831, DOI 10.1126/science.1077183; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Vazquez F, 2004, MOL CELL, V16, P69, DOI 10.1016/j.molcel.2004.09.028; WEGENER D, 1989, PLANT PHYSIOL, V90, P512, DOI 10.1104/pp.90.2.512; Yang ZY, 2006, NUCLEIC ACIDS RES, V34, P667, DOI 10.1093/nar/gkj474; Yu B, 2005, SCIENCE, V307, P932, DOI 10.1126/science.1107130	30	361	433	0	96	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 28	2007	447	7148					1126	U15		10.1038/nature05903	http://dx.doi.org/10.1038/nature05903			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	183HT	17538623				2022-12-28	WOS:000247564600040
J	Griffiths, C; Foster, G; Ramsay, J; Eldridge, S; Taylor, S				Griffiths, Chris; Foster, Gill; Ramsay, Jean; Eldridge, Sandra; Taylor, Stephanie			How effective are expert patient (lay led) education programmes for chronic disease?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SELF-MANAGEMENT PROGRAM; ARTHRITIS; CARE; REHABILITATION; INTERVENTIONS		Barts & London Queen Marys Sch Med & Dent, Hlth Sci Ctr, London E1 2A5, England	University of London; Queen Mary University London	Griffiths, C (corresponding author), Barts & London Queen Marys Sch Med & Dent, Hlth Sci Ctr, London E1 2A5, England.	c.j.griffiths@qmul.ac.uk	TAYLOR, STEPHANIE/GYV-4768-2022	Taylor, Stephanie/0000-0001-7454-6354	Medical Research Council [G0400503B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Barlow JH, 2000, HEALTH EDUC RES, V15, P665, DOI 10.1093/her/15.6.665; Bethell HJN, 2007, J PUBLIC HEALTH, V29, P57, DOI 10.1093/pubmed/fdl091; *BRIT THOR SOC, 2003, PULM REH SURV; BURY M, 2005, RAPID REV CURRENT ST; Buszewicz M, 2006, BMJ-BRIT MED J, V333, P879, DOI 10.1136/bmj.38965.375718.80; Coulter A, 1999, BRIT MED J, V319, P719, DOI 10.1136/bmj.319.7212.719; *DEP HLTH, 1999, CMND4386; Donaldson L, 2003, BRIT MED J, V326, P1279, DOI 10.1136/bmj.326.7402.1279; Griffiths C, 2005, BRIT J GEN PRACT, V55, P831; GRIFFITHS C, 2005, COCHRANE DB SYST REV; Haas M, 2005, J MANIP PHYSIOL THER, V28, P228, DOI 10.1016/j.jmpt.2005.03.010; Ismail K, 2004, LANCET, V363, P1589, DOI 10.1016/S0140-6736(04)16202-8; Jolliffe JA, 2000, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001800, DOI 10.1093/eurheartj/ehm316, DOI 10.1002/14651858.CD001800]; Kennedy A, 2007, J EPIDEMIOL COMMUN H, V61, P254, DOI 10.1136/jech.2006.053538; Lacasse Y, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003793.pub2; LEWIN B, 1992, LANCET, V339, P1036, DOI 10.1016/0140-6736(92)90547-G; Lewin SA, 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003267; Lorig KR, 1999, MED CARE, V37, P5, DOI 10.1097/00005650-199901000-00003; Lorig KR, 2003, NURS RES, V52, P361, DOI 10.1097/00006199-200311000-00003; LORIG KR, 1993, ARTHRITIS RHEUM, V36, P439, DOI 10.1002/art.1780360403; *NAT HLTH SERV, 2007, EXP PAT PROGR; Newman S, 2004, LANCET, V364, P1523, DOI 10.1016/S0140-6736(04)17277-2; *SECR STAT HLTH, 2001, EXP PAT NEW APPR CHR; Walters JAE, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001288.pub3; Wanless, 2002, SECURING OUR FUTURE; *WHO, 2007, CHRON DIS HLTH PROM	27	123	124	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 16	2007	334	7606					1254	1256		10.1136/bmj.39227.698785.47	http://dx.doi.org/10.1136/bmj.39227.698785.47			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	183AM	17569933	Green Published			2022-12-28	WOS:000247545100032
J	Zhao, HB; Holladay, JE; Brown, H; Zhang, ZC				Zhao, Haibo; Holladay, Johnathan E.; Brown, Heather; Zhang, Z. Conrad			Metal chlorides in ionic liquid solvents convert sugars to 5-hydroxymethylfurfural	SCIENCE			English	Article							D-FRUCTOSE; GLUCOSE; DEHYDRATION; WATER; DECOMPOSITION; CATALYSIS; MECHANISM; BIOMASS; ACID	Replacing petroleum feedstocks by biomass requires efficient methods to convert carbohydrates to a variety of chemical compounds. We report the catalytic conversion of sugars giving high yield to 5-hydroxymethylfurfural (HMF), a versatile intermediate. Metal halides in 1-alkyl-3-methylimidazolium chloride are catalysts, among which chromium (II) chloride is found to be uniquely effective, leading to the conversion of glucose to HMF with a yield near 70%. A wide range of metal halides is found to catalyze the conversion of fructose to HMF. Only a negligible amount of levulinic acid is formed in these reactions.	Pacific NW Natl Lab, Inst Interfacial Catalysis, Richland, WA 99352 USA	United States Department of Energy (DOE); Pacific Northwest National Laboratory	Zhang, ZC (corresponding author), Pacific NW Natl Lab, Inst Interfacial Catalysis, POB 999, Richland, WA 99352 USA.	conrad.zhang@pnl.gov						ANGYAL SJ, 1984, ADV CARBOHYD CHEM BI, V42, P15, DOI 10.1016/S0065-2318(08)60122-5; ANTAL MJ, 1990, CARBOHYD RES, V199, P91, DOI 10.1016/0008-6215(90)84096-D; Asghari FS, 2006, IND ENG CHEM RES, V45, P2163, DOI 10.1021/ie051088y; BIDER M, 2003, GREEN CHEM, V5, P280; DIETER KM, 1988, J AM CHEM SOC, V110, P2722, DOI 10.1021/ja00217a004; Huber GW, 2005, SCIENCE, V308, P1446, DOI 10.1126/science.1111166; Kabyemela BM, 1999, IND ENG CHEM RES, V38, P2888, DOI 10.1021/ie9806390; Kabyemela BM, 1997, IND ENG CHEM RES, V36, P1552, DOI 10.1021/ie960250h; Kamm B, 2006, BIOREFINERIES - INDUSTRIAL PROCESSES AND PRODUCTS: STATUS QUO AND FUTURE DIRECTIONS, VOL 2, P97; KUSTER BFM, 1990, STARCH-STARKE, V42, P314, DOI 10.1002/star.19900420808; Lansalot-Matras C, 2003, CATAL COMMUN, V4, P517, DOI 10.1016/S1566-7367(03)00133-X; Monsted L, 2005, INORG CHEM, V44, P1950, DOI 10.1021/ic0400989; Moreau C, 2006, J MOL CATAL A-CHEM, V253, P165, DOI 10.1016/j.molcata.2006.03.046; Remsing RC, 2006, CHEM COMMUN, P1271, DOI 10.1039/b600586c; Roman-Leshkov Y, 2006, SCIENCE, V312, P1933, DOI 10.1126/science.1126337; Srokol Z, 2004, CARBOHYD RES, V339, P1717, DOI 10.1016/j.carres.2004.04.018; Tyrlik SK, 1999, CARBOHYD RES, V315, P268, DOI 10.1016/S0008-6215(99)00037-3; Watanabe M, 2005, CARBOHYD RES, V340, P1925, DOI 10.1016/j.carres.2005.06.017; WERPY TA, 2004, DOEGO1020041992 US; Zhang ZC, 2006, ADV CATAL, V49, P153, DOI 10.1016/S0360-0564(05)49003-3	20	1663	1784	40	1262	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 15	2007	316	5831					1597	1600		10.1126/science.1141199	http://dx.doi.org/10.1126/science.1141199			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	178SH	17569858				2022-12-28	WOS:000247239900035
J	Wu, WC; Schifftner, TL; Henderson, WG; Eaton, CB; Poses, RM; Uttley, G; Sharma, SC; Vezeridis, M; Khuri, SF; Friedmann, PD				Wu, Wen-Chih; Schifftner, Tracy L.; Henderson, William G.; Eaton, Charles B.; Poses, Roy M.; Uttley, Georgette; Sharma, Satish C.; Vezeridis, Michael; Khuri, Shukri F.; Friedmann, Peter D.			Preoperative Hematocrit levels and postoperative outcomes in older patients undergoing noncardiac surgery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-ARTERY-DISEASE; RISK ADJUSTMENT; CARDIOVASCULAR-DISEASE; BLOOD-VISCOSITY; SURGICAL CARE; ANEMIA; TRANSFUSION; QUALITY; PREVALENCE; MORBIDITY	Context Elderly patients are at high risk of both abnormal hematocrit values and cardiovascular complications of noncardiac surgery. Despite nearly universal screening of patients for abnormal preoperative hematocrit levels, limited evidence demonstrates the adverse effects of preoperative anemia or polycythemia. Objective To evaluate the prevalence of preoperative anemia and polycythemia and their effects on 30-day postoperative outcomes in elderly veterans undergoing major noncardiac surgery. Design Retrospective cohort study using the VA National Surgical Quality Improvement Program database. Based on preoperative hematocrit levels, we stratified patients into standard categories of anemia ( hematocrit < 39.0%), normal hematocrit (39.0%- 53.9%), and polycythemia ( hematocrit >= 54%). We then estimated increases in 30-day postoperative cardiac event and mortality risks in relation to each hematocrit point deviation from the normal category. Setting and Patients A total of 310 311 veterans aged 65 years or older who underwent major noncardiac surgery between 1997 and 2004 in 132 Veterans' Affairs medical centers across the United States. Main Outcome Measures The primary outcome measure was 30-day postoperative mortality; a secondary outcome measure was composite 30-day postoperative mortality or cardiac events ( cardiac arrest or Q-wave myocardial infarction). Results Thirty-day mortality and cardiac event rates increased monotonically, with either positive or negative deviations from normal hematocrit levels. We found a 1.6% (95% confidence interval, 1.1%-2.2%) increase in 30-day postoperative mortality associated with every percentage-point increase or decrease in the hematocrit value from the normal range. Additional analyses suggest that the adjusted risk of 30-day postoperative mortality and cardiac morbidity begins to rise when hematocrit levels decrease to less than 39% or exceed 51%. Conclusions Even mild degrees of preoperative anemia or polycythemia were associated with an increased risk of 30-day postoperative mortality and cardiac events in older, mostly male veterans undergoing major noncardiac surgery. Future studies should determine whether these findings are reproducible in other populations and if preoperative management of anemia or polycythemia decreases the risk of postoperative mortality.	Providence Vet Affairs Med Ctr, Target Res Enhancement Program, Providence, RI USA; Mem Hosp Rhode Isl, Ctr Primary Care & Prevent, Dept Community Med, Providence, RI USA; Mem Hosp Rhode Isl, Ctr Primary Care & Prevent, Dept Med, Providence, RI USA; Providencey Vet Affairs Med Ctr, Dept Family Med, Providence, RI USA; Providencey Vet Affairs Med Ctr, Surg Serv, Providence, RI USA; Providencey Vet Affairs Med Ctr, Med Serv, Providence, RI USA; Brown Med Sch, Dept Surg, Providence, RI USA; Univ Colorado, Hlth Outcomes Program, Denver VA Med Ctr,Denver Data Anal Ctr, Natl Surg Qual Improvement Program, Denver, CO 80202 USA; Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; VA Boston Healthcare Syst, Surg Serv, Boston, MA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Providence VA Medical Center; Brown University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Denver; Harvard University; Harvard Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System	Wu, WC (corresponding author), 830 Chalkstone Ave, Providence, RI 02908 USA.	Wen-Chih.Wu@va.gov		Eaton, Charles/0000-0002-7723-9461				Androne AS, 2003, CIRCULATION, V107, P226, DOI 10.1161/01.CIR.0000052623.16194.80; [Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Blumberg M S, 1986, Med Care Rev, V43, P351, DOI 10.1177/107755878604300205; BLUMBERG MS, 1987, HEALTH SERV RES, V21, P715; BRAZIER J, 1974, SURGERY, V75, P508; Carallo C, 1998, CORONARY ARTERY DIS, V9, P113, DOI 10.1097/00019501-199809020-00008; Carson JL, 1996, LANCET, V348, P1055, DOI 10.1016/S0140-6736(96)04330-9; Centers for Disease Control and Prevention National Center for Health Statistics, 2005, VITAL HLTH STAT, V247, P1; CHAITMAN BR, 1981, CIRCULATION, V64, P360, DOI 10.1161/01.CIR.64.2.360; Daley J, 1997, J AM COLL SURGEONS, V185, P328, DOI 10.1016/S1072-7515(01)00939-5; Davis CL, 2007, J AM COLL SURGEONS, V204, P550, DOI 10.1016/j.jamcollsurg.2007.01.012; DUKE M, 1969, CIRCULATION, V39, P503, DOI 10.1161/01.CIR.39.4.503; GAGNON DR, 1994, AM HEART J, V127, P674, DOI 10.1016/0002-8703(94)90679-3; Garcia-Erce JA, 2006, TRANSFUSION MED, V16, P335, DOI 10.1111/j.1365-3148.2006.00682.x; Gibbs J, 1999, ARCH SURG-CHICAGO, V134, P36, DOI 10.1001/archsurg.134.1.36; GOLDMAN L, 1977, NEW ENGL J MED, V297, P845, DOI 10.1056/NEJM197710202971601; Goodnough LT, 1999, NEW ENGL J MED, V340, P525, DOI 10.1056/NEJM199902183400706; Goodnough LT, 2005, ANESTH ANALG, V101, P1858, DOI 10.1213/01.ANE.0000184124.29397.EB; GOUBALI A, 1995, ANGIOLOGY, V46, P719, DOI 10.1177/000331979504600811; Hees PS, 2006, J AM COLL CARDIOL, V47, P1440, DOI 10.1016/j.jacc.2005.11.052; Hoffman R, 2005, HEMATOLOGY BASIC PRI, P1209; Hogue CW, 1998, TRANSFUSION, V38, P924, DOI 10.1046/j.1537-2995.1998.381098440856.x; HUBBARD BL, 1992, ARCH INTERN MED, V152, P309, DOI 10.1001/archinte.152.2.309; JAN KM, 1977, AM J PHYSIOL, V233, pH106, DOI 10.1152/ajpheart.1977.233.1.H106; JOOSTEN E, 1992, GERONTOLOGY, V38, P111, DOI 10.1159/000213315; KERSHENOVICH S, 1992, AM HEART J, V123, P521, DOI 10.1016/0002-8703(92)90671-H; Khuri SF, 1997, J AM COLL SURGEONS, V185, P315, DOI 10.1016/S1072-7515(01)00938-3; KHURI SF, 1995, J AM COLL SURGEONS, V180, P519; LEVY PS, 1993, AM J PHYSIOL, V265, pH340, DOI 10.1152/ajpheart.1993.265.1.H340; LEVY PS, 1992, J TRAUMA, V32, P769, DOI 10.1097/00005373-199206000-00018; LOWE GDO, 1982, LANCET, V1, P472; Lubarsky D A, 1991, J Clin Anesth, V3, P99, DOI 10.1016/0952-8180(91)90004-7; MOHLER ER, 2006, WILLIAMS HEMATOLOGY, P2068; NELSON AH, 1993, CRIT CARE MED, V21, P860, DOI 10.1097/00003246-199306000-00013; *NIH CONS DEV C ST, 1988, PER RED CELL TRANSF; Olson RP, 2005, ANESTH ANALG, V101, P1337, DOI 10.1213/01.ANE.0000180836.02142.E6; PEARSON TC, 1981, CLIN ASPECTS BLOOD V, P97; PRCHAL JT, 2006, WILLIAMS HEMATOLOGY, P413; Slappendel R, 2006, ACTA ORTHOP, V77, P677, DOI 10.1080/17453670610012782; Smieja MJ, 1996, CAN MED ASSOC J, V155, P691; SPENCE RK, 1990, AM J SURG, V159, P320, DOI 10.1016/S0002-9610(05)81227-9; WANNAMETHEE G, 1994, J INTERN MED, V235, P163, DOI 10.1111/j.1365-2796.1994.tb01050.x; Weiskopf RB, 1998, JAMA-J AM MED ASSOC, V279, P217, DOI 10.1001/jama.279.3.217; WHO Scientific Group on Nutritional Anaemias & World Health Organization, 1968, NUTR AN REP WHO SCI; Wilson JD., HARRISONS PRINCIPLES, V1994, P472; Wu WC, 2001, NEW ENGL J MED, V345, P1230, DOI 10.1056/NEJMoa010615	46	382	404	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 13	2007	297	22					2481	2488		10.1001/jama.297.22.2481	http://dx.doi.org/10.1001/jama.297.22.2481			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	177TX	17565082				2022-12-28	WOS:000247176500022
J	Reinhardt, UE				Reinhardt, Uwe E.			Faith based health policy: the urge to privatise - Who owns health systems matters less than that the various enterprises are on a level playing field	BRITISH MEDICAL JOURNAL			English	Editorial Material									Princeton Univ, Princeton, NJ 08544 USA	Princeton University	Reinhardt, UE (corresponding author), Princeton Univ, Princeton, NJ 08544 USA.	reinhard@princeton.edu							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 9	2007	334	7605					1193	1193		10.1136/bmj.39237.433843.59	http://dx.doi.org/10.1136/bmj.39237.433843.59			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	179GF	17556471	Green Published			2022-12-28	WOS:000247277000029
J	von Hertzen, H; Piaggio, G; Huang, NTM; Arustamyan, K; Cabezas, E; Gomez, M; Khomassuridze, A; Shah, R; Mittal, S; Nair, R; Erdenetungalag, R; Huang, TM; Vy, ND; Phuong, NTN; Tuyet, HTD; Peregoudov, A				von Hertzen, Helena; Piaggio, Gilda; Huang, Nguyen Thi My; Arustamyan, Karine; Cabezas, Evelio; Gomez, Manuel; Khomassuridze, Archil; Shah, Rashmi; Mittal, Suneeta; Nair, Rajasekharan; Erdenetungalag, Radnaabazar; Huang, To Minh; Vy, Nguyen Duc; Phuong, Nguyen Thi Ngoc; Tuyet, Hoang Thi Diem; Peregoudov, Alexandre		WHO Res Grp Postovulatory Methods	Efficacy of two intervals and two routes of administration of misoprostol for termination of early pregnancy: a randomised controlled equivalence trial	LANCET			English	Article							EARLY MEDICAL ABORTION; VAGINAL MISOPROSTOL; UTERINE CONTRACTILITY; MIFEPRISTONE; GESTATION; REGIMENS	Background The most effective route and best interval between several doses of misoprostol to induce abortion have not been defined. Our aim was to assess the effects of the interval between multiple doses of misoprostol and the route of administration to terminate pregnancy. Methods 2066 healthy pregnant women requesting medical abortion with 63 days or less of gestation were randomly assigned within 11 gynaecological centres in six countries to the four treatment groups (three doses of 0.8 mg misoprostol given sublingually at 3-h intervals, vaginally 3 h, sublingually 12 h, and vaginally 12 h), stratifying by gestational age. This was an equivalence trial with a 5% margin of equivalence. The primary endpoints were efficacy of treatment to achieve complete abortion and to terminate pregnancy. The main efficacy analysis excluded women lost to follow-up. This trial is registered as an International Standard Randomised Controlled Trial, number ISRCTN10531821. Findings Efficacy outcomes were analysed for 2046 women (99%), excluding 20 lost to follow-up. Complete abortion rates at 2-week follow-up were recorded for 431 (84%) in the sublingual and for 434 (85%) women in the vaginal group when misoprostol was given at 3-h intervals (difference 0.4%, 95% CI -4.0 to 4.9, p=0.85 equivalence shown), and for 399 (78%) in the sublingual and for 425 (83%) in the vaginal 12-h groups (4.6%, -0.2 to 9.5, p=0.06, equivalence not shown). In the 3-h groups, pregnancy continued in 29 (6%) women after sublingual. and in 20 (4%) women after vaginal administration. (difference 1.8%, 95% CI -0.8 to 4.4, p=0.19, equivalence shown); in the 12-h groups it continued in 47 (9%) after sublingual and in 25 (5%) after vaginal administration (4.4%, 1.2-7.5, p=0.01, vaginal better than sublingual). Differences for complete abortion between intervals for sublingual and vaginal routes were 6% (95% CI 1.0-10.6, p=0.02, 3 h better than 12 h) and 2% (-2.9 to 6.1, p=0.49, equivalence not shown), respectively; for continuing pregnancies they were 4% (0-4-6.8, p=0.03, 3 h better than 12 h) and 1% (-1.5 to 3.5, p=0.44, equivalence shown), respectively. Interpretation Administration interval can be chosen between 3 h and 12 h when misoprostol is given vaginally. If administration is sublingual, the intervals between misoprostol doses need to be short, but side-effects are then increased. With 12-h intervals, vaginal route should be used, whereas with 3-h intervals either route could be chosen.	WHO, UNFPA,World Bank, Special Programme Res Dev & Res Training Human Re, Dept Reprod Hlth & Res, CH-1211 Geneva 27, Switzerland; Res Ctr Maternal & Child Hlth Protect, Yerevan, Armenia; Hosp Docente Gineco Obstet, Havana, Cuba; Hosp Cmdte Fajardo, Natl Inst Endocrinol, Havana, Cuba; Zhordania Inst Human Reprod, Tbilisi, Georgia; Indian Council Med Res, Natl Inst Res Reprod Hlth, Bombay, Maharashtra, India; All India Inst Med Sci, New Delhi, India; SAT Hosp, Coll Med, Trivandrum, Kerala, India; State Res Ctr MCH & Human Reprod, Ulaanbaatar, Mongolia; Hanoi Obstet & Gynaecol Hosp, Hanoi, Vietnam; Int Protect Mother & Newborn, Hanoi, Vietnam; Tu Du Hosp, Ho Chi Minh City, Vietnam	The World Bank; United Nations Population Fund; World Health Organization; Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Reproductive Health (NIRRH); All India Institute of Medical Sciences (AIIMS) New Delhi	von Hertzen, H (corresponding author), WHO, UNFPA,World Bank, Special Programme Res Dev & Res Training Human Re, Dept Reprod Hlth & Res, CH-1211 Geneva 27, Switzerland.	vonhertzenh@who.int						Aronsson A, 2004, HUM REPROD, V19, P81, DOI 10.1093/humrep/deh005; Ashok PW, 2002, BJOG-INT J OBSTET GY, V109, P1281, DOI 10.1016/S1470-0328(02)02956-7; Blanchard K, 2005, CONTRACEPTION, V72, P91, DOI 10.1016/j.contraception.2005.02.008; Creinin MD, 1999, CONTRACEPTION, V59, P11, DOI 10.1016/S0010-7824(98)00142-5; GEMZELLDANIELSS.K, 1999, OBSTET GYNECOL, V93, P275; Honkanen H, 2004, BJOG-INT J OBSTET GY, V111, P715, DOI 10.1111/j.1471-0528.2004.00153.x; Jain JK, 2002, HUM REPROD, V17, P1477, DOI 10.1093/humrep/17.6.1477; KOTSONIS FN, 1985, DIGEST DIS SCI, V30, pS142, DOI 10.1007/BF01309401; Ngai SW, 2000, HUM REPROD, V15, P1159, DOI 10.1093/humrep/15.5.1159; NORMAN JE, 1991, LANCET, V338, P1233, DOI 10.1016/0140-6736(91)92102-8; Pastuszak AL, 1998, NEW ENGL J MED, V338, P1881, DOI 10.1056/NEJM199806253382604; Piaggio G, 2006, JAMA-J AM MED ASSOC, V295, P1152, DOI 10.1001/jama.295.10.1152; Singh K, 1999, OBSTET GYNECOL, V94, P431, DOI 10.1016/S0029-7844(99)00272-0; SWAHN ML, 1990, BAILLIERE CLIN OB GY, V4, P293, DOI 10.1016/S0950-3552(05)80228-7; Tang OS, 2002, HUM REPROD, V17, P654, DOI 10.1093/humrep/17.3.654; von Hertzen H, 2003, BJOG-INT J OBSTET GY, V110, P808, DOI 10.1016/S1470-0328(03)02430-3; Wu YM, 2000, BRIT J OBSTET GYNAEC, V107, P524; 2003, EXP M MIS SPONS REPR	18	71	71	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 9	2007	369	9577					1938	1946		10.1016/S0140-6736(07)60914-3	http://dx.doi.org/10.1016/S0140-6736(07)60914-3			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	177IQ	17560446				2022-12-28	WOS:000247147200027
J	Krimsky, S; Simoncelli, T				Krimsky, Sheldon; Simoncelli, Tania			Testing pesticides in humans - Of mice and men divided by ten	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Columbia Univ, Ctr Hist & Eth Publ Hlth, Dept Sociomed Sci, Mailman Sch Publ Hlth, New York, NY 10032 USA; Amer Civil Liberties Union, Tech Liberty Program, New York, NY USA	Columbia University	Krimsky, S (corresponding author), Columbia Univ, Ctr Hist & Eth Publ Hlth, Dept Sociomed Sci, Mailman Sch Publ Hlth, 722 W 168th St, New York, NY 10032 USA.	sheldon.krimsky@tufts.edu	Krimsky, Sheldon/F-3147-2010					CAIN WS, 2005, HUMAN SENSORY IRRITA; Committee on International Human Rights of the Association of the Bar of the City of New York and The Center for Human Rights and Global Justice New York University School of Law, 2004, INT HUM DOS STUD EPA, P4; Gostin LO, 2007, JAMA-J AM MED ASSOC, V297, P737, DOI 10.1001/jama.297.7.737; Lockwood AH, 2004, AM J PUBLIC HEALTH, V94, P1908, DOI 10.2105/AJPH.94.11.1908; NEEDLEMAN H, 2000, COMMENTS USE DATA TE, pC1; Needleman HL, 2005, ENVIRON HEALTH PERSP, V113, pA804, DOI 10.1289/ehp.113-a804; Oleskey C, 2004, ENVIRON HEALTH PERSP, V112, P914, DOI 10.1289/ehp.6522; Resnik David B, 2007, Account Res, V14, P35, DOI 10.1080/08989620601122842; Resnik DB, 2007, AM J PUBLIC HEALTH, V97, P414, DOI 10.2105/AJPH.2005.081729; World Medical Association, DECL HELS ETH PRINC; 2006, FED REG, V71, P6137	11	5	5	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 6	2007	297	21					2405	2407		10.1001/jama.297.21.2405	http://dx.doi.org/10.1001/jama.297.21.2405			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	175IL	17551133				2022-12-28	WOS:000247007200022
J	Hawkes, N				Hawkes, Nigel			Independence day	BRITISH MEDICAL JOURNAL			English	Article												nigel.hawkes@thetimes.co.uk						APPLEBY J, 2007, CARE HLTH; *BRIT MED ASS, 2007, RAT WAY FORW NHS ENG; GLASBY J, 2007, THINGS CAN ONLY GET; GRICE A, 2006, INDEPENDENT     0925, P4; LANSLEY A, 2006, COMMUNICATION   1009; *NUFF TRUST, 2007, IND NHS REV OPT; REVILL J, 2007, OBSERVER        0506, P21; 2007, HLTH SERVICE J  0503, P7	8	1	1	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUN 2	2007	334	7604					1136	1138		10.1136/bmj.39223.746042.59	http://dx.doi.org/10.1136/bmj.39223.746042.59			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	177ES	17540940	Green Published			2022-12-28	WOS:000247137000025
J	Gupta, S; Ramjaun, AR; Haiko, P; Wang, YH; Warne, PH; Nicke, B; Nye, E; Stamp, G; Alitalo, K; Downward, J				Gupta, Surbhi; Ramjaun, Antoine R.; Haiko, Paula; Wang, Yihua; Warne, Patricia H.; Nicke, Barbara; Nye, Emma; Stamp, Gordon; Alitalo, Kari; Downward, Julian			Binding of Ras to phosphoinositide 3-kinase p110 alpha is required for Ras-driven tumorigenesis in mice	CELL			English	Article							PROTEIN-KINASE B; GROWTH-FACTOR; PHOSPHATIDYLINOSITOL 3-KINASE; VEGF RECEPTOR-3; ACTIVATION; TRANSFORMATION; CANCER; INHIBITION; DROSOPHILA; DEFICIENT	Ras proteins signal through direct interaction with a number of effector enzymes, including type I phosphoinositide (PI) 3-kinases. Although the ability of Ras to control PI 3-kinase has been well established in manipulated cell culture models, evidence for a role of the interaction of endogenous Ras with PI 3-kinase in normal and malignant cell growth in vivo has been lacking. Here we generate mice with mutations in the Pi3kca gene encoding the catalytic p110 alpha isoform that block its interaction with Ras. Cells from these mice show proliferative defects and selective disruption of signaling from growth factors to PI 3-kinase. The mice display defective development of the lymphatic vasculature, resulting in perinatal appearance of chylous ascites. Most importantly, they are highly resistant to endogenous Ras oncogene-induced tumorigenesis. The interaction of Ras with p110 alpha is thus required in vivo for certain normal growth factor signaling and for Ras-driven tumor formation.	Canc Res UK, London Res Inst, Signal Transduct Lab, London WC2A 3PX, England; Canc Res UK, London Res Inst, Expt Pathol Lab, London WC2A 3PX, England; Univ Helsinki, Biomedicum Helsinki, FIN-00014 Helsinki, Finland	Cancer Research UK; Cancer Research UK; University of Helsinki	Downward, J (corresponding author), Canc Res UK, London Res Inst, Signal Transduct Lab, 44 Lincolns Inn Fields, London WC2A 3PX, England.	downward@cancer.org.uk	Downward, Julian/A-3251-2012; Alitalo, Kari K/J-5013-2014	Alitalo, Kari K/0000-0002-7331-0902; Wang, Yihua/0000-0001-5561-0648; Downward, Julian/0000-0002-2331-4729				Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Bai YF, 2004, CANCER RES, V64, P8808, DOI 10.1158/0008-5472.CAN-04-3143; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Cully M, 2006, NAT REV CANCER, V6, P184, DOI 10.1038/nrc1819; Dajee M, 2002, ONCOGENE, V21, P1527, DOI 10.1038/sj.onc.1205287; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Dumont DJ, 1998, SCIENCE, V282, P946, DOI 10.1126/science.282.5390.946; Foukas LC, 2006, NATURE, V441, P366, DOI 10.1038/nature04694; Fruman DA, 2000, NAT GENET, V26, P379, DOI 10.1038/81715; Gale NW, 2002, DEV CELL, V3, P411, DOI 10.1016/S1534-5807(02)00217-4; Gonzalez-Garcia A, 2005, CANCER CELL, V7, P219, DOI 10.1016/j.ccr.2005.01.029; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Joukov V, 1996, EMBO J, V15, P1751; KAIPAINEN A, 1995, P NATL ACAD SCI USA, V92, P3566, DOI 10.1073/pnas.92.8.3566; Karkkainen MJ, 2004, NAT IMMUNOL, V5, P74, DOI 10.1038/ni1013; KAZLAUSKAS A, 1989, CELL, V58, P1121, DOI 10.1016/0092-8674(89)90510-2; Makinen T, 2001, EMBO J, V20, P4762, DOI 10.1093/emboj/20.17.4762; Makinen T, 2001, NAT MED, V7, P199, DOI 10.1038/84651; Malliri A, 2002, NATURE, V417, P867, DOI 10.1038/nature00848; Mattoon DR, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-24; Nakahara R, 2001, THORAX, V56, P302, DOI 10.1136/thorax.56.4.302; Ong SH, 2001, P NATL ACAD SCI USA, V98, P6074, DOI 10.1073/pnas.111114298; Orme MH, 2006, NAT CELL BIOL, V8, P1298, DOI 10.1038/ncb1493; Pacold ME, 2000, CELL, V103, P931, DOI 10.1016/S0092-8674(00)00196-3; PRESS OW, 1982, ANN INTERN MED, V96, P358, DOI 10.7326/0003-4819-96-3-358; Prober DA, 2002, GENE DEV, V16, P2286, DOI 10.1101/gad.991102; QUINTANILLA M, 1986, NATURE, V322, P78, DOI 10.1038/322078a0; Repasky GA, 2004, TRENDS CELL BIOL, V14, P639, DOI 10.1016/j.tcb.2004.09.014; RodriguezViciana P, 1997, CELL, V89, P457, DOI 10.1016/S0092-8674(00)80226-3; RODRIGUEZVICIANA P, 1994, NATURE, V370, P527, DOI 10.1038/370527a0; RodriguezViciana P, 1996, EMBO J, V15, P2442, DOI 10.1002/j.1460-2075.1996.tb00602.x; Saharinen P, 2004, TRENDS IMMUNOL, V25, P387, DOI 10.1016/j.it.2004.05.003; Schulze A, 2001, GENE DEV, V15, P981, DOI 10.1101/gad.191101; SOLTOFF SP, 1994, MOL CELL BIOL, V14, P3550, DOI 10.1128/MCB.14.6.3550; Suire S, 2002, CURR BIOL, V12, P1068, DOI 10.1016/S0960-9822(02)00933-8; Suire S, 2006, NAT CELL BIOL, V8, P1303, DOI 10.1038/ncb1494; van Weering DHJ, 1998, MOL CELL BIOL, V18, P1802, DOI 10.1128/MCB.18.4.1802; Vanhaesebroeck B, 1999, EXP CELL RES, V253, P239, DOI 10.1006/excr.1999.4701; Vanhaesebroeck B, 2005, TRENDS BIOCHEM SCI, V30, P194, DOI 10.1016/j.tibs.2005.02.008; Weir B, 2004, CANCER CELL, V6, P433, DOI 10.1016/j.ccr.2004.11.004; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; WHITMAN M, 1985, NATURE, V315, P239, DOI 10.1038/315239a0; Zhao JJ, 2006, P NATL ACAD SCI USA, V103, P16296, DOI 10.1073/pnas.0607899103	43	434	445	0	14	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 1	2007	129	5					957	968		10.1016/j.cell.2007.03.051	http://dx.doi.org/10.1016/j.cell.2007.03.051			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	176KT	17540175	Bronze			2022-12-28	WOS:000247084600015
J	Dutt, MVG; Childress, L; Jiang, L; Togan, E; Maze, J; Jelezko, F; Zibrov, AS; Hemmer, PR; Lukin, MD				Gurudev Dutt, M. V.; Childress, L.; Jiang, L.; Togan, E.; Maze, J.; Jelezko, F.; Zibrov, A. S.; Hemmer, P. R.; Lukin, M. D.			Quantum register based on individual electronic and nuclear spin qubits in diamond	SCIENCE			English	Article							ENTANGLEMENT; COMPUTATION; ATOM	The key challenge in experimental quantum information science is to identify isolated quantum mechanical systems with long coherence times that can be manipulated and coupled together in a scalable fashion. We describe the coherent manipulation of an individual electron spin and nearby individual nuclear spins to create a controllable quantum register. Using optical and microwave radiation to control an electron spin associated with the nitrogen vacancy (NV) color center in diamond, we demonstrated robust initialization of electron and nuclear spin quantum bits (qubits) and transfer of arbitrary quantum states between them at room temperature. Moreover, nuclear spin qubits could be well isolated from the electron spin, even during optical polarization and measurement of the electronic state. Finally, coherent interactions between individual nuclear spin qubits were observed and their excellent coherence properties were demonstrated. These registers can be used as a basis for scalable, optically coupled quantum information systems.	Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; Univ Stuttgart, Inst Phys, D-70550 Stuttgart, Germany; Texas A&M Univ, Dept Elect & Comp Engn, College Stn, TX 77843 USA	Harvard University; University of Stuttgart; Texas A&M University System; Texas A&M University College Station	Lukin, MD (corresponding author), Harvard Univ, Dept Phys, Cambridge, MA 02138 USA.	lukin@fas.harvard.edu	Jiang, Liang/GVU-8654-2022; Dutt, Gurudev/B-2889-2009; Zibrov, Alexander S/G-7419-2014; Jiang, Liang/A-9847-2008; Childress, Lilian/H-1359-2012; Maze, Jeronimo/E-7422-2013	Jiang, Liang/0000-0002-0000-9342; Jiang, Liang/0000-0002-0000-9342; Childress, Lilian/0000-0002-0507-6392; Maze, Jeronimo/0000-0003-0751-9182; Dutt, Gurudev/0000-0001-7426-9246				Benjamin SC, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/8/141; Blinov BB, 2004, NATURE, V428, P153, DOI 10.1038/nature02377; Briegel HJ, 1998, PHYS REV LETT, V81, P5932, DOI 10.1103/PhysRevLett.81.5932; Childress L, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.070504; Childress L, 2006, SCIENCE, V314, P281, DOI 10.1126/science.1131871; Cirac JI, 1997, PHYS REV LETT, V78, P3221, DOI 10.1103/PhysRevLett.78.3221; Duan LM, 2004, QUANTUM INF COMPUT, V4, P165; Epstein RJ, 2005, NAT PHYS, V1, P94, DOI 10.1038/nphys141; Gaebel T, 2006, NAT PHYS, V2, P408, DOI 10.1038/nphys318; Haffner H, 2005, NATURE, V438, P643, DOI 10.1038/nature04279; Hanson R, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.087601; Jelezko F, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.130501; Jelezko F, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.076401; Kane BE, 1998, NATURE, V393, P133, DOI 10.1038/30156; Koppens FHL, 2006, NATURE, V442, P766, DOI 10.1038/nature05065; Leibfried D, 2005, NATURE, V438, P639, DOI 10.1038/nature04251; Lukin MD, 2000, PHYS REV LETT, V84, P2818, DOI 10.1103/PhysRevLett.84.2818; MASSAR S, 1995, PHYS REV LETT, V74, P1259, DOI 10.1103/PhysRevLett.74.1259; Negrevergne C, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.170501; Petta JR, 2005, SCIENCE, V309, P2180, DOI 10.1126/science.1116955; Rabeau JR, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2158700; Santori C, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.247401; Steane AM, 2000, FORTSCHR PHYS, V48, P839, DOI 10.1002/1521-3978(200009)48:9/11<839::AID-PROP839>3.0.CO;2-V; Tamarat P, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.083002; van Loock P, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.240501; Vandersypen LMK, 2004, REV MOD PHYS, V76, P1037, DOI 10.1103/RevModPhys.76.1037; Wrachtrup J, 2001, OPT SPECTROSC+, V91, P429, DOI 10.1134/1.1405224	28	934	957	12	392	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 1	2007	316	5829					1312	1316		10.1126/science.1139831	http://dx.doi.org/10.1126/science.1139831			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173PS	17540898				2022-12-28	WOS:000246885600043
J	Deyo, RA				Deyo, Richard A.			Focus on research - Back surgery - Who needs it?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Washington, Dept Med, Seattle, WA 98195 USA; Univ Washington, Dept Hlth Serv, Seattle, WA USA; Univ Washington, Ctr Cost & Outcomes Res, Seattle, WA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Deyo, RA (corresponding author), Univ Washington, Dept Med, Seattle, WA 98195 USA.							Deyo RA, 2000, MED CARE, V38, P959, DOI 10.1097/00005650-200009000-00009; Deyo RA, 2004, NEW ENGL J MED, V350, P722, DOI 10.1056/NEJMsb031771; Gray DT, 2006, SPINE, V31, P1957, DOI 10.1097/01.brs.0000229148.63418.c1; Healthcare Cost and Utilization Project, HEALTHC COST UT PROJ; Vroomen PCAJ, 2002, BRIT J GEN PRACT, V52, P119	5	87	96	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 31	2007	356	22					2239	2243		10.1056/NEJMp078052	http://dx.doi.org/10.1056/NEJMp078052			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	172PO	17538083				2022-12-28	WOS:000246816500003
J	Andang'o, PEA; Osendarp, SJM; Ayah, R; West, CE; Mwaniki, DL; De Wolf, CA; Kraaijenhagen, R; Kok, FJ; Verhoef, H				Andang'o, Pauline E. A.; Osendarp, Saskia J. M.; Ayah, Rosemary; West, Clive E.; Mwaniki, David L.; De Wolf, Corine A.; Kraaijenhagen, Rob; Kok, Frans J.; Verhoef, Hans			Efficacy of iron-fortified whole maize flour on iron status of schoolchildren in Kenya: a randomised controlled trial	LANCET			English	Article							PLASMODIUM-FALCIPARUM MALARIA; EDTA NAFE(III)EDTA; FOOD FORTIFICANT; MISSING VALUES; ELEMENTAL IRON; CURRY POWDER; RAPID TESTS; WHEAT; SUPPLEMENTATION; BIOAVAILABILITY	Background Sodium iron edetic acid (NaFeEDTA) might be a more bioavailable source of iron than electrolytic iron, when added to maize flour. We aimed to assess the effect, on children's iron status, of consumption of whole maize flour fortified with iron as NaFeEDTA or electrolytic iron. Methods 516 children, aged 3-8 years, from four schools in Marafa, Kenya, were randomly assigned to four groups. All were given the same amount of porridge five times a week. The porridge for one group was made from unfortified whole maize flour; for the other three groups it was fortified with either high-dose NaFeEDTA (56 mg/kg), low-dose NaFeEDTA (28 mg/kg), or electrolytic iron (56 mg/kg). Concentrations of haemoglobin, plasma ferritin, and transferrin receptor were analysed in samples taken at baseline and at the end of the 5-month intervention. The primary outcome was iron-deficiency anaemia. We analysed data on an intention-to-treat basis. This trial is registered with ClinicalTrials.gov, number NCT00386074. Findings The prevalence of iron-deficiency anaemia in children given unfortified flour was 10%. Compared with placebo, the prevalence of iron-deficiency anaemia in children given flour fortified with high-dose NaFeEDTA, low-dose NaFeEDTA, and electrolytic iron changed by -89% (95% CI -97% to -49%), -48% (-77% to 20%), and 59% (-18% to 209%), respectively. Consumption of high-dose NaFeEDTA improved all measured iron-status indicators. Low-dose NaFeEDTA decreased the prevalence of iron deficiency but did not noticeably change the prevalence of anaemia. Electrolytic iron did not improve any of these iron-status indicators. Children who were iron-deficient at baseline benefited more from high-dose and low-dose NaFeEDTA than those with sufficient iron at baseline. Interpretation Consumption of whole maize flour fortified with NaFeEDTA caused modest, dose-dependent improvements in children's iron status. Fortification with electrolytic iron did not improve their iron status. Therefore, in high-phytate flours, NaFeEDTA is more suitable than electrolytic iron for supplementation of iron in the diet.	Kenya Govt Med Res Ctr, Ctr Publ Hlth Res, Nairobi, Kenya; Univ Wageningen & Res Ctr, Div Human Nutr, NL-6700 HB Wageningen, Netherlands; Unilever Food & Hlth Res Inst, Vlaardingen, Netherlands; Akzo Nobel Chem, Arnhem, Netherlands; Meander Med Ctr, Amersfoort, Netherlands; Univ Wageningen & Res Ctr, Cell Biol & Immunol Grp, NL-6700 HB Wageningen, Netherlands	Kenya Medical Research Institute; Wageningen University & Research; Unilever; AkzoNobel; Meander Medisch Centrum; Wageningen University & Research	Andang'o, PEA (corresponding author), Univ Wageningen & Res Ctr, Div Human Nutr Bode 62, POB 8129, NL-6700 EV Wageningen, Netherlands.	pauline.andango@wur.nl	Verhoef, Hans/AGD-5388-2022; Verhoef, Hans/L-3024-2015	Verhoef, Hans/0000-0002-9346-9689				BALLOT DE, 1989, AM J CLIN NUTR, V49, P162, DOI 10.1093/ajcn/49.1.162; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Davidsson L, 2005, AM J CLIN NUTR, V81, P104; Davidsson L, 2002, AM J CLIN NUTR, V75, P535, DOI 10.1093/ajcn/75.3.535; DAVIDSSON L, 1994, AM J CLIN NUTR, V60, P231, DOI 10.1093/ajcn/60.2.231; Feil B., 2001, Journal of New Seeds, V3, P1, DOI 10.1300/J153v03n03_01; Ganz T, 2002, ISRAEL MED ASSOC J, V4, P1043; GARBY L, 1974, ANN TROP MED PARASIT, V68, P467, DOI 10.1080/00034983.1974.11686972; Guthmann JP, 2002, T ROY SOC TROP MED H, V96, P254, DOI 10.1016/S0035-9203(02)90091-X; Hallberg L, 2001, ANNU REV NUTR, V21, P1, DOI 10.1146/annurev.nutr.21.1.1; Hallberg L, 2000, EUR J CLIN NUTR, V54, P650, DOI 10.1038/sj.ejcn.1601069; Huo JS, 2002, ASIA PAC J CLIN NUTR, V11, P123, DOI 10.1046/j.1440-6047.2002.00277.x; Hurrell R, 2002, NUTR REV, V60, P391, DOI 10.1301/002966402320964061; Hurrell R, 2002, NUTR REV, V60, pS7, DOI 10.1301/002966402320285137; Hurrell RF, 2000, BRIT J NUTR, V84, P903; International Nutritional Anemia Consultative Group, 1993, IR EDTA FOOD FORT; LAMPARELLI RD, 1987, AM J CLIN NUTR, V46, P335, DOI 10.1093/ajcn/46.2.335; LEE J, 1993, BRIT J IND MED, V50, P861; LEE J, 1995, INT J EPIDEMIOL, V24, P1066, DOI 10.1093/ije/24.5.1066; Liu YT, 2000, BRIT J HAEMATOL, V108, P295; Mboera LEG, 2006, ANN TROP MED PARASIT, V100, P115, DOI 10.1179/136485906X78571; MBOGO CNM, 1993, AM J TROP MED HYG, V49, P245, DOI 10.4269/ajtmh.1993.49.245; Nemeth E, 2006, ANNU REV NUTR, V26, P323, DOI 10.1146/annurev.nutr.26.061505.111303; Nestel P, 2004, INT J VITAM NUTR RES, V74, P35, DOI 10.1024/0300-9831.74.1.35; PHILAR R, 2005, SMALL SCALE MILL FOR; Sazawal S, 2006, LANCET, V367, P133, DOI 10.1016/S0140-6736(06)67962-2; SWENERTON H, 1971, SCIENCE, V173, P62, DOI 10.1126/science.173.3991.62; UNICEF and Micronutrient Initiative, 2004, VIT MIN DEF GLOB PRO; Unnebrink K, 2001, STAT MED, V20, P3931, DOI 10.1002/sim.1149; Van den Broek I, 2006, AM J TROP MED HYG, V75, P1209, DOI 10.4269/ajtmh.2006.75.1209; van der Heijden GJMG, 2006, J CLIN EPIDEMIOL, V59, P1102, DOI 10.1016/j.jclinepi.2006.01.015; WHO, 2001, IRON DEFICIENCY ANAE; Wieringa FT, 2002, J NUTR, V132, P3061, DOI 10.1093/jn/131.10.3061; Zimmermann MB, 2005, AM J CLIN NUTR, V82, P1276, DOI 10.1093/ajcn/82.6.1276	34	87	91	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 26	2007	369	9575					1799	1806		10.1016/S0140-6736(07)60817-4	http://dx.doi.org/10.1016/S0140-6736(07)60817-4			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	172QP	17531887	Green Submitted			2022-12-28	WOS:000246819300030
J	Reik, W				Reik, Wolf			Stability and flexibility of epigenetic gene regulation in mammalian development	NATURE			English	Review							REPRESSIVE HISTONE METHYLATION; PRIMORDIAL GERM-CELLS; EMBRYONIC STEM-CELLS; EARLY MOUSE EMBRYO; DNA METHYLATION; X-CHROMOSOME; ARGININE METHYLATION; PATERNAL GENOME; CLONED EMBRYOS; CHROMATIN	During development, cells start in a pluripotent state, from which they can differentiate into many cell types, and progressively develop a narrower potential. Their gene-expression programmes become more defined, restricted and, potentially, 'locked in'. Pluripotent stem cells express genes that encode a set of core transcription factors, while genes that are required later in development are repressed by histone marks, which confer short-term, and therefore flexible, epigenetic silencing. By contrast, the methylation of DNA confers long-term epigenetic silencing of particular sequences - transposons, imprinted genes and pluripotency-associated genes - in somatic cells. Long-term silencing can be reprogrammed by demethylation of DNA, and this process might involve DNA repair. It is not known whether any of the epigenetic marks has a primary role in determining cell and lineage commitment during development.	Babraham Inst, Lab Dev Genet & Imprinting, Cambridge CB22 3AT, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Reik, W (corresponding author), Babraham Inst, Lab Dev Genet & Imprinting, Cambridge CB22 3AT, England.	wolf.reik@bbsrc.ac.uk	jia, xu/A-8386-2016; Reik, Wolf/I-6794-2012	Reik, Wolf/0000-0003-0216-9881	MRC [G0200227] Funding Source: UKRI; Medical Research Council [G0200227] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Allis CD, 2007, EPIGENETICS; Ancelin K, 2006, NAT CELL BIOL, V8, P623, DOI 10.1038/ncb1413; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; BARLOW DP, 1993, SCIENCE, V260, P309, DOI 10.1126/science.8469984; Barreto G, 2007, NATURE, V445, P671, DOI 10.1038/nature05515; Bean CJ, 2004, NAT GENET, V36, P100, DOI 10.1038/ng1283; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Blewitt ME, 2006, PLOS GENET, V2, P399, DOI 10.1371/journal.pgen.0020049; Boiani M, 2002, GENE DEV, V16, P1209, DOI 10.1101/gad.966002; Bourc'his D, 2001, SCIENCE, V294, P2536, DOI 10.1126/science.1065848; Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Chaumeil J, 2006, GENE DEV, V20, P2223, DOI 10.1101/gad.380906; Dean W, 2001, P NATL ACAD SCI USA, V98, P13734, DOI 10.1073/pnas.241522698; Feldman N, 2006, NAT CELL BIOL, V8, P188, DOI 10.1038/ncb1353; Gehring M, 2006, CELL, V124, P495, DOI 10.1016/j.cell.2005.12.034; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; Heard E, 2006, GENE DEV, V20, P1848, DOI 10.1101/gad.1422906; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Howell CY, 2001, CELL, V104, P829, DOI 10.1016/S0092-8674(01)00280-X; Imamura M, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-34; Jelinic P, 2006, PLOS BIOL, V4, P1910, DOI 10.1371/journal.pbio.0040355; Kanduri C, 2006, EMBO J, V25, P2096, DOI 10.1038/sj.emboj.7601090; Kaneda M, 2004, NATURE, V429, P900, DOI 10.1038/nature02633; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Kohlmaier A, 2004, PLOS BIOL, V2, P991, DOI 10.1371/journal.pbio.0020171; Kurukuti S, 2006, P NATL ACAD SCI USA, V103, P10684, DOI 10.1073/pnas.0600326103; Lane N, 2003, GENESIS, V35, P88, DOI 10.1002/gene.10168; Lee J, 2002, DEVELOPMENT, V129, P1807; Lewis A, 2004, NAT GENET, V36, P1291, DOI 10.1038/ng1468; Lewis A, 2006, DEVELOPMENT, V133, P4203, DOI 10.1242/dev.02612; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; Maatouk DM, 2006, DEVELOPMENT, V133, P3411, DOI 10.1242/dev.02500; Mak W, 2004, SCIENCE, V303, P666, DOI 10.1126/science.1092674; Mancini-DiNardo D, 2006, GENE DEV, V20, P1268, DOI 10.1101/gad.1416906; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; Morales-Ruiz T, 2006, P NATL ACAD SCI USA, V103, P6853, DOI 10.1073/pnas.0601109103; Morgan HD, 2005, HUM MOL GENET, V14, pR47, DOI 10.1093/hmg/ddi114; Morgan HD, 2004, J BIOL CHEM, V279, P52353, DOI 10.1074/jbc.M407695200; Nakamura Y, 2006, ATHEROSCLEROSIS SUPP, V7, P64, DOI 10.1016/S1567-5688(06)80218-7; Namekawa SH, 2006, CURR BIOL, V16, P660, DOI 10.1016/j.cub.2006.01.066; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Okamoto I, 2005, NATURE, V438, P369, DOI 10.1038/nature04155; Okamoto I, 2004, SCIENCE, V303, P644, DOI 10.1126/science.1092727; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; Reik W, 2001, NAT GENET, V27, P255, DOI 10.1038/85804; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Rossant J, 2004, SEMIN CELL DEV BIOL, V15, P573, DOI 10.1016/j.semcdb.2004.04.003; Sado T, 2000, DEV BIOL, V225, P294, DOI 10.1006/dbio.2000.9823; Santos F, 2002, DEV BIOL, V241, P172, DOI 10.1006/dbio.2001.0501; Seki Y, 2005, DEV BIOL, V278, P440, DOI 10.1016/j.ydbio.2004.11.025; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Sleutels F, 2002, NATURE, V415, P810, DOI 10.1038/415810a; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; SURANI A, 2007, EPIGENETICS, P315; Surani MA, 2007, CELL, V128, P747, DOI 10.1016/j.cell.2007.02.010; Szutorisz H, 2005, MOL CELL BIOL, V25, P1804, DOI 10.1128/MCB.25.5.1804-1820.2005; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Torres-Padilla ME, 2007, NATURE, V445, P214, DOI 10.1038/nature05458; Turner BM, 2007, NAT CELL BIOL, V9, P2, DOI 10.1038/ncb0107-2; Umlauf D, 2004, NAT GENET, V36, P1296, DOI 10.1038/ng1467; Verona RI, 2003, ANNU REV CELL DEV BI, V19, P237, DOI 10.1146/annurev.cellbio.19.111401.092717; Whitelaw NC, 2006, HUM MOL GENET, V15, pR131, DOI 10.1093/hmg/ddl200; Yang XZ, 2007, NAT GENET, V39, P295, DOI 10.1038/ng1973	67	1405	1474	3	229	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 24	2007	447	7143					425	432		10.1038/nature05918	http://dx.doi.org/10.1038/nature05918			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170VA	17522676				2022-12-28	WOS:000246693100038
J	Beral, V; Bull, D; Green, J; Reeves, G				Beral, Valerie; Bull, Diana; Green, Jane; Reeves, Gillian		Million Women Study Collaborators	Ovarian cancer and hormone replacement therapy in the Million Women Study	LANCET			English	Article							NONCONTRACEPTIVE ESTROGEN USE; RISK; HEALTH	Background Ovarian cancer is the fourth most common cancer in women in the UK, with about 6700 developing the malignancy and 4600 dying from it every year. However, there is limited information about the risk of ovarian cancer associated with the use of hormone replacement therapy (HRT). Methods 948 576 postmenopausal women from the UK Million Women Study who did not have previous cancer or bilateral oophorectomy were followed-up for an average of 5.3 years for incident ovarian cancer and 6.9 years for death. Information on HRT use was obtained at recruitment and updated where possible. Relative risks for ovarian cancer were calculated, stratified by age and hysterectomy status, and adjusted by area of residence, socioeconomic group, time since menopause, parity; body-mass index, alcohol consumption, and use of oral contraceptives. Findings When they last reported HRT use, 287143 women (30%) were current users and 186 751 (20%) were past users. During follow-up, 2273 incident ovarian cancers and 15 91 deaths from the malignancy were recorded. Current users were significantly more likely to develop and die from ovarian cancer than never users (relative risk 1.20 [95% Cl 1.09-1.32; p=0.0002] for incident disease and 1.23 [1.09-1.38; p=0.0006] for death). For current users of HRT incidence of ovarian cancer increased with increasing duration of use, but did not differ significantly by type of preparation used, its constituents, or mode of administration. Risks associated with HRT varied significantly according to tumour histology (p < 0.0001), and in women with epithelial tumours the relative risk for current versus never use of HRT was greater for serous than for mucinous, endometroid, or clear cell tumours (1.53 [1.31-1.79], 0.72 [0.52-1.00], 1.05 [0.77-1.43], or 0.77 [0.48-1.23], respectively). Past users of HRT were not at an increased risk of ovarian cancer (0.98 [0.88-1.11] and 0.97 [0.84-1.11], respectively, for incident and fatal disease). Over 5 years, the standardised. incidence rates for ovarian cancer in current and never users of HRT were 2.6 (2.4-2.9) and 2.2 (2.1-2.3) per 1000, respectively-ie, one extra ovarian cancer in roughly 2500 users; death rates were 1.6 (1.4-1.8) and 1.3 (1.2-1.4) per 1000, respectively-ie, one extra ovarian cancer death in roughly 3300 users. Interpretation Women who use HRT are at an increased risk of both incident and fatal ovarian cancer. Since 1991, use of HRT has resulted in some 1300 additional ovarian cancers and 1000 additional deaths from the malignancy in the UK.	Mill Women Study Coordinating Ctr, Canc Res UK Epidemiol Unit, Oxford OX3 7LF, England	Cancer Research UK; University of Oxford	Beral, V (corresponding author), Mill Women Study Coordinating Ctr, Canc Res UK Epidemiol Unit, Richard Doll Bldg,Roosevelt Dr, Oxford OX3 7LF, England.	pa.valerie.beral@ceu.ox.ac.uk			MRC [G0700474] Funding Source: UKRI; Medical Research Council [G0700474] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Anderson GL, 2003, JAMA-J AM MED ASSOC, V290, P1739, DOI 10.1001/jama.290.13.1739; Bakken L, 2004, INT J CANCER, V112, P130, DOI 10.1002/ijc.20389; Banks E, 2001, J Epidemiol Biostat, V6, P357; Banks E, 2003, LANCET, V362, P419, DOI 10.1016/S0140-6736(03)14065-2; Beral V, 2005, LANCET, V365, P1543, DOI 10.1016/S0140-6736(05)66455-0; Beral V, 1997, LANCET, V350, P1047, DOI 10.1016/S0140-6736(97)08233-0; Beral V, 1999, J Epidemiol Biostat, V4, P191; BOSETTI C, 2001, JAMA-J AM MED ASSOC, V285, P308; Folsom AR, 2004, EPIDEMIOLOGY, V15, P100, DOI 10.1097/01.ede.0000091606.31903.8e; Glud E, 2004, ARCH INTERN MED, V164, P2253, DOI 10.1001/archinte.164.20.2253; HARTGE P, 1988, AM J EPIDEMIOL, V127, P990, DOI 10.1093/oxfordjournals.aje.a114902; Hempling RE, 1997, OBSTET GYNECOL, V89, P1012, DOI 10.1016/S0029-7844(97)00118-X; *IARC, 1999, IARC MON EV CARC RIS, V72; KAUFMAN DW, 1989, AM J EPIDEMIOL, V130, P1142, DOI 10.1093/oxfordjournals.aje.a115441; Lacey JV, 2006, JNCI-J NATL CANCER I, V98, P1397, DOI 10.1093/jnci/djj375; Lacey JV, 2002, JAMA-J AM MED ASSOC, V288, P334, DOI 10.1001/jama.288.3.334; LAVECCHIA C, 1982, J NATL CANCER I, V69, P1207; LUNN M, 1995, BIOMETRICS, V51, P524, DOI 10.2307/2532940; Pike MC, 2004, FERTIL STERIL, V82, P186, DOI 10.1016/j.fertnstert.2004.03.013; Purdie DM, 1999, BRIT J CANCER, V81, P559, DOI 10.1038/sj.bjc.6690731; Reeves GK, 2006, LANCET ONCOL, V7, P910, DOI 10.1016/S1470-2045(06)70911-1; Riman T, 2002, JNCI-J NATL CANCER I, V94, P497, DOI 10.1093/jnci/94.7.497; Risch HA, 1996, GYNECOL ONCOL, V63, P254, DOI 10.1006/gyno.1996.0315; Risch HA, 1996, AM J EPIDEMIOL, V144, P363, DOI 10.1093/oxfordjournals.aje.a008937; Rodriguez C, 2001, JAMA-J AM MED ASSOC, V285, P1460, DOI 10.1001/jama.285.11.1460; The Million Women Study Collaborative Group, 1999, BREAST CANCER RES, V1, P73, DOI DOI 10.1186/BCR16; WEISS NS, 1982, J NATL CANCER I, V68, P95; World Health Organization, 2022, INT CLASS DIS, V11th	28	298	314	1	29	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 20	2007	369	9574					1703	1710		10.1016/S0140-6736(07)60534-0	http://dx.doi.org/10.1016/S0140-6736(07)60534-0			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	169ZT	17512855				2022-12-28	WOS:000246631300026
J	Monnier, JD; Zhao, M; Pedretti, E; Thureau, N; Ireland, M; Muirhead, P; Berger, JP; Millan-Gabet, R; Van Belle, G; ten Brummelaar, T; McAlister, H; Ridgway, S; Turner, N; Sturmann, L; Sturmann, J; Berger, D				Monnier, John D.; Zhao, M.; Pedretti, E.; Thureau, N.; Ireland, M.; Muirhead, P.; Berger, J.-P.; Millan-Gabet, R.; Van Belle, G.; ten Brummelaar, T.; McAlister, H.; Ridgway, S.; Turner, N.; Sturmann, L.; Sturmann, J.; Berger, D.			Imaging the surface of Altair	SCIENCE			English	Article							RAPIDLY ROTATING STAR; CHARA ARRAY; A-TYPE; ACHERNAR; INTERFEROMETRY; OBLATENESS; CONSISTENT; VELOCITIES; ASTRONOMY; MODELS	Spatially resolving the surfaces of nearby stars promises to advance our knowledge of stellar physics. Using optical long-baseline interferometry, we constructed a near-infrared image of the rapidly rotating hot star Altair with a resolution of <1 milliarcsecond. The image clearly reveals the strong effect of gravity darkening on the highly distorted stellar photosphere. Standard models for a uniformly rotating star cannot explain our findings, which appear to result from differential rotation, alternative gravity-darkening laws, or both.	Univ Michigan, Dept Astron, Ann Arbor, MI 48109 USA; Univ St Andrews, Sch Phys & Astron, St Andrews KY16 9AJ, Fife, Scotland; Covendish Lab, Astrophys Grp, Cambridge CB3 0HA, England; CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; Cornell Univ, Dept Astron, Ithaca, NY 14850 USA; Observ Grenoble, Astrophys Lab, F-38041 Grenoble 9, France; CALTECH, Michelson Sci Ctr, Pasadena, CA 91125 USA; Georgia State Univ, Ctr High Angular Resolut Astron, Atlanta, GA 30302 USA; Natl Opt Astron Observ, Tucson, AZ 85719 USA	University of Michigan System; University of Michigan; University of St Andrews; University of Cambridge; California Institute of Technology; Cornell University; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); California Institute of Technology; University System of Georgia; Georgia State University; National Optical Astronomy Observatory	Monnier, JD (corresponding author), Univ Michigan, Dept Astron, Ann Arbor, MI 48109 USA.	monnier@umich.edu	van Belle, Gerard/ABE-1321-2021; Muirhead, Philip Steven/H-2273-2014	van Belle, Gerard/0000-0002-8552-158X; Muirhead, Philip Steven/0000-0002-0638-8822; Monnier, John D/0000-0002-3380-3307; Millan-Gabet, Rafael/0000-0003-0447-5866; Pedretti, Ettore/0000-0002-6214-0282; Ireland, Michael/0000-0002-6194-043X; Berger, Jean-Philippe/0000-0001-5025-0428				Abt HA, 2002, ASTROPHYS J, V573, P359, DOI 10.1086/340590; ABT HA, 1995, ASTROPHYS J SUPPL S, V99, P135, DOI 10.1086/192182; Aufdenberg JP, 2006, ASTROPHYS J, V645, P664, DOI 10.1086/504149; Barai P, 2004, ASTROPHYS J, V608, P989, DOI 10.1086/420875; Brown GE, 2000, NEW ASTRON, V5, P191, DOI 10.1016/S1384-1076(00)00026-9; Claret A, 2000, ASTRON ASTROPHYS, V359, P289; de Souza AD, 2003, ASTRON ASTROPHYS, V407, pL47, DOI 10.1051/0004-6361:20030786; Erspamer D, 2003, ASTRON ASTROPHYS, V398, P1121, DOI 10.1051/0004-6361:20021711; *EUR SPAC AG, 1997, HIPP TYCH CAT; Gehrels N, 2005, NATURE, V437, P851, DOI 10.1038/nature04142; Hogbom J. A., 1974, Astronomy and Astrophysics Supplement Series, V15, P417; Ireland MJ, 2006, PROC SPIE, V6268, DOI 10.1117/12.670940; Jackson S, 2005, ASTROPHYS J SUPPL S, V156, P245, DOI 10.1086/426587; Jackson S, 2004, ASTROPHYS J, V606, P1196, DOI 10.1086/383197; Kervella P, 2006, ASTRON ASTROPHYS, V453, P1059, DOI 10.1051/0004-6361:20054771; KURUCZ R, 1993, ATLAS9 STELLAR ATOMS; LANDSTREET JD, 1992, ASTRON ASTROPHYS REV, V4, P35, DOI 10.1007/BF00873569; Lovekin CC, 2006, ASTROPHYS J, V643, P460, DOI 10.1086/501492; Maeder A, 2000, ANNU REV ASTRON ASTR, V38, P143, DOI 10.1146/annurev.astro.38.1.143; McAlister HA, 2005, ASTROPHYS J, V628, P439, DOI 10.1086/430730; Monnier JD, 2004, P SOC PHOTO-OPT INS, V5491, P1370, DOI 10.1117/12.550804; Monnier JD, 2003, REP PROG PHYS, V66, P789, DOI 10.1088/0034-4885/66/5/203; NARAYAN R, 1986, ANNU REV ASTRON ASTR, V24, P127, DOI 10.1146/annurev.aa.24.090186.001015; Ohishi N, 2004, ASTROPHYS J, V612, P463, DOI 10.1086/422422; Peterson DM, 2006, ASTROPHYS J, V636, P1087, DOI 10.1086/497981; Peterson DM, 2006, NATURE, V440, P896, DOI 10.1038/nature04661; Pinsonneault M, 1997, ANNU REV ASTRON ASTR, V35, P557, DOI 10.1146/annurev.astro.35.1.557; ten Brummelaar TA, 2005, ASTROPHYS J, V628, P453, DOI 10.1086/430729; van Belle GT, 2006, ASTROPHYS J, V637, P494, DOI 10.1086/498334; van Belle GT, 2001, ASTROPHYS J, V559, P1155, DOI 10.1086/322340; Zeipel H.V., 1924, MNRAS, V84, P684	31	270	271	1	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 20	2007	317	5836					342	345		10.1126/science.1143205	http://dx.doi.org/10.1126/science.1143205			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191RR	17540860	Green Accepted			2022-12-28	WOS:000248150200038
J	Odegaard, JI; Ricardo-Gonzalez, RR; Goforth, MH; Morel, CR; Subramanian, V; Mukundan, L; Eagle, AR; Vats, D; Brombacher, F; Ferrante, AW; Chawla, A				Odegaard, Justin I.; Ricardo-Gonzalez, Roberto R.; Goforth, Matthew H.; Morel, Christine R.; Subramanian, Vidya; Mukundan, Lata; Eagle, Alex Red; Vats, Divya; Brombacher, Frank; Ferrante, Anthony W.; Chawla, Ajay			Macrophage-specific PPAR gamma controls alternative activation and improves insulin resistance	NATURE			English	Article							ADIPOSE-TISSUE; MITOCHONDRIAL DYSFUNCTION; OXIDATIVE-METABOLISM; OBESITY; INFLAMMATION; EXPRESSION; ADIPOCYTES; MONOCYTE; MICE	Obesity and insulin resistance, the cardinal features of metabolic syndrome, are closely associated with a state of low-grade inflammation(1,2). In adipose tissue chronic overnutrition leads to macrophage infiltration, resulting in local inflammation that potentiates insulin resistance(3,4). For instance, transgenic expression of Mcp1 (also known as chemokine ligand 2, Ccl2) in adipose tissue increases macrophage infiltration, inflammation and insulin resistance(5,6). Conversely, disruption of Mcp1 or its receptor Ccr2 impairs migration of macrophages into adipose tissue, thereby lowering adipose tissue inflammation and improving insulin sensitivity(5,7). These findings together suggest a correlation between macrophage content in adipose tissue and insulin resistance. However, resident macrophages in tissues display tremendous heterogeneity in their activities and functions, primarily reflecting their local metabolic and immune microenvironment(8). While Mcp1 directs recruitment of pro-inflammatory classically activated macrophages to sites of tissue damage(5,8), resident macrophages, such as those present in the adipose tissue of lean mice, display the alternatively activated phenotype(9). Despite their higher capacity to repair tissue(10), the precise role of alternatively activated macrophages in obesity-induced insulin resistance remains unknown. Using mice with macrophage-specific deletion of the peroxisome proliferator activated receptor-gamma (PPAR gamma), we showhere that PPAR gamma is required for maturation of alternatively activated macrophages. Disruption of PPAR gamma in myeloid cells impairs alternative macrophage activation, and predisposes these animals to development of diet-induced obesity, insulin resistance, and glucose intolerance. Furthermore, gene expression profiling revealed that downregulation of oxidative phosphorylation gene expression in skeletal muscle and liver leads to decreased insulin sensitivity in these tissues. Together, our findings suggest that resident alternatively activated macrophages have a beneficial role in regulating nutrient homeostasis and suggest that macrophage polarization towards the alternative state might be a useful strategy for treating type 2 diabetes.	Stanford Univ, Dept Med, Sch Med, Div Endocrinol Metab & Gerontol, Stanford, CA 94305 USA; Stanford Univ, Grad Program Immunol, Sch Med, Stanford, CA 94305 USA; Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; Univ Cape Town, Observ, Fac Hlth Sci, Inst Infect Dis & Mol Med,Div Immunol, ZA-7925 Cape Town, South Africa; Columbia Univ Coll Phys & Surg, Dept Med, Naomi Berrie Diabet Ctr, New York, NY 10032 USA	Stanford University; Stanford University; Stanford University; University of Cape Town; Columbia University	Chawla, A (corresponding author), Stanford Univ, Dept Med, Sch Med, Div Endocrinol Metab & Gerontol, Stanford, CA 94305 USA.	achawla@stanford.edu	Ferrante, Anthony/AAC-7763-2019	Ferrante, Anthony/0000-0001-9272-2593; Ricardo-Gonzalez, Roberto/0000-0002-6135-4035	NHLBI NIH HHS [R01 HL076746-04, R01 HL076746-05, R01 HL076746-01, R01 HL076746, R01 HL076746-03, R01 HL076746-02] Funding Source: Medline; NIAID NIH HHS [AI07290, T32 AI007290, F31 AI066402] Funding Source: Medline; NIDDK NIH HHS [R01 DK066525, K08 DK062386, R01 DK066525-05, K08 DK062386-05, R01 DK076760, K08 DK062386-06] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076746] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007290, F31AI066402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK062386, R01DK066525, R01DK076760] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Akiyama TE, 2002, MOL CELL BIOL, V22, P2607, DOI 10.1128/MCB.22.8.2607-2619.2002; Alexander J, 1999, J CELL SCI, V112, P2993; Civitarese AE, 2006, CELL METAB, V4, P75, DOI 10.1016/j.cmet.2006.05.002; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Herbert DR, 2004, IMMUNITY, V20, P623, DOI 10.1016/S1074-7613(04)00107-4; Holscher C, 2006, J IMMUNOL, V176, P1115, DOI 10.4049/jimmunol.176.2.1115; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Huang JT, 1999, NATURE, V400, P378, DOI 10.1038/22572; Kamei N, 2006, J BIOL CHEM, V281, P26602, DOI 10.1074/jbc.M601284200; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Lazar MA, 2005, SCIENCE, V307, P373, DOI 10.1126/science.1104342; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lumeng CN, 2007, AM J PHYSIOL-ENDOC M, V292, pE166, DOI 10.1152/ajpendo.00284.2006; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Pauleau AL, 2004, J IMMUNOL, V172, P7565, DOI 10.4049/jimmunol.172.12.7565; Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Rutschman R, 2001, J IMMUNOL, V166, P2173, DOI 10.4049/jimmunol.166.4.2173; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Vats D, 2006, CELL METAB, V4, P13, DOI 10.1016/j.cmet.2006.05.011; Vianna CR, 2006, CELL METAB, V4, P453, DOI 10.1016/j.cmet.2006.11.003; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451	30	1525	1609	6	162	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 28	2007	447	7148					1116	U12		10.1038/nature05894	http://dx.doi.org/10.1038/nature05894			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	183HT	17515919	Green Accepted			2022-12-28	WOS:000247564600038
J	Halvorsen, PA; Selmer, R; Kristiansen, IS				Halvorsen, Peder A.; Selmer, Randi; Kristiansen, Ivar Sonbo			Different ways to describe the benefits of risk-reducing treatments - A randomized trial	ANNALS OF INTERNAL MEDICINE			English	Article							NUMBER; INFORMATION; PERCEPTION; THERAPIES; OSTEOPOROSIS; PREFERENCES; PHYSICIANS; DECISIONS; REDUCTION; FRACTURE	Background: How physicians communicate the risks and benefits of medical care may influence patients' choices. Ways to communicate the benefits of risk-reducing drug therapies include the number needed to treat (NNT) to prevent adverse events, such as heart attacks or hip fractures, and gains in disease-free life expectancy or postponement of adverse events. Previous studies suggest that the magnitude of the NNT does not affect a layperson's decision about risk-reducing interventions, but postponement of an adverse event does affect such decisions. Objective: To examine laypersons' responses to scenarios that describe benefits as postponing an adverse event or the equivalent NNT. Design: Cross-sectional survey with random allocation to different scenarios. Setting: General community. Participants: Respondents to a population -based health study Intervention: The survey presented scenarios regarding a hypothetical drug therapy to reduce the risk for heart attacks (1754 respondents) or hip fractures (1000 respondents). The data sources for both scenarios were clinical trials. Respondents were randomly assigned to a scenario with 1 of 3 outcomes after 5 years of treatment. For the drug to prevent heart attacks, the outcomes were postponement by 2 months for all patients, postponement by 8 months for 1 of 4 patients, or an NNT of 13 patients to prevent 1 heart attack. For the drug to prevent hip fractures, the outcomes were postponement by 16 days for all patients, postponement by 16 months for 3 of 100 patients, or an NNT of 57 patients to prevent 1 fracture. Measurements: Consent to receive the intervention and perceived ease of understanding the treatment effect. Results: The overall rate of response to the survey was 81%. In the heart attack scenarios, 93% of respondents who were presented with the NNT outcome consented to drug therapy, 82% who were presented with the outcome of large postponement for some patients consented to therapy, and 69% who were presented with the outcome of short postponement for all patients consented to therapy (chi-square, 89.6; P < 0.001). Corresponding consent rates for the hip fracture scenarios were 74%, 56%, and 34%, respectively (chi-square, 91.5, P < 0.001). Respondents who said that they understood the treatment effect were more likely to consent to therapy. Limitation: Decisions were based on hypothetical scenarios, not real clinical encounters. Conclusions: Treatment effects expressed in terms of NNT yielded higher consent rates than did those expressed as equivalent postponements. This result suggests that the description of the anticipated outcome may influence the patient's willingness to accept a recommended intervention.	Univ Tromso, Tromso, Norway; Univ So Denmark, Odense, Denmark; Univ Oslo, Oslo, Norway; Norwegian Inst Publ Hlth, Oslo, Norway	UiT The Arctic University of Tromso; University of Southern Denmark; University of Oslo; Norwegian Institute of Public Health (NIPH)	Halvorsen, PA (corresponding author), Nordlys Legesenter, N-9509 Alta, Norway.	phalvor@online.no		Halvorsen, Peder A./0000-0002-6519-9669				BJARTVEIT K, 1983, ACTA MED SCAND, P1; Black DM, 2000, J CLIN ENDOCR METAB, V85, P4118, DOI 10.1210/jc.85.11.4118; BUCHER HC, 1994, BRIT MED J, V309, P761, DOI 10.1136/bmj.309.6957.761; Christensen PM, 2003, CLIN THER, V25, P2575, DOI 10.1016/S0149-2918(03)80318-1; COOK RJ, 1995, BRIT MED J, V310, P452, DOI 10.1136/bmj.310.6977.452; Edwards A, 2001, J HEALTH COMMUN, V6, P61, DOI 10.1080/10810730150501413; Eraker S A, 1981, Med Decis Making, V1, P29, DOI 10.1177/0272989X8100100105; FINCH J, 1987, SOCIOLOGY, V21, P105, DOI 10.1177/0038038587021001008; Getz L, 2005, BMJ-BRIT MED J, V331, P551, DOI 10.1136/bmj.38555.648623.8F; Ghosh AK, 2005, J LAB CLIN MED, V145, P171, DOI 10.1016/j.lab.2005.02.006; Gigerenzer G, 2003, BMJ-BRIT MED J, V327, P741, DOI 10.1136/bmj.327.7417.741; GIGERENZER G, 1999, SIMPLE HEURISTICS MA, P37; Halvorsen PA, 2005, ARCH INTERN MED, V165, P1140, DOI 10.1001/archinte.165.10.1140; Halvorsen PA, 2003, SCAND J PRIM HEALTH, V21, P162, DOI 10.1080/02813430310001158; HALVORSEN PA, 2004, MED DECIS MAKING, V24, P423; Henderson R, 2005, J MED ETHICS, V31, P703, DOI 10.1136/jme.2005.012427; Hsee CK, 1999, PSYCHOL BULL, V125, P576, DOI 10.1037/0033-2909.125.5.576; JONES TV, 1990, J CLIN EPIDEMIOL, V43, P805, DOI 10.1016/0895-4356(90)90241-G; Kristiansen IS, 2002, J CLIN EPIDEMIOL, V55, P888, DOI 10.1016/S0895-4356(02)00432-8; LAUPACIS A, 1988, NEW ENGL J MED, V318, P1728, DOI 10.1056/NEJM198806303182605; MCNEIL BJ, 1982, NEW ENGL J MED, V306, P1259, DOI 10.1056/NEJM198205273062103; Misselbrook D, 2001, BRIT J GEN PRACT, V51, P276; Nexoe J, 2005, FAM PRACT, V22, P126, DOI 10.1093/fampra/cmh706; Nexoe J, 2002, FAM PRACT, V19, P3, DOI 10.1093/fampra/19.1.3; PEDERSEN TR, 1994, LANCET, V344, P1383; Rajkumar SV, 1996, J GEN INTERN MED, V11, P357, DOI 10.1007/BF02600047; RIEGELMAN R, 1993, MED DECIS MAKING, V13, P247, DOI 10.1177/0272989X9301300312; Sackett DL, 2000, EVIDENCE BASED MED P, P105; Sheridan SL, 2003, J GEN INTERN MED, V18, P884, DOI 10.1046/j.1525-1497.2003.21102.x; Sheridan Stacey L, 2002, Eff Clin Pract, V5, P35; SOGAARD AJ, 2007, OSTEOPOROSIS INT; TVERSKY A, 1981, SCIENCE, V211, P453, DOI 10.1126/science.7455683; TVERSKY A, 1973, COGNITIVE PSYCHOL, V5, P207, DOI 10.1016/0010-0285(73)90033-9; van Hout BA, 2001, EUR HEART J, V22, P751, DOI 10.1053/euhj.2000.2308	34	60	62	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 19	2007	146	12					848	856		10.7326/0003-4819-146-12-200706190-00006	http://dx.doi.org/10.7326/0003-4819-146-12-200706190-00006			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	180FF	17577004				2022-12-28	WOS:000247347100003
J	Leroux, MR				Leroux, Michel R.			Taking vesicular transport to the cilium	CELL			English	Editorial Material							PROTEINS; COMPLEX; RAB8	Defects in protein trafficking within the cell body and cilia are thought to underlie the human disease Bardet-Biedl syndrome (BBS). In this issue, Nachury et al. (2007) reveal that a large complex of proteins implicated in BBS cooperates with Rabin8-the GTP exchange factor for the small GTPase Rab8-to promote cilia formation and presumably movement of membrane proteins from the cell into the cilium.	Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada	Simon Fraser University	Leroux, MR (corresponding author), Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada.	leroux@sfu.ca						Blacque OE, 2006, CELL MOL LIFE SCI, V63, P2145, DOI 10.1007/s00018-006-6180-x; Caspary T, 2007, DEV CELL, V12, P767, DOI 10.1016/j.devcel.2007.03.004; Dwyer ND, 2001, NEURON, V31, P277, DOI 10.1016/S0896-6273(01)00361-0; Follit JA, 2006, MOL BIOL CELL, V17, P3781, DOI 10.1091/mbc.E06-02-0133; Inglis PN, 2006, TRENDS GENET, V22, P491, DOI 10.1016/j.tig.2006.07.006; Jenkins D, 2007, AM J HUM GENET, V80, P1162, DOI 10.1086/518047; Moritz OL, 2001, MOL BIOL CELL, V12, P2341, DOI 10.1091/mbc.12.8.2341; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Qin HM, 2007, CURR BIOL, V17, P193, DOI 10.1016/j.cub.2006.12.040; Schafer JC, 2006, J CELL SCI, V119, P4088, DOI 10.1242/jcs.03187; Schrick JJ, 2006, AM J PATHOL, V168, P1288, DOI 10.2353/ajpath.2006.050941; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153	12	31	32	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 15	2007	129	6					1041	1043		10.1016/j.cell.2007.05.049	http://dx.doi.org/10.1016/j.cell.2007.05.049			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	180UA	17574016	Bronze			2022-12-28	WOS:000247390400007
J	Longmore, GD				Longmore, Gregory D.			Do cancer cells express functional erythropoietin receptors?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Washington Univ, St Louis, MO 63130 USA	Washington University (WUSTL)	Longmore, GD (corresponding author), Washington Univ, St Louis, MO 63130 USA.								0	22	22	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 14	2007	356	24					2447	2447		10.1056/NEJMp078112	http://dx.doi.org/10.1056/NEJMp078112			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	178DR	17568024				2022-12-28	WOS:000247201900002
J	Alisjahbana, B; van Crevel, R				Alisjahbana, Bachti; van Crevel, Reinout			Improved diagnosis of tuberculosis by better sputum quality	LANCET			English	Editorial Material							SMEAR MICROSCOPY		Padjadjaran State Univ, Hasan Sadikin Hosp, Fac Med, Dept Internal Med, Bandung, Indonesia; Radboud Univ Nijmegen Med Ctr, Dept Internal Med, Nijmegen, Netherlands	Dr Hasan Sadikin General Hospital; Universitas Padjadjaran; Radboud University Nijmegen	Alisjahbana, B (corresponding author), Padjadjaran State Univ, Hasan Sadikin Hosp, Fac Med, Dept Internal Med, Bandung, Indonesia.	bachti@melsa.net.id	van Crevel, reinout/A-6636-2010	van Crevel, reinout/0000-0002-6233-6410				Alisjahbana B, 2005, INT J TUBERC LUNG D, V9, P814; BOEHME CC, 2007, J CLIN MICROBIO 0328; Borgdorff MW, 2000, INT J TUBERC LUNG D, V4, P123; Fairall LR, 2005, BMJ-BRIT MED J, V331, P750, DOI 10.1136/bmj.331.7519.750; Godwin Marshall, 2003, BMC Med Res Methodol, V3, P28, DOI 10.1186/1471-2288-3-28; Khan MS, 2007, LANCET, V369, P1955, DOI 10.1016/S0140-6736(07)60916-7; Long NH, 2002, J CLIN EPIDEMIOL, V55, P115, DOI 10.1016/S0895-4356(01)00455-3; NGUYEN VH, 2007, LANCET INFECT DIS, V7, P238; Pai M, 2006, EXPERT REV MOL DIAGN, V6, P423, DOI 10.1586/14737159.6.3.423; Steingart K, 2006, LANCET INFECT DIS, V6, P570, DOI 10.1016/S1473-3099(06)70578-3; Steingart KR, 2006, LANCET INFECT DIS, V6, P664, DOI 10.1016/S1473-3099(06)70602-8; Tunis SR, 2003, JAMA-J AM MED ASSOC, V290, P1624, DOI 10.1001/jama.290.12.1624	12	5	5	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 9	2007	369	9577					1908	1909		10.1016/S0140-6736(07)60893-9	http://dx.doi.org/10.1016/S0140-6736(07)60893-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	177IQ	17560430				2022-12-28	WOS:000247147200007
J	Bradbury, PA; Shepherd, FA				Bradbury, Penelope A.; Shepherd, Frances A.			Chemotherapy and surgery for operable NSCLC	LANCET			English	Editorial Material							CELL LUNG-CANCER; VINORELBINE PLUS CISPLATIN; ADJUVANT CHEMOTHERAPY; TRIAL		Univ Toronto, Toronto, ON M5G 2M9, Canada; Princess Margaret Hosp, Univ Hlth Network, Toronto, ON M5G 2M9, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Shepherd, FA (corresponding author), Princess Margaret Hosp, Univ Hlth Network, Toronto, ON M5G 2M9, Canada.	Frances.Shepherd@uhn.on.ca						Alam N, 2005, LUNG CANCER, V47, P385, DOI 10.1016/j.lungcan.2004.08.016; ALBAIN KS, 2003, P AN M AM SOC CLIN, V22, P621; Aljubran A, 2006, J CLIN ONCOL, V24, p402S; Depierre A, 2002, J CLIN ONCOL, V20, P247, DOI 10.1200/JCO.20.1.247; Douillard JY, 2006, LANCET ONCOL, V7, P719, DOI 10.1016/S1470-2045(06)70804-X; GILLIGAN D, 2007, LANCET          0601, DOI DOI 10.1016/S0140-6736(07)60714-4; Le Chevalier T, 2004, NEW ENGL J MED, V350, P351, DOI 10.1056/nejmoa031644; Pignon JP, 2006, J CLIN ONCOL, V24, p366S; Pisters K, 2005, J CLIN ONCOL, V23, p624S; ROSELL R, 1994, NEW ENGL J MED, V330, P153, DOI 10.1056/NEJM199401203300301; ROTH JA, 1994, J NATL CANCER I, V86, P673, DOI 10.1093/jnci/86.9.673; Strauss GM, 2006, J CLIN ONCOL, V24, p365S; Winton T, 2005, NEW ENGL J MED, V352, P2589, DOI 10.1056/NEJMoa043623	13	11	11	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 9	2007	369	9577					1903	1904		10.1016/S0140-6736(07)60715-6	http://dx.doi.org/10.1016/S0140-6736(07)60715-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	177IQ	17544498				2022-12-28	WOS:000247147200004
J	Laporte, NT; Stabach, JA; Grosch, R; Lin, TS; Goetz, SJ				Laporte, Nadine T.; Stabach, Jared A.; Grosch, Robert; Lin, Tiffany S.; Goetz, Scott J.			Expansion of industrial logging in Central Africa	SCIENCE			English	Article							FOREST STRUCTURE; CONSERVATION		Woods Hole Res Ctr, Falmouth, MA 02540 USA	Woods Hole Research Center	Laporte, NT (corresponding author), Woods Hole Res Ctr, Falmouth, MA 02540 USA.	nlaporte@whrc.org	Goetz, Scott J/A-3393-2015; Stabach, Jared/AEX-9187-2022	Goetz, Scott J/0000-0002-6326-4308; Stabach, Jared/0000-0002-7896-1237				BUYS P, 2006, 4097 WPS WORLD BANK; Hall JS, 2003, FOREST ECOL MANAG, V183, P249, DOI 10.1016/S0378-1127(03)00107-5; Malcolm JR, 2000, CONSERV BIOL, V14, P1623, DOI [10.1046/j.1523-1739.2000.99070.x, 10.1111/j.1523-1739.2000.99070.x]; Robinson JG, 1999, SCIENCE, V284, P595, DOI 10.1126/science.284.5414.595; WHITE LIT, 1994, J TROP ECOL, V10, P309	5	223	228	1	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 8	2007	316	5830					1451	1451		10.1126/science.1141057	http://dx.doi.org/10.1126/science.1141057			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176EE	17556578				2022-12-28	WOS:000247066400034
J	Punglia, RS; Morrow, M; Winer, EP; Harris, JR				Punglia, Rinaa S.; Morrow, Monica; Winer, Eric P.; Harris, Jay R.			Current concepts: Local therapy and survival in breast cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							CONSERVING THERAPY; TUMOR RECURRENCE; POSTOPERATIVE RADIOTHERAPY; ADJUVANT CHEMOTHERAPY; RADIATION-THERAPY; SYSTEMIC THERAPY; PATIENTS PREFERENCES; PREMENOPAUSAL WOMEN; REGIONAL RECURRENCE; TOTAL MASTECTOMY		Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; Brigham & Womens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; Fox Chase Canc Ctr, Dept Surg Oncol, Philadelphia, PA 19111 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Fox Chase Cancer Center	Punglia, RS (corresponding author), Dana Farber Canc Inst, Dept Radiat Oncol, 44 Binney St,Smith 274, Boston, MA 02115 USA.	rpunglia@lroc.harvard.edu						Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Abe O, 2005, LANCET, V366, P2087; ABE O, 1995, NEW ENGL J MED, V333, P1444; Abe O, 1996, NEW ENGL J MED, V334, P1003; Bartelink H, 2001, NEW ENGL J MED, V345, P1378, DOI 10.1056/NEJMoa010874; Berry DA, 2005, NEW ENGL J MED, V353, P1784, DOI 10.1056/NEJMoa050518; *CLIN TRIAL SERV U, 2006, CONT LANC WEBS MAT E; de Bock GH, 2006, EUR J CANCER, V42, P351, DOI 10.1016/j.ejca.2005.10.006; Duric VM, 2007, PSYCHO-ONCOLOGY, V16, P48, DOI 10.1002/pon.1045; Duric VM, 2005, ANN ONCOL, V16, P1786, DOI 10.1093/annonc/mdi370; Elkhuizen PHM, 1998, INT J RADIAT ONCOL, V40, P859, DOI 10.1016/S0360-3016(97)00917-6; Elkhuizen PHM, 2001, INT J RADIAT ONCOL, V50, P387, DOI 10.1016/S0360-3016(01)01469-9; Fisher B, 1997, JNCI-J NATL CANCER I, V89, P1673, DOI 10.1093/jnci/89.22.1673; Fisher B, 2002, J CLIN ONCOL, V20, P4141, DOI 10.1200/JCO.2002.11.101; Fisher B, 1996, J CLIN ONCOL, V14, P1982, DOI 10.1200/JCO.1996.14.7.1982; FISHER B, 1977, CANCER, V40, P574, DOI 10.1002/1097-0142(197707)40:1+<574::AID-CNCR2820400724>3.0.CO;2-O; Fisher B, 2002, NEW ENGL J MED, V347, P1233, DOI 10.1056/NEJMoa022152; FISHER B, 1980, CANCER RES, V40, P3863; Fyles AW, 2004, NEW ENGL J MED, V351, P963, DOI 10.1056/NEJMoa040595; Goldstein NS, 2005, AM J CLIN PATHOL, V123, P679, DOI 10.1309/DP47PK9PVC52AU4R; Haffty BG, 1996, J CLIN ONCOL, V14, P52, DOI 10.1200/JCO.1996.14.1.52; Halsted WS, 1907, ANN SURG, V46, P1, DOI 10.1097/00000658-190707000-00001; HELLMAN S, 1994, J CLIN ONCOL, V12, P2229, DOI 10.1200/JCO.1994.12.10.2229; HELLMAN S, 1987, CANCER RES, V47, P339; Hughes KS, 2004, NEW ENGL J MED, V351, P971, DOI 10.1056/NEJMoa040587; Humphrey LL, 2002, ANN INTERN MED, V137, P347, DOI 10.7326/0003-4819-137-5_Part_1-200209030-00012; Lindley C, 1998, J CLIN ONCOL, V16, P1380, DOI 10.1200/JCO.1998.16.4.1380; MAMOUNAS E, 2005, SAN ANT BREAST CANC; Marks LB, 2000, INT J RADIAT ONCOL, V48, P625, DOI 10.1016/S0360-3016(00)00697-0; MATTHEWS RH, 1988, INT J RADIAT ONCOL, V14, P659, DOI 10.1016/0360-3016(88)90086-7; Meric F, 2003, CANCER, V97, P926, DOI 10.1002/cncr.11222; Morrow M, 2004, DIS BREAST, P719; *NAT CANC I, 2006, SEER CANC STAT REV; Nattinger AB, 2000, LANCET, V356, P1148, DOI 10.1016/S0140-6736(00)02757-4; Nielsen HM, 2006, RADIOTHER ONCOL, V79, P147, DOI 10.1016/j.radonc.2006.04.006; Nielsen HM, 2006, J CLIN ONCOL, V24, P2268, DOI 10.1200/JCO.2005.02.8738; NIXON AJ, 1994, J CLIN ONCOL, V12, P888, DOI 10.1200/JCO.1994.12.5.888; Overgaard M, 1999, LANCET, V353, P1641, DOI 10.1016/S0140-6736(98)09201-0; Overgaard M, 1997, NEW ENGL J MED, V337, P949, DOI 10.1056/NEJM199710023371401; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Park CC, 2000, J CLIN ONCOL, V18, P1668, DOI 10.1200/JCO.2000.18.8.1668; Ragaz J, 2005, JNCI-J NATL CANCER I, V97, P116, DOI 10.1093/jnci/djh297; Ragaz J, 1997, NEW ENGL J MED, V337, P956, DOI 10.1056/NEJM199710023371402; Smith TE, 2000, INT J RADIAT ONCOL, V48, P1281, DOI 10.1016/S0360-3016(00)01378-X; SOLIN LJ, 1989, INT J RADIAT ONCOL, V16, P373, DOI 10.1016/0360-3016(89)90333-7; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Vicini FA, 2003, CANCER, V97, P910, DOI 10.1002/cncr.11143; Vrieling C, 2003, EUR J CANCER, V39, P932, DOI 10.1016/S0959-8049(03)00123-0; WHELAN T, 1994, INT J RADIAT ONCOL, V30, P11, DOI 10.1016/0360-3016(94)90513-4; Wong J.S., 2004, DIS BREAST, P785	50	220	235	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 7	2007	356	23					2399	2405		10.1056/NEJMra065241	http://dx.doi.org/10.1056/NEJMra065241			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	175QY	17554121				2022-12-28	WOS:000247029300009
J	Holsinger, T; Deveau, J; Boustani, M; Williams, JW				Holsinger, Tracey; Deveau, Janie; Boustani, Malaz; Williams, John W., Jr.			Does this patient have dementia?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							MINI-MENTAL-STATE; QUALITY STANDARDS SUBCOMMITTEE; VERBAL-LEARNING TEST; VASCULAR RISK-FACTORS; CLOCK-DRAWING TEST; COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; PRIMARY-CARE; SCREENING-TEST; MEMORY COMPLAINTS	Context While as many as 5 million individuals in the United States have dementia, many others have memory complaints. Brief tests to screen for cognitive impairment could help guide dementia diagnosis. Objective To review the literature concerning the practicality and accuracy of brief cognitive screening instruments in primary care. Data Sources A search of MEDLINE ( including data from AIDSLINE, BioethicsLine, and HealthSTAR) and psycINFO was conducted from January 2000 through April 2006 to update previous reviews. Study Selection Studies of patients aged 60 years and older and use of an acceptable criterion standard to diagnose dementia were considered. Data Extraction Studies were assessed by 2 independent reviewers for eligibility and quality. A third independent reviewer adjudicated disagreements. Data for likelihood ratios ( LRs) were extracted. Data Synthesis Twenty-nine studies using 25 different screening instruments met inclusion criteria; some studies evaluated several different instruments, thus, information could be examined for 38 unique instrument/study combinations. Results For the commonly used Mini-Mental State Examination, the median LR for a positive result was 6.3 ( 95% confidence interval [ CI], 3.4-47.0) and the median LR for a negative result was 0.19 ( 95% CI, 0.06-0.37). Briefer approaches are available but have not been studied as frequently. Reports from an informant that the patient has memory loss yields an LR of 6.5 ( 95% CI, 4.4-9.6) for dementia. The Memory Impairment Screen takes 4 minutes to ask 4 items and has an LR for a positive result of 33 ( 95% CI, 15.0-72.0) and an LR for a negative result is 0.08 ( 95% CI, 0.02-0.3). Clock drawings are helpful in 1- to 3- minute forms, but must be scored appropriately and sensitivity to mild forms of impairment can be low. Conclusions Clinicians should select 1 primary tool based on ( 1) the population receiving care; ( 2) an awareness of the effects of educational level, race, and age on scoring; and ( 3) consideration of adding 1 or 2 other tools for special situations as needed.	Durham VA Med Ctr, Ctr Hlth Serv Res Primary Care, Durham, NC 27705 USA; Durham VA Med Ctr, Dept Psychiat, Durham, NC 27705 USA; Indiana Univ, Sch Med, Regenstrief Inst Inc, Dept Med, Indianapolis, IN 46204 USA; Duke Univ, Med Ctr, Div Gen Internal Med, Durham, NC 27710 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Indiana University System; Indiana University-Purdue University Indianapolis; Regenstrief Institute Inc; Duke University	Holsinger, T (corresponding author), Durham VA Med Ctr, Ctr Hlth Serv Res Primary Care, 508 Fulton St,Mail Stn 116A, Durham, NC 27705 USA.	tracey.holsinger@va.gov	Carpenter, Christopher R./E-3720-2013; Boustani, Malaz/Q-3850-2019	Carpenter, Christopher R./0000-0002-2603-7157; Boustani, Malaz/0000-0003-0330-677X	NATIONAL INSTITUTE ON AGING [K23AG026770] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Aevarsson O, 2000, DEMENT GERIATR COGN, V11, P166, DOI 10.1159/000017231; *ALZH ASS WEB SIT, ALZH FACTS FIG; *AM ASS GER PSYCHI, DES BRIEF ALZH SCREE; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; ANTHONY JC, 1982, PSYCHOL MED, V12, P397, DOI 10.1017/S0033291700046730; BASSETT SS, 1993, J GERIATR PSYCH NEUR, V6, P105, DOI 10.1177/089198879300600207; Baune BT, 2007, J PSYCHIATR RES, V41, P247, DOI 10.1016/j.jpsychires.2006.06.004; Belle SH, 2000, NEUROEPIDEMIOLOGY, V19, P43, DOI 10.1159/000026236; Berthier ML, 2005, DRUG AGING, V22, P163, DOI 10.2165/00002512-200522020-00006; Birks JS, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001191.pub3; Bland RC, 2001, CAN J PSYCHIAT, V46, P506, DOI 10.1177/070674370104600604; BLEECKER ML, 1988, NEUROLOGY, V38, P1565, DOI 10.1212/WNL.38.10.1565; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Borson S, 2003, J AM GERIATR SOC, V51, P1451, DOI 10.1046/j.1532-5415.2003.51465.x; Boustani M, 2003, ANN INTERN MED, V138, P927, DOI 10.7326/0003-4819-138-11-200306030-00015; BOUSTANI M, SCREENING DEMENTIA S; Bravo G, 1997, INT J GERIATR PSYCH, V12, P1008, DOI 10.1002/(SICI)1099-1166(199710)12:10<1008::AID-GPS676>3.0.CO;2-A; BRAYNE C, 1990, AGE AGEING, V19, P91, DOI 10.1093/ageing/19.2.91; Brodaty H, 2002, J AM GERIATR SOC, V50, P530, DOI 10.1046/j.1532-5415.2002.50122.x; Bynum JPW, 2004, J AM GERIATR SOC, V52, P187, DOI 10.1111/j.1532-5415.2004.52054.x; Cacchione PZ, 2003, J AM GERIATR SOC, V51, P819, DOI 10.1046/j.1365-2389.2003.51263.x; Callahan CM, 2006, JAMA-J AM MED ASSOC, V295, P2148, DOI 10.1001/jama.295.18.2148; CALLAHAN CM, 1995, ANN INTERN MED, V122, P422, DOI 10.7326/0003-4819-122-6-199503150-00004; Callahan CM, 2002, MED CARE, V40, P771, DOI 10.1097/00005650-200209000-00007; Canning SJD, 2004, NEUROLOGY, V62, P556, DOI 10.1212/WNL.62.4.556; Carr DB, 2000, NEUROLOGY, V55, P1724, DOI 10.1212/WNL.55.11.1724; Chodosh J, 2004, J AM GERIATR SOC, V52, P1051, DOI 10.1111/j.1532-5415.2004.52301.x; COSTA PT, 1996, AHCPR PUBLICATION; CRUM RM, 1993, JAMA-J AM MED ASSOC, V269, P2386, DOI 10.1001/jama.269.18.2386; Crystal HA, 2000, ARCH NEUROL-CHICAGO, V57, P713, DOI 10.1001/archneur.57.5.713; Cullen B, 2005, INT J GERIATR PSYCH, V20, P371, DOI 10.1002/gps.1291; Cummings JL, 2002, JAMA-J AM MED ASSOC, V287, P2335, DOI 10.1001/jama.287.18.2335; De Lepeleire J, 2005, J CLIN EPIDEMIOL, V58, P217, DOI 10.1016/j.jclinepi.2004.07.005; Doody RS, 2001, NEUROLOGY, V56, P1154, DOI 10.1212/WNL.56.9.1154; Dubois B, 2000, NEUROLOGY, V55, P1621, DOI 10.1212/WNL.55.11.1621; EATON W, 2004, RISK FACTORS MAJOR M; ERNST RL, 1994, AM J PUBLIC HEALTH, V84, P1261, DOI 10.2105/AJPH.84.8.1261; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Fischer P, 2006, ACTA NEUROL SCAND, V114, P84, DOI 10.1111/j.1600-0404.2006.00597.x; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Frank RM, 2000, INT J GERIATR PSYCH, V15, P317, DOI 10.1002/(SICI)1099-1166(200004)15:4<317::AID-GPS116>3.3.CO;2-Z; FRATIGLIONI L, 1993, J CLIN EPIDEMIOL, V46, P281, DOI 10.1016/0895-4356(93)90076-D; Freidl W, 1996, J CLIN EPIDEMIOL, V49, P73, DOI 10.1016/0895-4356(95)00541-2; Galvin JE, 2005, NEUROLOGY, V65, P559, DOI 10.1212/01.wnl.0000172958.95282.2a; Geerlings MI, 1999, AM J PSYCHIAT, V156, P531; Grady CL, 2000, CURR OPIN NEUROBIOL, V10, P224, DOI 10.1016/S0959-4388(00)00073-8; Greicius MD, 2002, J NEUROL NEUROSUR PS, V72, P691, DOI 10.1136/jnnp.72.6.691; Hall KS, 2000, INT J GERIATR PSYCH, V15, P521, DOI 10.1002/1099-1166(200006)15:6<521::AID-GPS182>3.0.CO;2-F; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; HAYNES RB, 1994, J AM MED INFORM ASSN, V1, P447, DOI 10.1136/jamia.1994.95153434; Hebert LE, 2003, ARCH NEUROL-CHICAGO, V60, P1119, DOI 10.1001/archneur.60.8.1119; HEEREN TJ, 1990, J AM GERIATR SOC, V38, P1093, DOI 10.1111/j.1532-5415.1990.tb01371.x; Heinik J, 2003, J GERIATR PSYCH NEUR, V16, P74, DOI 10.1177/0891988703016002002; Hess TM, 2005, PSYCHOL BULL, V131, P383, DOI 10.1037/0033-2909.131.3.383; Hogervorst E, 2002, DEMENT GERIATR COGN, V13, P13, DOI 10.1159/000048628; HUPPERT FA, 1995, BRIT J CLIN PSYCHOL, V34, P529, DOI 10.1111/j.2044-8260.1995.tb01487.x; Hy LX, 2000, NEUROLOGY, V55, P198, DOI 10.1212/WNL.55.2.198; IHI R, 1992, PSYCHIAT RES, V44, P93, DOI 10.1016/0165-1781(92)90044-4; John PS, 2003, J GERIATR PSYCH NEUR, V16, P80, DOI 10.1177/0891988703016002003; Jones RN, 2001, INT PSYCHOGERIATR, V13, P299, DOI 10.1017/S1041610201007694; Jonker C, 2000, INT J GERIATR PSYCH, V15, P983, DOI 10.1002/1099-1166(200011)15:11<983::AID-GPS238>3.0.CO;2-5; Jorm AF, 1996, AGE AGEING, V25, P125, DOI 10.1093/ageing/25.2.125; Jorm AF, 1997, ALZ DIS ASSOC DIS, V11, P158, DOI 10.1097/00002093-199709000-00008; Khachaturian AS, 2000, J CLIN EPIDEMIOL, V53, P531, DOI 10.1016/S0895-4356(99)00196-1; Kirby M, 2001, INT J GERIATR PSYCH, V16, P935, DOI 10.1002/gps.445; Knopman DS, 2001, NEUROLOGY, V56, P1143, DOI 10.1212/WNL.56.9.1143; Kukull WA, 2002, ARCH NEUROL-CHICAGO, V59, P1737, DOI 10.1001/archneur.59.11.1737; Kuslansky G, 2004, ARCH CLIN NEUROPSYCH, V19, P89, DOI 10.1016/S0887-6177(02)00217-2; Kuslansky G, 2002, J AM GERIATR SOC, V50, P1086, DOI 10.1046/j.1532-5415.2002.50265.x; Launer LJ, 2000, NEUROBIOL AGING, V21, P49, DOI 10.1016/S0197-4580(00)00096-8; LAUNER LJ, 1993, J GERONTOL, V48, pP271, DOI 10.1093/geronj/48.6.P271; Laurin D, 2001, ARCH NEUROL-CHICAGO, V58, P498, DOI 10.1001/archneur.58.3.498; Liebetrau M, 2003, STROKE, V34, P2617, DOI 10.1161/01.STR.0000094420.80781.A9; Lipton RB, 2003, J AM GERIATR SOC, V51, P1382, DOI 10.1046/j.1532-5415.2003.51455.x; Lobo A, 2000, NEUROLOGY, V54, pS4; Lolk A, 2000, ACTA PSYCHIAT SCAND, V102, P331, DOI 10.1034/j.1600-0447.2000.102005331.x; Luchsinger JA, 2005, NEUROLOGY, V65, P545, DOI 10.1212/01.wnl.0000172914.08967.dc; Mackinnon A, 1998, AM J PSYCHIAT, V155, P1529, DOI 10.1176/ajp.155.11.1529; Mackinnon A, 2003, J CLIN EPIDEMIOL, V56, P358, DOI 10.1016/S0895-4356(03)00009-X; Mackinnon A, 2001, INT J GERIATR PSYCH, V16, P892, DOI 10.1002/gps.442; Martin BC, 2000, ALZ DIS ASSOC DIS, V14, P151, DOI 10.1097/00002093-200007000-00006; MCGLONE J, 1990, ARCH NEUROL-CHICAGO, V47, P1189, DOI 10.1001/archneur.1990.00530110043015; McKeith I, 2004, LANCET NEUROL, V3, P19, DOI 10.1016/S1474-4422(03)00619-7; MENDEZ MF, 1992, J AM GERIATR SOC, V40, P1095, DOI 10.1111/j.1532-5415.1992.tb01796.x; Mendiondo MS, 2003, J ALZHEIMERS DIS, V5, P391, DOI 10.3233/JAD-2003-5506; Mesulam MM, 2003, NEW ENGL J MED, V349, P1535, DOI 10.1056/NEJMra022435; Mukamal KJ, 2003, JAMA-J AM MED ASSOC, V289, P1405, DOI 10.1001/jama.289.11.1405; MURDEN RA, 1991, J AM GERIATR SOC, V39, P149, DOI 10.1111/j.1532-5415.1991.tb01617.x; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; Nyenhuis DL, 1998, J AM GERIATR SOC, V46, P1437, DOI 10.1111/j.1532-5415.1998.tb06015.x; OCONNOR DW, 1989, PSYCHOL MED, V19, P771, DOI 10.1017/S0033291700024375; Olafsdottir M, 2000, DEMENT GERIATR COGN, V11, P223, DOI 10.1159/000017241; OLIN J, 2004, COCHRANE DB SYST REV; Olin J.T., 2002, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001747; Pearman A, 2004, J GERONTOL B-PSYCHOL, V59, pP4, DOI 10.1093/geronb/59.1.P4; PEDERSEN NL, 1996, J GERONTOL B-PSYCHOL, V51, P55; Petersen RC, 2001, NEUROLOGY, V56, P1133, DOI 10.1212/WNL.56.9.1133; Porter RJ, 2003, BRIT J PSYCHIAT, V182, P214, DOI 10.1192/bjp.182.3.214; Powsner S, 2005, AM J PSYCHIAT, V162, P627, DOI 10.1176/appi.ajp.162.3.627-a; Punglia RS, 2003, NEW ENGL J MED, V349, P335, DOI 10.1056/NEJMoa021659; Rait G, 2000, PSYCHOL MED, V30, P957, DOI 10.1017/S0033291799002305; Rapp MA, 2005, AM J PSYCHIAT, V162, P691, DOI 10.1176/appi.ajp.162.4.691; Riedel-Heller SG, 1999, EUR ARCH PSY CLIN N, V249, P197, DOI 10.1007/s004060050087; Robert PH, 2003, DEMENT GERIATR COGN, V15, P92, DOI 10.1159/000067971; Royall DR, 1998, J NEUROL NEUROSUR PS, V64, P588, DOI 10.1136/jnnp.64.5.588; SASTRE AA, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD14003154.PUB14651852; SASTRE AA, 2005, COCHRANE DB SYST REV; Scanlan J, 2001, INT J GERIATR PSYCH, V16, P216, DOI 10.1002/1099-1166(200102)16:2<216::AID-GPS316>3.0.CO;2-B; Shulman K. I., 1986, INT J GERIATR PSYCH, V1, P135, DOI [10.1002/gps.930010209, DOI 10.1002/GPS.930010209]; Sloane PD, 2002, ANNU REV PUBL HEALTH, V23, P213, DOI 10.1146/annurev.publhealth.23.100901.140525; Slooter AJC, 1998, ARCH NEUROL-CHICAGO, V55, P964, DOI 10.1001/archneur.55.7.964; Solomon PR, 2000, INT PSYCHOGERIATR, V12, P483, DOI 10.1017/S1041610200006608; Storey JE, 2001, INT J GERIATR PSYCH, V16, P394, DOI 10.1002/gps.352; SUMMERS WK, 1990, NEUROEPIDEMIOLOGY, V9, P193, DOI 10.1159/000110773; Swearer JM, 2002, CLIN NEUROPSYCHOL, V16, P128, DOI 10.1076/clin.16.2.128.13235; Tangalos EG, 1996, MAYO CLIN PROC, V71, P829, DOI 10.4065/71.9.829; Tariot PN, 2004, JAMA-J AM MED ASSOC, V291, P317, DOI 10.1001/jama.291.3.317; Teri L, 2003, JAMA-J AM MED ASSOC, V290, P2015, DOI 10.1001/jama.290.15.2015; Tierney MC, 2003, J AM GERIATR SOC, V51, P813, DOI 10.1046/j.1365-2389.2003.51262.x; TOBIANSKY R, 1995, PSYCHOL MED, V25, P779, DOI 10.1017/S0033291700035029; TOMBAUGH TN, 1992, J AM GERIATR SOC, V40, P922, DOI 10.1111/j.1532-5415.1992.tb01992.x; UHLMANN RF, 1991, J AM GERIATR SOC, V39, P876, DOI 10.1111/j.1532-5415.1991.tb04454.x; Valcour VG, 2000, ARCH INTERN MED, V160, P2964, DOI 10.1001/archinte.160.19.2964; Wang PN, 2000, J AM GERIATR SOC, V48, P295, DOI 10.1111/j.1532-5415.2000.tb02649.x; WATSON YI, 1993, J AM GERIATR SOC, V41, P1235, DOI 10.1111/j.1532-5415.1993.tb07308.x; Weiner M, 1998, J AM GERIATR SOC, V46, P762, DOI 10.1111/j.1532-5415.1998.tb03814.x; Whiting P, 2004, ANN INTERN MED, V140, P189, DOI 10.7326/0003-4819-140-3-200402030-00010; Winblad B, 2006, LANCET, V367, P1057, DOI 10.1016/S0140-6736(06)68350-5; Withers PJA, 2003, SOIL USE MANAGE, V19, P28, DOI 10.1111/j.1475-2743.2003.tb00276.x	130	170	177	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 6	2007	297	21					2391	2404		10.1001/jama.297.21.2391	http://dx.doi.org/10.1001/jama.297.21.2391			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	175IL	17551132				2022-12-28	WOS:000247007200021
J	Chuang, YC; Kan, YY				Chuang, Yi-Chen; Kan, Yuen-Yee			A girl with episodic abdominal pain	LANCET			English	Editorial Material									EDA Hosp, Dept Obstet & Gynaecol, Yan Chau Shiang 82445, Kaohsiung Cty, Taiwan; Kaohsiung Vet Gen Hosp, Dept Obstet & Gynaecol, Kaohsiung 81362, Taiwan	E-Da Hospital; Kaohsiung Veterans General Hospital	Chuang, YC (corresponding author), EDA Hosp, Dept Obstet & Gynaecol, 1st Yi Da Rd, Yan Chau Shiang 82445, Kaohsiung Cty, Taiwan.	dr-2190a@yahoo.com.tw							0	3	3	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 2	2007	369	9576					1890	1890		10.1016/S0140-6736(07)60855-1	http://dx.doi.org/10.1016/S0140-6736(07)60855-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	173ZS	17544769				2022-12-28	WOS:000246911600033
J	Rivalan, P; Delmas, V; Angulo, E; Bull, LS; Hall, RJ; Courchamp, F; Rosser, AM; Leader-Williams, N				Rivalan, Philippe; Delmas, Virginie; Angulo, Elena; Bull, Leigh S.; Hall, Richard J.; Courchamp, Franck; Rosser, Alison M.; Leader-Williams, Nigel			Can bans stimulate wildlife trade?	NATURE			English	Editorial Material									Univ Paris 11, CNRS, UMR 8079, Lab Ecol Systemat & Evolut, F-91405 Orsay, France; Univ Kent, Durrell Inst Conservat & Ecol, Canterbury CT2 7NR, Kent, England	AgroParisTech; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Paris Saclay; University of Kent	Rivalan, P (corresponding author), Univ Paris 11, CNRS, UMR 8079, Lab Ecol Systemat & Evolut, F-91405 Orsay, France.		Hall, Richard John/A-3931-2013; Courchamp, Franck/ABE-7204-2020; Angulo, Elena/A-8107-2013	Hall, Richard John/0000-0002-6102-4183; Courchamp, Franck/0000-0001-7605-4548; Angulo, Elena/0000-0001-5545-4032				Baillie J. E. M., 2004, 2004 IUCN RED LIST T; *FAO, 2001, FAO FOR RES ASS; *FAO FISH DEP, 2004, STAT WORLDS FISH AQ; Food and Agriculture Organization (FAO), 2007, 833 FAO; Hutton J., 2000, ENDANGERED SPECIES T; Hutton JM, 2003, ORYX, V37, P215, DOI 10.1017/S0030605303000395; *IUCN, 2000, TRAD MEAS MULT ENV A; Jackson P., 1996, BIOL CONSERVATION; Oldfield S., 1998, WORLD LIST THREATENE; PERALA J, 2003, 2006 IUCN RED LIST T; VANRIJSOORT J, 2000, NONTIMBER FOREST PRO	11	104	105	0	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 31	2007	447	7144					529	530		10.1038/447529a	http://dx.doi.org/10.1038/447529a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	172YZ	17538599	Green Submitted			2022-12-28	WOS:000246842000023
J	Evans, EA; Calderwood, DA				Evans, Evan A.; Calderwood, David A.			Forces and bond dynamics in cell adhesion	SCIENCE			English	Review							P-SELECTIN DETACHMENT; LEUKOCYTE INTERFACES; INTEGRIN ACTIVATION; MICROSCALE DYNAMICS; TALIN; CYTOSKELETON; BINDING; ACTIN; FLOW; DISSOCIATION	Adhesion of a biological cell to another cell or the extracellular matrix involves complex couplings between cell biochemistry, structural mechanics, and surface bonding. The interactions are dynamic and act through association and dissociation of bonds between very large molecules at rates that change considerably under stress. Combining molecular cell biology with single-molecule force spectroscopy provides a powerful tool for exploring the complexity of cell adhesion, that is, how cell signaling processes strengthen adhesion bonds and how forces applied to cell-surface bonds act on intracellular sites to catalyze chemical processes or switch molecular interactions on and off. Probing adhesion receptors on strategically engineered cells with force during functional stimulation can reveal key nodes of communication between the mechanical and chemical circuitry of a cell.	Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V6T 2A6, Canada; Univ British Columbia, Dept Phys & Astron, Vancouver, BC V6T 2A6, Canada; Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Interdept Program Vasc Biol & Transplantat, New Haven, CT 06520 USA	Boston University; University of British Columbia; University of British Columbia; Yale University; Yale University	Evans, EA (corresponding author), Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.	evans@physics.ubc.ca	Calderwood, David A/AAC-6954-2019	Calderwood, David A/0000-0002-0791-4142				Alon R, 2007, IMMUNITY, V26, P17, DOI 10.1016/j.immuni.2007.01.002; Arnaout MA, 2005, ANNU REV CELL DEV BI, V21, P381, DOI 10.1146/annurev.cellbio.21.090704.151217; Bayas MV, 2006, BIOPHYS J, V90, P1385, DOI 10.1529/biophysj.105.069583; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Brown CM, 2006, J CELL SCI, V119, P5204, DOI 10.1242/jcs.03321; Calderwood DA, 2003, P NATL ACAD SCI USA, V100, P2272, DOI 10.1073/pnas.262791999; Calderwood DA, 2004, J CELL SCI, V117, P657, DOI 10.1242/jcs.01014; Calderwood DA, 2003, NAT CELL BIOL, V5, P694, DOI 10.1038/ncb0803-694; Carman CV, 2003, CURR OPIN CELL BIOL, V15, P547, DOI 10.1016/j.ceb.2003.08.003; Chen X, 2006, CURR OPIN CELL BIOL, V18, P572, DOI 10.1016/j.ceb.2006.07.002; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Evans E, 1997, BIOPHYS J, V72, P1541, DOI 10.1016/S0006-3495(97)78802-7; Evans E, 2005, BIOPHYS J, V88, P2288, DOI 10.1529/biophysj.104.051698; Evans E, 2001, ANNU REV BIOPH BIOM, V30, P105, DOI 10.1146/annurev.biophys.30.1.105; Evans E, 2004, P NATL ACAD SCI USA, V101, P11281, DOI 10.1073/pnas.0401870101; EVANS E, 2007, METHODS CELL BIOL CE, V83, pCH16; Garcia-Alvarez B, 2003, MOL CELL, V11, P49, DOI 10.1016/S1097-2765(02)00823-7; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Geiger B, 2002, CELL, V110, P139, DOI 10.1016/S0092-8674(02)00831-0; Giannone G, 2006, TRENDS CELL BIOL, V16, P213, DOI 10.1016/j.tcb.2006.02.005; Giannone G, 2003, J CELL BIOL, V163, P409, DOI 10.1083/jcb.200302001; Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; He WZ, 2003, SCIENCE, V302, P109, DOI 10.1126/science.1086957; Heinrich V, 2005, BIOPHYS J, V88, P2299, DOI 10.1529/biophysj.104.051706; Hu K, 2007, SCIENCE, V315, P111, DOI 10.1126/science.1135085; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jiang GY, 2003, NATURE, V424, P334, DOI 10.1038/nature01805; Kiema T, 2006, MOL CELL, V21, P337, DOI 10.1016/j.molcel.2006.01.011; King MR, 2005, BIOPHYS J, V88, P1676, DOI 10.1529/biophysj.104.051805; Leckband D, 2006, ANNU REV BIOMED ENG, V8, P259, DOI 10.1146/annurev.bioeng.8.061505.095753; Liu SC, 2000, J CELL SCI, V113, P3563; Luo BH, 2006, CURR OPIN CELL BIOL, V18, P579, DOI 10.1016/j.ceb.2006.08.005; Marshall BT, 2003, NATURE, V423, P190, DOI 10.1038/nature01605; McEver RP, 2002, CURR OPIN CELL BIOL, V14, P581, DOI 10.1016/S0955-0674(02)00367-8; Orr AW, 2006, DEV CELL, V10, P11, DOI 10.1016/j.devcel.2005.12.006; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Perret E, 2004, P NATL ACAD SCI USA, V101, P16472, DOI 10.1073/pnas.0402085101; Sawada Y, 2006, CELL, V127, P1015, DOI 10.1016/j.cell.2006.09.044; Sixt M, 2006, CURR OPIN CELL BIOL, V18, P482, DOI 10.1016/j.ceb.2006.08.007; Sotomayor M, 2007, SCIENCE, V316, P1144, DOI 10.1126/science.1137591; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Tzima E, 2005, NATURE, V437, P426, DOI 10.1038/nature03952; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; Wulfing C, 1998, SCIENCE, V282, P2266, DOI 10.1126/science.282.5397.2266; Ziegler WH, 2006, TRENDS CELL BIOL, V16, P453, DOI 10.1016/j.tcb.2006.07.004	46	388	407	4	163	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 25	2007	316	5828					1148	1153		10.1126/science.1137592	http://dx.doi.org/10.1126/science.1137592			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171GQ	17525329				2022-12-28	WOS:000246724300031
J	Giblin, S				Giblin, Stephen			One electron makes current flow	SCIENCE			English	Editorial Material							OPERATION; PUMP		Natl Phys Lab, Quantum Detect Grp, Teddington TW11 0LW, Middx, England	National Physical Laboratory - UK	Giblin, S (corresponding author), Natl Phys Lab, Quantum Detect Grp, Teddington TW11 0LW, Middx, England.	stephen.giblin@npl.co.uk						Blumenthal MD, 2007, NAT PHYS, V3, P343, DOI 10.1038/nphys582; DEVORET MH, 1992, NATURE, V360, P547, DOI 10.1038/360547a0; DOLAN GJ, 1988, PHYSICA B, V152, P7, DOI 10.1016/0921-4526(88)90060-9; Feve G, 2007, SCIENCE, V316, P1169, DOI 10.1126/science.1141243; Gabelli J, 2006, SCIENCE, V313, P499, DOI 10.1126/science.1126940; Keller MW, 1997, IEEE T INSTRUM MEAS, V46, P307, DOI 10.1109/19.571841; Likharev KK, 1999, P IEEE, V87, P606, DOI 10.1109/5.752518; Lotkhov SV, 2001, APPL PHYS LETT, V78, P946, DOI 10.1063/1.1347017; Stace TM, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.126804; van Houten H., 1992, SINGLE CHARGE TUNNEL	10	1	1	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 25	2007	316	5828					1130	1131		10.1126/science.1143429	http://dx.doi.org/10.1126/science.1143429			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	171GQ	17525321				2022-12-28	WOS:000246724300022
J	Henderson, IR; Jacobsen, SE				Henderson, Ian R.; Jacobsen, Steven E.			Epigenetic inheritance in plants	NATURE			English	Review							DIRECTED DNA METHYLATION; MEDEA POLYCOMB GENE; ARABIDOPSIS-THALIANA; RNA-POLYMERASE; HISTONE METHYLATION; PROCESSING CENTER; DOMAIN PROTEIN; PARAMUTATION; HETEROCHROMATIN; VERNALIZATION	The function of plant genomes depends on chromatin marks such as the methylation of DNA and the posttranslational modification of histones. Techniques for studying model plants such as Arabidopsis thaliana have enabled researchers to begin to uncover the pathways that establish and maintain chromatin modifications, and genomic studies are allowing the mapping of modifications such as DNA methylation on a genome-wide scale. Small RNAs seem to be important in determining the distribution of chromatin modifications, and RNA might also underlie the complex epigenetic interactions that occur between homologous sequences. Plants use these epigenetic silencing mechanisms extensively to control development and parent-of-origin imprinted gene expression.	Univ Calif Los Angeles, Howard Hughes Med Inst, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA	Howard Hughes Medical Institute; University of California System; University of California Los Angeles	Jacobsen, SE (corresponding author), Univ Calif Los Angeles, Howard Hughes Med Inst, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.	jacobsen@ucla.edu	Henderson, Ian/A-2174-2012	Henderson, Ian/0000-0001-5066-1489				Agius F, 2006, P NATL ACAD SCI USA, V103, P11796, DOI 10.1073/pnas.0603563103; Alleman M, 2006, NATURE, V442, P295, DOI 10.1038/nature04884; Aufsatz W, 2002, P NATL ACAD SCI USA, V99, P16499, DOI 10.1073/pnas.162371499; Baroux U, 2006, GENE DEV, V20, P1081, DOI 10.1101/gad.378106; Barreto G, 2007, NATURE, V445, P671, DOI 10.1038/nature05515; Bastow R, 2004, NATURE, V427, P164, DOI 10.1038/nature02269; Bejerano G, 2006, NATURE, V441, P87, DOI 10.1038/nature04696; Bernard P, 2001, SCIENCE, V294, P2539, DOI 10.1126/science.1064027; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Cao XF, 2002, CURR BIOL, V12, P1138, DOI 10.1016/S0960-9822(02)00925-9; Cao XF, 2002, P NATL ACAD SCI USA, V99, P16491, DOI 10.1073/pnas.162371599; Cao XF, 2003, CURR BIOL, V13, P2212, DOI 10.1016/j.cub.2003.11.052; Chan SWL, 2006, PLOS BIOL, V4, P1923, DOI 10.1371/journal.pbio.0040363; Chan SWL, 2006, PLOS GENET, V2, P791, DOI 10.1371/journal.pgen.0020083; Chan SWL, 2004, SCIENCE, V303, P1336, DOI 10.1126/science.1095989; Chandler VL, 2004, NAT REV GENET, V5, P532, DOI 10.1038/nrg1378; Choi YH, 2002, CELL, V110, P33, DOI 10.1016/S0092-8674(02)00807-3; Comfort NC, 2001, TRENDS BIOCHEM SCI, V26, P454, DOI 10.1016/S0968-0004(01)01898-9; Danilevskaya ON, 2003, PLANT CELL, V15, P425, DOI 10.1105/tpc.006759; Fransz PF, 1996, PLANT J, V9, P421, DOI 10.1046/j.1365-313X.1996.09030421.x; Gehring M, 2006, CELL, V124, P495, DOI 10.1016/j.cell.2005.12.034; Gehring M, 2004, PLANT CELL, V16, pS203, DOI 10.1105/tpc.017988; Gendall AR, 2001, CELL, V107, P525, DOI 10.1016/S0092-8674(01)00573-6; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Gong ZH, 2002, CELL, V111, P803, DOI 10.1016/S0092-8674(02)01133-9; Gregory TR, 2005, ANN BOT-LONDON, V95, P133, DOI 10.1093/aob/mci009; Gutierrez-Marcos JF, 2006, NAT GENET, V38, P876, DOI 10.1038/ng1828; Hall Ira M., 2003, P205; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Henderson IR, 2006, NAT GENET, V38, P721, DOI 10.1038/ng1804; Herman H, 2003, NAT GENET, V34, P199, DOI 10.1038/ng1162; Herr AJ, 2005, SCIENCE, V308, P118, DOI 10.1126/science.1106910; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Jacobsen SE, 1997, SCIENCE, V277, P1100, DOI 10.1126/science.277.5329.1100; JOST JP, 1995, J BIOL CHEM, V270, P9734, DOI 10.1074/jbc.270.17.9734; Jullien PE, 2006, PLANT CELL, V18, P1360, DOI 10.1105/tpc.106.041178; Jullien PE, 2006, CURR BIOL, V16, P486, DOI 10.1016/j.cub.2006.01.020; Kankel MW, 2003, GENETICS, V163, P1109; Kanno T, 2005, NAT GENET, V37, P761, DOI 10.1038/ng1580; Kanno T, 2004, CURR BIOL, V14, P801, DOI 10.1016/j.cub.2004.04.037; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kinoshita T, 1999, PLANT CELL, V11, P1945, DOI 10.1105/tpc.11.10.1945; Kinoshita T, 2004, SCIENCE, V303, P521, DOI 10.1126/science.1089835; Kinoshita Y, 2007, PLANT J, V49, P38, DOI 10.1111/j.1365-313X.2006.02936.x; Kohler C, 2002, CURR OPIN CELL BIOL, V14, P773, DOI 10.1016/S0955-0674(02)00394-0; Levy YY, 2002, SCIENCE, V297, P243, DOI 10.1126/science.1072147; Li CF, 2006, CELL, V126, P93, DOI 10.1016/j.cell.2006.05.032; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Lisch D, 2002, P NATL ACAD SCI USA, V99, P6130, DOI 10.1073/pnas.052152199; Liu J, 2004, GENE DEV, V18, P2873, DOI 10.1101/gad.1217304; Lu C, 2005, SCIENCE, V309, P1567, DOI 10.1126/science.1114112; Mager J, 2003, NAT GENET, V33, P502, DOI 10.1038/ng1125; Malagnac F, 2002, EMBO J, V21, P6842, DOI 10.1093/emboj/cdf687; Matzke M, 2001, SCIENCE, V293, P1080, DOI 10.1126/science.1063051; Mochizuki K, 2002, CELL, V110, P689, DOI 10.1016/S0092-8674(02)00909-1; Morales-Ruiz T, 2006, P NATL ACAD SCI USA, V103, P6853, DOI 10.1073/pnas.0601109103; Mylne JS, 2006, P NATL ACAD SCI USA, V103, P5012, DOI 10.1073/pnas.0507427103; Onodera Y, 2005, CELL, V120, P613, DOI 10.1016/j.cell.2005.02.007; Pontes O, 2006, CELL, V126, P79, DOI 10.1016/j.cell.2006.05.031; Pontier D, 2005, GENE DEV, V19, P2030, DOI 10.1101/gad.348405; Qi YJ, 2006, NATURE, V443, P1008, DOI 10.1038/nature05198; Saze H, 2003, NAT GENET, V34, P65, DOI 10.1038/ng1138; Shiba H, 2006, NAT GENET, V38, P297, DOI 10.1038/ng1734; Soppe WJJ, 2000, MOL CELL, V6, P791, DOI 10.1016/S1097-2765(05)00090-0; Stam M, 2002, GENE DEV, V16, P1906, DOI 10.1101/gad.1006702; Stam M, 2002, GENETICS, V162, P917; Sung SB, 2004, NATURE, V427, P159, DOI 10.1038/nature02195; Sung SB, 2006, GENE DEV, V20, P3244, DOI 10.1101/gad.1493306; Sung SB, 2006, NAT GENET, V38, P706, DOI 10.1038/ng1795; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; WASSENEGGER M, 1994, CELL, V76, P567, DOI 10.1016/0092-8674(94)90119-8; Woodhouse MR, 2006, PLOS BIOL, V4, P1678, DOI 10.1371/journal.pbio.0040339; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695; Zilberman D, 2004, CURR BIOL, V14, P1214, DOI 10.1016/j.cub.2004.06.055; Zilberman D, 2007, NAT GENET, V39, P61, DOI 10.1038/ng1929	77	584	630	6	205	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 24	2007	447	7143					418	424		10.1038/nature05917	http://dx.doi.org/10.1038/nature05917			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170VA	17522675				2022-12-28	WOS:000246693100037
J	Cuzick, J; Ambroisine, L; Davidson, N; Jakesz, R; Kaufmann, M; Regan, M; Sainsbury, R				Cuzick, J.; Ambroisine, L.; Davidson, N.; Jakesz, R.; Kaufmann, M.; Regan, M.; Sainsbury, R.		LHRH agonists Early Breast Canc Ov	Use of luteinising-hormone-releasing hormone agonists as adjuvant treatment in premenopausal patients with hormone-receptor-positive breast cancer: a meta-analysis of individual patient data from randomised adjuvant trials	LANCET			English	Article							QUALITY-OF-LIFE; OVARIAN SUPPRESSION; GOSERELIN; CHEMOTHERAPY; CYCLOPHOSPHAMIDE; FLUOROURACIL; METHOTREXATE; TAMOXIFEN; THERAPY; WOMEN	Background Several trials have been done to assess treatment of premenopausal breast cancer with luteinising-hormone-releasing hormone (LHRH) agonists, but results have been inconclusive, especially for patients with hormone-receptor-positive cancer. Methods We collected individual patients' data from published trials and did analyses focused on women with tumours positive for oestrogen receptor, progesterone receptor, or both. The main endpoints were recurrence and death after recurrence. Findings We obtained data for 11906 premenopausal women with early breast cancer randomised in 16 trials. When used as the only systemic adjuvant treatment, LHRH agonists did not significantly reduce recurrence (28.4% relative reduction, 95% CI consistent with 50.5% reduction to 3.5% increase, p=0.08) or death after recurrence (17.8%, 52.8% reduction to 42.9% increase, p=0.49) in hormone-receptor-positive cancers. Addition of LHRH agonists to tamoxifen, chemotherapy, or both reduced recurrence by 12.7% (2.4-21.9, p=0.02); and death after recurrence by 15.1% (1.8-26.7, p=0.03). LHRH agonists showed similar efficacy to chemotherapy (recurrence 3.9% increase, 7.7% reduction to 17.0% increase; death after recurrence 6.7% reduction, 20.7% reduction to 9.6% increase; both not significant). No trials had assessed an LHRH agonist versus chemotherapy with tamoxifen in both arms. LHRH agonists were ineffective in hormone-receptor-negative tumours. Interpretation LHRH agonists provide an additional class of agents for treatment of premenopausal women with hormone-receptor-positive breast cancer. Optimum duration of use is unknown.	Univ London, Queen Marys Sch Med & Dent, Canc Res UK Ctr Epidemiol Math & Stat, Wolfson Inst Prevent Med, London EC1M 6BQ, England; Johns Hopkins Univ, Sydney Kimmel Comprehens Canc Ctr, Baltimore, MD USA; Med Univ Vienna, Vienna, Austria; Goethe Univ Frankfurt, Frauenklin, D-6000 Frankfurt, Germany; Dana Farber Canc Inst, Boston, MA 02115 USA; UCL, Dept Surg, London, England	Cancer Research UK; University of London; Queen Mary University London; Johns Hopkins University; Johns Hopkins Medicine; Medical University of Vienna; Goethe University Frankfurt; Harvard University; Dana-Farber Cancer Institute; University of London; University College London	Cuzick, J (corresponding author), Univ London, Queen Marys Sch Med & Dent, Canc Res UK Ctr Epidemiol Math & Stat, Wolfson Inst Prevent Med, London EC1M 6BQ, England.	jack.cuzick@cancer.org.uk						Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Arriagada R, 2005, ANN ONCOL, V16, P389, DOI 10.1093/annonc/mdi085; Baum M, 2006, EUR J CANCER, V42, P895, DOI 10.1016/j.ejca.2005.12.013; Bernhard J, 2007, J CLIN ONCOL, V25, P263, DOI 10.1200/JCO.2005.04.5393; Bliss JM, 2007, JNCI-J NATL CANCER I, V99, P516, DOI 10.1093/jnci/djk109; Boccardo F, 2000, J CLIN ONCOL, V18, P2718, DOI 10.1200/JCO.2000.18.14.2718; Castiglione-Gertsch M, 2003, JNCI-J NATL CANCER I, V95, P1833, DOI 10.1093/jnci/djg119; Davidson NE, 2005, J CLIN ONCOL, V23, P5973, DOI 10.1200/JCO.2005.05.551; de Haes H, 2003, J CLIN ONCOL, V21, P4510, DOI 10.1200/JCO.2003.11.064; De Placido S, 2005, BRIT J CANCER, V92, P467, DOI 10.1038/sj.bjc.6602355; FALKSON CI, 1991, EUR J CANCER, V27, P1208, DOI 10.1016/0277-5379(91)90082-O; Francis P., 2003, Breast, V12, pS44, DOI 10.1016/S0960-9776(03)80143-1; Gnant M, 2004, BREAST CANCER RES TR, V88, pS8; Jakesz R, 2002, J CLIN ONCOL, V20, P4621, DOI 10.1200/JCO.2002.09.112; Jonat W, 2002, J CLIN ONCOL, V20, P4628, DOI 10.1200/JCO.2002.05.042; Kaufmann M, 2004, J CLIN ONCOL, V22, p24S; Kaufmann M, 2003, EUR J CANCER, V39, P1711, DOI 10.1016/S0959-8049(03)00392-7; Mitsuyama Shosyu, 2005, Gan To Kagaku Ryoho, V32, P2071; Petrek JA, 2006, J CLIN ONCOL, V24, P1045, DOI 10.1200/JCO.2005.03.3969; Roche H, 2006, ANN ONCOL, V17, P1221, DOI 10.1093/annonc/mdl107; Sharp Sterne J, 1997, STATA TECH B, V7, P9; von Minckwitz G, 2006, EUR J CANCER, V42, P1780, DOI 10.1016/j.ejca.2006.04.006; Wallwiener D, 2004, J CLIN ONCOL, V22, p10S	23	286	308	0	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 20	2007	369	9574					1711	1723						13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	169ZT	17512856				2022-12-28	WOS:000246631300027
J	He, L; He, XY; Lim, LP; De Stanchina, E; Xuan, ZY; Liang, Y; Xue, W; Zender, L; Magnus, J; Ridzon, D; Jackson, AL; Linsley, PS; Chen, CF; Lowe, SW; Cleary, MA; Hannon, GJ				He, Lin; He, Xingyue; Lim, Lee P.; De Stanchina, Elisa; Xuan, Zhenyu; Liang, Yu; Xue, Wen; Zender, Lars; Magnus, Jill; Ridzon, Dana; Jackson, Aimee L.; Linsley, Peter S.; Chen, Caifu; Lowe, Scott W.; Cleary, Michele A.; Hannon, Gregory J.			A microRNA component of the p53 tumour suppressor network	NATURE			English	Article							SHORT-INTERFERING RNAS; HUMAN CANCERS; EXPRESSION; TRANSCRIPTION; RESPONSES; PATHWAY; TARGETS; GENES; PCR	A global decrease in microRNA (miRNA) levels is often observed in human cancers(1,2), indicating that small RNAs may have an intrinsic function in tumour suppression. To identify miRNA components of tumour suppressor pathways, we compared miRNA expression profiles of wild-type and p53-deficient cells. Here we describe a family of miRNAs, miR-34a-c, whose expression reflected p53 status. Genes encoding miRNAs in the miR-34 family are direct transcriptional targets of p53, whose induction by DNA damage and oncogenic stress depends on p53 both in vitro and in vivo. Ectopic expression of miR-34 induces cell cycle arrest in both primary and tumour-derived cell lines, which is consistent with the observed ability of miR-34 to downregulate a programme of genes promoting cell cycle progression. The p53 network suppresses tumour formation through the coordinated activation of multiple transcriptional targets, and miR-34 may act in concert with other effectors to inhibit inappropriate cell proliferation.	Rosetta Inpharmat, Seattle, WA 98109 USA; Cold Spring Harbor Lab, Howard Hughes Med Inst, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; SUNY Stony Brook, Genet Program, Stony Brook, NY 11794 USA; Appl Biosyst Inc, Adv Res & Technol, Foster City, CA 94404 USA	Merck & Company; Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Thermo Fisher Scientific; Applied Biosystems	Cleary, MA (corresponding author), Rosetta Inpharmat, 401 Terry Ave N, Seattle, WA 98109 USA.	michele_cleary@merck.com; hannon@cshl.org	Hannon, Gregory/AAB-3568-2019	Xuan, Zhenyu/0000-0001-9344-8493; Jackson, Aimee/0000-0002-3786-7391; Xue, Wen/0000-0002-9797-8042	NCI NIH HHS [K99 CA126186-01, K99 CA126186, P01 CA087497, P01 CA013106, P30 CA008748] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA087497, P30CA008748, P01CA013106, K99CA126186] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bagchi A, 2007, CELL, V128, P459, DOI 10.1016/j.cell.2006.11.052; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BRUGAROLAS J, 1995, NATURE, V377, P552, DOI 10.1038/377552a0; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Calin GA, 2004, P NATL ACAD SCI USA, V101, P11755, DOI 10.1073/pnas.0404432101; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; Fei PW, 2003, ONCOGENE, V22, P5774, DOI 10.1038/sj.onc.1206677; Giaccia AJ, 1998, GENE DEV, V12, P2973, DOI 10.1101/gad.12.19.2973; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; Levine AJ, 2006, CELL DEATH DIFFER, V13, P1027, DOI 10.1038/sj.cdd.4401910; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lohr K, 2003, J BIOL CHEM, V278, P32507, DOI 10.1074/jbc.M212517200; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; MIYASHITA T, 1995, CELL, V80, P293; Raymond CK, 2005, RNA, V11, P1737, DOI 10.1261/rna.2148705; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Sherr CJ, 2000, CURR OPIN GENET DEV, V10, P94, DOI 10.1016/S0959-437X(99)00038-6; Spurgers KB, 2006, J BIOL CHEM, V281, P25134, DOI 10.1074/jbc.M513901200; Sutcliffe JE, 2004, FEBS LETT, V567, P86, DOI 10.1016/j.febslet.2004.03.122; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; WELCH C, 2007, ONCOGENE; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529	29	2129	2301	5	310	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 28	2007	447	7148					1130	U16		10.1038/nature05939	http://dx.doi.org/10.1038/nature05939			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	183HT	17554337	Green Accepted			2022-12-28	WOS:000247564600041
J	Cassel, CK; Brennan, TE				Cassel, Christine K.; Brennan, Troyen E.			Managing medical resources - Return to the commons?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PHYSICIAN CHARTER; PROFESSIONALISM; PERFORMANCE; MILLENNIUM; PAY		Amer Board Internal Med, Philadelphia, PA 19106 USA; Aetna Inc, Hartford, CT USA	American Board of Internal Medicine	Cassel, CK (corresponding author), Amer Board Internal Med, 510 Walnut St,Suite 1700, Philadelphia, PA 19106 USA.	ccassel@abim.org						*AMB CAR QUAL ALL, 2005, 3 INV M SUMM REP PER; BARR M, 2006, ADV MED HOME PATIENT; Blank L, 2003, ANN INTERN MED, V138, P839, DOI 10.7326/0003-4819-138-10-200305200-00012; CROSSON J, 2004, KAIS PERM I HLTH POL; Cutler D., 2005, YOUR MONEY YOUR LIFE; DANIELS N, 1986, NEW ENGL J MED, V314, P1380, DOI 10.1056/NEJM198605223142109; ENTHOVEN A, 2004, 21 CENTURY HLTH SYST; *FDN RES ED AM HLT, 2006, DEV STAT LEV HLTH IN; Fisher ES, 2007, HEALTH AFFAIR, V26, pW44, DOI 10.1377/hlthaff.26.1.w44; Gruen RL, 2006, JAMA-J AM MED ASSOC, V296, P2467, DOI 10.1001/jama.296.20.2467; HIATT HH, 1975, NEW ENGL J MED, V293, P235, DOI 10.1056/NEJM197507312930506; Institute of Medicine's Committee on the Consequences of Uninsurance, 2004, INS AM HLTH PRINC RE; Kindig DA, 2006, JAMA-J AM MED ASSOC, V296, P2611, DOI 10.1001/jama.296.21.2611; Lipner RS, 2006, ANN INTERN MED, V144, P29, DOI 10.7326/0003-4819-144-1-200601030-00007; Pham HH, 2007, NEW ENGL J MED, V356, P1130, DOI 10.1056/NEJMsa063979; PLESTED WG, 2006, AMNEWS          1016; REICHARD J, 2007, CQ HEALTHNEWS   0109; Sox HC, 2002, ANN INTERN MED, V136, P243, DOI 10.7326/0003-4819-136-3-200202050-00012; Starr P, 1982, SOCIAL TRANSFORMATIO	19	27	27	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 13	2007	297	22					2518	2521		10.1001/jama.297.22.2518	http://dx.doi.org/10.1001/jama.297.22.2518			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	177TX	17565087				2022-12-28	WOS:000247176500027
J	Lipsky, PE				Lipsky, Peter E.			Why does rheumatoid arthritis involve the joints?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									NIAMSD, Autoimmun Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Lipsky, PE (corresponding author), NIAMSD, Autoimmun Branch, NIH, Bethesda, MD 20892 USA.							Amano T, 2003, GENE DEV, V17, P2436, DOI 10.1101/gad.1096603; Huber LC, 2006, RHEUMATOLOGY, V45, P669, DOI 10.1093/rheumatology/kel065; Lee DM, 2007, SCIENCE, V315, P1006, DOI 10.1126/science.1137306; Lipsky PE, 2000, NEW ENGL J MED, V343, P1594, DOI 10.1056/NEJM200011303432202; Lipsky PE, 2005, HARRISONS PRINCIPLES, P1968	5	24	28	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 7	2007	356	23					2419	2420		10.1056/NEJMcibr070846	http://dx.doi.org/10.1056/NEJMcibr070846			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	175QY	17554126				2022-12-28	WOS:000247029300015
J	Turner, S; Tonarini, S; Bindeman, I; Leeman, WP; Schaefer, BF				Turner, Simon; Tonarini, Sonia; Bindeman, Ilya; Leeman, William P.; Schaefer, Bruce F.			Boron and oxygen isotope evidence for recycling of subducted components over the past 2.5 Gyr	NATURE			English	Article							ENRICHED MANTLE BENEATH; SAO-MIGUEL; LITHIUM; GEOCHEMISTRY; GENERATION; BERYLLIUM; BASALTS; SAMPLES; ORIGIN; AZORES	Evidence for the deep recycling of surficial materials through the Earth's mantle and their antiquity has long been sought to understand the role of subducting plates and plumes in mantle convection. Radiogenic isotope evidence for such recycling remains equivocal because the age and location of parent-daughter fractionation are not known. Conversely, while stable isotopes can provide irrefutable evidence for low-temperature fractionation, their range in most unaltered oceanic basalts is limited and the age of any variation is unconstrained. Here we show that delta O-18 ratios in basalts from the Azores are often lower than in pristine mantle. This, combined with increased Nb/B ratios and a large range in delta B-11 ratios, provides compelling evidence for the recycling of materials that had undergone fractionation near the Earth's surface. Moreover, delta B-11 is negatively correlated with Os-187/Os-188 ratios, which extend to subchondritic values(1), constraining the age of the high Nb/B, B-11-enriched endmember to be more than 2.5 billion years ( Gyr) old. We infer this component to be melt- and fluid-depleted lithospheric mantle from a subducted oceanic plate, whereas other Azores basalts contain a contribution from similar to 3-Gyr-old melt-enriched basalt(2). We conclude that both components are most probably derived from an Archaean oceanic plate that was subducted, arguably into the deep mantle, where it was stored until thermal buoyancy caused it to rise beneath the Azores islands 3 Gyr later.	Macquarie Univ, GEMOC, Dept Earth & Planetary Sci, N Ryde, NSW 2109, Australia; Ist Geosci & Georisorse, I-56147 Pisa, Italy; Univ Wisconsin, Dept Geol & Geophys, Madison, WI 53706 USA; Natl Sci Fdn, Arlington, VA 22230 USA; Monash Univ, Sch Geosci, Clayton, Vic 3800, Australia	Macquarie University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Geoscienze e Georisorse (IGG-CNR); University of Wisconsin System; University of Wisconsin Madison; National Science Foundation (NSF); Monash University	Turner, S (corresponding author), Macquarie Univ, GEMOC, Dept Earth & Planetary Sci, N Ryde, NSW 2109, Australia.	sturner@els.mq.edu.au	Bindeman, Ilya N/D-2497-2012; Schaefer, Bruce F/C-8718-2018; GAU, geochemist/H-1985-2016; Turner, Simon/0000-0002-6426-6495	Bindeman, Ilya N/0000-0003-2778-9083; Schaefer, Bruce F/0000-0002-7366-0152; Turner, Simon/0000-0002-6426-6495				Bourdon B, 2005, EARTH PLANET SC LETT, V239, P42, DOI 10.1016/j.epsl.2005.08.008; Brenan JM, 1998, GEOCHIM COSMOCHIM AC, V62, P2129, DOI 10.1016/S0016-7037(98)00131-8; Brenan JM, 1998, GEOCHIM COSMOCHIM AC, V62, P3337, DOI 10.1016/S0016-7037(98)00224-5; CHAUSSIDON M, 1995, SCIENCE, V269, P383, DOI 10.1126/science.269.5222.383; CHAUSSIDON M, 1994, EARTH PLANET SC LETT, V121, P277, DOI 10.1016/0012-821X(94)90073-6; Cooper KM, 2004, EARTH PLANET SC LETT, V220, P297, DOI 10.1016/S0012-821X(04)00058-5; DEPAOLO DJ, 1976, GEOPHYS RES LETT, V3, P743, DOI 10.1029/GL003i012p00743; Eiler JM, 2001, REV MINERAL GEOCHEM, V43, P319, DOI 10.2138/gsrmg.43.1.319; Elliott T, 2007, GEOCHIM COSMOCHIM AC, V71, P219, DOI 10.1016/j.gca.2006.07.043; Elliott T, 2006, NATURE, V443, P565, DOI 10.1038/nature05144; Hofmann AW, 1997, NATURE, V385, P219, DOI 10.1038/385219a0; Hutko AR, 2006, NATURE, V441, P333, DOI 10.1038/nature04757; ISHIKAWA T, 1992, GEOCHIM COSMOCHIM AC, V56, P1633, DOI 10.1016/0016-7037(92)90230-G; Le Roux PJ, 2005, GEOCHIM COSMOCHIM AC, V69, pA94; Leeman WP, 2004, CHEM GEOL, V212, P101, DOI 10.1016/j.chemgeo.2004.08.010; LEEMAN WP, 1991, GEOCHIM COSMOCHIM AC, V55, P3901, DOI 10.1016/0016-7037(91)90085-J; MCKENZIE D, 1995, J PETROL, V36, P133, DOI 10.1093/petrology/36.1.133; Montelli R, 2004, SCIENCE, V303, P338, DOI 10.1126/science.1092485; Nakano T, 2001, PHYS EARTH PLANET IN, V127, P233, DOI 10.1016/S0031-9201(01)00230-8; Roy-Barman M, 1998, EARTH PLANET SC LETT, V154, P331, DOI 10.1016/S0012-821X(97)00180-5; Ryan JG, 1996, GEOCHIM COSMOCHIM AC, V60, P415, DOI 10.1016/0016-7037(95)00402-5; Salters VJM, 2004, GEOCHEM GEOPHY GEOSY, V5, DOI 10.1029/2003GC000597; Schaefer BF, 2002, NATURE, V420, P304, DOI 10.1038/nature01172; Sun S.-S., 1989, GEOLOGICAL SOC LONDO, V42, P323, DOI [10.1144/GSL.SP.1989.042.01.19, DOI 10.1144/GSL.SP.1989.042.01.19]; Tonarini S, 1997, CHEM GEOL, V142, P129, DOI 10.1016/S0009-2541(97)00087-9; Turner S, 1997, CHEM GEOL, V139, P145, DOI 10.1016/S0009-2541(97)00031-4; Valley JW, 1995, GEOCHIM COSMOCHIM AC, V59, P5223, DOI 10.1016/0016-7037(95)00386-X; van Keken PE, 2002, ANNU REV EARTH PL SC, V30, P493, DOI 10.1146/annurev.earth.30.091201.141236; Widom E, 2003, CHEM GEOL, V193, P237, DOI 10.1016/S0009-2541(02)00264-4; Widom E, 2002, NATURE, V420, P281, DOI 10.1038/420281a	30	56	56	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 7	2007	447	7145					702	705		10.1038/nature05898	http://dx.doi.org/10.1038/nature05898			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175RI	17554305				2022-12-28	WOS:000247030700041
J	Marris, E				Marris, Emma			Counting the chemicals	NATURE			English	News Item																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 31	2007	447	7144					516	517						2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172YZ	17563934				2022-12-28	WOS:000246842000010
J	Trepat, X; Deng, LH; An, SS; Navajas, D; Tschumperlin, DJ; Gerthoffer, WT; Butler, JP; Fredberg, JJ				Trepat, Xavier; Deng, Linhong; An, Steven S.; Navajas, Daniel; Tschumperlin, Daniel J.; Gerthoffer, William T.; Butler, James P.; Fredberg, Jeffrey J.			Universal physical responses to stretch in the living cell	NATURE			English	Article							AIRWAY SMOOTH-MUSCLE; SLOW DYNAMICS; FORCE; VISCOELASTICITY; RHEOLOGY; BEHAVIOR	With every beat of the heart, inflation of the lung or peristalsis of the gut, cell types of diverse function are subjected to substantial stretch. Stretch is a potent stimulus for growth, differentiation, migration, remodelling and gene expression(1,2). Here, we report that in response to transient stretch the cytoskeleton fluidizes in such a way as to define a universal response class. This finding implicates mechanisms mediated not only by specific signalling intermediates, as is usually assumed, but also by non-specific actions of a slowly evolving network of physical forces. These results support the idea that the cell interior is at once a crowded chemical space(3) and a fragile soft material in which the effects of biochemistry, molecular crowding and physical forces are complex and inseparable, yet conspire nonetheless to yield remarkably simple phenomenological laws. These laws seem to be both universal and primitive, and thus comprise a striking intersection between the worlds of cell biology and soft matter physics.	Harvard Univ, Sch Publ Hlth, Program Mol & Integrat Physiol Sci, Boston, MA 02115 USA; Chongqing Univ, Bioengn Coll, Project Lab Biomech & Tissue Repair 111, Chongqing 400044, Peoples R China; Johns Hopkins Bloomberg Sch Publ Hlth, Div Physiol, Baltimore, MD 21205 USA; Univ Barcelona, IDIBAPS, Unitat Biofis & Bioengn, E-08036 Barcelona, Spain; Inst Bioengn Catalunya, E-08036 Barcelona, Spain; Univ Nevada, Sch Med, Dept Pharmacol, Reno, NV 89557 USA	Harvard University; Harvard T.H. Chan School of Public Health; Chongqing University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Barcelona Institute of Science & Technology; Institut de Bioenginyeria de Catalunya; University of Barcelona; Nevada System of Higher Education (NSHE); University of Nevada Reno	Fredberg, JJ (corresponding author), Harvard Univ, Sch Publ Hlth, Program Mol & Integrat Physiol Sci, 665 Huntington Ave, Boston, MA 02115 USA.	jeffrey_fredberg@harvard.edu	Trepat, Xavier/I-3912-2015; Fredberg, Jeffrey/M-9877-2019; Deng, Linhong/C-1485-2009; An, Steven/AAM-3848-2020; Deng, Linhong/O-3218-2019; Navajas, Daniel/E-4233-2010	Trepat, Xavier/0000-0002-7621-5214; Deng, Linhong/0000-0003-1970-8239; An, Steven/0000-0003-4723-1888; Navajas, Daniel/0000-0001-7150-9363; Gerthoffer, William/0000-0001-5154-4962	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065960, P01HL033009, R01HL102373, R01HL084224] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL065960, P01 HL033009-06, P01 HL033009, R01 HL065960-07, R01 HL084224, R01 HL084224-03, R01 HL102373] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Alcaraz J, 2003, BIOPHYS J, V84, P2071, DOI 10.1016/S0006-3495(03)75014-0; Brujic J, 2006, NAT PHYS, V2, P282, DOI 10.1038/nphys269; BULATOV VV, 1994, MODEL SIMUL MATER SC, V2, P185, DOI 10.1088/0965-0393/2/2/002; Bursac P, 2005, NAT MATER, V4, P557, DOI 10.1038/nmat1404; Cloitre M, 2000, PHYS REV LETT, V85, P4819, DOI 10.1103/PhysRevLett.85.4819; Corwin EI, 2005, NATURE, V435, P1075, DOI 10.1038/nature03698; Deng LH, 2006, NAT MATER, V5, P636, DOI 10.1038/nmat1685; Fabry B, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.041914; Fabry B, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.148102; Fredberg JJ, 1997, AM J RESP CRIT CARE, V156, P1752, DOI 10.1164/ajrccm.156.6.9611016; Gardel ML, 2004, SCIENCE, V304, P1301, DOI 10.1126/science.1095087; Hoffman BD, 2006, P NATL ACAD SCI USA, V103, P10259, DOI 10.1073/pnas.0510348103; Ingber DE, 2003, J CELL SCI, V116, P1397, DOI 10.1242/jcs.00360; Johnson PA, 2005, NATURE, V437, P871, DOI 10.1038/nature04015; Kirschner M, 2005, PLAUSIBILITY LIFE RE; Kozlov MM, 2004, J CELL BIOL, V167, P1011, DOI 10.1083/jcb.200410017; Lau AWC, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.198101; MASON TG, 1995, PHYS REV LETT, V75, P2770, DOI 10.1103/PhysRevLett.75.2770; Matthews BD, 2006, J CELL SCI, V119, P508, DOI 10.1242/jcs.02760; Miguel MC, 2006, SCIENCE, V312, P1151, DOI 10.1126/science.1127729; Minton AP, 2006, J CELL SCI, V119, P2863, DOI 10.1242/jcs.03063; Moazzam F, 1997, P NATL ACAD SCI USA, V94, P5338, DOI 10.1073/pnas.94.10.5338; Rosenblatt N, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.168101; Sollich P, 1997, PHYS REV LETT, V78, P2020, DOI 10.1103/PhysRevLett.78.2020; Stamenovic D, 2004, J APPL PHYSIOL, V96, P1600, DOI 10.1152/japplphysiol.00595.2003; Storm C, 2005, NATURE, V435, P191, DOI 10.1038/nature03521; Trepat X, 2004, AM J PHYSIOL-LUNG C, V287, pL1025, DOI 10.1152/ajplung.00077.2004; Viasnoff V, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.065701; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; Yap B, 2005, J APPL PHYSIOL, V98, P1930, DOI 10.1152/japplphysiol.01226.2004	30	515	532	6	210	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 31	2007	447	7144					592	+		10.1038/nature05824	http://dx.doi.org/10.1038/nature05824			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172YZ	17538621	Green Accepted			2022-12-28	WOS:000246842000049
J	Stiell, IG; Spaite, DW; Field, B; Nesbitt, LP; Munkley, D; Maloney, J; Dreyer, J; Toohey, LL; Campeau, T; Dagnone, E; Lyver, M; Wells, GA; Stempien, MW; Parkinson, CI; Waldbillig, D; Ballah, KW; Jones, GJ; Halladay, MR; Dreyer, JF; Boyle, KA; Munkley, DP; Toohey, LGL; Maloney, JP; Trickett, JP; Arcieri, V; Fader, JW; Lees, MGJ; LaBarre, DD; Lepage, RS; Michaud, S; Affleck, AW; Tyson, TA; Fedoruk, JC; Gobet, M				Stiell, Ian G.; Spaite, Daniel W.; Field, Brian; Nesbitt, Lisa P.; Munkley, Doug; Maloney, Justin; Dreyer, Jon; Toohey, Lorraine Luinstra; Campeau, Tony; Dagnone, Eugene; Lyver, Marion; Wells, George A.; Stempien, M. W.; Parkinson, C. I.; Waldbillig, D.; Ballah, K. W.; Jones, G. J.; Halladay, M. R.; Dreyer, J. F.; Boyle, K. A.; Munkley, D. P.; Toohey, L. G. Luinstra; Maloney, J. P.; Trickett, J. P.; Arcieri, V.; Fader, J. W.; Lees, M. G. J.; LaBarre, D. D.; Lepage, R. S.; Michaud, S.; Affleck, A. W.; Tyson, T. A.; Fedoruk, J. C.; Gobet, M.		OPALS Study Grp	Advanced life support for out-of-hospital respiratory distress	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CARDIAC-ARREST; PREHOSPITAL TREATMENT; PULMONARY-EDEMA; PATIENT; TRIAL; OPALS; NITROGLYCERIN; METHODOLOGY; RATIONALE; MORPHINE	Background: Respiratory distress is a common symptom of patients transported to hospitals by emergency medical services (EMS) personnel. The benefit of advanced life support for such patients has not been established. Methods: The Ontario Prehospital Advanced Life Support (OPALS) Study was a controlled clinical trial that was conducted in 15 cities before and after the implementation of a program to provide advanced life support for patients with out-of-hospital respiratory distress. Paramedics were trained in standard advanced life support, including endotracheal intubation and the administration of intravenous drugs. Results: The clinical characteristics of the 8138 patients in the two phases of the study were similar. During the first phase, no patients were treated by paramedics trained in advanced life support; during the second phase, 56.6% of patients received this treatment. Endotracheal intubation was performed in 1.4% of the patients, and intravenous drugs were administered to 15.0% during the second phase. This phase of the study was also marked by a substantial increase in the use of nebulized salbutamol and sublingual nitroglycerin for the relief of symptoms. The rate of death among all patients decreased significantly, from 14.3% to 12.4% (absolute difference, 1.9%; 95% confidence interval [CI], 0.4 to 3.4; P=0.01) from the basic-life-support phase to the advanced-life-support phase (adjusted odds ratio, 1.3; 95% CI, 1.1 to 1.5). Conclusions: The addition of a specific regimen of out-of-hospital advanced-life-support interventions to an existing EMS system that provides basic life support was associated with a decrease in the rate of death of 1.9 percentage points among patients with respiratory distress.	Univ Ottawa, Ottawa Hlth Res Inst, Dept Emergency Med, Ottawa, ON, Canada; Univ Ottawa, Ottawa Hlth Res Inst, Dept Epidemiol & Community Med, Ottawa, ON, Canada; Univ Ottawa, Ottawa Hlth Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; Univ Arizona, Dept Emergency Med, Tucson, AZ USA; Queens Univ, Dept Emergency Med, Kingston, ON, Canada; Ontario Minist Hlth & Long Term Care, Emergency Hlth Serv, Toronto, ON, Canada; Niagara Reg Base Hosp, Niagara Falls, ON, Canada; Univ Western Ontario, Div Emergency Med, London, ON, Canada; Joseph Brant Mem Hosp, Burlington, ON, Canada; Interdev Technol, Toronto, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; University of Arizona; Queens University - Canada; Western University (University of Western Ontario)	Stiell, IG (corresponding author), Univ Ottawa, Ottawa Hlth Res Inst, Dept Emergency Med, Ottawa, ON, Canada.			Stiell, Ian/0000-0002-2583-6408; Spaite, Daniel/0000-0003-2601-6476				Bertini G, 1997, ANN EMERG MED, V30, P493, DOI 10.1016/S0196-0644(97)70009-X; BRUNS BM, 1992, AM J EMERG MED, V10, P53, DOI 10.1016/0735-6757(92)90127-J; Craven RA, 2000, ACAD EMERG MED, V7, P1065, DOI 10.1111/j.1553-2712.2000.tb02102.x; EMERMAN CL, 1990, AM J EMERG MED, V8, P512, DOI 10.1016/0735-6757(90)90153-Q; Gardtman M, 2000, Eur J Emerg Med, V7, P15; HOFFMAN JR, 1987, CHEST, V92, P586, DOI 10.1378/chest.92.4.586; Kallio Tarja, 2003, Prehosp Emerg Care, V7, P209, DOI 10.1080/10903120390936798; KELSEY SF, 1991, CONTROL CLIN TRIALS, V12, P525; Kosowsky J M, 2001, Prehosp Emerg Care, V5, P190, DOI 10.1080/10903120190940119; Maio RF, 1999, ANN EMERG MED, V33, P423, DOI 10.1016/S0196-0644(99)70307-0; MCCAIG LF, 2002, ADV DATA VITAL HLTH, V326; MOSESSO VN, 2003, PREHOSP EMERG CARE, P713; QUADREL M, 1995, ANN EMERG MED, V26, P469, DOI 10.1016/S0196-0644(95)70116-8; Stiell IG, 1998, ANN EMERG MED, V32, P180, DOI 10.1016/S0196-0644(98)70135-0; Stiell IG, 2004, NEW ENGL J MED, V351, P647, DOI 10.1056/NEJMoa040325; Stiell IG, 1999, JAMA-J AM MED ASSOC, V281, P1175, DOI 10.1001/jama.281.13.1175; Stiell IG, 1999, ANN EMERG MED, V34, P256, DOI 10.1016/S0196-0644(99)70241-6; WEISS SJ, 1994, ANN EMERG MED, V24, P873, DOI 10.1016/S0196-0644(94)70205-5; WUERZ R, 1994, ANN EMERG MED, V23, P31, DOI 10.1016/S0196-0644(94)70004-4; WUERZ RC, 1992, ANN EMERG MED, V21, P669, DOI 10.1016/S0196-0644(05)82777-5	20	73	73	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 24	2007	356	21					2156	2164		10.1056/NEJMoa060334	http://dx.doi.org/10.1056/NEJMoa060334			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	170ON	17522399				2022-12-28	WOS:000246673100005
J	Bramkamp, M; Rock, T; Schneemann, M; Binggeli, C; Kucher, N				Bramkamp, Matthias; Rock, Tobias; Schneemann, Markus; Binggeli, Christian; Kucher, Nils			Radiotherapy and the heart	LANCET			English	Editorial Material							ARTERY		Univ Zurich Hosp, Dept Internal Med, CH-8091 Zurich, Switzerland; Univ Zurich Hosp, Dept Cardiol, CH-8091 Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital	Bramkamp, M (corresponding author), Univ Zurich Hosp, Dept Internal Med, CH-8091 Zurich, Switzerland.	Matthias.Bramkamp@usz.ch						JOSEPH A, 1995, J INTERV CARDIOL, V8, P355, DOI 10.1111/j.1540-8183.1995.tb00557.x; Miltenyi Zsofia, 2004, Cardiovasc Radiat Med, V5, P38, DOI 10.1016/j.carrad.2004.04.004; SCHULMAN HE, 1994, CHEST, V105, P1881, DOI 10.1378/chest.105.6.1881; VANSON JAM, 1992, J THORAC CARDIOV SUR, V104, P1539, DOI 10.1016/S0022-5223(19)33881-4	4	4	4	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 20	2007	369	9574					1762	1762		10.1016/S0140-6736(07)60783-1	http://dx.doi.org/10.1016/S0140-6736(07)60783-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	169ZT	17512861				2022-12-28	WOS:000246631300032
J	Joura, EA; Leodolter, S; Hernandez-Avila, M; Wheeler, CM; Perez, G; Koutsky, LA; Garland, SM; Harper, DM; Tang, GWK; Ferris, DG; Steben, M; Jones, RW; Bryan, J; Taddeo, FJ; Bautista, OM; Esser, MT; Sings, HL; Nelson, M; Boslego, JW; Sattler, C; Barr, E; Paavonen, J				Joura, Elmar A.; Leodolter, Sepp; Hernandez-Avila, Mauricio; Wheeler, Cosette M.; Perez, Gonzalo; Koutsky, Laura A.; Garland, Suzanne M.; Harper, Diane M.; Tang, Grace W. K.; Ferris, Daron G.; Steben, Marc; Jones, Ronald W.; Bryan, Janine; Taddeo, Frank J.; Bautista, Oliver M.; Esser, Mark T.; Sings, Heather L.; Nelson, Micki; Boslego, John W.; Sattler, Carlos; Barr, Eliav; Paavonen, Jorma			Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials	LANCET			English	Article; Proceedings Paper	42nd Annual Meeting of the American-Society-of-Clinical-Oncology	JUN 02-06, 2006	Atlanta, GA	Amer Soc Clin Oncol			CERVICAL INTRAEPITHELIAL NEOPLASIA; SQUAMOUS-CELL CARCINOMA; COLD-KNIFE CONIZATION; TERM FOLLOW-UP; NATURAL-HISTORY; YOUNG-WOMEN; RISK; TRENDS; CANCER; HPV	Background Vulval and vaginal cancers among younger women are often related to infection with human papillomavirus (HPV). These cancers are preceded by high-grade vulval intraepithelial neoplasia (VIN2-3) and vaginal intraepithelial neoplasia (VaIN2-3). Our aim was to do a combined analysis of three randomised clinical trials to assess the effect of a prophylactic quadrivalent HPV vaccine on the incidence of these diseases. Methods 18 174 women (16-26 years) were enrolled and randomised to receive either quadrivalent HPV6/11/16/18 L1 virus-like-particle vaccine or placebo at day 1, and months 2 and 6. Individuals underwent detailed anogenital examination at day 1, 1 month after dose three, and at 6-12-month intervals for up to 48 months. Suspect genital lesions were biopsied and read by a panel of pathologists and vaccine HPV type-specific DNA testing was done. The primary endpoint was the combined incidence of VIN2-3 or VaIN2-3 associated with HPV16 or HPV18. Primary efficacy analyses were done in a per-protocol population. Findings The mean follow-up time was 3 years. Among women naive to HPV16 or HPV18 through 1 month after dose three (per-protocol population; vaccine n=7811; placebo n=7785), the vaccine was 100% effective (95% Cl 72-100) against VIN2-3 or VaIN2-3 associated with HPV16 or HPV18. In the intention-to-treat population (which included 18174 women who, at day 1, could have been infected with HPV16 or HPV18), vaccine efficacy against VIN2-3 or VaIN2-3 associated with HPV16 or HPV18 was 71% (37-88). The vaccine was 49% (18-69) effective against all VIN2-3 or VaIN2-3, irrespective of whether or not HPV DNA was detected in the lesion. The most common treatment-related adverse event was injection-site pain. Interpretation Prophylactic administration of quadrivalent HPV vaccine was effective in preventing high-grade vulval and vaginal lesions associated with HPV16 or HPV18 infection in women who were naive to these types before vaccination. With time, such vaccination could result in reduced rates of HPV-related vulval and vaginal cancers.	Univ Cent Hosp, Dept Obstet & Gynecol, Helsinki 00290, Finland; Med Univ Vienna, Dept Gynecol & Obstet, Vienna, Austria; Natl Inst Publ Hlth, Cuernavaca, Morelos, Mexico; Univ New Mexico, Dept Mol Genet & Microbiol, Albuquerque, NM 87131 USA; Univ New Mexico, Dept Obstet & Gynecol, Albuquerque, NM 87131 USA; Natl Res Ctr, Grp Saludcoop, Bogota, Colombia; Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; Univ Melbourne, Dept Microbiol & Infect Dis, Royal Hosp Women, Melbourne, Vic, Australia; Univ Melbourne, Dept Obstet & Gynecol, Melbourne, Vic, Australia; Dartmouth Coll Sch Med, Norris Cotton Canc Ctr, Dept Obstet & Gynecol, Hanover, NH USA; Dartmouth Coll Sch Med, Norris Cotton Canc Ctr, Dept Community & Family Med, Hanover, NH USA; Univ Hong Kong, Dept Obstet & Gynecol, Hong Kong, Peoples R China; Med Coll Georgia, Dept Family Med, Augusta, GA 30912 USA; Med Coll Georgia, Dept Obstet & Gynecol, Augusta, GA 30912 USA; Inst Natl Sante Publ Quebec, Direct Risques Biol Environn & Occupat, Montreal, PQ, Canada; Natl Womens Hosp, Vulvar Clin, Dept Gynecol Oncol, Auckland, New Zealand; Merck Res Labs, West Point, PA USA	University of Helsinki; Helsinki University Central Hospital; Medical University of Vienna; Instituto Nacional de Salud Publica; University of New Mexico; University of New Mexico; University of Washington; University of Washington Seattle; University of Melbourne; University of Melbourne; Dartmouth College; Norris Cotton Cancer Center; Dartmouth College; Norris Cotton Cancer Center; University of Hong Kong; University System of Georgia; Augusta University; University System of Georgia; Augusta University; Institut national de sante publique du Quebec (INSPQ); Merck & Company	Paavonen, J (corresponding author), Univ Cent Hosp, Dept Obstet & Gynecol, Haartmaninkatu 2, Helsinki 00290, Finland.	jorma.paavonen@hus.fi	Harper, Diane M./I-2180-2014; Chahchahi, Sarah/Q-6499-2016	Harper, Diane M./0000-0001-7648-883X; Bryan, Janine/0000-0002-4923-6247; Steben, Marc/0000-0002-1136-3208; Paavonen, Jorma/0000-0003-4775-606X				AHO M, 1991, CANCER, V68, P195, DOI 10.1002/1097-0142(19910701)68:1<195::AID-CNCR2820680135>3.0.CO;2-L; *AM CANC SOC, DET GUID VAG CANC WH; American College of Obstetricians and Gynecologists, HPV VACC ACOG REC; Block SL, 2006, PEDIATRICS, V118, P2135, DOI 10.1542/peds.2006-0461; Bryan JT, 2006, J MED VIROL, V78, P117, DOI 10.1002/jmv.20512; Chan ISF, 1998, COMMUN STAT-THEOR M, V27, P1305, DOI 10.1080/03610929808832160; Daling JR, 2002, GYNECOL ONCOL, V84, P263, DOI 10.1006/gyno.2001.6502; Dias D, 2005, CLIN DIAGN LAB IMMUN, V12, P959, DOI 10.1128/CDLI.12.8.959-969.2005; Dodge JA, 2001, GYNECOL ONCOL, V83, P363, DOI 10.1006/gyno.2001.6401; *FUTURE 2 STUD GRO, 2007, IN PRESS LANCET; Garland SM, 2003, CURR OPIN INFECT DIS, V16, P85, DOI 10.1097/00001432-200304000-00004; Garland SM, 2007, NEW ENGL J MED, V356, P1928, DOI 10.1056/NEJMoa061760; Goffin F, 2006, J MED VIROL, V78, P814, DOI 10.1002/jmv.20628; Hampl M, 2006, OBSTET GYNECOL, V108, P1361, DOI 10.1097/01.AOG.0000245786.86267.80; Herod JJO, 1996, BRIT J OBSTET GYNAEC, V103, P446, DOI 10.1111/j.1471-0528.1996.tb09771.x; Hillemanns P, 2006, GYNECOL ONCOL, V100, P276, DOI 10.1016/j.ygyno.2005.10.003; Hillemanns P, 2006, GYNECOL ONCOL, V100, P271, DOI 10.1016/j.ygyno.2005.08.012; Jones RW, 2005, OBSTET GYNECOL, V106, P1319, DOI 10.1097/01.AOG.0000187301.76283.7f; Jones RW, 2000, OBSTET GYNECOL, V96, P470, DOI 10.1016/S0029-7844(00)00949-2; Jones RW, 1997, OBSTET GYNECOL, V90, P448, DOI 10.1016/S0029-7844(97)00298-6; Jones RW, 2001, EUR J GYNAECOL ONCOL, V22, P393; Joura EA, 2002, CURR OPIN OBSTET GYN, V14, P39, DOI 10.1097/00001703-200202000-00007; Joura EA, 2000, J REPROD MED, V45, P613; Judson PL, 2006, OBSTET GYNECOL, V107, P1018, DOI 10.1097/01.AOG.0000210268.57527.a1; Kalbfleisch D., 1980, STAT ANAL FAILURE TI; Kalliala I, 2005, BRIT MED J, V331, P1183, DOI 10.1136/bmj.38663.459039.7C; Le T, 2006, AM J OBSTET GYNECOL, V194, P377, DOI 10.1016/j.ajog.2005.08.022; Lehtinen M, 2006, VACCINE, V24, P233, DOI 10.1016/j.vaccine.2006.05.109; Madeleine MM, 1997, JNCI-J NATL CANCER I, V89, P1516, DOI 10.1093/jnci/89.20.1516; Mao C, 2006, OBSTET GYNECOL, V107, P18, DOI 10.1097/01.AOG.0000192397.41191.fb; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; OLSSON SE, 2007, VACCINE         0420; Parkin DM, 2002, IARC SCI PUBL, P8; Partridge JM, 2006, LANCET INFECT DIS, V6, P21, DOI 10.1016/S1473-3099(05)70323-6; Reich O, 2002, OBSTET GYNECOL, V99, P193, DOI 10.1016/S0029-7844(01)01683-0; Reich O, 2001, OBSTET GYNECOL, V97, P428, DOI 10.1016/S0029-7844(00)01174-1; Reisinger KS, 2007, PEDIATR INFECT DIS J, V26, P201, DOI 10.1097/01.inf.0000253970.29190.5a; Srodon M, 2006, AM J SURG PATHOL, V30, P1513, DOI 10.1097/01.pas.0000213291.96401.48; STURGEON SS, 1987, AM J OBSTET GYNECOL, V166, P1482; TOKI T, 1991, INT J GYNECOL PATHOL, V10, P107, DOI 10.1097/00004347-199104000-00001; van Seters M, 2005, GYNECOL ONCOL, V97, P645, DOI 10.1016/j.ygyno.2005.02.012; Villa LL, 2006, BRIT J CANCER, V95, P1459, DOI 10.1038/sj.bjc.6603469; Villa LL, 2005, LANCET ONCOL, V6, P271, DOI 10.1016/S1470-2045(05)70101-7; Villa LL, 2007, NEW ENGL J MED, V356, P1915, DOI 10.1056/NEJMoa061741; Von Krogh G, 2001, EUR J DERMATOL, V11, P598; Wiley DJ, 2002, CLIN INFECT DIS, V35, pS210, DOI 10.1086/342109	46	383	397	1	39	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 20	2007	369	9574					1693	1702		10.1016/S0140-6736(07)60777-6	http://dx.doi.org/10.1016/S0140-6736(07)60777-6			10	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	169ZT	17512854				2022-12-28	WOS:000246631300025
J	Kiss, IZ; Rusin, CG; Kori, H; Hudson, JL				Kiss, Istvan Z.; Rusin, Craig G.; Kori, Hiroshi; Hudson, John L.			Engineering complex dynamical structures: Sequential patterns and desynchronization	SCIENCE			English	Article							SYNCHRONIZATION; NETWORKS	We used phase models to describe and tune complex dynamic structures to desired states; weak, nondestructive signals are used to alter interactions among nonlinear rhythmic elements. Experiments on electrochemical reactions on electrode arrays were used to demonstrate the power of mild model-engineered feedback to achieve a desired response. Applications are made to the generation of sequentially visited dynamic cluster patterns similar to reproducible sequences seen in biological systems and to the design of a nonlinear antipacemaker for the destruction of pathological synchronization of a population of interacting oscillators.	Univ Virginia, Dept Chem Engn, Charlottesville, VA 22904 USA; Hokkaido Univ, Dept Math, Kita Ku, Sapporo, Hokkaido 0600810, Japan	University of Virginia; Hokkaido University	Hudson, JL (corresponding author), Univ Virginia, Dept Chem Engn, 102 Engineers Way, Charlottesville, VA 22904 USA.	hudson@virginia.edu	Kori, Hiroshi/AAD-3700-2019; Kori, Hiroshi/C-6180-2011; Kiss, Istvan Z/C-1801-2008	Kiss, Istvan Z/0000-0003-0993-3184; Rusin, Craig/0000-0003-3812-8133				Ashwin P, 2005, NATURE, V436, P36, DOI 10.1038/436036b; Blasius B, 1999, NATURE, V399, P354, DOI 10.1038/20676; Carroll TL, 1996, PHYS REV E, V54, P4676, DOI 10.1103/PhysRevE.54.4676; Christini DJ, 2002, CHAOS, V12, P732, DOI 10.1063/1.1504061; Epstein I.R., 1998, INTRO NONLINEAR CHEM; ERTL G, 1991, SCIENCE, V254, P1750, DOI 10.1126/science.254.5039.1750; Galan RF, 2006, NEUROCOMPUTING, V69, P1112, DOI 10.1016/j.neucom.2005.12.055; Galan RF, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.158101; HAN SK, 1995, PHYS REV LETT, V75, P3190, DOI 10.1103/PhysRevLett.75.3190; HANSEL D, 1993, PHYS REV E, V48, P3470, DOI 10.1103/PhysRevE.48.3470; Izhikevich EM, 1999, IEEE T NEURAL NETWOR, V10, P499, DOI 10.1109/72.761707; Kiss IZ, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.248301; Kuramoto Y., 1984, CHEM OSCILLATIONS WA; Laurent G, 2002, NAT REV NEUROSCI, V3, P884, DOI 10.1038/nrn964; MANRUBIA SC, 2004, EMERGENCE DYNAMICAL; Mikhailov AS, 2006, PHYS REP, V425, P79, DOI 10.1016/j.physrep.2005.11.003; Miyazaki J, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.194101; Netoff TI, 2005, J NEUROPHYSIOL, V93, P1197, DOI 10.1152/jn.00982.2004; Ottino JM, 2004, NATURE, V427, P399, DOI 10.1038/427399a; Popovych OV, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.164102; Preyer AJ, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.138103; Rabinovich M, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.068102; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Rosenblum MG, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.114102; Strogatz SH, 2000, PHYSICA D, V143, P1, DOI 10.1016/S0167-2789(00)00094-4; Tass P.A., 1999, PHASE RESETTING MED; Uhhaas PJ, 2006, NEURON, V52, P155, DOI 10.1016/j.neuron.2006.09.020; Winfree A. T., 1980, GEOMETRY BIOL TIME, DOI 10.1007/978-1-4757-3484-3; YORK RA, 1991, IEEE T MICROW THEORY, V39, P1000, DOI 10.1109/22.81670	29	199	201	1	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 29	2007	316	5833					1886	1889		10.1126/science.1140858	http://dx.doi.org/10.1126/science.1140858			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	183WI	17525302				2022-12-28	WOS:000247602700036
J	Li, XH; Monks, B; Ge, QY; Birnbaum, MJ				Li, Xinghai; Monks, Bobby; Ge, Qingyuan; Birnbaum, Morris J.			Akt/PKB regulates hepatic metabolism by directly inhibiting PGC-1 alpha transcription coactivator	NATURE			English	Article							FATTY LIVER-DISEASE; PROTEIN-KINASE-B; CARDIOVASCULAR-DISEASE; RECEPTOR-ALPHA; INSULIN; GLUCONEOGENESIS; ACTIVATION; GLUCOSE; PGC-1; EXPRESSION	Type 2 diabetes mellitus, a disease with significant effects on the health and economy of Western societies, involves disturbances in both lipid and carbohydrate metabolism(1-3). In the insulin-resistant or diabetic state, the liver is unresponsive to the actions of insulin with regard to the suppression of glucose output but continues to produce large amounts of lipid, the latter mimicking the fed, insulin-replete condition(4,5). The disordered distribution of lipids contributes to the cardiovascular disease that is the greatest cause of mortality of type 2 diabetes mellitus(6,7). Yet the precise signal transduction pathways by which insulin regulates hepatic lipid synthesis and degradation remain largely unknown. Here we describe a mechanism by which insulin, through the intermediary protein kinase Akt2/protein kinase B (PKB)-beta, elicits the phosphorylation and inhibition of the transcriptional coactivator peroxisome proliferator-activated receptor-coactivator 1 alpha (PGC-1 alpha), a global regulator of hepatic metabolism during fasting. Phosphorylation prevents the recruitment of PGC-1 alpha to the cognate promoters, impairing its ability to promote gluconeogenesis and fatty acid oxidation. These results define a mechanism by which insulin controls lipid catabolism in the liver and suggest a novel site for therapy in type 2 diabetes mellitus.	Univ Penn, Sch Med, Inst Diabet Obes & Metab, Cox Inst, Philadelphia, PA 19104 USA; Howard Hughes Med Inst, Philadelphia, PA 19104 USA; Cell Signaling Technol Inc, Danvers, MA 01923 USA	University of Pennsylvania; Howard Hughes Medical Institute	Birnbaum, MJ (corresponding author), Univ Penn, Sch Med, Inst Diabet Obes & Metab, Cox Inst, Philadelphia, PA 19104 USA.	birnbaum@mail.med.upenn.edu		Birnbaum, Morris/0000-0001-9972-8680				Barthel A, 2005, TRENDS ENDOCRIN MET, V16, P183, DOI 10.1016/j.tem.2005.03.010; Barthel A, 2003, AM J PHYSIOL-ENDOC M, V285, pE685, DOI 10.1152/ajpendo.00253.2003; Bouche C, 2004, ENDOCR REV, V25, P807, DOI 10.1210/er.2003-0026; Brazil DP, 2004, TRENDS BIOCHEM SCI, V29, P233, DOI 10.1016/j.tibs.2004.03.006; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Diraison F, 2003, DIABETES METAB, V29, P478, DOI 10.1016/S1262-3636(07)70061-7; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI23621; Eckel RH, 2006, CIRCULATION, V113, P2943, DOI 10.1161/CIRCULATIONAHA.106.176583; Finck BN, 2006, CELL METAB, V4, P199, DOI 10.1016/j.cmet.2006.08.005; Huss JM, 2002, J BIOL CHEM, V277, P40265, DOI 10.1074/jbc.M206324200; Kanaya E, 2004, BIOCHEM J, V382, P913, DOI 10.1042/BJ20040432; Kohn AD, 1996, J BIOL CHEM, V271, P31372, DOI 10.1074/jbc.271.49.31372; Li XH, 2001, EMBO J, V20, P4122, DOI 10.1093/emboj/20.15.4122; Liao JF, 1998, J BIOL CHEM, V273, P27320, DOI 10.1074/jbc.273.42.27320; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; McGarry JD, 2002, DIABETES, V51, P7, DOI 10.2337/diabetes.51.1.7; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI200112876; Obata T, 2000, J BIOL CHEM, V275, P36108, DOI 10.1074/jbc.M005497200; Ono H, 2003, DIABETES, V52, P2905, DOI 10.2337/diabetes.52.12.2905; Pilegaard H, 2003, J PHYSIOL-LONDON, V546, P851, DOI 10.1113/jphysiol.2002.034850; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Schilling MM, 2006, NATURE, V443, pE10, DOI 10.1038/nature05288; Schreiber SN, 2003, J BIOL CHEM, V278, P9013, DOI 10.1074/jbc.M212923200; Ueki K, 1998, J BIOL CHEM, V273, P5315, DOI 10.1074/jbc.273.9.5315; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; Wolfrum C, 2003, P NATL ACAD SCI USA, V100, P11624, DOI 10.1073/pnas.1931483100; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	29	357	368	2	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 21	2007	447	7147					1012	U8		10.1038/nature05861	http://dx.doi.org/10.1038/nature05861			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	180NU	17554339				2022-12-28	WOS:000247373100049
J	Collins, R; Burch, J; Cranny, G; Aguiar-Ibanez, R; Craig, D; Wright, K; Berry, E; Gough, M; Kleijnen, J; Westwood, M				Collins, Ros; Burch, Jane; Cranny, Gillian; Aguiar-Ibanez, Raquel; Craig, Dawn; Wright, Kath; Berry, Elizabeth; Gough, Michael; Kleijnen, Jos; Westwood, Marie			Duplex ultrasonography, magnetic resonance angiography, and computed tomography angiography for diagnosis and assessment of symptomatic, lower limb peripheral arterial disease: systematic review	BMJ-BRITISH MEDICAL JOURNAL			English	Review							DIGITAL-SUBTRACTION-ANGIOGRAPHY; 3-DIMENSIONAL MR-ANGIOGRAPHY; LOWER-EXTREMITY ARTERIES; GENERATED RUN-OFF; POOL CONTRAST AGENT; OCCLUSIVE DISEASE; CT-ANGIOGRAPHY; RENAL-ARTERIES; LOWER LEG; PREOPERATIVE EVALUATION	Objectives To determine the diagnostic accuracy of duplex ultrasonography, magnetic resonance angiography, and computed tomography angiography, alone or in combination, for the assessment of tower limb peripheral arterial disease; to evaluate the impact of these assessment methods on management of patients and outcomes; and to evaluate the evidence regarding attitudes of patients to these technologies and summarise available data on adverse events. Design Systematic review. Methods Searches of 11 electronic databases (to April 2005), six journats, and reference lists of included papers for relevant studies. Two reviewers independently selected studies, extracted data, and assessed quality. Diagnostic accuracy studies were assessed for quality with the QUADAS checklist. Results 107 studies met the inclusion criteria; 58 studies provided data on diagnostic accuracy, one on outcomes in patients, four on attitudes of patients, and 44 on adverse events. Quality assessment highlighted limitations in the methods and quality of reporting. Most of the included studies reported results by arterial segment, rather than by limb or by patient, which does not account for the clustering of segments within patients, so specificities may be overstated. For the detection of stenosis of 50% or more in a lower limb vessel, contrast enhanced magnetic resonance angiography had the highest diagnostic accuracy with a median sensitivity of 95% (range 92-99.5%) and median specificity of 97% (64-99%). The results were 91% (89-99%) and 91% (83-97%) for computed tomography angiography and 88% (80-98%) and 96% (89-99%) for duplex ultrasonography. A controlled trial reported no significant differences in outcomes in patients after treatment plans based on duplex ultrasonography alone or conventional contrast angiography alone, though in 22% of patients supplementary contrast angiography was needed to form a treatment plan. The limited evidence available suggested that patients preferred magnetic resonance angiography (with or without contrast) to contrast angiography, with half expressing no preference between magnetic resonance angiography or duplex ultrasonography (among patients with no contraindications for magnetic resonance angiography, such as claustrophobia). Where data on adverse events were available, magnetic resonance angiography was associated with the highest proportion of adverse events, but these were mild. The most severe adverse events, although rare, were mainly associated with contrast angiography. Conclusions Contrast enhanced magnetic resonance angiography seems to be more specific than computed tomography angiography (that is, better at ruling out stenosis over 50%) and more sensitive than duplex ultrasonography (that is, better at ruling in stenosis over 50%) and Was generally preferred by patients over contrast angiography. Computed tomography angiography was also preferred by patients over contrast angiography; no data on patients' preference between duplex ultrasonography and contrast angiography were available. Where available, contrast enhanced magnetic resonance angiography might be a viable alternative to contrast angiography.	Univ York, Ctr Reviews & Disseminat, York YO10 5DD, N Yorkshire, England; Univ Leeds, Acad Unit Med Phys, Leeds, W Yorkshire, England; Leeds Teaching Hosp NHS Trust, Leeds, W Yorkshire, England; Kleijnen Systemat Reviews Ltd, York, N Yorkshire, England	University of York - UK; University of Leeds; University of Leeds; Kleijnen Systematic Reviews	Collins, R (corresponding author), Univ York, Ctr Reviews & Disseminat, York YO10 5DD, N Yorkshire, England.	rc14@york.ac.uk	Wade, Rosalind Fay/AAB-5808-2019; Wright, Kath/P-1516-2019; Wade, Ros/AAB-7268-2019	Wade, Rosalind Fay/0000-0002-8666-8110; Wright, Kath/0000-0002-9020-1572				ADAMIS MK, 1995, RADIOLOGY, V196, P689, DOI 10.1148/radiology.196.3.7644630; ALY SAA, 1998, THESIS LONDON U LOND; ASHLEIGH RJ, 1993, J INTERVENTIONAL RAD, V8, P133; Balzer JO, 2003, EUR RADIOL, V13, P2067, DOI 10.1007/s00330-002-1768-5; Baum RA, 1999, RADIOLOGY, V213P, P481; BAUM RA, 1995, JAMA-J AM MED ASSOC, V274, P875, DOI 10.1001/jama.274.11.875; BAXTER GM, 1993, CLIN RADIOL, V47, P91, DOI 10.1016/S0009-9260(05)81179-1; Beard JD, 2000, BRIT MED J, V320, P854, DOI 10.1136/bmj.320.7238.854; BERGAMINI TM, 1995, AM J SURG, V169, P564, DOI 10.1016/S0002-9610(99)80221-9; Bezooijen R, 2004, RADIOLOGY, V231, P263, DOI 10.1148/radiol.2311020845; Bossuyt PM, 2003, BRIT MED J, V326, P41, DOI 10.1136/bmj.326.7379.41; Bossuyt PM, 2003, ANN INTERN MED, V138, P40, DOI 10.7326/0003-4819-138-1-200301070-00010; Bostrom A, 2001, Vasc Surg, V35, P437, DOI 10.1177/153857440103500603; BREALEY S, 2007, IN PRESS BR J RADIOL; Catalano C, 2004, RADIOLOGY, V231, P555, DOI 10.1148/radiol.2312020920; Collins AJ, 2006, NEPHROLOGY, V11, P1, DOI 10.1111/j.1440-1797.2006.00557.x; Cortell ED, 1996, AM J ROENTGENOL, V167, P147, DOI 10.2214/ajr.167.1.8659360; Cronberg CN, 2003, ACTA RADIOL, V44, P59; CURRIE IC, 1995, EUR J VASC ENDOVASC, V9, P24, DOI 10.1016/S1078-5884(05)80220-5; DAVIES AH, 1992, BRIT J SURG, V79, P894, DOI 10.1002/bjs.1800790913; Eiberg JP, 2001, EUR J VASC ENDOVASC, V22, P331, DOI 10.1053/ejvs.2001.1474; Eklof H, 1998, ACTA RADIOL, V39, P663, DOI 10.3109/02841859809175493; ELKAYALI A, 2004, EMIRATES MED J, V22, P53; Fellner FA, 2000, NEW ASPECTS OF HIGH TECHNOLOGY IN MEDICINE, P323; FLETCHER JP, 1990, J CARDIOVASC SURG, V31, P364; Glickerman DJ, 1996, AM J ROENTGENOL, V167, P445, DOI 10.2214/ajr.167.2.8686623; Goyen M, 2003, J MAGN RESON IMAGING, V17, P565, DOI 10.1002/jmri.10302; Grassbaugh JA, 2003, J VASC SURG, V37, P1186, DOI 10.1016/S0741-5214(03)00328-8; Hany TF, 1997, RADIOLOGY, V204, P357, DOI 10.1148/radiology.204.2.9240520; HATSUKAMI TS, 1992, J VASC SURG, V16, P527, DOI 10.1016/0741-5214(92)90160-A; Heuschmid M, 2003, EUR J MED RES, V8, P389; Hirai T, 1998, Radiat Med, V16, P411; Ho KY, 1997, AM J ROENTGENOL, V169, P45, DOI 10.2214/ajr.169.1.9207499; Hoch JR, 1999, AM J SURG, V178, P166, DOI 10.1016/S0002-9610(99)00158-0; Hoch JR, 1996, J VASC SURG, V23, P792, DOI 10.1016/S0741-5214(96)70241-0; Hofmann WJ, 2004, J VASC SURG, V39, P169, DOI 10.1016/S0741-5214(03)01044-9; Hosten N, 1998, ROFO-FORTSCHR RONTG, V169, P495, DOI 10.1055/s-2007-1015326; Huber TS, 1997, J VASC SURG, V26, P415, DOI 10.1016/S0741-5214(97)70034-X; Ishikawa M, 1999, SURG TODAY, V29, P243; Ito Koichiro, 2000, Journal of Nippon Medical School, V67, P421, DOI 10.1272/jnms.67.421; JAKOBSEN JA, 1989, IOPENTOL CLIN TRIALS, P63; Jones L, 1998, CLIN RADIOL, V53, P333, DOI 10.1016/S0009-9260(98)80003-2; Karacagil S, 1996, EUR J VASC ENDOVASC, V12, P300, DOI 10.1016/S1078-5884(96)80248-6; Koelemay MJW, 1997, BRIT J SURG, V84, P1115, DOI 10.1046/j.1365-2168.1997.02760.x; Koelemay MJW, 1998, EUR J VASC ENDOVASC, V16, P13, DOI 10.1016/S1078-5884(98)80086-5; Koelemay MJW, 2001, J VASC SURG, V34, P661, DOI 10.1067/mva.2001.117887; Krause U, 2005, J MAGN RESON IMAGING, V21, P449, DOI 10.1002/jmri.20256; Krause UJ, 2004, ANGIOLOGY, V55, P119, DOI 10.1177/000331970405500202; Kreitner KF, 2000, AM J ROENTGENOL, V174, P171, DOI 10.2214/ajr.174.1.1740171; Kroencke TJ, 2001, RADIOLOGY, V221, P454; Lai D T, 1995, Australas Radiol, V39, P243, DOI 10.1111/j.1440-1673.1995.tb00284.x; Lai D T, 1996, Cardiovasc Surg, V4, P384, DOI 10.1016/0967-2109(95)00064-X; Laissy JP, 1998, JMRI-J MAGN RESON IM, V8, P1060, DOI 10.1002/jmri.1880080509; LEGEMATE DA, 1991, ULTRASOUND MED BIOL, V17, P769, DOI 10.1016/0301-5629(91)90159-T; Leiner T, 2004, INVEST RADIOL, V39, P435, DOI 10.1097/01.rli.0000129467.71381.8a; Leiner T, 2003, J VASC SURG, V37, P1255, DOI 10.1016/S0741-5214(02)75451-7; Lenhart M, 2000, ROFO-FORTSCHR RONTG, V172, P992, DOI 10.1055/s-2000-9215; Linke R J, 1994, Australas Radiol, V38, P320, DOI 10.1111/j.1440-1673.1994.tb00209.x; Loewe C, 2000, EUR RADIOL, V10, P725, DOI 10.1007/s003300050994; London NJM, 1999, BRIT J SURG, V86, P911, DOI 10.1046/j.1365-2168.1999.01180.x; LONDON NJM, 1995, BRIT J SURG, V82, P557; Loy CT, 2004, JAMA-J AM MED ASSOC, V292, P1602, DOI 10.1001/jama.292.13.1602; Lundin P, 2000, ACTA RADIOL, V41, P125, DOI 10.1080/028418500127345127; Martin ML, 2003, AM J ROENTGENOL, V180, P1085, DOI 10.2214/ajr.180.4.1801085; MCDERMOTT VG, 1995, CLIN RADIOL, V50, P741, DOI 10.1016/S0009-9260(05)83211-8; Meaney JFM, 1999, RADIOLOGY, V211, P59, DOI 10.1148/radiology.211.1.r99ap1859; MERGELSBERG M, 1986, DEUT MED WOCHENSCHR, V111, P1055, DOI 10.1055/s-2008-1068582; Mohler ER, 2004, J AM COLL CARDIOL, V43, p352A, DOI 10.1016/S0735-1097(04)91490-8; MOSES LE, 1993, STAT MED, V12, P1293, DOI 10.1002/sim.4780121203; MULLIGAN SA, 1991, RADIOLOGY, V178, P695, DOI 10.1148/radiology.178.3.1994405; *PAD, 2005, TRANSATLANTIC INT CO; Perreault P, 2003, RADIOLOGY, V229, P811, DOI 10.1148/radiol.2293021180; Pesaresi A, 2000, RADIOLOGY, V217, P132; Portugaller HR, 2004, EUR RADIOL, V14, P1681, DOI 10.1007/s00330-004-2289-1; Puls R, 2001, Rontgenpraxis, V54, P141; Rieker O, 1996, AM J ROENTGENOL, V166, P269, DOI 10.2214/ajr.166.2.8553929; Rieker O, 1997, AM J ROENTGENOL, V169, P1133, DOI 10.2214/ajr.169.4.9308477; ROBERTS DA, 2000, P INT SOC MAGN RES M, V8, P1811; Romano M, 2004, Minerva Cardioangiol, V52, P9; Romano M, 2004, EUR J RADIOL, V50, P303, DOI 10.1016/S0720-048X(03)00118-9; Sam AD, 2003, J VASC SURG, V38, P313, DOI 10.1016/S0741-5214(03)00315-X; Sarkar R, 1998, AM J SURG, V176, P203, DOI 10.1016/S0002-9610(98)00124-X; Schafer FKW, 2003, ROFO-FORTSCHR RONTG, V175, P556, DOI 10.1055/s-2003-38446; Sensier Y, 1996, EUR J VASC ENDOVASC, V12, P238, DOI 10.1016/S1078-5884(96)80113-4; Shaalan WE, 2003, J VASC SURG, V37, P960, DOI 10.1067/mva.2003.282; SNIDOW JJ, 1995, J VASC INTERV RADIOL, V6, P595, DOI 10.1016/S1051-0443(95)71143-5; Snidow JJ, 1996, RADIOLOGY, V198, P725, DOI 10.1148/radiology.198.3.8628861; Steffens CJ, 1997, AM J ROENTGENOL, V169, P749, DOI 10.2214/ajr.169.3.9275891; Steffens JC, 2003, ACTA RADIOL, V44, P185, DOI 10.1034/j.1600-0455.2003.00044.x; Sueyoshi E, 1999, RADIOLOGY, V210, P683, DOI 10.1148/radiology.210.3.r99fe22683; Swan JS, 2000, MED DECIS MAKING, V20, P79, DOI 10.1177/0272989X0002000110; Swan JS, 2000, AM J SURG, V180, P6, DOI 10.1016/S0002-9610(00)00412-8; Swan JS, 1997, ACAD RADIOL, V4, P475, DOI 10.1016/S1076-6332(97)80231-0; Timonina EA, 1999, KARDIOLOGIYA, V39, P14; Tins B, 2001, BRIT J RADIOL, V74, P219, DOI 10.1259/bjr.74.879.740219; Ubbink DT, 2002, J VASC SURG, V35, P392, DOI 10.1067/mva.2002.118087; UNGER EC, 1995, JMRI-J MAGN RESON IM, V5, P1, DOI 10.1002/jmri.1880050102; van der Zaag ES, 1998, EUR J VASC ENDOVASC, V16, P383, DOI 10.1016/S1078-5884(98)80004-X; Vavrik J, 2004, J ENDOVASC THER, V11, P294, DOI 10.1583/03-1144.1; Visser K, 2003, EUR J VASC ENDOVASC, V26, P537, DOI 10.1016/S1078-5884(03)00387-3; Vogt KC, 1998, ULTRASOUND MED BIOL, V24, P963, DOI 10.1016/S0301-5629(98)00068-4; Walter F, 2001, J RADIOL, V82, P473; Weishaupt D, 2000, AM J ROENTGENOL, V175, P189, DOI 10.2214/ajr.175.1.1750189; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; WHYMAN MR, 1992, BRIT J SURG, V79, P907, DOI 10.1002/bjs.1800790917; Wikstrom J, 2003, INVEST RADIOL, V38, P504, DOI 10.1097/01.rli.0000074585.46615.2e; Wikstrom J, 2001, ACTA RADIOL, V42, P1; Willmann JK, 2003, RADIOLOGY, V226, P798, DOI 10.1148/radiol.2271020014; Wilson YG, 1997, BRIT J SURG, V84, P1360, DOI 10.1002/bjs.1800841007; Winterer JT, 1999, J COMPUT ASSIST TOMO, V23, P583, DOI 10.1097/00004728-199907000-00019; Winterer JT, 2003, ROFO-FORTSCHR RONTG, V175, P28, DOI 10.1055/s-2003-36606; Wolff SD, 2002, AM J CARDIOL, V90, p131H; Wolosker N, 2003, ANGIOLOGY, V54, P163, DOI 10.1177/000331970305400204; Wyttenbach R, 2003, RADIOLOGY, V227, P261, DOI 10.1148/radiol.2271011989; YUCEL EK, 1993, RADIOLOGY, V187, P637, DOI 10.1148/radiology.187.3.8497608; ZAMORA J, 2003, METADISC WINDOWS SOF; ZEUCHNER J, 1994, ACTA RADIOL, V35, P270; Zhang HL, 2005, AM J ROENTGENOL, V184, P938, DOI 10.2214/ajr.184.3.01840938; 1996, BANDOLIER, P29	119	160	168	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 16	2007	334	7606					1257	1261		10.1136/bmj.39217.473275.55	http://dx.doi.org/10.1136/bmj.39217.473275.55			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	183AM	17548364	Green Published, Green Submitted, Bronze, Green Accepted			2022-12-28	WOS:000247545100033
J	Lachmann, HJ; Goodman, HJB; Gilbertson, JA; Gallimore, JR; Sabin, CA; Gillmore, JD; Hawkins, PN				Lachmann, Helen J.; Goodman, Hugh J. B.; Gilbertson, Janet A.; Gallimore, J. Ruth; Sabin, Caroline A.; Gillmore, Julian D.; Hawkins, Philip N.			Natural history and outcome in systemic AA amyloidosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SECONDARY AMYLOIDOSIS; SERUM; AL; PROTEIN; SCINTIGRAPHY; REGRESSION; BINDING; DISEASE	BACKGROUND: Deposition of amyloid fibrils derived from circulating acute-phase reactant serum amyloid A protein (SAA) causes systemic AA amyloidosis, a serious complication of many chronic inflammatory disorders. Little is known about the natural history of AA amyloidosis or its response to treatment. METHODS: We evaluated clinical features, organ function, and survival among 374 patients with AA amyloidosis who were followed for a median of 86 months. The SAA concentration was measured serially, and the amyloid burden was estimated with the use of whole-body serum amyloid P component scintigraphy. Therapy for inflammatory diseases was administered to suppress the production of SAA. RESULTS: Median survival after diagnosis was 133 months; renal dysfunction was the predominant disease manifestation. Mortality, amyloid burden, and renal prognosis all significantly correlated with the SAA concentration during follow-up. The risk of death was 17.7 times as high among patients with SAA concentrations in the highest eighth, or octile, (greater/equal 155 mg per liter) as among those with concentrations in the lowest octile (< 4 mg per liter); and the risk of death was four times as high in the next-to-lowest octile (4 to 9 mg per liter). The median SAA concentration during follow-up was 6 mg per liter in patients in whom renal function improved and 28 mg per liter in those in whom it deteriorated (P < 0.001). Amyloid deposits regressed in 60% of patients who had a median SAA concentration of less than 10 mg per liter, and survival among these patients was superior to survival among those in whom amyloid deposits did not regress (P=0.04). CONCLUSIONS: The effects of renal dysfunction dominate the course of AA amyloidosis, which is associated with a relatively favorable outcome in patients with SAA concentrations that remain in the low-normal range (< 4 mg per liter).	UCL Royal Free & Univ Coll Med Sch, Natl Amyloidosis Ctr, London, England; UCL Royal Free & Univ Coll Med Sch, Ctr Amyloidosis & Acute Phase Prot, Dept Med, London, England; UCL Royal Free & Univ Coll Med Sch, Dept Primary Care & Populat Sci, London, England	University of London; University College London; UCL Medical School; University of London; University College London; UCL Medical School; University of London; University College London; UCL Medical School	Lachmann, HJ (corresponding author), UCL Royal Free & Univ Coll Med Sch, Natl Amyloidosis Ctr, London, England.		Sabin, Caroline/C-2464-2008; Hawkins, Philip N/C-5573-2008	Sabin, Caroline/0000-0001-5173-2760; Lachmann, Helen/0000-0001-8378-2498	MRC [G7900510] Funding Source: UKRI; Medical Research Council [G7900510] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Gertz MA, 2005, AM J HEMATOL, V79, P319, DOI 10.1002/ajh.20381; Gillmore JD, 2001, LANCET, V358, P24, DOI 10.1016/S0140-6736(00)05252-1; HAMER JPM, 1992, EUR HEART J, V13, P623, DOI 10.1093/oxfordjournals.eurheartj.a060225; HAWKINS PN, 1993, Q J MED, V86, P365; HAWKINS PN, 1990, NEW ENGL J MED, V323, P508, DOI 10.1056/NEJM199008233230803; Hawkins PN, 2003, NEW ENGL J MED, V348, P2583, DOI 10.1056/NEJM200306193482523; HAZENBERG BPC, 1991, AMYLOID AND AMYLOIDOSIS 1990, P809; KISILEVSKY R, 1995, AMYLOID, V2, P128, DOI 10.3109/13506129509031899; Lachmann HJ, 2002, NEW ENGL J MED, V346, P1786, DOI 10.1056/NEJMoa013354; Laiho K, 1999, CLIN RHEUMATOL, V18, P122, DOI 10.1007/s100670050068; Ledue TB, 1998, ANN CLIN BIOCHEM, V35, P745, DOI 10.1177/000456329803500607; Merlini G, 2003, NEW ENGL J MED, V349, P583, DOI 10.1056/NEJMra023144; PARMELEE DC, 1982, BIOCHEMISTRY-US, V21, P3298, DOI 10.1021/bi00257a008; Pepys MB, 2006, ANNU REV MED, V57, P223, DOI 10.1146/annurev.med.57.121304.131243; Poole S, 1998, J IMMUNOL METHODS, V214, P1, DOI 10.1016/S0022-1759(98)00057-X; PUCHTLER H, 1962, J HISTOCHEM CYTOCHEM, V10, P355, DOI 10.1177/10.3.355; Rajkumar, 2006, MAYO CLIN PROC, V81, P1509; Rajkumar SV, 2006, MAYO CLIN PROC, V81, P693, DOI 10.4065/81.5.693; Rydh A, 1998, EUR J NUCL MED, V25, P709; Schnitzer T J, 1977, Arthritis Rheum, V20, P245; Shimojima Y, 2006, AMYLOID, V13, P184, DOI 10.1080/13506120600876930; Singh G, 2007, J RHEUMATOL, V34, P371; TANAKA K, 1995, INTERNAL MED, V34, P122, DOI 10.2169/internalmedicine.34.122; Urieli-Shoval S, 2000, CURR OPIN HEMATOL, V7, P64, DOI 10.1097/00062752-200001000-00012; WERDELIN O, 1966, ACTA PATHOL MIC SC, V68, P1	26	589	635	0	25	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 7	2007	356	23					2361	2371		10.1056/NEJMoa070265	http://dx.doi.org/10.1056/NEJMoa070265			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	175QY	17554117	Green Published			2022-12-28	WOS:000247029300005
J	Millard, SS; Flanagan, JJ; Pappu, KS; Wu, W; Zipursky, SL				Millard, S. Sean; Flanagan, John J.; Pappu, Kartik S.; Wu, Wei; Zipursky, S. Lawrence			Dscam2 mediates axonal tiling in the Drosophila visual system	NATURE			English	Article							REPRESSIBLE CELL MARKER; SENSORY NEURONS; MOLECULAR DIVERSITY; MOSAIC ANALYSIS; NERVOUS-SYSTEM; MORPHOGENESIS; SPECIFICITY; EXPRESSION	Sensory processing centres in both the vertebrate and the invertebrate brain are often organized into reiterated columns, thus facilitating an internal topographic representation of the external world. Cells within each column are arranged in a stereotyped fashion and form precise patterns of synaptic connections within discrete layers. These connections are largely confined to a single column, thereby preserving the spatial information from the periphery. Other neurons integrate this information by connecting to multiple columns. Restricting axons to columns is conceptually similar to tiling. Axons and dendrites of neighbouring neurons of the same class use tiling to form complete, yet non-overlapping, receptive fields(1-3). It is thought that, at the molecular level, cell-surface proteins mediate tiling through contact-dependent repulsive interactions(1,2,4,5), but proteins serving this function have not yet been identified. Here we show that the immunoglobulin superfamily member Dscam2 restricts the connections formed by L1 lamina neurons to columns in the Drosophila visual system. Our data support a model in which Dscam2 homophilic interactions mediate repulsion between neurites of L1 cells in neighbouring columns. We propose that Dscam2 is a tiling receptor for L1 neurons.	Univ Calif Los Angeles, Howard Hughes Med Inst, Dept Biol Chem, David Geffen Sch Med, Los Angeles, CA 90095 USA	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Zipursky, SL (corresponding author), Univ Calif Los Angeles, Howard Hughes Med Inst, Dept Biol Chem, David Geffen Sch Med, Los Angeles, CA 90095 USA.	lzipursky@mednet.ucla.edu	Millard, Sean/A-8522-2013	Millard, Sean/0000-0001-8573-4625; Zipursky, Stephen/0000-0001-5630-7181	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Barlow GM, 2002, BIOCHEM BIOPH RES CO, V299, P1, DOI 10.1016/S0006-291X(02)02548-2; BLACKSHAW SE, 1982, J PHYSIOL-LONDON, V326, P261, DOI 10.1113/jphysiol.1982.sp014190; Chen BE, 2006, CELL, V125, P607, DOI 10.1016/j.cell.2006.03.034; Clandinin TR, 2002, NEURON, V35, P827, DOI 10.1016/S0896-6273(02)00876-0; Fusaoka E, 2006, GENES CELLS, V11, P541, DOI 10.1111/j.1365-2443.2006.00962.x; Gong WJ, 2003, P NATL ACAD SCI USA, V100, P2556, DOI 10.1073/pnas.0535280100; Graveley BR, 2004, RNA, V10, P1499, DOI 10.1261/rna.7105504; Grueber WB, 2003, CURR BIOL, V13, P618, DOI 10.1016/S0960-9822(03)00207-0; Grueber WB, 2002, DEVELOPMENT, V129, P2867; Hughes ME, 2007, NEURON, V54, P417, DOI 10.1016/j.neuron.2007.04.013; Hummel T, 2003, NEURON, V37, P221, DOI 10.1016/S0896-6273(02)01183-2; Jan YN, 2003, NEURON, V40, P229, DOI 10.1016/S0896-6273(03)00631-7; KRAMER AP, 1985, J NEUROSCI, V5, P768; Lee CH, 2001, NEURON, V30, P437, DOI 10.1016/S0896-6273(01)00291-4; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; Lee TM, 2000, NEURON, V25, P307, DOI 10.1016/S0896-6273(00)80896-X; Matthews BJ, 2007, CELL, V129, P593, DOI 10.1016/j.cell.2007.04.013; Meinertzhagen I.A., 1993, DEV DROSOPHILA MELAN; Neves G, 2004, NAT GENET, V36, P240, DOI 10.1038/ng1299; Pappu KS, 2005, DEVELOPMENT, V132, P2895, DOI 10.1242/dev.01869; Sagasti A, 2005, CURR BIOL, V15, P804, DOI 10.1016/j.cub.2005.03.048; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; Soba P, 2007, NEURON, V54, P403, DOI 10.1016/j.neuron.2007.03.029; Wang J, 2002, NEURON, V33, P559, DOI 10.1016/S0896-6273(02)00570-6; Wojtowicz WM, 2004, CELL, V118, P619, DOI 10.1016/j.cell.2004.08.021; Yamakawa K, 1998, HUM MOL GENET, V7, P227, DOI 10.1093/hmg/7.2.227; Zhan XL, 2004, NEURON, V43, P673, DOI 10.1016/j.neuron.2004.07.020; Zhu HT, 2006, NAT NEUROSCI, V9, P349, DOI 10.1038/nn1652; Zipursky SL, 2006, TRENDS BIOCHEM SCI, V31, P581, DOI 10.1016/j.tibs.2006.08.003	30	108	108	2	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 7	2007	447	7145					720	U14		10.1038/nature05855	http://dx.doi.org/10.1038/nature05855			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175RI	17554308	Green Accepted			2022-12-28	WOS:000247030700045
J	Pengel, LHM; Refshauge, KM; Maher, CG; Nicholas, MK; Herbert, RD; McNair, P				Pengel, Liset H. M.; Refshauge, Kathryn M.; Maher, Christopher G.; Nicholas, Michael K.; Herbert, Robert D.; McNair, Peter			Physiotherapist-directed exercise, advice, or both for subacute low back pain - A randomized trial	ANNALS OF INTERNAL MEDICINE			English	Article							GRADED ACTIVITY; CLINICAL-TRIAL; SICK LEAVE; THERAPY; INTERVENTION; CARE; DISABILITY; GUIDELINES; OUTCOMES; PROGRAM	Background: Advice and exercise are widely recommended for subacute low back pain, but the effectiveness of these interventions is unclear. Objective: To investigate the effectiveness of physiotherapist-prescribed exercise, advice, or both for subacute low back pain. Design: Factorial randomized, placebo-controlled trial. Setting: 7 university hospitals and primary care clinics in Australia and New Zealand. Patients: 259 persons with subacute low back pain (>6 weeks and <3 months in duration). Intervention: Participants received 12 physiotherapist-directed exercise or sham exercise sessions and 3 physiotherapist-directed advice or sham advice sessions over 6 weeks. Measurements: Primary outcomes were average pain over the past week (scale, 0 to 10), function (Patient-Specific Functional Scale), and global perceived effect (11-point scale) at 6 weeks and 12 months. Secondary outcomes were disability (Roland-Morris Disability Questionnaire), number of health care contacts, and depression (Depression Anxiety Stress Scales-21). Results: Exercise and advice were each slightly more effective than placebo at 6 weeks but not at 12 months. The effect of advice on the pain scale was -0.7 point (95% CI, -1.2 to -0.2 point; P = 0.011) at 6 weeks and -0.4 point (CI, - 1.0 to 0.3 point P = 0.27) at 12 months, whereras the effect of exercise was -0.8 point (CI, -1.3 to -0.3 point; P 0.004) at 6 weeks and -0.5 point (CI, -1.1 to 0.2 point P 0.14) at 12 months. The effect of advice on the function scale was 0.7 point (CI, 0.1 to 1.3 points; P = 0.014) at 6 weeks and 0.6 point (CI, 0.1 to 1.2 points; P 0.023) at 12 months, and the effect of exercise was 0.4 point (CI, -0.2 to 1.0 point; P = 0.174) at 6 weeks and 0.5 point (CI, -0.1 to 1.0 point; P = 0.094) at 12 months. The effect of advice on the global perceived effect scale was 0.8 point (CI, 0.3 to 1.2 points; P < 0.001) at 6 weeks and 0.3 point (CI, -0.2 to 0.9 point; P = 0.24) at 12 months, and the effect of exercise was 0.5 point (CI, 0.1 to 1.0 point; P = 0.017) at 6 weeks and 0.4 point (CI, -0.1 to 1.0 point; P = 0.134) at 12 months. When administered together, exercise and advice had larger effects on all outcomes at 6 weeks (effect on pain, -1.5 [CI -2.2 to -0.7 point; P = 0.001], with similar results for other primary outcomes); however, by 12 months, there was a statistically significant effect only for function (effect 1.1 points [CI, 0.3 to 1.8 points]; P = 0.005). Limitation: Physiotherapists were not blinded. Conclusions: in participants with subacute low back pain, physiotherapist- directed exercise and advice were each slightly more effective than placebo at 6 weeks. The effect was greatest when the interventions were combined. At 12 months, the only effect that persisted was a small effect on participant-reported function.	Univ Sydney, Fac Hlth Sci, Discipline Physiotherapy, Lidcombe, NSW 1825, Australia; Royal Coll Surgeons England, London, England; Royal N Shore Hosp, St Leonards, NSW 2065, Australia; Univ Auckland Technol, Auckland, New Zealand	University of Sydney; Royal College of Surgeons of England; Royal North Shore Hospital; Auckland University of Technology; University of Auckland	Maher, CG (corresponding author), Univ Sydney, Fac Hlth Sci, Discipline Physiotherapy, POB 170, Lidcombe, NSW 1825, Australia.	c.maher@usyd.edu.au	Maher, Christopher/AAC-6267-2019	Maher, Christopher/0000-0002-1628-7857; Pengel, Liset/0000-0001-9620-8639; Herbert, Rob/0000-0003-4188-9195; refshauge, kathryn/0000-0002-8127-6847				[Anonymous], 2003, APPL LONGITUDINAL AN; BORKOVEC TD, 1972, J BEHAV THER EXP PSY, V3, P257, DOI 10.1016/0005-7916(72)90045-6; Britt H, 2005, GEN PRACTICE ACTIVIT; Cherkin DC, 1998, NEW ENGL J MED, V339, P1021, DOI 10.1056/NEJM199810083391502; Cherkin DC, 1996, SPINE, V21, P345, DOI 10.1097/00007632-199602010-00019; Chok B, 1999, PHYS THER, V79, P1032, DOI 10.1093/ptj/79.11.1032; DAVIES JE, 1979, RHEUMATOL REHABIL, V18, P243, DOI 10.1093/rheumatology/18.4.243; Farrar JT, 2001, PAIN, V94, P149, DOI 10.1016/S0304-3959(01)00349-9; Frost H, 2004, BRIT MED J, V329, P708, DOI 10.1136/bmj.38216.868808.7C; Hagen EM, 2000, SPINE, V25, P1973, DOI 10.1097/00007632-200008010-00017; Hayden JA, 2005, ANN INTERN MED, V142, P765, DOI 10.7326/0003-4819-142-9-200505030-00013; Hayden JA, 2005, ANN INTERN MED, V142, P776, DOI 10.7326/0003-4819-142-9-200505030-00014; Hides JA, 1996, SPINE, V21, P2763, DOI 10.1097/00007632-199612010-00011; INDAHL A, 1995, SPINE, V20, P473, DOI 10.1097/00007632-199502001-00011; Jellema P, 2005, BMJ-BRIT MED J, V331, P84, DOI 10.1136/bmj.38495.686736.E0; Koes BW, 2006, BMJ-BRIT MED J, V332, P1430, DOI 10.1136/bmj.332.7555.1430; Koes BW, 2001, SPINE, V26, P2504, DOI 10.1097/00007632-200111150-00022; LINDSTROM I, 1992, PHYS THER, V72, P279, DOI 10.1093/ptj/72.4.279; Linton SJ, 2000, SPINE, V25, P2825, DOI 10.1097/00007632-200011010-00017; Lovibond PF, 1998, J ABNORM PSYCHOL, V107, P520, DOI 10.1037/0021-843X.107.3.520; Mannion AF, 1999, SPINE, V24, P2435, DOI 10.1097/00007632-199912010-00004; Moffett JK, 1999, BRIT MED J, V319, P279, DOI 10.1136/bmj.319.7205.279; Nicholas M., 2004, MUSCULOSKELETAL PHYS, V2nd; NICHOLAS MK, 1992, PAIN, V48, P339, DOI 10.1016/0304-3959(92)90082-M; Norman GR, 2003, MED CARE, V41, P582, DOI 10.1097/00005650-200305000-00004; Pengel HM, 2002, CLIN REHABIL, V16, P811, DOI 10.1191/0269215502cr562oa; Pengel LHM, 2003, BMJ-BRIT MED J, V327, P323, DOI 10.1136/bmj.327.7410.323; ROLAND M, 1983, SPINE, V8, P141, DOI 10.1097/00007632-198303000-00004; Ross RG, 1997, ASSESSMENT OCCUPATIO, P123; Schiltenwolf M, 2006, EUR SPINE J, V15, P1083, DOI 10.1007/s00586-005-0008-5; Staal JB, 2004, ANN INTERN MED, V140, P77, DOI 10.7326/0003-4819-140-2-200401200-00007; Storheim K, 2003, J REHABIL MED, V35, P132, DOI 10.1080/16501970310010484; van Tulder M, 2003, SPINE, V28, P1290, DOI 10.1097/01.BRS.0000065484.95996.AF; Vlaeyen JWS, 2002, PAIN RES CL, V12, P83; Walker BF, 2004, J MANIP PHYSIOL THER, V27, P327, DOI 10.1016/j.jmpt.2004.04.006; Westaway MD, 1998, J ORTHOP SPORT PHYS, V27, P331, DOI 10.2519/jospt.1998.27.5.331	36	116	120	0	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 5	2007	146	11					787	796		10.7326/0003-4819-146-11-200706050-00007	http://dx.doi.org/10.7326/0003-4819-146-11-200706050-00007			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	175HR	17548410				2022-12-28	WOS:000247005200004
J	Der, CJ; Van Dyke, T				Der, Channing J.; Van Dyke, Terry			Stopping Ras in its tracks	CELL			English	Editorial Material							ACTIVATION; CANCER; MUTATIONS; GENE		Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Pharmacol, Chapel Hill, NC 27599 USA; Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Genet, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Der, CJ (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Pharmacol, Chapel Hill, NC 27599 USA.	cjder@med.unc.edu		Der, Channing/0000-0002-7751-2747				Aguirre AJ, 2003, GENE DEV, V17, P3112, DOI 10.1101/gad.1158703; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Gupta S, 2007, CELL; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Lim KH, 2005, CANCER CELL, V8, P381, DOI 10.1016/j.ccr.2005.10.014; Lim KH, 2005, CANCER CELL, V7, P533, DOI 10.1016/j.ccr.2005.04.030; Repasky GA, 2004, TRENDS CELL BIOL, V14, P639, DOI 10.1016/j.tcb.2004.09.014; Rodriguez-Viciana P, 2004, MOL CELL BIOL, V24, P4943, DOI 10.1128/MCB.24.11.4943-4954.2004; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502	10	16	19	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 1	2007	129	5					855	857		10.1016/j.cell.2007.05.031	http://dx.doi.org/10.1016/j.cell.2007.05.031			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	176KT	17540164	Bronze			2022-12-28	WOS:000247084600004
J	Dery, H; Dalal, P; Cywinski, L; Sham, LJ				Dery, H.; Dalal, P.; Cywinski, L.; Sham, L. J.			Spin-based logic in semiconductors for reconfigurable large-scale circuits	NATURE			English	Article							ROOM-TEMPERATURE; GIANT MAGNETORESISTANCE; CELLULAR-AUTOMATA; INJECTION; TRANSPORT; EXCHANGE; GAAS	Research in semiconductor spintronics aims to extend the scope of conventional electronics by using the spin degree of freedom of an electron in addition to its charge(1). Significant scientific advances in this area have been reported, such as the development of diluted ferromagnetic semiconductors(2,)3, spin injection into semiconductors from ferromagnetic metals(4-8) and discoveries of new physical phenomena involving electron spin(9,10). Yet no viable means of developing spintronics in semiconductors has been presented. Here we report a theoretical design that is a conceptual step forward-spin accumulation is used as the basis of a semiconductor computer circuit. Although the giant magnetoresistance effect in metals(11,12) has already been commercially exploited, it does not extend to semiconductor/ ferromagnet systems, because the effect is too weak for logic operations. We overcome this obstacle by using spin accumulation rather than spin flow(13-15). The basic element in our design is a logic gate that consists of a semiconductor structure with multiple magnetic contacts; this serves to perform fast and reprogrammable logic operations in a noisy, room-temperature environment. We then introduce a method to interconnect a large number of these gates to form a 'spin computer'. As the shrinking of conventional complementary metal-oxide-semiconductor (CMOS) transistors reaches its intrinsic limit, greater computational capability will mean an increase in both circuit area and power dissipation. Our spin-based approach may provide wide margins for further scaling and also greater computational capability per gate.	Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Dery, H (corresponding author), Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA.	hdery@ucsd.edu	Cywinski, Lukasz/E-5348-2010	Cywinski, Lukasz/0000-0002-0162-7943; Sham, Lu/0000-0001-5718-2077				BAIBICH MN, 1988, PHYS REV LETT, V61, P2472, DOI 10.1103/PhysRevLett.61.2472; BINASCH G, 1989, PHYS REV B, V39, P4828, DOI 10.1103/PhysRevB.39.4828; Cowburn RP, 2000, SCIENCE, V287, P1466, DOI 10.1126/science.287.5457.1466; Crooker SA, 2005, SCIENCE, V309, P2191, DOI 10.1126/science.1116865; DATTA S, 1990, APPL PHYS LETT, V56, P665, DOI 10.1063/1.102730; Dery H, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.046602; Dery H, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.161307; Dietl T, 2000, SCIENCE, V287, P1019, DOI 10.1126/science.287.5455.1019; Gerrits T, 2002, NATURE, V418, P509, DOI 10.1038/nature00905; Hanbicki AT, 2003, APPL PHYS LETT, V82, P4092, DOI 10.1063/1.1580631; Hanbicki AT, 2001, APPL PHYS LETT, V79, P1190, DOI 10.1063/1.1395523; Hauck S, 1998, P IEEE, V86, P615, DOI 10.1109/5.663540; Imre A, 2006, SCIENCE, V311, P205, DOI 10.1126/science.1120506; Jedema FJ, 2001, NATURE, V410, P345, DOI 10.1038/35066533; Jiang X, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.056601; JOHNSON M, 1993, SCIENCE, V260, P320, DOI 10.1126/science.260.5106.320; Johnson M., 2004, MAGNETOELECTRONICS, p[382, 273]; Kato YK, 2004, SCIENCE, V306, P1910, DOI 10.1126/science.1105514; Kikkawa JM, 1998, PHYS REV LETT, V80, P4313, DOI 10.1103/PhysRevLett.80.4313; Lou XH, 2007, NAT PHYS, V3, P197, DOI 10.1038/nphys543; Ney A, 2003, NATURE, V425, P485, DOI 10.1038/nature02014; Ohno Y, 1999, NATURE, V402, P790, DOI 10.1038/45509; Pikus G., 1984, MODERN PROBLEMS COND, V8, P73; Richter R, 2002, APPL PHYS LETT, V80, P1291, DOI 10.1063/1.1449536; Skumryev V, 2003, NATURE, V423, P850, DOI 10.1038/nature01687; Stephens J, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.097602; Tehrani S, 2000, IEEE T MAGN, V36, P2752, DOI 10.1109/20.908581; Wolf SA, 2001, SCIENCE, V294, P1488, DOI 10.1126/science.1065389; Wunderlich J, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.047204; Zhu HJ, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.016601	30	342	348	3	101	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 31	2007	447	7144					573	576		10.1038/nature05833	http://dx.doi.org/10.1038/nature05833			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172YZ	17538616				2022-12-28	WOS:000246842000044
J	Liao, LM; Creighton, SM				Liao, Lih Mei; Creighton, Sarah M.			Requests for cosmetic genitoplasty: how should healthcare providers respond?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							LABIA MINORA; PLASTIC-SURGERY; GENITAL SURGERY; REDUCTION; INTERSEX		Elizabeth Garrett Anderson & Obstet Hosp, UCL Inst Womens Hlth, Middlesex Ctr, London WC1E 6DH, England	University of London; University College London	Liao, LM (corresponding author), Elizabeth Garrett Anderson & Obstet Hosp, UCL Inst Womens Hlth, Middlesex Ctr, London WC1E 6DH, England.	lih-mei.liao@ucth.nhs.uk						Alter GJ, 1998, ANN PLAST SURG, V41, P685; BERMAN JR, 1991, CURR OPIN UROL, V9, P563; Boyle ME, 2005, J HEALTH PSYCHOL, V10, P573, DOI 10.1177/1359105305053431; Braun V., 2005, SEXUALITIES, V8, P407, DOI [https://doi.org/10.1177/1363460705056625, DOI 10.1177/1363460705056625]; Braun V., 2001, CULTURE HLTH SEXUALI, V3, P263, DOI [10.1080/13691050152484704, DOI 10.1080/13691050152484704]; *BRIT SOC AESTH PL, 2007, AUD SURG PROC; Cano SJ, 2004, BRIT J PLAST SURG, V57, P1, DOI 10.1016/j.bjps.2003.08.008; Choi HY, 2000, PLAST RECONSTR SURG, V105, P419, DOI 10.1097/00006534-200001000-00067; Conroy RM, 2006, BRIT MED J, V333, P106, DOI 10.1136/bmj.333.7559.106; Cook SA, 2003, BRIT J PLAST SURG, V56, P429, DOI 10.1016/S0007-1226(03)00183-8; Crouch NS, 2004, BJU INT, V93, P135, DOI 10.1111/j.1464-410X.2004.04572.x; Davis K., 1995, RESHAPING FEMALE BOD; Department of Health, 2006, COSM SURG INF PAT; Lloyd J, 2005, BJOG-INT J OBSTET GY, V112, P643, DOI 10.1111/j.1471-0528.2004.00517.x; Maas SM, 2000, PLAST RECONSTR SURG, V105, P1453, DOI 10.1097/00006534-200004040-00030; Martin-Alguacil N, 2006, J UROLOGY, V176, P456, DOI 10.1016/j.juro.2006.03.029; Minto CL, 2003, LANCET, V361, P1252, DOI 10.1016/S0140-6736(03)12980-7; *NAT HLTH SERV, OSP EP STAT 1999 200; Pardo J, 2006, INT J GYNECOL OBSTET, V93, P38, DOI 10.1016/j.ijgo.2006.01.002; Rouzier R, 2000, AM J OBSTET GYNECOL, V182, P35, DOI 10.1016/S0002-9378(00)70488-1; Shell-Duncan B, 2001, SOC SCI MED, V52, P1013, DOI 10.1016/S0277-9536(00)00208-2; Timmons MJ, 2000, ANN ROY COLL SURG, V82, P332	22	132	133	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 26	2007	334	7603					1090	1092		10.1136/bmj.39206.422269.BE	http://dx.doi.org/10.1136/bmj.39206.422269.BE			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	174XB	17525451	Green Published, Green Submitted			2022-12-28	WOS:000246975000030
J	van Tulder, M; Malmivaara, A; Koes, B				van Tulder, Maurits; Malmivaara, Antti; Koes, Bart			Repetitive strain injury	LANCET			English	Review							CARPAL-TUNNEL RELEASE; UPPER EXTREMITY DISORDERS; SOUTHAMPTON EXAMINATION SCHEDULE; RANDOMIZED CONTROLLED-TRIAL; CHRONIC NECK PAIN; MUSCULOSKELETAL DISORDERS; SHOULDER PAIN; UPPER-LIMB; FOLLOW-UP; LATERAL EPICONDYLITIS	Repetitive strain injury remains a controversial topic. The term repetitive strain injury includes specific disorders such as carpal tunnel syndrome, cubital tunnel syndrome, Guyon canal syndrome, lateral epicondylitis, and tendonitis of the wrist or hand. The diagnosis is usually made on the basis of history and clinical examination. Large high-quality studies using newer imaging techniques, such as MRI and ultrasonography are few. Consequently, the role of such imaging in diagnosis of upper limb disorders remains unclear. In many cases, no specific diagnosis can be established and complaints are labelled as non-specific. Little is known about the effectiveness of treatment options for upper limb disorders. Strong evidence for any intervention is scarce and the effect, if any, is mainly short-term pain relief Exercise is beneficial for non-specific upper limb disorders. Immobilising hand braces and open carpal tunnel surgery release are beneficial for carpal tunnel syndrome, and topical and oral non-steroidal anti-inflammatory drugs, and corticosteroid injections are helpful for lateral epicondylitis. Exercise is probably beneficial for neck pain, as are corticosteroid injections and exercise for shoulder pain. Although upper limb disorders occur frequently in the working population, most trials have not exclusively included a working population or assessed effects on work-related outcomes. Further high-quality trials should aim to include sufficient sample sizes, working populations, and work-related outcomes.	Vrije Univ Amsterdam Med Ctr, Inst Res Extramural Med, NL-1081 BT Amsterdam, Netherlands; Vrije Univ Amsterdam, Fac Earth & Life Sci, Inst Hlth Sci, Amsterdam, Netherlands; Finnish Off Hlth Care Technol Assessment, Helsinki, Finland; Univ Med Ctr Rotterdam, Erasmus MC, Dept Gen Practice, Rotterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; Erasmus University Rotterdam; Erasmus MC	van Tulder, M (corresponding author), Vrije Univ Amsterdam Med Ctr, Inst Res Extramural Med, NL-1081 BT Amsterdam, Netherlands.	mw.vantulder@vumc.nl	Koes, Bart w/K-4614-2016; van Tulder, Maurits/AAB-9785-2022	Koes, Bart w/0000-0002-0450-9969; van Tulder, Maurits/0000-0002-7589-8471				*ACR APPR CRIT, 2005, CHRON ELB PAIN; AGEE JM, 1992, J HAND SURG-AM, V17A, P987, DOI 10.1016/S0363-5023(09)91044-9; ASHWORTH N, 2005, CLIN EVID, V14, P1351; Assendelft Willem, 2004, Clin Evid, P1633; Baldwin ML, 2006, J OCCUP REHABIL, V16, P303, DOI 10.1007/s10926-006-9043-2; Bang MD, 2000, J ORTHOP SPORT PHYS, V30, P126, DOI 10.2519/jospt.2000.30.3.126; BENEDETTI RB, 1996, HANDCHIR MIKROCHIR P, V28, P151; BINDER A, 2005, CLIN EVIDENCE, V13, P1501; Bot SDM, 2005, ANN RHEUM DIS, V64, P118, DOI 10.1136/ard.2003.019349; BROWN RA, 1993, J BONE JOINT SURG AM, V75A, P1265, DOI 10.2106/00004623-199309000-00002; Bruser P, 1999, EUR J PLAST SURG, V22, P80, DOI 10.1007/s002380050153; Buchbinder R, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003524.pub2; Buchbinder R., 2003, COCHRANE DB SYST REV, V2003, pCD004016, DOI [DOI 10.1002/14651858.CD004016, 10.1002/14651858.CD004016]; Chapell R, 2003, PLAST RECONSTR SURG, V112, P983, DOI 10.1097/01.PRS.0000076222.77125.1F; Chen Y, 2005, OCCUP MED-OXFORD, V55, P252, DOI 10.1093/occmed/kqi108; COLE DC, 2005, AM J PUBLIC HEALTH, V95; D'Arcy CA, 2000, JAMA-J AM MED ASSOC, V283, P3110, DOI 10.1001/jama.283.23.3110; Descatha A, 2004, SCAND J WORK ENV HEA, V30, P234, DOI 10.5271/sjweh.784; Descatha A, 2003, J OCCUP ENVIRON MED, V45, P993, DOI 10.1097/01.jom.0000085888.37273.d9; deZwart BCH, 1997, INT ARCH OCC ENV HEA, V70, P352, DOI 10.1007/s004200050229; DUMONTIER C, 1995, J HAND SURG-BRIT EUR, V20B, P658, DOI 10.1016/S0266-7681(05)80130-5; Dunkow PD, 2004, J BONE JOINT SURG BR, V86B, P701, DOI 10.1302/0301-620X.86B5.14469; Dunkow PD, 2005, J BONE JOINT SURG AM, V87A, P467, DOI 10.2106/00004623-200502000-00050; ERDMANN MWH, 1994, J HAND SURG-BRIT EUR, V19B, P5, DOI 10.1016/0266-7681(94)90038-8; Ferdinand RD, 2002, J BONE JOINT SURG BR, V84B, P375, DOI 10.1302/0301-620X.84B3.12224; Ferguson D, 1976, Aust J Physiother, V22, P61, DOI 10.1016/S0004-9514(14)61001-1; FEUERSTEIN M, 1993, J OCCUP ENVIRON MED, V35, P396; Forde MS, 2005, J OCCUP ENVIRON HYG, V2, P203, DOI 10.1080/15459620590929635; Foucher G, 1993, Chirurgie, V119, P80; Gell N, 2005, J OCCUP REHABIL, V15, P47, DOI 10.1007/s10926-005-0873-0; Giebel G D, 1997, Zentralbl Chir, V122, P517; Goodyear-Smith F, 2004, ANN FAM MED, V2, P267, DOI 10.1370/afm.21; Green S, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005319; Green S, 2003, Cochrane Database Syst Rev, pCD004258; Green S, 2002, C CHRIST EC BAYL U, V1, DOI [10. 1002/14651858.CD003527, DOI 10.1002/14651858.CD003527]; Green S, 2002, COCHRANE DB SYST REV, V2; Gross AR, 2004, COCHRANE DB SYST REV, V1; GUN RT, 1990, MED J AUSTRALIA, V153, P376, DOI 10.5694/j.1326-5377.1990.tb125492.x; Haahr JP, 2005, ANN RHEUM DIS, V64, P760, DOI 10.1136/ard.2004.021188; Hagberg M, 2000, ARCH PHYS MED REHAB, V81, P1051, DOI 10.1053/apmr.2000.7582; Harrington JM, 1998, OCCUP ENVIRON MED, V55, P264, DOI 10.1136/oem.55.4.264; Helliwell PS, 2003, OCCUP MED-OXFORD, V53, P313, DOI 10.1093/occmed/kqg034; Helm RH, 2003, J HAND SURG-BRIT EUR, V28B, P251, DOI 10.1016/S0266-7681(02)000395-9/jhsb.2003.0900; Hoefnagels W A, 1997, Ned Tijdschr Geneeskd, V141, P878; Hoving JL, 2002, ANN INTERN MED, V136, P713, DOI 10.7326/0003-4819-136-10-200205210-00006; Hui ACF, 2005, NEUROLOGY, V64, P2074, DOI 10.1212/01.WNL.0000169017.79374.93; Jacobsen MB, 1996, J HAND SURG-BRIT EUR, V21B, P202, DOI 10.1016/S0266-7681(96)80097-0; JENSEN I, 1995, SCAND J REHABIL MED, V27, P19; Jianmongkol S, 2005, J HAND SURG-ASIAN-PA, V10, P67, DOI 10.1142/S0218810405002565; Jordan R, 2002, BRIT J GEN PRACT, V52, P670; Jugovac I, 2002, CROAT MED J, V43, P33; KAMWENDO K, 1991, SCAND J REHABIL MED, V23, P143; Karjalainen K, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002194; Kay T, 2005, COCHRANE DB SYST REV, V3; Konijnenberg HS, 2001, SCAND J WORK ENV HEA, V27, P299, DOI 10.5271/sjweh.618; KROELING P, 2005, COCHRANE DB SYST REV, V6; Kunnamo I, 2005, EVIDENCE BASED MED G; Labelle H, 1997, ARCH FAM MED, V6, P257, DOI 10.1001/archfami.6.3.257; Lacerda Eliana M, 2005, BMC Public Health, V5, P107, DOI 10.1186/1471-2458-5-107; LaJoie AS, 2005, PLAST RECONSTR SURG, V116, P502, DOI 10.1097/01.prs.0000172894.21006.e2; Lassen CF, 2005, SCAND J WORK ENV HEA, V31, P122, DOI 10.5271/sjweh.859; Lassen CF, 2004, AM J IND MED, V46, P521, DOI 10.1002/ajim.20081; Leboeuf C, 1987, J AUSTR CHIROPRACTOR, V17, P11; Leclerc A, 2004, OCCUP ENVIRON MED, V61, P39; Lee HY, 2005, J OCCUP HEALTH, V47, P311, DOI 10.1539/joh.47.311; LEVOSKA S, 1993, ARCH PHYS MED REHAB, V74, P425; Lowe JB, 2004, PLAST RECONSTR SURG, V113, p1E, DOI 10.1097/01.PRS.0000097287.10955.CC; Lundblad I, 1999, J OCCUP REHABIL, V9, P179, DOI 10.1023/A:1021301801292; Ly-Pen D, 2005, ARTHRITIS RHEUM-US, V52, P612, DOI 10.1002/art.20767; MacDermid JC, 2003, J HAND SURG-AM, V28A, P475, DOI 10.1053/jhsu.2003.50080; MacDermid Joy C, 2004, J Hand Ther, V17, P309, DOI 10.1197/j.jht.2004.02.015; Macfarlane GJ, 2000, BRIT MED J, V321, P676, DOI 10.1136/bmj.321.7262.676; MARSHALL S, 2002, COCHRANE DB SYST REV, V4; Miranda H, 2005, AM J EPIDEMIOL, V161, P847, DOI 10.1093/aje/kwi112; Mondelli M, 2005, J NEUROL SCI, V234, P5, DOI 10.1016/j.jns.2005.02.010; Moore LE, 1996, AM J CLIN HYPN, V39, P97; Mowlavi A, 2000, PLAST RECONSTR SURG, V106, P327, DOI 10.1097/00006534-200008000-00014; Muller Monique, 2004, J Hand Ther, V17, P210, DOI 10.1197/j.jht.2004.02.009; NIEMISTO L, 2003, COCHRANE DB SYST REV, V1; *NIOSH, 1997, 97141 NIOSH US DEP H; O'Connor D, 2003, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003219, DOI 10.1002/14651858.CD003219]; Padua L, 2002, CLIN NEUROPHYSIOL, V113, P1980, DOI 10.1016/S1388-2457(02)00295-X; Padua L, 2001, NEUROLOGY, V56, P1459, DOI 10.1212/WNL.56.11.1459; Palmer K, 2000, ANN RHEUM DIS, V59, P5, DOI 10.1136/ard.59.1.5; Palmer KT, 2003, BEST PRACT RES CL RH, V17, P113, DOI 10.1016/S1521-6942(02)00100-6; Pascarelli EF, 2001, J OCCUP REHABIL, V11, P1, DOI 10.1023/A:1016647923501; Pasternack I, 2001, ACTA RADIOL, V42, P434, DOI 10.1034/j.1600-0455.2001.420502.x; PELOSO P, 2005, COCHRANE DB SYST REV, V2; Picavet HSJ, 2003, PAIN, V102, P167, DOI 10.1016/S0304-3959(02)00372-X; Punnett L, 2004, OCCUP ENVIRON MED, V61, P668, DOI 10.1136/oem.2003.008979; Rempel D, 1999, J OCCUP ENVIRON MED, V41, P111, DOI 10.1097/00043764-199902000-00006; Roquelaure Y, 2002, OCCUP ENVIRON MED, V59, P452, DOI 10.1136/oem.59.7.452; *RSI HLTH COUNC NE, 2000, PUBL RSI; RUNDCRANTZ BL, 1991, SCAND J REHABIL MED, V23, P11; Salaffi F, 2005, CLIN EXP RHEUMATOL, V23, P819; Schlossberg EB, 2004, AM J IND MED, V46, P297, DOI 10.1002/ajim.20071; SCHOLTEN RJ, 2004, COCHRANE DB SYST REV, V4; Sluiter JK, 2001, SCAND J WORK ENV HEA, V27, P1; Smidt N, 2003, ANN MED, V35, P51, DOI 10.1080/07853890310004138; Smidt N, 2002, PAIN, V96, P23, DOI 10.1016/S0304-3959(01)00388-8; Speed Cathy, 2005, Clin Evid, P1543; SPENCE SH, 1995, PAIN, V63, P199, DOI 10.1016/0304-3959(95)00047-V; Stark B, 1996, Handchir Mikrochir Plast Chir, V28, P128; STAV A, 1993, ACTA ANAESTH SCAND, V37, P562, DOI 10.1111/j.1399-6576.1993.tb03765.x; Stralka S W, 1998, AAOHN J, V46, P233; Strobel G, 1996, Rehabilitation (Stuttg), V35, P176; Struijs PA, 2002, COCHRANE DB SYST REV, V1, DOI [10.1002/14651858.CD001821, DOI 10.1002/14651858.CD001821]; Taimela S, 2000, SPINE, V25, P1021, DOI 10.1097/00007632-200004150-00018; TAKALA EP, 1994, SCAND J REHABIL MED, V26, P17; Thoma A, 2004, PLAST RECONSTR SURG, V114, P1137, DOI 10.1097/01.prs.0000135850.37523.d0; Tittiranonda P, 1999, AM J IND MED, V35, P647; Tjepkema Michael, 2003, Health Rep, V14, P11; Treaster DE, 2004, ERGONOMICS, V47, P495, DOI 10.1080/00140130310001638171; Van Eerd D, 2003, J CLIN EPIDEMIOL, V56, P940, DOI 10.1016/S0895-4356(03)00157-4; Vasseljen O, 1995, SCAND J REHABIL MED, V27, P243; Verdugo RJ, 2003, COCHRANE DB SYST REV, V3; VERHAGEN AP, 2004, COCHRANE DB SYST REV, VB; Viikari-Juntura E, 1999, SCAND J WORK ENV HEA, V25, P163, DOI 10.5271/sjweh.423; Visser B, 2006, J ELECTROMYOGR KINES, V16, P1, DOI 10.1016/j.jelekin.2005.06.005; Waling K, 2002, SPINE, V27, P789, DOI 10.1097/00007632-200204150-00002; Waling K, 2000, PAIN, V85, P201, DOI 10.1016/S0304-3959(99)00265-1; Walker-Bone K, 2004, ARTHRIT RHEUM-ARTHR, V51, P642, DOI 10.1002/art.20535; Walker-Bone K, 2005, ANN RHEUM DIS, V64, P1112, DOI 10.1136/ard.2004.026484; Walker-Bone K, 2002, ANN RHEUM DIS, V61, P1103, DOI 10.1136/ard.61.12.1103; Walker-Bone KE, 2003, SEMIN ARTHRITIS RHEU, V33, P185, DOI 10.1016/S0049-0172(03)00128-8; Werner RA, 2005, J OCCUP REHABIL, V15, P37, DOI 10.1007/s10926-005-0872-1; Wilson JJ, 2005, AM FAM PHYSICIAN, V72, P811; Yassi A, 1997, LANCET, V349, P943, DOI 10.1016/S0140-6736(96)07221-2; Ylinen J, 2003, JAMA-J AM MED ASSOC, V289, P2509, DOI 10.1001/jama.289.19.2509	129	116	120	0	31	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 26	2007	369	9575					1815	1822		10.1016/S0140-6736(07)60820-4	http://dx.doi.org/10.1016/S0140-6736(07)60820-4			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	172QP	17531890				2022-12-28	WOS:000246819300033
J	Stuart, DR; Fagnou, K				Stuart, David R.; Fagnou, Keith			The catalytic cross-coupling of unactivated arenes	SCIENCE			English	Article							ARYL BOND FORMATION; DIRECT ARYLATION; DERIVATIVES; BENZENE; INDOLES	The industrially important coupling of aromatic compounds has generally required differential prefunctionalization of the arene coupling partners with a halide and an electropositive group. Here we report that palladium, in conjunction with a copper oxidant, can catalyze the cross-coupling of N-acetylindoles and benzenes in high yield and high regioselectivity across a range of indoles without recourse to activating groups. These reactions are completely selective for arene cross-coupling, with no products arising from indole or benzene homo-coupling detected by spectroscopic analysis. This efficient reactivity should be useful in the design of other oxidative arene cross-couplings as well.	Univ Ottawa, Dept Chem, Ctr Catalysis Res & Innovat, Ottawa, ON K1N 6N5, Canada	University of Ottawa	Fagnou, K (corresponding author), Univ Ottawa, Dept Chem, Ctr Catalysis Res & Innovat, 10 Marie Curie, Ottawa, ON K1N 6N5, Canada.	keith.fagnou@uottawa.ca						Alberico D, 2007, CHEM REV, V107, P174, DOI 10.1021/cr0509760; Diederich F., 1998, METAL CATALYZED CROS; Ding KL, 1997, CHEM COMMUN, P693, DOI 10.1039/a608256d; Ferreira EM, 2003, J AM CHEM SOC, V125, P9578, DOI 10.1021/ja035054y; Garcia-Cuadrado D, 2006, J AM CHEM SOC, V128, P1066, DOI 10.1021/ja056165v; Goossen LJ, 2006, SCIENCE, V313, P662, DOI 10.1126/science.1128684; Hassan J, 2002, CHEM REV, V102, P1359, DOI 10.1021/cr000664r; Hull KL, 2006, J AM CHEM SOC, V128, P14047, DOI 10.1021/ja065718e; Jia CG, 2000, J AM CHEM SOC, V122, P7252, DOI 10.1021/ja0005845; Lafrance M, 2006, J AM CHEM SOC, V128, P16496, DOI 10.1021/ja067144j; Lafrance M, 2006, J AM CHEM SOC, V128, P8754, DOI 10.1021/ja062509L; Lane BS, 2005, J AM CHEM SOC, V127, P8050, DOI 10.1021/ja043273t; Li RS, 2006, ORGANOMETALLICS, V25, P5973, DOI 10.1021/om060889d; Li XL, 2003, J ORG CHEM, V68, P5500, DOI 10.1021/jo0340206; Mukhopadhyay S, 2001, ADV SYNTH CATAL, V343, P455, DOI 10.1002/1615-4169(200107)343:5<455::AID-ADSC455>3.3.CO;2-F; Park CH, 2004, ORG LETT, V6, P1159, DOI 10.1021/ol049866q; SMRCINA M, 1992, J ORG CHEM, V57, P1917, DOI 10.1021/jo00032a055; Takahashi M, 2006, J AM CHEM SOC, V128, P10930, DOI 10.1021/ja060749v	18	898	900	6	257	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 25	2007	316	5828					1172	1175		10.1126/science.1141956	http://dx.doi.org/10.1126/science.1141956			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	171GQ	17525334				2022-12-28	WOS:000246724300037
J	Matsumoto, M; Hikosaka, O				Matsumoto, Masayuki; Hikosaka, Okihide			Lateral habenula as a source of negative reward signals in dopamine neurons	NATURE			English	Article							VENTRAL TEGMENTAL AREA; SUBSTANTIA-NIGRA; CAUDATE-NUCLEUS; COMPLEX; RATS; PREDICTION; MOTIVATION; SEROTONIN; RESPONSES; SACCADES	Midbrain dopamine neurons are key components of the brain's reward system(1), which is thought to guide reward-seeking behaviours(2-4). Although recent studies have shown how dopamine neurons respond to rewards and sensory stimuli predicting reward(1,5,6), it is unclear which parts of the brain provide dopamine neurons with signals necessary for these actions. Here we show that the primate lateral habenula, part of the structure called the epithalamus, is a major candidate for a source of negative reward-related signals in dopamine neurons. We recorded the activity of habenula neurons and dopamine neurons while rhesus monkeys were performing a visually guided saccade task with positionally biased reward outcomes(7). Many habenula neurons were excited by a no-reward-predicting target and inhibited by a reward-predicting target. In contrast, dopamine neurons were excited and inhibited by reward-predicting and no-reward-predicting targets, respectively. Each time the rewarded and unrewarded positions were reversed, both habenula and dopamine neurons reversed their responses as the bias in saccade latency reversed. In unrewarded trials, the excitation of habenula neurons started earlier than the inhibition of dopamine neurons. Furthermore, weak electrical stimulation of the lateral habenula elicited strong inhibitions in dopamine neurons. These results suggest that the inhibitory input from the lateral habenula plays an important role in determining the reward-related activity of dopamine neurons.	NEI, Sensorimotor Res Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Hikosaka, O (corresponding author), NEI, Sensorimotor Res Lab, NIH, Bldg 10, Bethesda, MD 20892 USA.	oh@lsr.nei.nih.gov	Jansen, Heiko T./A-5770-2008	Jansen, Heiko T./0000-0003-0178-396X	NATIONAL EYE INSTITUTE [Z01EY000415, ZIAEY000415] Funding Source: NIH RePORTER	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Amat J, 2001, BRAIN RES, V917, P118, DOI 10.1016/S0006-8993(01)02934-1; CALDECOTTHAZARD S, 1988, J NEUROSCI, V8, P1951; CHRISTOPH GR, 1986, J NEUROSCI, V6, P613; Daw ND, 2002, NEURAL NETWORKS, V15, P603, DOI 10.1016/S0893-6080(02)00052-7; ELLISON G, 1994, BRAIN RES REV, V19, P223, DOI 10.1016/0165-0173(94)90012-4; Gao DM, 1996, EUR J NEUROSCI, V8, P1474, DOI 10.1111/j.1460-9568.1996.tb01609.x; HERKENHAM M, 1979, J COMP NEUROL, V187, P19, DOI 10.1002/cne.901870103; Hikosaka O, 2006, J NEUROPHYSIOL, V95, P567, DOI 10.1152/jn.00458.2005; Houk JC, 1995, MODELS INFORMATION P, P249; Kawagoe R, 2004, J NEUROPHYSIOL, V91, P1013, DOI 10.1152/jn.00721.2003; Lauwereyns J, 2002, NATURE, V418, P413, DOI 10.1038/nature00892; Lecourtier L, 2005, NEUROPSYCHOPHARMACOL, V30, P484, DOI 10.1038/sj.npp.1300595; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; Murphy CA, 1996, BEHAV BRAIN RES, V81, P43, DOI 10.1016/S0166-4328(96)00041-1; Nakahara H, 2004, NEURON, V41, P269, DOI 10.1016/S0896-6273(03)00869-9; Nakamura K, 2006, J NEUROSCI, V26, P5360, DOI 10.1523/JNEUROSCI.4853-05.2006; PARENT A, 1981, BRAIN RES BULL, V6, P23, DOI 10.1016/S0361-9230(81)80066-4; Paton JJ, 2006, NATURE, V439, P865, DOI 10.1038/nature04490; SANDYK R, 1991, INT J NEUROSCI, V61, P189, DOI 10.3109/00207459108990738; Satoh T, 2003, J NEUROSCI, V23, P9913; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Seymour B, 2005, NAT NEUROSCI, V8, P1234, DOI 10.1038/nn1527; Shepard PD, 2006, SCHIZOPHRENIA BULL, V32, P417, DOI 10.1093/schbul/sbj083; SOLOMON RL, 1974, PSYCHOL REV, V81, P119, DOI 10.1037/h0036128; SUTHERLAND RJ, 1982, NEUROSCI BIOBEHAV R, V6, P1, DOI 10.1016/0149-7634(82)90003-3; Takikawa Y, 2004, J NEUROPHYSIOL, V92, P2520, DOI 10.1152/jn.00238.2004; THORNTON EW, 1989, PHYSIOL BEHAV, V45, P929, DOI 10.1016/0031-9384(89)90217-5; Ullsperger M, 2003, J NEUROSCI, V23, P4308, DOI 10.1523/jneurosci.23-10-04308.2003; Ungless MA, 2004, SCIENCE, V303, P2040, DOI 10.1126/science.1093360	31	834	858	2	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 28	2007	447	7148					1111	U11		10.1038/nature05860	http://dx.doi.org/10.1038/nature05860			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	183HT	17522629	Green Published			2022-12-28	WOS:000247564600037
J	Ozer, MM; Jia, Y; Zhang, ZY; Thompson, JR; Weitering, HH				Oezer, Mustafa M.; Jia, Yu; Zhang, Zhenyu; Thompson, James R.; Weitering, Hanno H.			Tuning the quantum stability and superconductivity of ultrathin metal alloys	SCIENCE			English	Article							THIN-FILMS; TEMPERATURE; ENERGY	Quantum confinement of itinerant electrons in atomically smooth ultrathin lead films produces strong oscillations in the thickness-dependent film energy. By adding extra electrons via bismuth alloying, we showed that both the structural stability and the superconducting properties of such films can be tuned. The phase boundary ( upper critical field) between the superconducting vortex state and the normal state indicates an anomalous suppression of superconducting order just below the critical temperature, T(c). This suppression varies systematically with the film thickness and the bismuth content and can be parametrized in terms of a characteristic temperature, T(c)* ( less than T(c)), that is inversely proportional to the scattering mean free path. The results indicate that the isotropic nature of the superconductive pairing in bulk lead-bismuth alloys is altered in the quantum regime.	Univ Tennessee, Dept Phys & Astron, Knoxville, TN 37996 USA; Zhengzhou Univ, Sch Phys & Engn, Zhengzhou 450052, Peoples R China; Oak Ridge Natl Lab, Div Mat Sci & Technol, Oak Ridge, TN 37831 USA	University of Tennessee System; University of Tennessee Knoxville; Zhengzhou University; United States Department of Energy (DOE); Oak Ridge National Laboratory	Weitering, HH (corresponding author), Univ Tennessee, Dept Phys & Astron, Knoxville, TN 37996 USA.	hanno@utk.edu	Weitering, Hanno H/I-2884-2017; jia, yu/HHR-9047-2022; OZER, MUSTAFA MURAT/AAZ-3589-2020	Weitering, Hanno H/0000-0001-6770-9039; OZER, MUSTAFA MURAT/0000-0001-5260-1391				Aballe L, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.196103; BAIBICH MN, 1988, PHYS REV LETT, V61, P2472, DOI 10.1103/PhysRevLett.61.2472; Danese AG, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.165420; DOLAN GJ, 1973, PHYS REV LETT, V30, P603, DOI 10.1103/PhysRevLett.30.603; DYNES RC, 1975, PHYS REV B, V11, P1884, DOI 10.1103/PhysRevB.11.1884; Eom D, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.027005; Guo Y, 2004, SCIENCE, V306, P1915, DOI 10.1126/science.1105130; Gvozdikov VM, 1999, LOW TEMP PHYS+, V25, P936, DOI 10.1063/1.593844; Hultgren R., 1973, SELECTED VALUES THER; Jia Y, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.035433; KRESSE G, 1993, PHYS REV B, V47, P558, DOI 10.1103/PhysRevB.47.558; Kresse G, 1996, COMP MATER SCI, V6, P15, DOI 10.1016/0927-0256(96)00008-0; Ozer MM, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.113409; Ozer MM, 2006, NAT PHYS, V2, P173, DOI 10.1038/nphys244; Ozer MM, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.235427; PERDEW JP, 1992, PHYS REV B, V45, P13244, DOI 10.1103/PhysRevB.45.13244; Schroder K., 1983, CRC HDB ELECT RESIST, V1; SIRNONIN J, 1986, PHYS REV B, V33, P7830; Smith AR, 1996, SCIENCE, V273, P226, DOI 10.1126/science.273.5272.226; SUO ZG, 1998, PHYS REV B, V45, P13244; Tinkham M., 1996, INTRO SUPERCONDUCTIV, V2nd ed.; TRIVEDI N, 1988, PHYS REV B, V38, P12298, DOI 10.1103/PhysRevB.38.12298; Upton MH, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.026802; Wei CM, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.233408; Yeh V, 2000, PHYS REV LETT, V85, P5158, DOI 10.1103/PhysRevLett.85.5158; Zhang ZY, 1998, PHYS REV LETT, V80, P5381, DOI 10.1103/PhysRevLett.80.5381	27	99	100	6	101	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 15	2007	316	5831					1594	1597		10.1126/science.1142159	http://dx.doi.org/10.1126/science.1142159			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178SH	17569857				2022-12-28	WOS:000247239900034
J	Smith, CD; Shu, SQ; Mungall, CJ; Karpen, GH				Smith, Christopher D.; Shu, ShengQiang; Mungall, Christopher J.; Karpen, Gary H.			The Release 5.1 annotation of Drosophila melanogaster heterochromatin	SCIENCE			English	Article							HONEY-BEE; IDENTIFICATION; CHROMOSOME; SEQUENCES; INTRONS; ODORANT	The repetitive DNA that constitutes most of the heterochromatic regions of metazoan genomes has hindered the comprehensive analysis of gene content and other functions. We have generated a detailed computational and manual annotation of 24 megabases of heterochromatic sequence in the Release 5 Drosophila melanogaster genome sequence. The heterochromatin contains a minimum of 230 to 254 protein-coding genes, which are conserved in other Drosophilids and more diverged species, as well as 32 pseudogenes and 13 noncoding RNAs. Improved methods revealed that more than 77% of this heterochromatin sequence, including introns and intergenic regions, is composed of fragmented and nested transposable elements and other repeated DNAs. Drosophila heterochromatin contains "islands" of highly conserved genes embedded in these "oceans" of complex repeats, which may require special expression and splicing mechanisms.	Univ Calif Berkeley, Lawrence Berkeley Lab, Dept Genome & Computat Biol, Drosophila Heterochromatin Genome Project, Berkeley, CA 94720 USA; San Francisco State Univ, Dept Biol, San Francisco, CA 94132 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Natl Ctr Biomed Ontol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; California State University System; San Francisco State University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Karpen, GH (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Dept Genome & Computat Biol, Drosophila Heterochromatin Genome Project, Berkeley, CA 94720 USA.	karpen@fruitfly.org	Mungall, Chris/I-6006-2019	Mungall, Chris/0000-0002-6601-2165; Shu, Shengqiang/0000-0002-4336-8994	NHGRI NIH HHS [R01 HG000747-16, P41 HG000739-15, U54 HG004028, U54 HG004028-01, R01 HG000747, R01-HG000747] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P41HG000739, R01HG000747, U54HG004028] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bergman CM, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-r112; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Burnette JM, 2005, GENETICS, V170, P661, DOI 10.1534/genetics.104.039701; Drysdale RA, 2005, NUCLEIC ACIDS RES, V33, pD390, DOI 10.1093/nar/gki046; Elgin SCR, 2003, CURR BIOL, V13, pR895, DOI 10.1016/j.cub.2003.11.006; Foret S, 2006, GENOME RES, V16, P1404, DOI 10.1101/gr.5075706; Harrison PM, 2003, NUCLEIC ACIDS RES, V31, P1033, DOI 10.1093/nar/gkg169; Hild M, 2004, GENOME BIOL, V5; HOSKINS RA, 2002, GENOME BIOL, V0003; Hoskins RA, 2007, SCIENCE, V316, P1625, DOI 10.1126/science.1139816; KAMINKER JS, 2002, GENOME BIOL, V0003; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lewis S.E., 2003, GENOME BIOL, V3, P1, DOI [10.1186/gb-2002-3-12-research0082, DOI 10.1186/GB-2002-3-12-RESEARCH0082]; Manak JR, 2006, NAT GENET, V38, P1151, DOI 10.1038/ng1875; O'Brien KP, 2005, NUCLEIC ACIDS RES, V33, pD476, DOI 10.1093/nar/gki107; Peterson KJ, 2004, P NATL ACAD SCI USA, V101, P6536, DOI 10.1073/pnas.0401670101; Quesneville H, 2005, PLOS COMPUT BIOL, V1, P166, DOI 10.1371/journal.pcbi.0010022; Reugels AM, 2000, GENETICS, V154, P759; Robertson HM, 2006, GENOME RES, V16, P1395, DOI 10.1101/gr.5057506; Slawson EE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r15; Smith CD, 2007, GENE, V389, P1, DOI 10.1016/j.gene.2006.09.011; Sullivan BA, 2001, NAT REV GENET, V2, P584, DOI 10.1038/35084512; Torrents D, 2003, GENOME RES, V13, P2559, DOI 10.1101/gr.1455503; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040	26	152	159	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 15	2007	316	5831					1586	1591		10.1126/science.1139815	http://dx.doi.org/10.1126/science.1139815			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178SH	17569856	Green Accepted			2022-12-28	WOS:000247239900032
J	Walkley, CR; Shea, JM; Sims, NA; Purton, LE; Orkin, SH				Walkley, Carl R.; Shea, Jeremy M.; Sims, Natalie A.; Purton, Louise E.; Orkin, Stuart H.			Rb regulates interactions between hematopoietic stem cells and their bone marrow microenvironment	CELL			English	Article							SELF-RENEWAL; IN-VIVO; NONAUTONOMOUS FUNCTION; TUMOR-SUPPRESSOR; DIFFERENTIATION; PROGENITOR; MICE; QUIESCENCE; EXPRESSION; OSTEOBLAST	Hematopoiesis is maintained by stem cells (HSCs) that undergo fate decisions by integrating intrinsic and extrinsic signals, with the latter derived from the bone marrow (BM) microenvironment. Cell-cycle regulation can modulate stem cell fate, but it is unknown whether this represents an intrinsic or extrinsic effector of fate decisions. We have investigated the role of the retinoblastoma protein (RB), a central regulator of the cell cycle, in hematopoiesis. Widespread inactivation of RB in the murine hematopoietic system resulted in profound myeloproliferation. HSCs were lost from the BM due to mobilization to extramedullary sites and differentiation. This phenotype was not intrinsic to HSCs, but, rather, was the consequence of an RB-dependent interaction between myeloid-derived cells and the microenvironment. These findings demonstrate that myeloproliferation may result from perturbed interactions between hematopoietic cells and the niche. Therefore, RB extrinsically regulates HSCs by maintaining the capacity of the BM to support normal hematopoiesis and HSCs.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Div HematolOncol,Dept Pediat Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Harvard Stem Cell Inst, Childrens Hosp Boston,Stem Cell Program, Boston, MA 02115 USA; Univ Melbourne, St Vincents Hosp, St Vincents Inst Med Res, Fitzroy, Vic 3065, Australia; Univ Melbourne, St Vincents Hosp, Dept Med, Fitzroy, Vic 3065, Australia; Harvard Univ, Stem Cell Inst, Ctr Regenerat Med, Boston, MA 02114 USA; Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; St Vincent's Hospital Melbourne; St. Vincent's Institute of Medical Research; University of Melbourne; St Vincent's Hospital Melbourne; University of Melbourne; Harvard University; Howard Hughes Medical Institute	Orkin, SH (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Div HematolOncol,Dept Pediat Oncol, Boston, MA 02115 USA.	stuart_orkin@dfci.harvard.edu	Sims, Natalie Ann/A-7192-2012; Walkley, Carl/AAO-6021-2020; Purton, Louise/AAI-8956-2021	Sims, Natalie Ann/0000-0003-1421-8468; Walkley, Carl/0000-0002-4784-9031; Purton, Louise/0000-0001-6593-3168	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL032259] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NHLBI NIH HHS [R01 HL032259-27, R01 HL032259] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adams GB, 2006, NAT IMMUNOL, V7, P333, DOI 10.1038/ni1331; Adams GB, 2006, NATURE, V439, P599, DOI 10.1038/nature04247; Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010; Anderson ARA, 2006, CELL, V127, P905, DOI 10.1016/j.cell.2006.09.042; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Araki T, 2004, NAT MED, V10, P849, DOI 10.1038/nm1084; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Bradford GB, 1997, EXP HEMATOL, V25, P445; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Chan IT, 2004, J CLIN INVEST, V113, P528, DOI 10.1172/JCI200420476; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Chien WM, 2006, P NATL ACAD SCI USA, V103, P4122, DOI 10.1073/pnas.0509514103; Clark AJ, 2004, BLOOD, V104, P1324, DOI 10.1182/blood-2004-02-0618; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Ghiaur G, 2006, BLOOD, V108, P2087, DOI 10.1182/blood-2006-02-001560; Gothot A, 1998, BLOOD, V92, P2641, DOI 10.1182/blood.V92.8.2641.420k36_2641_2649; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hideshima T, 2002, NAT REV CANCER, V2, P927, DOI 10.1038/nrc952; Hill R, 2005, CELL, V123, P1001, DOI 10.1016/j.cell.2005.09.030; HODGSON GS, 1979, NATURE, V281, P381, DOI 10.1038/281381a0; Hu NP, 1997, CANCER RES, V57, P4123; Iavarone A, 2004, NATURE, V432, P1040, DOI 10.1038/nature03068; Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Kenner L, 2004, J CELL BIOL, V164, P613, DOI 10.1083/jcb.200308155; Kollet O, 2006, NAT MED, V12, P657, DOI 10.1038/nm1417; Kramer AK, 2002, LEUKEMIA, V16, P1844, DOI 10.1038/sj.leu.2402609; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Krosl J, 2003, IMMUNITY, V18, P561, DOI 10.1016/S1074-7613(03)00090-6; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Kurose K, 2002, NAT GENET, V32, P355, DOI 10.1038/ng1013; Le DT, 2004, BLOOD, V103, P4243, DOI 10.1182/blood-2003-08-2650; LERNER C, 1990, EXP HEMATOL, V18, P114; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; LI CL, 1994, BLOOD, V84, P408, DOI 10.1182/blood.V84.2.408.bloodjournal842408; Martin TJ, 2005, TRENDS MOL MED, V11, P76, DOI 10.1016/j.molmed.2004.12.004; Mitsiades CS, 2006, EUR J CANCER, V42, P1564, DOI 10.1016/j.ejca.2005.12.025; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Oguro H, 2006, J EXP MED, V203, P2247, DOI 10.1084/jem.20052477; Oh P, 2004, NATURE, V429, P629, DOI 10.1038/nature02580; OKADA S, 1992, BLOOD, V80, P3044; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Passegue E, 2004, CELL, V119, P431, DOI 10.1016/j.cell.2004.10.010; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; Purton LE, 2000, BLOOD, V95, P470, DOI 10.1182/blood.V95.2.470; Purton LE, 1999, BLOOD, V94, P483, DOI 10.1182/blood.V94.2.483.414k12_483_495; Purton LE, 2006, J EXP MED, V203, P1283, DOI 10.1084/jem.20052105; Rasheed N, 2006, HUM MOL GENET, V15, P1938, DOI 10.1093/hmg/ddl116; Sage J, 2003, NATURE, V424, P223, DOI 10.1038/nature01764; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; Sherr CJ, 2004, GENE DEV, V18, P2699, DOI 10.1101/gad.1256504; SPANGRUDE GJ, 1995, BLOOD, V85, P1006, DOI 10.1182/blood.V85.4.1006.bloodjournal8541006; Spike BT, 2004, EMBO J, V23, P4319, DOI 10.1038/sj.emboj.7600432; St Croix B, 2000, SCIENCE, V289, P1197; Stead E, 2002, ONCOGENE, V21, P8320, DOI 10.1038/sj.onc.1206015; Stepanova L, 2005, BLOOD, V106, P827, DOI 10.1182/blood-2004-06-2242; Stier S, 2005, J EXP MED, V201, P1781, DOI 10.1084/jem.20041992; SZILVASSY SJ, 1990, P NATL ACAD SCI USA, V87, P8736, DOI 10.1073/pnas.87.22.8736; Tajima F, 2000, BLOOD, V96, P1989, DOI 10.1182/blood.V96.5.1989.h8001989_1989_1993; TASWELL C, 1981, J IMMUNOL, V126, P1614; TILL JE, 1961, RADIAT RES, V14, P213, DOI 10.2307/3570892; Varnum-Finney B, 1998, BLOOD, V91, P4084, DOI 10.1182/blood.V91.11.4084.411k05_4084_4091; Visnjic D, 2004, BLOOD, V103, P3258, DOI 10.1182/blood-2003-11-4011; Walkley CR, 2007, CELL, V129, P1097, DOI 10.1016/j.cell.2007.05.014; Walkley CR, 2006, P NATL ACAD SCI USA, V103, P9057, DOI 10.1073/pnas.0603389103; Walkley CR, 2005, NAT CELL BIOL, V7, P172, DOI 10.1038/ncb1214; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Whyatt D, 2002, EMBO REP, V3, P130, DOI 10.1093/embo-reports/kvf033; Wildwater M, 2005, CELL, V123, P1337, DOI 10.1016/j.cell.2005.09.042; Yang LP, 2005, BLOOD, V105, P2717, DOI 10.1182/blood-2004-06-2159; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Yuan YZ, 2004, NAT CELL BIOL, V6, P436, DOI 10.1038/ncb1126; Zhang CC, 2006, NAT MED, V12, P240, DOI 10.1038/nm1342; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	78	318	331	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 15	2007	129	6					1081	1095		10.1016/j.cell.2007.03.055	http://dx.doi.org/10.1016/j.cell.2007.03.055			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	180UA	17574022	Green Accepted, Bronze			2022-12-28	WOS:000247390400013
J	Yagoda, N; von Rechenberg, M; Zaganjor, E; Bauer, AJ; Yang, WS; Fridman, DJ; Wolpaw, AJ; Smukste, I; Peltier, JM; Boniface, JJ; Smith, R; Lessnick, SL; Sahasrabudhe, S; Stockwell, BR				Yagoda, Nicholas; von Rechenberg, Moritz; Zaganjor, Elma; Bauer, Andras J.; Yang, Wan Seok; Fridman, Daniel J.; Wolpaw, Adam J.; Smukste, Inese; Peltier, John M.; Boniface, J. Jay; Smith, Richard; Lessnick, Stephen L.; Sahasrabudhe, Sudhir; Stockwell, Brent R.			RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels	NATURE			English	Article							MITOCHONDRIAL OUTER-MEMBRANE; HUMAN TUMOR-CELLS; APOPTOSIS; MECHANISM; GENE; PERMEABILITY; ACTIVATION; THERAPY; LIBRARY; CANCER	Therapeutics that discriminate between the genetic makeup of normal cells and tumour cells are valuable for treating and understanding cancer. Small molecules with oncogene-selective lethality may reveal novel functions of oncoproteins and enable the creation of more selective drugs(1). Here we describe the mechanism of action of the selective anti-tumour agent erastin, involving the RAS - RAF - MEK signalling pathway functioning in cell proliferation, differentiation and survival. Erastin exhibits greater lethality in human tumour cells harbouring mutations in the oncogenes HRAS, KRAS or BRAF. Using affinity purification and mass spectrometry, we discovered that erastin acts through mitochondrial voltage-dependent anion channels (VDACs) - a novel target for anti-cancer drugs. We show that erastin treatment of cells harbouring oncogenic RAS causes the appearance of oxidative species and subsequent death through an oxidative, non-apoptotic mechanism. RNA-interference-mediated knockdown of VDAC2 or VDAC3 caused resistance to erastin, implicating these two VDAC isoforms in the mechanism of action of erastin. Moreover, using purified mitochondria expressing a single VDAC isoform, we found that erastin alters the permeability of the outer mitochondrial membrane. Finally, using a radiolabelled analogue and a filter-binding assay, we show that erastin binds directly to VDAC2. These results demonstrate that ligands to VDAC proteins can induce non-apoptotic cell death selectively in some tumour cells harbouring activating mutations in the RAS - RAF - MEK pathway.	Columbia Univ, Fairchild Ctr, Dept Biol Sci, New York, NY 10027 USA; Columbia Univ, Dept Chem, New York, NY 10027 USA; Prolexys Pharmaceut, Salt Lake City, UT 84116 USA; Huntsman Canc Inst, Ctr Children, Salt Lake City, UT 84112 USA	Columbia University; Columbia University; Huntsman Cancer Institute	Stockwell, BR (corresponding author), Columbia Univ, Fairchild Ctr, Dept Biol Sci, 1212 Amsterdam Ave,MC 2406, New York, NY 10027 USA.	stockwell@biology.columbia.edu	Stockwell, Brent R/AAE-7200-2019	Stockwell, Brent R/0000-0002-3532-3868; Wolpaw, Adam/0000-0002-1373-7648	NATIONAL CANCER INSTITUTE [R01CA097061] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA097061-02, R01 CA097061-01, R01 CA097061-05A1, R01 CA097061-03, R01 CA097061-08, R01 CA097061, R01 CA097061-04, R01 CA097061-07, R01 CA097061-09S1, R01 CA097061-06, R01 CA097061-09, R01 CA097061-08S1] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Baker MA, 2004, J BIOL CHEM, V279, P4811, DOI 10.1074/jbc.M311020200; Beck W T, 1991, Semin Cancer Biol, V2, P235; Cheng EHY, 2003, SCIENCE, V301, P513, DOI 10.1126/science.1083995; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dolma S, 2003, CANCER CELL, V3, P285, DOI 10.1016/S1535-6108(03)00050-3; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Graham BH, 2004, CURR TOP DEV BIOL, V59, P87, DOI 10.1016/S0070-2153(04)59004-X; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Kaelin WG, 2005, NAT REV CANCER, V5, P689, DOI 10.1038/nrc1691; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Koppel DA, 1998, J BIOL CHEM, V273, P13794, DOI 10.1074/jbc.273.22.13794; MAJNO G, 1995, AM J PATHOL, V146, P3; Mannella CA, 1997, J BIOENERG BIOMEMBR, V29, P525, DOI 10.1023/A:1022489832594; MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Poyurovsky MV, 2003, MOL CELL, V12, P875, DOI 10.1016/S1097-2765(03)00400-3; Root DE, 2003, CHEM BIOL, V10, P881, DOI 10.1016/j.chembiol.2003.08.009; Rostovtseva T, 1996, J BIOL CHEM, V271, P28006, DOI 10.1074/jbc.271.45.28006; Sage J, 2003, NATURE, V424, P223, DOI 10.1038/nature01764; Song ZW, 1999, TRENDS CELL BIOL, V9, pM49, DOI 10.1016/S0968-0004(99)01485-1; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0; Xu X, 1999, J MEMBRANE BIOL, V170, P89, DOI 10.1007/s002329900540; YUAN JY, 1993, CELL, V75, P641, DOI 10.1016/0092-8674(93)90485-9; Zhen YJ, 2004, J AM SOC MASS SPECTR, V15, P803, DOI 10.1016/j.jasms.2004.02.004	24	780	815	18	174	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 14	2007	447	7146					864	868		10.1038/nature05859	http://dx.doi.org/10.1038/nature05859			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178FV	17568748	Green Accepted			2022-12-28	WOS:000247207500046
J	Dickler, HB; Di Fang; Heinig, SJ; Johnson, E; Korn, D				Dickler, Howard B.; Di Fang; Heinig, Stephen J.; Johnson, Elizabeth; Korn, David			New physician-investigators receiving National Institutes of Health research project grants - A historical perspective on the "endangered species"	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CLINICAL-RESEARCH; NIH; CHALLENGES; SCIENTIST; SCIENCE; ERA	Context Although concerns have persisted for decades about the production of new physician clinical scientists and their success in receiving and sustaining research supported by the National Institutes of Health (NIH), no comprehensive analysis documents the experiences of first-time investigators with an MD over a long period. Objective To ascertain the perseverance and comparative success of physician-scientists competing for NIH research (R01) grants awarded over 40 years. Design, Setting, and Participants A longitudinal, comparative study of all first-time applicants and recipients of NIH R01 grants between 1964 and 2004 stratified by the principal investigators' major degrees ( MD, PhD, or MD and PhD) and their proposed involvement in research of humans or human tissues. Main Outcome Measures Number of first-and second-time NIH R01 grant applicants and recipients by academic degree and by research type ( clinical vs nonclinical). Results The annual number of first-time investigators with an MD only as NIH R01 grant applicants remained remarkably stable over 4 decades (41-year mean of 707 [ range, 537-983] applicants). Among first-time applicants, those with an MD consistently had less success in obtaining funding ( mean annual percentage [ MAP], 28%) than either investigators with a PhD ( MAP, 31%; P=. 03 vs MD only) or both an MD and a PhD ( MAP, 34%; P <. 001 vs MD only and P=. 002 vs PhD only). Among investigators who obtained a first R01 grant, those with an MD were consistently less likely ( MAP, 70%) than those with a PhD ( MAP, 73%; P=. 04 vs MD only) or those with an MD and a PhD ( MAP, 78%; P <. 001 vs MD only and P=. 007 vs PhD only) to obtain a subsequent R01 grant. First-time applicants with an MD were much more likely to propose clinical research ( MAP, 67%) than applicants with an MD and a PhD ( MAP, 43%) and applicants with a PhD only (39%). First-time applicants with an MD only who proposed clinical research were funded at lower rates than their MD-only counterparts proposing nonclinical research (23% vs 29%, respectively; P <. 001). Conclusions From 1964-2004, the number of physician-investigators applying for first R01 grants showed little net change. Physician-investigators consistently experienced higher rates of attrition and failure, even after receiving a first R01 grant, and those proposing clinical research were less successful in obtaining funding than physicians proposing nonclinical research.	Assoc Amer Med Coll, Div Biomed & Hlth Sci Res, Washington, DC 20037 USA; Amer Assoc Coll Nursing, Washington, DC USA; Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA	Association of American Medical Colleges; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Korn, D (corresponding author), Assoc Amer Med Coll, Div Biomed & Hlth Sci Res, 2450 N St NW, Washington, DC 20037 USA.	dkorn@aamc.org			NIH HHS [N01-OD-3-1015] Funding Source: Medline	NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Ahrens Jr. E. H., 1992, CRISIS CLIN RES; *ASS AM MED COLL, 2006, ASS AM MED COLL DAT; [Association of American Medical Colleges AAMC Task Force II on Clinical Research], 2006, PROM TRANSL CLIN SCI; Bush, 1945, SCI THE ENDLESS FRON, DOI DOI 10.1016/j.techsoc.2019.03.007; Dickler HB, 2006, PLOS MED, V3, P1492, DOI 10.1371/journal.pmed.0030378; Goldstein JL, 1997, J CLIN INVEST, V99, P2803, DOI 10.1172/JCI119470; Heinig SJ, 1999, ACAD MED, V74, P726, DOI 10.1097/00001888-199906000-00024; *I MED COMM ADD CA, 1984, CAR CLIN RES OBST OP; Korn D, 2002, SCIENCE, V296, P1401, DOI 10.1126/science.1072486; Kotchen TA, 2006, J INVEST MED, V54, P13, DOI 10.2310/6650.2005.05026; Kotchen TA, 2004, JAMA-J AM MED ASSOC, V291, P836, DOI 10.1001/jama.291.7.836; Ley TJ, 2005, JAMA-J AM MED ASSOC, V294, P1343, DOI 10.1001/jama.294.11.1343; Nathan DG, 1998, JAMA-J AM MED ASSOC, V280, P1427, DOI 10.1001/jama.280.16.1427; Nathan DG, 2003, NEW ENGL J MED, V349, P1860, DOI 10.1056/NEJMsb035066; *NIH, NIH RES PROJ GRANT P; *NIH, FUND LEV ADJ BIOM RE; Rosenberg LE, 1999, SCIENCE, V283, P331, DOI 10.1126/science.283.5400.331; Sung NS, 2003, JAMA-J AM MED ASSOC, V289, P1278, DOI 10.1001/jama.289.10.1278; Wolf M, 2002, ACAD MED, V77, P1084, DOI 10.1097/00001888-200211000-00004; WYNGAARDEN JB, 1979, NEW ENGL J MED, V301, P1254, DOI 10.1056/NEJM197912063012303; Zemlo TR, 2000, FASEB J, V14, P221, DOI 10.1096/fasebj.14.2.221; Zerhouni E, 2003, SCIENCE, V302, P63, DOI 10.1126/science.1091867; Zerhouni EA, 2005, NEW ENGL J MED, V353, P1621, DOI 10.1056/NEJMsb053723; Zerhouni EA, 2006, SCIENCE, V314, P1088, DOI 10.1126/science.1136931	24	84	85	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 13	2007	297	22					2496	2501		10.1001/jama.297.22.2496	http://dx.doi.org/10.1001/jama.297.22.2496			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	177TX	17565084	Bronze			2022-12-28	WOS:000247176500024
J	Gough-Palmer, A; McHugh, K				Gough-Palmer, A.; McHugh, K.			Rational imaging - Investigating hip pain in a well child	BRITISH MEDICAL JOURNAL			English	Article							CALVE-PERTHES-DISEASE		Great Ormond St Hosp Sick Children, London WC1N 3JH, England	University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Gough-Palmer, A (corresponding author), Great Ormond St Hosp Sick Children, Great Ormond St, London WC1N 3JH, England.	agoughpalmer@yahoo.com						Jaramillo D, 1999, RADIOLOGY, V212, P519, DOI 10.1148/radiology.212.2.r99au39519; Lamer S, 2002, PEDIATR RADIOL, V32, P580, DOI 10.1007/s00247-002-0732-5; Wiig O, 2006, J BONE JOINT SURG BR, V88B, P1217, DOI 10.1302/0301-620X.88B9.17400; Zamzam MM, 2006, J PEDIATR ORTHOP B, V15, P418, DOI 10.1097/01.bpb.0000228388.32184.7f	4	4	4	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUN 9	2007	334	7605					1216	1217		10.1136/bmj.39188.515741.47	http://dx.doi.org/10.1136/bmj.39188.515741.47			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	179GF	17556478	Green Published			2022-12-28	WOS:000247277000038
J	Kim, JB; Porreca, GJ; Song, L; Greenway, SC; Gorham, JM; Church, GM; Seidman, CE; Seidman, JG				Kim, Jae Bum; Porreca, Gregory J.; Song, Lei; Greenway, Steven C.; Gorham, Joshua M.; Church, George M.; Seidman, Christine E.; Seidman, J. G.			Polony multiplex analysis of gene expression (PMAGE) in mouse hypertrophic cardiomyopathy	SCIENCE			English	Article							GROWTH; REPRODUCIBILITY; TRANSCRIPTOME; MORPHOGENESIS; ABUNDANCE; MUTATION; RATS; HOP	We describe a sensitive mRNA profiling technology, PMAGE ( for "polony multiplex analysis of gene expression"), which detects messenger RNAs ( mRNAs) as rare as one transcript per three cells. PMAGE incorporates an improved ligation-based method to sequence 14-nucleotide tags derived from individual mRNA molecules. One sequence tag from each mRNA molecule is amplified onto a separate 1-micrometer bead, denoted as a polymerase colony or polony, and about 5 million polonies are arrayed in a flow cell for parallel sequencing. Using PMAGE, we identified early transcriptional changes that preceded pathological manifestations of hypertrophic cardiomyopathy in mice carrying a disease-causing mutation. PMAGE provided a comprehensive profile of cardiac mRNAs, including low-abundance mRNAs encoding signaling molecules and transcription factors that are likely to participate in disease pathogenesis.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA; Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Seidman, JG (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	cseidman@genetics.med.harvard.edu; seidman@genetics.med.harvard.edu	Greenway, Steven C/S-7777-2019	church, george/0000-0001-6232-9969				Ahmed MS, 2004, J MOL CELL CARDIOL, V36, P393, DOI 10.1016/j.yjmcc.2003.12.004; Albert Y, 2005, J CELL BIOL, V169, P257, DOI 10.1083/jcb.200501156; Asahi M, 2004, P NATL ACAD SCI USA, V101, P9199, DOI 10.1073/pnas.0402596101; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bienengraeber M, 2004, NAT GENET, V36, P382, DOI 10.1038/ng1329; BLACKSHAW S, 2002, CURRENT PROTOCOLS MO; Chen F, 2002, CELL, V110, P713, DOI 10.1016/S0092-8674(02)00932-7; Churchill GA, 2002, NAT GENET, V32, P490, DOI 10.1038/ng1031; Dinel S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni025; Draghici S, 2006, TRENDS GENET, V22, P101, DOI 10.1016/j.tig.2005.12.005; Dressman D, 2003, P NATL ACAD SCI USA, V100, P8817, DOI 10.1073/pnas.1133470100; GeisterferLowrance AAT, 1996, SCIENCE, V272, P731, DOI 10.1126/science.272.5262.731; Georgakopoulos D, 1999, NAT MED, V5, P327, DOI 10.1038/6549; Harris KM, 2006, CIRCULATION, V114, P216, DOI 10.1161/CIRCULATIONAHA.105.583500; HASTIE ND, 1976, CELL, V9, P761, DOI 10.1016/0092-8674(76)90139-2; Holland MJ, 2002, J BIOL CHEM, V277, P14363, DOI 10.1074/jbc.C200101200; LEE RT, 1988, J CLIN INVEST, V81, P431, DOI 10.1172/JCI113337; Lijnen PJ, 2000, MOL GENET METAB, V71, P418, DOI 10.1006/mgme.2000.3032; Maeda T, 2002, J BIOL CHEM, V277, P48889, DOI 10.1074/jbc.M206858200; Maron BJ, 2002, JAMA-J AM MED ASSOC, V287, P1308, DOI 10.1001/jama.287.10.1308; Norris RA, 2007, J CELL BIOCHEM, V101, P695, DOI 10.1002/jcb.21224; Seidman JG, 2001, CELL, V104, P557, DOI 10.1016/S0092-8674(01)00242-2; Shendure J, 2005, SCIENCE, V309, P1728, DOI 10.1126/science.1117389; Shin CH, 2002, CELL, V110, P725, DOI 10.1016/S0092-8674(02)00933-9; SRIVASTAVA D, 1995, SCIENCE, V270, P1995, DOI 10.1126/science.270.5244.1995; Varnava AM, 2001, AM J CARDIOL, V88, P275, DOI 10.1016/S0002-9149(01)01640-X; Velculescu VE, 1997, CELL, V88, P243, DOI 10.1016/S0092-8674(00)81845-0; Velculescu VE, 1999, NAT GENET, V23, P387, DOI 10.1038/70487; Zingman LV, 2002, P NATL ACAD SCI USA, V99, P13278, DOI 10.1073/pnas.212315199	29	146	229	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 8	2007	316	5830					1481	1484		10.1126/science.1137325	http://dx.doi.org/10.1126/science.1137325			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176EE	17556586				2022-12-28	WOS:000247066400044
J	Dember, LM; Hawkins, PN; Hazenberg, BPC; Gorevic, PD; Merlini, G; Butrimiene, I; Livneh, A; Lesnyak, O; Puechal, X; Lachmann, HJ; Obici, L; Balshaw, R; Garceau, D; Hauck, W; Skinner, M				Dember, Laura M.; Hawkins, Philip N.; Hazenberg, Bouke P. C.; Gorevic, Peter D.; Merlini, Giampaolo; Butrimiene, Irena; Livneh, Avi; Lesnyak, Olga; Puechal, Xavier; Lachmann, Helen J.; Obici, Laura; Balshaw, Robert; Garceau, Denis; Hauck, Wendy; Skinner, Martha		Eprodisate AA Amyloidosis Trial Gr	Eprodisate for the treatment of renal disease in AA amyloidosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							STEM-CELL TRANSPLANTATION; LIVER-TRANSPLANTATION; SYSTEMIC AMYLOIDOSIS; NEPHROTIC SYNDROME; AL AMYLOIDOSIS; MELPHALAN; PROTEOGLYCANS; SURVIVAL; PROTEIN	BACKGROUND Amyloid A (AA) amyloidosis is a complication of chronic inflammatory conditions that develops when proteolytic fragments of serum amyloid A protein (SAA) are deposited in tissues as amyloid fibrils. Amyloid deposition in the kidney causes progressive deterioration in renal function. Eprodisate is a member of a new class of compounds designed to interfere with interactions between amyloidogenic proteins and glycosaminoglycans and thereby inhibit polymerization of amyloid fibrils and deposition of the fibrils in tissues. METHODS We performed a multicenter, randomized, double-blind, placebo-controlled trial to evaluate the efficacy and safety of eprodisate in patients with AA amyloidosis and kidney involvement. We randomly assigned 183 patients from 27 centers to receive eprodisate or placebo for 24 months. The primary composite end point was an assessment of renal function or death. Disease was classified as worsened if any one of the following occurred: doubling of the serum creatinine level, reduction in creatinine clearance by 50% or more, progression to end-stage renal disease, or death. RESULTS At 24 months, disease was worsened in 24 of 89 patients who received eprodisate (27%) and 38 of 94 patients given placebo (40%, P=0.06); the hazard ratio for worsening disease with eprodisate treatment was 0.58 (95% confidence interval, 0.37 to 0.93; P=0.02). The mean rates of decline in creatinine clearance were 10.9 and 15.6 ml per minute per 1.73 m(sup 2) of body-surface area per year in the eprodisate and the placebo groups, respectively (P=0.02). The drug had no significant effect on progression to end-stage renal disease (hazard ratio, 0.54; P=0.20) or risk of death (hazard ratio, 0.95; P=0.94). The incidence of adverse events was similar in the two groups. CONCLUSIONS Eprodisate slows the decline of renal function in AA amyloidosis.	Boston Univ, Sch Med, Renal Sect, Boston, MA 02118 USA; Royal Free Hosp, Natl Amyloidosis Ctr, London, England; Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands; Mt Sinai Med Ctr, New York, NY 10029 USA; Fdn IRCCS Policlin St Matteo, Amyloidosis Ctr, Pavia, Italy; Vilnius State Univ, Inst Clin & Expt Med, Vilnius, Lithuania; Chaim Sheba Med Ctr, IL-52621 Tel Hashomer, Israel; Reg Hosp No 1, Ekaterinburg, Russia; Ctr Hosp Mans, Le Mans, France; Neurochem, Laval, PQ, Canada; Univ British Columbia, Syreon, Vancouver, BC V5Z 1M9, Canada	Boston University; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of Groningen; Icahn School of Medicine at Mount Sinai; IRCCS Fondazione San Matteo; Vilnius University; Chaim Sheba Medical Center; Centre Hospitalier Le Mans; University of British Columbia	Dember, LM (corresponding author), Boston Univ, Sch Med, Renal Sect, EBRC 504,650 Albany St, Boston, MA 02118 USA.	ldember@bu.edu	Hawkins, Philip N/C-5573-2008; Obici, Laura/AAC-3060-2019; Lesnyak, Olga M/J-5512-2013; Hazenberg, Bouke PC/I-2866-2016; Merlini, Giampaolo/A-3817-2008; Puéchal, Xavier/P-1555-2017	Obici, Laura/0000-0001-7468-700X; Lesnyak, Olga M/0000-0002-0143-0614; Hazenberg, Bouke PC/0000-0003-1827-0482; Merlini, Giampaolo/0000-0001-7680-3254; Puéchal, Xavier/0000-0003-3573-9203; Balshaw, Robert/0000-0002-2455-8792; Lachmann, Helen/0000-0001-8378-2498	Medical Research Council [G7900510] Funding Source: Medline; FDA HHS [FD-R-002007] Funding Source: Medline; MRC [G7900510] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); FDA HHS; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		CROWLEY S, 1989, AM J KIDNEY DIS, V13, P333, DOI 10.1016/S0272-6386(89)80041-1; Dember LM, 2001, ANN INTERN MED, V134, P746, DOI 10.7326/0003-4819-134-9_Part_1-200105010-00011; Dispenzieri A, 2004, BLOOD, V103, P3960, DOI 10.1182/blood-2003-12-4192; GERTZ MA, 1991, MEDICINE, V70, P246, DOI 10.1097/00005792-199107000-00002; Gervais F, 2001, AMYLOID, V8, P28; Gervais Francine, 2003, Current Medicinal Chemistry - Immunology Endocrine & Metabolic Agents, V3, P361, DOI 10.2174/1568013033483294; Gervais F, 2007, NEUROBIOL AGING, V28, P537, DOI 10.1016/j.neurobiolaging.2006.02.015; Gillmore JD, 2001, LANCET, V358, P24, DOI 10.1016/S0140-6736(00)05252-1; Hazenberg BPC, 1999, ANN RHEUM DIS, V58, P96, DOI 10.1136/ard.58.2.96; Herlenius G, 2004, TRANSPLANTATION, V77, P64, DOI 10.1097/01.TP.0000092307.98347.CB; HOLMGREN G, 1993, LANCET, V341, P1113, DOI 10.1016/0140-6736(93)93127-M; KISILEVSKY R, 1995, NAT MED, V1, P143, DOI 10.1038/nm0295-143; Kisilevsky R, 2000, AMYLOID, V7, P23, DOI 10.3109/13506120009146820; LYON AW, 1991, LAB INVEST, V64, P785; Merlini G, 2003, NEW ENGL J MED, V349, P583, DOI 10.1056/NEJMra023144; Palladini G, 2004, BLOOD, V103, P2936, DOI 10.1182/blood-2003-08-2788; Skinner M, 2004, ANN INTERN MED, V140, P85, DOI 10.7326/0003-4819-140-2-200401200-00008; SNOW AD, 1987, LAB INVEST, V56, P120; STENSTAD T, 1994, BIOCHEM J, V303, P663, DOI 10.1042/bj3030663; Verschueren P, 2003, ANN RHEUM DIS, V62, P368, DOI 10.1136/ard.62.4.368; WILKINS J, 1994, CLIN CHEM, V40, P1284	21	154	160	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 7	2007	356	23					2349	2360		10.1056/NEJMoa065644	http://dx.doi.org/10.1056/NEJMoa065644			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	175QY	17554116	Green Published			2022-12-28	WOS:000247029300004
J	Wapenaar, K; Snieder, R				Wapenaar, Kees; Snieder, Roel			Determinism - chaos tamed	NATURE			English	Editorial Material									Delft Univ Technol, Dept Geotechnol, NL-2600 GA Delft, Netherlands; Colorado Sch Mines, Ctr Wave Phenomena, Golden, CO 80401 USA	Delft University of Technology; Colorado School of Mines	Wapenaar, K (corresponding author), Delft Univ Technol, Dept Geotechnol, POB 5048, NL-2600 GA Delft, Netherlands.		wapenaar, kees/M-4256-2014	wapenaar, kees/0000-0002-1620-8282				BERRY MV, 1987, PROC R SOC LON SER-A, V413, P183, DOI 10.1098/rspa.1987.0109; Snieder RK, 1998, PHYS REV E, V58, P5668, DOI 10.1103/PhysRevE.58.5668; Snieder R, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.036103; Weaver RL, 2005, SCIENCE, V307, P1568, DOI 10.1126/science.1109834	4	5	5	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 7	2007	447	7145					643	643		10.1038/447643a	http://dx.doi.org/10.1038/447643a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175RI	17554291	Bronze			2022-12-28	WOS:000247030700026
J	O'Higgins, P; Elton, S				O'Higgins, Paul; Elton, Sarah			Anthropology - Walking on trees	SCIENCE			English	Editorial Material							FUNCTIONAL-MORPHOLOGY; HUMAN-EVOLUTION; LOCOMOTION; BIPEDALISM; ORIGIN; APE; OREOPITHECUS; ADAPTATION		Univ York, Hull York Med Sch, Funct Morphol & Evolut Unit, York YO10 5DD, N Yorkshire, England; Univ Hull, Hull York Med Sch, Funct Morphol & Evolut Unit, Kingston Upon Hull HU6 7RX, N Humberside, England	University of Hull; University of York - UK; University of Hull; University of York - UK	O'Higgins, P (corresponding author), Univ York, Hull York Med Sch, Funct Morphol & Evolut Unit, York YO10 5DD, N Yorkshire, England.	paul.ohiggins@hyms.ac.uk; sarah.elton@hyms.ac.uk	Rohlf, F J/A-8710-2008	O'Higgins, Paul/0000-0002-9797-0809				Andrews P, 1999, HUMAN EVOLUT SER, P282; Andrews Peter, 2005, P103; Dainton M, 1999, J HUM EVOL, V36, P171, DOI 10.1006/jhev.1998.0265; GEBO DL, 1992, AM J PHYS ANTHROPOL, V89, P29, DOI 10.1002/ajpa.1330890105; Harcourt-Smith WEH, 2004, J ANAT, V204, P403, DOI 10.1111/j.0021-8782.2004.00296.x; HUNT KD, 1994, J HUM EVOL, V26, P183, DOI 10.1006/jhev.1994.1011; JABLONSKI NG, 1993, J HUM EVOL, V24, P259, DOI 10.1006/jhev.1993.1021; Kohler M, 1997, P NATL ACAD SCI USA, V94, P11747, DOI 10.1073/pnas.94.21.11747; LOVEJOY CO, 1981, SCIENCE, V211, P341, DOI 10.1126/science.211.4480.341; MacLatchy L, 2000, J HUM EVOL, V39, P159, DOI 10.1006/jhev.2000.0407; Richmond BG, 2002, J HUM EVOL, V43, P529, DOI 10.1006/jhev.2002.0594; RICHMOND BG, 2002, YB PHYS ANTHR S, V33, P70; Rook L, 1999, P NATL ACAD SCI USA, V96, P8795, DOI 10.1073/pnas.96.15.8795; Sarmiento Esteban E., 1994, American Museum Novitates, V3091, P1; Stern J., 1975, YEARB PHYS ANTHROPOL, V19, P59; STRAUS WL, 1949, Q REV BIOL, V24, P200, DOI 10.1086/397067; Thorpe SKS, 2007, SCIENCE, V316, P1328, DOI 10.1126/science.1140799; TUTTLE R, 1974, CURR ANTHROPOL, V15, P389, DOI 10.1086/201494; WHEELER PE, 1991, J HUM EVOL, V21, P107, DOI 10.1016/0047-2484(91)90002-D; Wood B, 2000, J ANAT, V197, P19, DOI 10.1046/j.1469-7580.2000.19710019.x	20	9	9	1	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 1	2007	316	5829					1292	1294		10.1126/science.1143571	http://dx.doi.org/10.1126/science.1143571			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	173PS	17540890	Green Accepted			2022-12-28	WOS:000246885600035
J	Virshup, DM; Forger, DB				Virshup, David M.; Forger, Daniel B.			After hours keeps clock researchers CRYing overtime	CELL			English	Editorial Material							DROSOPHILA PERIOD PROTEIN; CIRCADIAN CLOCK; POSTTRANSLATIONAL REGULATION; DEGRADATION; CRYPTOCHROME; OSCILLATION		Univ Utah, Dept Pediat, Salt Lake City, UT 84112 USA; Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA; Univ Michigan, Dept Math, Math Biol Res Grp, Ann Arbor, MI 48109 USA; Univ Michigan, Ctr Computat Med & Biol, Ann Arbor, MI 48109 USA	Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Virshup, DM (corresponding author), Univ Utah, Dept Pediat, Salt Lake City, UT 84112 USA.	david.virshup@hci.utah.edu; forger@umich.edu	Forger, Daniel/C-5552-2015; Virshup, David M/C-1449-2009	Forger, Daniel/0000-0001-7581-4031; Virshup, David M/0000-0001-6976-850X				Ang XLL, 2005, ONCOGENE, V24, P2860, DOI 10.1038/sj.onc.1208614; Busino L, 2007, SCIENCE, V316, P900, DOI 10.1126/science.1141194; Gallego M, 2007, NAT REV MOL CELL BIO, V8, P139, DOI 10.1038/nrm2106; Gallego M, 2006, P NATL ACAD SCI USA, V103, P10618, DOI 10.1073/pnas.0604511103; Godinho SIH, 2007, SCIENCE, V316, P897, DOI 10.1126/science.1141138; Ko HW, 2002, NATURE, V420, P673, DOI 10.1038/nature01272; Koh K, 2006, SCIENCE, V312, P1809, DOI 10.1126/science.1124951; Nakajima M, 2005, SCIENCE, V308, P414, DOI 10.1126/science.1108451; Partch CL, 2006, P NATL ACAD SCI USA, V103, P10467, DOI 10.1073/pnas.0604138103; Sathyanarayanan S, 2004, CELL, V116, P603, DOI 10.1016/S0092-8674(04)00128-X; SIEPKA SM, 2007, CELL	11	13	14	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 1	2007	129	5					857	859		10.1016/j.cell.2007.05.015	http://dx.doi.org/10.1016/j.cell.2007.05.015			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	176KT	17540165	Bronze			2022-12-28	WOS:000247084600005
J	Chattopadhyay, S; Chandra, P				Chattopadhyay, Sudipta; Chandra, Puvana			Putaminal necrosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									HM Stanley Hosp, St Asaph LL17 0RS, Wales		Chattopadhyay, S (corresponding author), HM Stanley Hosp, St Asaph LL17 0RS, Wales.	dlptochatt@yahoo.co.uk	Chattopadhyay, Sudipta/AAM-1617-2020	Chattopadhyay, Sudipta/0000-0002-6421-6762					0	4	4	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 31	2007	356	22					E23	E23		10.1056/NEJMicm060009	http://dx.doi.org/10.1056/NEJMicm060009			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	172PO	17538081				2022-12-28	WOS:000246816500011
J	Gomes, KK; Pasupathy, AN; Pushp, A; Ono, S; Ando, Y; Yazdani, A				Gomes, Kenjiro K.; Pasupathy, Abhay N.; Pushp, Aakash; Ono, Shimpei; Ando, Yoichi; Yazdani, Ali			Visualizing pair formation on the atomic scale in the high-T-c superconductor Bi2Sr2CaCu2O8+delta	NATURE			English	Article							HIGH-TEMPERATURE SUPERCONDUCTORS; CUPRATE SUPERCONDUCTORS; PSEUDOGAP; STATE; EXCITATIONS; COHERENCE	Pairing of electrons in conventional superconductors occurs at the superconducting transition temperature T-c, creating an energy gap D in the electronic density of states (DOS)(1). In the high-T-c superconductors, a partial gap in the DOS exists for a range of temperatures above T-c (ref. 2). A key question is whether the gap in the DOS above T-c is associated with pairing, and what determines the temperature at which incoherent pairs form. Here we report the first spatially resolved measurements of gap formation in a high-T-c superconductor, measured on Bi2Sr2CaCu2O8+delta samples with different T-c values ( hole concentration of 0.12 to 0.22) using scanning tunnelling microscopy. Over a wide range of doping from 0.16 to 0.22 we find that pairing gaps nucleate in nanoscale regions above T-c. These regions proliferate as the temperature is lowered, resulting in a spatial distribution of gap sizes in the superconducting state(3-5). Despite the inhomogeneity, we find that every pairing gap develops locally at a temperature T-p, following the relation 2 Delta/k(B)T(p) = 7.9 +/- 0.5. At very low doping (<= 0.14), systematic changes in the DOS indicate the presence of another phenomenon(6-9), which is unrelated and perhaps competes with electron pairing. Our observation of nanometre-sized pairing regions provides the missing microscopic basis for understanding recent reports(10-13) of fluctuating superconducting response above T-c in hole-doped high-T-c copper oxide superconductors.	Cent Res Inst Elect Power Ind, Tokyo 2018511, Japan; Princeton Univ, Joseph Henry Labs, Dept Phys, Princeton, NJ 08544 USA	Central Research Institute of Electric Power Industry - Japan; Princeton University	Yazdani, A (corresponding author), Princeton Univ, Joseph Henry Labs, Dept Phys, Princeton, NJ 08544 USA.	yazdani@princeton.edu	Pushp, Aakash/G-6626-2011; Ono, Shimpei/D-2918-2017; Ando, Yoichi/B-8163-2013	Ando, Yoichi/0000-0002-3553-3355; Yazdani, Ali/0000-0003-4996-8904; Ono, Shimpei/0000-0003-1514-8879				Andersen BM, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.060501; Balatsky AV, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.094517; CARBOTTE JP, 1990, REV MOD PHYS, V62, P1027, DOI 10.1103/RevModPhys.62.1027; Corson J, 1999, NATURE, V398, P221, DOI 10.1038/18402; Damascelli A, 2003, REV MOD PHYS, V75, P473, DOI 10.1103/RevModPhys.75.473; Hanaguri T, 2004, NATURE, V430, P1001, DOI 10.1038/nature02861; Howald C, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.100504; Kugler M, 2001, PHYS REV LETT, V86, P4911, DOI 10.1103/PhysRevLett.86.4911; Le Tacon M, 2006, NAT PHYS, V2, P537, DOI 10.1038/nphys362; Lee PA, 2006, REV MOD PHYS, V78, P17, DOI 10.1103/RevModPhys.78.17; McElroy K, 2005, SCIENCE, V309, P1048, DOI 10.1126/science.1113095; McElroy K, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.197005; Norman MR, 2005, ADV PHYS, V54, P715, DOI [10.1080/00018730500459906, 10.1080/00018730500489906]; Norman MR, 1998, NATURE, V392, P157, DOI 10.1038/32366; Pan SH, 2001, NATURE, V413, P282, DOI 10.1038/35095012; Randeria M, 1998, P INT SCH PHYS, V136, P53; Renner C, 1998, PHYS REV LETT, V80, P149, DOI 10.1103/PhysRevLett.80.149; Tallon JL, 2001, PHYSICA C, V349, P53, DOI 10.1016/S0921-4534(00)01524-0; Tanaka K, 2006, SCIENCE, V314, P1910, DOI 10.1126/science.1133411; Timusk T, 1999, REP PROG PHYS, V62, P61, DOI 10.1088/0034-4885/62/1/002; Tinkham M., 1975, INTRO SUPERCONDUCTIV; Valla T, 2006, SCIENCE, V314, P1914, DOI 10.1126/science.1134742; Vershinin M, 2004, SCIENCE, V303, P1995, DOI 10.1126/science.1093384; Wang YY, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.247002; Xu ZA, 2000, NATURE, V406, P486, DOI 10.1038/35020016	28	387	390	2	96	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 31	2007	447	7144					569	572		10.1038/nature05881	http://dx.doi.org/10.1038/nature05881			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172YZ	17538615	Green Submitted			2022-12-28	WOS:000246842000043
J	Kamerow, D				Kamerow, Douglas			Great health care, guaranteed	BRITISH MEDICAL JOURNAL			English	Editorial Material												dkamerow@bmj.com		Kamerow, Douglas/0000-0001-7000-9957					0	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAY 26	2007	334	7603					1086	1086		10.1136/bmj.39223.635451.59	http://dx.doi.org/10.1136/bmj.39223.635451.59			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	174XB	17525446	Green Published			2022-12-28	WOS:000246975000026
J	Tanne, JH				Tanne, Janice Hopkins			Study links diabetes-drug to heart deaths	BRITISH MEDICAL JOURNAL			English	News Item																			0	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAY 26	2007	334	7603					1073	1073		10.1136/bmj.39224.364630.DB	http://dx.doi.org/10.1136/bmj.39224.364630.DB			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	174XB	17525413	Green Published			2022-12-28	WOS:000246975000012
J	Grewal, SIS; Elgin, SCR				Grewal, Shiv I. S.; Elgin, Sarah C. R.			Transcription and RNA interference in the formation of heterochromatin	NATURE			English	Review							POSITION-EFFECT VARIEGATION; DOUBLE-STRANDED-RNA; FISSION YEAST; HISTONE H3; EPIGENETIC CONTROL; LYSINE-9 METHYLATION; CHROMODOMAIN PROTEIN; UBIQUITIN LIGASE; DOMAIN PROTEIN; DROSOPHILA	Transcription in heterochromatin seems to be an oxymoron - surely the 'silenced' form of chromatin should not be transcribed. But there have been frequent reports of low-level transcription in heterochromatic regions, and several hundred genes are found in these regions in Drosophila. Most strikingly, recent investigations implicate RNA interference mechanisms in targeting and maintaining heterochromatin, and these mechanisms are inherently dependent on transcription. Silencing of chromatin might involve transacting sources of the crucial small RNAs that carry out RNA interference, but in some cases, transcription of the region to be silenced seems to be required - an apparent contradiction.	Washington Univ, Dept Biol, St Louis, MO 63130 USA; NCI, Biochem & Mol Biol Lab, NIH, Bethesda, MD 20892 USA	Washington University (WUSTL); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Elgin, SCR (corresponding author), Washington Univ, Dept Biol, CB1137, St Louis, MO 63130 USA.	grewals@mail.nih.gov; selgin@biology.wustl.edu		Grewal, Shiv/0000-0002-4552-9261; Elgin, Sarah C. R./0000-0002-5176-2510	NIGMS NIH HHS [R01 GM068388, R01 GM068388-19] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068388] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahmad K, 2001, CELL, V104, P839, DOI 10.1016/S0092-8674(01)00281-1; ALLSHIRE RC, 1995, GENE DEV, V9, P218, DOI 10.1101/gad.9.2.218; Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Aravin AA, 2001, CURR BIOL, V11, P1017, DOI 10.1016/S0960-9822(01)00299-8; Aulner N, 2002, MOL CELL BIOL, V22, P1218, DOI 10.1128/MCB.22.4.1218-1232.2002; Ayoub N, 2003, MOL CELL BIOL, V23, P4356, DOI 10.1128/MCB.23.12.4356-4370.2003; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Blattes R, 2006, EMBO J, V25, P2397, DOI 10.1038/sj.emboj.7601125; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Buhler M, 2006, CELL, V125, P873, DOI 10.1016/j.cell.2006.04.025; Cam HP, 2005, NAT GENET, V37, P809, DOI 10.1038/ng1602; Cheutin T, 2003, SCIENCE, V299, P721, DOI 10.1126/science.1078572; Cryderman DE, 1999, NUCLEIC ACIDS RES, V27, P3364, DOI 10.1093/nar/27.16.3364; Deshpande G, 2005, GENE DEV, V19, P1680, DOI 10.1101/gad.1316805; Djupedal I, 2005, GENE DEV, V19, P2301, DOI 10.1101/gad.344205; EISSENBERG JC, 1990, P NATL ACAD SCI USA, V87, P9923, DOI 10.1073/pnas.87.24.9923; Elgin S.C.R., 2007, EPIGENETICS, P81; Festenstein R, 2003, SCIENCE, V299, P719, DOI 10.1126/science.1078694; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fukagawa T, 2004, NAT CELL BIOL, V6, P784, DOI 10.1038/ncb1155; George JA, 2003, GENETICS, V163, P625; Greil F, 2007, EMBO J, V26, P741, DOI 10.1038/sj.emboj.7601527; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Grewal SIS, 2002, CURR OPIN GENET DEV, V12, P178, DOI 10.1016/S0959-437X(02)00284-8; Grewal SIS, 2003, SCIENCE, V301, P798, DOI 10.1126/science.1086887; Grewal SIS, 1997, GENETICS, V146, P1221; Grishok A, 2005, GENE DEV, V19, P683, DOI 10.1101/gad.1247705; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Hall IM, 2003, P NATL ACAD SCI USA, V100, P193, DOI 10.1073/pnas.232688099; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Haynes KA, 2006, CURR BIOL, V16, P2222, DOI 10.1016/j.cub.2006.09.035; Hong Eun-Jin Erica, 2005, RNA Biol, V2, P106, DOI 10.4161/rna.2.3.2131; Horn PJ, 2005, GENE DEV, V19, P1705, DOI 10.1101/gad.1328005; Huertas D, 2004, CURR BIOL, V14, P1611, DOI 10.1016/j.cub.2004.09.024; Huisinga KL, 2006, CHROMOSOMA, V115, P110, DOI 10.1007/s00412-006-0052-x; Irvine DV, 2006, SCIENCE, V313, P1134, DOI 10.1126/science.1128813; Jia ST, 2005, NAT CELL BIOL, V7, P1007, DOI 10.1038/ncb1300; Jia ST, 2004, SCIENCE, V304, P1971, DOI 10.1126/science.1099035; Kalmykova AI, 2005, NUCLEIC ACIDS RES, V33, P2052, DOI 10.1093/nar/gki323; Kanoh J, 2005, CURR BIOL, V15, P1808, DOI 10.1016/j.cub.2005.09.041; Kato H, 2005, SCIENCE, V309, P467, DOI 10.1126/science.1114955; Kim HS, 2004, J BIOL CHEM, V279, P42850, DOI 10.1074/jbc.M407259200; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; LOCKE J, 1988, GENETICS, V120, P181; Mochizuki K, 2004, CURR OPIN GENET DEV, V14, P181, DOI 10.1016/j.gde.2004.01.004; Motamedi MR, 2004, CELL, V119, P789, DOI 10.1016/j.cell.2004.11.034; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Nakayama J, 2000, CELL, V101, P307, DOI 10.1016/S0092-8674(00)80840-5; Noma K, 2004, NAT GENET, V36, P1174, DOI 10.1038/ng1452; Pal-Bhadra M, 2004, SCIENCE, V303, P669, DOI 10.1126/science.1092653; Pal-Bhadra M, 2002, MOL CELL, V9, P315, DOI 10.1016/S1097-2765(02)00440-9; Partridge JF, 2002, CURR BIOL, V12, P1652, DOI 10.1016/S0960-9822(02)01177-6; Peng JC, 2007, NAT CELL BIOL, V9, P25, DOI 10.1038/ncb1514; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; REUTER G, 1990, NATURE, V344, P219, DOI 10.1038/344219a0; Richards EJ, 2002, CELL, V108, P489, DOI 10.1016/S0092-8674(02)00644-X; Robert VJP, 2005, GENE DEV, V19, P782, DOI 10.1101/gad.332305; Rudolph T, 2007, MOL CELL, V26, P103, DOI 10.1016/j.molcel.2007.02.025; Sadaie M, 2004, EMBO J, V23, P3825, DOI 10.1038/sj.emboj.7600401; Saito K, 2006, GENE DEV, V20, P2214, DOI 10.1101/gad.1454806; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; SCHULTZ D, 2002, GENE DEV, V16, P1855; Shaffer CD, 2002, P NATL ACAD SCI USA, V99, P14332, DOI 10.1073/pnas.212458899; Sugiyama T, 2005, P NATL ACAD SCI USA, V102, P152, DOI 10.1073/pnas.0407641102; Sugiyama T, 2007, CELL, V128, P491, DOI 10.1016/j.cell.2006.12.035; Sullivan BA, 2004, NAT STRUCT MOL BIOL, V11, P1076, DOI 10.1038/nsmb845; Sun FL, 2004, MOL CELL BIOL, V24, P8210, DOI 10.1128/MCB.24.18.8210-8220.2004; Sun FL, 2001, MOL CELL BIOL, V21, P2867, DOI 10.1128/MCB.21.8.2867-2879.2001; Talbert PB, 2006, NAT REV GENET, V7, P793, DOI 10.1038/nrg1920; Thon G, 2005, GENETICS, V171, P1583, DOI 10.1534/genetics.105.048298; TSCHIERSCH B, 1994, EMBO J, V13, P3822, DOI 10.1002/j.1460-2075.1994.tb06693.x; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; van Rij RP, 2006, GENE DEV, V20, P2985, DOI 10.1101/gad.1482006; Vastenhouw NL, 2006, NATURE, V442, P882, DOI 10.1038/442882a; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; WALLRATH LL, 1995, GENE DEV, V9, P1263, DOI 10.1101/gad.9.10.1263; Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694; Yamada T, 2005, MOL CELL, V20, P173, DOI 10.1016/j.molcel.2005.10.002; Yasuhara JC, 2006, TRENDS GENET, V22, P330, DOI 10.1016/j.tig.2006.04.008; Zofall M, 2006, COLD SPRING HARB SYM, V71, P487, DOI 10.1101/sqb.2006.71.059; Zofall M, 2007, J BIOL CHEM, V282, P14065, DOI 10.1074/jbc.M700292200	83	326	337	2	42	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 24	2007	447	7143					399	406		10.1038/nature05914	http://dx.doi.org/10.1038/nature05914			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170VA	17522672	Green Accepted, Green Submitted			2022-12-28	WOS:000246693100034
J	Phibbs, CS; Baker, LC; Caughey, AB; Danielsen, B; Schmitt, SK; Phibbs, RH				Phibbs, Ciaran S.; Baker, Laurence C.; Caughey, Aaron B.; Danielsen, Beate; Schmitt, Susan K.; Phibbs, Roderic H.			Level and volume of neonatal intensive care and mortality in very-low-birth-weight infants	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SOUTH-CAROLINA; PERINATAL-CARE; OUTCOMES; DELIVERY; PRETERM; DEATH; REGIONALIZATION; POPULATION; WASHINGTON; NEWBORNS	Background: There has been a large increase in both the number of neonatal intensive care units (NICUs) in community hospitals and the complexity of the cases treated in these units. We examined differences in neonatal mortality among infants with very low birth weight (below 1500 g) among NICUs with various levels of care and different volumes of very-low-birth-weight infants. Methods: We linked birth certificates, hospital discharge abstracts (including interhospital transfers), and fetal and infant death certificates to assess neonatal mortality rates among 48,237 very-low-birth-weight infants who were born in California hospitals between 1991 and 2000. Results: Mortality rates among very-low-birth-weight infants varied according to both the volume of patients and the level of care at the delivery hospital. The effect of volume also varied according to the level of care. As compared with a high level of care and a high volume of very-low-birth-weight infants (more than 100 per year), lower levels of care and lower volumes (except for those of two small groups of hospitals) were associated with significantly higher odds ratios for death, ranging from 1.19 (95% confidence interval [CI], 1.04 to 1.37) to 2.72 (95% CI, 2.37 to 3.12). Less than one quarter of very-low-birth-weight deliveries occurred in facilities with NICUs that offered a high level of care and had a high volume, but 92% of very-low-birth-weight deliveries occurred in urban areas with more than 100 such deliveries. Conclusions: Mortality among very-low-birth-weight infants was lowest for deliveries that occurred in hospitals with NICUs that had both a high level of care and a high volume of such patients. Our results suggest that increased use of such facilities might reduce mortality among very-low-birth-weight infants.	VA Palo Alton Hlth Care Syst, Hlth Econ Resource Ctr, Menlo Pk, CA 94025 USA; VA Palo Alton Hlth Care Syst, Ctr Hlth Care Evolut, Menlo Pk, CA USA; Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Ctr Primary Care Outcomes Res, Stanford, CA 94305 USA; Natl Bur Econ Res, Cambridge, MA 02138 USA; Univ Calif San Francisco, Dept Obstet & Gynecol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; Hlth Informat Solut, Rocklin, CA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; Stanford University; Stanford University; National Bureau of Economic Research; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Phibbs, CS (corresponding author), VA Palo Alton Hlth Care Syst, Hlth Econ Resource Ctr, 152,795 Willow Rd, Menlo Pk, CA 94025 USA.	cphibbs@stanford.edu		Baker, Laurence/0000-0001-5032-794X; Phibbs, Ciaran/0000-0002-4353-3507	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD036914] Funding Source: NIH RePORTER; NICHD NIH HHS [HD-36914] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BHATT DR, 2002, CALIFORNIA DIRECTORY; Blackmon L, 2004, PEDIATRICS, V114, P1341, DOI 10.1542/peds.2004-1697; Bode MM, 2001, AM J OBSTET GYNECOL, V184, P1302, DOI 10.1067/mob.2001.114484; Chien LY, 2001, OBSTET GYNECOL, V98, P247, DOI 10.1016/S0029-7844(01)01438-7; Cifuentes J, 2002, PEDIATRICS, V109, P745, DOI 10.1542/peds.109.5.745; Danielsen B, 2000, PROBABILISTIC RECORD; FANAROFF AA, 1995, AM J OBSTET GYNECOL, V173, P1423, DOI 10.1016/0002-9378(95)90628-2; GILSTRAP LC, 1995, JAMA-J AM MED ASSOC, V273, P413, DOI 10.1001/jama.1995.03520290065031; Goodman DC, 2002, NEW ENGL J MED, V346, P1538, DOI 10.1056/NEJMoa011921; Goodman DC, 2001, PEDIATRICS, V108, P426, DOI 10.1542/peds.108.2.426; Haberland CA, 2006, PEDIATRICS, V118, pE1667, DOI 10.1542/peds.2006-0612; Halm EA, 2002, ANN INTERN MED, V137, P511, DOI 10.7326/0003-4819-137-6-200209170-00012; Herrchen B, 1997, COMPUT BIOMED RES, V30, P290, DOI 10.1006/cbmr.1997.1448; Horbar JD, 2002, PEDIATRICS, V110, P143, DOI 10.1542/peds.110.1.143; HOSMER DW, 1991, AM J PUBLIC HEALTH, V81, P1630, DOI 10.2105/AJPH.81.12.1630; Howell EM, 2002, AM J PUBLIC HEALTH, V92, P119, DOI 10.2105/AJPH.92.1.119; JOBE AH, 1993, NEW ENGL J MED, V328, P861; Johansson S, 2004, PEDIATRICS, V113, P1230, DOI 10.1542/peds.113.5.1230; Kahn JM, 2006, NEW ENGL J MED, V355, P41, DOI 10.1056/NEJMsa053993; Kirby R S, 1996, J Perinatol, V16, P43; LUFT HS, 1979, NEW ENGL J MED, V301, P1364, DOI 10.1056/NEJM197912203012503; Mathews T J, 2002, Natl Vital Stat Rep, V50, P1; MAYFIELD JA, 1990, AM J PUBLIC HEALTH, V80, P819, DOI 10.2105/AJPH.80.7.819; Menard MK, 1998, AM J OBSTET GYNECOL, V179, P374, DOI 10.1016/S0002-9378(98)70367-9; MEUX EF, 1990, REPORT RESULTS OSHPD; PANETH N, 1987, AM J DIS CHILD, V141, P60, DOI 10.1001/archpedi.1987.04460010060024; PANETH N, 1982, NEW ENGL J MED, V307, P149, DOI 10.1056/NEJM198207153070303; PANETH N, 1984, PEDIATRICS, V73, P854; Phibbs CS, 1996, JAMA-J AM MED ASSOC, V276, P1054, DOI 10.1001/jama.276.13.1054; POWELL SL, 1995, AM J OBSTET GYNECOL, V173, P1585, DOI 10.1016/0002-9378(95)90653-3; Rogowski JA, 2004, HEALTH AFFAIR, V23, P88, DOI 10.1377/hlthaff.23.5.88; Rogowski JA, 2004, JAMA-J AM MED ASSOC, V291, P202, DOI 10.1001/jama.291.2.202; ROSENBLATT RA, 1988, WESTERN J MED, V149, P98; Sanderson M, 2000, AM J OBSTET GYNECOL, V183, P1504, DOI 10.1067/mob.2000.107357; STARK AR, 2005, PEDIATRICS, V115, P1118; Synnes AR, 2006, MED CARE, V44, P754, DOI 10.1097/01.mlr.0000218780.16064.df; VERLOOVEVANHORICK SP, 1988, PEDIATRICS, V81, P404; WILLIAMS RL, 1979, MED CARE, V17, P95, DOI 10.1097/00005650-197902000-00001; Yeast JD, 1998, AM J OBSTET GYNECOL, V178, P131, DOI 10.1016/S0002-9378(98)70639-8; 2003, STATA USERS GUIDE	40	341	348	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 24	2007	356	21					2165	2175		10.1056/NEJMsa065029	http://dx.doi.org/10.1056/NEJMsa065029			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	170ON	17522400				2022-12-28	WOS:000246673100006
J	Gregg, EW; Gu, Q; Cheng, YJ; Narayan, V; Cowie, CC				Gregg, Edward W.; Gu, Qiuping; Cheng, Yiling J.; Narayan, Venkat; Cowie, Catherine C.			Mortality trends in men and women with diabetes, 1971 to 2000	ANNALS OF INTERNAL MEDICINE			English	Article							HEART-DISEASE MORTALITY; UNITED-STATES; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; NATIONAL-HEALTH; SEX-DIFFERENCES; SECULAR TRENDS; ADULTS; POPULATION; PREVALENCE	Background: Whether mortality rates among diabetic adults or excess mortality associated with diabetes in the United States has declined in recent decades is not known. Objective: To examine whether all-cause and cardiovascular disease mortality rates have declined among the U.S. population with and without self-reported diabetes. Design: Comparison of 3 consecutive, nationally representative cohorts. Setting: Population-based health surveys (National Health and Nutrition Examination Surveys I, II, and III) with mortality follow-up assessment. Patients: Survey participants age 35 to 74 years with and without diabetes. Measurements: Diabetes was determined by self-report for each survey (1971-1975, 1976-1980, and 1988-1994), and mortality rates were determined through 1986, 1992, and 2000 for the 3 surveys, respectively. Results: Among diabetic men, the all-cause mortality rate decreased by 18.2 annual deaths per 1000 persons (from 42.6 to 24.4 annual deaths per 1000 persons; P = 0.03) between 1971 to 1986 and 1988 to 2000, accompanying decreases in the nondiabetic population. Trends for cardiovascular disease mortality paralleled those of all-cause mortality, with 26.4 annual deaths per 1000 persons in 1971 to 1986 and 12.8 annual deaths per 1000 persons in 1988 to 2000 (P = 0.06). Among women with diabetes, however, neither all-cause nor cardiovascular disease mortality declined between 1971 to 1986 and 1988 to 2000, and the all-cause mortality rate difference between diabetic and nondiabetic women more than doubled (from a difference of 8.3 to 18.2 annual deaths per 1000 persons). The difference in all-cause mortality rates by sex among people with diabetes in 1971 to 1986 were essentially eliminated in 1988 to 2000. Limitations: Diabetes was assessed by self-report, and statistical power to examine the factors explaining mortality trends was limited. Conclusions: Progress in reducing mortality rates among persons with diabetes has been limited to men. Diabetes continues to greatly increase the risk for death, particularly among women.	Ctr Dis Control & Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA USA; Ctr Dis Control & Prevent, Natl Ctr Hlth Stat, Hyattsville, MD 20782 USA; NIDDKD, NIH, Bethesda, MD 20892 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; CDC National Center for Health Statistics (NCHS); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Gregg, EW (corresponding author), Ctr Dis Control & Prevent, Div Diabet Translat, K 10,4770 Buford Highway NE, Atlanta, GA 30341 USA.		Cheng, Yiling J/A-6547-2009	Cheng, Yiling J/0000-0002-5053-0814; Gregg, Edward/0000-0003-2381-6822				ABBOTT RD, 1988, JAMA-J AM MED ASSOC, V260, P3456, DOI 10.1001/jama.260.23.3456; BARRETTCONNOR E, 1983, AM J EPIDEMIOL, V118, P489, DOI 10.1093/oxfordjournals.aje.a113654; Briefel RR, 2004, ANNU REV NUTR, V24, P401, DOI 10.1146/annurev.nutr.23.011702.073349; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P80; Chandra NC, 1998, ARCH INTERN MED, V158, P981, DOI 10.1001/archinte.158.9.981; Cohen B B, 1987, Vital Health Stat 1, P1; Cooper R, 2000, CIRCULATION, V102, P3137; Cowie CC, 2006, DIABETES CARE, V29, P1263, DOI 10.2337/dc06-0062; Ergin A, 2004, AM J MED, V117, P219, DOI 10.1016/j.amjmed.2004.03.017; Ernst ND, 1997, AM J CLIN NUTR, V66, P965; Flaherty JD, 2005, JAMA-J AM MED ASSOC, V293, P1501, DOI 10.1001/jama.293.12.1501; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; FORTHOFER RN, 1983, AM J EPIDEMIOL, V117, P507, DOI 10.1093/oxfordjournals.aje.a113568; Fox CS, 2004, JAMA-J AM MED ASSOC, V292, P2495, DOI 10.1001/jama.292.20.2495; Gaede P, 2003, NEW ENGL J MED, V348, P383, DOI 10.1056/NEJMoa021778; Geiss Linda, 2005, Diabetes Technol Ther, V7, P198, DOI 10.1089/dia.2005.7.198; Goldberg RB, 1998, CIRCULATION, V98, P2513, DOI 10.1161/01.CIR.98.23.2513; Gregg EW, 2004, DIABETES CARE, V27, P2806, DOI 10.2337/diacare.27.12.2806; Gu K, 1999, JAMA-J AM MED ASSOC, V281, P1291, DOI 10.1001/jama.281.14.1291; Gustafsson I, 2004, J AM COLL CARDIOL, V43, P771, DOI 10.1016/j.jacc.2003.11.024; Hajjar I, 2003, JAMA-J AM MED ASSOC, V290, P199, DOI 10.1001/jama.290.2.199; Hoehner CM, 2006, J DIABETES COMPLICAT, V20, P8, DOI 10.1016/j.jdiacomp.2005.06.003; Imperatore G, 2004, AM J EPIDEMIOL, V160, P531, DOI 10.1093/aje/kwh232; Kanaya AM, 2002, ARCH INTERN MED, V162, P1737, DOI 10.1001/archinte.162.15.1737; Koopman RJ, 2005, ANN FAM MED, V3, P60, DOI 10.1370/afm.214; KORN EL, 1999, ANAL HLTH SURVEYS, P279; LABBATE A, 2005, PHARM REP, V57; Lipscombe LL, 2007, LANCET, V369, P750, DOI 10.1016/S0140-6736(07)60361-4; Loria C M, 1999, Vital Health Stat 1, P1; McDowell A, 1981, Vital Health Stat 1, P1; MOHADJER L, 1996, NATL HLTH NUTR EXAMI; Narayan KMV, 2000, DIABETES RES CLIN PR, V50, pS77; Natarajan S, 2005, ARCH INTERN MED, V165, P430, DOI 10.1001/archinte.165.4.430; National Center for Health Statistics, 1996, AN REP GUID 3 NAT HL; Nichol KL, 1998, ARCH INTERN MED, V158, P1769, DOI 10.1001/archinte.158.16.1769; Pambianco G, 2006, DIABETES, V55, P1463, DOI 10.2337/db05-1423; Pavkov ME, 2004, DIABETES CARE, V27, P1132, DOI 10.2337/diacare.27.5.1132; Persell SD, 2004, ARCH INTERN MED, V164, P2492, DOI 10.1001/archinte.164.22.2492; Plan and operation of the Third National Health and Nutrition Examination Survey, 1994, VITAL HLTH STAT, P1; Saaddine JB, 2006, ANN INTERN MED, V144, P465, DOI 10.7326/0003-4819-144-7-200604040-00005; Saydah SH, 2004, JAMA-J AM MED ASSOC, V291, P335, DOI 10.1001/jama.291.3.335; Saydah SH, 2004, ANN EPIDEMIOL, V14, P507, DOI 10.1016/j.annepidem.2003.09.016; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Steffes MW, 2003, JAMA-J AM MED ASSOC, V290, P2159, DOI 10.1001/jama.290.16.2159; STEINGART RM, 1991, NEW ENGL J MED, V325, P226, DOI 10.1056/NEJM199107253250402; Stettler C, 2006, AM HEART J, V152, P27, DOI 10.1016/j.ahj.2005.09.015; Thomas RJ, 2003, ARCH INTERN MED, V163, P445, DOI 10.1001/archinte.163.4.445; Tierney EF, 2004, DIABETES CARE, V27, P2723, DOI 10.2337/diacare.27.11.2723	48	339	343	1	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 7	2007	147	3					149	155		10.7326/0003-4819-147-3-200708070-00167	http://dx.doi.org/10.7326/0003-4819-147-3-200708070-00167			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	196AV	17576993				2022-12-28	WOS:000248454700001
J	Ousman, SS; Tomooka, BH; van Noort, JM; Wawrousek, EF; O'Connor, KC; Hafler, DA; Sobel, RA; Robinson, WH; Steinman, L				Ousman, Shalina S.; Tomooka, Beren H.; van Noort, Johannes M.; Wawrousek, Eric F.; O'Connor, Kevin C.; Hafler, David A.; Sobel, Raymond A.; Robinson, William H.; Steinman, Lawrence			Protective and therapeutic role for alpha B-crystallin in autoimmune demyelination	NATURE			English	Article							CENTRAL-NERVOUS-SYSTEM; LENS EPITHELIAL-CELLS; NF-KAPPA-B; MULTIPLE-SCLEROSIS; CANDIDATE AUTOANTIGEN; A-CRYSTALLIN; APOPTOSIS; EXPRESSION; DISEASE; ENCEPHALOMYELITIS	alpha B-crystallin (CRYAB) is the most abundant gene transcript present in early active multiple sclerosis lesions, whereas such transcripts are absent in normal brain tissue(1). This crystallin has anti-apoptotic(2-7) and neuroprotective(8) functions. CRYAB is the major target of CD4(+) T-cell immunity to the myelin sheath from multiple sclerosis brain(9,10). The pathophysiological implications of this immune response were investigated here. We demonstrate that CRYAB is a potent negative regulator acting as a brake on several inflammatory pathways in both the immune system and central nervous system (CNS). Cryab(-/-) mice showed worse experimental autoimmune encephalomyelitis (EAE) at the acute and progressive phases, with higher Th1 and Th17 cytokine secretion from T cells and macrophages, and more intense CNS inflammation, compared with their wild-type counterparts. Furthermore, Cryab(-/-) astrocytes showed more cleaved caspase-3 and more TUNEL staining, indicating an anti-apoptotic function of Cryab. Antibody to CRYAB was detected in cerebrospinal fluid from multiple sclerosis patients and in sera from mice with EAE. Administration of recombinant CRYAB ameliorated EAE. Thus, the immune response against a negative regulator of inflammation, CRYAB, in multiple sclerosis, would exacerbate inflammation and demyelination. This can be countered by giving CRYAB itself for therapy of ongoing disease.	Stanford Univ, Dept Neurol & Neurol Sci, Sch Med, Stanford, CA 94305 USA; Stanford Univ, Div Rheumatol & Immunol, Sch Med, Stanford, CA 94305 USA; Vet Affairs Palo Alto Hlth Care Syst, Lab Serv, Palo Alto, CA 94304 USA; Vet Affairs Palo Alto Hlth Care Syst, GRECC, Palo Alto, CA 94304 USA; TNO Qual Life, Dept Biosci, NL-2301 CE Leiden, Netherlands; NEI, NIH, Bethesda, MD 20892 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA	Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Netherlands Organization Applied Science Research; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Harvard University; Brigham & Women's Hospital; Harvard Medical School	Steinman, L (corresponding author), Stanford Univ, Dept Neurol & Neurol Sci, Sch Med, Stanford, CA 94305 USA.	steinman@stanford.edu	Wawrousek, Eric/A-4547-2008	van Noort, Johannes/0000-0002-9060-5921; Sobel, Raymond/0000-0002-0477-9002; Steinman, Lawrence/0000-0002-2437-2250; Robinson, William/0000-0003-4385-704X	NATIONAL EYE INSTITUTE [ZIAEY000286, Z01EY000286] Funding Source: NIH RePORTER; Multiple Sclerosis Society [835] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Multiple Sclerosis Society(National Multiple Sclerosis Society)		Andley UP, 2000, J BIOL CHEM, V275, P36823, DOI 10.1074/jbc.M004233200; AOYAMA A, 1993, MOL CELL BIOL, V13, P1824, DOI 10.1128/MCB.13.3.1824; Bajramovic JJ, 2000, J IMMUNOL, V164, P4359, DOI 10.4049/jimmunol.164.8.4359; Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; Brady JP, 2001, INVEST OPHTH VIS SCI, V42, P2924; Chabas D, 2001, SCIENCE, V294, P1731, DOI 10.1126/science.1062960; Cobb BA, 2000, J BIOL CHEM, V275, P6664, DOI 10.1074/jbc.275.9.6664; DASGUPTA S, 1992, EXP EYE RES, V54, P461, DOI 10.1016/0014-4835(92)90058-Z; Doerwald L, 2004, J MOL EVOL, V59, P674, DOI 10.1007/s00239-004-2659-y; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Ellmerich S, 2004, EUR J IMMUNOL, V34, P1839, DOI 10.1002/eji.200324044; Finley EL, 1998, PROTEIN SCI, V7, P2391, DOI 10.1002/pro.5560071116; Huang DR, 2001, J EXP MED, V193, P713, DOI 10.1084/jem.193.6.713; Kamradt MC, 2002, J BIOL CHEM, V277, P38731, DOI 10.1074/jbc.M201770200; Korlimbinis A, 2006, BIOCHEMISTRY-US, V45, P1852, DOI 10.1021/bi051737+; Li DWC, 2001, EXP CELL RES, V266, P279, DOI 10.1006/excr.2001.5223; Liu JP, 2004, EXP EYE RES, V79, P393, DOI 10.1016/j.exer.2004.06.015; Mao YW, 2001, J BIOL CHEM, V276, P43435, DOI 10.1074/jbc.M102195200; Masilamoni JG, 2006, BBA-MOL BASIS DIS, V1762, P284, DOI 10.1016/j.bbadis.2005.11.007; Matsuoka Y, 2003, J NEUROSCI, V23, P29; Mehlen P, 1996, EMBO J, V15, P2695, DOI 10.1002/j.1460-2075.1996.tb00630.x; Morrison LE, 2003, CIRC RES, V92, P203, DOI 10.1161/01.RES.0000052989.83995.A5; Robinson WH, 2003, NAT BIOTECHNOL, V21, P1033, DOI 10.1038/nbt859; Suzuki A, 1998, J CELL BIOL, V140, P1113, DOI 10.1083/jcb.140.5.1113; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van Loo G, 2006, NAT IMMUNOL, V7, P954, DOI 10.1038/ni1372; van Noort JM, 2006, MULT SCLER J, V12, P287, DOI 10.1191/135248506ms1271oa; VANNOORT JM, 1995, NATURE, V375, P798, DOI 10.1038/375798a0; Webster KA, 2003, CIRC RES, V92, P130, DOI 10.1161/01.RES.0000056967.51841.21; Youssef S, 2006, NAT IMMUNOL, V7, P901, DOI 10.1038/ni0906-901	30	399	413	1	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 26	2007	448	7152					474	U7		10.1038/nature05935	http://dx.doi.org/10.1038/nature05935			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	193VG	17568699				2022-12-28	WOS:000248302700047
J	Kurs, A; Karalis, A; Moffatt, R; Joannopoulos, JD; Fisher, P; Soljacic, M				Kurs, Andre; Karalis, Aristeidis; Moffatt, Robert; Joannopoulos, J. D.; Fisher, Peter; Soljacic, Marin			Wireless power transfer via strongly coupled magnetic resonances	SCIENCE			English	Article								Using self-resonant coils in a strongly coupled regime, we experimentally demonstrated efficient nonradiative power transfer over distances up to 8 times the radius of the coils. We were able to transfer 60 watts with similar to 40% efficiency over distances in excess of 2 meters. We present a quantitative model describing the power transfer, which matches the experimental results to within 5%. We discuss the practical applicability of this system and suggest directions for further study.	MIT, Dept Phys, Cambridge, MA 02139 USA; MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; MIT, Dept Phys, Cambridge, MA 02139 USA; MIT, Nucl Sci Lab, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Kurs, A (corresponding author), MIT, Dept Phys, Cambridge, MA 02139 USA.	akurs@mit.edu	Karalis, Aristeidis/H-1947-2011; jiang, xiying/F-8106-2018; Soljacic, Marin/AAA-4868-2019; Joannopoulos, John D/E-6401-2013	Karalis, Aristeidis/0000-0002-4719-0222; 				Aoki T, 2006, NATURE, V443, P671, DOI 10.1038/nature05147; EDSON WA, 1953, VACUUM TUBE OSCILIAT; ESSER A, 1991, IEEE T IND APPL, V27, P872, DOI 10.1109/28.90341; Fernandez JM, 2001, US Patent, Patent No. 6184651; Haus H. A., 1984, WAVES FIELDS OPTOELE; Hirai J, 2000, IEEE T POWER ELECTR, V15, P21, DOI 10.1109/63.817358; IEEE, 2006, C9512005 IEEE STD; KALAI L, 2006, Patent No. 7042196; Karalis A., 2007, ANN PHYS; OBRIEN K, 2003, IECON 03 29 ANN C IE; Pendry JB, 2004, SCIENCE, V306, P1353, DOI 10.1126/science.1104467; SENSIPER S, 1951, THESIS MIT; Tesla N., 1914, U.S. Patent, Patent No. 1119732; Vanderelli T. A., 2006, U.S. Patent, Patent No. [7 027 311, 7027311]	14	3582	4116	81	1740	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 6	2007	317	5834					83	86		10.1126/science.1143254	http://dx.doi.org/10.1126/science.1143254			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186KD	17556549				2022-12-28	WOS:000247776700055
J	Foster, SL; Hargreaves, DC; Medzhitov, R				Foster, Simmie L.; Hargreaves, Diana C.; Medzhitov, Ruslan			Gene-specific control of inflammation by TLR-induced chromatin modifications	NATURE			English	Article							KAPPA-B; MACROPHAGE ACTIVATION; MOLECULAR-MECHANISMS; MURINE MACROPHAGES; BACTERIAL PYROGENS; MESSENGER-RNA; TNF-ALPHA; IN-VITRO; RECEPTOR; LIPOPOLYSACCHARIDE	Toll-like receptors (TLRs) induce a multi-component inflammatory response that must be tightly regulated to avoid tissue damage. Most known regulatory mechanisms target TLR signalling pathways and thus broadly inhibit multiple aspects of the inflammatory response. Given the functional diversity of TLR-induced genes, we proposed that additional, gene-specific regulatory mechanisms exist to allow individual aspects of the TLR-induced response to be differentially regulated. Using an in vitro system of lipopolysaccharide tolerance in murine macrophages, we show that TLR-induced genes fall into two categories on the basis of their functions and regulatory requirements. We demonstrate that representatives from the two classes acquire distinct patterns of TLR-induced chromatin modifications. These gene-specific chromatin modifications are associated with transient silencing of one class of genes, which includes pro-inflammatory mediators, and priming of the second class, which includes antimicrobial effectors. These findings illustrate an adaptive response in macrophages and reveal component-specific regulation of inflammation.	Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06405 USA; Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06405 USA	Howard Hughes Medical Institute; Yale University; Yale University	Medzhitov, R (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06405 USA.	ruslan.medzhitov@yale.edu						BEESON PB, 1947, J EXP MED, V86, P29, DOI 10.1084/jem.86.1.29; BEESON PB, 1947, J EXP MED, V86, P39, DOI 10.1084/jem.86.1.39; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Cavaillon JM, 2006, CRIT CARE, V10, DOI 10.1186/cc5055; Chi T, 2004, NAT REV IMMUNOL, V4, P965, DOI 10.1038/nri1501; De Bosscher K, 2003, ENDOCR REV, V24, P488, DOI 10.1210/er.2002-0006; Dobrovolskaia MA, 2003, J IMMUNOL, V170, P508, DOI 10.4049/jimmunol.170.1.508; Dobrovolskaia MA, 2002, MICROBES INFECT, V4, P903, DOI 10.1016/S1286-4579(02)01613-1; Flohe S, 1999, CYTOKINE, V11, P796, DOI 10.1006/cyto.1998.0490; Fujihara M, 2000, J LEUKOCYTE BIOL, V68, P267; Fujihara M, 2003, PHARMACOL THERAPEUT, V100, P171, DOI 10.1016/j.pharmthera.2003.08.003; HENRICSON BE, 1993, INFECT IMMUN, V61, P2325, DOI 10.1128/IAI.61.6.2325-2333.1993; Huang Q, 2001, SCIENCE, V294, P870, DOI 10.1126/science.294.5543.870; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Karin M, 2006, CELL, V124, P823, DOI 10.1016/j.cell.2006.02.016; Kaufmann A, 2000, EUR J IMMUNOL, V30, P1562, DOI 10.1002/1521-4141(200006)30:6<1562::AID-IMMU1562>3.0.CO;2-Q; Kurdistani SK, 2003, NAT REV MOL CELL BIO, V4, P276, DOI 10.1038/nrm1075; Learn CA, 2000, J BIOL CHEM, V275, P12185, DOI 10.1074/jbc.275.16.12185; Leoni F, 2005, MOL MED, V11, P1, DOI 10.2119/2006-00005.Dinarello; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Medvedev AE, 2000, J IMMUNOL, V164, P5564, DOI 10.4049/jimmunol.164.11.5564; Medvedev AE, 2002, J IMMUNOL, V169, P5209, DOI 10.4049/jimmunol.169.9.5209; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; Nieuwdorp M, 2005, CURR OPIN PHARMACOL, V5, P155, DOI 10.1016/j.coph.2004.10.003; Nusinzon I, 2005, J INTERF CYTOK RES, V25, P745, DOI 10.1089/jir.2005.25.745; Ogawa S, 2005, CELL, V122, P707, DOI 10.1016/j.cell.2005.06.029; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Ramirez-Carrozzi VR, 2006, GENE DEV, V20, P282, DOI 10.1101/gad.1383206; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; Shnyra A, 1998, J IMMUNOL, V160, P3729; Smale ST, 2003, NAT IMMUNOL, V4, P607, DOI 10.1038/ni0703-607; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; West MA, 2002, CRIT CARE MED, V30, pS64, DOI 10.1097/00003246-200201001-00009	37	874	914	6	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 21	2007	447	7147					972	U4		10.1038/nature05836	http://dx.doi.org/10.1038/nature05836			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	180NU	17538624				2022-12-28	WOS:000247373100040
J	Furuhashi, M; Tuncman, G; Gorgun, CZ; Makowski, L; Atsumi, G; Vaillancourt, E; Kono, K; Babaev, VR; Fazio, S; Linton, MF; Sulsky, R; Robl, JA; Parker, RA; Hotamisligil, GS				Furuhashi, Masato; Tuncman, Guerol; Goerguen, Cem Z.; Makowski, Liza; Atsumi, Genichi; Vaillancourt, Eric; Kono, Keita; Babaev, Vladimir R.; Fazio, Sergio; Linton, MacRae F.; Sulsky, Richard; Robl, Jeffrey A.; Parker, Rex A.; Hotamisligil, Goekhan S.			Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2	NATURE			English	Article							HUMAN THP-1 MACROPHAGES; FOAM CELL-FORMATION; INSULIN-RESISTANCE; METABOLIC-RESPONSES; MURINE MACROPHAGES; DEFICIENT MICE; EXPRESSION; OBESITY; GENE; ACTIVATION	Adipocyte fatty-acid-binding protein, aP2 (FABP4) is expressed in adipocytes and macrophages, and integrates inflammatory and metabolic responses. Studies in aP2-deficient mice have shown that this lipid chaperone has a significant role in several aspects of metabolic syndrome, including type 2 diabetes and atherosclerosis. Here we demonstrate that an orally active small-molecule inhibitor of aP2 is an effective therapeutic agent against severe atherosclerosis and type 2 diabetes in mouse models. In macrophage and adipocyte cell lines with or without aP2, we also show the target specificity of this chemical intervention and its mechanisms of action on metabolic and inflammatory pathways. Our findings demonstrate that targeting aP2 with small-molecule inhibitors is possible and can lead to a new class of powerful therapeutic agents to prevent and treat metabolic diseases such as type 2 diabetes and atherosclerosis.	Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA; Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN 37232 USA; Bristol Myers Squibb Co, Pharmaceut Res Inst, Princeton, NJ 08543 USA	Harvard University; Harvard T.H. Chan School of Public Health; Vanderbilt University; Bristol-Myers Squibb	Hotamisligil, GS (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, 665 Huntington Ave, Boston, MA 02115 USA.	ghotamis@hsph.harvard.edu	Eckhardt, Erik/G-1567-2010; Vaillancourt, Eric/HGD-0666-2022; Furuhashi, Masato/AAT-5518-2021	Vaillancourt, Eric/0000-0002-1810-126X; Furuhashi, Masato/0000-0002-0145-3541; Makowski, Liza/0000-0002-5337-8037	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL075970] Funding Source: NIH RePORTER; NHLBI NIH HHS [F32 HL075970] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Babaev VR, 2000, J BIOL CHEM, V275, P26293, DOI 10.1074/jbc.M002423200; BLASI E, 1985, NATURE, V318, P667, DOI 10.1038/318667a0; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boord JB, 2002, ARTERIOSCL THROM VAS, V22, P1686, DOI 10.1161/01.ATV.0000033090.81345.E6; Cao H, 2006, DIABETES, V55, P1915, DOI 10.2337/db05-1496; DISTEL RJ, 1992, J BIOL CHEM, V267, P5937; Fisher RM, 2001, DIABETOLOGIA, V44, P1268, DOI 10.1007/s001250100643; Fu YC, 2002, ATHEROSCLEROSIS, V165, P259, DOI 10.1016/S0021-9150(02)00305-2; Fu YC, 2000, J LIPID RES, V41, P2017; Hertzel AV, 2000, TRENDS ENDOCRIN MET, V11, P175; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hotamisligil GS, 1996, SCIENCE, V274, P1377, DOI 10.1126/science.274.5291.1377; HUNT CR, 1986, P NATL ACAD SCI USA, V83, P3786, DOI 10.1073/pnas.83.11.3786; Kazemi MR, 2005, ARTERIOSCL THROM VAS, V25, P1220, DOI 10.1161/01.ATV.0000159163.52632.1b; Kim JK, 2000, J CLIN INVEST, V105, P1791, DOI 10.1172/JCI8305; Llaverias G, 2004, BIOCHEM BIOPH RES CO, V318, P265, DOI 10.1016/j.bbrc.2004.04.021; Maeda K, 2005, CELL METAB, V1, P107, DOI 10.1016/j.cmet.2004.12.008; Makowski L, 2005, J BIOL CHEM, V280, P12888, DOI 10.1074/jbc.M413788200; Makowski L, 2001, NAT MED, V7, P699, DOI 10.1038/89076; MELKI SA, 1993, J LIPID RES, V34, P1527; Pelton PD, 1999, BIOCHEM BIOPH RES CO, V261, P456, DOI 10.1006/bbrc.1999.1071; Scheja L, 1999, DIABETES, V48, P1987, DOI 10.2337/diabetes.48.10.1987; Sethi JK, 2000, FEBS LETT, V469, P77, DOI 10.1016/S0014-5793(00)01250-3; SULSKY R, IN PRESS BIOORG MED; Tuncman G, 2006, P NATL ACAD SCI USA, V103, P6970, DOI 10.1073/pnas.0602178103; Tuncman G, 2006, P NATL ACAD SCI USA, V103, P10741, DOI 10.1073/pnas.0603509103; Uysal KT, 2000, ENDOCRINOLOGY, V141, P3388, DOI 10.1210/en.141.9.3388	28	529	571	2	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 21	2007	447	7147					959	U2		10.1038/nature05844	http://dx.doi.org/10.1038/nature05844			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	180NU	17554340	Green Accepted			2022-12-28	WOS:000247373100038
J	Belonoshko, AB; Skorodumova, NV; Davis, S; Osiptsov, AN; Rosengren, A; Johansson, B				Belonoshko, Anatoly B.; Skorodumova, Natalia V.; Davis, Sergio; Osiptsov, Alexander N.; Rosengren, Anders; Johansson, Boerje			Origin of the low rigidity of the Earth's inner core	SCIENCE			English	Article							MOLECULAR-DYNAMICS; IRON; ELASTICITY; GPA	Earth's solid-iron inner core has a low rigidity that manifests itself in the anomalously low velocities of shear waves as compared to shear wave velocities measured in iron alloys. Normally, when estimating the elastic properties of a polycrystal, one calculates an average over different orientations of a single crystal. This approach does not take into account the grain boundaries and defects that are likely to be abundant at high temperatures relevant for the inner core conditions. By using molecular dynamics simulations, we show that, if defects are considered, the calculated shear modulus and shear wave velocity decrease dramatically as compared to those estimates obtained from the averaged single-crystal values. Thus, the low shear wave velocity in the inner core is explained.	Royal Inst Technol, Dept Mat Sci & Engn, SE-10044 Stockholm, Sweden; Royal Inst Technol, Dept Theoret Phys, AlbaNova Univ Ctr, SE-10691 Stockholm, Sweden; Uppsala Univ, Dept Phys, Condensed Matter Theory Grp, Uppsala, Sweden; Moscow MV Lomonosov State Univ, Inst Mech, Moscow 142432, Russia; Dalian Univ Technol, Coll Adv Sci & Technol, Dalian 116024, Peoples R China; Dalian Univ Technol, Sch Phys & Optoelect Technol, Dalian 116024, Peoples R China	Royal Institute of Technology; Royal Institute of Technology; Uppsala University; Lomonosov Moscow State University; Dalian University of Technology; Dalian University of Technology	Belonoshko, AB (corresponding author), Royal Inst Technol, Dept Mat Sci & Engn, SE-10044 Stockholm, Sweden.	anatoly.belonoshko@fysik.uu.se	Belonoshko, Anatoly/AAC-4815-2021; Davis, Sergio/F-3415-2011; Davis, Sergio/U-7227-2019	Davis, Sergio/0000-0003-2757-332X; Davis, Sergio/0000-0003-2757-332X; Belonoshko, Anatoly/0000-0001-7531-3210; Osiptsov, Alexander/0000-0003-0956-1595				ALTSHULER IV, 1958, ZH EKSP TEOR FIZ, V34, P874; Antonangeli D, 2004, EARTH PLANET SC LETT, V225, P243, DOI 10.1016/j.epsl.2004.06.004; Belonoshko AB, 2006, PHYS REV B, V74, DOI [10.1103/PhysRevB.74.214102, 10.1103/PhysRevB.214102]; Belonoshko AB, 2000, PHYS REV LETT, V84, P3638, DOI 10.1103/PhysRevLett.84.3638; Belonoshko AB, 2003, NATURE, V424, P1032, DOI 10.1038/nature01954; Belonoshko AB, 2001, PHYS REV LETT, V87, part. no., DOI 10.1103/PhysRevLett.87.165505; BIRCH F, 1952, J GEOPHYS RES, V57, P227, DOI 10.1029/JZ057i002p00227; Buffett BA, 2000, SCIENCE, V288, P2007, DOI 10.1126/science.288.5473.2007; Cao AM, 2005, SCIENCE, V308, P1453, DOI 10.1126/science.1109134; DZIEWONSKI AM, 1981, PHYS EARTH PLANET IN, V25, P297, DOI 10.1016/0031-9201(81)90046-7; HALL EO, 1951, P PHYS SOC LOND B, V64, P747, DOI 10.1088/0370-1301/64/9/303; Hemley RJ, 2001, INT GEOL REV, V43, P1; Koci L, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.224113; Kresse G, 1996, COMP MATER SCI, V6, P15, DOI 10.1016/0927-0256(96)00008-0; Le Page Y, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.104104; Lehmann I., 1936, PUBL BUR CTR SEISM A, V14, P3; Mao HK, 1998, NATURE, V396, P741, DOI 10.1038/25506; NIELSEN OH, 1983, PHYS REV LETT, V50, P697, DOI 10.1103/PhysRevLett.50.697; PHILLPOT SR, 1995, J APPL PHYS, V78, P847, DOI 10.1063/1.360275; Schiotz J, 1999, PHYS REV B, V60, P11971, DOI 10.1103/PhysRevB.60.11971; Seo YS, 1999, MATER SCI RES INT, V5, P13; Singh SC, 2000, SCIENCE, V287, P2471, DOI 10.1126/science.287.5462.2471; STEVENSON DJ, 1981, SCIENCE, V214, P611, DOI 10.1126/science.214.4521.611; Sumita I, 1996, GEOPHYS J INT, V124, P502, DOI 10.1111/j.1365-246X.1996.tb07034.x; Van Swygenhoven H, 2004, NAT MATER, V3, P399, DOI 10.1038/nmat1136; Vocadlo L, 2003, NATURE, V424, P536, DOI 10.1038/nature01829; Vocadlo L, 2007, EARTH PLANET SC LETT, V254, P227, DOI 10.1016/j.epsl.2006.09.046; Voigt W., 1910, LEHRBUCH KRISTALLPHY; Zener C, 1941, PHYS REV, V60, P906, DOI 10.1103/PhysRev.60.906	29	58	58	1	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 15	2007	316	5831					1603	1605		10.1126/science.1141374	http://dx.doi.org/10.1126/science.1141374			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178SH	17569860				2022-12-28	WOS:000247239900037
J	Birney, E; Stamatoyannopoulos, JA; Dutta, A; Guigo, R; Gingeras, TR; Margulies, EH; Weng, ZP; Snyder, M; Dermitzakis, ET; Stamatoyannopoulos, JA; Thurman, RE; Kuehn, MS; Taylor, CM; Neph, S; Koch, CM; Asthana, S; Malhotra, A; Adzhubei, I; Greenbaum, JA; Andrews, RM; Flicek, P; Boyle, PJ; Cao, H; Carter, NP; Clelland, GK; Davis, S; Day, N; Dhami, P; Dillon, SC; Dorschner, MO; Fiegler, H; Giresi, PG; Goldy, J; Hawrylycz, M; Haydock, A; Humbert, R; James, KD; Johnson, BE; Johnson, EM; Frum, TT; Rosenzweig, ER; Karnani, N; Lee, K; Lefebvre, GC; Navas, PA; Neri, F; Parker, SCJ; Sabo, PJ; Sandstrom, R; Shafer, A; Vetrie, D; Weaver, M; Wilcox, S; Yu, M; Collins, FS; Dekker, J; Lieb, JD; Tullius, TD; Crawford, GE; Sunyaev, S; Noble, WS; Dunham, I; Dutta, A; Guigo, R; Denoeud, F; Reymond, A; Kapranov, P; Rozowsky, J; Zheng, DY; Castelo, R; Frankish, A; Harrow, J; Ghosh, S; Sandelin, A; Hofacker, IL; Baertsch, R; Keefe, D; Flicek, P; Dike, S; Cheng, J; Hirsch, HA; Sekinger, EA; Lagarde, J; Abril, JF; Shahab, A; Flamm, C; Fried, C; Hackermuller, J; Hertel, J; Lindemeyer, M; Missal, K; Tanzer, A; Washietl, S; Korbel, J; Emanuelsson, O; Pedersen, JS; Holroyd, N; Taylor, R; Swarbreck, D; Matthews, N; Dickson, MC; Thomas, DJ; Weirauch, MT; Gilbert, J; Drenkow, J; Bell, I; Zhao, X; Srinivasan, KG; Sung, WK; Ooi, HS; Chiu, KP; Foissac, S; Alioto, T; Brent, M; Pachter, L; Tress, ML; Valencia, A; Choo, SW; Choo, CY; Ucla, C; Manzano, C; Wyss, C; Cheung, E; Clark, TG; Brown, JB; Ganesh, M; Patel, S; Tammana, H; Chrast, J; Henrichsen, CN; Kai, C; Kawai, J; Nagalakshmi, U; Wu, JQ; Lian, Z; Lian, J; Newburger, P; Zhang, XQ; Bickel, P; Mattick, JS; Carninci, P; Hayashizaki, Y; Weissman, S; Dermitzakis, ET; Margulies, EH; Hubbard, T; Myers, RM; Rogers, J; Stadler, PF; Lowe, TM; Wei, CL; Ruan, YJ; Snyder, M; Birney, E; Struhl, K; Gerstein, M; Antonarakis, SE; Gingeras, TR; Brown, JB; Flicek, P; Fu, YT; Keefe, D; Birney, E; Denoeud, F; Gerstein, M; Green, ED; Kapranov, P; Karaoz, U; Myers, RM; Noble, WS; Reymond, A; Rozowsky, J; Struhl, K; Siepel, A; Stamatoyannopoulos, JA; Taylor, CM; Taylor, J; Thurman, RE; Tullius, TD; Washietl, S; Zheng, DY; Liefer, LA; Wetterstrand, KA; Good, PJ; Feingold, EA; Guyer, MS; Collins, FS; Margulies, EH; Cooper, GM; Asimenos, G; Thomas, DJ; Dewey, CN; Siepel, A; Birney, E; Keefe, D; Hou, MM; Taylor, J; Nikolaev, S; Montoya-Burgos, JI; Loytynoja, A; Whelan, S; Pardi, F; Massingham, T; Brown, JB; Huang, HY; Zhang, NR; Bickel, P; Holmes, I; Mullikin, JC; Ureta-Vidal, A; Paten, B; Seringhaus, M; Church, D; Rosenbloom, K; Kent, WJ; Stone, EA; Gerstein, M; Antonarakis, SE; Batzoglou, S; Goldman, N; Hardison, RC; Haussler, D; Miller, W; Pachter, L; Green, ED; Sidow, A; Weng, ZP; Trinklein, ND; Fu, YT; Zhang, ZDD; Karaoz, U; Barrera, L; Stuart, R; Zheng, DY; Ghosh, S; Flicek, P; King, DC; Taylor, J; Ameur, A; Enroth, S; Bieda, MC; Koch, CM; Hirsch, HA; Wei, CL; Cheng, J; Kim, J; Bhinge, AA; Giresi, PG; Jiang, N; Liu, J; Yao, F; Sung, WK; Chiu, KP; Vega, VB; Lee, CWH; Ng, P; Shahab, A; Sekinger, EA; Yang, A; Moqtaderi, Z; Zhu, Z; Xu, XQ; Squazzo, S; Oberley, MJ; Inman, D; Singer, MA; Richmond, TA; Munn, KJ; Rada-Iglesias, A; Wallerman, O; Komorowski, J; Clelland, GK; Wilcox, S; Dillon, SC; Andrews, RM; Fowler, JC; Couttet, P; James, KD; Lefebvre, GC; Bruce, AW; Dovey, OM; Ellis, PD; Dhami, P; Langford, CF; Carter, NP; Vetrie, D; Kapranov, P; Nix, DA; Bell, I; Patel, S; Rozowsky, J; Euskirchen, G; Hartman, S; Lian, J; Wu, JQ; Urban, AE; Kraus, P; Van Calcar, S; Heintzman, N; Kim, TH; Wang, K; Qu, CX; Hon, G; Luna, R; Glass, CK; Rosenfeld, MG; Aldred, SF; Cooper, SJ; Halees, A; Lin, JM; Shulha, HP; Zhang, XL; Xu, MS; Haidar, JNS; Yu, Y; Birney, E; Weissman, S; Ruan, YJ; Lieb, JD; Iyer, VR; Green, RD; Gingeras, TR; Wadelius, C; Dunham, I; Struhl, K; Hardison, RC; Gerstein, M; Farnham, PJ; Myers, RM; Ren, B; Snyder, M; Thomas, DJ; Rosenbloom, K; Harte, RA; Hinrichs, AS; Trumbower, H; Clawson, H; Hillman-Jackson, J; Zweig, AS; Smith, K; Thakkapallayil, A; Barber, G; Kuhn, RM; Karolchik, D; Haussler, D; Kent, WJ; Dermitzakis, ET; Armengol, L; Bird, CP; Clark, TG; Cooper, GM; de Bakker, PIW; Kern, AD; Lopez-Bigas, N; Martin, JD; Stranger, BE; Thomas, DJ; Woodroffe, A; Batzoglou, S; Davydov, E; Dimas, A; Eyras, E; Hallgrimsdottir, IB; Hardison, RC; Huppert, J; Sidow, A; Taylor, J; Trumbower, H; Zody, MC; Guigo, R; Mullikin, JC; Abecasis, GR; Estivill, X; Birney, E; Bouffard, GG; Guan, XB; Hansen, NF; Idol, JR; Maduro, VVB; Maskeri, B; McDowell, JC; Park, M; Thomas, PJ; Young, AC; Blakesley, RW; Muzny, DM; Sodergren, E; Wheeler, DA; Worley, KC; Jiang, HY; Weinstock, GM; Gibbs, RA; Graves, T; Fulton, R; Mardis, ER; Wilson, RK; Clamp, M; Cuff, J; Gnerre, S; Jaffe, DB; Chang, JL; Lindblad-Toh, K; Lander, ES; Koriabine, M; Nefedov, M; Osoegawa, K; Yoshinaga, Y; Zhu, BL; de Jong, PJ				Birney, Ewan; Stamatoyannopoulos, John A.; Dutta, Anindya; Guigo, Roderic; Gingeras, Thomas R.; Margulies, Elliott H.; Weng, Zhiping; Snyder, Michael; Dermitzakis, Emmanouil T.; Stamatoyannopoulos, John A.; Thurman, Robert E.; Kuehn, Michael S.; Taylor, Christopher M.; Neph, Shane; Koch, Christoph M.; Asthana, Saurabh; Malhotra, Ankit; Adzhubei, Ivan; Greenbaum, Jason A.; Andrews, Robert M.; Flicek, Paul; Boyle, Patrick J.; Cao, Hua; Carter, Nigel P.; Clelland, Gayle K.; Davis, Sean; Day, Nathan; Dhami, Pawandeep; Dillon, Shane C.; Dorschner, Michael O.; Fiegler, Heike; Giresi, Paul G.; Goldy, Jeff; Hawrylycz, Michael; Haydock, Andrew; Humbert, Richard; James, Keith D.; Johnson, Brett E.; Johnson, Ericka M.; Frum, Tristan T.; Rosenzweig, Elizabeth R.; Karnani, Neerja; Lee, Kirsten; Lefebvre, Gregory C.; Navas, Patrick A.; Neri, Fidencio; Parker, Stephen C. J.; Sabo, Peter J.; Sandstrom, Richard; Shafer, Anthony; Vetrie, David; Weaver, Molly; Wilcox, Sarah; Yu, Man; Collins, Francis S.; Dekker, Job; Lieb, Jason D.; Tullius, Thomas D.; Crawford, Gregory E.; Sunyaev, Shamil; Noble, William S.; Dunham, Ian; Dutta, Anindya; Guigo, Roderic; Denoeud, France; Reymond, Alexandre; Kapranov, Philipp; Rozowsky, Joel; Zheng, Deyou; Castelo, Robert; Frankish, Adam; Harrow, Jennifer; Ghosh, Srinka; Sandelin, Albin; Hofacker, Ivo L.; Baertsch, Robert; Keefe, Damian; Flicek, Paul; Dike, Sujit; Cheng, Jill; Hirsch, Heather A.; Sekinger, Edward A.; Lagarde, Julien; Abril, Josep F.; Shahab, Atif; Flamm, Christoph; Fried, Claudia; Hackermueller, Joerg; Hertel, Jana; Lindemeyer, Manja; Missal, Kristin; Tanzer, Andrea; Washietl, Stefan; Korbel, Jan; Emanuelsson, Olof; Pedersen, Jakob S.; Holroyd, Nancy; Taylor, Ruth; Swarbreck, David; Matthews, Nicholas; Dickson, Mark C.; Thomas, Daryl J.; Weirauch, Matthew T.; Gilbert, James; Drenkow, Jorg; Bell, Ian; Zhao, XiaoDong; Srinivasan, K. G.; Sung, Wing-Kin; Ooi, Hong Sain; Chiu, Kuo Ping; Foissac, Sylvain; Alioto, Tyler; Brent, Michael; Pachter, Lior; Tress, Michael L.; Valencia, Alfonso; Choo, Siew Woh; Choo, Chiou Yu; Ucla, Catherine; Manzano, Caroline; Wyss, Carine; Cheung, Evelyn; Clark, Taane G.; Brown, James B.; Ganesh, Madhavan; Patel, Sandeep; Tammana, Hari; Chrast, Jacqueline; Henrichsen, Charlotte N.; Kai, Chikatoshi; Kawai, Jun; Nagalakshmi, Ugrappa; Wu, Jiaqian; Lian, Zheng; Lian, Jin; Newburger, Peter; Zhang, Xueqing; Bickel, Peter; Mattick, John S.; Carninci, Piero; Hayashizaki, Yoshihide; Weissman, Sherman; Dermitzakis, Emmanouil T.; Margulies, Elliott H.; Hubbard, Tim; Myers, Richard M.; Rogers, Jane; Stadler, Peter F.; Lowe, Todd M.; Wei, Chia-Lin; Ruan, Yijun; Snyder, Michael; Birney, Ewan; Struhl, Kevin; Gerstein, Mark; Antonarakis, Stylianos E.; Gingeras, Thomas R.; Brown, James B.; Flicek, Paul; Fu, Yutao; Keefe, Damian; Birney, Ewan; Denoeud, France; Gerstein, Mark; Green, Eric D.; Kapranov, Philipp; Karaoez, Ulas; Myers, Richard M.; Noble, William S.; Reymond, Alexandre; Rozowsky, Joel; Struhl, Kevin; Siepel, Adam; Stamatoyannopoulos, John A.; Taylor, Christopher M.; Taylor, James; Thurman, Robert E.; Tullius, Thomas D.; Washietl, Stefan; Zheng, Deyou; Liefer, Laura A.; Wetterstrand, Kris A.; Good, Peter J.; Feingold, Elise A.; Guyer, Mark S.; Collins, Francis S.; Margulies, Elliott H.; Cooper, Gregory M.; Asimenos, George; Thomas, Daryl J.; Dewey, Colin N.; Siepel, Adam; Birney, Ewan; Keefe, Damian; Hou, Minmei; Taylor, James; Nikolaev, Sergey; Montoya-Burgos, Juan I.; Loeytynoja, Ari; Whelan, Simon; Pardi, Fabio; Massingham, Tim; Brown, James B.; Huang, Haiyan; Zhang, Nancy R.; Bickel, Peter; Holmes, Ian; Mullikin, James C.; Ureta-Vidal, Abel; Paten, Benedict; Seringhaus, Michael; Church, Deanna; Rosenbloom, Kate; Kent, W. James; Stone, Eric A.; Gerstein, Mark; Antonarakis, Stylianos E.; Batzoglou, Serafim; Goldman, Nick; Hardison, Ross C.; Haussler, David; Miller, Webb; Pachter, Lior; Green, Eric D.; Sidow, Arend; Weng, Zhiping; Trinklein, Nathan D.; Fu, Yutao; Zhang, Zhengdong D.; Karaoez, Ulas; Barrera, Leah; Stuart, Rhona; Zheng, Deyou; Ghosh, Srinka; Flicek, Paul; King, David C.; Taylor, James; Ameur, Adam; Enroth, Stefan; Bieda, Mark C.; Koch, Christoph M.; Hirsch, Heather A.; Wei, Chia-Lin; Cheng, Jill; Kim, Jonghwan; Bhinge, Akshay A.; Giresi, Paul G.; Jiang, Nan; Liu, Jun; Yao, Fei; Sung, Wing-Kin; Chiu, Kuo Ping; Vega, Vinsensius B.; Lee, Charlie W. H.; Ng, Patrick; Shahab, Atif; Sekinger, Edward A.; Yang, Annie; Moqtaderi, Zarmik; Zhu, Zhou; Xu, Xiaoqin; Squazzo, Sharon; Oberley, Matthew J.; Inman, David; Singer, Michael A.; Richmond, Todd A.; Munn, Kyle J.; Rada-Iglesias, Alvaro; Wallerman, Ola; Komorowski, Jan; Clelland, Gayle K.; Wilcox, Sarah; Dillon, Shane C.; Andrews, Robert M.; Fowler, Joanna C.; Couttet, Phillippe; James, Keith D.; Lefebvre, Gregory C.; Bruce, Alexander W.; Dovey, Oliver M.; Ellis, Peter D.; Dhami, Pawandeep; Langford, Cordelia F.; Carter, Nigel P.; Vetrie, David; Kapranov, Philipp; Nix, David A.; Bell, Ian; Patel, Sandeep; Rozowsky, Joel; Euskirchen, Ghia; Hartman, Stephen; Lian, Jin; Wu, Jiaqian; Urban, Alexander E.; Kraus, Peter; Van Calcar, Sara; Heintzman, Nate; Kim, Tae Hoon; Wang, Kun; Qu, Chunxu; Hon, Gary; Luna, Rosa; Glass, Christopher K.; Rosenfeld, M. Geoff; Force Aldred, Shelley; Cooper, Sara J.; Halees, Anason; Lin, Jane M.; Shulha, Hennady P.; Zhang, Xiaoling; Xu, Mousheng; Haidar, Jaafar N. S.; Yu, Yong; Birney, Ewan; Weissman, Sherman; Ruan, Yijun; Lieb, Jason D.; Iyer, Vishwanath R.; Green, Roland D.; Gingeras, Thomas R.; Wadelius, Claes; Dunham, Ian; Struhl, Kevin; Hardison, Ross C.; Gerstein, Mark; Farnham, Peggy J.; Myers, Richard M.; Ren, Bing; Snyder, Michael; Thomas, Daryl J.; Rosenbloom, Kate; Harte, Rachel A.; Hinrichs, Angie S.; Trumbower, Heather; Clawson, Hiram; Hillman-Jackson, Jennifer; Zweig, Ann S.; Smith, Kayla; Thakkapallayil, Archana; Barber, Galt; Kuhn, Robert M.; Karolchik, Donna; Haussler, David; Kent, W. James; Dermitzakis, Emmanouil T.; Armengol, Lluis; Bird, Christine P.; Clark, Taane G.; Cooper, Gregory M.; de Bakker, Paul I. W.; Kern, Andrew D.; Lopez-Bigas, Nuria; Martin, Joel D.; Stranger, Barbara E.; Thomas, Daryl J.; Woodroffe, Abigail; Batzoglou, Serafim; Davydov, Eugene; Dimas, Antigone; Eyras, Eduardo; Hallgrimsdottir, Ingileif B.; Hardison, Ross C.; Huppert, Julian; Sidow, Arend; Taylor, James; Trumbower, Heather; Zody, Michael C.; Guigo, Roderic; Mullikin, James C.; Abecasis, Goncalo R.; Estivill, Xavier; Birney, Ewan; Bouffard, Gerard G.; Guan, Xiaobin; Hansen, Nancy F.; Idol, Jacquelyn R.; Maduro, Valerie V. B.; Maskeri, Baishali; McDowell, Jennifer C.; Park, Morgan; Thomas, Pamela J.; Young, Alice C.; Blakesley, Robert W.; Muzny, Donna M.; Sodergren, Erica; Wheeler, David A.; Worley, Kim C.; Jiang, Huaiyang; Weinstock, George M.; Gibbs, Richard A.; Graves, Tina; Fulton, Robert; Mardis, Elaine R.; Wilson, Richard K.; Clamp, Michele; Cuff, James; Gnerre, Sante; Jaffe, David B.; Chang, Jean L.; Lindblad-Toh, Kerstin; Lander, Eric S.; Koriabine, Maxim; Nefedov, Mikhail; Osoegawa, Kazutoyo; Yoshinaga, Yuko; Zhu, Baoli; de Jong, Pieter J.		ENCODE Project Consortium	Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project	NATURE			English	Review							FACTOR-BINDING-SITES; POLYCOMB TARGET GENES; SEQUENCE TAG ANALYSIS; HIGH-RESOLUTION; ANTISENSE TRANSCRIPTION; REGULATORY ELEMENTS; ADENINE TRACT; C-MYC; DNA; REPLICATION	We report the generation and analysis of functional data from multiple, diverse experiments performed on a targeted 1% of the human genomeas part of the pilot phase of the ENCODE Project. These data have been further integrated and augmented by a number of evolutionary and computational analyses. Together, our results advance the collective knowledge about human genome function in several major areas. First, our studies provide convincing evidence that the genome is pervasively transcribed, such that the majority of its bases can be found in primary transcripts, including non-protein-coding transcripts, and those that extensively overlap one another. Second, systematic examination of transcriptional regulation has yielded new understanding about transcription start sites, including their relationship to specific regulatory sequences and features of chromatin accessibility and histone modification. Third, a more sophisticated view of chromatin structure has emerged, including its inter-relationship with DNA replication and transcriptional regulation. Finally, integration of these new sources of information, in particular with respect to mammalian evolution based on inter-and intra-species sequence comparisons, has yielded new mechanistic and evolutionary insights concerning the functional landscape of the human genome. Together, these studies are defining a path for pursuit of a more comprehensive characterization of human genome function.	EMBL European Bioinformat Inst, Cambridge CB10 1SD, England; Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; Univ Virginia, Sch Med, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA; Univ Pompeu Fabra, Inst Municipal Invest Med, Res Grp Biomed Informat, Barcelona 08003, Spain; Univ Pompeu Fabra, Ctr Genom Regulat, Genom Bioinformat Program, Barcelona 08003, Spain; Affymetrix Inc, Santa Clara, CA 95051 USA; NHGRI, Genome Technol Branch, NIH, Bethesda, MD 20892 USA; Boston Univ, Bioinformat Program, Boston, MA 02215 USA; Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; Univ Washington, Div Med Genet, Seattle, WA 98195 USA; Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Boston Univ, Dept Chem, Boston, MA 02215 USA; Boston Univ, Program Bioinformat, Boston, MA 02215 USA; NCI, Genet Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA; Allen Inst Brain Sci, Seattle, WA 98103 USA; Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA; Duke Univ, Dept Pediat, Durham, NC 27708 USA; Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA; Univ Lausanne, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland; Univ Geneva, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; RIKEN, Yokohama Inst, RIKEN Genom Sci Ctr, Genome Explorat Res Grp,Tsurumi Ku, Kanagawa 2300045, Japan; Univ Vienna, Inst Theoret Chem, A-1090 Vienna, Austria; Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA; Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Univ Barcelona, Fac Biol, Dept Genet, Barcelona 08028, Catalonia, Spain; Bioinformat Inst, Singapore 138671, Singapore; Univ Leipzig, Interdisciplinary Ctr Bioinformat, D-04107 Leipzig, Germany; Univ Leipzig, Dept Comp Sci, Bioinformat Grp, D-04107 Leipzig, Germany; Fraunhofer Inst Zelltherapie & Immunol, D-04103 Leipzig, Germany; Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; Genome Inst Singapore, Singapore 138672, Singapore; Washington Univ, Lab Computat Genom, St Louis, MO 63130 USA; Univ Calif Berkeley, Dept Math & Comp Sci, Berkeley, CA 94720 USA; Spanish Natl Canc Res Ctr, CNIO, E-28029 Madrid, Spain; Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Publ Hlth, London W2 1PG, England; Univ Calif Berkeley, Dept Appl Sci & Technol, Berkeley, CA 94720 USA; RIKEN, Wako Inst, Discovery & Res Inst, Genome Sci Lab, Wako, Saitama 3510198, Japan; Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; Univ Massachusetts, Sch Med, Dept Pediat, Worcester, MA 01605 USA; Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA; Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia; Santa Fe Inst, Santa Fe, NM 87501 USA; Yale Univ, Dept Comp Sci, New Haven, CT 06520 USA; Yale Univ, Program Computat Biol & Bioinformat, New Haven, CT 06520 USA; NHGRI, NIH Intramural Sequencing Ctr, NIH, Bethesda, MD 20892 USA; Penn State Univ, Dept Comp Sci & Engn, University Pk, PA 16802 USA; Penn State Univ, Ctr Comparat Genom & Bioinformat, Huck Inst Life Sci, University Pk, PA 16802 USA; NHGRI, Div Extramural Res, NIH, Bethesda, MD 20892 USA; NHGRI, Off Director, NIH, Bethesda, MD 20892 USA; Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; Univ Wisconsin, Dept Biostat & Med Informat, Madison, WI 53706 USA; Univ Geneva, Fac Sci, Dept Zool & Anim Biol, CH-1205 Geneva, Switzerland; Stanford Univ, Dept Stat, Stanford, CA 94305 USA; Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; NIH, Natl Ctr Biotechnol Informat, Bethesda, MD 20894 USA; Penn State Univ, HUck Inst Life Sci, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; Univ Calif Santa Cruz, Howard Hughes Med Inst, Santa Cruz, CA 95064 USA; Penn State Univ, Dept Biol, University Pk, PA 16802 USA; Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, HUman Genome Sequencing Ctr, Houston, TX 77030 USA; Washington Univ, Genom Sequencing Ctr, St Louis, MO 63108 USA; Harvard Univ, Broad Inst, Cambridge, MA 02141 USA; MIT, Cambridge, MA 02141 USA; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; Childrens Hosp, Oakland Res Inst, BACPAC Resources, Oakland, CA 94609 USA; Ludwig Inst Canc Res, La Jolla, CA 92093 USA; Uppsala Univ, Linnaeus Ctr Bioinformat, SE-75124 Uppsala, Sweden; Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA; Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; Univ Texas, Inst Mol & Cellular Biol, Austin, TX 78712 USA; NimbleGen Syst Inc, Madison, WI 53711 USA; Univ Wisconsin, Sch Med, Madison, WI 53706 USA; Uppsala Univ, Dept Genet & Pathol, Rudbeck Lab, SE-75185 Uppsala, Sweden; Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA; Ctr Genom Regulat, Genes & Dis Program, Barcelona 08003, Spain; MIT, Broad Inst, Cambridge, MA 02142 USA; Harvard Univ, Cambridge, MA 02142 USA; Ctr Stat Genet, Dept Biostat, Ann Arbor, MI 48109 USA; Univ Oxford, Dept Stat, Oxford OX1 3TG, England	European Molecular Biology Laboratory (EMBL); University of Washington; University of Washington Seattle; University of Virginia; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Affymetrix; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Boston University; Boston University; Yale University; Yale University; Wellcome Trust Sanger Institute; University of Washington; University of Washington Seattle; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Boston University; Boston University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Allen Institute for Brain Science; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Duke University; Duke University; University of Lausanne; University of Geneva; RIKEN; University of Vienna; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; Harvard University; Harvard Medical School; University of Barcelona; Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); Leipzig University; Leipzig University; Fraunhofer Gesellschaft; Stanford University; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Washington University (WUSTL); University of California System; University of California Berkeley; Centro Nacional de Investigaciones Oncologicas (CNIO); Imperial College London; University of California System; University of California Berkeley; RIKEN; Yale University; University of Massachusetts System; University of Massachusetts Worcester; University of California System; University of California Berkeley; University of Queensland; The Santa Fe Institute; Yale University; Yale University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Stanford University; University of Wisconsin System; University of Wisconsin Madison; University of Geneva; Stanford University; University of California System; University of California Berkeley; National Institutes of Health (NIH) - USA; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Howard Hughes Medical Institute; University of California System; University of California Santa Cruz; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Stanford University; Baylor College of Medicine; Baylor College of Medicine; Washington University (WUSTL); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute; Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute; Ludwig Institute for Cancer Research; Uppsala University; University of California System; University of California Davis; University of California System; University of California Davis; University of Texas System; University of Texas Austin; Roche Holding; Roche NimbleGen; University of Wisconsin System; University of Wisconsin Madison; Uppsala University; University of California System; University of California San Diego; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; University of Oxford	Birney, E (corresponding author), EMBL European Bioinformat Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SD, England.	birney@ebi.ac.uk; jstam@u.washington.edu; ad8q@virginia.edu; rguigo@imim.es; Tom_Gingeras@affymetrix.com; elliott@nhgri.nih.gov; zhiping@bu.edu; michael.snyder@yale.edu; md4@sanger.ac.uk	Dillon, Shane/A-2280-2011; Kim, Jonghwan/AAR-2815-2021; Zhang, Xiaoling/A-7132-2013; Stone, Eric/Q-7840-2016; Hinrichs, Angie S./H-9159-2019; Lagarde, Julien/AAI-1686-2020; Ferrando, Josep F Abril/B-3877-2014; Cooper, Gregory/D-6914-2011; Valencia, Alfonso/I-3127-2015; Parker, Stephen/ABF-1063-2021; Mattick, John S/I-7789-2012; Pedersen, Jakob/C-4985-2009; Oberley, Matthew/I-8107-2019; Clark, Taane G./AAM-2570-2020; Estivill, Xavier/A-3125-2013; Wilson, Richard K./AAF-4139-2019; Alioto, Tyler/K-7267-2015; Whelan, Simon/A-6638-2011; Carninci, Piero/K-1568-2014; Enroth, Stefan/C-7396-2009; Hackermüller, Jörg/F-2494-2016; Weirauch, Matthew/M-5459-2019; Mattick, John/ABH-6130-2020; Abecasis, Goncalo R/B-7840-2010; Lowe, Todd Michael/ABJ-5261-2022; Califano, Andrea/F-7239-2012; Eyras, Eduardo/A-1560-2010; Huppert, Julian/C-6664-2008; Taylor, James/F-1026-2011; Oberley, Matthew/L-4326-2019; Glass, Christopher/AAI-3933-2021; Bruce, Alexander W/H-4235-2014; Dutta, Anindya/P-3203-2016; Malhotra, Ankit/J-8130-2019; Brent, Michael/AAK-3702-2020; Hor, Charlotte/H-5908-2015; Tanzer, Andrea/L-3147-2015; Davis, Sean/AAD-1801-2021; Tullius, Thomas D./A-9685-2008; Mardis, Elaine/W-2202-2019; Estivill, Xavier/E-2957-2012; Pedersen, Jakob/G-3382-2012; Taylor, Christopher M./AAF-5480-2020; Gasull, Martina/J-4076-2019; Antonarakis, Stylianos E/N-8866-2014; Tanzer, Andrea/AAY-5431-2021; Karaoz, Ulas/J-7093-2014; Dermitzakis, Emmanouil/B-7687-2013; Kutalik, Zoltan/HHZ-5697-2022; Eyras, Eduardo/ABG-7144-2020; Brown, James/H-2971-2015; Wheeler, David A/M-9740-2018; Choo, Siew Woh/E-3406-2010; Guigo, Roderic/D-1303-2010; Komorowski, Jan/M-2667-2013; Hardison, Ross C/G-1142-2010; Komorowski, Jan/AAP-1685-2020; Hor, Charlotte/AAB-4850-2020; Eduardo, Eyras/L-1053-2014; Peng, Bo/A-6920-2009; de Bakker, Paul IW/B-8730-2009; Stadler, Peter F. F/L-7857-2015; Clawson, Hiram/ABE-6101-2020; Karnani, Neerja/G-2539-2012; Lopez-Bigas, Nuria/F-6193-2011; Alioto, Tyler/AAF-6342-2020; Ameur, Adam/E-6207-2011; Schor, Jana/F-8503-2017; Castelo, Robert/A-4679-2010; Weinstock, George M/C-6314-2013; Hubbard, Tim J/C-2567-2008; Nikolaev, Sergey/F-3148-2012; Malhotra, Ankit/I-3752-2012; Couttet, Philippe/AAH-5489-2019; Frankish, Adam/G-6545-2011; Korbel, Jan O/G-6470-2012; Komorowski, Jan/A-9175-2010; Chiu, Kuo-Ping/AAG-8855-2020; Sandelin, Albin/G-2881-2011; Hofacker, Ivo L/A-2378-2013; Hubbard, Tim J.P./AAT-4571-2020; Kawai, Jun/A-6451-2016	Hinrichs, Angie S./0000-0002-1697-1130; Lagarde, Julien/0000-0002-0290-7445; Ferrando, Josep F Abril/0000-0001-7793-589X; Cooper, Gregory/0000-0001-5509-9923; Valencia, Alfonso/0000-0002-8937-6789; Mattick, John S/0000-0002-7680-7527; Oberley, Matthew/0000-0001-6419-2513; Clark, Taane G./0000-0001-8985-9265; Estivill, Xavier/0000-0002-0723-2256; Wilson, Richard K./0000-0002-1992-1358; Alioto, Tyler/0000-0002-2960-5420; Carninci, Piero/0000-0001-7202-7243; Enroth, Stefan/0000-0002-5056-9137; Hackermüller, Jörg/0000-0003-4920-7072; Mattick, John/0000-0002-7680-7527; Huppert, Julian/0000-0001-5207-4886; Taylor, James/0000-0001-5079-840X; Glass, Christopher/0000-0003-4344-3592; Bruce, Alexander W/0000-0003-4297-4412; Malhotra, Ankit/0000-0002-1905-0732; Brent, Michael/0000-0002-8689-0299; Hor, Charlotte/0000-0002-5361-2372; Tanzer, Andrea/0000-0003-2873-4236; Davis, Sean/0000-0002-8991-6458; Tullius, Thomas D./0000-0003-4425-796X; Pedersen, Jakob/0000-0002-7236-4001; Taylor, Christopher M./0000-0002-7983-5275; Antonarakis, Stylianos E/0000-0001-8907-5823; Tanzer, Andrea/0000-0003-2873-4236; Karaoz, Ulas/0000-0002-8238-6757; Kutalik, Zoltan/0000-0001-8285-7523; Eyras, Eduardo/0000-0003-0793-6218; Wheeler, David A/0000-0002-9056-6299; Guigo, Roderic/0000-0002-5738-4477; Komorowski, Jan/0000-0002-0766-8789; Hardison, Ross C/0000-0003-4084-7516; Komorowski, Jan/0000-0002-0766-8789; Hor, Charlotte/0000-0002-5361-2372; Eduardo, Eyras/0000-0003-0793-6218; Peng, Bo/0000-0001-8225-2284; de Bakker, Paul IW/0000-0001-7735-7858; Stadler, Peter F. F/0000-0002-5016-5191; Lopez-Bigas, Nuria/0000-0003-4925-8988; Alioto, Tyler/0000-0002-2960-5420; Ameur, Adam/0000-0001-6085-6749; Schor, Jana/0000-0003-1200-6234; Castelo, Robert/0000-0003-2229-4508; Weinstock, George M/0000-0002-2997-4592; Hubbard, Tim J/0000-0002-1767-9318; Korbel, Jan O/0000-0002-2798-3794; Chiu, Kuo-Ping/0000-0001-9144-0674; Sandelin, Albin/0000-0002-7109-7378; Hofacker, Ivo L/0000-0001-7132-0800; Hubbard, Tim J.P./0000-0002-1767-9318; Karnani, Neerja/0000-0002-5301-409X; Kandhadayar, Gopalan Srinivasan/0000-0003-4387-8502; Holmes, Ian/0000-0001-7639-5369; Koch, Christof/0000-0001-6482-8067; Abecasis, Goncalo/0000-0003-1509-1825; Stuart, Rhona/0000-0001-5916-9693; Stone, Eric/0000-0002-2725-4209; /0000-0001-9150-3954; Newburger, Peter/0000-0002-8615-673X; Clawson, Hiram/0000-0002-0480-0545; Kim, Jonghwan/0000-0002-9919-9843; Marz, Manja/0000-0003-4783-8823; Harrow, Jennifer/0000-0003-0338-3070; Zheng, Deyou/0000-0003-4354-5337; Frankish, Adam/0000-0002-4333-628X; Sung, Wing-Kin/0000-0001-7806-7086; Pachter, Lior/0000-0002-9164-6231; Hallgrimsdottir, Ingileif/0000-0002-4710-0047; Reiche, Kristin/0000-0002-4452-4872; Lefebvre, Greg/0000-0001-7519-2316; FRUM, Tristan/0000-0003-3452-8762; Bhinge, Akshay/0000-0003-2939-099X; Foissac, Sylvain/0000-0002-2631-5356; Gingeras, Thomas/0000-0001-9106-3573; Swarbreck, David/0000-0002-5453-1013; Halees, Anason/0000-0001-5880-7067; Loytynoja, Ari/0000-0001-5389-6611; Dutta, Anindya/0000-0002-4319-0073; Dunham, Ian/0000-0003-2525-5598; Flamm, Christoph/0000-0001-5500-2415; Rada-Iglesias, Alvaro/0000-0001-7137-1341; Lieb, Jason/0000-0001-7601-8061; Rozowsky, Joel/0000-0002-3565-0762; Kapranov, Philipp/0000-0003-2647-4856; Cooper, Sara/0000-0002-9627-0309; Sandstrom, Richard/0000-0002-3356-1547; Soriaga, Leah/0000-0001-5852-741X; Farnham, Peggy/0000-0003-4469-7914; Flicek, Paul/0000-0002-3897-7955; Vetrie, David/0000-0003-2075-4662; Worley, Kim/0000-0002-0282-1000; Siepel, Adam/0000-0002-3557-7219; Kim, Tae Hoon/0000-0003-3950-7557; Reymond, Alexandre/0000-0003-1030-8327; Fosker, Christine/0000-0002-3799-9474; Adzhubey, Ivan/0000-0002-1483-9259; Goldman, Nick/0000-0001-8486-2211; King, David/0000-0003-1601-1612; Cuff, James/0000-0003-0570-4106; Stranger, Barbara/0000-0001-9021-7331; Birney, Ewan/0000-0001-8314-8497; Wallerman, Ola/0000-0003-1037-7904; Montoya-Burgos, Juan I./0000-0001-9080-9820; Snyder, Michael/0000-0003-0784-7987; Denoeud, France/0000-0001-8819-7634; Tress, Michael/0000-0001-9046-6370	NCI NIH HHS [F32 CA108313] Funding Source: Medline; NHGRI NIH HHS [R01 HG003143, R01 HG003521, R01 HG003521-01, U01 HG003156-03, R01 HG003541-03, K22 HG003169, U54 HG003273, U01 HG003161-03, U01 HG003162, U01 HG003156, P41 HG002371, U01 HG003150-03, R01 HG003532, R01 HG002238-15, U01 HG003150, U01 HG002523-01, U01 HG003168-02, R01 HG002238, R01 HG003129-03, U01 HG003161, U54 HG003067, U01 HG002523, U01 HG003162-03, U01 HG003147, U01 HG003157-03, P41 HG002371-03S1, U54 HG003067-01, R01 HG003541, U01 HG003151-03, R01 HG003532-01, U54 HG003079-01, R01 HG003110-03, R01 HG003110, U01 HG003157, U01 HG003151, U54 HG003273-01, U01 HG003147-02, U54 HG003079, R01 HG003143-04, K22 HG003169-01A1] Funding Source: Medline; Wellcome Trust [062023, 077198] Funding Source: Medline; NATIONAL CANCER INSTITUTE [F32CA108313] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003532, R01HG003143, Z01HG000196, U01HG003156, U01HG003147, U01HG003151, P41HG002371, U01HG003157, U01HG002523, U01HG003150, R01HG003521, K22HG003169, R01HG002238, Z01HG200341, R01HG003129, R01HG003541, U54HG003273, U54HG003067, R01HG003110, U54HG003079, U01HG003168, Z01HG000060, Z01HG200330, U01HG003162, U01HG003161] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [Z01LM000160] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Andolfatto P, 2005, NATURE, V437, P1149, DOI 10.1038/nature04107; Aparicio S, 2002, SCIENCE, V297, P1301, DOI 10.1126/science.1072104; ASTHANA S, UNPUB PLOS COMP BIOL; Azuara V, 2003, NAT CELL BIOL, V5, P668, DOI 10.1038/ncb1006; Bajic VB, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s3; Balakirev ES, 2003, ANNU REV GENET, V37, P123, DOI 10.1146/annurev.genet.37.040103.103949; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; Bhinge AA, 2007, GENOME RES, V17, P910, DOI 10.1101/gr.5574907; Bieda M, 2006, GENOME RES, V16, P595, DOI 10.1101/gr.4887606; Blakesley RW, 2004, GENOME RES, V14, P2235, DOI 10.1101/gr.2648404; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Bray N, 2004, GENOME RES, V14, P693, DOI 10.1101/gr.1960404; Brudno M, 2003, GENOME RES, V13, P721, DOI 10.1101/gr.926603; BURKHOFF AM, 1988, NATURE, V331, P455, DOI 10.1038/331455a0; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; Cheng J, 2005, SCIENCE, V308, P1149, DOI 10.1126/science.1108625; Cheng Z, 2005, NATURE, V437, P88, DOI 10.1038/nature04000; *CHIMP SEQ AN CONS, 2005, NATURE, V0437; CLARK TG, 2007, UNPUB GENOME BIOL; Cohen SM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-301; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; Cooper GM, 2004, GENOME RES, V14, P539, DOI 10.1101/gr.2034704; Cooper GM, 2003, GENOME RES, V13, P813, DOI 10.1101/gr.1064503; Cooper SJ, 2006, GENOME RES, V16, P1, DOI 10.1101/gr.4222606; Crawford GE, 2006, NAT METHODS, V3, P503, DOI 10.1038/NMETH888; de Laat W, 2003, CHROMOSOME RES, V11, P447, DOI 10.1023/A:1024922626726; Delaval K, 2006, BIOESSAYS, V28, P453, DOI 10.1002/bies.20407; Denoeud F, 2007, GENOME RES, V17, P746, DOI 10.1101/gr.5660607; Dermitzakis ET, 2005, NAT REV GENET, V6, P151, DOI 10.1038/nrg1527; Dermitzakis ET, 2002, MOL BIOL EVOL, V19, P1114, DOI 10.1093/oxfordjournals.molbev.a004169; Dillon N, 2006, CHROMOSOME RES, V14, P117, DOI 10.1007/s10577-006-1027-8; Dorschner M, 2004, NAT METHODS, V1, P219, DOI 10.1038/NMETH721; Drake JA, 2006, NAT GENET, V38, P223, DOI 10.1038/ng1710; Eddy SR, 2005, PLOS BIOL, V3, P95, DOI 10.1371/journal.pbio.0030010; Emanuelsson O, 2007, GENOME RES, V17, P886, DOI 10.1101/gr.5014606; Euskirchen GM, 2007, GENOME RES, V17, P898, DOI 10.1101/gr.5583007; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Gartler SM, 1999, HUM MOL GENET, V8, P1085, DOI 10.1093/hmg/8.6.1085; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Gilbert DM, 2002, CURR OPIN CELL BIOL, V14, P377, DOI 10.1016/S0955-0674(02)00326-5; Gilbert N, 2004, CELL, V118, P555, DOI 10.1016/j.cell.2004.08.011; Giresi PG, 2007, GENOME RES, V17, P877, DOI 10.1101/gr.5533506; Greenbaum JA, 2007, GENOME RES, V17, P940, DOI 10.1101/gr.5602807; GUIGO R, 2006, GENOME BIOL S1, V7, P1; Halees AS, 2004, NUCLEIC ACIDS RES, V32, pW191, DOI 10.1093/nar/gkh433; Harrison PM, 2005, NUCLEIC ACIDS RES, V33, P2374, DOI 10.1093/nar/gki531; Harrow J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s4; HATTON KS, 1988, MOL CELL BIOL, V8, P2149, DOI 10.1128/MCB.8.5.2149; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Hogan GJ, 2006, PLOS GENET, V2, P1433, DOI 10.1371/journal.pgen.0020158; Horak CE, 2002, P NATL ACAD SCI USA, V99, P2924, DOI 10.1073/pnas.052706999; HUDSON RR, 1987, GENETICS, V116, P153; Iyer VR, 2001, NATURE, V409, P533, DOI 10.1038/35054095; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Jeon Y, 2005, P NATL ACAD SCI USA, V102, P6419, DOI 10.1073/pnas.0405088102; Kapranov P, 2005, GENOME RES, V15, P987, DOI 10.1101/gr.3455305; Kapranov P, 2002, SCIENCE, V296, P916, DOI 10.1126/science.1068597; Karnani N, 2007, GENOME RES, V17, P865, DOI 10.1101/gr.5427007; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Kim JW, 2005, NAT METHODS, V2, P47, DOI 10.1038/NMETH726; Kim TH, 2005, GENOME RES, V15, P830, DOI 10.1101/gr.3430605; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Kirmizis A, 2004, GENE DEV, V18, P1592, DOI 10.1101/gad.1200204; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Ludwig MZ, 2005, PLOS BIOL, V3, P588, DOI 10.1371/journal.pbio.0030093; LUDWIG MZ, 1995, MOL BIOL EVOL, V12, P1002; MacAlpine DM, 2004, GENE DEV, V18, P3094, DOI 10.1101/gad.1246404; Margulies EH, 2005, P NATL ACAD SCI USA, V102, P4795, DOI 10.1073/pnas.0409882102; Margulies EH, 2003, GENOME RES, V13, P2507, DOI 10.1101/gr.1602203; Margulies EH, 2007, GENOME RES, V17, P760, DOI 10.1101/gr.6034307; Maston GA, 2006, ANNU REV GENOM HUM G, V7, P29, DOI 10.1146/annurev.genom.7.080505.115623; McAuliffe JD, 2005, P NATL ACAD SCI USA, V102, P7900, DOI 10.1073/pnas.0502790102; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Mighell AJ, 2000, FEBS LETT, V468, P109, DOI 10.1016/S0014-5793(00)01199-6; Mito Y, 2005, NAT GENET, V37, P1090, DOI 10.1038/ng1637; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Ng P, 2005, NAT METHODS, V2, P105, DOI 10.1038/NMETH733; Nobrega MA, 2003, SCIENCE, V302, P413, DOI 10.1126/science.1088328; Orian A, 2003, GENE DEV, V17, P1101, DOI 10.1101/gad.1066903; Parra G, 2006, GENOME RES, V16, P37, DOI 10.1101/gr.4145906; PRICE MA, 1993, BIOCHEMISTRY-US, V32, P127, DOI 10.1021/bi00052a018; Rada-Iglesias A, 2005, HUM MOL GENET, V14, P3435, DOI 10.1093/hmg/ddi378; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Rozowsky JS, 2007, GENOME RES, V17, P732, DOI 10.1101/gr.5696007; Runte M, 2001, HUM MOL GENET, V10, P2687, DOI 10.1093/hmg/10.23.2687; RUPPERT S, 1993, NATURE, V362, P175, DOI 10.1038/362175a0; Sabo PJ, 2006, NAT METHODS, V3, P511, DOI 10.1038/NMETH890; Schubeler D, 2002, NAT GENET, V32, P438, DOI 10.1038/ng1005; Schwaiger M, 2006, CURR OPIN GENET DEV, V16, P177, DOI 10.1016/j.gde.2006.02.007; Seidl CIM, 2006, EMBO J, V25, P3565, DOI 10.1038/sj.emboj.7601245; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Smale ST, 2003, ANNU REV BIOCHEM, V72, P449, DOI 10.1146/annurev.biochem.72.121801.161520; Stone EA, 2005, ANNU REV GENOM HUM G, V6, P143, DOI 10.1146/annurev.genom.6.080604.162146; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Thomas JW, 2002, GENOME RES, V12, P1277, DOI 10.1101/gr.283202; Thurman RE, 2007, GENOME RES, V17, P917, DOI 10.1101/gr.6081407; Tress ML, 2007, P NATL ACAD SCI USA, V104, P5495, DOI 10.1073/pnas.0700800104; Trinklein ND, 2007, GENOME RES, V17, P720, DOI 10.1101/gr.5716607; Trinklein ND, 2003, GENOME RES, V13, P308, DOI 10.1101/gr.794803; Turner BM, 2005, NAT STRUCT MOL BIOL, V12, P110, DOI 10.1038/nsmb0205-110; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Washietl S, 2007, GENOME RES, V17, P852, DOI 10.1101/gr.5650707; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; White EJ, 2004, P NATL ACAD SCI USA, V101, P17771, DOI 10.1073/pnas.0408170101; Willingham AT, 2006, CELL, V125, P1215, DOI 10.1016/j.cell.2006.06.009; Woodfine K, 2004, HUM MOL GENET, V13, P191, DOI 10.1093/hmg/ddh016; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007; Yelin R, 2003, NAT BIOTECHNOL, V21, P379, DOI 10.1038/nbt808; Yusufzai TM, 2004, MOL CELL, V13, P291, DOI 10.1016/S1097-2765(04)00029-2; Zhang ZDD, 2007, GENOME RES, V17, P787, DOI 10.1101/gr.5573107; Zheng DY, 2007, GENOME RES, V17, P839, DOI 10.1101/gr.5586307; Zheng D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s13; Zheng DY, 2005, J MOL BIOL, V349, P27, DOI 10.1016/j.jmb.2005.02.072; [No title captured]	128	3798	3984	8	520	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 14	2007	447	7146					799	816		10.1038/nature05874	http://dx.doi.org/10.1038/nature05874			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178FV	17571346	Bronze, Green Published, Green Accepted, Green Submitted			2022-12-28	WOS:000247207500034
J	Bowman, MA; Rubenstein, AH; Levine, AS				Bowman, Marjorie A.; Rubenstein, Arthur H.; Levine, Arthur S.			Clinical revenue investment in biomedical research - Lessons from two academic medical centers	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HEALTH; SCHOOLS		Univ Pittsburgh, Sch Med, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Sch Hlth Sci, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Levine, AS (corresponding author), Univ Pittsburgh, Sch Med, 3550 Terrace St,Suite 401, Pittsburgh, PA 15261 USA.	alevine@hs.pitt.edu	bowman, marjorie a/F-7235-2013	bowman, marjorie a/0000-0002-1945-9212				*AAMC, FAC ROST BENCHM REP; [Association of American Medical Colleges AAMC Task Force II on Clinical Research], 2006, PROM TRANSL CLIN SCI; Bland CJ, 2005, ACAD MED, V80, P225, DOI 10.1097/00001888-200503000-00006; Joiner KA, 2005, ACAD MED, V80, P211, DOI 10.1097/00001888-200503000-00004; Konetzka RT, 2005, ACAD MED, V80, P1069, DOI 10.1097/00001888-200511000-00020; LEVIN S, 2005, PITTSBURGH POST 1227, pA1; LOMBARDI JV, 2003, TOP AM RES U ANN REP; LOMBARDI JV, 2005, TOP AM RES U ANN REP; Mallon WT, 2003, ACAD MED, V78, P302, DOI 10.1097/00001888-200303000-00014; MOORE DB, 2007, GROUP I ADV PROF DEV; Moy E, 2000, NEW ENGL J MED, V342, P250, DOI 10.1056/NEJM200001273420406; QUON A, 1991, CHANGES US MED SCH N; Rajan TV, 2000, JAMA-J AM MED ASSOC, V283, P1963, DOI 10.1001/jama.283.15.1963; Rodin J, 2004, ACAD MED, V79, P171, DOI 10.1097/00001888-200402000-00014	14	23	23	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 13	2007	297	22					2521	2524		10.1001/jama.297.22.2521	http://dx.doi.org/10.1001/jama.297.22.2521			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	177TX	17565088				2022-12-28	WOS:000247176500028
J	Wohrl, S; Geusau, A				Woehrl, Stefan; Geusau, Alexandra			Clinical update: syphilis in adults	LANCET			English	Article							NEUROSYPHILIS; EPIDEMIC; HIV; TESTS		Med Univ Vienna, Dept Dermatol, Div Immunol Allergy & Infect Dis, A-1090 Vienna, Austria	Medical University of Vienna	Wohrl, S (corresponding author), Med Univ Vienna, Dept Dermatol, Div Immunol Allergy & Infect Dis, A-1090 Vienna, Austria.	stefan.woehrl@meduniwien.ac.at	Wöhrl, Stefan/B-6954-2013; Geusau, Alexandra/AAL-5272-2020	Wöhrl, Stefan/0000-0002-6324-0007; Geusau, Alexandra/0000-0003-0347-065X				Antal GM, 2002, MICROBES INFECT, V4, P83, DOI 10.1016/S1286-4579(01)01513-1; Augenbraun MH, 2002, CLIN INFECT DIS, V35, pS187, DOI 10.1086/342106; Aynalem G, 2006, SEX TRANSM INFECT, V82, P439, DOI 10.1136/sti.2006.020412; *BRIT ASS SEX HLTH, 2006, BASHH CLIN EFF GUID; Centers for Disease Control and Prevention, 2006, MMWR Recomm Rep, V55, P1; Chen ZQ, 2007, LANCET, V369, P132, DOI 10.1016/S0140-6736(07)60074-9; Flood JM, 1998, J INFECT DIS, V177, P931, DOI 10.1086/515245; Geusau A, 2005, INT J STD AIDS, V16, P722, DOI 10.1258/095646205774763207; Goh BT, 2001, INT J STD AIDS, V12, P14, DOI 10.1258/0956462011924065; JOHNS DR, 1987, NEW ENGL J MED, V316, P1569, DOI 10.1056/NEJM198706183162503; LARSEN SA, 1995, CLIN MICROBIOL REV, V8, P1; Lukehart SA, 2004, NEW ENGL J MED, V351, P154, DOI 10.1056/NEJMoa040216; Marcus U, 2005, SEX TRANSM INFECT, V81, P456, DOI 10.1136/sti.2005.014555; Marra CM, 2004, J INFECT DIS, V189, P369, DOI 10.1086/381227; Nicoll A, 2002, BMJ-BRIT MED J, V324, P1324, DOI 10.1136/bmj.324.7349.1324; Reynolds SJ, 2006, SEX TRANSM INFECT, V82, P121, DOI 10.1136/sti.2005.015040; Romano A, 2004, ANN INTERN MED, V141, P16, DOI 10.7326/0003-4819-141-1-200407060-00010; Simms I, 2005, SEX TRANSM DIS, V32, P220, DOI 10.1097/01.olq.0000149848.03733.c1; Wohrl S, 2006, ACTA DERM-VENEREOL, V86, P335, DOI 10.2340/00015555-0092	19	20	23	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 9	2007	369	9577					1912	1914		10.1016/S0140-6736(07)60895-2	http://dx.doi.org/10.1016/S0140-6736(07)60895-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	177IQ	17560432				2022-12-28	WOS:000247147200009
J	Brudzinski, MR; Thurber, CH; Hacker, BR; Engdahl, ER				Brudzinski, Michael R.; Thurber, Clifford H.; Hacker, Bradley R.; Engdahl, E. Robert			Global prevalence of double Benioff zones	SCIENCE			English	Article							DOUBLE SEISMIC ZONE; INTERMEDIATE-DEPTH EARTHQUAKES; NORTHEASTERN JAPAN ARC; SUBDUCTION ZONE; PLATE BENEATH; DEHYDRATION; MANTLE; LITHOSPHERE; TRANSITION; SERPENTINE	Double Benioff zones provide opportunities for insight into seismogenesis because the underlying mechanism must explain two layers of deep earthquakes and the separation between them. We characterize layer separation inside subducting plates with a coordinate rotation to calculate the slab-normal distribution of earthquakes. Benchmark tests on well-established examples confirm that layer separation is accurately quantified with global seismicity catalogs alone. Global analysis reveals double Benioff zones in 30 segments, including all 16 subduction zones investigated, with varying subducting plate ages and stress orientations, which implies that they are inherent in subducting plates. Layer separation increases with age and is more consistent with dehydration of antigorite than chlorite.	Miami Univ, Dept Geol, Oxford, OH 45056 USA; Univ Wisconsin, Dept Geol & Geophys, Madison, WI 53706 USA; Univ Calif Santa Barbara, Dept Earth Sci, Santa Barbara, CA 93106 USA; Univ Colorado, Dept Phys, Boulder, CO 80309 USA	University System of Ohio; Miami University; University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California Santa Barbara; University of Colorado System; University of Colorado Boulder	Brudzinski, MR (corresponding author), Miami Univ, Dept Geol, Oxford, OH 45056 USA.	brudzimr@muohio.edu	Brudzinski, Michael/A-8301-2011	Thurber, Clifford/0000-0002-4940-4618; Engdahl, Eric Robert/0000-0003-4248-4798				ABERS GA, 1992, GEOPHYS RES LETT, V19, P2019, DOI 10.1029/92GL02060; ABERS GA, 1996, AM GEOPHYSICAL UNION, V96, P223; Dobson DP, 2002, SCIENCE, V298, P1407, DOI 10.1126/science.1075390; Du WX, 2004, GEOPHYS J INT, V158, P1088, DOI 10.1111/j.1365-246X.2004.02366.x; Engdahl ER, 1998, B SEISMOL SOC AM, V88, P722; ENGDAHL ER, 1977, GEOPHYS RES LETT, V4, P473, DOI 10.1029/GL004i010p00473; Engdahl ER, 2002, INT HDB EARTHQUAKE E, P665, DOI DOI 10.1016/S0074-6142(02)80244-3; FUJITA K, 1981, GEOPHYS J ROY ASTR S, V66, P131, DOI 10.1111/j.1365-246X.1981.tb05950.x; Green HW, 1996, TECTONOPHYSICS, V256, P39, DOI 10.1016/0040-1951(95)00164-6; Hacker BR, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2001JB001129; Hacker BR, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2001JB001127; HAMAGUCHI H, 1983, J PHYS EARTH, V31, P329, DOI 10.4294/jpe1952.31.329; HARTIGAN JA, 1985, ANN STAT, V13, P70, DOI 10.1214/aos/1176346577; HASEGAWA A, 1978, GEOPHYS J ROY ASTR S, V54, P281, DOI 10.1111/j.1365-246X.1978.tb04260.x; HUDNUT KW, 1987, GEOPHYS RES LETT, V14, P143, DOI 10.1029/GL014i002p00143; Igarashi T, 2001, J GEOPHYS RES-SOL EA, V106, P2177, DOI 10.1029/2000JB900386; ISACKS BL, 1977, GEOMETRY BENIOF ZONE, V1, P99; Jung H, 2004, NATURE, V428, P545, DOI 10.1038/nature02412; KAO H, 1994, J GEOPHYS RES-SOL EA, V99, P6913, DOI 10.1029/93JB03409; Kao H, 1999, J GEOPHYS RES-SOL EA, V104, P1015, DOI 10.1029/1998JB900010; Kerrick DM, 2001, EARTH PLANET SC LETT, V189, P19, DOI 10.1016/S0012-821X(01)00347-8; KIRBY S, 1995, REV GEOPHYS, V33, P287, DOI 10.1029/95RG00353; Kirby S., 1996, SUBDUCTION TOP BOTTO, V96, P195, DOI DOI 10.1029/GM096P0195; Menke W, 1989, GEOPHYS DATA ANAL DI, P289; Muller RD, 1997, J GEOPHYS RES-SOL EA, V102, P3211, DOI 10.1029/96JB01781; Peacock SM, 2001, GEOLOGY, V29, P299, DOI 10.1130/0091-7613(2001)029<0299:ATLPOD>2.0.CO;2; RALEIGH CB, 1965, J GEOPHYS RES, V70, P3965, DOI 10.1029/JZ070i016p03965; Ratchkovsky NA, 1997, TECTONOPHYSICS, V281, P163, DOI 10.1016/S0040-1951(97)00042-5; Rietbrock A, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019610; Scholz C. H., 1990, MECH EARTHQUAKES FAU; SLEEP NH, 1979, J GEOPHYS RES, V84, P4565, DOI 10.1029/JB084iB09p04565; Yamasaki T, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB001918; Zhang HJ, 2004, GEOLOGY, V32, P361, DOI 10.1130/G20261.2	33	128	131	1	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 8	2007	316	5830					1472	1474		10.1126/science.1139204	http://dx.doi.org/10.1126/science.1139204			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176EE	17556583	Green Submitted			2022-12-28	WOS:000247066400041
J	Lee, H; Cheng, YC; Fleming, GR				Lee, Hohjai; Cheng, Yuan-Chung; Fleming, Graham R.			Coherence dynamics in photosynthesis: Protein protection of excitonic coherence	SCIENCE			English	Article							ENERGY-TRANSFER DYNAMICS; RHODOBACTER-SPHAEROIDES; REACTION CENTERS; PHOTON-ECHO; ELECTRON-DONOR; SPECTROSCOPY	The role of quantum coherence in promoting the efficiency of the initial stages of photosynthesis is an open and intriguing question. We performed a two-color photon echo experiment on a bacterial reaction center that enabled direct visualization of the coherence dynamics in the reaction center. The data revealed long-lasting coherence between two electronic states that are formed by mixing of the bacteriopheophytin and accessory bacteriochlorophyll excited states. This coherence can only be explained by strong correlation between the protein-induced fluctuations in the transition energy of neighboring chromophores. Our results suggest that correlated protein environments preserve electronic coherence in photosynthetic complexes and allow the excitation to move coherently in space, enabling highly efficient energy harvesting and trapping in photosynthesis.	Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA; Univ Calif Berkeley, QB3 Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Fleming, GR (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	GRFleming@lbl.gov	Cheng, Yuan-Chung/A-6566-2008	Cheng, Yuan-Chung/0000-0003-0125-4267				Agarwal R, 2002, J CHEM PHYS, V116, P6243, DOI 10.1063/1.1459414; [Anonymous], 2002, PHOTOSYNTHETICA; Arnett DC, 1999, J PHYS CHEM B, V103, P2014, DOI 10.1021/jp984464j; BREE PD, 1979, J CHEM PHYS, V70, P790, DOI 10.1063/1.437512; Brixner T, 2004, J CHEM PHYS, V121, P4221, DOI 10.1063/1.1776112; Engel GS, 2007, NATURE, V446, P782, DOI 10.1038/nature05678; ERMLER U, 1994, STRUCTURE, V2, P925, DOI 10.1016/S0969-2126(94)00094-8; Groot ML, 1998, J PHYS CHEM B, V102, P5923, DOI 10.1021/jp9808680; Jackson JA, 1997, J PHYS CHEM B, V101, P5747, DOI 10.1021/jp970380j; Jang SJ, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.218301; JEAN JM, 1995, J CHEM PHYS, V103, P2092, DOI 10.1063/1.469684; Jordanides XJ, 2004, J PHYS CHEM B, V108, P1753, DOI 10.1021/jp036516x; Kuhn O, 2002, CHEM PHYS, V275, P15, DOI 10.1016/S0301-0104(01)00526-2; Meier T, 1997, J CHEM PHYS, V107, P8759, DOI 10.1063/1.475169; Novoderezhkin V, 2003, J PHYS CHEM B, V107, P11534, DOI 10.1021/jp035432l; OHTSUKI Y, 1989, J CHEM PHYS, V91, P3903, DOI 10.1063/1.456822; Parkinson DY, 2007, J PHYS CHEM B, V111, P7449, DOI 10.1021/jp070029q; PISILAKOV AV, 2006, J CHEM PHYS, V124; Renger T, 2001, PHYS REP, V343, P138, DOI 10.1016/S0370-1573(00)00078-8; Rickard MA, 2006, J PHYS CHEM A, V110, P11384, DOI 10.1021/jp063917e; Rubtsov IV, 2003, P NATL ACAD SCI USA, V100, P5601, DOI 10.1073/pnas.0931292100; Souaille M, 1997, J AM CHEM SOC, V119, P3948, DOI 10.1021/ja943841c; Stanley RJ, 1996, J PHYS CHEM-US, V100, P12052, DOI 10.1021/jp9614916; TREUTLEIN H, 1992, P NATL ACAD SCI USA, V89, P75, DOI 10.1073/pnas.89.1.75; van Grondelle R, 2006, PHYS CHEM CHEM PHYS, V8, P793, DOI 10.1039/b514032c; Vos MH, 1997, J PHYS CHEM B, V101, P9820, DOI 10.1021/jp971486h; WRAIGHT CA, 1974, BIOCHIM BIOPHYS ACTA, V333, P246, DOI 10.1016/0005-2728(74)90009-7; WYNNE K, 1993, CHEM PHYS, V171, P179, DOI 10.1016/0301-0104(93)85142-U	28	860	869	4	229	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 8	2007	316	5830					1462	1465		10.1126/science.1142188	http://dx.doi.org/10.1126/science.1142188			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176EE	17556580	Green Submitted			2022-12-28	WOS:000247066400038
J	Kasahara, M; Naruse, K; Sasaki, S; Nakatani, Y; Qu, W; Ahsan, B; Yamada, T; Nagayasu, Y; Doi, K; Kasai, Y; Jindo, T; Kobayashi, D; Shimada, A; Toyoda, A; Kuroki, Y; Fujiyama, A; Sasaki, T; Shimizu, A; Asakawa, S; Shimizu, N; Hashimoto, SI; Yang, J; Lee, Y; Matsushima, K; Sugano, S; Sakaizumi, M; Narita, T; Ohishi, K; Haga, S; Ohta, F; Nomoto, H; Nogata, K; Morishita, T; Endo, T; Shin-I, T; Takeda, H; Morishita, S; Kohara, Y				Kasahara, Masahiro; Naruse, Kiyoshi; Sasaki, Shin; Nakatani, Yoichiro; Qu, Wei; Ahsan, Budrul; Yamada, Tomoyuki; Nagayasu, Yukinobu; Doi, Koichiro; Kasai, Yasuhiro; Jindo, Tomoko; Kobayashi, Daisuke; Shimada, Atsuko; Toyoda, Atsushi; Kuroki, Yoko; Fujiyama, Asao; Sasaki, Takashi; Shimizu, Atsushi; Asakawa, Shuichi; Shimizu, Nobuyoshi; Hashimoto, Shin-ichi; Yang, Jun; Lee, Yongjun; Matsushima, Kouji; Sugano, Sumio; Sakaizumi, Mitsuru; Narita, Takanori; Ohishi, Kazuko; Haga, Shinobu; Ohta, Fumiko; Nomoto, Hisayo; Nogata, Keiko; Morishita, Tomomi; Endo, Tomoko; Shin-, Tadasu, I; Takeda, Hiroyuki; Morishita, Shinichi; Kohara, Yuji			The medaka draft genome and insights into vertebrate genome evolution	NATURE			English	Article							MITOCHONDRIAL-DNA SEQUENCES; RAY-FINNED FISHES; GENE MAP; DUPLICATION; CHROMOSOMES; PERSPECTIVE; PHYLOGENY; ZEBRAFISH; LATIPES; DMY	Teleosts comprise more than half of all vertebrate species and have adapted to a variety of marine and freshwater habitats(1). Their genome evolution and diversification are important subjects for the understanding of vertebrate evolution. Although draft genome sequences of two pufferfishes have been published(2,3), analysis of more fish genomes is desirable. Here we report a high-quality draft genome sequence of a small egg-laying freshwater teleost, medaka ( Oryzias latipes). Medaka is native to East Asia and an excellent model system for a wide range of biology, including ecotoxicology, carcinogenesis, sex determination(4-6) and developmental genetics(7). In the assembled medaka genome ( 700 megabases), which is less than half of the zebrafish genome, we predicted 20,141 genes, including 2,900 new genes, using 5'-end serial analysis of gene expression tag information. We found single nucleotide polymorphisms ( SNPs) at an average rate of 3.42% between the two inbred strains derived from two regional populations; this is the highest SNP rate seen in any vertebrate species. Analyses based on the dense SNP information show a strict genetic separation of 4 million years ( Myr) between the two populations, and suggest that differential selective pressures acted on specific gene categories. Four-way comparisons with the human, pufferfish ( Tetraodon), zebrafish and medaka genomes revealed that eight major interchromosomal rearrangements took place in a remarkably short period of similar to 50 Myr after the whole-genome duplication event in the teleost ancestor and afterwards, intriguingly, the medaka genome preserved its ancestral karyotype for more than 300 Myr.	Univ Tokyo, Dept Computat Biol, Grad Sch Frontier Sci, Kashiwa, Chiba 2770882, Japan; Univ Tokyo, Dept Biol Sci, Grad Sch Sci, Tokyo 1130033, Japan; RIKEN, Genom Sci Ctr, Yokohama, Kanagawa 2300045, Japan; Natl Inst Informat, Tokyo 1018430, Japan; Keio Univ, Sch Med, Dept Mol Biol, Tokyo 1608582, Japan; Univ Tokyo, Dept Mol Prevent Med, Sch Med, Tokyo 1130033, Japan; Univ Tokyo, Dept Med Genome Sci, Grad Sch Frontier Sci, Tokyo 1088639, Japan; Niigata Univ, Dept Environm Sci, Fac Sci, Niigata 9502181, Japan; Natl Inst Genet, Ctr Genet Resource Informat, Mishima, Shizuoka 4118540, Japan	University of Tokyo; University of Tokyo; RIKEN; Research Organization of Information & Systems (ROIS); National Institute of Informatics (NII) - Japan; Keio University; University of Tokyo; University of Tokyo; Niigata University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan	Kohara, Y (corresponding author), Univ Tokyo, Dept Computat Biol, Grad Sch Frontier Sci, Kashiwa, Chiba 2770882, Japan.	htakeda@biol.s.u-tokyo.ac.jp; ykohara@lab.nig.ac.jp	Narita, Takanori/F-1092-2011; Sasaki, Takashi/AAD-1461-2019; TAKEDA, HIROYUKI/G-4950-2014	Kobayashi, Daisuke/0000-0001-9755-6168; Nakatani, Yoichiro/0000-0001-7604-0242; Sasaki, Takashi/0000-0002-6275-046X; Morishita, Shinichi/0000-0002-6201-8885; Narita, Takanori/0000-0003-0295-5014; Naruse, Kiyoshi/0000-0001-9185-3495; Kasahara, Masahiro/0000-0001-8430-1414				Aida T, 1921, GENETICS, V6, P554; ALTSCHUL SF, 1997, NUCLEIC ACIDS RES, V25, P3402; Aparicio S, 2002, SCIENCE, V297, P1301, DOI 10.1126/science.1072104; Christoffels A, 2004, MOL BIOL EVOL, V21, P1146, DOI 10.1093/molbev/msh114; Crow KD, 2006, MOL BIOL EVOL, V23, P121, DOI 10.1093/molbev/msj020; Furutani-Seiki M, 2004, MECH DEVELOP, V121, P629, DOI 10.1016/j.mod.2004.05.010; Hashimoto S, 2004, NAT BIOTECHNOL, V22, P1146, DOI 10.1038/nbt998; Hedges SB, 2002, SCIENCE, V297, P1283; Hyodo-Taguchi Y, 1996, FISH BIOL J MEDAKA, V8, P11; Inoue JG, 2003, MOL PHYLOGENET EVOL, V26, P110, DOI 10.1016/S1055-7903(02)00331-7; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Kondo M, 2001, GENET RES, V78, P23, DOI 10.1017/S0016672301005109; Matsuda M, 2002, NATURE, V417, P559, DOI 10.1038/nature751; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Miya M, 2003, MOL PHYLOGENET EVOL, V26, P121, DOI 10.1016/S1055-7903(02)00332-9; Naruse K, 2004, MECH DEVELOP, V121, P619, DOI 10.1016/j.mod.2004.04.014; Naruse K, 2004, GENOME RES, V14, P820, DOI 10.1101/gr.2004004; Nelson JS., 2016, FISHES WORLD, DOI DOI 10.1002/9781119174844.FMATTER; Ohno S., 1970, EVOLUTION GENE DUPLI; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Takehana Y, 2005, MOL PHYLOGENET EVOL, V36, P417, DOI 10.1016/j.ympev.2005.01.016; Takehana Y, 2003, ZOOL SCI, V20, P1279, DOI 10.2108/zsj.20.1279; Taylor JS, 2003, GENOME RES, V13, P382, DOI 10.1101/gr.640303; Vandepoele K, 2004, P NATL ACAD SCI USA, V101, P1638, DOI 10.1073/pnas.0307968100; Wittbrodt J, 2002, NAT REV GENET, V3, P53, DOI 10.1038/nrg704; Woods IG, 2005, GENOME RES, V15, P1307, DOI 10.1101/gr.4134305; YAMAMOTO TO, 1953, J EXP ZOOL, V123, P571, DOI 10.1002/jez.1401230309; Yamanoue Y, 2006, GENES GENET SYST, V81, P29, DOI 10.1266/ggs.81.29; Zhang JZ, 2004, GENETICS, V166, P1887, DOI 10.1534/genetics.166.4.1887	30	797	839	7	120	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 7	2007	447	7145					714	719		10.1038/nature05846	http://dx.doi.org/10.1038/nature05846			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175RI	17554307	hybrid			2022-12-28	WOS:000247030700044
J	Hanvoravongchai, P				Hanvoravongchai, Piya			Scaling up health workforces in response to critical shortages	LANCET			English	Editorial Material							HUMAN-RESOURCES		Chulalongkorn Univ, Fac Med, Dept Prevent & Social Med, Bangkok 10330, Thailand	Chulalongkorn University	Hanvoravongchai, P (corresponding author), Chulalongkorn Univ, Fac Med, Dept Prevent & Social Med, Bangkok 10330, Thailand.	phanvora@hsph.harvard.edu	Hanvoravongchai, Piya/A-1569-2012	Hanvoravongchai, Piya/0000-0003-4256-1271				Chen L, 2004, LANCET, V364, P1984, DOI 10.1016/S0140-6736(04)17482-5; Hongoro C, 2004, LANCET, V364, P1451, DOI 10.1016/S0140-6736(04)17229-2; MULLAN F, 2007, LANCET; Muula AS, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-97; Richardson G, 1998, HEALTH POLICY, V45, P119, DOI 10.1016/S0168-8510(98)00038-4; *WHO, 2007, COUNTR SHOWC BEN SCA; World Health Organization, 2006, TAK STOCK HLTH WORK; World Health Organization (WHO), 2006, WORLD HLTH REP 2006	8	8	9	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC-JAN	2007	370	9605					2080	2081		10.1016/S0140-6736(07)60786-7	http://dx.doi.org/10.1016/S0140-6736(07)60786-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	247DY	17574661				2022-12-28	WOS:000252058600009
J	Sakamoto, N; Seto, Y; Itoh, S; Kuramoto, K; Fujino, K; Nagashima, K; Krot, AN; Yurimoto, H				Sakamoto, Naoya; Seto, Yusuke; Itoh, Shoichi; Kuramoto, Kiyoshi; Fujino, Kiyoshi; Nagashima, Kazuhide; Krot, Alexander N.; Yurimoto, Hisayoshi			Remnants of the early solar system water enriched in heavy oxygen isotopes	SCIENCE			English	Article							CARBONACEOUS CHONDRITES; NEBULA; METEORITES; MAGNETITE; RESERVOIR; EVOLUTION; ALLENDE; MATRIX; ORIGIN; GAS	Oxygen isotopic composition of our solar system is believed to have resulted from mixing of two isotopically distinct nebular reservoirs, O-16-rich and O-17,O-18-rich relative to Earth. The nature and composition of the O-17,O-18-rich reservoir are poorly constrained. We report an in situ discovery of a chemically and isotopically unique material distributed ubiquitously in fine-grained matrix of a primitive carbonaceous chondrite Acfer 094. This material formed by oxidation of Fe, Ni-metal and sulfides by water either in the solar nebula or on a planetesimal. Oxygen isotopic composition of this material indicates that the water was highly enriched in O-17 and O-18 (delta O-17,18(SMOW) = + 180 parts per thousand per mil), providing the first evidence for an extremely O-17,O-18-rich reservoir in the early solar system.	Hokkaido Univ, Dept Nat Hist Sci, Sapporo, Hokkaido 0600810, Japan; Hokkaido Univ, Dept Cosmosci, Sapporo, Hokkaido 0600810, Japan; Univ Hawaii Manoa, Hawaii Inst Geophys & Planetol, Sch Ocean & Earth Sci & Technol, Honolulu, HI 96822 USA; Hokkaido Univ, Isotope Imaging Lab, Creat Res Initiat Sousei, Sapporo, Hokkaido 0010021, Japan	Hokkaido University; Hokkaido University; University of Hawaii System; University of Hawaii Manoa; Hokkaido University	Yurimoto, H (corresponding author), Hokkaido Univ, Dept Nat Hist Sci, Sapporo, Hokkaido 0600810, Japan.	yuri@ep.sci.hokudai.ac.jp	Seto, Yusuke/D-5751-2015; Yurimoto, Hisayoshi/S-9938-2018	Seto, Yusuke/0000-0002-5423-2136; Yurimoto, Hisayoshi/0000-0003-0702-0533; Kuramoto, Kiyoshi/0000-0002-6757-8064; Nagashima, Kazuhide/0000-0002-9322-3187; Itoh, Shoichi/0000-0001-9431-0525				CHASE JMW, 1998, J PHYS CHEM REFERE 1, V9; CHASE JMW, 1998, J PHYS CHEM REFERE 2, V9; Choi BG, 1998, NATURE, V392, P577, DOI 10.1038/33356; CLAYTON RN, 1993, ANNU REV EARTH PL SC, V21, P115, DOI 10.1146/annurev.earth.21.1.115; Clayton RN, 2002, NATURE, V415, P860, DOI 10.1038/415860b; Clayton RN, 1999, GEOCHIM COSMOCHIM AC, V63, P2089, DOI 10.1016/S0016-7037(99)00090-3; Clayton RN, 2006, SCIENCE, V313, P1743, DOI 10.1126/science.1133137; Fuchs L. H., 1973, SMITHSON CONTRIB EAR, V10, P1, DOI DOI 10.5479/SI.00810274.10.1; Greshake A, 1997, GEOCHIM COSMOCHIM AC, V61, P437, DOI 10.1016/S0016-7037(96)00332-8; Hong Y, 1998, METEORIT PLANET SCI, V33, P1101, DOI 10.1111/j.1945-5100.1998.tb01715.x; Ireland TR, 2006, NATURE, V440, P776, DOI 10.1038/nature04611; Itoh S, 2003, NATURE, V423, P728, DOI 10.1038/nature01699; Kobayashi S, 2003, GEOCHEM J, V37, P663, DOI 10.2343/geochemj.37.663; Krot A. N., 2000, Protostars and planets 4, P1019; Krot AN, 2002, SCIENCE, V295, P1051, DOI 10.1126/science.1068200; Krot AN, 2005, ASTROPHYS J, V622, P1333, DOI 10.1086/428382; Kunihiro T, 2005, GEOCHIM COSMOCHIM AC, V69, P763, DOI 10.1016/j.gca.2004.07.024; Lyons JR, 2005, NATURE, V435, P317, DOI 10.1038/nature03557; Nagashima K, 2004, NATURE, V428, P921, DOI 10.1038/nature02510; TOMEOKA K, 1985, GEOCHIM COSMOCHIM AC, V49, P2149, DOI 10.1016/0016-7037(85)90073-0; Young ED, 1998, SCIENCE, V282, P452, DOI 10.1126/science.282.5388.452; Young ED, 2001, PHILOS T ROY SOC A, V359, P2095, DOI 10.1098/rsta. 2001.0900; YOUNG ED, 2006, LUNAR PLANET SCI, V37; Yurimoto H, 2004, SCIENCE, V305, P1763, DOI 10.1126/science.1100989; Yurimoto H, 1998, SCIENCE, V282, P1874, DOI 10.1126/science.282.5395.1874; Yurimoto H, 2002, METEORIT PLANET SCI, V37, pA153; Yurimoto H., 2007, PROTOSTARS PLANETS, P849; Yurimoto L, 2003, APPL SURF SCI, V203, P793, DOI 10.1016/S0169-4332(02)00825-5	30	204	206	0	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 13	2007	317	5835					231	233		10.1126/science.1142021	http://dx.doi.org/10.1126/science.1142021			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	189DC	17569827	Green Submitted			2022-12-28	WOS:000247968600038
J	Wentz, FJ; Ricciardulli, L; Hilburn, K; Mears, C				Wentz, Frank J.; Ricciardulli, Lucrezia; Hilburn, Kyle; Mears, Carl			How much more rain will global warming bring?	SCIENCE			English	Article							HYDROLOGICAL CYCLE; CLIMATE; SENSITIVITY	Climate models and satellite observations both indicate that the total amount of water in the atmosphere will increase at a rate of 7% per kelvin of surface warming. However, the climate models predict that global precipitation will increase at a much slower rate of 1 to 3% per kelvin. A recent analysis of satellite observations does not support this prediction of a muted response of precipitation to global warming. Rather, the observations suggest that precipitation and total atmospheric water have increased at about the same rate over the past two decades.	Remote Sensing Syst, Santa Rosa, CA 95401 USA		Wentz, FJ (corresponding author), Remote Sensing Syst, 438 1st St, Santa Rosa, CA 95401 USA.	frank.wentz@remss.com						Adler RF, 2003, J HYDROMETEOROL, V4, P1147, DOI 10.1175/1525-7541(2003)004<1147:TVGPCP>2.0.CO;2; Allen MR, 2002, NATURE, V419, P224, DOI 10.1038/nature01092; COLLINS WD, 2004, TN464 STR NCAR; Covey C, 2003, GLOBAL PLANET CHANGE, V37, P103, DOI 10.1016/S0921-8181(02)00193-5; GATES WL, 1992, B AM METEOROL SOC, V73, P1962, DOI 10.1175/1520-0477(1992)073<1962:ATAMIP>2.0.CO;2; Held IM, 2006, J CLIMATE, V19, P5686, DOI 10.1175/JCLI3990.1; Hurrell J. W., 2003, N ATLANTIC OSCILLATI, V134, P1, DOI [10.1029/134GM01, DOI 10.1029/134GM01]; Mears CA, 2005, SCIENCE, V309, P1548, DOI 10.1126/science.1114772; Meehl GA, 2005, SCIENCE, V307, P1769, DOI 10.1126/science.1106663; MITCHELL JFB, 1987, Q J ROY METEOR SOC, V113, P293, DOI 10.1256/smsqj.47516; PEIXOTO JP, 1992, PHYS CLIMATE, P170; Smith TM, 2005, J CLIMATE, V18, P2021, DOI 10.1175/JCLI3362.1; Soden BJ, 2000, J CLIMATE, V13, P538, DOI 10.1175/1520-0442(2000)013<0538:TSOTTH>2.0.CO;2; Trenberth KE, 2005, CLIM DYNAM, V24, P741, DOI 10.1007/s00382-005-0017-4; Vecchi GA, 2006, NATURE, V441, P73, DOI 10.1038/nature04744; Wentz FJ, 2000, NATURE, V403, P414, DOI 10.1038/35000184; Wentz FJ, 1997, J GEOPHYS RES-OCEANS, V102, P8703, DOI 10.1029/96JC01751	17	692	737	17	177	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 13	2007	317	5835					233	235		10.1126/science.1140746	http://dx.doi.org/10.1126/science.1140746			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	189DC	17540863				2022-12-28	WOS:000247968600039
J	Mata-Haro, V; Cekic, C; Martin, M; Chilton, PM; Casella, CR; Mitchell, TC				Mata-Haro, Veronica; Cekic, Caglar; Martin, Michael; Chilton, Paula M.; Casella, Carolyn R.; Mitchell, Thomas C.			The vaccine adjuvant monophosphoryl lipid A as a TRIF-biased agonist of TLR4	SCIENCE			English	Article							SIGNALING PATHWAY; TOLL; LIPOPOLYSACCHARIDE; EXPRESSION; ACTIVATION; ENDOTOXIN; RESPONSES; GENES; CELLS; BETA	The inflammatory toxicity of lipopolysaccharide (LPS), a component of bacterial cell walls, is driven by the adaptor proteins myeloid differentiation factor 88 (MyD88) and Toll-interleukin 1 receptor domain-containing adapter inducing interferon-beta (TRIF), which together mediate signaling by the endotoxin receptor Toll-like receptor 4 (TLR4). Monophosphoryl lipid A (MPLA) is a low-toxicity derivative of LPS with useful immunostimulatory properties, which is nearing regulatory approval for use as a human vaccine adjuvant. We report here that, in mice, the low toxicity of MPLA's adjuvant function is associated with a bias toward TRIF signaling, which we suggest is likely caused by the active suppression, rather than passive loss, of proinflammatory activity of this LPS derivative. This finding may have important implications for the development of future vaccine adjuvants.	Univ Louisville, Inst Cellular Therapeut, Louisville, KY 40202 USA; Univ Louisville, Dept Microbiol & Immunol, Louisville, KY 40202 USA; Univ Louisville, Oral Hlth & Systemat Dis Res Grp, Louisville, KY 40202 USA	University of Louisville; University of Louisville; University of Louisville	Mitchell, TC (corresponding author), Univ Louisville, Inst Cellular Therapeut, 570 S Preston St, Louisville, KY 40202 USA.	tom.mitchell@louisville.edu	Mata-Haro, Veronica/K-2559-2015; Mitchell, Thomas C/B-4193-2013	Mata-Haro, Veronica/0000-0002-7394-4569; Cekic, Caglar/0000-0001-8081-508X; Chilton, Paula/0000-0002-8749-0975	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051377, K02AI059023, R01AI071047] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI071047, K02 AI059023, R01 AI051377, AI51377, AI059023] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aliprantis AO, 2000, EMBO J, V19, P3325, DOI 10.1093/emboj/19.13.3325; Baldridge JR, 2004, EXPERT OPIN BIOL TH, V4, P1129, DOI 10.1517/14712598.4.7.1129; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; Bjorkbacka H, 2004, PHYSIOL GENOMICS, V19, P319, DOI 10.1152/physiolgenomics.00128.2004; Evans Jay T, 2003, Expert Rev Vaccines, V2, P219, DOI 10.1586/14760584.2.2.219; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Gavin AL, 2006, SCIENCE, V314, P1936, DOI 10.1126/science.1135299; Harper DM, 2006, LANCET, V367, P1247, DOI 10.1016/S0140-6736(06)68439-0; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Horng T, 2002, NATURE, V420, P329, DOI 10.1038/nature01180; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kawai T, 2001, J IMMUNOL, V167, P5887, DOI 10.4049/jimmunol.167.10.5887; Kolumam GA, 2005, J EXP MED, V202, P637, DOI 10.1084/jem.20050821; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; OKERNOTO K, 2006, J IMMUNOL, V176, P1203; Pasare C, 2004, IMMUNITY, V21, P733, DOI 10.1016/j.immuni.2004.10.006; Petrovsky N, 2004, IMMUNOL CELL BIOL, V82, P488, DOI 10.1111/j.0818-9641.2004.01272.x; QURESHI N, 1982, J BIOL CHEM, V257, P1808; Thoelen S, 1998, VACCINE, V16, P708, DOI 10.1016/S0264-410X(97)00254-5; Thomas KE, 2006, J BIOL CHEM, V281, P31119, DOI 10.1074/jbc.M604958200; Vernacchio L, 2002, VACCINE, V20, P3658, DOI 10.1016/S0264-410X(02)00413-9; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262	26	615	662	5	101	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 15	2007	316	5831					1628	1632		10.1126/science.1138963	http://dx.doi.org/10.1126/science.1138963			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178SH	17569868				2022-12-28	WOS:000247239900045
J	Popescu, I; Vaughan-Sarrazin, MS; Rosenthal, GE				Popescu, Ioana; Vaughan-Sarrazin, Mary S.; Rosenthal, Gary E.			Differences in mortality and use of revascularization in black and white patients with acute MI admitted to hospitals with and without revascularization services	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE MYOCARDIAL-INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; RACIAL VARIATION; REPERFUSION THERAPY; CARDIAC REVASCULARIZATION; ADMINISTRATIVE DATA; ETHNIC-DIFFERENCES; SEX-DIFFERENCES; RACE; OUTCOMES	Context Racial differences in the use of coronary revascularization after acute myocardial infarction ( AMI) have been widely reported. However, few studies have examined patterns of care for AMI patients admitted to hospitals with and without revascularization services. Objective To compare rates of hospital transfer, coronary revascularization, and mortality after AMI for black and white patients admitted to hospitals with and without revascularization services. Design, Setting, and Participants Retrospective cohort study of 1 215 924 black and white Medicare beneficiaries aged 68 years and older, admitted with AMI between January 1, 2000, and June 30, 2005, to 4627 US hospitals with and without revascularization services. Main Outcome Measures For patients admitted to nonrevascularization hospitals, transfer to another hospital with revascularization services; for all patients, risk-adjusted rates of 30-day coronary revascularization and 1-year mortality. Results Black patients admitted to hospitals without revascularization were less likely (25.2% vs 31.0%; P <. 001) to be transferred. Black patients admitted to hospitals with or without revascularization services were less likely to undergo revascularization than white patients (34.3% vs 50.2% and 18.3% vs 25.9%; P <. 001) and had higher 1-year mortality (35.3% vs 30.2% and 39.7% vs 37.6%; P <. 001). After adjustment for sociodemographics, comorbidity, and illness severity, blacks remained less likely to be transferred ( hazard ratio [HR], 0.78; 95% confidence interval [CI], 0.75-0.81; P <. 001) and undergo revascularization ( HR, 0.71; 95% CI, 0.69-0.74; P <. 001; and HR, 0.68; 95% CI, 0.65-0.70; P <. 001 in hospitals with and without revascularization, respectively). Risk-adjusted mortality was lower for blacks during the first 30 days after admission ( HR, 0.91; 95% CI, 0.88-0.93; P <. 001; and HR, 0.90; 95% CI, 0.87-0.92; P <. 001 in hospitals with and without revascularization, respectively) but was higher ( P <. 001) thereafter. Conclusions Black patients admitted to hospitals with and without coronary revascularization services are less likely to receive coronary revascularization. The higher long-term mortality of black patients may reflect the lower use of revascularization or other aspects of AMI care.	Univ Iowa, Carver Coll Med, Dept Internal Med, Div Gen Internal Med, Iowa City, IA USA; Iowa City VA Med Ctr, Ctr Res Implementat Innovat Strategies Practice, Iowa City, IA USA	University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Popescu, I (corresponding author), Univ Iowa Hosp & Clin, Dept Internal Med, 200 Hawkins Dr,SE615-GH, Iowa City, IA 52240 USA.	ioana-popescu@uiowa.edu		Vaughan Sarrazin, Mary/0000-0001-8717-1061				Aversano T, 2002, JAMA-J AM MED ASSOC, V287, P1943, DOI 10.1001/jama.287.15.1943; AYANIAN JZ, 1993, JAMA-J AM MED ASSOC, V269, P2642, DOI 10.1001/jama.269.20.2642; BLUSTEIN J, 1995, MED CARE, V33, P864, DOI 10.1097/00005650-199508000-00010; Bradley EH, 2004, JAMA-J AM MED ASSOC, V292, P1563, DOI 10.1001/jama.292.13.1563; Canto JG, 2000, NEW ENGL J MED, V342, P1094, DOI 10.1056/NEJM200004133421505; Conigliaro J, 2000, ARCH INTERN MED, V160, P1329, DOI 10.1001/archinte.160.9.1329; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Ford E, 2000, AM J PUBLIC HEALTH, V90, P1128, DOI 10.2105/AJPH.90.7.1128; GILES WH, 1995, ARCH INTERN MED, V155, P318, DOI 10.1001/archinte.155.3.318; Gordon HS, 1996, JAMA-J AM MED ASSOC, V276, P1639, DOI 10.1001/jama.276.20.1639; Gregory PM, 1999, AM HEART J, V138, P507, DOI 10.1016/S0002-8703(99)70154-7; Grines CL, 2002, J AM COLL CARDIOL, V39, P1713, DOI 10.1016/S0735-1097(02)01870-3; Gurwitz JH, 2002, AM J MED, V112, P528, DOI 10.1016/S0002-9343(02)01072-0; Hannan EL, 1999, MED CARE, V37, P68, DOI 10.1097/00005650-199901000-00010; Hochman JS, 2006, NEW ENGL J MED, V355, P2395, DOI 10.1056/NEJMoa066139; Ibrahim SA, 2003, AM J PUBLIC HEALTH, V93, P1689, DOI 10.2105/AJPH.93.10.1689; Keeley EC, 2004, ANN INTERN MED, V141, P298, DOI 10.7326/0003-4819-141-4-200408170-00010; Kelly RF, 2005, AM J CARDIOL, V96, P215, DOI 10.1016/j.amjcard.2005.03.047; Konety SH, 2005, CIRCULATION, V111, P1210, DOI 10.1161/01.CIR.0000157728.49918.9F; Manhapra A, 2001, AM HEART J, V142, P604, DOI 10.1067/mhj.2001.118464; Mehta RH, 1999, AM HEART J, V138, P688, DOI 10.1016/S0002-8703(99)70184-5; Nallamothu BK, 2005, CIRCULATION, V111, P761, DOI 10.1161/01.CIR.0000155258.44268.F8; Petersen LA, 2002, MED CARE, V40, P86; Peterson ED, 1997, NEW ENGL J MED, V336, P480, DOI 10.1056/NEJM199702133360706; PETERSON ED, 1994, JAMA-J AM MED ASSOC, V271, P1175, DOI 10.1001/jama.271.15.1175; Rathore SS, 2000, CIRCULATION, V102, P642, DOI 10.1161/01.CIR.102.6.642; Sabatine MS, 2005, CIRCULATION, V111, P1217, DOI 10.1161/01.CIR.0000157733.50479.B9; Sheifer SE, 2000, CIRCULATION, V102, P1651, DOI 10.1161/01.CIR.102.14.1651; Sheifer SE, 2000, AM HEART J, V139, P848, DOI 10.1016/S0002-8703(00)90017-6; Skinner J, 2005, CIRCULATION, V112, P2634, DOI 10.1161/CIRCULATIONAHA.105.543231; Sonel AF, 2005, CIRCULATION, V111, P1225, DOI 10.1161/01.CIR.0000157732.03358.64; Southern DA, 2004, MED CARE, V42, P355, DOI 10.1097/01.mlr.0000118861.56848.ee; Vaccarino V, 2005, NEW ENGL J MED, V353, P671, DOI 10.1056/NEJMsa032214; Zerwic JJ, 2003, NURS RES, V52, P159, DOI 10.1097/00006199-200305000-00005; Zijlstra F, 2003, EUR HEART J, V24, P21, DOI 10.1016/S0195-668X(02)00693-0	35	85	85	0	8	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 13	2007	297	22					2489	2495		10.1001/jama.297.22.2489	http://dx.doi.org/10.1001/jama.297.22.2489			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	177TX	17565083	Bronze			2022-12-28	WOS:000247176500023
J	Moore, DD				Moore, David D.			Sister act	SCIENCE			English	Editorial Material							KLOTHO; HOMEOSTASIS; RECEPTORS; REGULATOR; SIGNAL; FGF23		Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Baylor College of Medicine	Moore, DD (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.	moore@bcm.edu						Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Ito S, 2005, J CLIN INVEST, V115, P2202, DOI 10.1172/JCI23076; Ito S, 2002, BBA-GENE STRUCT EXPR, V1576, P341, DOI 10.1016/S0167-4781(02)00281-6; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kharitonenkov A, 2007, ENDOCRINOLOGY, V148, P774, DOI 10.1210/en.2006-1168; Kolek OI, 2005, AM J PHYSIOL-GASTR L, V289, pG1036, DOI 10.1152/ajpgi.00243.2005; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Michalik L, 2006, PHARMACOL REV, V58, P726, DOI 10.1124/pr.58.4.5; Ogawa Y, 2007, P NATL ACAD SCI USA, V104, P7432, DOI 10.1073/pnas.0701600104; Shimada T, 2004, J BONE MINER RES, V19, P429, DOI 10.1359/JBMR.0301264; Shulman AI, 2005, NEW ENGL J MED, V353, P604, DOI 10.1056/NEJMra043590; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; Zhang JF, 2006, NATURE, V439, P340, DOI 10.1038/nature04368	16	39	47	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 8	2007	316	5830					1436	1438		10.1126/science.1144837	http://dx.doi.org/10.1126/science.1144837			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176EE	17556573				2022-12-28	WOS:000247066400028
J	Cossu, G; Tajbakhsh, S				Cossu, Giulio; Tajbakhsh, Shahragim			Oriented cell divisions and muscle satellite cell heterogeneity	CELL			English	Editorial Material							PROGENITOR CELLS		Stem Cell Res Inst, I-20132 Milan, Italy; Univ Milan, Dept Biol, I-20133 Milan, Italy; San Raffaele Biomed Sci Pk Rome, I-00128 Rome, Italy; Inst Pasteur, Dept Dev Biol, Stem Cell & Dev, CNRS URA 2578, F-75724 Paris 15, France	University of Milan; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Cossu, G (corresponding author), Stem Cell Res Inst, Via Olgettina 58, I-20132 Milan, Italy.	cossu.giulio@hsr.it; shaht@pasteur.fr						Conboy IM, 2002, DEV CELL, V3, P397, DOI 10.1016/S1534-5807(02)00254-X; Henrique D, 1997, CURR BIOL, V7, P661, DOI 10.1016/S0960-9822(06)00293-4; Kassar-Duchossoy L, 2005, GENE DEV, V19, P1426, DOI 10.1101/gad.345505; KUANG S, 2007, CELL; Schuster-Gossler K, 2007, P NATL ACAD SCI USA, V104, P537, DOI 10.1073/pnas.0608281104; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Shinin V, 2006, NAT CELL BIOL, V8, P677, DOI 10.1038/ncb1425; Vasyutina E, 2007, P NATL ACAD SCI USA, V104, P4443, DOI 10.1073/pnas.0610647104; Zammit PS, 2006, J HISTOCHEM CYTOCHEM, V54, P1177, DOI 10.1369/jhc.6R6995.2006	9	25	28	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 1	2007	129	5					859	861		10.1016/j.cell.2007.05.029	http://dx.doi.org/10.1016/j.cell.2007.05.029			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	176KT	17540166	Bronze			2022-12-28	WOS:000247084600006
J	Petrini, JHJ				Petrini, John H. J.			A touching response to damage	SCIENCE			English	Editorial Material							14-3-3 PROTEINS; BRCA1; HELICASE; DOMAINS; COMPLEX; CANCER; CTIP		Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Petrini, JHJ (corresponding author), Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA.	petrinij@mskcc.org		Petrini, John/0000-0001-5102-5679	NCI NIH HHS [R13 CA162528] Funding Source: Medline; NIGMS NIH HHS [R01 GM059413] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059413] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anderson SE, 1998, NAT GENET, V19, P254, DOI 10.1038/930; Barber LJ, 2006, DNA REPAIR, V5, P1499, DOI 10.1016/j.dnarep.2006.08.009; Bochar DA, 2000, CELL, V102, P257, DOI 10.1016/S0092-8674(00)00030-1; Cantor SB, 2001, CELL, V105, P149, DOI 10.1016/S0092-8674(01)00304-X; Chen JJ, 1998, MOL CELL, V2, P317, DOI 10.1016/S1097-2765(00)80276-2; Kim H, 2007, SCIENCE, V316, P1202, DOI 10.1126/science.1139621; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Tzivion G, 2001, ONCOGENE, V20, P6331, DOI 10.1038/sj.onc.1204777; Usui T, 2007, P NATL ACAD SCI USA, V104, P2797, DOI 10.1073/pnas.0611259104; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Wilker E, 2004, J MOL CELL CARDIOL, V37, P633, DOI 10.1016/j.yjmcc.2004.04.015; Yaffe MB, 2001, CURR OPIN CELL BIOL, V13, P131, DOI 10.1016/S0955-0674(00)00189-7; Yu X, 1998, J BIOL CHEM, V273, P25388, DOI 10.1074/jbc.273.39.25388; Zhao GY, 2007, MOL CELL, V25, P663, DOI 10.1016/j.molcel.2007.01.029	15	19	20	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 25	2007	316	5828					1138	1139		10.1126/science.1143700	http://dx.doi.org/10.1126/science.1143700			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	171GQ	17525326				2022-12-28	WOS:000246724300028
J	Weikum, WM; Vouloumanos, A; Navarra, J; Soto-Faraco, S; Sebastian-Galles, N; Werker, JF				Weikum, Whitney M.; Vouloumanos, Athena; Navarra, Jordi; Soto-Faraco, Salvador; Sebastian-Galles, Nuria; Werker, Janet F.			Visual language discrimination in infancy	SCIENCE			English	Article							PERCEPTION		Univ British Columbia, Vancouver, BC V6T 1Z4, Canada; McGill Univ, Montreal, PQ H3A 1B1, Canada; Univ Oxford, Oxford OX1 3UD, England; Univ Barcelona, E-08028 Barcelona, Spain; ICREA, Barcelona 08010, Spain	University of British Columbia; McGill University; University of Oxford; University of Barcelona; ICREA	Weikum, WM (corresponding author), Univ British Columbia, Vancouver, BC V6T 1Z4, Canada.	whitney@psych.ubc.ca	SOTO-FARACO, SALVADOR/B-8400-2011; Navarra, Jordi/AAB-1649-2019; Sebastian-Galles, Nuria/A-4215-2008	SOTO-FARACO, SALVADOR/0000-0002-4799-3762; Navarra, Jordi/0000-0003-0779-4117; Sebastian-Galles, Nuria/0000-0001-6938-2498; Werker, Janet F./0000-0002-1168-9013	ICREA Funding Source: Custom	ICREA(ICREA)		Bosch L, 1997, COGNITION, V65, P33, DOI 10.1016/S0010-0277(97)00040-1; DODD B, 1988, VOLTA REV, V90, P45; Hannon EE, 2005, P NATL ACAD SCI USA, V102, P12639, DOI 10.1073/pnas.0504254102; Kuhl PK, 2006, DEVELOPMENTAL SCI, V9, pF13, DOI 10.1111/j.1467-7687.2006.00468.x; Lewkowicz DJ, 2006, P NATL ACAD SCI USA, V103, P6771, DOI 10.1073/pnas.0602027103; MEHLER J, 1988, COGNITION, V29, P143, DOI 10.1016/0010-0277(88)90035-2; Pascalis O, 2005, P NATL ACAD SCI USA, V102, P5297, DOI 10.1073/pnas.0406627102; Soto-Faraco S, 2007, PERCEPT PSYCHOPHYS, V69, P218, DOI 10.3758/BF03193744; SUMBY WH, 1954, J ACOUST SOC AM, V26, P212, DOI 10.1121/1.1907309; WERKER JF, 1984, INFANT BEHAV DEV, V7, P49, DOI 10.1016/S0163-6383(84)80022-3	10	241	241	1	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 25	2007	316	5828					1159	1159		10.1126/science.1137686	http://dx.doi.org/10.1126/science.1137686			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	171GQ	17525331				2022-12-28	WOS:000246724300033
J	Taylor, PD; Day, T; Wild, G				Taylor, Peter D.; Day, Troy; Wild, Geoff			Evolution of cooperation in a finite homogeneous graph	NATURE			English	Article							KIN SELECTION; VISCOUS POPULATIONS; INCLUSIVE FITNESS; STABILITY; ALTRUISM; EVOLVE; MODEL	Recent theoretical studies of selection in finite structured populations(1-7) have worked with one of two measures of selective advantage of an allele: fixation probability and inclusive fitness. Each approach has its own analytical strengths, but given certain assumptions they provide equivalent results(1). In most instances the structure of the population can be specified by a network of nodes connected by edges ( that is, a graph)(8-10), and much of the work here has focused on a continuous-time model of evolution, first described by ref. 11. Working in this context, we provide an inclusive fitness analysis to derive a surprisingly simple analytical condition for the selective advantage of a cooperative allele in any graph for which the structure satisfies a general symmetry condition ('bi-transitivity'). Our results hold for a broad class of population structures, including most of those analysed previously, as well as some for which a direct calculation of fixation probability has appeared intractable. Notably, under some forms of population regulation, the ability of a cooperative allele to invade is seen to be independent of the nature of population structure ( and in particular of how game partnerships are specified) and is identical to that for an unstructured population. For other types of population regulation our results reveal that cooperation can invade if players choose partners along relatively 'high-weight' edges.	Queens Univ, Dept Math & Stat, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Taylor, PD (corresponding author), Queens Univ, Dept Math & Stat, Kingston, ON K7L 3N6, Canada.	peter.taylor@queensu.ca		Day, Troy/0000-0002-1052-6140				FRANK SA, 1994, P ROY SOC B-BIOL SCI, V258, P153, DOI 10.1098/rspb.1994.0156; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; Lessard S, 2005, THEOR POPUL BIOL, V68, P19, DOI 10.1016/j.tpb.2005.04.001; Lieberman E, 2005, NATURE, V433, P312, DOI 10.1038/nature03204; MICHOD RE, 1980, NATURE, V288, P694, DOI 10.1038/288694a0; Moran P., 1962, STAT PROCESSES EVOLU; Nowak MA, 2004, NATURE, V428, P646, DOI 10.1038/nature02414; Ohtsuki H, 2006, P ROY SOC B-BIOL SCI, V273, P2249, DOI 10.1098/rspb.2006.3576; Ohtsuki H, 2006, NATURE, V441, P502, DOI 10.1038/nature04605; Orzack SH, 2005, EVOLUTION, V59, P1183; Proulx S. R., 2001, SELECTION, V2, P1, DOI DOI 10.1556/SELECT.2.2001.1-2.1; Rousset F, 2000, J EVOLUTION BIOL, V13, P814, DOI 10.1046/j.1420-9101.2000.00219.x; Taylor P. A. I., 2000, SELECTION, V1, P83, DOI [10.1556/select. 1.2000.1-3.15, DOI 10.1556/SELECT.1.2000.1-3.15]; Taylor PD, 1996, J THEOR BIOL, V180, P27, DOI 10.1006/jtbi.1996.0075; TAYLOR PD, 1992, P ROY SOC B-BIOL SCI, V249, P299, DOI 10.1098/rspb.1992.0118; TAYLOR PD, 1992, EVOL ECOL, V6, P352, DOI 10.1007/BF02270971; Wild G, 2004, P ROY SOC B-BIOL SCI, V271, P2345, DOI 10.1098/rspb.2004.2862; WILSON DS, 1992, EVOL ECOL, V6, P331, DOI 10.1007/BF02270969; Wright S, 1943, GENETICS, V28, P114	19	233	235	3	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 24	2007	447	7143					469	472		10.1038/nature05784	http://dx.doi.org/10.1038/nature05784			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170VA	17522682				2022-12-28	WOS:000246693100046
J	Frieden, TR; Bloomberg, MR				Frieden, Thomas R.; Bloomberg, Michael R.			How to prevent 100 million deaths from tobacco	LANCET			English	Article							NEW-YORK-CITY; SMOKING-CESSATION; CONTROL PROGRAM; UNITED-STATES; CONSUMPTION; CALIFORNIA; MORTALITY; DISEASE		New York City Dept Hlth & Mental Hyg, New York, NY 10013 USA; Off Mayor, New York, NY USA	New York City Department of Health & Mental Hygiene	Frieden, TR (corresponding author), New York City Dept Hlth & Mental Hyg, 125 Worth St,CN28,Room 331, New York, NY 10013 USA.	tfrieden@health.nyc.gov		Frieden, Thomas/0000-0002-4759-2256				Biener L, 2000, BRIT MED J, V321, P351, DOI 10.1136/bmj.321.7257.351; Borland R, 2006, TOB CONTROL, V15, P42, DOI 10.1136/tc.2005.012492; CDC, 1999, BEST PRACT COMPR TOB; *CDCP, 1998, MMWR-MORBID MORTAL W, V47, P605; Chaloupka FJ, 2000, TOBACCO CONTROL DEVE, P237; Chang C, 2004, AM J IND MED, V46, P188, DOI 10.1002/ajim.20030; Dalton MA, 2003, LANCET, V362, P281, DOI 10.1016/S0140-6736(03)13970-0; Emery S, 2005, ARCH PEDIAT ADOL MED, V159, P639, DOI 10.1001/archpedi.159.7.639; *FED TRAD COMM, 2007, FED TRAD COMM CIG RE; Fichtenberg CM, 2000, NEW ENGL J MED, V343, P1772, DOI 10.1056/NEJM200012143432406; FIORE MC, 2000, TREATING TOBACCO USE; Frieden TR, 2005, AM J PUBLIC HEALTH, V95, P1016, DOI 10.2105/AJPH.2004.058164; Jha P, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P869; Jha P, 2006, LANCET, V368, P367, DOI 10.1016/S0140-6736(06)68975-7; Joossens L, 2003, INT J TUBERC LUNG D, V7, P214; Mackay J, 2006, TOBACCO ATLAS; Mendez D, 1998, AM J EPIDEMIOL, V148, P249; Miller N, 2005, LANCET, V365, P1849, DOI 10.1016/S0140-6736(05)66615-9; Mostashari F, 2005, J URBAN HEALTH, V82, P58, DOI 10.1093/jurban/jti008; Peto R., 2001, CRITICAL ISSUES GLOB, P154, DOI DOI 10.4314/NMP.V55I6.45441; Reed MB, 2005, CANCER EPIDEM BIOMAR, V14, P2131, DOI 10.1158/1055-9965.EPI-04-0919; Saffer H, 2000, J HEALTH ECON, V19, P1117, DOI 10.1016/S0167-6296(00)00054-0; SEEMAN I, 1992, VITAL HLTH STAT, V20; *US DEP HHS, 2006, HLTH CONS INV EXP TO; Warren CW, 2006, LANCET, V367, P749, DOI 10.1016/S0140-6736(06)68192-0; *WHO, 2006, UNAIDS0620E1105 JOIN; *WHO, 2005, WHOHTMMAL20051105; World Health Organization, 2006, STOP TB STRATEGY BUI	28	94	98	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 20	2007	369	9574					1758	1761		10.1016/S0140-6736(07)60782-X	http://dx.doi.org/10.1016/S0140-6736(07)60782-X			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	169ZT	17512860				2022-12-28	WOS:000246631300031
J	Sayegh, MH; Remuzzi, G				Sayegh, Mohamed H.; Remuzzi, Giuseppe			Clinical update: immunosuppression minimisation	LANCET			English	Article							EARLY CYCLOSPORINE WITHDRAWAL; SIROLIMUS-BASED THERAPY; RENAL-TRANSPLANTATION; KIDNEY-TRANSPLANTATION; REJECTION; TOLERANCE; CHALLENGES; BELATACEPT; CAMPATH-1H; SURVIVAL		Mario Negri Inst Pharmacol Res, Negri Bergamo Labs, I-24125 Bergamo, Italy; Harvard Univ, Sch Med, Brigham & Womens Hosp, Transplantat Res Ctr, Boston, MA USA; Harvard Univ, Sch Med, Childrens Hosp, Boston, MA USA	Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School	Remuzzi, G (corresponding author), Mario Negri Inst Pharmacol Res, Negri Bergamo Labs, I-24125 Bergamo, Italy.	gremuzzi@marionegri.it	; Remuzzi, Giuseppe/V-9766-2017	Sayegh, Mohamed/0000-0002-2847-588X; Remuzzi, Giuseppe/0000-0002-6194-3446				Barth RN, 2006, TRANSPL INT, V19, P885, DOI 10.1111/j.1432-2277.2006.00388.x; Curtis JJ, 2004, AM J TRANSPLANT, V4, P671, DOI 10.1111/j.1600-6143.2004.00474.x; Ekberg H, 2007, AM J TRANSPLANT, V7, P560, DOI 10.1111/j.1600-6143.2006.01645.x; Halloran PF, 2004, NEW ENGL J MED, V351, P2715, DOI 10.1056/NEJMra033540; Hariharan S, 2000, NEW ENGL J MED, V342, P605, DOI 10.1056/NEJM200003023420901; Harmon W, 2006, J AM SOC NEPHROL, V17, P1735, DOI 10.1681/ASN.2006010049; Hricik DE, 2002, AM J TRANSPLANT, V2, P19, DOI 10.1034/j.1600-6143.2002.020105.x; Kirk AD, 2003, TRANSPLANTATION, V76, P120, DOI 10.1097/01.TP.0000071362.99021.D9; Kreis H, 2004, J AM SOC NEPHROL, V15, P809, DOI 10.1097/01.ASN.0000113248.59077.76; Meier-Kriesche HU, 2004, AM J TRANSPLANT, V4, P378, DOI 10.1111/j.1600-6143.2004.00332.x; Mota A, 2004, AM J TRANSPLANT, V4, P953, DOI 10.1111/j.1600-6143.2004.00446.x; Najafian N, 2006, J AM SOC NEPHROL, V17, P2652, DOI 10.1681/ASN.2005070707; Salama AD, 2001, J CLIN INVEST, V108, P943, DOI 10.1172/JCI200114142; Sayegh MH, 2006, NAT CLIN PRACT NEPHR, V2, P134, DOI 10.1038/ncpneph0125; Sayegh MH, 2004, NEW ENGL J MED, V351, P2761, DOI 10.1056/NEJMon043418; Starzl TE, 2003, LANCET, V361, P1502, DOI 10.1016/S0140-6736(03)13175-3; Strom TB, 2005, NEW ENGL J MED, V353, P2394, DOI 10.1056/NEJMe058257; Terasaki PI, 2005, CURR OPIN IMMUNOL, V17, P541, DOI 10.1016/j.coi.2005.07.018; Vincenti F, 2003, J AM SOC NEPHROL, V14, P1940, DOI 10.1097/01.ASN.0000076844.59963.CF; Vincenti F, 2005, NEW ENGL J MED, V353, P770, DOI 10.1056/NEJMoa050085	20	26	28	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 20	2007	369	9574					1676	1678		10.1016/S0140-6736(07)60762-4	http://dx.doi.org/10.1016/S0140-6736(07)60762-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	169ZT	17512842				2022-12-28	WOS:000246631300010
J	Ranson, MK; Sinha, T; Chatterjee, M; Gandhi, F; Jayswal, R; Patel, F; Morris, SS; Mills, AJ				Ranson, M. Kent; Sinha, Tara; Chatterjee, Mirai; Gandhi, Fenil; Jayswal, Rupa; Patel, Falguni; Morris, Saul S.; Mills, Anne J.			Equitable utilisation of Indian community based health insurance scheme among its rural membership: cluster randomised controlled trial	BRITISH MEDICAL JOURNAL			English	Article							COMPLEX INTERVENTIONS; CARE; EXPENDITURES; INEQUALITIES; COUNTRIES; GUJARAT; SECTOR; IMPACT	Objective To evaluate alternative strategies for improving the uptake of benefits of a community based health insurance scheme by its poorest members. Design Prospective cluster randomised controlled trial. Setting Self Employed Women's Association (SEWA) community based health insurance scheme in rural India. Participants 713 claimants at baseline (2003) and 1440 claimants two years later among scheme members in 16 rural sub-districts. Interventions After sales service with supportive supervision, prospective reimbursement, both packages, and neither package, randornised by sub-district. Main outcome measures The primary outcome was socioeconomic status of claimants relative to members living in the same sub-district. Secondary outcomes were enrolment rates in SEWA Insurance, mean socioeconomic status of the insured population relative to the general rural population, and rate of claim submission. Results Between 2003 and 2005, the mean socioeconomic status of SEWA Insurance members (relative to the rural population of Gujarat) increased significantly. Rates of claims also increased significantly, on average by 21.6 per 1000 members (P < 0.001). However, differences between the intervention groups and the standard scheme were not significant. No systematic effect of time or interventions on the socioeconomic status of claimants relative to members in the same sub-district was found. Conclusions Neither intervention was sufficient to ensure that the poorer members in each sub-district were able to enjoy the greater share of the scheme benefits. Claim submission increased as a result of interventions that seem to have strengthened awareness of and trust in a community based health insurance scheme.	Univ London London Sch Hyg & Trop Med, Hlth Policy Unit, Hlth Econ & Financing Programme, London WC1E 7HT, England; Univ London London Sch Hyg & Trop Med, Nutr & Publ Hlth Intervent Res Unit, London WC1E 7HT, England; SEWA Recept Ctr, Ahmadabad 380001, Gujarat, India	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Ranson, MK (corresponding author), Univ London London Sch Hyg & Trop Med, Hlth Policy Unit, Hlth Econ & Financing Programme, Keppel St, London WC1E 7HT, England.	kent.ranson@tshtm.ac.uk		Mills, Anne/0000-0001-9863-9950; Morris, Saul/0000-0002-9372-7342	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Becerra-Posada F, 2004, LANCET, V364, P997, DOI 10.1016/S0140-6736(04)17026-8; Bennett S., 1998, HLTH INSURANCE SCHEM; Bhat R, 1996, INT J HEALTH PLAN M, V11, P253; Criel B, 1999, SOC SCI MED, V48, P897, DOI 10.1016/S0277-9536(98)00391-8; Devadasan N, 2006, HEALTH POLICY, V78, P224, DOI 10.1016/j.healthpol.2005.10.005; Dror DM, 2006, HEALTH POLICY, V77, P304, DOI 10.1016/j.healthpol.2005.08.001; Ekman B, 2004, HEALTH POLICY PLANN, V19, P249, DOI 10.1093/heapol/czh031; Ghosh SK, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-123; GUPTA I, 2005, EC POLIT WKLY   0917, P4132; Gwatkin D. R., 2005, REACHING POOR HLTH N; GWATKIN DR, 2000, SOCIOECONOMIC DIFFER; Hawe P, 2004, J EPIDEMIOL COMMUN H, V58, P788, DOI 10.1136/jech.2003.014415; Hawe P, 2004, BMJ-BRIT MED J, V328, P1561, DOI 10.1136/bmj.328.7455.1561; Hayes RJ, 1999, INT J EPIDEMIOL, V28, P319, DOI 10.1093/ije/28.2.319; HENRY C, 2000, ASSESSING RELATIVE P; *ILO U PROGR, 2002, EXT SOC PROT HLTH CO, P79; *INT LAB OFF U PRO, 2002, EXT SOC PROT HLTH CO, P79; Jakab M, 2004, HLTH FINANCING POOR, P201; Kenward MG, 1997, BIOMETRICS, V53, P983, DOI 10.2307/2533558; MAHAL A, 2000, WHO BENEFITS PUBLIC; Makinen M, 2000, B WORLD HEALTH ORGAN, V78, P55; Matthies S, 2004, IRDA J, V2, P7; Ministry of Health and Family Welfare, 2002, NAT HLTH POL 2002; MORRIS SS, 2006, CONT CLIN TRIAL 1014; MORRIS SS, 2005, MEASURING HLTH EQUIT, P1; Murray DM, 1998, DESIGN ANAL GROUP RA; Oakley A, 2006, BRIT MED J, V332, P413, DOI 10.1136/bmj.332.7538.413; Peters D.H., 2002, BETTER HLTH SYSTEMS; Ranson MK, 2006, SOC SCI MED, V62, P707, DOI 10.1016/j.socscimed.2005.06.037; Ranson MK, 2003, NATL MED J INDIA, V16, P79; Ranson MK, 2002, B WORLD HEALTH ORGAN, V80, P613; Rothwell PM, 2005, LANCET, V365, P82, DOI 10.1016/S0140-6736(04)17670-8; SCHIEBER G, 2006, DIS CONTROL PRIORITI, P1401; Schneider P, 2006, HEALTH ECON, V15, P19, DOI 10.1002/hec.1014; Sinha T, 2006, HEALTH POLICY PLANN, V21, P132, DOI 10.1093/heapol/czj010; Victora CG, 2004, AM J PUBLIC HEALTH, V94, P400, DOI 10.2105/AJPH.94.3.400; Wagstaff A, 2002, B WORLD HEALTH ORGAN, V80, P97; WHO, 2006, WORK TOG HLTH WORLD; *WORLD BANK, 2005, WORLD DEV REP 2006 E; World Health Organization, 2000, WORLD HLTH REP 2000; Xu K, 2003, LANCET, V362, P111, DOI 10.1016/S0140-6736(03)13861-5	41	22	22	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUN 23	2007	334	7607					1309	1312A		10.1136/bmj.39192.719583.AE	http://dx.doi.org/10.1136/bmj.39192.719583.AE			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	184MI	17526594	Green Published, Bronze, Green Accepted			2022-12-28	WOS:000247645400031
J	Brown, ME; Schaller, EL				Brown, Michael E.; Schaller, Emily L.			The mass of dwarf planet Eris	SCIENCE			English	Article							KUIPER-BELT; SIZED OBJECT; PLUTO; SATELLITES; ALBEDO; CHARON; UB313		CALTECH, Dept Geol & Planetary Sci, Pasadena, CA 91125 USA	California Institute of Technology	Brown, ME (corresponding author), CALTECH, Dept Geol & Planetary Sci, Pasadena, CA 91125 USA.	mbrown@caltech.edu		Brown, Michael E./0000-0002-8255-0545; Schaller, Emily/0000-0001-8967-5423				Bertoldi F, 2006, NATURE, V439, P563, DOI 10.1038/nature04494; Brown ME, 2006, ASTROPHYS J, V643, pL61, DOI 10.1086/504843; Brown ME, 2006, ASTROPHYS J, V639, pL43, DOI 10.1086/501524; Brown ME, 2005, ASTROPHYS J, V635, pL97, DOI 10.1086/499336; Buie MW, 2006, ASTRON J, V132, P290, DOI 10.1086/504422; Canup RM, 2005, SCIENCE, V307, P546, DOI 10.1126/science.1106818; Jewitt DC, 2002, ASTRON J, V123, P2110, DOI 10.1086/339557; McKinnon WB, 1995, SPACE SCI S, P807; Rabinowitz DL, 2006, ASTROPHYS J, V639, P1238, DOI 10.1086/499575; SMITH BA, 1989, SCIENCE, V246, P1422, DOI 10.1126/science.246.4936.1422; Stansberry JA, 2006, ASTROPHYS J, V643, P556, DOI 10.1086/502674; Wizinowich PL, 2006, PUBL ASTRON SOC PAC, V118, P297, DOI 10.1086/499290	13	71	71	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 15	2007	316	5831					1585	1585		10.1126/science.1139415	http://dx.doi.org/10.1126/science.1139415			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178SH	17569855				2022-12-28	WOS:000247239900031
J	Knight, RT				Knight, Robert T.			Neuroscience - Neural networks debunk phrenology	SCIENCE			English	Editorial Material							OSCILLATIONS; HUMANS		Univ Calif Berkeley, Helen Wills Neurosci Inst, Dept Psychol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Knight, RT (corresponding author), Univ Calif Berkeley, Helen Wills Neurosci Inst, Dept Psychol, Berkeley, CA 94720 USA.	rtknight@berkeley.edu						Barcelo F, 2000, NAT NEUROSCI, V3, P399, DOI 10.1038/73975; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; FRIES P, 2005, TRENDS COGN SCI, V291, P1560; Jacobs J, 2007, J NEUROSCI, V27, P3839, DOI 10.1523/JNEUROSCI.4636-06.2007; LISMAN JE, 1995, SCIENCE, V267, P1512, DOI 10.1126/science.7878473; Raz A, 2006, NAT REV NEUROSCI, V7, P367, DOI 10.1038/nrn1903; Saalmann YB, 2007, SCIENCE, V316, P1612, DOI 10.1126/science.1139140; Womelsdorf T, 2007, SCIENCE, V316, P1609, DOI [10.1126/science.1139597, 10.1126/science.1139178]	10	63	63	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 15	2007	316	5831					1578	1579		10.1126/science.1144677	http://dx.doi.org/10.1126/science.1144677			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178SH	17569852				2022-12-28	WOS:000247239900028
J	Zallen, JA				Zallen, Jennifer A.			Planar polarity and tissue morphogenesis	CELL			English	Review							7-PASS TRANSMEMBRANE CADHERIN; EPITHELIAL-CELL POLARITY; CONVERGENT EXTENSION; VAN-GOGH; ZEBRAFISH; PRICKLE; GENE; ESTABLISHMENT; POLARIZATION; ORIENTATION	Planar polarity is a global, tissue-level phenomenon that coordinates cell behavior in a two-dimensional plane. The Frizzled/planar cell polarity (PCP) and anterior-posterior (AP) patterning systems for planar polarity operate in a variety of cell types and provide direction to cells with different morphologies and behaviors. These two systems involve different sets of proteins but both use directional cues provided locally by communication between neighboring cells. This review describes our current understanding of the mechanisms that transmit directional signals from cell to cell and compares the strategies for generating global systems of spatial information in stationary and dynamic cell populations.	Sloan Kettering Inst, Dev Biol Program, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Zallen, JA (corresponding author), Sloan Kettering Inst, Dev Biol Program, New York, NY 10021 USA.	zallenj@mskcc.org						Adler PN, 2000, MECH DEVELOP, V96, P197, DOI 10.1016/S0925-4773(00)00392-0; Adler PN, 2002, DEV CELL, V2, P525, DOI 10.1016/S1534-5807(02)00176-4; Adler PN, 1997, CURR BIOL, V7, P940, DOI 10.1016/S0960-9822(06)00413-1; Amonlirdviman K, 2005, SCIENCE, V307, P423, DOI 10.1126/science.1105471; Axelrod JD, 2001, GENE DEV, V15, P1182; AXELROD JD, 2002, SCI WORLD J, V15, P434; Baena-Lopez LA, 2005, CURR BIOL, V15, P1640, DOI 10.1016/j.cub.2005.07.062; Bastock R, 2003, DEVELOPMENT, V130, P3007, DOI 10.1242/dev.00526; Bertet C, 2004, NATURE, V429, P667, DOI 10.1038/nature02590; Blankenship JT, 2006, DEV CELL, V11, P459, DOI 10.1016/j.devcel.2006.09.007; Casal J, 2006, DEVELOPMENT, V133, P4561, DOI 10.1242/dev.02641; Chae J, 1999, DEVELOPMENT, V126, P5421; Chen XY, 2005, NAT CELL BIOL, V7, P262, DOI 10.1038/ncb1226; Ciruna B, 2006, NATURE, V439, P220, DOI 10.1038/nature04375; Classen AK, 2005, DEV CELL, V9, P805, DOI 10.1016/j.devcel.2005.10.016; Colosimo PF, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000009; Concha ML, 1998, DEVELOPMENT, V125, P983; Curtin JA, 2003, CURR BIOL, V13, P1129, DOI 10.1016/S0960-9822(03)00374-9; Dabdoub A, 2005, J NEUROBIOL, V64, P446, DOI 10.1002/neu.20171; Das G, 2004, DEVELOPMENT, V131, P4467, DOI 10.1242/dev.01317; Davidson LA, 2006, CURR BIOL, V16, P833, DOI 10.1016/j.cub.2006.03.038; Eaton S, 1996, J CELL BIOL, V135, P1277, DOI 10.1083/jcb.135.5.1277; Elul T, 2000, DEV BIOL, V224, P3, DOI 10.1006/dbio.2000.9746; Fischer E, 2006, NAT GENET, V38, P21, DOI 10.1038/ng1701; Franke JD, 2005, CURR BIOL, V15, P2208, DOI 10.1016/j.cub.2005.11.064; Gho M, 1998, NATURE, V393, P178, DOI 10.1038/30265; Gibson MC, 2006, NATURE, V442, P1038, DOI 10.1038/nature05014; Glickman NS, 2003, DEVELOPMENT, V130, P873, DOI 10.1242/dev.00314; Gong Y, 2004, NATURE, V430, P689, DOI 10.1038/nature02796; Goto T, 2005, CURR BIOL, V15, P787, DOI 10.1016/j.cub.2005.03.040; Goto T, 2002, DEV BIOL, V247, P165, DOI 10.1006/dbio.2002.0673; GUBB D, 1982, J EMBRYOL EXP MORPH, V68, P37; Gubb D, 1999, GENE DEV, V13, P2315, DOI 10.1101/gad.13.17.2315; Guo N, 2004, P NATL ACAD SCI USA, V101, P9277, DOI 10.1073/pnas.0402802101; Harris TJC, 2004, J CELL BIOL, V167, P135, DOI 10.1083/jcb.200406024; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; Hyodo-Miura J, 2006, DEV CELL, V11, P69, DOI 10.1016/j.devcel.2006.04.019; IRVINE KD, 1994, DEVELOPMENT, V120, P827; Jenny A, 2005, NAT CELL BIOL, V7, P691, DOI 10.1038/ncb1271; Jenny A, 2003, EMBO J, V22, P4409, DOI 10.1093/emboj/cdg424; Jiang D, 2005, CURR BIOL, V15, P79; Jones C, 2007, BIOESSAYS, V29, P120, DOI 10.1002/bies.20526; Keller R, 2002, SCIENCE, V298, P1950, DOI 10.1126/science.1079478; Keller R, 2000, PHILOS T R SOC B, V355, P897, DOI 10.1098/rstb.2000.0626; Keller R, 2006, DEVELOPMENT, V133, P2291, DOI 10.1242/dev.02406; Kilian B, 2003, MECH DEVELOP, V120, P467, DOI 10.1016/S0925-4773(03)00004-2; Klein TJ, 2005, ANNU REV CELL DEV BI, V21, P155, DOI 10.1146/annurev.cellbio.21.012704.132806; KLINGENSMITH J, 1994, GENE DEV, V8, P118, DOI 10.1101/gad.8.1.118; Koppen M, 2006, DEVELOPMENT, V133, P2671, DOI 10.1242/dev.02439; Lawrence PA, 2004, DEVELOPMENT, V131, P4651, DOI 10.1242/dev.01351; Lawrence PA, 2002, DEVELOPMENT, V129, P2749; Le Garrec JF, 2006, DEV DYNAM, V235, P235, DOI 10.1002/dvdy.20617; Lengyel JA, 2002, DEV BIOL, V243, P1, DOI 10.1006/dbio.2002.0577; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lu BW, 1999, CURR BIOL, V9, P1247, DOI 10.1016/S0960-9822(99)80505-3; Marsden M, 2003, CURR BIOL, V13, P1182, DOI 10.1016/S0960-9822(03)00433-0; Matakatsu H, 2004, DEVELOPMENT, V131, P3785, DOI 10.1242/dev.01254; Matakatsu H, 2006, DEVELOPMENT, V133, P2315, DOI 10.1242/dev.02401; Miller JR, 1999, J CELL BIOL, V146, P427, DOI 10.1083/jcb.146.2.427; Mlodzik M, 2002, TRENDS GENET, V18, P564, DOI 10.1016/S0168-9525(02)02770-1; Montcouquiol M, 2003, NATURE, V423, P173, DOI 10.1038/nature01618; Myers DC, 2002, TRENDS GENET, V18, P447, DOI 10.1016/S0168-9525(02)02725-7; Myers DC, 2002, DEV BIOL, V243, P81, DOI 10.1006/dbio.2001.0523; Ninomiya H, 2004, NATURE, V430, P364, DOI 10.1038/nature02620; Price MH, 2006, J CELL SCI, V119, P403, DOI 10.1242/jcs.02761; Sahai E, 2002, NAT CELL BIOL, V4, P408, DOI 10.1038/ncb796; Seifert JRK, 2007, NAT REV GENET, V8, P126, DOI 10.1038/nrg2042; SHIH J, 1992, DEVELOPMENT, V116, P901; Shimada Y, 2001, CURR BIOL, V11, P859, DOI 10.1016/S0960-9822(01)00233-0; Shimada Y, 2006, DEV CELL, V10, P209, DOI 10.1016/j.devcel.2005.11.016; Simon MA, 2004, DEVELOPMENT, V131, P6175, DOI 10.1242/dev.01550; Strutt D, 2007, DEV BIOL, V302, P181, DOI 10.1016/j.ydbio.2006.09.026; Strutt DI, 2002, SEMIN CELL DEV BIOL, V13, P225, DOI 10.1016/S1084-9521(02)00041-1; Strutt DI, 2001, MOL CELL, V7, P367, DOI 10.1016/S1097-2765(01)00184-8; Strutt H, 2005, BIOESSAYS, V27, P1218, DOI 10.1002/bies.20318; Tada M, 2000, DEVELOPMENT, V127, P2227; Tawk M, 2007, NATURE, V446, P797, DOI 10.1038/nature05722; Taylor J, 1998, GENETICS, V150, P199; THEISEN H, 1994, DEVELOPMENT, V120, P347; Tree DRP, 2002, CELL, V109, P371, DOI 10.1016/S0092-8674(02)00715-8; Turner CM, 1998, MECH DEVELOP, V70, P181, DOI 10.1016/S0925-4773(97)00194-9; Usui T, 1999, CELL, V98, P585, DOI 10.1016/S0092-8674(00)80046-X; VINSON CR, 1987, NATURE, V329, P549, DOI 10.1038/329549a0; Wallingford JB, 2002, DEV CELL, V2, P695, DOI 10.1016/S1534-5807(02)00197-1; Wallingford JB, 2000, NATURE, V405, P81, DOI 10.1038/35011077; Walters JW, 2006, DEV BIOL, V297, P323, DOI 10.1016/j.ydbio.2006.04.454; Wang JB, 2006, DEVELOPMENT, V133, P1767, DOI 10.1242/dev.02347; Wang YS, 2007, DEVELOPMENT, V134, P647, DOI 10.1242/dev.02772; Winter CG, 2001, CELL, V105, P81, DOI 10.1016/S0092-8674(01)00298-7; Wolff T, 1998, DEVELOPMENT, V125, P1149; Wong HC, 2003, MOL CELL, V12, P1251, DOI 10.1016/S1097-2765(03)00427-1; WONG LL, 1993, J CELL BIOL, V123, P209, DOI 10.1083/jcb.123.1.209; Yang CH, 2002, CELL, V108, P675, DOI 10.1016/S0092-8674(02)00658-X; Zallen JA, 2004, J PHYS-CONDENS MAT, V16, pS5073, DOI 10.1088/0953-8984/16/44/005; Zallen JA, 2004, DEV CELL, V6, P343, DOI 10.1016/S1534-5807(04)00060-7; Zeidler MP, 2000, DEV BIOL, V228, P181, DOI 10.1006/dbio.2000.9940; ZHENG L, 1995, DEVELOPMENT, V121, P3045	97	320	331	1	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 15	2007	129	6					1051	1063		10.1016/j.cell.2007.05.050	http://dx.doi.org/10.1016/j.cell.2007.05.050			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	180UA	17574020	Bronze			2022-12-28	WOS:000247390400011
J	Manzoni, P; Stolfi, I; Pugni, L; Decembrino, L; Magnani, C; Vetrano, G; Tridapalli, E; Corona, G; Giovannozzi, C; Farina, D; Arisio, R; Merletti, F; Maule, M; Mosca, F; Pedicino, R; Stronati, M; Mostert, M; Gomirato, G				Manzoni, Paolo; Stolfi, Ilaria; Pugni, Lorenza; Decembrino, Lidia; Magnani, Cristiana; Vetrano, Gennaro; Tridapalli, Elisabetta; Corona, Giuseppina; Giovannozzi, Chiara; Farina, Daniele; Arisio, Riccardo; Merletti, Franco; Maule, Milena; Mosca, Fabio; Pedicino, Roberto; Stronati, Mauro; Mostert, Michael; Gomirato, Giovanna		Italian Task Force Study Preventio	A multicenter, randomized trial of prophylactic fluconazole in preterm neonates	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LOW-BIRTH-WEIGHT; LATE-ONSET SEPSIS; INTENSIVE-CARE; RISK-FACTORS; FUNGAL COLONIZATION; INVASIVE CANDIDIASIS; SURGICAL-PATIENTS; CRITICALLY-ILL; INFECTIONS; INFANTS	BACKGROUND: Invasive candida infections are a major cause of morbidity and mortality in preterm infants. We performed a multicenter, randomized, double-blind, placebo-controlled trial of fluconazole for the prevention of fungal colonization and infection in very-low-birth-weight neonates. METHODS: During a 15-month period, all neonates weighing less than 1500 g at birth from eight tertiary Italian neonatal intensive care units (322 infants) were randomly assigned to receive either fluconazole (at a dose of either 6 mg or 3 mg per kilogram of body weight) or placebo from birth until day 30 of life (day 45 for neonates weighing < 1000 g at birth). We performed weekly surveillance cultures and systematic fungal susceptibility testing. RESULTS: Among infants receiving fluconazole, fungal colonization occurred in 9.8% in the 6-mg group and 7.7% in the 3-mg group, as compared with 29.2% in the placebo group (P < 0.001 for both fluconazole groups vs. the placebo group). The incidence of invasive fungal infection was 2.7% in the 6-mg group and 3.8% in the 3-mg group, as compared with 13.2% in the placebo group (P=0.005 for the 6-mg group and P=0.02 for the 3-mg group vs. the placebo group). The use of fluconazole did not modify the relationship between colonization and the subsequent development of invasive fungal infection. Overall mortality was similar among groups, as was the incidence of cholestasis. No evidence for the emergence of resistant candida species was observed, but the study did not have substantial power to detect such an effect. CONCLUSIONS: Prophylactic fluconazole reduces the incidence of colonization and invasive candida infection in neonates weighing less than 1500 g at birth. The benefit of treating candida colonization is unclear.	St Anna Hosp, Neonatol & Hosp Neonatal Intens Care Unit, I-10126 Turin, Italy; Policlin Umberto 1, I-00161 Rome, Italy; Univ Milan, Mangiagalli Hosp IRCCS, Milan, Italy; San Matteo Hosp, Pavia, Italy; Arcispedale, Reggio Emilia, Italy; Fatebenefratelli Hosp, Benevento, Italy; Univ Bologna, Bologna, Italy; Univ Messina, Messina, Italy; Univ Turin, Turin, Italy	A.O.U. Citta della Salute e della Scienza di Torino; University of Ferrara; Arcispedale Sant'Anna; Sapienza University Rome; University Hospital Sapienza Rome; University of Milan; IRCCS Fondazione San Matteo; University of Bologna; University of Messina; University of Turin	Manzoni, P (corresponding author), St Anna Hosp, Neonatol & Hosp Neonatal Intens Care Unit, Corso Spezia 60, I-10126 Turin, Italy.	paolomanzoni@hotmail.com	Maule, Milena M/K-3858-2018; Arisio, Riccardo/GZK-6395-2022; Mosca, Fabio/C-5826-2017; Decembrino, Lidia/AAC-3477-2021	Maule, Milena M/0000-0003-2142-1288; Mosca, Fabio/0000-0001-6477-0299; decembrino, lidia/0000-0002-6272-8668; Stronati, Mauro/0000-0002-8367-3264				Ascioglu S, 2002, CLIN INFECT DIS, V34, P7, DOI 10.1086/323335; AUSTIN NC, 2004, COCHRANE DB SYST REV, V1; Benjamin DK, 2006, PEDIATRICS, V117, P84, DOI 10.1542/peds.2004-2292; Bertini G, 2005, J PEDIATR-US, V147, P162, DOI 10.1016/j.jpeds.2005.02.020; Blot S, 2006, J ANTIMICROB CHEMOTH, V58, P474, DOI 10.1093/jac/dkl241; Castagnola E, 2004, CLIN MICROBIOL INFEC, V10, P86, DOI 10.1111/j.1470-9465.2004.00847.x; Cotten CM, 2006, PEDIATRICS, V118, P717, DOI 10.1542/peds.2005-2677; El-Masry FAY, 2002, ACTA PAEDIATR, V91, P198, DOI 10.1080/080352502317285216; Fanaroff AA, 2006, PEDIATRICS, V117, P214, DOI 10.1542/peds.2005-2183; Feja KN, 2005, J PEDIATR-US, V147, P156, DOI 10.1016/j.jpeds.2005.02.021; Fridkin SK, 2006, PEDIATRICS, V117, P1680, DOI 10.1542/peds.2005-1996; GOTZSCHE PC, 2002, COCHRANE DATABASE SY, V2; Healy CM, 2005, J PEDIATR-US, V147, P166, DOI 10.1016/j.jpeds.2005.04.016; Ho KM, 2005, CRIT CARE, V9, pR710, DOI 10.1186/cc3883; Hope W, 2002, J HOSP INFECT, V50, P56, DOI 10.1053/jhin.2001.1131; Huang YC, 1998, PEDIATR INFECT DIS J, V17, P819, DOI 10.1097/00006454-199809000-00014; Johnsson H, 2004, ACTA PAEDIATR, V93, P954, DOI [10.1080/08035250410030964, 10.1111/j.1651-2227.2004.tb02695.x]; Kaufman D, 2005, J PEDIATR-US, V147, P172, DOI 10.1016/j.jpeds.2005.03.036; Kaufman D, 2004, CLIN MICROBIOL REV, V17, P638, DOI 10.1128/CMR.17.3.638-680.2004; Kaufman D, 2004, CURR OPIN INFECT DIS, V17, P253, DOI 10.1097/00001432-200406000-00014; Kaufman D, 2003, SEMIN PERINATOL, V27, P414, DOI 10.1016/S0146-0005(03)00067-3; Kaufman D, 2001, NEW ENGL J MED, V345, P1660, DOI 10.1056/NEJMoa010494; KAUFMAN D, 2005, PEDIAT INFECT FORUM, V7, P2; Kicklighter SD, 2001, PEDIATRICS, V107, P293, DOI 10.1542/peds.107.2.293; Laverdiere M, 2000, J ANTIMICROB CHEMOTH, V46, P1001, DOI 10.1093/jac/46.6.1001; Long SS, 2005, J PEDIATR-US, V147, P135, DOI 10.1016/j.jpeds.2005.04.033; Makhoul IR, 2002, PEDIATRICS, V109, P34, DOI 10.1542/peds.109.1.34; Manzoni P, 2006, PEDIATRICS, V117, pE22, DOI 10.1542/peds.2004-2227; Manzoni P, 2004, Pediatr Med Chir, V26, P89; Marr KA, 2000, J INFECT DIS, V181, P309, DOI 10.1086/315193; MCGUIRE W, 2004, COCHRANE DB SYST REV, V1, P3850; Munoz P, 2000, INT J ANTIMICROB AG, V15, P83, DOI 10.1016/S0924-8579(00)00147-3; [NCCLS]National Committee for Clinical Laboratory Standards, 1997, M27A NCCLS; Neely MN, 2001, PEDIATRICS, V107, P404, DOI 10.1542/peds.107.2.404; Pappas PG, 2004, CLIN INFECT DIS, V38, P161, DOI 10.1086/380796; Playford EG, 2006, J ANTIMICROB CHEMOTH, V57, P628, DOI 10.1093/jac/dki491; Saiman L, 2000, PEDIATR INFECT DIS J, V19, P319, DOI 10.1097/00006454-200004000-00011; Saiman L, 2001, PEDIATR INFECT DIS J, V20, P1119, DOI 10.1097/00006454-200112000-00005; SMITH PB, 2006, 2006 ANN M PED AC SO; Stoll BJ, 2004, JAMA-J AM MED ASSOC, V292, P2357, DOI 10.1001/jama.292.19.2357; Stoll BJ, 2002, PEDIATRICS, V110, P285, DOI 10.1542/peds.110.2.285; Uko S, 2006, PEDIATRICS, V117, P1243, DOI 10.1542/peds.2005-1969	42	231	245	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 14	2007	356	24					2483	2495		10.1056/NEJMoa065733	http://dx.doi.org/10.1056/NEJMoa065733			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	178DR	17568029	Bronze			2022-12-28	WOS:000247201900008
J	Moncrieff, G; Fletcher, J				Moncrieff, George; Fletcher, John			10-minute consultation - Tiredness	BRITISH MEDICAL JOURNAL			English	Editorial Material									Bicester Hlth Ctr, Bicester OX26 6AT, Oxon, England		Moncrieff, G (corresponding author), Bicester Hlth Ctr, Bicester OX26 6AT, Oxon, England.	georgemoncrieff@hotmail.com							0	1	1	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 9	2007	334	7605					1221	1221		10.1136/bmj.39182.615405.94	http://dx.doi.org/10.1136/bmj.39182.615405.94			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	179GF	17556480	Green Published			2022-12-28	WOS:000247277000040
J	Spence, D				Spence, Des			Wanted: stress monkeys	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUN 9	2007	334	7605					1224	1224		10.1136/bmj.39237.429178.59	http://dx.doi.org/10.1136/bmj.39237.429178.59			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	179GF	17556483	Green Published			2022-12-28	WOS:000247277000042
J	Verroust, N; Zegdi, R; Ciobotaru, V; Tsatsaris, V; Goffinet, F; Fabiani, JN; Mignon, A				Verroust, Nicolas; Zegdi, Rachid; Ciobotaru, Vlad; Tsatsaris, Vassilis; Goffinet, Francois; Fabiani, Jean-Noel; Mignon, Alexandre			Ventricular fibrillation during termination of pregnancy	LANCET			English	Editorial Material							AMNIOTIC-FLUID EMBOLISM		Univ Paris 05, Hop Cochin SVP, Assistance Publ Hop Paris, Dept Anesthesie Reanimat, Paris, France; Univ Paris 05, Hop Europeen Georges Pompidou, Assistance Publ Hop Paris, Serv Chirurg Cardiothorac, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite	Mignon, A (corresponding author), Univ Paris 05, Hop Cochin SVP, Assistance Publ Hop Paris, Dept Anesthesie Reanimat, Paris, France.	alexandre.mignon@cch.aphp.fr		GOFFINET, Francois/0000-0001-9643-0299				CLARK SL, 1995, AM J OBSTET GYNECOL, V172, P1158, DOI 10.1016/0002-9378(95)91474-9; Gilbert WM, 1999, OBSTET GYNECOL, V93, P973, DOI 10.1016/S0029-7844(99)00004-6; Hsieh YY, 2000, AM J OBSTET GYNECOL, V183, P496, DOI 10.1067/mob.2000.104834; Moore J, 2006, LANCET, V368, P1399, DOI 10.1016/S0140-6736(06)69581-0; Tuffnell DJ, 2003, CURR OPIN OBSTET GYN, V15, P119, DOI 10.1097/00001703-200304000-00006	5	10	11	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 2	2007	369	9576					1900	1900		10.1016/S0140-6736(07)60857-5	http://dx.doi.org/10.1016/S0140-6736(07)60857-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	173ZS	17544771				2022-12-28	WOS:000246911600035
J	Villa, L; Perez, G; Kjaer, S; Lehtinen, M; Paavonen, J; Munoz, N; Sigurdsson, K; Hernandez-Avila, M; Iversen, OE; Thoresen, S; Garcia, P; Majewski, S; Tay, EH; Bosch, FX; Dillner, J; Olsson, SE; Ault, K; Brown, D; Ferris, D; Giuliano, A; Koutsky, L; Kurman, R; Myers, E; Barr, E; Boslego, J; Bryan, J; Esser, M; Hesley, T; Lupinacci, L; Railkar, R; Sings, H; Taddeo, F; Thornton, A				Villa, L.; Perez, G.; Kjaer, S.; Lehtinen, M.; Paavonen, J.; Munoz, N.; Sigurdsson, K.; Hernandez-Avila, M.; Iversen, O. E.; Thoresen, S.; Garcia, P.; Majewski, S.; Tay, E. H.; Bosch, F. X.; Dillner, J.; Olsson, S. E.; Ault, K.; Brown, D.; Ferris, D.; Giuliano, A.; Koutsky, L.; Kurman, R.; Myers, E.; Barr, E.; Boslego, J.; Bryan, J.; Esser, M.; Hesley, T.; Lupinacci, L.; Railkar, R.; Sings, H.; Taddeo, F.; Thornton, A.		Future II Study Grp	Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials	LANCET			English	Article							QUADRIVALENT VACCINE; SUSTAINED EFFICACY; FOLLOW-UP; TYPE-18; ADOLESCENTS; LESIONS; WOMEN	Background Cervical cancer and its obligate precursors, cervical intraepithelial neoplasia grades 2 and 3 (CIN2/3), and adenocarcinona in situ (AIS), are caused by oncogenic human papillomavirus (HPV). In this combined analysis of four clinical trials we assessed the effect of prophylactic HPV vaccination on these diseases. Methods 20 583 women aged 16-26 years were randomised to receive quadrivalent HPV6/11/16/18 vaccine (n=9087), its HPV16 vaccine component (n=1204), or placebo (n=10292). They underwent periodic Papanicolaou testing, with colposcopy or biopsy for detected abnormalities. The primary composite endpoint was the combined incidence of HPV16/18-related CIN2/3, AIS, or cervical cancer. These trials are registered at ClinicalTrials.gov, numbers NCT00365378, NCT00365716, NCT00092521, and NCT00092534. Findings Mean follow-up was 3.0 years (SD 0.66) after first dose. In women negative for HPV16 or HPV18 infection during the vaccination regimen (n=17129, per protocol), vaccine efficacy was 99% for the primary endpoint (95% Cl 93-100), meeting the statistical criterion for success. In an intention-to-treat analysis of all randomised women (including those who were HPV16/18 naive or HPV16/18-infected at day 1), efficacy was 44% (95% Cl 31-55); all but one case in vaccine recipients occurred in women infected with HPV16 or HPV18 before vaccination. In a second intention-to-treat analysis we noted an 18% reduction (95% CI 7-29) in the overall rate of CIN2/3 or AIS due to any HPV type. Interpretation Administration of HPV vaccine to HPV-naive women, and women who are already sexually active, could substantially reduce the incidence of HPV16/18-related cervical precancers and cervical cancer.	Emory Univ, Sch Med, Dept Obstet & Gynecol, Atlanta, GA 30303 USA; Ludwig Inst Canc Res, Dept Virol, Sao Paulo, Brazil; Natl Res Ctr, Grp Saludcoop, Bogota, Colombia; Danish Canc Soc Rigshosp, Inst Canc Epidemiol, Dept Virus Hormones & Canc, Copenhagen, Denmark; Natl Publ Hlth Inst, Dept Oulu, Oulu, Finland; Univ Helsinki, Dept Obstet & Gynecol, Helsinki, Finland; Int Agcy Res Canc, F-69372 Lyon, France; Natl Canc Detent Clin, Reykjavik, Iceland; Natl Inst Publ Hlth, Cuernavaca, Morelos, Mexico; Haukeland Hosp, Dept Obstet & Gynecol, N-5021 Bergen, Norway; Univ Bergen, Inst Clin Med, Bergen, Norway; Canc Registry Norway, Montebello, Norway; Univ Peruana Cayetano Heredia, Epidemiol HIV & STD Unit, Lima, Peru; Warsaw Med Univ, Ctr Diagnost & Treatment Sexually Transmitted Dis, Dept Dermatol & Venereol, Warsaw, Poland; KK Womens & Childrens Hosp, Singapore, Singapore; IDIBELL, Inst Catala Oncol, Barcelona, Spain; Lund Univ, Dept Med Microbiol, S-22100 Lund, Sweden; Danderyd Hosp, Karolinska Inst, Stockholm, Sweden; Indiana Univ, Sch Med, Dept Med, Indianapolis, IN USA; Med Coll Georgia, Dept Family Med & Obstet & Gynecol, Augusta, GA 30912 USA; Univ Arizona, Ctr Canc, Tucson, AZ USA; Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; Johns Hopkins Univ, Sch Med, Dept Gynecol & Obstet, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; Duke Univ, Med Ctr, Dept Obstet & Gynecol, Durham, NC 27710 USA; Merck Res Labs, West Point, PA USA	Emory University; Ludwig Institute for Cancer Research; Danish Cancer Society; Finland National Institute for Health & Welfare; University of Helsinki; World Health Organization; International Agency for Research on Cancer (IARC); Instituto Nacional de Salud Publica; University of Bergen; Haukeland University Hospital; University of Bergen; University of Oslo; Universidad Peruana Cayetano Heredia; Medical University of Warsaw; KK Women's & Children's Hospital; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Lund University; Danderyds Hospital; Karolinska Institutet; Indiana University System; Indiana University-Purdue University Indianapolis; University System of Georgia; Augusta University; University of Arizona; University of Washington; University of Washington Seattle; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Duke University; Merck & Company	Ault, K (corresponding author), Emory Univ, Sch Med, Dept Obstet & Gynecol, 69 Jesse Hill Jr Dr SE, Atlanta, GA 30303 USA.	kevin.ault@emory.edu	JOSÉ, FRANCESC XAVIER BOSCH/J-6339-2012; VILLA, LUISA/AAH-4761-2019	JOSÉ, FRANCESC XAVIER BOSCH/0000-0002-7172-3412; VILLA, LUISA/0000-0003-4074-2335; lehtinen, matti/0000-0002-9481-0535				Block SL, 2006, PEDIATRICS, V118, P2135, DOI 10.1542/peds.2006-0461; Bryan JT, 2006, J MED VIROL, V78, P117, DOI 10.1002/jmv.20512; Castellsague X, 2006, JNCI-J NATL CANCER I, V98, P303, DOI 10.1093/jnci/djj067; Chan ISF, 1998, COMMUN STAT-THEOR M, V27, P1305, DOI 10.1080/03610929808832160; Collins S, 2002, BJOG-INT J OBSTET GY, V109, P96, DOI 10.1111/j.1471-0528.2002.01053.x; Dias D, 2005, CLIN DIAGN LAB IMMUN, V12, P959, DOI 10.1128/CDLI.12.8.959-969.2005; Elbasha EH, 2007, EMERG INFECT DIS, V13, P28, DOI 10.3201/eid1301.060438; Ferlay J., 2002, GLOBOCAN 2002 CANC I; Garland SM, 2007, NEW ENGL J MED, V356, P1928, DOI 10.1056/NEJMoa061760; Harper DM, 2006, LANCET, V367, P1247, DOI 10.1016/S0140-6736(06)68439-0; Joura EA, 2007, LANCET, V369, P1693, DOI 10.1016/S0140-6736(07)60777-6; Kalbfleisch D., 1980, STAT ANAL FAILURE TI; Mao C, 2006, OBSTET GYNECOL, V107, P18, DOI 10.1097/01.AOG.0000192397.41191.fb; Martin DO, 1996, EPIDEMIOLOGY, V7, P29, DOI 10.1097/00001648-199601000-00006; Moscicki AB, 1996, OBSTET GYN CLIN N AM, V23, P675; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Pagliusi SR, 2004, VACCINE, V23, P569, DOI 10.1016/j.vaccine.2004.07.046; PRATT D, 1 FDA; Sheets EE, 2002, CURR OPIN OBSTET GYN, V14, P53, DOI 10.1097/00001703-200202000-00009; STOELR MH, 2004, CERVICAL CANC ETIOLO, P3; Villa LL, 2006, BRIT J CANCER, V95, P1459, DOI 10.1038/sj.bjc.6603469; Villa LL, 2005, LANCET ONCOL, V6, P271, DOI 10.1016/S1470-2045(05)70101-7; Villa LL, 2007, NEW ENGL J MED, V356, P1915, DOI 10.1056/NEJMoa061741; Winer RL, 2003, AM J EPIDEMIOL, V157, P218, DOI 10.1093/aje/kwf180; Zaino RJ, 2002, INT J GYNECOL PATHOL, V21, P314, DOI 10.1097/00004347-200210000-00002	25	432	449	2	39	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 2	2007	369	9576					1861	1868		10.1016/S0140-6736(07)60852-6	http://dx.doi.org/10.1016/S0140-6736(07)60852-6			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	173ZS	17544766				2022-12-28	WOS:000246911600029
J	Hoch, RC				Hoch, Robert C.			"Staging" pneumothorax	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Minnesota Lung Ctr, Minneapolis, MN 55407 USA		Hoch, RC (corresponding author), Minnesota Lung Ctr, Minneapolis, MN 55407 USA.	roberthoch@gmail.com							0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 31	2007	356	22					2312	2312		10.1056/NEJMicm061662	http://dx.doi.org/10.1056/NEJMicm061662			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	172PO	17538090				2022-12-28	WOS:000246816500010
J	Carlson, RW; Boyet, M; Horan, M				Carlson, Richard W.; Boyet, Maud; Horan, Mary			Chondrite barium, neodymium, and samarium isotopic heterogeneity and early earth differentiation	SCIENCE			English	Article							DIVERSE SUPERNOVA SOURCES; S-PROCESS BA; NEUTRON-CAPTURE; CROSS-SECTIONS; P-PROCESS; ND; GRAINS	Isotopic variability in barium, neodymium, and samarium in carbonaceous chondrites reflects the distinct stellar nucleosynthetic contributions to the early solar system. We used Nd-148/Nd-144 to correct for the observed s-process deficiency, which produced a chondrite Sm-146-Nd-142 isochron consistent with previous estimates of the initial solar system abundance of Sm-146 and a Nd-142/Nd-144 at average chondrite Sm/Nd ratio that is lower than that measured in terrestrial rocks by 21 +/- 3 parts per million. This result strengthens the conclusion that the deficiency in Nd-142 in chondrites relative to terrestrial rocks reflects Sm-146 decay and early planetary differentiation processes.			Carlson, RW (corresponding author), Carnegie Inst Sci, Dept Terr Magnetism, 5241 Broad Branch Rd NW, Washington, DC 20015 USA.	carlson@dtm.ciw.edu						AMARI S, 1992, ASTROPHYS J, V394, pL43, DOI 10.1086/186468; Andreasen R, 2006, SCIENCE, V314, P806, DOI 10.1126/science.1131708; Arlandini C, 1999, ASTROPHYS J, V525, P886, DOI 10.1086/307938; Boyet M, 2005, SCIENCE, V309, P576, DOI 10.1126/science.1113634; Brandon AD, 2005, SCIENCE, V309, P1233, DOI 10.1126/science.1115053; BREARLEY AJ, 1998, REV MINERAL, V36, P3; BURBIDGE EM, 1957, REV MOD PHYS, V29, P547, DOI 10.1103/RevModPhys.29.547; Dauphas N, 2002, ASTROPHYS J, V569, pL139, DOI 10.1086/340580; Fujii T, 2006, EARTH PLANET SC LETT, V247, P1, DOI 10.1016/j.epsl.2006.04.034; Gallino R, 1997, AIP CONF PROC, P115, DOI 10.1063/1.53327; Hidaka H, 2003, EARTH PLANET SC LETT, V214, P455, DOI 10.1016/S0012-821X(03)00393-5; Hoppe P, 1997, AIP CONF PROC, P27, DOI 10.1063/1.53314; JACOBSEN SB, 1984, EARTH PLANET SC LETT, V67, P137, DOI 10.1016/0012-821X(84)90109-2; LUGMAIR GW, 1992, GEOCHIM COSMOCHIM AC, V56, P1673, DOI 10.1016/0016-7037(92)90234-A; MCCULLOCH MT, 1978, ASTROPHYS J, V220, pL15, DOI 10.1086/182628; MEYER BS, 2006, METEORITES EARLY SOL, V2, P69; PROMBO CA, 1993, ASTROPHYS J, V410, P393, DOI 10.1086/172756; Qian YZ, 1998, ASTROPHYS J, V494, P285, DOI 10.1086/305198; Ranen MC, 2006, SCIENCE, V314, P809, DOI 10.1126/science.1132595; Rankenburg K, 2006, SCIENCE, V312, P1369, DOI 10.1126/science.1126114; RICHTER S, 1993, NUCLEI IN THE COSMOS, P127; ROTARU M, 1992, NATURE, V358, P465, DOI 10.1038/358465a0; Russell SS., 2006, METEORITES EARLY SOL; Wadhwa M., 2006, METEORITES EARLY SOL, P715; Wisshak K, 1998, PHYS REV C, V57, P391, DOI 10.1103/PhysRevC.57.391; WOOSLEY SE, 1978, ASTROPHYS J SUPPL S, V36, P285, DOI 10.1086/190501; Yin QZ, 2002, NATURE, V415, P881, DOI 10.1038/415881a; ZINNER E, 1991, ASTROPHYS J, V382, pL47, DOI 10.1086/186210	28	196	199	1	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2007	316	5828					1175	1178		10.1126/science.1140189	http://dx.doi.org/10.1126/science.1140189			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171GQ	17525335				2022-12-28	WOS:000246724300038
J	Feinberg, AP				Feinberg, Andrew P.			Phenotypic plasticity and the epigenetics of human disease	NATURE			English	Review							BECKWITH-WIEDEMANN-SYNDROME; DNA METHYLATION; IMPRINTED GENES; NORMAL TISSUE; FREQUENT LOSS; RETT-SYNDROME; CANCER; IGF2; HISTONE; H19	It is becoming clear that epigenetic changes are involved in human disease as well as during normal development. A unifying theme of disease epigenetics is defects in phenotypic plasticity - cells' ability to change their behaviour in response to internal or external environmental cues. This model proposes that hereditary disorders of the epigenetic apparatus lead to developmental defects, that cancer epigenetics involves disruption of the stem-cell programme, and that common diseases with late-onset phenotypes involve interactions between the epigenome, the genome and the environment. Increased understanding of epigenetic-disease mechanisms could lead to disease-risk stratification for targeted intervention and to targeted therapies.	Johns Hopkins Univ, Sch Med, Dept Med, Inst Basic Biomed Sci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Ctr Epigenet, Inst Basic Biomed Sci, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Feinberg, AP (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Inst Basic Biomed Sci, 720 Rutland Ave, Baltimore, MD 21205 USA.	afeinberg@jhu.edu	Feinberg, Andrew/AAY-7666-2020	Feinberg, Andrew/0000-0002-8364-1991	NATIONAL CANCER INSTITUTE [R37CA054358, R01CA054358] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA054358, R37 CA054358-17, R37 CA054358] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Astuti D, 2005, BRIT J CANCER, V92, P1574, DOI 10.1038/sj.bjc.6602478; Bachman KE, 2003, CANCER CELL, V3, P89, DOI 10.1016/S1535-6108(02)00234-9; BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bienvenu T, 2006, NAT REV GENET, V7, P415, DOI 10.1038/nrg1878; Bjornsson HT, 2004, TRENDS GENET, V20, P350, DOI 10.1016/j.tig.2004.06.009; Blanco-Betancourt CE, 2004, BLOOD, V103, P2683, DOI 10.1182/blood-2003-08-2632; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Brueckner B, 2007, CANCER RES, V67, P1419, DOI 10.1158/0008-5472.CAN-06-4074; Callinan PA, 2006, HUM MOL GENET, V15, pR95, DOI 10.1093/hmg/ddl095; Chen WY, 2003, NAT GENET, V33, P197, DOI 10.1038/ng1077; Costello JF, 2000, NAT GENET, V24, P132, DOI 10.1038/72785; Cui HM, 1998, NAT MED, V4, P1276, DOI 10.1038/3260; Cui HM, 2003, SCIENCE, V299, P1753, DOI 10.1126/science.1080902; Debaun Michael R., 2004, P758; DeBaun MR, 2003, AM J HUM GENET, V72, P156, DOI 10.1086/346031; DeBaun MR, 2002, AM J HUM GENET, V70, P604, DOI 10.1086/338934; DeBaun MR, 1998, J PEDIATR-US, V132, P398, DOI 10.1016/S0022-3476(98)70008-3; Diaz-Meyer N, 2005, J MED GENET, V42, P648, DOI 10.1136/jmg.2004.030593; Eden A, 2003, SCIENCE, V300, P455, DOI 10.1126/science.1083557; Esteller M, 2001, CANCER RES, V61, P3225; Esteve PO, 2006, GENE DEV, V20, P3089, DOI 10.1101/gad.1463706; FEINBERG AP, 1983, NATURE, V301, P89, DOI 10.1038/301089a0; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; FEINBERG AP, 1993, NAT GENET, V4, P110, DOI 10.1038/ng0693-110; Fraga MF, 2005, NAT GENET, V37, P391, DOI 10.1038/ng1531; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Frigola J, 2006, NAT GENET, V38, P540, DOI 10.1038/ng1781; Gaudet F, 2003, SCIENCE, V300, P489, DOI 10.1126/science.1083558; Gibbons RJ, 2000, AM J MED GENET, V97, P204, DOI 10.1002/1096-8628(200023)97:3<204::AID-AJMG1038>3.0.CO;2-X; Giovannucci E, 2004, J NUTR, V134, p2475S, DOI 10.1093/jn/134.9.2475S; Gius D, 2004, CANCER CELL, V6, P361, DOI 10.1016/j.ccr.2004.08.029; GREGER V, 1989, HUM GENET, V83, P155, DOI 10.1007/BF00286709; Harper J, 2006, CANCER RES, V66, P1940, DOI 10.1158/0008-5472.CAN-05-2036; Hattori N, 2004, GENOME RES, V14, P1733, DOI 10.1101/gr.2431504; Hochedlinger K, 2004, GENE DEV, V18, P1875, DOI 10.1101/gad.1213504; Holm TM, 2005, CANCER CELL, V8, P275, DOI 10.1016/j.ccr.2005.09.007; Holst CR, 2003, CANCER RES, V63, P1596; Horsthemke B, 2006, CYTOGENET GENOME RES, V113, P292, DOI 10.1159/000090844; Horton SJ, 2005, CANCER RES, V65, P9245, DOI 10.1158/0008-5472.CAN-05-1691; Hu M, 2005, NAT GENET, V37, P899, DOI 10.1038/ng1596; Iyer NG, 2004, ONCOGENE, V23, P4225, DOI 10.1038/sj.onc.1207118; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Kates WR, 2004, AM J PSYCHIAT, V161, P539, DOI 10.1176/appi.ajp.161.3.539; Kato T, 2005, MOL PSYCHIATR, V10, P622, DOI 10.1038/sj.mp.4001662; KONDO M, 1995, ONCOGENE, V10, P1193; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; KURODA SY, 1965, FOUND LANG, V1, P30; LAIRD PW, 1995, CELL, V81, P197, DOI 10.1016/0092-8674(95)90329-1; Lalande M, 2001, J CLIN INVEST, V107, P793, DOI 10.1172/JCI12645; Lehner B, 2006, NAT GENET, V38, P896, DOI 10.1038/ng1844; Lu Q, 2006, AGEING RES REV, V5, P449, DOI 10.1016/j.arr.2006.07.001; Mack GS, 2006, J NATL CANCER I, V98, P1443, DOI 10.1093/jnci/djj447; McInnis MG, 2003, MOL PSYCHIATR, V8, P288, DOI 10.1038/sj.mp.4001277; Murphy SK, 2006, MOL CANCER RES, V4, P283, DOI 10.1158/1541-7786.MCR-05-0138; Niemitz EL, 2004, AM J HUM GENET, V75, P844, DOI 10.1086/425343; Niemitz EL, 2004, AM J HUM GENET, V74, P599, DOI 10.1086/382897; OGAWA O, 1993, NATURE, V362, P749, DOI 10.1038/362749a0; Palferman S, 2001, HUM MOL GENET, V10, P973; Pedersen IS, 1999, CANCER RES, V59, P5449; Petrif F., 2002, NATURE, V376, P348; Phiel CJ, 2001, J BIOL CHEM, V276, P36734, DOI 10.1074/jbc.M101287200; QUDDUS J, 1993, J CLIN INVEST, V92, P38, DOI 10.1172/JCI116576; Raefski AS, 2005, NAT GENET, V37, P620, DOI 10.1038/ng1567; RAINIER S, 1993, NATURE, V362, P747, DOI 10.1038/362747a0; Ravenel JD, 2001, JNCI-J NATL CANCER I, V93, P1698, DOI 10.1093/jnci/93.22.1698; Richardson B, 2003, CLIN IMMUNOL, V109, P72, DOI 10.1016/S1521-6616(03)00206-7; Rozenblatt-Rosen O, 1998, P NATL ACAD SCI USA, V95, P4152, DOI 10.1073/pnas.95.8.4152; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Sakatani T, 2005, SCIENCE, V307, P1976, DOI 10.1126/science.1108080; SCOTT MRD, 1983, CELL, V34, P557, DOI 10.1016/0092-8674(83)90388-4; SCRABLE H, 1989, P NATL ACAD SCI USA, V86, P7480, DOI 10.1073/pnas.86.19.7480; Skuse DH, 1997, NATURE, V387, P705, DOI 10.1038/42706; Sollars V, 2003, NAT GENET, V33, P70, DOI 10.1038/ng1067; Sparago A, 2004, NAT GENET, V36, P958, DOI 10.1038/ng1410; Sutherland JE, 2003, ANN NY ACAD SCI, V983, P151, DOI 10.1111/j.1749-6632.2003.tb05970.x; Tamaru H, 2001, NATURE, V414, P277, DOI 10.1038/35104508; Terranova R, 2006, P NATL ACAD SCI USA, V103, P6629, DOI 10.1073/pnas.0507425103; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; Uyeno S, 1996, CANCER RES, V56, P5356; van Roozendaal CEP, 1998, FEBS LETT, V437, P107, DOI 10.1016/S0014-5793(98)01211-3; Van Speybroeck L, 2002, ANN NY ACAD SCI, V981, P61; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Veigl ML, 1998, P NATL ACAD SCI USA, V95, P8698, DOI 10.1073/pnas.95.15.8698; Versteege I, 1998, NATURE, V394, P203, DOI 10.1038/28212; Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003; Waterland RA, 2006, HUM MOL GENET, V15, P705, DOI 10.1093/hmg/ddi484; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Wilson AS, 2007, BBA-REV CANCER, V1775, P138, DOI 10.1016/j.bbcan.2006.08.007; Woodson K, 2004, JNCI-J NATL CANCER I, V96, P407, DOI 10.1093/jnci/djh042; Wu HJ, 2005, NATURE, V438, P981, DOI 10.1038/nature04225; Xu GL, 1999, NATURE, V402, P187, DOI 10.1038/46052; Yamada Y, 2005, P NATL ACAD SCI USA, V102, P13580, DOI 10.1073/pnas.0506612102; Yee KWL, 2005, ANN HEMATOL, V84, P18, DOI 10.1007/s00277-005-0019-7; Yuan JH, 2003, CANCER RES, V63, P4174; Zheng YJ, 2004, METHOD ENZYMOL, V376, P188	100	1166	1210	5	324	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 24	2007	447	7143					433	440		10.1038/nature05919	http://dx.doi.org/10.1038/nature05919			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170VA	17522677				2022-12-28	WOS:000246693100039
J	Wernig, M; Meissner, A; Foreman, R; Brambrink, T; Ku, MC; Hochedlinger, K; Bernstein, BE; Jaenisch, R				Wernig, Marius; Meissner, Alexander; Foreman, Ruth; Brambrink, Tobias; Ku, Manching; Hochedlinger, Konrad; Bernstein, Bradley E.; Jaenisch, Rudolf			In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state	NATURE			English	Article							DE-NOVO METHYLATION; DEVELOPMENTAL REGULATORS; RETROVIRAL GENOMES; SOMATIC-CELLS; EXPRESSION; DIFFERENTIATION; TRANSCRIPTION; POLYCOMB; CLONING; GENES	Nuclear transplantation can reprogramme a somatic genome back into an embryonic epigenetic state, and the reprogrammed nucleus can create a cloned animal or produce pluripotent embryonic stem cells. One potential use of the nuclear cloning approach is the derivation of 'customized' embryonic stem (ES) cells for patient-specific cell treatment, but technical and ethical considerations impede the therapeutic application of this technology. Reprogramming of fibroblasts to a pluripotent state can be induced in vitro through ectopic expression of the four transcription factors Oct4 (also called Oct3/4 or Pou5f1), Sox2, c-Myc and Klf4. Here we show that DNA methylation, gene expression and chromatin state of such induced reprogrammed stem cells are similar to those of ES cells. Notably, the cells - derived from mouse fibroblasts - can form viable chimaeras, can contribute to the germ line and can generate live late-term embryos when injected into tetraploid blastocysts. Our results show that the biological potency and epigenetic state of in-vitro-reprogrammed induced pluripotent stem cells are indistinguishable from those of ES cells.	MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02142 USA; Massachusetts Gen Hosp, Mol Pathol Unit, Charlestown, MA 02129 USA; Massachusetts Gen Hosp, Ctr Canc Res, Charlestown, MA 02129 USA; Harvard Univ, Broad Inst, Cambridge, MA 02142 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School	Jaenisch, R (corresponding author), MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA.	jaenisch@wi.mit.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; NIGMS NIH HHS [T32 GM007753] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Blelloch R, 2006, STEM CELLS, V24, P2007, DOI 10.1634/stemcells.2006-0050; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brambrink T, 2006, P NATL ACAD SCI USA, V103, P933, DOI 10.1073/pnas.0510485103; CHAPMAN V, 1984, NATURE, V307, P284, DOI 10.1038/307284a0; Cowan CA, 2005, SCIENCE, V309, P1369, DOI 10.1126/science.1116447; Eads Cindy A, 2002, Methods Mol Biol, V200, P71; Eggan K, 2001, P NATL ACAD SCI USA, V98, P6209, DOI 10.1073/pnas.101118898; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Hochedlinger K, 2003, NEW ENGL J MED, V349, P275, DOI 10.1056/NEJMra035397; Hochedlinger K, 2006, NATURE, V441, P1061, DOI 10.1038/nature04955; Holm TM, 2005, CANCER CELL, V8, P275, DOI 10.1016/j.ccr.2005.09.007; Jackson-Grusby L, 2001, NAT GENET, V27, P31, DOI 10.1038/83730; Jaenisch R, 2004, NEW ENGL J MED, V351, P2787, DOI 10.1056/NEJMp048304; JAHNER D, 1982, NATURE, V298, P623, DOI 10.1038/298623a0; LABOSKY PA, 1994, DEVELOPMENT, V120, P3197; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Lucifero D, 2002, GENOMICS, V79, P530, DOI 10.1006/geno.2002.6732; MAHERALI N, IN PRESS CELL STEM C; Meissner A, 2005, NUCLEIC ACIDS RES, V33, P5868, DOI 10.1093/nar/gki901; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Peitz M, 2002, P NATL ACAD SCI USA, V99, P4489, DOI 10.1073/pnas.032068699; STEWART CL, 1982, P NATL ACAD SCI-BIOL, V79, P4098, DOI 10.1073/pnas.79.13.4098; Tada M, 2001, CURR BIOL, V11, P1553, DOI 10.1016/S0960-9822(01)00459-6; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Walsh CP, 1998, NAT GENET, V20, P116, DOI 10.1038/2413; Wernig M, 2004, J NEUROSCI, V24, P5258, DOI 10.1523/JNEUROSCI.0428-04.200; Yang XZ, 2007, NAT GENET, V39, P295, DOI 10.1038/ng1973	34	2027	2300	3	354	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 19	2007	448	7151					318	U2		10.1038/nature05944	http://dx.doi.org/10.1038/nature05944			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191GC	17554336				2022-12-28	WOS:000248118300050
J	Chan, CS; Guzman, JN; Ilijic, E; Mercer, JN; Rick, C; Tkatch, T; Meredith, GE; Surmeier, DJ				Chan, C. Savio; Guzman, Jaime N.; Ilijic, Ema; Mercer, Jeff N.; Rick, Caroline; Tkatch, Tatiana; Meredith, Gloria E.; Surmeier, D. James			'Rejuvenation' protects neurons in mouse models of Parkinson's disease	NATURE			English	Article							MIDBRAIN DOPAMINERGIC-NEURONS; MITOCHONDRIAL-DNA DELETIONS; SUBSTANTIA-NIGRA NEURONS; MEDIUM SPINY NEURONS; CA2+ CHANNELS; CHOLINERGIC INTERNEURONS; CALCIUM-ANTAGONISTS; STRIATAL LEVEL; PATHOGENESIS; MECHANISMS	Why dopamine-containing neurons of the brain's substantia nigra pars compacta die in Parkinson's disease has been an enduring mystery. Our studies suggest that the unusual reliance of these neurons on L-type Ca(v)1.3 Ca2+ channels to drive their maintained, rhythmic pacemaking renders them vulnerable to stressors thought to contribute to disease progression. The reliance on these channels increases with age, as juvenile dopamine-containing neurons in the substantia nigra pars compacta use pacemaking mechanisms common to neurons not affected in Parkinson's disease. These mechanisms remain latent in adulthood, and blocking Ca(v)1.3 Ca2+ channels in adult neurons induces a reversion to the juvenile form of pacemaking. Such blocking ('rejuvenation') protects these neurons in both in vitro and in vivo models of Parkinson's disease, pointing to a new strategy that could slow or stop the progression of the disease.	Northwestern Univ, Dept Physiol, Feinberg Sch Med, Chicago, IL 60611 USA; Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Dept Mol & Cellular Pharmacol, Chicago, IL 60064 USA	Northwestern University; Feinberg School of Medicine; Chicago Medical School; Rosalind Franklin University Medical & Science	Surmeier, DJ (corresponding author), Northwestern Univ, Dept Physiol, Feinberg Sch Med, Chicago, IL 60611 USA.	j-surmeier@northwestern.edu	Tuluc, Petronel/C-2527-2011	Chan, C. Savio/0000-0002-3474-1718; Tkatch, Tatiana/0000-0001-6626-7435	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008152] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abou-Sleiman PM, 2006, NAT REV NEUROSCI, V7, P207, DOI 10.1038/nrn1868; Ai Y, 2003, J COMP NEUROL, V461, P250, DOI 10.1002/cne.10689; Beal MF, 1998, ANN NEUROL, V44, pS110; Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Braak H, 2004, CELL TISSUE RES, V318, P121, DOI 10.1007/s00441-004-0956-9; Bywood PT, 2003, EXP NEUROL, V179, P47, DOI 10.1006/exnr.2002.8044; Chan CS, 2004, J NEUROSCI, V24, P9921, DOI 10.1523/JNEUROSCI.2162-04.2004; Coleman M, 2005, NAT REV NEUROSCI, V6, P889, DOI 10.1038/nrn1788; COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; Fahn S, 2005, J NEUROL, V252, P37, DOI 10.1007/s00415-005-4008-5; GRACE AA, 1984, J NEUROSCI, V4, P2866; GRACE AA, 1989, J NEUROSCI, V9, P3463; Greenamyre JT, 2004, SCIENCE, V304, P1120, DOI 10.1126/science.1098966; GROSSMAN E, 1991, AM J CARDIOL, V68, P65, DOI 10.1016/0002-9149(91)90712-T; Hasbani DM, 2005, J NEUROSCI, V25, P9428, DOI 10.1523/JNEUROSCI.0130-05.2005; Hines ML, 2001, NEUROSCIENTIST, V7, P123, DOI 10.1177/107385840100700207; HORNYKIEWICZ O, 1966, PHARMACOL REV, V18, P925; Hows MEP, 2004, J NEUROSCI METH, V137, P221, DOI 10.1016/j.jneumeth.2004.02.011; Jiang Q, 2006, J NEUROSCI, V26, P4318, DOI 10.1523/JNEUROSCI.0118-06.2006; Johnson BA, 2001, AM J PSYCHIAT, V158, P1191, DOI 10.1176/appi.ajp.158.8.1191; Kazuno AA, 2006, PLOS GENET, V2, P1167, DOI 10.1371/journal.pgen.0020128; KISH SJ, 1988, NEW ENGL J MED, V318, P876, DOI 10.1056/NEJM198804073181402; Koschak A, 2001, J BIOL CHEM, V276, P22100, DOI 10.1074/jbc.M101469200; Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778; Krieger C, 2002, EUR J PHARMACOL, V447, P177, DOI 10.1016/S0014-2999(02)01842-3; Kupsch A, 1996, BRAIN RES, V741, P185, DOI 10.1016/S0006-8993(96)00917-1; KUPSCH A, 1995, NEUROREPORT, V6, P621, DOI 10.1097/00001756-199503000-00009; Kwong JQ, 2006, J NEUROCHEM, V97, P1659, DOI 10.1111/j.1471-4159.2006.03990.x; Mandir AS, 1999, P NATL ACAD SCI USA, V96, P5774, DOI 10.1073/pnas.96.10.5774; Maurice N, 2004, J NEUROSCI, V24, P10289, DOI 10.1523/JNEUROSCI.2155-04.2004; MERCURI NB, 1994, BRIT J PHARMACOL, V113, P831, DOI 10.1111/j.1476-5381.1994.tb17068.x; Meredith GE, 2006, MOVEMENT DISORD, V21, P1595, DOI 10.1002/mds.21010; MICHEL D, 1990, CERAM TRANS, V6, P435; MIGLIORE M, 1995, J NEUROPHYSIOL, V73, P1157, DOI 10.1152/jn.1995.73.3.1157; NEDERGAARD S, 1993, J PHYSIOL-LONDON, V466, P727; Nelson EL, 1996, J COMP NEUROL, V369, P361, DOI 10.1002/(SICI)1096-9861(19960603)369:3<361::AID-CNE3>3.0.CO;2-3; Neuhoff H, 2002, J NEUROSCI, V22, P1290, DOI 10.1523/JNEUROSCI.22-04-01290.2002; Olson PA, 2005, J NEUROSCI, V25, P1050, DOI 10.1523/JNEUROSCI.3327-04.2005; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Paxinos G, 2004, MOUSE BRAIN STEREOTA; Petroske E, 2001, NEUROSCIENCE, V106, P589, DOI 10.1016/S0306-4522(01)00295-0; Phinney AL, 2006, PARKINSONISM RELAT D, V12, P228, DOI 10.1016/j.parkreldis.2005.12.002; Platzer J, 2000, CELL, V102, P89, DOI 10.1016/S0092-8674(00)00013-1; Przedborski S, 2003, ANN NY ACAD SCI, V991, P189; RIEDERER P, 1976, J NEURAL TRANSM, V38, P277, DOI 10.1007/BF01249445; Rodnitzky RL, 1999, DRUGS, V57, P845, DOI 10.2165/00003495-199957060-00001; Scholze A, 2001, MOL ENDOCRINOL, V15, P1211, DOI 10.1210/me.15.7.1211; Shen WX, 2005, J NEUROSCI, V25, P7449, DOI 10.1523/JNEUROSCI.1381-05.2005; Shepard PD, 1999, BRAIN RES, V817, P104, DOI 10.1016/S0006-8993(98)01231-1; Song WJ, 1998, J NEUROSCI, V18, P3124; Surmeier DJ, 2005, CURR OPIN NEUROBIOL, V15, P312, DOI 10.1016/j.conb.2005.05.007; Surmeier DJ, 1996, J NEUROSCI, V16, P6579, DOI 10.1523/jneurosci.16-20-06579.1996; Swerdlow RH, 1996, ANN NEUROL, V40, P663, DOI 10.1002/ana.410400417; Tkatch T, 1998, NEUROREPORT, V9, P1935, DOI 10.1097/00001756-199806220-00004; Verkhratsky A, 2005, PHYSIOL REV, V85, P201, DOI 10.1152/physrev.00004.2004; Wang J, 2002, NEURON, V36, P451, DOI 10.1016/S0896-6273(02)00968-6; Wilson CJ, 2000, J NEUROPHYSIOL, V83, P3084, DOI 10.1152/jn.2000.83.5.3084; Xu WF, 2001, J NEUROSCI, V21, P5944, DOI 10.1523/JNEUROSCI.21-16-05944.2001; YAMADA T, 1990, BRAIN RES, V526, P303, DOI 10.1016/0006-8993(90)91236-A; YUNG WH, 1991, J PHYSIOL-LONDON, V436, P643, DOI 10.1113/jphysiol.1991.sp018571; Zecca L, 2003, TRENDS NEUROSCI, V26, P578, DOI 10.1016/j.tins.2003.08.009; Zhang L, 2005, HUM MOL GENET, V14, P2063, DOI 10.1093/hmg/ddi211; Zolles G, 2006, NEURON, V52, P1027, DOI 10.1016/j.neuron.2006.12.005	66	615	632	0	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 28	2007	447	7148					1081	U5		10.1038/nature05865	http://dx.doi.org/10.1038/nature05865			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	183HT	17558391				2022-12-28	WOS:000247564600031
J	Day, M				Day, Michael			Don't blame it all on the bogey	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Sydney, Sch Publ Hlth, Sydney, NSW 2006, Australia	University of Sydney	Day, M (corresponding author), Univ Sydney, Sch Publ Hlth, Sydney, NSW 2006, Australia.	miday@f2s.com							0	3	3	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 16	2007	334	7606					1250	1251		10.1136/bmj.39244.680880.59	http://dx.doi.org/10.1136/bmj.39244.680880.59			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	183AM	17569929	Green Published			2022-12-28	WOS:000247545100029
J	Agami, R				Agami, Reuven			All roads lead to IKK epsilon	CELL			English	Editorial Material							ONCOGENE-INDUCED SENESCENCE; GENETIC SCREEN	Extensive genetic alterations have been found in many epithelial malignancies. Using three complementary genetic approaches, Boehm et al. (2007) identify IKBKE - which encodes IKK epsilon, a component of the NF-kappa B pathway-as a breast cancer oncogene.	Netherlands Canc Inst, Div Tumor Biol, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute	Agami, R (corresponding author), Netherlands Canc Inst, Div Tumor Biol, NL-1066 CX Amsterdam, Netherlands.	r.agami@nki.nl	agami, reuven/GOG-8289-2022	Agami, Reuven/0000-0002-2848-2473				Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Harris J, 2006, J IMMUNOL, V177, P2527, DOI 10.4049/jimmunol.177.4.2527; Kolfschoten IGM, 2005, CELL, V121, P849, DOI 10.1016/j.cell.2005.04.017; Peeper DS, 2002, NAT CELL BIOL, V4, P148, DOI 10.1038/ncb742; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Westbrook TF, 2005, CELL, V121, P837, DOI 10.1016/j.cell.2005.03.033	8	9	9	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 15	2007	129	6					1043	1045		10.1016/j.cell.2007.05.048	http://dx.doi.org/10.1016/j.cell.2007.05.048			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	180UA	17574017	Bronze			2022-12-28	WOS:000247390400008
J	Hill, F				Hill, Frank			Astronomy - Waves in the Sun's core	SCIENCE			English	Editorial Material							GONG		Natl Opt Astron Observ, Natl Solar Observ, Tucson, AZ 85726 USA	National Optical Astronomy Observatory	Hill, F (corresponding author), Natl Opt Astron Observ, Natl Solar Observ, Tucson, AZ 85726 USA.	fhill@nso.edu						Bahcall JN, 2001, ASTROPHYS J, V555, P990, DOI 10.1086/321493; Domingo V, 1995, SOL PHYS, V162, P1, DOI 10.1007/BF00733425; GARCIA RA, 2007, SCIENCE         0503; Garcia RA, 2007, SCIENCE, V316, P1591, DOI 10.1126/science.1140598; Harvey JW, 1996, SCIENCE, V272, P1284, DOI 10.1126/science.272.5266.1284; Mason D, 2006, ASTROPHYS J, V645, P1543, DOI 10.1086/503761; Thompson MJ, 2003, ANNU REV ASTRON ASTR, V41, P599, DOI 10.1146/annurev.astro.41.011802.094848	7	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 15	2007	316	5831					1573	1574		10.1126/science.1144337	http://dx.doi.org/10.1126/science.1144337			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178SH	17569849				2022-12-28	WOS:000247239900025
J	Jordan, N; Boody, G; Broussard, W; Glover, JD; Keeney, D; McCown, BH; McIsaac, G; Muller, M; Murray, H; Neal, J; Pansing, C; Turner, RE; Warner, K; Wyse, D				Jordan, N.; Boody, G.; Broussard, W.; Glover, J. D.; Keeney, D.; McCown, B. H.; McIsaac, G.; Muller, M.; Murray, H.; Neal, J.; Pansing, C.; Turner, R. E.; Warner, K.; Wyse, D.			Environment - Sustainable development of the agricultural bio-economy	SCIENCE			English	Editorial Material							UNITED-STATES; BIOMASS; BIOFUELS		Univ Minnesota, Dept Agron & Plant Genet, St Paul, MN 55018 USA; Land Stewardship Project, White Bear Lake, MN 55110 USA; Louisiana State Univ, Dept Oceanog & Coastal Sci, Baton Rouge, LA 70803 USA; Land Inst, Salina, KS 67401 USA; Inst Agr & Trade Policy, Minneapolis, MN 55404 USA; Univ Wisconsin, Ctr Integrated Agr Syst, Madison, WI 53706 USA; Univ Illinois, Dept Nat Resources & Environm Sci, Urbana, IL 61801 USA; Univ Minnesota, Minnesota Inst Sustainable Agr, St Paul, MN 55108 USA; Iowa State Univ, Leopold Ctr Sustainable Agr, Ames, IA 50011 USA; Mississippi River Basin Alliance, Minneapolis, MN USA; Louisiana State Univ, Coastal Ecol Inst, Baton Rouge, LA 70803 USA; Santa Clara Univ, Inst Environm Studies, Santa Clara, CA 94053 USA	University of Minnesota System; University of Minnesota Twin Cities; Louisiana State University System; Louisiana State University; University of Wisconsin System; University of Wisconsin Madison; University of Illinois System; University of Illinois Urbana-Champaign; University of Minnesota System; University of Minnesota Twin Cities; Iowa State University; Louisiana State University System; Louisiana State University; Santa Clara University	Jordan, N (corresponding author), Univ Minnesota, Dept Agron & Plant Genet, St Paul, MN 55018 USA.	jorda020@umn.edu		Broussard, Whitney/0000-0001-6000-2751				Boody G, 2005, BIOSCIENCE, V55, P27, DOI 10.1641/0006-3568(2005)055[0027:MAITUS]2.0.CO;2; Brown RA, 2000, AGR ECOSYST ENVIRON, V78, P31, DOI 10.1016/S0167-8809(99)00115-2; DUFFY M, 2004, AGDM NEWSL       OCT; Eaglesham A., 2006, SUMM P 3 ANN WORLD C; ERS, 2007, FARM INC DAT FIL; GANTZER CJ, 1990, J SOIL WATER CONSERV, V45, P641; Green RE, 2005, SCIENCE, V307, P550, DOI 10.1126/science.1106049; Hey DL, 2005, ECOL ENG, V24, P279, DOI 10.1016/j.ecoleng.2004.11.014; *IATP, 2006, ASS BIOEC SURV; Jorgensen U, 2005, BIOMASS BIOENERG, V28, P237, DOI 10.1016/j.biombioe.2004.08.006; Keeney D, 2004, NATO ASI S 4 SCI TEC, V41, P29; Kennedy D, 2007, SCIENCE, V316, P515, DOI 10.1126/science.1142978; Kleijn D, 2006, ECOL LETT, V9, P243, DOI 10.1111/j.1461-0248.2005.00869.x; LUBOWSKI RN, 2006, 25 ERS; Reijnders L, 2006, ENERG POLICY, V34, P863, DOI 10.1016/j.enpol.2004.09.001; Robertson GP, 2000, SCIENCE, V289, P1922, DOI 10.1126/science.289.5486.1922; STOFFERHAN CW, 2006, IND FORMING ITS RELA; SULLIVAN P, 2004, 834 ERS; Thornley P, 2006, ENERG POLICY, V34, P2087, DOI 10.1016/j.enpol.2005.02.006; Tilman D, 2006, SCIENCE, V314, P1598, DOI 10.1126/science.1133306; *USDA ERS, 2000, HIST AM AGR 1607 200	21	189	196	6	117	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 15	2007	316	5831					1570	1571		10.1126/science.1141700	http://dx.doi.org/10.1126/science.1141700			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178SH	17569847				2022-12-28	WOS:000247239900023
J	Lin, H; Jen, Y				Lin, Hon-Yi; Jen, Yee-Min			Diffuse chemoradiotherapy-related enterocolitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Triserv Gen Hosp, Taipei 114, Taiwan	Tri-Service General Hospital	Lin, H (corresponding author), Triserv Gen Hosp, Taipei 114, Taiwan.	doc31221@ndmctsgh.edu.tw							0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 14	2007	356	24					2514	2514		10.1056/NEJMicm063001	http://dx.doi.org/10.1056/NEJMicm063001			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	178DR	17568032				2022-12-28	WOS:000247201900011
J	Rucci, M; Iovin, R; Poletti, M; Santini, F				Rucci, Michele; Iovin, Ramon; Poletti, Martina; Santini, Fabrizio			Miniature eye movements enhance fine spatial detail	NATURE			English	Article							VISUAL-CORTEX; MOTION; MICROSACCADES; VISION; IMAGES; STATISTICS; FIXATION; STRIATE; CELLS	Our eyes are constantly in motion. Even during visual fixation, small eye movements continually jitter the location of gaze(1-4). It is known that visual percepts tend to fade when retinal image motion is eliminated in the laboratory(5-9). However, it has long been debated whether, during natural viewing, fixational eye movements have functions in addition to preventing the visual scene from fading(10-17). In this study, we analysed the influence in humans of fixational eye movements on the discrimination of gratings masked by noise that has a power spectrum similar to that of natural images. Using a new method of retinal image stabilization(18), we selectively eliminated the motion of the retinal image that normally occurs during the intersaccadic intervals of visual fixation. Here we show that fixational eye movements improve discrimination of high spatial frequency stimuli, but not of low spatial frequency stimuli. This improvement originates from the temporal modulations introduced by fixational eye movements in the visual input to the retina, which emphasize the high spatial frequency harmonics of the stimulus. In a natural visual world dominated by low spatial frequencies, fixational eye movements appear to constitute an effective sampling strategy by which the visual system enhances the processing of spatial detail.	Boston Univ, Dept Cognit & Neural Syst, Boston, MA 02215 USA	Boston University	Rucci, M (corresponding author), Boston Univ, Dept Cognit & Neural Syst, Boston, MA 02215 USA.	rucci@cns.bu.edu		Poletti, Martina/0000-0002-4773-8745; Rucci, Michele/0000-0002-3066-1964				Ahissar E, 2001, NEURON, V32, P185, DOI 10.1016/S0896-6273(01)00466-4; AREND LE, 1973, PSYCHOL REV, V80, P374, DOI 10.1037/h0020072; Averill HL, 1925, J COMP PSYCHOL, V5, P147, DOI 10.1037/h0072373; Ditchburn R. W., 1955, OPT ACTA, V1, P171; FIELD DJ, 1987, J OPT SOC AM A, V4, P2379, DOI 10.1364/JOSAA.4.002379; Greschner M, 2002, NAT NEUROSCI, V5, P341, DOI 10.1038/nn821; HERING E, 1899, MATH PHYS KLASSE, V20, P16; KAPOULA ZA, 1986, EXP BRAIN RES, V61, P386; KELLY DH, 1979, J OPT SOC AM, V69, P1266, DOI 10.1364/JOSA.69.001266; KOENDERINK JJ, 1972, J OPT SOC AM, V62, P685, DOI 10.1364/JOSA.62.000685; Leopold DA, 1998, EXP BRAIN RES, V123, P341, DOI 10.1007/s002210050577; Macmillan NA., 1991, DETECTION THEORY USE; Marshall W. H., 1942, BIOL S VISUAL MECHAN, V7, P117; Martinez-Conde S, 2006, NEURON, V49, P297, DOI 10.1016/j.neuron.2005.11.033; Martinez-Conde S, 2000, NAT NEUROSCI, V3, P251, DOI 10.1038/72961; Murakami I, 1998, NATURE, V395, P798, DOI 10.1038/27435; Olveczky BP, 2003, NATURE, V423, P401, DOI 10.1038/nature01652; RATLIFF F, 1950, J EXP PSYCHOL, V40, P687, DOI 10.1037/h0057754; RIGGS LA, 1953, J OPT SOC AM, V43, P495, DOI 10.1364/JOSA.43.000495; RIGGS LA, 1952, J OPT SOC AM, V42, P872; Rucci M, 2005, NETWORK-COMP NEURAL, V16, P121, DOI 10.1080/09548980500300507; SANTINI F, IN PRESS BEHAV RES M; Snodderly DM, 2001, VISUAL NEUROSCI, V18, P259, DOI 10.1017/S0952523801182118; STEINMAN RM, 1967, SCIENCE, V155, P1577, DOI 10.1126/science.155.3769.1577; STEINMAN RM, 1973, SCIENCE, V181, P810, DOI 10.1126/science.181.4102.810; STEINMAN RM, 1980, VISION RES, V20, P415, DOI 10.1016/0042-6989(80)90032-2; TULUNAY-KEESEY U, 1976, Vision Research, V16, P481, DOI 10.1016/0042-6989(76)90026-2; TULUNAYKEESEY U, 1982, J OPT SOC AM, V72, P440, DOI 10.1364/JOSA.72.000440; Yarbus A.L., 1967, EYE MOVEMENTS VISION, DOI 10.1007/978-1-4899-5379-7	30	230	231	2	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 14	2007	447	7146					851	854		10.1038/nature05866	http://dx.doi.org/10.1038/nature05866			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178FV	17568745				2022-12-28	WOS:000247207500043
J	Debatin, KM				Debatin, Klaus-Michael			Chronic lymphocytic leukemia: Keeping cell death at bay	CELL			English	Editorial Material							APOPTOSIS; LINEAGE; GENES		Univ Ulm, Dept Pediat & Adolescent Med, D-89075 Ulm, Germany	Ulm University	Debatin, KM (corresponding author), Univ Ulm, Dept Pediat & Adolescent Med, Eythstr 24, D-89075 Ulm, Germany.	klaus-michael.debatin@uniklinik-ulm.de	Debatin, Klaus-Michael/J-9704-2014	Debatin, Klaus-Michael/0000-0002-8397-1886				Bhalla KN, 2005, J CLIN ONCOL, V23, P3971, DOI 10.1200/JCO.2005.16.600; Bialik S, 2006, ANNU REV BIOCHEM, V75, P189, DOI 10.1146/annurev.biochem.75.103004.142615; Calin GA, 2006, NEW ENGL J MED, V355, P533; Calmon MF, 2007, CANCER GENET CYTOGEN, V173, P31, DOI 10.1016/j.cancergencyto.2006.09.008; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chiorazzi N, 2005, NEW ENGL J MED, V352, P804, DOI 10.1056/NEJMra041720; Holleman A, 2006, BLOOD, V107, P769, DOI 10.1182/blood-2005-07-2930; Inbal B, 1997, NATURE, V390, P180, DOI 10.1038/36599; Inoue S, 2006, CANCER RES, V66, P6785, DOI 10.1158/0008-5472.CAN-05-4563; RAVAL A, 2007, CELL; Sellick GS, 2006, SEMIN ONCOL, V33, P195, DOI 10.1053/j.seminoncol.2006.01.013	11	5	6	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 1	2007	129	5					853	855		10.1016/j.cell.2007.05.023	http://dx.doi.org/10.1016/j.cell.2007.05.023			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	176KT	17540163	Bronze			2022-12-28	WOS:000247084600003
J	Downie, JA				Downie, J. Allan			Plant science - Infectious heresy	SCIENCE			English	Editorial Material							NODULATION; RHIZOBIUM; ABSENCE		John Innes Ctr Plant Sci Res, Dept Mol Microbiol, Norwich NR4 7UH, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Downie, JA (corresponding author), John Innes Ctr Plant Sci Res, Dept Mol Microbiol, Norwich NR4 7UH, Norfolk, England.	allan.downie@bbsrc.ac.uk	Downie, Allan/I-3487-2012	Downie, Allan/0000-0003-1011-4960				COOPER JB, 1994, PLANT CELL, V6, P215, DOI 10.1105/tpc.6.2.215; Gargantini PR, 2006, PLANT J, V48, P843, DOI 10.1111/j.1365-313X.2006.02910.x; Giraud E, 2007, SCIENCE, V316, P1307, DOI 10.1126/science.1139548; Goormachtig S, 2004, TRENDS PLANT SCI, V9, P518, DOI 10.1016/j.tplants.2004.09.005; Kurakawa T, 2007, NATURE, V445, P652, DOI 10.1038/nature05504; Murray JD, 2007, SCIENCE, V315, P101, DOI 10.1126/science.1132514; NEWMAN JD, 1994, J BACTERIOL, V176, P3286, DOI 10.1128/jb.176.11.3286-3294.1994; Oldroyd GED, 2004, NAT REV MOL CELL BIO, V5, P566, DOI 10.1038/nrm1424; Spaink HP, 2000, ANNU REV MICROBIOL, V54, P257, DOI 10.1146/annurev.micro.54.1.257; Tirichine L, 2007, SCIENCE, V315, P104, DOI 10.1126/science.1132397	10	8	8	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 1	2007	316	5829					1296	1297		10.1126/science.1143870	http://dx.doi.org/10.1126/science.1143870			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	173PS	17540893				2022-12-28	WOS:000246885600038
J	Eisner, JA				Eisner, J. A.			Water vapour and hydrogen in the terrestrial-planet-forming region of a protoplanetary disk	NATURE			English	Article							MOLECULAR CLOUDS; ACCRETION; EMISSION; STELLAR; SPECTROSCOPY; STARS	Planetary systems (ours included) formed in disks of dust and gas around young stars. Disks are an integral part of the star and planet formation process(1,2), and knowledge of the distribution and temperature of inner-disk material is crucial for understanding terrestrial planet formation(3), giant planet migration(4), and accretion onto the central star(5). Although the inner regions of protoplanetary disks in nearby star-forming regions subtend only a few nano-radians, near-infrared interferometry has recently enabled the spatial resolution of these terrestrial zones. Most observations have probed only dust(6), which typically dominates the near-infrared emission. Here I report spectrally dispersed near-infrared interferometric observations that probe the gas (which dominates the mass and dynamics of the inner disk), in addition to the dust, within one astronomical unit (1 AU, the Sun Earth distance) of the young star MWC480. I resolve gas, including water vapour and atomic hydrogen, interior to the edge of the dust disk; this contrasts with results of previous spectrally dispersed interferometry observations(7,8). Interactions of this accreting gas with migrating planets may lead to short-period exoplanets like those detected around main-sequence stars(4). The observed water vapour is probably produced by the sublimation of migrating icy bodies(9), and provides a potential reservoir of water for terrestrial planets(10).	Univ Calif Berkeley, Dept Astron, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Eisner, JA (corresponding author), Univ Calif Berkeley, Dept Astron, 601 Campbell Hall, Berkeley, CA 94720 USA.	jae@astro.berkeley.edu						Calvet N, 1998, ASTROPHYS J, V509, P802, DOI 10.1086/306527; Carr JS, 2004, ASTROPHYS J, V603, P213, DOI 10.1086/381356; Colavita MM, 2003, P SOC PHOTO-OPT INS, V4838, P79, DOI 10.1117/12.456768; COLAVITA MM, 2003, ASTROPHYS J LETT, V592, P83; Drake MJ, 2005, METEORIT PLANET SCI, V40, P519, DOI 10.1111/j.1945-5100.2005.tb00960.x; Dullemond CP, 2001, ASTROPHYS J, V560, P957, DOI 10.1086/323057; Eisner JA, 2007, ASTROPHYS J, V657, P347, DOI 10.1086/510833; Eisner JA, 2007, ASTROPHYS J, V654, pL77, DOI 10.1086/510717; Eisner JA, 2004, ASTROPHYS J, V613, P1049, DOI 10.1086/423314; Isella A, 2005, ASTRON ASTROPHYS, V438, P899, DOI 10.1051/0004-6361:20052773; KONIGL A, 1991, ASTROPHYS J, V370, pL39, DOI 10.1086/185972; Lin DNC, 1996, NATURE, V380, P606, DOI 10.1038/380606a0; LUDWIG CB, 1971, APPL OPTICS, V10, P1057, DOI 10.1364/AO.10.001057; Malbet F, 2007, ASTRON ASTROPHYS, V464, P43, DOI 10.1051/0004-6361:20053924; Mannings V, 1997, NATURE, V388, P555, DOI 10.1038/41505; MARCY G, 2005, PROGR THEORETICAL PH, V158, P24; Millan-Gabet R, 2007, PROTOSTARS PLANETS, P539; Monnier JD, 2006, ASTROPHYS J, V647, P444, DOI 10.1086/505340; Muzerolle J, 2004, ASTROPHYS J, V617, P406, DOI 10.1086/425260; Najita J, 1996, ASTROPHYS J, V456, P292, DOI 10.1086/176649; OSTERBROCK DE, 1989, ASTROPHYSICS GASEOUS, pCH4; POLLACK JB, 1994, ASTROPHYS J, V421, P615, DOI 10.1086/173677; Raymond SN, 2004, ICARUS, V168, P1, DOI 10.1016/j.icarus.2003.11.019; Reipurth B., 2007, PROTOSTARS PLANETS, VV, P507; Safronov V.S, 1969, TTF677 NASA; SHU F, 1994, ASTROPHYS J, V429, P781, DOI 10.1086/174363; SHU FH, 1987, ANNU REV ASTRON ASTR, V25, P23, DOI 10.1146/annurev.aa.25.090187.000323; Tatulli E, 2007, ASTRON ASTROPHYS, V464, P55, DOI 10.1051/0004-6361:20065719; van den Ancker ME, 1998, ASTRON ASTROPHYS, V330, P145	30	43	43	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 31	2007	447	7144					562	564		10.1038/nature05867	http://dx.doi.org/10.1038/nature05867			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172YZ	17538613	Green Submitted			2022-12-28	WOS:000246842000041
J	Kim, H; Chen, JJ; Yu, XH				Kim, Hongtae; Chen, Junjie; Yu, Xiaochun			Ubiquitin-binding protein RAP80 mediates BRCA1-dependent DNA damage response	SCIENCE			English	Article							BRCA1; CHECKPOINT; BRCA1-BARD1; INTERACTS; REPAIR; KINASE; FANCD2; CHK1	Mutations in the breast cancer susceptibility gene 1 (BRCA1) are associated with an increased risk of breast and ovarian cancers. BRCA1 participates in the cellular DNA damage response. We report the identification of receptor-associated protein 80 (RAP80) as a BRCA1-interacting protein in humans. RAP80 contains a tandem ubiquitin-interacting motif domain, which is required for its binding with ubiquitin in vitro and its damage-induced foci formation in vivo. Moreover, RAP80 specifically recruits BRCA1 to DNA damage sites and functions with BRCA1 in G(2)/M checkpoint control. Together, these results suggest the existence of a ubiquitination-dependent signaling pathway involved in the DNA damage response.	Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06520 USA; Univ Michigan, Sch Med, Dept Internal Med, Div Med & Mol Genet, Ann Arbor, MI 48109 USA	Yale University; University of Michigan System; University of Michigan	Chen, JJ (corresponding author), Yale Univ, Sch Med, Dept Therapeut Radiol, POB 208040, New Haven, CT 06520 USA.	Junjie.chen@yale.edu; xiayu@med.umich.edu	高, 雨莉/HGU-8187-2022		NATIONAL CANCER INSTITUTE [R01CA089239] Funding Source: NIH RePORTER; NCI NIH HHS [R01CA089239] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Cantor SB, 2001, CELL, V105, P149, DOI 10.1016/S0092-8674(01)00304-X; Chen A, 2002, J BIOL CHEM, V277, P22085, DOI 10.1074/jbc.M201252200; Couch FJ, 1997, NEW ENGL J MED, V336, P1409, DOI 10.1056/NEJM199705153362002; de Oca RM, 2005, BLOOD, V105, P1003, DOI 10.1182/blood-2003-11-3997; Deming PB, 2001, P NATL ACAD SCI USA, V98, P12044, DOI 10.1073/pnas.221430898; Deng CX, 2000, BIOESSAYS, V22, P728; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; Hahn WC, 2002, NEW ENGL J MED, V347, P1593, DOI 10.1056/NEJMra021902; Hashizume R, 2001, J BIOL CHEM, V276, P14537, DOI 10.1074/jbc.C000881200; Hirano S, 2006, NAT STRUCT MOL BIOL, V13, P272, DOI 10.1038/nsmb1051; Liu QH, 2000, GENE DEV, V14, P1448; Rouse J, 2002, SCIENCE, V297, P547, DOI 10.1126/science.1074740; Su TT, 2006, ANNU REV GENET, V40, P187, DOI 10.1146/annurev.genet.40.110405.090428; Takai H, 2000, GENE DEV, V14, P1439; Wang XZ, 2004, MOL CELL BIOL, V24, P5850, DOI 10.1128/MCB.24.13.5850-5862.2004; Xu B, 2001, MOL CELL BIOL, V21, P3445, DOI 10.1128/MCB.21.10.3445-3450.2001; Yan ZJ, 2002, J BIOL CHEM, V277, P32379, DOI 10.1074/jbc.M203475200; Yarden RI, 2002, NAT GENET, V30, P285, DOI 10.1038/ng837; Yu XC, 2004, MOL CELL BIOL, V24, P9478, DOI 10.1128/MCB.24.21.9478-9486.2004; Yu XC, 2006, GENE DEV, V20, P1721, DOI 10.1101/gad.1431006; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	21	437	446	1	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2007	316	5828					1202	1205		10.1126/science.1139621	http://dx.doi.org/10.1126/science.1139621			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171GQ	17525342				2022-12-28	WOS:000246724300046
J	Matsuoka, S; Ballif, BA; Smogorzewska, A; McDonald, ER; Hurov, KE; Luo, J; Bakalarski, CE; Zhao, ZM; Solimini, N; Lerenthal, Y; Shiloh, Y; Gygi, SP; Elledge, SJ				Matsuoka, Shuhei; Ballif, Bryan A.; Smogorzewska, Agata; McDonald, E. Robert, III; Hurov, Kristen E.; Luo, Ji; Bakalarski, Corey E.; Zhao, Zhenming; Solimini, Nicole; Lerenthal, Yaniv; Shiloh, Yosef; Gygi, Steven P.; Elledge, Stephen J.			ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage	SCIENCE			English	Article							TYROSINE PHOSPHORYLATION; IDENTIFICATION; CHECKPOINTS; INVOLVEMENT; PROTEOMICS; PATHWAYS; FANCD2; SITES; SMC1	Cellular responses to DNA damage are mediated by a number of protein kinases, including ATM ( ataxia telangiectasia mutated) and ATR ( ATM and Rad3-related). The outlines of the signal transduction portion of this pathway are known, but little is known about the physiological scope of the DNA damage response (DDR). We performed a large-scale proteomic analysis of proteins phosphorylated in response to DNA damage on consensus sites recognized by ATM and ATR and identified more than 900 regulated phosphorylation sites encompassing over 700 proteins. Functional analysis of a subset of this data set indicated that this list is highly enriched for proteins involved in the DDR. This set of proteins is highly interconnected, and we identified a large number of protein modules and networks not previously linked to the DDR. This database paints a much broader landscape for the DDR than was previously appreciated and opens new avenues of investigation into the responses to DNA damage in mammals.	Harvard Univ, Brigham & Womens Hosp, Sch Med,Howard HUghes Med Inst, Dept Genet, Boston, MA 02115 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med,Howard HUghes Med Inst, Ctr Genet & Genom, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Taplin Biol Mass Spectrometry Facil, Boston, MA 02115 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02214 USA; Tel Aviv Univ, Sackler Sch Med, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Tel Aviv University; Sackler Faculty of Medicine	Elledge, SJ (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med,Howard HUghes Med Inst, Dept Genet, Boston, MA 02115 USA.	steven_gygi@hms.harvard.edu; selledge@genetics.med.harvard.edu	Smogorzewska, Agata/B-8891-2011	Bakalarski, Corey/0000-0003-1085-7828; Smogorzewska, Agata/0000-0001-6285-1562	PHS HHS [1U19A1067751] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Azzalin CM, 2006, CURR BIOL, V16, P433, DOI 10.1016/j.cub.2006.01.018; Ballif BA, 2006, J PROTEOME RES, V5, P2372, DOI 10.1021/pr060206k; Brumbaugh KM, 2004, MOL CELL, V14, P585, DOI 10.1016/j.molcel.2004.05.005; Cortez D, 2004, P NATL ACAD SCI USA, V101, P10078, DOI 10.1073/pnas.0403410101; DeLaBarre B, 2003, NAT STRUCT BIOL, V10, P856, DOI 10.1038/nsb972; Dephoure N, 2005, P NATL ACAD SCI USA, V102, P17940, DOI 10.1073/pnas.0509080102; Groisman R, 2003, CELL, V113, P357, DOI 10.1016/S0092-8674(03)00316-7; Hirao A, 2000, SCIENCE, V287, P1824, DOI 10.1126/science.287.5459.1824; Ho GPH, 2006, MOL CELL BIOL, V26, P7005, DOI 10.1128/MCB.02018-05; Huang HJ, 2006, SCIENCE, V314, P294, DOI 10.1126/science.1130512; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kim ST, 1999, J BIOL CHEM, V274, P37538, DOI 10.1074/jbc.274.53.37538; Kim ST, 2002, GENE DEV, V16, P560, DOI 10.1101/gad.970602; Kozlov SV, 2006, EMBO J, V25, P3504, DOI 10.1038/sj.emboj.7601231; Mann M, 2006, NAT REV MOL CELL BIO, V7, P952, DOI 10.1038/nrm2067; Niedernhofer LJ, 2006, NATURE, V444, P1038, DOI 10.1038/nature05456; O'Neill T, 2000, J BIOL CHEM, V275, P22719, DOI 10.1074/jbc.M001002200; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Salomon AR, 2003, P NATL ACAD SCI USA, V100, P443, DOI 10.1073/pnas.2436191100; Shiloh Y, 2006, TRENDS BIOCHEM SCI, V31, P402, DOI 10.1016/j.tibs.2006.05.004; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; THORNE KC, 2000, J BIOL CHEM, V275, P35233; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Xia B, 2006, MOL CELL, V22, P719, DOI 10.1016/j.molcel.2006.05.022; Yang DQ, 2000, NAT CELL BIOL, V2, P893, DOI 10.1038/35046542; Yazdi PT, 2002, GENE DEV, V16, P571, DOI 10.1101/gad.970702; Yoo HY, 2004, J BIOL CHEM, V279, P53353, DOI 10.1074/jbc.M408026200; Yoshizawa-Sugata N, 2007, J BIOL CHEM, V282, P2729, DOI 10.1074/jbc.M605596200; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005; Ziv Y, 2006, NAT CELL BIOL, V8, P870, DOI 10.1038/ncb1446	31	2257	2783	9	289	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2007	316	5828					1160	1166		10.1126/science.1140321	http://dx.doi.org/10.1126/science.1140321			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171GQ	17525332				2022-12-28	WOS:000246724300034
J	Albo, ME; Richter, HE; Brubaker, L; Norton, P; Kraus, SR; Zimmern, PE; Zyczynski, H; Diokno, AC; Tennstedt, S; Nager, C; Lloyd, LK; FitzGerald, M; Lemack, GE; Johnson, HW; Leng, W; Mallett, V; Stoddard, AM; Menefee, S; Varner, RE; Kenton, K; Moalli, P; Sirls, L; Dandreo, KJ; Kusek, JW; Nyberg, LM; Steers, W; Steers, W; Diokno, A; Khandwala, S; Brubaker, L; FitzGerald, M; Richter, HE; Lloyd, LK; Albo, M; Nager, C; Chai, T; Johnson, HW; Zyczynski, HM; Leng, W; Zimmern, P; Lemack, G; Kraus, S; Rozanski, T; Norton, P; Kerr, L; Tennstedt, S; Stoddard, A; Chang, D; Kusek, JW; Nyberg, LM; Weber, AM; Ashford, RS; Baker, J; Borello-France, D; Burgio, KL; Chiang, S; Dabbous, A; Goode, PS; Hammontree, LN; Kenton, K; Lesser, D; Luber, K; Lukacz, E; Markland, A; Menefee, S; Moalli, P; Peters, K; Sagan, E; Schaffer, J; Simsiman, A; Sirls, L; Starr, R; Varner, RE; Bradt, R; Debes, K; Dinh, R; Gruss, J; Hall, L; Howell, A; Jesse, K; Kalinoski, DL; Koches, K; Leemon, B; Mislanovich, K; O'Meara, S; Parent, J; Pope, N; Prather, C; Rogers, T; Sluder, S; Tulke, M; Dandreo, KJ; Leifer, CJ; McDermott, S; Stoddard, A; Tennstedt, S; Tinsley, L; Wruck, L; Xu, Y; Gormley, EA; Abrams, P; Bland, D; Clemens, JQ; Connett, J; Henderson, W; Fenner, D; Kelsey, S; Myers, D; Mostwin, J; Wadie, B				Albo, Michael E.; Richter, Holly E.; Brubaker, Linda; Norton, Peggy; Kraus, Stephen R.; Zimmern, Philippe E.; Zyczynski, Halina; Diokno, Ananias C.; Tennstedt, Sharon; Nager, Charles; Lloyd, L. Keith; FitzGerald, MaryPat; Lemack, Gary E.; Johnson, Harry W.; Leng, Wendy; Mallett, Veronica; Stoddard, Anne M.; Menefee, Shawn; Varner, R. Edward; Kenton, Kimberly; Moalli, Pam; Sirls, Larry; Dandreo, Kimberly J.; Kusek, John W.; Nyberg, Leroy M.; Steers, William; Steers, W.; Diokno, A.; Khandwala, S.; Brubaker, L.; FitzGerald, M.; Richter, H. E.; Lloyd, L. K.; Albo, M.; Nager, C.; Chai, T.; Johnson, H. W.; Zyczynski, H. M.; Leng, W.; Zimmern, P.; Lemack, G.; Kraus, S.; Rozanski, T.; Norton, P.; Kerr, L.; Tennstedt, S.; Stoddard, A.; Chang, D.; Kusek, J. W.; Nyberg, L. M.; Weber, A. M.; Ashford, R. S., II; Baker, J.; Borello-France, D.; Burgio, K. L.; Chiang, S.; Dabbous, A.; Goode, P. S.; Hammontree, L. N.; Kenton, K.; Lesser, D.; Luber, K.; Lukacz, E.; Markland, A.; Menefee, S.; Moalli, P.; Peters, K.; Sagan, E.; Schaffer, J.; Simsiman, A.; Sirls, L.; Starr, R.; Varner, R. E.; Bradt, R.; Debes, K.; Dinh, R.; Gruss, J.; Hall, L.; Howell, A.; Jesse, K.; Kalinoski, D. L.; Koches, K.; Leemon, B.; Mislanovich, K.; O'Meara, S.; Parent, J.; Pope, N.; Prather, C.; Rogers, T.; Sluder, S.; Tulke, M.; Dandreo, K. J.; Leifer, C. J.; McDermott, S.; Stoddard, A.; Tennstedt, S.; Tinsley, L.; Wruck, L.; Xu, Y.; Gormley, E. A.; Abrams, P.; Bland, D.; Clemens, J. Q.; Connett, J.; Henderson, W.; Fenner, D.; Kelsey, S.; Myers, D.; Mostwin, J.; Wadie, B.		Urinary Incontinence Treatment Net	Burch colposuspension versus fascial sling to reduce urinary stress incontinence	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SURGERY; WOMEN; STANDARDIZATION; TERMINOLOGY; DEFINITION; COMMITTEE; BLADDER; IMPACT	Background: Many surgical procedures are available for women with urinary stress incontinence, yet few randomized clinical trials have been conducted to provide a basis for treatment recommendations. Methods: We performed a multicenter, randomized clinical trial comparing two procedures - the pubovaginal sling, using autologous rectus fascia, and the Burch colposuspension - among women with stress incontinence. Women were eligible for the study if they had predominant symptoms associated with the condition, a positive stress test, and urethral hypermobility. The primary outcomes were success in terms of overall urinary-incontinence measures, which required a negative pad test, no urinary incontinence (as recorded in a 3-day diary), a negative cough and Valsalva stress test, no self-reported symptoms, and no retreatment for the condition, and success in terms of measures of stress incontinence specifically, which required only the latter three criteria. We also assessed postoperative urge incontinence, voiding dysfunction, and adverse events. Results: A total of 655 women were randomly assigned to study groups: 326 to undergo the sling procedure and 329 to undergo the Burch procedure; 520 women (79%) completed the outcome assessment. At 24 months, success rates were higher for women who underwent the sling procedure than for those who underwent the Burch procedure, for both the overall category of success (47% vs. 38%, P=0.01) and the category specific to stress incontinence (66% vs. 49%, P < 0.001). However, more women who underwent the sling procedure had urinary tract infections, difficulty voiding, and postoperative urge incontinence. Conclusions: The autologous fascial sling results in a higher rate of successful treatment of stress incontinence but also greater morbidity than the Burch colposuspension.	Univ Calif San Diego, San Diego Med Ctr, Div Urol, San Diego, CA 92103 USA; Univ Alabama Birmingham, Birmingham, AL USA; Loyola Univ, Med Ctr, Maywood, IL 60153 USA; Univ Utah, Hlth Sci Ctr, Salt Lake City, UT USA; Univ Texas, Hlth Sci Ctr, San Antonio, TX USA; Univ Texas SW, Dallas, TX USA; Univ Maryland, Baltimore, MD 21201 USA; Univ Pittsburgh, Magee Womens Hosp, Pittsburgh, PA 15213 USA; Beaumont Hosp, Med Ctr, Royal Oak, MI USA; New England Res Inst, Watertown, MA 02172 USA; Oakwood Hosp, Dearborn, MI USA; NIDDKD, Bethesda, MD 20892 USA; Univ Virginia Hlth Syst, Charlottesville, VA USA	University of California System; University of California San Diego; University of Alabama System; University of Alabama Birmingham; Loyola University Chicago; Utah System of Higher Education; University of Utah; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Southwestern Medical Center Dallas; University System of Maryland; University of Maryland Baltimore; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Beaumont Health; HealthCore, Inc; Beaumont Health; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Virginia	Albo, ME (corresponding author), Univ Calif San Diego, San Diego Med Ctr, Div Urol, 200 W Arbor Dr, San Diego, CA 92103 USA.		Brubaker, Linda/J-5918-2019	Brubaker, Linda/0000-0002-8598-2589; Chai, Toby/0000-0002-1119-546X; Wadie, Bassem/0000-0002-6977-6849; Richter, Holly E/0000-0001-7741-5771	NCATS NIH HHS [UL1 TR000005] Funding Source: Medline; NIDDK NIH HHS [U01 DK60379, U01 DK58234, U01 DK58225, U01 DK058225, U01 DK58231, U01 DK60393, U01 DK60395, U01 DK60401, U01 DK60380, U01 DK60397, U01 DK58229] Funding Source: Medline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK060397, U01DK058231, U01DK060395, U01DK060393, U01DK060401, U01DK058229, U01DK058225, U01DK060379, U01DK060380, U01DK058234] Funding Source: NIH RePORTER	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abrams P, 2003, UROLOGY, V61, P37, DOI 10.1016/S0090-4295(02)02243-4; ALCALAY M, 1995, BRIT J OBSTET GYNAEC, V102, P740, DOI 10.1111/j.1471-0528.1995.tb11434.x; Alcalay M, 1996, BRIT J OBSTET GYNAEC, V103, P290; Bezerra CA, 2005, COCHRANE DB SYST REV, V3; Black N, 1997, BRIT MED J, V315, P1493, DOI 10.1136/bmj.315.7121.1493; Black NA, 1996, BRIT J UROL, V78, P497, DOI 10.1046/j.1464-410X.1996.01422.x; Blaivas JG, 1997, NEUROUROL URODYNAM, V16, P145, DOI 10.1002/(SICI)1520-6777(1997)16:3<145::AID-NAU2>3.0.CO;2-E; Bump RC, 1996, AM J OBSTET GYNECOL, V175, P10, DOI 10.1016/S0002-9378(96)70243-0; Chaikin DC, 1998, J UROLOGY, V160, P1312, DOI 10.1016/S0022-5347(01)62524-2; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Hampel C, 1997, UROLOGY, V50, P4, DOI 10.1016/S0090-4295(97)00578-5; HERZOG AR, 1990, J GERONTOL, V45, pM67, DOI 10.1093/geronj/45.2.M67; Hilton P, 2002, BJOG-INT J OBSTET GY, V109, P1081, DOI 10.1111/j.1471-0528.2002.02011.x; JARVIS GJ, 1994, BRIT J OBSTET GYNAEC, V101, P371, DOI 10.1111/j.1471-0528.1994.tb11907.x; Kalbfleisch J.D., 2002, STAT ANAL FAILURE TI; KELLY MJ, 1991, UROLOGY, V37, P213, DOI 10.1016/0090-4295(91)80287-H; KJOLHEDE P, 1994, ACTA OBSTET GYN SCAN, V73, P642, DOI 10.3109/00016349409013459; Korn AP, 1996, UROLOGY, V48, P609, DOI 10.1016/S0090-4295(96)00298-1; LAPITAN MC, 2005, COCHRANE DB SYST REV, V3; Leach GE, 1997, J UROLOGY, V158, P875, DOI 10.1016/S0022-5347(01)64346-5; LOSE G, 1989, ACTA OBSTET GYN SCAN, V68, P211, DOI 10.3109/00016348909020991; Mattiasson A, 1998, NEUROUROL URODYNAM, V17, P249, DOI 10.1002/(SICI)1520-6777(1998)17:3<249::AID-NAU9>3.3.CO;2-I; McGuire EJ, 2002, J UROLOGY, V167, P1120, DOI 10.1016/S0022-5347(02)80355-X; Melville JL, 2005, ARCH INTERN MED, V165, P537, DOI 10.1001/archinte.165.5.537; Norton P, 2006, LANCET, V367, P57, DOI 10.1016/S0140-6736(06)67925-7; Nygaard IE, 2004, OBSTET GYNECOL, V104, P607, DOI 10.1097/01.AOG.0000137874.84862.94; Schafer W, 2002, NEUROUROL URODYNAM, V21, P261, DOI 10.1002/nau.10066; Shull BL, 1999, INCONTINENCE, P333; SHUMAKER SA, 1994, QUAL LIFE RES, V3, P291, DOI 10.1007/BF00451721; Smith ARB, 2005, INCONTINENCE, VOLS 1 AND 2, P1297; Steers W, 2005, UROLOGY, V66, P1213, DOI 10.1016/j.urology.2005.06.089; TANAGHO EA, 1976, J UROLOGY, V116, P751, DOI 10.1016/S0022-5347(17)58997-1; Thom D, 1998, J AM GERIATR SOC, V46, P473, DOI 10.1111/j.1532-5415.1998.tb02469.x; Thom DH, 2005, J UROLOGY, V173, P1295, DOI 10.1097/01.ju.0000155679.77895.cb; Waetjen LE, 2003, OBSTET GYNECOL, V101, P671, DOI 10.1016/S0029-7844(02)03124-1; Ward KL, 2004, AM J OBSTET GYNECOL, V190, P324, DOI 10.1016/j.ajog.2003.07.029; Weber AM, 2001, INT UROGYNECOL J PEL, V12, P178, DOI 10.1007/PL00004033; WEBSTER GD, 2002, CAMPBELLS UROLOGY, P1140; Wilson L, 2001, OBSTET GYNECOL, V98, P398, DOI 10.1016/S0029-7844(01)01464-8; WYMAN JF, 1988, OBSTET GYNECOL, V71, P812	41	345	348	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 24	2007	356	21					2143	2155		10.1056/NEJMoa070416	http://dx.doi.org/10.1056/NEJMoa070416			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	170ON	17517855				2022-12-28	WOS:000246673100004
J	Davis, MC; Dahn, RD; Shubin, NH				Davis, Marcus C.; Dahn, Randall D.; Shubin, Neil H.			An autopodial-like pattern of Hox expression in the fins of a basal actinopterygian fish	NATURE			English	Article							SONIC-HEDGEHOG EXPRESSION; PECTORAL FIN; POLARIZING ACTIVITY; POLYODON-SPATHULA; LIMB; EVOLUTION; GENES; ORIGIN; DHAND; BUD	Comparative analyses of Hox gene expression and regulation in teleost fish and tetrapods support the long-entrenched notion that the distal region of tetrapod limbs, containing the wrist, ankle and digits, is an evolutionary novelty(1-4). Data from fossils support the notion that the unique features of tetrapod limbs were assembled over evolutionary time in the paired fins of fish(5). The challenge in linking developmental and palaeontological approaches has been that developmental data for fins and limbs compare only highly derived teleosts and tetrapods; what is lacking are data from extant taxa that retain greater portions of the fin skeletal morphology considered primitive to all bony fish(6,7). Here, we report on the expression and function of genes implicated in the origin of the autopod in a basal actinopterygian, Polyodon spathula. Polyodon exhibits a late-phase, inverted collinear expression of 5' HoxD genes, a pattern of expression long considered a developmental hallmark of the autopod and shown in tetrapods to be controlled by a 'digit enhancer' region. These data show that aspects of the development of the autopod are primitive to tetrapods and that the origin of digits entailed the redeployment of ancient patterns of gene activity.	Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA; Field Museum Nat Hist, Chicago, IL 60605 USA	University of Chicago; Field Museum of Natural History (Chicago)	Shubin, NH (corresponding author), Univ Chicago, Dept Organismal Biol & Anat, 1025 E 57Th St, Chicago, IL 60637 USA.	nshubin@uchicago.edu		Davis, Marcus/0000-0002-2462-0138				Altaba ARI, 1999, DEVELOPMENT, V126, P3205; BEMIS WE, 1992, J MORPHOL, V213, P47, DOI 10.1002/jmor.1052130106; Charite J, 2000, DEVELOPMENT, V127, P2461; Dahn RD, 2007, NATURE, V445, P311, DOI 10.1038/nature05436; Davis MC, 2004, J MORPHOL, V262, P608, DOI 10.1002/jmor.10264; Fernandez-Teran M, 2000, DEVELOPMENT, V127, P2133; Freitas R, 2006, NATURE, V442, P1033, DOI 10.1038/nature04984; Hoffman L, 2002, INT J DEV BIOL, V46, P949; Litingtung Y, 2002, NATURE, V418, P979, DOI 10.1038/nature01033; Mabee PM, 2000, AM ZOOL, V40, P789, DOI 10.1668/0003-1569(2000)040[0789:DDAPSE]2.0.CO;2; Metscher BD, 2005, EVOL DEV, V7, P186, DOI 10.1111/j.1525-142X.2005.05021.x; Prince VE, 1998, DEVELOPMENT, V125, P407; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; Ros MA, 2003, DEVELOPMENT, V130, P527, DOI 10.1242/dev.00245; Shubin N, 1997, NATURE, V388, P639, DOI 10.1038/41710; Shubin N.H., 2006, NATURE, V440, P747; Sordino P, 1996, TRENDS ECOL EVOL, V11, P114, DOI 10.1016/0169-5347(96)81089-5; SORDINO P, 1995, NATURE, V375, P678, DOI 10.1038/375678a0; Spitz F, 2003, CELL, V113, P405, DOI 10.1016/S0092-8674(03)00310-6; Tarchini B, 2006, DEV CELL, V10, P93, DOI 10.1016/j.devcel.2005.11.014; Wagner GR, 2001, J EXP ZOOL, V291, P226, DOI 10.1002/jez.1100; Yelon D, 2000, DEVELOPMENT, V127, P2573	22	106	113	1	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 24	2007	447	7143					473	U3		10.1038/nature05838	http://dx.doi.org/10.1038/nature05838			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170VA	17522683				2022-12-28	WOS:000246693100047
J	Chen, LH; Wilson, ME; Schlagenhauf, P				Chen, Lin H.; Wilson, Mary E.; Schlagenhauf, Patricia			Controversies and misconceptions in malaria chemoprophylaxis for travelers	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							PLASMODIUM-VIVAX MALARIA; RESPIRATORY-DISTRESS-SYNDROME; ANOPHELES-GAMBIAE COMPLEX; PLACEBO-CONTROLLED TRIAL; IMPORTED MALARIA; DOUBLE-BLIND; CLINICAL-FEATURES; ADVERSE EVENTS; FIELD-EVALUATION; REPELLENT FORMULATIONS	Context Controversies in malaria prevention arise from the absence of data, conflicting data between different studies, conflicting recommendations, deviation of local practice from scientific data, and varying risk thresholds. Misconceptions about the seriousness of malaria, the tolerability of chemoprophylaxis drugs, and the efficacy and safety of repellents contribute to the controversies. Objectives To compare several national guidelines on malaria chemoprophylaxis to identify variations in recommendations. We reviewed studies on tolerability of mefloquine with particular focus on its neuropsychiatric adverse effects and influence on performance. We also describe why most recommended chemoprophylactic regimens fail to prevent relapses of Plasmodium vivax malaria and review available options. Evidence Acquisition We searched scientific publications in MEDLINE via PubMED for relevant articles with a cutoff date of December 2006 using the search terms malaria, chemoprophylaxis, travel, mefloquine, neuropsychiatric adverse events, tolerability, vivax malaria, and primaquine. Additional references were obtained from bibliographies of the selected articles. There were no language restrictions. Evidence Synthesis Gaps and conflicts exist among current guidelines. Health authorities vary in the chemoprophylaxis drugs they recommend, the indications for continuous prophylaxis vs no prophylaxis, and the use of standby emergency treatment. Despite widespread reports on the adverse effects of mefloquine, controlled studies found that serious neuropsychiatric adverse events occur at rates comparable with or lower than other chemoprophylaxis drugs. Moreover, mefloquine does not appear to impair performance while driving, flying, or diving. Vivax malaria causes significant illness in travelers, but current first-line chemoprophylaxis agents do not prevent relapses of vivax malaria. Although not licensed in most countries as primary prophylaxis, primaquine effectively prevents relapses of vivax malaria. Conclusions Prevention of malaria in travelers requires detailed knowledge of malaria epidemiology and host-vector-parasite interactions. Decisions are complicated by a lack of standardized recommendations, controversies, and misconceptions. Improved international consensus is indicated to minimize conflicting guidelines, clarify controversies, and promote adherence to preventive measures.	Mt Auburn Hosp, Travel Med Ctr, Div Infect Dis, Cambridge, MA 02238 USA; Harvard Univ, Sch Med, Boston, MA USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; Univ Zurich, Ctr Travel Med, Zurich, Switzerland	Harvard University; Mount Auburn Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; University of Zurich	Chen, LH (corresponding author), Mt Auburn Hosp, Travel Med Ctr, Div Infect Dis, 330 Mt Auburn St, Cambridge, MA 02238 USA.	lchen@hms.harvard.edu	Chen, Lin/ADS-6751-2022	Schlagenhauf, Patricia/0000-0002-1075-7010; Chen, Lin/0000-0002-5684-8436				Aarnoudse ALHJ, 2006, CLIN PHARMACOL THER, V80, P367, DOI 10.1016/j.clpt.2006.07.003; ALVING AS, 1955, J LAB CLIN MED, V46, P301; *AM AC PED, FOLL SAF PREC US DEE; [Anonymous], 1988, Bull World Health Organ, V66, P177; Anstey NM, 2007, J INFECT DIS, V195, P589, DOI 10.1086/510756; Antibiotic Expert Group, 2006, THER GUID ANT; Baas MC, 2006, J TRAVEL MED, V13, P2, DOI 10.1111/j.1708-8305.2006.00003.x; Badolo A, 2004, TROP MED INT HEALTH, V9, P330, DOI 10.1111/j.1365-3156.2004.01206.x; Baird J Kevin, 2007, Curr Infect Dis Rep, V9, P39, DOI 10.1007/s11908-007-0021-4; Baird JK, 2007, AM J TROP MED HYG, V76, P201, DOI 10.4269/ajtmh.2007.76.201; Baird JK, 2004, CLIN INFECT DIS, V39, P1336, DOI 10.1086/424663; Baird JK, 2003, CLIN INFECT DIS, V37, P1659, DOI 10.1086/379714; Baird JK, 2001, CLIN INFECT DIS, V33, P1990, DOI 10.1086/324085; BAIRD JK, 1991, AM J TROP MED HYG, V44, P547, DOI 10.4269/ajtmh.1991.44.547; Barrett PJ, 1996, BRIT MED J, V313, P525, DOI 10.1136/bmj.313.7056.525; Barrionuevo JA, 1996, MATH RES LETT, V3, P61; Beg MA, 2002, AM J TROP MED HYG, V67, P230, DOI 10.4269/ajtmh.2002.67.230; BERN JL, 1992, J TROP MED HYG, V95, P167; BIALEK R, 2007, EMPFEHLUNGEN MALARIA; BOREHAM RE, 1991, MED J AUSTRALIA, V155, P754, DOI 10.5694/j.1326-5377.1991.tb94028.x; Bottieau E, 2006, AM J TROP MED HYG, V75, P133, DOI 10.4269/ajtmh.2006.75.133; BOUDREAU E, 1993, TROP MED PARASITOL, V44, P257; Bradley D J, 2003, Commun Dis Public Health, V6, P180; Carlini ME, 1999, CLIN INFECT DIS, V28, P1182, DOI 10.1086/517779; Carlsson, 1996, J Travel Med, V3, P62, DOI 10.1111/j.1708-8305.1996.tb00700.x; Causer LM, 2004, CLIN INFECT DIS, V39, P1583, DOI 10.1086/425311; *CDCP, 2005, HLTH INF INT TRAV; *CDCP, IN PRESS YELL FEV VA; Chen LH, 2005, INFECT DIS CLIN N AM, V19, P185, DOI 10.1016/j.idc.2004.10.006; Chen LH, 2006, JAMA-J AM MED ASSOC, V296, P2234, DOI 10.1001/jama.296.18.2234; Chiodini P, 2007, GUIDELINES MALARIA P; Cockburn R, 2005, PLOS MED, V2, P302, DOI 10.1371/journal.pmed.0020100; Committee to Advise on Tropical Medicine and Travel (CATMAT), 2004, Can Commun Dis Rep, V30 Suppl 1, P1; Corbett EL, 1996, BRIT MED J, V313, P1552, DOI 10.1136/bmj.313.7071.1552b; Costantini C, 2004, T ROY SOC TROP MED H, V98, P644, DOI 10.1016/j.trstmh.2003.12.015; CROFT AM, 2000, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000138; Croft AMJ, 1996, LANCET, V347, P326, DOI 10.1016/S0140-6736(96)90500-0; Davis TME, 1996, BRIT J CLIN PHARMACO, V42, P415, DOI 10.1111/j.1365-2125.1996.tb00003.x; Delaunay P, 2000, BRIT MED J, V321, P1288; Eliades M. James, 2005, Morbidity and Mortality Weekly Report, V54, P25; Elliott JH, 2004, J TRAVEL MED, V11, P213, DOI 10.2310/7060.2004.19004; Frances SP, 2004, J MED ENTOMOL, V41, P414, DOI 10.1603/0022-2585-41.3.414; Frances SP, 2002, J MED ENTOMOL, V39, P541, DOI 10.1603/0022-2585-39.3.541; FRYAUFF DJ, 1995, LANCET, V346, P1190, DOI 10.1016/S0140-6736(95)92898-7; GENTILINI M, 1981, T ROY SOC TROP MED H, V75, P455, DOI 10.1016/0035-9203(81)90120-6; Gockel HR, 2006, INFECTION, V34, P43, DOI 10.1007/s15010-006-4126-8; Goller JL, 2007, AM J TROP MED HYG, V76, P203, DOI 10.4269/ajtmh.2007.76.203; Guerra CA, 2006, TRENDS PARASITOL, V22, P353, DOI 10.1016/j.pt.2006.06.006; HATZ C, 2007, B BUNDESAMT GESUNDHE, V11, P212; Hemmer CJ, 2006, TROP MED INT HEALTH, V11, P817, DOI 10.1111/j.1365-3156.2006.01635.x; Hessen-Soderman, 1995, J Travel Med, V2, P66, DOI 10.1111/j.1708-8305.1995.tb00629.x; Hill DR, 2006, AM J TROP MED HYG, V75, P402, DOI 10.4269/ajtmh.2006.75.402; HILL DR, PRACTICE TRAVEL MED; Hoebe C, 1997, EUR J CLIN PHARMACOL, V52, P269, DOI 10.1007/s002280050288; Hughes C, 2003, Commun Dis Public Health, V6, P200; *I VEILL SAN, 2006, B EPIDEMIOLOGIQUE HE, V23, P153; Jelinek, 1994, J Travel Med, V1, P199, DOI 10.1111/j.1708-8305.1994.tb00595.x; Jimenez BC, 2006, J TRAVEL MED, V13, P373, DOI 10.1111/j.1708-8305.2006.00073.x; Kain KC, 1998, CLIN INFECT DIS, V27, P142, DOI 10.1086/514616; KARUNAWEERA ND, 1992, P NATL ACAD SCI USA, V89, P3200, DOI 10.1073/pnas.89.8.3200; Kitchener SJ, 2005, MED J AUSTRALIA, V182, P168, DOI 10.5694/j.1326-5377.2005.tb06647.x; Kochar DK, 2005, EMERG INFECT DIS, V11, P132, DOI 10.3201/eid1101.040519; Lawn SD, 2003, T ROY SOC TROP MED H, V97, P551, DOI 10.1016/S0035-9203(03)80024-X; LOBEL HO, 1993, LANCET, V341, P848, DOI 10.1016/0140-6736(93)93058-9; Lobel HO, 2001, J TRAVEL MED, V8, P167, DOI 10.2310/7060.2001.22206; MACPHERSON D, 1997, 5 INT C TRAV MED MAR; MANNINO S, 1992, P 2 INT C PREV INF M; Meier CR, 2004, DRUG SAFETY, V27, P203, DOI 10.2165/00002018-200427030-00005; Mendis K, 2001, AM J TROP MED HYG, V64, P97, DOI 10.4269/ajtmh.2001.64.97; Muhlberger N, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-5; Newton PN, 2006, PLOS MED, V3, P752, DOI 10.1371/journal.pmed.0030197; Newton PN, 2006, LANCET INFECT DIS, V6, P602, DOI 10.1016/S1473-3099(06)70581-3; NOTHDURFT HD, 1995, TROP MED PARASITOL, V46, P161; Oh MD, 2001, AM J TROP MED HYG, V65, P143, DOI 10.4269/ajtmh.2001.65.143; Ohrt C, 1997, ANN INTERN MED, V126, P963, DOI 10.7326/0003-4819-126-12-199706150-00006; Ollivier L, 2004, ANN TROP MED PARASIT, V98, P639, DOI 10.1179/000349804225021262; Overbosch D, 2001, CLIN INFECT DIS, V33, P1015, DOI 10.1086/322694; Phillips, 1996, J Travel Med, V3, P40, DOI 10.1111/j.1708-8305.1996.tb00695.x; PHILLIPSHOWARD PA, 1995, DRUG SAFETY, V12, P370, DOI 10.2165/00002018-199512060-00003; Potasman I, 2000, J TRAVEL MED, V7, P5; Povinelli L, 2003, J TRAVEL MED, V10, P353, DOI 10.2310/7060.2003.9318; Reyburn H, 2004, BMJ-BRIT MED J, V329, P1212, DOI 10.1136/bmj.38251.658229.55; Robinson P, 2001, J TRAVEL MED, V8, P76, DOI 10.2310/7060.2001.24309; Rodriguez-Morales AJ, 2006, J TRAVEL MED, V13, P325, DOI 10.1111/j.1708-8305.2006.0064_1.x; Saleri N, 2006, J TRAVEL MED, V13, P112, DOI 10.1111/j.1708-8305.2006.00024.x; Schlagenhauf P, 2003, BMJ-BRIT MED J, V327, P1078, DOI 10.1136/bmj.327.7423.1078; Schlagenhauf P, 1996, TROP MED INT HEALTH, V1, P485, DOI 10.1046/j.1365-3156.1996.d01-85.x; Schlagenhauf P, 1997, AM J TROP MED HYG, V56, P235, DOI 10.4269/ajtmh.1997.56.235; SCHLAGENHAUF P, 1995, B WORLD HEALTH ORGAN, V73, P215; SCHLAGENHAUF P, 2004, TRAVEL MED, P137; SCHLAGENHAUFLAW.P, 2005, PDQ TRAVELERS MALARI; Schwartz E, 2003, NEW ENGL J MED, V349, P1510, DOI 10.1056/NEJMoa021592; Schwartz E, 2001, AM J TROP MED HYG, V65, P189, DOI 10.4269/ajtmh.2001.65.189; SCHWARTZ IK, 1991, NEW ENGL J MED, V324, P927; Sina Barbara, 2002, Trends in Parasitology, V18, P287, DOI 10.1016/S1471-4922(02)02329-2; Skarbinski Jacek, 2006, Morbidity and Mortality Weekly Report, V55, P23; Smoak BL, 1997, AM J TROP MED HYG, V56, P231, DOI 10.4269/ajtmh.1997.56.231; Soto J, 1998, ANN INTERN MED, V129, P241, DOI 10.7326/0003-4819-129-3-199808010-00013; STEFFEN R, 1993, LANCET, V341, P1299, DOI 10.1016/0140-6736(93)90814-W; *STUD GROUP MAL PR, 2005, MAL PREV GUID JAP TR, P1; STURCHLER D, 1990, NEW ENGL J MED, V322, P1752; Sudakin DL, 2003, J TOXICOL-CLIN TOXIC, V41, P831, DOI 10.1081/CLT-120025348; SVENSON JE, 1995, ARCH INTERN MED, V155, P861, DOI 10.1001/archinte.155.8.861; Torres JR, 1997, LANCET, V350, P31, DOI 10.1016/S0140-6736(05)66241-1; *US DEP HHS, 2005, HLTH INF INT TRAV 20; van Riemsdijk MA, 2005, J CLIN PSYCHIAT, V66, P199, DOI 10.4088/JCP.v66n0207; van Riemsdijk MM, 2002, EUR J CLIN PHARMACOL, V58, P441, DOI 10.1007/s00228-002-0492-z; van Riemsdijk MM, 2002, CLIN PHARMACOL THER, V72, P294, DOI 10.1067/mcp.2002.127113; Vuurman EFPM, 1996, EUR J CLIN PHARMACOL, V50, P475, DOI 10.1007/s002280050144; WEINKE T, 1991, AM J TROP MED HYG, V45, P86, DOI 10.4269/ajtmh.1991.45.86; Wells TS, 2006, AM J TROP MED HYG, V74, P744, DOI 10.4269/ajtmh.2006.74.744; *WHO, 2005, INT TRAV HLTH 2005, P154; *WHO, 2005, INT TRAV HLTH, P132; WITTES RC, 1995, CAN MED ASSOC J, V152, P515	114	69	72	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 23	2007	297	20					2251	2263		10.1001/jama.297.20.2251	http://dx.doi.org/10.1001/jama.297.20.2251			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	170JM	17519415	Bronze			2022-12-28	WOS:000246659700025
J	Dawson, S; Gould, DA				Dawson, Steven; Gould, Derek A.			Procedural simulation's developing role in medicine	LANCET			English	Editorial Material							EDUCATION		Massachusetts Gen Hosp, Dept Radiol, Cambridge, MA 02139 USA; Royal Liverpool Univ Trust, Dept Radiol, Liverpool, Merseyside, England	Harvard University; Massachusetts General Hospital	Dawson, S (corresponding author), Massachusetts Gen Hosp, Dept Radiol, Cambridge, MA 02139 USA.	sdawson@partners.org						Dawson S, 2006, J VASC INTERV RADIOL, V17, P205, DOI 10.1097/01.RVI.0000194871.97225.CA; Leach DC, 2005, ACGME B, P2; Mayo WJ, 1927, J AMER MED ASSOC, V88, P1377, DOI 10.1001/jama.1927.02680440011004; Patel AA, 2006, J VASC INTERV RADIOL, V17, pS163, DOI 10.1097/01.RVI.0000247928.77832.C4; Patel AD, 2006, J AM COLL CARDIOL, V47, P1796, DOI 10.1016/j.jacc.2005.12.053; Reznick RK, 2006, NEW ENGL J MED, V355, P2664, DOI 10.1056/NEJMra054785; Wenger Etienne., 1998, COMMUNITIES PRACTICE, V18th ed; 2005, ACGME B          DEC, P1	8	16	17	0	7	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 20	2007	369	9574					1671	1673		10.1016/S0140-6736(07)60760-0	http://dx.doi.org/10.1016/S0140-6736(07)60760-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	169ZT	17512839				2022-12-28	WOS:000246631300007
J	Mucida, D; Park, Y; Kim, G; Turovskaya, O; Scott, I; Kronenberg, M; Cheroutre, H				Mucida, Daniel; Park, Yunji; Kim, Gisen; Turovskaya, Olga; Scott, Iain; Kronenberg, Mitchell; Cheroutre, Hilde			Reciprocal T(H)17 and regulatory T cell differentiation mediated by retinoic acid	SCIENCE			English	Article							TGF-BETA; INFLAMMATION; GENERATION; FOXP3	The cytokine transforming growth factor-beta (TGF-beta) converts naive T cells into regulatory T (Treg) cells that prevent autoimmunity. However, in the presence of interleukin-6 (IL-6), TGF-beta has also been found to promote the differentiation of naive T lymphocytes into proinflammatory IL-17 cytokine-producing T helper 17 (TH17) cells, which promote autoimmunity and inflammation. This raises the question of how TGF-beta can generate such distinct outcomes. We identified the vitamin A metabolite retinoic acid as a key regulator of TGF-beta-dependent immune responses, capable of inhibiting the IL-6-driven induction of proinflammatory TH17 cells and promoting anti-inflammatory Treg cell differentiation. These findings indicate that a common metabolite can regulate the balance between pro- and anti-inflammatory immunity.	La Jolla Inst Allergy & Immunol, La Jolla, CA 92037 USA	La Jolla Institute for Immunology	Cheroutre, H (corresponding author), La Jolla Inst Allergy & Immunol, 9420 Athena Circle, La Jolla, CA 92037 USA.	hilde@liai.org	Kronenberg, Mitchell/AAT-6078-2021; Eckhardt, Erik/G-1567-2010	Park, Yunji/0000-0003-0042-202X; Mucida, Daniel/0000-0002-0000-0452	NIAID NIH HHS [R01 AI050265-06] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050265] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Davidson TS, 2007, J IMMUNOL, V178, P4022, DOI 10.4049/jimmunol.178.7.4022; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Furuzawa-Carballeda J, 2007, AUTOIMMUN REV, V6, P169, DOI 10.1016/j.autrev.2006.10.002; Hadley GA, 1997, J IMMUNOL, V159, P3748; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Iwasaki A, 2007, ANNU REV IMMUNOL, V25, P381, DOI 10.1146/annurev.immunol.25.022106.141634; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Izcue A, 2006, IMMUNOL REV, V212, P256, DOI 10.1111/j.0105-2896.2006.00423.x; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Li Y, 1999, J BIOL CHEM, V274, P15360, DOI 10.1074/jbc.274.22.15360; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Mucida D, 2005, J CLIN INVEST, V115, P1923, DOI 10.1172/JCI24487; SOMMER A, 1993, J INFECT DIS, V167, P1003, DOI 10.1093/infdis/167.5.1003; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001	17	1490	1596	1	105	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 13	2007	317	5835					256	260		10.1126/science.1145697	http://dx.doi.org/10.1126/science.1145697			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	189DC	17569825				2022-12-28	WOS:000247968600046
J	Yang, T; Shadlen, MN				Yang, Tianming; Shadlen, Michael N.			Probabilistic reasoning by neurons	NATURE			English	Article							LATERAL INTRAPARIETAL AREA; POSTERIOR PARIETAL CORTEX; DEVELOPING OCULOMOTOR COMMANDS; PERCEPTUAL DECISION; VISUAL-CORTEX; SENSORY STIMULI; PREMOTOR CORTEX; MACAQUE MONKEY; REPRESENTATION; TASK	Our brains allow us to reason about alternatives and to make choices that are likely to pay off. Often there is no one correct answer, but instead one that is favoured simply because it is more likely to lead to reward. A variety of probabilistic classification tasks probe the covert strategies that humans use to decide among alternatives based on evidence that bears only probabilistically on outcome. Here we show that rhesus monkeys can also achieve such reasoning. We have trained two monkeys to choose between a pair of coloured targets after viewing four shapes, shown sequentially, that governed the probability that one of the targets would furnish reward. Monkeys learned to combine probabilistic information from the shape combinations. Moreover, neurons in the parietal cortex reveal the addition and subtraction of probabilistic quantities that underlie decision-making on this task.	Univ Washington, Howard Hughes Med Inst, Dept Physiol & Biophys, Natl Primate Res Ctr, Seattle, WA 98195 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Yang, T (corresponding author), Univ Washington, Howard Hughes Med Inst, Dept Physiol & Biophys, Natl Primate Res Ctr, Box 357290, Seattle, WA 98195 USA.	tianming@u.washington.edu; shadlen@u.washington.edu	Yang, Tianming/D-3582-2014; Shadlen, Michael Neil/AAL-1870-2020	Yang, Tianming/0000-0001-6976-9246; Shadlen, Michael/0000-0002-2002-2210	NCRR NIH HHS [P51 RR000166] Funding Source: Medline; NEI NIH HHS [R01 EY011378] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000166] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY011378] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BARLOW H, 1990, VISION RES, V30, P1561, DOI 10.1016/0042-6989(90)90144-A; Bisley JW, 2004, J NEUROSCI, V24, P1833, DOI 10.1523/JNEUROSCI.5007-03.2004; Bracewell RM, 1996, J NEUROPHYSIOL, V76, P1457, DOI 10.1152/jn.1996.76.3.1457; CARPENTER RHS, 1995, NATURE, V377, P59, DOI 10.1038/377059a0; Cisek P, 2005, NEURON, V45, P801, DOI 10.1016/j.neuron.2005.01.027; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; Ditterich J, 2003, NAT NEUROSCI, V6, P891, DOI 10.1038/nn1094; Dorris MC, 2004, NEURON, V44, P365, DOI 10.1016/j.neuron.2004.09.009; GEISLER WS, 1997, VISUAL CORTEX NEURON, P897; Glimcher PW, 2003, ANNU REV NEUROSCI, V26, P133, DOI 10.1146/annurev.neuro.26.010302.081134; Gluck MA, 2002, LEARN MEMORY, V9, P408, DOI 10.1101/lm.45202; GNADT JW, 1988, EXP BRAIN RES, V70, P216; Gold JI, 2000, NATURE, V404, P390, DOI 10.1038/35006062; Gold JI, 2003, J NEUROSCI, V23, P632, DOI 10.1523/JNEUROSCI.23-02-00632.2003; Gold JI, 2001, TRENDS COGN SCI, V5, P10, DOI 10.1016/S1364-6613(00)01567-9; Gold JI, 2002, NEURON, V36, P299, DOI 10.1016/S0896-6273(02)00971-6; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; GOOD IJ, 1979, BIOMETRIKA, V66, P393, DOI 10.1093/biomet/66.2.393; GREEN DM, 1966, SIGNAL DETECTION THE; Hanks TD, 2006, NAT NEUROSCI, V9, P682, DOI 10.1038/nn1683; Hanks TD, 2006, BAYESIAN BRAIN PROBA, P209, DOI [10.7551/mitpress/9780262042383.003.0010, DOI 10.7551/MITPRESS/9780262042383.003.0010]; Hayes A, 1982, WESCON C P, V2, P1; HIKOSAKA O, 1983, J NEUROPHYSIOL, V49, P1268; Holmes P, 2005, IEICE T FUND ELECTR, VE88A, P2496, DOI [10.1093/ietfec/e88-a.10.2496, 10.1093/ietfec/e88.a.10.2496]; Horwitz GD, 2004, J NEUROPHYSIOL, V91, P2281, DOI 10.1152/jn.00872.2003; Huk AC, 2005, J NEUROSCI, V25, P10420, DOI 10.1523/JNEUROSCI.4684-04.2005; Ipata AE, 2006, J NEUROSCI, V26, P3656, DOI 10.1523/JNEUROSCI.5074-05.2006; Jazayeri M, 2006, NAT NEUROSCI, V9, P690, DOI 10.1038/nn1691; Kim JN, 1999, NAT NEUROSCI, V2, P176, DOI 10.1038/5739; Knowlton B J, 1994, Learn Mem, V1, P106; Knowlton BJ, 1996, SCIENCE, V273, P1399, DOI 10.1126/science.273.5280.1399; Leon MI, 2003, NEURON, V38, P317, DOI 10.1016/S0896-6273(03)00185-5; Lewis JW, 2000, J COMP NEUROL, V428, P112, DOI 10.1002/1096-9861(20001204)428:1<112::AID-CNE8>3.0.CO;2-9; Lewis JW, 2000, J COMP NEUROL, V428, P79, DOI 10.1002/1096-9861(20001204)428:1<79::AID-CNE7>3.0.CO;2-Q; LINK SW, 1975, PSYCHOMETRIKA, V40, P77, DOI 10.1007/BF02291481; Ma WJ, 2006, NAT NEUROSCI, V9, P1432, DOI 10.1038/nn1790; Parker AJ, 1998, ANNU REV NEUROSCI, V21, P227, DOI 10.1146/annurev.neuro.21.1.227; Platt ML, 1997, J NEUROPHYSIOL, V78, P1574, DOI 10.1152/jn.1997.78.3.1574; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; ROBINSON DA, 1963, IEEE T BIO-MED ENG, VBM10, P137, DOI 10.1109/TBMEL.1963.4322822; Roitman JD, 2002, J NEUROSCI, V22, P9475; Romo R, 2004, NEURON, V41, P165, DOI 10.1016/S0896-6273(03)00817-1; Schall JD, 2003, CURR OPIN NEUROBIOL, V13, P182, DOI 10.1016/S0959-4388(03)00039-4; Sereno AB, 1998, NATURE, V395, P500, DOI 10.1038/26752; Sereno AB, 2006, J NEUROPHYSIOL, V95, P1078, DOI 10.1152/jn.00431.2005; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Smith PL, 2004, TRENDS NEUROSCI, V27, P161, DOI 10.1016/j.tins.2004.01.006; Sugrue LP, 2004, SCIENCE, V304, P1782, DOI 10.1126/science.1094765; Sugrue LP, 2005, NAT REV NEUROSCI, V6, P363, DOI 10.1038/nrn1666; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; TOLHURST DJ, 1983, VISION RES, V23, P775, DOI 10.1016/0042-6989(83)90200-6; Van Essen DC, 2001, VISION RES, V41, P1359, DOI 10.1016/S0042-6989(01)00045-1; Wald A., 1947, SEQUENTIAL ANAL; Wise SP, 1999, HIPPOCAMPUS, V9, P101, DOI 10.1002/(SICI)1098-1063(1999)9:2<101::AID-HIPO3>3.0.CO;2-L; ZOHARY E, 1994, NATURE, V370, P1405; ZOHARY E, 1994, NATURE, V371, P6495	57	338	345	3	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 28	2007	447	7148					1075	U2		10.1038/nature05852	http://dx.doi.org/10.1038/nature05852			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	183HT	17546027				2022-12-28	WOS:000247564600030
J	Hotez, PJ				Hotez, Peter J.			Control of onchocerciasis - the next generation	LANCET			English	Editorial Material							IVERMECTIN; VOLVULUS; VACCINE		George Washington Univ, Sabin Vaccine Inst, Washington, DC 20037 USA; George Washington Univ, Dept Microbiol Immunol & Trop Med, Washington, DC 20037 USA	George Washington University; George Washington University	Hotez, PJ (corresponding author), George Washington Univ, Sabin Vaccine Inst, Washington, DC 20037 USA.	mtmpjh@gwumc.edu		Hotez, Peter/0000-0001-8770-1042				Amazigo UV, 2002, ANN TROP MED PARASIT, V96, P41, DOI 10.1179/000349802125000646; Basanez MG, 2006, PLOS MED, V3, P1454, DOI 10.1371/journal.pmed.0030371; Boatin BA, 2006, ADV PARASIT, V61, P349, DOI 10.1016/S0065-308X(05)61009-3; Eng JKL, 2006, MOL BIOCHEM PARASIT, V150, P229, DOI 10.1016/j.molbiopara.2006.08.007; Hotez PJ, 2006, VACCINE, V24, P5787, DOI 10.1016/j.vaccine.2006.05.008; Hotez PJ, 2004, J INVEST MED, V52, P246, DOI 10.1136/jim-52-04-32; Levine R, 2004, MILLIONS SAVED PROVE, P57; Lustigman S, 2002, TRENDS PARASITOL, V18, P135, DOI 10.1016/S1471-4922(01)02211-5; Molyneux DH, 2005, PLOS MED, V2, P1064, DOI 10.1371/journal.pmed.0020336; Nutman TB, 2002, TRENDS PARASITOL, V18, P237, DOI 10.1016/S1471-4922(02)02310-3; Osei-Atweneboano MY, 2007, LANCET, V369, P2021, DOI 10.1016/S0140-6736(07)60942-8; Seketeli A, 2002, ANN TROP MED PARASIT, V96, P15, DOI 10.1179/000349802125000628; Taylor MJ, 2005, ADV PARASIT, V60, P245, DOI 10.1016/S0065-308X(05)60004-8	13	14	14	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 16	2007	369	9578					1979	1980		10.1016/S0140-6736(07)60923-4	http://dx.doi.org/10.1016/S0140-6736(07)60923-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	180HT	17574078				2022-12-28	WOS:000247354400006
J	Mitra, PK; Tasker, PRW; Ell, MS				Mitra, Prabir Kumar; Tasker, Peter R. W.; Ell, M. S.			10-minute consultation - Chronic kidney disease	BRITISH MEDICAL JOURNAL			English	Editorial Material									Queen Elizabeth Hosp, Kings Lynn PE30 4ET, Norfolk, England; St James Med Practice, Kings Lynn, England		Mitra, PK (corresponding author), Queen Elizabeth Hosp, Kings Lynn PE30 4ET, Norfolk, England.	mitra_prabir@yahoo.co.uk							0	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 16	2007	334	7606					1273	1273		10.1136/bmj.39196.714491.94	http://dx.doi.org/10.1136/bmj.39196.714491.94			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	183AM	17569937	Green Published			2022-12-28	WOS:000247545100043
J	Perry, JM; Li, LH				Perry, John M.; Li, Linheng			Disrupting the stem cell niche: Good seeds in bad soil	CELL			English	Editorial Material							HEMATOPOIETIC STEM	Stem cells reside in a microenvironment or niche that is critical for stem cell maintenance and regulation. But what happens when a stem cell niche is disrupted? In this issue of Cell, two reports (Walkley et al., 2007a, 2007b) demonstrate in mice that alterations in the niche for hematopoietic stem cells lead to the development of myeloproliferative disease.	Stowers Inst Med Res, Kansas City, MO 64110 USA; Univ Kansas, Med Ctr, Dept Pathol, Kansas City, KS 66160 USA	Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center	Li, LH (corresponding author), Stowers Inst Med Res, 1000 E 50th St, Kansas City, MO 64110 USA.	lil@stowers-institute.org		Li, Linheng/0000-0001-9963-430X				Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Flynn CM, 2007, BLOOD, V109, P2688, DOI 10.1182/blood-2006-07-021980; Jones DH, 2006, NATURE, V440, P692, DOI 10.1038/nature04524; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kopp HG, 2005, PHYSIOLOGY, V20, P349, DOI 10.1152/physiol.00025.2005; Li LH, 2006, CANCER RES, V66, P4553, DOI 10.1158/0008-5472.CAN-05-3986; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	9	49	51	2	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 15	2007	129	6					1045	1047		10.1016/j.cell.2007.05.053	http://dx.doi.org/10.1016/j.cell.2007.05.053			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	180UA	17574018	Bronze			2022-12-28	WOS:000247390400009
J	Tabita, FR				Tabita, F. Robert			Rubisco: The enzyme that keeps on giving	CELL			English	Editorial Material							RIBULOSE-BISPHOSPHATE CARBOXYLASE; ESCHERICHIA-COLI; 1,5-BISPHOSPHATE CARBOXYLASE/OXYGENASE; RBCX GENE; OXYGENASE; PRODUCT	In cyanobacteria, the RbcX protein enhances the production of Rubisco, the multisubunit enzyme that catalyzes the first step of carbon dioxide fixation in most autotrophic organisms. In this issue of Cell, Saschenbrecker et al. (2007) report that RbcX acts as a specific assembly chaperone that mobilizes the large subunits of Rubisco to a specific oligomeric core that can then combine with the small subunits of Rubisco to form the functional holoenzyme.	Ohio State Univ, Dept Microbiol & Plant Mol Biol, Biotechnol Program, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Tabita, FR (corresponding author), Ohio State Univ, Dept Microbiol & Plant Mol Biol, Biotechnol Program, 484 W 12th Ave, Columbus, OH 43210 USA.	tabita.1@osu.edu						BARRACLOUGH R, 1980, BIOCHIM BIOPHYS ACTA, V608, P18; Emlyn-Jones D, 2006, PLANT CELL PHYSIOL, V47, P1630, DOI 10.1093/pcp/pcl028; GATENBY AA, 1985, NATURE, V314, P617, DOI 10.1038/314617a0; GOLOUBINOFF P, 1989, NATURE, V337, P44, DOI 10.1038/337044a0; LARIMER FW, 1993, GENE, V126, P85, DOI 10.1016/0378-1119(93)90593-R; Li LA, 1997, J BACTERIOL, V179, P3793, DOI 10.1128/jb.179.11.3793-3796.1997; Onizuka T, 2004, PLANT CELL PHYSIOL, V45, P1390, DOI 10.1093/pcp/pch160; Tabita FR, 1999, PHOTOSYNTH RES, V60, P1, DOI 10.1023/A:1006211417981; TABITA FR, 1985, P NATL ACAD SCI USA, V82, P6100, DOI 10.1073/pnas.82.18.6100	9	13	14	1	11	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 15	2007	129	6					1039	1040		10.1016/j.cell.2007.06.002	http://dx.doi.org/10.1016/j.cell.2007.06.002			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	180UA	17574015	Bronze			2022-12-28	WOS:000247390400006
J	Burch, JL; Goldstein, J; Lewis, WS; Young, DT; Coates, AJ; Dougherty, MK; Andre, N				Burch, J. L.; Goldstein, J.; Lewis, W. S.; Young, D. T.; Coates, A. J.; Dougherty, M. K.; Andre, N.			Tethys and Dione as sources of outward-flowing plasma in Saturn's magnetosphere	NATURE			English	Article							VOYAGER-1; TRANSPORT	Rotating at over twice the angular speed of Earth, Saturn imposes a rapid spin on its magnetosphere. As a result, cold, dense plasma is believed to be flung outward from the inner magnetosphere by centrifugal force and replaced by hotter, more tenuous plasma from the outer magnetosphere. The centrifugal interchange(1) of plasmas in rotating magnetospheres was predicted many years ago(2-4) and was conclusively demonstrated by observations in Jupiter's magnetosphere(5-7), which - like that of Saturn ( but unlike that of Earth) - is rotationally dominated. Recent observations in Saturn's magnetosphere(8-10) have revealed narrow injections of hot, tenuous plasma believed to be the inward-moving portion of the centrifugal interchange cycle. Here we report observations of the distribution of the angle between the electron velocity vector and the magnetic field vector ('pitch angle') obtained in the cold, dense plasma adjacent to these inward injection regions. The observed pitch-angle distributions are indicative of outward plasma flow and consistent with centrifugal interchange in Saturn's magnetosphere. Further, we conclude that the observed double-peaked ('butterfly') pitch-angle distributions result from the transport of plasma from regions near the orbits of Dione and Tethys, supporting the idea of distinct plasma tori associated with these moons(11-13).	SW Res Inst, San Antonio, TX 78228 USA; UCL, Mullard Space Sci Lab, Dorking RH5 6NT, Surrey, England; Univ London Imperial Coll Sci Technol & Med, Blackett Lab, London SW7 2BZ, England; European Space Agcy, Res & Sci Support Dept, NL-2200 AG Noordwijk, Netherlands	Southwest Research Institute; University of London; University College London; Imperial College London; European Space Agency	Lewis, WS (corresponding author), SW Res Inst, PO Drawer 28510, San Antonio, TX 78228 USA.	wlewis@swri.edu	Coates, Andrew/C-2396-2008	Coates, Andrew/0000-0002-6185-3125	UK Space Agency [PP/D00084X/1] Funding Source: researchfish	UK Space Agency		Alexeev II, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025896; ANDRE N, UNPUB GEOPHYS RES LE; Bolton SJ, 1997, GEOPHYS RES LETT, V24, P2123, DOI 10.1029/97GL02020; Burch JL, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022611; CONNERNEY JEP, 1982, NATURE, V298, P44, DOI 10.1038/298044a0; FRANK LA, 1980, J GEOPHYS RES-SPACE, V85, P5695, DOI 10.1029/JA085iA11p05695; Frank LA, 2000, J GEOPHYS RES-SPACE, V105, P16017, DOI 10.1029/1999JA000250; Hill TW, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022620; HILL TW, 1976, PLANET SPACE SCI, V24, P1151, DOI 10.1016/0032-0633(76)90152-5; KRUSKAL M, 1954, PROC R SOC LON SER-A, V223, P348, DOI 10.1098/rspa.1954.0120; Mauk BH, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022485; MICHEL FC, 1974, PLANET SPACE SCI, V22, P1501, DOI 10.1016/0032-0633(74)90015-4; PONTIUS DH, 1986, GEOPHYS RES LETT, V13, P1097, DOI 10.1029/GL013i011p01097; RICHARDSON JD, 1986, J GEOPHYS RES, V91, P8749, DOI 10.1029/JA091iA08p08749; Rymer AM, 2007, J GEOPHYS RES-SPACE, V112, DOI 10.1029/2006JA012017; Sittler EC, 2006, PLANET SPACE SCI, V54, P1197, DOI 10.1016/j.pss.2006.05.038; SITTLER EC, 1983, J GEOPHYS RES-SPACE, V88, P8847, DOI 10.1029/JA088iA11p08847; Thorne RM, 1999, J GEOPHYS RES-SPACE, V104, P14755, DOI 10.1029/1999JA900132; Thorne RM, 1997, GEOPHYS RES LETT, V24, P2131, DOI 10.1029/97GL01788; Wahlund JE, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022699	20	49	49	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 14	2007	447	7146					833	835		10.1038/nature05906	http://dx.doi.org/10.1038/nature05906			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178FV	17568741				2022-12-28	WOS:000247207500038
J	Khuri, FR				Khuri, Fadlo R.			Weighing the hazards of erythropoirsis stimulation in patients with cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DOUBLE-BLIND		Emory Winship Canc Inst, Atlanta, GA USA		Khuri, FR (corresponding author), Emory Winship Canc Inst, Atlanta, GA USA.		Khuri, Fadlo R./AAU-4942-2020	Khuri, Fadlo R./0000-0002-8638-7618				Goldberg P, 2007, CANC LETT, V33, P1; Henke, 2007, J CLIN ONCOL, V25, P1457, DOI 10.1200/JCO.2007.11.6244; Henke M, 2003, LANCET, V362, P1255, DOI 10.1016/S0140-6736(03)14567-9; Henke M, 2006, J CLIN ONCOL, V24, P4708, DOI 10.1200/JCO.2006.06.2737; Leyland-Jones B, 2005, J CLIN ONCOL, V23, P5960, DOI 10.1200/JCO.2005.06.150; Wright JR, 2007, J CLIN ONCOL, V25, P1027, DOI 10.1200/JCO.2006.07.1514	6	83	93	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 14	2007	356	24					2445	2448		10.1056/NEJMp078101	http://dx.doi.org/10.1056/NEJMp078101			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	178DR	17568023				2022-12-28	WOS:000247201900001
J	Perron, JT; Mitrovica, JX; Manga, M; Matsuyama, I; Richards, MA				Perron, J. Taylor; Mitrovica, Jerry X.; Manga, Michael; Matsuyama, Isamu; Richards, Mark A.			Evidence for an ancient martian ocean in the topography of deformed shorelines	NATURE			English	Article							MARS GLOBAL SURVEYOR; ALTIMETER MOLA DATA; NORTHERN PLAINS; POLAR WANDER; TESTS; EVOLUTION; THARSIS; GRAVITY; FIELD; FATE	A suite of observations suggests that the northern plains of Mars, which cover nearly one third of the planet's surface, may once have contained an ocean(1-7). Perhaps the most provocative evidence for an ancient ocean is a set of surface features that ring the plains for thousands of kilometres and that have been interpreted as a series of palaeoshorelines of different age(1,7). It has been shown, however, that topographic profiles along the putative shorelines contain long-wavelength trends with amplitudes of up to several kilometres(4,5,8), and these trends have been taken as an argument against the martian shoreline ( and ocean) hypothesis(8). Here we show that the long-wavelength topography of the shorelines is consistent with deformation caused by true polar wander - a change in the orientation of a planet with respect to its rotation pole - and that the inferred pole path has the geometry expected for a true polar wander event that postdates the formation of the massive Tharsis volcanic rise.	Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA; Univ Toronto, Dept Phys, Toronto, ON M5S 1A7, Canada; Carnegie Inst Washington, Dept Terr Magnetism, Washington, DC 20015 USA	University of California System; University of California Berkeley; University of Toronto; Carnegie Institution for Science	Perron, JT (corresponding author), Harvard Univ, Dept Earth & Planetary Sci, 20 Oxford St, Cambridge, MA 02138 USA.	perron@eps.harvard.edu	Manga, Michael/D-3847-2013; Perron, J. Taylor/D-8983-2012	Perron, J. Taylor/0000-0002-0404-8701; Matsuyama, Isamu/0000-0002-2917-8633; Manga, Michael/0000-0003-3286-4682				Arkani-Hamed J, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2003JE002229; BAKER VR, 1991, NATURE, V352, P589, DOI 10.1038/352589a0; BANERDT WB, 1992, MARS, P249; Carr MH, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001963; Clifford SM, 2001, ICARUS, V154, P40, DOI 10.1006/icar.2001.6671; Elkins-Tanton LT, 2005, EARTH PLANET SC LETT, V236, P1, DOI 10.1016/j.epsl.2005.04.044; GOLD T, 1955, NATURE, V175, P526, DOI 10.1038/175526a0; Head JW, 1999, SCIENCE, V286, P2134, DOI 10.1126/science.286.5447.2134; Head JW, 1998, GEOPHYS RES LETT, V25, P4401, DOI 10.1029/1998GL900116; Hood LL, 2005, ICARUS, V177, P144, DOI 10.1016/j.icarus.2005.02.008; Ivanov MA, 2001, J GEOPHYS RES-PLANET, V106, P3275, DOI 10.1029/2000JE001257; Lambeck K, 2005, EARTHS VARIABLE ROTA; Leverington DW, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2003JE002141; Malin MC, 1999, GEOPHYS RES LETT, V26, P3049, DOI 10.1029/1999GL002342; Matsuyama I, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002447; Mound JE, 1998, SCIENCE, V279, P534, DOI 10.1126/science.279.5350.534; PARKER TJ, 1989, ICARUS, V82, P111, DOI 10.1016/0019-1035(89)90027-4; PARKER TJ, 1993, J GEOPHYS RES-PLANET, V98, P11061, DOI 10.1029/93JE00618; Redmond HL, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2003JE002228; Roberts JH, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2003JE002226; SABADINI R, 1990, NATURE, V345, P708, DOI 10.1038/345708a0; Searls ML, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002666; Smith DE, 1999, SCIENCE, V286, P94, DOI 10.1126/science.286.5437.94; Sohl F, 1997, J GEOPHYS RES-PLANET, V102, P1613, DOI 10.1029/96JE03419; Webb VE, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2003JE002205; WILLEMANN RJ, 1984, ICARUS, V60, P701, DOI 10.1016/0019-1035(84)90174-X; WILLEMANN RJ, 1982, J GEOPHYS RES, V87, P9793, DOI 10.1029/JB087iB12p09793; Zuber MT, 1997, J GEOPHYS RES-PLANET, V102, P28673, DOI 10.1029/97JE02527; Zuber MT, 2000, SCIENCE, V287, P1788, DOI 10.1126/science.287.5459.1788	29	142	143	1	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 14	2007	447	7146					840	843		10.1038/nature05873	http://dx.doi.org/10.1038/nature05873			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178FV	17568743				2022-12-28	WOS:000247207500040
J	Nijnik, A; Woodbine, L; Marchetti, C; Dawson, S; Lambe, T; Liu, C; Rodrigues, NP; Crockford, TL; Cabuy, E; Vindigni, A; Enver, T; Bell, JI; Slijepcevic, P; Goodnow, CC; Jeggo, PA; Cornall, RJ				Nijnik, Anastasia; Woodbine, Lisa; Marchetti, Caterina; Dawson, Sara; Lambe, Teresa; Liu, Cong; Rodrigues, Neil P.; Crockford, Tanya L.; Cabuy, Erik; Vindigni, Alessandro; Enver, Tariq; Bell, John I.; Slijepcevic, Predrag; Goodnow, Christopher C.; Jeggo, Penelope A.; Cornall, Richard J.			DNA repair is limiting for haematopoietic stem cells during ageing	NATURE			English	Article							STRAND BREAK REPAIR; LIGASE-IV; COMBINED IMMUNODEFICIENCY; MUTATIONS; TELOMERE; IDENTIFICATION; LETHALITY; MECHANISM; APOPTOSIS; COMPLEX	Accumulation of DNA damage leading to adult stem cell exhaustion has been proposed to be a principal mechanism of ageing. Here we address this question by taking advantage of the highly specific role of DNA ligase IV in the repair of DNA double-strand breaks by non-homologous end-joining, and by the discovery of a unique mouse strain with a hypomorphic Lig4(Y288C) mutation. The Lig4(Y288C) mouse, identified by means of a mutagenesis screening programme, is a mouse model for human LIG4 syndrome, showing immunodeficiency and growth retardation. Diminished DNA double-strand break repair in the Lig4(Y288C) strain causes a progressive loss of haematopoietic stem cells and bone marrow cellularity during ageing, and severely impairs stem cell function in tissue culture and transplantation. The sensitivity of haematopoietic stem cells to non-homologous end-joining deficiency is therefore a key determinant of their ability to maintain themselves against physiological stress over time and to withstand culture and transplantation.	Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England; Univ Oxford, Oxford OX3 9DU, England; Int Ctr Genet Engn & Biotechnol, I-34012 Trieste, Italy; Australian Natl Univ, Australia & Australian Phenom Facil, Australian Canc Res Fdn Genet Lab, John Curtin Sch Med Res, Canberra, ACT 2601, Australia; Univ Oxford, Weatherall Inst Mol Med, Oxford OX3 9DS, England; Brunel Univ, Brunel Inst Canc Genet & Pharmacogenom, Uxbridge UB8 3PH, Middx, England	University of Sussex; University of Oxford; International Center for Genetic Engineering & Biotechnology (ICGEB); Australian National University; John Curtin School of Medical Research; University of Oxford; Brunel University	Jeggo, PA (corresponding author), Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England.	p.a.jeggo@sussex.ac.uk; richard.cornall@ndm.ox.ac.uk	Liu, Cong/GOE-5572-2022; Goodnow, Christopher C/V-8108-2018; Lambe, Teresa/E-5733-2016; Nijnik, Anastasia/W-2697-2019	Liu, Cong/0000-0001-5192-6784; Goodnow, Christopher C/0000-0001-5296-6155; Lambe, Teresa/0000-0001-7711-897X; Rodrigues, Neil/0000-0002-1925-7733	Medical Research Council [G0300662B] Funding Source: researchfish; MRC [MC_U137884178, G0500897, MC_U137973817] Funding Source: UKRI; Medical Research Council [MC_U137884178, MC_U137973817, G0500897] Funding Source: Medline; Wellcome Trust Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Ahnesorg P, 2006, CELL, V124, P301, DOI 10.1016/j.cell.2005.12.031; Barnes DE, 1998, CURR BIOL, V8, P1395, DOI 10.1016/S0960-9822(98)00021-9; Becker KA, 2007, J CELL PHYSIOL, V210, P517, DOI 10.1002/jcp.20903; Ben-Omran TI, 2005, AM J MED GENET A, V137A, P283, DOI 10.1002/ajmg.a.30869; Bender CF, 2002, GENE DEV, V16, P2237, DOI 10.1101/gad.1007902; Bhattacharya D, 2006, J EXP MED, V203, P73, DOI 10.1084/jem.20051714; Buck D, 2006, CELL, V124, P287, DOI 10.1016/j.cell.2005.12.030; Cabuy E, 2004, CYTOM PART A, V62A, P150, DOI 10.1002/cyto.a.20096; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; di Fagagna FD, 2001, CURR BIOL, V11, P1192, DOI 10.1016/S0960-9822(01)00328-1; Dumble M, 2007, BLOOD, V109, P1736, DOI 10.1182/blood-2006-03-010413; Enders A, 2006, J IMMUNOL, V176, P5060, DOI 10.4049/jimmunol.176.8.5060; Frank KM, 1998, NATURE, V396, P173, DOI 10.1038/24172; Girard PM, 2004, HUM MOL GENET, V13, P2369, DOI 10.1093/hmg/ddh274; Grawunder U, 1997, NATURE, V388, P492, DOI 10.1038/41358; Gruhn B, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-5; Hasty P, 2004, AGING CELL, V3, P55, DOI 10.1111/j.1474-9728.2004.00082.x; Hock H, 2004, NATURE, V431, P1002, DOI 10.1038/nature02994; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P12454, DOI 10.1073/pnas.96.22.12454; Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989; Karanjawala ZE, 2002, CURR BIOL, V12, P397, DOI 10.1016/S0960-9822(02)00684-X; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Lieber MR, 2003, NAT REV MOL CELL BIO, V4, P712, DOI 10.1038/nrm1202; Marchetti C, 2006, DNA REPAIR, V5, P788, DOI 10.1016/j.dnarep.2006.03.011; Morrison SJ, 1996, NAT MED, V2, P1011, DOI 10.1038/nm0996-1011; Nelms KA, 2001, IMMUNITY, V15, P409, DOI 10.1016/S1074-7613(01)00199-6; O'Driscoll M, 2001, MOL CELL, V8, P1175, DOI 10.1016/S1097-2765(01)00408-7; OKADA S, 1992, BLOOD, V80, P3044; Orelio C, 2007, LEUKEMIA LYMPHOMA, V48, P16, DOI 10.1080/10428190601032529; Park Y, 2005, ANNU REV MED, V56, P495, DOI 10.1146/annurev.med.56.082103.104546; Quwailid MM, 2004, MAMM GENOME, V15, P585, DOI 10.1007/s00335-004-2379-z; Riballo E, 2004, MOL CELL, V16, P715, DOI 10.1016/j.molcel.2004.10.029; Rodriguez-Lopez J, 2005, LECT SER COMPUTER CO, V2, P106; Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102; Sedelnikova OA, 2004, NAT CELL BIOL, V6, P168, DOI 10.1038/ncb1095; Sekiguchi JM, 2006, CELL, V124, P260, DOI 10.1016/j.cell.2006.01.010; Toita N, 2007, AM J MED GENET A, V143A, P742, DOI 10.1002/ajmg.a.31644; van der Burg M, 2006, J CLIN INVEST, V116, P137, DOI 10.1172/JCI26121; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Wang Y, 2006, BLOOD, V107, P358, DOI 10.1182/blood-2005-04-1418; Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X; Weterings E, 2004, DNA REPAIR, V3, P1425, DOI 10.1016/j.dnarep.2004.06.003	42	411	432	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 7	2007	447	7145					686	U9		10.1038/nature05875	http://dx.doi.org/10.1038/nature05875			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175RI	17554302				2022-12-28	WOS:000247030700037
J	Radelet, S; Siddiqi, B				Radelet, Steven; Siddiqi, Bilal			Global Fund grant programmes: an analysis of evaluation scores	LANCET			English	Article								Background The Global Fund to Fight AIDS, Tuberculosis and Malaria evaluates programme performance after 2 years to help decide whether to continue funding. We aimed to identify the correlation between programme evaluation scores and characteristics of the programme, the health sector, and the recipient country. Methods We obtained data on the first 140 Global Fund grants evaluated in 2006, and analysed 134 of these. We used an ordered probit multivariate analysis to link evaluation scores to different characteristics, allowing us to record the association between changes in those characteristics and the probability of a programme receiving a particular evaluation score. Findings Programmes that had government agencies as principal recipients, had a large amount of funding, were focused on malaria, had weak initial proposals, or were evaluated by the accounting firm KPMG, scored lowest. Countries with a high number of doctors per head, high measles immunisation rates, few health-sector donors, and high disease-prevalence rates had higher evaluation scores. Poor countries, those with small government budget deficits, and those that have or have had socialist governments also received higher scores. Interpretation Our results show associations, not causality, and they focus on evaluation scores rather than actual performance of the programmes. Yet they provide some early indications of characteristics that can help the Global Fund identify and monitor programmes that might be at risk. The results should not be used to influence the distribution of funding, but rather to allocate resources for oversight and risk management.	Ctr Global Dev, Washington, DC 20036 USA		Radelet, S (corresponding author), Ctr Global Dev, 1776 Massachusetts Ave NW, Washington, DC 20036 USA.	sradelet@cgdev.org						*AIDSPAN, 2005, AN GLOB FUND GRANTS; Gauri V, 2002, WORLD DEV, V30, P2109, DOI 10.1016/S0305-750X(02)00151-1; *GLOB FUND FIGHT A, 2006, INV IMP MID RES REP; *GLOB FUND FIGHT A, 2005, 3 GFATM; *GLOB FUND FIGHT A, TUB MAL PHAS 2 GRANT; *GLOB FUND FIGHT A, CURR GRNT COMM DISB; Lu C, 2006, LANCET, V368, P483, DOI 10.1016/S0140-6736(06)69156-3; Radelet S., 2004, GLOBAL FUND FIGHT AI; *TECHN EV REF GROU, 2005, REP ASS COUNTR COORD; *US GOV ACC OFF, 2005, GLOB FUND FIGHT AIDS; *WORLD BANK, 2006, WORLDW GOV IND	11	20	20	0	6	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 26	2007	369	9575					1807	1813		10.1016/S0140-6736(07)60818-6	http://dx.doi.org/10.1016/S0140-6736(07)60818-6			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	172QP	17531888				2022-12-28	WOS:000246819300031
J	Fraser, P; Bickmore, W				Fraser, Peter; Bickmore, Wendy			Nuclear organization of the genome and the potential for gene regulation	NATURE			English	Review							CHROMOSOME TERRITORIES; CHROMATIN DECONDENSATION; TRANSCRIPTION FACTORIES; SPATIAL-ORGANIZATION; INTERPHASE NUCLEI; INACTIVE GENES; X-INACTIVATION; SC-35 DOMAINS; RNA; ASSOCIATION	Much work has been published on the cis-regulatory elements that affect gene function locally, as well as on the biochemistry of the transcription factors and chromatin- and histone-modifying complexes that influence gene expression. However, surprisingly little information is available about how these components are organized within the three-dimensional space of the nucleus. Technological advances are now helping to identify the spatial relationships and interactions of genes and regulatory elements in the nucleus and are revealing an unexpectedly extensive network of communication within and between chromosomes. A crucial unresolved issue is the extent to which this organization affects gene function, rather than just reflecting it.	MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; Babraham Inst, Lab Chromatin & Gene Express, Cambridge CB2 4AT, England	University of Edinburgh; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Bickmore, W (corresponding author), MRC, Human Genet Unit, Crewe Rd, Edinburgh EH4 2XU, Midlothian, Scotland.	peter.fraser@bbsrc.ac.uk; w.bickmore@hgu.mrc.ac.uk	Bickmore, Wendy A/C-7314-2013; Fraser, Peter/B-7549-2009	Bickmore, Wendy A/0000-0001-6660-7735; Fraser, Peter/0000-0002-0041-1227	Medical Research Council [G117/530, MC_U127527202] Funding Source: Medline; MRC [G117/530, MC_U127527202] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abranches R, 1998, J CELL BIOL, V143, P5, DOI 10.1083/jcb.143.1.5; Bacher CP, 2006, NAT CELL BIOL, V8, P293, DOI 10.1038/ncb1365; Bickmore WA, 2002, CHROMOSOME RES, V10, P707, DOI 10.1023/A:1021589031769; Bolzer A, 2005, PLOS BIOL, V3, P826, DOI 10.1371/journal.pbio.0030157; Branco MR, 2006, PLOS BIOL, V4, P780, DOI 10.1371/journal.pbio.0040138; Brown JM, 2006, J CELL BIOL, V172, P177, DOI 10.1083/jcb.200507073; Chakalova L, 2005, NAT REV GENET, V6, P669, DOI 10.1038/nrg1673; Chambeyron S, 2004, GENE DEV, V18, P1119, DOI 10.1101/gad.292104; Chaumeil J, 2006, GENE DEV, V20, P2223, DOI 10.1101/gad.380906; Chuang CH, 2006, CURR BIOL, V16, P825, DOI 10.1016/j.cub.2006.03.059; Chubb JR, 2006, CURR BIOL, V16, P1018, DOI 10.1016/j.cub.2006.03.092; Chubb JR, 2002, CURR BIOL, V12, P439, DOI 10.1016/S0960-9822(02)00695-4; Cremer T, 2006, CURR OPIN CELL BIOL, V18, P307, DOI 10.1016/j.ceb.2006.04.007; Eggan E, 2004, NATURE, V428, P44, DOI 10.1038/nature02375; Iborra FJ, 1996, J CELL SCI, V109, P1427; Johnson C, 2000, J CELL BIOL, V150, P417, DOI 10.1083/jcb.150.3.417; Kurz A, 1996, J CELL BIOL, V135, P1195, DOI 10.1083/jcb.135.5.1195; LaSalle JM, 1996, SCIENCE, V272, P725, DOI 10.1126/science.272.5262.725; Li JS, 2004, NATURE, V428, P393, DOI 10.1038/nature02433; Ling JQ, 2006, SCIENCE, V312, P269, DOI 10.1126/science.1123191; Lomvardas S, 2006, CELL, V126, P403, DOI 10.1016/j.cell.2006.06.035; Mahy NL, 2002, J CELL BIOL, V159, P753, DOI 10.1083/jcb.200207115; Mahy NL, 2002, J CELL BIOL, V157, P579, DOI 10.1083/jcb.200111071; Moen PT, 2004, MOL BIOL CELL, V15, P197, DOI 10.1091/mbc.e03-06-0388; Molenaar C, 2004, J CELL BIOL, V165, P191, DOI 10.1083/jcb.200310139; Morey C, 2006, NAT CELL BIOL, V8, P207, DOI 10.1038/ncb0306-207; Morey C, 2007, DEVELOPMENT, V134, P909, DOI 10.1242/dev.02779; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; Parada LA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-7-r44; Parada LA, 2002, TRENDS CELL BIOL, V12, P425, DOI 10.1016/S0962-8924(02)02351-6; Ragoczy T, 2006, GENE DEV, V20, P1447, DOI 10.1101/gad.1419506; Sadoni N, 2004, CHROMOSOME RES, V12, P439, DOI 10.1023/B:CHRO.0000034739.96307.8d; Serizawa S, 2003, SCIENCE, V302, P2088, DOI 10.1126/science.1089122; Shopland LS, 2006, J CELL BIOL, V174, P27, DOI 10.1083/jcb.200603083; Shopland LS, 2003, J CELL BIOL, V162, P981, DOI 10.1083/jcb.200303131; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Spilianakis CG, 2005, NATURE, V435, P637, DOI 10.1038/nature03574; Sproul D, 2005, NAT REV GENET, V6, P775, DOI 10.1038/nrg1688; Volpi EV, 2000, J CELL SCI, V113, P1565; Williams RRE, 2002, EXP CELL RES, V272, P163, DOI 10.1006/excr.2001.5400; Wurtele H, 2006, CHROMOSOME RES, V14, P477, DOI 10.1007/s10577-006-1075-0; Xie SQ, 2006, MOL BIOL CELL, V17, P1723, DOI 10.1091/mbc.E05-08-0726; Xu N, 2006, SCIENCE, V311, P1149, DOI 10.1126/science.1122984; Zhao Z, 2006, NAT GENET, V38, P1341, DOI 10.1038/ng1891	44	552	575	0	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 24	2007	447	7143					413	417		10.1038/nature05916	http://dx.doi.org/10.1038/nature05916			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170VA	17522674				2022-12-28	WOS:000246693100036
J	Eccles, SA; Welch, DR				Eccles, Suzanne A.; Welch, Danny R.			Metastasis: recent discoveries and novel treatment strategies	LANCET			English	Review							BREAST-CANCER METASTASIS; EPITHELIAL-MESENCHYMAL TRANSITION; ENDOTHELIAL GROWTH-FACTOR; LYMPH-NODE METASTASIS; MATRIX-METALLOPROTEINASE INHIBITORS; HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; HISTONE DEACETYLASE INHIBITORS; GENE-EXPRESSION SIGNATURE; DISSEMINATED TUMOR-CELLS; STEM-CELLS	Most cancer deaths are due to the development of metastases, hence the most important improvements in morbidity and mortality will result from prevention (or elimination) of such disseminated disease. Some would argue that treatments directed against metastasis are too late because cells have already escaped from the primary tumour. Such an assertion runs contrary to the significant but (for many common adult cancers) fairly modest improvements in survival following the use of adjuvant radiation and chemotherapy designed to eliminate disseminated cells after surgical removal of the primary tumour. Nonetheless, the debate raises important issues concerning the accurate early identification of clonogenic, metastatic cells, the discovery of novel, tractable targets for therapy, and the monitoring of minimal residual disease. We focus on recent findings regarding intrinsic and extrinsic molecular mechanisms controlling metastasis that determine how, when, and where cancers metastasise, and their implications for patient management in the 21st century.	Inst Canc Res, Tumour Biol & Metastasis Canc Res UK Ctr Canc The, McElwain Labs, Sutton SM2 5NG, Surrey, England; Univ Alabama Birmingham, Dept Pathol, Ctr Comprehens Canc, Natl Fdn Canc Res Ctr Metastasis Res, Birmingham, AL USA	University of London; Institute of Cancer Research - UK; University of Alabama System; University of Alabama Birmingham	Eccles, SA (corresponding author), Inst Canc Res, Tumour Biol & Metastasis Canc Res UK Ctr Canc The, McElwain Labs, Cotswold Rd, Sutton SM2 5NG, Surrey, England.	Sue.Eccles@icr.ac.uk	Vickers, Michael M/E-4095-2010; Welch, Danny R/B-7310-2009	Welch, Danny R/0000-0002-1951-4947	NCI NIH HHS [R01 CA087728-07, R01 CA087728-06, R01 CA087728, R01 CA062168-06] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA087728, R01CA062168] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abrahamsen B, 2005, CURR OPIN MOL THER, V7, P604; Achen MG, 2006, BRIT J CANCER, V94, P1355, DOI 10.1038/sj.bjc.6603120; Achen MG, 2006, INT J CANCER, V119, P1755, DOI 10.1002/ijc.21899; Adler AS, 2006, NAT GENET, V38, P421, DOI 10.1038/ng1752; Aguirre-Ghiso JA, 2006, CELL CYCLE, V5, P1740, DOI 10.4161/cc.5.16.3165; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010; Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Athale C, 2005, J THEOR BIOL, V233, P469, DOI 10.1016/j.jtbi.2004.10.019; Bandyopadhyay A, 2005, CANCER BIOL THER, V4, P168; Bandyopadhyay S, 2004, ONCOGENE, V23, P5675, DOI 10.1038/sj.onc.1207734; Bandyopadhyay S, 2006, NAT MED, V12, P933, DOI 10.1038/nm1444; Bardelli A, 2003, SCIENCE, V300, P949, DOI 10.1126/science.1082596; Beasley NJP, 2002, CANCER RES, V62, P1315; Behbod F, 2005, CARCINOGENESIS, V26, P703, DOI 10.1093/carcin/bgh293; Berger JC, 2005, CANCER BIOL THER, V4, P805, DOI 10.4161/cbt.4.8.1865; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Bidus MA, 2006, CLIN CANCER RES, V12, P83, DOI 10.1158/1078-0432.CCR-05-0835; Bild AH, 2006, NAT REV CANCER, V6, P735, DOI 10.1038/nrc1976; Bindra RS, 2005, MUTAT RES-FUND MOL M, V569, P75, DOI 10.1016/j.mrfmmm.2004.03.013; Bissell MJ, 2005, COLD SH Q B, V70, P343, DOI 10.1101/sqb.2005.70.013; Blagosklonny MV, 2006, LEUKEMIA, V20, P385, DOI 10.1038/sj.leu.2404075; Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; BUICK RN, 1984, CANCER RES, V44, P4909; BUTLER TP, 1975, CANCER RES, V35, P512; Cao RH, 2004, CANCER CELL, V6, P333, DOI 10.1016/j.ccr.2004.08.034; Cao YH, 2005, NAT REV CANCER, V5, P735, DOI 10.1038/nrc1693; Carducci MA, 2006, CLIN CANCER RES, V12, p6296S, DOI 10.1158/1078-0432.CCR-06-0929; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Chang HY, 2005, P NATL ACAD SCI USA, V102, P3738, DOI 10.1073/pnas.0409462102; Chen YP, 2003, CLIN EXP METASTAS, V20, P111, DOI 10.1023/A:1022675031185; Christofori G, 2003, EMBO J, V22, P2318, DOI 10.1093/emboj/cdg228; Chu JH, 2006, CANCER LETT, V233, P79, DOI 10.1016/j.canlet.2005.03.034; CIFONE MA, 1981, P NATL ACAD SCI-BIOL, V78, P6949, DOI 10.1073/pnas.78.11.6949; Cohnheim J., 1875, VIRCHOWS ARCH, V65, P64, DOI DOI 10.1007/BF01978936; Comoglio PM, 2005, NAT MED, V11, P1156, DOI 10.1038/nm1105-1156; Condeelis J, 2005, ANNU REV CELL DEV BI, V21, P695, DOI 10.1146/annurev.cellbio.21.122303.120306; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Dachs GU, 2000, EUR J CANCER, V36, P1649, DOI 10.1016/S0959-8049(00)00159-3; Dadras SS, 2005, MODERN PATHOL, V18, P1232, DOI 10.1038/modpathol.3800410; Dai CY, 2006, SEMIN RADIAT ONCOL, V16, P102, DOI 10.1016/j.semradonc.2005.12.005; Dano K, 2005, THROMB HAEMOSTASIS, V93, P676, DOI 10.1160/TH05-01-0054; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; DOURNA S, 2004, NATURE, V430, P1034; Duffy MJ, 2004, CURR PHARM DESIGN, V10, P39, DOI 10.2174/1381612043453559; Eccles SA, 2005, LANCET, V365, P1006, DOI 10.1016/S0140-6736(05)71116-8; Eccles SA, 2005, CURR OPIN GENET DEV, V15, P77, DOI 10.1016/j.gde.2004.12.001; Eccles SA, 2004, INT J DEV BIOL, V48, P583, DOI 10.1387/ijdb.041820se; Eckhardt BL, 2005, MOL CANCER RES, V3, P1; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Ein-Dor L, 2005, BIOINFORMATICS, V21, P171, DOI 10.1093/bioinformatics/bth469; Elvin P, 2005, CURR OPIN PHARMACOL, V5, P374, DOI 10.1016/j.coph.2005.02.008; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Ewing J., 1919, NEOPLASTIC DIS; Fehm T, 2006, CANCER-AM CANCER SOC, V107, P885, DOI 10.1002/cncr.22076; FIDLER IJ, 1970, JNCI-J NATL CANCER I, V45, P773; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Folkins C, 2007, CANCER RES, V67, P3560, DOI 10.1158/0008-5472.CAN-06-4238; Folkman J, 2006, ANNU REV MED, V57, P1, DOI 10.1146/annurev.med.57.121304.131306; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Frisch SM, 1997, CURR OPIN CELL BIOL, V9, P701, DOI 10.1016/S0955-0674(97)80124-X; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; Geiger TR, 2005, CANCER RES, V65, P7033, DOI 10.1158/0008-5472.CAN-05-0709; Glinsky GV, 2006, CELL CYCLE, V5, P1208, DOI 10.4161/cc.5.11.2796; Glinsky GV, 2005, CELL CYCLE, V4, P1171, DOI 10.4161/cc.4.9.2001; Glinsky GV, 2005, J CLIN INVEST, V115, P1503, DOI 10.1172/JCI23412; Gospodarowicz MK, 2004, CANCER, V100, P1, DOI 10.1002/cncr.11898; GUISE TA, 2005, CLIN BREAST CANC S2, V5, P46; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HART IR, 1981, BIOCHIM BIOPHYS ACTA, V651, P37, DOI 10.1016/0304-419X(81)90004-4; He YL, 2005, CANCER RES, V65, P4739, DOI 10.1158/0008-5472.CAN-04-4576; Hedley Benjamin D, 2006, Future Oncol, V2, P627, DOI 10.2217/14796694.2.5.627; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; Hendrix MJC, 2003, ANN NY ACAD SCI, V995, P151, DOI 10.1111/j.1749-6632.2003.tb03218.x; Heppner GH, 1998, INT REV CYTOL, V177, P1; Herynk MH, 2003, CANCER RES, V63, P2990; Hess-Stumpp H, 2007, INT J BIOCHEM CELL B, V39, P1388, DOI 10.1016/j.biocel.2007.02.009; Hill R, 2005, CELL, V123, P1001, DOI 10.1016/j.cell.2005.09.030; Hirakawa S, 2005, J EXP MED, V201, P1089, DOI 10.1084/jem.20041896; Hirschmann-Jax C, 2004, P NATL ACAD SCI USA, V101, P14228, DOI 10.1073/pnas.0400067101; Hoang CD, 2005, CANCER DETECT PREV, V29, P509, DOI 10.1016/j.cdp.2005.09.006; HUARIG LE, 2007, J MOL MED, V85, P139; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Hunter K, 2006, NAT REV CANCER, V6, P141, DOI 10.1038/nrc1803; Jodele S, 2006, CANCER METAST REV, V25, P35, DOI 10.1007/s10555-006-7887-8; Jones J, 2005, CLIN CANCER RES, V11, P5730, DOI 10.1158/1078-0432.CCR-04-2225; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Kaplan RN, 2006, CANCER METAST REV, V25, P521, DOI 10.1007/s10555-006-9036-9; Kauffman EC, 2003, J UROLOGY, V169, P1122, DOI 10.1097/01.ju.0000051580.89109.4b; Kitamura T, 2007, NAT GENET, V39, P467, DOI 10.1038/ng1997; Klein S, 2005, NAT REV CANCER, V5, P573, DOI 10.1038/nrc1651; Klos KS, 2006, CANCER RES, V66, P2028, DOI 10.1158/0008-5472.CAN-04-4559; Knerr K, 2004, INT J CANCER, V111, P152, DOI 10.1002/ijc.20223; Kopfstein L, 2006, CELL MOL LIFE SCI, V63, P449, DOI 10.1007/s00018-005-5296-8; Kramer I, 2007, J CLIN PHARM THER, V32, P1, DOI 10.1111/j.1365-2710.2007.00800.x; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Kurose K, 2001, HUM MOL GENET, V10, P1907, DOI 10.1093/hmg/10.18.1907; Larue L, 2005, ONCOGENE, V24, P7443, DOI 10.1038/sj.onc.1209091; Lee H, 2003, INT J CANCER, V107, P528, DOI 10.1002/ijc.11428; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Leenders WPJ, 2002, ENDOTHELIUM-J ENDOTH, V9, P83, DOI 10.1080/10623320212006; Leong KG, 2006, BLOOD, V107, P2223, DOI 10.1182/blood-2005-08-3329; Liotta LA, 2004, NATURE, V430, P973, DOI 10.1038/430973a; Liu LP, 2004, CANCER BIOL THER, V3, P492, DOI 10.4161/cbt.3.6.1010; Liu SL, 2006, CANCER RES, V66, P6063, DOI 10.1158/0008-5472.CAN-06-0054; Liu T, 2006, CANCER TREAT REV, V32, P157, DOI 10.1016/j.ctrv.2005.12.006; Marchion D, 2007, EXPERT REV ANTICANC, V7, P583, DOI 10.1586/14737140.7.4.583; Maroni P, 2007, CARCINOGENESIS, V28, P267, DOI 10.1093/carcin/bgl129; Massague J, 2007, NEW ENGL J MED, V356, P294, DOI 10.1056/NEJMe068292; Mehlen P, 2006, NAT REV CANCER, V6, P449, DOI 10.1038/nrc1886; Michaelson JS, 2005, BRIT J CANCER, V93, P1244, DOI 10.1038/sj.bjc.6602848; Millar AW, 2003, NAT REV CANCER, V3, P540, DOI 10.1038/nrc1124; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Minn AJ, 2005, J CLIN INVEST, V115, P44, DOI 10.1172/JCI200522320; Mizukami Y, 2006, J BIOL CHEM, V281, P13957, DOI 10.1074/jbc.M511763200; Moreira IS, 2007, ANTI-CANCER AGENT ME, V7, P223; Mueller MM, 2004, NAT REV CANCER, V4, P839, DOI 10.1038/nrc1477; Murdoch C, 2004, BLOOD, V104, P2224, DOI 10.1182/blood-2004-03-1109; Nagaraja GM, 2006, ONCOGENE, V25, P2328, DOI 10.1038/sj.onc.1209265; Nakamura K, 2006, CANCER RES, V66, P4249, DOI 10.1158/0008-5472.CAN-05-2789; Nash KT, 2007, JNCI-J NATL CANCER I, V99, P309, DOI 10.1093/jnci/djk053; Nash KT, 2006, FRONT BIOSCI-LANDMRK, V11, P647, DOI 10.2741/1824; Naumov GN, 2006, JNCI-J NATL CANCER I, V98, P316, DOI 10.1093/jnci/djj068; NERI A, 1982, J NATL CANCER I, V68, P507; NICOLSON GL, 1982, BIOCHIM BIOPHYS ACTA, V695, P113, DOI 10.1016/0304-419X(82)90020-8; NICOLSON GL, 1993, CANCER METAST REV, V12, P325, DOI 10.1007/BF00665961; Norton L, 2006, NAT MED, V12, P875, DOI 10.1038/nm0806-875; O-charoenrat P, 2001, CANCER-AM CANCER SOC, V92, P556, DOI 10.1002/1097-0142(20010801)92:3<556::AID-CNCR1355>3.0.CO;2-Q; O'Donnell RK, 2005, ONCOGENE, V24, P1244, DOI 10.1038/sj.onc.1208285; Overall CM, 2006, BRIT J CANCER, V94, P941, DOI 10.1038/sj.bjc.6603043; Paget S, 1989, LANCET, V8, P98, DOI [DOI 10.1016/S0140-6736(00)49915-0, 10.1016/S0140-6736(00)49915-0]; Palmieri D, 2005, JNCI-J NATL CANCER I, V97, P632, DOI 10.1093/jnci/dji111; Panares RL, 2007, EXPERT REV ANTICANC, V7, P433, DOI 10.1586/14737140.7.4.433; Pantel K, 2005, BBA-REV CANCER, V1756, P53, DOI 10.1016/j.bbcan.2005.07.002; Pantel K, 2004, NAT REV CANCER, V4, P448, DOI 10.1038/nrc1370; Park YG, 2005, NAT GENET, V37, P1055, DOI 10.1038/ng1635; Parker C, 1998, J HISTOCHEM CYTOCHEM, V46, P595, DOI 10.1177/002215549804600505; Peng XH, 2006, J BIOL CHEM, V281, P25903, DOI 10.1074/jbc.M603414200; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Phillips RJ, 2005, J BIOL CHEM, V280, P22473, DOI 10.1074/jbc.M500963200; Pierce G B, 1967, Curr Top Dev Biol, V2, P223; Polyak K, 2006, NAT MED, V12, P296, DOI 10.1038/nm1379; Poste G, 1982, Cancer Metastasis Rev, V1, P141, DOI 10.1007/BF00048224; Puisieux A, 2006, BRIT J CANCER, V94, P13, DOI 10.1038/sj.bjc.6602876; Quesnel B, 2006, EXPERT REV VACCINES, V5, P773, DOI 10.1586/14760584.5.6.773; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Raubenheimer EJ, 2006, J ORAL PATHOL MED, V35, P129, DOI 10.1111/j.1600-0714.2006.00360.x; Rehman AO, 2006, TRENDS CELL BIOL, V16, P293, DOI 10.1016/j.tcb.2006.04.003; Rinker-Schaeffer CW, 2006, CLIN CANCER RES, V12, P3882, DOI 10.1158/1078-0432.CCR-06-1014; Robson EJD, 2006, DIFFERENTIATION, V74, P254, DOI 10.1111/j.1432-0436.2006.00075.x; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; Rothenberg ML, 2003, NAT REV CANCER, V3, P303, DOI 10.1038/nrc1047; Saharinen P, 2004, TRENDS IMMUNOL, V25, P387, DOI 10.1016/j.it.2004.05.003; Salmon BA, 2007, INT J RADIAT ONCOL, V68, P211, DOI 10.1016/j.ijrobp.2006.12.051; Sawyers CL, 2005, COLD SH Q B, V70, P479, DOI 10.1101/sqb.2005.70.034; Schioppa T, 2003, J EXP MED, V198, P1391, DOI 10.1084/jem.20030267; Schmidt-Kittler O, 2003, P NATL ACAD SCI USA, V100, P7737, DOI 10.1073/pnas.1331931100; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shevde LA, 2003, CANCER LETT, V198, P1, DOI 10.1016/S0304-3835(03)00304-5; Shinozaki M, 2005, CLIN CANCER RES, V11, P2156, DOI 10.1158/1078-0432.CCR-04-1810; Skobe M, 2001, NAT MED, V7, P192, DOI 10.1038/84643; Sledge GW, 2006, CLIN CANCER RES, V12, P6321, DOI 10.1158/1078-0432.CCR-06-1655; Sleeman JP, 2000, RECENT RESULTS CANC, V157, P55; Smid M, 2006, J CLIN ONCOL, V24, P2261, DOI 10.1200/JCO.2005.03.8802; Smith I, 2007, LANCET, V369, P29, DOI 10.1016/S0140-6736(07)60028-2; Sobin Leslie H, 2003, Semin Surg Oncol, V21, P19, DOI 10.1002/ssu.10017; Sorlie T, 2004, EUR J CANCER, V40, P2667, DOI 10.1016/j.ejca.2004.08.021; Souglakos J, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1516; Spannhoff A, 2007, J MED CHEM, V50, P2319, DOI 10.1021/jm061250e; Steeg Patricia S, 2003, Clin Breast Cancer, V4, P51, DOI 10.3816/CBC.2003.n.012; Steeg PS, 2003, NAT REV CANCER, V3, P55, DOI 10.1038/nrc967; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Strauss BS, 1998, SEMIN CANCER BIOL, V8, P431, DOI 10.1006/scbi.1998.0092; Strieter RM, 2006, EUR J CANCER, V42, P768, DOI 10.1016/j.ejca.2006.01.006; Tammela T, 2005, TRENDS CELL BIOL, V15, P434, DOI 10.1016/j.tcb.2005.06.004; Tanaka T, 2005, CANCER SCI, V96, P317, DOI 10.1111/j.1349-7006.2005.00059.x; Tarin D, 2005, CANCER RES, V65, P5996, DOI 10.1158/0008-5472.CAN-05-0699; Tenta R., 2005, Journal of Musculoskeletal & Neuronal Interactions, V5, P135; Thiele W, 2006, J BIOTECHNOL, V124, P224, DOI 10.1016/j.jbiotec.2006.01.007; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Thompson EW, 2005, CANCER RES, V65, P5991, DOI 10.1158/0008-5472.CAN-05-0616; Topczewska JM, 2006, NAT MED, V12, P925, DOI 10.1038/nm1448; Townson JL, 2003, CURR MOL MED, V3, P631, DOI 10.2174/1566524033479483; Van Trappen PO, 2001, GYNECOL ONCOL, V82, P1, DOI 10.1006/gyno.2001.6292; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wang WG, 2005, TRENDS CELL BIOL, V15, P138, DOI 10.1016/j.tcb.2005.01.003; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Weigelt B, 2003, P NATL ACAD SCI USA, V100, P15901, DOI 10.1073/pnas.2634067100; Weigelt B, 2005, BRIT J CANCER, V93, P924, DOI 10.1038/sj.bjc.6602794; Weil RJ, 2005, AM J PATHOL, V167, P913, DOI 10.1016/S0002-9440(10)61180-7; Welch DR, 2004, BREAST CANCER RES, V6, P61, DOI 10.1186/bcr736; WELCH DR, 1985, CLIN EXP METASTAS, V3, P151, DOI 10.1007/BF01786761; Wicha MS, 2006, CANCER RES, V66, P1883, DOI 10.1158/0008-5472.CAN-05-3153; Wicki A, 2006, CANCER CELL, V9, P261, DOI 10.1016/j.ccr.2006.03.010; Witte MH, 2006, CANCER METAST REV, V25, P159, DOI 10.1007/s10555-006-8496-2; Woelfle U, 2003, CANCER RES, V63, P5679; Wong CW, 2001, CANCER RES, V61, P333; Wong SY, 2006, CELL CYCLE, V5, P812, DOI 10.4161/cc.5.8.2646; Workman Paul, 2005, Future Oncol, V1, P315, DOI 10.1517/14796694.1.3.315; Wu MJ, 2007, BIOORG MED CHEM LETT, V17, P869, DOI 10.1016/j.bmcl.2006.11.060; Wulfing P, 2006, CLIN CANCER RES, V12, P1715, DOI 10.1158/1078-0432.CCR-05-2087; Xi LQ, 2006, CLIN CANCER RES, V12, P2484, DOI 10.1158/1078-0432.CCR-05-2037; Xi LQ, 2005, CLIN CANCER RES, V11, P4128, DOI 10.1158/1078-0432.CCR-04-2525; Xu JC, 2006, PROSTATE, V66, P1664, DOI 10.1002/pros.20488; Yang HY, 2006, J PROTEOME RES, V5, P1555, DOI 10.1021/pr0504283; Yoo CB, 2006, NAT REV DRUG DISCOV, V5, P37, DOI 10.1038/nrd1930; Zayzafoon M, 2004, J BIOL CHEM, V279, P3662, DOI 10.1074/jbc.M308158200; Zhang LL, 2006, CANCER RES, V66, P5696, DOI 10.1158/0008-5472.CAN-05-3876; Zhou BHP, 2005, CELL CYCLE, V4, P772, DOI 10.4161/cc.4.6.1744	212	548	573	1	70	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 20	2007	369	9574					1742	1757		10.1016/S0140-6736(07)60781-8	http://dx.doi.org/10.1016/S0140-6736(07)60781-8			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	169ZT	17512859	Green Accepted			2022-12-28	WOS:000246631300030
J	Leon, DA; Saburova, L; Tomkins, S; Andreev, E; Kiryanov, N; Mckee, M; Shkolnikov, VM				Leon, David A.; Saburova, Lyudmila; Tomkins, Susannah; Andreev, Evgueny; Kiryanov, Nikolay; McKee, Martin; Shkolnikov, Vladimir M.			Hazardous alcohol drinking and premature mortality in Russia: a population based case-control study	LANCET			English	Article							CARDIOVASCULAR-DISEASE; PROXY RESPONDENTS; BINGE DRINKING; CONSUMPTION; PATTERNS; NOVOSIBIRSK; AGREEMENT; COHORT; CRISIS; RATES	Background The reason for the low life expectancy in Russian men and large fluctuations in mortality are unknown. We investigated the contribution of alcohol, and hazardous drinking in particular, to male mortality in a typical Russian city. Methods Cases were all deaths in men aged 25-54 years living in Izhevsk occurring between Oct 20, 2003, to Oct 3, 2005. Controls were selected at random from the city population and were frequency matched to deaths by age. Interviews with proxy informants living in the same household as cases were done between Dec 11, 2003, and Nov, 16 2005, and were obtained for 62% (1750/2835) of cases and 57% (1750/3078) of controls. We ascertained frequency and usual amount of beer, wine, and spirits consumed and frequency of consumption of manufactured ethanol-based liquids not intended to be drunk (non-beverage alcohol), and markers of problem drinking. Complete information on markers of problem drinking, frequency of alcohol consumption, education, and smoking was available for 1468 cases and 1496 controls. Findings 751 (51%) cases were classed as problem drinkers or drank non-beverage alcohol, compared with 192 (13%) controls. The mortality odds ratio (OR) for these men, compared with those who either abstained or were non-problematic beverage drinkers, was 6.0 (95% CI 5.0-7-3) after adjustment for smoking and education. The mortality ORs for drinking non-beverage alcohol in the past year (yes vs no) was 9.2 (7.2-11.7) after adjustment for age. Adjustment for volume of ethanol consumed from beverages lowered the OR to 8.3 (6.5-10.7), and further adjustment for education and smoking reduced it to 7.0 (5.5-9.0). A strong direct gradient with mortality was seen for frequency of non-beverage alcohol drinking independent of volume of beverage ethanol consumed. 43% of mortality was attributable to hazardous drinking (problem drinking or non-beverage alcohol consumption, or both) adjusted for smoking and education. Interpretation Almost half of all deaths in working age men in a typical Russian city may be accounted for by hazardous drinking. Our analyses provide indirect support for the contention that the sharp fluctuations seen in Russian mortality in the early 1990s could be related to hazardous drinking as indicated by consumption of non-beverage alcohol.	Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1E 7HT, England; Social Technol Inst, Izhevsk, Russia; Max Planck Inst Demogr Res, Rostock, Germany; Izhevsk Med Acad, Izhevsk, Russia	University of London; London School of Hygiene & Tropical Medicine; Max Planck Society	Leon, DA (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, Keppel St, London WC1E 7HT, England.	david.leon@lshtm.ac.uk	Saburova, Lyudmila A./K-2275-2018; Shkolnikov, Vladimir/D-2986-2017; Mckee, Martin/E-6673-2018; McKee, Marc D/E-2187-2011; Leon, David A/G-2195-2010	Saburova, Lyudmila A./0000-0002-7243-652X; Shkolnikov, Vladimir/0000-0003-2259-5423; Mckee, Martin/0000-0002-0121-9683; McKee, Marc D/0000-0001-8349-965X; Leon, David A/0000-0001-9747-1762	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Bobak M, 2004, J EPIDEMIOL COMMUN H, V58, P238, DOI 10.1136/jech.2003.011825; Bobak M, 1999, ADDICTION, V94, P857, DOI 10.1046/j.1360-0443.1999.9468579.x; Carlson P, 2001, J EPIDEMIOL COMMUN H, V55, P806, DOI 10.1136/jech.55.11.806; Dawson DA, 2000, J SUBST ABUSE, V12, P1, DOI 10.1016/S0899-3289(00)00037-7; Gmel G., 2004, CONTEMP DRUG PROBL, V31, P467, DOI [10.1177/009145090403100304, DOI 10.1177/009145090403100304, DOI 10.1111/J.1360-0443.2005.01224.X]; GRAHAM P, 1993, AM J EPIDEMIOL, V138, P443, DOI 10.1093/oxfordjournals.aje.a116876; GREENLAND S, 1987, STAT MED, V6, P701, DOI 10.1002/sim.4780060607; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; LEBACH WK, 1974, RES ADV ALCOHOL DRUG, V1, P93; Leon DA, 1998, JAMA-J AM MED ASSOC, V279, P790, DOI 10.1001/jama.279.10.790; Leon DA, 1997, LANCET, V350, P383, DOI 10.1016/S0140-6736(97)03360-6; MAKELA K, 1979, UNRECORDED CONSUMPTI; Malyutina S, 2002, LANCET, V360, P1448, DOI 10.1016/S0140-6736(02)11470-X; Malyutina S, 2001, ADDICTION, V96, P987, DOI 10.1046/j.1360-0443.2001.9679877.x; McKee M, 2005, ALCOHOL CLIN EXP RES, V29, P1884, DOI 10.1097/01.alc.0000183012.93303.90; McKee M, 2001, ANN EPIDEMIOL, V11, P1, DOI 10.1016/S1047-2797(00)00080-6; MESLE F., 2004, DEMOGRAPHIC RES SPEC, V2, P45, DOI DOI 10.4054/DEMRES.2004.S2.3; Mitchell F., 1997, PREMATURE DEATH NEW, P220; NELSON LM, 1994, EPIDEMIOLOGY, V5, P204, DOI 10.1097/00001648-199403000-00011; Nemtsov AV, 2002, ADDICTION, V97, P1413, DOI 10.1046/j.1360-0443.2002.00262.x; Nicholson A, 2005, B WORLD HEALTH ORGAN, V83, P812; Nilssen O, 2005, INT J EPIDEMIOL, V34, P781, DOI 10.1093/ije/dyi078; Rehm J, 2003, EUR ADDICT RES, V9, P147, DOI 10.1159/000072221; REHM J, 2006, RUSSIAN FEDERATION; Rehn J, 2006, ADDICTION, V101, P1086, DOI 10.1111/j.1360-0443.2006.01491.x; Room R, 2005, INT J EPIDEMIOL, V34, P788, DOI 10.1093/ije/dyi117; Shkolnikov V, 2001, LANCET, V357, P917, DOI 10.1016/S0140-6736(00)04212-4; SHKOLNIKOV V, 2001, NATO SIC SERIES, V327; Shkolnikov V, 2004, DEMRES, V2, P71; Shkolnikov VM, 2004, HYGIEA INT, V4, P29, DOI DOI 10.3384/HYGIEA.1403-8668.044129; STACK S, 1994, J MARRIAGE FAM, V56, P805, DOI 10.2307/353593; Tomkins S, 2007, ADDICTION, V102, P544, DOI 10.1111/j.1360-0443.2006.01693.x; Tomkins Susannah, 2006, THESIS U LONDON; Vannoy Dana, 1999, MARRIAGES RUSSIA COU; Walberg P, 1998, BRIT MED J, V317, P312, DOI 10.1136/bmj.317.7154.312	35	272	302	0	13	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 16	2007	369	9578					2001	2009		10.1016/S0140-6736(07)60941-6	http://dx.doi.org/10.1016/S0140-6736(07)60941-6			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	180HT	17574092				2022-12-28	WOS:000247354400023
J	Saalmann, YB; Pigarev, IN; Vidyasagar, TR				Saalmann, Yuri B.; Pigarev, Ivan N.; Vidyasagar, Trichur R.			Neural mechanisms of visual attention: How top-down feedback highlights relevant locations	SCIENCE			English	Article							LATERAL INTRAPARIETAL AREA; POSTERIOR PARIETAL CORTEX; EXTRASTRIATE CORTEX; FEATURE-INTEGRATION; DIRECTED ATTENTION; FUNCTIONAL MRI; MODULATION; SPOTLIGHT; MACAQUE; MONKEY	Attention helps us process potentially important objects by selectively increasing the activity of sensory neurons that represent the relevant locations and features of our environment. This selection process requires top-down feedback about what is important in our environment. We investigated how parietal cortical output influences neural activity in early sensory areas. Neural recordings were made simultaneously from the posterior parietal cortex and an earlier area in the visual pathway, the medial temporal area, of macaques performing a visual matching task. When the monkey selectively attended to a location, the timing of activities in the two regions became synchronized, with the parietal cortex leading the medial temporal area. Parietal neurons may thus selectively increase activity in earlier sensory areas to enable focused spatial attention.	Univ Melbourne, Dept Optometry & Vis Sci, Parkville, Vic 3010, Australia; Russian Acad Sci, Inst Informat Transmiss Problems, Moscow 127994, Russia	University of Melbourne; Kharkevich Institute for Information Transmission Problems of the RAS; Russian Academy of Sciences	Vidyasagar, TR (corresponding author), Univ Melbourne, Dept Optometry & Vis Sci, Parkville, Vic 3010, Australia.	trv@unimelb.edu.au	Vidyasagar, Trichur/D-9665-2012; Saalmann, Yuri B/AAW-5814-2021; ivan, pigarev/AAP-5502-2021	Vidyasagar, Trichur/0000-0002-4148-2048; Saalmann, Yuri/0000-0001-8880-6698				Balan PF, 2006, J NEUROSCI, V26, P9239, DOI 10.1523/JNEUROSCI.1898-06.2006; Bisley JW, 2003, SCIENCE, V299, P81, DOI 10.1126/science.1077395; BLATT GJ, 1990, J COMP NEUROL, V299, P421, DOI 10.1002/cne.902990404; Brefczynski JA, 1999, NAT NEUROSCI, V2, P370, DOI 10.1038/7280; BULLIER J, 1988, EXP BRAIN RES, V70, P90; Bullier J, 2001, BRAIN RES REV, V36, P96, DOI 10.1016/S0165-0173(01)00085-6; BUSHNELL MC, 1981, J NEUROPHYSIOL, V46, P755, DOI 10.1152/jn.1981.46.4.755; CORBETTA M, 1993, J NEUROSCI, V13, P1202; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; ECKHORN R, 1988, BIOL CYBERN, V60, P121, DOI 10.1007/BF00202899; Gottlieb JP, 1998, NATURE, V391, P481, DOI 10.1038/35135; Jarvis MR, 2001, NEURAL COMPUT, V13, P717, DOI 10.1162/089976601300014312; Kastner S, 1998, SCIENCE, V282, P108, DOI 10.1126/science.282.5386.108; Lewis JW, 2000, J COMP NEUROL, V428, P112, DOI 10.1002/1096-9861(20001204)428:1<112::AID-CNE8>3.0.CO;2-9; Maunsell JHR, 2006, TRENDS NEUROSCI, V29, P317, DOI 10.1016/j.tins.2006.04.001; MESULAM MM, 1981, ANN NEUROL, V10, P309, DOI 10.1002/ana.410100402; Mitra PP, 1999, BIOPHYS J, V76, P691, DOI 10.1016/S0006-3495(99)77236-X; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; MOTTER BC, 1993, J NEUROPHYSIOL, V70, P909, DOI 10.1152/jn.1993.70.3.909; Sejnowski TJ, 2006, J NEUROSCI, V26, P1673, DOI 10.1523/JNEUROSCI.3737-05d.2006; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.neuro.18.1.555; Somers DC, 1999, P NATL ACAD SCI USA, V96, P1663, DOI 10.1073/pnas.96.4.1663; STEINMETZ MA, 1995, CEREB CORTEX, V5, P448, DOI 10.1093/cercor/5.5.448; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Treue S, 1996, NATURE, V382, P539, DOI 10.1038/382539a0; Vidyasagar TR, 1998, NEUROREPORT, V9, P1947, DOI 10.1097/00001756-199806220-00006; Vidyasagar TR, 1999, BRAIN RES REV, V30, P66, DOI 10.1016/S0165-0173(99)00005-3; WOLFE JM, 1994, PSYCHON B REV, V1, P202, DOI 10.3758/BF03200774; Yantis S, 2003, CURR OPIN NEUROBIOL, V13, P187, DOI 10.1016/S0959-4388(03)00033-3	29	299	302	2	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 15	2007	316	5831					1612	1615		10.1126/science.1139140	http://dx.doi.org/10.1126/science.1139140			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178SH	17569863				2022-12-28	WOS:000247239900040
J	Hayes, DF				Hayes, Daniel F.			Follow-up of patients with early breast cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GUIDELINES; THERAPY; WOMEN; RISK; POPULATION; PATTERNS; UPDATE; COHORT; MRI		Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Hayes, DF (corresponding author), Univ Michigan, Ctr Comprehens Canc, 6312 Canc Ctr,1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	hayesdf@umich.edu	Hayes, Daniel/ABE-1129-2020					Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; *ACOG COMM OP, 2006, OBSTET GYNECOL, V107, P1475; Agency for Healthcare Research and Quality, 2012, GUID CLIN PREV SERV; Altaha R, 2005, CANCER-AM CANCER SOC, V103, P442, DOI 10.1002/cncr.20813; Bast RC, 2002, J CLIN ONCOL, V20, P2213; Bast RC, 2001, J CLIN ONCOL, V19, P4185; Bast RC, 2001, J CLIN ONCOL, V19, P1865, DOI 10.1200/JCO.2001.19.6.1865; Berg AO, 2005, ANN INTERN MED, V143, P355, DOI 10.7326/0003-4819-143-5-200509060-00011; Caswell M, 2002, J COSMET SCI, V53, P81; DELTURCO MR, 1994, JAMA-J AM MED ASSOC, V271, P1593, DOI 10.1001/jama.1994.03510440053032; GHEZZI P, 1994, JAMA-J AM MED ASSOC, V271, P1587, DOI 10.1001/jama.1994.03510440047031; Hess KR, 2003, BREAST CANCER RES TR, V78, P105, DOI 10.1023/A:1022166517963; Holmberg L, 2004, LANCET, V363, P453, DOI 10.1016/S0140-6736(04)15493-7; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; JI J, IN PRESS BREAST CANC; Khatcheressian JL, 2006, J CLIN ONCOL, V24, P5091, DOI 10.1200/JCO.2006.08.8575; KIROVA YM, IN PRESS INT J RAD O; Leach MO, 2005, LANCET, V365, P1769, DOI 10.1016/S0140-6736(05)66481-1; Lehman CD, 2007, NEW ENGL J MED, V356, P1295, DOI 10.1056/NEJMoa065447; Mandelblatt JS, 2006, J CLIN ONCOL, V24, P77, DOI 10.1200/JCO.2005.02.2681; Mellemkjaer L, 2006, INT J CANCER, V118, P2285, DOI 10.1002/ijc.21651; *NAT COMPR CANC NE, 2006, BREAST CANC SCREEN D; *NAT COMPR CANC NE, 2007, CLIN PRACT GUID ONC; Nelson HD, 2002, ANN INTERN MED, V137, P529, DOI 10.7326/0003-4819-137-6-200209170-00015; *PREV SERV TASK FO, 2005, ANN INTERN MED, V143, P547; Risch HA, 2006, JNCI-J NATL CANCER I, V98, P1694, DOI 10.1093/jnci/djj465; Rowland JH, 2006, J CLIN ONCOL, V24, P5101, DOI 10.1200/JCO.2006.09.2700; Saslow D, 2007, CA-CANCER J CLIN, V57, P75, DOI 10.3322/canjclin.57.2.75; Smith Roy E, 2003, Clin Breast Cancer, V4, P273, DOI 10.3816/CBC.2003.n.032; Stewart HJ, 1996, BRIT J CANCER, V74, P297, DOI 10.1038/bjc.1996.356; Wadsworth EJK, 2005, HUM PSYCHOPHARM CLIN, V20, P561, DOI 10.1002/hup.725; Winer EP, 2005, J CLIN ONCOL, V23, P619, DOI 10.1200/JCO.2005.09.121	32	60	60	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 14	2007	356	24					2505	2513		10.1056/NEJMcp067260	http://dx.doi.org/10.1056/NEJMcp067260			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	178DR	17568031				2022-12-28	WOS:000247201900010
J	Litvin, CB				Litvin, Cara B.			In the dark - The case for electronic health records	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									NYU, Med Ctr, Dept Med, New York, NY 10016 USA	New York University	Litvin, CB (corresponding author), NYU, Med Ctr, Dept Med, New York, NY 10016 USA.							Baron RJ, 2005, ANN INTERN MED, V143, P222, DOI 10.7326/0003-4819-143-3-200508020-00008; Jha AK, 2003, NEW ENGL J MED, V348, P2218, DOI 10.1056/NEJMsa021899; Jha AK, 2006, HEALTH AFFAIR, V25, pW496, DOI 10.1377/hlthaff.25.w496; Kaushal R, 2005, ANN INTERN MED, V143, P165, DOI 10.7326/0003-4819-143-3-200508020-00002; The White House, 2004, NEW GEN AM INN	5	6	6	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 14	2007	356	24					2454	2455		10.1056/NEJMp068283	http://dx.doi.org/10.1056/NEJMp068283			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	178DR	17568027				2022-12-28	WOS:000247201900005
J	Stone, JH				Stone, John H.			Communication between physicians and patients in the era of e-medicine	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							IMPACT; CARE		Johns Hopkins Univ, Sch Med, Baltimore, MD USA; Vasculitis Ctr, Baltimore, MD USA	Johns Hopkins University	Stone, JH (corresponding author), UpToDate, Rheumatol, Waltham, MA USA.							Anand SG, 2005, PEDIATRICS, V115, P1283, DOI 10.1542/peds.2004-1297; Chaudhry B, 2006, ANN INTERN MED, V144, P742, DOI 10.7326/0003-4819-144-10-200605160-00125; Liederman EM, 2005, J GEN INTERN MED, V20, P52, DOI 10.1111/j.1525-1497.2005.40009.x; Wachter RM, 2004, INTERNAL BLEEDING TR; *WHIT HOUS, 2006, TRANSF HLTH CAR PRES	5	42	44	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 14	2007	356	24					2451	2454		10.1056/NEJMp068198	http://dx.doi.org/10.1056/NEJMp068198			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	178DR	17568026				2022-12-28	WOS:000247201900004
J	McAlister, FA; Ezekowitz, J; Hooton, N; Ben Vandermeer; Spooner, C; Dryden, DM; Page, RL; Hlatky, MA; Rowe, BH				McAlister, Finlay A.; Ezekowitz, Justin; Hooton, Nicola; Ben Vandermeer; Spooner, Carol; Dryden, Donna M.; Page, Richard L.; Hlatky, Mark A.; Rowe, Brian H.			Cardiac resynchronization therapy for patients with left ventricular systolic dysfunction - A systematic review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							CONGESTIVE-HEART-FAILURE; IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR; CHRONIC ATRIAL-FIBRILLATION; INTRAVENTRICULAR-CONDUCTION DELAY; RANDOMIZED CONTROLLED-TRIALS; TERM-FOLLOW-UP; CARE-HF TRIAL; RESYNCHRONISATION THERAPY; CORONARY-SINUS; COST-EFFECTIVENESS	Context Left ventricular (LV) systolic dysfunction causes substantial morbidity and mortality, even with optimal pharmacotherapy. Atrial-synchronized biventricular pacemakers ( cardiac resynchronization therapy [CRT]) received US Food and Drug Administration (FDA) approval for use in selected patients with LV systolic dysfunction in 2001. Objective To summarize the current evidence base for the efficacy, effectiveness, and safety of CRT in patients with LV systolic dysfunction. Evidence Acquisition A search of multiple electronic databases until November 2006 was supplemented by hand searches of reference lists of included studies and review articles, proceedings booklets from meetings, FDA reports, and contact with primary study authors and device manufacturers. A total of 14 randomized trials ( 4420 patients) were included for the CRT efficacy review, 106 studies ( 9209 patients) for the CRT effectiveness review, and 89 studies ( 9677 patients) reported safety outcomes with implantation of a CRT device. Evidence Synthesis All patients in the CRT studies had LV systolic dysfunction ( mean LV ejection fraction [LVEF] range, 21%-30%), prolonged QRS duration ( mean range, 155-209 milliseconds), and 91% had New York Heart Association (NYHA) class 3 or 4 heart failure symptoms despite optimal pharmacotherapy. CRT improved LVEF ( weighted mean difference, 3.0%; 95% confidence interval [CI], 0.9%-5.1%), quality of life ( weighted mean reduction in Minnesota Living With Heart Failure Questionnaire, 8.0 points; 95% CI, 5.6-10.4 points), and functional status ( improvements of >= 1 NYHA class were observed in 59% of CRT recipients in the randomized trials). CRT decreased hospitalizations by 37% ( 95% CI, 7%-57%), and all-cause mortality decreased by 22% ( 95% CI, 9%-33%). Implant success rate was 93.0% ( 95% CI, 92.2%-93.7%) and 0.3% of patients died during implantation ( 95% CI, 0.1%-0.6%). During a median 11-month follow-up, 6.6% ( 95% CI, 5.6%-7.4%) of CRT devices exhibited lead problems and 5% ( 95% CI, 4%-7%) malfunctioned. Conclusions CRT reduces morbidity and mortality in patients with LV systolic dysfunction, prolonged QRS duration, and NYHA class 3 or 4 symptoms when combined with optimal pharmacotherapy. The incremental benefits of combined CRT plus implantable cardioverter-defibrillator devices vs CRT-alone devices in patients with LV systolic dysfunction remain uncertain.	Univ Alberta, Evidence Based Practice Ctr, Edmonton, AB, Canada; Univ Alberta, Div Gen Internal Med, Edmonton, AB, Canada; Univ Alberta, Div Cardiol, Edmonton, AB, Canada; Univ Alberta, Dept Emergency Med, Edmonton, AB, Canada; Univ Washington, Sch Med, Div Cardiol, Seattle, WA USA; Stanford Univ, Dept Hlth Res & Policy, Stanford, CA 94305 USA	University of Alberta; University of Alberta; University of Alberta; University of Alberta; University of Washington; University of Washington Seattle; Stanford University	McAlister, FA (corresponding author), Univ Alberta Hosp, 2E3-24 WMC,8440 112th St, Edmonton, AB T6G 2R7, Canada.	finlay.mcalister@ualberta.ca	Ezekowitz, Justin A/C-4579-2013; McAlister, Finlay/C-4151-2013; Page, Richard L./L-5501-2014	Ezekowitz, Justin A/0000-0002-2724-4086; McAlister, Finlay/0000-0001-7435-3341; Page, Richard L./0000-0001-5603-1330; Hlatky, Mark/0000-0003-4686-9441	PHS HHS [290-02-0023] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Abraham WT, 2004, CIRCULATION, V110, P2864, DOI 10.1161/01.CIR.0000146336.92331.D1; Abraham WT, 2002, NEW ENGL J MED, V346, P1845, DOI 10.1056/NEJMoa013168; Achilli A, 2003, J AM COLL CARDIOL, V42, P2117, DOI 10.1016/j.jacc.2003.08.024; Adamson PB, 2004, CIRCULATION, V110, P2389, DOI 10.1161/01.CIR.0000139841.42454.78; Al-Khatib SM, 2005, J AM COLL CARDIOL, V46, P1536, DOI 10.1016/j.jacc.2005.04.063; Albertsen AE, 2005, PACE, V28, P483, DOI 10.1111/j.1540-8159.2005.40066.x; Alonso C, 1999, AM J CARDIOL, V84, P1417, DOI 10.1016/S0002-9149(99)00588-3; Ammann P, 2004, SWISS MED WKLY, V134, P277; Ansalone G, 2002, J AM COLL CARDIOL, V39, P489, DOI 10.1016/S0735-1097(01)01772-7; Aranda JM, 2005, AM J CARDIOL, V95, P889, DOI 10.1016/j.amjcard.2004.12.023; Auricchio A, 2002, J AM COLL CARDIOL, V39, P2026, DOI 10.1016/S0735-1097(02)01895-8; Auricchio A, 2003, J AM COLL CARDIOL, V42, P2109, DOI 10.1016/j.jacc.2003.04.003; Auricchio A, 2002, AM J CARDIOL, V89, P198, DOI 10.1016/S0002-9149(01)02200-7; Azizi M, 2006, Herzschrittmacherther Elektrophysiol, V17, P13, DOI 10.1007/s00399-006-0502-4; Baker CM, 2002, PACE, V25, P1166, DOI 10.1046/j.1460-9592.2002.01166.x; Bax JJ, 2003, AM J CARDIOL, V92, P1238, DOI 10.1016/j.amjcard.2003.06.016; Bax JJ, 2004, J AM COLL CARDIOL, V44, P1834, DOI 10.1016/j.jacc.2004.08.016; Birnie DH, 2006, CURR OPIN CARDIOL, V21, P20, DOI 10.1097/01.hco.0000198983.93755.99; Bleeker GB, 2006, AM J CARDIOL, V98, P230, DOI 10.1016/j.amjcard.2006.01.080; Bleeker GB, 2005, AM J CARDIOL, V96, P420, DOI 10.1016/j.amjcard.2005.03.091; Bleeker GB, 2006, AM J CARDIOL, V97, P260, DOI 10.1016/j.amjcard.2005.08.030; Bleeker GB, 2005, J AM COLL CARDIOL, V46, P2264, DOI 10.1016/j.jacc.2005.04.069; Bocchiardo M, 2000, EUR HEART J SUPPL, V2, pJ36; Bonanno Carlo, 2004, Ital Heart J, V5, P364; Bordachar P, 2004, J AM COLL CARDIOL, V44, P2157, DOI 10.1016/j.jacc.2004.08.065; Boriani G, 2006, PEPTIDES, V27, P1776, DOI 10.1016/j.peptides.2006.02.010; Boriani G, 2006, AM HEART J, V151, P1050, DOI 10.1016/j.ahj.2005.08.019; Boriani G, 2006, AM HEART J, V152, P527, DOI 10.1016/j.ahj.2006.03.003; Bradley DJ, 2003, JAMA-J AM MED ASSOC, V289, P730, DOI 10.1001/jama.289.6.730; Braun MU, 2005, HEART, V91, P601, DOI 10.1136/hrt.2003.030338; Braunschweig F, 2005, AM J CARDIOL, V95, P1104, DOI 10.1016/j.amjcard.2004.12.069; Bristow MR, 2004, NEW ENGL J MED, V350, P2140, DOI 10.1056/NEJMoa032423; Calvert MJ, 2005, EUR HEART J, V26, P2681, DOI 10.1093/eurheartj/ehi662; Cazeau S, 2003, ARCH MAL COEUR VAISS, V96, P659; Cazeau S, 2001, NEW ENGL J MED, V344, P873, DOI 10.1056/NEJM200103223441202; Chalil S, 2006, J AM COLL CARDIOL, V47, P2486, DOI 10.1016/j.jacc.2005.12.074; Chan KL, 2003, CAN J CARDIOL, V19, P387; Chugh A, 2005, PACE, V28, P44, DOI 10.1111/j.1540-8159.2005.09499.x; Cleland JGF, 2005, NEW ENGL J MED, V352, P1539, DOI 10.1056/NEJMoa050496; Cleland JGF, 2006, EUR HEART J, V27, P1928, DOI 10.1093/eurheartj/ehl099; Cowburn PJ, 2005, EUR J HEART FAIL, V7, P899, DOI 10.1016/j.ejheart.2004.10.023; Da Costa A, 2006, HEART RHYTHM, V3, P406, DOI 10.1016/j.hrthm.2005.12.017; Daubert JC, 1998, PACE, V21, P239, DOI 10.1111/j.1540-8159.1998.tb01096.x; Davis DR, 2005, CAN J CARDIOL, V21, P413; de Cock CC, 2004, EUROPACE, V6, P43, DOI 10.1016/j.eupc.2003.09.002; De Lurgio DB, 2005, J CARD FAIL, V11, P233, DOI 10.1016/j.cardfail.2004.08.163; De Martino G, 2005, EUROPACE, V7, P73, DOI 10.1016/j.eupc.2004.09.006; De Martino G, 2004, J INTERV CARD ELECTR, V10, P227, DOI 10.1023/B:JICE.0000026916.15278.2e; De Sisti A, 2005, PACE, V28, P1260, DOI 10.1111/j.1540-8159.2005.00266.x; Diaz-Infante E, 2005, AM J CARDIOL, V95, P1436, DOI 10.1016/j.amjcard.2005.02.009; Dixon LJ, 2004, EUROPACE, V6, P586, DOI 10.1016/j.eupc.2004.08.006; Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377; Duncan AM, 2006, EUR HEART J, V27, P2426, DOI 10.1093/eurheartj/ehl179; Ellenbogen KA, 2003, AM J CARDIOL, V92, P740, DOI 10.1016/S0002-9149(03)00844-0; Ellery S, 2005, PACE, V28, pS31, DOI 10.1111/j.1540-8159.2005.00084.x; Ermis C, 2005, J AM COLL CARDIOL, V46, P2258, DOI 10.1016/j.jacc.2005.04.067; Ermis C, 2004, J CARDIOVASC ELECTR, V15, P862, DOI 10.1046/j.1540-8167.2004.04044.x; Feldman AM, 2005, J AM COLL CARDIOL, V46, P2311, DOI 10.1016/j.jacc.2005.08.033; Fox M, 2006, EFFECTIVENESS COST E; Fung JWH, 2005, AM J CARDIOL, V96, P728, DOI 10.1016/j.amjcard.2005.04.053; Gaita F, 2000, AM J CARDIOL, V86, p165K, DOI 10.1016/S0002-9149(00)01229-7; Galvao Silas S, 2002, Arq Bras Cardiol, V78, P39; Gasparini M, 2005, J CARDIOVASC ELECTR, V16, P1279, DOI 10.1111/j.1540-8167.2005.00247.x; Gasparini M, 2003, PACE, V26, P169, DOI 10.1046/j.1460-9592.2003.00010.x; Gras D, 2002, EUR J HEART FAIL, V4, P311, DOI 10.1016/S1388-9842(02)00018-1; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Higgins SL, 2003, J AM COLL CARDIOL, V42, P1454, DOI 10.1016/S0735-1097(03)01042-8; Hua W, 2006, CHINESE MED J-PEKING, V119, P1507, DOI 10.1097/00029330-200609020-00002; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Kautzner J, 2004, PACE, V27, P783, DOI 10.1111/j.1540-8159.2004.00529.x; Kies P, 2006, HEART, V92, P490, DOI 10.1136/hrt.2005.064816; Kies P, 2005, AM J CARDIOL, V96, P108, DOI 10.1016/j.amjcard.2005.02.055; Kindermann M, 2006, J AM COLL CARDIOL, V47, P1927, DOI 10.1016/j.jacc.2005.12.056; Koos R, 2004, AM J CARDIOL, V94, P59, DOI 10.1016/j.amjcard.2004.03.031; Krahn AD, 2002, CAN J CARDIOL, V18, P380; Kuhlkamp V, 2002, J AM COLL CARDIOL, V39, P790, DOI 10.1016/S0735-1097(01)01819-8; Leclercq C, 2000, AM J CARDIOL, V85, P1154, DOI 10.1016/S0002-9149(00)00716-5; Leclercq C, 2002, EUR HEART J, V23, P1780, DOI 10.1053/euhj.2002.3232; Leclercq C, 2002, ARCH MAL COEUR VAISS, V95, P253; LECLERCQ C, 2003, EUR SOC CARD C AUG 3; Lecoq G, 2005, EUR HEART J, V26, P1094, DOI 10.1093/eurheartj/ehi146; Leon AR, 2005, J AM COLL CARDIOL, V46, P2298, DOI 10.1016/j.jacc.2005.08.032; LEONOM V, 2005, REV MED LIEGE, V60, P101; LEWICKANOWAK E, 2005, FOLIA CARDIOL, V12, P343; Linde C, 2006, AM HEART J, V151, P288, DOI 10.1016/j.ahj.2005.03.002; Lindner O, 2005, EUR HEART J, V26, P70, DOI 10.1093/eurheartj/ehi046; Macioce R, 2005, Minerva Cardioangiol, V53, P329; Madrid AH, 2004, REV ESP CARDIOL, V57, P299; Mair H, 2005, EUR J CARDIO-THORAC, V27, P235, DOI 10.1016/j.ejcts.2004.09.029; Mangiavacchi M, 2006, AM HEART J, V151, DOI 10.1016/j.ahj.2005.08.008; Marai I, 2006, PACE, V29, P880, DOI 10.1111/j.1540-8159.2006.00455.x; Mascioli Giosue, 2002, Ital Heart J, V3, P598; McAlister FA, 2006, EUR HEART J, V27, P323, DOI 10.1093/eurheartj/ehi446; McAlister FA, 2004, ANN INTERN MED, V141, P381, DOI 10.7326/0003-4819-141-5-200409070-00101; Medina-Ravell VA, 2003, CIRCULATION, V107, P740, DOI 10.1161/01.CIR.0000048126.07819.37; Mehra MR, 2004, J AM COLL CARDIOL, V43, P1145, DOI 10.1016/j.jacc.2003.10.050; Mele D, 2006, EUR HEART J, V27, P1070, DOI 10.1093/eurheartj/ehi814; Molhoek SG, 2005, J CARDIOVASC ELECTR, V16, P701, DOI 10.1111/j.1540-8167.2005.40685.x; Molhoek SG, 2004, AM J CARDIOL, V94, P1506, DOI 10.1016/j.amjcard.2004.08.028; Molhoek SG, 2004, PACE, V27, P308, DOI 10.1111/j.1540-8159.2004.00433.x; Molhoek SG, 2004, AM J CARDIOL, V93, P860, DOI 10.1016/j.amjcard.2003.12.024; Molhoek SG, 2002, AM J CARDIOL, V90, P379, DOI 10.1016/S0002-9149(02)02493-1; Mortensen PT, 2004, PACE, V27, P339, DOI 10.1111/j.1540-8159.2004.00438.x; Moss AJ, 2005, ANN NONINVAS ELECTRO, V10, P34, DOI 10.1111/j.1542-474X.2005.00073.x; Murphy RT, 2006, AM J CARDIOL, V97, P1615, DOI 10.1016/j.amjcard.2005.12.054; NAGELE H, 2001, HERZSCHRITTMACHER, V21, P53; Navia JL, 2005, ANN THORAC SURG, V79, P1536, DOI 10.1016/j.athoracsur.2004.10.041; Nichol G, 2004, ANN INTERN MED, V141, P343, DOI 10.7326/0003-4819-141-5-200409070-00102; Niu HX, 2006, CHINESE MED J-PEKING, V119, P449, DOI 10.1097/00029330-200603020-00003; Notabartolo D, 2004, AM J CARDIOL, V94, P817, DOI 10.1016/j.amjcard.2004.05.072; O'Donnell D, 2005, PACE, V28, pS24, DOI 10.1111/j.1540-8159.2005.00070.x; Oliva F, 2005, J HEART LUNG TRANSPL, V24, pS84, DOI 10.1016/j.healun.2004.11.152; Ollitrault J, 2003, PACE, V26, P185, DOI 10.1046/j.1460-9592.2003.00013.x; Pappone C, 2003, AM J CARDIOL, V91, p74F, DOI 10.1016/S0002-9149(02)03341-6; Penicka M, 2004, CIRCULATION, V109, P978, DOI 10.1161/01.CIR.0000116765.43251.D7; Pitzalis MV, 2005, J AM COLL CARDIOL, V45, P65, DOI 10.1016/j.jacc.2004.09.058; Porciani MC, 2006, EUR J ECHOCARDIOGR, V7, P31, DOI 10.1016/j.euje.2005.03.008; Porciania MC, 2006, INT J CARDIOL, V112, P322, DOI 10.1016/j.ijcard.2005.10.002; Puglisi A, 2004, EUR HEART J, V25, P1063, DOI 10.1016/j.ehj.2004.04.016; PUMODE P, 2004, LOUV MED, V123, P18; Purerfellner H, 2000, AM J CARDIOL, V86, p157K, DOI 10.1016/S0002-9149(00)01299-6; Reuter S, 2002, AM J CARDIOL, V89, P346, DOI 10.1016/S0002-9149(01)02240-8; Reuter S, 2000, PACE, V23, P1713; Reynolds MR, 2006, J AM COLL CARDIOL, V47, P2493, DOI 10.1016/j.jacc.2006.02.049; Ricci R, 2002, J INTERV CARD ELECTR, V6, P279, DOI 10.1023/A:1019570022647; Ritter O, 2006, INT J CARDIOL, V110, P359, DOI 10.1016/j.ijcard.2005.08.025; Rivero-Ayerza M, 2006, EUR HEART J, V27, P2682, DOI 10.1093/eurheartj/ehl203; Romeyer-Bouchard C, 2005, HEART RHYTHM, V2, P714, DOI 10.1016/j.hrthm.2005.04.005; ROSAMOND W, 2006, CIRCULATION; Rossillo A, 2004, J CARDIOVASC ELECTR, V15, P1120, DOI 10.1046/j.1540-8167.2004.04089.x; Salukhe TV, 2005, INT J CARDIOL, V100, P5, DOI 10.1016/j.ijcard.2005.01.010; Sawhney NS, 2004, HEART RHYTHM, V1, P562, DOI 10.1016/j.hrthm.2004.07.006; Saxon LA, 2006, J CARDIOVASC ELECTR, V17, P520, DOI 10.1111/j.1540-8167.2006.00440.x; Schuchert A, 2004, PACE, V27, P1610, DOI 10.1111/j.1540-8159.2004.00693.x; Sogaard P, 2002, J AM COLL CARDIOL, V40, P723, DOI 10.1016/S0735-1097(02)02010-7; Stahlberg M, 2005, PACE, V28, P1013, DOI 10.1111/j.1540-8159.2005.00217.x; Taieb J., 2002, Annales de Cardiologie et d'Angeiologie, V51, P289, DOI 10.1016/S0003-3928(02)00126-9; Tedrow UB, 2006, AM J CARDIOL, V97, P1737, DOI 10.1016/j.amjcard.2006.01.033; Teo W. S., 2003, SMJ Singapore Medical Journal, V44, P114; Theuns DAMJ, 2005, EUR J HEART FAIL, V7, P1027, DOI 10.1016/j.ejheart.2005.05.006; Toma M, 2006, AM J CARDIOL, V97, P882, DOI 10.1016/j.amjcard.2005.09.138; Toussaint JF, 2003, PACE, V26, P1815, DOI 10.1046/j.1460-9592.2003.t01-1-00275.x; *US FDA, 2005, ST JUD MED FRONT MOD; *US FDA, 2005, ST JUD MED EP HF SYS; Vidal B, 2006, AM J CARDIOL, V97, P876, DOI 10.1016/j.amjcard.2005.09.137; Waggoner AD, 2006, J AM SOC ECHOCARDIOG, V19, P307, DOI 10.1016/j.echo.2005.10.014; Witte KKA, 2006, J CARD FAIL, V12, P199, DOI 10.1016/j.cardfail.2005.12.003; Woo GW, 2005, J INTERV CARD ELECTR, V12, P107, DOI 10.1007/s10840-005-6545-3; Yao GQ, 2007, EUR HEART J, V28, P42, DOI 10.1093/eurheartj/ehl382; Young JB, 2003, JAMA-J AM MED ASSOC, V289, P2685, DOI 10.1001/jama.289.20.2685; Ypenburg C, 2006, J AM COLL CARDIOL, V48, P464, DOI 10.1016/j.jacc.2006.04.072; Yu CM, 2005, AM HEART J, V149, P600, DOI 10.1016/j.ahj.2004.12.013; Yu CM, 2003, AM J CARDIOL, V91, P684, DOI 10.1016/S0002-9149(02)03404-5; Yu CM, 2004, J CARDIOVASC ELECTR, V15, P1058, DOI 10.1046/j.1540-8167.2004.03648.x; Yu CM, 2002, CIRCULATION, V105, P438, DOI 10.1161/hc0402.102623; Yu CM, 2005, CIRCULATION, V112, P1580, DOI 10.1161/CIRCULATIONAHA.105.538272; Zhang Q, 2006, EUR HEART J, V27, P1423, DOI 10.1093/eurheartj/ehi885	157	419	439	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 13	2007	297	22					2502	2514		10.1001/jama.297.22.2502	http://dx.doi.org/10.1001/jama.297.22.2502			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	177TX	17565085				2022-12-28	WOS:000247176500025
J	Fields, S				Fields, Stanley			Site-seeing by sequencing	SCIENCE			English	Editorial Material							BINDING-SITES; PROTEIN; YEAST		Univ Washington, Howard Hughes Med Inst, Dept Genome Sci, Seattle, WA 98195 USA; Univ Washington, Howard Hughes Med Inst, Dept Med, Seattle, WA 98195 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Fields, S (corresponding author), Univ Washington, Howard Hughes Med Inst, Dept Genome Sci, Seattle, WA 98195 USA.	fields@u.washington.edu						CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; Horak CE, 2002, P NATL ACAD SCI USA, V99, P2924, DOI 10.1073/pnas.052706999; Iyer VR, 2001, NATURE, V409, P533, DOI 10.1038/35054095; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Liu CL, 2005, PLOS BIOL, V3, P1753, DOI 10.1371/journal.pbio.0030328; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Weinmann AS, 2002, GENE DEV, V16, P235, DOI 10.1101/gad.943102	9	20	26	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 8	2007	316	5830					1441	1442		10.1126/science.1144479	http://dx.doi.org/10.1126/science.1144479			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176EE	17556576				2022-12-28	WOS:000247066400032
J	Nishimura, K; Sugiyama, D; Kogata, Y; Tsuji, G; Nakazawa, T; Kawano, S; Saigo, K; Morinobu, A; Koshiba, M; Kuntz, KM; Kamae, I; Kumagai, S				Nishimura, Kunihiro; Sugiyama, Daisuke; Kogata, Yoshinori; Tsuji, Goh; Nakazawa, Takashi; Kawano, Seiji; Saigo, Katsuyasu; Morinobu, Akio; Koshiba, Masahiro; Kuntz, Karen M.; Kamae, Isao; Kumagai, Shunichi			Meta-analysis: Diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis	ANNALS OF INTERNAL MEDICINE			English	Review							ANTIKERATIN ANTIBODIES; ANTIPERINUCLEAR FACTOR; CLINICAL UTILITY; PROGNOSTIC VALUE; PREDICTIVE-VALUE; RECENT-ONSET; FILAGGRIN ANTIBODIES; LATEX AGGLUTINATION; RADIOLOGICAL PROGRESSION; DIFFERENTIAL-DIAGNOSIS	Background: Rheumatoid factor (RF) and autoantibodies against cyclic citrullinated peptide (CCP) are markers that might help physicians diagnose rheumatoid arthritis. Purpose: To determine whether anti-CCP antibody more accurately identifies patients with rheumatoid arthritis and better predicts radiographic progression than does RF. Data Sources: IMEDLINE through September 2006 and reference lists of retrieved studies and review articles. Study Selection: Studies in any language that enrolled at least 10 participants and that examined the role of anti-CCP antibody and RF in the diagnosis or prognosis of known or suspected rheumatoid arthritis. Data Extraction: Two authors independently evaluated studies for inclusion, rated methodological quality, and abstracted relevant data. Data Synthesis: The DerSimonian-Laird random-effects method was used to summarize sensitivities, specificities, and positive and negative likelihood ratios from 37 studies of anti-CCP antibody and 50 studies of RF. The pooled sensitivity, specificity, and positive and negative likelihood ratios for anti-CCP antibody were 67% (95% CI, 62% to 72%), 95% (CI, 94% to 97%), 12.46 (CI, 9.72 to 15.98), and 0.36 (CI, 0.31 to 0.42), respectively. For IgM RF, the values were 69% (CI, 65% to 73%), 85% (CI, 82% to 88%), 4.86 (CI, 3.95 to 5.97), and 0.38 (CI, 0.33 to 0.44). Likelihood ratios among IgM RF, IgG RF, and IgA RF seemed to be similar. Results from studies of patients with early rheumatoid arthritis were similar to those from all studies. Three of 4 studies found that risk for radiographic progression was greater with anti-CCP antibody positivity than with IgM RF positivity. Limitations: Many studies had methodological limitations. Studies of RF were heterogeneous and had wide ranges of sensitivity and specificity. Conclusions: Anti-CCP antibodies are more specific than RF for diagnosing rheumatoid arthritis and may better predict erosive disease.	Harvard Univ, Sch Publ Hlth, Dept Hlth Policy Management, Boston, MA 02215 USA; Hyogo Coll Med, Hyogo, Japan; Kobe Univ, Grad Sch Med, Hyogo, Japan	Harvard University; Harvard T.H. Chan School of Public Health; Hyogo College of Medicine; Kobe University	Nishimura, K (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy Management, 718 Huntington Ave, Boston, MA 02215 USA.	knishimu@hsph.harvard.edu	Sugiyama, Daisuke/L-4347-2013	Sugiyama, Daisuke/0000-0002-6487-8934				Aho K, 1999, SCAND J RHEUMATOL, V28, P113; Aman S, 2000, RHEUMATOLOGY, V39, P1009, DOI 10.1093/rheumatology/39.9.1009; Anuradha V, 2005, J RHEUMATOL, V32, P2343; Aotsuka S, 2005, CLIN EXP RHEUMATOL, V23, P475; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Aupperle KR, 1996, Z RHEUMATOL, V55, P158; BANCHUIN N, 1992, ASIAN PAC J ALLERGY, V10, P47; Bas S, 2000, RHEUMATOLOGY, V39, P1082, DOI 10.1093/rheumatology/39.10.1082; Bas S, 2003, RHEUMATOLOGY, V42, P677, DOI 10.1093/rheumatology/keg184; Bas S, 2002, RHEUMATOLOGY, V41, P809, DOI 10.1093/rheumatology/41.7.809; Bas S, 2002, ANN RHEUM DIS, V61, P505, DOI 10.1136/ard.61.6.505; Berglin E, 2004, ARTHRITIS RES THER, V6, pR303, DOI 10.1186/ar1187; BERTHELOT JM, 1995, BRIT J RHEUMATOL, V34, P716; Bizzaro N, 2001, CLIN CHEM, V47, P1089; Bombardieri M, 2004, ARTHRITIS RES THER, V6, pR137, DOI 10.1186/ar1041; Brennan P, 1996, BRIT MED J, V313, P471; Bukhari MAS, 2003, ARTHRITIS RHEUM-US, V48, P46, DOI 10.1002/art.10727; Cantaert T, 2006, ARTHRITIS RHEUM-US, V54, P3381, DOI 10.1002/art.22206; CARPENTER AB, 1989, CLIN CHEM, V35, P464; Choi SW, 2005, J KOREAN MED SCI, V20, P473, DOI 10.3346/jkms.2005.20.3.473; Cook AD, 2004, ARTHRITIS RES THER, V6, pR477, DOI 10.1186/ar1213; Cordonnier C, 1996, BRIT J RHEUMATOL, V35, P620; Correa Paula A, 2004, Biomed., V24, P140; Das H, 2004, CLIN RHEUMATOL, V23, P218, DOI 10.1007/s10067-003-0860-9; DAVIS P, 1989, BRIT J RHEUMATOL, V28, P546; De Rycke L, 2004, ANN RHEUM DIS, V63, P1587, DOI 10.1136/ard.2003.017574; deBois MHW, 1996, SCAND J RHEUMATOL, V25, P155, DOI 10.3109/03009749609080006; Deeks~ JJ, 2001, SYSTEMATIC REV HLTH; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DESPRES N, 1994, J RHEUMATOL, V21, P1027; Dixey J, 2004, J RHEUMATOL, V31, P48; Dorner T, 2004, CURR OPIN RHEUMATOL, V16, P246; Dubucquoi S, 2004, ANN RHEUM DIS, V63, P415, DOI 10.1136/ard.2003.008623; Fernandez-Suarez A, 2005, CLIN CHEM LAB MED, V43, P1234, DOI 10.1515/CCLM.2005.214; Forslind K, 2004, SCAND J RHEUMATOL, V33, P154, DOI 10.1080/03009740410006862; Garcia-Berrocal B, 2005, CLIN CHIM ACTA, V354, P123, DOI 10.1016/j.cccn.2004.11.025; Girelli F, 2004, Eur Ann Allergy Clin Immunol, V36, P127; Goldbach-Mansky R, 2000, ARTHRITIS RES, V2, P236, DOI 10.1186/ar93; GOMESDAUDRIX V, 1994, ANN RHEUM DIS, V53, P735, DOI 10.1136/ard.53.11.735; Goronzy JJ, 2004, ARTHRITIS RHEUM-US, V50, P43, DOI 10.1002/art.11445; Greiner A, 2005, ANN NY ACAD SCI, V1050, P295, DOI 10.1196/annals.1313.031; Grootenboer-Mignot S, 2004, SCAND J RHEUMATOL, V33, P218, DOI 10.1080/03009740410005403; Hitchon CA, 2004, J RHEUMATOL, V31, P2336; HOFFMAN RM, 1991, SPINE, V16, P623, DOI 10.1097/00007632-199106000-00005; IRWIG L, 1994, ANN INTERN MED, V120, P667, DOI 10.7326/0003-4819-120-8-199404150-00008; *IUIS WHO AF CDC C, 2004, ARTHRITIS RHEUM, V51, P291; Jansen ALMA, 2002, J RHEUMATOL, V29, P2074; Jansen LMA, 2001, ANN RHEUM DIS, V60, P924, DOI 10.1136/ard.60.10.924; Jansen LMA, 2003, J RHEUMATOL, V30, P1691; Jansen TLTA, 2004, J RHEUMATOL, V31, P1012; Jonsson T, 1998, RHEUMATOL INT, V18, P119, DOI 10.1007/s002960050069; Kamali S, 2005, CLIN RHEUMATOL, V24, P673, DOI 10.1007/s10067-005-1104-y; KENT DL, 1992, INVEST RADIOL, V27, P245, DOI 10.1097/00004424-199203000-00014; Kroot EJJA, 2000, ARTHRITIS RHEUM, V43, P1831, DOI 10.1002/1529-0131(200008)43:8<1831::AID-ANR19>3.0.CO;2-6; Kumagai Shunichi, 2004, Rinsho Byori, V52, P836; Kwok JSY, 2005, SCAND J RHEUMATOL, V34, P359, DOI 10.1080/03009740510026634; Landewe RBM, 2003, ARTHRITIS RHEUM, V48, P1, DOI 10.1002/art.10732; Lard LR, 2001, AM J MED, V111, P446, DOI 10.1016/S0002-9343(01)00872-5; Lee DM, 2001, LANCET, V358, P903, DOI 10.1016/S0140-6736(01)06075-5; Lee DM, 2003, ANN RHEUM DIS, V62, P870, DOI 10.1136/ard.62.9.870; Lopez-Hoyos M, 2004, RHEUMATOLOGY, V43, P655, DOI 10.1093/rheumatology/keh143; Masson-Bessiere C, 2001, J IMMUNOL, V166, P4177, DOI 10.4049/jimmunol.166.6.4177; Meyer O, 2003, ANN RHEUM DIS, V62, P120, DOI 10.1136/ard.62.2.120; Meyer O, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1896; MIDGETTE AS, 1993, MED DECIS MAKING, V13, P253, DOI 10.1177/0272989X9301300313; MOSES LE, 1993, STAT MED, V12, P1293, DOI 10.1002/sim.4780121203; Nell VPK, 2005, ANN RHEUM DIS, V64, P1731, DOI 10.1136/ard.2005.035691; Nielen MMJ, 2005, ANN RHEUM DIS, V64, P1199, DOI 10.1136/ard.2004.029389; Nielen MMJ, 2004, ARTHRITIS RHEUM-US, V50, P380, DOI 10.1002/art.20018; NIENHUIS RL, 1964, ANN RHEUM DIS, V23, P302, DOI 10.1136/ard.23.4.302; Owens DK, 1996, ANN INTERN MED, V124, P803, DOI 10.7326/0003-4819-124-9-199605010-00004; Quinn MA, 2006, RHEUMATOLOGY, V45, P478, DOI 10.1093/rheumatology/kei203; RANSOHOFF DF, 1978, NEW ENGL J MED, V299, P926, DOI 10.1056/NEJM197810262991705; Rantapaa-Dahlqvist S, 2003, ARTHRITIS RHEUM, V48, P2741, DOI 10.1002/art.11223; Raza K, 2005, J RHEUMATOL, V32, P231; Riedemann JP, 2005, CLIN EXP RHEUMATOL, V23, pS69; Saraux A, 2003, J RHEUMATOL, V30, P2535; SARAUX A, 1995, REV RHUM, V62, P16; Saraux A, 2002, ARTHRIT RHEUM-ARTHR, V47, P155, DOI 10.1002/art.10241; Sauerland U, 2005, ANN NY ACAD SCI, V1050, P314, DOI 10.1196/annals.1313.033; Schellekens GA, 1998, J CLIN INVEST, V101, P273, DOI 10.1172/JCI1316; Schellekens GA, 2000, ARTHRITIS RHEUM-US, V43, P155, DOI 10.1002/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3; SHMERLING RH, 1992, ARCH INTERN MED, V152, P2417, DOI 10.1001/archinte.152.12.2417; Soderlin MK, 2004, SCAND J RHEUMATOL, V33, P185, DOI 10.1080/03009740310004856; Spiritus T, 2004, ANN RHEUM DIS, V63, P1169, DOI 10.1136/ard.2003.013854; Sutton AJAK, 2000, METHODS METAANALYSIS; Suzuki K, 2003, SCAND J RHEUMATOL, V32, P197, DOI 10.1080/03009740310003677; Swedler W, 1997, J RHEUMATOL, V24, P1037; Tanaka N, 2005, RHEUMATOL INT, V25, P103, DOI 10.1007/s00296-003-0404-2; Thammanichanond D, 2005, ASIAN PAC J ALLERGY, V23, P165; Union A, 2002, ARTHRITIS RHEUM, V46, P1185, DOI 10.1002/art.10229; Vallbracht I, 2004, ANN RHEUM DIS, V63, P1079, DOI 10.1136/ard.2003.019877; van Boekel MAM, 2002, ARTHRITIS RES, V4, P87, DOI 10.1186/ar395; van Gaalen FA, 2005, ANN RHEUM DIS, V64, P1510, DOI 10.1136/ard.2004.035089; van Jaarsveld CHM, 1999, CLIN EXP RHEUMATOL, V17, P689; van Leeuwen M A, 1988, Scand J Rheumatol Suppl, V75, P25; van Venrooij W J, 2003, Ned Tijdschr Geneeskd, V147, P191; van Venrooij Walther J, 2004, Autoimmun Rev, V3 Suppl 1, pS17; VANLEEUWEN MA, 1995, SCAND J RHEUMATOL, V24, P146, DOI 10.3109/03009749509099303; VANZEBEN D, 1993, J RHEUMATOL, V20, P1288; Vasiliauskiene L, 2001, ANN RHEUM DIS, V60, P459, DOI 10.1136/ard.60.5.459; Vencovsky J, 2003, ANN RHEUM DIS, V62, P427, DOI 10.1136/ard.62.5.427; Vincent C, 1999, ANN RHEUM DIS, V58, P42, DOI 10.1136/ard.58.1.42; Vincent C, 2002, ARTHRITIS RHEUM, V46, P2051, DOI 10.1002/art.10436; Visser H, 1996, ANN RHEUM DIS, V55, P157, DOI 10.1136/ard.55.3.157; Vittecoq O, 2004, CLIN EXP IMMUNOL, V135, P173, DOI 10.1111/j.1365-2249.2004.02341.x; Vittecoq O, 2001, RHEUMATOLOGY, V40, P1126, DOI 10.1093/rheumatology/40.10.1126; Vossenaar ER, 2003, BIOESSAYS, V25, P1106, DOI 10.1002/bies.10357; Vossenaar ER, 2004, ARTHRITIS RES THER, V6, pR142, DOI 10.1186/ar1149; Vossenaar ER, 2004, ANN RHEUM DIS, V63, P373, DOI 10.1136/ard.2003.012211; WINKLES JW, 1989, CLIN CHEM, V35, P303; YOUNG A, 1991, ARTHRITIS RHEUM, V34, P1425; YOUNG BJJ, 1979, BRIT MED J, V2, P97, DOI 10.1136/bmj.2.6182.97; Zeng XF, 2003, J RHEUMATOL, V30, P1451; 2003, ANN INTER MED, V138, P40	115	511	565	0	39	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 5	2007	146	11					797	808		10.7326/0003-4819-146-11-200706050-00008	http://dx.doi.org/10.7326/0003-4819-146-11-200706050-00008			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	175HR	17548411				2022-12-28	WOS:000247005200005
J	Coleman, P				Coleman, Piers			Physics - Watching electrons break up	SCIENCE			English	Editorial Material							QUANTUM PHASE-TRANSITIONS		Rutgers State Univ, Ctr Mat Theory, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick	Coleman, P (corresponding author), Rutgers State Univ, Ctr Mat Theory, Piscataway, NJ 08854 USA.	coleman@physics.rutgers.edu						Coleman P, 2005, NATURE, V433, P226, DOI 10.1038/nature03279; Custers J, 2003, NATURE, V424, P524, DOI 10.1038/nature01774; Mathur ND, 1998, NATURE, V394, P39, DOI 10.1038/27838; MILLIS AJ, 1993, PHYS REV B, V48, P7183, DOI 10.1103/PhysRevB.48.7183; Nakatsuji S, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.016401; Norman MR, 1998, NATURE, V392, P157, DOI 10.1038/32366; Paglione J, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.216602; PAIS A, 1982, SUBTLE LORD SCI LIFE, P389; Pepin C, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.066402; Petrovic C, 2001, J PHYS-CONDENS MAT, V13, pL337, DOI 10.1088/0953-8984/13/17/103; Senthil T, 2005, PHYSICA B, V359, P9, DOI 10.1016/j.physb.2004.12.041; Si QM, 2001, NATURE, V413, P804, DOI 10.1038/35101507; Tanatar MA, 2007, SCIENCE, V316, P1320, DOI 10.1126/science.1140762; VONLOHNEYSEN H, 1994, PHYS REV LETT, V72, P3262, DOI 10.1103/PhysRevLett.72.3262	14	2	2	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 1	2007	316	5829					1290	1291		10.1126/science.1143504	http://dx.doi.org/10.1126/science.1143504			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	173PS	17540888				2022-12-28	WOS:000246885600033
J	Khosla, S; Melton, LJ				Khosla, Sundeep; Melton, L. Joseph, III			Osteopenia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BONE-MINERAL DENSITY; X-RAY ABSORPTIOMETRY; VERTEBRAL FRACTURE; PREVENTING OSTEOPOROSIS; POSTMENOPAUSAL WOMEN; METAANALYSIS; RISK; ALENDRONATE; PREDICTION; INTERVENTION		Mayo Clin Coll Med, Endocrine Res Unit, Dept Internal Med, Div Endocrinol & Metab, Rochester, MN 55905 USA; Mayo Clin Coll Med, Dept Hlth Sci Res, Div Epidemiol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Khosla, S (corresponding author), Mayo Clin Coll Med, Endocrine Res Unit, Dept Internal Med, Div Endocrinol & Metab, 200 1st St SW,5-194 Joseph, Rochester, MN 55905 USA.	khosla.sundeep@mayo.edu	Khosla, Sundeep/AAE-6170-2020; Varacallo, Matthew A/E-4752-2018	Khosla, Sundeep/0000-0002-2936-4372; Varacallo, Matthew A/0000-0001-6377-6621	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR027065] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG004875] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		[Anonymous], 1994, World Health Organ Tech Rep Ser, V843, P1; Blake GM, 2005, OSTEOPOROSIS INT, V16, P2149, DOI 10.1007/s00198-005-2018-x; Cauley JA, 2003, JAMA-J AM MED ASSOC, V290, P1729, DOI 10.1001/jama.290.13.1729; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; COOPER A, 1842, TREATISE DISLOCATION; Cranney A, 2002, ENDOCR REV, V23, P508, DOI 10.1210/er.2001-2002; Cranney A, 2002, ENDOCR REV, V23, P524, DOI 10.1210/er.2001-4002; Cranney A, 2002, ENDOCR REV, V23, P517, DOI 10.1210/er.2001-3002; Cummings SR, 1998, JAMA-J AM MED ASSOC, V280, P2077, DOI 10.1001/jama.280.24.2077; Cummings SR, 2002, LANCET, V359, P1761, DOI 10.1016/S0140-6736(02)08657-9; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; De Laet C, 2005, OSTEOPOROSIS INT, V16, P313, DOI 10.1007/s00198-004-1689-z; *DHHS, 2004, BON HLTH OST REP SUR, P68; EDDY DM, 1998, OSTEOPOROS INT S4, V8, pS1; Ettinger B, 2006, MENOPAUSE, V13, P340, DOI 10.1097/01.gme.0000222475.93345.b3; Gaugris S, 2005, QJM-INT J MED, V98, P667, DOI 10.1093/qjmed/hci096; Gavin JR, 1997, DIABETES CARE, V20, P1183; Hannon R, 2000, OSTEOPOROSIS INT, V11, P30, DOI 10.1007/s001980070004; HODGSON SF, 2004, ENDOCR PRACT, V10, P90; HODGSON SF, 2003, ENDOCR PRACT, V9, P544; Jackson RD, 2006, NEW ENGL J MED, V354, P1102; Jackson RD, 2006, NEW ENGL J MED, V354, P669, DOI 10.1056/NEJMoa055218; Jamal SA, 2005, OSTEOPOROSIS INT, V16, P534, DOI 10.1007/s00198-004-1718-y; Kanis JA, 2005, OSTEOPOROSIS INT, V16, P737, DOI 10.1007/s00198-004-1640-3; Kanis JA, 2004, BONE, V35, P375, DOI 10.1016/j.bone.2004.03.024; Kanis JA, 2001, OSTEOPOROSIS INT, V12, P989, DOI 10.1007/s001980170006; Kanis JA, 2003, BONE, V33, P293, DOI 10.1016/S8756-3282(03)00200-X; Kanis JA, 2002, OSTEOPOROSIS INT, V13, P527, DOI 10.1007/s001980200069; KANIS JA, 1994, J BONE MINER RES, V9, P1137, DOI 10.1002/jbmr.5650090802; Kaptoge S, 2006, OSTEOPOROSIS INT, V17, P1369, DOI 10.1007/s00198-005-0067-9; Lewiecki EM, 2006, J CLIN ENDOCR METAB, V91, P4215, DOI 10.1210/jc.2006-1178; Lochmuller EM, 2002, BONE, V31, P77, DOI 10.1016/S8756-3282(02)00792-5; Marshall D, 1996, BRIT MED J, V312, P1254, DOI 10.1136/bmj.312.7041.1254; Martyn-St James M, 2006, OSTEOPOROSIS INT, V17, P1225, DOI 10.1007/s00198-006-0083-4; Melton LJ, 2001, CALCIFIED TISSUE INT, V69, P179, DOI 10.1007/s00223-001-1043-9; Miller PD, 1999, J CLIN DENSITOM, V2, P323, DOI 10.1385/JCD:2:3:323; Miller PD, 1999, J CLIN ENDOCR METAB, V84, P1867, DOI 10.1210/jc.84.6.1867; Moynihan R, 2002, BRIT MED J, V324, P886, DOI 10.1136/bmj.324.7342.886; National Osteoporosis Foundation, 2003, PHYS GUID PREV TREAT; Orces CH, 2003, SOUTH MED J, V96, P458, DOI 10.1097/01.SMJ.0000051905.38128.B4; Palombaro Kerstin M, 2005, J Geriatr Phys Ther, V28, P102; Papadimitropoulos E, 2002, ENDOCR REV, V23, P560, DOI 10.1210/er.2001-8002; Pasco JA, 2006, OSTEOPOROSIS INT, V17, P1404, DOI 10.1007/s00198-006-0135-9; Quandt SA, 2005, MAYO CLIN PROC, V80, P343, DOI 10.4065/80.3.343; Raisz LG, 2005, NEW ENGL J MED, V353, P164, DOI 10.1056/NEJMcp042092; Rosen CJ, 2005, NEW ENGL J MED, V353, P595, DOI 10.1056/NEJMcp043801; Schousboe JT, 2005, ANN INTERN MED, V142, P734, DOI 10.7326/0003-4819-142-9-200505030-00008; Seibel Markus J, 2005, Clin Biochem Rev, V26, P97; Shea B, 2002, ENDOCR REV, V23, P552, DOI 10.1210/er.2001-7002; Sinnott B, 2006, OSTEOPOROSIS INT, V17, P684, DOI 10.1007/s00198-005-0034-5; Siris ES, 2004, ARCH INTERN MED, V164, P1108, DOI 10.1001/archinte.164.10.1108; Wells G, 2002, ENDOCR REV, V23, P529, DOI 10.1210/er.2001-5002; Wilkins CH, 2004, J NATL MED ASSOC, V96, P461	54	73	75	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 31	2007	356	22					2293	2300		10.1056/NEJMcp070341	http://dx.doi.org/10.1056/NEJMcp070341			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	172PO	17538088				2022-12-28	WOS:000246816500008
J	Sriver, RL; Huber, M				Sriver, Ryan L.; Huber, Matthew			Observational evidence for an ocean heat pump induced by tropical cyclones	NATURE			English	Article							MERIDIONAL OVERTURNING CIRCULATION; INTERNAL WAVES; WORLD OCEAN; HURRICANE; WATER; TRANSPORT; PACIFIC; CLIMATE; ENERGY; LAYER	Ocean mixing affects global climate and the marine biosphere because it is linked to the ocean's ability to store and transport heat(1) and nutrients(2). Observations have constrained the magnitude of upper ocean mixing associated with certain processes(3,4), but mixing rates measured directly(3,5) are significantly lower than those inferred from budget analyses(6), suggesting that other processes may play an important role. The winds associated with tropical cyclones are known to lead to localized mixing of the upper ocean(7-9), but the hypothesis that tropical cyclones are important mixing agents at the global scale(10) has not been tested. Here we calculate the effect of tropical cyclones on surface ocean temperatures by comparing surface temperatures before and after storm passage, and use these results to calculate the vertical mixing induced by tropical cyclone activity. Our results indicate that tropical cyclones are responsible for significant cooling and vertical mixing of the surface ocean in tropical regions. Assuming that all the heat that is mixed downwards is balanced by heat transport towards the poles, we calculate that approximately 15 per cent of peak ocean heat transport may be associated with the vertical mixing induced by tropical cyclones. Furthermore, our analyses show that the magnitude of this mixing is strongly related to sea surface temperature, indicating that future changes in tropical sea surface temperatures may have significant effects on ocean circulation and ocean heat transport that are not currently accounted for in climate models.	Purdue Univ, Dept Earth & Atmospher Sci, W Lafayette, IN 47907 USA; Purdue Univ, Purdue Climate Change Res Ctr, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Huber, M (corresponding author), Purdue Univ, Dept Earth & Atmospher Sci, W Lafayette, IN 47907 USA.	huberm@purdue.edu	Huber, Matthew/A-7677-2008	Huber, Matthew/0000-0002-2771-9977				Alford MH, 2003, NATURE, V423, P159, DOI 10.1038/nature01628; Boos WR, 2004, J PHYS OCEANOGR, V34, P334, DOI 10.1175/1520-0485(2004)034<0334:TDMATM>2.0.CO;2; Bugnion V, 2006, J CLIMATE, V19, P3732, DOI 10.1175/JCLI3787.1; D'Asaro EA, 2003, J PHYS OCEANOGR, V33, P561, DOI 10.1175/1520-0485(2003)033<0561:TOBLBH>2.0.CO;2; Dalan F, 2005, J CLIMATE, V18, P2460, DOI 10.1175/JCLI3411.1; Emanuel K, 2005, NATURE, V436, P686, DOI 10.1038/nature03906; Emanuel K, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD001002; Emanuel K, 2001, J GEOPHYS RES-ATMOS, V106, P14771, DOI 10.1029/2000JD900641; Ganachaud A, 2003, J CLIMATE, V16, P696, DOI 10.1175/1520-0442(2003)016<0696:LSOHAF>2.0.CO;2; Garabato ACN, 2004, SCIENCE, V303, P210, DOI 10.1126/science.1090929; Gregg MC, 2003, NATURE, V422, P513, DOI 10.1038/nature01507; Herweijer C, 2005, TELLUS A, V57, P662, DOI 10.1111/j.1600-0870.2005.00121.x; Jacob SD, 2000, J PHYS OCEANOGR, V30, P1407, DOI 10.1175/1520-0485(2000)030<1407:TOMLRT>2.0.CO;2; KORTY RL, UNPUB J CLIM; LEDWELL JR, 1993, NATURE, V364, P701, DOI 10.1038/364701a0; Levitus S, 2000, SCIENCE, V287, P2225, DOI 10.1126/science.287.5461.2225; LIN W, 2003, GEOPHYS RES LETT, V30, DOI DOI 10.1029/2003GL017141; McWilliams JC, 1996, TELLUS A, V48, P179, DOI 10.1034/j.1600-0870.1996.00010.x; Nof D, 2000, DEEP-SEA RES PT I, V47, P2317, DOI 10.1016/S0967-0637(00)00029-7; Nof D, 1999, J PHYS OCEANOGR, V29, P2285, DOI 10.1175/1520-0485(1999)029<2285:ADPOTE>2.0.CO;2; Oakey NS, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC002193; PRICE JF, 1981, J PHYS OCEANOGR, V11, P153, DOI 10.1175/1520-0485(1981)011<0153:UORTAH>2.0.CO;2; Raymond DJ, 2004, B AM METEOROL SOC, V85, P1341, DOI 10.1175/BAMS-85-9-1341; Schneider EK, 2000, J PHYS OCEANOGR, V30, P1158, DOI 10.1175/1520-0485(2000)030<1158:ADIWAT>2.0.CO;2; Scott JR, 2002, J PHYS OCEANOGR, V32, P3578, DOI 10.1175/1520-0485(2002)032<3578:TLODMA>2.0.CO;2; SHAY LK, IN PRESS ATMOSPHERE, V2; Sluijs A, 2006, NATURE, V441, P610, DOI 10.1038/nature04668; Sriver R, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026167; Wunsch C, 2004, ANNU REV FLUID MECH, V36, P281, DOI 10.1146/annurev.fluid.36.050802.122121; Zedler SE, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2001JC000969	30	192	199	7	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 31	2007	447	7144					577	580		10.1038/nature05785	http://dx.doi.org/10.1038/nature05785			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172YZ	17538617				2022-12-28	WOS:000246842000045
J	Gornall, J				Gornall, Jonathan			Protection for the innocent	BMJ-BRITISH MEDICAL JOURNAL			English	Article												jgornall@mac.com						BATT J, 2004, STOLEN INNOCENCE STO; *BRIS CHILDR YOUNG, 2002, SUDD UN DEATHS CHILD; *DEP ED SKILLS, 2006, WORK SAF CHILDR; Dyer C, 2005, BRIT MED J, V331, P1355, DOI 10.1136/bmj.331.7529.1355-a; Dyer C, 2005, BRIT MED J, V330, P1463, DOI 10.1136/bmj.330.7506.1463-a; Dyer C, 2007, BRIT MED J, V334, P602, DOI 10.1136/bmj.39160.770637.DB; Dyer O, 2004, BRIT MED J, V329, P366, DOI 10.1136/bmj.329.7462.366-a; Fleming PJ, 2004, BMJ-BRIT MED J, V328, P331, DOI 10.1136/bmj.328.7435.331; FLEMING PJ, 1990, BRIT MED J, V301, P85, DOI 10.1136/bmj.301.6743.85; *ROYAL COLL PAED C, 2002, FUT PAED PATH SERV; *ROYAL COLL PAED C, 2007, INV NAT IMP COMPL MA; *ROYAL COLL PATH R, 2004, SUDD UN DEATH INF; Williams C, 2007, PEDIATRICS, V119, P800, DOI 10.1542/peds.2006-1980	13	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 26	2007	334	7603					1083	1085		10.1136/bmj.39206.389711.AD	http://dx.doi.org/10.1136/bmj.39206.389711.AD			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	174XB	17525445	Green Published			2022-12-28	WOS:000246975000025
J	Idro, R; Ndiritu, M; Ogutu, B; Mithwani, S; Maitland, K; Berkley, J; Crawley, J; Fegan, G; Bauni, E; Peshu, N; Marsh, K; Neville, B; Newton, C				Idro, Richard; Ndiritu, Moses; Ogutu, Bernhards; Mithwani, Sadik; Maitland, Kathryn; Berkley, James; Crawley, Jane; Fegan, Gregory; Bauni, Evasius; Peshu, Norbert; Marsh, Kevin; Neville, Brian; Newton, Charles			Burden, features, and outcome of neurological involvement in acute falciparum malaria in Kenyan children	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PLASMODIUM-FALCIPARUM; CEREBRAL MALARIA; PROGNOSTIC INDICATORS; BACTERIAL-MENINGITIS; CLINICAL-FEATURES; CHILDHOOD MALARIA; TRANSMISSION; CONVULSIONS; EPILEPSY; AFRICA	Context Plasmodium falciparum appears to have a particular propensity to involve the brain but the burden, risk factors, and full extent of neurological involvement have not been systematically described. Objectives To determine the incidence and describe the clinical phenotypes and outcomes of neurological involvement in African children with acute falciparum malaria. Design, Setting, and Patients A review of records of all children younger than 14 years admitted to a Kenyan district hospital with malaria from January 1992 through December 2004. Neurological involvement was defined as convulsive seizures, agitation, prostration, or impaired consciousness or coma. Main Outcome Measures The incidence, pattern, and outcome of neurological involvement. Results Of 58 239 children admitted, 19 560 (33.6%) had malaria as the primary clinical diagnosis. Neurological involvement was observed in 9313 children (47.6%) and manifested as seizures (6563/17517 [37.5%]), agitation (316/11193 [2.8%]), prostration (3223/15643 [20.6%]), and impaired consciousness or coma (2129/16080 [13.2%]). In children younger than 5 years, the mean annual incidence of admissions with malaria was 2694 per 100 000 persons and the incidence of malaria with neurological involvement was 1156 per 100 000 persons. However, readmissions may have led to a 10% overestimate in incidence. Children with neurological involvement were older (median, 26 [interquartile range {IQR}, 15-41] vs 21 [IQR, 10-40] months; P < .001), had a shorter duration of illness (median, 2 [IQR, 1-3] vs 3 [IQR, 2-3] days; P < .001), and a higher geometric mean parasite density (42.0 [95% confidence interval {CI}, 40.0-44.1] vs 30.4 [95% CI, 29.0-31.8] x 10(3)/mu L; P < .001). Factors independently associated with neurological involvement included past history of seizures (adjusted odds ratio [AOR], 3.50; 95% CI, 2.78-4.42), fever lasting 2 days or less (AOR, 2.02; 95% CI, 1.64-2.49), delayed capillary refill time (AOR, 3.66; 95% CI, 2.40-5.56), metabolic acidosis (AOR, 1.55; 95% CI, 1.29-1.87), and hypoglycemia (AOR, 2.11; 95% CI, 1.31-3.37). Mortality was higher in patients with neurological involvement (4.4% [95% CI, 4.2%-5.1%] vs 1.3% [95% CI, 1.1%-1.5%]; P < .001). At discharge, 159 (2.2%) of 7281 patients had neurological deficits. Conclusions Neurological involvement is common in children in Kenya with acute falciparum malaria, and is associated with metabolic derangements, impaired perfusion, parasitemia, and increased mortality and neurological sequelae. This study suggests that falciparum malaria exposes many African children to brain insults.	Kenya Govt Med Res Ctr, Wellcome Trust Res Labs, Ctr Geog Med Res, Kilifi 80108, Kenya; Makerere Univ, Mulago Hosp, Dept Pediat & Child Hlth, Kampala, Uganda; Kenya Govt Med Res Ctr, Clin Res Ctr, Walter Reed Project, Kisumu, Kenya; Univ London Imperial Coll Sci Technol & Med, Fac Med, London, England; Univ London Imperial Coll Sci Technol & Med, Wellcome Trust Ctr Trop Med, London, England; Univ Oxford, Ctr Clin Vaccinol & Trop Med, Oxford, England; London Sch Hyg & Trop Med, Dept Infect & Trop Dis, Infect Dis Epidemiol Unit, London WC1, England; UCL, Inst Child Hlth, Wolfson Ctr, Neurosci Unit, London, England	Kenya Medical Research Institute; Makerere University; Mulago National Referral Hospital; Kenya Medical Research Institute; Imperial College London; Imperial College London; University of Oxford; University of London; London School of Hygiene & Tropical Medicine; University of London; University College London	Idro, R (corresponding author), Kenya Govt Med Res Ctr, Wellcome Trust Res Labs, Ctr Geog Med Res, POB 230, Kilifi 80108, Kenya.	ridro@kilifi.kemri-wellcome.org	Newton, Charles/V-7872-2019; Newton, Charles/C-6222-2009; , Ridro/ABD-3556-2020; Newton, Charles RJC/B-7578-2014; Fegan, Greg W/O-8079-2018	Newton, Charles/0000-0002-6999-5507; Newton, Charles RJC/0000-0002-6999-5507; Fegan, Greg W/0000-0002-2663-2765; Berkley, James/0000-0002-1236-849X; Idro, Richard/0000-0003-4728-4605; Maitland, Kathryn/0000-0002-0007-0645	Wellcome Trust [070114] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		AKPEDE GO, 1993, J TROP PEDIATRICS, V39, P350, DOI 10.1093/tropej/39.6.350; [Anonymous], 1990, Trans R Soc Trop Med Hyg, V84 Suppl 2, P1; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Berkley JA, 2003, BRIT MED J, V326, P361, DOI 10.1136/bmj.326.7385.361; Berkley JA, 1999, QJM-INT J MED, V92, P151, DOI 10.1093/qjmed/92.3.151; Berkley JA, 2001, LANCET, V357, P1753, DOI 10.1016/S0140-6736(00)04897-2; Carter JA, 2005, J NEUROL NEUROSUR PS, V76, P476, DOI 10.1136/jnnp.2004.043893; Carter JA, 2004, EPILEPSIA, V45, P978, DOI 10.1111/j.0013-9580.2004.65103.x; *CENTR BUR STAT, 2001, KEN 1999 POP HOUS CE, V1; Central Bureau of Statistics, 1994, KEN POP CENS 1989, VI; Cowgill KD, 2006, JAMA-J AM MED ASSOC, V296, P671, DOI 10.1001/jama.296.6.671; Gravenor MB, 1998, P NATL ACAD SCI USA, V95, P7620, DOI 10.1073/pnas.95.13.7620; Hay SI, 2000, T ROY SOC TROP MED H, V94, P113, DOI 10.1016/S0035-9203(00)90246-3; Idro R, 2006, ANN TROP MED PARASIT, V100, P95, DOI 10.1179/136485906X91459; Idro R, 2006, TROP MED INT HEALTH, V11, P115, DOI 10.1111/j.1365-3156.2005.01518.x; Idro R, 2005, LANCET NEUROL, V4, P827, DOI 10.1016/S1474-4422(05)70247-7; Kihara M, 2006, TROP MED INT HEALTH, V11, P386, DOI 10.1111/j.1365-3156.2006.01579.x; Kirigia JM, 1998, TROP MED INT HEALTH, V3, P145, DOI 10.1046/j.1365-3156.1998.00204.x; MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102; Mbogo CM, 2003, AM J TROP MED HYG, V68, P734; MOLYNEUX ME, 1989, Q J MED, V71, P441; Murphy SC, 2001, AM J TROP MED HYG, V64, P57, DOI 10.4269/ajtmh.2001.64.57; MWENESI HA, 1995, J BIOSOC SCI, V27, P235, DOI 10.1017/S0021932000022720; Newton CRJC, 1998, PHARMACOL THERAPEUT, V79, P1, DOI 10.1016/S0163-7258(98)00008-4; Newton CRJC, 1998, ANN NEUROL, V43, P695, DOI 10.1002/ana.410430603; Newton CRJC, 1997, T ROY SOC TROP MED H, V91, P161, DOI 10.1016/S0035-9203(97)90207-8; Ngoungou EB, 2006, EPILEPSIA, V47, P2147, DOI 10.1111/j.1528-1167.2006.00890.x; Snow Robert W., 1994, Afr J Health Sci, V1, P71; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Turner G, 1997, BRAIN PATHOL, V7, P569, DOI 10.1111/j.1750-3639.1997.tb01075.x; Versteeg AC, 2003, TROP MED INT HEALTH, V8, P12, DOI 10.1046/j.1365-3156.2003.00965.x; Waruiru CM, 1996, T ROY SOC TROP MED H, V90, P152, DOI 10.1016/S0035-9203(96)90120-0; WATTANAGOON Y, 1994, T ROY SOC TROP MED H, V88, P426, DOI 10.1016/0035-9203(94)90415-4	34	96	97	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 23	2007	297	20					2232	2240		10.1001/jama.297.20.2232	http://dx.doi.org/10.1001/jama.297.20.2232			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	170JM	17519413	Bronze, Green Accepted			2022-12-28	WOS:000246659700023
J	Brown, H				Brown, Hannah			Tony Blair's legacy for the UK's National Health Service	LANCET			English	Editorial Material								10 years of New Labour health reforms have injected badly needed funds into the UK's National Health Service. But through repeated restructuring and micromanagement, Blair's government seems also to have eroded clinicians' flexibility to care for patients. Hannah Brown reports.											0	3	3	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 20	2007	369	9574					1679	1682		10.1016/S0140-6736(07)60763-6	http://dx.doi.org/10.1016/S0140-6736(07)60763-6			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	169ZT	17523221				2022-12-28	WOS:000246631300011
J	Guirguis-Blake, J; Calonge, N; Miller, T; Siu, A; Teutsch, S; Whitlock, E				Guirguis-Blake, Janelle; Calonge, Ned; Miller, Therese; Siu, Albert; Teutsch, Steven; Whitlock, Evelyn		U S Prevent Serv Task Force	Current processes of the US preventive services task force: Refining evidence-based recommendation development	ANNALS OF INTERNAL MEDICINE			English	Article								The U.S. Preventive Services Task Force (USPSTF), an independent panel that has provided the gold standard for evidence-based guidelines in prevention for the past 2 decades, continuously refines its methodology. To keep up with the evolving field of evidence-based medicine and to update recommendations in a timely, efficient, and transparent manner, the USPSTF has developed new methods for evidence reviews and recommendation development. This article summarizes the most recent changes in the recommendation development process, including how the USPSTF solicits and prioritizes topics for review, updates evidence reviews and recommendations, and communicates with its audience.	Agcy Healthcare Res & Qual, US Prevent Serv Task Force, Rockville, MD USA	Agency for Healthcare Research & Quality	Guirguis-Blake, J (corresponding author), Agcy Healthcare Res & Qual, US Prevent Serv Task Force, Rockville, MD USA.							Armstrong K, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(00)00263-4; Barton MB, 2007, ANN INTERN MED, V147, P123, DOI 10.7326/0003-4819-147-2-200707170-00171; US Preventive Services Task Force, 2007, ANN INTERN MED, V146, P361, DOI 10.7326/0003-4819-146-5-200703060-00008; Whitlock EP, 2006, ANN INTERN MED, V145, P209, DOI 10.7326/0003-4819-145-3-200608010-00009	4	91	93	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 17	2007	147	2					117	122		10.7326/0003-4819-147-2-200707170-00170	http://dx.doi.org/10.7326/0003-4819-147-2-200707170-00170			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	192CV	17576998				2022-12-28	WOS:000248179300006
J	Young, ED				Young, Edward D.			Geochemistry - Strange water in the solar system	SCIENCE			English	Editorial Material							OXYGEN; NEBULA; ANOMALIES; EVOLUTION; ORIGIN		Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Geophys & Planetary Phys, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Young, ED (corresponding author), Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90095 USA.	eyoung@ess.ucla.edu		Young, Edward/0000-0002-1299-0801				ANDERS E, 1989, GEOCHIM COSMOCHIM AC, V53, P197, DOI 10.1016/0016-7037(89)90286-X; Brittain SD, 2005, ASTROPHYS J, V626, P283, DOI 10.1086/429310; CLAYTON DD, 1988, ASTROPHYS J, V334, P191, DOI 10.1086/166829; Clayton RN, 2002, NATURE, V415, P860, DOI 10.1038/415860b; CLAYTON RN, 1973, SCIENCE, V182, P485, DOI 10.1126/science.182.4111.485; CLAYTON RN, 1984, EARTH PLANET SC LETT, V67, P151, DOI 10.1016/0012-821X(84)90110-9; Hester JJ, 2004, SCIENCE, V304, P1116, DOI 10.1126/science.1096808; Lyons JR, 2005, NATURE, V435, P317, DOI 10.1038/nature03557; Marcus RA, 2004, J CHEM PHYS, V121, P8201, DOI 10.1063/1.1803507; Sakamoto N, 2007, SCIENCE, V317, P231, DOI 10.1126/science.1142021; THIEMENS MH, 1983, SCIENCE, V219, P1073, DOI 10.1126/science.219.4588.1073; Young ED, 2001, PHILOS T ROY SOC A, V359, P2095, DOI 10.1098/rsta. 2001.0900; YOUNG ED, 2003, 34 LUN PLAN SCI C HO; Yurimoto H, 2004, SCIENCE, V305, P1763, DOI 10.1126/science.1100989; YURIMOTO H, 2002, 65 ANN MET SOC M LOS	16	13	13	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 13	2007	317	5835					211	212		10.1126/science.1145055	http://dx.doi.org/10.1126/science.1145055			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	189DC	17569826				2022-12-28	WOS:000247968600031
J	Kumar, P; Wu, HQ; McBride, JL; Jung, KE; Kim, MH; Davidson, BL; Lee, SK; Shankar, P; Manjunath, N				Kumar, Priti; Wu, Haoquan; McBride, Jodi L.; Jung, Kyeong-Eun; Kim, Moon Hee; Davidson, Beverly L.; Lee, Sang Kyung; Shankar, Premlata; Manjunath, N.			Transvascular delivery of small interfering RNA to the central nervous system	NATURE			English	Article							CELL-PENETRATING PEPTIDES; INHIBITS TUMOR-GROWTH; IN-VIVO DELIVERY; INTRACELLULAR DELIVERY; MODIFIED SIRNAS; GENE-THERAPY; BRAIN; VIRUS; RECEPTORS; TRANSPORTERS	A major impediment in the treatment of neurological diseases is the presence of the blood - brain barrier, which precludes the entry of therapeutic molecules from blood to brain. Here we show that a short peptide derived from rabies virus glycoprotein (RVG) enables the transvascular delivery of small interfering RNA ( siRNA) to the brain. This 29-amino-acid peptide specifically binds to the acetylcholine receptor expressed by neuronal cells. To enable siRNA binding, a chimaeric peptide was synthesized by adding nonamer arginine residues at the carboxy terminus of RVG. This RVG-9R peptide was able to bind and transduce siRNA to neuronal cells in vitro, resulting in efficient gene silencing. After intravenous injection into mice, RVG-9R delivered siRNA to the neuronal cells, resulting in specific gene silencing within the brain. Furthermore, intravenous treatment with RVG-9R-bound antiviral siRNA afforded robust protection against fatal viral encephalitis in mice. Repeated administration of RVG-9R-bound siRNA did not induce inflammatory cytokines or anti-peptide antibodies. Thus, RVG-9R provides a safe and noninvasive approach for the delivery of siRNA and potentially other therapeutic molecules across the blood - brain barrier.	Harvard Univ, Sch Med, CBR Inst Biomed Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; Univ Iowa, Dept Internal Med, Roy J & Lucille J Carver Coll Med, Iowa City, IA 52242 USA; Samchully Pharm Co Ltd, Res Ctr, Seoul 135735, South Korea; Hanyang Univ, Dept Bioengn, Seoul 133791, South Korea; Hanyang Univ, Hanyang Fus Mat Program, Seoul 133791, South Korea	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; University of Iowa; Hanyang University; Hanyang University	Manjunath, N (corresponding author), Harvard Univ, Sch Med, CBR Inst Biomed Res, Boston, MA 02115 USA.	shankar@cbrinstitute.org; swamy@cbrinstitute.org	Kumar, Priti/C-5699-2009; McBride, Jodi/C-4494-2016	McBride, Jodi/0000-0002-4816-7569; Wu, Haoquan/0000-0001-9386-3187; Davidson, Beverly/0000-0002-3715-6290				Akaneya Y, 2005, J NEUROPHYSIOL, V93, P594, DOI 10.1152/jn.00161.2004; Chen TJ, 2005, CHINESE J PHYSIOL, V48, P129; de Boer AG, 2007, ANNU REV PHARMACOL, V47, P323, DOI 10.1146/annurev.pharmtox.47.120505.105237; Deshayes S, 2005, CELL MOL LIFE SCI, V62, P1839, DOI 10.1007/s00018-005-5109-0; Diamond MS, 2003, J VIROL, V77, P2578, DOI 10.1128/JVI.77.4.2578-2586.2003; Dietz GPH, 2005, BRAIN RES BULL, V68, P103, DOI 10.1016/j.brainresbull.2005.08.015; Dorn G, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh044; Gotti C, 2004, PROG NEUROBIOL, V74, P363, DOI 10.1016/j.pneurobio.2004.09.006; Gupta B, 2005, ADV DRUG DELIVER REV, V57, P637, DOI 10.1016/j.addr.2004.10.007; Henriques ST, 2006, BIOCHEM J, V399, P1, DOI 10.1042/BJ20061100; Hino T, 2006, BIOCHEM BIOPH RES CO, V340, P263, DOI 10.1016/j.bbrc.2005.11.173; Hoyer D, 2006, J RECEPT SIG TRANSD, V26, P527, DOI 10.1080/10799890600929663; Hu-Lieskovan S, 2005, CANCER RES, V65, P8984, DOI 10.1158/0008-5472.CAN-05-0565; Judge AD, 2005, NAT BIOTECHNOL, V23, P457, DOI 10.1038/nbt1081; Juliano RL, 2005, CURR OPIN MOL THER, V7, P132; Kim WL, 2006, MOL THER, V14, P343, DOI 10.1016/j.ymthe.2006.03.022; Kumar P, 2006, PLOS MED, V3, P505, DOI 10.1371/journal.pmed.0030096; Lafon M, 2005, J NEUROVIROL, V11, P82, DOI 10.1080/13550280590900427; Lentz T L, 1990, J Mol Recognit, V3, P82, DOI 10.1002/jmr.300030205; LENTZ TL, 1982, SCIENCE, V215, P182, DOI 10.1126/science.7053569; Leonard S, 2001, Nicotine Tob Res, V3, P203; Mazarakis ND, 2001, HUM MOL GENET, V10, P2109, DOI 10.1093/hmg/10.19.2109; Melikov K, 2005, CELL MOL LIFE SCI, V62, P2739, DOI 10.1007/s00018-005-5293-y; Miller G, 2002, SCIENCE, V297, P1116, DOI 10.1126/science.297.5584.1116; Morrissey DV, 2005, NAT BIOTECHNOL, V23, P1002, DOI 10.1038/nbt1122; Neyts J, 1999, Verh K Acad Geneeskd Belg, V61, P661; Noble CO, 2004, EXPERT OPIN THER TAR, V8, P335, DOI 10.1517/14728222.8.4.335; NOTTER MFD, 1985, J CELL PHYSIOL, V125, P476, DOI 10.1002/jcp.1041250317; Rubio CA, 2003, EUR J CLIN INVEST, V33, P406, DOI 10.1046/j.1365-2362.2003.01151.x; Schlachetzki F, 2004, NEUROLOGY, V62, P1275, DOI 10.1212/01.WNL.0000120551.38463.D9; Schutz B, 2005, J NEUROSCI, V25, P7805, DOI 10.1523/JNEUROSCI.2038-05.2005; Song EW, 2005, NAT BIOTECHNOL, V23, P709, DOI 10.1038/nbt1101; Soutschek J, 2004, NATURE, V432, P173, DOI 10.1038/nature03121; Wender PA, 2000, P NATL ACAD SCI USA, V97, P13003, DOI 10.1073/pnas.97.24.13003; Zhang Y, 2004, CLIN CANCER RES, V10, P3667, DOI 10.1158/1078-0432.CCR-03-0740; Zimmermann TS, 2006, NATURE, V441, P111, DOI 10.1038/nature04688	36	927	1061	15	257	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 5	2007	448	7149					39	43		10.1038/nature05901	http://dx.doi.org/10.1038/nature05901			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185OS	17572664				2022-12-28	WOS:000247720900032
J	Zuo, T; Wang, LZ; Morrison, C; Chang, X; Zhang, HM; Li, WQ; Liu, Y; Wang, Y; Liu, XL; Chan, MWY; Liu, JQ; Love, R; Liu, CG; Godfrey, V; Shen, RL; Huang, THM; Yang, TY; Park, BK; Wang, CY; Zheng, P; Liu, Y				Zuo, Tao; Wang, Lizhong; Morrison, Carl; Chang, Xing; Zhang, Huiming; Li, Weiquan; Liu, Yan; Wang, Yin; Liu, Xingluo; Chan, Michael W. Y.; Liu, Jin-Qing; Love, Richard; Liu, Chang-gong; Godfrey, Virginia; Shen, Rulong; Huang, Tim H. -M.; Yang, Tianyu; Park, Bae Keun; Wang, Cun-Yu; Zheng, Pan; Liu, Yang			FOXP3 is an X-linked breast cancer suppressor gene and an important repressor of the HER-2/ErbB2 oncogene	CELL			English	Article							IN-SITU HYBRIDIZATION; SCURFY SF MOUSE; LYMPHORETICULAR DISEASE; OVARIAN-CANCER; NEU ONCOGENE; T-CELLS; PROTEIN; AMPLIFICATION; CHROMOSOME; IMMUNOHISTOCHEMISTRY	The X-linked Foxp3 is a member of the forkhead/winged helix transcription factor family. Germline mutations cause lethal autoimmune diseases in males. Serendipitously, we observed that female mice heterozygous for the "scurfin'' mutation of the Foxp3 gene (Foxp3(sf/+)) developed cancer at a high rate. The majority of the cancers were mammary carcinomas in which the wild-type Foxp3 allele was inactivated and HER-2/ErbB2 was overexpressed. Foxp3 bound and repressed the HER-2/ErbB2 promoter. Deletion, functionally significant somatic mutations, and downregulation of the FOXP3 gene were commonly found in human breast cancer samples and correlated significantly with HER-2/ErbB2 overexpression, regardless of the status of HER-2 amplification. Our data demonstrate that FOXP3 is an X-linked breast cancer suppressor gene and an important regulator of the HER-2/ErbB2 oncogene.	Univ Michigan, Ctr Comprehens Canc, Dept Surg, Sect Gen Surg,Div Immunotherapy, Ann Arbor, MI 48109 USA; Univ Michigan, Program Mol Mech Dis, Ann Arbor, MI 48109 USA; Ohio State Univ, Med Ctr, Dept Virol Immunol & Med Genet, Program Mol Cellular & Dev Biol, Columbus, OH 43210 USA; Ohio State Univ, Med Ctr, Dept Pathol, Columbus, OH 43210 USA; Ohio State Univ, Med Ctr, Dept Internal Med, Columbus, OH 43210 USA; Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; Univ N Carolina, Dept Pathol, Chapel Hill, NC 27599 USA; Univ Michigan, Dept Biol & Mat Sci, Lab Mol Signaling & Apoptosis, Sch Dent, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University of North Carolina; University of North Carolina Chapel Hill; University of Michigan System; University of Michigan	Zheng, P (corresponding author), Univ Michigan, Ctr Comprehens Canc, Dept Surg, Sect Gen Surg,Div Immunotherapy, Ann Arbor, MI 48109 USA.	panz@umich.edu; yangl@umich.edu	Wang, Lizhong/J-4268-2019; Shen, Rulong/E-4079-2011; Li, Weiquan/B-4897-2011; Zheng, Pan/E-8691-2011; Chan, Michael/F-9615-2018	Wang, Lizhong/0000-0003-1980-4730; Zheng, Pan/0000-0003-2598-3544; Chan, Michael/0000-0003-1431-322X; Liu, Yang/0000-0002-9442-700X; Chan, Michael/0000-0003-0314-2437; Chang, Xing/0000-0002-5072-9225	NATIONAL CANCER INSTITUTE [R01CA058033, R01CA112001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064350, R01AI051342] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA058033-15, R01 CA112001-02, R01 CA112001, R01 CA058033] Funding Source: Medline; NIAID NIH HHS [R01 AI051342-05, R01 AI064350-01A2, R01 AI064350, R01 AI051342] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Bofin AM, 2004, AM J CLIN PATHOL, V122, P110, DOI 10.1309/8A2DJFT07NE6EWHE; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Chang X, 2005, J EXP MED, V202, P1141, DOI 10.1084/jem.20050157; Chatila TA, 2000, J CLIN INVEST, V106, pR75, DOI 10.1172/JCI11679; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; DEPALAZZO IG, 1993, INT J BIOL MARKER, V8, P233; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; GODFREY VL, 1994, AM J PATHOL, V145, P281; GODFREY VL, 1991, P NATL ACAD SCI USA, V88, P5528, DOI 10.1073/pnas.88.13.5528; Im Hogune, 2004, Methods Mol Biol, V284, P129; Jimenez RE, 2000, MODERN PATHOL, V13, P37, DOI 10.1038/modpathol.3880007; KALLIONIEMI OP, 1992, P NATL ACAD SCI USA, V89, P5321, DOI 10.1073/pnas.89.12.5321; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Kristiansen M, 2005, J MED GENET, V42, P877, DOI 10.1136/jmg.2005.032433; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Piao Z, 2002, GENE CHROMOSOME CANC, V33, P262, DOI 10.1002/gcc.10024; Richardson AL, 2006, CANCER CELL, V9, P121, DOI 10.1016/j.ccr.2006.01.013; Romanov SR, 2001, NATURE, V409, P633, DOI 10.1038/35054579; Roncuzzi L, 2002, CANCER GENET CYTOGEN, V135, P173, DOI 10.1016/S0165-4608(01)00652-5; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; SCHECHTER AL, 1984, NATURE, V312, P513, DOI 10.1038/312513a0; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Spatz A, 2004, NAT REV CANCER, V4, P617, DOI 10.1038/nrc1413; Todorovic-Rakovic N, 2005, PATHOL INT, V55, P318, DOI 10.1111/j.1440-1827.2005.01831.x; Wang CY, 1999, NAT MED, V5, P412, DOI 10.1038/7410; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Wooster R, 2003, NEW ENGL J MED, V348, P2339, DOI 10.1056/NEJMra012284; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0; Xing XM, 2000, NAT MED, V6, P189, DOI 10.1038/72294; Yaziji H, 2004, JAMA-J AM MED ASSOC, V291, P1972, DOI 10.1001/jama.291.16.1972; Ziegler SF, 2006, ANNU REV IMMUNOL, V24, P209, DOI 10.1146/annurev.immunol.24.021605.090547	35	310	335	1	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 29	2007	129	7					1275	1286		10.1016/j.cell.2007.04.034	http://dx.doi.org/10.1016/j.cell.2007.04.034			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	188HQ	17570480	Green Accepted, Bronze, Green Submitted			2022-12-28	WOS:000247911400014
J	Williams, HC				Williams, Hywel C.			Change page - Established corticosteroid creams should be applied only once daily in patients with atopic eczema	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Nottingham, Queens Med Ctr, Ctr Evidence Based Dermatol, Nottingham NG7 2UH, England	University of Nottingham	Williams, HC (corresponding author), Univ Nottingham, Queens Med Ctr, Ctr Evidence Based Dermatol, Nottingham NG7 2UH, England.	hywel.williams@nottingham.ac.uk		williams, hywel/0000-0002-5646-3093					0	31	33	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 16	2007	334	7606					1272	1272		10.1136/bmj.39195.636319.80	http://dx.doi.org/10.1136/bmj.39195.636319.80			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	183AM	17569936	Green Submitted, Green Accepted, Green Published			2022-12-28	WOS:000247545100042
J	Alsos, IG; Eidesen, PB; Ehrich, D; Skrede, I; Westergaard, K; Jacobsen, GH; Landvik, JY; Taberlet, P; Brochmann, C				Alsos, Inger Greve; Eidesen, Pernille Bronken; Ehrich, Dorothee; Skrede, Inger; Westergaard, Kristine; Jacobsen, Gro Hilde; Landvik, Jon Y.; Taberlet, Pierre; Brochmann, Christian			Frequent long-distance plant colonization in the changing Arctic	SCIENCE			English	Article							ENVIRONMENTAL-CHANGE; CLIMATE-CHANGE; DISPERSAL; SVALBARD; DISTRIBUTIONS; MECHANISMS; MIGRATION; EUROPE; AREA	The ability of species to track their ecological niche after climate change is a major source of uncertainty in predicting their future distribution. By analyzing DNA fingerprinting ( amplified fragment-length polymorphism) of nine plant species, we show that long-distance colonization of a remote arctic archipelago, Svalbard, has occurred repeatedly and from several source regions. Propagules are likely carried by wind and drifting sea ice. The genetic effect of restricted colonization was strongly correlated with the temperature requirements of the species, indicating that establishment limits distribution more than dispersal. Thus, it may be appropriate to assume unlimited dispersal when predicting long-term range shifts in the Arctic.	Univ Oslo, Museum Nat Hist, Natl Ctr Biosystemat, NO-0318 Oslo, Norway; Univ Tromso, Tromso Univ Museum, NO-9037 Tromso, Norway; Norwegian Univ Life Sci, NO-1432 As, Norway; Univ Grenoble 1, CNRS, UMR 5553, Lab Ecol Alpine, F-38041 Grenoble 09, France	University of Oslo; UiT The Arctic University of Tromso; Norwegian University of Life Sciences; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite de Savoie	Alsos, IG (corresponding author), Univ Ctr Svalbard, POB 156, NO-9171 Svalbard, Norway.	ingera@unis.no	Westergaard, Kristine Bakke/GYJ-6582-2022; Ehrich, Dorothee/F-6492-2015; Alsos, Inger Greve/O-8154-2019; Brochmann, Christian/A-4105-2009; Westergaard, Kristine/M-7084-2018; Alsos, Inger G/A-9507-2016; Taberlet, Pierre/D-1178-2010	Ehrich, Dorothee/0000-0002-3028-9488; Alsos, Inger Greve/0000-0002-8610-1085; Westergaard, Kristine/0000-0003-4609-8704; Alsos, Inger G/0000-0002-8610-1085; Taberlet, Pierre/0000-0002-3554-5954; Skrede, Inger/0000-0002-1113-7403				Abbott RJ, 2000, SCIENCE, V289, P1343, DOI 10.1126/science.289.5483.1343; ACIA, 2006, ARCT CLIM IMP ASS SC; BIRKS HH, 1994, J QUATERNARY SCI, V9, P133, DOI 10.1002/jqs.3390090207; Brochmann C, 2003, TAXON, V52, P417, DOI 10.2307/3647444; Cain ML, 2000, AM J BOT, V87, P1217, DOI 10.2307/2656714; Callaghan TV, 2004, AMBIO, V33, P404, DOI 10.1639/0044-7447(2004)033[0404:BDAAOA]2.0.CO;2; Cooper EJ, 2004, J VEG SCI, V15, P115, DOI 10.1111/j.1654-1103.2004.tb02244.x; Elven R, 2005, CHECKLIST PANARCTIC; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Higgins SI, 2003, ECOLOGY, V84, P1945, DOI 10.1890/01-0616; Hulten E., 1986, ATLAS N EUROPEAN VAS, V1-3; Karlsen SR, 2003, J BIOGEOGR, V30, P1469, DOI 10.1046/j.1365-2699.2003.00942.x; Landvik JY, 1998, QUATERNARY SCI REV, V17, P43, DOI 10.1016/S0277-3791(97)00066-8; Landvik JY, 2003, GEOLOGY, V31, P905, DOI 10.1130/G19703.1; Moore KA, 2006, ECOL LETT, V9, P797, DOI 10.1111/j.1461-0248.2006.00923.x; Nathan R, 2002, NATURE, V418, P409, DOI 10.1038/nature00844; Nathan R, 2003, OIKOS, V103, P261, DOI 10.1034/j.1600-0706.2003.12146.x; Nathan R, 2006, SCIENCE, V313, P786, DOI 10.1126/science.1124975; Neilson RP, 2005, BIOSCIENCE, V55, P749, DOI 10.1641/0006-3568(2005)055[0749:FRTGPM]2.0.CO;2; Ronning O.I., 1963, N ATLANTIC BIOTA THE, P99; Svenning JC, 2004, ECOL LETT, V7, P565, DOI 10.1111/j.1461-0248.2004.00614.x; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102	23	265	286	4	138	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 15	2007	316	5831					1606	1609		10.1126/science.1139178	http://dx.doi.org/10.1126/science.1139178			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178SH	17569861				2022-12-28	WOS:000247239900038
J	Davidson, EM; Frothingham, R; Cook-Deegan, R				Davidson, E. Megan; Frothingham, Richard; Cook-Deegan, Robert			Science and security - Practical experiences in dual-use review	SCIENCE			English	Editorial Material									Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA; Duke Univ, Med Ctr, Duke Human Vaccine Inst, Durham, NC 27710 USA	Duke University; Duke University	Cook-Deegan, R (corresponding author), Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA.	bob.cd@duke.edu		Cook-Deegan, Robert/0000-0002-8251-4237	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057157] Funding Source: NIH RePORTER; NIAID NIH HHS [U54 AI 057157, U54 AI057157] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Atlas RM, 2006, BIOSECUR BIOTERROR, V4, P276, DOI 10.1089/bsp.2006.4.276; *COMM GEN DAT BIOT, 2004, SEEK SEC PATH OP ACC; Committee on Advances in Technology and the Prevention of Their Application to Next Generation Biowarfare Threats Institute of Medicine and National Research Council, 2006, GLOB BIOS FUT LIF SC; *DUK U OCC ENV SAF, 2006, REC DNA REG FORM; *J ED AUTH GROUP, 2003, SCIENCE, V299, P1149; National Research Council, 2004, BIOT RES AG TERR, DOI [10.17226/10827, DOI 10.17226/10827]; *SERCEB POL ETH LA, 2005, DUAL US DIL BIOSC RE; *U FL DEP ENV HLTH, 2006, REC DNA RES REG; *WORK GROUP OV FRA, 2006, M NAT SCI ADV BOARD; *WORK GROUP OV FRA, 2007, M NAT SCI ADV BOARD	10	8	8	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 8	2007	316	5830					1432	1433		10.1126/science.1142873	http://dx.doi.org/10.1126/science.1142873			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176EE	17556571				2022-12-28	WOS:000247066400026
J	Terzolo, M; Angeli, A; Fassnacht, M; Daffara, F; Tauchmanova, L; Conton, PA; Rossetto, R; Buci, L; Sperone, P; Grossrubatscher, E; Reimondo, G; Bollito, E; Papotti, M; Saeger, W; Hahner, S; Koschker, A; Arvat, E; Ambrosi, B; Loli, P; Lombardi, G; Mannelli, M; Bruzzi, P; Mantero, F; Allolio, B; Dogliotti, L; Berruti, A				Terzolo, Massimo; Angeli, Alberto; Fassnacht, Martin; Daffara, Fulvia; Tauchmanova, Libuse; Conton, Pier Antonio; Rossetto, Ruth; Buci, Lisa; Sperone, Paola; Grossrubatscher, Erika; Reimondo, Giuseppe; Bollito, Enrico; Papotti, Mauro; Saeger, Wolfgang; Hahner, Stefanie; Koschker, Ann-Cathrin; Arvat, Emanuela; Ambrosi, Bruno; Loli, Paola; Lombardi, Gaetano; Mannelli, Massimo; Bruzzi, Paolo; Mantero, Franco; Allolio, Bruno; Dogliotti, Luigi; Berruti, Alfredo			Adjuvant mitotane treatment for adrenocortical carcinoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ADRENAL-CORTICAL CARCINOMA; EXPERIENCE; MANAGEMENT; RECURRENCE; SURVIVAL; FEATURES; O,P'-DDD; THERAPY; CANCER; SERIES	BACKGROUND: Adrenocortical carcinoma is a rare neoplasm characterized by a high risk of recurrence after radical resection. Whether the use of mitotane is beneficial as an adjuvant treatment has been controversial. Our aim was to evaluate the efficacy of adjuvant mitotane in prolonging recurrence-free survival. METHODS: We performed a retrospective analysis involving 177 patients with adrenocortical cancer who had undergone radical surgery at 8 centers in Italy and 47 centers in Germany between 1985 and 2005. Adjuvant mitotane was administered to 47 Italian patients after radical surgery (mitotane group), whereas 55 Italian patients and 75 German patients (control groups 1 and 2, respectively) did not receive adjuvant treatment after surgery. RESULTS: Baseline features in the mitotane group and the control group from Italy were similar; the German patients were significantly older (P=0.03) and had more stage I or II adrenocortical carcinomas (P=0.02) than did patients in the mitotane group. Recurrence-free survival was significantly prolonged in the mitotane group, as compared with the two control groups (median recurrence-free survival, 42 months, as compared with 10 months in control group 1 and 25 months in control group 2). Hazard ratios for recurrence were 2.91 (95% confidence interval [CI], 1.77 to 4.78; P < 0.001) and 1.97 (95% CI, 1.21 to 3.20; P=0.005), respectively. Multivariate analysis indicated that mitotane treatment had a significant advantage for recurrence-free survival. Adverse events associated with mitotane were mainly of grade 1 or 2, but temporary dose reduction was needed in 13% of patients. CONCLUSIONS: Adjuvant mitotane may prolong recurrence-free survival in patients with radically resected adrenocortical carcinoma.	Univ Turin, Turin, Italy; Univ Wurzburg, Wurzburg, Germany; Univ Naples Federico II, Naples, Italy; Univ Padua, Padua, Italy; Univ Florence, Florence, Italy; Osped Niguarda Milano, Milan, Italy; Univ Milan, Milan, Italy; Marien Hosp, Inst Pathol, Hamburg, Germany; Ist Nazl Ric Canc, I-16132 Genoa, Italy	University of Turin; University of Wurzburg; University of Naples Federico II; University of Padua; University of Florence; Ospedale Niguarda Ca' Granda; University of Milan; St. Marien Hospital; University of Genoa; IRCCS AOU San Martino IST	Terzolo, M (corresponding author), ASO San Luigi, Med Interna 1, Reg Gonzole 10, I-10043 Orbassano, Italy.	terzolo@usa.net	Reimondo, Giuseppe/I-9156-2018; Bruzzi, Paolo/AAU-3363-2021; Berruti, Alfredo/AAC-2069-2019; Fassnacht, Martin/N-9614-2019; Terzolo, Massimo/D-5051-2015	Fassnacht, Martin/0000-0001-6170-6398; Hahner, Stefanie/0000-0003-1616-8986; REIMONDO, Giuseppe Matteo/0000-0001-9489-2094; Terzolo, Massimo/0000-0002-4171-2851; BOLLITO, ENRICO/0000-0002-8483-893X; Mannelli, Massimo/0000-0002-8001-9857; Bruzzi, Paolo/0000-0002-7874-2077; ARVAT, Emanuela/0000-0001-5689-4400				Allolio B, 2006, J CLIN ENDOCR METAB, V91, P2027, DOI 10.1210/jc.2005-2639; [Anonymous], 2003, COMM TERM CRIT ADV E; Barzon L, 1997, ONCOLOGY, V54, P490; Baudin E, 2001, CANCER, V92, P1385, DOI 10.1002/1097-0142(20010915)92:6&lt;1385::AID-CNCR1461&gt;3.0.CO;2-2; Bellantone R, 1997, SURGERY, V122, P1212, DOI 10.1016/S0039-6060(97)90229-4; Berruti A, 2005, ENDOCR-RELAT CANCER, V12, P657, DOI 10.1677/erc.1.01025; BODIE B, 1989, J UROLOGY, V141, P257, DOI 10.1016/S0022-5347(17)40734-8; Dackiw APB, 2001, WORLD J SURG, V25, P914, DOI 10.1007/s00268-001-0030-7; Dickstein G, 1998, J CLIN ENDOCR METAB, V83, P3100, DOI 10.1210/jc.83.9.3100; Fassnacht M, 2006, J CLIN ENDOCR METAB, V91, P4501, DOI 10.1210/jc.2006-1007; Gicquel C, 2001, CANCER RES, V61, P6762; HAAK HR, 1994, BRIT J CANCER, V69, P947, DOI 10.1038/bjc.1994.183; Hahner Stefanie, 2005, Curr Opin Investig Drugs, V6, P386; HENLEY DJ, 1983, SURGERY, V94, P926; Icard P, 2001, WORLD J SURG, V25, P891, DOI 10.1007/s00268-001-0047-y; Kasperlik-Zaluska AA, 2000, BRAZ J MED BIOL RES, V33, P1191, DOI 10.1590/S0100-879X2000001000008; KASPERLIKZALUSKA AA, 1995, CANCER, V75, P2587, DOI 10.1002/1097-0142(19950515)75:10<2587::AID-CNCR2820751028>3.0.CO;2-5; Kirschner LS, 2006, J CLIN ENDOCR METAB, V91, P14, DOI 10.1210/jc.2005-1739; LEE JE, 1995, SURGERY, V118, P1090, DOI 10.1016/S0039-6060(05)80119-9; LUTON JP, 1990, NEW ENGL J MED, V322, P1195, DOI 10.1056/NEJM199004263221705; MACFARLANE D A, 1958, Ann R Coll Surg Engl, V23, P155; POMMIER RF, 1992, SURGERY, V112, P963; Schteingart DE, 2005, ENDOCR-RELAT CANCER, V12, P667, DOI 10.1677/erc.1.01029; SCHTEINGART DE, 1982, ARCH SURG-CHICAGO, V117, P1142; Schulick RD, 1999, ANN SURG ONCOL, V6, P719, DOI 10.1007/s10434-999-0719-7; Stojadinovic A, 2002, J CLIN ONCOL, V20, P941, DOI 10.1200/JCO.2002.20.4.941; SULLIVAN M, 1978, J UROLOGY, V120, P660, DOI 10.1016/S0022-5347(17)57317-6; Vassilopoulou-Sellin R, 2001, CANCER, V92, P1113, DOI 10.1002/1097-0142(20010901)92:5<1113::AID-CNCR1428>3.0.CO;2-I; VASSILOPOULOUSELLIN R, 1993, CANCER, V71, P3119, DOI 10.1002/1097-0142(19930515)71:10<3119::AID-CNCR2820711037>3.0.CO;2-8; VENKATESH S, 1989, CANCER, V64, P765, DOI 10.1002/1097-0142(19890801)64:3<765::AID-CNCR2820640333>3.0.CO;2-I; Wajchenberg BL, 2000, CANCER-AM CANCER SOC, V88, P711, DOI 10.1002/(SICI)1097-0142(20000215)88:4<711::AID-CNCR1>3.0.CO;2-W; WEISS LM, 1989, AM J SURG PATHOL, V13, P202, DOI 10.1097/00000478-198903000-00004; WEISS LM, 1984, AM J SURG PATHOL, V8, P163, DOI 10.1097/00000478-198403000-00001	33	525	546	3	30	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 7	2007	356	23					2372	2380		10.1056/NEJMoa063360	http://dx.doi.org/10.1056/NEJMoa063360			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	175QY	17554118	Green Published			2022-12-28	WOS:000247029300006
J	Dzirlo, L; Hubner, M; Muller, C; Blaha, B; Formann, E; Dellinger, C; Petzelbauer, P; Mullauer, L; Huber, K; Kneussl, M; Gschwantler, M				Dzirlo, Larisa; Hubner, Marianne; Mueller, Christian; Blaha, Benedikt; Formann, Elisabeth; Dellinger, Christoph; Petzelbauer, Peter; Muellauer, Leonhard; Huber, Kurt; Kneussl, Meinhard; Gschwantler, Michael			A mimic of sarcoidosis	LANCET			English	Editorial Material							WHIPPLES-DISEASE		Wilhelminenspital Stadt Wien, Dept Internal Med Gastroenterol & Hepatol 4, Vienna, Austria; Wilhelminenspital Stadt Wien, Dept Internal Med Pulm Med 2, Vienna, Austria; Wilhelminenspital Stadt Wien, Dept Internal Med Cardiol 3, Vienna, Austria; Wilhelminenspital Stadt Wien, Dept Pathol, Vienna, Austria; Med Univ Vienna, Dept Internal Med 4, Div Gastroenterol & Hepatol, Vienna, Austria; Med Univ Vienna, Dept Dermatol, Div Gen Dermatol, Vienna, Austria; Med Univ Vienna, Inst Clin Pathol, Vienna, Austria	Wilhelminenspital; Wilhelminenspital; Wilhelminenspital; Wilhelminenspital; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Dzirlo, L (corresponding author), Wilhelminenspital Stadt Wien, Dept Internal Med Gastroenterol & Hepatol 4, Vienna, Austria.	Larisa.Dzirlo@chello.at	Müllauer, Leonhard/GSN-9884-2022; petzelbauer, peter/GLU-3941-2022	Müllauer, Leonhard/0000-0002-3399-078X; Petzelbauer, Peter/0000-0001-7080-5259				CHO C, 1984, GASTROENTEROLOGY, V87, P941; Marth T, 2003, LANCET, V361, P239, DOI 10.1016/S0140-6736(03)12274-X; Muller SA, 2005, INFECTION, V33, P39, DOI 10.1007/s15010-005-4067-7; RELMAN DA, 1992, NEW ENGL J MED, V327, P293, DOI 10.1056/NEJM199207303270501; SCULLY RE, 1997, NEW ENGL J MED, V337, P1612	5	14	15	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 26	2007	369	9575					1832	1832		10.1016/S0140-6736(07)60822-8	http://dx.doi.org/10.1016/S0140-6736(07)60822-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	172QP	17531892				2022-12-28	WOS:000246819300035
J	Cushing, MC; Anseth, KS				Cushing, Melinda C.; Anseth, Kristi S.			Hydrogel cell cultures	SCIENCE			English	Editorial Material							PROTEIN; GROWTH		Univ Colorado, Dept Chem & Biol Engn, Boulder, CO 80309 USA; Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder	Cushing, MC (corresponding author), Univ Colorado, Dept Chem & Biol Engn, Boulder, CO 80309 USA.	kristi.anseth@colorado.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089260] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016523] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL089260-01A1, R01 HL089260] Funding Source: Medline; NIDCR NIH HHS [R01 DE016523, R01 DE016523-04] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Dodla MC, 2006, J BIOMED MATER RES A, V78A, P213, DOI 10.1002/jbm.a.30747; Ehrick JD, 2005, NAT MATER, V4, P298, DOI 10.1038/nmat1352; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Hu CJ, 2006, MOL CELL BIOL, V26, P3514, DOI 10.1128/MCB.26.9.3514-3526.2006; Klein Y, 2007, SCIENCE, V315, P1116, DOI 10.1126/science.1135994; Liu H, 2005, TISSUE ENG, V11, P319, DOI 10.1089/ten.2005.11.319; Luo Y, 2004, NAT MATER, V3, P249, DOI 10.1038/nmat1092; Lutolf MR, 2003, NAT BIOTECHNOL, V21, P513, DOI 10.1038/nbt818; Mahoney MJ, 2006, BIOMATERIALS, V27, P2265, DOI 10.1016/j.biomaterials.2005.11.007; Malkoch M, 2006, CHEM COMMUN, P2774, DOI 10.1039/b603438a; Murakami Y, 2005, BIOMACROMOLECULES, V6, P2927, DOI 10.1021/bm0504330; PETERSEN OW, 1992, P NATL ACAD SCI USA, V89, P9064, DOI 10.1073/pnas.89.19.9064; Salinas CN, 2007, TISSUE ENG, V13, P1025, DOI 10.1089/ten.2006.0126; Shen W, 2006, NAT MATER, V5, P153, DOI 10.1038/nmat1573; Tsang VL, 2007, FASEB J, V21, P790, DOI 10.1096/fj.06-7117com	15	402	413	17	257	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2007	316	5828					1133	1134		10.1126/science.1140171	http://dx.doi.org/10.1126/science.1140171			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	171GQ	17525324				2022-12-28	WOS:000246724300025
J	Chan, AT; Ogino, S; Fuchs, CS				Chan, Andrew T.; Ogino, Shuji; Fuchs, Charles S.			Aspirin and the risk of colorectal cancer in relation to the expression of COX-2	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; CYCLOOXYGENASE-2 GENE-EXPRESSION; FOOD FREQUENCY QUESTIONNAIRE; MALE HEALTH-PROFESSIONALS; CORONARY-HEART-DISEASE; RANDOMIZED-TRIAL; ADENOMA RECURRENCE; COMPETING RISKS; UP-REGULATION; PREVENTION	Background: Regular use of aspirin reduces the risk of a colorectal neoplasm, but the mechanism by which aspirin affects carcinogenesis in the colon is not well understood. Methods: We estimated cyclooxygenase-2 (COX-2) expression by immunohistochemical assay of sections from paraffin-embedded colorectal-cancer specimens from two large cohorts of participants who provided data on aspirin use from a questionnaire every 2 years. We applied Cox regression to a competing-risks analysis to compare the effects of aspirin use on the relative risk of colorectal cancer in relation to the expression of COX-2 in the tumor. Results: During 2,446,431 person-years of follow-up of 82,911 women and 47,363 men, we found 636 incident colorectal cancers that were accessible for determination of COX-2 expression. Of the tumors, 423 (67%) had moderate or strong COX-2 expression. The effect of aspirin use differed significantly in relation to COX-2 expression (P for heterogeneity=0.02). Regular aspirin use conferred a significant reduction in the risk of colorectal cancers that overexpressed COX-2 (multivariate relative risk, 0.64; 95% confidence interval [CI], 0.52 to 0.78), whereas regular aspirin use had no influence on tumors with weak or absent expression of COX-2 (multivariate relative risk, 0.96; 95% CI, 0.73 to 1.26). The age-standardized incidence rate for cancers that overexpressed COX-2 was 37 per 100,000 person-years among regular aspirin users, as compared with 56 per 100,000 person-years among those who did not use aspirin regularly; in contrast, the rate for cancers with weak or absent COX-2 expression was 27 per 100,000 person-years among regular aspirin users, as compared with 28 per 100,000 person-years among nonregular aspirin users. Conclusions: Regular use of aspirin appears to reduce the risk of colorectal cancers that overexpress COX-2 but not the risk of colorectal cancers with weak or absent expression of COX-2.	Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital	Chan, AT (corresponding author), Massachusetts Gen Hosp, Gastrointestinal Unit, 55 Fruit St,GRJ 728A, Boston, MA 02114 USA.	achan@partners.org	Chan, Andrew T/P-8293-2014; Chan, Andy/D-3361-2013	Chan, Andrew T/0000-0001-7284-6767; Ogino, Shuji/0000-0002-3909-2323	NCI NIH HHS [CA87969, CA10741, CA55075] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA087969] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Arber N, 2006, NEW ENGL J MED, V355, P885, DOI 10.1056/NEJMoa061652; Baron JA, 2003, NEW ENGL J MED, V348, P891, DOI 10.1056/NEJMoa021735; Baron JA, 2006, GASTROENTEROLOGY, V131, P1674, DOI 10.1053/j.gastro.2006.08.079; Benamouzig R, 2003, GASTROENTEROLOGY, V125, P328, DOI 10.1016/S0016-5085(03)00887-4; Bertagnolli MM, 2006, NEW ENGL J MED, V355, P873, DOI 10.1056/NEJMoa061355; Brown JR, 2005, J CLIN ONCOL, V23, P2840, DOI 10.1200/JCO.2005.09.051; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; Chan AT, 2004, ANN INTERN MED, V140, P157, DOI 10.7326/0003-4819-140-3-200402030-00006; Chan AT, 2005, JAMA-J AM MED ASSOC, V294, P914, DOI 10.1001/jama.294.8.914; Chan AT, 2003, CANCER CAUSE CONTROL, V14, P413, DOI 10.1023/A:1024986220526; Chan TA, 1998, P NATL ACAD SCI USA, V95, P681, DOI 10.1073/pnas.95.2.681; Chulada PC, 2000, CANCER RES, V60, P4705; Cianchi F, 2001, GASTROENTEROLOGY, V121, P1339, DOI 10.1053/gast.2001.29691; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; EBERHART CE, 1994, GASTROENTEROLOGY, V107, P1183, DOI 10.1016/0016-5085(94)90246-1; GIOVANNUCCI E, 1995, NEW ENGL J MED, V333, P609, DOI 10.1056/NEJM199509073331001; GIOVANNUCCI E, 1994, ANN INTERN MED, V121, P241, DOI 10.7326/0003-4819-121-4-199408150-00001; Glynn RJ, 2005, AM J EPIDEMIOL, V162, P975, DOI 10.1093/aje/kwi309; Haile Robert W, 2005, Clin Colorectal Cancer, V4, P390, DOI 10.3816/CCC.2005.n.011; Hanif R, 1996, BIOCHEM PHARMACOL, V52, P237, DOI 10.1016/0006-2952(96)00181-5; He TC, 1999, CELL, V99, P335, DOI 10.1016/S0092-8674(00)81664-5; Hu FB, 1999, AM J EPIDEMIOL, V149, P531, DOI 10.1093/oxfordjournals.aje.a009849; Huls G, 2003, LANCET, V362, P230, DOI 10.1016/S0140-6736(03)13915-3; KOPP E, 1994, SCIENCE, V265, P956, DOI 10.1126/science.8052854; LUNN M, 1995, BIOMETRICS, V51, P524, DOI 10.2307/2532940; Martinez ME, 2003, P NATL ACAD SCI USA, V100, P7859, DOI 10.1073/pnas.1332465100; Masunaga R, 2000, CLIN CANCER RES, V6, P4064; Ogino S, 2006, MODERN PATHOL, V19, P59, DOI 10.1038/modpathol.3800482; Ogino S, 2006, NEOPLASIA, V8, P458, DOI 10.1593/neo.06247; Patrono C, 2005, NEW ENGL J MED, V353, P2373, DOI 10.1056/NEJMra052717; RIMM EB, 1992, AM J EPIDEMIOL, V135, P1114, DOI 10.1093/oxfordjournals.aje.a116211; Sandler RS, 2003, NEW ENGL J MED, V348, P883, DOI 10.1056/NEJMoa021633; Sandler RS, 2003, NEW ENGL J MED, V348, P1939; Schwenger P, 1997, P NATL ACAD SCI USA, V94, P2869, DOI 10.1073/pnas.94.7.2869; Serhan CN, 2007, ANNU REV IMMUNOL, V25, P101, DOI 10.1146/annurev.immunol.25.022106.141647; Shureiqi I, 2000, CANCER RES, V60, P6846; Soumaoro LT, 2004, CLIN CANCER RES, V10, P8465, DOI 10.1158/1078-0432.CCR-04-0653; STAMPFER MJ, 1984, AM J EPIDEMIOL, V119, P837, DOI 10.1093/oxfordjournals.aje.a113804; Steinbach G, 2000, NEW ENGL J MED, V342, P1946, DOI 10.1056/NEJM200006293422603; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; Zhang H, 2002, AM J GASTROENTEROL, V97, P1037; Zhang L, 2000, SCIENCE, V290, P989, DOI 10.1126/science.290.5493.989	42	590	616	2	79	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 24	2007	356	21					2131	2142		10.1056/NEJMoa067208	http://dx.doi.org/10.1056/NEJMoa067208			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	170ON	17522398	Bronze			2022-12-28	WOS:000246673100003
J	Gohel, MS; Barwell, JR; Taylor, M; Chant, T; Foy, C; Earnshaw, JJ; Heather, BP; Mitchell, DC; Whyman, MR; Poskitt, KR				Gohel, Manjit S.; Barwell, Jamie R.; Taylor, Maxine; Chant, Terry; Foy, Chris; Earnshaw, Jonothan J.; Heather, Brian P.; Mitchell, David C.; Whyman, Mark R.; Poskitt, Keith R.			Long term results of compression therapy alone versus compression plus surgery in chronic venous ulceration (ESCHAR): randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LEG ULCERS; SAPHENOUS-VEIN; CLINICAL-TRIAL; POPULATION; REFLUX; INCOMPETENCE; MANAGEMENT; INSUFFICIENCY; PREVALENCE; RECURRENCE	Objective To determine whether recurrence of leg ulcers may be prevented by surgical correction of superficial venous reflux in addition to compression. Design Randomised controlled trial. Setting Specialist nurse led leg ulcer clinics in three UK vascular centres. Participants 500 patients (500 legs) with open or recently healed leg ulcers and superficial venous reflux. Interventions Compression alone or compression plus saphenous surgery. Main outcome measures Primary outcomes were ulcer healing and ulcer recurrence. The secondary outcome was ulcer free time. Results Ulcer healing rates at three years were 89% for the compression group and 93% for the compression plus surgery group (P=0.73, log rank test). Rates of ulcer recurrence at four years were 56% for the compression group and 31% for the compression plus surgery group (P < 0.01). For patients with isolated superficial reflux, recurrence rates at four years were 51% for the compression group and 27% for the compress plus surgery group (P < 0.01). For patients who had superficial with segmental deep reflux, recurrence rates at three years were 52% for the compression group and 24% for the compression plus surgery group (P=0.04). For patients with superficial and total deep reflux, recurrence rates at three years were 46% for the compression group and 32% for the compression plus surgery group (P=0.33). Patients in the compression plus surgery group experienced a greater proportion of ulcer free time after three years compared with patients in the compression group (78% v 71%; P=0.007, Mann-Whitney U test). Conclusions Surgical correction of superficial venous reflux in addition to compression bandaging does not improve ulcer healing but reduces the recurrence of ulcers at four years and results in a greater proportion of ulcer free time.	Cheltenham Gen Hosp, Gloucester GL53 7AN, England; Derriford Hosp, Plymouth PL6 8DH, Devon, England; Southmead Hosp, Bristol, Avon, England; Gloucestershire Hosp NHS Trust, Gloucester, England; Gloucestershire Royal Hosp, Gloucester GL1 3NN, England	Gloucestershire Hospitals NHS Foundation Trust; Cheltenham General Hospital; Derriford Hospital; Southmead Hospital; Cranfield University; Gloucestershire Hospitals NHS Foundation Trust; Gloucestershire Royal Hospital	Poskitt, KR (corresponding author), Cheltenham Gen Hosp, Gloucester GL53 7AN, England.	keith.poskitt@gtos.nhs.uk						Adam DJ, 2003, EUR J VASC ENDOVASC, V25, P469, DOI 10.1053/ejvs.2002.1894; Barwell JR, 2000, EUR J VASC ENDOVASC, V20, P363, DOI 10.1053/ejvs.2000.1196; Barwell JR, 2004, LANCET, V363, P1854, DOI 10.1016/S0140-6736(04)16353-8; Carpentier PH, 2004, J VASC SURG, V40, P650, DOI 10.1016/j.jvs.2004.07.025; Charles H, 2004, J Wound Care, V13, P209; Clarke-Moloney M, 2005, IRISH J MED SCI, V174, P21, DOI 10.1007/BF03169124; DARKE SG, 1992, EUR J VASCULAR SURG, V6, P4, DOI 10.1016/S0950-821X(05)80086-6; Dix FP, 2003, EUR J VASC ENDOVASC, V25, P556, DOI 10.1053/ejvs.2002.1885; Ghauri ASK, 1998, EUR J VASC ENDOVASC, V16, P238, DOI 10.1016/S1078-5884(98)80226-8; Ghauri ASK, 2000, BRIT J SURG, V87, P1048, DOI 10.1046/j.1365-2168.2000.01491.x; Gohel MS, 2005, BRIT J SURG, V92, P291, DOI 10.1002/bjs.4837; Gohel MS, 2005, EUR J VASC ENDOVASC, V29, P78, DOI 10.1016/j.ejvs.2004.09.016; Grabs AJ, 1996, BRIT J SURG, V83, P1380, DOI 10.1002/bjs.1800831016; Guest M, 1999, BRIT J SURG, V86, P1437, DOI 10.1046/j.1365-2168.1999.01288.x; Guest M, 2003, PHLEBOLOGY, V18, P130, DOI 10.1258/026835503322381333; HANRAHAN LM, 1991, J VASC SURG, V13, P805; HARDY SC, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001097.PUB2; HARPER D, 1995, PHLEBOLOGY S, V1, P872; Lurie F, 2003, J VASC SURG, V38, P207, DOI 10.1016/S0741-5214(03)00228-3; MacKenzie RK, 2004, EUR J VASC ENDOVASC, V28, P104, DOI 10.1016/j.ejvs.2004.03.009; Magnusson MB, 2001, EUR J VASC ENDOVASC, V21, P353, DOI 10.1053/ejvs.2000.1307; MOFFATT CJ, 1992, BRIT MED J, V305, P1389, DOI 10.1136/bmj.305.6866.1389; Morrell CJ, 1998, BMJ-BRIT MED J, V316, P1487, DOI 10.1136/bmj.316.7143.1487; Nelson EA, 2000, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002303; Nelzen O, 1996, BRIT J SURG, V83, P255, DOI 10.1046/j.1365-2168.1996.02099.x; Nelzen O, 2000, PHLEBOLOGY, V15, P110, DOI 10.1007/s005230070005; NICOLAIDES AN, 1993, J VASC SURG, V17, P414, DOI 10.1016/0741-5214(93)90426-M; Pascarella L, 2006, ANN VASC SURG, V20, P83, DOI 10.1007/s10016-005-9381-0; Ruckley CV, 2002, J VASC SURG, V36, P520, DOI 10.1067/mva.2002.126547; Sharif MA, 2006, BRIT J SURG, V93, P831, DOI 10.1002/bjs.5351; Sullivan JG, 1998, PHLEBOLOGY, V13, P142, DOI 10.1007/s005230050012; Tennvall GR, 2005, WOUND REPAIR REGEN, V13, P13, DOI 10.1111/j.1067-1927.2005.130103.x; Walsh J C, 1994, Ann Vasc Surg, V8, P566, DOI 10.1007/BF02017413; Winterborn RJ, 2004, J VASC SURG, V40, P634, DOI 10.1016/j.jvs.2004.07.003; Zamboni P, 2003, EUR J VASC ENDOVASC, V25, P313, DOI 10.1053/ejvs.2002.1871	35	244	256	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 14	2007	335	7610					83	87		10.1136/bmj.39216.542442.BE	http://dx.doi.org/10.1136/bmj.39216.542442.BE			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	192JM	17545185	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000248197500034
J	Jackson, DJ; Macis, L; Reitner, J; Degnan, BM; Worheide, G				Jackson, Daniel J.; Macis, Luciana; Reitner, Joachim; Degnan, Bernard M.; Woerheide, Gert			Sponge paleogenomics reveals an ancient role for carbonic anhydrase in skeletogenesis	SCIENCE			English	Article							MATRIX PROTEIN; EVOLUTION; SHELL	Sponges (phylum Porifera) were prolific reef-building organisms during the Paleozoic and Mesozoic similar to 542 to 65 million years ago. These ancient animals inherited components of the first multicellular skeletogenic toolkit from the last common ancestor of the Metazoa. Using a paleogenomics approach, including gene- and protein-expression techniques and phylogenetic reconstruction, we show that a molecular component of this toolkit was the precursor to the alpha-carbonic anhydrases (alpha-CAs), a gene family used by extant animals in a variety of fundamental physiological processes. We used the coralline demosponge Astrosclera willeyana, a "living fossil" that has survived from the Mesozoic, to provide insight into the evolution of the ability to biocalcify, and show that the alpha-CA family expanded from a single ancestral gene through several independent gene- duplication events in sponges and eumetazoans.	Geosci Ctr Gottingen, Dept Geobiol, D-37077 Gottingen, Germany; Univ Queensland, Sch Integrat Biol, Brisbane, Qld 4072, Australia	University of Gottingen; University of Queensland	Worheide, G (corresponding author), Geosci Ctr Gottingen, Dept Geobiol, Goldschmidtstr 3, D-37077 Gottingen, Germany.	gert.woerheide@geo.uni-goettingen.de	Wörheide, Gert/C-1080-2008; Jackson, Daniel J./J-5158-2012	Wörheide, Gert/0000-0002-6380-7421; Jackson, Daniel J./0000-0001-9045-381X; Degnan, Bernard/0000-0001-7573-8518				BENGTSON S, 1992, SCIENCE, V257, P367, DOI 10.1126/science.257.5068.367; Bottjer DJ, 2006, SCIENCE, V314, P956, DOI 10.1126/science.1132310; Chombard C, 1997, BIOL BULL, V193, P359, DOI 10.2307/1542938; deBoer ML, 2006, BIOL BULL-US, V211, P18, DOI 10.2307/4134574; Henry RP, 1996, ANNU REV PHYSIOL, V58, P523, DOI 10.1146/annurev.ph.58.030196.002515; HewettEmmett D, 1996, MOL PHYLOGENET EVOL, V5, P50, DOI 10.1006/mpev.1996.0006; JACKSON DJ, 2006, BMC BIOL, V4; Kawasaki K, 2006, J EXP ZOOL PART B, V306B, P295, DOI 10.1002/jez.b.21088; KEMPE S, 1985, CHEM GEOL, V53, P95, DOI 10.1016/0009-2541(85)90023-3; Knoll AH, 2003, REV MINERAL GEOCHEM, V54, P329, DOI 10.2113/0540329; Lindskog S, 1997, PHARMACOL THERAPEUT, V74, P1, DOI 10.1016/S0163-7258(96)00198-2; Livingston BT, 2006, DEV BIOL, V300, P335, DOI 10.1016/j.ydbio.2006.07.047; Love AC, 2007, EVOL DEV, V9, P51, DOI 10.1111/j.1525-142X.2006.00137.x; Miyamoto H, 2003, J MOLLUS STUD, V69, P87, DOI 10.1093/mollus/69.1.87; Miyamoto H, 1996, P NATL ACAD SCI USA, V93, P9657, DOI 10.1073/pnas.93.18.9657; Morris SC, 2000, P NATL ACAD SCI USA, V97, P4426, DOI 10.1073/pnas.97.9.4426; Rahman MA, 2006, MAR BIOTECHNOL, V8, P415, DOI 10.1007/s10126-005-6150-6; Shen XY, 1997, J BIOL CHEM, V272, P32472, DOI 10.1074/jbc.272.51.32472; WILBUR KM, 1948, J BIOL CHEM, V176, P147; WOOD R, 1990, AM SCI, V78, P224; Worheide G, 1998, FACIES, V38, P1, DOI 10.1007/BF02537358	21	98	102	1	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 29	2007	316	5833					1893	1895		10.1126/science.1141560	http://dx.doi.org/10.1126/science.1141560			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	183WI	17540861				2022-12-28	WOS:000247602700038
J	Denny, CC; Emanuel, EJ; Pearson, SD				Denny, Colleen C.; Emanuel, Ezekiel J.; Pearson, Steven D.			Why well-insured patients should demand value-based insurance benefits	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							METASTATIC COLORECTAL-CANCER; PLUS IRINOTECAN; CARE; INNOVATION; QUALITY; COSTS		NIH, Dept Bioeth, NIH Clin Ctr, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Emanuel, EJ (corresponding author), NIH, Dept Bioeth, NIH Clin Ctr, 10 Ctr Dr,Bldg 10,Room 1C118, Bethesda, MD 20892 USA.	eemanuel@cc.nih.gov		Denny, Colleen/0000-0001-5671-6540				AARON H, 2006, LOS ANGELES TIM 0130; Blumenthal D, 2006, NEW ENGL J MED, V355, P195, DOI 10.1056/NEJMhpr060704; Bodenheimer T, 2005, ANN INTERN MED, V142, P932, DOI 10.7326/0003-4819-142-11-200506070-00012; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; DENAVASWALT C, 2005, INCOME POVERTY HLTH; Deyo R. A., 2004, SPINE J, V4, p138S; Fendrick AM, 2001, AM J MANAG CARE, V7, P861; Fendrick AM, 2006, AM J MANAG CARE, V12, P18; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; *KAIS FAM FDN HLTH, 2005, EMPL HLTH BEN 2005 A; Krohmal BJ, 2007, ARCH INTERN MED, V167, P433, DOI 10.1001/archinte.167.5.433; Pauly MV, 2005, HEALTH AFFAIR, V24, P1523, DOI 10.1377/hlthaff.24.6.1523; Pearson S. D., 2008, NO MARGIN NO MISSION; Pearson SD, 2005, JAMA-J AM MED ASSOC, V294, P2618, DOI 10.1001/jama.294.20.2618; Poisal JA, 2007, HEALTH AFFAIR, V26, pW242, DOI 10.1377/hlthaff.26.2.w242; Polsky D, 2006, AM J PSYCHIAT, V163, P2047, DOI 10.1176/appi.ajp.163.12.2047; *SACR HLTH DEC, 2001, COST EFF CRIT MED CO; Schrag D, 2004, NEW ENGL J MED, V351, P317, DOI 10.1056/NEJMp048143; Selingo J., 2003, CHRON HIGHER EDUC, pA22; Ubel P.A., 2000, PRICING LIFE WHY ITS; VU P, 2006, TUITION HIKES SMALLE; ZAPPONE C, 2006, HEALTHCARE ENERGY DR; 2003, WASHINGTON POST ABC	23	12	12	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 13	2007	297	22					2515	2518		10.1001/jama.297.22.2515	http://dx.doi.org/10.1001/jama.297.22.2515			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	177TX	17565086				2022-12-28	WOS:000247176500026
J	Karsak, M; Gaffal, E; Date, R; Wang-Eckhardt, L; Rehnelt, J; Petrosino, S; Starowicz, K; Steuder, R; Schlicker, E; Cravatt, B; Mechoulam, R; Buettner, R; Werner, S; Di Marzo, V; Tuting, T; Zimmer, A				Karsak, Meliha; Gaffal, Evelyn; Date, Rahul; Wang-Eckhardt, Lihua; Rehnelt, Jennifer; Petrosino, Stefania; Starowicz, Katarzyna; Steuder, Regina; Schlicker, Eberhard; Cravatt, Benjamin; Mechoulam, Raphael; Buettner, Reinhard; Werner, Sabine; Di Marzo, Vincenzo; Tueting, Thomas; Zimmer, Andreas			Attenuation of allergic contact dermatitis through the endocannabinoid system	SCIENCE			English	Article							CANNABINOID CB2 RECEPTOR; INVERSE AGONIST; GENE ONTOLOGY; KNOCKOUT MICE; ANANDAMIDE; HYPERSENSITIVITY; INVOLVEMENT; NEUTROPHILS; PROTEIN-1; DEFICIENT	Allergic contact dermatitis affects about 5% of men and 11% of women in industrialized countries and is one of the leading causes for occupational diseases. In an animal model for cutaneous contact hypersensitivity, we show that mice lacking both known cannabinoid receptors display exacerbated allergic inflammation. In contrast, fatty acid amide hydrolase-deficient mice, which have increased levels of the endocannabinoid anandamide, displayed reduced allergic responses in the skin. Cannabinoid receptor antagonists exacerbated allergic inflammation, whereas receptor agonists attenuated inflammation. These results demonstrate a protective role of the endocannabinoid system in contact allergy in the skin and suggest a target for therapeutic intervention.	Univ Bonn, Dept Mol Psychiat, D-5300 Bonn, Germany; Univ Bonn, Dept Dermatol, Lab Expt Dermatol, D-5300 Bonn, Germany; Life & Brain GmbH, Bonn, Germany; CNR, Inst Biomol Chem, Endocannabinoid Res Grp, Naples, Italy; Univ Bonn, Inst Pharmacol & Toxicol, D-5300 Bonn, Germany; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA USA; Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; Hebrew Univ Jerusalem, Dept Med Chem & Nat Prod, IL-91905 Jerusalem, Israel; Univ Bonn, Dept Pathol, D-5300 Bonn, Germany; ETH, Inst Cell Biol, CH-8093 Zurich, Switzerland	University of Bonn; University of Bonn; Consiglio Nazionale delle Ricerche (CNR); University of Bonn; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Hebrew University of Jerusalem; University of Bonn; Swiss Federal Institutes of Technology Domain; ETH Zurich	Zimmer, A (corresponding author), Univ Bonn, Dept Mol Psychiat, D-5300 Bonn, Germany.	thomas.tueting@ukb.uni-bonn.de; a.zimmer@uni-bonn.de	Schlicker, Eberhard/GVT-2661-2022; Zimmer, Andreas/B-8357-2009; Starowicz, Katarzyna/AAB-8595-2022; Di Marzo, Vincenzo/AAD-7742-2019; Tüting, Thomas/AAJ-3610-2021	Di Marzo, Vincenzo/0000-0002-1490-3070; Tüting, Thomas/0000-0001-7146-0934; Karsak, Meliha/0000-0001-6612-6317; Werner, Sabine/0000-0001-7397-8710; Date, Rahul/0000-0002-6322-1201; Starowicz, Katarzyna/0000-0003-0091-0066				Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bachmann MF, 2006, NAT REV IMMUNOL, V6, P159, DOI 10.1038/nri1776; Bisogno T, 2005, PHARMACOL BIOCHEM BE, V81, P224, DOI 10.1016/j.pbb.2005.01.027; Buckley  NE, 2000, EUR J PHARMACOL, V396, P141, DOI 10.1016/S0014-2999(00)00211-9; Cravatt BF, 2001, P NATL ACAD SCI USA, V98, P9371, DOI 10.1073/pnas.161191698; Cravatt BF, 2004, P NATL ACAD SCI USA, V101, P10821, DOI 10.1073/pnas.0401292101; de Paulis A, 2001, INT ARCH ALLERGY IMM, V124, P146, DOI 10.1159/000053694; Di Marzo V, 2000, J NEUROCHEM, V75, P2434, DOI 10.1046/j.1471-4159.2000.0752434.x; Grabbe S, 1998, IMMUNOL TODAY, V19, P37, DOI 10.1016/S0167-5699(97)01186-9; Ibrahim MM, 2005, P NATL ACAD SCI USA, V102, P3093, DOI 10.1073/pnas.0409888102; Klein TW, 2005, NAT REV IMMUNOL, V5, P400, DOI 10.1038/nri1602; KNOP J, 1982, NATURE, V296, P757, DOI 10.1038/296757a0; Lee JSM, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-189; LEHRER RI, 1969, NATURE, V223, P78, DOI 10.1038/223078a0; Lunn CA, 2006, J PHARMACOL EXP THER, V316, P780, DOI 10.1124/JPET.105.093500; Maccarrone M, 2003, J BIOL CHEM, V278, P33896, DOI 10.1074/jbc.M303994200; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Oka S, 2006, J IMMUNOL, V177, P8796, DOI 10.4049/jimmunol.177.12.8796; Stander S, 2005, J DERMATOL SCI, V38, P177, DOI 10.1016/j.jdermsci.2005.01.007; TAUB DD, 1995, J CLIN INVEST, V95, P1370, DOI 10.1172/JCI117788; Ueda Y, 2005, EUR J PHARMACOL, V520, P164, DOI 10.1016/j.ejphar.2005.08.013; WERNER S, 1994, SCIENCE, V266, P819, DOI 10.1126/science.7973639; Zimmer A, 1999, P NATL ACAD SCI USA, V96, P5780, DOI 10.1073/pnas.96.10.5780	23	253	279	4	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 8	2007	316	5830					1494	1497		10.1126/science.1142265	http://dx.doi.org/10.1126/science.1142265			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176EE	17556587				2022-12-28	WOS:000247066400048
J	Rietbrock, A				Rietbrock, Andreas			Listening to the crackle of subducting oceanic plates	SCIENCE			English	Editorial Material							NORTHEASTERN JAPAN ARC; DEEP SEISMIC ZONE; EARTHQUAKES		Univ Liverpool, Dept Earth & Ocean Sci, Liverpool L69 3GP, Merseyside, England	University of Liverpool	Rietbrock, A (corresponding author), Univ Liverpool, Dept Earth & Ocean Sci, Liverpool L69 3GP, Merseyside, England.	A.Rietbrock@liverpool.ac.uk			Natural Environment Research Council [NE/C000315/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Brudzinski MR, 2007, SCIENCE, V316, P1472, DOI 10.1126/science.1139204; Hacker BR, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2001JB001127; HASEGAWA A, 1978, TECTONOPHYSICS, V47, P43, DOI 10.1016/0040-1951(78)90150-6; Igarashi T, 2001, J GEOPHYS RES-SOL EA, V106, P2177, DOI 10.1029/2000JB900386; KIRBY S, 1995, REV GEOPHYS, V33, P287, DOI 10.1029/95RG00353; Rietbrock A, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019610	6	0	0	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 8	2007	316	5830					1439	1440		10.1126/science.1141921	http://dx.doi.org/10.1126/science.1141921			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176EE	17556575				2022-12-28	WOS:000247066400030
J	Ford, ES; Ajani, UA; Croft, JB; Critchley, JA; Labarthe, DR; Kottke, TE; Giles, WH; Capewell, S				Ford, Earl S.; Ajani, Umed A.; Croft, Janet B.; Critchley, Julia A.; Labarthe, Darwin R.; Kottke, Thomas E.; Giles, Wayne H.; Capewell, Simon			Explaining the decrease in US deaths from coronary disease, 1980-2000	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NUTRITION EXAMINATION SURVEY; IMPAIRED GLUCOSE-TOLERANCE; RISK-FACTOR CHANGES; HEART-DISEASE; UNITED-STATES; NATIONAL-HEALTH; MYOCARDIAL-INFARCTION; MORTALITY-RATES; DECLINE; PREVALENCE	BACKGROUND: Mortality from coronary heart disease in the United States has decreased substantially in recent decades. We conducted a study to determine how much of this decrease could be explained by the use of medical and surgical treatments as opposed to changes in cardiovascular risk factors. METHODS: We applied a previously validated statistical model, IMPACT, to data on the use and effectiveness of specific cardiac treatments and on changes in risk factors between 1980 and 2000 among U.S. adults 25 to 84 years old. The difference between the observed and expected number of deaths from coronary heart disease in 2000 was distributed among the treatments and risk factors included in the analyses. RESULTS: From 1980 through 2000, the age-adjusted death rate for coronary heart disease fell from 542.9 to 266.8 deaths per 100,000 population among men and from 263.3 to 134.4 deaths per 100,000 population among women, resulting in 341,745 fewer deaths from coronary heart disease in 2000. Approximately 47% of this decrease was attributed to treatments, including secondary preventive therapies after myocardial infarction or revascularization (11%), initial treatments for acute myocardial infarction or unstable angina (10%), treatments for heart failure (9%), revascularization for chronic angina (5%), and other therapies (12%). Approximately 44% was attributed to changes in risk factors, including reductions in total cholesterol (24%), systolic blood pressure (20%), smoking prevalence (12%), and physical inactivity (5%), although these reductions were partially offset by increases in the body-mass index and the prevalence of diabetes, which accounted for an increased number of deaths (8% and 10%, respectively). CONCLUSIONS: Approximately half the decline in U.S. deaths from coronary heart disease from 1980 through 2000 may be attributable to reductions in major risk factors and approximately half to evidence-based medical therapies.	Univ Liverpool, Div Publ Hlth, Liverpool L69 3GB, Merseyside, England; Ctr Dis Control & Prevent, Div Adult & Community Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA USA; Ctr Dis Control & Prevent, Div Heart Dis & Stroke Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA USA; Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Healthpartners Res Fdn, Minneapolis, MN USA	University of Liverpool; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Newcastle University - UK; HealthPartners Institute for Education & Research	Capewell, S (corresponding author), Univ Liverpool, Div Publ Hlth, Whelan Bldg, Liverpool L69 3GB, Merseyside, England.	capewell@liverpool.ac.uk	Shao, Ruitai/AAU-7642-2021	Critchley, Julia/0000-0002-5248-4188	MRC [G0500920] Funding Source: UKRI; Medical Research Council [G0500920] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		[Anonymous], MED EXP PAN SURV; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; BEAGLEHOLE R, 1986, BMJ-BRIT MED J, V292, P33, DOI 10.1136/bmj.292.6512.33; Bots M L, 1996, J Cardiovasc Risk, V3, P271, DOI 10.1097/00043798-199606000-00002; BRIGGS A, 1994, HEALTH ECON, V3, P95, DOI 10.1002/hec.4730030206; Burt VL, 1996, HYPERTENSION, V27, P1192; BURT VL, 1995, HYPERTENSION, V26, P60, DOI 10.1161/01.HYP.26.1.60; Butler J, 2002, J AM COLL CARDIOL, V40, P1589, DOI 10.1016/S0735-1097(02)02379-3; Capewell S, 1999, HEART, V81, P380, DOI 10.1136/hrt.81.4.380; Capewell S, 2000, EUR HEART J, V21, P1833, DOI 10.1053/euhj.2000.2318; Capewell S, 2000, CIRCULATION, V102, P1511, DOI 10.1161/01.CIR.102.13.1511; *CDCP, PERC AD WHO CURR FOR; Cooper Keith, 2002, Health Care Manag Sci, V5, P259, DOI 10.1023/A:1020378022303; Critchley J, 2004, CIRCULATION, V110, P1236, DOI 10.1161/01.CIR.0000140668.91896.AE; Critchley JA, 2003, JAMA-J AM MED ASSOC, V290, P86, DOI 10.1001/jama.290.1.86; DOLISZNY KM, 1994, J AM COLL CARDIOL, V24, P95, DOI 10.1016/0735-1097(94)90547-9; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; Ford ES, 2003, CIRCULATION, V107, P2185, DOI 10.1161/01.CIR.0000066320.27195.B4; GOLDMAN L, 1984, ANN INTERN MED, V101, P825, DOI 10.7326/0003-4819-101-6-825; Hajjar I, 2003, JAMA-J AM MED ASSOC, V290, P199, DOI 10.1001/jama.290.2.199; HARRIS MI, 1987, DIABETES, V36, P523, DOI 10.2337/diabetes.36.4.523; Harris MI, 1998, DIABETES CARE, V21, P518, DOI 10.2337/diacare.21.4.518; Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847; Hippisley-Cox J, 2006, BRIT MED J, V332, P912; Hunink MGM, 1997, JAMA-J AM MED ASSOC, V277, P535, DOI 10.1001/jama.277.7.535; JOHNSON CL, 1993, JAMA-J AM MED ASSOC, V269, P3002, DOI 10.1001/jama.269.23.3002; Laatikainen T, 2005, AM J EPIDEMIOL, V162, P764, DOI 10.1093/aje/kwi274; LAW MR, 1994, BMJ-BRIT MED J, V308, P367, DOI 10.1136/bmj.308.6925.367; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lewington S, 2003, LANCET, V361, P1060; MANT J, 1995, BMJ-BRIT MED J, V311, P793, DOI 10.1136/bmj.311.7008.793; McAlister FA, 2002, INT J EPIDEMIOL, V31, P76, DOI 10.1093/ije/31.1.76; Mokdad Ali H, 2003, MMWR Recomm Rep, V52, P1; *MORB MORT, 2004, 2004 CHART BOOK CARD; *NAT CTR HLTH STAT, 2000, DHHS PUBL; *NAT CTR HLTH STAT, NHANES 1999 2000; Nichol MB, 1999, ANN PHARMACOTHER, V33, P531, DOI 10.1345/aph.18233; Olshansky SJ, 2005, NEW ENGL J MED, V352, P1138, DOI 10.1056/NEJMsr043743; Rogers WJ, 2000, J AM COLL CARDIOL, V36, P2056, DOI 10.1016/S0735-1097(00)00996-7; Rosamond W, 2007, CIRCULATION, V115, pE69, DOI 10.1161/CIRCULATIONAHA.106.179918; RYAN R, 2001, HLTH STAT Q, V12, P34; Thom T, 2006, CIRCULATION, V113, pE696, DOI 10.1161/CIRCULATIONAHA.106.174501; Thom T, 2006, CIRCULATION, V113, pE85, DOI 10.1161/CIRCULATIONAHA.105.171600; Thom T, 2006, CIRCULATION, V114, pE630, DOI 10.1161/CIRCULATIONAHA.106.180110; Unal B, 2005, BMJ-BRIT MED J, V331, P614, DOI 10.1136/bmj.38561.633345.8F; Unal B, 2005, AM J PUBLIC HEALTH, V95, P103, DOI 10.2105/AJPH.2003.029579; Unal B, 2004, CIRCULATION, V109, P1101, DOI 10.1161/01.CIR.0000118498.35499.B2; URAL B, 2006, IMPACT VALIDATED COM; VARTIAINEN E, 1994, BMJ-BRIT MED J, V309, P23, DOI 10.1136/bmj.309.6946.23; World Health Organization, 2004, ICD 10 INT STAT CLAS, V2nd; World Health Organization, 1980, INT CLASSIFICATION D; 2004, MMWR MORB MORTAL WKL, V53, P82; [No title captured]	53	1931	2020	1	69	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 7	2007	356	23					2388	2398		10.1056/NEJMsa053935	http://dx.doi.org/10.1056/NEJMsa053935			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	175QY	17554120				2022-12-28	WOS:000247029300008
J	Markman, M				Markman, Maurie			Human papillomavirus vaccines to prevent cervical cancer	LANCET			English	Editorial Material							PARTICLE VACCINE; YOUNG-WOMEN; HPV VACCINE; TYPE-16; EFFICACY; RISK; INFECTION; PRECANCER		Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Markman, M (corresponding author), Univ Texas, MD Anderson Canc Ctr, 1515 Holcombe Blvd, Houston, TX 77030 USA.	mmarkman@mdanderson.org						ADAMI HO, 1994, CANCER-AM CANCER SOC, V73, P140, DOI 10.1002/1097-0142(19940101)73:1<140::AID-CNCR2820730124>3.0.CO;2-2; Agosti JM, 2007, NEW ENGL J MED, V356, P1908, DOI 10.1056/NEJMp078053; Bjorge T, 2002, BRIT J CANCER, V87, P61, DOI 10.1038/sj.bjc.6600350; Castle PE, 2005, JNCI-J NATL CANCER I, V97, P1066, DOI 10.1093/jnci/dji186; Collins Y, 2006, GYNECOL ONCOL, V102, P552, DOI 10.1016/j.ygyno.2006.07.022; Frazer IH, 2004, NAT REV IMMUNOL, V4, P46, DOI 10.1038/nri1260; Garland SM, 2007, NEW ENGL J MED, V356, P1928, DOI 10.1056/NEJMoa061760; Gostin LO, 2007, JAMA-J AM MED ASSOC, V297, P1921, DOI 10.1001/jama.297.17.1921; GOSTIN LO, 2007, GYNECOL ONCOL, V297, P1921; Harper DM, 2004, LANCET, V364, P1757, DOI 10.1016/S0140-6736(04)17398-4; Harper DM, 2006, LANCET, V367, P1247, DOI 10.1016/S0140-6736(06)68439-0; Joura EA, 2007, LANCET, V369, P1693, DOI 10.1016/S0140-6736(07)60777-6; Katz IT, 2006, NEW ENGL J MED, V354, P1110, DOI 10.1056/NEJMp068031; Khan MJ, 2005, JNCI-J NATL CANCER I, V97, P1072, DOI 10.1093/jnci/dji187; Koutsky LA, 2002, NEW ENGL J MED, V347, P1645, DOI 10.1056/NEJMoa020586; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Villa L, 2007, LANCET, V369, P1861, DOI 10.1016/S0140-6736(07)60852-6; Villa LL, 2005, LANCET ONCOL, V6, P271, DOI 10.1016/S1470-2045(05)70101-7; Villa LL, 2007, NEW ENGL J MED, V356, P1915, DOI 10.1056/NEJMoa061741; Waggoner SE, 2003, LANCET, V361, P2217, DOI 10.1016/S0140-6736(03)13778-6; Zimmerman RK, 2006, VACCINE, V24, P4812, DOI 10.1016/j.vaccine.2006.03.019	21	9	9	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 2	2007	369	9576					1837	1839		10.1016/S0140-6736(07)60828-9	http://dx.doi.org/10.1016/S0140-6736(07)60828-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	173ZS	17544748				2022-12-28	WOS:000246911600005
J	Richards, T				Richards, Tessa			Europe on the rocks - Doctors should do more to tackle alcohol abuse - could a European initiative help galvanise them?	BRITISH MEDICAL JOURNAL			English	Editorial Material												trichards@bmj.com							0	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUN 2	2007	334	7604					1142	1142		10.1136/bmj.39227.654838.59	http://dx.doi.org/10.1136/bmj.39227.654838.59			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	177ES	17540942	Green Published			2022-12-28	WOS:000247137000027
J	Wang, XB; Qin, XH; Demirtas, H; Li, JP; Mao, GY; Huo, Y; Sun, NL; Liu, LH; Xu, XP				Wang, Xiaobin; Qin, Xianhui; Demirtas, Hakan; Li, Jianping; Mao, Guangyun; Huo, Yong; Sun, Ningling; Liu, Lisheng; Xu, Xiping			Efficacy of folic acid supplementation in stroke prevention: a meta-analysis	LANCET			English	Article							RANDOMIZED CONTROLLED-TRIALS; ACUTE MYOCARDIAL-INFARCTION; CORONARY-ARTERY DISEASE; ISCHEMIC-HEART-DISEASE; CARDIOVASCULAR EVENTS; PLASMA HOMOCYSTEINE; VASCULAR-DISEASE; CEREBROVASCULAR-DISEASE; SECONDARY PREVENTION; UNITED-STATES	Background The efficacy of treatments that lower homocysteine concentrations in reducing the risk of cardiovascular disease remains controversial. Our aim was to do a meta-analysis of relevant randomised trials to assess the efficacy of folic acid supplementation in the prevention of stroke. Methods We collected data from eight randomised trials of folic acid that had stroke reported as one of the endpoints. Relative risk (RR) was used as a measure of the effect of folic acid supplementation on the risk of stroke with a random effect model. The analysis was further stratified by factors that could affect the treatment effects. Findings Folic acid supplementation significantly reduced the risk of stroke by 18% (RR 0.82, 95% CI 0.68-1.00; p=0.045). In the stratified analyses, a greater beneficial effect was seen in those trials with a treatment duration of more than 36 months (0.71, 0.57-0.87; p=0.001), a decrease in the concentration of homocysteine of more than 20% (0.77, 0.63-0.94; p=0.012), no fortification or partly fortified grain (0.75, 0.62-0.91; p=0.003), and no history of stroke (0.75, 0.62-0.90; p=0.002). In the corresponding comparison groups, the estimated RRs were attenuated and insignificant. Interpretation Our findings indicate that folic acid supplementation can effectively reduce the risk of stroke in primary prevention.	Childrens Mem Hosp, Mary Ann & J Milburn Smith Child Hlth Res Program, Chicago, IL 60614 USA; Northwestern Univ, Feinberg Sch Med, Childrens Mem Res Ctr, Chicago, IL 60611 USA; Anhui Med Univ, Inst Biomed, Hefei, Peoples R China; Univ Illinois, Chicago Sch Publ Hlth, Div Epidemiol & Biostat, Chicago, IL USA; Peking Univ, Hosp 1, Dept Cardiol, Beijing 100871, Peoples R China; Peking Univ, Peoples Hosp, Dept Cardiol, Beijing 100871, Peoples R China; Fu Wai Hosp, Div Hypertens, Beijing, Peoples R China; Chinese Acad Med Sci, Cardiovasc Inst, Beijing 100037, Peoples R China	Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Anhui Medical University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Peking University; Peking University; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College	Wang, XB (corresponding author), Childrens Mem Hosp, Mary Ann & J Milburn Smith Child Hlth Res Program, 2300 Childrens Plaza,Box 157, Chicago, IL 60614 USA.	xbwang@childrensmemorial.org		Qin, Xianhui/0000-0001-7812-7982				Ades AE, 2005, MED DECIS MAKING, V25, P646, DOI 10.1177/0272989X05282643; BAKER F, 2002, CIRCULATION S2, V106, P2; Baker RI, 2002, CEREBROVASC DIS, V13, P120; Bazzano LA, 2006, JAMA-J AM MED ASSOC, V296, P2720, DOI 10.1001/jama.296.22.2720; Bonaa KH, 2006, NEW ENGL J MED, V354, P1578, DOI 10.1056/NEJMoa055227; BOUSHEY CJ, 1995, JAMA-J AM MED ASSOC, V274, P1049, DOI 10.1001/jama.274.13.1049; Brattstrom L, 1996, J NUTR, V126, pS1276, DOI 10.1093/jn/126.suppl_4.1276S; Clarke R, 2005, AM J CLIN NUTR, V82, P806, DOI 10.1093/ajcn/82.4.806; Clarke R, 2002, JAMA-J AM MED ASSOC, V288, P2015, DOI 10.1001/jama.288.16.2015; CLARKE R, 1991, NEW ENGL J MED, V324, P1149, DOI 10.1056/NEJM199104253241701; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Danesh J, 1998, J Cardiovasc Risk, V5, P229, DOI 10.1097/00043798-199808000-00004; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; FLEISS JL, 1991, J CLIN EPIDEMIOL, V44, P127, DOI 10.1016/0895-4356(91)90261-7; Galan P, 2003, J Nutr Health Aging, V7, P428; GU DF, 2006, CHIN J PREV CHRON NO, V14, P149; JACOB RA, 1994, J NUTR, V124, P1072, DOI 10.1093/jn/124.7.1072; Lange H, 2004, NEW ENGL J MED, V350, P2673, DOI 10.1056/NEJMoa032845; Liem A, 2005, HEART, V91, P1213, DOI 10.1136/hrt.2004.035030; Liem A, 2003, J AM COLL CARDIOL, V41, P2105, DOI 10.1016/S0735-1097(03)00485-6; Liem AH, 2004, INT J CARDIOL, V93, P175, DOI 10.1016/j.ijcard.2003.02.001; Lonn E, 2006, NEW ENGL J MED, V354, P1567, DOI 10.1056/NEJMoa060900; MacMahon M, 2000, NUTR METAB CARDIOVAS, V10, P195; Mark SD, 1996, AM J EPIDEMIOL, V143, P658, DOI 10.1093/oxfordjournals.aje.a008798; Mark SD, 1998, EPIDEMIOLOGY, V9, P9, DOI 10.1097/00001648-199801000-00005; MCCULLY KS, 1969, AM J PATHOL, V56, P111; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; Nygard O, 1997, NEW ENGL J MED, V337, P230, DOI 10.1056/NEJM199707243370403; Patel A, 2005, EUR HEART J, V26, P1910, DOI 10.1093/eurheartj/ehi407; Righetti M, 2003, MED SCI MONITOR, V9, pPI19; Righetti M, 2006, BLOOD PURIFICAT, V24, P379, DOI 10.1159/000093680; Schnyder G, 2002, JAMA-J AM MED ASSOC, V288, P973, DOI 10.1001/jama.288.8.973; SELHUB J, 1993, JAMA-J AM MED ASSOC, V270, P2693, DOI 10.1001/jama.270.22.2693; SELHUB J, 1995, NEW ENGL J MED, V332, P286, DOI 10.1056/NEJM199502023320502; Staessen JA, 2000, LANCET, V355, P865, DOI 10.1016/S0140-6736(99)07330-4; STAMPFER MJ, 1992, JAMA-J AM MED ASSOC, V268, P877, DOI 10.1001/jama.268.7.877; Thom T, 2006, CIRCULATION, V113, pE85, DOI 10.1161/CIRCULATIONAHA.105.171600; Toole JF, 2004, JAMA-J AM MED ASSOC, V291, P565, DOI 10.1001/jama.291.5.565; Undas A, 2007, J THROMB HAEMOST, V5, P1070, DOI 10.1111/j.1538-7836.2007.02459.x; *WAFACS, 2007, CLIN CARDIOL, V30, P50; WALD A, 1945, ANN MATH STAT, V16, P118; Wald DS, 2006, BMJ-BRIT MED J, V333, P1114, DOI 10.1136/bmj.39000.486701.68; Wald DS, 2002, BMJ-BRIT MED J, V325, P1202, DOI 10.1136/bmj.325.7374.1202; Wald NJ, 1998, ARCH INTERN MED, V158, P862, DOI 10.1001/archinte.158.8.862; Wang XB, 2006, NEW ENGL J MED, V355, P207; WILCKEN DEL, 1976, J CLIN INVEST, V57, P1079, DOI 10.1172/JCI108350; Wrone EM, 2004, J AM SOC NEPHROL, V15, P420, DOI 10.1097/01.ASN.0000110181.64655.6C; Yang QH, 2006, CIRCULATION, V113, P1335, DOI 10.1161/CIRCULATIONAHA.105.570846; Zoungas S, 2006, J AM COLL CARDIOL, V47, P1108, DOI 10.1016/j.jacc.2005.10.064	49	422	498	4	101	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 2	2007	369	9576					1876	1882		10.1016/S0140-6736(07)60854-X	http://dx.doi.org/10.1016/S0140-6736(07)60854-X			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	173ZS	17544768				2022-12-28	WOS:000246911600031
J	Mangan, KP; Levenson, JM				Mangan, Kile P.; Levenson, Jonathan M.			Turning back the clock on neurodegeneration	CELL			English	Editorial Material							MEMORY; P25		Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI 53719 USA; Univ Wisconsin, Dept Physiol, Madison, WI 53719 USA; Univ Wisconsin, Dept Pharmacol, Madison, WI 53719 USA; Univ Wisconsin, Waisman Ctr, Madison, WI 53719 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Levenson, JM (corresponding author), Galenea Corp, 300 Technol Sq, Cambridge, MA 02139 USA.	jlevenson@wisc.edu						Cruz JC, 2003, NEURON, V40, P471, DOI 10.1016/S0896-6273(03)00627-5; Ferrante RJ, 2003, J NEUROSCI, V23, P9418; Fischer A, 2005, NEURON, V48, P825, DOI 10.1016/j.neuron.2005.10.033; Fischer A, 2007, NATURE, V447, P178, DOI 10.1038/nature05772; Levenson JM, 2005, NAT REV NEUROSCI, V6, P108, DOI 10.1038/nrn1604; Tsankova NM, 2006, NAT NEUROSCI, V9, P519, DOI 10.1038/nn1659; VECSEY CG, 2007, J NEUROSCI; Williams BM, 2001, PHYSIOL BEHAV, V73, P649, DOI 10.1016/S0031-9384(01)00543-1	8	0	0	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 1	2007	129	5					851	853		10.1016/j.cell.2007.05.033	http://dx.doi.org/10.1016/j.cell.2007.05.033			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	176KT	17540162	Bronze			2022-12-28	WOS:000247084600002
J	Murata, S; Sasaki, K; Kishimoto, T; Niwa, S; Hayashi, H; Takahama, Y; Tanaka, K				Murata, Shigeo; Sasaki, Katsuhiro; Kishimoto, Toshihiko; Niwa, Shin-ichiro; Hayashi, Hidemi; Takahama, Yousuke; Tanaka, Keiji			Regulation of CD8+ T cell development by thymus-specific proteasomes	SCIENCE			English	Article							20S PROTEASOME; ANTIGEN PRESENTATION; MICE LACKING; GENERATION; SELECTION; PROTEINS; IMMUNOPROTEASOMES; TOLERANCE	Proteasomes are responsible for generating peptides presented by the class I major histocompatibility complex (MHC) molecules of the immune system. Here, we report the identification of a previously unrecognized catalytic subunit called beta 5t. beta 5t is expressed exclusively in cortical thymic epithelial cells, which are responsible for the positive selection of developing thymocytes. Although the chymotrypsin-like activity of proteasomes is considered to be important for the production of peptides with high affinities for MHC class I clefts, incorporation of beta 5t into proteasomes in place of beta 5 or beta 5i selectively reduces this activity. We also found that beta 5t-deficient mice displayed defective development of CD8(+) T cells in the thymus. Our results suggest a key role for beta 5t in generating the MHC class I-restricted CD8(+) T cell repertoire during thymic selection.	Tokyo Metropolitan Inst Med Sci, Lab Frontier Sci Core Technol & Res Ctr, Bunkyo Ku, Tokyo 1138613, Japan; Japan Sci & TEchnol Agcy, Precursory Res Embryon Sci & Technol, Kawaguchi, Saitama 3320012, Japan; Toho Univ, Fac Sci, Proteome Anal Ctr, Chiba 2748510, Japan; Toho Univ, Fac Sci, Dept Biomol Sci, Chiba 2748510, Japan; Link Genom, Chuo Ku, Tokyo 1030024, Japan; Univ Tokushima, Grad Sch Med Sci, Inst Genome Res, Div Expt Immunol, Tokushima 7708503, Japan	Tokyo Metropolitan Institute of Medical Science; Japan Science & Technology Agency (JST); Toho University; Toho University; Tokushima University	Murata, S (corresponding author), Tokyo Metropolitan Inst Med Sci, Lab Frontier Sci Core Technol & Res Ctr, Bunkyo Ku, Tokyo 1138613, Japan.	smurata@rinshoken.or.jp	Murata, Shigeo/A-1426-2010; Takahama, Yousuke/A-5863-2010	Murata, Shigeo/0000-0002-3177-3503; Takahama, Yousuke/0000-0002-4992-9174				Akiyama T, 2005, SCIENCE, V308, P248, DOI 10.1126/science.1105677; Anderson G, 2001, NAT REV IMMUNOL, V1, P31, DOI 10.1038/35095500; Cascio P, 2001, EMBO J, V20, P2357, DOI 10.1093/emboj/20.10.2357; Chen P, 1996, CELL, V86, P961, DOI 10.1016/S0092-8674(00)80171-3; COUK O, 1996, ANNU REV BIOCHEM, V65, P801; FEHLING HJ, 1994, SCIENCE, V265, P1234, DOI 10.1126/science.8066463; GACZYNSKA M, 1994, P NATL ACAD SCI USA, V91, P9213, DOI 10.1073/pnas.91.20.9213; Gill J, 2002, NAT IMMUNOL, V3, P635, DOI 10.1038/ni812; Goldrath AW, 1999, NATURE, V402, P255, DOI 10.1038/35005508; Gray DHD, 2002, J IMMUNOL METHODS, V260, P15, DOI 10.1016/S0022-1759(01)00493-8; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Hogquist KA, 2005, NAT REV IMMUNOL, V5, P772, DOI 10.1038/nri1707; Kisselev AF, 2006, J BIOL CHEM, V281, P8582, DOI 10.1074/jbc.M509043200; KOLLER BH, 1990, SCIENCE, V248, P1227, DOI 10.1126/science.2112266; MACDONALD HR, 1988, EUR J IMMUNOL, V18, P519, DOI 10.1002/eji.1830180405; Murata S, 2001, EMBO J, V20, P5898, DOI 10.1093/emboj/20.21.5898; Rock KL, 1999, ANNU REV IMMUNOL, V17, P739, DOI 10.1146/annurev.immunol.17.1.739; Rock KL, 2004, NAT IMMUNOL, V5, P670, DOI 10.1038/ni1089; Schmidtke G, 1996, EMBO J, V15, P6887, DOI 10.1002/j.1460-2075.1996.tb01081.x; SEEMULLER E, 1995, SCIENCE, V268, P579, DOI 10.1126/science.7725107; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Tanaka K, 1998, IMMUNOL REV, V163, P161; URINO M, 2002, STRUCTURE, V10, P609; von Boehmer H, 2003, IMMUNOL REV, V191, P62, DOI 10.1034/j.1600-065X.2003.00010.x; VONBOEHMER H, 1994, CELL, V76, P219, DOI 10.1016/0092-8674(94)90330-1; YOUNG ACM, 1995, FASEB J, V9, P26, DOI 10.1096/fasebj.9.1.7821756	26	424	432	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 1	2007	316	5829					1349	1353		10.1126/science.1141915	http://dx.doi.org/10.1126/science.1141915			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173PS	17540904				2022-12-28	WOS:000246885600053
J	Porter, SM				Porter, Susannah M.			Seawater chemistry and early carbonate biomineralization	SCIENCE			English	Article							FLUID INCLUSIONS; OSCILLATIONS; HALITE; RATIO		Univ Calif Santa Barbara, Dept Earth Sci, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	Porter, SM (corresponding author), Univ Calif Santa Barbara, Dept Earth Sci, Santa Barbara, CA 93106 USA.	porter@geol.ucsb.edu						Bengtson S., 1992, ORIGIN EARLY EVOLUTI, P447; Brennan ST, 2004, GEOLOGY, V32, P473, DOI 10.1130/g20251.1; Knoll AH, 2003, REV MINERAL GEOCHEM, V54, P329, DOI 10.2113/0540329; Kovalevych VM, 2006, TERRA NOVA, V18, P95, DOI 10.1111/j.1365-3121.2006.00668.x; Lowenstein TK, 2001, SCIENCE, V294, P1086, DOI 10.1126/science.1064280; Maloof AC, 2005, CAN J EARTH SCI, V42, P2195, DOI 10.1139/E05-062; Morse JW, 1997, GEOLOGY, V25, P85, DOI 10.1130/0091-7613(1997)025<0085:IOTAMC>2.3.CO;2; Petrychenko OY, 2005, CHEM GEOL, V219, P149, DOI 10.1016/j.chemgeo.2005.02.003; Ries JB, 2005, PALEOBIOLOGY, V31, P445, DOI 10.1666/0094-8373(2005)031[0445:APICSE]2.0.CO;2; Stanley SM, 1998, PALAEOGEOGR PALAEOCL, V144, P3, DOI 10.1016/S0031-0182(98)00109-6; Weiner S, 2003, REV MINERAL GEOCHEM, V54, P1, DOI 10.2113/0540001	11	138	145	0	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 1	2007	316	5829					1302	1302		10.1126/science.1137284	http://dx.doi.org/10.1126/science.1137284			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173PS	17540895				2022-12-28	WOS:000246885600040
J	Wilan, KH				Wilan, Ken Howard			Opening up the ivory tower	CELL			English	Editorial Material																			0	5	5	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 1	2007	129	5					847	850		10.1016/j.cell.2007.05.032	http://dx.doi.org/10.1016/j.cell.2007.05.032			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	176KT	17540161	Bronze			2022-12-28	WOS:000247084600001
J	Gilmore, CK; McCarthy, SE; Spelke, ES				Gilmore, Camilla K.; McCarthy, Shannon E.; Spelke, Elizabeth S.			Symbolic arithmetic knowledge without instruction	NATURE			English	Article							NUMBER WORDS; CHILDREN	Symbolic arithmetic is fundamental to science, technology and economics, but its acquisition by children typically requires years of effort, instruction and drill(1,2). When adults perform mental arithmetic, they activate nonsymbolic, approximate number representations(3,4), and their performance suffers if this nonsymbolic system is impaired(5). Nonsymbolic number representations also allow adults, children, and even infants to add or subtract pairs of dot arrays and to compare the resulting sum or difference to a third array, provided that only approximate accuracy is required(6-10). Here we report that young children, who have mastered verbal counting and are on the threshold of arithmetic instruction, can build on their nonsymbolic number system to perform symbolic addition and subtraction(11-15). Children across a broad socio-economic spectrum solved symbolic problems involving approximate addition or subtraction of large numbers, both in a laboratory test and in a school setting. Aspects of symbolic arithmetic therefore lie within the reach of children who have learned no algorithms for manipulating numerical symbols. Our findings help to delimit the sources of children's difficulties learning symbolic arithmetic, and they suggest ways to enhance children's engagement with formal mathematics.	Univ Nottingham, Learning Sci Res Inst, Nottingham NG8 1BB, England; Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA	University of Nottingham; Harvard University	Gilmore, CK (corresponding author), Univ Nottingham, Learning Sci Res Inst, Wollaton Rd, Nottingham NG8 1BB, England.	camilla.gilmore@nottingham.ac.uk; spelke@wjh.harvard.edu	Gilmore, Camilla/G-1425-2012					ASHCRAFT MH, 1982, J EXP CHILD PSYCHOL, V33, P216, DOI 10.1016/0022-0965(82)90017-0; Baroody A. J., 2003, DEV ARITHMETIC CONCE; Barth H, 2006, COGNITION, V98, P199, DOI 10.1016/j.cognition.2004.09.011; Barth H, 2005, P NATL ACAD SCI USA, V102, P14116, DOI 10.1073/pnas.0505512102; Dehaene S., 1997, NUMBER SENSE; Feigenson L, 2004, TRENDS COGN SCI, V8, P307, DOI 10.1016/j.tics.2004.05.002; GALLISTEL CR, 1992, COGNITION, V44, P43, DOI 10.1016/0010-0277(92)90050-R; Geary DC, 2000, EUR CHILD ADOLES PSY, V9, P11; Griffin S, 1996, MONOGR SOC RES CHILD, V61, P83, DOI 10.1111/j.1540-5834.1996.tb00538.x; Hauser MD, 2004, COGNITIVE NEUROSCIENCES III, THIRD EDITION, P853; Le Corre M, 2006, COGNITIVE PSYCHOL, V52, P130, DOI 10.1016/j.cogpsych.2005.07.002; LEFEVRE J, 2003, DEV ARITHMETIC CONCE, P203; Lemer C, 2003, NEUROPSYCHOLOGIA, V41, P1942, DOI 10.1016/S0028-3932(03)00123-4; Lipton JS, 2005, CHILD DEV, V76, P978, DOI 10.1111/j.1467-8624.2005.00891.x; McCrink K, 2004, PSYCHOL SCI, V15, P776, DOI 10.1111/j.0956-7976.2004.00755.x; Pica P, 2004, SCIENCE, V306, P499, DOI 10.1126/science.1102085; Temple E, 1998, P NATL ACAD SCI USA, V95, P7836, DOI 10.1073/pnas.95.13.7836; VANOEFFELEN MP, 1982, PERCEPT PSYCHOPHYS, V32, P163, DOI 10.3758/BF03204275; Zur O, 2004, EARLY CHILD RES Q, V19, P121, DOI 10.1016/j.ecresq.2004.01.003	19	191	194	0	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 31	2007	447	7144					589	+		10.1038/nature05850	http://dx.doi.org/10.1038/nature05850			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	172YZ	17538620	Green Published, Green Accepted			2022-12-28	WOS:000246842000048
J	Smolen, JS; Aletaha, D; Koeller, M; Weisman, MH; Emery, P				Smolen, Josef S.; Aletaha, Daniel; Koeller, Marcus; Weisman, Michael H.; Emery, Paul			New therapies for treatment of rheumatoid arthritis	LANCET			English	Review							PLACEBO-CONTROLLED TRIAL; NECROSIS-FACTOR-ALPHA; ANTI-INTERLEUKIN-6 RECEPTOR ANTIBODY; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; COSTIMULATION MODULATOR ABATACEPT; MODIFYING ANTIRHEUMATIC DRUGS; RANDOMIZED CONTROLLED-TRIAL; MEDIATED JOINT DESTRUCTION; COLLAGEN-INDUCED ARTHRITIS; CONTROLLED CLINICAL-TRIAL	Rheumatoid arthritis is characterised by pain, swelling, and destruction of joints, with resultant disability. Only disease-modifying antirheumatic drugs can interfere with the disease process. In the past few years, biological agents, especially inhibitors of tumour necrosis factor, have allowed for hitherto unseen therapeutic benefit, although even with these drugs the frequency and degree of responses are restricted. Therefore, new agents are needed, and three novel biological compounds for treatment of rheumatoid arthritis have already been used in practice or are on the horizon: rituximab (anti-CD20), abatacept (cytotoxic T-lymphocyte antigen 4 immunoglobulin), and tocilizumab (anti-interleukin 6 receptor). We discuss the targets of these drugs, the roles of these targets in the pathogenesis of rheumatoid arthritis, and the efficacy and adverse effects of these agents from clinical trial data. Novel therapeutic strategies in conjunction with optimised disease assessment for better treatment of rheumatoid arthritis and an outlook into potential future targets are also presented.	Med Univ Vienna, Dept Internal Med 3, Div Rheumatol, A-1090 Vienna, Austria; Hietzing Hosp, Dept Med 2, Vienna, Austria; Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; Chapel Allerton Hosp, Leeds, W Yorkshire, England	Medical University of Vienna; Hietzing Hospital; Cedars Sinai Medical Center; Chapel Allerton Hospital	Smolen, JS (corresponding author), Med Univ Vienna, Dept Internal Med 3, Div Rheumatol, Waehringer Guertel 18-20, A-1090 Vienna, Austria.	josef.smolen@wienkav.at	emery, paul/B-3560-2013					Aletaha D, 2006, RHEUM DIS CLIN N AM, V32, P9, DOI 10.1016/j.rdc.2005.09.005; Aletaha D, 2005, ARTHRITIS RHEUM-US, V52, P2625, DOI 10.1002/art.21235; Aletaha D, 2005, ARTHRITIS RES THER, V7, pR796, DOI 10.1186/ar1740; Aletaha D, 2002, J RHEUMATOL, V29, P1631; ALETAHA D, IN PRESS ARTHRITIS R; Aletaha D, 2006, ARTHRITIS RHEUM-US, V54, P2784, DOI 10.1002/art.22052; [Anonymous], MED NEWS TODAY; ARINGER M, 2003, TARGETED THERAPIES R, P404; Asquith DL, 2007, CURR OPIN RHEUMATOL, V19, P246, DOI 10.1097/BOR.0b013e3280eec78c; Baecklund E, 2006, ARTHRITIS RHEUM, V54, P692, DOI 10.1002/art.21675; Barksby HE, 2006, ARTHRITIS RHEUM-US, V54, P3244, DOI 10.1002/art.22167; Baslund B, 2005, ARTHRITIS RHEUM-US, V52, P2686, DOI 10.1002/art.21249; Berger JA, 2006, IEEE ACM T COMPUT BI, V3, P2, DOI 10.1109/TCBB.2006.10; BOMBARA MP, 1993, J LEUKOCYTE BIOL, V54, P399, DOI 10.1002/jlb.54.5.399; Breedveld FC, 2006, ARTHRITIS RHEUM-US, V54, P26, DOI 10.1002/art.21519; Brown AK, 2006, ARTHRITIS RHEUM, V54, P4034; Browning JL, 2006, NAT REV DRUG DISCOV, V5, P564, DOI 10.1038/nrd2085; Buch MH, 2005, ARTHRITIS RHEUM-US, V52, P42, DOI 10.1002/art.20711; Choi HK, 2002, LANCET, V359, P1173, DOI 10.1016/S0140-6736(02)08213-2; Choy EHS, 2002, RHEUMATOLOGY, V41, P1133, DOI 10.1093/rheumatology/41.10.1133; Choy EHS, 2002, ARTHRITIS RHEUM-US, V46, P3143, DOI 10.1002/art.10623; CHU CQ, 1991, ARTHRITIS RHEUM, V34, P1125, DOI 10.1002/art.1780340908; Clair EWS, 2004, ARTHRITIS RHEUM-US, V50, P3432, DOI 10.1002/art.20568; Clynes RA, 2000, NAT MED, V6, P443, DOI 10.1038/74704; Cohen S, 2002, ARTHRITIS RHEUM, V46, P614, DOI 10.1002/art.10141; Cohen SB, 2006, ARTHRITIS RHEUM, V54, pS831; Cohen SB, 2006, ARTHRITIS RHEUM-US, V54, P2793, DOI 10.1002/art.22025; Collins AV, 2002, IMMUNITY, V17, P201, DOI 10.1016/S1074-7613(02)00362-X; Czuczman MS, 2001, ANTI-CANCER DRUG, V12, pS15; De Rycke L, 2005, ANN RHEUM DIS, V64, P299, DOI 10.1136/ard.2004.023523; DEBETS JMH, 1988, J IMMUNOL, V141, P1197; Diarra D, 2007, NAT MED, V13, P156, DOI 10.1038/nm1538; DINARELLO CA, 2007, IN PRESS CONT TARGET; Edwards JCW, 2001, RHEUMATOLOGY, V40, P205, DOI 10.1093/rheumatology/40.2.205; Edwards JCW, 2004, NEW ENGL J MED, V350, P2572, DOI 10.1056/NEJMoa032534; Ehrenstein MR, 2004, J EXP MED, V200, P277, DOI 10.1084/jem.20040165; EINFELD DA, 1988, EMBO J, V7, P711, DOI 10.1002/j.1460-2075.1988.tb02867.x; Emery P, 2006, ARTHRITIS RHEUM, V54, P1390, DOI 10.1002/art.21778; Emery P, 2006, J RHEUMATOL, V33, P681; EMERY P, 1995, ANN RHEUM DIS, V54, P944, DOI 10.1136/ard.54.12.944; Emery P, 2006, LANCET, V368, P821, DOI 10.1016/S0140-6736(06)69301-X; *EUR MED AG, AUTH MED HUM US MABT; *FDA, MEDWATCH 2006 SAF IN; Feldmann M, 2001, CURR DIRECT AUTOIMMU, V3, P188; FELSON DT, 1995, ARTHRITIS RHEUM, V38, P727, DOI 10.1002/art.1780380602; FIRESTEIN GS, 1990, J IMMUNOL, V144, P3347; Firestein GS, 1996, ARTHRITIS RHEUM, V39, P1781, DOI 10.1002/art.1780391103; FOLKMAN J, 2003, TARGETED THERAPIES R, P111; Frauwirth KA, 2002, J CLIN INVEST, V109, P295, DOI 10.1172/JCI200214941; FRIES JF, 1980, ARTHRITIS RHEUM, V23, P137, DOI 10.1002/art.1780230202; Furst DE, 2005, ANN RHEUM DIS, V64, P2, DOI 10.1136/ard.2005.044941; Gabriel SE, 2001, RHEUM DIS CLIN N AM, V27, P269, DOI 10.1016/S0889-857X(05)70201-5; *GEN, FULL PRESCR INF RIT; GENANT HK, 1983, AM J MED, V75, P35, DOI 10.1016/0002-9343(83)90473-4; Genovese MC, 2005, NEW ENGL J MED, V353, P1114, DOI 10.1056/NEJMoa050524; Geusens PP, 2006, ARTHRITIS RHEUM-US, V54, P1772, DOI 10.1002/art.21896; Goekoop-Ruiterman YPM, 2005, ARTHRITIS RHEUM-US, V52, P3381, DOI [10.1002/art.21405, 10.1002/art.23364]; GOLDSMITH CH, 1993, J RHEUMATOL, V20, P561; Gracie JA, 1999, J CLIN INVEST, V104, P1393, DOI 10.1172/JCI7317; Gravallese EM, 1998, AM J PATHOL, V152, P943; GREGERSEN PK, 1987, ARTHRITIS RHEUM, V30, P1205, DOI 10.1002/art.1780301102; Grey A, 2005, EXPERT OPIN INV DRUG, V14, P265, DOI 10.1517/13543784.14.3.265; Grigor C, 2004, LANCET, V364, P263, DOI 10.1016/S0140-6736(04)16676-2; Haringman Jasper J, 2005, Expert Opin Emerg Drugs, V10, P299, DOI 10.1517/14728214.10.2.299; Itoh K, 2006, ARTHRITIS RHEUM, V54, P1020, DOI 10.1002/art.21721; Jarrett SJ, 2006, ARTHRITIS RHEUM-US, V54, P1410, DOI 10.1002/art.21824; Johnson PWM, 2001, BRIT J CANCER, V85, P1619, DOI 10.1054/bjoc.2001.2127; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kay J, 2006, ARTHRITIS RHEUM, V54, pS833; Keystone E, 2006, ANN RHEUM DIS, V65, P58; Keystone E, 2002, ANN RHEUM DIS, V61, P43; Keystone EC, 2004, ARTHRITIS RHEUM, V50, P1400, DOI 10.1002/art.20217; Klareskog L, 2004, LANCET, V363, P675, DOI 10.1016/S0140-6736(04)15640-7; Kong YY, 1999, NATURE, V402, P304, DOI 10.1038/35005552; Kotake S, 1996, J BONE MINER RES, V11, P88; Kremer JM, 2005, ARTHRITIS RHEUM, V52, P2263, DOI 10.1002/art.21201; Kremer JM, 2003, NEW ENGL J MED, V349, P1907, DOI 10.1056/NEJMoa035075; Kremer JM, 2006, ARTHRITIS RHEUM, V54, P4116; Kremer JM, 2006, ANN INTERN MED, V144, P865, DOI 10.7326/0003-4819-144-12-200606200-00003; Leandro MJ, 2006, ARTHRITIS RHEUM-US, V54, P613, DOI 10.1002/art.21617; Lee Z.H., 2003, TARGETED THERAPIES R, P133; LINSLEY PS, 1991, J EXP MED, V174, P561, DOI 10.1084/jem.174.3.561; Lipsky PE, 2000, NEW ENGL J MED, V343, P1594, DOI 10.1056/NEJM200011303432202; Maini RN, 2006, ARTHRITIS RHEUM-US, V54, P2817, DOI 10.1002/art.22033; Maini RN, 1998, ARTHRITIS RHEUM, V41, P1552, DOI 10.1002/1529-0131(199809)41:9<1552::AID-ART5>3.0.CO;2-W; Makinen H, 2005, ANN RHEUM DIS, V64, P1410, DOI 10.1136/ard.2005.037333; Maloney DG, 2002, SEMIN ONCOL, V29, P2, DOI 10.1053/sonc.2002.30156; McClung MR, 2006, NEW ENGL J MED, V354, P821, DOI 10.1056/NEJMoa044459; McInnes IB, 2005, ARTHRITIS RES THER, V7, P38, DOI 10.1186/ar1497; McInnes IB, 1997, NAT MED, V3, P189, DOI 10.1038/nm0297-189; Mierau M, 2007, RHEUMATOLOGY, V46, P975, DOI 10.1093/rheumatology/kem007; Mihara M, 2001, CLIN IMMUNOL, V98, P319, DOI 10.1006/clim.2000.4989; Moreland LW, 2002, ARTHRITIS RHEUM, V46, P1470, DOI 10.1002/art.10294; MUELLER DL, 1989, ANNU REV IMMUNOL, V7, P445, DOI 10.1146/annurev.iy.07.040189.002305; MullerLadner U, 1996, AM J PATHOL, V149, P1607; MURAKAMI M, 1993, SCIENCE, V260, P1808, DOI 10.1126/science.8511589; Nell VPK, 2005, ANN RHEUM DIS, V64, P1731, DOI 10.1136/ard.2005.035691; Nishimoto N, 2004, ARTHRITIS RHEUM-US, V50, P1761, DOI 10.1002/art.20303; Nishimoto N, 2003, J RHEUMATOL, V30, P1426; Nishimoto N, 2005, BLOOD, V106, P2627, DOI 10.1182/blood-2004-12-4602; Nishimoto N, 2003, TARGETED THERAPIES R, P231; Nishimoto N, 2007, ANN RHEUM DIS, V66, P1162, DOI 10.1136/ard.2006.068064; Panayi GS, 2005, RHEUMATOLOGY, V44, pII3, DOI 10.1093/rheumatology/keh616; Pap T, 2003, ARTHRITIS RES THER, V5, pR163, DOI 10.1186/ar752; PINCUS T, 1994, ANN INTERN MED, V120, P26, DOI 10.7326/0003-4819-120-1-199401010-00005; Pincus T, 2003, CLIN EXP RHEUMATOL, V21, pS179; Quinn MA, 2005, ARTHRITIS RHEUM-US, V52, P27, DOI 10.1002/art.20712; Rantapaa-Dahlqvist S, 2005, SCAND J RHEUMATOL, V34, P83, DOI 10.1080/03009740510017689; Redlich K, 2002, J CLIN INVEST, V110, P1419, DOI 10.1172/JCI200215582; Redlich K, 2002, ARTHRITIS RHEUM, V46, P785, DOI 10.1002/art.10097; REFF ME, 1994, BLOOD, V83, P435; Rodriguez-Pinto D, 2005, CELL IMMUNOL, V238, P67, DOI 10.1016/j.cellimm.2006.02.005; Roll P, 2006, ARTHRITIS RHEUM-US, V54, P2377, DOI 10.1002/art.22019; Salomon B, 2001, ANNU REV IMMUNOL, V19, P225, DOI 10.1146/annurev.immunol.19.1.225; Schiff M, 2006, ARTHRITIS RHEUM, V54, P4117; Schiff M, 2001, ARTHRITIS RHEUM, V44, pS79; SHARP JT, 1985, ARTHRITIS RHEUM, V28, P1326, DOI 10.1002/art.1780281203; SHARP JT, 1971, ARTHRITIS RHEUM-US, V14, P706, DOI 10.1002/art.1780140605; Shevach EM, 2004, ARTHRITIS RHEUM, V50, P2721, DOI 10.1002/art.20500; Smolen JS, 2007, ANN RHEUM DIS, V66, P143, DOI 10.1136/ard.2006.061002; Smolen JS, 2003, RHEUMATOLOGY, V42, P244, DOI 10.1093/rheumatology/keg072; Smolen JS, 2005, ARTHRITIS RHEUM, V52, P1020, DOI 10.1002/art.20982; Smolen JS, 2004, ANN RHEUM DIS, V63, P221, DOI 10.1136/ard.2003.012575; Smolen JS, 2006, ARTHRITIS RHEUM-US, V54, P702, DOI 10.1002/art.21678; Smolen JS, 2003, CLIN EXP RHEUMATOL, V21, pS209; Smolen JS, 2003, NAT REV DRUG DISCOV, V2, P473, DOI 10.1038/nrd1109; Smolen JS, 2006, CLIN EXP RHEUMATOL, V24; STASHENKO P, 1980, J IMMUNOL, V125, P1678; Steiner G, 1999, RHEUMATOLOGY, V38, P202, DOI 10.1093/rheumatology/38.3.202; Steiner G, 2006, RHEUMATOID ARTHRITIS, P194; Strand V, 2003, ARTHRITIS RHEUM-US, V48, P21, DOI 10.1002/art.10683; SZEKANECZ Z, 2003, TARGETED THERAPIES R, P345; Takagi N, 1998, ARTHRITIS RHEUM, V41, P2117, DOI 10.1002/1529-0131(199812)41:12<2117::AID-ART6>3.3.CO;2-G; Tang QZ, 2006, IMMUNOL REV, V212, P217, DOI 10.1111/j.0105-2896.2006.00421.x; THOMAS R, 2003, TARGETED THERPIES RH, P61; *US FDA, AB LAB INF; *US FDA, RIT RIT LAB INF; VALENTINE MA, 1989, J BIOL CHEM, V264, P11282; van der Heijde D, 2005, ANN RHEUM DIS, V64, P1582, DOI 10.1136/ard.2004.034371; van Gestel AM, 1999, J RHEUMATOL, V26, P705; van Vollenhoven R, 2003, ANN RHEUM DIS, V62, P1195, DOI 10.1136/ard.2003.009589; Vanags D, 2006, LANCET, V368, P855, DOI 10.1016/S0140-6736(06)69210-6; VANDERHEIJDE DM, 1989, LANCET, V1, P1036, DOI 10.1016/S0140-6736(89)92442-2; VANDERHEIJDE DMFM, 1992, ANN RHEUM DIS, V51, P177, DOI 10.1136/ard.51.2.177; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Webb LMC, 1996, EUR J IMMUNOL, V26, P2320, DOI 10.1002/eji.1830261008; Weinblatt M, 2006, ARTHRITIS RHEUM, V54, P2807, DOI 10.1002/art.22070; Weinblatt ME, 2003, ANN RHEUM DIS, V62, P94, DOI 10.1136/ard.62.suppl_2.ii94; Weinblatt ME, 1999, NEW ENGL J MED, V340, P253, DOI 10.1056/NEJM199901283400401; Weinblatt ME, 1995, BRIT J RHEUMATOL, V34, P43; Weinblatt M, 2007, ANN RHEUM DIS, V66, P228, DOI 10.1136/ard.2006.055111; WENDLING D, 1993, J RHEUMATOL, V20, P259; Yousry TA, 2006, NEW ENGL J MED, V354, P924, DOI 10.1056/NEJMoa054693; Zuany-Amorim C, 2002, NAT REV DRUG DISCOV, V1, P797, DOI 10.1038/nrd914; Zwerina J, 2005, ANN NY ACAD SCI, V1051, P716, DOI 10.1196/annals.1361.116	155	663	715	6	96	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 1	2007	370	9602					1861	1874		10.1016/S0140-6736(07)60784-3	http://dx.doi.org/10.1016/S0140-6736(07)60784-3			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	240LI	17570481				2022-12-28	WOS:000251588700034
J	Maamar, H; Raj, A; Dubnau, D				Maamar, Hedia; Raj, Arjun; Dubnau, David			Noise in gene expression determines cell fate in Bacillus subtilis	SCIENCE			English	Article							COMPETENCE TRANSCRIPTION FACTOR; POSITIVE FEEDBACK; ESCHERICHIA-COLI; K-STATE; COMK; DIFFERENTIATION; STOCHASTICITY; PROTEIN; SWITCH; VISUALIZATION	Random cell-to-cell variations in gene expression within an isogenic population can lead to transitions between alternative states of gene expression. Little is known about how these variations ( noise) in natural systems affect such transitions. In Bacillus subtilis, noise in ComK, the protein that regulates competence for DNA uptake, is thought to cause cells to transition to the competent state in which genes encoding DNA uptake proteins are expressed. We demonstrate that noise in comK expression selects cells for competence and that experimental reduction of this noise decreases the number of competent cells. We also show that transitions are limited temporally by a reduction in comK transcription. These results illustrate how such stochastic transitions are regulated in a natural system and suggest that noise characteristics are subject to evolutionary forces.	Univ Med & Dent New Jersey, Publ Hlth Res Inst Ctr, Newark, NJ 07103 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Dubnau, D (corresponding author), Univ Med & Dent New Jersey, Publ Hlth Res Inst Ctr, 225 Warren St, Newark, NJ 07103 USA.	dubnauda@umdnj.edu		Raj, Arjun/0000-0002-2915-6960	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070357, R01GM057720] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM057720, GM 070357, R01 GM070357, GM 57720] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Acar M, 2005, NATURE, V435, P228, DOI 10.1038/nature03524; Albano M, 2005, J BACTERIOL, V187, P2010, DOI 10.1128/JB.187.6.2010-2019.2005; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; Dubnau D, 2006, MOL MICROBIOL, V61, P564, DOI 10.1111/j.1365-2958.2006.05249.x; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Femino A, 1998, SCIENCE, V280, P585, DOI 10.1126/science.280.5363.585; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; HAHN J, 1994, J BACTERIOL, V176, P5753, DOI 10.1128/JB.176.18.5753-5761.1994; Hamoen LW, 1998, GENE DEV, V12, P1539, DOI 10.1101/gad.12.10.1539; Hoa TT, 2002, MOL MICROBIOL, V43, P15, DOI 10.1046/j.1365-2958.2002.02727.x; Isaacs FJ, 2003, P NATL ACAD SCI USA, V100, P7714, DOI 10.1073/pnas.1332628100; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Leisner M, 2007, MOL MICROBIOL, V63, P1806, DOI 10.1111/j.1365-2958.2007.05628.x; Maamar H, 2005, MOL MICROBIOL, V56, P615, DOI 10.1111/j.1365-2958.2005.04592.x; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Prepiak P, 2007, MOL CELL, V26, P639, DOI 10.1016/j.molcel.2007.05.011; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Rodriguez AJ, 2006, J CELL BIOL, V175, P67, DOI 10.1083/jcb.200512137; Smits WK, 2006, NAT REV MICROBIOL, V4, P259, DOI 10.1038/nrmicro1381; Smits WK, 2005, MOL MICROBIOL, V56, P604, DOI 10.1111/j.1365-2958.2005.04488.x; Suel GM, 2007, SCIENCE, V315, P1716, DOI 10.1126/science.1137455; Suel GM, 2006, NATURE, V440, P545, DOI 10.1038/nature04588; Swain PS, 2002, P NATL ACAD SCI USA, V99, P12795, DOI 10.1073/pnas.162041399; Thattai M, 2001, P NATL ACAD SCI USA, V98, P8614, DOI 10.1073/pnas.151588598; VANSINDEREN D, 1994, J BACTERIOL, V176, P5762, DOI 10.1128/JB.176.18.5762-5770.1994; VANSINDEREN D, 1995, MOL MICROBIOL, V15, P455	30	481	536	3	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 27	2007	317	5837					526	529		10.1126/science.1140818	http://dx.doi.org/10.1126/science.1140818			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194JD	17569828	Green Accepted			2022-12-28	WOS:000248339800049
J	Osei-Atweneboano, MY; Eng, JKL; Boakye, DA; Gyapong, JO; Prichard, RK				Osei-Atweneboano, Mike Y.; Eng, Jeffrey K. L.; Boakye, Daniel A.; Gyapong, John O.; Prichard, Roger K.			Prevalence and intensity of Onchocerca volvulus infection and efficacy of ivermectin in endemic communities in Ghana: a two-phase epidemiological study	LANCET			English	Article							MULTIPLE TREATMENTS; CONTROL-PROGRAM; P-GLYCOPROTEIN; WEST-AFRICA; SELECTION; CHEMOTHERAPY; VACCINE; FOCI	Background Ivermectin has been used for onchocerciasis control since 1987. Because of the long-term use of this drug and the development of resistance in other nematodes, we have assessed Onchocerca volvulus burdens, effectiveness of ivermectin as a microfilaricide, and its effect on adult female worm reproduction. Methods For the first phase of the study, 2501 individuals in Ghana, from 19 endemic communities who had received six to 18 annual rounds of ivermectin and one ivermectin naive community, were assessed for microfilarial loads 7 days before the 2004 yearly ivermectin treatment, by means of skin snips, and 30 days after treatment to assess the ivermectin microfilaricidal action. For the second phase, skin snips were taken from 342 individuals from ten communities, who were microfilaria positive at pretreatment assessment, on days 90 and 180 after treatment, to identify the effects of ivermectin on female worm fertility, assessed by microfilaria repopulation. Findings 487 (19%) of the 2501 participants were microfilaria positive. The microfilaria prevalence and community microfilarial load in treated communities ranged from 2.2% to 51.8%, and 0.06 microfilariae per snip to 2.85 microfilariae per snip, respectively. Despite treatment, the prevalence rate doubled between 2000 and 2005 in two communities. Microfilaria assessment 30 days after ivermectin treatment showed 100% clearance of microfilaria in more than 99% of people. At day 90 after treatment, four of ten communities had significant microfilaria repopulation, from 7.1% to 21.1% of pretreatment counts, rising to 53.9% by day 180. Interpretation Ivermectin remains a potent microfilaricide. However, our results suggest that resistant adult parasite populations, which are not responding as expected to ivermectin, are emerging. A high rate of repopulation of skin with microfilariae will allow parasite transmission, possibly with ivermectin-resistant 0 volvulus, which could eventually lead to recrudescence of the disease.	McGill Univ, Inst Parasitol, Ste Anne De Bellevue, PQ H9X 3V9, Canada; Univ Ghana, Noguchi Mem Inst Med Res, Accra, Ghana; Ghana Hlth Serv, Hlth Res Unit, Accra, Ghana	McGill University; University of Ghana; Ghana Health Service	Prichard, RK (corresponding author), McGill Univ, Inst Parasitol, 21111 Lakeshore Rd, Ste Anne De Bellevue, PQ H9X 3V9, Canada.	roger.prichard@mcgill.ca		Gyapong, John/0000-0002-8415-1468				Ali MMM, 2002, ACTA TROP, V84, P49, DOI 10.1016/S0001-706X(02)00117-1; ALLEY ES, 1994, T ROY SOC TROP MED H, V88, P581, DOI 10.1016/0035-9203(94)90172-4; [Anonymous], 1995, WHO TECHN REP SER; Ardelli BF, 2006, PARASITOLOGY, V132, P375, DOI 10.1017/S0031182005008991; Ardelli BF, 2006, MOL BIOCHEM PARASIT, V145, P94, DOI 10.1016/j.molbiopara.2005.09.011; Ardelli BF, 2005, MOL BIOCHEM PARASIT, V143, P58, DOI 10.1016/j.molbiopara.2005.05.006; Ardelli BF, 2004, ANN TROP MED PARASIT, V98, P371, DOI 10.1179/000349804225003415; AWADZI K, 1985, ANN TROP MED PARASIT, V79, P63, DOI 10.1080/00034983.1985.11811889; Awadzi K, 2004, ANN TROP MED PARASIT, V98, P231, DOI 10.1179/000349804225003253; Awadzi K, 2004, ANN TROP MED PARASIT, V98, P359, DOI 10.1179/000349804225003442; AWADZI K, 1995, TROP MED PARASITOL, V46, P131; AWADZI K, 1989, TROP MED PARASITOL, V40, P361; Basanez MG, 2006, PLOS MED, V3, P1454, DOI 10.1371/journal.pmed.0030371; BOATIN BA, 1998, ANN TROP MED PARASIT, V92, P46; Borsboom GJJM, 2003, FILARIA J, V2, P1; CHAVASSE DC, 1992, TROP MED PARASITOL, V43, P256; DUKE BOL, 1992, AM J TROP MED HYG, V46, P189, DOI 10.4269/ajtmh.1992.46.189; Eng JKL, 2006, MOL BIOCHEM PARASIT, V150, P229, DOI 10.1016/j.molbiopara.2006.08.007; Eng JKL, 2005, MOL BIOCHEM PARASIT, V142, P193, DOI 10.1016/j.molbiopara.2005.01.021; GREENE BM, 1985, NEW ENGL J MED, V313, P133, DOI 10.1056/NEJM198507183130301; Hoerauf A, 2001, LANCET, V357, P1415, DOI 10.1016/S0140-6736(00)04581-5; Lustigman S, 2002, TRENDS PARASITOL, V18, P135, DOI 10.1016/S1471-4922(01)02211-5; *MIN SAL PUBL, 2000, ORG DES CONTR PROC D, P1; Nutman TB, 2002, TRENDS PARASITOL, V18, P237, DOI 10.1016/S1471-4922(02)02310-3; PETER J, 2006, VACCINE, V24, P5787; PLAISIER AP, 1995, J INFECT DIS, V172, P204, DOI 10.1093/infdis/172.1.204; REMME J, 1986, B WORLD HEALTH ORGAN, V64, P667; REMME J, 1990, ACT LEIDENS, V59, P177; SCHULZ-KEY H, 1986, Parasitology Today, V2, P284, DOI 10.1016/0169-4758(86)90138-9; Whitworth JAG, 1996, TROP MED INT HEALTH, V1, P786; *WHO, 2001, OCP TDR M IMP IV ONC; Wolstenholme AJ, 2004, TRENDS PARASITOL, V20, P469, DOI 10.1016/j.pt.2004.07.010	32	279	284	0	28	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 16	2007	369	9578					2021	2029		10.1016/S0140-6736(07)60942-8	http://dx.doi.org/10.1016/S0140-6736(07)60942-8			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	180HT	17574093				2022-12-28	WOS:000247354400026
J	Hoskins, RA; Carlson, JW; Kennedy, C; Acevedo, D; Evans-Holm, M; Frise, E; Wan, KH; Park, S; Mendez-Lago, M; Rossi, F; Villasante, A; Dimitri, P; Karpen, GH; Celniker, SE				Hoskins, Roger A.; Carlson, Joseph W.; Kennedy, Cameron; Acevedo, David; Evans-Holm, Martha; Frise, Erwin; Wan, Kenneth H.; Park, Soo; Mendez-Lago, Maria; Rossi, Fabrizio; Villasante, Alfredo; Dimitri, Patrizio; Karpen, Gary H.; Celniker, Susan E.			Sequence finishing and mapping of Drosophila melanogaster heterochromatin	SCIENCE			English	Article							CENTRIC HETEROCHROMATIN; INSERTIONS; ELEMENTS	Genome sequences for most metazoans and plants are incomplete because of the presence of repeated DNA in the heterochromatin. The heterochromatic regions of Drosophila melanogaster contain 20 million bases (Mb) of sequence amenable to mapping, sequence assembly, and finishing. We describe the generation of 15 Mb of finished or improved heterochromatic sequence with the use of available clone resources and assembly methods. We also constructed a bacterial artificial chromosome-based physical map that spans 13 Mb of the pericentromeric heterochromatin and a cytogenetic map that positions 11 Mb in specific chromosomal locations. We have approached a complete assembly and mapping of the nonsatellite component of Drosophila heterochromatin. The strategy we describe is also applicable to generating substantially more information about heterochromatin in other species, including humans.	Univ Calif Berkeley, Lawrence Berkeley Lab, Dept Genome & Computat Biol, Berkeley, CA 94720 USA; UAM, CSIC, Ctr Biol Mol Severo Ochoa, Madrid 28049, Spain; Univ Roma La Sapienza, Dipartimento Genet & Biol Mol, I-00185 Rome, Italy; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Sapienza University Rome; University of California System; University of California Berkeley	Celniker, SE (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Dept Genome & Computat Biol, Berkeley, CA 94720 USA.	celniker@fruitfly.org			NHGRI NIH HHS [R01 HG00747, P50-HG00750, R01 HG000747-16, R01 HG000747] Funding Source: Medline; NIGMS NIH HHS [R01 GM066272] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG000750, R01HG000747] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066272] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abad JP, 2004, MOL BIOL EVOL, V21, P1613, DOI 10.1093/molbev/msh174; Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; CELNIKER SE, 2002, GENOME BIOL, V0003; CELNIKER SE, 2006, BDGP RELEASE 5 GENOM; Dernburg AF, 1996, CELL, V85, P745, DOI 10.1016/S0092-8674(00)81240-4; Eichler EE, 2004, NAT REV GENET, V5, P345, DOI 10.1038/nrg1322; GATTI M, 1994, METHOD CELL BIOL, V44, P371, DOI 10.1016/S0091-679X(08)60924-3; GATTI M, 1992, ANNU REV GENET, V26, P239, DOI 10.1146/annurev.ge.26.120192.001323; HOSKINS RA, 2002, GENOME BIOL, V0003; Hoskins RA, 2000, SCIENCE, V287, P2271, DOI 10.1126/science.287.5461.2271; JOHN B, 1988, EUKARYOTE GENOME DEV, P416; Karpen GH, 1996, SCIENCE, V273, P118, DOI 10.1126/science.273.5271.118; Konev AY, 2003, GENETICS, V165, P2039; LOHE AR, 1986, P NATL ACAD SCI USA, V83, P696, DOI 10.1073/pnas.83.3.696; Marra MA, 1997, GENOME RES, V7, P1072, DOI 10.1101/gr.7.11.1072; Stapleton M, 2002, GENOME RES, V12, P1294, DOI 10.1101/gr.269102; Talbert PB, 2006, NAT REV GENET, V7, P793, DOI 10.1038/nrg1920; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Wallrath L, 1998, CURR OPIN GENET DEV, V8, P147, DOI 10.1016/S0959-437X(98)80135-4; Yan CM, 2002, GENETICS, V161, P217	21	213	238	0	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 15	2007	316	5831					1625	1628		10.1126/science.1139816	http://dx.doi.org/10.1126/science.1139816			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178SH	17569867	Green Submitted, Green Accepted			2022-12-28	WOS:000247239900044
J	Womelsdorf, T; Schoffelen, JM; Oostenveld, R; Singer, W; Desimone, R; Engel, AK; Fries, P				Womelsdorf, Thilo; Schoffelen, Jan-Mathijs; Oostenveld, Robert; Singer, Wolf; Desimone, Robert; Engel, Andreas K.; Fries, Pascal			Modulation of neuronal interactions through neuronal synchronization	SCIENCE			English	Article							VISUAL-CORTEX; GAMMA-OSCILLATIONS; SYNAPTIC MODIFICATIONS; INTERNEURON NETWORKS; CORTICAL NEURON; BEHAVING RAT; COINCIDENCE; HIPPOCAMPUS; RESPONSES; MEMORY	Brain processing depends on the interactions between neuronal groups. Those interactions are governed by the pattern of anatomical connections and by yet unknown mechanisms that modulate the effective strength of a given connection. We found that the mutual influence among neuronal groups depends on the phase relation between rhythmic activities within the groups. Phase relations supporting interactions between the groups preceded those interactions by a few milliseconds, consistent with a mechanistic role. These effects were specific in time, frequency, and space, and we therefore propose that the pattern of synchronization flexibly determines the pattern of neuronal interactions.	Radboud Univ Nijmegen, FC Donders Ctr Cognit Neuroimaging, NL-6525 ED Nijmegen, Netherlands; Max Planck Inst Brain Res, Dept Neurophysiol, D-60528 Frankfurt, Germany; Univ Frankfurt, Frankfurt Inst Adv Studies, D-60438 Frankfurt, Germany; NIMH, Neuropsychol Lab, NIH, Bethesda, MD 20892 USA; MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; Univ Med Ctr Hamburg Eppendorf, Dept Neurophysiol & Pathophysiol, D-20246 Hamburg, Germany; Radboud Univ Nijmegen, Dept Biophys, NL-6525 EZ Nijmegen, Netherlands	Radboud University Nijmegen; Max Planck Society; Goethe University Frankfurt; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Massachusetts Institute of Technology (MIT); University of Hamburg; University Medical Center Hamburg-Eppendorf; Radboud University Nijmegen	Womelsdorf, T (corresponding author), Radboud Univ Nijmegen, FC Donders Ctr Cognit Neuroimaging, NL-6525 ED Nijmegen, Netherlands.	thilo.womelsdorf@tcdonders.ru.nl; jan.schoffelen@tcdonders.ru.nl	Engel, Andreas K./AAH-6384-2019; Desimone, Robert/G-1121-2018; Singer, Wolf/D-6874-2012; Engel, Andreas K/C-7781-2012; Oostenveld, Robert/D-3259-2009; Schoffelen, Jan-Mathijs/D-3716-2009; Womelsdorf, Thilo/C-3096-2015; Fries, Pascal/E-3196-2010	Engel, Andreas K./0000-0003-4899-8466; Engel, Andreas K/0000-0003-4899-8466; Oostenveld, Robert/0000-0002-1974-1293; Schoffelen, Jan-Mathijs/0000-0003-0923-6610; Womelsdorf, Thilo/0000-0001-6921-4187; Fries, Pascal/0000-0002-4270-1468	NEI NIH HHS [R01EY017292] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY017292] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Azouz R, 2003, NEURON, V37, P513, DOI 10.1016/S0896-6273(02)01186-8; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BRAGIN A, 1995, J NEUROSCI, V15, P47; BUZSAKI G, 1992, SCIENCE, V256, P1025, DOI 10.1126/science.1589772; BUZSEKI G, 2006, RHYTHMS BRAIN; Csicsvari J, 2003, NEURON, V37, P311, DOI 10.1016/S0896-6273(02)01169-8; ENGEL AK, 1991, P NATL ACAD SCI USA, V88, P6048, DOI 10.1073/pnas.88.14.6048; Fell J, 2001, NAT NEUROSCI, V4, P1259, DOI 10.1038/nn759; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Fries P, 1997, P NATL ACAD SCI USA, V94, P12699, DOI 10.1073/pnas.94.23.12699; Fries P, 2002, J NEUROSCI, V22, P3739; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Gross J, 2004, P NATL ACAD SCI USA, V101, P13050, DOI 10.1073/pnas.0404944101; Hasenstaub A, 2005, NEURON, V47, P423, DOI 10.1016/j.neuron.2005.06.016; Konig P, 1996, TRENDS NEUROSCI, V19, P130, DOI 10.1016/S0166-2236(96)80019-1; KONIG P, 1995, NEURAL COMPUT, V7, P469, DOI 10.1162/neco.1995.7.3.469; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Mishra J, 2006, NEURAL NETWORKS, V19, P1329, DOI 10.1016/j.neunet.2006.08.005; Pesaran B, 2002, NAT NEUROSCI, V5, P805, DOI 10.1038/nn890; Roelfsema PR, 1997, NATURE, V385, P157, DOI 10.1038/385157a0; Salinas E, 2001, NAT REV NEUROSCI, V2, P539, DOI 10.1038/35086012; Schoffelen JM, 2005, SCIENCE, V308, P111, DOI 10.1126/science.1107027; Tallon-Baudry C, 2004, CEREB CORTEX, V14, P713, DOI 10.1093/cercor/bhh031; Vida I, 2006, NEURON, V49, P107, DOI 10.1016/j.neuron.2005.11.036; Wespatat V, 2004, J NEUROSCI, V24, P9067, DOI 10.1523/JNEUROSCI.2221-04.2004; Womelsdorf T, 2006, NATURE, V439, P733, DOI 10.1038/nature04258	28	899	914	0	92	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 15	2007	316	5831					1609	1612		10.1126/science.1139597	http://dx.doi.org/10.1126/science.1139597			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178SH	17569862	Green Published			2022-12-28	WOS:000247239900039
J	Magnani, F; Mencuccini, M; Borghetti, M; Berbigier, P; Berninger, F; Delzon, S; Grelle, A; Hari, P; Jarvis, PG; Kolari, P; Kowalski, AS; Lankreijer, H; Law, BE; Lindroth, A; Loustau, D; Manca, G; Moncrieff, JB; Rayment, M; Tedeschi, V; Valentini, R; Grace, J				Magnani, Federico; Mencuccini, Maurizio; Borghetti, Marco; Berbigier, Paul; Berninger, Frank; Delzon, Sylvain; Grelle, Achim; Hari, Pertti; Jarvis, Paul G.; Kolari, Pasi; Kowalski, Andrew S.; Lankreijer, Harry; Law, Beverly E.; Lindroth, Anders; Loustau, Denis; Manca, Giovanni; Moncrieff, John B.; Rayment, Mark; Tedeschi, Vanessa; Valentini, Riccardo; Grace, John			The human footprint in the carbon cycle of temperate and boreal forests	NATURE			English	Article							NITROGEN DEPOSITION; EUROPEAN FORESTS; PINE FORESTS; ECOSYSTEM; STORAGE; BALANCE; STAND; CHRONOSEQUENCE; SEQUESTRATION; RESPIRATION	Temperate and boreal forests in the Northern Hemisphere cover an area of about 2 x 10(7) square kilometres and act as a substantial carbon sink (0.6 - 0.7 petagrams of carbon per year)(1). Although forest expansion following agricultural abandonment is certainly responsible for an important fraction of this carbon sink activity, the additional effects on the carbon balance of established forests of increased atmospheric carbon dioxide, increasing temperatures, changes in management practices and nitrogen deposition are difficult to disentangle, despite an extensive network of measurement stations(2,3). The relevance of this measurement effort has also been questioned(4), because spot measurements fail to take into account the role of disturbances, either natural ( fire, pests, windstorms) or anthropogenic ( forest harvesting). Here we show that the temporal dynamics following stand-replacing disturbances do indeed account for a very large fraction of the overall variability in forest carbon sequestration. After the confounding effects of disturbance have been factored out, however, forest net carbon sequestration is found to be overwhelmingly driven by nitrogen deposition, largely the result of anthropogenic activities(5). The effect is always positive over the range of nitrogen deposition covered by currently available data sets, casting doubts on the risk of widespread ecosystem nitrogen saturation(6) under natural conditions. The results demonstrate that mankind is ultimately controlling the carbon balance of temperate and boreal forests, either directly ( through forest management) or indirectly ( through nitrogen deposition).	Univ Bologna, Dept Fruit Tree & Woody Plant Sci, I-40127 Bologna, Italy; Univ Edinburgh, Sch Geosci, Edinburgh EH9 3JU, Midlothian, Scotland; Univ Basilicata, Dept Crop Syst Forestry & Environm Sci, I-85100 Potenza, Italy; INRA, UR1263 EPHYSE, F-33883 Villenave Dornon, France; Univ Quebec, Dept Sci Biol, Montreal, PQ H3C 3P8, Canada; Swedish Univ Agr Sci, Dept Ecol & Environm Res, SE-75007 Uppsala, Sweden; Univ Helsinki, Dept Forest Ecol, FIN-00014 Helsinki, Finland; Lund Univ, Dept Forest Geog & Ecosyst Anal, S-22362 Lund, Sweden; Oregon State Univ, Coll Forestry, Corvallis, OR 97331 USA; Univ Tuscia, Dept Forest Resources & Environm, I-01100 Viterbo, Italy	University of Bologna; University of Edinburgh; University of Basilicata; INRAE; University of Quebec; University of Quebec Montreal; Swedish University of Agricultural Sciences; University of Helsinki; Lund University; Oregon State University; Tuscia University	Magnani, F (corresponding author), Univ Bologna, Dept Fruit Tree & Woody Plant Sci, I-40127 Bologna, Italy.	federico.magnani@unibo.it	Berninger, Frank/A-8891-2010; Sigurdsson, Bjarni D/E-4592-2012; Magnani, Federico/A-2448-2011; Rayment, Mark/L-9848-2016; Delzon, Sylvain/R-9538-2018; Lindroth, Anders/N-4697-2014; Valentini, Riccardo/D-1226-2010; Borghetti, Marco/C-4262-2012; Mencuccini, Maurizio/B-9052-2011; Law, Beverly Elizabeth/G-3882-2010; Kowalski, Andrew S./A-7515-2008; Grace, John/N-9280-2013	Berninger, Frank/0000-0001-7718-1661; Magnani, Federico/0000-0003-4479-0916; Delzon, Sylvain/0000-0003-3442-1711; Lindroth, Anders/0000-0002-7669-784X; Valentini, Riccardo/0000-0002-6756-5634; Borghetti, Marco/0000-0003-3159-6655; Mencuccini, Maurizio/0000-0003-0840-1477; Law, Beverly Elizabeth/0000-0002-1605-1203; Kowalski, Andrew S./0000-0001-9777-9708; Loustau, Denis/0000-0003-3990-400X; Kolari, Pasi/0000-0001-7271-633X				Aber J, 1998, BIOSCIENCE, V48, P921, DOI 10.2307/1313296; Andren O, 1997, ECOL APPL, V7, P1226, DOI 10.1890/1051-0761(1997)007[1226:ITICBM]2.0.CO;2; Bond-Lamberty B, 2004, GLOBAL CHANGE BIOL, V10, P473, DOI 10.1111/j.1529-8817.2003.0742.x; BOONE RD, 1988, ECOLOGY, V69, P714, DOI 10.2307/1941019; Davis MR, 2003, FOREST ECOL MANAG, V177, P313, DOI 10.1016/S0378-1127(02)00333-X; De Vries W, 2006, GLOBAL CHANGE BIOL, V12, P1151, DOI 10.1111/j.1365-2486.2006.01151.x; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Goodale CL, 2002, ECOL APPL, V12, P891, DOI 10.2307/3060997; Harmon ME, 2004, ECOSYSTEMS, V7, P498, DOI 10.1007/s10021-004-0140-9; Hogberg P, 2006, GLOBAL CHANGE BIOL, V12, P489, DOI 10.1111/j.1365-2486.2006.01102.x; Holland EA, 2005, ECOL APPL, V15, P38, DOI 10.1890/03-5162; Howard EA, 2004, GLOBAL CHANGE BIOL, V10, P1267, DOI 10.1111/j.1529-8817.2003.00804.x; JOHNSON DW, 1992, J ENVIRON QUAL, V21, P1, DOI 10.2134/jeq1992.00472425002100010001x; Knohl A, 2003, AGR FOREST METEOROL, V118, P151, DOI 10.1016/S0168-1923(03)00115-1; Korner C, 2003, SCIENCE, V300, P1242, DOI 10.1126/science.1084460; Landsberg JJ, 1997, FOREST ECOL MANAG, V95, P209, DOI 10.1016/S0378-1127(97)00026-1; Law BE, 2003, GLOBAL CHANGE BIOL, V9, P510, DOI 10.1046/j.1365-2486.2003.00624.x; Law BE, 2002, AGR FOREST METEOROL, V113, P97, DOI 10.1016/S0168-1923(02)00104-1; Litvak M, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2001JD000854; Magill AH, 2004, FOREST ECOL MANAG, V196, P7, DOI 10.1016/j.foreco.2004.03.033; Mund M., 2004, THESIS G AUGUST U GO; Nadelhoffer KJ, 1999, NATURE, V398, P145, DOI 10.1038/18205; PETERSON BJ, 1985, TELLUS B, V37, P117, DOI 10.1111/j.1600-0889.1985.tb00060.x; Pregitzer KS, 2004, GLOBAL CHANGE BIOL, V10, P2052, DOI 10.1111/j.1365-2486.2004.00866.x; Rothstein DE, 2004, CAN J FOREST RES, V34, P1908, DOI [10.1139/x04-063, 10.1139/X04-063]; Schimel JP, 2004, ECOLOGY, V85, P591, DOI 10.1890/03-8002; Thornton PE, 2002, AGR FOREST METEOROL, V113, P185, DOI 10.1016/S0168-1923(02)00108-9; Townsend AR, 1996, ECOL APPL, V6, P806, DOI 10.2307/2269486; Valentini R, 2000, NATURE, V404, P861, DOI 10.1038/35009084; Wirth C, 2002, TELLUS B, V54, P611, DOI 10.1034/j.1600-0889.2002.01343.x	30	739	804	19	601	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 14	2007	447	7146					848	850		10.1038/nature05847	http://dx.doi.org/10.1038/nature05847			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178FV	17568744				2022-12-28	WOS:000247207500042
J	Reboli, AC; Rotstein, C; Pappas, PG; Chapman, SW; Kett, DH; Kumar, D; Betts, R; Wible, M; Goldstein, BP; Schranz, J; Krause, DS; Walsh, TJ; Van Wijngaerden, E; Bow, E; Garber, G; Laverdiere, M; Libman, M; Pelletier, R; Sanche, S; Cornely, O; Kern, W; Ruhnke, M; Carosi, G; Verweij, P; Anaissie, E; Bochan, M; Carpenter, C; Cicogna, C; Cleary, J; Finley, N; Fetchick, R; Friedman, B; Graham, D; Graybill, R; Hsiao, C; Jones, R; Kerkering, T; Kurtz, T; McClain, D; Nowakowski, J; Ostrosky-Zeichner, L; Perfect, J; Pullman, J; Quartin, A; Reinhardt, J; Segal, B; Shahryar, S; Shoham, S; Sioson, P; Sloan, L; Solomkin, J; Vazquez, J; Zapata-Molina, N				Reboli, Annette C.; Rotstein, Coleman; Pappas, Peter G.; Chapman, Stanley W.; Kett, Daniel H.; Kumar, Deepali; Betts, Robert; Wible, Michele; Goldstein, Beth P.; Schranz, Jennifer; Krause, David S.; Walsh, Thomas J.; Van Wijngaerden, E.; Bow, E.; Garber, G.; Laverdiere, M.; Libman, M.; Pelletier, R.; Sanche, S.; Cornely, O.; Kern, W.; Ruhnke, M.; Carosi, G.; Verweij, P.; Anaissie, E.; Bochan, M.; Carpenter, C.; Cicogna, C.; Cleary, J.; Finley, N.; Fetchick, R.; Friedman, B.; Graham, D.; Graybill, R.; Hsiao, C.; Jones, R.; Kerkering, T.; Kurtz, T.; McClain, D.; Nowakowski, J.; Ostrosky-Zeichner, L.; Perfect, J.; Pullman, J.; Quartin, A.; Reinhardt, J.; Segal, B.; Shahryar, S.; Shoham, S.; Sioson, P.; Sloan, L.; Solomkin, J.; Vazquez, J.; Zapata-Molina, N.		Anidulafungin Study Grp	Anidulafungin versus fluconazole for invasive candidiasis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BLOOD-STREAM INFECTIONS; ANTIMICROBIAL SURVEILLANCE PROGRAM; AMPHOTERICIN-B; UNITED-STATES; CANDIDEMIA; EPIDEMIOLOGY; INFERIORITY; CASPOFUNGIN; TRENDS; TRIAL	BACKGROUND: Anidulafungin, a new echinocandin, has potent activity against candida species. We compared anidulafungin with fluconazole in a randomized, double-blind, noninferiority trial of treatment for invasive candidiasis. METHODS: Adults with invasive candidiasis were randomly assigned to receive either intravenous anidulafungin or intravenous fluconazole. All patients could receive oral fluconazole after 10 days of intravenous therapy. The primary efficacy analysis assessed the global response (clinical and microbiologic) at the end of intravenous therapy in patients who had a positive baseline culture. Efficacy was also assessed at other time points. RESULTS: Eighty-nine percent of the 245 patients in the primary analysis had candidemia only. Candida albicans was isolated in 62% of the 245 patients. In vitro fluconazole resistance was infrequent. Most of the patients (97%) did not have neutropenia. At the end of intravenous therapy, treatment was successful in 75.6% of patients treated with anidulafungin, as compared with 60.2% of those treated with fluconazole (difference, 15.4 percentage points; 95% confidence interval [CI], 3.9 to 27.0). The results were similar for other efficacy end points. The statistical analyses failed to show a ``center effect''; when data from the site enrolling the largest number of patients were removed, success rates at the end of intravenous therapy were 73.2% in the anidulafungin group and 61.1% in the fluconazole group (difference, 12.1 percentage points; 95% CI, -1.1 to 25.3). The frequency and types of adverse events were similar in the two groups. The rate of death from all causes was 31% in the fluconazole group and 23% in the anidulafungin group (P=0.13). CONCLUSIONS: Anidulafungin was shown to be noninferior to fluconazole in the treatment of invasive candidiasis.	Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Div Infect Dis, Cooper Univ Hosp, Camden, NJ 08103 USA; Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Camden, NJ 08103 USA; McMaster Univ, Hamilton, ON, Canada; Univ Alabama Birmingham, Birmingham, AL USA; Univ Mississippi, Jackson, MS 39216 USA; Univ Miami, Miller Sch Med, Miami, FL 33152 USA; Univ Toronto, Univ Hlth Network, Toronto, ON, Canada; Univ Rochester, Rochester, NY USA; Vicuron Pharmaceut, King Of Prussia, PA USA; NCI, Bethesda, MD 20892 USA	Cooper University Hospital; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; McMaster University; University of Alabama System; University of Alabama Birmingham; University of Mississippi; University of Miami; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Rochester; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Reboli, AC (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Div Infect Dis, Cooper Univ Hosp, Educ & Res Bldg,401 Haddon Ave,Rm 270, Camden, NJ 08103 USA.	reboli-annette@cooperhealth.edu	Kalra, D/H-6661-2019; Van Wijngaerden, Eric/AAB-9187-2021; Cornely, Oliver A./J-5095-2013	Kalra, D/0000-0001-5254-4067; Van Wijngaerden, Eric/0000-0001-8926-099X; Cornely, Oliver A./0000-0001-9599-3137	NATIONAL CANCER INSTITUTE [Z01SC006830] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BECKSAGUE CM, 1993, J INFECT DIS, V167, P1247, DOI 10.1093/infdis/167.5.1247; Brown AL, 2003, NEW ENGL J MED, V348, P1287; Chuang-Stein C, 2001, DRUG INF J, V35, P141, DOI 10.1177/009286150103500115; Denning DW, 2003, LANCET, V362, P1142, DOI 10.1016/S0140-6736(03)14472-8; Diekema DJ, 2003, J CLIN MICROBIOL, V41, P3655, DOI 10.1128/JCM.41.8.3655-3660.2003; Dismukes WE, 2000, CLIN INFECT DIS, V30, P653, DOI 10.1086/313748; Dunnett CW, 1996, STAT MED, V15, P1729; Espinel-Ingroff Ana, 2003, Revista Iberoamericana de Micologia, V20, P121; Ghannoum M, 2005, INFECT DIS CLIN PRAC, V13, P165, DOI 10.1097/01.idc.0000170684.37817.6c; Graybill J R, 2001, Curr Opin Investig Drugs, V2, P468; Klepser ME, 1997, ANTIMICROB AGENTS CH, V41, P1392, DOI 10.1128/AAC.41.6.1392; Krause DS, 2004, ANTIMICROB AGENTS CH, V48, P2021, DOI 10.1128/AAC.48.6.2021-2024.2004; Kullberg BJ, 2005, LANCET, V366, P1435, DOI 10.1016/S0140-6736(05)67490-9; Lewis RE, 1998, ANTIMICROB AGENTS CH, V42, P1382, DOI 10.1128/AAC.42.6.1382; Mora-Duarte J, 2002, NEW ENGL J MED, V347, P2020, DOI 10.1056/NEJMoa021585; NCCLS, 2002, REF METH BROTH DIL A, V22; Pappas PG, 2004, CLIN INFECT DIS, V38, P161, DOI 10.1086/380796; Park S, 2005, ANTIMICROB AGENTS CH, V49, P3264, DOI 10.1128/AAC.49.8.3264-3273.2005; PARK SP, 2006, 46 INT C ANT AG CHEM; Petraitiene R, 1999, ANTIMICROB AGENTS CH, V43, P2148, DOI 10.1128/AAC.43.9.2148; Pfaller MA, 2000, ANTIMICROB AGENTS CH, V44, P747, DOI 10.1128/AAC.44.3.747-751.2000; Pfaller MA, 2005, J CLIN MICROBIOL, V43, P5425, DOI 10.1128/JCM.43.11.5425-5427.2005; Pfaller MA, 2002, J CLIN MICROBIOL, V40, P852, DOI 10.1128/JCM.40.3.852-856.2002; REX JH, 1994, NEW ENGL J MED, V331, P1325, DOI 10.1056/NEJM199411173312001; Rex JH, 2003, CLIN INFECT DIS, V36, P1221, DOI 10.1086/374850; Trick WE, 2002, CLIN INFECT DIS, V35, P627, DOI 10.1086/342300; Walsh TJ, 2006, NEW ENGL J MED, V354, P1215; Wiens BL, 2001, DRUG INF J, V35, P241, DOI 10.1177/009286150103500128; Wisplinghoff H, 2005, CLIN INFECT DIS, V40, P1077; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946	30	608	634	0	29	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 14	2007	356	24					2472	2482		10.1056/NEJMoa066906	http://dx.doi.org/10.1056/NEJMoa066906			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	178DR	17568028				2022-12-28	WOS:000247201900007
J	Steinbrook, R				Steinbrook, Robert			Erythropoietin, the FDA, and oncology	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material												rsteinbrook@attglobal.net						Berenson Alex, 2007, NY TIMES        0509, pA1; Food and Drug Administration, 2007, FDA AL INF HEALTHC P; *ONC DRUG ADV COMM, 2007, CONT REASS RISKS ER; Steinbrook R, 2006, LANCET, V368, P2191, DOI 10.1016/S0140-6736(06)69707-9	4	47	50	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 14	2007	356	24					2448	2451		10.1056/NEJMp078100	http://dx.doi.org/10.1056/NEJMp078100			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	178DR	17568025				2022-12-28	WOS:000247201900003
J	Wollert, T; Pasche, B; Rochon, M; Deppenmeier, S; van den Heuvel, J; Gruber, AD; Heinz, DW; Lengeling, A; Schubert, WD				Wollert, Thomas; Pasche, Bastian; Rochon, Maike; Deppenmeier, Stefanie; van den Heuvel, Joop; Gruber, Achim D.; Heinz, Dirk W.; Lengeling, Andreas; Schubert, Wolf-Dieter			Extending the host range of Listeria monocytogenes by rational protein design	CELL			English	Article							GUINEA-PIG; E-CADHERIN; INTERNALIN; RECEPTOR; INVASION; CELLS; ENTRY; SPECIFICITY; MODEL; PLACENTA	In causing disease, pathogens outmaneuver host defenses through a dedicated arsenal of virulence determinants that specifically bind or modify individual host molecules. This dedication limits the intruder to a defined range of hosts. Newly emerging diseases mostly involve existing pathogens whose arsenal has been altered to allow them to infect previously inaccessible hosts. We have emulated this chance occurrence by extending the host range accessible to the human pathogen Listeria monocytogenes by the intestinal route to include the mouse. Analyzing the recognition complex of the listerial invasion protein InIA and its human receptor E-cadherin, we postulated and verified amino acid substitutions in InIA to increase its affinity for E-cadherin. Two single substitutions increase binding affinity by four orders of magnitude and extend binding specificity to include formerly incompatible murine E-cadherin. By rationally adapting a single protein, we thus create a versatile murine model of human listeriosis.	Helmholtz Ctr Infect Res, Div Struct Biol, Mol Host Pathogen Interact, D-38124 Braunschweig, Germany; Helmholtz Ctr Infect Res, Dept Expt Mouse Genet, D-38124 Braunschweig, Germany; Helmholtz Ctr Infect Res, Div Struct Biol, D-38124 Braunschweig, Germany; Free Univ Berlin, Dept Vet Pathol, D-14163 Berlin, Germany	Helmholtz Association; Helmholtz-Center for Infection Research; Helmholtz Association; Helmholtz-Center for Infection Research; Helmholtz Association; Helmholtz-Center for Infection Research; Free University of Berlin	Lengeling, A (corresponding author), Helmholtz Ctr Infect Res, Div Struct Biol, Mol Host Pathogen Interact, Inhoffenstr 7, D-38124 Braunschweig, Germany.	wolf-dieter.schubert@helmholtz-hzi.de; andreas.lengeling@helmholtz-hzi.de	Gruber, Achim D./ABA-4514-2021; Schubert, Wolf-Dieter/A-5617-2009	Schubert, Wolf-Dieter/0000-0003-4998-519X; Wollert, Thomas/0000-0001-9732-4789				Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bakardjiev AI, 2005, J INFECT DIS, V191, P1889, DOI 10.1086/430090; Bakardjiev AI, 2004, INFECT IMMUN, V72, P489, DOI 10.1128/IAI.72.1.489-497.2004; Boneca IG, 2007, P NATL ACAD SCI USA, V104, P997, DOI 10.1073/pnas.0609672104; CHAKRABORTY T, 1992, J BACTERIOL, V174, P568, DOI 10.1128/jb.174.2.568-574.1992; CLARK MA, 2002, CELL BIOL, V118, P137; Cossart P, 2004, SCIENCE, V304, P242, DOI 10.1126/science.1090124; Cossart P, 2003, TRENDS CELL BIOL, V13, P23, DOI 10.1016/S0962-8924(02)00006-5; D'Souza-Schorey C, 2005, TRENDS CELL BIOL, V15, P19, DOI 10.1016/j.tcb.2004.11.002; Dietrich G, 1998, NAT BIOTECHNOL, V16, P181, DOI 10.1038/nbt0298-181; Dramsi S, 1997, INFECT IMMUN, V65, P1615, DOI 10.1128/IAI.65.5.1615-1625.1997; Drevets DA, 1999, INFECT IMMUN, V67, P3512, DOI 10.1128/IAI.67.7.3512-3517.1999; ELSINGHORST EA, 1994, METHOD ENZYMOL, V236, P405; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GAILLARD JL, 1991, CELL, V65, P1127, DOI 10.1016/0092-8674(91)90009-N; Gamblin SJ, 2004, SCIENCE, V303, P1838, DOI 10.1126/science.1093155; Guimaraes VD, 2005, MICROBES INFECT, V7, P836, DOI 10.1016/j.micinf.2005.02.012; Hamon M, 2006, NAT REV MICROBIOL, V4, P423, DOI 10.1038/nrmicro1413; Heeney JL, 2006, SCIENCE, V313, P462, DOI 10.1126/science.1123016; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; Khelef N, 2006, CELL MICROBIOL, V8, P457, DOI 10.1111/j.1462-5822.2005.00634.x; Kissinger CR, 1999, ACTA CRYSTALLOGR D, V55, P484, DOI 10.1107/S0907444998012517; Kraehenbuhl JP, 2000, ANNU REV CELL DEV BI, V16, P301, DOI 10.1146/annurev.cellbio.16.1.301; Lauer P, 2002, J BACTERIOL, V184, P4177, DOI 10.1128/JB.184.15.4177-4186.2002; Le Monnier A, 2006, INFECT IMMUN, V74, P663, DOI 10.1128/IAI.74.1.663-672.2006; Le Monnier A, 2007, INFECT IMMUN, V75, P950, DOI 10.1128/IAI.01570-06; Lecuit M, 2005, CLIN MICROBIOL INFEC, V11, P430, DOI 10.1111/j.1469-0691.2005.01146.x; Lecuit M, 2004, P NATL ACAD SCI USA, V101, P6152, DOI 10.1073/pnas.0401434101; Lecuit M, 2002, TRENDS MOL MED, V8, P537, DOI 10.1016/S1471-4914(02)02413-9; Lecuit M, 2001, SCIENCE, V292, P1722, DOI 10.1126/science.1059852; Lecuit M, 1999, EMBO J, V18, P3956, DOI 10.1093/emboj/18.14.3956; Lewis DB, 2006, ANNU REV MED, V57, P139, DOI 10.1146/annurev.med.57.121304.131333; Li F, 2005, SCIENCE, V309, P1864, DOI 10.1126/science.1116480; LINGNAU A, 1995, INFECT IMMUN, V63, P3896, DOI 10.1128/IAI.63.10.3896-3903.1995; Marco AJ, 1997, MICROB PATHOGENESIS, V23, P255, DOI 10.1006/mpat.1997.0144; Mengaud J, 1996, CELL, V84, P923, DOI 10.1016/S0092-8674(00)81070-3; Moffett A, 2006, NAT REV IMMUNOL, V6, P584, DOI 10.1038/nri1897; Mowat AM, 2003, NAT REV IMMUNOL, V3, P331, DOI 10.1038/nri1057; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Neuenhahn M, 2006, IMMUNITY, V25, P619, DOI 10.1016/j.immuni.2006.07.017; Pasche B, 2005, INFECT IMMUN, V73, P5952, DOI 10.1128/IAI.73.9.5952-5960.2005; Pentecost M, 2006, PLOS PATHOG, V2, P29, DOI 10.1371/journal.ppat.0020003; Sabet C, 2005, INFECT IMMUN, V73, P6912, DOI 10.1128/IAI.73.10.6912-6922.2005; Schubert WD, 2002, CELL, V111, P825, DOI 10.1016/S0092-8674(02)01136-4; Shen Y, 2000, CELL, V103, P501, DOI 10.1016/S0092-8674(00)00141-0; Sleator RD, 2006, CURR OPIN BIOTECH, V17, P211, DOI 10.1016/j.copbio.2006.01.006; Stevens J, 2006, SCIENCE, V312, P404, DOI 10.1126/science.1124513; Vazquez-Boland JA, 2001, CLIN MICROBIOL REV, V14, P584, DOI 10.1128/CMR.14.3.584-640.2001; Weiss RA, 2003, CURR TOP MICROBIOL, V278, P47; Wheelock MJ, 2003, ANNU REV CELL DEV BI, V19, P207, DOI 10.1146/annurev.cellbio.19.011102.111135; Yap GS, 2002, CELL MICROBIOL, V4, P627, DOI 10.1046/j.1462-5822.2002.00224.x	52	156	157	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 1	2007	129	5					891	902		10.1016/j.cell.2007.03.049	http://dx.doi.org/10.1016/j.cell.2007.03.049			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	176KT	17540170	Bronze, Green Published			2022-12-28	WOS:000247084600010
J	Peul, WC; van Houwelingen, HC; van den Hout, WB; Brand, R; Eekhof, JAH; Tans, JTJ; Thomeer, RTWM; Koes, BW				Peul, Wilco C.; van Houwelingen, Hans C.; van den Hout, Wilbert B.; Brand, Ronald; Eekhof, Just A. H.; Tans, Joseph T. J.; Thomeer, Ralph T. W. M.; Koes, Bart W.		Leiden-The Hague Spine Interventio	Surgery versus prolonged conservative treatment for sciatica	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LUMBAR DISC HERNIATION; BACK-PAIN; BED REST; TRIAL; OUTCOMES; SPINE; MICRODISCECTOMY; DISKECTOMY	BACKGROUND: Lumbar-disk surgery often is performed in patients who have sciatica that does not resolve within 6 weeks, but the optimal timing of surgery is not known. METHODS: We randomly assigned 283 patients who had had severe sciatica for 6 to 12 weeks to early surgery or to prolonged conservative treatment with surgery if needed. The primary outcomes were the score on the Roland Disability Questionnaire, the score on the visual-analogue scale for leg pain, and the patient's report of perceived recovery during the first year after randomization. Repeated-measures analysis according to the intention-to-treat principle was used to estimate the outcome curves for both groups. RESULTS: Of 141 patients assigned to undergo early surgery, 125 (89%) underwent microdiskectomy after a mean of 2.2 weeks. Of 142 patients designated for conservative treatment, 55 (39%) were treated surgically after a mean of 18.7 weeks. There was no significant overall difference in disability scores during the first year (P=0.13). Relief of leg pain was faster for patients assigned to early surgery (P < 0.001). Patients assigned to early surgery also reported a faster rate of perceived recovery (hazard ratio, 1.97; 95% confidence interval, 1.72 to 2.22; P < 0.001). In both groups, however, the probability of perceived recovery after 1 year of follow-up was 95%. CONCLUSIONS: The 1-year outcomes were similar for patients assigned to early surgery and those assigned to conservative treatment with eventual surgery if needed, but the rates of pain relief and of perceived recovery were faster for those assigned to early surgery.	Leiden Univ, Med Ctr, Dept Neurosurg, NL-2300 RC Leiden, Netherlands; Med Ctr Haaglanden, Dept Neurol & Neurosurg, The Hague, Netherlands; Erasmus Univ, Med Ctr, Dept Gen Practice, Rotterdam, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Haaglanden Medical Center; Erasmus University Rotterdam; Erasmus MC	Peul, WC (corresponding author), Leiden Univ, Med Ctr, Dept Neurosurg, POB 9600, NL-2300 RC Leiden, Netherlands.	w.c.peul@lumc.nl	Eekhof, Just/GPC-4405-2022; Koes, Bart w/K-4614-2016; van houwelingen, hans c/C-1872-2008	Koes, Bart w/0000-0002-0450-9969; van houwelingen, hans c/0000-0002-0494-4637; van den Hout, Wilbert B./0000-0002-6425-0135				Andersson GBJ, 1996, SPINE, V21, pS75, DOI 10.1097/00007632-199612151-00009; Atlas SJ, 1996, SPINE, V21, P1777, DOI 10.1097/00007632-199608010-00011; Awad JN, 2006, CLIN ORTHOP RELAT R, P183, DOI 10.1097/01.blo.0000198724.54891.3a; BALDERSTON RA, 1991, J SPINAL DISORD, V4, P22; BRAZIER JE, 1992, BMJ-BRIT MED J, V305, P160, DOI 10.1136/bmj.305.6846.160; Buttermann GR, 2004, J BONE JOINT SURG AM, V86A, P670, DOI 10.2106/00004623-200404000-00002; Carragee EJ, 2006, SPINE, V31, P653, DOI 10.1097/01.brs.0000203714.76250.68; CHERKIN DC, 1994, SPINE, V19, P1201, DOI 10.1097/00007632-199405310-00001; Collins SL, 1997, PAIN, V72, P95, DOI 10.1016/S0304-3959(97)00005-5; FRYMOYER JW, 1988, NEW ENGL J MED, V318, P291, DOI 10.1056/NEJM198802043180506; Hofstee DJ, 2002, J NEUROSURG, V96, P45, DOI 10.3171/spi.2002.96.1.0045; *LEID U MED CTR DE, PROMISE VERS 2 PROJ; Luijsterburg PAJ, 2004, CLIN NEUROL NEUROSUR, V106, P313, DOI 10.1016/j.clineuro.2004.02.003; Mixter W.J., 1934, NEW ENGL J MED, V211, P210, DOI [10.1056/NEJM193408022110506, DOI 10.1056/NEJM193408022110506]; Moher D, 2001, LANCET, V357, P1191, DOI 10.1016/S0140-6736(00)04337-3; Osterman H, 2006, SPINE, V31, P2409; PATRICK DL, 1995, SPINE, V20, P1899, DOI 10.1097/00007632-199509000-00011; Peul WC, 2005, BMC MUSCULOSKEL DIS, V6, DOI 10.1186/1471-2474-6-8; PROLO DJ, 1986, SPINE, V11, P601, DOI 10.1097/00007632-198607000-00012; *SPSS, SPSS SOFTW VERS 12 0; Stam J, 1996, Ned Tijdschr Geneeskd, V140, P2621; Thome C, 2005, J NEUROSURG-SPINE, V2, P271, DOI 10.3171/spi.2005.2.3.0271; Vader JP, 2000, SPINE, V25, P1831, DOI 10.1097/00007632-200007150-00015; VANTULDER MW, 1995, PAIN, V62, P233, DOI 10.1016/0304-3959(94)00272-G; Vroomen PCAJ, 1999, NEW ENGL J MED, V340, P418, DOI 10.1056/NEJM199902113400602; WEBER H, 1983, SPINE, V8, P131, DOI 10.1097/00007632-198303000-00003; WEBER H, 1975, ACTA ORTHOP SCAND, V46, P631, DOI 10.3109/17453677508989245; Weinstein JN, 2006, JAMA-J AM MED ASSOC, V296, P2441, DOI 10.1001/jama.296.20.2441	28	441	454	0	42	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 31	2007	356	22					2245	2256		10.1056/NEJMoa064039	http://dx.doi.org/10.1056/NEJMoa064039			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	172PO	17538084				2022-12-28	WOS:000246816500004
J	Wolf, M; van Doorn, GS; Leimar, O; Weissing, FJ				Wolf, Max; van Doorn, G. Sander; Leimar, Olof; Weissing, Franz J.			Life-history trade-offs favour the evolution of animal personalities	NATURE			English	Article							INDIVIDUAL-DIFFERENCES; BEHAVIORAL-DIFFERENCES; AVIAN PERSONALITIES; HERITABILITY; CONSEQUENCES; STICKLEBACKS; POPULATIONS; BOLDNESS; SHYNESS	In recent years evidence has been accumulating that personalities are not only found in humans(1) but also in a wide range of other animal species(2-8). Individuals differ consistently in their behavioural tendencies and the behaviour in one context is correlated with the behaviour in multiple other contexts. From an adaptive perspective, the evolution of animal personalities is still a mystery, because a more flexible structure of behaviour should provide a selective advantage(9-11). Accordingly, many researchers view personalities as resulting from constraints imposed by the architecture of behaviour(7) (but see ref. 12). In contrast, we show here that animal personalities can be given an adaptive explanation. Our argument is based on the insight that the trade-off between current and future reproduction(13) often results in polymorphic populations(14) in which some individuals put more emphasis on future fitness returns than others. Life-history theory predicts that such differences in fitness expectations should result in systematic differences in risk-taking behaviour(15). Individuals with high future expectations (who have much to lose) should be more risk-averse than individuals with low expectations. This applies to all kinds of risky situations, so individuals should consistently differ in their behaviour. By means of an evolutionary model we demonstrate that this basic principle results in the evolution of animal personalities. It simultaneously explains the coexistence of behavioural types, the consistency of behaviour through time and the structure of behavioural correlations across contexts. Moreover, it explains the common finding that explorative behaviour and risk-related traits like boldness and aggressiveness are common characteristics of animal personalities(2-8).	Univ Groningen, Theoret Biol Grp, Ctr Ecol & Evolutionary Studies, NL-9751 NN Haren, Netherlands; Stockholm Univ, Dept Zool, SE-10691 Stockholm, Sweden	University of Groningen; Stockholm University	Weissing, FJ (corresponding author), Univ Groningen, Theoret Biol Grp, Ctr Ecol & Evolutionary Studies, NL-9751 NN Haren, Netherlands.	f.j.weissing@rug.nl	van Doorn, G. Sander/G-3247-2011; Leimar, Olof/L-3781-2014; Wolf, Max/L-4903-2013	van Doorn, G. Sander/0000-0002-4703-3788; Leimar, Olof/0000-0001-8621-6977; Wolf, Max/0000-0001-8878-0504; Weissing, Franz J./0000-0003-3281-663X				BAKKER TCM, 1986, BEHAVIOUR, V98, P1, DOI 10.1163/156853986X00937; Bell AM, 2005, J EVOLUTION BIOL, V18, P464, DOI 10.1111/j.1420-9101.2004.00817.x; Bell AM, 2004, ANIM BEHAV, V68, P1339, DOI 10.1016/j.anbehav.2004.05.007; BOISSY A, 1995, Q REV BIOL, V70, P165, DOI 10.1086/418981; CLARK CW, 1994, BEHAV ECOL, V5, P159, DOI 10.1093/beheco/5.2.159; Coleman K, 1998, ANIM BEHAV, V56, P927, DOI 10.1006/anbe.1998.0852; Dall SRX, 2004, ECOL LETT, V7, P734, DOI 10.1111/j.1461-0248.2004.00618.x; Dingemanse NJ, 2002, ANIM BEHAV, V64, P929, DOI 10.1006/anbe.2002.2006; Dingemanse NJ, 2004, P ROY SOC B-BIOL SCI, V271, P847, DOI 10.1098/rspb.2004.2680; Drent PJ, 2003, P ROY SOC B-BIOL SCI, V270, P45, DOI 10.1098/rspb.2002.2168; Gosling SD, 1999, CURR DIR PSYCHOL SCI, V8, P69, DOI 10.1111/1467-8721.00017; Gosling SD, 2001, PSYCHOL BULL, V127, P45, DOI 10.1037//0033-2909.127.1.45; Groothuis TGG, 2005, NEUROSCI BIOBEHAV R, V29, P137, DOI 10.1016/j.neubiorev.2004.06.010; Hedrick AV, 2000, P ROY SOC B-BIOL SCI, V267, P671, DOI 10.1098/rspb.2000.1054; HUNTINGFORD FA, 1976, ANIM BEHAV, V24, P245, DOI 10.1016/S0003-3472(76)80034-6; Koolhaas JM, 1999, NEUROSCI BIOBEHAV R, V23, P925, DOI 10.1016/S0149-7634(99)00026-3; Maynard Smith J., 1982, pi; McNamara JM, 2004, NATURE, V428, P745, DOI 10.1038/nature02432; Pervin L., 1999, HDB PERSONALITY THEO, V2nd; Rands SA, 2003, NATURE, V423, P432, DOI 10.1038/nature01630; Reale D, 2000, ANIM BEHAV, V60, P589, DOI 10.1006/anbe.2000.1530; Roff Derek, 2002, pi; Rueffler C, 2004, THEOR POPUL BIOL, V65, P165, DOI 10.1016/j.tpb.2003.10.001; Rueffler C, 2006, TRENDS ECOL EVOL, V21, P238, DOI 10.1016/j.tree.2006.03.003; Sih A, 2004, Q REV BIOL, V79, P241, DOI 10.1086/422893; Sih A, 2004, TRENDS ECOL EVOL, V19, P372, DOI 10.1016/j.tree.2004.04.009; Sinn DL, 2006, J EVOLUTION BIOL, V19, P1437, DOI 10.1111/j.1420-9101.2006.01136.x; Van Doorn GS, 2006, EVOLUTION, V60, P2226, DOI 10.1554/06-291.1; Wilson DS, 1998, PHILOS T R SOC B, V353, P199, DOI 10.1098/rstb.1998.0202; WILSON DS, 1994, TRENDS ECOL EVOL, V9, P442, DOI 10.1016/0169-5347(94)90134-1	30	909	926	11	652	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 31	2007	447	7144					581	584		10.1038/nature05835	http://dx.doi.org/10.1038/nature05835			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172YZ	17538618				2022-12-28	WOS:000246842000046
J	Po, ALW				Po, Alain Li Wan			Personalised medicine: who is an Asian?	LANCET			English	Editorial Material									Natl Genet Educ & Dev Ctr, Birmingham, W Midlands, England; Ctr Evidence Based Pharmaotherapy, Nottingham NG9 3FD, England		Po, ALW (corresponding author), Natl Genet Educ & Dev Ctr, Birmingham, W Midlands, England.	a.liwanpo@talk21.com						Bhopal R, 2004, J EPIDEMIOL COMMUN H, V58, P441, DOI 10.1136/jech.2003.013466; *COMM HUM MED MED, 2006, CURRENT PROBLEMS PHA, V31, P4; *DEP COMM LOC GOV, 2006, CONN BRIT HIND ENQ I; Fargher EA, 2007, J CLIN PHARM THER, V32, P187, DOI 10.1111/j.1365-2710.2007.00805.x; Lee E, 2005, CLIN PHARMACOL THER, V78, P330, DOI 10.1016/j.clpt.2005.06.013; Luo HR, 2006, CLIN PHARMACOL THER, V80, P33, DOI 10.1016/j.clpt.2006.03.003; Rasanathan K, 2006, ETHNIC HEALTH, V11, P211, DOI 10.1080/13557850600565525; *ROYAL PHARM SOC G, 2004, PHARM J, V273, P169; *ROYAL SOC, 2004, PERS MED HOP REAL; SINGH KS, 1994, BIOL VARIATION INDIA; Taylor AL, 2004, NEW ENGL J MED, V351, P2049, DOI 10.1056/NEJMoa042934; Thatcher N, 2005, LANCET, V366, P1527, DOI 10.1016/S0140-6736(05)67625-8	12	4	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 26	2007	369	9575					1770	1771		10.1016/S0140-6736(07)60793-4	http://dx.doi.org/10.1016/S0140-6736(07)60793-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	172QP	17531869				2022-12-28	WOS:000246819300007
J	Bird, A				Bird, Adrian			Perceptions of epigenetics	NATURE			English	Editorial Material							DNA METHYLATION	Geneticists study the gene; however, for epigeneticists, there is no obvious `epigene'. Nevertheless, during the past year, more than 2,500 articles, numerous scientific meetings and a new journal were devoted to the subject of epigenetics. It encompasses some of the most exciting contemporary biology and is portrayed by the popular press as a revolutionary new science - an antidote to the idea that we are hard-wired by our genes. So what is epigenetics?	Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland	University of Edinburgh	Bird, A (corresponding author), Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Kings Bldg, Edinburgh EH9 3JR, Midlothian, Scotland.	apbird@staffmail.ed.ac.uk		Bird, Adrian/0000-0002-8600-0372	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Cavalli G, 1998, CELL, V93, P505, DOI 10.1016/S0092-8674(00)81181-2; Chong SY, 2004, CURR OPIN GENET DEV, V14, P692, DOI 10.1016/j.gde.2004.09.001; Cubas P, 1999, NATURE, V401, P157, DOI 10.1038/43657; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Hong EJ, 2005, CURR OPIN NEUROBIOL, V15, P21, DOI 10.1016/j.conb.2005.01.002; JEGGO PA, 1986, MOL CELL BIOL, V6, P2944, DOI 10.1128/MCB.6.8.2944; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Kunkel TA, 2004, J BIOL CHEM, V279, P16895, DOI 10.1074/jbc.R400006200; Laird CD, 2004, P NATL ACAD SCI USA, V101, P204, DOI 10.1073/pnas.2536758100; Riggs A. D., 1996, EPIGENETIC MECH GENE, P29; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; SILVA AJ, 1993, DEV BIOL, V156, P391, DOI 10.1006/dbio.1993.1086; Sollars V, 2003, NAT GENET, V33, P70, DOI 10.1038/ng1067; Waddington C., 1957, STRATEGY GENES; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Wong AHC, 2005, HUM MOL GENET, V14, pR11, DOI 10.1093/hmg/ddi116	18	1813	1935	18	640	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 24	2007	447	7143					396	398		10.1038/nature05913	http://dx.doi.org/10.1038/nature05913			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	170VA	17522671	Bronze			2022-12-28	WOS:000246693100033
J	Visbeck, M				Visbeck, Martin			Oceanography - Power of pull	NATURE			English	Editorial Material									Univ Kiel, Leibniz Inst Marine Sci, D-24105 Kiel, Germany	Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; University of Kiel	Visbeck, M (corresponding author), Univ Kiel, Leibniz Inst Marine Sci, Dusternbrooker Weg 20, D-24105 Kiel, Germany.		Visbeck, Martin/G-2461-2011; zhu, xiaoting/E-9873-2011; Visbeck, Martin H/B-6541-2016	Visbeck, Martin/0000-0002-0844-834X; Visbeck, Martin H/0000-0002-0844-834X					0	22	23	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 24	2007	447	7143					383	383		10.1038/447383a	http://dx.doi.org/10.1038/447383a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	170VA	17522660	Bronze			2022-12-28	WOS:000246693100023
J	[Anonymous]				[Anonymous]			A new institute for global health evaluations	LANCET			English	Editorial Material																			0	7	7	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 9	2007	369	9577					1902	1902		10.1016/S0140-6736(07)60792-2	http://dx.doi.org/10.1016/S0140-6736(07)60792-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	177IQ	17560426				2022-12-28	WOS:000247147200002
J	Murray, C; Lu, CL; Michaud, C				Murray, Christopher; Lu, Chunling; Michaud, Catherine			The performance of the Global Fund	LANCET			English	Editorial Material							CAPACITY		Harvard Initiat Global Hlth, Cambridge, MA 02138 USA	Harvard University	Murray, C (corresponding author), Harvard Initiat Global Hlth, Cambridge, MA 02138 USA.	christopher_murray@harvard.edu						Bhutta ZA, 2006, LANCET, V368, P428, DOI 10.1016/S0140-6736(06)69129-0; Lu C, 2006, LANCET, V368, P483, DOI 10.1016/S0140-6736(06)69156-3; *MEASURE DHS MACR, DEM HLTH SURV; Radelet S, 2007, LANCET, V369, P1807, DOI 10.1016/S0140-6736(07)60818-6; United Nations Children's Fund (UNICEF), MULT IND CLUST SURV	5	7	7	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 26	2007	369	9575					1768	1769		10.1016/S0140-6736(07)60792-2	http://dx.doi.org/10.1016/S0140-6736(07)60792-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	172QP	17560426				2022-12-28	WOS:000246819300006
